Citrus Sinensis ID: 011508

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480----
Protein Sequence
MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMSCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVKNVRGQPATYVTA
Secondary Structure (PSIPRED)
cccccccccccHHHHccccccEEEcccccccccccHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHcccccccHHHHHHHHcccccccEEEcccccEEEEEEEcccccccEEEEEEEEcccccccHHHHHHHHHHHcccccccccEEEEccccccccccEEEEEEcccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHHcccccccccccccccccccccccHHcccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHcccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEcccccccccccccccccccEEEEcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccHHHHHccccEEcHHHHHHHHccccHccEEccccccEEEEEEccccccEEEEEEEEcccccccccHHHHHHHHHHHHHHHHHHHHHHcccccccccccccEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEccccHHHEEccccccEEEccHcHHHHccccccccccccEEEEEEEcccccccHHHHccccccccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHcHHHHccHHHccccccccHHHHHccccccccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHHccccccccccccEEEcc
Coil and Loop (DISEMBL)
mngnffqgnipsslsslrgienldlsqnnlsgripkylenfpflqnlnlsfnhfegevpikgvfsnssaisldgnvnlcggiselhlctcstkeskqsrSRSLKLIIPIVTGILFLTGMSCLIITswwsktkrepstppsALLASVLRVSYQNLfkatdgfslenligagsfgsvykgifdhddhETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHycetpivhcdlkpsnvlldgeltAHVSDFGLAKFLPeaannlssnqsssvgvkgtvgyaapeygmgsevstsgdvySFGILLLEMftgkgptnemftgnltlhnFVKEALPERLAEIVDPvllvereegetseanahkqrtrsfggkecLVSVLGIGvicsselprerMNMEEVAAQLLSFRNKLVknvrgqpatyvta
Flexible Loop (DISEMBL)
mngnffqgnipsslsSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCGGISELHLCTCSTkeskqsrsrslKLIIPIVTGILFLTGMSCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANnlssnqsssvgvKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEreegetseanahkqrtrsfggkecLVSVLGIGVICSSELPRERMNMEEVAAQLLSfrnklvknvrgqpatyvta
Low Complexity Region (SEG)
MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMSCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAnnlssnqsssVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVKNVRGQPATYVTA
Disordered region (IsUnstruct)
****************************NLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCGGISELHLCTCS**********SLKLIIPIVTGILFLTGMSCLIITSWWSK**********ALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP***************VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLV*******************FGGKECLVSVLGIGVICSSEL********EVAAQLLSFRNKLVK************
Disordered Region (DISOPRED)
MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCGGIS*********************LIIPIVTGILFLTGMSCLIITS********************LRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE*************GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEG***********TRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL**************
Disordered Region (DISEMBL)
MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCGGISELHLCT************SLKLIIPIVTGILFLTGMSCLIITSWWSK*********SALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREE***************FGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVKNVRGQPATYVTA
Disordered Region (DISPRO)
**GNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCGGISELHLCTCSTK*****RSRSLKLIIPIVTGILFLTGMSCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR*****************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMSCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVKNVRGQPATYVTA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	484	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	yes	no	0.946	0.453	0.491	1e-124
C0LGT6	1031	LRR receptor-like serine/	no	no	0.913	0.428	0.474	1e-115
Q9SD62	1025	Putative receptor-like pr	no	no	0.944	0.445	0.486	1e-112
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.911	0.45	0.375	2e-75
Q9FL28	1173	LRR receptor-like serine/	no	no	0.915	0.377	0.347	2e-64
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.904	0.349	0.326	2e-57
Q9LYN8	1192	Leucine-rich repeat recep	no	no	0.865	0.351	0.329	3e-57
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.892	0.345	0.328	3e-56
O22476	1196	Protein BRASSINOSTEROID I	no	no	0.809	0.327	0.333	5e-54
Q9ZPS9	1143	Serine/threonine-protein	no	no	0.921	0.390	0.317	2e-53

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  446 bits (1146), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 240/488 (49%), Positives = 321/488 (65%), Gaps = 30/488 (6%)

Query: 1    MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
            + GN F G+IP  L  L G++ +DLS N+LSG IP+Y  +F  L+ LNLSFN+ EG+VP+
Sbjct: 536  LEGNLFYGDIPD-LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPV 594

Query: 61   KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKES---KQSRSRSLKLIIPIVTGILFLT 117
            KG+F N++ +S+ GN +LCGGI    L  C ++     K+  SR  K++I +  GI  L 
Sbjct: 595  KGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLL 654

Query: 118  GMSCLIITSWW---SKTKREPSTP-PSALLASVLRVSYQNLFKATDGFSLENLIGAGSFG 173
             +    +T  W    K  +E + P PS L     ++SY +L  AT+GFS  N++G+GSFG
Sbjct: 655  LLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFG 714

Query: 174  SVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ 233
            +VYK +   +  + +VAVKVLN+Q RGA KSF+AEC++L+ IRHRNLVK++T+C S+DFQ
Sbjct: 715  TVYKALLLTE--KKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQ 772

Query: 234  GNDFEALVYELMVNGSLEEWLH------LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC 287
            GN+F AL+YE M NGSL+ WLH      ++R + R L LL+RL+IA+DVAS L+YLH +C
Sbjct: 773  GNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPS-RTLTLLERLNIAIDVASVLDYLHVHC 831

Query: 288  ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE 347
              PI HCDLKPSNVLLD +LTAHVSDFGLA+ L +       NQ SS GV+GT+GYAAPE
Sbjct: 832  HEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPE 891

Query: 348  YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVL 407
            YG+G + S +GDVYSFGILLLEMFTGK PTNE+F GN TL+++ K ALPER+ +IVD   
Sbjct: 892  YGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVD--- 948

Query: 408  LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR 467
                      E+  H      F   ECL  V  +G+ C  E P  R+    V  +L+S R
Sbjct: 949  ----------ESILHIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998

Query: 468  NKLVKNVR 475
             +  K  R
Sbjct: 999  ERFFKASR 1006

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  416 bits (1070), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 230/485 (47%), Positives = 301/485 (62%), Gaps = 43/485 (8%)

Query: 1    MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
            M GN F G IP  +S L  ++N+D S NNLSGRIP+YL + P L+NLNLS N FEG VP 
Sbjct: 544  MQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPT 602

Query: 61   KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMS 120
             GVF N++A+S+ GN N+CGG+ E+ L  C  + S + R + L +   +V+GI       
Sbjct: 603  TGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKR-KPLSVRKKVVSGICIGIASL 661

Query: 121  CLIIT----SWWSKTKRE----PSTPPSALLASVL--RVSYQNLFKATDGFSLENLIGAG 170
             LII      W+ K K++       P  +    +   +VSY+ L  AT  FS  NLIG+G
Sbjct: 662  LLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSG 721

Query: 171  SFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSV 230
            +FG+V+KG+   ++   LVAVKVLNL   GA+KSF+AEC+  + IRHRNLVK+IT C S+
Sbjct: 722  NFGNVFKGLLGPENK--LVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSL 779

Query: 231  DFQGNDFEALVYELMVNGSLEEWLHLN-----RDAPRNLNLLQRLSIAVDVASTLEYLHH 285
            D +GNDF ALVYE M  GSL+ WL L       D  R+L   ++L+IA+DVAS LEYLH 
Sbjct: 780  DSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHV 839

Query: 286  YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAA 345
            +C  P+ HCD+KPSN+LLD +LTAHVSDFGLA+ L +       NQ SS GV+GT+GYAA
Sbjct: 840  HCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAA 899

Query: 346  PEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDP 405
            PEYGMG + S  GDVYSFGILLLEMF+GK PT+E F G+  LH++ K  L          
Sbjct: 900  PEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL---------- 949

Query: 406  VLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS 465
                    G TS   ++          E L  VL +G+ CS E PR+RM  +E   +L+S
Sbjct: 950  -------SGCTSSGGSNAI-------DEGLRLVLQVGIKCSEEYPRDRMRTDEAVRELIS 995

Query: 466  FRNKL 470
             R+K 
Sbjct: 996  IRSKF 1000

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  404 bits (1039), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 237/487 (48%), Positives = 306/487 (62%), Gaps = 30/487 (6%)

Query: 1    MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
            + GN F G IP  +  L G+  LDLS+NNLSG IP+Y+ NF  LQNLNLS N+F+G VP 
Sbjct: 552  LQGNSFVGPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPT 610

Query: 61   KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMS 120
            +GVF N+SA+S+ GN+NLCGGI  L L  CS +  ++  S    + I +   +  L  + 
Sbjct: 611  EGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLC 670

Query: 121  CLIITSWWSKTK--------REPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSF 172
              ++   W K +         E     S + +   ++SY  L+K T GFS  NLIG+G+F
Sbjct: 671  LCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGNF 730

Query: 173  GSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDF 232
            G+V+KG     +    VA+KVLNL  RGA+KSFIAEC+AL  IRHRNLVK++T C S DF
Sbjct: 731  GAVFKGFLGSKNKA--VAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSDF 788

Query: 233  QGNDFEALVYELMVNGSLEEWLHLNR-----DAPRNLNLLQRLSIAVDVASTLEYLHHYC 287
            +GNDF ALVYE M NG+L+ WLH +      +  R L L  RL+IA+DVAS L YLH YC
Sbjct: 789  EGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTYC 848

Query: 288  ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE 347
              PI HCD+KPSN+LLD +LTAHVSDFGLA+ L +   +    Q SS GV+GT+GYAAPE
Sbjct: 849  HNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAPE 908

Query: 348  YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA-EIVDPV 406
            YGMG   S  GDVYSFGI+LLE+FTGK PTN++F   LTLH+F K AL +R A +I D  
Sbjct: 909  YGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITD-- 966

Query: 407  LLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF 466
                    ET    A+ Q    F   ECL  V  +GV CS E P  R++M E  ++L+S 
Sbjct: 967  --------ETILRGAYAQH---FNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVSI 1015

Query: 467  RNKLVKN 473
            R    ++
Sbjct: 1016 RESFFRD 1022

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  283 bits (725), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 177/472 (37%), Positives = 261/472 (55%), Gaps = 31/472 (6%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
           N F   +PSSL  L  ++ LD+S N L+G IP   +    L++LN SFN   G V  KG 
Sbjct: 501 NGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGS 560

Query: 64  FSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMSCLI 123
           FS  +  S  G+  LCG I  +  C    K+ K        L+  I T +L + G   + 
Sbjct: 561 FSKLTIESFLGDSLLCGSIKGMQACK---KKHKYPSVLLPVLLSLIATPVLCVFGYPLVQ 617

Query: 124 ITSW------WSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYK 177
            + +      ++K + E     +       R+SYQ L  AT GF+  +LIG+G FG VYK
Sbjct: 618 RSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYK 677

Query: 178 GIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND 236
           G+  ++   T VAVKVL+ +     S SF  ECQ L+  RHRNL++IIT+C         
Sbjct: 678 GVLRNN---TKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTC-----SKPG 729

Query: 237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDL 296
           F ALV  LM NGSLE  L+    + +NL+L+Q ++I  DVA  + YLHHY    +VHCDL
Sbjct: 730 FNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDL 789

Query: 297 KPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG-----VKGTVGYAAPEYGMG 351
           KPSN+LLD E+TA V+DFG+++ +      +S++ S S G     + G+VGY APEYGMG
Sbjct: 790 KPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMG 849

Query: 352 SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVER 411
              ST GDVYSFG+LLLE+ +G+ PT+ +     +LH F+K   P+ L  I++  L   +
Sbjct: 850 KRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWK 909

Query: 412 EEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL 463
            +G+  +             +E ++ ++ +G++C+   P  R +M +VA ++
Sbjct: 910 PQGKPEKCEKL--------WREVILEMIELGLVCTQYNPSTRPDMLDVAHEM 953

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  246 bits (629), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 165/475 (34%), Positives = 257/475 (54%), Gaps = 32/475 (6%)

Query: 4    NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
            N F G IP S  ++  + +LDLS NNL+G IP+ L N   L++L L+ N+ +G VP  GV
Sbjct: 708  NSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPESGV 767

Query: 64   FSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLII-----PIVTGILFLTG 118
            F N +A  L GN +LCG    L  CT   K S  S+   + LII      ++  +L +  
Sbjct: 768  FKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLLVLI 827

Query: 119  MSCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKG 178
            ++C        +   E S P       + R   + L +ATD F+  N+IG+ S  +VYKG
Sbjct: 828  LTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTVYKG 887

Query: 179  IFDHDDHETLVAVKVLNLQHRGA--SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND 236
              +     T++AVKVLNL+   A   K F  E + L  ++HRNLVKI+       ++   
Sbjct: 888  QLEDG---TVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWESGK 940

Query: 237  FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDL 296
             +ALV   M NG+LE+ +H    AP   +LL+++ + V +AS ++YLH     PIVHCDL
Sbjct: 941  TKALVLPFMENGNLEDTIH-GSAAPIG-SLLEKIDLCVHIASGIDYLHSGYGFPIVHCDL 998

Query: 297  KPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVST 356
            KP+N+LLD +  AHVSDFG A+ L    +   S  +S+   +GT+GY APE+    +V+T
Sbjct: 999  KPANILLDSDRVAHVSDFGTARILGFRED--GSTTASTSAFEGTIGYLAPEFAYMRKVTT 1056

Query: 357  SGDVYSFGILLLEMFTGKGPT--NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEG 414
              DV+SFGI+++E+ T + PT  N+  + ++TL   V++++      +V    +++ E G
Sbjct: 1057 KADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVR---VLDMELG 1113

Query: 415  ETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK 469
            ++           S   +E +   L + + C+S  P +R +M E+   L+  R K
Sbjct: 1114 DS---------IVSLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEILTHLMKLRGK 1159

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  223 bits (568), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 163/500 (32%), Positives = 246/500 (49%), Gaps = 62/500 (12%)

Query: 4    NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
            N F G IPS++S+L  +E+LDLS N L G +P  + +   L  LNLS+N+ EG+  +K  
Sbjct: 779  NNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGK--LKKQ 836

Query: 64   FSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMSCLI 123
            FS   A +  GN  LCG      L  C+   SK  RS S K ++ I++ I  L  ++ ++
Sbjct: 837  FSRWQADAFVGNAGLCGS----PLSHCNRAGSKNQRSLSPKTVV-IISAISSLAAIALMV 891

Query: 124  IT---------SWWSKTK----------REPSTPPSALLASVLRVSYQNLFKATDGFSLE 164
            +            + K +               P  +   +   + + ++ +AT   + E
Sbjct: 892  LVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEE 951

Query: 165  NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
             +IG+G  G VYK   +  + ET+   K+L      ++KSF  E + L +IRHR+LVK++
Sbjct: 952  FMIGSGGSGKVYKA--ELKNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLM 1009

Query: 225  TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN--LNLLQRLSIAVDVASTLEY 282
              C S   + +    L+YE M NGS+ +WLH N +  +   L    RL IA+ +A  +EY
Sbjct: 1010 GYCSS---KADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEY 1066

Query: 283  LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
            LH+ C  PIVH D+K SNVLLD  + AH+ DFGLAK L     N  +N  S+    G+ G
Sbjct: 1067 LHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKIL---TGNYDTNTESNTMFAGSYG 1123

Query: 343  YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL-----PE 397
            Y APEY    + +   DVYS GI+L+E+ TGK PT  MF     +  +V+  L      E
Sbjct: 1124 YIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSE 1183

Query: 398  RLAEIVDPVL--LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN 455
               +++D  L  L+  EE                   E    VL I + C+   P+ER +
Sbjct: 1184 AREKLIDSELKSLLPCEE-------------------EAAYQVLEIALQCTKSYPQERPS 1224

Query: 456  MEEVAAQLLSFRNKLVKNVR 475
              + +  LL+  N    + R
Sbjct: 1225 SRQASEYLLNVFNNRAASYR 1244

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1

 Score =  223 bits (567), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 164/497 (32%), Positives = 243/497 (48%), Gaps = 78/497 (15%)

Query: 4    NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
            N F G IPS L +L  +E LD+S+N LSG IP  +   P L+ LNL+ N+  GEVP  GV
Sbjct: 734  NKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGV 793

Query: 64   FSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMSCLI 123
              + S   L GN  LCG +       C  + +K   +  +  ++   T I+F+   S   
Sbjct: 794  CQDPSKALLSGNKELCGRVVG---SDCKIEGTKLRSAWGIAGLMLGFTIIVFVFVFSL-- 848

Query: 124  ITSWWSKTKR--------------------------------EPSTPPSALLAS-VLRVS 150
                W+ TKR                                EP +   A+    +L+V 
Sbjct: 849  --RRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVR 906

Query: 151  YQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQ 210
              ++ +ATD FS +N+IG G FG+VYK        E  VAVK L+      ++ F+AE +
Sbjct: 907  LGDIVEATDHFSKKNIIGDGGFGTVYKACLPG---EKTVAVKKLSEAKTQGNREFMAEME 963

Query: 211  ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
             L  ++H NLV ++  C       ++ + LVYE MVNGSL+ WL         L+  +RL
Sbjct: 964  TLGKVKHPNLVSLLGYC-----SFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRL 1018

Query: 271  SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSN 330
             IAV  A  L +LHH     I+H D+K SN+LLDG+    V+DFGLA+ +    +++S+ 
Sbjct: 1019 KIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTV 1078

Query: 331  QSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFT----GNLT 386
                  + GT GY  PEYG  +  +T GDVYSFG++LLE+ TGK PT   F     GNL 
Sbjct: 1079 ------IAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNL- 1131

Query: 387  LHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICS 446
            +   +++    +  +++DP+L+                   S   K   + +L I ++C 
Sbjct: 1132 VGWAIQKINQGKAVDVIDPLLV-------------------SVALKNSQLRLLQIAMLCL 1172

Query: 447  SELPRERMNMEEVAAQL 463
            +E P +R NM +V   L
Sbjct: 1173 AETPAKRPNMLDVLKAL 1189

Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  219 bits (559), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 163/496 (32%), Positives = 241/496 (48%), Gaps = 64/496 (12%)

Query: 4    NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
            N F G+IPS++ +L  +E LDLS N L+G +P  + +   L  LN+SFN+  G+  +K  
Sbjct: 778  NNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGK--LKKQ 835

Query: 64   FSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMSCLI 123
            FS   A S  GN  LCG  S L  C      +KQ    +  ++I      L   G+  L+
Sbjct: 836  FSRWPADSFLGNTGLCG--SPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILV 893

Query: 124  ITSWWSK--------------------TKREPSTPPSALLASVLRVSYQNLFKATDGFSL 163
            I  ++ +                    + +    P     AS   + ++++ +AT   S 
Sbjct: 894  IALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSE 953

Query: 164  ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKI 223
            E +IG+G  G VYK   + ++ ET+   K+L      ++KSF  E + L  IRHR+LVK+
Sbjct: 954  EFMIGSGGSGKVYKA--ELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKL 1011

Query: 224  ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP------RNLNLLQRLSIAVDVA 277
            +  C S   +      L+YE M NGS+ +WLH   D P      + L+   RL IAV +A
Sbjct: 1012 MGYCSS---KSEGLNLLIYEYMKNGSIWDWLH--EDKPVLEKKKKLLDWEARLRIAVGLA 1066

Query: 278  STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
              +EYLHH C  PIVH D+K SNVLLD  + AH+ DFGLAK L E   N  +N  S+   
Sbjct: 1067 QGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTE---NCDTNTDSNTWF 1123

Query: 338  KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK---EA 394
              + GY APEY    + +   DVYS GI+L+E+ TGK PT+ +F   + +  +V+   E 
Sbjct: 1124 ACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEV 1183

Query: 395  LPERLAEIVDPVL--LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRE 452
                  +++DP L  L+  EE                   +    VL I + C+   P+E
Sbjct: 1184 AGSARDKLIDPKLKPLLPFEE-------------------DAACQVLEIALQCTKTSPQE 1224

Query: 453  RMNMEEVAAQLLSFRN 468
            R +  +    LL   N
Sbjct: 1225 RPSSRQACDSLLHVYN 1240

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1

 Score =  212 bits (540), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 149/447 (33%), Positives = 216/447 (48%), Gaps = 55/447 (12%)

Query: 4    NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
            N   G+IP  +  LRG+  LDLS N L GRIP+ +     L  ++LS N+  G +P  G 
Sbjct: 688  NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ 747

Query: 64   FSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRS-----LKLIIPIVTGILF-LT 117
            F          N  LCG    L  C  S  +      RS       L   +  G+LF   
Sbjct: 748  FETFPPAKFLNNPGLCG--YPLPRCDPSNADGYAHHQRSHGRRPASLAGSVAMGLLFSFV 805

Query: 118  GMSCLII---------------------------------TSW-WSKTKREPSTPPSALL 143
             +  LI+                                 T+W  +  K   S   +A  
Sbjct: 806  CIFGLILVGREMRKRRRKKEAELEMYAEGHGNSGDRTANNTNWKLTGVKEALSINLAAFE 865

Query: 144  ASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK 203
              + ++++ +L +AT+GF  ++LIG+G FG VYK I    D   +   K++++  +G  +
Sbjct: 866  KPLRKLTFADLLQATNGFHNDSLIGSGGFGDVYKAILK--DGSAVAIKKLIHVSGQG-DR 922

Query: 204  SFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN 263
             F+AE + +  I+HRNLV ++  C     +  D   LVYE M  GSLE+ LH  + A   
Sbjct: 923  EFMAEMETIGKIKHRNLVPLLGYC-----KVGDERLLVYEFMKYGSLEDVLHDPKKAGVK 977

Query: 264  LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA 323
            LN   R  IA+  A  L +LHH C   I+H D+K SNVLLD  L A VSDFG+A+ +   
Sbjct: 978  LNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAM 1037

Query: 324  ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG 383
              +LS +      + GT GY  PEY      ST GDVYS+G++LLE+ TGK PT+    G
Sbjct: 1038 DTHLSVST-----LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFG 1092

Query: 384  NLTLHNFVKEALPERLAEIVDPVLLVE 410
            +  L  +VK+    R++++ DP L+ E
Sbjct: 1093 DNNLVGWVKQHAKLRISDVFDPELMKE 1119

Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1

 Score =  210 bits (534), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 160/504 (31%), Positives = 239/504 (47%), Gaps = 58/504 (11%)

Query: 4    NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
            N   G IP ++  L+ +   D S N L G+IP+   N  FL  ++LS N   G +P +G 
Sbjct: 645  NQLSGEIPFTIGQLKNLGVFDASDNRLQGQIPESFSNLSFLVQIDLSNNELTGPIPQRGQ 704

Query: 64   FSNSSAISLDGNVNLCG--------GISELHLCTCSTKESKQSRSRSLKLIIPIVTGILF 115
             S   A     N  LCG        G ++L   T   K +K   +R+      IV G+L 
Sbjct: 705  LSTLPATQYANNPGLCGVPLPECKNGNNQLPAGTEEGKRAKHG-TRAASWANSIVLGVLI 763

Query: 116  LTGMSCLII----------------------------TSWWSKTKREPSTPPSALLASVL 147
                 C++I                            T+W  + ++EP +   A     L
Sbjct: 764  SAASVCILIVWAIAVRARRRDADDAKMLHSLQAVNSATTWKIEKEKEPLSINVATFQRQL 823

Query: 148  R-VSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFI 206
            R + +  L +AT+GFS  ++IG G FG V+K      D  ++   K++ L  +G  + F+
Sbjct: 824  RKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLK--DGSSVAIKKLIRLSCQG-DREFM 880

Query: 207  AECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR--DAPRNL 264
            AE + L  I+HRNLV ++  C     +  +   LVYE M  GSLEE LH  R  +  R L
Sbjct: 881  AEMETLGKIKHRNLVPLLGYC-----KIGEERLLVYEFMQYGSLEEVLHGPRTGEKRRIL 935

Query: 265  NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAA 324
               +R  IA   A  L +LHH C   I+H D+K SNVLLD ++ A VSDFG+A+ +    
Sbjct: 936  GWEERKKIAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDMEARVSDFGMARLISALD 995

Query: 325  NNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
             +LS +      + GT GY  PEY      +  GDVYS G+++LE+ +GK PT++   G+
Sbjct: 996  THLSVST-----LAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEILSGKRPTDKEEFGD 1050

Query: 385  LTLHNFVK-EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGV 443
              L  + K +A   +  E++D  LL   +EG +   N  +        KE ++  L I +
Sbjct: 1051 TNLVGWSKMKAREGKHMEVIDEDLL---KEGSSESLNEKEGFEGGVIVKE-MLRYLEIAL 1106

Query: 444  ICSSELPRERMNMEEVAAQLLSFR 467
             C  + P +R NM +V A L   R
Sbjct: 1107 RCVDDFPSKRPNMLQVVASLRELR 1130

Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	484
359486510	965	PREDICTED: probable LRR receptor-like se	0.952	0.477	0.614	1e-160
359482058	1040	PREDICTED: probable LRR receptor-like se	0.962	0.448	0.582	1e-152
147853780	1904	hypothetical protein VITISV_030954 [Viti	0.962	0.244	0.580	1e-150
255581223	1015	receptor-kinase, putative [Ricinus commu	0.954	0.455	0.568	1e-149
224113117	1006	predicted protein [Populus trichocarpa]	0.969	0.466	0.563	1e-145
255570308	1033	receptor-kinase, putative [Ricinus commu	0.946	0.443	0.556	1e-144
449441592	1023	PREDICTED: probable LRR receptor-like se	0.946	0.447	0.557	1e-143
224121660	774	predicted protein [Populus trichocarpa]	0.977	0.611	0.552	1e-143
255586722	936	serine-threonine protein kinase, plant-t	0.944	0.488	0.568	1e-142
449499190	1023	PREDICTED: LOW QUALITY PROTEIN: probable	0.948	0.448	0.552	1e-141

>gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera]

 Score =  572 bits (1475), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 292/475 (61%), Positives = 360/475 (75%), Gaps = 14/475 (2%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           M GNFFQG+IPSS SSLRGI  LDLS NNLSG+IP++L++  F Q +NLS+N FEG +P 
Sbjct: 480 MKGNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIHF-QLVNLSYNDFEGILPT 538

Query: 61  KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKE-SKQSRSRSLKLIIPIVTGILFLTGM 119
           +GVF N SA S+ GN  LCGGI E  L  C+ +E  K+  S +LK+II  V+G+L +T +
Sbjct: 539 EGVFKNVSATSIMGNSKLCGGIPEFQLPKCNLQEPKKRGLSLALKIIIATVSGLLAITCV 598

Query: 120 SCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGI 179
              +I  W  K K EP++  S+   S+L+VSYQ+L +ATDGFS  NLIG GSFGSVYKGI
Sbjct: 599 LSFLIFLWLRKKKGEPAS--SSSEKSLLKVSYQSLLRATDGFSSSNLIGVGSFGSVYKGI 656

Query: 180 FDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA 239
            DHD   T +AVKVLNL  +GASKSFIAEC+ALR+IRHRNLVK++T+C  VD+QGNDF+A
Sbjct: 657 LDHDG--TAIAVKVLNLLRKGASKSFIAECEALRNIRHRNLVKVLTACSGVDYQGNDFKA 714

Query: 240 LVYELMVNGSLEEWLHLNRDA------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVH 293
           +VYE MVNGSLE+WLH           PR LN LQRL+IA+DVA  L+YLHH C+TPIVH
Sbjct: 715 VVYEFMVNGSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAIDVACALDYLHHQCQTPIVH 774

Query: 294 CDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE 353
           CDLKPSNVLLD E+T HV DFG+AKFLPEAA  +   QSSS+G++GT+GYAAPEYGMGSE
Sbjct: 775 CDLKPSNVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAAPEYGMGSE 834

Query: 354 VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREE 413
           VSTSGDVYSFGILLLEMFTGK PT +MF  +L +HNFVK A+PER+AEI DPVLL  +E 
Sbjct: 835 VSTSGDVYSFGILLLEMFTGKRPTEDMFKDSLNIHNFVKTAVPERVAEIADPVLL--QEG 892

Query: 414 GETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN 468
            E     + ++   S   +ECL+S+ GIG+ CS+ELPRER N+ + AA+L S R+
Sbjct: 893 VEMDNTTSQRRMASSHDAQECLISIFGIGLACSAELPRERKNITDAAAELNSVRD 947

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  543 bits (1400), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 283/486 (58%), Positives = 353/486 (72%), Gaps = 20/486 (4%)

Query: 1    MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
            M GNFF+G+IP S  SLRG+ +LDLS+NNLSG+IP++L+    L NLNLSFN+FEG++P 
Sbjct: 553  MEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPT 611

Query: 61   KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRS-RSLKLIIPIVTGILFLTGM 119
            KGVF+N+++ S+ GN  LCGGI ELHL  C   + K   S R LKL+I ++TG L L  +
Sbjct: 612  KGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLI 671

Query: 120  SCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGI 179
              L++ +   + KREPS   ++    +L VSY  LFKAT GFS  NLIG G FGSVYKGI
Sbjct: 672  MSLLVINRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGI 731

Query: 180  FDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA 239
               D  ET+VAVKV+ L  RGA KSF AEC+ALR+IRHRNLVK++T+C SVD+QGNDF+A
Sbjct: 732  LGQD--ETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKA 789

Query: 240  LVYELMVNGSLEEWLH-------LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIV 292
            LVYE M NGSLE WLH       +N D  R L+L QRL+IA+DVAS L+YLHH+C  PIV
Sbjct: 790  LVYEFMPNGSLENWLHPVPTPDEIN-DVLRILSLPQRLNIAIDVASALDYLHHHCHKPIV 848

Query: 293  HCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS 352
            HCDLKPSN+LLD ++TAHV DFGLA+F+PEAA     +QSSS+G+KGT+GYAAPEYGMG+
Sbjct: 849  HCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGT 908

Query: 353  EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLL-VER 411
            +VS  GD YS+GILLLEMFTGK PT  MF+  L LHNFVK ALPER+A+I+DP  L  E 
Sbjct: 909  KVSALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEA 968

Query: 412  EEGETSEAN----AHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR 467
            +E ET+ A+    AH +R +     ECL+S+L IGV CS E PRERM + E   +L   R
Sbjct: 969  KEEETTAADSSNLAHMKREKM---HECLISILRIGVSCSLESPRERMAITEAIKELQLIR 1025

Query: 468  NKLVKN 473
              L+ N
Sbjct: 1026 KILLGN 1031

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera]

 Score =  539 bits (1388), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 282/486 (58%), Positives = 352/486 (72%), Gaps = 20/486 (4%)

Query: 1    MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
            M GNFF+G+IP S  SLRG+ +LDLS+NNLSG+IP++L+    L NLNLSFN+FEG++P 
Sbjct: 584  MEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNFEGQLPT 642

Query: 61   KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRS-RSLKLIIPIVTGILFLTGM 119
            KGVF+N+++ S+ GN  LCGGI ELHL  C   + K   S R LKL+I ++TG L L  +
Sbjct: 643  KGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGFLGLVLI 702

Query: 120  SCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGI 179
              L++ +   + KREPS   ++    +L VSY  LFKAT GFS  NLIG G FGSVYKG 
Sbjct: 703  MSLLVINRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGX 762

Query: 180  FDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA 239
               D  ET+VAVKV+ L  RGA KSF AEC+ALR+IRHRNLVK++T+C SVD+QGNDF+A
Sbjct: 763  LGQD--ETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKA 820

Query: 240  LVYELMVNGSLEEWLH-------LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIV 292
            LVYE M NGSLE WLH       +N D  R L+L QRL+IA+DVAS L+YLHH+C  PIV
Sbjct: 821  LVYEFMPNGSLENWLHPVPTPDEIN-DVLRILSLPQRLNIAIDVASALDYLHHHCHKPIV 879

Query: 293  HCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS 352
            HCDLKPSN+LLD ++TAHV DFGLA+F+PEAA     +QSSS+G+KGT+GYAAPEYGMG+
Sbjct: 880  HCDLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGT 939

Query: 353  EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLL-VER 411
            +VS  GD YS+GILLLEMFTGK PT  MF+  L LHNFVK ALPER+A+I+DP  L  E 
Sbjct: 940  KVSALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEA 999

Query: 412  EEGETSEAN----AHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR 467
            +E ET+ A+    AH +R +     ECL+S+L IGV CS E PRERM + E   +L   R
Sbjct: 1000 KEEETTAADSSNLAHMKREKM---HECLISILRIGVSCSLESPRERMAITEAIKELQLIR 1056

Query: 468  NKLVKN 473
              L+ N
Sbjct: 1057 KILLGN 1062

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255581223|ref|XP_002531424.1| receptor-kinase, putative [Ricinus communis] gi|223528974|gb|EEF30966.1| receptor-kinase, putative [Ricinus communis]

 Score =  534 bits (1375), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 271/477 (56%), Positives = 349/477 (73%), Gaps = 15/477 (3%)

Query: 1    MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
            + GNFF G +PSSLSSLRG+  LD S NNLSG IP++L++F  L++LNLS+N+FEG VP+
Sbjct: 545  LQGNFFDGLVPSSLSSLRGLRVLDFSSNNLSGEIPEFLQSFDLLESLNLSYNNFEGRVPV 604

Query: 61   KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMS 120
            +G+F N+S   + GN  LCGGI E HL  C+ K  K+  +  LK++I  +  +L L+ + 
Sbjct: 605  EGIFRNASTTLVMGNDKLCGGIPEFHLAKCNAKSPKK-LTLLLKIVISTICSLLGLSFIL 663

Query: 121  CLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIF 180
               +T W  K K EP++ P   L  +L VS+Q+L +ATDGFS  NLIG GSFG VYKG  
Sbjct: 664  IFALTFWLRKKKEEPTSDPYGHL--LLNVSFQSLLRATDGFSSANLIGRGSFGHVYKGFL 721

Query: 181  DHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEAL 240
            D  +    +AVKVLNL H GAS SFIAEC+ALR+IRHRNLVK++T+C  +D+QGNDF+AL
Sbjct: 722  DEGN--VTIAVKVLNLLHHGASTSFIAECEALRNIRHRNLVKVLTACSGIDYQGNDFKAL 779

Query: 241  VYELMVNGSLEEWLH-LNR----DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCD 295
            VYE MVNGSLEEWLH + R    + PR+LNLLQRL+IA+DVAS L+YLH+ C TPIVHCD
Sbjct: 780  VYEYMVNGSLEEWLHPIPRTEEVEPPRSLNLLQRLNIAIDVASALDYLHNQCTTPIVHCD 839

Query: 296  LKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVS 355
            LKPSNVLLD E+  HVSDFGLAK L E+ N+   +QSSS+GV+GTVG+A PEYG+GS VS
Sbjct: 840  LKPSNVLLDSEMNGHVSDFGLAKILSESTNSFPVSQSSSIGVRGTVGFAPPEYGVGSNVS 899

Query: 356  TSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGE 415
            T GDVYS+GILLLE+FTGK PT++MF  +L LHNF + A  ++LAE+ DP+LL E    E
Sbjct: 900  TYGDVYSYGILLLELFTGKRPTDDMFKEDLNLHNFAEIAFRDQLAEVADPILLQETAVRE 959

Query: 416  TSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVK 472
            T   +   QR      +ECL S+L IGV CS+E+P+ERM + +V   L + R+KLV+
Sbjct: 960  TRLNSRKCQRL-----EECLFSMLRIGVACSTEMPQERMKINDVVTGLHAIRDKLVR 1011

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa]

 Score =  521 bits (1342), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 272/483 (56%), Positives = 351/483 (72%), Gaps = 14/483 (2%)

Query: 1    MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
            + GNF QG+IP  LSSLR ++ L+LS NNL+G+IP++L +F  LQ L+LSFNH EGE+P 
Sbjct: 528  LEGNFLQGSIPELLSSLRALQYLNLSYNNLTGQIPRFLADFQLLQRLDLSFNHLEGEMPT 587

Query: 61   KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSR-SRSLKLIIPIVTGILFLTGM 119
            + VF N SA+S+ GN  LCGGIS+L+L  C++ E ++ + S  LKL+I I  G +    +
Sbjct: 588  QRVFGNVSAVSVLGNDKLCGGISQLNLSRCTSNELRKPKFSTKLKLVISIPCGFIIALLL 647

Query: 120  SCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGI 179
               ++   W KTK EP++  S  + S  RV+Y+ L++AT GFS  N IG GSFGSVYK I
Sbjct: 648  ISSLLIHSWRKTKNEPASGASWEV-SFRRVTYEELYQATGGFSSSNFIGGGSFGSVYKAI 706

Query: 180  FDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA 239
               D    +VAVKV NL  +GASKS++AEC AL +IRHRNLVKI+T+C S+DF+GNDF+A
Sbjct: 707  LAPDG--MIVAVKVFNLLRKGASKSYMAECAALINIRHRNLVKILTACSSLDFRGNDFKA 764

Query: 240  LVYELMVNGSLEEWLHL--NRDAPR---NLNLLQRLSIAVDVASTLEYLHHYCETPIVHC 294
            LVYE MVNGSLEEWLH     D  R   NLNL+QRL++A+DVAS L+YLH++C+  +VHC
Sbjct: 765  LVYEFMVNGSLEEWLHPVHTSDEEREQGNLNLIQRLNVAIDVASALDYLHYHCQMAVVHC 824

Query: 295  DLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV 354
            DLKPSNVLLDG++TAHV DFGLA+F PEA+  LSSNQ+SS+G+KGTVGYAAPEYG+G+EV
Sbjct: 825  DLKPSNVLLDGDMTAHVGDFGLARFRPEASVQLSSNQNSSIGLKGTVGYAAPEYGIGNEV 884

Query: 355  STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEG 414
            ST GDVYS+GILLLE+ TGK PT+  F   L LH +VK ALP+R+ E+VDP+LL E E+ 
Sbjct: 885  STYGDVYSYGILLLEILTGKTPTDGSFKEGLNLHKYVKMALPDRVVEVVDPILLREIEQ- 943

Query: 415  ETSEANAHKQRTRSFGGK--ECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVK 472
              + ANA     R    K  ECLVS++ +GV CS +LPRER N+  V A+L   R  L+ 
Sbjct: 944  --TSANASDGMKRIGNDKVLECLVSIMEVGVSCSVDLPRERTNISNVVAELHRIRGILLG 1001

Query: 473  NVR 475
              R
Sbjct: 1002 TRR 1004

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255570308|ref|XP_002526114.1| receptor-kinase, putative [Ricinus communis] gi|223534611|gb|EEF36308.1| receptor-kinase, putative [Ricinus communis]

 Score =  516 bits (1329), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 265/476 (55%), Positives = 347/476 (72%), Gaps = 18/476 (3%)

Query: 1    MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
            M  N F+G+IPSSLS+LRG++ +DLS NNLSG+IP++L +FPFLQ+LNLSFN FEG VP 
Sbjct: 548  MRDNSFKGSIPSSLSALRGLQVVDLSHNNLSGQIPEFLGSFPFLQSLNLSFNDFEGLVPT 607

Query: 61   KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMS 120
            +GVF N+S+ S+ GN  LCGG+S+ HL  C+ + S    +R LKL   I+  +  L G  
Sbjct: 608  EGVFKNASSTSVMGNNKLCGGVSDFHLLACNIRSST---NRRLKLK-AIIASVAVLLGAL 663

Query: 121  CLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIF 180
             ++      +++++   P  +    +LRVSYQNL  AT GFS  NLI  G FGSVY+G+ 
Sbjct: 664  LMLSFLLILRSRKKSQAPALSSEIPLLRVSYQNLHDATKGFSSSNLINVGGFGSVYQGVL 723

Query: 181  DHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEAL 240
                   LVAVKVLN+QH+ A+KSF+ EC+ L+SIRHRNLVK++T+C S+D+QGNDF+AL
Sbjct: 724  GESGQ--LVAVKVLNVQHQTAAKSFMVECEVLKSIRHRNLVKVLTACSSIDYQGNDFKAL 781

Query: 241  VYELMVNGSLEEWLHL-----NRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCD 295
            VYE MVNGSLEEWLH      + + P+ L+LLQRL+IA+D+AS LEYL ++CET IVHCD
Sbjct: 782  VYEFMVNGSLEEWLHPVVVDGSDEPPKKLDLLQRLNIAIDIASALEYLQNHCETTIVHCD 841

Query: 296  LKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVS 355
            LKPSNVLLD ELT HVSDFG+AKFL +  NN S+N SSSV ++GT+GYA PEYGMG +VS
Sbjct: 842  LKPSNVLLDAELTGHVSDFGIAKFLLKDNNNRSTNLSSSVQLRGTIGYAPPEYGMGGQVS 901

Query: 356  TSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGE 415
              GD+YS+GILLLEMFTGK PTN+MF   L LH F K ALP+ +AEI+DPVLL      E
Sbjct: 902  IFGDIYSYGILLLEMFTGKRPTNDMFKEGLNLHKFAKSALPDGVAEILDPVLL-----QE 956

Query: 416  TSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV 471
            + E ++   RT+     +CL+S++ IGV CS+ELP +R+   +VA +L S R+KL+
Sbjct: 957  SGEIDSRSIRTKKI--MDCLISIVDIGVSCSAELPGDRVCTSDVALKLSSIRSKLL 1010

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449441592|ref|XP_004138566.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus]

 Score =  514 bits (1325), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 262/470 (55%), Positives = 342/470 (72%), Gaps = 12/470 (2%)

Query: 1    MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
            ++GNF +G IP SLSSLRGIE LDLS+NNLSG+IP YL+ F  L  LNLSFN+ EGEVP 
Sbjct: 551  LDGNFLEGPIPESLSSLRGIEELDLSRNNLSGKIPTYLQEFEVLSYLNLSFNNLEGEVPT 610

Query: 61   KGVFSNSSAISLDGNVNLCGGISELHLCTCSTK-ESKQSRSRSLKLIIPIVTGIL-FLTG 118
            +GVF N++A S+ GN  LC GI+EL+L  C      KQ  +  LK+II +V+G++  L  
Sbjct: 611  QGVFKNTTAFSILGNKKLCNGINELNLPRCRLDYPRKQKLTTKLKIIISVVSGLVGALLI 670

Query: 119  MSCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKG 178
            + CL+   +WS+ K+  S    +L AS   VSY +L KAT+ FS +NLIG G +GSVYKG
Sbjct: 671  ICCLLF--FWSRKKKNKSDLSPSLKASYFAVSYNDLLKATNEFSPDNLIGVGGYGSVYKG 728

Query: 179  IFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE 238
            I   D  +++VAVKV NLQHRGASKSF+AEC+AL++IRHRNLV+I+++C  VDFQGNDF 
Sbjct: 729  ILSQD--KSVVAVKVFNLQHRGASKSFLAECEALKNIRHRNLVRILSACSGVDFQGNDFM 786

Query: 239  ALVYELMVNGSLEEWLH----LNRDAPR-NLNLLQRLSIAVDVASTLEYLHHYCETPIVH 293
            ALV++ MVNGSLE+WLH    LN++  +  LN++QRL IA+DVAS L+YLH+    PI H
Sbjct: 787  ALVFDFMVNGSLEKWLHPVDNLNQEGEKMYLNIMQRLDIAIDVASALDYLHNGSPMPIAH 846

Query: 294  CDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE 353
            CDLKPSNVLLD ++TAHV DFGLAKF+ E +    S +S S+G++GTVGYA PEY MGS+
Sbjct: 847  CDLKPSNVLLDADMTAHVGDFGLAKFMAETSFQNRSTESESIGIRGTVGYAPPEYAMGSK 906

Query: 354  VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREE 413
            +ST GDVYS+GILLLEMFTGK PT+ MF   LTL+N+V  ALPER+ EI DP + ++   
Sbjct: 907  ISTYGDVYSYGILLLEMFTGKSPTDNMFKDGLTLNNYVLTALPERVQEIADPTMGIQELN 966

Query: 414  GETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL 463
            G     N   +  +S   K+CL S+  IGV CS+++P +RMN+ +V +QL
Sbjct: 967  G-MGNNNLMFEANQSLRIKDCLFSIFSIGVACSTQMPNQRMNISDVVSQL 1015

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224121660|ref|XP_002330621.1| predicted protein [Populus trichocarpa] gi|222872225|gb|EEF09356.1| predicted protein [Populus trichocarpa]

 Score =  513 bits (1321), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 268/485 (55%), Positives = 352/485 (72%), Gaps = 12/485 (2%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           + GNFF+G+IP SLSSLR ++ LDLS NNLSG+IPK+L +   L++L+LSFN  EG+VP+
Sbjct: 284 LKGNFFKGSIPESLSSLRALKVLDLSYNNLSGQIPKFLGDLKLLESLDLSFNDLEGQVPV 343

Query: 61  KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMS 120
           +GVF N+S IS+ GN  LCGGI +L+L  C+T ES + +S +  LI+ +  G+L +  + 
Sbjct: 344 QGVFGNTSVISIAGNKKLCGGIPQLNLSRCTTNESAKLKSSTKILIVAMSGGLLVVILLV 403

Query: 121 CLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIF 180
             ++  ++ KTK   ++  S       RV+YQ+L  AT+ FS  N IG GSFGSVY+GI 
Sbjct: 404 SSMLFYFFRKTKDMQASSTSTWGIPFRRVAYQDLLLATNEFSSANSIGVGSFGSVYRGIL 463

Query: 181 DHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEAL 240
             D     VAVKVLNL  +GAS+SF+AEC AL +IRHRNLV+++++C S+DFQGNDF+A+
Sbjct: 464 PPDGMA--VAVKVLNLLRKGASRSFMAECAALVNIRHRNLVRVVSACSSIDFQGNDFKAI 521

Query: 241 VYELMVNGSLEEWLHL-----NRDAPRNLNLLQRLSIAVDVASTLEYLHHYC-ETPIVHC 294
           VYELMVNGSLEEWLH      N    R+LNL+QRL+I++DVA+ L YLH +C  TPIVHC
Sbjct: 522 VYELMVNGSLEEWLHPIHQPNNAQELRSLNLIQRLNISIDVANALNYLHQHCGSTPIVHC 581

Query: 295 DLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV 354
           DLKPSNVLL+ E+TA V DFGLA+  PE ++ LSS Q+SSVG+KGT+GYAAPEYG+GS+V
Sbjct: 582 DLKPSNVLLNAEMTACVGDFGLARLRPEVSHQLSSGQTSSVGLKGTIGYAAPEYGVGSDV 641

Query: 355 STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEG 414
           ST GDVYSFGILLLEMFTGK PT  MF   L LHN+ + AL  R++E+V+P+LL  RE+ 
Sbjct: 642 STYGDVYSFGILLLEMFTGKRPTEGMFKDGLNLHNYAEMALHGRVSEVVEPILL--REDV 699

Query: 415 ETSEANAHKQRTRSFGG-KECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV-K 472
           E S  ++H+      G   ECL+S++ IGV CS ELPRERM+M  V A+L   R+ L   
Sbjct: 700 ERSIHSSHRMNHIETGKILECLISIIKIGVACSVELPRERMDMSIVVAELHRIRDILSGT 759

Query: 473 NVRGQ 477
            +RGQ
Sbjct: 760 RIRGQ 764

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255586722|ref|XP_002533985.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526036|gb|EEF28405.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  511 bits (1315), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 274/482 (56%), Positives = 347/482 (71%), Gaps = 25/482 (5%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           M GN FQG IPSSL SL+ ++ LDLS NNLSG+IP++L     LQ LNLS N+FEG VP 
Sbjct: 471 MKGNNFQGLIPSSLGSLKALQVLDLSHNNLSGQIPEFLSQIVLLQ-LNLSHNNFEGPVPA 529

Query: 61  KGVFSNSSAISLDGNVNLCGGISELHLCTC-STKESKQSRSRSLKLIIPIVTGILFLTGM 119
           KGVF N SA SL+GN  LCGGI E HL  C ST+  K   + +L++++  V     L G+
Sbjct: 530 KGVFRNVSATSLEGNNKLCGGIPEFHLAPCISTRHKKSGLTHNLRIVVATVC---VLVGV 586

Query: 120 SCL--IITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYK 177
           + L  +I  ++ K KR   +  S      L +SY  L+KATDGFS  N +GAGSFG+V+K
Sbjct: 587 TLLLWVIVVFFLKKKRRKESSSSFSEKKALELSYHTLYKATDGFSSANTLGAGSFGTVFK 646

Query: 178 GIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF 237
           G  +    ET +AVKV NL   GA KSFIAEC+ALR+IRHRNLVK++T+C SVD+QGN+F
Sbjct: 647 G--ELGGGETSIAVKVFNLMRHGAFKSFIAECEALRNIRHRNLVKVLTACSSVDYQGNEF 704

Query: 238 EALVYELMVNGSLEEWLHLNRDA---PR-NLNLLQRLSIAVDVASTLEYLHHYCETPIVH 293
           +ALVYE MVNGSLEEWLH   +A   PR NLN+LQRL+IAVDVA  L+YLH++CETPI+H
Sbjct: 705 KALVYEFMVNGSLEEWLHPPDEAKAIPRNNLNILQRLNIAVDVACALDYLHNHCETPIIH 764

Query: 294 CDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE 353
           CDLKPSN+LLD E+T HV DFGLAKF  E      S+QSSS+G++G++GYA  EYG G+E
Sbjct: 765 CDLKPSNILLDNEMTGHVGDFGLAKFYRE-----RSHQSSSIGIRGSLGYAPAEYGTGNE 819

Query: 354 VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREE 413
           VSTSGDVYS+GILLLE+FTGK P ++ F  +++LHN+VK ALPE++ EI+DP L  E E 
Sbjct: 820 VSTSGDVYSYGILLLEIFTGKRPMDDWFNEDVSLHNYVKNALPEQVVEILDPTLFQEGEG 879

Query: 414 GET--SEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV 471
           G +    +NA   RT      ECL+S+  IGV CS+E P ERMN+ +VA QL+S RNKL+
Sbjct: 880 GISLIRRSNASINRT-----MECLISICEIGVACSAETPGERMNICDVAGQLVSIRNKLL 934

Query: 472 KN 473
           +N
Sbjct: 935 RN 936

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449499190|ref|XP_004160745.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus]

 Score =  509 bits (1311), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 259/469 (55%), Positives = 338/469 (72%), Gaps = 10/469 (2%)

Query: 1    MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
            ++GNF +G IP SLSSLRGIE LDLS+NNLSG+IP YL+ F  L  LNLSFN+ EGEVP 
Sbjct: 551  LDGNFLEGPIPESLSSLRGIEELDLSRNNLSGKIPTYLQEFEVLSYLNLSFNNLEGEVPT 610

Query: 61   KGVFSNSSAISLDGNVNLCGGISELHLCTCSTK-ESKQSRSRSLKLIIPIVTGILFLTGM 119
            +GVF N++A S+ GN  LC GI+EL+L  C      KQ  +  LK+II +V+G++    +
Sbjct: 611  QGVFKNTTAFSILGNKKLCNGINELNLPRCRLDYPRKQKLTTKLKIIISVVSGLVGALLI 670

Query: 120  SCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGI 179
             C ++     + K +    PS L AS   VSY +L KAT+ FS +NLIG G +GSVYKGI
Sbjct: 671  ICCLLFXLVKEEKNKSDLSPS-LKASYFAVSYNDLLKATNEFSPDNLIGVGGYGSVYKGI 729

Query: 180  FDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA 239
               D  +++VAVKV NLQHRGASKSF+AEC+AL++IRHRNLV+I+++C  VDFQGNDF A
Sbjct: 730  LSQD--KSVVAVKVFNLQHRGASKSFLAECEALKNIRHRNLVRILSACSGVDFQGNDFMA 787

Query: 240  LVYELMVNGSLEEWLH----LNRDAPR-NLNLLQRLSIAVDVASTLEYLHHYCETPIVHC 294
            LV++ MVNGSLE+WLH    LN++  +  LN++QRL IA+DVAS L+YLH+    PI HC
Sbjct: 788  LVFDFMVNGSLEKWLHPVDNLNQEGEKMYLNIMQRLDIAIDVASALDYLHNGSPMPIAHC 847

Query: 295  DLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV 354
            DLKPSNVLLD ++TAHV DFGLAKF+ E +    S +S S+G++GTVGYA PEY MGS++
Sbjct: 848  DLKPSNVLLDADMTAHVGDFGLAKFMAETSFQNRSTESESIGIRGTVGYAPPEYAMGSKI 907

Query: 355  STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEG 414
            ST GDVYS+GILLLEMFTGK PT+ MF   LTL+N+V  ALPER+ EI DP + ++   G
Sbjct: 908  STYGDVYSYGILLLEMFTGKSPTDNMFKDGLTLNNYVLTALPERVQEIADPTMGIQELNG 967

Query: 415  ETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL 463
                 N   +  +S   K+CL S+  IGV CS+++P +RMN+ +V +QL
Sbjct: 968  -MGNNNLMFEANQSLRIKDCLFSIFSIGVACSTQMPNQRMNISDVVSQL 1015

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	484
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.938	0.449	0.483	1.9e-113
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.946	0.453	0.483	3.2e-113
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.948	0.454	0.480	9.7e-112
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.942	0.444	0.481	1e-109
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.807	0.379	0.5	1.7e-107
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.944	0.445	0.454	7.7e-103
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.735	0.709	0.484	2.1e-94
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.915	0.452	0.365	2.4e-69
UNIPROTKB|O24435	813	O24435 "Receptor kinase-like p	0.553	0.329	0.498	1.4e-64
TAIR|locus:2170483	1173	FLS2 "FLAGELLIN-SENSITIVE 2" [	0.921	0.380	0.355	1.6e-64

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 1119 (399.0 bits), Expect = 1.9e-113, P = 1.9e-113
 Identities = 234/484 (48%), Positives = 313/484 (64%)

Query:     4 NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
             N F G IP  +  L G++N+DLS NNLSG I +Y ENF  L+ LNLS N+FEG VP +G+
Sbjct:   540 NHFDGTIPD-IKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNFEGRVPTEGI 598

Query:    64 FSNSSAISLDGNVNLCGGISELHLCTCSTKESK-QSRSRSL--KLIIPIVTGILFLTGMS 120
             F N++ +S+ GN NLCG I EL L  C  +    ++R  SL  K+ I +  GI  L  + 
Sbjct:   599 FQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKKVAIGVSVGIALLL-LL 657

Query:   121 CLIITSWWSKTKREPSTPPSALLASVL---RVSYQNLFKATDGFSLENLIGAGSFGSVYK 177
              ++  SW+ K K       SA     +   ++SY +L  ATDGFS  N++G+GSFG+V+K
Sbjct:   658 FIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIVGSGSFGTVFK 717

Query:   178 GIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF 237
              +   ++   +VAVKVLN+Q RGA KSF+AEC++L+ IRHRNLVK++T+C S+DFQGN+F
Sbjct:   718 ALLQTENK--IVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACASIDFQGNEF 775

Query:   238 EALVYELMVNGSLEEWLH------LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPI 291
              AL+YE M NGSL++WLH      ++R + R L LL+RL+IA+DVAS L+YLH +C  PI
Sbjct:   776 RALIYEFMPNGSLDKWLHPEEVEEIHRPS-RTLTLLERLNIAIDVASVLDYLHVHCHEPI 834

Query:   292 VHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMG 351
              HCDLKPSN+LLD +LTAHVSDFGLA+ L +             GV+GT+GYAAPEYGMG
Sbjct:   835 AHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSAGVRGTIGYAAPEYGMG 894

Query:   352 SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVER 411
              + S  GDVYSFG+L+LEMFTGK PTNE+F GN TL+++ K ALPER+ +I D  +L   
Sbjct:   895 GQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPERVLDIADKSIL--- 951

Query:   412 EEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV 471
                       H      F   ECL  +L +G+ C  E P  R+   E A +L+S R +  
Sbjct:   952 ----------HSGLRVGFPVLECLKGILDVGLRCCEESPLNRLATSEAAKELISIRERFF 1001

Query:   472 KNVR 475
             K  R
Sbjct:  1002 KTRR 1005

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 1117 (398.3 bits), Expect = 3.2e-113, P = 3.2e-113
 Identities = 236/488 (48%), Positives = 317/488 (64%)

Query:     1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
             + GN F G+IP  L  L G++ +DLS N+LSG IP+Y  +F  L+ LNLSFN+ EG+VP+
Sbjct:   536 LEGNLFYGDIPD-LKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPV 594

Query:    61 KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKES---KQSRSRSLKLIIPIVTGILFLT 117
             KG+F N++ +S+ GN +LCGGI    L  C ++     K+  SR  K++I +  GI  L 
Sbjct:   595 KGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLLL 654

Query:   118 GMSCLIITSWW---SKTKREPSTP-PSALLASVLRVSYQNLFKATDGFSLENLIGAGSFG 173
              +    +T  W    K  +E + P PS L     ++SY +L  AT+GFS  N++G+GSFG
Sbjct:   655 LLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSFG 714

Query:   174 SVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ 233
             +VYK +   +  + +VAVKVLN+Q RGA KSF+AEC++L+ IRHRNLVK++T+C S+DFQ
Sbjct:   715 TVYKALLLTE--KKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQ 772

Query:   234 GNDFEALVYELMVNGSLEEWLH------LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC 287
             GN+F AL+YE M NGSL+ WLH      ++R + R L LL+RL+IA+DVAS L+YLH +C
Sbjct:   773 GNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPS-RTLTLLERLNIAIDVASVLDYLHVHC 831

Query:   288 ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPE 347
               PI HCDLKPSNVLLD +LTAHVSDFGLA+ L +             GV+GT+GYAAPE
Sbjct:   832 HEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTIGYAAPE 891

Query:   348 YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVL 407
             YG+G + S +GDVYSFGILLLEMFTGK PTNE+F GN TL+++ K ALPER+ +IVD  +
Sbjct:   892 YGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILDIVDESI 951

Query:   408 LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR 467
             L             H      F   ECL  V  +G+ C  E P  R+    V  +L+S R
Sbjct:   952 L-------------HIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISIR 998

Query:   468 NKLVKNVR 475
              +  K  R
Sbjct:   999 ERFFKASR 1006

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1103 (393.3 bits), Expect = 9.7e-112, P = 9.7e-112
 Identities = 234/487 (48%), Positives = 310/487 (63%)

Query:     1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
             + GN F G IP+ +  L G+  +DLS N+LSG IP+Y  NF  L+ LNLS N+F G+VP 
Sbjct:   537 LQGNSFDGAIPN-IRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEYLNLSINNFTGKVPS 595

Query:    61 KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKES--KQSRSRSLKLIIPIVT-GI-LFL 116
             KG F NS+ + + GN NLCGGI +L L  C  +E   +   S  LK +  +V+ GI L L
Sbjct:   596 KGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKVAILVSIGIALLL 655

Query:   117 TGMSCLIITSWWSKTKREPSTP---PSALLASVLRVSYQNLFKATDGFSLENLIGAGSFG 173
               +   ++  W+ K ++   T    PS L     ++SY +L  AT+GFS  N++G+GSFG
Sbjct:   656 LLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNGFSSSNMVGSGSFG 715

Query:   174 SVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ 233
             +V+K +   +    +VAVKVLN+Q RGA KSF+AEC++L+  RHRNLVK++T+C S DFQ
Sbjct:   716 TVFKALLPTESK--IVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTACASTDFQ 773

Query:   234 GNDFEALVYELMVNGSLEEWLHLN-----RDAPRNLNLLQRLSIAVDVASTLEYLHHYCE 288
             GN+F AL+YE + NGS++ WLH       R  PR L LL+RL+I +DVAS L+YLH +C 
Sbjct:   774 GNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLDYLHVHCH 833

Query:   289 TPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEY 348
              PI HCDLKPSNVLL+ +LTAHVSDFGLA+ L +             GV+GT+GYAAPEY
Sbjct:   834 EPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSAGVRGTIGYAAPEY 893

Query:   349 GMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLL 408
             GMG + S  GDVYSFG+LLLEMFTGK PT+E+F GNLTLH++ K ALPE++ EI D  +L
Sbjct:   894 GMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLALPEKVFEIADKAIL 953

Query:   409 VEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN 468
                          H      F   ECL  VL +G+ C  E P  R+   EVA +L+S R 
Sbjct:   954 -------------HIGLRVGFRTAECLTLVLEVGLRCCEEYPTNRLATSEVAKELISIRE 1000

Query:   469 KLVKNVR 475
             +  K  R
Sbjct:  1001 RFFKTRR 1007

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1084 (386.6 bits), Expect = 1.0e-109, P = 1.0e-109
 Identities = 235/488 (48%), Positives = 306/488 (62%)

Query:     1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
             + GN F G IP  +  L G+  LDLS+NNLSG IP+Y+ NF  LQNLNLS N+F+G VP 
Sbjct:   552 LQGNSFVGPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNFDGAVPT 610

Query:    61 KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRS--RSLKLIIPIVTGILFLTG 118
             +GVF N+SA+S+ GN+NLCGGI  L L  CS +  ++  S  + + + +  V   L L  
Sbjct:   611 EGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMAALLLLC 670

Query:   119 MSCLIITSWWS---KTKREPSTPPSALLASVL----RVSYQNLFKATDGFSLENLIGAGS 171
             + C++   W+    K+ R  +       + V     ++SY  L+K T GFS  NLIG+G+
Sbjct:   671 L-CVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNLIGSGN 729

Query:   172 FGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVD 231
             FG+V+KG     +    VA+KVLNL  RGA+KSFIAEC+AL  IRHRNLVK++T C S D
Sbjct:   730 FGAVFKGFLGSKNKA--VAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICSSSD 787

Query:   232 FQGNDFEALVYELMVNGSLEEWLHLNR-----DAPRNLNLLQRLSIAVDVASTLEYLHHY 286
             F+GNDF ALVYE M NG+L+ WLH +      +  R L L  RL+IA+DVAS L YLH Y
Sbjct:   788 FEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALVYLHTY 847

Query:   287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
             C  PI HCD+KPSN+LLD +LTAHVSDFGLA+ L +             GV+GT+GYAAP
Sbjct:   848 CHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAGVRGTIGYAAP 907

Query:   347 EYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA-EIVDP 405
             EYGMG   S  GDVYSFGI+LLE+FTGK PTN++F   LTLH+F K AL +R A +I D 
Sbjct:   908 EYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQALDITDE 967

Query:   406 VLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS 465
              +L            A+ Q    F   ECL  V  +GV CS E P  R++M E  ++L+S
Sbjct:   968 TIL----------RGAYAQH---FNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLVS 1014

Query:   466 FRNKLVKN 473
              R    ++
Sbjct:  1015 IRESFFRD 1022

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 998 (356.4 bits), Expect = 1.7e-107, Sum P(2) = 1.7e-107
 Identities = 205/410 (50%), Positives = 272/410 (66%)

Query:     1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
             M GN F G IP  +S L  ++N+D S NNLSGRIP+YL + P L+NLNLS N FEG VP 
Sbjct:   544 MQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPT 602

Query:    61 KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILF-LTGM 119
              GVF N++A+S+ GN N+CGG+ E+ L  C  + S + R + L +   +V+GI   +  +
Sbjct:   603 TGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKR-KPLSVRKKVVSGICIGIASL 661

Query:   120 SCLIITS---WWSKTKREPST----PPSALLASVL--RVSYQNLFKATDGFSLENLIGAG 170
               +II +   W+ K K++ +     P  +    +   +VSY+ L  AT  FS  NLIG+G
Sbjct:   662 LLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSATSRFSSTNLIGSG 721

Query:   171 SFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSV 230
             +FG+V+KG+   ++   LVAVKVLNL   GA+KSF+AEC+  + IRHRNLVK+IT C S+
Sbjct:   722 NFGNVFKGLLGPENK--LVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVCSSL 779

Query:   231 DFQGNDFEALVYELMVNGSLEEWLHLN-----RDAPRNLNLLQRLSIAVDVASTLEYLHH 285
             D +GNDF ALVYE M  GSL+ WL L       D  R+L   ++L+IA+DVAS LEYLH 
Sbjct:   780 DSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEYLHV 839

Query:   286 YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAA 345
             +C  P+ HCD+KPSN+LLD +LTAHVSDFGLA+ L +             GV+GT+GYAA
Sbjct:   840 HCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIGYAA 899

Query:   346 PEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL 395
             PEYGMG + S  GDVYSFGILLLEMF+GK PT+E F G+  LH++ K  L
Sbjct:   900 PEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL 949

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 1019 (363.8 bits), Expect = 7.7e-103, P = 7.7e-103
 Identities = 215/473 (45%), Positives = 296/473 (62%)

Query:     1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
             +  N   G+IPS+L  L+G+E LDLS NNLSG+IP  L +   L +LNLSFN F GEVP 
Sbjct:   552 LQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPT 611

Query:    61 KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMS 120
              G F+ +S IS+ GN  LCGGI +LHL  C      +     L + + +   +  L+ + 
Sbjct:   612 IGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAALAILSSLY 671

Query:   121 CLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIF 180
              LI  +W  +TK+    P    +     VSY  L KATDGF+  NL+G+GSFGSVYKG  
Sbjct:   672 LLI--TWHKRTKK--GAPSRTSMKGHPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKL 727

Query:   181 DHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEAL 240
             +  DH   VAVKVL L++  A KSF AEC+ALR++RHRNLVKI+T C S+D +GNDF+A+
Sbjct:   728 NIQDH---VAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAI 784

Query:   241 VYELMVNGSLEEWLH--LNRDAP-RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLK 297
             VY+ M NGSLE+W+H   N  A  R+LNL +R++I +DVA  L+YLH +   P+VHCD+K
Sbjct:   785 VYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIK 844

Query:   298 PSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTS 357
              SNVLLD ++ AHV DFGLA+ L +            +G  GT+GYAAPEYG+G   ST 
Sbjct:   845 SSNVLLDSDMVAHVGDFGLARILVDGTSLIQQSTSS-MGFIGTIGYAAPEYGVGLIASTH 903

Query:   358 GDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETS 417
             GD+YS+GIL+LE+ TGK PT+  F  +L L  +V+  L  R+ ++VD  L+++ E    S
Sbjct:   904 GDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWLNS 963

Query:   418 EANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL 470
               N+  +R       EC+V +L +G+ CS ELP  R    ++  +L + +  L
Sbjct:   964 TNNSPCRRIT-----ECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNL 1011

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 872 (312.0 bits), Expect = 2.1e-94, Sum P(2) = 2.1e-94
 Identities = 190/392 (48%), Positives = 243/392 (61%)

Query:    20 IENLDLSQNNLSGRIPKYLENFPFLQNLNLSFN--------HFEGEVPIKGVFSNSSAIS 71
             + +LDL    LSG I   + N  FL++LNL  N         FEG VP KGVF N + +S
Sbjct:    75 VTSLDLGGFKLSGSISPSIGNLSFLRSLNLGDNSFQSNIPQEFEGSVPTKGVFQNGTTVS 134

Query:    72 LDGNVNLCGGISELHLCTCSTKESKQSRSRSL--KLIIPIVTGILFLTGMSCLIITSW-W 128
             + GN NLCGG+ E+ L  C  +  +Q +  SL  K+ + +   +LFL     +I+ S  W
Sbjct:   135 VFGNENLCGGVIEMQLKPC-IESPRQKKPFSLGEKVAVGVGVALLFLF----IIVASLSW 189

Query:   129 SKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETL 188
              K K +             ++SY+ L+ AT GFS  NLIG+G+F  V+KG+   +  E L
Sbjct:   190 FKKKND-------------KISYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLE--EKL 234

Query:   189 VAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNG 248
             VAVKVLNL   GA+KSFIAEC++ + IRHRNL K+IT C S+D QGNDF ALVYE M  G
Sbjct:   235 VAVKVLNLLKHGATKSFIAECESFKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKG 294

Query:   249 SLEEWLHLN-----RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL 303
             SL+ WL         +  R+L   ++++IA+DVAS LEYLH YC  P+ HCD+KPSNVLL
Sbjct:   295 SLDMWLQPEDLESANNHSRSLTFAEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLL 354

Query:   304 DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSF 363
             D +LTAHVSDFGLA+ L               GV+GT+GYAAPEYGMGS+ S  GDVYSF
Sbjct:   355 DDDLTAHVSDFGLARLLYNFDEKTFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSF 414

Query:   364 GILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL 395
             G+LLLEMFTGK PT+  F G   LH + K  L
Sbjct:   415 GVLLLEMFTGKKPTDNSFGGGYNLHGYTKSVL 446

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 703 (252.5 bits), Expect = 2.4e-69, P = 2.4e-69
 Identities = 174/476 (36%), Positives = 262/476 (55%)

Query:     1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
             ++ N F   +PSSL  L  ++ LD+S N L+G IP   +    L++LN SFN   G V  
Sbjct:   498 LSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSD 557

Query:    61 KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIV-TGILFLTGM 119
             KG FS  +  S  G+  LCG I  +  C    K+  +  S  L +++ ++ T +L + G 
Sbjct:   558 KGSFSKLTIESFLGDSLLCGSIKGMQAC----KKKHKYPSVLLPVLLSLIATPVLCVFGY 613

Query:   120 SCLIITSW------WSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFG 173
               +  + +      ++K + E     +       R+SYQ L  AT GF+  +LIG+G FG
Sbjct:   614 PLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFG 673

Query:   174 SVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDF 232
              VYKG+  ++   T VAVKVL+ +     S SF  ECQ L+  RHRNL++IIT+C     
Sbjct:   674 HVYKGVLRNN---TKVAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSK--- 727

Query:   233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIV 292
              G  F ALV  LM NGSLE  L+    + +NL+L+Q ++I  DVA  + YLHHY    +V
Sbjct:   728 PG--FNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPVKVV 785

Query:   293 HCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVG-----VKGTVGYAAPE 347
             HCDLKPSN+LLD E+TA V+DFG+++ +               G     + G+VGY APE
Sbjct:   786 HCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPE 845

Query:   348 YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVL 407
             YGMG   ST GDVYSFG+LLLE+ +G+ PT+ +     +LH F+K   P+ L  I++  L
Sbjct:   846 YGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQAL 905

Query:   408 LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL 463
                + +G+  +             +E ++ ++ +G++C+   P  R +M +VA ++
Sbjct:   906 SRWKPQGKPEKCEKL--------WREVILEMIELGLVCTQYNPSTRPDMLDVAHEM 953

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 658 (236.7 bits), Expect = 1.4e-64, P = 1.4e-64
 Identities = 138/277 (49%), Positives = 190/277 (68%)

Query:     1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
             +  NF  G+IP +L+ L+G++ LDLS NNLSG+IP  L + P L +LNLSFN F GEVP 
Sbjct:   526 LQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLGDMPLLHSLNLSFNSFHGEVPT 585

Query:    61 KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPI-VTGILFLTGM 119
              GVF+N+S I + GN ++CGGI ELHL TCS K  K+ + + L L++ I +   L +  +
Sbjct:   586 NGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKKKKHQILLLVVVICLVSTLAVFSL 645

Query:   120 SCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGI 179
               +++T    + K  P+T  +++    + ++Y+ L KATDGFS  +L+G+GSFGSVYKG 
Sbjct:   646 LYMLLTCHKRRKKEVPAT--TSMQGHPM-ITYKQLVKATDGFSSSHLLGSGSFGSVYKGE 702

Query:   180 FDHDDHE--TLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF 237
             FD  D E  +LVAV+VL L+   A KSF AEC+ LR+ RHRNLVKI+T C S+D +GNDF
Sbjct:   703 FDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNTRHRNLVKIVTICSSIDNRGNDF 762

Query:   238 EALVYELMVNGSLEEWLH--LNRDAP-RNLNLLQRLS 271
             +A+VY+ M NGSLE+WLH   N  A  R+L L QR+S
Sbjct:   763 KAIVYDFMPNGSLEDWLHPETNDQAEQRHLTLHQRVS 799

GO:0004672 "protein kinase activity" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0016567 "protein ubiquitination" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 666 (239.5 bits), Expect = 1.6e-64, P = 1.6e-64
 Identities = 170/478 (35%), Positives = 260/478 (54%)

Query:     1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
             ++ N F G IP S  ++  + +LDLS NNL+G IP+ L N   L++L L+ N+ +G VP 
Sbjct:   705 LSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANLSTLKHLKLASNNLKGHVPE 764

Query:    61 KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMS 120
              GVF N +A  L GN +LCG    L  CT   K S  S+   + LII      L L  + 
Sbjct:   765 SGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRTRVILIILGSAAALLLVLLL 824

Query:   121 CLIITSWWSKTKREPSTPPSAL--LASVLRVSY---QNLFKATDGFSLENLIGAGSFGSV 175
              LI+T    K K+  ++  S+L  L S L++     + L +ATD F+  N+IG+ S  +V
Sbjct:   825 VLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELEQATDSFNSANIIGSSSLSTV 884

Query:   176 YKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVKIITSCVSVDFQ 233
             YKG  +     T++AVKVLNL+   A   K F  E + L  ++HRNLVKI+       ++
Sbjct:   885 YKGQLEDG---TVIAVKVLNLKEFSAESDKWFYTEAKTLSQLKHRNLVKIL----GFAWE 937

Query:   234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVH 293
                 +ALV   M NG+LE+ +H    AP   +LL+++ + V +AS ++YLH     PIVH
Sbjct:   938 SGKTKALVLPFMENGNLEDTIH-GSAAPIG-SLLEKIDLCVHIASGIDYLHSGYGFPIVH 995

Query:   294 CDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSE 353
             CDLKP+N+LLD +  AHVSDFG A+ L                 +GT+GY APE+    +
Sbjct:   996 CDLKPANILLDSDRVAHVSDFGTARIL--GFREDGSTTASTSAFEGTIGYLAPEFAYMRK 1053

Query:   354 VSTSGDVYSFGILLLEMFTGKGPT--NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVER 411
             V+T  DV+SFGI+++E+ T + PT  N+  + ++TL   V++++      +V    +++ 
Sbjct:  1054 VTTKADVFSFGIIMMELMTKQRPTSLNDEDSQDMTLRQLVEKSIGNGRKGMVR---VLDM 1110

Query:   412 EEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK 469
             E G++  +   ++    F  K CL         C+S  P +R +M E+   L+  R K
Sbjct:  1111 ELGDSIVSLKQEEAIEDFL-KLCL--------FCTSSRPEDRPDMNEILTHLMKLRGK 1159

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004675 "transmembrane receptor protein serine/threonine kinase activity" evidence=ISS

GO:0016020 "membrane" evidence=ISS;IDA

GO:0016045 "detection of bacterium" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IMP

GO:0052544 "defense response by callose deposition in cell wall" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0016310 "phosphorylation" evidence=RCA

GO:0005768 "endosome" evidence=IDA

GO:0006898 "receptor-mediated endocytosis" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00029263001 SubName- Full=Chromosome chr13 scaffold_48, whole genome shotgun sequence; (886 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	484
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-44
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-44
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-43
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-40
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-36
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-36
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-32
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-29
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-27
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	3e-26
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-24
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-21
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-21
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-19
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-18
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-18
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-18
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-17
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	4e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-17
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-17
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	7e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	7e-17
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-16
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-16
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-16
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	5e-16
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-15
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-15
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-14
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-14
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-14
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	7e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-13
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-13
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	9e-13
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-12
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-12
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-12
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	6e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	8e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-11
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-11
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-11
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-11
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-11
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	4e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-11
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-11
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-11
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-11
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-10
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-10
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	4e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-10
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-10
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-10
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-10
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	7e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	9e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-08
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-08
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-08
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-08
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-08
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-08
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-08
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	9e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-07
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-07
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-07
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-07
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-06
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-06
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-06
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	8e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	9e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	8e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-04
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-04
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	7e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.001
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.001
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.001
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.002
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.002

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  155 bits (394), Expect = 1e-44
 Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 23/207 (11%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK-SFIAECQALRSIRHRNLVKIIT 225
           +G G FG+VY            VA+K++  +   +     + E + L+ + H N+VK+  
Sbjct: 1   LGEGGFGTVYLAR--DKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
                     +   LV E    GSL++ L  N      L+  + L I + +   LEYLH 
Sbjct: 59  VFED-----ENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLH- 109

Query: 286 YCETPIVHCDLKPSNVLLD-GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYA 344
                I+H DLKP N+LLD       ++DFGL+K L    + L +       + GT  Y 
Sbjct: 110 --SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-------IVGTPAYM 160

Query: 345 APEYGMG-SEVSTSGDVYSFGILLLEM 370
           APE  +G    S   D++S G++L E+
Sbjct: 161 APEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  154 bits (393), Expect = 5e-44
 Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 23/217 (10%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRN 219
           + +   +G GSFG VY    D    + LVA+KV+  +  +   +  + E + L+ ++H N
Sbjct: 1   YEILEKLGEGSFGKVYLAR-DKKTGK-LVAIKVIKKKKIKKDRERILREIKILKKLKHPN 58

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           +V++        F+  D   LV E    G L + L         L+  +       + S 
Sbjct: 59  IVRLYDV-----FEDEDKLYLVMEYCEGGDLFDLLKKRG----RLSEDEARFYLRQILSA 109

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           LEYLH      IVH DLKP N+LLD +    ++DFGLA+        L   +  +  V G
Sbjct: 110 LEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQ-------LDPGEKLTTFV-G 158

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           T  Y APE  +G     + D++S G++L E+ TGK P
Sbjct: 159 TPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  152 bits (386), Expect = 6e-43
 Identities = 75/219 (34%), Positives = 107/219 (48%), Gaps = 24/219 (10%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHR 218
           + L   +G+GSFG+VYK    H     +VAVK+L  +   + K  +   E + LR + H 
Sbjct: 1   YELLRKLGSGSFGTVYKAK--HKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHP 58

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+V++I +     F+  D   LV E    G L ++L         L+  +   IA+ +  
Sbjct: 59  NIVRLIDA-----FEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILR 109

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            LEYLH      I+H DLKP N+LLD      ++DFGLAK        L  + SS     
Sbjct: 110 GLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKK-------LLKSSSSLTTFV 159

Query: 339 GTVGYAAPE-YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           GT  Y APE    G+      DV+S G++L E+ TGK P
Sbjct: 160 GTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  144 bits (367), Expect = 3e-40
 Identities = 73/239 (30%), Positives = 109/239 (45%), Gaps = 29/239 (12%)

Query: 162 SLENLIGAGSFGSVYKGIFDH--DDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
           +L   +G G+FG VYKG         +  VAVK L         + F+ E + +R + H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+VK++  C     +   +  +V E M  G L  +L  NR     L+L   LS A+ +A 
Sbjct: 62  NVVKLLGVCTE---EEPLY--IVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIAR 113

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            +EYL        +H DL   N L+   L   +SDFGL++ L +             G K
Sbjct: 114 GMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY------RKRGGK 164

Query: 339 GTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE 393
             + + APE    G  +  S   DV+SFG+LL E+FT G+ P   M   N  +  ++K 
Sbjct: 165 LPIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTLGEQPYPGM--SNEEVLEYLKN 218

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  143 bits (363), Expect = 1e-39
 Identities = 74/239 (30%), Positives = 111/239 (46%), Gaps = 28/239 (11%)

Query: 162 SLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
           +L   +G G+FG VYKG            VAVK L         + F+ E + +R + H 
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+VK++  C     +      +V E M  G L ++L  NR  P+ L+L   LS A+ +A 
Sbjct: 62  NIVKLLGVCTE---EEP--LMIVMEYMPGGDLLDYLRKNR--PKELSLSDLLSFALQIAR 114

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            +EYL        +H DL   N L+   L   +SDFGL++ L +             G K
Sbjct: 115 GMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK------GGK 165

Query: 339 GTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE 393
             + + APE    G  +  S   DV+SFG+LL E+FT G+ P   M   N  +  ++K+
Sbjct: 166 LPIRWMAPESLKEGKFTSKS---DVWSFGVLLWEIFTLGEEPYPGM--SNAEVLEYLKK 219

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  141 bits (359), Expect = 5e-39
 Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 19/216 (8%)

Query: 161 FSLENLIGAGSFGSVYKGI--FDHDDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRH 217
             L   +G G+FG VYKG    D +  ET VAVK L         + F+ E   ++ + H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            N+V+++  C     QG     +V E M  G L ++L   R     L L   L +A+ +A
Sbjct: 61  PNIVRLLGVCT----QGEPL-YIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIA 112

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
             +EYL        VH DL   N L+   L   +SDFGL++ + E             G 
Sbjct: 113 KGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYE-----DDYYRKRGGG 164

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
           K  + + APE     + ++  DV+SFG+LL E+FT 
Sbjct: 165 KLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (343), Expect = 1e-36
 Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 23/224 (10%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGA--SKSFIAECQALRSIR 216
           ++   L+G GSFGSVY  +    D +T  L+AVK + L        ++   E + L S++
Sbjct: 2   WTRGELLGRGSFGSVYLAL----DKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ 57

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N+V+   S    +    +   +  E +  GSL     L +       ++++ +    +
Sbjct: 58  HPNIVRYYGSERDEE---KNTLNIFLEYVSGGSLSS--LLKKFGKLPEPVIRKYTR--QI 110

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
              L YLH      IVH D+K +N+L+D +    ++DFG AK L +      +       
Sbjct: 111 LEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS----- 162

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           V+GT  + APE   G E   + D++S G  ++EM TGK P +E+
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  134 bits (339), Expect = 4e-36
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 30/220 (13%)

Query: 165 NLIGAGSFGSVYKGIFDH-DDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLVK 222
             +G G+FG VYKG     D   T VAVK L        +  F+ E + ++ + H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA-----PRNLNLLQRLSIAVDVA 277
           ++  C     +   +  LV E M  G L ++L  +R          L+L   LS A+ +A
Sbjct: 61  LLGVCTE---EEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
             +EYL        VH DL   N L+  +L   +SDFGL++ +                 
Sbjct: 116 KGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY----------DDDYYR 162

Query: 338 KGT-----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           K T     + + APE       ++  DV+SFG+LL E+FT
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (310), Expect = 3e-32
 Identities = 82/216 (37%), Positives = 111/216 (51%), Gaps = 28/216 (12%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           L   IG G FG V  G +        VAVK L      A+++F+AE   + ++RH NLV+
Sbjct: 10  LGATIGKGEFGDVMLGDYRGQK----VAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQ 64

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN-LNLLQRLSIAVDVASTLE 281
           ++     V  QGN    +V E M  GSL ++L   R   R  + L Q+L  A+DV   +E
Sbjct: 65  LL----GVVLQGNPL-YIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGME 116

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           YL    E   VH DL   NVL+  +L A VSDFGLAK          ++Q    G K  V
Sbjct: 117 YLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK---------EASQGQDSG-KLPV 163

Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            + APE     + ST  DV+SFGILL E+++ G+ P
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  129 bits (326), Expect = 7e-32
 Identities = 109/389 (28%), Positives = 167/389 (42%), Gaps = 44/389 (11%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
           N   G IP+S S +  +  LDLSQN LSG IPK L N   L  +N+S NH  G +P  G 
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592

Query: 64  FSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMSCLI 123
           F   +A ++ GN++LCGG +   L  C     +  ++ S    I    G   +  +    
Sbjct: 593 FLAINASAVAGNIDLCGGDTTSGLPPCK----RVRKTPSWWFYITCTLGAFLVLALVAFG 648

Query: 124 IT-------SWWSKTKREPSTPPSALLASVLRVSYQNLFKAT-DGFSLENLIGAGSFGSV 175
                        + + E  T       S  +VS              EN+I  G  G+ 
Sbjct: 649 FVFIRGRNNLELKRVENEDGTWELQFFDS--KVSKSITINDILSSLKEENVISRGKKGAS 706

Query: 176 YKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN 235
           YKG    +  + +V  K +N        S IA+   +  ++H N+VK+I  C S      
Sbjct: 707 YKGKSIKNGMQFVV--KEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGLCRS-----E 755

Query: 236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCD 295
               L++E +   +L E L       RNL+  +R  IA+ +A  L +LH  C   +V  +
Sbjct: 756 KGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808

Query: 296 LKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVS 355
           L P  +++DG+   H     L   LP      +    SS        Y APE     +++
Sbjct: 809 LSPEKIIIDGKDEPH-----LRLSLPGLLCTDTKCFISS-------AYVAPETRETKDIT 856

Query: 356 TSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
              D+Y FG++L+E+ TGK P +  F  +
Sbjct: 857 EKSDIYGFGLILIELLTGKSPADAEFGVH 885

Length = 968

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  123 bits (309), Expect = 4e-31
 Identities = 80/225 (35%), Positives = 107/225 (47%), Gaps = 23/225 (10%)

Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIR 216
            + +   +G GSFG VY           LVA+KVL  +        + F+ E Q L S+ 
Sbjct: 1   SYRILRKLGEGSFGEVYLAR-----DRKLVALKVLAKKLESKSKEVERFLREIQILASLN 55

Query: 217 H-RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           H  N+VK+        FQ      LV E +  GSLE+ L         L+  + L I   
Sbjct: 56  HPPNIVKLYDF-----FQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQ 109

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELT-AHVSDFGLAKFLPEAANNLSSNQSSS 334
           + S LEYLH      I+H D+KP N+LLD +     + DFGLAK LP+  +  S     S
Sbjct: 110 ILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166

Query: 335 VGVKGTVGYAAPEYGMGSE---VSTSGDVYSFGILLLEMFTGKGP 376
             V GT GY APE  +G      S+S D++S GI L E+ TG  P
Sbjct: 167 TSV-GTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  117 bits (295), Expect = 5e-30
 Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 39/234 (16%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQA----LRSIR 216
           + L +LIG G+FG VYKG+ + +  +  VA+K ++L+     +  +         L++++
Sbjct: 2   YQLGDLIGRGAFGVVYKGL-NLETGDF-VAIKQISLE--KIKEEALKSIMQEIDLLKNLK 57

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N+VK I S      + +D   ++ E   NGSL + +      P +L       +AV V
Sbjct: 58  HPNIVKYIGS-----IETSDSLYIILEYAENGSLRQIIKKFGPFPESL-------VAVYV 105

Query: 277 AST---LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
                 L YLH   E  ++H D+K +N+L   +    ++DFG+A         L+     
Sbjct: 106 YQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVA-------TKLNDVSKD 155

Query: 334 SVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK------GPTNEMF 381
              V GT  + APE    S  ST+ D++S G  ++E+ TG        P   +F
Sbjct: 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF 209

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  116 bits (292), Expect = 1e-29
 Identities = 68/229 (29%), Positives = 103/229 (44%), Gaps = 31/229 (13%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           F +   IG G FG VYK    H      VA+KV+ L+ +   +  I E Q L+  +H N+
Sbjct: 2   FEILEKIGKGGFGEVYKAR--HKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNI 59

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK   S     +   D   +V E    GSL++ L   +   + L   Q   +  ++   L
Sbjct: 60  VKYYGS-----YLKKDELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGL 111

Query: 281 EYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
           EYLH      I+H D+K +N+LL  DGE+   + DFGL+  L    ++  +  +      
Sbjct: 112 EYLHSN---GIIHRDIKAANILLTSDGEV--KLIDFGLSAQL----SDTKARNTMV---- 158

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK------GPTNEMF 381
           GT  + APE   G       D++S GI  +E+  GK       P   +F
Sbjct: 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF 207

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  115 bits (291), Expect = 2e-29
 Identities = 75/217 (34%), Positives = 109/217 (50%), Gaps = 25/217 (11%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V++G++++    T VAVK L        K F+AE Q ++ +RH  L+++   
Sbjct: 14  LGAGQFGEVWEGLWNNT---TPVAVKTLKPGTMDP-KDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL--H 284
           C        +   +V ELM  GSL E+L     A R L L Q + +A  VAS + YL   
Sbjct: 70  CTL-----EEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAAQVASGMAYLEAQ 122

Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYA 344
           +Y     +H DL   NVL+       V+DFGLA+ + E          +  G K  + + 
Sbjct: 123 NY-----IHRDLAARNVLVGENNICKVADFGLARVIKEDIYE------AREGAKFPIKWT 171

Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
           APE  + +  S   DV+SFGILL E+ T G+ P   M
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  114 bits (286), Expect = 2e-28
 Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 16/211 (7%)

Query: 165 NLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLV 221
             +G G FG V    +D     T   VAVK LN       +S F  E + LR++ H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           K    C   +  G     L+ E + +GSL ++L  +RD    +NL + L  +  +   ++
Sbjct: 70  KYKGVC---EKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMD 123

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           YL        +H DL   N+L++ E    +SDFGLAK LPE  +     +     +    
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF--- 177

Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            + APE    S+ S++ DV+SFG+ L E+FT
Sbjct: 178 -WYAPECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  112 bits (282), Expect = 3e-28
 Identities = 71/218 (32%), Positives = 110/218 (50%), Gaps = 23/218 (10%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           F+LE  +G+G FG V++G++ +      VA+K+L        + F  E QAL+ +RH++L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKN---RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL 64

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP-RNLNLLQRLSIAVDVAST 279
           + +   C        +   ++ ELM  GSL  +L   R    + L +   + +A  VA  
Sbjct: 65  ISLFAVC-----SVGEPVYIITELMEKGSLLAFL---RSPEGQVLPVASLIDMACQVAEG 116

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           + YL    E   +H DL   N+L+  +L   V+DFGLA+ + E   ++  +    +  K 
Sbjct: 117 MAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE---DVYLSSDKKIPYKW 170

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           T    APE       ST  DV+SFGILL EMFT G+ P
Sbjct: 171 T----APEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 3e-27
 Identities = 74/229 (32%), Positives = 101/229 (44%), Gaps = 41/229 (17%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKI 223
           +G GSFG V        D   L A+KVL  +    R   +  + E   L  I H  +VK+
Sbjct: 1   LGKGSFGKVLLVR--KKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL 58

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS------IAVDVA 277
             +     FQ  +   LV E    G L  + HL++          R S       A ++ 
Sbjct: 59  HYA-----FQTEEKLYLVLEYAPGGEL--FSHLSK--------EGRFSEERARFYAAEIV 103

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
             LEYLH      I++ DLKP N+LLD +    ++DFGLAK        LSS  S +   
Sbjct: 104 LALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAK-------ELSSEGSRTNTF 153

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMF 381
            GT  Y APE  +G     + D +S G+LL EM TGK P       E++
Sbjct: 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY 202

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 3e-26
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 21/217 (9%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
             LE  +GAG FG V+ G ++     T VAVK L      + ++F+ E Q ++ +RH  L
Sbjct: 8   LKLERKLGAGQFGEVWMGTWNG---TTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKL 63

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V++   C     +      +V E M  GSL ++L       + L L Q + +A  +A  +
Sbjct: 64  VQLYAVCS----EEEPI-YIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGM 116

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
            YL        +H DL   N+L+   L   ++DFGLA+ + +  +  ++ + +   +K T
Sbjct: 117 AYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIED--DEYTAREGAKFPIKWT 171

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
               APE       +   DV+SFGILL E+ T G+ P
Sbjct: 172 ----APEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  102 bits (255), Expect = 1e-24
 Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 25/220 (11%)

Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIR 216
            F L  +IG G+FG V   I    D + + A+K +N Q    +G+ ++ + E + L+ + 
Sbjct: 1   HFELLRVIGKGAFGKVC--IVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN 58

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H  LV +  S     FQ  +   LV +L++ G L    HL++    +   ++      ++
Sbjct: 59  HPFLVNLWYS-----FQDEENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVK--FWICEI 109

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
              LEYLH      I+H D+KP N+LLD +   H++DF +A  +           + +  
Sbjct: 110 VLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP--------DTLTTS 158

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT GY APE       S + D +S G+   E   GK P
Sbjct: 159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 2e-24
 Identities = 70/213 (32%), Positives = 101/213 (47%), Gaps = 26/213 (12%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA--SKSFIAECQALRSIRHRNLVKII 224
           +G+G FG V+ G +        VA+K++     GA     FI E + +  + H NLV++ 
Sbjct: 12  LGSGQFGVVHLGKWRGKID---VAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQLY 65

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C     Q   F  +V E M NG L  +L   R+    L     L +  DV   +EYL 
Sbjct: 66  GVCTK---QRPIF--IVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLE 117

Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYA 344
                  +H DL   N L+  +    VSDFGLA+++      L    +SS G K  V +A
Sbjct: 118 SNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV------LDDQYTSSQGTKFPVKWA 168

Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            PE    S  S+  DV+SFG+L+ E+F+ GK P
Sbjct: 169 PPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  100 bits (252), Expect = 6e-24
 Identities = 68/273 (24%), Positives = 112/273 (41%), Gaps = 38/273 (13%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQAL-RSIR 216
           F    +IG GSF +V        + E   A+K+L+ +        K    E + L R   
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKE--YAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H  ++K+  +     FQ  +    V E   NG L +++        +L+       A ++
Sbjct: 61  HPGIIKLYYT-----FQDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAEI 111

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE----AANNLSSNQS 332
              LEYLH      I+H DLKP N+LLD ++   ++DFG AK L       +N   +   
Sbjct: 112 LLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168

Query: 333 SSVGVK---------GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG 383
            S   K         GT  Y +PE         S D+++ G ++ +M TGK P       
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS-NE 227

Query: 384 NLTLHNFVKEAL------PERLAEIVDPVLLVE 410
            LT    +K         P    ++++ +L+++
Sbjct: 228 YLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLD 260

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  100 bits (250), Expect = 9e-24
 Identities = 71/224 (31%), Positives = 101/224 (45%), Gaps = 28/224 (12%)

Query: 165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHRNLVK 222
           N IG G+FG VY  + + D  E L+AVK + +Q       K    E + L  ++H NLVK
Sbjct: 6   NKIGGGTFGKVYTAV-NLDTGE-LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 223 IITSCVSVDFQGNDFEALVY---ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
                  V+         VY   E    G+LEE L   R      ++++  ++ +     
Sbjct: 64  ----YYGVEVHREK----VYIFMEYCSGGTLEELLEHGRILD--EHVIRVYTLQLLEG-- 111

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           L YLH      IVH D+KP+N+ LD      + DFG A  L      +     S     G
Sbjct: 112 LAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA---G 165

Query: 340 TVGYAAPEYGMGSEVSTSG---DVYSFGILLLEMFTGKGPTNEM 380
           T  Y APE   G +    G   D++S G ++LEM TGK P +E+
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 98.8 bits (247), Expect = 2e-23
 Identities = 63/222 (28%), Positives = 101/222 (45%), Gaps = 43/222 (19%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA-ECQALRSIRHRNLVKIIT 225
           +G GS G VYK    H     + A+K +++      +  +  E + LRS     +VK   
Sbjct: 9   LGQGSSGVVYKVR--HKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK--- 63

Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL---------SIAVDV 276
            C    ++  +  ++V E M  GSL +             LL+++          IA  +
Sbjct: 64  -CYGAFYKEGEI-SIVLEYMDGGSLAD-------------LLKKVGKIPEPVLAYIARQI 108

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
              L+YLH   +  I+H D+KPSN+L+   GE    ++DFG++K L    +  ++     
Sbjct: 109 LKGLDYLHT--KRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCNTFV--- 161

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
               GTV Y +PE   G   S + D++S G+ LLE   GK P
Sbjct: 162 ----GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 98.2 bits (245), Expect = 4e-23
 Identities = 70/220 (31%), Positives = 103/220 (46%), Gaps = 26/220 (11%)

Query: 167 IGAGSFGSVYKGIF-DHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLVKII 224
           +G G+FGSV KG++      E  VAVK L  +H  A K  F+ E   +  + H  +V++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C            LV EL   G L ++L   R+ P   +L +   +A  VA  + YL 
Sbjct: 63  GVCKGEPLM------LVMELAPLGPLLKYLKKRREIP-VSDLKE---LAHQVAMGMAYLE 112

Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYA 344
                  VH DL   NVLL     A +SDFG+++    A    S    ++   +  + + 
Sbjct: 113 ---SKHFVHRDLAARNVLLVNRHQAKISDFGMSR----ALGAGSDYYRATTAGRWPLKWY 165

Query: 345 APE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
           APE   YG   + S+  DV+S+G+ L E F+ G  P  EM
Sbjct: 166 APECINYG---KFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 61/214 (28%), Positives = 108/214 (50%), Gaps = 21/214 (9%)

Query: 167 IGAGSFGSVYKGIF--DHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVKI 223
           +G+G+FG+VYKG++  + +  +  VA+KVL       A+K  + E   + S+ H ++V++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+S   Q      L+ +LM  G L +++  ++D   N+     L+  V +A  + YL
Sbjct: 75  LGICLSSQVQ------LITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYL 125

Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGY 343
               E  +VH DL   NVL+       ++DFGLAK L      +   +  + G K  + +
Sbjct: 126 E---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD-----VDEKEYHAEGGKVPIKW 177

Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            A E  +    +   DV+S+G+ + E+ T G  P
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 78/218 (35%), Positives = 110/218 (50%), Gaps = 28/218 (12%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
             L   IG G FG V  G    D     VAVK +  ++   +++F+AE   +  +RH NL
Sbjct: 8   LKLLQTIGKGEFGDVMLG----DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNL 61

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN-LNLLQRLSIAVDVAST 279
           V+++   V V+ +G  +  +V E M  GSL ++L   R   R+ L     L  ++DV   
Sbjct: 62  VQLLG--VIVEEKGGLY--IVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEA 114

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           +EYL        VH DL   NVL+  +  A VSDFGL K   EA    SS Q +    K 
Sbjct: 115 MEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EA----SSTQDTG---KL 161

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            V + APE     + ST  DV+SFGILL E+++ G+ P
Sbjct: 162 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.0 bits (236), Expect = 4e-22
 Identities = 71/222 (31%), Positives = 114/222 (51%), Gaps = 30/222 (13%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
            +L  +IG G FG+V +G +        VAVK  N++    +++F+ E   +  + H+NL
Sbjct: 8   LTLGEIIGEGEFGAVLQGEYTGQK----VAVK--NIKCDVTAQAFLEETAVMTKLHHKNL 61

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNL-NLLQRLSIAVDVAST 279
           V+++   +           +V ELM  G+L  +L   R   R L +++Q L  ++DVA  
Sbjct: 62  VRLLGVILHNGLY------IVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEG 112

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           +EYL       +VH DL   N+L+  +  A VSDFGLA+      +N      S + VK 
Sbjct: 113 MEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN------SKLPVKW 163

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
           T    APE     + S+  DV+S+G+LL E+F+ G+ P  +M
Sbjct: 164 T----APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 95.2 bits (237), Expect = 6e-22
 Identities = 74/231 (32%), Positives = 111/231 (48%), Gaps = 40/231 (17%)

Query: 167 IGAGSFGSVYKGIFDH---DDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG V+ G   H   ++ + LVAVK L       A K F  E + L + +H N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN-RDA---------PRNLNLLQRLSI 272
               C     +G D   +V+E M +G L ++L  +  DA            L L Q L I
Sbjct: 73  FYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQI 127

Query: 273 AVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSN 330
           AV +AS + YL   H+     VH DL   N L+  +L   + DFG+++       ++ + 
Sbjct: 128 AVQIASGMVYLASQHF-----VHRDLATRNCLVGYDLVVKIGDFGMSR-------DVYTT 175

Query: 331 QSSSVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
               VG  G     + +  PE  M  + +T  DV+SFG++L E+FT GK P
Sbjct: 176 DYYRVG--GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 93.8 bits (233), Expect = 1e-21
 Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 34/229 (14%)

Query: 167 IGAGSFGSV----YKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G FG V    ++G +D       VA+K++  +   +   FI E + +  + H  LV+
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-------VAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQ 63

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +   C     Q   +  +V E M NG L  +L   R+  +     Q L +  DV   + Y
Sbjct: 64  LYGVCTK---QRPIY--IVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCKDVCEGMAY 115

Query: 283 L--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
           L    +     +H DL   N L+D +    VSDFGL++++      L    +SSVG K  
Sbjct: 116 LESKQF-----IHRDLAARNCLVDDQGCVKVSDFGLSRYV------LDDEYTSSVGSKFP 164

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
           V ++ PE  + S+ S+  DV++FG+L+ E+++ GK P            
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 94.5 bits (236), Expect = 1e-21
 Identities = 69/229 (30%), Positives = 96/229 (41%), Gaps = 43/229 (18%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---------LQHRGASKSFIAEC 209
           D F     +G GSFG V   +  H       A+K+L+         ++H       + E 
Sbjct: 1   DDFEFIKTLGTGSFGRVM--LVRHKGSGKYYALKILSKAKIVKLKQVEH------VLNEK 52

Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
           + L+SIRH  LV +  S     FQ +    LV E +  G L  + HL +           
Sbjct: 53  RILQSIRHPFLVNLYGS-----FQDDSNLYLVMEYVPGGEL--FSHLRKS--GRFPEPVA 103

Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD--GELTAHVSDFGLAKFLPEAANNL 327
              A  V   LEYLH   +  IV+ DLKP N+LLD  G +   ++DFG AK +      L
Sbjct: 104 RFYAAQVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIK--ITDFGFAKRVKGRTYTL 158

Query: 328 SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                      GT  Y APE  +      + D ++ GIL+ EM  G  P
Sbjct: 159 C----------GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 93.8 bits (233), Expect = 1e-21
 Identities = 64/224 (28%), Positives = 112/224 (50%), Gaps = 22/224 (9%)

Query: 163 LENLIGAGSFGSVYKGIFDH-DDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNL 220
           +E +IGAG FG V +G        E  VA+K L   +     + F++E   +    H N+
Sbjct: 8   IEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67

Query: 221 VK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           +    ++T    V         ++ E M NG+L+ +L  N        ++Q + +   +A
Sbjct: 68  IHLEGVVTKSRPV--------MIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIA 116

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
           + ++YL    E   VH DL   N+L++  L   VSDFGL++FL +  ++     +SS+G 
Sbjct: 117 AGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD--PTYTSSLGG 171

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLE-MFTGKGPTNEM 380
           K  + + APE     + +++ DV+S+GI++ E M  G+ P  +M
Sbjct: 172 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 92.3 bits (229), Expect = 4e-21
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 26/213 (12%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA--SKSFIAECQALRSIRHRNLVKII 224
           IG+G FG V+ G +        VA+K +     GA   + FI E Q +  + H  LV++ 
Sbjct: 12  IGSGQFGLVWLGYWLEKRK---VAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C            LV+E M +G L ++L   R       LL    + +DV   + YL 
Sbjct: 66  GVCTE-----RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLG---MCLDVCEGMAYLE 117

Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYA 344
                 ++H DL   N L+       VSDFG+ +F+      L    +SS G K  V ++
Sbjct: 118 SSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV------LDDQYTSSTGTKFPVKWS 168

Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           +PE    S+ S+  DV+SFG+L+ E+F+ GK P
Sbjct: 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 92.4 bits (230), Expect = 4e-21
 Identities = 63/228 (27%), Positives = 109/228 (47%), Gaps = 31/228 (13%)

Query: 162 SLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQHRGASKS----FIAECQALRSIR 216
           ++E +IG G FG V +G        E  VA+K L     G+S      F+ E   +    
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL---KAGSSDKQRLDFLTEASIMGQFD 63

Query: 217 HRNLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
           H N+++   ++T    V         ++ E M NGSL+++L  N        + Q + + 
Sbjct: 64  HPNIIRLEGVVTKSRPV--------MIITEYMENGSLDKFLRENDG---KFTVGQLVGML 112

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
             +AS ++YL        VH DL   N+L++  L   VSDFGL++ L ++    ++    
Sbjct: 113 RGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK--- 166

Query: 334 SVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             G K  + + APE     + +++ DV+SFGI++ E+ + G+ P  +M
Sbjct: 167 --GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 92.2 bits (230), Expect = 7e-21
 Identities = 58/224 (25%), Positives = 105/224 (46%), Gaps = 32/224 (14%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     LVA+K + +++   G   + I E + L+ +RH N+V++ 
Sbjct: 7   IGEGTYGQVYKAR--NKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64

Query: 225 TSCVSVDFQGNDFEALVYELM---VNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
               S   +G+ +  +V+E M   + G     L  + +        Q       +   L+
Sbjct: 65  EIVTS-KGKGSIY--MVFEYMDHDLTG-----LLDSPEVK--FTESQIKCYMKQLLEGLQ 114

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAANNLSSNQSSSVGVKGT 340
           YLH      I+H D+K SN+L++ +    ++DFGLA+      + + ++       V  T
Sbjct: 115 YLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNR------VI-T 164

Query: 341 VGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGP---TNEM 380
           + Y  PE  +G+       D++S G +L E+F GK     + E+
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 91.1 bits (226), Expect = 1e-20
 Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 27/215 (12%)

Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 9   TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 65

Query: 222 KIITSCVSVDFQGNDFEALVY---ELMVNGSLEEWLHLNRDAPRN-LNLLQRLSIAVDVA 277
           +++  C          E   Y   E M  G+L ++L   R+  R  +N +  L +A  ++
Sbjct: 66  QLLGVCTR--------EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQIS 114

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
           S +EYL    +   +H DL   N L+       V+DFGL++ +           ++  G 
Sbjct: 115 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------DTYTAHAGA 165

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           K  + + APE    ++ S   DV++FG+LL E+ T
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 90.0 bits (223), Expect = 4e-20
 Identities = 69/217 (31%), Positives = 100/217 (46%), Gaps = 34/217 (15%)

Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVL----NLQHRGASKSFIAECQALRSIRHRNL 220
           +G G FG V    +D  +D    +VAVK L      Q+      +  E   L+++ H N+
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT---SGWKKEINILKTLYHENI 68

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN-LNLLQRLSIAVDVAST 279
           VK    C     QG     L+ E +  GSL ++L      P++ LNL Q L  A  +   
Sbjct: 69  VKYKGCCSE---QGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEG 119

Query: 280 LEYLH--HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAN--NLSSNQSSSV 335
           + YLH  HY     +H DL   NVLLD +    + DFGLAK +PE      +  +  S  
Sbjct: 120 MAYLHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP- 173

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                V + A E    ++ S + DV+SFG+ L E+ T
Sbjct: 174 -----VFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 89.8 bits (223), Expect = 4e-20
 Identities = 69/211 (32%), Positives = 103/211 (48%), Gaps = 19/211 (9%)

Query: 166 LIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLV 221
            +G G+FGSV    +D   D+   +VAVK   LQH  A   + F  E + L+S++H N+V
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           K    C S    G     LV E +  GSL ++L  +R+   +  LL   S    +   +E
Sbjct: 69  KYKGVCYSA---GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS---QICKGME 122

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           YL        VH DL   N+L++ E    + DFGL K LP+        +      +  +
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPG----ESPI 175

Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            + APE    S+ S + DV+SFG++L E+FT
Sbjct: 176 FWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.9 bits (220), Expect = 6e-20
 Identities = 68/222 (30%), Positives = 112/222 (50%), Gaps = 24/222 (10%)

Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR 216
             +   L   +G G FG V+ G ++ +   T VAVK L      + +SF+ E Q ++ +R
Sbjct: 4   PRESLQLIKKLGNGQFGEVWMGTWNGN---TKVAVKTLK-PGTMSPESFLEEAQIMKKLR 59

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP-RNLNLLQRLSIAVD 275
           H  LV++  + VS      +   +V E M  GSL ++L   +D   R L L   + +A  
Sbjct: 60  HDKLVQLY-AVVS-----EEPIYIVTEYMSKGSLLDFL---KDGEGRALKLPNLVDMAAQ 110

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           VA+ + Y+        +H DL+ +N+L+   L   ++DFGLA+ + +  N  ++ Q    
Sbjct: 111 VAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQ---- 161

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           G K  + + APE  +    +   DV+SFGILL E+ T G+ P
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 88.3 bits (220), Expect = 8e-20
 Identities = 60/228 (26%), Positives = 93/228 (40%), Gaps = 27/228 (11%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           + +   IG GSFG VY      D    L  +K ++L +      +  + E + L+ + H 
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDG--KLYVLKEIDLSNMSEKEREDALNEVKILKKLNHP 59

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL--QRLSIAVDV 276
           N++K   S     F+      +V E    G L +   + +           Q L   V +
Sbjct: 60  NIIKYYES-----FEEKGKLCIVMEYADGGDLSQ--KIKKQKKEGKPFPEEQILDWFVQL 112

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
              L+YLH      I+H D+KP N+ L       + DFG++K        LSS    +  
Sbjct: 113 CLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-------LSSTVDLAKT 162

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           V GT  Y +PE       +   D++S G +L E+ T K P    F G 
Sbjct: 163 VVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 88.2 bits (218), Expect = 1e-19
 Identities = 68/219 (31%), Positives = 112/219 (51%), Gaps = 22/219 (10%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 6   ESLRLEVKLGQGCFGEVWMGTWNG---TTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 61

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 62  KLVQLY-AVVS-----EEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIAS 113

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +  N  ++ Q    G K
Sbjct: 114 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQ----GAK 164

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             + + APE  +    +   DV+SFGILL E+ T G+ P
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 87.8 bits (218), Expect = 1e-19
 Identities = 67/239 (28%), Positives = 105/239 (43%), Gaps = 25/239 (10%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETL-VAVKVL---NLQHRGASKSFIAECQALRSIRHRNLV 221
            +G GSFG V +G +     + + VAVK L    L        F+ E   + S+ H NL+
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLI 59

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           ++    ++          +V EL   GSL + L  +      ++ L     AV +A+ + 
Sbjct: 60  RLYGVVLTHPLM------MVTELAPLGSLLDRLRKDALGHFLISTL--CDYAVQIANGMR 111

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           YL        +H DL   N+LL  +    + DFGL + LP+  ++    +   V      
Sbjct: 112 YLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV----PF 164

Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERL 399
            + APE       S + DV+ FG+ L EMFT G+ P   + +G+  L    KE   ERL
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEG--ERL 220

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 88.3 bits (219), Expect = 4e-19
 Identities = 74/248 (29%), Positives = 118/248 (47%), Gaps = 34/248 (13%)

Query: 138 PPSALLASVLRVSYQNLFKATDGFS-LE--NLIGAGSFGSVYKGIFDHDDHETLVAVKVL 194
           P S+  +S    +  +   A    S LE  N IG+G+ G+VYK I  H     L A+KV+
Sbjct: 50  PSSSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVI--HRPTGRLYALKVI 107

Query: 195 NLQHRGASKSFIA-ECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEW 253
              H    +  I  E + LR + H N+VK    C  +     + + L+ E M  GSLE  
Sbjct: 108 YGNHEDTVRRQICREIEILRDVNHPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEG- 161

Query: 254 LHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD 313
            H+  +            +A  + S + YLH      IVH D+KPSN+L++      ++D
Sbjct: 162 THIADEQ-------FLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIAD 211

Query: 314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE-----YGMGSEVSTSGDVYSFGILLL 368
           FG+++ L +  +      +SSV   GT+ Y +PE        G+    +GD++S G+ +L
Sbjct: 212 FGVSRILAQTMDPC----NSSV---GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264

Query: 369 EMFTGKGP 376
           E + G+ P
Sbjct: 265 EFYLGRFP 272

Length = 353

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 68/253 (26%), Positives = 119/253 (47%), Gaps = 29/253 (11%)

Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-------RGASKSF---IAEC 209
            +++   +G+G+FG VYK +   ++ + L+A+K +N+ +       R   KS    ++E 
Sbjct: 1   EYAVLEHLGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59

Query: 210 QALR-SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQ 268
             ++  +RH N+V+   +     F  ND   +V +L+    L E  +  ++  +     +
Sbjct: 60  TIIKEQLRHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEER 114

Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLS 328
             +I V +   L YLH   E  IVH DL P+N++L  +    ++DFGLAK          
Sbjct: 115 IWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--------QK 164

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP--TNEMFTGNLT 386
             +S    V GT+ Y+ PE           DV++FG +L +M T + P  +  M +    
Sbjct: 165 QPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK 224

Query: 387 LHNFVKEALPERL 399
           +   V E LPE +
Sbjct: 225 IVEAVYEPLPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 86.4 bits (214), Expect = 5e-19
 Identities = 62/213 (29%), Positives = 86/213 (40%), Gaps = 23/213 (10%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +G G FG V            + A K L+   L+ R   +  + E + L  +  R +V  
Sbjct: 1   LGKGGFGEVCA--CQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIV-- 56

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
               ++  F+  D   LV  LM  G L+   H+           + +  A  +   LE+L
Sbjct: 57  ---SLAYAFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFPEARAIFYAAQIICGLEHL 111

Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGY 343
           H   +  IV+ DLKP NVLLD      +SD GLA  L               G  GT GY
Sbjct: 112 H---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--------GKKIKGRAGTPGY 160

Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            APE   G     S D ++ G  L EM  G+ P
Sbjct: 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 86.4 bits (214), Expect = 6e-19
 Identities = 73/251 (29%), Positives = 113/251 (45%), Gaps = 45/251 (17%)

Query: 165 NLIGAGSFGSVYKG----IFDHDDHETLVAVKVLNLQHRGAS----KSFIAECQALRSIR 216
           N +G+G+FG VY+G    I         VAVK L    +GA+    K F+ E   + +  
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEKKEFLKEAHLMSNFN 57

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA------PRNLNLLQRL 270
           H N+VK++  C+      N+ + ++ ELM  G L   L   RDA      P  L L + L
Sbjct: 58  HPNIVKLLGVCLL-----NEPQYIIMELMEGGDL---LSYLRDARVERFGPPLLTLKELL 109

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL-----DGELTAHVSDFGLAKFLPEAAN 325
            I +DVA    YL    +   +H DL   N L+     D +    + DFGLA+       
Sbjct: 110 DICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR------- 159

Query: 326 NLSSNQSSSVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFT 382
           ++  +       +G   V + APE  +  + +T  DV+SFG+L+ E+ T G+ P   +  
Sbjct: 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-- 217

Query: 383 GNLTLHNFVKE 393
            N  +   V  
Sbjct: 218 NNQEVLQHVTA 228

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 86.2 bits (213), Expect = 7e-19
 Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 24/223 (10%)

Query: 164 ENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLV 221
           + +IGAG FG V++GI       E  VA+K L   +    +  F++E   +    H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           ++    V   F+      ++ E M NG+L+++L   RD     +  Q + +   +A+ ++
Sbjct: 70  RL--EGVVTKFKP---AMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMK 121

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAANNLSSNQSSSVGVK 338
           YL    +   VH DL   N+L++  L   VSDFGL++ L   PE     S       G K
Sbjct: 122 YL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS-------GGK 171

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             + + APE     + +++ DV+SFGI++ E+ + G+ P  +M
Sbjct: 172 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 26/221 (11%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVKI 223
           I  G++G V+           + A+KV+    +  +      + E   L   +   +VK+
Sbjct: 1   ISKGAYGRVFLAK--KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLH----LNRDAPRNLNLLQRLSIAVDVAST 279
             S     FQG     LV E +  G L   L     L+ D  R            ++   
Sbjct: 59  YYS-----FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLA 105

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAANNLSSNQSSSVGVK 338
           LEYLH      I+H DLKP N+L+D      ++DFGL+K  L     NL+ ++     + 
Sbjct: 106 LEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
           GT  Y APE  +G   S + D +S G +L E   G  P + 
Sbjct: 163 GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 25/212 (11%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+ G VYK        E  VA+K + L+ +   +  I E   ++  +H N+V    S
Sbjct: 27  IGEGASGEVYKATDRATGKE--VAIKKMRLR-KQNKELIINEILIMKDCKHPNIVDYYDS 83

Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E M  GSL + +  N      +N  Q   +  +V   LEYLH  
Sbjct: 84  -----YLVGDELWVVMEYMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLH-- 133

Query: 287 CETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYA 344
               ++H D+K  N+LL  DG +   ++DFG A         L+  +S    V GT  + 
Sbjct: 134 -SQNVIHRDIKSDNILLSKDGSVK--LADFGFAA-------QLTKEKSKRNSVVGTPYWM 183

Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           APE     +     D++S GI+ +EM  G+ P
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 70/224 (31%), Positives = 103/224 (45%), Gaps = 35/224 (15%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK-SFIAECQALRSIRHRNLVKII 224
            IG G+FG VYKG+       T VAVK          K  F+ E + L+   H N+VK+I
Sbjct: 2   KIGKGNFGDVYKGVLKG---NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58

Query: 225 TSCVSVDFQGNDFEAL--VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
             CV         + +  V EL+  GSL  +L   ++      LLQ   +++D A+ +EY
Sbjct: 59  GVCV-------QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQ---MSLDAAAGMEY 108

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL--SSNQSSSVGVKGT 340
           L        +H DL   N L+       +SDFG+++   E    +   S+    + +K T
Sbjct: 109 LESKN---CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWT 162

Query: 341 VGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
               APE   YG     ++  DV+S+GILL E F+ G  P   M
Sbjct: 163 ----APEALNYG---RYTSESDVWSYGILLWETFSLGDTPYPGM 199

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.8 bits (207), Expect = 5e-18
 Identities = 68/228 (29%), Positives = 109/228 (47%), Gaps = 30/228 (13%)

Query: 162 SLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRN 219
            +E +IGAG FG V  G        E  VA+K L   +     + F++E   +    H N
Sbjct: 7   KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 220 LVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           ++    ++T    V         +V E M NGSL+ +L   R       ++Q + +   +
Sbjct: 67  IIHLEGVVTKSKPV--------MIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGI 115

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAANNLSSNQSS 333
           AS ++YL    +   VH DL   N+L++  L   VSDFGL++ L   PEAA        +
Sbjct: 116 ASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA-------YT 165

Query: 334 SVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLE-MFTGKGPTNEM 380
           + G K  + + APE     + +++ DV+S+GI++ E M  G+ P  EM
Sbjct: 166 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 84.0 bits (207), Expect = 6e-18
 Identities = 67/225 (29%), Positives = 117/225 (52%), Gaps = 28/225 (12%)

Query: 166 LIGAGSFGSVYKGIF--DHDDHETLVAVKVLNLQHRG--ASKSFIAECQALRSIRHRNLV 221
           ++G+G+FG+VYKGI+  + +  +  VA+K+LN +  G  A+  F+ E   + S+ H +LV
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           +++  C+S   Q      LV +LM +G L +++H ++D   N+     L+  V +A  + 
Sbjct: 73  RLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMM 123

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           YL    E  +VH DL   NVL+       ++DFGLA+ L       +++     G K  +
Sbjct: 124 YLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD-----GGKMPI 175

Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG------PTNEM 380
            + A E     + +   DV+S+G+ + E+ T  G      PT E+
Sbjct: 176 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 53/210 (25%), Positives = 99/210 (47%), Gaps = 20/210 (9%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA---ECQALRSIRHRNLVK 222
           L+G+G FG+V+KGI+  +     + V +  +Q R   ++F        A+ S+ H  +V+
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           ++  C     Q      LV +L   GSL + +  +RD   +L+  + L+  V +A  + Y
Sbjct: 74  LLGICPGASLQ------LVTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYY 124

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           L  +    +VH +L   N+LL  +    ++DFG+A  L         ++      K  + 
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE-----HKTPIK 176

Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + A E  +    +   DV+S+G+ + EM +
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 82.6 bits (204), Expect = 8e-18
 Identities = 64/235 (27%), Positives = 111/235 (47%), Gaps = 32/235 (13%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   L   +GAG FG V+ G ++     T VA+K L  Q   + ++F+AE   ++ ++H 
Sbjct: 6   ETLKLVKKLGAGQFGEVWMGYYNGH---TKVAIKSLK-QGSMSPEAFLAEANLMKQLQHP 61

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++                ++ E M NGSL ++L         L + + + +A  +A 
Sbjct: 62  RLVRLYAVVTQEPIY------IITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAE 113

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            + ++        +H DL+ +N+L+   L   ++DFGLA+ + +      +  ++  G K
Sbjct: 114 GMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIED------NEYTAREGAK 164

Query: 339 GTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP----TNEMFTGNL 385
             + + APE   YG     +   DV+SFGILL E+ T G+ P    TN     NL
Sbjct: 165 FPIKWTAPEAINYGT---FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 22/216 (10%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           F +   +G GS+GSVYK I  H +   +VA+KV+ ++     +  I E   L+      +
Sbjct: 5   FDILEKLGEGSYGSVYKAI--HKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYI 60

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK   S     +  N    +V E    GS+ + + +     + L   +  +I       L
Sbjct: 61  VKYYGS-----YFKNTDLWIVMEYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGL 112

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
           EYLH       +H D+K  N+LL+ E  A ++DFG++         L+   +    V GT
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSG-------QLTDTMAKRNTVIGT 162

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             + APE       +   D++S GI  +EM  GK P
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 82.6 bits (204), Expect = 1e-17
 Identities = 69/226 (30%), Positives = 109/226 (48%), Gaps = 36/226 (15%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNL---------QHRGASKSFIAECQALRSIR 216
           LIG+GSFGSVY G+  +     L+AVK + L         + R    +   E   L+ ++
Sbjct: 7   LIGSGSFGSVYLGM--NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 217 HRNLVKIITSCVSVDFQGNDFEAL----VYELMVN-GSLEEWLHLNRDAPRNLNLLQRLS 271
           H N+V+ + S +  D      E +    V  L+ N G+ EE L  N              
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN-------------- 110

Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLS-SN 330
               +   L YLH+     I+H D+K +N+L+D +    +SDFG++K L   AN+LS   
Sbjct: 111 FVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKT 165

Query: 331 QSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             +   ++G+V + APE    +  +   D++S G L++EM TGK P
Sbjct: 166 NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 38/235 (16%)

Query: 161 FSLENL-----IGAGSFGSVYKGIF---DHDDHETLVAVKVLNLQHRGASKS-FIAECQA 211
             L  +     +G G+FG VYKG     +     T VA+K L        +  F  E + 
Sbjct: 2   IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAEL 61

Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN------------RD 259
           +  ++H N+V ++  C            +++E + +G L E+L  N              
Sbjct: 62  MSDLQHPNIVCLLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 260 APRNLNLLQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA 317
              +L+    L IA+ +A+ +EYL  HH+     VH DL   N L+   LT  +SDFGL+
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHHF-----VHRDLAARNCLVGEGLTVKISDFGLS 171

Query: 318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + +  A  +    QS S+     V +  PE  +  + +T  D++SFG++L E+F+
Sbjct: 172 RDIYSA--DYYRVQSKSL---LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 82.3 bits (203), Expect = 2e-17
 Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 36/229 (15%)

Query: 167 IGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKI 223
           +G G+FG V+     +   +  + LVAVK L      A + F  E + L  ++H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN-----------RDAPRNLNLLQRLSI 272
              C            +V+E M +G L  +L  +             AP  L L Q L+I
Sbjct: 73  YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 273 AVDVASTLEYLH--HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSN 330
           A  +AS + YL   H+     VH DL   N L+   L   + DFG+++       ++ S 
Sbjct: 128 ASQIASGMVYLASLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSR-------DIYST 175

Query: 331 QSSSVGVKGT--VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
               VG +    + +  PE  +  + +T  D++SFG++L E+FT GK P
Sbjct: 176 DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 67/213 (31%), Positives = 101/213 (47%), Gaps = 26/213 (12%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA--SKSFIAECQALRSIRHRNLVKII 224
           +G+G FG V+ G +     +  VA+K +N    GA   + FI E + +  + H  LV++ 
Sbjct: 12  LGSGQFGVVHLGKWRA---QIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLY 65

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C     Q   +  +V E M NG L  +L   +       LL   S+  DV   +EYL 
Sbjct: 66  GVCTQ---QKPLY--IVTEFMENGCLLNYLRQRQGKLSKDMLL---SMCQDVCEGMEYLE 117

Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYA 344
                  +H DL   N L+       VSDFG+ +++      L    +SS G K  V ++
Sbjct: 118 ---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV------LDDEYTSSSGAKFPVKWS 168

Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            PE    S+ S+  DV+SFG+L+ E+FT GK P
Sbjct: 169 PPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 70/234 (29%), Positives = 105/234 (44%), Gaps = 37/234 (15%)

Query: 163 LENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
           L+  +G G+FG V+            + LVAVK L      A K F  E + L +++H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN------------RDAPRNLNLL 267
           +VK    C        D   +V+E M +G L ++L  +            R A   L L 
Sbjct: 69  IVKFYGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 123

Query: 268 QRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAN 325
           Q L IA  +AS + YL   H+     VH DL   N L+   L   + DFG+++       
Sbjct: 124 QMLHIASQIASGMVYLASQHF-----VHRDLATRNCLVGANLLVKIGDFGMSR------- 171

Query: 326 NLSSNQSSSVGVKGT--VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           ++ S     VG      + +  PE  M  + +T  DV+SFG++L E+FT GK P
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 81.3 bits (200), Expect = 3e-17
 Identities = 64/219 (29%), Positives = 108/219 (49%), Gaps = 22/219 (10%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   L+  +G G FG V+ G ++     T VA+K L        ++F+ E Q ++ +RH 
Sbjct: 6   ESLRLDVKLGQGCFGEVWMGTWNG---TTKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHD 61

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV +  + VS      +   +V E M  GSL ++L       + L L Q + +A  +A 
Sbjct: 62  KLVPLY-AVVS-----EEPIYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIAD 113

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            + Y+        +H DL+ +N+L+   L   ++DFGLA+ + +  N  ++ Q    G K
Sbjct: 114 GMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIED--NEYTARQ----GAK 164

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             + + APE  +    +   DV+SFGILL E+ T G+ P
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK   D    E +VA+K + L+    G  K+ + E + L+ + H N++K++
Sbjct: 7   IGEGTYGVVYKA-RDKLTGE-IVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V     D   LV+E M      +   L +D  R L      S    +   L + H
Sbjct: 65  ----DVFRHKGDL-YLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYA 344
            +    I+H DLKP N+L++ E    ++DFGLA+       +  S          T  Y 
Sbjct: 116 SH---GILHRDLKPENLLINTEGVLKLADFGLAR-------SFGSPVRPYTHYVVTRWYR 165

Query: 345 APEYGMGSEVSTSG-DVYSFGILLLEMFTGK 374
           APE  +G +  ++  D++S G +  E+ + +
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 66/227 (29%), Positives = 103/227 (45%), Gaps = 30/227 (13%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS-KSFIAECQALRSIRH 217
           D + L  +IG G+   VY  I    ++E  VA+K ++L+    S      E QA+    H
Sbjct: 1   DDYELIEVIGVGATAVVYAAICL-PNNEK-VAIKRIDLEKCQTSVDELRKEVQAMSQCNH 58

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV--- 274
            N+VK  TS     F   D   LV   +  GSL   L + + +      L    IA    
Sbjct: 59  PNVVKYYTS-----FVVGDELWLVMPYLSGGSL---LDIMKSSYPR-GGLDEAIIATVLK 109

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
           +V   LEYLH   +   +H D+K  N+LL  + +  ++DFG++  L +  +     + + 
Sbjct: 110 EVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166

Query: 335 VGVKGTVGYAAPE-----YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           V   GT  + APE     +G   +     D++SFGI  +E+ TG  P
Sbjct: 167 V---GTPCWMAPEVMEQVHGYDFKA----DIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 80.6 bits (199), Expect = 5e-17
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 21/218 (9%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHR 218
           F + N IG GSFG V+K +   D    + A+K ++L   +R   +  I E + L  +   
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKR--VYAMKQIDLSKMNRREREEAIDEARVLAKLDSS 59

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            +++   S     F       +V E   NG L + L + R  P   + + R  I + +  
Sbjct: 60  YIIRYYES-----FLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG- 113

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            L +LH      I+H D+K  N+ LD      + D G+AK L  + N   +N      + 
Sbjct: 114 -LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANT-----IV 162

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           GT  Y +PE       +   DV++ G++L E  TGK P
Sbjct: 163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 80.9 bits (200), Expect = 5e-17
 Identities = 63/234 (26%), Positives = 112/234 (47%), Gaps = 28/234 (11%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDD--HETLVAVKVLNLQHRGASKS----FIAECQAL 212
           D  +L +L+  G+FG ++ GI   +    E  V VK +      AS+      + E   L
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK---DHASEIQVTLLLQESCLL 62

Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN----LNLLQ 268
             + H+N++ I+  C     +  +   ++Y  M  G+L+ +L   R    N    L+  Q
Sbjct: 63  YGLSHQNILPILHVC----IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQ 118

Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAANNL 327
            + +A+ +A  + YLH      ++H D+   N ++D EL   ++D  L++ L P   + L
Sbjct: 119 LVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL 175

Query: 328 SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             N++  V       + A E  +  E S++ DV+SFG+LL E+ T G+ P  E+
Sbjct: 176 GDNENRPVK------WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 80.2 bits (198), Expect = 7e-17
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 15/214 (7%)

Query: 165 NLIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVK 222
            +IG G FG VY G + D D  +   AVK LN +      + F+ E   ++   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           ++  C+    +G+    L Y  M +G L    +  R    N  +   +   + VA  +EY
Sbjct: 61  LLGICL--PSEGSPLVVLPY--MKHGDL---RNFIRSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           L        VH DL   N +LD   T  V+DFGLA+ + +       N +   G K  V 
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT---GAKLPVK 167

Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           + A E     + +T  DV+SFG+LL E+ T   P
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 80.5 bits (199), Expect = 7e-17
 Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 35/222 (15%)

Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKS----FIAECQALRSIRHRN 219
           +G GSFG VY+G+       + ET VA+K +N     AS      F+ E   ++     +
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70

Query: 220 LVKIITSCVSVDFQGNDFEALV-YELMVNGSLEEWLHLNRDAPRNLN------LLQRLSI 272
           +V+++   VS    G     LV  ELM  G L+ +L   R    N        L + + +
Sbjct: 71  VVRLL-GVVS---TGQ--PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           A ++A  + YL        VH DL   N ++  +LT  + DFG+ + + E      ++  
Sbjct: 125 AAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE------TDYY 175

Query: 333 SSVGVKGT--VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
              G KG   V + APE       +T  DV+SFG++L EM T
Sbjct: 176 RKGG-KGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 67/214 (31%), Positives = 99/214 (46%), Gaps = 26/214 (12%)

Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGA-SKSFIAECQALRSIRHRNLVKI 223
           +G G FG V    +D +   T   VAVK L  +  G        E + LR++ H N+VK 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN---LNLLQRLSIAVDVASTL 280
              C      G +   L+ E + +GSL+E+L      PRN   +NL Q+L  AV +   +
Sbjct: 72  KGICTE---DGGNGIKLIMEFLPSGSLKEYL------PRNKNKINLKQQLKYAVQICKGM 122

Query: 281 EYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
           +YL    Y     VH DL   NVL++ E    + DFGL K +       +        + 
Sbjct: 123 DYLGSRQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD----LD 173

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
             V + APE  + S+   + DV+SFG+ L E+ T
Sbjct: 174 SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 68/223 (30%), Positives = 94/223 (42%), Gaps = 35/223 (15%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS---FIAECQALRSIRH 217
           F +   +G GSFG V   I  H       A+K L  +     K       E   L  + H
Sbjct: 20  FEMGETLGTGSFGRVR--IAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH 77

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             +V ++ S     FQ  +    + E +V G L  + HL R A R  N + +   A ++ 
Sbjct: 78  PFIVNMMCS-----FQDENRVYFLLEFVVGGEL--FTHL-RKAGRFPNDVAKFYHA-ELV 128

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
              EYLH      I++ DLKP N+LLD +    V+DFG AK +P+    L          
Sbjct: 129 LAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC--------- 176

Query: 338 KGTVGYAAPEY----GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            GT  Y APE     G G  V    D ++ G+LL E   G  P
Sbjct: 177 -GTPEYLAPEVIQSKGHGKAV----DWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 52/234 (22%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNL-----QHRGASKSFIAECQALRSIRHRNL 220
           L+G+GSFGSVY+G+  + D     AVK ++L       + A K    E   L  ++H N+
Sbjct: 7   LLGSGSFGSVYEGL--NLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64

Query: 221 VKIITSCVSVDFQGNDFEALVY---ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           V+ + +           E  +Y   EL+  GSL               LL++     +  
Sbjct: 65  VQYLGTERE--------EDNLYIFLELVPGGSLA-------------KLLKKYGSFPEPV 103

Query: 278 ---------STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLS 328
                      LEYLH   +   VH D+K +N+L+D      ++DFG+AK + E +   S
Sbjct: 104 IRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMF 381
                    KG+  + APE          + D++S G  +LEM TGK P +++ 
Sbjct: 161 --------FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 68/223 (30%), Positives = 98/223 (43%), Gaps = 27/223 (12%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGASKSFIA-ECQALRSIRH 217
           F+L   IG GSFG VYK I    D  T  +VA+KV++L+        I  E Q L   R 
Sbjct: 3   FTLLECIGKGSFGEVYKAI----DKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS 58

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             + K   S     F       ++ E    GS    L L +  P  L+      I  +V 
Sbjct: 59  PYITKYYGS-----FLKGSKLWIIMEYCGGGSC---LDLLK--PGKLDETYIAFILREVL 108

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
             LEYLH   E   +H D+K +N+LL  E    ++DFG+       +  L+S  S     
Sbjct: 109 LGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGV-------SGQLTSTMSKRNTF 158

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
            GT  + APE    S      D++S GI  +E+  G+ P +++
Sbjct: 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 23/226 (10%)

Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHRGASKS-FIAECQAL 212
             D  +L   +G G+FG VY+G++     D  E  VAVK L        +S F+ E   +
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQR 269
               H+N+V+     + V F+      ++ ELM  G L+ +L  NR   + P +L +   
Sbjct: 64  SKFNHQNIVR----LIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAANN 326
           L  A DVA   +YL    E   +H D+   N LL  +     A ++DFG+A+ +   A+ 
Sbjct: 119 LFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-YRASY 174

Query: 327 LSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                 + + +K    +  PE  +    ++  DV+SFG+LL E+F+
Sbjct: 175 YRKGGRAMLPIK----WMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 67/228 (29%), Positives = 110/228 (48%), Gaps = 25/228 (10%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETL-VAVKVLNLQHRGAS--KSFIAECQALRSIRH 217
             L  ++G G FGSV +G    DD   L VAVK + L     S  + F++E   ++   H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 218 RNLVKIITSCVSVDFQGNDFEAL-----VYELMVNGSLEEWLHLNR--DAPRNLNLLQRL 270
            N++K+I  C    F+ +  + +     +   M +G L  +L  +R    P  L L   L
Sbjct: 61  PNVMKLIGVC----FEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSN 330
              VD+A  +EYL +      +H DL   N +L  ++T  V+DFGL+K +  + +     
Sbjct: 117 KFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKI-YSGDYYRQG 172

Query: 331 QSSSVGVKGTVGYAAPEYGMGSEVSTS-GDVYSFGILLLEMFT-GKGP 376
           + + + VK    + A E  +   V TS  DV++FG+ + E+ T G+ P
Sbjct: 173 RIAKMPVK----WIAIE-SLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 26/223 (11%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ-HRGASKSFIAECQALRSIRHRNLV 221
           LE L G G++ +VYKG         +VA+K ++L    G   + I E   ++ ++H N+V
Sbjct: 5   LEKL-GEGTYATVYKGRNRTTGE--IVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           ++            +   LV+E M +  L++++  +      L+     S    +   + 
Sbjct: 62  RL-----HDVIHTENKLMLVFEYM-DKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIA 114

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           + H   E  ++H DLKP N+L++      ++DFGLA+      N  S+          T+
Sbjct: 115 FCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-------TL 164

Query: 342 GYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGK----GPTNE 379
            Y AP+  +GS   STS D++S G ++ EM TG+    G  NE
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE 207

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 77/242 (31%), Positives = 114/242 (47%), Gaps = 37/242 (15%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIR 216
           D F +   IG G++G VYK   D D  E LVA+K + L +   G   + I E + LR + 
Sbjct: 7   DKFDIIGQIGEGTYGQVYKAR-DKDTGE-LVALKKVRLDNEKEGFPITAIREIKILRQLN 64

Query: 217 HRNLVK---IITSCV-SVDFQGNDFEA--LVYELM---VNGSLEEWL-HLNRDAPRNLNL 266
           HRN+V    I+T    ++DF+  D  A  LV+E M   + G LE  L H + D       
Sbjct: 65  HRNIVNLKEIVTDKQDALDFK-KDKGAFYLVFEYMDHDLMGLLESGLVHFSED------- 116

Query: 267 LQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANN 326
               S    +   L Y H   +   +H D+K SN+LL+ +    ++DFGLA+      + 
Sbjct: 117 -HIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 327 LSSNQSSSVGVKGTVGYAAPEYGMGSEVST-SGDVYSFGILLLEMFTGKGPTNEMFTGNL 385
             +N+        T+ Y  PE  +G E    + DV+S G +L E+FT K     +F  N 
Sbjct: 173 PYTNKVI------TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK----PIFQANQ 222

Query: 386 TL 387
            L
Sbjct: 223 EL 224

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 68/225 (30%), Positives = 113/225 (50%), Gaps = 24/225 (10%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVKII 224
           +G+G+FG+V KG++     E  VAVK+L   +   +     + E   ++ + +  +V++I
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP-RNL-NLLQRLSIAVDVASTLEY 282
             C +  +       LV EL   G L ++L  N+    +N+  L+ ++S+       ++Y
Sbjct: 63  GICEAESWM------LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG------MKY 110

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           L    ET  VH DL   NVLL  +  A +SDFGL+K L    N     ++ + G K  V 
Sbjct: 111 LE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY---KAKTHG-KWPVK 163

Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           + APE     + S+  DV+SFG+L+ E F+ G+ P   M    +T
Sbjct: 164 WYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 43/224 (19%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA-ECQALRSIRH---RNLV 221
           LIG G++G+VY+G   H     +VA+K++NL       S I  E   L  +R     N+ 
Sbjct: 8   LIGRGAYGAVYRGK--HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 222 KIITS-------CVSVDF-QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
           K   S        + +++ +G      V  LM  G + E         + ++++ R    
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGS----VRTLMKAGPIAE---------KYISVIIR---- 108

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
            +V   L+Y+H      ++H D+K +N+L+       + DFG+A  L    N  SS +S+
Sbjct: 109 -EVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL----NQNSSKRST 160

Query: 334 SVGVKGTVGYAAPEYGM-GSEVSTSGDVYSFGILLLEMFTGKGP 376
            V   GT  + APE    G    T  D++S GI + EM TG  P
Sbjct: 161 FV---GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 78.3 bits (194), Expect = 4e-16
 Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 24/217 (11%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKV--LNLQHRGASKSFIAECQALRSIRHR 218
           +     +G G++G VYK   D    E  VA+K   L+ +  G   + + E   L+ ++H 
Sbjct: 1   YEKLEKLGEGTYGVVYKAR-DKKTGEI-VALKKIRLDNEEEGIPSTALREISLLKELKHP 58

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+VK++    +          LV+E   +  L+++L   R  P + NL++  SI   +  
Sbjct: 59  NIVKLLDVIHTERKL-----YLVFEYC-DMDLKKYLD-KRPGPLSPNLIK--SIMYQLLR 109

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            L Y H +    I+H DLKP N+L++ +    ++DFGLA+         +        V 
Sbjct: 110 GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE------VV 160

Query: 339 GTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGK 374
            T+ Y APE  +GS+  ST+ D++S G +  EM TGK
Sbjct: 161 -TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 59/220 (26%), Positives = 99/220 (45%), Gaps = 37/220 (16%)

Query: 165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIR---HRN 219
             IG G++G+VYK    +      VA+K +   L   G   S + E   L+ +    H N
Sbjct: 5   AEIGEGAYGTVYKARDLNTGR--FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNL------NLLQRLS 271
           +V+++  C            LV+E +     ++ L   L++     L      +L+++L 
Sbjct: 63  IVRLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLPPETIKDLMRQLL 117

Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQ 331
             VD      +LH +    IVH DLKP N+L+  +    ++DFGLA+          S +
Sbjct: 118 RGVD------FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY--------SFE 160

Query: 332 SSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
            +   V  T+ Y APE  + S  +T  D++S G +  E+F
Sbjct: 161 MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 24/218 (11%)

Query: 162 SLENL--IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA-SKSFIAECQALRSIRHR 218
            LE L  +GAG+ G V K +        ++AVK + L+   A  K  + E   L      
Sbjct: 2   DLEYLGELGAGNSGVVSKVLHRPTGK--IMAVKTIRLEINEAIQKQILRELDILHKCNSP 59

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            +V    +     +   D  ++  E M  GSL++ L   +       +L ++++AV    
Sbjct: 60  YIVGFYGAF----YNNGDI-SICMEYMDGGSLDKILKEVQG-RIPERILGKIAVAV--LK 111

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            L YLH   +  I+H D+KPSN+L++      + DFG++  L      ++S   + VG  
Sbjct: 112 GLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVG-- 161

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            T  Y APE   G++ S   D++S G+ L+E+ TG+ P
Sbjct: 162 -TSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 77.3 bits (190), Expect = 6e-16
 Identities = 62/216 (28%), Positives = 110/216 (50%), Gaps = 18/216 (8%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK-SFIAECQALRSIRHRNLVKIIT 225
           +G+G+FG V KG++     +  VA+KVL  ++  + +   + E + +  + +  +V++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
            C +          LV E+   G L ++L   +D     N+++ +     V+  ++YL  
Sbjct: 63  VCEAEALM------LVMEMASGGPLNKFLSGKKDEITVSNVVELMH---QVSMGMKYLE- 112

Query: 286 YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAA 345
                 VH DL   NVLL  +  A +SDFGL+K L   A++ S  ++ S G K  + + A
Sbjct: 113 --GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL--GADD-SYYKARSAG-KWPLKWYA 166

Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
           PE     + S+  DV+S+GI + E F+ G+ P  +M
Sbjct: 167 PECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 77.5 bits (191), Expect = 6e-16
 Identities = 57/218 (26%), Positives = 100/218 (45%), Gaps = 21/218 (9%)

Query: 162 SLENLIGAGSFGSVYKGIF-DHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRN 219
           +L   IG G FG VY+G++   ++ +  VAVK        + +  F+ E   +R   H +
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           +VK+I           +   +V EL   G L  +L +N+    +L+L   +  +  +++ 
Sbjct: 69  IVKLIGVIT------ENPVWIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTA 119

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           L YL        VH D+   NVL+       + DFGL+++L +      S   +S G K 
Sbjct: 120 LAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-----ESYYKASKG-KL 170

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            + + APE       +++ DV+ FG+ + E+   G  P
Sbjct: 171 PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 25/223 (11%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIR---HRNLV 221
           IG G++G+VYK    H  H   VA+K + +Q    G   S + E   L+ +    H N+V
Sbjct: 8   IGVGAYGTVYKARDPHSGH--FVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           +++  C +          LV+E  V+  L  +L  ++  P  L       +       L+
Sbjct: 66  RLMDVCATSRTDRETKVTLVFE-HVDQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           +LH  C   IVH DLKP N+L+       ++DFGLA+        + S Q +   V  T+
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR--------IYSCQMALTPVVVTL 171

Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
            Y APE  + S  +T  D++S G +  EMF  K     +F GN
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFCGN 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 61/234 (26%), Positives = 109/234 (46%), Gaps = 47/234 (20%)

Query: 167 IGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGAS----KSFIAECQALRSIRHR 218
           IG G+FG V++    G+  ++   T+VAVK+L      AS      F  E   +    H 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEP-FTMVAVKMLK---EEASADMQADFQREAALMAEFDHP 68

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN--------------- 263
           N+VK++  C      G     L++E M  G L E+L     +PR                
Sbjct: 69  NIVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLR--HRSPRAQCSLSHSTSSARKCG 121

Query: 264 -----LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                L+  ++L IA  VA+ + YL    E   VH DL   N L+   +   ++DFGL++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Query: 319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            +  +A+   ++++ ++ ++    +  PE    +  +T  DV+++G++L E+F+
Sbjct: 179 NI-YSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 76.8 bits (190), Expect = 1e-15
 Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 45/226 (19%)

Query: 164 ENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGASK-----SFIAECQALRSIR 216
              +G G++  VYK      D ET  +VA+K + L  R  +K     + + E + L+ ++
Sbjct: 5   GKKLGEGTYAVVYKAR----DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N++ +    + V F       LV+E M    LE    + +D  +++     L+ A D+
Sbjct: 61  HPNIIGL----LDV-FGHKSNINLVFEFM-ETDLE---KVIKD--KSI----VLTPA-DI 104

Query: 277 AS-------TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSS 329
            S        LEYLH      I+H DLKP+N+L+  +    ++DFGLA+        ++ 
Sbjct: 105 KSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH 161

Query: 330 NQSSSVGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGK 374
                     T  Y APE   G+     G D++S G +  E+    
Sbjct: 162 QVV-------TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 27/222 (12%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   L   +GAG FG V+ G +++    T VAVK L      + ++F+ E   +++++H 
Sbjct: 6   ESIKLVKKLGAGQFGEVWMGYYNN---STKVAVKTLK-PGTMSVQAFLEEANLMKTLQHD 61

Query: 219 NLVKIITSCVSVDFQGNDFEALVY---ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
            LV++              E  +Y   E M  GSL ++L    D    + L + +  +  
Sbjct: 62  KLVRLYAVVTK--------EEPIYIITEYMAKGSLLDFL--KSDEGGKVLLPKLIDFSAQ 111

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           +A  + Y+        +H DL+ +NVL+   L   ++DFGLA+ + +  N  ++ +    
Sbjct: 112 IAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTARE---- 162

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           G K  + + APE       +   DV+SFGILL E+ T GK P
Sbjct: 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 27/212 (12%)

Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQ--HRGASKSFIAECQALRSIRHRNLVK 222
           IG G+ G V+K      D ET   VA+K + L+    G     + E +AL++ +H  +VK
Sbjct: 8   IGEGAHGIVFKAK----DRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVK 63

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           ++     V   G+ F  LV E M    L E L   RD  R L   Q  S    +   + Y
Sbjct: 64  LL----DVFPHGSGF-VLVMEYMP-SDLSEVL---RDEERPLPEAQVKSYMRMLLKGVAY 114

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           +H      I+H DLKP+N+L+  +    ++DFGLA+   E    L S+Q        T  
Sbjct: 115 MH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV------ATRW 165

Query: 343 YAAPEYGMGSEVSTSG-DVYSFGILLLEMFTG 373
           Y APE   G+     G D+++ G +  E+  G
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 16/220 (7%)

Query: 158 TDGFSLENLIGAGSFGSVYKGI-FDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR 216
              F +E  IG G F  VYK I         L  V++  +    A +  + E   L+ + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N++K + S     F  N+   +V EL   G L   +   +   R +         V +
Sbjct: 61  HPNVIKYLAS-----FIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
            S LE++H      I+H D+KP+NV +       + D GL +F        SS  +++  
Sbjct: 116 CSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF-------FSSKTTAAHS 165

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           + GT  Y +PE    +  +   D++S G LL EM   + P
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 31/223 (13%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           + L   IG+G++G VYK          LVA+KV+ L+     +    E   L+  RH N+
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATG--ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V    S     +   D   +V E    GSL++   + R     L+ LQ   +  +    L
Sbjct: 63  VAYFGS-----YLRRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGL 114

Query: 281 EYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            YLH   ET  +H D+K +N+LL  DG++   ++DFG++  L      ++  +S      
Sbjct: 115 AYLH---ETGKIHRDIKGANILLTEDGDV--KLADFGVSAQL---TATIAKRKS----FI 162

Query: 339 GTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGP 376
           GT  + APE  + +     G     D+++ GI  +E+   + P
Sbjct: 163 GTPYWMAPE--VAAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 76.4 bits (189), Expect = 3e-15
 Identities = 61/239 (25%), Positives = 104/239 (43%), Gaps = 37/239 (15%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNL--QHRGASKSFIAECQALRSIR 216
           + L   IG+G++G V   +    D  T   VA+K ++        +K  + E + LR +R
Sbjct: 2   YELLKPIGSGAYGVVCSAV----DKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR 57

Query: 217 HRNLVKIITSCVSVDFQGNDFEAL--VYELMVNGS-LEEWLHLNRDAPRNLNLLQRLSIA 273
           H N++ ++   +       DF  +  V ELM   + L + +     +P+ L         
Sbjct: 58  HENIIGLLD--ILRPPSPEDFNDVYIVTELM--ETDLHKVIK----SPQPLTDDHIQYFL 109

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAANNLSSN 330
             +   L+YLH      ++H DLKPSN+L++      + DFGLA+ +    +    L+  
Sbjct: 110 YQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE- 165

Query: 331 QSSSVGVKGTVGYAAPE-YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH 388
                 V  T  Y APE     S  + + D++S G +  E+ T K P   +F G   + 
Sbjct: 166 -----YVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-P---LFPGRDYID 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 75.5 bits (185), Expect = 3e-15
 Identities = 64/221 (28%), Positives = 106/221 (47%), Gaps = 14/221 (6%)

Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHRN 219
           +L   +G G FGSV +G  + DD    VAVK + +    R   + F++E   ++   H N
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61

Query: 220 LVKIITSCV-SVDFQGNDFEALVYELMVNGSLEEWLHLNR--DAPRNLNLLQRLSIAVDV 276
           ++++I  C+ +V+ +G     ++   M +G L  +L  +R  D P+ L     +    D+
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
           AS +EYL        +H DL   N +L+  +   V+DFGL+K   +  N     Q     
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK---KIYNGDYYRQGRI-- 173

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            K  V + A E       +T  DV+SFG+ + E+ T G+ P
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 75.6 bits (186), Expect = 5e-15
 Identities = 71/224 (31%), Positives = 102/224 (45%), Gaps = 30/224 (13%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQAL-RSIRHRNLVK 222
           IG GSFG V   +  H       AVKVL  +    +   K  +AE   L ++++H  LV 
Sbjct: 3   IGKGSFGKVL--LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +  S     FQ  D    V +  VNG  E + HL R+  R+    +    A ++AS L Y
Sbjct: 61  LHYS-----FQTADKLYFVLD-YVNGG-ELFFHLQRE--RSFPEPRARFYAAEIASALGY 111

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           LH      I++ DLKP N+LLD +    ++DFGL K        +  ++++S    GT  
Sbjct: 112 LH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK------EGIEHSKTTST-FCGTPE 161

Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMF 381
           Y APE         + D +  G +L EM  G  P     T EM+
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY 205

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 74.8 bits (184), Expect = 5e-15
 Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 50/271 (18%)

Query: 161 FSLENL-----IGAGSFGSVY----KGIFDHDDHETLVAVKVLNLQHR---GASKSFIAE 208
           F   NL     +G G FG V+    KGI +    ETLV VK L  Q          F  E
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGG-ETLVLVKAL--QKTKDENLQSEFRRE 58

Query: 209 CQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA-----PRN 263
               R + H+N+V+++  C     +  +   ++ E    G L+++L   +       P  
Sbjct: 59  LDMFRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113

Query: 264 LNLLQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
           L+  Q++++   +A  +++L    +     VH DL   N L+  +    VS   L+K   
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNARF-----VHRDLAARNCLVSSQREVKVSLLSLSK--- 165

Query: 322 EAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP---- 376
              +  +S           + + APE     + ST  DV+SFG+L+ E+FT G+ P    
Sbjct: 166 ---DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL 222

Query: 377 TNEMF-----TGNLTLHNFVKEALPERLAEI 402
           ++E        G L L   V E  P RL ++
Sbjct: 223 SDEEVLNRLQAGKLELP--VPEGCPSRLYKL 251

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 72/235 (30%), Positives = 111/235 (47%), Gaps = 51/235 (21%)

Query: 150 SYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAE 208
           +Y+ L K          +G GS+ +VYKG         LVA+K + L+H  GA  + I E
Sbjct: 6   TYKKLDK----------LGEGSYATVYKGRSKLTGQ--LVALKEIRLEHEEGAPFTAIRE 53

Query: 209 CQALRSIRHRNLV---KIITSCVSVDFQGNDFEALVYELMVNGSLEEWL--HLNRDAPRN 263
              L+ ++H N+V    II +  ++         LV+E +    L++++       +  N
Sbjct: 54  ASLLKDLKHANIVTLHDIIHTKKTL--------TLVFEYLDT-DLKQYMDDCGGGLSMHN 104

Query: 264 --LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD--GELTAHVSDFGLAKF 319
             L L Q L         L Y H      ++H DLKP N+L+   GEL   ++DFGLA+ 
Sbjct: 105 VRLFLFQLLR-------GLAYCHQ---RRVLHRDLKPQNLLISERGELK--LADFGLAR- 151

Query: 320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTG 373
               A ++ S   S+  V  T+ Y  P+  +GS E STS D++  G +  EM TG
Sbjct: 152 ----AKSVPSKTYSNEVV--TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 74.2 bits (183), Expect = 7e-15
 Identities = 59/234 (25%), Positives = 91/234 (38%), Gaps = 56/234 (23%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVK-- 222
           IG GSFG+V K +    D + LV  K ++  +      +  ++E   LR ++H N+V+  
Sbjct: 8   IGKGSFGTVRK-VRRKSDGKILV-WKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 223 ------------IITSCVSVDFQGNDFEALV---YELMVNGSLEE---WLHLNRDAPRNL 264
                       I+         G D   L+    +      +EE   W           
Sbjct: 66  DRIIDRSNQTLYIVMEYCE----GGDLAQLIQKCKKE--RKYIEEEFIW----------- 108

Query: 265 NLLQRLSIAVDVASTLEYLHH--YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE 322
            +L +L +A      L   H+       ++H DLKP+N+ LD      + DFGLAK L  
Sbjct: 109 RILTQLLLA------LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162

Query: 323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                SS   + V   GT  Y +PE           D++S G L+ E+     P
Sbjct: 163 D----SSFAKTYV---GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 67/231 (29%), Positives = 106/231 (45%), Gaps = 34/231 (14%)

Query: 163 LENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
           L+  +G G+FG V+     +   +  + LVAVK L      A K F  E + L +++H +
Sbjct: 9   LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN---------RDAPRNLNLLQRL 270
           +VK    CV       D   +V+E M +G L ++L  +          + P  L   Q L
Sbjct: 69  IVKFYGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 271 SIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLS 328
            IA  +A+ + YL   H+     VH DL   N L+   L   + DFG+++       ++ 
Sbjct: 124 HIAQQIAAGMVYLASQHF-----VHRDLATRNCLVGENLLVKIGDFGMSR-------DVY 171

Query: 329 SNQSSSVGVKGT--VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           S     VG      + +  PE  M  + +T  DV+S G++L E+FT GK P
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.1 bits (182), Expect = 8e-15
 Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 22/214 (10%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +G G FG V            L A K LN   L+ R   +  + E + L  +  R +V +
Sbjct: 1   LGKGGFGEVSAC--QMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTLEY 282
             +     FQ      LV  +M  G L   ++ ++ + P      +       + S LE+
Sbjct: 59  AYA-----FQTKTDLCLVMTIMNGGDLRYHIYNVDEENP-GFPEPRACFYTAQIISGLEH 112

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           LH   +  I++ DLKP NVLLD +    +SD GLA         L   QS + G  GT G
Sbjct: 113 LH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAV-------ELKDGQSKTKGYAGTPG 162

Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           + APE   G E   S D ++ G+ L EM   +GP
Sbjct: 163 FMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK-SFIAECQALRSIRHRNLVKII 224
           L+G G+FG V+KG       +T VAVK          K  F++E + L+   H N+VK+I
Sbjct: 2   LLGKGNFGEVFKGTLKD---KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C            +V EL+  G    +L   +D    L   Q +  A+D A+ + YL 
Sbjct: 59  GVCTQ-----RQPIYIVMELVPGGDFLSFLRKKKD---ELKTKQLVKFALDAAAGMAYLE 110

Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYA 344
                  +H DL   N L+       +SDFG+++   E     SS+    + +K T    
Sbjct: 111 ---SKNCIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWT---- 161

Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE       S+  DV+S+GILL E F+
Sbjct: 162 APEALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 58/222 (26%), Positives = 109/222 (49%), Gaps = 21/222 (9%)

Query: 154 LFKATDGFSLENLIGAGSFGSVYKGIF--DHDDHETLVAVKVL-NLQHRGASKSFIAECQ 210
           + K T+ F    ++G+G+FG+VYKG++  + +  +  VA+K L       A+K  + E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
            + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D   N+     L
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD---NIGSQYLL 112

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSN 330
           +  V +A  + YL    E  +VH DL   NVL+       ++DFGLAK L          
Sbjct: 113 NWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----GADEK 164

Query: 331 QSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           +  + G K  + + A E  +    +   DV+S+G+ + E+ T
Sbjct: 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 59/211 (27%), Positives = 108/211 (51%), Gaps = 22/211 (10%)

Query: 166 LIGAGSFGSVYKGIF--DHDDHETLVAVKVL--NLQHRGASKSFIAECQALRSIRHRNLV 221
           ++G+G+FG+VYKGI+  D ++ +  VA+KVL  N   + A+K  + E   +  +    + 
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAGVGSPYVC 72

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           +++  C++   Q      LV +LM  G L +++  N+D   + +LL   +  V +A  + 
Sbjct: 73  RLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDLL---NWCVQIAKGMS 123

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           YL    E  +VH DL   NVL+       ++DFGLA+ L     ++   +  + G K  +
Sbjct: 124 YLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----DIDETEYHADGGKVPI 175

Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            + A E  +    +   DV+S+G+ + E+ T
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 58/227 (25%), Positives = 108/227 (47%), Gaps = 31/227 (13%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNL------QHRGASKSFI----AECQALRSI 215
           LIG G++G VY  +  +     ++AVK + L      +H    K  +    +E + L+ +
Sbjct: 8   LIGKGTYGRVYLAL--NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
            H N+V+     +  +    ++ ++  E +  GS+   L           L++  +    
Sbjct: 66  DHLNIVQ----YLGFE-TTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLVRFFT--EQ 116

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           V   L YLH      I+H DLK  N+L+D +    +SDFG++K   ++ +   ++Q+ S 
Sbjct: 117 VLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMS- 169

Query: 336 GVKGTVGYAAPEYGMGSEVSTSG--DVYSFGILLLEMFTGKGPTNEM 380
            ++G+V + APE         S   D++S G ++LEMF G+ P ++ 
Sbjct: 170 -MQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 21/208 (10%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLVKIIT 225
           IG G+FG V+ G    D+  T VAVK          K+ F+ E + L+   H N+V++I 
Sbjct: 3   IGRGNFGEVFSGRLRADN--TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
            C     Q      +V EL+  G    +L    + PR L + + + +  + A+ +EYL  
Sbjct: 61  VCT----QKQPI-YIVMELVQGGDFLTFLR--TEGPR-LKVKELIQMVENAAAGMEYLES 112

Query: 286 YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT-VGYA 344
                 +H DL   N L+  +    +SDFG+++   E  + +    +S+ G+K   V + 
Sbjct: 113 KH---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGV---YASTGGMKQIPVKWT 163

Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE       S+  DV+SFGILL E F+
Sbjct: 164 APEALNYGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 69/247 (27%), Positives = 118/247 (47%), Gaps = 38/247 (15%)

Query: 159 DGFSLENLIGAGSFGSVYKGIF---DHDDHETLVAVKVLNLQ-HRGASKSFIAECQALRS 214
           D  +L   +G G+FG V K      D+ +  + VAVK+L            ++E + ++ 
Sbjct: 12  DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71

Query: 215 I-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR--------DAPRNL- 264
           I +H+N++ ++  C     +G  +  +V E   +G+L ++L   R        D PR   
Sbjct: 72  IGKHKNIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126

Query: 265 -NLLQR--LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
             L Q+  +S A  VA  +E+L        +H DL   NVL+  +    ++DFGLA+ + 
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI- 182

Query: 322 EAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVST-SGDVYSFGILLLEMFTGKG----- 375
              +++   + ++ G +  V + APE  +   V T   DV+SFG+LL E+FT  G     
Sbjct: 183 ---HHIDYYRKTTNG-RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237

Query: 376 -PTNEMF 381
            P  E+F
Sbjct: 238 IPVEELF 244

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 58/217 (26%), Positives = 103/217 (47%), Gaps = 22/217 (10%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
             LE  +GAG FG V+   ++     T VAVK +         +F+AE   +++++H  L
Sbjct: 8   LKLEKKLGAGQFGEVWMATYNK---HTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKL 63

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK+                ++ E M  GSL ++L    D      L + +  +  +A  +
Sbjct: 64  VKLHAVVTKEPIY------IITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGM 115

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
            ++    +   +H DL+ +N+L+   L   ++DFGLA+ + +  N  ++ +    G K  
Sbjct: 116 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTARE----GAKFP 166

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + + APE       +   DV+SFGILL+E+ T G+ P
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 23/222 (10%)

Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRH 217
            F +   +G GS+GSVYK     D+     A+K ++L      +    + E + L S+ H
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQF--YALKEVDLGSMSQKEREDAVNEIRILASVNH 58

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL-SIAVDV 276
            N++    +   +D  GN    +V E    G L + +   R   R L   Q +  I + +
Sbjct: 59  PNIISYKEA--FLD--GNKL-CIVMEYAPFGDLSKAIS-KRKKKRKLIPEQEIWRIFIQL 112

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
              L+ LH   E  I+H DLK +N+LL       + D G++K L     N++  Q     
Sbjct: 113 LRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI---- 162

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
             GT  Y APE   G   S   D++S G LL EM T   P  
Sbjct: 163 --GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 70/227 (30%), Positives = 115/227 (50%), Gaps = 38/227 (16%)

Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ-HRGASKSFIAECQALRSI 215
           AT   +LE L G GS+ +VYKGI   +    LVA+KV++++   G   + I E   L+ +
Sbjct: 4   ATSYLNLEKL-GEGSYATVYKGISRINGQ--LVALKVISMKTEEGVPFTAIREASLLKGL 60

Query: 216 RHRNLV---KIITSCVSVDFQGNDFEALVYELMVNGSLEEWL--HLNRDAPRNLNLLQRL 270
           +H N+V    II +  ++ F        V+E M +  L +++  H     P N+ L    
Sbjct: 61  KHANIVLLHDIIHTKETLTF--------VFEYM-HTDLAQYMIQHPGGLHPYNVRLFM-- 109

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD--GELTAHVSDFGLAKFLPEAANNLS 328
                +   L Y+H      I+H DLKP N+L+   GEL   ++DFGLA+     A ++ 
Sbjct: 110 ---FQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELK--LADFGLAR-----AKSIP 156

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGK 374
           S   SS  V  T+ Y  P+  +G+ + S++ D++  G + +EM  G+
Sbjct: 157 SQTYSSEVV--TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 15/223 (6%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETL-VAVKVLNLQHRGAS--KSFIAECQALRSIRH 217
           F+L  ++G G FGSV +     +D     VAVK+L      +S  + F+ E   ++   H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 218 RNLVKIITSCVSVDFQGN-DFEALVYELMVNGSLEEWLHLNR--DAPRNLNLLQRLSIAV 274
            N++K+I   +    +G      ++   M +G L  +L ++R  + P  L L   +   +
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
           D+AS +EYL        +H DL   N +L+  +T  V+DFGL+K +  + +      +S 
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKI-YSGDYYRQGCASK 176

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + VK    + A E    +  +T  DV++FG+ + E+ T G+ P
Sbjct: 177 LPVK----WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 27/220 (12%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G G+FG VYK    H +     A K++ ++     + F+ E   L   +H N+V +   
Sbjct: 13  LGDGAFGKVYKA--QHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY-- 68

Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                F  N    L+ E    G+L+  + L  +    L   Q   +   +   L +LH  
Sbjct: 69  --EAYFYENKLWILI-EFCDGGALDS-IMLELERG--LTEPQIRYVCRQMLEALNFLH-- 120

Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAP 346
               ++H DLK  N+LL  +    ++DFG++      A N S+ Q     + GT  + AP
Sbjct: 121 -SHKVIHRDLKAGNILLTLDGDVKLADFGVS------AKNKSTLQKRDTFI-GTPYWMAP 172

Query: 347 EYGMGSEVSTS------GDVYSFGILLLEMFTGKGPTNEM 380
           E  +  E           D++S GI L+E+   + P +E+
Sbjct: 173 EV-VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 72.2 bits (178), Expect = 7e-14
 Identities = 78/242 (32%), Positives = 112/242 (46%), Gaps = 56/242 (23%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA---ECQALRSIR------- 216
           +G G++G V+K I D    E  VA+K          K F A      A R+ R       
Sbjct: 15  LGKGAYGIVWKAI-DRRTKEV-VALK----------KIFDAFRNATDAQRTFREIMFLQE 62

Query: 217 ---HRNLVKIITSCVSVDFQGNDFEA-LVYELMVNGSLEEWLHLNRDAPRNLNLLQRL-- 270
              H N+VK++    +V    ND +  LV+E M     E  LH    A    N+L+ +  
Sbjct: 63  LGDHPNIVKLL----NVIKAENDKDIYLVFEYM-----ETDLH----AVIRANILEDVHK 109

Query: 271 -SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSS 329
             I   +   L+Y+H      ++H DLKPSN+LL+ +    ++DFGLA+ L    + L  
Sbjct: 110 RYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSL----SELEE 162

Query: 330 NQSSSVGVK--GTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNEMFTGNLT 386
           N  + V      T  Y APE  +GS   T G D++S G +L EM  GK P   +F G  T
Sbjct: 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK-P---LFPGTST 218

Query: 387 LH 388
           L+
Sbjct: 219 LN 220

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 24/221 (10%)

Query: 161 FSLENLIGAGSFGSVYKG--IFDHDDHETLVAVK---VLNLQHRGASKSFIAECQALRSI 215
           F +E  IG G F  VY+   + D       VA+K   + +L    A    I E   L+ +
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDG----VPVALKKVQIFDLMDAKARADCIKEIDLLKQL 59

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
            H N++K   S +    + N+   +V EL   G L   +   +   R +         V 
Sbjct: 60  NHPNVIKYYASFI----EDNELN-IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           + S LE++H      ++H D+KP+NV +       + D GL +F        SS  +++ 
Sbjct: 115 LCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF-------FSSKTTAAH 164

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y +PE    +  +   D++S G LL EM   + P
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 73.3 bits (180), Expect = 1e-13
 Identities = 52/192 (27%), Positives = 80/192 (41%), Gaps = 17/192 (8%)

Query: 189 VAVKVLNLQH-RGAS--KSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELM 245
           VA+K+L             F  E      + H N+V ++ S  +           V+E +
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA----PPGLLFAVFEYV 61

Query: 246 VNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL-- 303
              +L E   L  D         RL + V     L+ L       IVH DLKP N+++  
Sbjct: 62  PGRTLRE--VLAADGALPAGETGRLMLQV-----LDALACAHNQGIVHRDLKPQNIMVSQ 114

Query: 304 -DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYS 362
                 A V DFG+   LP   +   +  + +  V GT  Y APE   G  V+ + D+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174

Query: 363 FGILLLEMFTGK 374
           +G++ LE  TG+
Sbjct: 175 WGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 68/256 (26%), Positives = 100/256 (39%), Gaps = 65/256 (25%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSI 215
           D F +  +IG G+FG V+  + D D  + + A+KVL    +  R       AE   L   
Sbjct: 1   DDFEVIKVIGRGAFGEVWL-VRDKDTGQ-VYAMKVLRKSDMIKRNQIAHVRAERDILADA 58

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI--- 272
               +VK+  S     FQ  +   LV E M  G L             +NLL R  +   
Sbjct: 59  DSPWIVKLYYS-----FQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFPE 100

Query: 273 ------AVDVASTLEYLH--HYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPE 322
                   ++   L+ +H   +     +H D+KP N+L+D     H+  +DFGL K + +
Sbjct: 101 ETARFYIAELVLALDSVHKLGF-----IHRDIKPDNILIDA--DGHIKLADFGLCKKMNK 153

Query: 323 AAN-----NLSSNQSSSVGVK-----------------GTVGYAAPEYGMGSEVSTSGDV 360
           A +     N S N      V                  GT  Y APE   G+      D 
Sbjct: 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDW 213

Query: 361 YSFGILLLEMFTGKGP 376
           +S G++L EM  G  P
Sbjct: 214 WSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 65/242 (26%), Positives = 102/242 (42%), Gaps = 44/242 (18%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHE---TLVAVKVLNLQHRGASKS----FIAECQALRSI 215
           L   +G G FG V K            T VAVK+L      AS S     ++E   L+ +
Sbjct: 4   LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK---ENASSSELRDLLSEFNLLKQV 60

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR----------------- 258
            H +++K+  +C       +    L+ E    GSL  +L  +R                 
Sbjct: 61  NHPHVIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115

Query: 259 -DAP--RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG 315
            D P  R L +   +S A  ++  ++YL    E  +VH DL   NVL+       +SDFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172

Query: 316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GK 374
           L++ + E  + +  ++      +  V + A E       +T  DV+SFG+LL E+ T G 
Sbjct: 173 LSRDVYEEDSYVKRSKG-----RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227

Query: 375 GP 376
            P
Sbjct: 228 NP 229

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 40/233 (17%)

Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSI-RHRN 219
             E++IG G+FG V + +   D  +   A+K+L         + F  E + L  +  H N
Sbjct: 5   KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------DAPRNLNLL 267
           ++ ++ +C     +   +  +  E    G+L ++L  +R                 L   
Sbjct: 65  IINLLGAC-----ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119

Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL 327
           Q L  A DVA+ ++YL    E   +H DL   NVL+   L + ++DFGL++         
Sbjct: 120 QLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR--------- 167

Query: 328 SSNQSSSVGVKGTVG-----YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG 375
                  V VK T+G     + A E    S  +T  DV+SFG+LL E+ +  G
Sbjct: 168 ----GEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGG 216

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 70.3 bits (173), Expect = 2e-13
 Identities = 63/225 (28%), Positives = 88/225 (39%), Gaps = 43/225 (19%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKI 223
           +G G FG V              A+K +  +H    G  +   +E + L    H  +VK+
Sbjct: 1   LGVGGFGRVELVK--VKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL 58

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQ----RLSIAVDVAST 279
             +     F+   +  ++ E  + G L           R+  L      R  IA  V   
Sbjct: 59  YRT-----FKDKKYIYMLMEYCLGGEL-------WTILRDRGLFDEYTARFYIAC-VVLA 105

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK- 338
            EYLH+     I++ DLKP N+LLD      + DFG AK L               G K 
Sbjct: 106 FEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL-------------KSGQKT 149

Query: 339 ----GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
               GT  Y APE  +      S D +S GILL E+ TG+ P  E
Sbjct: 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE 194

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 16/217 (7%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHE-TLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
           F +E  IG G F  VY+     D     L  V++  +    A +  + E   L+ + H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           ++K + S     F  ++   +V EL   G L + +   +   R +         V + S 
Sbjct: 64  VIKYLDS-----FIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           +E++H      ++H D+KP+NV +       + D GL +F        SS  +++  + G
Sbjct: 119 VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF-------FSSKTTAAHSLVG 168

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           T  Y +PE    +  +   D++S G LL EM   + P
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 23/219 (10%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS-----KSFIAECQALRSIRHRNL 220
           L+G G+FG VY   +D D    L AVK +              +   E Q L++++H  +
Sbjct: 9   LLGQGAFGRVYL-CYDVDTGREL-AVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V+    C+  D   + F     E M  GS+++   L         + ++ +    +   +
Sbjct: 67  VQYY-GCLRDDETLSIF----MEYMPGGSVKD--QLKAYGALTETVTRKYT--RQILEGV 117

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
           EYLH      IVH D+K +N+L D      + DFG +K L      + S+ +    V GT
Sbjct: 118 EYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICSSGTGMKSVTGT 170

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
             + +PE   G       DV+S G  ++EM T K P  E
Sbjct: 171 PYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 27/210 (12%)

Query: 166 LIGAGSFGSVY--KGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLV 221
           ++G G+FG V+  +   D      LV +K + ++   +    +   ECQ L+ + H N++
Sbjct: 7   VVGRGAFGIVHLCRRKADQ----KLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII 62

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           +   +     F  +    +V E    G+L E++    ++     LL   +I       L 
Sbjct: 63  EYYEN-----FLEDKALMIVMEYAPGGTLAEYIQKRCNS-----LLDEDTILHFFVQILL 112

Query: 282 YLHHYCETPIVHCDLKPSNVLLDG-ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
            LHH     I+H DLK  N+LLD  ++   + DFG++K L        S++S +  V GT
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--------SSKSKAYTVVGT 164

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEM 370
             Y +PE   G   +   D+++ G +L E+
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 62/227 (27%), Positives = 92/227 (40%), Gaps = 39/227 (17%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNL---------QHRGASKSFIAEC 209
           D       +G G+FG V+         E   A+KV+ +         QH    K      
Sbjct: 1   DDLERIKTVGTGTFGRVHLV--RDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRV---- 54

Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
             L+ + H  ++++       D     F  ++ E +  G L  +L   R++ R  N    
Sbjct: 55  --LKEVSHPFIIRLF--WTEHD---QRFLYMLMEYVPGGELFSYL---RNSGRFSNSTGL 104

Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSS 329
              A ++   LEYLH      IV+ DLKP N+LLD E    ++DFG AK L +    L  
Sbjct: 105 F-YASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC- 159

Query: 330 NQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                    GT  Y APE       + + D ++ GIL+ EM  G  P
Sbjct: 160 ---------GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.3 bits (169), Expect = 5e-13
 Identities = 66/249 (26%), Positives = 106/249 (42%), Gaps = 40/249 (16%)

Query: 159 DGFSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQA 211
           D  +L   +G G FG V      GI D D  +  V V V  L+     K     ++E + 
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGI-DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 73

Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNR 258
           ++ I +H+N++ ++ +C     Q      +V E    G+L E+L             + R
Sbjct: 74  MKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIAR 128

Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                +     +S    VA  +EYL        +H DL   NVL+       ++DFGLA+
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185

Query: 319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
                 NN+   + ++ G +  V + APE       +   DV+SFG+L+ E+FT  G   
Sbjct: 186 ----DVNNIDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240

Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 241 PGIPVEELF 249

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 68.8 bits (168), Expect = 6e-13
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 24/211 (11%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+ G+VY  I      E  VA+K +NLQ +   +  I E   +R  +H N+V  + S
Sbjct: 27  IGQGASGTVYTAIDVATGQE--VAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E +  GSL + +         ++  Q  ++  +    LE+LH  
Sbjct: 85  -----YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLH-- 132

Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGL-AKFLPEAANNLSSNQSSSVGVKGTVGYAA 345
               ++H D+K  N+LL  + +  ++DFG  A+  PE        QS    + GT  + A
Sbjct: 133 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--------QSKRSTMVGTPYWMA 183

Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           PE           D++S GI+ +EM  G+ P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 6e-13
 Identities = 67/225 (29%), Positives = 99/225 (44%), Gaps = 44/225 (19%)

Query: 166 LIGAGSFGSVY--KGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKI 223
           ++G GSFG V+  + I    D   L A+KVL        K+ +     +R+   R+++  
Sbjct: 3   VLGQGSFGKVFLVRKITG-PDAGQLYAMKVLK-------KATLKVRDRVRTKMERDIL-- 52

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV--------- 274
                  +        L Y     G L    +L  D  R  +L  RLS  V         
Sbjct: 53  ------AEVNHPFIVKLHYAFQTEGKL----YLILDFLRGGDLFTRLSKEVMFTEEDVKF 102

Query: 275 ---DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQ 331
              ++A  L++LH      I++ DLKP N+LLD E    ++DFGL+K   E+ ++     
Sbjct: 103 YLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAY 156

Query: 332 SSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           S      GTV Y APE       + S D +SFG+L+ EM TG  P
Sbjct: 157 SFC----GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 68.4 bits (167), Expect = 7e-13
 Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 26/225 (11%)

Query: 162 SLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQHRGAS----KSFIAECQALRSIR 216
            +E ++G G FG + +G        E  VA+  L     G S    + F+AE   L    
Sbjct: 8   KIERILGTGRFGELCRGCLKLPSKRELPVAIHTL---RAGCSDKQRRGFLAEALTLGQFD 64

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N+V++      V  +GN    +V E M NG+L+ +L   R     L   Q + +   +
Sbjct: 65  HSNIVRL----EGVITRGNTM-MIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGL 116

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
           AS ++YL    E   VH  L    VL++ +L   +S F     L E   + S    +++ 
Sbjct: 117 ASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRR---LQE---DKSEAIYTTMS 167

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLE-MFTGKGPTNEM 380
            K  V +AAPE       S++ DV+SFGI++ E M  G+ P  +M
Sbjct: 168 GKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 54/181 (29%), Positives = 79/181 (43%), Gaps = 18/181 (9%)

Query: 196 LQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH 255
           ++ R      + E Q L  +  R +V +  +     ++  D   LV  LM  G L+   H
Sbjct: 38  IKKRKGESMALNEKQILEKVNSRFVVSLAYA-----YETKDALCLVLTLMNGGDLK--FH 90

Query: 256 LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG 315
           +           + +  A ++   LE LH   +  IV+ DLKP N+LLD      +SD G
Sbjct: 91  IYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLG 147

Query: 316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG 375
           LA  +PE          +  G  GTVGY APE       + S D ++ G LL EM  G+ 
Sbjct: 148 LAVHVPEG--------QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199

Query: 376 P 376
           P
Sbjct: 200 P 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 63/235 (26%), Positives = 112/235 (47%), Gaps = 42/235 (17%)

Query: 163 LENLIGAGSFGSVY------------KGIFDHDDHETLVAVKVLNLQ-HRGASKSFIAEC 209
           L+  +G G FG V+            +G  + D    LVAVK+L     + A   F+ E 
Sbjct: 9   LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68

Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----------HLNRD 259
           + +  +++ N+++++  CVS     +D   ++ E M NG L ++L          H N +
Sbjct: 69  KIMSRLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHAN-N 122

Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
            P ++++   L +AV +AS ++YL        VH DL   N L+    T  ++DFG+++ 
Sbjct: 123 IP-SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR- 177

Query: 320 LPEAANNLSSNQSSSVGVKGT--VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                 NL S     +  +    + + A E  +  + +T+ DV++FG+ L EMFT
Sbjct: 178 ------NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 70/250 (28%), Positives = 109/250 (43%), Gaps = 42/250 (16%)

Query: 159 DGFSLENLIGAGSFGSVYK----GI-FDHDDHETLVAVKVLNLQHRGASKSF---IAECQ 210
           D   L   +G G FG V +    GI     D    VAVK+L  +     K     I+E +
Sbjct: 12  DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML--KDNATDKDLADLISEME 69

Query: 211 ALRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR--------DAP 261
            ++ I +H+N++ ++  C     Q      +V E    G+L E+L   R        D  
Sbjct: 70  LMKLIGKHKNIINLLGVCT----QEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDIT 124

Query: 262 R----NLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA 317
           +     L+    +S A  VA  +EYL        +H DL   NVL+  +    ++DFGLA
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLA 181

Query: 318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG-- 375
           +      +++   + +S G +  V + APE       +   DV+SFGIL+ E+FT  G  
Sbjct: 182 R----GVHDIDYYKKTSNG-RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236

Query: 376 ----PTNEMF 381
               P  E+F
Sbjct: 237 YPGIPVEELF 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 74/229 (32%), Positives = 103/229 (44%), Gaps = 38/229 (16%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQAL-RSIRHRNLV 221
           +IG GSFG V   +  H   E   AVKVL    +  +   K  ++E   L ++++H  LV
Sbjct: 2   VIGKGSFGKVL--LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD----APRNLNLLQRLSIAVDVA 277
            +  S     FQ  D    V + +  G L  + HL R+     PR      R   A ++A
Sbjct: 60  GLHFS-----FQTADKLYFVLDYINGGEL--FYHLQRERCFLEPR-----ARF-YAAEIA 106

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
           S L YLH      IV+ DLKP N+LLD +    ++DFGL K       N+  N ++S   
Sbjct: 107 SALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK------ENIEHNGTTST-F 156

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMF 381
            GT  Y APE         + D +  G +L EM  G  P     T EM+
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 69/247 (27%), Positives = 107/247 (43%), Gaps = 40/247 (16%)

Query: 161 FSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALR 213
            +L   +G G FG V      GI D D     V V V  L+     K     ++E + ++
Sbjct: 14  LTLGKPLGEGCFGQVVMAEAIGI-DKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72

Query: 214 SI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR--------DAPR-- 262
            I +H+N++ ++ +C     Q      LV E    G+L E+L   R        D  +  
Sbjct: 73  MIGKHKNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLP 127

Query: 263 --NLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
              L     +S A  VA  +EYL        +H DL   NVL+  +    ++DFGLA+  
Sbjct: 128 EEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR-- 182

Query: 321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG----- 375
               +N+   + ++ G +  V + APE       +   DV+SFG+LL E+FT  G     
Sbjct: 183 --DVHNIDYYKKTTNG-RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Query: 376 -PTNEMF 381
            P  E+F
Sbjct: 240 IPVEELF 246

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 69/240 (28%), Positives = 102/240 (42%), Gaps = 55/240 (22%)

Query: 161 FSLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS-KSFIAECQALRS 214
           F+ E+L     IG G+FG+V K +  H    T++AVK +         K  + +   +  
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKML--HKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV-- 56

Query: 215 IRHRNLVKIITSCVSVDFQGNDF---EALV-YELMVNGSLEE-----WLHLNRDAPRNLN 265
           +R  +   I      V F G  F   +  +  ELM + SL++     +  L    P  + 
Sbjct: 57  MRSSDCPYI------VKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEI- 108

Query: 266 LLQRLS-IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAA 324
               L  IAV     L YL    E  I+H D+KPSN+LLD      + DFG++  L +  
Sbjct: 109 ----LGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-- 160

Query: 325 NNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSG--------DVYSFGILLLEMFTGKGP 376
              S  ++   G +    Y APE      +  S         DV+S GI L E+ TGK P
Sbjct: 161 ---SIAKTRDAGCR---PYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 72/235 (30%), Positives = 118/235 (50%), Gaps = 40/235 (17%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVK--- 222
           +G G++ +V+KG       E LVA+K + L+H  GA  + I E   L++++H N+V    
Sbjct: 13  LGEGTYATVFKG--RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV-DVASTLE 281
           II +   +         LV+E + +  L+++L    D   NL  +  + I +  +   L 
Sbjct: 71  IIHTERCL--------TLVFEYL-DSDLKQYL----DNCGNLMSMHNVKIFMFQLLRGLS 117

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           Y H      I+H DLKP N+L++ +    ++DFGLA+     A ++ +   S+  V  T+
Sbjct: 118 YCHK---RKILHRDLKPQNLLINEKGELKLADFGLAR-----AKSVPTKTYSNEVV--TL 167

Query: 342 GYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL 395
            Y  P+  +GS E ST  D++  G +L EM TG+     MF G+      VKE L
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR----PMFPGST-----VKEEL 213

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 2e-12
 Identities = 55/225 (24%), Positives = 98/225 (43%), Gaps = 26/225 (11%)

Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALRSIR 216
            + +E  IG G++G VYK    +       A+K       Q+ G S+S   E   LR ++
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEW--LHLNRDAPRNLNLLQRL--SI 272
           H N+V ++   +         +  VY L      + W  +  +R   + +++   +  S+
Sbjct: 61  HENVVSLVEVFL------EHADKSVYLLFDYAEHDLWQIIKFHR-QAKRVSIPPSMVKSL 113

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH----VSDFGLAKFLPEAANNLS 328
              + + + YLH      ++H DLKP+N+L+ GE        + D GLA+        L+
Sbjct: 114 LWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFT 372
                   V  T+ Y APE  +G+   T   D+++ G +  E+ T
Sbjct: 171 DLD----PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 63/230 (27%), Positives = 91/230 (39%), Gaps = 55/230 (23%)

Query: 166 LIGAGSFGSV----YKG--------------IFDHDDHE-TLVAVKVLNLQHRGASKSFI 206
           ++G GSFG V     KG              I   DD E T+   +VL L  +       
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK------- 54

Query: 207 AECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNL 266
                     H  L ++  SC    FQ  D    V E +  G L    H+ R      + 
Sbjct: 55  ----------HPFLTQLH-SC----FQTKDRLFFVMEYVNGGDL--MFHIQRS--GRFDE 95

Query: 267 LQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANN 326
            +    A ++   L++LH   E  I++ DLK  NVLLD E    ++DFG+ K        
Sbjct: 96  PRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK------EG 146

Query: 327 LSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           +    ++S    GT  Y APE         + D ++ G+LL EM  G+ P
Sbjct: 147 ILGGVTTST-FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 74/238 (31%), Positives = 108/238 (45%), Gaps = 55/238 (23%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+FG VY+      D   + A+KVL      + K  +A+ +   +I  RN    I  
Sbjct: 1   IGKGTFGQVYQ--VRKKDTRRIYAMKVL------SKKEIVAKKEVAHTIGERN----ILV 48

Query: 227 CVSVD-----------FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
              +D           FQ +    LV + M  G L  + HL ++  R      +  IA +
Sbjct: 49  RTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEG-RFSEDRAKFYIA-E 104

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS--DFGLAKFLPEAANNLSSNQSS 333
           +   LE+LH Y    IV+ DLKP N+LLD   T H++  DFGL+K       NL+ N+++
Sbjct: 105 LVLALEHLHKY---DIVYRDLKPENILLDA--TGHIALCDFGLSK------ANLTDNKTT 153

Query: 334 SVGVKGTVGYAAPEY-----GMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMF 381
           +    GT  Y APE      G    V    D +S G+L+ EM  G  P     T +M+
Sbjct: 154 NT-FCGTTEYLAPEVLLDEKGYTKHV----DFWSLGVLVFEMCCGWSPFYAEDTQQMY 206

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 28/223 (12%)

Query: 159 DGFSLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRS 214
           +  S    +GAG+FG V +         D    VAVK+L    H    ++ ++E + +  
Sbjct: 35  NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94

Query: 215 I-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
           +  H N+V ++ +C      G     ++ E    G L  +L   R++   L  L  LS +
Sbjct: 95  LGNHENIVNLLGACTI---GGPIL--VITEYCCYGDLLNFLRRKRESFLTLEDL--LSFS 147

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
             VA  + +L        +H DL   NVLL       + DFGLA+ +   +N +      
Sbjct: 148 YQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV------ 198

Query: 334 SVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
              VKG     V + APE       +   DV+S+GILL E+F+
Sbjct: 199 ---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 67/252 (26%), Positives = 112/252 (44%), Gaps = 33/252 (13%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALR---SIRHRNLV 221
           IG G++G V+K   D  +    VA+K + +Q    G   S I E   LR   +  H N+V
Sbjct: 9   IGEGAYGKVFKA-RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           ++   C            LV+E  V+  L  +L    +       ++   +   +   L+
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIK--DMMFQLLRGLD 124

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           +LH +    +VH DLKP N+L+       ++DFGLA+        + S Q +   V  T+
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--------IYSFQMALTSVVVTL 173

Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAE 401
            Y APE  + S  +T  D++S G +  EMF  K     +F G+  +         ++L +
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSDV---------DQLGK 220

Query: 402 IVDPVLLVEREE 413
           I+D + L   E+
Sbjct: 221 ILDVIGLPGEED 232

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 66.0 bits (161), Expect = 4e-12
 Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 30/223 (13%)

Query: 166 LIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHRGAS------KSFIAECQALRSIRHR 218
            +G G+F S Y+     D    TL+AVK +      +S      ++   E + +  + H 
Sbjct: 7   QLGTGAFSSCYQA---RDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           ++++     +    + + F   V E M  GS+   L   +       ++   +    +  
Sbjct: 64  HIIR----MLGATCEDSHFNLFV-EWMAGGSVSHLLS--KYGAFKEAVIINYTE--QLLR 114

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAH---VSDFGLAKFLPEAANNLSSNQSSSV 335
            L YLH   E  I+H D+K +N+L+D   T     ++DFG A  L          Q   +
Sbjct: 115 GLSYLH---ENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
           G   T+ + APE   G +   S DV+S G +++EM T K P N
Sbjct: 170 G---TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 66.0 bits (161), Expect = 5e-12
 Identities = 60/223 (26%), Positives = 96/223 (43%), Gaps = 31/223 (13%)

Query: 166 LIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           ++G G++G VY      D   +  +A+K +  +     +    E      ++HRN+V+ +
Sbjct: 15  VLGKGTYGIVYAA---RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
            S        N F  +  E +  GSL   L  ++  P   N    +     +   L+YLH
Sbjct: 72  GSDSE-----NGFFKIFMEQVPGGSLSALLR-SKWGPLKDNEQTIIFYTKQILEGLKYLH 125

Query: 285 HYCETPIVHCDLKPSNVLLDG-ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGY 343
              +  IVH D+K  NVL++       +SDFG +K L    N  +          GT+ Y
Sbjct: 126 ---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTET------FTGTLQY 175

Query: 344 AAPEY------GMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
            APE       G G+      D++S G  ++EM TGK P  E+
Sbjct: 176 MAPEVIDKGPRGYGA----PADIWSLGCTIVEMATGKPPFIEL 214

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 66.0 bits (162), Expect = 5e-12
 Identities = 52/164 (31%), Positives = 76/164 (46%), Gaps = 35/164 (21%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALR---SIR----HRN 219
           +G G+FGSVY    + +  E LVA+K +    +    S+  EC  LR   S+R    H N
Sbjct: 7   LGDGTFGSVYLAR-NKETGE-LVAIKKM----KKKFYSW-EECMNLREVKSLRKLNEHPN 59

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL---SIAVDV 276
           +VK+      V F+ ND    V+E M  G+L     L +D  R           SI   +
Sbjct: 60  IVKL----KEV-FRENDELYFVFEYM-EGNL---YQLMKD--RKGKPFSESVIRSIIYQI 108

Query: 277 ASTLEYLHH--YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
              L ++H   +      H DLKP N+L+ G     ++DFGLA+
Sbjct: 109 LQGLAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR 147

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 65.7 bits (160), Expect = 5e-12
 Identities = 65/251 (25%), Positives = 114/251 (45%), Gaps = 34/251 (13%)

Query: 165 NLIGAGSFGSVYKGIFDHDDHETLVAVK--VLNLQHRGAS----KSFIAECQALRSIRHR 218
            ++G G++G+VY G+ +      L+AVK   L+  +  A+    +    E   L+S++H 
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQ---LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHV 62

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+V+ + +C+      ++  ++  E +  GS+     LNR  P    +  + +    +  
Sbjct: 63  NIVQYLGTCLD-----DNTISIFMEFVPGGSISS--ILNRFGPLPEPVFCKYT--KQILD 113

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLS-SNQSSSVGV 337
            + YLH+ C   +VH D+K +NV+L       + DFG A+ L     + + SN   S+  
Sbjct: 114 GVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM-- 168

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM-------FTGNLTLHNF 390
            GT  + APE    S      D++S G  + EM TGK P   M       + G    H  
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA---HRG 225

Query: 391 VKEALPERLAE 401
           +   LP+  + 
Sbjct: 226 LMPRLPDSFSA 236

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 66.1 bits (161), Expect = 6e-12
 Identities = 56/224 (25%), Positives = 103/224 (45%), Gaps = 31/224 (13%)

Query: 163 LENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++ LIG G FG VY  +   DH  +   VA K+ NL+    +++ + E     +I   + 
Sbjct: 16  IDKLIGCGGFGCVYETQCASDHCINNQAVA-KIENLE----NETIVMETLVYNNIYDIDK 70

Query: 221 VKIITSCVSVDFQG---------NDFEALVYELMVNGSLEEWLHLN------RDAPRNLN 265
           + +  +  ++D  G              + Y  +    L E L  N      R   +N  
Sbjct: 71  IALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFI----LLEKLVENTKEIFKRIKCKNKK 126

Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAN 325
           L++  +I  D+ +TLEY+H +    I H D+KP N+++DG    ++ D+G+A        
Sbjct: 127 LIK--NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGK 181

Query: 326 NLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLE 369
           ++  ++      +GT+ YA  +   G+ V+  GD+ S G  +L+
Sbjct: 182 HIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 37/226 (16%)

Query: 167 IGAGSFGSVYKG--IFDHDDHETLVAVKVL----NLQHRGASKSFIAECQALRSIRHRNL 220
           +G  +FG +YKG       DH  LVA+K L    N Q  G    F  E   +  + H N+
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG---EFQQEASLMAELHHPNI 69

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHL-------------NRDAPRNLNLL 267
           V     C+           +++E +  G L E+L +             +     +L+  
Sbjct: 70  V-----CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124

Query: 268 QRLSIAVDVASTLEYL-HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANN 326
             L IA+ +A+ +EYL  H+     VH DL   N+L+  +L   +SD GL++ +  A  +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF----FVHKDLAARNILIGEQLHVKISDLGLSREIYSA--D 178

Query: 327 LSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               Q  S+     + +  PE  M  + S+  D++SFG++L E+F+
Sbjct: 179 YYRVQPKSLL---PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 65.5 bits (159), Expect = 8e-12
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 21/220 (9%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           F+    IG GSFG V+KGI   +  + +VA+K+++L+    ++  I + Q   ++  +  
Sbjct: 6   FTKLERIGKGSFGEVFKGI--DNRTQQVVAIKIIDLEE---AEDEIEDIQQEITVLSQCD 60

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
              +T       +G     ++ E +  GS    L L R  P   +  Q  ++  ++   L
Sbjct: 61  SPYVTKYYGSYLKGTKL-WIIMEYLGGGSA---LDLLRAGP--FDEFQIATMLKEILKGL 114

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
           +YLH       +H D+K +NVLL  +    ++DFG+A         L+  Q       GT
Sbjct: 115 DYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVA-------GQLTDTQIKRNTFVGT 164

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
             + APE    S   +  D++S GI  +E+  G+ P ++M
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 22/213 (10%)

Query: 165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKI 223
           N IG G++G VY+   D    E +   KV     R G   S + E   L ++RH N+V++
Sbjct: 13  NRIGEGTYGIVYRA-RDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVEL 71

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWL-HLNRDAPRNLNLLQRLSIAVDVASTLEY 282
               V     G   +++    +V    E+ L  L  + P   +  Q   + + +   L+Y
Sbjct: 72  KEVVV-----GKHLDSI---FLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           LH      I+H DLK SN+LL  +    ++DFGLA+     A  ++           T+ 
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-------TLW 173

Query: 343 YAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGK 374
           Y APE  +G    T+  D+++ G +L E+   K
Sbjct: 174 YRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 67/226 (29%), Positives = 104/226 (46%), Gaps = 25/226 (11%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG GSFG V +      D + + A+K +   H   S+S +    A R++  +     I  
Sbjct: 1   IGKGSFGKVMQ--VRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFI-- 55

Query: 227 CVSVDFQGNDFEALVYEL-MVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
            V + F     E L   L  +NG  E + HL R+   +L+  +  +  +  A  LE LH 
Sbjct: 56  -VPLKFSFQSPEKLYLVLAFINGG-ELFHHLQREGRFDLSRARFYTAELLCA--LENLHK 111

Query: 286 YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAA 345
           +    +++ DLKP N+LLD +    + DFGL K       N+  +  ++    GT  Y A
Sbjct: 112 F---NVIYRDLKPENILLDYQGHIALCDFGLCKL------NMKDDDKTNT-FCGTPEYLA 161

Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMFTGNLT 386
           PE  +G   + + D ++ G+LL EM TG  P      NEM+   L 
Sbjct: 162 PELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 33/223 (14%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G G+FG VYK    + +   L A KV++ +     + ++ E   L S  H N+VK++ +
Sbjct: 13  LGDGAFGKVYKA--QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70

Query: 227 CVSVDFQGNDFEALVYELMVNGSLEE-WLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
                +  N+   L+ E    G+++   L L R        L    I V    TLE L++
Sbjct: 71  F----YYENNLWILI-EFCAGGAVDAVMLELERP-------LTEPQIRVVCKQTLEALNY 118

Query: 286 YCETPIVHCDLKPSNVL--LDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGY 343
             E  I+H DLK  N+L  LDG++   ++DFG+      +A N  + Q     + GT  +
Sbjct: 119 LHENKIIHRDLKAGNILFTLDGDIK--LADFGV------SAKNTRTIQRRDSFI-GTPYW 169

Query: 344 AAPEYGMGSEVST------SGDVYSFGILLLEMFTGKGPTNEM 380
            APE  M  E S         DV+S GI L+EM   + P +E+
Sbjct: 170 MAPEVVM-CETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 22/221 (9%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA-SKSFIAECQALRSIRH 217
           +     + +G G+ GSV K      +   + A+K +         K  + E +  +S + 
Sbjct: 1   EKIVELSRLGEGAGGSVTKCR--LKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKS 58

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAVD 275
             +VK   + +  +   +   A+  E    GSL+        R       +L +  IA  
Sbjct: 59  PYIVKYYGAFLD-ESSSSIGIAM--EYCEGGSLDSIYKKVKKRGGRIGEKVLGK--IAES 113

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           V   L YLH      I+H D+KPSN+LL  +    + DFG++    E  N+L+       
Sbjct: 114 VLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGT----- 162

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              GT  Y APE   G   S + DV+S G+ LLE+   + P
Sbjct: 163 -FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 81/270 (30%), Positives = 115/270 (42%), Gaps = 43/270 (15%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRS--IRHRNLVKII 224
           +GAG+ GSV K    H    T++A KV+   H GA  S     Q LR   I H      I
Sbjct: 13  LGAGNGGSVSK--VKHIPTGTVMAKKVV---HIGAKSSV--RKQILRELQIMHECRSPYI 65

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
            S     F   +   +  E M  GSL+      +  P  + +L +  IAV V   L YL 
Sbjct: 66  VSFYGA-FLNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILGK--IAVAVVEGLTYL- 119

Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYA 344
            Y    I+H D+KPSN+L++      + DFG++    E  N+++          GT  Y 
Sbjct: 120 -YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADT------FVGTSTYM 169

Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFTGKGP---TNEMFTGNLT-------LHNFVKE- 393
           +PE   G + +   DV+S GI ++E+  GK P   +N    G          L   V+E 
Sbjct: 170 SPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229

Query: 394 -------ALPERLAEIVDPVLLVEREEGET 416
                    PE L + VD  LL +  E  T
Sbjct: 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 42/132 (31%), Positives = 62/132 (46%), Gaps = 12/132 (9%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP- 59
           ++GN  +GNIP SL S+  +E LDLS N+ +G IP+ L     L+ LNL+ N   G VP 
Sbjct: 449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPA 508

Query: 60  -IKGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTG 118
            + G   + ++ +   N  LC GI  L  C         S    + +   +    LFL  
Sbjct: 509 ALGGRLLHRASFNFTDNAGLC-GIPGLRACG-----PHLSVGAKIGIAFGVSVAFLFLVI 562

Query: 119 MSCLIITSWWSK 130
             C +   WW +
Sbjct: 563 --CAMC--WWKR 570

Length = 623

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 61/237 (25%), Positives = 97/237 (40%), Gaps = 29/237 (12%)

Query: 144 ASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK 203
            S      +N  K  D F+    +G GSFG V    + ++D    VA+K      R    
Sbjct: 16  DSTKEPKRKNKMKYED-FNFIRTLGTGSFGRVILATYKNEDFPP-VAIK------RFEKS 67

Query: 204 SFIAECQALRSIRHRNLVKIITS--CVSV--DFQGNDFEALVYELMVNGSLEEWLHLNRD 259
             I + Q       R ++  I    CV++   F+   +  LV E ++ G    +L  N+ 
Sbjct: 68  KIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR 127

Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
            P ++        A  +    EYL       IV+ DLKP N+LLD +    ++DFG AK 
Sbjct: 128 FPNDVGCF----YAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180

Query: 320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           +           + +  + GT  Y APE  +      + D ++ GI + E+  G  P
Sbjct: 181 V----------DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 62/213 (29%), Positives = 107/213 (50%), Gaps = 29/213 (13%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVK--- 222
           +G G++ +VYKG     D+  LVA+K + L+H  GA  + I E   L+ ++H N+V    
Sbjct: 14  LGEGTYATVYKGRSKLTDN--LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           II +  S+         LV+E + +  L+++L    D   ++N+         +   L Y
Sbjct: 72  IIHTEKSL--------TLVFEYL-DKDLKQYLD---DCGNSINMHNVKLFLFQLLRGLNY 119

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
            H      ++H DLKP N+L++      ++DFGLA+     A ++ +   S+  V  T+ 
Sbjct: 120 CH---RRKVLHRDLKPQNLLINERGELKLADFGLAR-----AKSIPTKTYSNEVV--TLW 169

Query: 343 YAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGK 374
           Y  P+  +GS + ST  D++  G +  EM TG+
Sbjct: 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 52/181 (28%), Positives = 76/181 (41%), Gaps = 18/181 (9%)

Query: 196 LQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH 255
           ++ R      + E Q L  +  + +V +  +     ++  D   LV  +M  G L+   H
Sbjct: 38  IKKRKGESMALNEKQILEKVNSQFVVNLAYA-----YETKDALCLVLTIMNGGDLK--FH 90

Query: 256 LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG 315
           +           + L  A ++   LE LH       V+ DLKP N+LLD      +SD G
Sbjct: 91  IYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLG 147

Query: 316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG 375
           LA  +PE          S  G  GTVGY APE       + S D +  G L+ EM  G+ 
Sbjct: 148 LAVKIPEG--------ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199

Query: 376 P 376
           P
Sbjct: 200 P 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 39/230 (16%)

Query: 167 IGAGSFGSVY--------------KGIFDHDDHETLVAVKVLNL-QHRGASKSFIAECQA 211
           +G G FG V+                  D+ D   LVAVKVL       A + F+ E + 
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72

Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR-- 269
           L  +   N+ +++  C       +    ++ E M NG L ++L  +      L    +  
Sbjct: 73  LSRLSDPNIARLLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 270 -----LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAA 324
                L +A  +AS + YL        VH DL   N L+    T  ++DFG++       
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMS------- 177

Query: 325 NNLSSNQSSSVGVKGT--VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            NL S+    V  +    + + A E  +  + +T  DV++FG+ L E+ T
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 70/227 (30%), Positives = 113/227 (49%), Gaps = 39/227 (17%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           D F     +GAG+ G V K +  H     ++A K+++L+ + A ++     Q +R +   
Sbjct: 1   DDFEKLGELGAGNGGVVTKVL--HRPSGLIMARKLIHLEIKPAIRN-----QIIREL--- 50

Query: 219 NLVKIITSCVS---VDFQG---NDFE-ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
              K++  C S   V F G   +D E ++  E M  GSL++ L      P N+  L ++S
Sbjct: 51  ---KVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENI--LGKIS 105

Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAANNLSS 329
           IAV     L YL    +  I+H D+KPSN+L+   GE+   + DFG++  L ++  N   
Sbjct: 106 IAV--LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIK--LCDFGVSGQLIDSMAN--- 156

Query: 330 NQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              S VG   T  Y +PE   G+  +   D++S G+ L+EM  G+ P
Sbjct: 157 ---SFVG---TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 48/145 (33%), Positives = 65/145 (44%), Gaps = 13/145 (8%)

Query: 232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPI 291
           ++  D   LV  LM  G L+   H+        +  + +  A ++   LE LH      I
Sbjct: 69  YETKDALCLVLTLMNGGDLK--FHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERI 123

Query: 292 VHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG 351
           V+ DLKP N+LLD      +SD GLA  +PE          +  G  GTVGY APE    
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEG--------ETIRGRVGTVGYMAPEVVKN 175

Query: 352 SEVSTSGDVYSFGILLLEMFTGKGP 376
              + S D +  G L+ EM  GK P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 68/216 (31%), Positives = 95/216 (43%), Gaps = 27/216 (12%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQAL-RSIRHRNLV 221
           +IG GSFG V   +       +  AVKVL    +  +      +AE   L ++++H  LV
Sbjct: 2   VIGKGSFGKVL--LAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 222 KIITSCVSVDFQGNDFEALVYEL-MVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
            +  S     FQ    E L + L  VNG  E + HL R+  R     +    A +VAS +
Sbjct: 60  GLHYS-----FQTA--EKLYFVLDYVNGG-ELFFHLQRE--RCFLEPRARFYAAEVASAI 109

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
            YLH      I++ DLKP N+LLD +    ++DFGL K   E     S+         GT
Sbjct: 110 GYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-------FCGT 159

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             Y APE         + D +  G +L EM  G  P
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 31/222 (13%)

Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FG VYK      + ET  L A KV+  +     + ++ E + L +  H  +VK++
Sbjct: 20  LGDGAFGKVYKA----KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEE-WLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
            +     F  +    ++ E    G+++   L L+R        L    I V     LE L
Sbjct: 76  GA-----FYWDGKLWIMIEFCPGGAVDAIMLELDRG-------LTEPQIQVICRQMLEAL 123

Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGY 343
            +     I+H DLK  NVLL  +    ++DFG+      +A N+ + Q     + GT  +
Sbjct: 124 QYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGV------SAKNVKTLQRRDSFI-GTPYW 176

Query: 344 AAPEYGMGSEVSTS-----GDVYSFGILLLEMFTGKGPTNEM 380
            APE  M   +  +      D++S GI L+EM   + P +E+
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 64.0 bits (155), Expect = 3e-11
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 24/211 (11%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+ G+V+  I      E  VA+K +NLQ +   +  I E   ++ +++ N+V  + S
Sbjct: 27  IGQGASGTVFTAIDVATGQE--VAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                F   D   +V E +  GSL + +         ++  Q  ++  +    LE+LH  
Sbjct: 85  -----FLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALEFLH-- 132

Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGL-AKFLPEAANNLSSNQSSSVGVKGTVGYAA 345
               ++H D+K  NVLL  + +  ++DFG  A+  PE        QS    + GT  + A
Sbjct: 133 -ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--------QSKRSTMVGTPYWMA 183

Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           PE           D++S GI+ +EM  G+ P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 32/230 (13%)

Query: 167 IGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASK-SFIAECQALRSIRHRNLVK 222
           +G GSFG VY+GI      D+ ET VA+K +N       +  F+ E   ++     ++V+
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN------LNLLQRLSIAVDV 276
           ++     V  QG     ++ ELM  G L+ +L   R    N       +L + + +A ++
Sbjct: 74  LL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
           A  + YL+       VH DL   N ++  + T  + DFG+ +       ++        G
Sbjct: 129 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIYETDYYRKG 178

Query: 337 VKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-----GKGPTNE 379
            KG   V + +PE       +T  DV+SFG++L E+ T      +G +NE
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE 228

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 29/222 (13%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           D F   + +GAG+ G V+K    H     ++A K+++L+ + A ++ I        IR  
Sbjct: 5   DDFEKISELGAGNGGVVFK--VSHKPSGLIMARKLIHLEIKPAIRNQI--------IREL 54

Query: 219 NLVKIITSCVSVDFQG---NDFE-ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
            ++    S   V F G   +D E ++  E M  GSL++ L      P  +  L ++SIAV
Sbjct: 55  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIAV 112

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
                L YL    +  I+H D+KPSN+L++      + DFG++  L ++  N        
Sbjct: 113 --IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-------- 160

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
               GT  Y +PE   G+  S   D++S G+ L+EM  G+ P
Sbjct: 161 -SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 29/214 (13%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG+ G V K    H     ++A K+++L+ + A ++ I        IR   ++    S
Sbjct: 13  LGAGNGGVVTK--VQHKPSGLIMARKLIHLEIKPAIRNQI--------IRELQVLHECNS 62

Query: 227 CVSVDFQG---NDFE-ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
              V F G   +D E ++  E M  GSL++ L   +  P  +  L ++SIAV     L Y
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI--LGKVSIAV--LRGLAY 118

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           L    +  I+H D+KPSN+L++      + DFG++  L ++  N            GT  
Sbjct: 119 LRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---------SFVGTRS 167

Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           Y +PE   G+  S   D++S G+ L+E+  G+ P
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 47/145 (32%), Positives = 72/145 (49%), Gaps = 14/145 (9%)

Query: 232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPI 291
           FQ  +    V E +  G L    H+ +D  R  +L +    A ++   L++LH      I
Sbjct: 65  FQTKEHLFFVMEFLNGGDL--MFHI-QDKGR-FDLYRATFYAAEIVCGLQFLH---SKGI 117

Query: 292 VHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG 351
           ++ DLK  NV+LD +    ++DFG+ K      N    N++S+    GT  Y APE   G
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCK-----ENVFGDNRASTFC--GTPDYIAPEILQG 170

Query: 352 SEVSTSGDVYSFGILLLEMFTGKGP 376
            + + S D +SFG+LL EM  G+ P
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 33/225 (14%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKI 223
           +G G+FG VYK          +VA+K + L H    G   + + E + L+ ++H N+V +
Sbjct: 16  LGEGTFGEVYKAR--QIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKHPNVVPL 72

Query: 224 ITSCVSVDFQGNDFEALVYELMV--------NGSLEEWLHLNRDAPR-NLNLLQRLSIAV 274
           I   V    +       VY  MV        +G LE         P   L   Q     +
Sbjct: 73  IDMAVERPDKSKRKRGSVY--MVTPYMDHDLSGLLEN--------PSVKLTESQIKCYML 122

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSS----N 330
            +   + YLH   E  I+H D+K +N+L+D +    ++DFGLA+       N        
Sbjct: 123 QLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 331 QSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
                 +  T  Y  PE  +G    +T+ D++  G +  EMFT +
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 24/211 (11%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+ G+VY  +      E  VA++ +NLQ +   +  I E   +R  ++ N+V  + S
Sbjct: 28  IGQGASGTVYTAMDVATGQE--VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E +  GSL + +         ++  Q  ++  +    LE+LH  
Sbjct: 86  -----YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLH-- 133

Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGL-AKFLPEAANNLSSNQSSSVGVKGTVGYAA 345
               ++H D+K  N+LL  + +  ++DFG  A+  PE        QS    + GT  + A
Sbjct: 134 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--------QSKRSTMVGTPYWMA 184

Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           PE           D++S GI+ +EM  G+ P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 35/221 (15%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG GSFG V+KGI   +  + +VA+K+++L+    ++  I + Q          + +++ 
Sbjct: 12  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEE---AEDEIEDIQ--------QEITVLSQ 58

Query: 227 CVS---VDFQGNDFEA----LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           C S     + G+  +     ++ E +  GS  + L      P  L+  Q  +I  ++   
Sbjct: 59  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKG 113

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           L+YLH       +H D+K +NVLL       ++DFG+A         L+  Q       G
Sbjct: 114 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA-------GQLTDTQIKRNTFVG 163

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           T  + APE    S   +  D++S GI  +E+  G+ P +E+
Sbjct: 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 65/241 (26%), Positives = 107/241 (44%), Gaps = 28/241 (11%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+ G+VY  I      E  VA+K +NLQ +   +  I E   +R  ++ N+V  + S
Sbjct: 27  IGQGASGTVYTAIDIATGQE--VAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E +  GSL + +         ++  Q  ++  +    L++LH  
Sbjct: 85  -----YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLH-- 132

Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGL-AKFLPEAANNLSSNQSSSVGVKGTVGYAA 345
               ++H D+K  N+LL  + +  ++DFG  A+  PE        QS    + GT  + A
Sbjct: 133 -SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--------QSKRSTMVGTPYWMA 183

Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFTGKGP---TNEMFTGNLTLHNFVKEAL-PERLAE 401
           PE           D++S GI+ +EM  G+ P    N +    L   N   E   PERL+ 
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSA 243

Query: 402 I 402
           +
Sbjct: 244 V 244

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 68/250 (27%), Positives = 107/250 (42%), Gaps = 38/250 (15%)

Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHE-----TLVAVKVLNLQHRGASKS-FIAECQ 210
             D   L   +G G FG V        D E     T VAVK+L         S  I+E +
Sbjct: 16  PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME 75

Query: 211 ALRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR----------- 258
            ++ I +H+N++ ++ +C     Q      +V E    G+L E+L   R           
Sbjct: 76  MMKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPT 130

Query: 259 -DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA 317
                 L+    +S A  VA  +EYL        +H DL   NVL+  +    ++DFGLA
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 187

Query: 318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG-- 375
           + +    +++   + ++ G +  V + APE       +   DV+SFG+LL E+FT  G  
Sbjct: 188 RDI----HHIDYYKKTTNG-RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242

Query: 376 ----PTNEMF 381
               P  E+F
Sbjct: 243 YPGVPVEELF 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 62.6 bits (152), Expect = 6e-11
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 41/226 (18%)

Query: 164 ENLIGAGSFGSVYKGIF-----DHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           E+L G G+F  ++KGI        + H+T V +KVL+  HR  S+SF      +  + H+
Sbjct: 1   ESL-GQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHK 59

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           +LV     CV       D   +V E +  GSL+ +L  N++    +N+  +L +A  +A 
Sbjct: 60  HLVLNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKNL---INISWKLEVAKQLAW 111

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            L +L    +  + H ++   NVLL  E      +    K              S  G+ 
Sbjct: 112 ALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL-------------SDPGIS 155

Query: 339 GTV----------GYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTG 373
            TV           +  PE     + +S + D +SFG  L E+F+G
Sbjct: 156 ITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 40/230 (17%)

Query: 165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSI-RHRNLVK 222
           ++IG G+FG V K     D      A+K +     +   + F  E + L  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------DAPRNLNLLQRL 270
           ++ +C     +   +  L  E   +G+L ++L  +R                 L+  Q L
Sbjct: 61  LLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSN 330
             A DVA  ++YL    +   +H DL   N+L+     A ++DFGL++            
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR------------ 160

Query: 331 QSSSVGVKGTVG-----YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG 375
               V VK T+G     + A E    S  +T+ DV+S+G+LL E+ +  G
Sbjct: 161 -GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 209

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.8 bits (152), Expect = 7e-11
 Identities = 67/226 (29%), Positives = 108/226 (47%), Gaps = 33/226 (14%)

Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALR 213
           F   D +     +G GS+ +VYKG      +  LVA+KV+ LQ   G   + I E   L+
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKG--KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLK 58

Query: 214 SIRHRNLV---KIITSCVSVDFQGNDFEALVYELMVNGSLEEWL--HLNRDAPRNLNLLQ 268
            ++H N+V    II +  ++         LV+E  V+  L +++  H     P N+ L  
Sbjct: 59  GLKHANIVLLHDIIHTKETL--------TLVFE-YVHTDLCQYMDKHPGGLHPENVKLF- 108

Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLS 328
                  +   L Y+H   +  I+H DLKP N+L+       ++DFGLA+     A ++ 
Sbjct: 109 ----LFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLAR-----AKSVP 156

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTG 373
           S+  S+  V  T+ Y  P+  +GS E ST  D++  G + +EM  G
Sbjct: 157 SHTYSNEVV--TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 26/237 (10%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG GS G V      H   +  VAVK ++L+ +   +    E   +R   H N+V +  S
Sbjct: 30  IGEGSTGIVCIATEKHTGKQ--VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87

Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E +  G+L + +   R     +N  Q  ++ + V   L YLH+ 
Sbjct: 88  -----YLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLSVLRALSYLHN- 136

Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAP 346
               ++H D+K  ++LL  +    +SDFG   F  + +  +   +S    + GT  + AP
Sbjct: 137 --QGVIHRDIKSDSILLTSDGRIKLSDFG---FCAQVSKEVPKRKS----LVGTPYWMAP 187

Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFTGKGPT-NEMFTGNLTLHNFVKEALPERLAEI 402
           E        T  D++S GI+++EM  G+ P  NE     L     +++ LP R+ + 
Sbjct: 188 EVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE---PPLQAMRRIRDNLPPRVKDS 241

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 62.7 bits (152), Expect = 7e-11
 Identities = 42/137 (30%), Positives = 62/137 (45%), Gaps = 13/137 (9%)

Query: 240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPS 299
           LV  LM  G L+   H+     R L + + +  +  +   + +LH      IV+ D+KP 
Sbjct: 70  LVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPE 124

Query: 300 NVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGD 359
           NVLLD +    +SD GLA  L +     +  Q +     GT GY APE       S   D
Sbjct: 125 NVLLDDQGNCRLSDLGLAVELKDGK---TITQRA-----GTNGYMAPEILKEEPYSYPVD 176

Query: 360 VYSFGILLLEMFTGKGP 376
            ++ G  + EM  G+ P
Sbjct: 177 WFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 73/229 (31%), Positives = 100/229 (43%), Gaps = 38/229 (16%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQAL-RSIRHRNLV 221
           +IG GSFG V       D      AVKVL    + +R   K  +AE   L ++++H  LV
Sbjct: 2   VIGKGSFGKVLLAKRKLDG--KCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD----APRNLNLLQRLSIAVDVA 277
            +  S     FQ  +    V +  VNG  E + HL R+     PR      R   A ++A
Sbjct: 60  GLHYS-----FQTTEKLYFVLDF-VNGG-ELFFHLQRERSFPEPR-----ARFYAA-EIA 106

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
           S L YLH      IV+ DLKP N+LLD +    ++DFGL K   E      +   ++   
Sbjct: 107 SALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK---EGI----AQSDTTTTF 156

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMF 381
            GT  Y APE         + D +  G +L EM  G  P       EM+
Sbjct: 157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY 205

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 8e-11
 Identities = 67/237 (28%), Positives = 102/237 (43%), Gaps = 32/237 (13%)

Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI- 215
            T  F L  +IG G++G VYK    H     LVA+K++++      +    E   LR   
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKAR--HKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYS 60

Query: 216 RHRNLVKIITSCVSVDFQGNDFEA-LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
            H N+     + +  +  GND +  LV EL   GS+ + +   R   + L       I  
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS--DFGLAKFLPEAANNLSSNQS 332
           +    L YLH   E  ++H D+K  N+LL     A V   DFG           +S+   
Sbjct: 121 ETLRGLAYLH---ENKVIHRDIKGQNILLTKN--AEVKLVDFG-----------VSAQLD 164

Query: 333 SSVGVKGT-VG---YAAPEYGMGSEVSTS-----GDVYSFGILLLEMFTGKGPTNEM 380
           S++G + T +G   + APE     E   +      DV+S GI  +E+  GK P  +M
Sbjct: 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 62.4 bits (151), Expect = 9e-11
 Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 21/220 (9%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           F+    IG GSFG VYKGI +    + +VA+K+++L+    ++  I + Q   ++  +  
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRT--KEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCD 60

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
              IT       +G     ++ E +  GS  + L      P  L      +I  ++   L
Sbjct: 61  SPYITRYYGSYLKGTKL-WIIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGL 114

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
           +YLH   +   +H D+K +NVLL  +    ++DFG+       A  L+  Q       GT
Sbjct: 115 DYLHSERK---IHRDIKAANVLLSEQGDVKLADFGV-------AGQLTDTQIKRNTFVGT 164

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
             + APE    S      D++S GI  +E+  G+ P +++
Sbjct: 165 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 62.2 bits (151), Expect = 9e-11
 Identities = 80/267 (29%), Positives = 120/267 (44%), Gaps = 55/267 (20%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G G+ G+VYK    H     ++AVKV+ L           E Q  + I     ++I+  
Sbjct: 9   LGHGNGGTVYKAY--HLLTRRILAVKVIPL-------DITVELQ--KQIMSE--LEILYK 55

Query: 227 CVS---VDFQGNDFE----ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           C S   + F G  F     ++  E M  GSL+ +    R  P ++  L R  IAV V   
Sbjct: 56  CDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHV--LGR--IAVAVVKG 107

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           L YL       I+H D+KPSN+L++      + DFG++  L      ++S   + VG   
Sbjct: 108 LTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL------VNSIAKTYVG--- 155

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERL 399
           T  Y APE   G +     DV+S GI  +E+  G+ P  ++     +L       +P +L
Sbjct: 156 TNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-------MPLQL 208

Query: 400 AE-IVD---PVLLVEREEGETSEANAH 422
            + IVD   PVL V    G+ SE   H
Sbjct: 209 LQCIVDEDPPVLPV----GQFSEKFVH 231

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 36/222 (16%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS------FIAECQALRSIRHRNL 220
           IG G FG V  G       +  V VK L      AS +      F+ E Q  R + H N+
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELR-----ASATPDEQLLFLQEVQPYRELNHPNV 57

Query: 221 VKIITSCVSVDFQGNDFEA----LVYELMVNGSLEEWLHLNRDAPRNL---NLLQRLSIA 273
           ++ +  C+         E+    LV E    G L+ +L  NR     +   ++LQR+  A
Sbjct: 58  LQCLGQCI---------ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--A 106

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
            +VAS L +LH   +   +H DL   N  L  +L+  + D+GLA       +   +    
Sbjct: 107 CEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCH 162

Query: 334 SVGVKGTVGYAAPEYG---MGSEVSTSGDVYSFGILLLEMFT 372
           +V ++          G   +  + +   +++S G+ + E+FT
Sbjct: 163 AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 47/223 (21%)

Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKV--LNLQHRGASKSFIAECQALRSIRHRNLVK 222
           IG G++G VYK      +  T  +VA+K   L+ +  G   + I E   L+ + H N+VK
Sbjct: 8   IGEGTYGVVYKA----RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVK 63

Query: 223 IITSCVSVDFQGNDFEA-LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           ++      D    + +  LV+E            L++D  + ++      I + +  +  
Sbjct: 64  LL------DVIHTENKLYLVFEF-----------LHQDLKKFMDASPLSGIPLPLIKS-- 104

Query: 282 YLHH------YCET-PIVHCDLKPSNVLLDGELTAHVSDFGLAKF--LPEAANNLSSNQS 332
           YL        +C +  ++H DLKP N+L++ E    ++DFGLA+   +P     + +   
Sbjct: 105 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-----VRTYTH 159

Query: 333 SSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGK 374
             V    T+ Y APE  +G +  ST+ D++S G +  EM T +
Sbjct: 160 EVV----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 30/226 (13%)

Query: 161 FSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRS 214
           F L  ++G G++G V+  + +  HD    L A+KVL     +Q    ++    E Q L +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHD-AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 215 IRHRN-LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
           +R    LV +  +     FQ +    L+ +  VNG  E + HL +      + + R+ IA
Sbjct: 61  VRRCPFLVTLHYA-----FQTDTKLHLILDY-VNGG-ELFTHLYQREHFTESEV-RVYIA 112

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK-FLPEAANNLSSNQS 332
            ++   L++LH   +  I++ D+K  N+LLD E    ++DFGL+K FL E        + 
Sbjct: 113 -EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-------EEE 161

Query: 333 SSVGVKGTVGYAAPEYGMGSEV--STSGDVYSFGILLLEMFTGKGP 376
            +    GT+ Y APE   G       + D +S G+L  E+ TG  P
Sbjct: 162 RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 54/237 (22%), Positives = 95/237 (40%), Gaps = 43/237 (18%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNL----QHRGASKSFIAEC--------- 209
               +G G++G V K   D      +VA+K + +          +  +  C         
Sbjct: 13  KGAHLGEGTYGKVEKAY-DTLTG-KIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRE 70

Query: 210 -QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQ 268
            + +  I+H N++ ++   V       DF  LV ++M    L++ +    D    L   Q
Sbjct: 71  LKIMNEIKHENIMGLVDVYVE-----GDFINLVMDIM-ASDLKKVV----DRKIRLTESQ 120

Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA----------K 318
              I + + + L  LH +     +H DL P+N+ ++ +    ++DFGLA           
Sbjct: 121 VKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177

Query: 319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGK 374
              +         +S V    T+ Y APE  MG+E      D++S G +  E+ TGK
Sbjct: 178 LSKDETMQRREEMTSKV---VTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 76/270 (28%), Positives = 103/270 (38%), Gaps = 62/270 (22%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRH 217
           F    L+G G  G V+  +        L A+KVL+   +  R   K  + E + L ++ H
Sbjct: 3   FKKIKLLGKGDVGRVF--LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI---AV 274
             L  +  S     FQ   +  LV +    G L  +  L R   +    L        A 
Sbjct: 61  PFLPTLYAS-----FQTETYLCLVMDYCPGGEL--FRLLQR---QPGKCLSEEVARFYAA 110

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPE-------AAN 325
           +V   LEYLH      IV+ DLKP N+LL    + H+  SDF L+K           A  
Sbjct: 111 EVLLALEYLH--LLG-IVYRDLKPENILLHE--SGHIMLSDFDLSKQSDVEPPPVSKALR 165

Query: 326 NLSSNQSSSVGVK---------------GTVGYAAPE----YGMGSEVSTSGDVYSFGIL 366
             S   S +                   GT  Y APE     G GS V    D ++ GIL
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV----DWWTLGIL 221

Query: 367 LLEMFTGKGPTNEMFTG---NLTLHNFVKE 393
           L EM  G  P    F G   + T  N +K+
Sbjct: 222 LYEMLYGTTP----FKGSNRDETFSNILKK 247

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 71/266 (26%), Positives = 113/266 (42%), Gaps = 34/266 (12%)

Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRH 217
            +    ++G GS+G V   +  H        +K LNL++  R   K+   E Q L  ++H
Sbjct: 1   AYCFVRVVGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH 58

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELM---VNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
            N+V    S     ++G D   L+Y +M     G L  +  L     + L   Q +   V
Sbjct: 59  PNIVAYRES-----WEGED--GLLYIVMGFCEGGDL--YHKLKEQKGKLLPENQVVEWFV 109

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
            +A  L+YLH   E  I+H DLK  NV L       V D G+A+ L E   +++S     
Sbjct: 110 QIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMAST---- 161

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA 394
             + GT  Y +PE       +   DV++ G  + EM T K   N     +L ++  ++  
Sbjct: 162 --LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRIIEGK 218

Query: 395 LPE-------RLAEIVDPVLLVEREE 413
           LP         L E++  +L    E+
Sbjct: 219 LPPMPKDYSPELGELIATMLSKRPEK 244

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 24/216 (11%)

Query: 163 LENL--IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           LEN   IG GS G V      H   +  VAVK+++L+ +   +    E   +R  +H+N+
Sbjct: 23  LENYIKIGEGSTGIVCIAREKHSGRQ--VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNV 80

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V++  S +     G +   L+ E +  G+L + +   R     LN  Q  ++   V   L
Sbjct: 81  VEMYKSYLV----GEELWVLM-EFLQGGALTDIVSQTR-----LNEEQIATVCESVLQAL 130

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
            YLH      ++H D+K  ++LL  +    +SDFG   F  + + ++   +S    + GT
Sbjct: 131 CYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFG---FCAQISKDVPKRKS----LVGT 180

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             + APE    +   T  D++S GI+++EM  G+ P
Sbjct: 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 67/235 (28%), Positives = 96/235 (40%), Gaps = 19/235 (8%)

Query: 152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQA 211
           ++L   TD + +   IG G++G VYK     D   +L AVK+L+       +   AE   
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDG--SLAAVKILD-PISDVDEEIEAEYNI 71

Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
           L+S+  H N+VK        D        LV EL   GS+ E   L +        L   
Sbjct: 72  LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTE---LVKGLLICGQRLDEA 128

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSN 330
            I+  +   L  L H     I+H D+K +N+LL  E    + DFG++  L      L  N
Sbjct: 129 MISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST--RLRRN 186

Query: 331 QSSSVGVKGTVGYAAPEY-----GMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
            S      GT  + APE                DV+S GI  +E+  G  P  +M
Sbjct: 187 TSV-----GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 48/234 (20%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK   D   +ET +A+K + L+    G   + I E   L+ ++H N+V++ 
Sbjct: 10  IGEGTYGVVYKA-RDRVTNET-IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL- 66

Query: 225 TSCVSVDFQGNDFEA-LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
                 D   ++    LV+E + +  L++ +  + D  +N  L++  +    +   + Y 
Sbjct: 67  -----QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIK--TYLYQILRGIAYC 118

Query: 284 HHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAK--------FLPEAANNLSSNQSSS 334
           H +    ++H DLKP N+L+D    A  ++DFGLA+        F  E            
Sbjct: 119 HSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV---------- 165

Query: 335 VGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEM------FTGKGPTNEMF 381
                T+ Y APE  +GS   ST  D++S G +  EM      F G    +E+F
Sbjct: 166 -----TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214

Length = 294

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 33/221 (14%)

Query: 167 IGAGSFGSVYKGIFD---HDDHETLVAVKVLN----LQHRGASKSFIAECQALRSIRHRN 219
           +G GSFG VY+G        + ET VAVK +N    L+ R     F+ E   ++     +
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHH 70

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNL-----NLLQRLSIA 273
           +V+++     V  +G     +V ELM +G L+ +L  L  +A  N       L + + +A
Sbjct: 71  VVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
            ++A  + YL+       VH DL   N ++  + T  + DFG+ +       ++      
Sbjct: 126 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYETDYY 175

Query: 334 SVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
             G KG   V + APE       +TS D++SFG++L E+ +
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 29/231 (12%)

Query: 174 SVYKGIFDHDDHETLVAVKVLNLQHRGASK---SFIAECQALRSIRHRNLVKIITSCVSV 230
           S+YKGIF++      V ++     H+G          E + LR I   N++KI    + +
Sbjct: 35  SIYKGIFNN----KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90

Query: 231 DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP 290
                   +L+ E    G L E L   +D    L+   +L +A+D    L  L+ Y   P
Sbjct: 91  -VDDLPRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYTNKP 145

Query: 291 IVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEY-- 348
             + +L   + L+       +   GL K L       SS    +V     + Y + +   
Sbjct: 146 --YKNLTSVSFLVTENYKLKIICHGLEKIL-------SSPPFKNVN---FMVYFSYKMLN 193

Query: 349 GMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG---NLTLHNFVKEALP 396
            + SE +   D+YS G++L E+FTGK P   + T    +L ++      LP
Sbjct: 194 DIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP 244

Length = 283

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 41/222 (18%)

Query: 167 IGAGSFGSVY----KGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           I  G+FGSVY    +   D+       A+KVL  +    +K+ +   +A R+I       
Sbjct: 4   ISKGAFGSVYLAKKRSTGDY------FAIKVLK-KSDMIAKNQVTNVKAERAIMMIQGES 56

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLH----LNRDAPRNLNLLQRLSIAVDVAS 278
              + +   FQ  D+  LV E +  G     +     L  D  +            +V  
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--------IAEVVL 108

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSSSVG 336
            +E LH   +  I+H D+KP N+L+D   T H+  +DFGL           S N   +  
Sbjct: 109 GVEDLH---QRGIIHRDIKPENLLIDQ--TGHLKLTDFGL-----------SRNGLENKK 152

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
             GT  Y APE  +G       D +S G ++ E   G  P +
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 10/104 (9%)

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           A ++   L++LH      IV+ DLK  N+LLD +    ++DFG+ K      N L   ++
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK-----ENMLGDAKT 153

Query: 333 SSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            +    GT  Y APE  +G + +TS D +SFG+LL EM  G+ P
Sbjct: 154 CTFC--GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 52/226 (23%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYKG   +     +VA+K + L+    G   + I E   L+ ++H N+V + 
Sbjct: 8   IGEGTYGVVYKG--RNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V  Q +    L++E            L+ D  + L+ L +    +D      YL+
Sbjct: 66  ----DVLMQESRL-YLIFEF-----------LSMDLKKYLDSLPKGQ-YMDAELVKSYLY 108

Query: 285 H------YCETP-IVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
                  +C +  ++H DLKP N+L+D +    ++DFGLA+               + G+
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR---------------AFGI 153

Query: 338 K--------GTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
                     T+ Y APE  +GS   ST  D++S G +  EM T K
Sbjct: 154 PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 63/239 (26%), Positives = 100/239 (41%), Gaps = 50/239 (20%)

Query: 161 FSLENLIGAGSFGSVY---KGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRS 214
           F +   +G G +G V+   K     D  E +VA+K +    L      +  + E   L +
Sbjct: 3   FQILTQVGQGGYGQVFLAKK----KDTGE-IVALKRMKKSLLFKLNEVRHVLTERDILTT 57

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQ----RL 270
            +   LVK++ +     FQ +++  L  E +  G     L+       NL +L     R 
Sbjct: 58  TKSEWLVKLLYA-----FQDDEYLYLAMEYVPGGDFRTLLN-------NLGVLSEDHARF 105

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLS 328
            +A    + ++ LH   E   +H DLKP N L+D   + H+  +DFGL+K +   AN+  
Sbjct: 106 YMAEMFEA-VDALH---ELGYIHRDLKPENFLIDA--SGHIKLTDFGLSKGIVTYANS-- 157

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMFT 382
                   V G+  Y APE   G     + D +S G +L E   G  P      NE + 
Sbjct: 158 --------VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE 208

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 37/104 (35%), Positives = 56/104 (53%), Gaps = 10/104 (9%)

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           A ++   L++LH   +  I++ DLK  NVLLD +    ++DFG+ K      N     ++
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCK-----ENMNGEGKA 153

Query: 333 SSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           S+    GT  Y APE   G + + S D +SFG+LL EM  G+ P
Sbjct: 154 STFC--GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 50/181 (27%), Positives = 78/181 (43%), Gaps = 18/181 (9%)

Query: 196 LQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH 255
           ++ R      + E + L  +  R +V +     +  ++  D   LV  +M  G L+   H
Sbjct: 38  IKKRKGEAMALNEKRILEKVNSRFVVSL-----AYAYETKDALCLVLTIMNGGDLK--FH 90

Query: 256 LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG 315
           +        +  + +  A ++   LE L       IV+ DLKP N+LLD      +SD G
Sbjct: 91  IYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLG 147

Query: 316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG 375
           LA  +PE          +  G  GTVGY APE     + + S D +  G L+ EM  G+ 
Sbjct: 148 LAVQIPEG--------ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199

Query: 376 P 376
           P
Sbjct: 200 P 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 28/222 (12%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVL--NLQHRGASKSFIAECQALRSIRHRNLVKI 223
           L+G GS+G V K    H +   +VA+K    +   +   K  + E + L+ +RH NLV +
Sbjct: 8   LVGEGSYGMVMK--CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           I       F+      LV+E + +  L++        P  L+  +       +   +E+ 
Sbjct: 66  IEV-----FRRKKRLYLVFEFVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFC 116

Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGY 343
           H +    I+H D+KP N+L+       + DFG A+        L++          T  Y
Sbjct: 117 HSH---NIIHRDIKPENILVSQSGVVKLCDFGFART-------LAAPGEVYTDYVATRWY 166

Query: 344 AAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
            APE  +G ++   + D+++ G L+ EM TG      +F G+
Sbjct: 167 RAPELLVGDTKYGRAVDIWAVGCLVTEMLTG----EPLFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 40/232 (17%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVL-NLQHRGASKSFIAECQAL-RSIRHRNL 220
            +++IG G+FG V K     D      A+K +     +   + F  E + L +   H N+
Sbjct: 11  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------DAPRNLNLLQ 268
           + ++ +C     +   +  L  E   +G+L ++L  +R                 L+  Q
Sbjct: 71  INLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLS 328
            L  A DVA  ++YL    +   +H DL   N+L+     A ++DFGL++          
Sbjct: 126 LLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---------- 172

Query: 329 SNQSSSVGVKGTVG-----YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG 375
                 V VK T+G     + A E    S  +T+ DV+S+G+LL E+ +  G
Sbjct: 173 ---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 221

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 61.7 bits (150), Expect = 5e-10
 Identities = 39/120 (32%), Positives = 59/120 (49%), Gaps = 18/120 (15%)

Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD--GELTAHVSDFGLAKFLP------ 321
           LSI   + +T+EY+H      ++H DLKP N+LL   GE+   + D+G A F        
Sbjct: 116 LSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVV--ILDWGAAIFKKLEEEDL 170

Query: 322 -----EAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                +  N   S+ +    + GT  Y APE  +G   S S D+Y+ G++L +M T   P
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 60.0 bits (146), Expect = 5e-10
 Identities = 59/224 (26%), Positives = 98/224 (43%), Gaps = 49/224 (21%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK          +VA+K + L+    G   + I E   L+ + H N+V+++
Sbjct: 7   IGEGTYGVVYKARDKLTGE--IVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V    N    LV+E            L+ D  + ++      +   +  +  YL+
Sbjct: 65  ----DVVHSENKL-YLVFE-----------FLDLDLKKYMDSSPLTGLDPPLIKS--YLY 106

Query: 285 H------YCET-PIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
                  YC +  ++H DLKP N+L+D E    ++DFGLA+             +  V V
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-------------AFGVPV 153

Query: 338 KG------TVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGK 374
           +       T+ Y APE  +GS + ST  D++S G +  EM   +
Sbjct: 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 25/211 (11%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIIT 225
           +G G++ +V+KG       E LVA+K + L+H  GA  + I E   L+ ++H N+V +  
Sbjct: 14  LGEGTYATVFKG--RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL-H 70

Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV-DVASTLEYLH 284
             V  D        LV+E + +  L++++    D   N+  +  + I +  +   L Y H
Sbjct: 71  DIVHTD----KSLTLVFEYL-DKDLKQYM----DDCGNIMSMHNVKIFLYQILRGLAYCH 121

Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYA 344
                 ++H DLKP N+L++      ++DFGLA+     A ++ +   S+  V  T+ Y 
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLAR-----AKSVPTKTYSNEVV--TLWYR 171

Query: 345 APEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
            P+  +G SE ST  D++  G +  EM +G+
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 59.6 bits (144), Expect = 6e-10
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 30/218 (13%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK-SFIAECQALRSIRHRNLVKIIT 225
           IG G FG V  G  +       V VK L +      +  F+ E Q  RS++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPR---NLNLLQRLSIAVDVASTLEY 282
            C  V         LV E    G L+ +L   R A     +   LQR+  A ++A  L +
Sbjct: 63  QCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLH 115

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           LH   +   +H DL   N LL  +LT  + D+GL+    +    ++ +Q         + 
Sbjct: 116 LH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV-----PLR 167

Query: 343 YAAPEYGMGSEV---------STSGDVYSFGILLLEMF 371
           + APE  +  EV         +   +V+S G+ + E+F
Sbjct: 168 WIAPE--LVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 51/203 (25%), Positives = 94/203 (46%), Gaps = 29/203 (14%)

Query: 185 HETLVAVKVLNLQ-HRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE 243
              LVAVK+L    ++ A   F+ E + L  ++  N+++++  CV       D   ++ E
Sbjct: 45  RPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITE 99

Query: 244 LMVNGSLEEWLH----LNRDAPRNLNLLQR-----------LSIAVDVASTLEYLHHYCE 288
            M NG L ++L      +++   N  +              L +A+ +AS ++YL     
Sbjct: 100 YMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SS 156

Query: 289 TPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEY 348
              VH DL   N L+   LT  ++DFG+++ L   A +    Q  +V     + + A E 
Sbjct: 157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNL--YAGDYYRIQGRAV---LPIRWMAWEC 211

Query: 349 GMGSEVSTSGDVYSFGILLLEMF 371
            +  + +T+ DV++FG+ L E+ 
Sbjct: 212 ILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 23/211 (10%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKI 223
           ++G G++G V K   +    E +VA+K            K+ + E + LR +RH N+V +
Sbjct: 8   VVGEGAYGVVLK-CRNKATGE-IVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
             +      +G  +  LV+E  V  +L E L  +   P  L      S    +   + Y 
Sbjct: 66  KEAFRR---KGRLY--LVFEY-VERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYC 116

Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGY 343
           H      I+H D+KP N+L+       + DFG A+ L        S  +  V    T  Y
Sbjct: 117 H---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA---SPLTDYV---ATRWY 167

Query: 344 AAPEYGMGS-EVSTSGDVYSFGILLLEMFTG 373
            APE  +G        DV++ G ++ E+  G
Sbjct: 168 RAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 24/211 (11%)

Query: 167 IGAGSFGSVYKGIFDHDDH-ETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIIT 225
           IG GS G V       D      VAVK ++L+ +   +    E   +R  +H N+V++ +
Sbjct: 27  IGEGSTGIV---CIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83

Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
           S     +   D   +V E +  G+L + +   R     +N  Q  ++ + V   L +LH 
Sbjct: 84  S-----YLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLAVLKALSFLH- 132

Query: 286 YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAA 345
                ++H D+K  ++LL  +    +SDFG   F  + +  +   +S    + GT  + A
Sbjct: 133 --AQGVIHRDIKSDSILLTSDGRVKLSDFG---FCAQVSKEVPRRKS----LVGTPYWMA 183

Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           PE        T  D++S GI+++EM  G+ P
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 29/228 (12%)

Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALR 213
           F     +   + IG G++G V      H      VA+K ++  +H+   +  + E + LR
Sbjct: 1   FDVGPRYQNLSYIGEGAYGMVCSAT--HKPTGVKVAIKKISPFEHQTFCQRTLREIKILR 58

Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS-- 271
             +H N++ I+       F+  +   +V ELM     E  L+        L   Q LS  
Sbjct: 59  RFKHENIIGILDIIRPPSFESFNDVYIVQELM-----ETDLY-------KLIKTQHLSND 106

Query: 272 ----IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL 327
                   +   L+Y+H      ++H DLKPSN+LL+      + DFGLA+     A+  
Sbjct: 107 HIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR----IADPE 159

Query: 328 SSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGK 374
             +         T  Y APE  + S   + + D++S G +L EM + +
Sbjct: 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 66/231 (28%), Positives = 112/231 (48%), Gaps = 47/231 (20%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVK----VLNLQHRGASKSFIAECQ-ALRSIRH 217
           +E L G G++G V K    H    T++AVK     +N Q +   K  + +   ++RS   
Sbjct: 6   IEEL-GRGAYGVVDK--MRHVPTGTIMAVKRIRATVNSQEQ---KRLLMDLDISMRS--- 56

Query: 218 RNLVKIITSCV-SVDFQGNDF-EALVY---ELMVNGSLEEWLHLNRDAPRNL--NLLQRL 270
                    C  +V F G  F E  V+   E+M + SL+++     D    +  ++L + 
Sbjct: 57  -------VDCPYTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK- 107

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSN 330
            IAV +   LEYLH   +  ++H D+KPSNVL++      + DFG++ +L    ++++  
Sbjct: 108 -IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL---VDSVAKT 161

Query: 331 QSSSVGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGP 376
             +     G   Y APE  +  E++  G     DV+S GI ++E+ TG+ P
Sbjct: 162 IDA-----GCKPYMAPER-INPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 67/259 (25%), Positives = 105/259 (40%), Gaps = 65/259 (25%)

Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETL----VAVK-------VLNLQHRGASK 203
           F     +     IG+G++G V   I      +T     VA+K       V  L  R    
Sbjct: 1   FDVGSRYKPIENIGSGAYGVVCSAI------DTRSGKKVAIKKIPHAFDVPTLAKRT--- 51

Query: 204 SFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA--LVYELMVNGSLEEWLHLNRD-- 259
             + E + LR  +H N++ I          G DF+   +V +LM    L   +H ++   
Sbjct: 52  --LRELKILRHFKHDNIIAIRDILRP---PGADFKDVYVVMDLM-ESDLHHIIHSDQPLT 105

Query: 260 -APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                  L Q L         L+Y+H      ++H DLKPSN+L++ +    + DFG+A+
Sbjct: 106 EEHIRYFLYQLL-------RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155

Query: 319 FLPEAANNLSSNQSSSVGVKG-------TVGYAAPEYGMGS--EVSTSGDVYSFGILLLE 369
            L           SS    K        T  Y APE  + S  E +T+ D++S G +  E
Sbjct: 156 GL----------SSSPTEHKYFMTEYVATRWYRAPEL-LLSLPEYTTAIDMWSVGCIFAE 204

Query: 370 MFTGKGPTNEMFTGNLTLH 388
           M  G+    ++F G   +H
Sbjct: 205 ML-GR---RQLFPGKNYVH 219

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 35/225 (15%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G+V+K   + + HE +VA+K + L     G   S + E   L+ ++H+N+V++ 
Sbjct: 8   IGEGTYGTVFKAK-NRETHE-IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS----TL 280
                     +    LV+E           + ++D  +  +          V S     L
Sbjct: 66  DV-----LHSDKKLTLVFE-----------YCDQDLKKYFDSCNGDIDPEIVKSFMFQLL 109

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
           + L       ++H DLKP N+L++      ++DFGLA+     A  +     S+  V  T
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-----AFGIPVRCYSAEVV--T 162

Query: 341 VGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           + Y  P+   G+++ STS D++S G +  E+     P   +F GN
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 58/237 (24%), Positives = 110/237 (46%), Gaps = 42/237 (17%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL--NLQHRGASKSFIAECQALRSIRHR 218
           F +  ++G G++G V K    H + + +VA+K    + ++    ++ + E + LR+++  
Sbjct: 3   FEVLGVVGEGAYGVVLK--CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+V++  +     F+      LV+E +    LE              LL+ +   V    
Sbjct: 61  NIVELKEA-----FRRRGKLYLVFEYVEKNMLE--------------LLEEMPNGVPPEK 101

Query: 279 TLEYLH------HYC-ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQ 331
              Y++      H+C +  IVH D+KP N+L+       + DFG A+ L E +N   +N 
Sbjct: 102 VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN---ANY 158

Query: 332 SSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLE------MFTGKGPTNEMFT 382
           +  V    T  Y +PE  +G+    + D++S G +L E      +F G+   +++FT
Sbjct: 159 TEYV---ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 66/228 (28%), Positives = 104/228 (45%), Gaps = 47/228 (20%)

Query: 167 IGAGSFGSVYKGIFDHDDH-ETLVAVKVLNLQHRGASKSF---IAECQALRSIRHRNLVK 222
           IG GSFG+VY   F  D     +VA+K ++   + +++ +   I E + L+ +RH N   
Sbjct: 23  IGHGSFGAVY---FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN--- 76

Query: 223 IITSCVSVDFQG---NDFEA-LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---D 275
                 +++++G    +  A LV E  + GS  + L +++        LQ + IA     
Sbjct: 77  ------TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKP------LQEVEIAAICHG 123

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
               L YLH +     +H D+K  N+LL    T  ++DFG A        +L S  +S V
Sbjct: 124 ALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA--------SLVSPANSFV 172

Query: 336 GVKGTVGYAAPEYGMG-SEVSTSG--DVYSFGILLLEMFTGKGPTNEM 380
              GT  + APE  +   E    G  DV+S GI  +E+   K P   M
Sbjct: 173 ---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 70/267 (26%), Positives = 118/267 (44%), Gaps = 42/267 (15%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG GS G V   I        LVAVK ++L+ +   +    E   +R  +H N+V++  S
Sbjct: 28  IGEGSTGIVC--IATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85

Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E +  G+L + +   R     +N  Q  ++ + V   L  LH  
Sbjct: 86  -----YLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLKALSVLH-- 133

Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAP 346
               ++H D+K  ++LL  +    +SDFG   F  + +  +   +S    + GT  + AP
Sbjct: 134 -AQGVIHRDIKSDSILLTHDGRVKLSDFG---FCAQVSKEVPRRKS----LVGTPYWMAP 185

Query: 347 EY----GMGSEVSTSGDVYSFGILLLEMFTGKGPT-NEMFTGNLTLHNFVKEALPERLAE 401
           E       G EV    D++S GI+++EM  G+ P  NE     L     +++ LP +L  
Sbjct: 186 ELISRLPYGPEV----DIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPKLKN 238

Query: 402 I--VDPVL------LVEREEGETSEAN 420
           +  V P L      L+ R+  + + A 
Sbjct: 239 LHKVSPSLKGFLDRLLVRDPAQRATAA 265

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 24/214 (11%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRHRNLVK 222
           L+G G+FG V   +          A+K+L  +    +      + E + L++ RH  L  
Sbjct: 2   LLGKGTFGKVI--LVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +  S     FQ  D    V E  VNG  E + HL+R+  R  +  +      ++ S L+Y
Sbjct: 60  LKYS-----FQTKDRLCFVME-YVNGG-ELFFHLSRE--RVFSEDRTRFYGAEIVSALDY 110

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           LH      IV+ DLK  N++LD +    ++DFGL K   E   + ++ ++      GT  
Sbjct: 111 LH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFC----GTPE 160

Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 58.3 bits (141), Expect = 3e-09
 Identities = 51/211 (24%), Positives = 89/211 (42%), Gaps = 28/211 (13%)

Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
           G+++   +  GS G V+  +         V +K+      G   + + E   L+++ H +
Sbjct: 67  GYTVIKTLTPGSEGRVF--VATKPGQPDPVVLKI------GQKGTTLIEAMLLQNVNHPS 118

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           ++++  + VS          +V     +  L  +L   R  P  L + Q L I   +   
Sbjct: 119 VIRMKDTLVS-----GAITCMVLP-HYSSDLYTYLT-KRSRP--LPIDQALIIEKQILEG 169

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           L YLH      I+H D+K  N+ ++      + D G A+F   A   L        G+ G
Sbjct: 170 LRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL--------GLAG 218

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEM 370
           TV   APE     + ++  D++S GI+L EM
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 26/224 (11%)

Query: 161 FSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRS 214
           F L  ++G G++G V+  + +  HD  + L A+KVL     +Q    ++    E Q L  
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGK-LYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           IR      ++T  +   FQ +    L+ + +  G L  + HL++        +Q  S  +
Sbjct: 61  IRQSPF--LVT--LHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGEI 114

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
            +A  LE+LH   +  I++ D+K  N+LLD      ++DFGL+K   E           +
Sbjct: 115 VLA--LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV------ERA 163

Query: 335 VGVKGTVGYAAPEYGMGSEV--STSGDVYSFGILLLEMFTGKGP 376
               GT+ Y AP+   G +     + D +S G+L+ E+ TG  P
Sbjct: 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 66/229 (28%), Positives = 101/229 (44%), Gaps = 40/229 (17%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIIT 225
           +IG G FG VY       D   + A+K L+ + R   K    E  AL     R ++ +++
Sbjct: 1   IIGRGGFGEVYG--CRKADTGKMYAMKCLD-KKRIKMKQ--GETLALN---ERIMLSLVS 52

Query: 226 S-------CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           +       C+S  F   D  + + +LM  G L    HL++      +  +    A ++  
Sbjct: 53  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGV--FSEAEMRFYAAEIIL 108

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA----KFLPEAANNLSSNQSSS 334
            LE++H+     +V+ DLKP+N+LLD      +SD GLA    K  P A          S
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----------S 155

Query: 335 VGVKGTVGYAAPE-YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFT 382
           V   GT GY APE    G    +S D +S G +L ++  G  P  +  T
Sbjct: 156 V---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 32/237 (13%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHR 218
           + ++ +IG GS+G V   I  H   +  VA+K +N   +H   +   + E + LR +RH 
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEK--VAIKKINDVFEHVSDATRILREIKLLRLLRHP 59

Query: 219 NLVKIITSCVSVDFQGNDFEAL--VYELMVNGSLEEWLHLNRDAPRN---LNLLQRLSIA 273
           ++V+I    +       +F+ +  V+ELM    L + +  N D         L Q L   
Sbjct: 60  DIVEIKHIMLPPS--RREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLR-- 114

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
                 L+Y+H      + H DLKP N+L + +    + DFGLA+     A N +     
Sbjct: 115 -----ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR----VAFNDTPTAIF 162

Query: 334 SVGVKGTVGYAAPEY--GMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH 388
                 T  Y APE      S+ + + D++S G +  E+ TGK     +F G   +H
Sbjct: 163 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK----PLFPGKNVVH 215

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 56.9 bits (137), Expect = 4e-09
 Identities = 67/246 (27%), Positives = 106/246 (43%), Gaps = 29/246 (11%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLV---AVKVLNLQHRGASKSFIAECQALRSIRH 217
           + +   IG GSFG +Y      D    ++    +  + ++ + ASK    E   L  ++H
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKH 58

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            N+V    S     FQ N    +V E    G L +   +NR      +  Q LS  V ++
Sbjct: 59  PNIVTFFAS-----FQENGRLFIVMEYCDGGDLMK--RINRQRGVLFSEDQILSWFVQIS 111

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
             L+++H   +  I+H D+K  N+ L    + A + DFG+A+ L    N+      + VG
Sbjct: 112 LGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCVG 164

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP 396
              T  Y +PE       +   D++S G +L E+ T K P    F GN  LH  V +   
Sbjct: 165 ---TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGN-NLHQLVLKICQ 216

Query: 397 ERLAEI 402
              A I
Sbjct: 217 GYFAPI 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 67/235 (28%), Positives = 103/235 (43%), Gaps = 52/235 (22%)

Query: 166 LIGAGSFGSVYK-GIFDHDDHETLVAVKVL-------NLQHRGASKSFIAECQALRSIRH 217
           ++G G +G V++       D   + A+KVL       N +    +K   AE   L +++H
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK---AERNILEAVKH 59

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNL----LQRLSIA 273
             +V +I +     FQ      L+ E +  G L  ++HL R+     +     L  +S+A
Sbjct: 60  PFIVDLIYA-----FQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLA 112

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
                 LE+LH      I++ DLKP N+LLD +    ++DFGL K            +S 
Sbjct: 113 ------LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK------------ESI 151

Query: 334 SVGVK-----GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG 383
             G       GT+ Y APE  M S    + D +S G L+ +M TG  P    FT 
Sbjct: 152 HEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP----FTA 202

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 19/175 (10%)

Query: 200 GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD 259
           G       E   LR+I H +++++  +     F  N F  L+         +  L+    
Sbjct: 125 GQRGGTATEAHILRAINHPSIIQLKGT-----FTYNKFTCLILP-----RYKTDLYCYLA 174

Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
           A RN+ +   L+I   V   ++YLH   E  I+H D+K  N+ ++      + DFG A F
Sbjct: 175 AKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231

Query: 320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
                  +  N +   G  GT+   APE         + D++S GI+L EM T  
Sbjct: 232 ------PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 23/189 (12%)

Query: 189 VAVKVLN--LQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA--LVYEL 244
           VAVK L+   Q++  +K    E   L+ + H+N++ ++ +  +      +F+   LV EL
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL-NVFTPQKSLEEFQDVYLVMEL 107

Query: 245 MVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD 304
           M + +L + +H+  D  R   LL ++   +      ++LH      I+H DLKPSN+++ 
Sbjct: 108 M-DANLCQVIHMELDHERMSYLLYQMLCGI------KHLH---SAGIIHRDLKPSNIVVK 157

Query: 305 GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFG 364
            + T  + DFGLA+    A  N             T  Y APE  +G     + D++S G
Sbjct: 158 SDCTLKILDFGLAR---TACTNFMMTPYVV-----TRYYRAPEVILGMGYKENVDIWSVG 209

Query: 365 ILLLEMFTG 373
            ++ E+  G
Sbjct: 210 CIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 65/230 (28%), Positives = 98/230 (42%), Gaps = 35/230 (15%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSI 215
           D F +  +IG G+FG V   +      E + A+K+LN   +  R  +  F  E    R++
Sbjct: 1   DDFEIIKVIGRGAFGEV--AVVKMKHTERIYAMKILNKWEMLKRAETACFREE----RNV 54

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA-PRNLN--LLQRLSI 272
                 + IT+ +   FQ  ++  LV +  V G L   L    D  P ++    +  + +
Sbjct: 55  LVNGDCQWITT-LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVL 113

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           A+     L Y         VH D+KP NVLLD      ++DFG    +     N      
Sbjct: 114 AIHSIHQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKM-----NQDGTVQ 159

Query: 333 SSVGVKGTVGYAAPEY------GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           SSV V GT  Y +PE       GMG +     D +S G+ + EM  G+ P
Sbjct: 160 SSVAV-GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 40/223 (17%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIIT 225
           +IG G FG VY       D   + A+K L+ + R   K    E  AL     R ++ +++
Sbjct: 1   IIGRGGFGEVYG--CRKADTGKMYAMKCLD-KKRIKMKQ--GETLALN---ERIMLSLVS 52

Query: 226 S-------CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           +       C++  F   D    + +LM  G L    HL++    +   ++    A ++  
Sbjct: 53  TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGVFSEKEMR--FYATEIIL 108

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA----KFLPEAANNLSSNQSSS 334
            LE++H+     +V+ DLKP+N+LLD      +SD GLA    K  P A+          
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---------- 155

Query: 335 VGVKGTVGYAAPE-YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
               GT GY APE    G+   +S D +S G +L ++  G  P
Sbjct: 156 ---VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 56.6 bits (137), Expect = 8e-09
 Identities = 51/213 (23%), Positives = 99/213 (46%), Gaps = 20/213 (9%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVK--VLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G+FG V+K    H   + +VA+K  ++  +  G   + + E + L+ ++H N+V +I
Sbjct: 20  IGQGTFGEVFKA--RHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLH----LNRDAPRNLNLLQRLSIAVDVASTL 280
             C +     N ++   Y +      E   H    L  +      L +   +   + + L
Sbjct: 78  EICRTKATPYNRYKGSFYLVF-----EFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGL 132

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
            Y+H      I+H D+K +N+L+  +    ++DFGLA+    + N+  +  ++ V    T
Sbjct: 133 YYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV---VT 186

Query: 341 VGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFT 372
           + Y  PE  +G  +     D++  G ++ EM+T
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 56.6 bits (137), Expect = 9e-09
 Identities = 65/232 (28%), Positives = 94/232 (40%), Gaps = 48/232 (20%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA---ECQALRS--- 214
           F    ++G G FG V   + ++     L A+K L        K  I    E ++L     
Sbjct: 1   FRCLAVLGRGHFGKVL--LAEYKKTGELYAIKALK-------KGDIIARDEVESLMCEKR 51

Query: 215 -------IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD---APRNL 264
                   RH  LV +  +C    FQ  D    V E    G L   +H++ D    PR +
Sbjct: 52  IFETANSERHPFLVNLF-AC----FQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAV 104

Query: 265 NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAA 324
                   A  V   L+YLH   E  IV+ DLK  N+LLD E    ++DFGL K      
Sbjct: 105 ------FYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK------ 149

Query: 325 NNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             +     +S    GT  + APE    +  + + D +  G+L+ EM  G+ P
Sbjct: 150 EGMGFGDRTST-FCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 30/231 (12%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRN 219
           F L  ++G G++G VYKG   H     L A+KV+++      +    E   L+    HRN
Sbjct: 18  FELVEVVGNGTYGQVYKG--RHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRN 74

Query: 220 LVKIITSCVSVDFQGNDFEA-LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           +     + +     G+D +  LV E    GS+ + +   +      N L+   IA     
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-----NALKEDWIAYICRE 129

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            L  L H     ++H D+K  NVLL       + DFG           +S+    +VG +
Sbjct: 130 ILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG-----------VSAQLDRTVGRR 178

Query: 339 ----GTVGYAAPEYGMGSEVSTS-----GDVYSFGILLLEMFTGKGPTNEM 380
               GT  + APE     E   +      D++S GI  +EM  G  P  +M
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 60/238 (25%), Positives = 105/238 (44%), Gaps = 19/238 (7%)

Query: 149 VSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAE 208
           + + +    +D + +   IG G++G V+K +   +  +   AVK+L+  H    +   AE
Sbjct: 8   IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKA--AVKILDPIH-DIDEEIEAE 64

Query: 209 CQALRSIR-HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL 267
              L+++  H N+VK        D +  D   LV EL   GS+ +   L +   +    +
Sbjct: 65  YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD---LVKGFLKRGERM 121

Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL 327
           +   IA  +   L  L H      +H D+K +N+LL  E    + DFG++  L     + 
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL----TST 177

Query: 328 SSNQSSSVGVKGTVGYAAPEY-----GMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
              +++SV   GT  + APE       + S      DV+S GI  +E+  G  P  ++
Sbjct: 178 RLRRNTSV---GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 54/238 (22%), Positives = 109/238 (45%), Gaps = 39/238 (16%)

Query: 159 DGFSLENLIGAGSFGSVY----KGIFDHDDHE----------TLVAVKVLNLQ-HRGASK 203
              + +  +G G FG V+    +G+    D +           LVAVK+L    ++ A  
Sbjct: 5   KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64

Query: 204 SFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL--HLNRDAP 261
            F+ E + +  ++  N+++++  C++     +D   ++ E M NG L ++L  H  ++A 
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAA 119

Query: 262 -----RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL 316
                  ++    + +A  +AS ++YL        VH DL   N L+    T  ++DFG+
Sbjct: 120 EKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGM 176

Query: 317 AKFLPEAANNLSSNQSSSVGVKGT--VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           ++       NL S     +  +    + + + E  +  + +T+ DV++FG+ L E+ T
Sbjct: 177 SR-------NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 55.5 bits (133), Expect = 1e-08
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 27/222 (12%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKV-LNLQHRGASKSFIA---ECQALRSIRHRNLV 221
           L+G G+FG VY   +D D    L A +V  + +    SK   A   E Q L++++H  +V
Sbjct: 9   LLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH----LNRDAPRNLNLLQRLSIAVDVA 277
           +    C+    +      +  E M  GS+++ L     L     R             + 
Sbjct: 68  QYY-GCLRD--RAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR--------QIL 116

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
             + YLH      IVH D+K +N+L D      + DFG +K L     + +  +S    V
Sbjct: 117 EGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS----V 169

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
            GT  + +PE   G       DV+S G  ++EM T K P  E
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 23/214 (10%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSIRHRNLVK 222
           L+G G+FG V   +          A+K+L  +   A       + E + L++ RH  L  
Sbjct: 2   LLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +  S     FQ +D    V E    G L  + HL+R+  R  +  +      ++ S L+Y
Sbjct: 60  LKYS-----FQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARFYGAEIVSALDY 110

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           LH   E  +V+ DLK  N++LD +    ++DFGL K   E   + ++ ++      GT  
Sbjct: 111 LH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFC----GTPE 161

Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 162 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 66/230 (28%), Positives = 98/230 (42%), Gaps = 37/230 (16%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKV-LNLQHRGASKSFIA-EC--QALRSIRHR 218
           L  L+G G+FG VY   +D D    L   +V  +   +  SK   A EC  Q L+++RH 
Sbjct: 6   LGKLLGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH----LNRDAPRNL--NLLQRLSI 272
            +V+    C+  D +       V E M  GS+++ L     L  +  R     +LQ +S 
Sbjct: 65  RIVQYY-GCLR-DPEEKKLSIFV-EYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS- 120

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
                    YLH      IVH D+K +N+L D      + DFG       A+  + +   
Sbjct: 121 ---------YLH---SNMIVHRDIKGANILRDSAGNVKLGDFG-------ASKRIQTICM 161

Query: 333 SSVGVKGTVG---YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
           S  G+K   G   + +PE   G       DV+S    ++EM T K P  E
Sbjct: 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 10/104 (9%)

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           + +++  L YLH   E  I++ DLK  NVLLD E    ++D+G+ K        L    +
Sbjct: 102 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------EGLRPGDT 152

Query: 333 SSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           +S    GT  Y APE   G +   S D ++ G+L+ EM  G+ P
Sbjct: 153 TST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 46/145 (31%), Positives = 65/145 (44%), Gaps = 14/145 (9%)

Query: 232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPI 291
           FQ      LV E +  G L    H+ R   R L        A ++   L +LH   E  I
Sbjct: 65  FQTTSRLFLVIEYVNGGDL--MFHMQRQ--RKLPEEHARFYAAEICIALNFLH---ERGI 117

Query: 292 VHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG 351
           ++ DLK  NVLLD +    ++D+G+ K        L    ++S    GT  Y APE   G
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCK------EGLGPGDTTST-FCGTPNYIAPEILRG 170

Query: 352 SEVSTSGDVYSFGILLLEMFTGKGP 376
            E   S D ++ G+L+ EM  G+ P
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 41/231 (17%)

Query: 161 FSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRS 214
           F L  ++G G++G V+  + +  HD  + L A+KVL     +Q     +    E   L  
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGK-LYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLNRDAPRNLNLLQRL 270
           +R      ++T  +   FQ      L+ + +  G +   L    + + D  R        
Sbjct: 61  VRQSPF--LVT--LHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVR-------- 108

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSN 330
             + ++   LE+LH   +  IV+ D+K  N+LLD E    ++DFGL+K        LS  
Sbjct: 109 FYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF------LSEE 159

Query: 331 QSSSVGVKGTVGYAAPEY-----GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           +  +    GT+ Y APE      G G  V    D +S GIL+ E+ TG  P
Sbjct: 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAV----DWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 61/233 (26%), Positives = 94/233 (40%), Gaps = 34/233 (14%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRN 219
           F L  L+G G++G VYKG   H     L A+KV+++      +    E   L+    HRN
Sbjct: 8   FELVELVGNGTYGQVYKG--RHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRN 64

Query: 220 LVKIITSCVSVDFQGNDFEA-LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           +     + +  +  G D +  LV E    GS+ + +   +      N L+   IA     
Sbjct: 65  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWIAYICRE 119

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            L  L H  +  ++H D+K  NVLL       + DFG           +S+    +VG +
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG-----------VSAQLDRTVGRR 168

Query: 339 GTVGYAAPEYGMGSEV-----------STSGDVYSFGILLLEMFTGKGPTNEM 380
            T  +    Y M  EV               D++S GI  +EM  G  P  +M
Sbjct: 169 NT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 10/104 (9%)

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           + +++  L +LH   E  I++ DLK  NVLLD E    ++D+G+ K        +    +
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK------EGIRPGDT 152

Query: 333 SSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           +S    GT  Y APE   G +   S D ++ G+L+ EM  G+ P
Sbjct: 153 TST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 37/130 (28%), Positives = 56/130 (43%), Gaps = 14/130 (10%)

Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQ 331
           + V +   L YL    +  ++H D+KPSN+LLD      + DFG++  L ++     S  
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-- 174

Query: 332 SSSVGVKGTVGYAAPEY----GMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL 387
                  G   Y APE         +     DV+S GI L+E+ TG+ P     T    L
Sbjct: 175 ------AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVL 228

Query: 388 HNFVKEALPE 397
              ++E  P 
Sbjct: 229 TKILQEEPPS 238

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 68/239 (28%), Positives = 109/239 (45%), Gaps = 31/239 (12%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRN 219
           + L N+IG GSFG VY+ I   D  E +   KVL + Q++        E   ++++ H N
Sbjct: 68  YKLGNIIGNGSFGVVYEAIC-IDTSEKVAIKKVLQDPQYKN------RELLIMKNLNHIN 120

Query: 220 LVKI----ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           ++ +     T C   + + N F  +V E +     +   H  R+       L +L  +  
Sbjct: 121 IIFLKDYYYTECFKKN-EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL-YSYQ 178

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVSDFGLAKFLPEAANNLSSNQSSS 334
           +   L Y+H      I H DLKP N+L+D    T  + DFG AK       NL + Q  S
Sbjct: 179 LCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-------NLLAGQ-RS 227

Query: 335 VGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
           V    +  Y APE  +G+   +T  D++S G ++ EM  G      +F+G  ++   V+
Sbjct: 228 VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY----PIFSGQSSVDQLVR 282

Length = 440

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 56/241 (23%), Positives = 101/241 (41%), Gaps = 33/241 (13%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK---SFIAECQALRSIRHRNLVKI 223
           IG G FG V       D     V VK   L+   +SK    F+ +    R ++H N+++ 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVK--ELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 224 ITSCVSVDFQGNDFEA----LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           +  CV         EA    LV+E    G L+ +L   +   RN  LL    +A ++A+ 
Sbjct: 61  LGQCV---------EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           + ++H +     +H DL   N  L  +LT  V D+G+        + + +     V ++ 
Sbjct: 112 VTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLR- 166

Query: 340 TVGYAAPEYG-------MGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              + APE         + +E +   +V++ G+ L E+F          +    L++ +K
Sbjct: 167 ---WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK 223

Query: 393 E 393
           +
Sbjct: 224 D 224

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 26/211 (12%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVK--VLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           IG GS+G V+K    + +   +VA+K  V +       K  + E + L+ ++H NLV +I
Sbjct: 9   IGEGSYGVVFK--CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                  F+      LV+E   +  L E   L ++ PR +       I       + + H
Sbjct: 67  EV-----FRRKRKLHLVFEYCDHTVLNE---LEKN-PRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 285 -HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGY 343
            H C    +H D+KP N+L+  +    + DFG A+ L         + +  V    T  Y
Sbjct: 118 KHNC----IHRDVKPENILITKQGQIKLCDFGFARIL----TGPGDDYTDYV---ATRWY 166

Query: 344 AAPEYGMG-SEVSTSGDVYSFGILLLEMFTG 373
            APE  +G ++     DV++ G +  E+ TG
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 45/241 (18%)

Query: 151 YQNLFKATDGFSLENLIGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSF 205
           YQNL            IG+G+ G V   Y  +   +     VA+K L+   Q+   +K  
Sbjct: 18  YQNL----------KPIGSGAQGIVCAAYDTVTGQN-----VAIKKLSRPFQNVTHAKRA 62

Query: 206 IAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA--LVYELMVNGSLEEWLHLNRDAPRN 263
             E   ++ + H+N++ ++ +  +      +F+   LV ELM + +L + + ++ D  R 
Sbjct: 63  YRELVLMKLVNHKNIIGLL-NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERM 120

Query: 264 LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA 323
             LL ++   +      ++LH      I+H DLKPSN+++  + T  + DFGLA+     
Sbjct: 121 SYLLYQMLCGI------KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----T 167

Query: 324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG 383
           A          V    T  Y APE  +G     + D++S G ++ EM  G      +F G
Sbjct: 168 AGTSFMMTPYVV----TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT----VLFPG 219

Query: 384 N 384
            
Sbjct: 220 T 220

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 45/137 (32%), Positives = 64/137 (46%), Gaps = 8/137 (5%)

Query: 256 LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG 315
           L+ D    L  L  LS    VA  +E+L        VH DL   NVLL       + DFG
Sbjct: 226 LSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFG 282

Query: 316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG 375
           LA+ +    +N  S  S+ + VK    + APE    +  +T  DV+S+GILL E+F+  G
Sbjct: 283 LARDIMHD-SNYVSKGSTFLPVK----WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337

Query: 376 PTNEMFTGNLTLHNFVK 392
                   + T +N +K
Sbjct: 338 TPYPGMIVDSTFYNKIK 354

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 63/215 (29%), Positives = 90/215 (41%), Gaps = 25/215 (11%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRSIRHRNLV 221
           ++G GSFG V            L AVKVL     LQ      + + E + L   R+   +
Sbjct: 2   VLGKGSFGKVMLARLKESGR--LYAVKVLKKDVILQDDDVECT-MTEKRILSLARNHPFL 58

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
             +  C    FQ  D    V E +  G L    H+ +   R  +  +    A ++ S L 
Sbjct: 59  TQLYCC----FQTPDRLFFVMEFVNGGDL--MFHIQKS--RRFDEARARFYAAEITSALM 110

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           +LH   +  I++ DLK  NVLLD E    ++DFG+ K   E   N  +  +      GT 
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFC----GTP 160

Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            Y APE         S D ++ G+LL EM  G  P
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 29/217 (13%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRSIRHRNLV 221
           ++G GSFG V        D   + A+KVL     LQ      +   +     + +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDE--VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR--DAPRNLNLLQRLSIAVDVAST 279
            +        FQ  D    V E +  G L   +  +R  D PR+     R   A +V   
Sbjct: 60  ALHCC-----FQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS-----RF-YAAEVTLA 108

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           L +LH +    +++ DLK  N+LLD E    ++DFG+ K   E   N  +  +      G
Sbjct: 109 LMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFC----G 158

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           T  Y APE     E   S D ++ G+L+ EM  G+ P
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 53.9 bits (129), Expect = 4e-08
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 19/221 (8%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKV-LNLQHRGASKSFIA---ECQALRSIRHR 218
           L  L+G G+FG VY   +D D    L   +V  + +    SK   A   E Q L+++ H 
Sbjct: 6   LGKLLGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            +V+    C+  D       ++  E M  GS+++   L        N+ ++ +  +    
Sbjct: 65  RIVQYY-GCLR-DPMERTL-SIFMEHMPGGSIKD--QLKSYGALTENVTRKYTRQI---- 115

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            LE + +     IVH D+K +N+L D      + DFG +K L      +  + +    V 
Sbjct: 116 -LEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL----QTICLSGTGMKSVT 170

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
           GT  + +PE   G       D++S G  ++EM T K P  E
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 24/214 (11%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRHRNLVK 222
           L+G G+FG V   +          A+K+L  +    +      + E + L++ RH  L  
Sbjct: 2   LLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL-- 57

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
              + +   FQ +D    V E    G L  + HL+R+  R     +      ++ S LEY
Sbjct: 58  ---TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFTEERARFYGAEIVSALEY 110

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           LH      +V+ D+K  N++LD +    ++DFGL K   E      S+ ++     GT  
Sbjct: 111 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGI----SDGATMKTFCGTPE 160

Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 61/232 (26%), Positives = 98/232 (42%), Gaps = 42/232 (18%)

Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVK-VLNLQHRGASKSFIAECQALRSIR-- 216
            + L   +G G++G V          E  VA+K + N+     SK  +A+ +ALR ++  
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV----FSKKILAK-RALRELKLL 55

Query: 217 -----HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
                H+N+  +    + + F GN  E  +YE ++   L + +             Q L+
Sbjct: 56  RHFRGHKNITCLYD--MDIVFPGNFNELYLYEELMEADLHQIIRSG----------QPLT 103

Query: 272 IA------VDVASTLEYLHHYCETPIVHCDLKPSNVL--LDGELTAHVSDFGLAKFLPEA 323
            A        +   L+Y+H      ++H DLKP N+L   D EL   + DFGLA+   E 
Sbjct: 104 DAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELK--ICDFGLARGFSE- 157

Query: 324 ANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
             N   N         T  Y APE  +     + + DV+S G +L E+   K
Sbjct: 158 --NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 65/233 (27%), Positives = 95/233 (40%), Gaps = 41/233 (17%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSI 215
           D F +  +IG G+FG V   +    +   + A+K+LN   +  R  +  F  E    R +
Sbjct: 1   DDFEILKVIGRGAFGEV--AVVKMKNTGQVYAMKILNKWEMLKRAETACFREE----RDV 54

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL-----HLNRDAPRNLNLLQRL 270
                 + IT+ +   FQ  +   LV +  V G L   L      L  D  R    L  +
Sbjct: 55  LVNGDRRWITN-LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY--LAEM 111

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG-LAKFLPEAANNLSS 329
            +A+D    L Y         VH D+KP NVLLD      ++DFG   + L +       
Sbjct: 112 VLAIDSVHQLGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT----- 157

Query: 330 NQSSSVGVKGTVGYAAPEY------GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              S+V V GT  Y +PE       G G       D +S G+ + EM  G+ P
Sbjct: 158 -VQSNVAV-GTPDYISPEILQAMEDGKGR-YGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 54.2 bits (131), Expect = 6e-08
 Identities = 66/250 (26%), Positives = 103/250 (41%), Gaps = 71/250 (28%)

Query: 147 LRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL-----NLQHRGA 201
           +   YQNL          + +G+G++G V          +  VA+K L     +  H   
Sbjct: 13  VPDRYQNL----------SPVGSGAYGQVCSAFDTKTGRK--VAIKKLSRPFQSAIH--- 57

Query: 202 SKSFIAECQALRSIRHRN---LVKIITSCVSV-DFQGNDFEALVYELMVNGSLEEWLHLN 257
           +K    E + L+ + H N   L+ + T   S+ DFQ  D   LV  LM  G+      LN
Sbjct: 58  AKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ--DV-YLVTHLM--GA-----DLN 107

Query: 258 RDAPRNLNLLQRLS------IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV 311
                N+   Q+LS      +   +   L+Y+H      I+H DLKPSN+ ++ +    +
Sbjct: 108 -----NIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKI 159

Query: 312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE-------YGMGSEVSTSGDVYSFG 364
            DFGLA+                 G   T  Y APE       Y      + + D++S G
Sbjct: 160 LDFGLAR----------HTDDEMTGYVATRWYRAPEIMLNWMHY------NQTVDIWSVG 203

Query: 365 ILLLEMFTGK 374
            ++ E+ TGK
Sbjct: 204 CIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 67/224 (29%), Positives = 103/224 (45%), Gaps = 40/224 (17%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS-KSFIAECQALRSIRHRNLVKIIT 225
           +G G++GSVYK +  H      +A+K + L+   +     I E   L    H+       
Sbjct: 9   LGKGNYGSVYKVL--HRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HK------- 55

Query: 226 SCVS---VDFQGNDF-EALVY---ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
             VS   VDF G  F E  VY   E M  GSL++ L+    A   +       I   V  
Sbjct: 56  -AVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVK 113

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            L++L    E  I+H D+KP+NVL++G     + DFG+      + N ++S   +++G +
Sbjct: 114 GLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGV------SGNLVASLAKTNIGCQ 165

Query: 339 GTVGYAAPEY---GMGSEVST---SGDVYSFGILLLEMFTGKGP 376
               Y APE    G  ++  T     DV+S G+ +LEM  G+ P
Sbjct: 166 ---SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 53.9 bits (129), Expect = 7e-08
 Identities = 62/229 (27%), Positives = 95/229 (41%), Gaps = 33/229 (14%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSI 215
           + F +  +IG G+FG V   +    + + + A+K+LN   +  R  +  F  E    R +
Sbjct: 1   EDFEILKVIGRGAFGEV--AVVKLKNADKVFAMKILNKWEMLKRAETACFREE----RDV 54

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA-PRNLN--LLQRLSI 272
                 + IT+ +   FQ  +   LV +  V G L   L    D  P ++    L  + I
Sbjct: 55  LVNGDNQWITT-LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVI 113

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           A+D    L Y+H          D+KP N+L+D      ++DFG    L E          
Sbjct: 114 AIDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFGSCLKLME-----DGTVQ 159

Query: 333 SSVGVKGTVGYAAPEYGMGSE-----VSTSGDVYSFGILLLEMFTGKGP 376
           SSV V GT  Y +PE     E          D +S G+ + EM  G+ P
Sbjct: 160 SSVAV-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 8e-08
 Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 43/219 (19%)

Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
           GF++   +  GS G V++    H D+   V VK       G   S + E + LR + H  
Sbjct: 170 GFAIHRALTPGSEGCVFES--SHPDYPQRVVVKA------GWYASSVHEARLLRRLSHPA 221

Query: 220 LVKII-------TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           ++ ++        +C+ +    +D                + +L     R L L Q  ++
Sbjct: 222 VLALLDVRVVGGLTCLVLPKYRSDL---------------YTYLGA-RLRPLGLAQVTAV 265

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           A  + S ++Y+H   E  I+H D+K  NVL++G     + DFG A F          + S
Sbjct: 266 ARQLLSAIDYIH--GEG-IIHRDIKTENVLVNGPEDICLGDFGAACFA-------RGSWS 315

Query: 333 SSV--GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLE 369
           +    G+ GTV   APE   G   + S D++S G+++ E
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 54.5 bits (131), Expect = 9e-08
 Identities = 26/56 (46%), Positives = 33/56 (58%), Gaps = 1/56 (1%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP 59
           N F G +P S  S R +ENLDLS+N  SG +P+ L +   L  L LS N   GE+P
Sbjct: 462 NKFFGGLPDSFGSKR-LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIP 516

Length = 968

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.7 bits (129), Expect = 9e-08
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 24/214 (11%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVK 222
           L+G G+FG V   +          A+K+L    +  +      + E + L++ RH  L  
Sbjct: 2   LLGKGTFGKVI--LVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +  S     FQ +D    V E   NG  E + HL+R+  R  +  +      ++ S L Y
Sbjct: 60  LKYS-----FQTHDRLCFVMEY-ANGG-ELFFHLSRE--RVFSEDRARFYGAEIVSALGY 110

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           LH      +V+ DLK  N++LD +    ++DFGL K        +S   +      GT  
Sbjct: 111 LH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK------EGISDGATMKT-FCGTPE 160

Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 66/233 (28%), Positives = 96/233 (41%), Gaps = 33/233 (14%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSI 215
           + F    LI  G++G+VY  +  H +     A+K +N Q    R   +    E   L   
Sbjct: 1   EDFETIKLISNGAYGAVY--LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA 58

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
            +  +V +  S     F+      +V E +  G     L      P ++    R+  A  
Sbjct: 59  ENPFVVSMFCS-----FETKRHLCMVMEYVEGGDCATLLKNIGALPVDM---ARMYFAET 110

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAANNL------- 327
           V + LEYLH+Y    IVH DLKP N+L+       ++DFGL+K  L     NL       
Sbjct: 111 VLA-LEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 328 SSNQSSSVGVKGTVGYAAPEY----GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + +     V GT  Y APE     G G  V    D ++ GI+L E   G  P
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPV----DWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 25/70 (35%), Positives = 45/70 (64%), Gaps = 1/70 (1%)

Query: 7   QGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFS 65
           +G IP+ +S LR +++++LS N++ G IP  L +   L+ L+LS+N F G +P   G  +
Sbjct: 431 RGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490

Query: 66  NSSAISLDGN 75
           +   ++L+GN
Sbjct: 491 SLRILNLNGN 500

Length = 623

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 43/125 (34%), Positives = 66/125 (52%), Gaps = 16/125 (12%)

Query: 264 LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL-DGELTAHVSDFGLAKFLPE 322
           L+ +  +  +  VA+ +E+L        VH DL   NVL+ +G+L   + DFGLA+ +  
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLV-KICDFGLARDIMR 291

Query: 323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG------P 376
            +N +S   S+ + +K    + APE    +  +T  DV+SFGILL E+FT  G      P
Sbjct: 292 DSNYISKG-STFLPLK----WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346

Query: 377 TNEMF 381
            NE F
Sbjct: 347 MNEQF 351

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 55/230 (23%), Positives = 88/230 (38%), Gaps = 36/230 (15%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK-SFI-AECQALRSIRHRNLVKI 223
           LIG      +   +  H    TLVAVK +NL          +  E    R ++H N++  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWL--HLNRDAPRNLNLLQRLSIAV---DVAS 278
           +TS +      ++   +V  LM  GS E+ L  H     P        L+IA    DV +
Sbjct: 65  VTSFIV----DSEL-YVVSPLMAYGSCEDLLKTHFPEGLP-------ELAIAFILKDVLN 112

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            L+Y+H       +H  +K S++LL G+    +S    +  + +                
Sbjct: 113 ALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSV 169

Query: 339 GTVGYAAPE--------YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
             + + +PE        Y   S      D+YS GI   E+  G  P  +M
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKS------DIYSVGITACELANGHVPFKDM 213

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 39/122 (31%), Positives = 60/122 (49%), Gaps = 16/122 (13%)

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           A ++A  L +LH      I++ DLK  NV+LD E    ++DFG+ K       N+   ++
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK------ENIFGGKT 157

Query: 333 SSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMFTGNLTL 387
           +     GT  Y APE         S D ++FG+LL EM  G+ P      +E+F  ++  
Sbjct: 158 TRT-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ-SIME 215

Query: 388 HN 389
           HN
Sbjct: 216 HN 217

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 31/215 (14%)

Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 222 KIITSCVSVDFQGNDFEA--LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++   +     
Sbjct: 80  SLL-NVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI----- 132

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
            ++LH      I+H DLKPSN+++  + T  + DFGLA+         +           
Sbjct: 133 -KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAGTSFMMTPYVV 180

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 33/226 (14%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALR 213
              F +  ++G GSFG V   + +    + L A+K+L     +Q      + + E + L 
Sbjct: 1   DFNFLM--VLGKGSFGKVM--LAERKGTDELYAIKILKKDVVIQDDDVECTMV-EKRVLA 55

Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
                  +  + SC    FQ  D    V E +  G L    H+ +         Q +  A
Sbjct: 56  LQDKPPFLTQLHSC----FQTVDRLYFVMEYVNGGDL--MYHIQQVG--KFKEPQAVFYA 107

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
            +++  L +LH      I++ DLK  NV+LD E    ++DFG+ K           +   
Sbjct: 108 AEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------EHMVD 154

Query: 334 SVGVK---GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            V  +   GT  Y APE         S D +++G+LL EM  G+ P
Sbjct: 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 45/227 (19%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSIRHRNLVKI 223
           IG GSFG+VY     H +   +VAVK ++   +  ++ +   I E + L+ ++H N    
Sbjct: 29  IGHGSFGAVYFATNSHTNE--VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN---- 82

Query: 224 ITSCVSVDFQG---NDFEA-LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
                +++++G    +  A LV E  + GS  + L +++        LQ + IA      
Sbjct: 83  -----TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKP------LQEVEIAAITHGA 130

Query: 280 LE---YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
           L+   YLH +    ++H D+K  N+LL       ++DFG A        + SS  +S V 
Sbjct: 131 LQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA--------SKSSPANSFV- 178

Query: 337 VKGTVGYAAPEYGMG-SEVSTSG--DVYSFGILLLEMFTGKGPTNEM 380
             GT  + APE  +   E    G  DV+S GI  +E+   K P   M
Sbjct: 179 --GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 63/229 (27%), Positives = 103/229 (44%), Gaps = 43/229 (18%)

Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++G+V   +    D  T   VA+K L    Q    +K    E + L+ ++H N   
Sbjct: 23  VGSGAYGTVCSAL----DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIG 78

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVN--GSLEEWLHLNRDAPRNLNLLQRLSIAV-DV 276
           L+ + T  +S+D + +DF  LV   M    G L +   L+ D         R+   V  +
Sbjct: 79  LLDVFTPDLSLD-RFHDF-YLVMPFMGTDLGKLMKHEKLSED---------RIQFLVYQM 127

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
              L+Y+H      I+H DLKP N+ ++ +    + DFGLA+             S   G
Sbjct: 128 LKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----------QTDSEMTG 174

Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
              T  Y APE  +     + + D++S G ++ EM TGK     +F G+
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK----PLFKGH 219

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 35/83 (42%), Positives = 42/83 (50%), Gaps = 2/83 (2%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
           N   G IP  +  L  + +LDL  NNL+G IP  L N   LQ L L  N   G +P   +
Sbjct: 222 NNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP-PSI 280

Query: 64  FSNSSAISLDGNVN-LCGGISEL 85
           FS    ISLD + N L G I EL
Sbjct: 281 FSLQKLISLDLSDNSLSGEIPEL 303

Length = 968

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 37/107 (34%), Positives = 50/107 (46%), Gaps = 16/107 (14%)

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           A ++A  L +LH      I++ DLK  NV+LD E    ++DFG+ K           N  
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------ENMW 153

Query: 333 SSVGVK---GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             V  K   GT  Y APE         S D ++FG+LL EM  G+ P
Sbjct: 154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 43/234 (18%)

Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVK--VLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           IG G++G VYK      D  T  LVA+K   L +   G   + + E   L+ +     + 
Sbjct: 9   IGEGTYGKVYKA----RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIV 64

Query: 223 IITSCVSVDFQ-GNDFEALVYELMVNGSLEEWLHLNRDAPRN---LNLLQRLSIAVDVAS 278
            +     V+ + G     LV+E + +  L++++  N   P        ++     +    
Sbjct: 65  RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL---- 119

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAANNLSSNQSSSVGV 337
            L+ + H  +  ++H DLKP N+L+D +     ++D GL +             + S+ V
Sbjct: 120 -LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-------------AFSIPV 165

Query: 338 KG------TVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           K       T+ Y APE  +GS   ST  D++S G +  EM         +F G+
Sbjct: 166 KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK----QPLFPGD 215

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 32/216 (14%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---L 220
            +G+G++GSV   I D    E  VA+K L+   Q    +K    E   L+ ++H N   L
Sbjct: 22  QVGSGAYGSVCSAI-DKRTGEK-VAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGL 79

Query: 221 VKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           + + TS VS D FQ  DF  ++  +  +        L+ D  + L + Q L         
Sbjct: 80  LDVFTSAVSGDEFQ--DFYLVMPYMQTDLQKIMGHPLSEDKVQYL-VYQMLC-------G 129

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           L+Y+H      I+H DLKP N+ ++ +    + DFGLA+             +   G   
Sbjct: 130 LKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR----------HADAEMTGYVV 176

Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ EM TGK
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 42/222 (18%)

Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLVK 222
           IG G++G V        + ET   VA+K +     +R  +K  + E + LR + H N++ 
Sbjct: 13  IGRGAYGIVCSAK----NSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIA 68

Query: 223 IITSCVSVDFQGNDFEA--LVYELMVNGSLEEWLHLNRDAPRNLN-------LLQRLSIA 273
           I    +        F    +VYELM     +  LH    + + L+       L Q L   
Sbjct: 69  IKD--IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLR-- 119

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
                 L+Y+H      ++H DLKPSN+LL+      + DFGLA+       +   +  +
Sbjct: 120 -----GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR-----TTSEKGDFMT 166

Query: 334 SVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
              V  T  Y APE  +  SE +T+ DV+S G +  E+   K
Sbjct: 167 EYVV--TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 37/218 (16%)

Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86

Query: 220 -LVKIITSCVSVDFQGNDFEAL--VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
            L+ + T   S++    +F+ +  V ELM + +L + + +  D  R   LL ++   +  
Sbjct: 87  GLLNVFTPQKSLE----EFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI-- 139

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
               ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V 
Sbjct: 140 ----KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV- 187

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
              T  Y APE  +G     + D++S G ++ EM  G 
Sbjct: 188 ---TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 51.2 bits (122), Expect = 4e-07
 Identities = 55/224 (24%), Positives = 100/224 (44%), Gaps = 33/224 (14%)

Query: 167 IGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGASKSFIAECQALRS-IRHRNLVK 222
           +G   FG VYKG +F     E    VA+K L  +  G  +        +RS ++H N+V 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV- 71

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHL------------NRDAPRNLNLLQRL 270
               C+          ++++    +  L E+L +            ++     L     +
Sbjct: 72  ----CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127

Query: 271 SIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLS 328
            I   +A+ +E+L  HH     +VH DL   NVL+  +L   +SD GL + +  AA+   
Sbjct: 128 HIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREV-YAADYYK 181

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
              +S + ++    + +PE  M  + S   D++S+G++L E+F+
Sbjct: 182 LMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 21/217 (9%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G G++G VYK        E   A+K   ++  G S S   E   LR ++H N++ +   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALK--QIEGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEW----LHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
            +S        +  V+ L      + W     H    A +    L R  +   +   L+ 
Sbjct: 67  FLSHS------DRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELT----AHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
           +H+     ++H DLKP+N+L+ GE        ++D G A+        L+      V   
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--- 177

Query: 339 GTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGK 374
            T  Y APE  +G+   T   D+++ G +  E+ T +
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 43/143 (30%), Positives = 64/143 (44%), Gaps = 18/143 (12%)

Query: 256 LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG 315
            + +    L+L   L  +  VA  +++L        +H D+   NVLL     A + DFG
Sbjct: 201 EDTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFG 257

Query: 316 LAKFLPEAANNLSSNQSSSVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
           LA+ +         N S+ V VKG     V + APE       +   DV+S+GILL E+F
Sbjct: 258 LARDI--------MNDSNYV-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 308

Query: 372 T-GKGPTNEMFTGNLTLHNFVKE 393
           + GK P   +   N   +  VK 
Sbjct: 309 SLGKSPYPGILV-NSKFYKMVKR 330

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 41/225 (18%)

Query: 167 IGAGSFGSVYKGIFDHDDHET-LVAVKVLNLQHRGASKSF---IAECQALRSIRHRNLVK 222
           IG GSFG+VY   F  D     +VA+K ++   + +++ +   I E + L+ I+H N   
Sbjct: 33  IGHGSFGAVY---FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN--- 86

Query: 223 IITSCVSVDFQGNDFEA----LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
                 S++++G         LV E  + GS  + L +++        LQ + IA     
Sbjct: 87  ------SIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKP------LQEVEIAAITHG 133

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            L+ L +     ++H D+K  N+LL       ++DFG A        +++S  +S V   
Sbjct: 134 ALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSA--------SIASPANSFV--- 182

Query: 339 GTVGYAAPEYGMG-SEVSTSG--DVYSFGILLLEMFTGKGPTNEM 380
           GT  + APE  +   E    G  DV+S GI  +E+   K P   M
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 60/245 (24%), Positives = 95/245 (38%), Gaps = 44/245 (17%)

Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALR 213
           F+ T+ +     +G G+FG V     D    + +   K++        +K    E + L+
Sbjct: 6   FEITNRYVDLQPVGMGAFGLVCSA-RDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLK 64

Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEA--LVYELMVNGSLEEWLH-LNRDAPRNLNLLQRL 270
            +RH N++ +    +S        E    V EL+        LH L    P     +Q  
Sbjct: 65  HLRHENIISLSDIFIS------PLEDIYFVTELLGTD-----LHRLLTSRPLEKQFIQYF 113

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSN 330
                +   L+Y+H      +VH DLKPSN+L++      + DFGLA+            
Sbjct: 114 --LYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----------Q 158

Query: 331 QSSSVGVKGTVGYAAPEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNL 385
                G   T  Y APE  +       EV    D++S G +  EM  GK     +F G  
Sbjct: 159 DPQMTGYVSTRYYRAPEIMLTWQKYDVEV----DIWSAGCIFAEMLEGK----PLFPGKD 210

Query: 386 TLHNF 390
            ++ F
Sbjct: 211 HVNQF 215

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.5 bits (121), Expect = 9e-07
 Identities = 63/258 (24%), Positives = 108/258 (41%), Gaps = 39/258 (15%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G GS G V+  +    D    VAVK + L    + K  + E + +R + H N+VK+   
Sbjct: 13  LGCGSNGLVFSAVDSDCDKR--VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS------IAVDVASTL 280
                    +    + EL     ++E++  +     N+     LS          +   L
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETDL---ANVLEQGPLSEEHARLFMYQLLRGL 127

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVSDFGLAKFL-PEAANN--LSSNQSSSVG 336
           +Y+H      ++H DLKP+NV ++ E L   + DFGLA+ + P  ++   LS        
Sbjct: 128 KYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV---- 180

Query: 337 VKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL 395
              T  Y +P   +     T   D+++ G +  EM TGK     +F G   L        
Sbjct: 181 ---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----PLFAGAHEL-------- 225

Query: 396 PERLAEIVDPVLLVEREE 413
            E++  I++ V +V  E+
Sbjct: 226 -EQMQLILESVPVVREED 242

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.0 bits (122), Expect = 1e-06
 Identities = 33/82 (40%), Positives = 43/82 (52%), Gaps = 2/82 (2%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-G 62
           N   G IP  +  L+ +E L L  NN +G+IP  L + P LQ L L  N F GE+P   G
Sbjct: 294 NSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLG 353

Query: 63  VFSNSSAISLDGNVNLCGGISE 84
             +N + + L  N NL G I E
Sbjct: 354 KHNNLTVLDLSTN-NLTGEIPE 374

Length = 968

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 49.9 bits (120), Expect = 1e-06
 Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 40/237 (16%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNL--QHRGASKSFIAECQALRS 214
           D +   N I  G++G VY+      D +T  +VA+K L +  +  G   + + E   L  
Sbjct: 5   DEYEKLNRIEEGTYGVVYRAR----DKKTGEIVALKKLKMEKEKEGFPITSLREINILLK 60

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSI 272
           ++H N+V +    V  +    D   +V E + +   SL E +           L+ +L  
Sbjct: 61  LQHPNIVTVKEVVVGSNL---DKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLS 117

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLD--GELTAHVSDFGLAKFLPEAANNLSSN 330
            V       +LH   +  I+H DLK SN+LL+  G L   + DFGLA+         +  
Sbjct: 118 GVA------HLH---DNWILHRDLKTSNLLLNNRGILK--ICDFGLAREYGSPLKPYTQL 166

Query: 331 QSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYS----FGILLLE--MFTGKGPTNEM 380
               V    T+ Y APE  +G  E ST+ D++S    F  LL +  +F GK   +++
Sbjct: 167 ---VV----TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL 216

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 49/232 (21%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV    +D    +  VAVK L+   Q    ++    E + L+ ++H N   L+
Sbjct: 23  VGSGAYGSVCSA-YDTRLRQK-VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 222 KIITSCVSVDFQGNDFEA--LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS------IA 273
            + T   S++    +F    LV  LM  G+      LN     N+   Q+LS      + 
Sbjct: 81  DVFTPATSIE----NFNEVYLVTNLM--GA-----DLN-----NIVKCQKLSDEHVQFLI 124

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
             +   L+Y+H      I+H DLKPSNV ++ +    + DFGLA+   +A + ++     
Sbjct: 125 YQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADDEMT----- 173

Query: 334 SVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
             G   T  Y APE  +     + + D++S G ++ E+  GK     +F GN
Sbjct: 174 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA----LFPGN 219

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 51/217 (23%), Positives = 90/217 (41%), Gaps = 21/217 (9%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G G++G VYK        +   A+K   ++  G S S   E   LR ++H N++ +   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALK--QIEGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEW----LHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
            +S        +  V+ L      + W     H    A +    L R  +   +   L+ 
Sbjct: 67  FLS------HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELT----AHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
           +H+     ++H DLKP+N+L+ GE        ++D G A+        L+      V   
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--- 177

Query: 339 GTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGK 374
            T  Y APE  +G+   T   D+++ G +  E+ T +
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 21/163 (12%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALRSIRH 217
           F +   I  G+FG VY G     ++  L AVKV+   ++ ++       AE  AL   + 
Sbjct: 6   FVIVKPISRGAFGKVYLG--RKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR--DAPRNLNLLQRLSIAVD 275
             +V +  S      Q  +   LV E ++ G ++  LH+    D       +    I+ +
Sbjct: 64  PFIVHLYYS-----LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYIS-E 112

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
           VA  L+YLH +    I+H DLKP N+L+  E    ++DFGL+K
Sbjct: 113 VALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 71/244 (29%), Positives = 100/244 (40%), Gaps = 56/244 (22%)

Query: 159 DGFSLENLIGAGSFGSVY----KGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQAL 212
             F +++L+G G FG V     K   D      + A+KV+      A +  SF  E    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGD------IYAMKVMKKSVLLAQETVSFFEE---E 51

Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           R I   +    I   +   FQ  D   LV E    G L             L+LL R   
Sbjct: 52  RDILSISNSPWIPQ-LQYAFQDKDNLYLVMEYQPGGDL-------------LSLLNRYED 97

Query: 273 AVD-------VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEA 323
             D       +A  +  +H   +   VH D+KP NVL+D   T H+  +DFG       +
Sbjct: 98  QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID--RTGHIKLADFG-------S 148

Query: 324 ANNLSSNQS--SSVGVKGTVGYAAPEY--GM-GSEVSTSG---DVYSFGILLLEMFTGKG 375
           A  L++N+   S + V GT  Y APE    M G    T G   D +S G++  EM  G+ 
Sbjct: 149 AARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207

Query: 376 PTNE 379
           P +E
Sbjct: 208 PFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 63/250 (25%), Positives = 98/250 (39%), Gaps = 47/250 (18%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           D F    +IG G+FG V   +    D   + A+K+L  +     K  +A  +A R I   
Sbjct: 1   DDFESLKVIGRGAFGEVR--LVQKKDTGHIYAMKILR-KADMLEKEQVAHIRAERDILVE 57

Query: 219 N----LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
                +VK+  S     FQ      L+ E +  G +   L + +D       L   +   
Sbjct: 58  ADGAWVVKMFYS-----FQDKRNLYLIMEFLPGGDMMTLL-MKKDT------LSEEATQF 105

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAA-----NNLSS 329
            +A T+  +    +   +H D+KP N+LLD +    +SDFGL   L +A       NL+ 
Sbjct: 106 YIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 165

Query: 330 NQSSSVGVK-----------------------GTVGYAAPEYGMGSEVSTSGDVYSFGIL 366
           N  S    +                       GT  Y APE  M +  +   D +S G++
Sbjct: 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225

Query: 367 LLEMFTGKGP 376
           + EM  G  P
Sbjct: 226 MYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 64/229 (27%), Positives = 91/229 (39%), Gaps = 31/229 (13%)

Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQAL 212
           KA D F +  +IG G+FG V   +  H   + + A+K+L+   +  R  S  F  E    
Sbjct: 41  KAED-FDVIKVIGRGAFGEVQ--LVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE---- 93

Query: 213 RSIR-HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           R I  H N   I+    +  FQ + +  +V E M  G L   L  N D P       R  
Sbjct: 94  RDIMAHANSEWIVQLHYA--FQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKW---ARFY 147

Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQ 331
            A +V   L+ +H       +H D+KP N+LLD      ++DFG    +           
Sbjct: 148 TA-EVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT- 202

Query: 332 SSSVGVKGTVGYAAPEY----GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  GT  Y +PE     G         D +S G+ L EM  G  P
Sbjct: 203 -----AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 55/240 (22%)

Query: 149 VSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKS 204
             YQNL          + +G+G++GSV        D +T   VAVK L+   Q    +K 
Sbjct: 17  ERYQNL----------SPVGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKR 62

Query: 205 FIAECQALRSIRHRN---LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
              E + L+ ++H N   L+ + T   S++ + ND   LV  LM  G+      LN    
Sbjct: 63  TYRELRLLKHMKHENVIGLLDVFTPARSLE-EFNDV-YLVTHLM--GA-----DLN---- 109

Query: 262 RNLNLLQRLS------IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG 315
            N+   Q+L+      +   +   L+Y+H      I+H DLKPSN+ ++ +    + DFG
Sbjct: 110 -NIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG 165

Query: 316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           LA+   +             G   T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 166 LARHTDD----------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 49.1 bits (117), Expect = 4e-06
 Identities = 31/96 (32%), Positives = 45/96 (46%), Gaps = 9/96 (9%)

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK--GT 340
           +HH     ++H D+K +N+LL       + DFG +K         ++  S  VG    GT
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY-------AATVSDDVGRTFCGT 208

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             Y APE       S   D++S G+LL E+ T K P
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244

Length = 496

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 10/99 (10%)

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           + S + Y+H   +  I+H D+K  N+ L       + DFG++K L        S  S + 
Sbjct: 110 IVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL-------GSEYSMAE 159

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
            V GT  Y +PE   G + +   D+++ G +L E+ T K
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 39/223 (17%)

Query: 161 FSLENLIGAGSFGSVYKGIFDH--DDHETLVAVKVLNLQHRGASKSFIA--ECQALRSIR 216
           + L+  +G GSFG+VY  + D      E L  +K + +     +++  A  E Q L  + 
Sbjct: 2   YILQQRLGKGSFGTVYL-VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 217 HRNLVKIITS-------CVSVDF-QGNDFEALVYELMVNG-SLEEWLHLNRDAPRNLNLL 267
           H  +VK   S       C+  ++ +G D +  + EL   G +L E         +     
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE--------NQVCEWF 112

Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL 327
            +L + V       Y+H   +  I+H DLK  N+ L   L   + DFG+++ L  + +  
Sbjct: 113 IQLLLGVH------YMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLA 162

Query: 328 SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEM 370
           ++         GT  Y +PE        +  D++S G +L EM
Sbjct: 163 TT-------FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 48.3 bits (115), Expect = 7e-06
 Identities = 24/56 (42%), Positives = 32/56 (57%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP 59
           N F G +PS  + L  +  LD+S NNL GRI     + P LQ L+L+ N F G +P
Sbjct: 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469

Length = 968

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.2 bits (114), Expect = 7e-06
 Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 24/170 (14%)

Query: 208 ECQALRSIRHRNLVKIITSCVSVDF-----QGNDFEALVYELMVNGSLEEWLHLNRDAPR 262
           E  AL  + H N++KI     S        Q  DF+  +Y  M + + + W    +D P 
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFD--LYSFMYDEAFD-W----KDRPL 265

Query: 263 NLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE 322
              L Q  +I   +   +EY+H   +  ++H D+K  N+ L+ +    + DFG A    +
Sbjct: 266 ---LKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319

Query: 323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                   ++   G  GTV   +PE   G       D++S G++LL+M +
Sbjct: 320 ------EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 48.3 bits (115), Expect = 8e-06
 Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 2/83 (2%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           ++ N   G IP+ + S   ++ LDL  N L G+IP  L N   L+ L L+ N   G++P 
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206

Query: 61  K-GVFSNSSAISLDGNVNLCGGI 82
           + G   +   I L  N NL G I
Sbjct: 207 ELGQMKSLKWIYLGYN-NLSGEI 228

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 48.3 bits (115), Expect = 8e-06
 Identities = 24/57 (42%), Positives = 37/57 (64%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           N   G IP S+ SL+ + +LDLS N+LSG IP+ +     L+ L+L  N+F G++P+
Sbjct: 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326

Length = 968

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 47.9 bits (114), Expect = 8e-06
 Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 33/227 (14%)

Query: 144 ASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK 203
           ASV+R+ Y N+  +         +  GS G V+      D+    V VK +        K
Sbjct: 87  ASVVRMQY-NILSS---------LTPGSEGEVFVCTKHGDEQRKKVIVKAVT-----GGK 131

Query: 204 SFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN 263
           +   E   L++I HR ++ +I            +++ V  +M     + + +++R  P  
Sbjct: 132 TPGREIDILKTISHRAIINLI--------HAYRWKSTVCMVMPKYKCDLFTYVDRSGPLP 183

Query: 264 LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA 323
           L   Q ++I   +   L YLH      I+H D+K  N+ LD    A + DFG A  L   
Sbjct: 184 LE--QAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA- 237

Query: 324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEM 370
                 +     G  GT+   +PE           D++S G++L EM
Sbjct: 238 ----HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 47.4 bits (112), Expect = 9e-06
 Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 41/225 (18%)

Query: 167 IGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHRGASKSF---IAECQALRSIRHRNLVK 222
           IG GSFG+VY   F  D  +  +VA+K ++   + +++ +   I E + L+ +RH N   
Sbjct: 23  IGHGSFGAVY---FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN--- 76

Query: 223 IITSCVSVDFQGNDFEA----LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
                 ++ ++G         LV E  + GS  + L +++        LQ + IA     
Sbjct: 77  ------TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKP------LQEVEIAAVTHG 123

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            L+ L +     ++H D+K  N+LL       + DFG A  +  A   +           
Sbjct: 124 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV----------- 172

Query: 339 GTVGYAAPEYGMG-SEVSTSG--DVYSFGILLLEMFTGKGPTNEM 380
           GT  + APE  +   E    G  DV+S GI  +E+   K P   M
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 47.9 bits (114), Expect = 1e-05
 Identities = 41/142 (28%), Positives = 62/142 (43%), Gaps = 36/142 (25%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIP----------KYL----ENF----- 41
           ++G    G I S++  L  I+ ++LS N LSG IP          +YL     NF     
Sbjct: 76  LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP 135

Query: 42  ----PFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNV------NLCGGISELHLCTC 90
               P L+ L+LS N   GE+P   G FS+   + L GNV      N    ++ L   T 
Sbjct: 136 RGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195

Query: 91  STKE------SKQSRSRSLKLI 106
           ++ +       +  + +SLK I
Sbjct: 196 ASNQLVGQIPRELGQMKSLKWI 217

Length = 968

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 61/234 (26%), Positives = 96/234 (41%), Gaps = 41/234 (17%)

Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQAL 212
           KA D + +  +IG G+FG V   +  H   + + A+K+L+   +  R  S  F  E   +
Sbjct: 41  KAED-YDVVKVIGRGAFGEVQ--LVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
                  +V++  +     FQ + +  +V E M  G L   L  N D P           
Sbjct: 98  AFANSPWVVQLFCA-----FQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF----Y 147

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
             +V   L+ +H      ++H D+KP N+LLD      ++DFG           +  +++
Sbjct: 148 TAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTC---------MKMDET 195

Query: 333 SSVGVKGTVGYAAPEYGMGSEV--STSGDVY--------SFGILLLEMFTGKGP 376
             V     VG   P+Y +  EV  S  GD Y        S G+ L EM  G  P
Sbjct: 196 GMVRCDTAVG--TPDY-ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 10/96 (10%)

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           L+YLH      I+H D+KP N+L++      + DFGLA+ + E   +    Q        
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVV----- 166

Query: 340 TVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGK 374
           T  Y APE  MGS   TS  D++S G +  E+   +
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 30/218 (13%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F L   IG+G++G VYK    + +   L A+KV+ L+          E   ++  +H 
Sbjct: 9   EDFELIQRIGSGTYGDVYKA--RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHS 66

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+V    S     +   D   +  E    GSL++  H+    P     L    IA     
Sbjct: 67  NIVAYFGS-----YLRRDKLWICMEFCGGGSLQDIYHVT--GP-----LSESQIAYVSRE 114

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
           TL+ L++      +H D+K +N+LL       ++DFG++         +++  +      
Sbjct: 115 TLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSA-------QITATIAKRKSFI 167

Query: 339 GTVGYAAPEYGMGSEVSTSG------DVYSFGILLLEM 370
           GT  + APE    + V   G      D+++ GI  +E+
Sbjct: 168 GTPYWMAPEV---AAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 43/230 (18%)

Query: 167 IGAGSFGSVYKGIF-DHDDHETL---------VAVKVLNLQHRGASKSFIAECQALRSIR 216
           +G G+   +Y GI    DD E           V +KVL+  HR  S +F      +R + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVN-GSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           H+++V +   CV       D E ++ E  V  G L+ ++H   D    L    +  +A  
Sbjct: 63  HKHIVLLYGVCV------RDVENIMVEEFVEFGPLDLFMHRKSDV---LTTPWKFKVAKQ 113

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLL-----DGELTAHV--SDFGLAKFLPEAANNLS 328
           +AS L YL    +  +VH ++   N+LL     DGE    +  SD G+   +      LS
Sbjct: 114 LASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LS 164

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEM-FTGKGP 376
             +         + + APE    S+  S + D +SFG  L E+ + G+ P
Sbjct: 165 RQECVE-----RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 29/161 (18%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK-SFIAECQALRSIR-HRNLVKII 224
           IG G+F  V K            A+K +    +   + + + E QALR +  H N++++I
Sbjct: 7   IGEGTFSEVLKA--QSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 225 -------TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
                  T  +          ALV+ELM + +L E   L +   R L   +  S    + 
Sbjct: 65  EVLFDRKTGRL----------ALVFELM-DMNLYE---LIKGRKRPLPEKRVKSYMYQLL 110

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
            +L+++H      I H D+KP N+L+  +    ++DFG  +
Sbjct: 111 KSLDHMHR---NGIFHRDIKPENILIKDD-ILKLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 64/234 (27%), Positives = 95/234 (40%), Gaps = 41/234 (17%)

Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQAL 212
           KA D + +  +IG G+FG V   +  H     + A+K+L+   +  R  S  F  E   +
Sbjct: 41  KAED-YEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
                  +V++  +     FQ + +  +V E M  G L   L  N D P       R   
Sbjct: 98  AFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKW---ARFYT 148

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           A +V   L+ +H       +H D+KP N+LLD      ++DFG           +  N+ 
Sbjct: 149 A-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC---------MKMNKE 195

Query: 333 SSVGVKGTVGYAAPEYGMGSEV--STSGDVY--------SFGILLLEMFTGKGP 376
             V     VG   P+Y +  EV  S  GD Y        S G+ L EM  G  P
Sbjct: 196 GMVRCDTAVG--TPDY-ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 32/217 (14%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA-ECQALRSIRHRN 219
           + L   +G+G++G VYK    H     L AVK++ L+  G   S I  E   ++  +H N
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGE--LAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCN 67

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           +V    S +S      +   +  E    GSL++  H+    P     L  L IA     T
Sbjct: 68  IVAYFGSYLS-----REKLWICMEYCGGGSLQDIYHVT--GP-----LSELQIAYVCRET 115

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           L+ L +      +H D+K +N+LL       ++DFG+A         +++  +      G
Sbjct: 116 LQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAA-------KITATIAKRKSFIG 168

Query: 340 TVGYAAPEYGMGSEVSTSG------DVYSFGILLLEM 370
           T  + APE    + V  +G      D+++ GI  +E+
Sbjct: 169 TPYWMAPEV---AAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 59/255 (23%), Positives = 98/255 (38%), Gaps = 57/255 (22%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---------NLQHRGASKSFIAEC 209
           + F    +IG G+FG V   +    D   + A+K+L          + H  A +  + E 
Sbjct: 1   EDFESLKVIGRGAFGEVR--LVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58

Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
            +L       +VK+  S     FQ      L+ E +  G +   L + +D       L  
Sbjct: 59  DSLW------VVKMFYS-----FQDKLNLYLIMEFLPGGDMMTLL-MKKDT------LTE 100

Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAA----- 324
                 +A T+  +    +   +H D+KP N+LLD +    +SDFGL   L +A      
Sbjct: 101 EETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160

Query: 325 -------------NNLSSNQSS----------SVGVKGTVGYAAPEYGMGSEVSTSGDVY 361
                         N++S + +          +    GT  Y APE  M +  +   D +
Sbjct: 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW 220

Query: 362 SFGILLLEMFTGKGP 376
           S G+++ EM  G  P
Sbjct: 221 SLGVIMYEMLIGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 5e-05
 Identities = 59/251 (23%), Positives = 90/251 (35%), Gaps = 60/251 (23%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +IG G+FG V   +    D   + A+K L    +  +       AE   L    +  +VK
Sbjct: 8   VIGRGAFGEVR--LVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVK 65

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLNRDAPRNLNLLQRLSIAVDVAS 278
           +  S     FQ  ++  L+ E +  G +   L        +  R    +    +A+D   
Sbjct: 66  LYYS-----FQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY--IAETILAIDSIH 118

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFL-----PEAANNLSSNQ 331
            L Y+H          D+KP N+LLD     H+  SDFGL   L      E    LS   
Sbjct: 119 KLGYIHR---------DIKPDNLLLDA--KGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167

Query: 332 SSSVGVK--------------------------GTVGYAAPEYGMGSEVSTSGDVYSFGI 365
            S+                              GT  Y APE  + +  +   D +S G+
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227

Query: 366 LLLEMFTGKGP 376
           ++ EM  G  P
Sbjct: 228 IMYEMLVGYPP 238

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 44.9 bits (106), Expect = 6e-05
 Identities = 38/116 (32%), Positives = 53/116 (45%), Gaps = 17/116 (14%)

Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSS 329
           LS +  VA  + +L        +H DL   N+LL       + DFGLA+ +         
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI--------R 265

Query: 330 NQSSSVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
           N S+ V VKG     V + APE       +   DV+S+GILL E+F+ G  P   M
Sbjct: 266 NDSNYV-VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 45.2 bits (107), Expect = 8e-05
 Identities = 30/83 (36%), Positives = 48/83 (57%), Gaps = 2/83 (2%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           + GN   G IP+SL++L  +E L L+ N L G+IP+ L     L+ + L +N+  GE+P 
Sbjct: 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY 230

Query: 61  K-GVFSNSSAISLDGNVNLCGGI 82
           + G  ++ + + L  N NL G I
Sbjct: 231 EIGGLTSLNHLDLVYN-NLTGPI 252

Length = 968

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 50/190 (26%), Positives = 75/190 (39%), Gaps = 25/190 (13%)

Query: 192 KVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ------GNDFEALVYELM 245
           KVL +      ++FI +     S   R  + II  CV             D   LV +  
Sbjct: 8   KVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHA 67

Query: 246 VNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG 305
             G L  W H+++        ++R +  + VA  L+ LH      IV  DL P+N+LLD 
Sbjct: 68  EGGKL--WSHISKFLNIPEECVKRWAAEMVVA--LDALH---REGIVCRDLNPNNILLDD 120

Query: 306 ELTAHVSDFG-LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFG 364
                ++ F   ++           N            Y APE G  SE + + D +S G
Sbjct: 121 RGHIQLTYFSRWSEVEDSCDGEAVENM-----------YCAPEVGGISEETEACDWWSLG 169

Query: 365 ILLLEMFTGK 374
            +L E+ TGK
Sbjct: 170 AILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.4 bits (100), Expect = 8e-05
 Identities = 31/144 (21%), Positives = 58/144 (40%), Gaps = 21/144 (14%)

Query: 182 HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV--KIITSCVSVDFQGNDFEA 239
               E  V +K+   + +GA      E   L+ +  + L   K++ S      + + +  
Sbjct: 18  GTKDEDYV-LKINPSREKGAD--REREVAILQLLARKGLPVPKVLAS-----GESDGWSY 69

Query: 240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPS 299
           L+ E +   +L+E           ++  ++  IA  +A  L  LH      + H DL P 
Sbjct: 70  LLMEWIEGETLDE-----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPG 118

Query: 300 NVLLDGELTAHVSDFGLAKFLPEA 323
           N+L+D      + D+  A + P A
Sbjct: 119 NILVDDGKILGIIDWEYAGYGPPA 142

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 25/56 (44%), Positives = 31/56 (55%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP 59
           N F G IP +L     +  LDLS NNL+G IP+ L +   L  L L  N  EGE+P
Sbjct: 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397

Length = 968

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 28/216 (12%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNL-QHRGASKSFIAECQALRSIRHRNLVKII 224
           ++G GSFG     +  H + +   A+K + L +   A +    E   L  ++H N+V   
Sbjct: 7   VVGEGSFGRAL--LVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA--PRN--LNLLQRLSIAVDVASTL 280
            S     F+ +    +V E    G L + + L R    P +  L    ++ + V      
Sbjct: 65  ES-----FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ----- 114

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
               H  E  ++H D+K  N+ L       + DFG A+        L+S  + +    GT
Sbjct: 115 ----HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL-------LTSPGAYACTYVGT 163

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             Y  PE       +   D++S G +L E+ T K P
Sbjct: 164 PYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 57/242 (23%), Positives = 103/242 (42%), Gaps = 52/242 (21%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVKI 223
           IG G FG V+  +  H   +     K ++   L+ R  S+  + E   +R ++H+N+V+ 
Sbjct: 21  IGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQ-LVIEVNVMRELKHKNIVRY 77

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS------IAVDVA 277
           I   ++   + N    ++ E    G L      +R+  +   +  ++       I   + 
Sbjct: 78  IDRFLN---KANQKLYILMEFCDAGDL------SRNIQKCYKMFGKIEEHAIVDITRQLL 128

Query: 278 STLEYLHHYCETP----IVHCDLKPSNVLLD------GELTAH-----------VSDFGL 316
             L Y H+  + P    ++H DLKP N+ L       G++TA            + DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188

Query: 317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVS--TSGDVYSFGILLLEMFTGK 374
           +K +      + S   S V   GT  Y +PE  +    S     D+++ G ++ E+ +GK
Sbjct: 189 SKNI-----GIESMAHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Query: 375 GP 376
            P
Sbjct: 241 TP 242

Length = 1021

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 31/215 (14%)

Query: 167 IGAGSFGSVYKGIF--DHDDHETLVAVKVLNL-----QHRGASKSFIAECQALRSIRHRN 219
           IG GSFG   K I     +D +  V +K +N+     + R  S+    E   L +++H N
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYV-IKEINISKMSPKEREESRK---EVAVLSNMKHPN 60

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           +V+   S     F+ N    +V +    G L + ++  R      +  Q L   V +   
Sbjct: 61  IVQYQES-----FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPED--QILDWFVQICLA 113

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           L+++H   +  I+H D+K  N+ L  + T  + DFG+A+ L    N+      + +   G
Sbjct: 114 LKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCI---G 163

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y +PE       +   D+++ G +L EM T K
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 37/209 (17%)

Query: 183 DDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVY 242
           +  E  V +KVL+  HR  + +F      +  + H +L  +   CV    +G++   +V 
Sbjct: 41  NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCV----RGSE-NIMVE 95

Query: 243 ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVL 302
           E + +G L+  L   R     + +  ++++A  +AS L YL    +  +VH ++   N+L
Sbjct: 96  EFVEHGPLDVCL---RKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNIL 149

Query: 303 LDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT----------VGYAAPE-YGMG 351
           L        +  GLA+            + S  GV  T          + + APE    G
Sbjct: 150 L--------ARLGLAE------GTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGG 195

Query: 352 SEVSTSGDVYSFGILLLEM-FTGKGPTNE 379
           + +ST+ D +SFG  LLE+ F G+ P  E
Sbjct: 196 NSLSTAADKWSFGTTLLEICFDGEVPLKE 224

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 34/114 (29%), Positives = 55/114 (48%), Gaps = 9/114 (7%)

Query: 264 LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA 323
           L L   +S +  VA  +E+L        +H DL   N+LL       + DFGLA+ + + 
Sbjct: 170 LTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 226

Query: 324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            + +     + + +K    + APE       +T  DV+SFG+LL E+F+ G  P
Sbjct: 227 PDYVRKG-DARLPLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 33/146 (22%), Positives = 59/146 (40%), Gaps = 40/146 (27%)

Query: 267 LQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL---------A 317
           L R  IA ++   +E +H   +   +H D+KP N+L+D +    ++DFGL         +
Sbjct: 102 LARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157

Query: 318 KF-------------LPEAANNLSSNQSSSVGVK--------------GTVGYAAPEYGM 350
           K+               E  + +   +   +  +              GT  Y APE  +
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217

Query: 351 GSEVSTSGDVYSFGILLLEMFTGKGP 376
            +  +   D +S G++L EM  G+ P
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 41.8 bits (99), Expect = 4e-04
 Identities = 32/110 (29%), Positives = 46/110 (41%), Gaps = 23/110 (20%)

Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT-AHVSDFGLAKFLPEAANNLSSN 330
           I   +   L  LH +    I+H D+K  NVL D      ++ D+GL K            
Sbjct: 114 IIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCK------------ 158

Query: 331 QSSSVGVK----GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
               +G      GT+ Y +PE   G     S D ++ G+L  E+ TGK P
Sbjct: 159 ---IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 57/233 (24%), Positives = 95/233 (40%), Gaps = 42/233 (18%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           + L  L+G     + +      D  E +VA  V+    R A+ +  +E   L +  H  +
Sbjct: 69  YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYAR-SELHCLAACDHFGI 127

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS--------- 271
           VK        DF+ +D   L+ E    G L            N  + QRL          
Sbjct: 128 VKHFD-----DFKSDDKLLLIMEYGSGGDL------------NKQIKQRLKEHLPFQEYE 170

Query: 272 ---IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLS 328
              +   +   L+ +H      ++H DLK +N+ L       + DFG +K   + ++++S
Sbjct: 171 VGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK---QYSDSVS 224

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT----GKGPT 377
            + +SS    GT  Y APE       S   D++S G++L E+ T     KGP+
Sbjct: 225 LDVASSFC--GTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275

Length = 478

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 41.5 bits (97), Expect = 7e-04
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 9/102 (8%)

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           VA  +E+L        +H DL   N+LL       + DFGLA+ + +  + +    S+ +
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG-SARL 238

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            +K    + APE       +T  DV+SFG+LL E+F+ G  P
Sbjct: 239 PLK----WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 22/65 (33%), Positives = 35/65 (53%), Gaps = 1/65 (1%)

Query: 20  IENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLD-GNVNL 78
           + ++DLS  N+SG+I   +   P++Q +NLS N   G +P     ++SS   L+  N N 
Sbjct: 71  VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130

Query: 79  CGGIS 83
            G I 
Sbjct: 131 TGSIP 135

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.4 bits (97), Expect = 0.001
 Identities = 31/90 (34%), Positives = 43/90 (47%), Gaps = 4/90 (4%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           ++ N  QG I S    +  ++ L L++N   G +P    +   L+NL+LS N F G VP 
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPR 493

Query: 61  K-GVFSNSSAISLDGNVNLCGGI-SELHLC 88
           K G  S    + L  N  L G I  EL  C
Sbjct: 494 KLGSLSELMQLKLSEN-KLSGEIPDELSSC 522

Length = 968

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 31/114 (27%), Positives = 52/114 (45%), Gaps = 9/114 (7%)

Query: 264 LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA 323
           L L   +  +  VA  +E+L        +H DL   N+LL       + DFGLA+ + + 
Sbjct: 176 LTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232

Query: 324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            + +    +     +  + + APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 233 PDYVRKGDA-----RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 17/55 (30%), Positives = 29/55 (52%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEV 58
           N  +G IP SL + R +  + L  N+ SG +P      P +  L++S N+ +G +
Sbjct: 390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444

Length = 968

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 31/111 (27%), Positives = 49/111 (44%), Gaps = 12/111 (10%)

Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLS--- 328
           I       L+Y H   E  ++H DLKP N+L+  E +  V D    + LP     +    
Sbjct: 236 IIFQTGVALDYFH--TELHLMHTDLKPENILM--ETSDTVVDPVTNRALPPDPCRVRICD 291

Query: 329 -----SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
                  + S   +  T  Y +PE  +G     S D++S G ++ E++TGK
Sbjct: 292 LGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	484
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.98
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.88
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.87
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.82
PRK10345	210	hypothetical protein; Provisional	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
smart00090	237	RIO RIO-like kinase.	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.73
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.61
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.61
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.47
PLN03150	623	hypothetical protein; Provisional	99.44
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.42
KOG1243	690	consensus Protein kinase [General function predict	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.32
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.28
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.28
COG4248	637	Uncharacterized protein with protein kinase and he	99.26
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.2
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.18
KOG3087	229	consensus Serine/threonine protein kinase [General	99.12
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.1
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.09
PLN03150	623	hypothetical protein; Provisional	99.07
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.04
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	98.99
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.98
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.86
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.84
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.81
PRK09902	216	hypothetical protein; Provisional	98.8
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.78
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.59
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.56
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.53
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.51
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.48
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.46
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.45
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.44
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.4
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.36
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.34
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.31
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.23
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.15
PF01636	239	APH: Phosphotransferase enzyme family This family	98.13
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.13
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.13
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.04
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.02
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.02
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.02
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.0
PLN02876	822	acyl-CoA dehydrogenase	97.96
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	97.92
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	97.88
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.85
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	97.85
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.83
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	97.69
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.63
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.62
PRK10593	297	hypothetical protein; Provisional	97.58
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	97.57
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	97.49
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	97.46
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.45
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	97.45
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.41
KOG4237	498	consensus Extracellular matrix protein slit, conta	97.39
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.39
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.38
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.35

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4e-55  Score=481.45  Aligned_cols=416  Identities=26%  Similarity=0.437  Sum_probs=277.8

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|+++|.+|..++++++|+.|||++|+++|.+|..+.++++|+.|++++|+|+|.+|..+.+..+....+.+|+.+||
T Consensus       530 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~  609 (968)
T PLN00113        530 LSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCG  609 (968)
T ss_pred             CCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccC
Confidence            35566666666666666666666666666666666666666666666666666666666555555555566677777776


Q ss_pred             CCccccccccccccccccccccceEEehhhhhhHHHhhhhheeeeeecccCCCC-CCCC-Cchhh-------hhhccccH
Q 011508           81 GISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMSCLIITSWWSKTKRE-PSTP-PSALL-------ASVLRVSY  151 (484)
Q Consensus        81 ~~~~~~~~~c~~~~~~~~~~~~~~~~i~~v~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~-------~~~~~~~~  151 (484)
                      ..+....+.|...   . ......+++++++++++++++++++++.++++++.. .... .....       .....+++
T Consensus       610 ~~~~~~~~~c~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  685 (968)
T PLN00113        610 GDTTSGLPPCKRV---R-KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITI  685 (968)
T ss_pred             CccccCCCCCccc---c-ccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhH
Confidence            5433222334221   0 111222333333333333222222222222221111 1000 00000       00112333


Q ss_pred             HhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeec
Q 011508          152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVD  231 (484)
Q Consensus       152 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  231 (484)
                      +++.   ..|...+.||+|+||.||+|+..  .++..||+|.++....    ....|++.+++++||||++++++|..  
T Consensus       686 ~~~~---~~~~~~~~ig~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~--  754 (968)
T PLN00113        686 NDIL---SSLKEENVISRGKKGASYKGKSI--KNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRS--  754 (968)
T ss_pred             HHHH---hhCCcccEEccCCCeeEEEEEEC--CCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEc--
Confidence            3332   45777889999999999999853  3568899998864332    12356889999999999999999754  


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEE
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV  311 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl  311 (484)
                         .+..++||||+++|+|.++++       .++|.++..++.|+++||+|||+.++.+|+||||||+||+++.++.+++
T Consensus       755 ---~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~  824 (968)
T PLN00113        755 ---EKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL  824 (968)
T ss_pred             ---CCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence               346799999999999999996       2789999999999999999999777789999999999999999988887


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      . ||.......           .....++..|+|||++.+..++.++|||||||++|||+||+.||+........+.+|.
T Consensus       825 ~-~~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~  892 (968)
T PLN00113        825 R-LSLPGLLCT-----------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA  892 (968)
T ss_pred             E-ecccccccc-----------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHH
Confidence            5 554433211           1112578999999999999999999999999999999999999976555555666776


Q ss_pred             Hhhcchh-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          392 KEALPER-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       392 ~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      +...... ...++|+.+.....                 ...++..++.+++.+||+.||++||||+||+++|+++.+..
T Consensus       893 ~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        893 RYCYSDCHLDMWIDPSIRGDVS-----------------VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             HHhcCccchhheeCccccCCCC-----------------ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            6544332 44555655433111                 02334667899999999999999999999999999886644

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-55  Score=420.00  Aligned_cols=289  Identities=41%  Similarity=0.660  Sum_probs=244.3

Q ss_pred             hhccccHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEe
Q 011508          145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII  224 (484)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~  224 (484)
                      ....|++.++..+|++|+..+.||+|+||.||+|.+.+   ++.||||++.........+|.+|++++.+++|||+|+++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~---~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~Ll  137 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD---GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLL  137 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC---CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEE
Confidence            45679999999999999999999999999999999874   478999988765433145699999999999999999999


Q ss_pred             eeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 011508          225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD  304 (484)
Q Consensus       225 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~  304 (484)
                      |||.+.+    .+.+||||||++|+|.++|+.....  .++|..|++|+.++|+||+|||+.+..+|+||||||+|||||
T Consensus       138 GyC~e~~----~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD  211 (361)
T KOG1187|consen  138 GYCLEGG----EHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD  211 (361)
T ss_pred             EEEecCC----ceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence            9996433    2589999999999999999865433  789999999999999999999998788999999999999999


Q ss_pred             CCCceEEcccCccccccc-ccccCCCCccccccc-cccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCc-
Q 011508          305 GELTAHVSDFGLAKFLPE-AANNLSSNQSSSVGV-KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMF-  381 (484)
Q Consensus       305 ~~~~~kl~Dfg~a~~~~~-~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~-  381 (484)
                      +++++||+|||+|+..+. ...        .... .||.+|+|||+...+..+.|+|||||||+|+||+||+.|.+... 
T Consensus       212 ~~~~aKlsDFGLa~~~~~~~~~--------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~  283 (361)
T KOG1187|consen  212 EDFNAKLSDFGLAKLGPEGDTS--------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP  283 (361)
T ss_pred             CCCCEEccCccCcccCCccccc--------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC
Confidence            999999999999976543 110        0111 69999999999999999999999999999999999999887644 


Q ss_pred             cCCccHhHHHHhhcchh-hhhhcCccccc-ccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHH
Q 011508          382 TGNLTLHNFVKEALPER-LAEIVDPVLLV-EREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEV  459 (484)
Q Consensus       382 ~~~~~~~~~~~~~~~~~-~~~~~d~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev  459 (484)
                      .+...+..|........ +.+++|+.+.. ...                  ..++...+..++..|++.+|++||+|.||
T Consensus       284 ~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~------------------~~~~~~~~~~~a~~C~~~~~~~RP~m~~V  345 (361)
T KOG1187|consen  284 RGELSLVEWAKPLLEEGKLREIVDPRLKEGEYP------------------DEKEVKKLAELALRCLRPDPKERPTMSQV  345 (361)
T ss_pred             cccccHHHHHHHHHHCcchhheeCCCccCCCCC------------------hHHHHHHHHHHHHHHcCcCCCcCcCHHHH
Confidence            34455888887777764 99999999863 111                  11347779999999999999999999999


Q ss_pred             HHHHHHHHH
Q 011508          460 AAQLLSFRN  468 (484)
Q Consensus       460 l~~L~~i~~  468 (484)
                      +++|+.+..
T Consensus       346 v~~L~~~~~  354 (361)
T KOG1187|consen  346 VKELEGILS  354 (361)
T ss_pred             HHHHHhhcc
Confidence            999966543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=379.82  Aligned_cols=260  Identities=34%  Similarity=0.477  Sum_probs=209.4

Q ss_pred             CccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc--hHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA--SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       162 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      .+.+.||+|+||+||+|.|+.   ...||||++.......  .+.|.+|+.+|.+++|||||+++|+|....    ...+
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g---~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~  116 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRG---TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLC  116 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCC---ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceE
Confidence            445669999999999999872   2339999998654333  458999999999999999999999985432    2579


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeecCCCCCCeeecCCC-ceEEcccCcc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP-IVHCDLKPSNVLLDGEL-TAHVSDFGLA  317 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlk~~NIll~~~~-~~kl~Dfg~a  317 (484)
                      +|||||++|+|.++++..  ....+++..++.++.|||+||.|||   +++ ||||||||+|||++.++ ++||+|||++
T Consensus       117 iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             EEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            999999999999999864  3456999999999999999999999   777 99999999999999997 9999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccC--CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM--GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +......       .......||+.|||||++.  ...|+.|+||||||+++|||+||+.||..... .......+..  
T Consensus       192 r~~~~~~-------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~--  261 (362)
T KOG0192|consen  192 REKVISK-------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVG--  261 (362)
T ss_pred             eeecccc-------ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhc--
Confidence            8764321       1122256999999999999  66999999999999999999999999987533 1111111100  


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHhh
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVK  472 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~  472 (484)
                                ....                   ..+..|+..+..++.+||+.||.+||++.|++..|+.+......
T Consensus       262 ----------~~Rp-------------------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  262 ----------GLRP-------------------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             ----------CCCC-------------------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence                      0000                   01233678899999999999999999999999999999877654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-50  Score=362.30  Aligned_cols=251  Identities=27%  Similarity=0.369  Sum_probs=205.4

Q ss_pred             CccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc-eee
Q 011508          162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND-FEA  239 (484)
Q Consensus       162 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~-~~~  239 (484)
                      +..+.||+|..|+||+++  +..+++.+|+|++..... ...+++.+|+++++..+||+||++||.|..     +. ...
T Consensus        82 e~~~~lG~G~gG~V~kv~--Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~-----~~~~is  154 (364)
T KOG0581|consen   82 ERLGVLGSGNGGTVYKVR--HKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS-----NGEEIS  154 (364)
T ss_pred             hhhhhcccCCCcEEEEEE--EcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe-----CCceEE
Confidence            456889999999999999  666789999999965443 345789999999999999999999999643     33 589


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      |+||||++|||++++...    +++++...-+|+.++++||.|||+  .++||||||||+|||++..|++||||||.+..
T Consensus       155 I~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~  228 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI  228 (364)
T ss_pred             eehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence            999999999999999743    459999999999999999999995  49999999999999999999999999999987


Q ss_pred             cccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhh
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERL  399 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  399 (484)
                      +...         ....+.||..|||||.+.+..|+.++||||||++++|+.+|+.||.........+.+...       
T Consensus       229 lvnS---------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~-------  292 (364)
T KOG0581|consen  229 LVNS---------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC-------  292 (364)
T ss_pred             hhhh---------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH-------
Confidence            7432         234567999999999999999999999999999999999999999764222222222211       


Q ss_pred             hhhcCcccccccccccchhhhhhhccccccchh-HHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          400 AEIVDPVLLVEREEGETSEANAHKQRTRSFGGK-ECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       400 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                       .+++    ..+..               . +. .|..++..++..||+.||.+|||++|+++.
T Consensus       293 -~Iv~----~ppP~---------------l-P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  293 -AIVD----EPPPR---------------L-PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             -HHhc----CCCCC---------------C-CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             1221    11000               0 22 367889999999999999999999999864

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-49  Score=372.84  Aligned_cols=256  Identities=31%  Similarity=0.486  Sum_probs=211.4

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeE
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.+.+.||+|.||.||.|.|+   ....||+|.++.. ....++|.+|+++|++|+|+|||+++++|...+     .++|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~---~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyI  278 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWN---GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYI  278 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEc---CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEE
Confidence            456788999999999999998   3457999999865 334578999999999999999999999985433     7899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      |||||+.|+|.+||+.  .....+...+.+.++.|||+|++||+   ++++|||||.++||||+++..+||+|||+|+..
T Consensus       279 VtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             EEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc
Confidence            9999999999999985  34556899999999999999999999   999999999999999999999999999999955


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERL  399 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  399 (484)
                      .++..      .......-+..|.|||.+..+.++.|||||||||+||||+| |+.|+..+...     +.+.       
T Consensus       354 ~d~~Y------~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~-----ev~~-------  415 (468)
T KOG0197|consen  354 GDDEY------TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE-----EVLE-------  415 (468)
T ss_pred             CCCce------eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH-----HHHH-------
Confidence            43332      12223345788999999999999999999999999999999 99998765321     1111       


Q ss_pred             hhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          400 AEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       400 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                        .++.                   ..+-..|+.|+.++.++|..||+.+|++|||++.+...|+++...
T Consensus       416 --~le~-------------------GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  416 --LLER-------------------GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             --HHhc-------------------cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence              1111                   111222778999999999999999999999999999998887543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-48  Score=372.10  Aligned_cols=249  Identities=26%  Similarity=0.347  Sum_probs=208.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeecc---CccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .+|...+.||+|||+.||+++  +..++..||+|++.+.   .....+...+|+++.++|+|||||+++++     |++.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~--~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~-----FEDs   90 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEAR--DLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF-----FEDS   90 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEE--EcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE-----eecC
Confidence            579999999999999999999  4447889999999753   34455778999999999999999999999     6778


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ++.|+|.|+|+.++|..+++.    .+.+++.++..+.+||+.||.|||   +++|+|||||..|+|++++.++||+|||
T Consensus        91 ~nVYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   91 NNVYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             CceEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccc
Confidence            899999999999999999973    346999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +|..+...       .......+||+.|.|||++.....+..+||||+||+||.|++|++||+..     .+.+..... 
T Consensus       164 LAt~le~~-------~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety~~I-  230 (592)
T KOG0575|consen  164 LATQLEYD-------GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETYNKI-  230 (592)
T ss_pred             eeeeecCc-------ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHHHHH-
Confidence            99987432       24455689999999999999999999999999999999999999999752     111111110 


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                             .    ..++                 ..|.....+..+||..+|++||.+|||+++|+..
T Consensus       231 -------k----~~~Y-----------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  231 -------K----LNEY-----------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -------H----hcCc-----------------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                   0    0000                 0012225567899999999999999999999854

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-49  Score=346.41  Aligned_cols=256  Identities=23%  Similarity=0.333  Sum_probs=205.5

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|.+.++||+|+||.||++.  ...++..+|.|.++...  .........|+.+|++|+|||||+++++-+   .+++..
T Consensus        20 ~y~Il~~IG~GsFg~vykv~--~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f---~~~~ev   94 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQ--CLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSF---IEDNEV   94 (375)
T ss_pred             HHHHHHHHcCCcchheEEee--eccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhh---hccchh
Confidence            46788999999999999998  55578999999987443  233457889999999999999999988532   233444


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeecCCCceEEcccC
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP--IVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      .+||||+|..|+|.+.++..+...+.+++..+|+++.|++.||.++|+.. ..  |+||||||.||+++.+|.+||+|||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccch
Confidence            89999999999999999998888889999999999999999999999421 44  9999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +++.+...       .......+||+.||+||.+...+|+.||||||+||++|||..-++||.+.     .+...-...-
T Consensus       174 L~r~l~s~-------~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~  241 (375)
T KOG0591|consen  174 LGRFLSSK-------TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIE  241 (375)
T ss_pred             hHhHhcch-------hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHH
Confidence            99987543       33445578999999999999999999999999999999999999999763     2221111110


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVA  460 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  460 (484)
                      ......+                           ..+-.+..+..|+..|+..||+.||+.-.++
T Consensus       242 qgd~~~~---------------------------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v  279 (375)
T KOG0591|consen  242 QGDYPPL---------------------------PDEHYSTDLRELINMCIAVDPEQRPDTVPYV  279 (375)
T ss_pred             cCCCCCC---------------------------cHHHhhhHHHHHHHHHccCCcccCCCcchHH
Confidence            0000000                           0133467889999999999999999854433

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3e-48  Score=355.11  Aligned_cols=202  Identities=31%  Similarity=0.528  Sum_probs=177.7

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeecc--CccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ..++|.+.+.||+|+||+||+|+.+  .++..||||.+.+.  .....+.+..|+.+|+.++|||||.+++++.     .
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~--~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-----~   80 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHK--KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-----D   80 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEec--cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-----c
Confidence            3468999999999999999999954  45689999999766  3445567889999999999999999999954     4


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC------Cc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE------LT  308 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~------~~  308 (484)
                      +++.++|||||.||+|.+|++...    .+++..+..++.||+.||++||   +++||||||||+||||+..      -.
T Consensus        81 ~~~i~lVMEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~  153 (429)
T KOG0595|consen   81 DDFIYLVMEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPV  153 (429)
T ss_pred             CCeEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCce
Confidence            459999999999999999998543    5899999999999999999999   9999999999999999765      46


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      +||+|||+|+.+..        .......+|++.|||||++...+|+.|+|+||+|+++|++++|+.||+..
T Consensus       154 LKIADFGfAR~L~~--------~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  154 LKIADFGFARFLQP--------GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             EEecccchhhhCCc--------hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            89999999998853        23334578999999999999999999999999999999999999999864

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-48  Score=354.12  Aligned_cols=254  Identities=24%  Similarity=0.344  Sum_probs=202.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-------chHHHHHHHHHHHcCCCCCceeEeeeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-------ASKSFIAECQALRSIRHRNLVKIITSCVSV  230 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  230 (484)
                      .+.|.+.+.||+|+||.|-+|.  +..+++.||||++++....       ......+|+++|++|+|||||+++++    
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~--e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~----  244 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAY--EKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF----  244 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEE--EcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee----
Confidence            3568889999999999999999  5667899999999864321       12345799999999999999999999    


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC---C
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE---L  307 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~---~  307 (484)
                       +...+..|+||||++||+|.+++-.+.    .+.+..-..+++|++.|+.|||   ++||+||||||+|||++.+   .
T Consensus       245 -f~~~ds~YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~  316 (475)
T KOG0615|consen  245 -FEVPDSSYMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDC  316 (475)
T ss_pred             -eecCCceEEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcce
Confidence             455558899999999999999987443    3667777889999999999999   9999999999999999765   7


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCC---CcccceehhhHHHHHHHhCCCCCCCCccCC
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV---STSGDVYSFGILLLEMFTGKGPTNEMFTGN  384 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dvws~Gvvl~elltg~~p~~~~~~~~  384 (484)
                      .+||+|||+|+...        ........+||+.|.|||++.+..+   ..+.|+||+||+||-+++|.+||.+.....
T Consensus       317 llKItDFGlAK~~g--------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~  388 (475)
T KOG0615|consen  317 LLKITDFGLAKVSG--------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP  388 (475)
T ss_pred             EEEecccchhhccc--------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence            89999999999763        2344456899999999999887543   347899999999999999999998754332


Q ss_pred             ccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          385 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ....+..+..+            ...                 ...+.+...+..+++.+||..||++|||+.|+++.
T Consensus       389 sl~eQI~~G~y------------~f~-----------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  389 SLKEQILKGRY------------AFG-----------------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cHHHHHhcCcc------------ccc-----------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            11111111111            110                 01134557788999999999999999999999864

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.1e-46  Score=373.08  Aligned_cols=264  Identities=28%  Similarity=0.445  Sum_probs=215.6

Q ss_pred             CCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      +....+.||+|+||+||+|+...-   +....||||.++..... ...+|++|++++..++|||||+++|.|...+    
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~----  562 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD----  562 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC----
Confidence            345668899999999999986422   34578999999877665 5679999999999999999999999986544    


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRD----------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG  305 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~  305 (484)
                       ..++|+|||..|||.+||.....          .+.+++..+.+.||.|||.|+.||-   ++.+|||||..+|+||.+
T Consensus       563 -P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  563 -PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGE  638 (774)
T ss_pred             -eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceecc
Confidence             88999999999999999974321          1344899999999999999999999   999999999999999999


Q ss_pred             CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCC
Q 011508          306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGN  384 (484)
Q Consensus       306 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~  384 (484)
                      +..|||+|||+++..-..+.....     ....-..+|||||.+..+++|.+||||||||+|||+++ |+.||.+..+++
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~-----~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E  713 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVR-----GNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE  713 (774)
T ss_pred             ceEEEecccccchhhhhhhhhccc-----CCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence            999999999999876443322111     12235789999999999999999999999999999999 999998754331


Q ss_pred             ccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          385 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                        ..+           .+-+..+.                    ..++.|+.++..||+.||+.+|++||+++||-..|+
T Consensus       714 --VIe-----------~i~~g~lL--------------------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~  760 (774)
T KOG1026|consen  714 --VIE-----------CIRAGQLL--------------------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ  760 (774)
T ss_pred             --HHH-----------HHHcCCcc--------------------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence              111           11111111                    116789999999999999999999999999999998


Q ss_pred             HHHHH
Q 011508          465 SFRNK  469 (484)
Q Consensus       465 ~i~~~  469 (484)
                      ..-+.
T Consensus       761 ~~~~~  765 (774)
T KOG1026|consen  761 AWAQA  765 (774)
T ss_pred             HHHhc
Confidence            87554

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.9e-46  Score=325.48  Aligned_cols=277  Identities=20%  Similarity=0.301  Sum_probs=203.9

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      +.|+...++|+|+||.||+++  ++.+|+.||||++.....+  ..+-.++|+++|++++|+|+|.++.+     |....
T Consensus         2 ekYE~LgkvGEGSYGvV~KCr--nk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEV-----Frrkr   74 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCR--NKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEV-----FRRKR   74 (396)
T ss_pred             cHHhhhhccccCcceEEEEec--cCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHH-----HHhcc
Confidence            457788899999999999998  6678999999999654332  23457899999999999999999999     55666


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++|+|||+. ++.+-|..   .+..++...+.+++.|++.|+.|+|   +++++||||||+|||++.++.+||||||+
T Consensus        75 klhLVFE~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGF  147 (396)
T KOG0593|consen   75 KLHLVFEYCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGF  147 (396)
T ss_pred             eeEEEeeecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchh
Confidence            89999999965 55555543   3456889999999999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCc--cHhHHHHh
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNL--TLHNFVKE  393 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~  393 (484)
                      |+.+...       ....+..+.|.+|+|||.+.+ .+|+...||||+||++.||++|.+.|.+..+-+.  .+......
T Consensus       148 AR~L~~p-------gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~  220 (396)
T KOG0593|consen  148 ARTLSAP-------GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGN  220 (396)
T ss_pred             hHhhcCC-------cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcc
Confidence            9987532       233445678999999999877 7899999999999999999999999876432111  11111222


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..|.. ..+....-..   .+..-....+ ...-.........-+++++..|++.||++|++-+|++.
T Consensus       221 L~prh-q~iF~~N~~F---~Gv~lP~~~~-~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  221 LIPRH-QSIFSSNPFF---HGVRLPEPEH-PEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             cCHHH-HHHhccCCce---eeeecCCCCC-ccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            22222 2222111000   0000000000 00000112233557899999999999999999999984

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=334.72  Aligned_cols=244  Identities=30%  Similarity=0.385  Sum_probs=200.3

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      ..++|++.+.||+|+||+||.++.  .++++.+|+|++++..   ....+....|..+|.+++||.||+++..     |+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk--~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ys-----FQ   95 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRK--KDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYS-----FQ   95 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEE--cccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEe-----cc
Confidence            346789999999999999999994  4678999999998653   3445778899999999999999999877     77


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      +....|+|+||+.||.|..+|+..    ..+++..+.-++..|+.||.|||   +++||||||||+|||||++|+++|+|
T Consensus        96 t~~kLylVld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtD  168 (357)
T KOG0598|consen   96 TEEKLYLVLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTD  168 (357)
T ss_pred             cCCeEEEEEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEec
Confidence            788999999999999999999843    35889999999999999999999   99999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||+++..-..       .......+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...     +..++...
T Consensus       169 FgL~k~~~~~-------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~-----~~~~~~~~  236 (357)
T KOG0598|consen  169 FGLCKEDLKD-------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE-----DVKKMYDK  236 (357)
T ss_pred             cccchhcccC-------CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc-----cHHHHHHH
Confidence            9999854222       23334578999999999999999999999999999999999999999763     22222222


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM  454 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  454 (484)
                      ....+        +...                    +.-...+..+++...+..||++|-
T Consensus       237 I~~~k--------~~~~--------------------p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  237 ILKGK--------LPLP--------------------PGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             HhcCc--------CCCC--------------------CccCCHHHHHHHHHHhccCHHHhc
Confidence            22111        0000                    011145678899999999999996

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-45  Score=347.84  Aligned_cols=260  Identities=26%  Similarity=0.372  Sum_probs=211.5

Q ss_pred             HHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeee
Q 011508          155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSV  230 (484)
Q Consensus       155 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  230 (484)
                      .+...+|.+++.||+|+|++|++|+  +..+++.||||++.+..   ....+-...|-.+|.+| .||.|++++..    
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~--~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~T----  142 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAR--EKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFT----  142 (604)
T ss_pred             cCChhhcchhheeccccceeEEEee--ecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEE----
Confidence            3455789999999999999999999  55578999999997542   22334567888999999 89999999977    


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH  310 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k  310 (484)
                       |+++..+|+|+||+++|+|.++|+...    .+++.....++.+|+.||+|||   ++|||||||||+|||||+|+++|
T Consensus       143 -FQD~~sLYFvLe~A~nGdll~~i~K~G----sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhik  214 (604)
T KOG0592|consen  143 -FQDEESLYFVLEYAPNGDLLDLIKKYG----SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIK  214 (604)
T ss_pred             -eecccceEEEEEecCCCcHHHHHHHhC----cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEE
Confidence             677779999999999999999998654    4899999999999999999999   99999999999999999999999


Q ss_pred             EcccCcccccccccccC----CCCcccc--ccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCC
Q 011508          311 VSDFGLAKFLPEAANNL----SSNQSSS--VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN  384 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~----~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~  384 (484)
                      |+|||.|+.++......    .......  ..++||..|.+||++.....++.+|||+|||+||+|+.|++||....+ -
T Consensus       215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-y  293 (604)
T KOG0592|consen  215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-Y  293 (604)
T ss_pred             EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-H
Confidence            99999999997655431    1112222  558999999999999999999999999999999999999999976311 1


Q ss_pred             ccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          385 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..            +..+++-....                     +++.+..+.+|+.+.|..||.+|+|.+||-+.
T Consensus       294 li------------FqkI~~l~y~f---------------------p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  294 LI------------FQKIQALDYEF---------------------PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HH------------HHHHHHhcccC---------------------CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            11            11222211111                     23335678899999999999999999888765

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-45  Score=337.40  Aligned_cols=261  Identities=30%  Similarity=0.408  Sum_probs=202.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      .++...+.||+|+||+||++...  .++...|||.+........+.+.+|+.+|++++|||||+.+|......   +..+
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~--~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~---~~~~   91 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNK--KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE---NDEY   91 (313)
T ss_pred             chhhhhccccCccceEEEEEEec--CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc---Ceee
Confidence            45677899999999999999954  347889999987664333567899999999999999999999632211   1368


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEcccCcc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG-ELTAHVSDFGLA  317 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~a  317 (484)
                      +++|||+++|+|.+++.....   .+++..+..+.+||++||+|||   +++|+||||||+|||++. ++.+||+|||++
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a  165 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLA  165 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccc
Confidence            899999999999999986542   5999999999999999999999   999999999999999999 799999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +......    ..........||+.|||||++..+ ....++||||+||++.||+||+.||....    ....+.-....
T Consensus       166 ~~~~~~~----~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~----~~~~~~~~ig~  237 (313)
T KOG0198|consen  166 KKLESKG----TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF----EEAEALLLIGR  237 (313)
T ss_pred             ccccccc----ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc----chHHHHHHHhc
Confidence            8765311    112223346799999999999854 33459999999999999999999997630    11111110000


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                      ..    .-|.+                       +...+.+..+++..|+..||++|||+.|+++.--.
T Consensus       238 ~~----~~P~i-----------------------p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  238 ED----SLPEI-----------------------PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             cC----CCCCC-----------------------CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            00    00000                       22235678899999999999999999999986543

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=332.27  Aligned_cols=267  Identities=25%  Similarity=0.343  Sum_probs=209.1

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc-hHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA-SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ..+.|++.+.||.|..++||+|+.  ...+..||||++..+.... .+.+.+|+..|+.++||||++++..|.     .+
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c--~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-----v~   96 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARC--IPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-----VD   96 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeee--cccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-----ec
Confidence            346799999999999999999994  4456899999998765443 478999999999999999999998854     44


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...|+||+||.+||+.+.++....  ..+++..+..|++++++||.|||   .+|.||||||+.||||+++|.+||+|||
T Consensus        97 ~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen   97 SELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             ceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCce
Confidence            589999999999999999986653  44999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC--CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG--SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      .+..+....   ...........||+.|||||++..  ..|+.|+||||||++..||.+|..||.....-...+... ..
T Consensus       172 vsa~l~~~G---~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-qn  247 (516)
T KOG0582|consen  172 VSASLFDSG---DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-QN  247 (516)
T ss_pred             eeeeecccC---ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-cC
Confidence            987775543   111112256789999999999543  469999999999999999999999998754332222211 11


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..|.......|..      +                 .......+.+++..||+.||++|||++++++.
T Consensus       248 ~pp~~~t~~~~~d------~-----------------~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  248 DPPTLLTSGLDKD------E-----------------DKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CCCCcccccCChH------H-----------------hhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            1110000000000      0                 11224578899999999999999999999853

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4e-44  Score=348.49  Aligned_cols=268  Identities=24%  Similarity=0.378  Sum_probs=205.2

Q ss_pred             hcCCCCccCccccccceeEEEEEEc---CCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeeec
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSVD  231 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  231 (484)
                      ..++|++.+.||+|+||.||+|...   ....+..||+|+++.... .....+.+|+.++.++ +||||++++++|.   
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~---   81 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT---   81 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec---
Confidence            3467899999999999999999752   223456899999875432 2345788999999999 8999999999873   


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCC---------------------------------------------------
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDA---------------------------------------------------  260 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------  260 (484)
                       ..+...++||||+++|+|.+++......                                                   
T Consensus        82 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          82 -KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             -CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence             3344678999999999999999753210                                                   


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccc
Q 011508          261 -------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS  333 (484)
Q Consensus       261 -------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  333 (484)
                             ...+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++........     ..
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-----~~  232 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-----VR  232 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-----hc
Confidence                   134788899999999999999999   899999999999999999999999999999865322111     11


Q ss_pred             cccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccc
Q 011508          334 SVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVERE  412 (484)
Q Consensus       334 ~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  412 (484)
                      .....++..|+|||++.+..++.++|||||||++|||++ |..||....... .+...           +.+.....   
T Consensus       233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~-----------~~~~~~~~---  297 (338)
T cd05102         233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQR-----------LKDGTRMR---  297 (338)
T ss_pred             ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHH-----------HhcCCCCC---
Confidence            112345678999999998899999999999999999997 999997532211 00000           00000000   


Q ss_pred             cccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          413 EGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       413 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                                       .+..++..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus       298 -----------------~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         298 -----------------APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             -----------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                             012235678999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-45  Score=348.10  Aligned_cols=270  Identities=27%  Similarity=0.409  Sum_probs=211.4

Q ss_pred             cHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeee
Q 011508          150 SYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSC  227 (484)
Q Consensus       150 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~  227 (484)
                      +.+++....+.+.+...||+|.||+||+|+|.     ..||||+++....  ...+.|.+|+..+++-+|.||+-+.|+|
T Consensus       383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-----GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~  457 (678)
T KOG0193|consen  383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-----GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC  457 (678)
T ss_pred             cccccccCHHHhhccceeccccccceeecccc-----cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence            33455555566778899999999999999986     3499999987654  3457899999999999999999999997


Q ss_pred             eeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 011508          228 VSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL  307 (484)
Q Consensus       228 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~  307 (484)
                      ....     . .||+.+|+|-+|..+++..+   ..++..+.+.|+.||++|+.|||   .++|||||||..||++.+++
T Consensus       458 ~~p~-----~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~  525 (678)
T KOG0193|consen  458 MNPP-----L-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDL  525 (678)
T ss_pred             cCCc-----e-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCC
Confidence            5332     3 99999999999999998543   45899999999999999999999   99999999999999999999


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCC---CCCCcccceehhhHHHHHHHhCCCCCCCCccCC
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG---SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN  384 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~  384 (484)
                      .|||+|||++..-..-.     .........|...|||||++..   .+|++.+||||||+|+|||+||..||.....+.
T Consensus       526 kVkIgDFGLatvk~~w~-----g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq  600 (678)
T KOG0193|consen  526 KVKIGDFGLATVKTRWS-----GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ  600 (678)
T ss_pred             cEEEecccceeeeeeec-----cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh
Confidence            99999999987543221     1111122347889999998764   579999999999999999999999997322221


Q ss_pred             ccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          385 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      ..+ ..-+.        .+.+.+                    ......|+.++.+|+..||..++++||.+.+|+..|+
T Consensus       601 Iif-mVGrG--------~l~pd~--------------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~  651 (678)
T KOG0193|consen  601 IIF-MVGRG--------YLMPDL--------------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE  651 (678)
T ss_pred             eEE-Eeccc--------ccCccc--------------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence            110 00000        000000                    0113456889999999999999999999999999999


Q ss_pred             HHHHHH
Q 011508          465 SFRNKL  470 (484)
Q Consensus       465 ~i~~~~  470 (484)
                      ++..++
T Consensus       652 ~l~~~~  657 (678)
T KOG0193|consen  652 ELLPSL  657 (678)
T ss_pred             Hhhhcc
Confidence            887754

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-44  Score=337.30  Aligned_cols=280  Identities=26%  Similarity=0.287  Sum_probs=205.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      +.|+.+++||+|.||.||+|+  +..+++.||+|++..+.  .+...-..+||.+|++|+||||+++.+...+.   ...
T Consensus       117 ~~feki~kIGeGTyg~VYkAr--~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~  191 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKAR--DLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSG  191 (560)
T ss_pred             HHHHHHHHhcCcchhheeEee--ecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCc
Confidence            457778999999999999999  66788999999998665  44556678999999999999999999986543   245


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      .+|+|+|||+ -+|.-++..   ..-.+++.++..+++|++.||+|+|   .++|+|||||.+|||||.+|.+||+|||+
T Consensus       192 siYlVFeYMd-hDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGL  264 (560)
T KOG0600|consen  192 SIYLVFEYMD-HDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGL  264 (560)
T ss_pred             eEEEEEeccc-chhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccc
Confidence            7899999995 488888762   2346999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      |+++.....      ...+..+-|.+|+|||++.+ ..|+.+.|+||.||||.||++|++.|.+... -..++...+..-
T Consensus       265 Ar~y~~~~~------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-veQl~kIfklcG  337 (560)
T KOG0600|consen  265 ARFYTPSGS------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-VEQLHKIFKLCG  337 (560)
T ss_pred             eeeccCCCC------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-HHHHHHHHHHhC
Confidence            998755432      22345678999999998877 5799999999999999999999999876321 111222222111


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .+....+--..+........   ........++. ....+...++|+..+|..||.+|.|+.++++
T Consensus       338 SP~e~~W~~~kLP~~~~~kp---~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  338 SPTEDYWPVSKLPHATIFKP---QQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCChhccccccCCcccccCC---CCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            11100000000100000000   00000000000 1223566789999999999999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=341.78  Aligned_cols=269  Identities=22%  Similarity=0.309  Sum_probs=204.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchH-HHHHHHHHHHcCC-CCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK-SFIAECQALRSIR-HRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|.+.++||.|.||.||+|+  ...++..||||.++.......+ .-.+|+..|++|+ |||||++.+.+     .++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~--~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi-----~d~   81 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAK--SKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVI-----RDN   81 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEee--ecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHh-----hcc
Confidence            4678999999999999999999  5556788999999865543322 3468999999998 99999999985     333


Q ss_pred             c-eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          236 D-FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       236 ~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      + ..++||||| ..+|.++++..   .+.+++..+..|+.||++||+|+|   .+|+.|||+||+|||+..+..+||+||
T Consensus        82 ~~~L~fVfE~M-d~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDF  154 (538)
T KOG0661|consen   82 DRILYFVFEFM-DCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADF  154 (538)
T ss_pred             CceEeeeHHhh-hhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccc
Confidence            3 899999999 67999999854   567999999999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccC-CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |+|+....        .+..+..+.|.+|+|||++. .+.|+.+.|+||+|||++|+.+-++.|.+..+-+ .+.+.. +
T Consensus       155 GLARev~S--------kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-qi~KIc-~  224 (538)
T KOG0661|consen  155 GLAREVRS--------KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-QIYKIC-E  224 (538)
T ss_pred             cccccccc--------CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-HHHHHH-H
Confidence            99997632        33445678999999999754 5789999999999999999999999987643211 111111 1


Q ss_pred             hc--------ch--hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 AL--------PE--RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~--------~~--~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .+        ++  .+...+.-.+..-.        .   .......+. +..+.++++.+|+++||.+|||+.|.++.
T Consensus       225 VLGtP~~~~~~eg~~La~~mnf~~P~~~--------~---~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  225 VLGTPDKDSWPEGYNLASAMNFRFPQVK--------P---SPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HhCCCccccchhHHHHHHHhccCCCcCC--------C---CChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11        00  01111111110000        0   000111122 57889999999999999999999999864

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=309.54  Aligned_cols=278  Identities=19%  Similarity=0.239  Sum_probs=222.1

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ...++|++.+.||+|||+-||.++  +-.++..+|+|++......+.+..++|++..++++|||++++++++....-...
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~--~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVK--GLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeec--ccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            345789999999999999999998  555788999999988877778889999999999999999999999877655566


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...|++++|...|||.+.+......+..+++.+++.|+.++++||++||.. ..+++||||||.||++++++.++|.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence            789999999999999999998777777899999999999999999999943 3459999999999999999999999999


Q ss_pred             cccccccccccCCCC--ccccccccccccccCccccC---CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          316 LAKFLPEAANNLSSN--QSSSVGVKGTVGYAAPEYGM---GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      .+...+-...+....  ...+.....|..|+|||.+.   +...++++|||||||+||+|+.|..||+.....+.++.--
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA  254 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA  254 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence            998764432211111  11122345789999999865   3467899999999999999999999998755443332211


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                                 +....+..- .                  ....+..+.+++..|++.||.+||++.+++..++.+
T Consensus       255 -----------v~n~q~s~P-~------------------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  255 -----------VQNAQISIP-N------------------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -----------eeccccccC-C------------------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                       111111110 0                  011266789999999999999999999999998765

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=342.27  Aligned_cols=251  Identities=24%  Similarity=0.329  Sum_probs=208.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ..|....+||+|+.|.||.|.  ...++..||||++........+-+.+|+.+|+..+|+|||.+++.+...     +..
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~--~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deL  345 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVAR--KISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DEL  345 (550)
T ss_pred             hhhcchhhhccccccceeeee--eccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----cee
Confidence            457778899999999999998  5556778999999988777777889999999999999999999986543     589


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      |+|||||++|+|.+.+....     +++.++..|++++++||+|||   .++|+|||||.+|||++.++.+||+|||++.
T Consensus       346 WVVMEym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFca  417 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCA  417 (550)
T ss_pred             EEEEeecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeee
Confidence            99999999999999987443     899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      .+....       ......+||+.|||||+.....|++|.||||||++++||+-|++||-..    ..+.....      
T Consensus       418 qi~~~~-------~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE----~PlrAlyL------  480 (550)
T KOG0578|consen  418 QISEEQ-------SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE----NPLRALYL------  480 (550)
T ss_pred             cccccc-------CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC----ChHHHHHH------
Confidence            775433       3445578999999999999999999999999999999999999998531    11111110      


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      +..--.+.+..                     ++.....+.+++.+||+.||.+||++.|+++.
T Consensus       481 Ia~ng~P~lk~---------------------~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  481 IATNGTPKLKN---------------------PEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             HhhcCCCCcCC---------------------ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            11111111111                     23346789999999999999999999999864

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1e-43  Score=307.28  Aligned_cols=277  Identities=21%  Similarity=0.266  Sum_probs=205.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|...+.||+|.||.||+|+  +..+++.||||+++...  .+......+|++.|+.++|+||+.++++     |...+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~--d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~-----F~~~~   74 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKAR--DTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDV-----FPHKS   74 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEE--ecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhh-----ccCCC
Confidence            467888999999999999999  66788999999998654  2334678899999999999999999999     55666


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ...+|+||| ..+|+..++.   ....++..++..++.++++|++|+|   .+.|+||||||.|+|++++|.+||+|||+
T Consensus        75 ~l~lVfEfm-~tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGL  147 (318)
T KOG0659|consen   75 NLSLVFEFM-PTDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGL  147 (318)
T ss_pred             ceEEEEEec-cccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccc
Confidence            889999999 5699999973   3456899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      |+.+....       ......+-|..|+|||.+.+ ..|+...|+||.||++.||+-|.+-|.+..+ -..+....+..-
T Consensus       148 Ar~f~~p~-------~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LG  219 (318)
T KOG0659|consen  148 ARFFGSPN-------RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALG  219 (318)
T ss_pred             hhccCCCC-------cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcC
Confidence            99875432       22223368999999998877 5799999999999999999999877655321 111222222111


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .+...++-+-.-..++.+-.     .......+.....+....++++..++..||.+|+|+.|++++
T Consensus       220 TP~~~~WP~~~~lpdY~~~~-----~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  220 TPTPDQWPEMTSLPDYVKIQ-----QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CCCcccCccccccccHHHHh-----cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            11111111111111110000     000000110122345667999999999999999999999865

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-44  Score=340.66  Aligned_cols=256  Identities=25%  Similarity=0.393  Sum_probs=210.5

Q ss_pred             hccccHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEee
Q 011508          146 VLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIIT  225 (484)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~  225 (484)
                      ...++|+++       ...+-||.|+.|.||+|++.    ++.||||+++..       -..+++-|++|+|+||+.+.|
T Consensus       118 ~WeiPFe~I-------sELeWlGSGaQGAVF~Grl~----netVAVKKV~el-------kETdIKHLRkLkH~NII~FkG  179 (904)
T KOG4721|consen  118 LWEIPFEEI-------SELEWLGSGAQGAVFLGRLH----NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKG  179 (904)
T ss_pred             hccCCHHHh-------hhhhhhccCcccceeeeecc----CceehhHHHhhh-------hhhhHHHHHhccCcceeeEee
Confidence            456667666       33567999999999999986    567999987522       235788899999999999999


Q ss_pred             eeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 011508          226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG  305 (484)
Q Consensus       226 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~  305 (484)
                      +|....     .+|||||||..|-|.+.|+.    .+.++......|..+||.|+.|||   .+.|||||||.-||||+.
T Consensus       180 VCtqsP-----cyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~  247 (904)
T KOG4721|consen  180 VCTQSP-----CYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISY  247 (904)
T ss_pred             eecCCc-----eeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeec
Confidence            996544     88999999999999999983    445888888999999999999999   999999999999999999


Q ss_pred             CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCc
Q 011508          306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNL  385 (484)
Q Consensus       306 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~  385 (484)
                      +..+||+|||.++...+        ......++||..|||||++...+.++|.||||||||||||+||..||.+.....+
T Consensus       248 ~d~VKIsDFGTS~e~~~--------~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI  319 (904)
T KOG4721|consen  248 DDVVKISDFGTSKELSD--------KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI  319 (904)
T ss_pred             cceEEeccccchHhhhh--------hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee
Confidence            99999999999987633        2344567899999999999999999999999999999999999999976432211


Q ss_pred             cHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          386 TLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                                   +..+-...+                   .-..+..|+..+.-|++.||+..|..||++.+++..|+.
T Consensus       320 -------------IwGVGsNsL-------------------~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  320 -------------IWGVGSNSL-------------------HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             -------------EEeccCCcc-------------------cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence                         011111111                   112267789999999999999999999999999999987


Q ss_pred             HHHHHh
Q 011508          466 FRNKLV  471 (484)
Q Consensus       466 i~~~~~  471 (484)
                      ....+.
T Consensus       368 a~pell  373 (904)
T KOG4721|consen  368 ASPELL  373 (904)
T ss_pred             cCHHHh
Confidence            766553

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-44  Score=366.90  Aligned_cols=280  Identities=27%  Similarity=0.427  Sum_probs=222.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCC---eeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDH---ETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      ....++.+.||+|.||.||.|.+.+...   ...||+|.++... .+...+|.+|..+|+.++|||||+++|.|..    
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~----  766 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD----  766 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC----
Confidence            3455677899999999999999876543   3459999887654 3455789999999999999999999999965    


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRD---APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH  310 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k  310 (484)
                       ....+|++|||++|+|..||++.+.   ....++..+.+.++.|||+|+.||+   ++++|||||.++|+||++...+|
T Consensus       767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VK  842 (1025)
T KOG1095|consen  767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVK  842 (1025)
T ss_pred             -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEE
Confidence             3377999999999999999986532   2456999999999999999999999   99999999999999999999999


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhH
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHN  389 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~  389 (484)
                      |+|||+|+.+..........     ...-...|||||.+..+.++.|+|||||||+|||++| |..||....+.+. +..
T Consensus       843 IaDFGlArDiy~~~yyr~~~-----~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-~~~  916 (1025)
T KOG1095|consen  843 IADFGLARDIYDKDYYRKHG-----EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-LLD  916 (1025)
T ss_pred             EcccchhHhhhhchheeccC-----ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH-HHH
Confidence            99999999553332221111     1234578999999999999999999999999999999 9999876422211 111


Q ss_pred             HHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          390 FVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                      +...           .                     +-..+..|+..+.++|..||+.+|++||++..+++++..+.+.
T Consensus       917 ~~~g-----------g---------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  917 VLEG-----------G---------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             HHhC-----------C---------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            1110           0                     1122678899999999999999999999999999999999877


Q ss_pred             HhhccCC-Ccceeec
Q 011508          470 LVKNVRG-QPATYVT  483 (484)
Q Consensus       470 ~~~~~~~-~~~~~~~  483 (484)
                      ......+ .++.|.+
T Consensus       965 ~~~~~~~~~~a~~~~  979 (1025)
T KOG1095|consen  965 ALGTIYGPLPADYES  979 (1025)
T ss_pred             hccCcccccccccCc
Confidence            6544333 3555543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-43  Score=337.75  Aligned_cols=257  Identities=25%  Similarity=0.342  Sum_probs=204.4

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeecc----Cc-cchHHHHHHHHHHHcCC-CCCceeEeeeeee
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ----HR-GASKSFIAECQALRSIR-HRNLVKIITSCVS  229 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  229 (484)
                      ...++|.+.+.||+|+||+|+.|..  ..++..||+|++...    .. ...+.+.+|+.++++++ ||||++++.++  
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~--~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~--   89 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKH--RLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF--   89 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeee--ccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE--
Confidence            4457899999999999999999984  445689999977653    12 23456778999999998 99999999995  


Q ss_pred             eccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-Cc
Q 011508          230 VDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LT  308 (484)
Q Consensus       230 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~  308 (484)
                         ......++||||+.+|+|.+++..    ..++.+.....++.|++.|++|+|   +++|+||||||+|||++.+ ++
T Consensus        90 ---~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~  159 (370)
T KOG0583|consen   90 ---ATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGN  159 (370)
T ss_pred             ---ecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCC
Confidence               444479999999999999999985    345888999999999999999999   9999999999999999999 99


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCCC-CC-cccceehhhHHHHHHHhCCCCCCCCccCCcc
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE-VS-TSGDVYSFGILLLEMFTGKGPTNEMFTGNLT  386 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~  386 (484)
                      +||+|||++.....       ........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.     .
T Consensus       160 ~Kl~DFG~s~~~~~-------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----~  227 (370)
T KOG0583|consen  160 LKLSDFGLSAISPG-------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----N  227 (370)
T ss_pred             EEEeccccccccCC-------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----c
Confidence            99999999987631       122334568999999999999877 75 7899999999999999999999872     1


Q ss_pred             HhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHH-HHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          387 LHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKEC-LVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                      .......        +....+.                     .+..+ ..++..++.+|+..||.+|+|+.||+ .-.-
T Consensus       228 ~~~l~~k--------i~~~~~~---------------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w  277 (370)
T KOG0583|consen  228 VPNLYRK--------IRKGEFK---------------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPW  277 (370)
T ss_pred             HHHHHHH--------HhcCCcc---------------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChh
Confidence            1111111        1111000                     02222 45678999999999999999999999 4444


Q ss_pred             HHH
Q 011508          466 FRN  468 (484)
Q Consensus       466 i~~  468 (484)
                      ++.
T Consensus       278 ~~~  280 (370)
T KOG0583|consen  278 FQK  280 (370)
T ss_pred             hcc
Confidence            443

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-43  Score=321.41  Aligned_cols=287  Identities=25%  Similarity=0.291  Sum_probs=208.3

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      .|...+++|.|+||.||+|.....  +..||||+...+.+.    -.+|+++|+.++|||||+++-++....-.+.-+..
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~--~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRET--EEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCC--CceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            456678999999999999997643  688999988654332    24699999999999999999887765433234667


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEcccCccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVSDFGLAK  318 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~a~  318 (484)
                      +|||||+. +|.++++........++...+.-+..||.+||+|||   +.+|+||||||+|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            99999965 899999876666677888899999999999999999   8999999999999999987 899999999999


Q ss_pred             ccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .+....        .......|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+. .+...+...++-.-.+
T Consensus       175 ~L~~~e--------pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~-s~~dQL~eIik~lG~P  245 (364)
T KOG0658|consen  175 VLVKGE--------PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD-SSVDQLVEIIKVLGTP  245 (364)
T ss_pred             eeccCC--------CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC-CHHHHHHHHHHHhCCC
Confidence            885433        2244568899999998877 57999999999999999999999999873 2222233333322211


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH--HHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ--LLSFRNK  469 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~~  469 (484)
                      ...++-.-...  +.+........+ ...+ +.......+.++++.++++.+|.+|.++.|++..  ..+++..
T Consensus       246 t~e~I~~mn~~--y~~~~~p~ik~~-~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  246 TREDIKSMNPN--YTEFKFPQIKAH-PWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             CHHHHhhcCcc--cccccCcccccc-ccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            11111110000  000000000000 0000 1123346788999999999999999999999853  4555443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=350.85  Aligned_cols=261  Identities=25%  Similarity=0.428  Sum_probs=215.0

Q ss_pred             CCCccCccccccceeEEEEEEcCCC-CeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ...+.++||.|.||.||+|+++... ....||||.++....+ ...+|+.|..||.+++||||+++.|+     ......
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGV-----VTks~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGV-----VTKSKP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEE-----EecCce
Confidence            3467889999999999999986432 3568999999976543 34689999999999999999999998     445568


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .+||+|||++|+|+.||+.+.   ..+++.+...++++|+.|++||-   +.++|||||.++|||++.+..+|++|||++
T Consensus       705 vMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLS  778 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLS  778 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccce
Confidence            899999999999999998655   34999999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.+.++.    .......+..-..+|.|||.+..++++.+|||||||+||||.++ |..||-++.+.  +..+-+.+   
T Consensus       779 Rvledd~----~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--dVIkaIe~---  849 (996)
T KOG0196|consen  779 RVLEDDP----EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVIKAIEQ---  849 (996)
T ss_pred             eecccCC----CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--HHHHHHHh---
Confidence            9885543    11222223345688999999999999999999999999999988 99998765332  11111110   


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                                                  ..+-..+.+|+..|.+||+.||+.|-.+||++.||+..|.++..
T Consensus       850 ----------------------------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  850 ----------------------------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             ----------------------------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence                                        11122278899999999999999999999999999999988753

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.6e-43  Score=331.62  Aligned_cols=248  Identities=31%  Similarity=0.452  Sum_probs=205.9

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|.+.+.||+|+||.||||+  .+.+...||+|.+.+..+.  ..+.+.+|+++++.++||||+.++++     |+...
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgr--rK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~es-----fEt~~   74 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGR--RKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLES-----FETSA   74 (808)
T ss_pred             cchhHHHHhcCCccceeeecc--cccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHh-----hcccc
Confidence            578888999999999999998  5567899999999765543  34678999999999999999999998     66777


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      +.|+|.||+.| +|..++...    ..+++..+..|+.++..||.|||   +.+|.|||+||.|||++.++.+|++|||+
T Consensus        75 ~~~vVte~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~  146 (808)
T KOG0597|consen   75 HLWVVTEYAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGL  146 (808)
T ss_pred             eEEEEehhhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhh
Confidence            99999999965 999999744    35999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      |+.+..       .........||+.|||||+..+.+|+..+|.||+||++||+++|++||...     .+.+.++....
T Consensus       147 Ar~m~~-------~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~  214 (808)
T KOG0597|consen  147 ARAMST-------NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILK  214 (808)
T ss_pred             hhhccc-------CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhc
Confidence            997643       233445578999999999999999999999999999999999999999642     22222222211


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      +.       ...                      +......+..++...+..||.+|.|..+++..
T Consensus       215 d~-------v~~----------------------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  215 DP-------VKP----------------------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             CC-------CCC----------------------cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            11       000                      11225668889999999999999999998753

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-43  Score=318.74  Aligned_cols=287  Identities=24%  Similarity=0.297  Sum_probs=211.1

Q ss_pred             HHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEee--ccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeec
Q 011508          154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVD  231 (484)
Q Consensus       154 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  231 (484)
                      .+.....|...+.||+|+||.|+.|+  ++.++..||||++.  .......++..+|+++|+.++|+||+.+++......
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~--~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~   94 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAK--DKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS   94 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEE--EcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc
Confidence            34455667778999999999999999  55567999999987  344455678899999999999999999999876644


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEE
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV  311 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl  311 (484)
                      ...-...|+|+|+| +.+|.+.++..    +.++...+..+.+|+++||+|+|   +.+|+||||||+|++++.+...||
T Consensus        95 ~~~f~DvYiV~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI  166 (359)
T KOG0660|consen   95 RDKFNDVYLVFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKI  166 (359)
T ss_pred             ccccceeEEehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEe
Confidence            44556789999999 77999999743    34899999999999999999999   999999999999999999999999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccC-CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      +|||+|+..+..     ......+..+.|.+|+|||++. ...|+...||||.||++.||++|++.|.+..  .....+.
T Consensus       167 ~DFGLAR~~~~~-----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d--~v~Ql~l  239 (359)
T KOG0660|consen  167 CDFGLARYLDKF-----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKD--YVHQLQL  239 (359)
T ss_pred             ccccceeecccc-----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCc--hHHHHHH
Confidence            999999987543     1223335577899999999754 4689999999999999999999999987632  1112222


Q ss_pred             HHhhcch---h-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          391 VKEALPE---R-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       391 ~~~~~~~---~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      +....+.   . +..+-.............   ....+... . ........++|+.+||..||.+|+|++|+++.
T Consensus       240 I~~~lGtP~~e~l~~i~s~~ar~yi~slp~---~p~~~f~~-~-fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  240 ILELLGTPSEEDLQKIRSEKARPYIKSLPQ---IPKQPFSS-I-FPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHhcCCCCHHHHHHhccHHHHHHHHhCCC---CCCCCHHH-H-cCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            2222111   1 111111110000000000   00000000 0 11335678999999999999999999999864

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-41  Score=322.44  Aligned_cols=251  Identities=24%  Similarity=0.316  Sum_probs=198.3

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc---hHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA---SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALV  241 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  241 (484)
                      ..||+|+++.||+|.+.    ++.||||.++......   .+.+.+|+.+|++++||||+++++++.... ......++|
T Consensus        26 ~~i~~g~~~~v~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv  100 (283)
T PHA02988         26 VLIKENDQNSIYKGIFN----NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLI  100 (283)
T ss_pred             eEEeeCCceEEEEEEEC----CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEE
Confidence            67999999999999863    6789999997654333   467789999999999999999999875421 233467899


Q ss_pred             eecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccc
Q 011508          242 YELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP  321 (484)
Q Consensus       242 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~  321 (484)
                      |||+++|+|.+++...    ..+++...+.++.|++.||+|||+  ..+++||||||+||++++++.+||+|||+++...
T Consensus       101 ~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988        101 LEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             EEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            9999999999999743    358899999999999999999993  2488899999999999999999999999988653


Q ss_pred             cccccCCCCccccccccccccccCccccCC--CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhh
Q 011508          322 EAANNLSSNQSSSVGVKGTVGYAAPEYGMG--SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERL  399 (484)
Q Consensus       322 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  399 (484)
                      ...          ....++..|+|||++.+  ..++.++|||||||++|||++|+.||.....     .+......... 
T Consensus       175 ~~~----------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~~~~i~~~~-  238 (283)
T PHA02988        175 SPP----------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEIYDLIINKN-  238 (283)
T ss_pred             ccc----------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcC-
Confidence            211          12357889999999876  6899999999999999999999999975321     11111100000 


Q ss_pred             hhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          400 AEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       400 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                         ....                       .+..|+.++.+++.+||+.||++|||++|+++.|+.+..
T Consensus       239 ---~~~~-----------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        239 ---NSLK-----------------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ---CCCC-----------------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence               0000                       012346789999999999999999999999999998753

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-42  Score=335.37  Aligned_cols=250  Identities=23%  Similarity=0.305  Sum_probs=207.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .+.|.+++.||.|+.|.|-.|+  +..+|+.+|||++.+..   ......+.+|+-+|+-+.|||++++++.     +++
T Consensus        11 iGpwkLgkTLG~Gstg~vrlak--h~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydV-----we~   83 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAK--HAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDV-----WEN   83 (786)
T ss_pred             ccceeccccccCCCCceehhhh--cccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeee-----ecc
Confidence            3678999999999999999998  77789999999997552   2223568899999999999999999998     677


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      +.++|+|.||+++|-|.+++-..    +++++.+..+++.||+.|+.|+|   ..+|+||||||+|+|||..+++||+||
T Consensus        84 ~~~lylvlEyv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADF  156 (786)
T KOG0588|consen   84 KQHLYLVLEYVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADF  156 (786)
T ss_pred             CceEEEEEEecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeecc
Confidence            88999999999999999999743    45899999999999999999999   889999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |+|..-.+        ...-...+|++.|.|||++.+.+| +.++||||+|||||.|+||+.||++.     .+......
T Consensus       157 GMAsLe~~--------gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir~LLlK  223 (786)
T KOG0588|consen  157 GMASLEVP--------GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIRVLLLK  223 (786)
T ss_pred             ceeecccC--------CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHHHHHHH
Confidence            99976422        233445689999999999999988 57999999999999999999999852     22222211


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      ...            +.+                 ..+...+.+..+|+.+|+..||.+|.|++||++.-
T Consensus       224 V~~------------G~f-----------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  224 VQR------------GVF-----------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             HHc------------Ccc-----------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            110            000                 00223366788999999999999999999998763

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=334.86  Aligned_cols=269  Identities=27%  Similarity=0.379  Sum_probs=212.3

Q ss_pred             HhHHHhcCCCCccCccccccceeEEEEEEcCCCC--eeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeee
Q 011508          152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDH--ETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITS  226 (484)
Q Consensus       152 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~  226 (484)
                      +.++...++..+.++||+|+||.||+|++.....  ...||||..+...   .....++.+|.++|++++|||||+++|+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3334445556777999999999999999876543  2238999988522   4455789999999999999999999999


Q ss_pred             eeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 011508          227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE  306 (484)
Q Consensus       227 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~  306 (484)
                      +..     ...+++|||+|.||+|.++|+....   .++..+++.++.+.|.||+|||   +++++||||.++|+|++.+
T Consensus       230 a~~-----~~Pl~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~  298 (474)
T KOG0194|consen  230 AVL-----EEPLMLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKK  298 (474)
T ss_pred             EcC-----CCccEEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCC
Confidence            654     3488999999999999999986543   5999999999999999999999   9999999999999999999


Q ss_pred             CceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCc
Q 011508          307 LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNL  385 (484)
Q Consensus       307 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~  385 (484)
                      +.+||+|||+++......       .......-+..|+|||.+....++.++|||||||++||+++ |..||.+....  
T Consensus       299 ~~vKISDFGLs~~~~~~~-------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--  369 (474)
T KOG0194|consen  299 GVVKISDFGLSRAGSQYV-------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--  369 (474)
T ss_pred             CeEEeCccccccCCccee-------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--
Confidence            999999999987653111       00001135688999999999999999999999999999999 88898774222  


Q ss_pred             cHhHHH-HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          386 TLHNFV-KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       386 ~~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      ....++ ...++..                               .+...+..+..++..||..+|++||||.++.+.|+
T Consensus       370 ~v~~kI~~~~~r~~-------------------------------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~  418 (474)
T KOG0194|consen  370 EVKAKIVKNGYRMP-------------------------------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE  418 (474)
T ss_pred             HHHHHHHhcCccCC-------------------------------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence            111111 1111000                               01223677888999999999999999999999999


Q ss_pred             HHHHHHh
Q 011508          465 SFRNKLV  471 (484)
Q Consensus       465 ~i~~~~~  471 (484)
                      .+.....
T Consensus       419 ~~~~~~~  425 (474)
T KOG0194|consen  419 ALEKKKE  425 (474)
T ss_pred             HHHhccc
Confidence            9987654

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.8e-42  Score=327.79  Aligned_cols=267  Identities=24%  Similarity=0.369  Sum_probs=200.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCC--------------CCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeE
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHD--------------DHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKI  223 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~--------------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~  223 (484)
                      ++|.+.+.||+|+||.||+|.+...              ..+..||+|++...... ....+.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            5788899999999999999986432              23457999998754332 34578999999999999999999


Q ss_pred             eeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 011508          224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD---------------APRNLNLLQRLSIAVDVASTLEYLHHYCE  288 (484)
Q Consensus       224 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  288 (484)
                      ++++..     .+..++||||+++|+|.+++.....               ....+++..++.++.||+.||+|||   +
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~  156 (304)
T cd05096          85 LGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---S  156 (304)
T ss_pred             EEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---H
Confidence            998643     3478999999999999999864321               1134788899999999999999999   8


Q ss_pred             CCeeecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHH
Q 011508          289 TPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLL  368 (484)
Q Consensus       289 ~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~  368 (484)
                      .+|+||||||+||+++.++.+||+|||+++.......     ........++..|+|||++....++.++||||||+++|
T Consensus       157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~  231 (304)
T cd05096         157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW  231 (304)
T ss_pred             CCccccCcchhheEEcCCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHH
Confidence            9999999999999999999999999999876532211     01112234578899999998888999999999999999


Q ss_pred             HHHh--CCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccC
Q 011508          369 EMFT--GKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICS  446 (484)
Q Consensus       369 ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  446 (484)
                      ||++  +..||......  .....+............                        ...+..|+..+.+++.+||
T Consensus       232 el~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~li~~cl  285 (304)
T cd05096         232 EILMLCKEQPYGELTDE--QVIENAGEFFRDQGRQVY------------------------LFRPPPCPQGLYELMLQCW  285 (304)
T ss_pred             HHHHccCCCCCCcCCHH--HHHHHHHHHhhhcccccc------------------------ccCCCCCCHHHHHHHHHHc
Confidence            9987  56677653211  111111111100000000                        0002234678999999999


Q ss_pred             CCCcCCCCCHHHHHHHHH
Q 011508          447 SELPRERMNMEEVAAQLL  464 (484)
Q Consensus       447 ~~dP~~RPt~~evl~~L~  464 (484)
                      +.||++|||+.||.+.|+
T Consensus       286 ~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         286 SRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             cCCchhCcCHHHHHHHHh
Confidence            999999999999998876

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=326.57  Aligned_cols=251  Identities=25%  Similarity=0.351  Sum_probs=204.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ...|+..+.||+|+||.||+|.  +..+++.||+|++..... ...+++++|+.+|.+++++||.++|+.+...     .
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~--d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~   84 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAI--DNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----T   84 (467)
T ss_pred             ccccccchhccccccceeeeee--eccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----c
Confidence            3457777999999999999999  666789999999987654 3457889999999999999999999986543     3


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..+++||||.||++.+.++.    ...+++..+.-|+++++.|+.|||   .++.+|||||+.|||+..+|.+||+|||.
T Consensus        85 ~LwiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgV  157 (467)
T KOG0201|consen   85 KLWIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGV  157 (467)
T ss_pred             cHHHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecce
Confidence            88999999999999999973    233578888889999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +..+....       .....++||+.|||||++....|+.|+||||||++.+||.+|.+|+.....-...      ..++
T Consensus       158 a~ql~~~~-------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------flIp  224 (467)
T KOG0201|consen  158 AGQLTNTV-------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------FLIP  224 (467)
T ss_pred             eeeeechh-------hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------Eecc
Confidence            98764432       2335678999999999999889999999999999999999999998764331100      0001


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..    --|.+                       ...+...+.+++..||+.||+.||++.++++.
T Consensus       225 k~----~PP~L-----------------------~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  225 KS----APPRL-----------------------DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CC----CCCcc-----------------------ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            00    00111                       11336678999999999999999999999853

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=7.5e-42  Score=336.09  Aligned_cols=262  Identities=25%  Similarity=0.376  Sum_probs=201.2

Q ss_pred             CCCCccCccccccceeEEEEEEc---CCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  233 (484)
                      ++|++.+.||+|+||.||+|++.   ...++..||||+++... ....+.+.+|+.++..+ +||||++++++|.     
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~-----  109 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT-----  109 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec-----
Confidence            46888999999999999999752   23456789999987443 23345788999999999 8999999999864     


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCC------------------------------------------------------
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRD------------------------------------------------------  259 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  259 (484)
                      .....++||||+++|+|.+++.....                                                      
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            34478999999999999999964321                                                      


Q ss_pred             -----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccccc
Q 011508          260 -----------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE  322 (484)
Q Consensus       260 -----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  322 (484)
                                       ....+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                             1124788999999999999999999   89999999999999999999999999999986533


Q ss_pred             ccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhh
Q 011508          323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAE  401 (484)
Q Consensus       323 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  401 (484)
                      ....     .......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...+.+...       
T Consensus       267 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~-------  333 (375)
T cd05104         267 DSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEG-------  333 (375)
T ss_pred             cccc-----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhC-------
Confidence            2210     11112235678999999999999999999999999999998 888986532211 111111100       


Q ss_pred             hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          402 IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       402 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                           ....                   .+..++.++.+++..||+.||++|||+.||++.|++
T Consensus       334 -----~~~~-------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         334 -----YRML-------------------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             -----ccCC-------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                 0000                   011124578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4e-42  Score=306.38  Aligned_cols=279  Identities=22%  Similarity=0.258  Sum_probs=203.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      +.|+..+.|++|+||.||+|+  ++.+++.||+|+++...  .+..-...+|+.+|.+++|||||.+-.+.....   -+
T Consensus        76 ~efe~lnrI~EGtyGiVYRak--dk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d  150 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAK--DKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MD  150 (419)
T ss_pred             HHHHHHhhcccCcceeEEEec--cCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---cc
Confidence            457888999999999999998  77788999999998654  334456789999999999999999988765433   44


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..|+|||||+ -+|..++..-   .+++...++..+..|+++|++|||   .+.|+|||||++|+|++..|.+||+|||+
T Consensus       151 ~iy~VMe~~E-hDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGL  223 (419)
T KOG0663|consen  151 KIYIVMEYVE-HDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGL  223 (419)
T ss_pred             eeeeeHHHHH-hhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccch
Confidence            6899999994 5899999743   357999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      |+.+...       .......+-|.+|+|||++.+ ..|+.+.|+||+|||+.||+++++.|.+..  +.+..+.+-...
T Consensus       224 AR~ygsp-------~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s--E~dQl~~If~ll  294 (419)
T KOG0663|consen  224 AREYGSP-------LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS--EIDQLDKIFKLL  294 (419)
T ss_pred             hhhhcCC-------cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc--hHHHHHHHHHHh
Confidence            9987443       223345678999999998776 569999999999999999999999987632  222222221111


Q ss_pred             --ch-hhh-hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 --PE-RLA-EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 --~~-~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                        |. .+. .+-..-.......... .....+....   .......-.+|+...+..||.+|.|++|.++.
T Consensus       295 GtPte~iwpg~~~lp~~k~~~f~~~-pyn~lr~kF~---~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  295 GTPSEAIWPGYSELPAVKKMTFSEH-PYNNLRKKFG---ALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CCCccccCCCccccchhhccccCCC-Cchhhhhhcc---ccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence              11 111 1100000000000000 0000111111   11123556789999999999999999998753

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=347.01  Aligned_cols=272  Identities=22%  Similarity=0.252  Sum_probs=211.4

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  235 (484)
                      ...++++.+.|.+|||+.||.|....  .+..||+|++-..+....+...+|+++|++|+ |+|||.+++........++
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~--~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVK--GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecC--CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            44567888999999999999999543  34889999998777777788999999999995 9999999994333222222


Q ss_pred             --ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          236 --DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       236 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                        -+.+|.||||.+|.|-+++......  .|++.++++|+.|+++|+++||.. ..+|||||||.+||||+.+++.||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence              4678999999999999999865433  399999999999999999999965 77899999999999999999999999


Q ss_pred             cCccccccccccc--CCCCccccccccccccccCcccc---CCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHh
Q 011508          314 FGLAKFLPEAANN--LSSNQSSSVGVKGTVGYAAPEYG---MGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH  388 (484)
Q Consensus       314 fg~a~~~~~~~~~--~~~~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~  388 (484)
                      ||.+.........  .............|+.|+|||.+   .+..+++|+|||+|||+||-|+....||++...-     
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-----  264 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-----  264 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence            9998643221100  00001111234579999999964   4678999999999999999999999999864221     


Q ss_pred             HHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          389 NFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                                  .|++.....              +.     .......+.+||+.||+.||.+||++.||++.+.++..
T Consensus       265 ------------aIlng~Y~~--------------P~-----~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  265 ------------AILNGNYSF--------------PP-----FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             ------------eEEeccccC--------------CC-----CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                        111111111              00     12337789999999999999999999999999998875


Q ss_pred             H
Q 011508          469 K  469 (484)
Q Consensus       469 ~  469 (484)
                      +
T Consensus       314 ~  314 (738)
T KOG1989|consen  314 K  314 (738)
T ss_pred             C
Confidence            4

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-42  Score=318.19  Aligned_cols=261  Identities=25%  Similarity=0.342  Sum_probs=200.5

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--------------ccchHHHHHHHHHHHcCCCCCcee
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--------------RGASKSFIAECQALRSIRHRNLVK  222 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~h~niv~  222 (484)
                      .-+.|++...||+|.||.|-+|+  +..+++.||||++.+..              ....+...+|+.+|++++|||||+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar--~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLAR--DEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEe--ecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            34689999999999999999998  66678999999996432              112257889999999999999999


Q ss_pred             EeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 011508          223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN-LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNV  301 (484)
Q Consensus       223 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NI  301 (484)
                      ++.+.-   -...+..|+|+|||..|.+...=     .... +++.+++++++++..||+|||   .++|+||||||+|+
T Consensus       173 LiEvLD---DP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNL  241 (576)
T KOG0585|consen  173 LIEVLD---DPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNL  241 (576)
T ss_pred             EEEeec---CcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhhe
Confidence            999853   34466899999999988875421     2233 899999999999999999999   99999999999999


Q ss_pred             eecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCC----CCcccceehhhHHHHHHHhCCCCC
Q 011508          302 LLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE----VSTSGDVYSFGILLLEMFTGKGPT  377 (484)
Q Consensus       302 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~Gvvl~elltg~~p~  377 (484)
                      ||+++|++||+|||.+.......+  ...........||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||
T Consensus       242 Ll~~~g~VKIsDFGVs~~~~~~~~--~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  242 LLSSDGTVKISDFGVSNEFPQGSD--EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             EEcCCCcEEeeccceeeecccCCc--cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            999999999999999987643311  11122223467999999999876632    467899999999999999999999


Q ss_pred             CCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                      .+.+.     .+.        ...++...+.. ++                  ..+....+.+|+.++|+.||++|.+..
T Consensus       320 ~~~~~-----~~l--------~~KIvn~pL~f-P~------------------~pe~~e~~kDli~~lL~KdP~~Ri~l~  367 (576)
T KOG0585|consen  320 FDDFE-----LEL--------FDKIVNDPLEF-PE------------------NPEINEDLKDLIKRLLEKDPEQRITLP  367 (576)
T ss_pred             ccchH-----HHH--------HHHHhcCcccC-CC------------------cccccHHHHHHHHHHhhcChhheeehh
Confidence            75311     111        11222222211 00                  112256788999999999999999999


Q ss_pred             HHHHHHH
Q 011508          458 EVAAQLL  464 (484)
Q Consensus       458 evl~~L~  464 (484)
                      +|.....
T Consensus       368 ~ik~Hpw  374 (576)
T KOG0585|consen  368 DIKLHPW  374 (576)
T ss_pred             hheecce
Confidence            9876654

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.3e-41  Score=334.11  Aligned_cols=264  Identities=25%  Similarity=0.395  Sum_probs=201.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeeecc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSVDF  232 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  232 (484)
                      .++|.+.+.||+|+||.||+|+...   ..+...||+|+++.... .....+.+|+++++.+ +|+||++++++|.    
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~----  112 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT----  112 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec----
Confidence            3468899999999999999998532   22345799999975432 2345688999999999 8999999999864    


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCC-----------------------------------------------------
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRD-----------------------------------------------------  259 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------  259 (484)
                       .....++||||+++|+|.+++.....                                                     
T Consensus       113 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         113 -HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             -CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence             34478999999999999999864221                                                     


Q ss_pred             -------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccccccccc
Q 011508          260 -------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANN  326 (484)
Q Consensus       260 -------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~  326 (484)
                                   ....+++..+++++.||+.||+|||   +++|+||||||+||++++++.+||+|||+++....... 
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~-  267 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-  267 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc-
Confidence                         1134788999999999999999999   89999999999999999999999999999876532211 


Q ss_pred             CCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhhhcCc
Q 011508          327 LSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAEIVDP  405 (484)
Q Consensus       327 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  405 (484)
                          ........++..|+|||++.+..++.++|||||||++|||++ |+.||....... .........        ...
T Consensus       268 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~--------~~~  334 (374)
T cd05106         268 ----YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRG--------YQM  334 (374)
T ss_pred             ----eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcc--------cCc
Confidence                011112235678999999988899999999999999999997 999997532211 111111100        000


Q ss_pred             ccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          406 VLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       406 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                      ..                       +...+.++.+++..||+.||++|||+.+|++.|+++
T Consensus       335 ~~-----------------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         335 SR-----------------------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             cC-----------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            00                       011145788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=302.78  Aligned_cols=198  Identities=29%  Similarity=0.386  Sum_probs=176.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|+..+.||.|+||.|.+++.+  .++..+|+|++++..-   ...+...+|..+|+.+.||.++++++.+     .+.
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k--~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~  116 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREK--HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDN  116 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEc--cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccC
Confidence            45788899999999999999944  4678999999986643   2345678999999999999999999884     556


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||.+||.|.++++..    +++++..+.-++.||+.||+|||   +.+|++|||||+|||+|.+|.+||+|||
T Consensus       117 ~~lymvmeyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFG  189 (355)
T KOG0616|consen  117 SNLYMVMEYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFG  189 (355)
T ss_pred             CeEEEEEeccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEecc
Confidence            6999999999999999999843    35899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      +|+...          ......+||+.|+|||++....++.++|.|||||++|||+.|.+||...
T Consensus       190 FAK~v~----------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~  244 (355)
T KOG0616|consen  190 FAKRVS----------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD  244 (355)
T ss_pred             ceEEec----------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence            999763          2245678999999999999999999999999999999999999999764

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.7e-42  Score=323.92  Aligned_cols=211  Identities=27%  Similarity=0.397  Sum_probs=179.9

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      ...++|++...||+|+||.||+|+  ...+|..+|+|++++..   .+..+....|-.+|...++|.||+++..     |
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLar--Kk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYs-----F  210 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLAR--KKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYS-----F  210 (550)
T ss_pred             CCcccchhheeeccccceeEEEEE--EccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEE-----e
Confidence            355789999999999999999999  55678999999998654   4556778899999999999999999988     7


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                      ++.+++||||||++||++..+|..    ...+++..+..++.+++-|+..||   ..|+|||||||+|+|||..|++||+
T Consensus       211 QD~~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLS  283 (550)
T KOG0605|consen  211 QDKEYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLS  283 (550)
T ss_pred             cCCCeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeec
Confidence            788899999999999999999973    346999999999999999999999   9999999999999999999999999


Q ss_pred             ccCcccccccccc------------cC----CCCcc------------------------ccccccccccccCccccCCC
Q 011508          313 DFGLAKFLPEAAN------------NL----SSNQS------------------------SSVGVKGTVGYAAPEYGMGS  352 (484)
Q Consensus       313 Dfg~a~~~~~~~~------------~~----~~~~~------------------------~~~~~~g~~~y~aPE~~~~~  352 (484)
                      |||++.-+.....            ..    .....                        .....+||+.|+|||++.+.
T Consensus       284 DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k  363 (550)
T KOG0605|consen  284 DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK  363 (550)
T ss_pred             cccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC
Confidence            9999965432110            00    00000                        01235799999999999999


Q ss_pred             CCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          353 EVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       353 ~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      .|+..+|.||+|||+||||.|.+||...
T Consensus       364 gY~~~cDwWSLG~ImyEmLvGyPPF~s~  391 (550)
T KOG0605|consen  364 GYGKECDWWSLGCIMYEMLVGYPPFCSE  391 (550)
T ss_pred             CCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999999864

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.9e-41  Score=319.34  Aligned_cols=253  Identities=25%  Similarity=0.318  Sum_probs=196.2

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .|+..+.||+|+||.||+|...  .+++.||+|.+.....   .....+.+|+.++++++|+|++++++++     ..++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~   73 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKD   73 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEe--cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCC
Confidence            3677889999999999999854  3578899999875432   2234678899999999999999999885     3445


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++|+|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+||++++++.+||+|||+
T Consensus        74 ~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~  148 (285)
T cd05631          74 ALCLVLTIMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGL  148 (285)
T ss_pred             eEEEEEEecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence            8899999999999998886432  235899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.......        ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......  ....+.... 
T Consensus       149 ~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~-  217 (285)
T cd05631         149 AVQIPEGE--------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV--KREEVDRRV-  217 (285)
T ss_pred             cEEcCCCC--------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch--hHHHHHHHh-
Confidence            97653221        1123468999999999999999999999999999999999999997532211  000010000 


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-----HHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-----MEEVAAQ  462 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  462 (484)
                            .......                     +......+.+|+.+||+.||++||+     ++|+++.
T Consensus       218 ------~~~~~~~---------------------~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         218 ------KEDQEEY---------------------SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             ------hcccccC---------------------CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence                  0000000                     1122557889999999999999997     7888863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.6e-41  Score=317.63  Aligned_cols=272  Identities=27%  Similarity=0.354  Sum_probs=203.2

Q ss_pred             CccCccccccceeEEEEEEc--CCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          162 SLENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       162 ~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      .+.+.||+|+||+||++.+.  ...++..||+|.++.... .....+.+|++++++++||||+++++++..   ......
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~~   83 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGGKGL   83 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCCceE
Confidence            78899999999999887643  234567899999875432 234678899999999999999999998643   234467


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++++|.+++...     .+++.+++.++.|++.||+|||   +++|+||||||+||++++++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccc
Confidence            8999999999999999642     3899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc-ch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL-PE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~  397 (484)
                      .........    .......++..|+|||......++.++||||||+++|||+||..||.................. ..
T Consensus       156 ~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05080         156 AVPEGHEYY----RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV  231 (283)
T ss_pred             ccCCcchhh----ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchh
Confidence            764322110    1111223566799999998888999999999999999999999998653211111000000000 00


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                      .+.+.++.....                   ..+..++.++.+++..||+.+|++|||+++|++.|+++.
T Consensus       232 ~~~~~~~~~~~~-------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         232 RLIELLERGMRL-------------------PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhhcCCCC-------------------CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            011111111100                   002234678999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-41  Score=324.27  Aligned_cols=246  Identities=24%  Similarity=0.316  Sum_probs=196.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|..  ..+++.||+|++.....   ...+.+.+|+.++++++||||+++++++     .++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~   73 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRD--RISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQ   73 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEE--cCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccC
Confidence            4688999999999999999984  44578899999875321   2345688999999999999999999874     455


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg  146 (291)
T cd05612          74 RFLYMLMEYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFG  146 (291)
T ss_pred             CeEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecC
Confidence            6889999999999999999743    35889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++......          .....|++.|+|||++.+..++.++|||||||++|||++|+.||.....     ......  
T Consensus       147 ~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~--  209 (291)
T cd05612         147 FAKKLRDR----------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEK--  209 (291)
T ss_pred             cchhccCC----------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH--
Confidence            98765321          1124589999999999988899999999999999999999999965311     111111  


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-----HHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-----MEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  462 (484)
                            +.......                     +......+.+++.+||+.||.+||+     ++|+++.
T Consensus       210 ------i~~~~~~~---------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         210 ------ILAGKLEF---------------------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ------HHhCCcCC---------------------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                  11000000                     1112456789999999999999995     8888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-42  Score=312.89  Aligned_cols=248  Identities=22%  Similarity=0.348  Sum_probs=205.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .+|++.+.||+|.||.|-+|+  ....++.||||.+++....   +.-.+.+|+++|+.|+||||+.++.+     |++.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~--e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENk  125 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAY--EHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENK  125 (668)
T ss_pred             hHHHHHHHhcCCcccceeehh--hccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCC
Confidence            578889999999999999998  5457899999999765433   33467899999999999999999998     7888


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +...|||||..+|.|.+|+....    .+++.+...+++||..|+.|+|   .++++|||||.+|||+|.++++||+|||
T Consensus       126 dKIvivMEYaS~GeLYDYiSer~----~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFG  198 (668)
T KOG0611|consen  126 DKIVIVMEYASGGELYDYISERG----SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFG  198 (668)
T ss_pred             ceEEEEEEecCCccHHHHHHHhc----cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccc
Confidence            89999999999999999998543    5999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ++..+...        .....++|++-|.+||+..+.+| ++..|-||+||+||.|+.|.-||++.     +....+++.
T Consensus       199 LSNly~~~--------kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~-----Dhk~lvrQI  265 (668)
T KOG0611|consen  199 LSNLYADK--------KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR-----DHKRLVRQI  265 (668)
T ss_pred             hhhhhccc--------cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-----hHHHHHHHh
Confidence            99876332        23446789999999999999888 67999999999999999999999873     112222211


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      ...            .+.+                  .+-+....-||++||..+|++|.|+++|....
T Consensus       266 s~G------------aYrE------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  266 SRG------------AYRE------------------PETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             hcc------------cccC------------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence            110            0000                  00033456789999999999999999998765

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.6e-41  Score=314.58  Aligned_cols=258  Identities=25%  Similarity=0.365  Sum_probs=201.2

Q ss_pred             CCCCccCccccccceeEEEEEEcC-CCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDH-DDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .+|++.+.||+|+||.||+|.+.. ...+..||+|.++.... .....+.+|+.++.+++||||+++++++.     .++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence            468889999999999999998643 23467899999876533 23357889999999999999999999853     345


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++|+|.+++...   ...+++..++.++.|++.||+|||   +++++||||||+||+++.++.++++|||.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~  153 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRR  153 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcc
Confidence            789999999999999999743   235899999999999999999999   89999999999999999999999999998


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.......      ........++..|+|||.+.+..++.++|||||||++||+++ |+.||......  ...+.+    
T Consensus       154 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--~~~~~~----  221 (266)
T cd05064         154 LQEDKSEA------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--DVIKAV----  221 (266)
T ss_pred             cccccccc------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHH----
Confidence            76432111      011112235678999999988999999999999999999875 99999653211  011110    


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                             .+....                    ..+..++..+.+++..||+.+|++||+++||.+.|+++
T Consensus       222 -------~~~~~~--------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         222 -------EDGFRL--------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -------HCCCCC--------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                   000000                    00233466789999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.6e-41  Score=317.27  Aligned_cols=253  Identities=34%  Similarity=0.539  Sum_probs=192.6

Q ss_pred             ccCccccccceeEEEEEEc--CCCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          163 LENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       163 ~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      +.+.||.|.||.||+|.+.  ....+..|+||.++..... ..+.+.+|++.+++++||||++++|+|.     .....+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence            4578999999999999998  4556788999999654332 3578999999999999999999999985     233589


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      +|+||+++|+|.+++...  ....+++..++.|+.||+.||+|||   +++++|+||+++||++++++.+||+|||++..
T Consensus        78 lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~  152 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRP  152 (259)
T ss_dssp             EEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred             cccccccccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence            999999999999999865  2345899999999999999999999   88999999999999999999999999999987


Q ss_pred             cccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchh
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      ......     ............|+|||.+....++.++||||||+++||+++ |+.||.....     .++.....   
T Consensus       153 ~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~~~~~~---  219 (259)
T PF07714_consen  153 ISEKSK-----YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEIIEKLK---  219 (259)
T ss_dssp             TTTSSS-----EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHHHHHHH---
T ss_pred             cccccc-----ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccccc---
Confidence            622111     111122346788999999988889999999999999999999 7888765311     11111110   


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                           +....                    ..+..|+..+.+++..||+.||++|||+.|++++|
T Consensus       220 -----~~~~~--------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  220 -----QGQRL--------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----TTEET--------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----ccccc--------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 00000                    00223466789999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-42  Score=292.65  Aligned_cols=250  Identities=24%  Similarity=0.337  Sum_probs=205.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++++.||+|-||.||.|+  .+.++-.||+|++.+..   .+...++.+|+++-+.|+||||+++|++     |.+.
T Consensus        22 ~dfeigr~LgkgkFG~vYlar--ekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~-----fhd~   94 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAR--EKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGY-----FHDS   94 (281)
T ss_pred             hhccccccccCCccccEeEee--eccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhh-----eecc
Confidence            578999999999999999999  44567889999987543   3445789999999999999999999999     4556


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...|+++||.++|++...|+...  ...+++.....+..|+|.||.|+|   .++++||||||+|+|++.++..||+|||
T Consensus        95 ~riyLilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfG  169 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFG  169 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCC
Confidence            69999999999999999998443  345888888999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      .+...+         .......+||..|.|||...+...+...|+|++|++.||++.|.+||+....+ ........   
T Consensus       170 wsV~~p---------~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~-etYkrI~k---  236 (281)
T KOG0580|consen  170 WSVHAP---------SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS-ETYKRIRK---  236 (281)
T ss_pred             ceeecC---------CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH-HHHHHHHH---
Confidence            987543         22334578999999999999999999999999999999999999999875311 11111111   


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                          .++.+                          +.....+..+++..|+..+|.+|.+..||++.=
T Consensus       237 ----~~~~~--------------------------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  237 ----VDLKF--------------------------PSTISGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             ----ccccC--------------------------CcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence                11111                          112255678999999999999999999998753

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.1e-41  Score=325.64  Aligned_cols=242  Identities=23%  Similarity=0.285  Sum_probs=191.3

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALV  241 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  241 (484)
                      +.||+|+||.||+|+.  ..+++.||+|+++...   ......+.+|+.++++++||||+++++++     ..++..++|
T Consensus         1 ~~lG~G~~g~Vy~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv   73 (323)
T cd05571           1 KLLGKGTFGKVILVRE--KATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFV   73 (323)
T ss_pred             CeeeeCCCeEEEEEEE--CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEE
Confidence            4699999999999984  4467889999997532   22335678899999999999999999884     445588999


Q ss_pred             eecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccc
Q 011508          242 YELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP  321 (484)
Q Consensus       242 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~  321 (484)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        74 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~  146 (323)
T cd05571          74 MEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence            9999999999998743    35889999999999999999999   8999999999999999999999999999987532


Q ss_pred             cccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhh
Q 011508          322 EAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAE  401 (484)
Q Consensus       322 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  401 (484)
                      ..       ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ......        
T Consensus       147 ~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~--------  206 (323)
T cd05571         147 SD-------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFEL--------  206 (323)
T ss_pred             cC-------CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHH--------
Confidence            11       1112235689999999999999999999999999999999999999965211     111110        


Q ss_pred             hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHH
Q 011508          402 IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAA  461 (484)
Q Consensus       402 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~  461 (484)
                      +.......                     +.....++.+++.+||+.||++||     ++.|+++
T Consensus       207 ~~~~~~~~---------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         207 ILMEEIRF---------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHcCCCCC---------------------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            00000000                     111255688999999999999999     7998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=326.93  Aligned_cols=254  Identities=21%  Similarity=0.280  Sum_probs=198.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|+..  .+++.||+|+++...   ......+.+|++++..++||||+++++++     ..+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~   73 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKK--DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDD   73 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEEC--CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcC
Confidence            36889999999999999999954  356789999997542   22345688999999999999999999885     345


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg  146 (333)
T cd05600          74 EYLYLAMEYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFG  146 (333)
T ss_pred             CEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCc
Confidence            5889999999999999999743    34889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++.....          ......|++.|+|||++.+..++.++|||||||++|||++|+.||......     +......
T Consensus       147 ~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-----~~~~~i~  211 (333)
T cd05600         147 LSKGIVT----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-----ETWENLK  211 (333)
T ss_pred             CCccccc----------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-----HHHHHHH
Confidence            9876532          122346899999999999989999999999999999999999999753211     1110000


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .  .............                   ...+..++.+++.+||..+|++||+++|+++.
T Consensus       212 ~--~~~~~~~~~~~~~-------------------~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         212 Y--WKETLQRPVYDDP-------------------RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             h--ccccccCCCCCcc-------------------ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0  0000000000000                   01225578899999999999999999999965

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.5e-41  Score=327.99  Aligned_cols=279  Identities=22%  Similarity=0.285  Sum_probs=198.7

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|++.+.||+|+||.||+|+.  ..++..||+|++....  ......+.+|++++++++||||+++++++..........
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAID--THTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEE--CCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence            478889999999999999984  4467889999987432  223356889999999999999999999876544334446


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+ +++|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        79 ~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~  150 (338)
T cd07859          79 IYVVFELM-ESDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLA  150 (338)
T ss_pred             EEEEEecC-CCCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccc
Confidence            89999999 57899988633    34899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCC--CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG--SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.......    .........|+..|+|||++.+  ..++.++|||||||++|||+||+.||.....  ......+....
T Consensus       151 ~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~--~~~~~~~~~~~  224 (338)
T cd07859         151 RVAFNDTP----TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV--VHQLDLITDLL  224 (338)
T ss_pred             cccccccC----ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh--HHHHHHHHHHh
Confidence            75432211    0111223568999999998765  6789999999999999999999999965321  11111111110


Q ss_pred             c----hhhhhhcCccccc---ccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 P----ERLAEIVDPVLLV---EREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~----~~~~~~~d~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .    .....+.......   .......  .    ....  ....+...+.+++.+||+.||++|||++|+++.
T Consensus       225 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~----~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         225 GTPSPETISRVRNEKARRYLSSMRKKQP--V----PFSQ--KFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CCCCHHHHHHhhhhhHHHHHHhhcccCC--C----chHH--hcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0    0011110000000   0000000  0    0000  001124567899999999999999999999964

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-41  Score=327.17  Aligned_cols=246  Identities=24%  Similarity=0.302  Sum_probs=196.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|+..  .+++.||+|+++...   ....+.+.+|+.++++++||||+++++++     ..+
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~   90 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHK--GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDE   90 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEEC--CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcC
Confidence            56889999999999999999954  457889999987532   22345688999999999999999999985     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        91 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         91 NRVYFLLEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             CEEEEEEcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeecc
Confidence            5889999999999999999743    34788899999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++.......          ....|++.|+|||++.+..++.++|||||||++|||++|+.||.....     .+...   
T Consensus       164 ~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~---  225 (329)
T PTZ00263        164 FAKKVPDRT----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYE---  225 (329)
T ss_pred             CceEcCCCc----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHH---
Confidence            998653211          124689999999999998899999999999999999999999965211     11111   


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-----HHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-----MEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  462 (484)
                           .+....+..                     +..+...+.+++.+||+.||++||+     ++++++.
T Consensus       226 -----~i~~~~~~~---------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        226 -----KILAGRLKF---------------------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -----HHhcCCcCC---------------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                 111110000                     1112456789999999999999997     6777744

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-40  Score=322.21  Aligned_cols=200  Identities=27%  Similarity=0.382  Sum_probs=170.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .++|++.+.||+|+||.||+++.  ..++..+|+|++..... .....+.+|++++++++||||+++++++..     ++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~   76 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQH--KPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DG   76 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEE--CCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CC
Confidence            46899999999999999999984  44578899999876532 234578999999999999999999998643     44


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++...    ..+++..+..++.|++.||+|||+  ..+|+||||||+||+++.++.+||+|||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  150 (331)
T cd06649          77 EISICMEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV  150 (331)
T ss_pred             EEEEEeecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcc
Confidence            789999999999999999743    348899999999999999999993  24699999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      +.......         .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       151 ~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         151 SGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             cccccccc---------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            87653211         1224589999999999998999999999999999999999999965

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.5e-41  Score=324.33  Aligned_cols=267  Identities=25%  Similarity=0.362  Sum_probs=204.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeeecc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSVDF  232 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  232 (484)
                      .++|++.+.||+|+||.||+|...+.   .+++.||+|+++.... ...+.+.+|+.++.++ +|+||++++++|.    
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~----   81 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT----   81 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe----
Confidence            45789999999999999999974322   2357899999875432 2235678899999999 8999999999874    


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCC----------------------------------------------------
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDA----------------------------------------------------  260 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------  260 (484)
                      ..+...+++|||+++++|.+++......                                                    
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            3345778999999999999998643210                                                    


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccc
Q 011508          261 -----PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV  335 (484)
Q Consensus       261 -----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~  335 (484)
                           ...+++..+..++.||+.||+|||   +++|+||||||+||++++++.++|+|||++..+.......     ...
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~-----~~~  233 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-----RKG  233 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh-----hcc
Confidence                 125899999999999999999999   8999999999999999999999999999998763322111     111


Q ss_pred             cccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccc
Q 011508          336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEG  414 (484)
Q Consensus       336 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  414 (484)
                      ...++..|+|||++.+..++.++|||||||++|||++ |..||....... .+.....    ..    ....        
T Consensus       234 ~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~----~~----~~~~--------  296 (337)
T cd05054         234 DARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLK----EG----TRMR--------  296 (337)
T ss_pred             CCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHh----cc----CCCC--------
Confidence            2345678999999999999999999999999999998 999986532111 1111000    00    0000        


Q ss_pred             cchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          415 ETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                                     .+..+..++.+++.+||+.+|++||++.||++.|+++.+
T Consensus       297 ---------------~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         297 ---------------APEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             ---------------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                           011225578999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.5e-40  Score=314.41  Aligned_cols=265  Identities=28%  Similarity=0.445  Sum_probs=206.5

Q ss_pred             CCCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|.+.+.||+|+||.||++....   ..++..+|+|.+........+.+.+|++++++++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            568889999999999999997532   2345679999987655555667999999999999999999999864     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRD---------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE  306 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~  306 (484)
                      ...++||||+++++|.+++.....         ....+++..++.++.|++.||+|||   +++++||||||+||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence            578999999999999999974431         2235899999999999999999999   8999999999999999999


Q ss_pred             CceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCc
Q 011508          307 LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNL  385 (484)
Q Consensus       307 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~  385 (484)
                      +.+||+|||.+........     ........++..|+|||.+.+..++.++|||||||++|||++ |..||......  
T Consensus       157 ~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--  229 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--  229 (288)
T ss_pred             CcEEeccCCccccccCCce-----eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            9999999999876532211     011112335778999999988889999999999999999998 89998653211  


Q ss_pred             cHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          386 TLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                         .....        +........                    +..++.++.+++.+||+.||.+|||+.||.+.|+.
T Consensus       230 ---~~~~~--------i~~~~~~~~--------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~  278 (288)
T cd05093         230 ---EVIEC--------ITQGRVLQR--------------------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQN  278 (288)
T ss_pred             ---HHHHH--------HHcCCcCCC--------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence               11110        000000000                    11124578999999999999999999999999999


Q ss_pred             HHHH
Q 011508          466 FRNK  469 (484)
Q Consensus       466 i~~~  469 (484)
                      +...
T Consensus       279 ~~~~  282 (288)
T cd05093         279 LAKA  282 (288)
T ss_pred             HHHh
Confidence            8754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.8e-41  Score=318.70  Aligned_cols=277  Identities=21%  Similarity=0.279  Sum_probs=198.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||.||+|+..  .++..||+|+++....  ...+.+.+|+.+++.++||||+++++++     ..++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~   73 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHK--ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRG   73 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEEC--CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCC
Confidence            46899999999999999999954  4578899999875432  2345788999999999999999999885     3455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||++++.+..+..    ....+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        74 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~  146 (287)
T cd07848          74 KLYLVFEYVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGF  146 (287)
T ss_pred             EEEEEEecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccC
Confidence            8899999998877665443    1235889999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH--hh
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK--EA  394 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--~~  394 (484)
                      +.......      ........|+..|+|||++.+..++.++|||||||++|||++|+.||....... .+.....  ..
T Consensus       147 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~  219 (287)
T cd07848         147 ARNLSEGS------NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID-QLFTIQKVLGP  219 (287)
T ss_pred             cccccccc------cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhhCC
Confidence            98653221      111123468999999999988889999999999999999999999997632211 1111000  01


Q ss_pred             cchh-hhhh-cCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 LPER-LAEI-VDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 ~~~~-~~~~-~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .+.. .... .++...........     ............++..+.+++.+||+.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         220 LPAEQMKLFYSNPRFHGLRFPAVN-----HPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CCHHHHHhhhccchhcccccCccc-----CcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            1111 1000 00000000000000     0000000001123567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.3e-40  Score=312.78  Aligned_cols=262  Identities=22%  Similarity=0.342  Sum_probs=205.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|+...  +++.||+|.++...   ......+.+|+++++.++|||++++++++..     .
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   74 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLL--DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----D   74 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeC--CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----C
Confidence            578999999999999999998543  56789999876432   2223568899999999999999999998543     3


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++|+||+++++|.+++.........+++..++.++.|++.||+|||   +++++|+||||+||+++.++.++|+|||
T Consensus        75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g  151 (267)
T cd08228          75 NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccc
Confidence            4789999999999999998754444455889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      .+.......       .......++..|+|||.+.+..++.++||||||+++|||++|+.||......   ...+.... 
T Consensus       152 ~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~---~~~~~~~~-  220 (267)
T cd08228         152 LGRFFSSKT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LFSLCQKI-  220 (267)
T ss_pred             cceeccchh-------HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc---HHHHHHHH-
Confidence            988654321       1111235788999999998888999999999999999999999998643221   11111110 


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                          .....+..                      ....++..+.+++.+||+.+|++||++.||++.++.++
T Consensus       221 ----~~~~~~~~----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         221 ----EQCDYPPL----------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             ----hcCCCCCC----------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                00000000                      01223567899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=329.87  Aligned_cols=244  Identities=27%  Similarity=0.350  Sum_probs=201.5

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeecc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDF  232 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  232 (484)
                      .-++|.+..+||+|+||+|+++..+.  ++..+|||++++..   .++.+....|.+++... +||.++.++.+     |
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~--~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~-----f  438 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKG--TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSC-----F  438 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcC--CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccc-----c
Confidence            34678999999999999999999654  56799999998764   45567888899988877 59999999988     6


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                      +..++.+.||||+.||++..+.+     ...+++..+.-++..++.||.|||   +++||+||||.+|||||.+|.+||+
T Consensus       439 QT~~~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiA  510 (694)
T KOG0694|consen  439 QTKEHLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIA  510 (694)
T ss_pred             ccCCeEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEec
Confidence            77789999999999999544433     345999999999999999999999   9999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||+++..-       .......+++||+.|+|||++.+..|+.+.|.|||||+||||+.|+.||.+...+         
T Consensus       511 DFGlcKe~m-------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------  574 (694)
T KOG0694|consen  511 DFGLCKEGM-------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------  574 (694)
T ss_pred             ccccccccC-------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH---------
Confidence            999998642       2234556789999999999999999999999999999999999999999863221         


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM  456 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  456 (484)
                              ++.|..+..++                 .-|..++.+.+.++.+++..+|++|--+
T Consensus       575 --------e~FdsI~~d~~-----------------~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  575 --------EVFDSIVNDEV-----------------RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --------HHHHHHhcCCC-----------------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence                    11222221111                 1134457788999999999999999876

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1e-40  Score=328.94  Aligned_cols=266  Identities=29%  Similarity=0.411  Sum_probs=203.9

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCC-CCCceeEeeeeeeec
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQHR-GASKSFIAECQALRSIR-HRNLVKIITSCVSVD  231 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  231 (484)
                      ..++|.+.+.||+|+||.||+|+....   .....||||+++.... ...+.+.+|+++++++. ||||++++++|.   
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~---  111 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT---  111 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc---
Confidence            356889999999999999999985322   2245799999975433 23457899999999996 999999999964   


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCC----------------------------------------------------
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRD----------------------------------------------------  259 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------  259 (484)
                        .....++||||+++|+|.+++.....                                                    
T Consensus       112 --~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         112 --KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             --cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence              34578999999999999999865321                                                    


Q ss_pred             ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 011508          260 ----------------------------------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPS  299 (484)
Q Consensus       260 ----------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~  299 (484)
                                                              ....+++..++.++.|++.||+|||   +.+|+||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~  266 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAAR  266 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChH
Confidence                                                    0134788889999999999999999   899999999999


Q ss_pred             CeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCC
Q 011508          300 NVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN  378 (484)
Q Consensus       300 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~  378 (484)
                      ||+++.++.+||+|||+++.......     ........++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       267 Nill~~~~~~kL~DfGla~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~  341 (400)
T cd05105         267 NVLLAQGKIVKICDFGLARDIMHDSN-----YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP  341 (400)
T ss_pred             hEEEeCCCEEEEEeCCcceecccccc-----ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence            99999999999999999986532211     111122346788999999988889999999999999999997 999987


Q ss_pred             CCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHH
Q 011508          379 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEE  458 (484)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  458 (484)
                      ........ ...+.    ..    ..  ..                     .+..++..+.+++.+||+.||++|||+.+
T Consensus       342 ~~~~~~~~-~~~~~----~~----~~--~~---------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~  389 (400)
T cd05105         342 GMIVDSTF-YNKIK----SG----YR--MA---------------------KPDHATQEVYDIMVKCWNSEPEKRPSFLH  389 (400)
T ss_pred             ccchhHHH-HHHHh----cC----CC--CC---------------------CCccCCHHHHHHHHHHCccCHhHCcCHHH
Confidence            53221110 00000    00    00  00                     01233567899999999999999999999


Q ss_pred             HHHHHHHHH
Q 011508          459 VAAQLLSFR  467 (484)
Q Consensus       459 vl~~L~~i~  467 (484)
                      |.+.|+.+.
T Consensus       390 l~~~l~~l~  398 (400)
T cd05105         390 LSDIVESLL  398 (400)
T ss_pred             HHHHHHHHc
Confidence            999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-40  Score=315.69  Aligned_cols=261  Identities=27%  Similarity=0.463  Sum_probs=203.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCC---CeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDD---HETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ++|++.+.||+|+||.||+|......   ....||+|.+..... .....+.+|+.++.+++||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence            36788999999999999999865332   346799999875432 23356889999999999999999999853     3


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDA------------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVL  302 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIl  302 (484)
                      ....+++|||+++++|.+++......            ...+++..++.++.|++.||+|||   +++++||||||+||+
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil  156 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCL  156 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEE
Confidence            45789999999999999999754221            145889999999999999999999   899999999999999


Q ss_pred             ecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCc
Q 011508          303 LDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMF  381 (484)
Q Consensus       303 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~  381 (484)
                      +++++.++|+|||++........     ........++..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS  231 (283)
T ss_pred             EcCCCcEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999999999999876532211     111122346788999999988899999999999999999998 999987532


Q ss_pred             cCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          382 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..  .+...+.           .....                    ..+..++.++.+++.+||+.||.+||++.||++
T Consensus       232 ~~--~~~~~i~-----------~~~~~--------------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~  278 (283)
T cd05048         232 NQ--EVIEMIR-----------SRQLL--------------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHT  278 (283)
T ss_pred             HH--HHHHHHH-----------cCCcC--------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            11  1111110           00000                    002344778999999999999999999999999


Q ss_pred             HHHH
Q 011508          462 QLLS  465 (484)
Q Consensus       462 ~L~~  465 (484)
                      .|+.
T Consensus       279 ~l~~  282 (283)
T cd05048         279 RLRS  282 (283)
T ss_pred             HHhc
Confidence            9975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.2e-40  Score=315.18  Aligned_cols=275  Identities=23%  Similarity=0.291  Sum_probs=198.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcC---CCCCceeEeeeeeeeccC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSI---RHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~  233 (484)
                      .+|++.+.||+|+||.||+|+... .++..||+|+++....  .....+.+|+.+++.+   +||||++++++|......
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLK-NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcC-CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            368899999999999999998532 2357899999875432  2234566777777765   699999999988654444


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||++ ++|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence            5567899999995 69999987433  235889999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||++......        .......|+..|+|||.+.+..++.++|||||||++|||++|+.||...... ..+......
T Consensus       154 fg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~  224 (290)
T cd07862         154 FGLARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDV  224 (290)
T ss_pred             ccceEeccCC--------cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHH
Confidence            9999765322        1122345899999999998888999999999999999999999999764221 111111111


Q ss_pred             hc---chhhhhhc---CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 AL---PERLAEIV---DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~---~~~~~~~~---d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..   +.......   ...+....      .     ...... ..++...+.+++.+|++.||++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~------~-----~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         225 IGLPGEEDWPRDVALPRQAFHSKS------A-----QPIEKF-VTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hCCCChhhchhhhcccchhccCCC------C-----CCHHHH-ccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00   00000000   00000000      0     000000 1123556789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-40  Score=316.58  Aligned_cols=273  Identities=28%  Similarity=0.402  Sum_probs=204.9

Q ss_pred             CCCCccCccccccceeEEEEEEc--CCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .+|++.+.||+|+||.||++...  +..++..||+|.+........+.+.+|++++++++||||+++++++..   .+..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS---AGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc---CCCC
Confidence            46888999999999999999864  344577899999876655555788999999999999999999998643   2344


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++....   ..+++..++.++.|++.||+|||   +++++||||||+||++++++.+||+|||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcc
Confidence            6789999999999999997432   34899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +..........    .......++..|+|||++.+..++.++|||||||++|||++|..|+......   ..........
T Consensus       155 ~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~  227 (284)
T cd05081         155 TKVLPQDKEYY----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQ  227 (284)
T ss_pred             cccccCCCcce----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccc
Confidence            98764322110    0011122445699999998888999999999999999999988775432110   0000000000


Q ss_pred             -----hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          397 -----ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       397 -----~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                           ..+.+.+....                   ....+..++.++.+++.+||+.+|++|||+.||++.|+.+
T Consensus       228 ~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         228 GQMIVYHLIELLKNNG-------------------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccchHHHHHHHhcCC-------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence                 00011111000                   0001233466799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-40  Score=314.95  Aligned_cols=260  Identities=30%  Similarity=0.469  Sum_probs=203.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ++|.+.+.||+|+||.||+|...+.   .....||+|.++..... ..+.+.+|+++++.++|+||+++++++..     
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----   79 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-----   79 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-----
Confidence            4678889999999999999986433   34578999998765443 34689999999999999999999998643     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRD----------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD  304 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~  304 (484)
                      ....++||||+++++|.+++.....          ....+++.++..++.|++.|++|||   +++++||||||+||+++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~  156 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVG  156 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEc
Confidence            3578999999999999999975421          2245789999999999999999999   89999999999999999


Q ss_pred             CCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccC
Q 011508          305 GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTG  383 (484)
Q Consensus       305 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~  383 (484)
                      .++.+||+|||.+........     ........++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus       157 ~~~~~kl~d~g~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~  231 (280)
T cd05049         157 YDLVVKIGDFGMSRDVYTTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE  231 (280)
T ss_pred             CCCeEEECCcccceecccCcc-----eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999999999999875432211     011112345788999999999999999999999999999998 99998653211


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                        ...+.+.           ......                    .+..++..+.+++.+||+.||++||++.||++.|
T Consensus       232 --~~~~~~~-----------~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l  278 (280)
T cd05049         232 --EVIECIT-----------QGRLLQ--------------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL  278 (280)
T ss_pred             --HHHHHHH-----------cCCcCC--------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence              1111110           000000                    0112356789999999999999999999999988


Q ss_pred             H
Q 011508          464 L  464 (484)
Q Consensus       464 ~  464 (484)
                      +
T Consensus       279 ~  279 (280)
T cd05049         279 Q  279 (280)
T ss_pred             h
Confidence            6

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-41  Score=322.06  Aligned_cols=240  Identities=26%  Similarity=0.340  Sum_probs=188.7

Q ss_pred             cccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       167 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      ||+|+||.||+|+..  .+++.||+|+++...   ......+.+|+.++.+++||||+++++++     ..++..++|||
T Consensus         1 lg~G~~g~Vy~~~~~--~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e   73 (312)
T cd05585           1 IGKGSFGKVMQVRKR--DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLA   73 (312)
T ss_pred             CCcCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEc
Confidence            799999999999854  456789999987432   23345678899999999999999999885     34458899999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccc
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA  323 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  323 (484)
                      |+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        74 ~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  146 (312)
T cd05585          74 FINGGELFHHLQRE----GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD  146 (312)
T ss_pred             CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence            99999999999743    34889999999999999999999   899999999999999999999999999998754221


Q ss_pred             cccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhc
Q 011508          324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIV  403 (484)
Q Consensus       324 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (484)
                      .       .......||+.|+|||++.+..++.++|||||||++|||++|+.||....     ..+.....        .
T Consensus       147 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-----~~~~~~~~--------~  206 (312)
T cd05585         147 D-------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-----VNEMYRKI--------L  206 (312)
T ss_pred             C-------CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-----HHHHHHHH--------H
Confidence            1       11223468999999999999999999999999999999999999996531     11111111        1


Q ss_pred             CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC---HHHHHH
Q 011508          404 DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN---MEEVAA  461 (484)
Q Consensus       404 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt---~~evl~  461 (484)
                      ......                     +..+..++.+++.+||+.||++||+   +.|++.
T Consensus       207 ~~~~~~---------------------~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         207 QEPLRF---------------------PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             cCCCCC---------------------CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            100000                     1122557889999999999999985   555554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=323.07  Aligned_cols=260  Identities=27%  Similarity=0.431  Sum_probs=214.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCC--CCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHD--DHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .+...+.++||.|.||.||+|++.+-  +..-.||||..+.+. ....+.|..|..+|++++||||++++|.|.+.    
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~----  463 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ----  463 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc----
Confidence            34455678899999999999997544  233468999888644 34567899999999999999999999998643    


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                        ..|||||.++.|.|..||+.+.   ..++......++.||+.||+|||   +.++|||||..+|||+....-+||+||
T Consensus       464 --P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDF  535 (974)
T KOG4257|consen  464 --PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADF  535 (974)
T ss_pred             --ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeeccc
Confidence              5799999999999999998554   35888999999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |+++.+..+......      ...-+..|||||.+.-..++.+||||.|||.+||++. |..||.+..+.+...      
T Consensus       536 GLSR~~ed~~yYkaS------~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~------  603 (974)
T KOG4257|consen  536 GLSRYLEDDAYYKAS------RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG------  603 (974)
T ss_pred             chhhhccccchhhcc------ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE------
Confidence            999998665432221      2345788999999999999999999999999999988 999998754432110      


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                                    .-  +           ...+-..++.|+..|..|+.+||+.+|.+||.+.|+.+.|+++.+
T Consensus       604 --------------~i--E-----------nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  604 --------------HI--E-----------NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             --------------Ee--c-----------CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                          00  0           111222377899999999999999999999999999999999886

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-41  Score=319.73  Aligned_cols=253  Identities=24%  Similarity=0.318  Sum_probs=208.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|..++++|+|+||.++.++  ++.+.+.+++|.+.....  .......+|+.++++++|||||.+.+.+.    .++.
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvr--hk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~   77 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVR--HKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQ   77 (426)
T ss_pred             chhhhhhhcCccccchhhhhh--hccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCc
Confidence            578899999999999999988  555677999999875542  22346789999999999999999999852    3333


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..+|||+||+||++.+.+...+  +..+++..++.++.|++.|+.|||   ++.|+|||||+.|||++.+..+||+|||+
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGl  152 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGL  152 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhh
Confidence            4999999999999999998655  456999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      |+.+....       .......||+.|++||++.+.+|..|+||||+||++|||++-+++|......     ..+....+
T Consensus       153 aK~l~~~~-------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-----~Li~ki~~  220 (426)
T KOG0589|consen  153 AKILNPED-------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-----ELILKINR  220 (426)
T ss_pred             hhhcCCch-------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-----HHHHHHhh
Confidence            99875432       2334567999999999999999999999999999999999999999764222     12211111


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                          ..+++.                        +.....++..++..|++.+|..||++.+++.+
T Consensus       221 ----~~~~Pl------------------------p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 ----GLYSPL------------------------PSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ----ccCCCC------------------------CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                111111                        22236789999999999999999999999987

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.4e-40  Score=316.05  Aligned_cols=275  Identities=23%  Similarity=0.291  Sum_probs=196.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|++.+.||+|+||.||+|+.  ..++..||+|+++.... .....+.+|+.++++++||||+++++++     ..+..
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~   77 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRS--KLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERC   77 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEE--CCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCe
Confidence            5799999999999999999984  44578899999875432 2345678999999999999999999984     34457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||++ ++|.+++...   ...+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        78 ~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~  150 (288)
T cd07871          78 LTLVFEYLD-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLA  150 (288)
T ss_pred             EEEEEeCCC-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcce
Confidence            899999996 5999988643   234788999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh--
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA--  394 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~--  394 (484)
                      +......       .......++..|+|||++.+ ..++.++||||+||++|||+||+.||....... .+.......  
T Consensus       151 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~  222 (288)
T cd07871         151 RAKSVPT-------KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLLGT  222 (288)
T ss_pred             eeccCCC-------ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCC
Confidence            7543211       11123457899999998765 568999999999999999999999997532211 111111100  


Q ss_pred             -cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 -LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 -~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                       .++....+.+..-......... ...   +..  ........+..+++.+||+.||.+|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~--~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         223 PTEETWPGITSNEEFRSYLFPQY-RAQ---PLI--NHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CChHHhhccccchhhhccccCcc-CCC---chH--HhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence             0000111110000000000000 000   000  000122456789999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.3e-41  Score=339.83  Aligned_cols=255  Identities=20%  Similarity=0.233  Sum_probs=200.4

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      .|.+.+.||+|++|.||+|..... .+..||+|.+..........+.+|+.+++.++||||+++++++..     ++..+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~-~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-----~~~~~  141 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSD-PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-----DDKLL  141 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCC-CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-----CCEEE
Confidence            488899999999999999984432 256788887765544445667889999999999999999998643     45889


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      +||||+++|+|.++++........+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~  218 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ  218 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCcee
Confidence            999999999999998754434456899999999999999999999   89999999999999999999999999999986


Q ss_pred             cccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhh
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERL  399 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  399 (484)
                      +.....     ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ..........  
T Consensus       219 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~--  286 (478)
T PTZ00267        219 YSDSVS-----LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYG--  286 (478)
T ss_pred             cCCccc-----cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhC--
Confidence            643211     1112335689999999999999999999999999999999999999964211     1111110000  


Q ss_pred             hhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          400 AEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       400 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                        ..++.                        +..+..++.+++..||+.||++||++.+++.
T Consensus       287 --~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        287 --KYDPF------------------------PCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --CCCCC------------------------CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence              00000                        1122557899999999999999999999975

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-40  Score=321.14  Aligned_cols=262  Identities=24%  Similarity=0.395  Sum_probs=202.9

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCC--eeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDH--ETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .+|++.+.||+|+||.||+|++...+.  ...||+|.++.... ...+.+.+|+.+++.++||||++++++|..      
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------   80 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   80 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence            468999999999999999998654322  34589999875432 334678899999999999999999998743      


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++|+||+++|+|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG  154 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFG  154 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccc
Confidence            24579999999999999997432   35889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      +++.........     ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+....  .+.....  
T Consensus       155 ~a~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~--  225 (316)
T cd05108         155 LAKLLGADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILE--  225 (316)
T ss_pred             ccccccCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHh--
Confidence            998764322110     1112234678999999999999999999999999999998 99998653111  0111100  


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                                .....                   ..+..|...+.+++..||+.+|++||++.+++..+..+....
T Consensus       226 ----------~~~~~-------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         226 ----------KGERL-------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             ----------CCCCC-------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence                      00000                   001223567889999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8.7e-41  Score=319.90  Aligned_cols=279  Identities=23%  Similarity=0.325  Sum_probs=196.5

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ..++|.+.+.||+|+||.||+|+.  ..+++.||+|++..... .....+.+|+.+++.++||||+++++++     ..+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~   75 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKS--KVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII-----HTK   75 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEE--CCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE-----ecC
Confidence            457899999999999999999984  34578899999875432 2234678899999999999999999985     345


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+ .++|.+++...   ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        76 ~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg  148 (303)
T cd07869          76 ETLTLVFEYV-HTDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFG  148 (303)
T ss_pred             CeEEEEEECC-CcCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCC
Confidence            5889999999 57888888643   235888999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ++.......       .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.........+.......
T Consensus       149 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  221 (303)
T cd07869         149 LARAKSVPS-------HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVL  221 (303)
T ss_pred             cceeccCCC-------ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHh
Confidence            987542211       11123457899999998765 4578899999999999999999999976422111111111100


Q ss_pred             cch---hhhhhc-CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 LPE---RLAEIV-DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 ~~~---~~~~~~-d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...   ...... .+....+.... ....    ..............+.+++..|++.||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         222 GTPNEDTWPGVHSLPHFKPERFTL-YSPK----NLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             CCCChhhccchhhccccccccccc-cCCc----cHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            000   000000 00000000000 0000    00000000111356789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-40  Score=310.60  Aligned_cols=259  Identities=26%  Similarity=0.423  Sum_probs=203.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||.||+|.+... .....||+|.++..... ....+.+|+.++++++|+||+++++++     ..+.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TKSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ecCC
Confidence            5688999999999999999997543 23568999998754332 345788999999999999999999985     3445


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||++++++.++|+|||+
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~  152 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGL  152 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccch
Confidence            7899999999999999997432   35899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.........     .......++..|+|||.+.+..++.++||||||+++|||++ |..||......  ...+.+.   
T Consensus       153 ~~~~~~~~~~-----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~---  222 (266)
T cd05033         153 SRRLEDSEAT-----YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVE---  222 (266)
T ss_pred             hhcccccccc-----eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHH---
Confidence            9876421111     11112235678999999998899999999999999999998 99998653211  1111110   


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                              +.....                    .+..++..+.+++.+|++.+|++||++.||++.|+++
T Consensus       223 --------~~~~~~--------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         223 --------DGYRLP--------------------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             --------cCCCCC--------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    000000                    0122356789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-40  Score=321.71  Aligned_cols=243  Identities=23%  Similarity=0.290  Sum_probs=191.1

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALV  241 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  241 (484)
                      +.||+|+||.||++..  ..++..||+|+++...   ......+.+|+++++.++||||+++++++     ..++..++|
T Consensus         1 ~~lG~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv   73 (323)
T cd05595           1 KLLGKGTFGKVILVRE--KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFV   73 (323)
T ss_pred             CeeeeCCCEEEEEEEE--CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEE
Confidence            4699999999999984  4467889999997542   22345677899999999999999999885     344588999


Q ss_pred             eecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccc
Q 011508          242 YELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP  321 (484)
Q Consensus       242 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~  321 (484)
                      |||+++|+|..++...    ..+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++....
T Consensus        74 ~E~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  146 (323)
T cd05595          74 MEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  146 (323)
T ss_pred             EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence            9999999999888643    35889999999999999999999   8999999999999999999999999999987532


Q ss_pred             cccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhh
Q 011508          322 EAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAE  401 (484)
Q Consensus       322 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  401 (484)
                      ...       .......|++.|+|||++.+..++.++|||||||++|||++|+.||......     .....        
T Consensus       147 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~--------  206 (323)
T cd05595         147 SDG-------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFEL--------  206 (323)
T ss_pred             CCC-------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHH--------
Confidence            111       1112346899999999999989999999999999999999999999653111     11110        


Q ss_pred             hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHH
Q 011508          402 IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQ  462 (484)
Q Consensus       402 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  462 (484)
                      +.......                     +..+..++.+++.+||+.||++||     ++.++++.
T Consensus       207 ~~~~~~~~---------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         207 ILMEEIRF---------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             HhcCCCCC---------------------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            00000000                     112256788999999999999998     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-40  Score=310.61  Aligned_cols=265  Identities=26%  Similarity=0.433  Sum_probs=203.1

Q ss_pred             CCccCccccccceeEEEEEEcCCC-CeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-CCCc
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDF-QGND  236 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  236 (484)
                      |.+.+.||+|+||.||+|....+. ....||+|+++....  .....+.+|++.++.++|+||+++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567899999999999999875432 457899999875432  233578899999999999999999998754332 2234


Q ss_pred             eeeEEeecccCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          237 FEALVYELMVNGSLEEWLHLNR--DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ..++|+||+++|+|..++....  .....+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence            5789999999999999986432  12346899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |.++........     ........+..|+|||.+.+..++.++|||||||++|||++ |..||......  .+.+..  
T Consensus       158 g~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~--  228 (273)
T cd05035         158 GLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYL--  228 (273)
T ss_pred             cceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHH--
Confidence            999866432211     01111234678999999988889999999999999999999 88888653211  111111  


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                               .+.....                    .+..++.++.+++.+||+.||++|||+.||++.|+++
T Consensus       229 ---------~~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         229 ---------RHGNRLK--------------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ---------HcCCCCC--------------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     1000000                    0122366789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.5e-40  Score=321.40  Aligned_cols=243  Identities=25%  Similarity=0.303  Sum_probs=191.9

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALV  241 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  241 (484)
                      +.||+|+||.||++..  ..++..||+|++....   ......+.+|+.+++.++||||+++++++     ..++..++|
T Consensus         1 ~~lG~G~~g~Vy~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv   73 (328)
T cd05593           1 KLLGKGTFGKVILVRE--KASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFV   73 (328)
T ss_pred             CeeeeCCCEEEEEEEE--CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEE
Confidence            4699999999999984  4467889999997542   22345778899999999999999999874     445588999


Q ss_pred             eecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccc
Q 011508          242 YELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP  321 (484)
Q Consensus       242 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~  321 (484)
                      |||+++|+|.+++...    ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        74 ~Ey~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~  146 (328)
T cd05593          74 MEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGI  146 (328)
T ss_pred             EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence            9999999999988643    35889999999999999999999   8999999999999999999999999999987532


Q ss_pred             cccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhh
Q 011508          322 EAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAE  401 (484)
Q Consensus       322 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  401 (484)
                      ...       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ..........    
T Consensus       147 ~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-----~~~~~~~~~~----  210 (328)
T cd05593         147 TDA-------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILME----  210 (328)
T ss_pred             Ccc-------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-----HHHHHHhccC----
Confidence            211       112234689999999999988999999999999999999999999965311     1111110000    


Q ss_pred             hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHH
Q 011508          402 IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQ  462 (484)
Q Consensus       402 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  462 (484)
                        +..+                       +.....++.+++.+||+.||++||     ++.|+++.
T Consensus       211 --~~~~-----------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 --DIKF-----------------------PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             --CccC-----------------------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence              0000                       112255688999999999999997     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=5.8e-40  Score=312.37  Aligned_cols=265  Identities=29%  Similarity=0.435  Sum_probs=206.1

Q ss_pred             CCCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .+|.+.+.||+|+||.||+|....   ..+...+++|.+........+.+.+|++++++++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence            357888999999999999998543   2245678999887655444567899999999999999999999864     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRD------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL  303 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll  303 (484)
                      ...++||||+++++|.+++.....            ....+++..++.++.|++.||+|||   +++|+||||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEE
Confidence            578999999999999999975431            1234899999999999999999999   8999999999999999


Q ss_pred             cCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCcc
Q 011508          304 DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFT  382 (484)
Q Consensus       304 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~  382 (484)
                      +.++.++|+|||++........     ........++..|+|||.+.+..++.++|||||||++|||+| |+.||.....
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             ccCCcEEECCCCcccccCCCce-----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999876533211     111122346788999999988899999999999999999999 9999865321


Q ss_pred             CCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          383 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .     .....        +.......                    .+..++..+.+++.+||+.+|++|||+.+|+++
T Consensus       232 ~-----~~~~~--------~~~~~~~~--------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~  278 (291)
T cd05094         232 T-----EVIEC--------ITQGRVLE--------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI  278 (291)
T ss_pred             H-----HHHHH--------HhCCCCCC--------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            1     11110        00000000                    011225678999999999999999999999999


Q ss_pred             HHHHHHH
Q 011508          463 LLSFRNK  469 (484)
Q Consensus       463 L~~i~~~  469 (484)
                      |+++...
T Consensus       279 l~~~~~~  285 (291)
T cd05094         279 LHALGKA  285 (291)
T ss_pred             HHHHHhh
Confidence            9998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.6e-40  Score=310.06  Aligned_cols=256  Identities=25%  Similarity=0.444  Sum_probs=201.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      .+|++.+.||+|+||.||+|.+..  .++.||+|.+.... .....+.+|++++++++|+||+++++++.     .+...
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~--~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   77 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF   77 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEec--CCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCc
Confidence            357788999999999999999653  46789999987442 33467889999999999999999999864     34478


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++++|.+++....  ...+++..++.++.|++.||+|||   +++++||||||+||++++++.+||+|||.+.
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~  152 (263)
T cd05052          78 YIITEFMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR  152 (263)
T ss_pred             EEEEEeCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence            99999999999999997432  345899999999999999999999   8999999999999999999999999999988


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......      .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....     .+....    
T Consensus       153 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~----  217 (263)
T cd05052         153 LMTGDTY------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYEL----  217 (263)
T ss_pred             cccccee------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHH----
Confidence            6543211      11111234568999999988899999999999999999998 9999865311     111111    


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                           +......+                   .+..++.++.+++.+||+.+|++|||+.|++++|+.+
T Consensus       218 -----~~~~~~~~-------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         218 -----LEKGYRME-------------------RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -----HHCCCCCC-------------------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                 00000000                   0122366789999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-40  Score=336.25  Aligned_cols=265  Identities=21%  Similarity=0.252  Sum_probs=205.9

Q ss_pred             HHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       155 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      ....++|.+.+.||+|+||+||+|+.  ..+++.||||++.....  .....+.+|+..+..++|+|++++...+...+.
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKR--VSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEE--cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            34557999999999999999999984  34578999999875432  234567889999999999999998876543221


Q ss_pred             C---CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 011508          233 Q---GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA  309 (484)
Q Consensus       233 ~---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~  309 (484)
                      .   .....++||||+++|+|.+++.........+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCE
Confidence            1   112467999999999999999865555567999999999999999999999   8999999999999999999999


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhH
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHN  389 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~  389 (484)
                      ||+|||+++.+.....     ........||+.|+|||++.+..++.++|||||||++|||++|+.||....     ...
T Consensus       183 kL~DFGls~~~~~~~~-----~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~  252 (496)
T PTZ00283        183 KLGDFGFSKMYAATVS-----DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEE  252 (496)
T ss_pred             EEEecccCeecccccc-----ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHH
Confidence            9999999986533211     111223568999999999999999999999999999999999999996531     111


Q ss_pred             HHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          390 FVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ........    ..++                        .+..++.++.+++..||+.||++||++.++++.
T Consensus       253 ~~~~~~~~----~~~~------------------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        253 VMHKTLAG----RYDP------------------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHhcC----CCCC------------------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11111100    0000                        012235678999999999999999999999864

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.7e-40  Score=309.68  Aligned_cols=255  Identities=26%  Similarity=0.435  Sum_probs=200.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.++||+|+||.||+|...   ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+     .....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~---~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~   75 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN---NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEP   75 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec---CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCC
Confidence            357889999999999999999854   34679999876433 2356889999999999999999999884     34457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++....  ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||.+
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~  150 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLA  150 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccc
Confidence            899999999999999997532  345888999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ........      .......++..|+|||+.....++.++|||||||++|+|+| |+.||......  .....+..   
T Consensus       151 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~---  219 (261)
T cd05072         151 RVIEDNEY------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--DVMSALQR---  219 (261)
T ss_pred             eecCCCce------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--HHHHHHHc---
Confidence            86533211      11112335678999999988889999999999999999998 99998653211  11111100   


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                           ...    ..                   ....++.++.+++.+|++.+|++||+++++.+.|++
T Consensus       220 -----~~~----~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         220 -----GYR----MP-------------------RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             -----CCC----CC-------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                 000    00                   011225578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.1e-40  Score=311.13  Aligned_cols=265  Identities=26%  Similarity=0.440  Sum_probs=201.0

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-CCCce
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDF-QGNDF  237 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  237 (484)
                      |.+.+.||+|+||.||+|.+........+|+|.++...  ....+.+.+|+++++.++|+||++++++|..... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            45678999999999999997655444579999887542  3334678899999999999999999998754321 12235


Q ss_pred             eeEEeecccCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          238 EALVYELMVNGSLEEWLHLNR--DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      .+++|||+++|+|.+++....  .....+++..+..++.|++.||+|||   +++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999999885332  22345899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      +++........     .......++..|+|||...+..++.++||||||+++|||++ |+.||......  .+.+.+.  
T Consensus       158 ~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~--  228 (272)
T cd05075         158 LSKKIYNGDYY-----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLR--  228 (272)
T ss_pred             cccccCcccce-----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH--
Confidence            99876432110     01112235678999999998899999999999999999999 88898652111  1111100  


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                               ......                    .+..++..+.+++.+||+.||++|||+.|+++.|+++
T Consensus       229 ---------~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         229 ---------QGNRLK--------------------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             ---------cCCCCC--------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     000000                    0112356789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-40  Score=323.29  Aligned_cols=247  Identities=23%  Similarity=0.317  Sum_probs=196.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|.+.+.||+|+||.||+|.+... ....||+|++....   ....+.+.+|+.+++.++||||+++++++.     .+
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~  103 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNE-DFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----DE  103 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECC-CCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----eC
Confidence            5688999999999999999986432 24689999986432   233456889999999999999999999854     44


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus       104 ~~~~lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG  176 (340)
T PTZ00426        104 SYLYLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFG  176 (340)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCC
Confidence            5889999999999999999743    35889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++......          .....||+.|+|||++.+..++.++|||||||++|||++|+.||......     ....   
T Consensus       177 ~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~---  238 (340)
T PTZ00426        177 FAKVVDTR----------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----LIYQ---  238 (340)
T ss_pred             CCeecCCC----------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----HHHH---
Confidence            99865321          12346899999999998888999999999999999999999999753110     0001   


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  462 (484)
                           .+.+.....                     +......+.+++.+|++.||++|+     +++|+++.
T Consensus       239 -----~i~~~~~~~---------------------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        239 -----KILEGIIYF---------------------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -----HHhcCCCCC---------------------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                 111110000                     111244578999999999999995     88888764

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.8e-40  Score=314.52  Aligned_cols=265  Identities=26%  Similarity=0.392  Sum_probs=204.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||.||+|...+.+....+++|.++... ....+.+.+|++++.++ +||||+++++++.     ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence            5788999999999999999987655444567888887432 23346788999999999 7999999999853     344


Q ss_pred             eeeEEeecccCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 011508          237 FEALVYELMVNGSLEEWLHLNRD------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD  304 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~  304 (484)
                      ..++|+||+++++|.+++.....            ....+++..++.++.|++.||+|||   +++|+||||||+||+++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEEC
Confidence            78999999999999999975321            1235889999999999999999999   89999999999999999


Q ss_pred             CCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccC
Q 011508          305 GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTG  383 (484)
Q Consensus       305 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~  383 (484)
                      +++.+||+|||++.......        .......+..|+|||+..+..++.++|||||||++|||++ |..||..... 
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-  224 (297)
T cd05089         154 ENLASKIADFGLSRGEEVYV--------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-  224 (297)
T ss_pred             CCCeEEECCcCCCcccccee--------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-
Confidence            99999999999986432110        0111123567999999988889999999999999999997 9999965321 


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                          .......         .......                   .+..++..+.+++.+||+.+|.+|||+.++++.|
T Consensus       225 ----~~~~~~~---------~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l  272 (297)
T cd05089         225 ----AELYEKL---------PQGYRME-------------------KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL  272 (297)
T ss_pred             ----HHHHHHH---------hcCCCCC-------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                1111110         0000000                   0122356789999999999999999999999999


Q ss_pred             HHHHHHHhh
Q 011508          464 LSFRNKLVK  472 (484)
Q Consensus       464 ~~i~~~~~~  472 (484)
                      +.+.+....
T Consensus       273 ~~~~~~~~~  281 (297)
T cd05089         273 SRMLEARKA  281 (297)
T ss_pred             HHHHHhhcc
Confidence            998876643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.4e-40  Score=310.03  Aligned_cols=261  Identities=23%  Similarity=0.328  Sum_probs=204.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|++|.||+|..  ..++..+|+|.+.....   .....+.+|+.+++.++|+||+++++++..     +
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~--~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~   74 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATC--LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----D   74 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEee--cCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----C
Confidence            4688889999999999999984  33568899998764322   233578899999999999999999998643     4


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..+++|||+++++|.+++.........+++..++.++.|++.||+|||   +++++|+||||+||+++.++.++|+|||
T Consensus        75 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg  151 (267)
T cd08229          75 NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcch
Confidence            4789999999999999998754444456899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      .+.......       .......++..|+|||.+.+..++.++||||||+++|+|++|..||.....+.   .....   
T Consensus       152 ~~~~~~~~~-------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~---  218 (267)
T cd08229         152 LGRFFSSKT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCK---  218 (267)
T ss_pred             hhhccccCC-------cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH---HHHhh---
Confidence            987653321       11122458889999999988889999999999999999999999986432111   11110   


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                        .+.....+..                      ....++..+.+++.+||+.||++|||+.+|++.++++
T Consensus       219 --~~~~~~~~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         219 --KIEQCDYPPL----------------------PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             --hhhcCCCCCC----------------------CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence              0000000000                      0122356789999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=6.5e-40  Score=308.07  Aligned_cols=262  Identities=24%  Similarity=0.330  Sum_probs=206.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|...  .+++.||+|.++...   ....+.+.+|++++++++|+|++++++++.     .+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~   74 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICL--LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----EN   74 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEc--CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cC
Confidence            57899999999999999999954  356789999886432   223467889999999999999999999864     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++++|.+++.........+++.+++.++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~  151 (267)
T cd08224          75 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLG  151 (267)
T ss_pred             CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccc
Confidence            5789999999999999999765444556899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      .+.......       .......++..|+|||.+.+..++.++|||||||++|+|++|+.||.....   ...+......
T Consensus       152 ~~~~~~~~~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~  221 (267)
T cd08224         152 LGRFFSSKT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIE  221 (267)
T ss_pred             eeeeccCCC-------cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhh
Confidence            987653221       111223578899999999888899999999999999999999999864321   1111111100


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                              ......                   .....+...+.+++..||+.+|++|||+.+|+++|+.+.
T Consensus       222 --------~~~~~~-------------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         222 --------KCDYPP-------------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             --------cCCCCC-------------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                    000000                   001123557889999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.8e-40  Score=307.00  Aligned_cols=251  Identities=28%  Similarity=0.422  Sum_probs=195.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|++.+.||+|+||.||+|.+.   .+..+|+|.+.... .....+.+|++++++++||||+++++++.     .....
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~---~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   74 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR---AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPL   74 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec---cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCE
Confidence            45788899999999999999865   34579999876432 23467889999999999999999999853     34578


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++|+|.++++...   ..+++..++.++.|++.||+|||   +++++||||||+||++++++.+||+|||.++
T Consensus        75 ~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~  148 (256)
T cd05114          75 YIVTEFMENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTR  148 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCcc
Confidence            99999999999999987432   24889999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......      .......++..|+|||...+..++.++||||||+++|||++ |+.||.....     .+........
T Consensus       149 ~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~~~~~i~~~  217 (256)
T cd05114         149 YVLDDEY------TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVVEMISRG  217 (256)
T ss_pred             ccCCCce------eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCC
Confidence            6532211      11112235678999999988889999999999999999999 8999865311     1111110000


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      .  ....                          +......+.+++.+||+.+|++||+++|+++.|
T Consensus       218 ~--~~~~--------------------------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         218 F--RLYR--------------------------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             C--CCCC--------------------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            0  0000                          011145689999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.5e-40  Score=323.33  Aligned_cols=249  Identities=26%  Similarity=0.361  Sum_probs=189.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|+..+.||+|+||.||+|+..  .+++.||||++..... .....+.+|+++++.++|+||+++++++     ..++.
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~  146 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHR--PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE  146 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEEC--CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence            34567789999999999999843  4578899999865433 2345788999999999999999999984     44558


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+..        ..++..+..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||++
T Consensus       147 ~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~  215 (353)
T PLN00034        147 IQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVS  215 (353)
T ss_pred             EEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccc
Confidence            89999999999986532        2567788899999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCC-----CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-----SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      +.+....       .......|+..|+|||++..     ...+.++|||||||++|||++|+.||......  .+.....
T Consensus       216 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~--~~~~~~~  286 (353)
T PLN00034        216 RILAQTM-------DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG--DWASLMC  286 (353)
T ss_pred             eeccccc-------ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc--cHHHHHH
Confidence            8653221       11123468999999998743     23456899999999999999999999732111  1111111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .....     ..+.                       .+..+..++.+++.+||+.||++|||+.|+++.
T Consensus       287 ~~~~~-----~~~~-----------------------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        287 AICMS-----QPPE-----------------------APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHhcc-----CCCC-----------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000     0000                       012235678999999999999999999999875

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.4e-40  Score=306.84  Aligned_cols=251  Identities=28%  Similarity=0.427  Sum_probs=196.7

Q ss_pred             ccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       166 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      .||+|+||.||+|.+....++..+|+|+++....  ...+.+.+|+.+++.++|+||+++++++.      .+..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence            5899999999999876666788999999875432  23467889999999999999999999752      235689999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccc
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA  323 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  323 (484)
                      |+++++|.+++...    ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||.+......
T Consensus        76 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~  148 (257)
T cd05116          76 LAELGPLNKFLQKN----KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD  148 (257)
T ss_pred             cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence            99999999999632    35889999999999999999999   899999999999999999999999999999866432


Q ss_pred             cccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhhh
Q 011508          324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAEI  402 (484)
Q Consensus       324 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (484)
                      ...    ........++..|+|||.+....++.++|||||||++|||++ |+.||......  .+.+.+.          
T Consensus       149 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~----------  212 (257)
T cd05116         149 ENY----YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIE----------  212 (257)
T ss_pred             CCe----eeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH----------
Confidence            211    011112234678999999888889999999999999999998 99999753211  1111111          


Q ss_pred             cCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          403 VDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       403 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                        ......                   .+..++.++.+++..||+.||++||++.+|.+.|+.+
T Consensus       213 --~~~~~~-------------------~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         213 --SGERME-------------------CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             --CCCCCC-------------------CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence              000000                   0122366789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=321.45  Aligned_cols=263  Identities=25%  Similarity=0.438  Sum_probs=214.8

Q ss_pred             HhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeec
Q 011508          152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVD  231 (484)
Q Consensus       152 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  231 (484)
                      ++++....+....++||-|.||.||.|+|+.  ..-.||||.++.+ ....++|+.|..+|+.++|||+|+++|+|....
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk--yslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep  336 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP  336 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeec--cceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence            4444445556777899999999999999975  3467999999754 345689999999999999999999999986544


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEE
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV  311 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl  311 (484)
                           ..|||+|||.+|+|.+||++...  ..++.-..+.++.||+.|++||.   .+++|||||..+|+|+.++..+|+
T Consensus       337 -----PFYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKv  406 (1157)
T KOG4278|consen  337 -----PFYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKV  406 (1157)
T ss_pred             -----CeEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEe
Confidence                 78999999999999999986543  34677778899999999999999   999999999999999999999999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  390 (484)
                      +|||+++++..+...      ..-...-...|.|||-+....++.|+|||+|||+|||+.| |-.||.+.     ++.+.
T Consensus       407 ADFGLsRlMtgDTYT------AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi-----dlSqV  475 (1157)
T KOG4278|consen  407 ADFGLSRLMTGDTYT------AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQV  475 (1157)
T ss_pred             eccchhhhhcCCcee------cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc-----cHHHH
Confidence            999999988654321      1122335678999999999999999999999999999998 99998763     22221


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                      .         +++..-.                   +...+++|+..+.+||+.||+++|.+||++.|+-+.++.+
T Consensus       476 Y---------~LLEkgy-------------------RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  476 Y---------GLLEKGY-------------------RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             H---------HHHhccc-------------------cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence            1         1221111                   2223788999999999999999999999999999988764

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.4e-40  Score=318.09  Aligned_cols=200  Identities=27%  Similarity=0.394  Sum_probs=170.1

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .++|++.+.||+|+||.||++..  ..++..+|+|.+..... .....+.+|++++++++|+||++++++|..     ++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~--~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~   76 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSH--KPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DG   76 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEE--CCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CC
Confidence            46899999999999999999984  44577899998875432 233578899999999999999999999643     44


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++...    ..+++..+..++.|++.||.|||+  ..+|+||||||+||+++.++.+||+|||+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~  150 (333)
T cd06650          77 EISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV  150 (333)
T ss_pred             EEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCc
Confidence            889999999999999999743    347889999999999999999993  24799999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      +.......         .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       151 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         151 SGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             chhhhhhc---------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            87553211         1123588999999999988899999999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=8.9e-40  Score=309.11  Aligned_cols=260  Identities=23%  Similarity=0.345  Sum_probs=199.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCC--eeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDH--ETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|.+...+.  ...+++|.+..... ....++..|+.++++++||||+++++++.      .
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------G   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------C
Confidence            467888999999999999999753322  23588888754332 22356778888999999999999999852      2


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++++||+++|+|.+++....   ..+++..++.++.|++.||+|||   +++++||||||+||++++++.+||+|||
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg  154 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFG  154 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCc
Confidence            24678999999999999997432   35899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      .++.......     ........++..|+|||...+..++.++|||||||++||+++ |+.||.+....  ...+.+.  
T Consensus       155 ~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~--  225 (279)
T cd05111         155 VADLLYPDDK-----KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--EVPDLLE--  225 (279)
T ss_pred             cceeccCCCc-----ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH--
Confidence            9986533211     111122446778999999988899999999999999999998 99998653211  1111111  


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                                .....                   ..+..|...+.+++.+||..||++|||+.|+++.|..+..
T Consensus       226 ----------~~~~~-------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         226 ----------KGERL-------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             ----------CCCcC-------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence                      00000                   0011234567889999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.8e-40  Score=309.67  Aligned_cols=262  Identities=24%  Similarity=0.396  Sum_probs=200.7

Q ss_pred             hcCCCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      .+++|++.+.||+|+||.||+|....   ...+..||+|++..... ....++.+|+.+++.++|+||+++++++     
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----   78 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----   78 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence            45679999999999999999998642   23457799998864332 2345688999999999999999999985     


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDA------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE  306 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~  306 (484)
                      ..+...++||||+++++|.+++......      ...+++..++.++.|++.||+|||   +.+++||||||+||+++++
T Consensus        79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED  155 (277)
T ss_pred             cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCC
Confidence            3445789999999999999999753321      234678899999999999999999   8999999999999999999


Q ss_pred             CceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCc
Q 011508          307 LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNL  385 (484)
Q Consensus       307 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~  385 (484)
                      +.++|+|||+++........     .......++..|+|||++.+..++.++|||||||++|||++ |..||.....   
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---  227 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---  227 (277)
T ss_pred             CCEEECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence            99999999998765322110     01111245778999999988889999999999999999999 7888865311   


Q ss_pred             cHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          386 TLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                        .+....        +.......                    .+..++..+.+++.+|++.||++|||+.|+++.|+
T Consensus       228 --~~~~~~--------~~~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         228 --EQVLRF--------VMEGGLLD--------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             --HHHHHH--------HHcCCcCC--------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence              111110        00000000                    01223567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.9e-40  Score=299.26  Aligned_cols=281  Identities=22%  Similarity=0.287  Sum_probs=203.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCC-ceeEeeeeeeec-cCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRN-LVKIITSCVSVD-FQG  234 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~-~~~  234 (484)
                      ..|...++||+|+||+||+|+..  .++..||+|++.....  +......+|+.+|+.++|+| |+.+++++.... +..
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~--~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSK--RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEe--cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            34566678999999999999944  4568999999986644  34567789999999999999 999999975433 122


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++|+||+ .-+|.+++.........++...+..++.||+.||+|||   +++|+||||||+||+++++|.+||+||
T Consensus        89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDF  164 (323)
T KOG0594|consen   89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADF  164 (323)
T ss_pred             cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeecc
Confidence            34778999999 67999999866543345777899999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |+|+.....       ........+|..|+|||++.+. .|+...||||+||++.||++++..|.+..... .+....+-
T Consensus       165 GlAra~~ip-------~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~-ql~~If~~  236 (323)
T KOG0594|consen  165 GLARAFSIP-------MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID-QLFRIFRL  236 (323)
T ss_pred             chHHHhcCC-------cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH-HHHHHHHH
Confidence            999965322       2223445689999999998886 79999999999999999999999987753311 11111111


Q ss_pred             hc-ch--hhhhhc---CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 AL-PE--RLAEIV---DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~-~~--~~~~~~---d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .- |.  .+..+.   +-..  .+.... ........      .........+++..|++.+|.+|.|++.++++
T Consensus       237 lGtP~e~~Wp~v~~~~~~k~--~f~~~~-~~~~l~~~------~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  237 LGTPNEKDWPGVSSLPDYKA--PFPKWP-GPKDLSSI------LPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccCCCCccccccccc--cCcCCC-CccchHHh------ccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            10 10  011110   1000  000000 00000000      00001467899999999999999999999986

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-40  Score=324.29  Aligned_cols=259  Identities=21%  Similarity=0.273  Sum_probs=195.9

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||||++....   ......+.+|++++..++||||+++++++     ..+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~   73 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQK--KDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDE   73 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEE--CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcC
Confidence            4688999999999999999994  4457889999997532   23345678899999999999999999985     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        74 ~~~~lv~E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  146 (364)
T cd05599          74 NYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFG  146 (364)
T ss_pred             CeEEEEECCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecc
Confidence            5899999999999999999743    34899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCC-------------------------------ccccccccccccccCccccCCCCCCcccceehhh
Q 011508          316 LAKFLPEAANNLSSN-------------------------------QSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFG  364 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~-------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~G  364 (484)
                      ++..+..........                               ........||+.|+|||++....++.++||||||
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  226 (364)
T cd05599         147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG  226 (364)
T ss_pred             cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence            987653221000000                               0001124699999999999988999999999999


Q ss_pred             HHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhc
Q 011508          365 ILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVI  444 (484)
Q Consensus       365 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  444 (484)
                      |++|||++|..||......     .......     .. ...+.. +.                  ...+..++.+++.+
T Consensus       227 ~il~el~~G~~Pf~~~~~~-----~~~~~i~-----~~-~~~~~~-~~------------------~~~~s~~~~~li~~  276 (364)
T cd05599         227 VIMYEMLVGYPPFCSDNPQ-----ETYRKII-----NW-KETLQF-PD------------------EVPLSPEAKDLIKR  276 (364)
T ss_pred             hHHHHhhcCCCCCCCCCHH-----HHHHHHH-----cC-CCccCC-CC------------------CCCCCHHHHHHHHH
Confidence            9999999999999753211     1111000     00 000000 00                  00114467788888


Q ss_pred             cCCCCcCCCCC---HHHHHHH
Q 011508          445 CSSELPRERMN---MEEVAAQ  462 (484)
Q Consensus       445 cl~~dP~~RPt---~~evl~~  462 (484)
                      |+. +|.+|++   ++|+++.
T Consensus       277 ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         277 LCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             Hcc-CHhhcCCCCCHHHHhcC
Confidence            886 9999998   8888763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=309.63  Aligned_cols=280  Identities=28%  Similarity=0.332  Sum_probs=200.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHc--CCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRS--IRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .+..+.++||+|.||.||+|.+.    ++.||||++...   ..+.|.+|-++.+.  ++|+||++++++-...+ ....
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~----~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~  281 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD----NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRM  281 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc----CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCC-cccc
Confidence            44566789999999999999976    488999999754   33677777777664  58999999998743332 2245


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeecCCCCCCeeecCCCceE
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC------ETPIVHCDLKPSNVLLDGELTAH  310 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~dlk~~NIll~~~~~~k  310 (484)
                      .++||+||.+.|+|.+||+.+.     ++|....+|+..+++||+|||+..      +.+|+|||||++||||..|+++.
T Consensus       282 eywLVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc  356 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC  356 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence            7899999999999999998554     899999999999999999999753      56899999999999999999999


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCCCC------CCcccceehhhHHHHHHHhCCCCCCC-CccC
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE------VSTSGDVYSFGILLLEMFTGKGPTNE-MFTG  383 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dvws~Gvvl~elltg~~p~~~-~~~~  383 (484)
                      |+|||+|..+....     ........+||.+|||||++.+..      .-.+.||||+|.|||||+++..-+.. ...+
T Consensus       357 IaDFGLAl~~~p~~-----~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~  431 (534)
T KOG3653|consen  357 IADFGLALRLEPGK-----PQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPE  431 (534)
T ss_pred             eeccceeEEecCCC-----CCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCc
Confidence            99999999886432     223334478999999999987642      22478999999999999997644421 1000


Q ss_pred             -CccHhHHHHhhcc-hhhhh-hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHH
Q 011508          384 -NLTLHNFVKEALP-ERLAE-IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVA  460 (484)
Q Consensus       384 -~~~~~~~~~~~~~-~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  460 (484)
                       ...+...+..... +.+.+ ++.........+.+.              ...-+..+.+.+..||+.||+.|-|+.=|.
T Consensus       432 Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~--------------~h~~~~~l~et~EeCWDhDaeARLTA~Cv~  497 (534)
T KOG3653|consen  432 YQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWR--------------KHAGMAVLCETIEECWDHDAEARLTAGCVE  497 (534)
T ss_pred             ccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhh--------------cCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence             1111111111100 01111 111111110000000              011166789999999999999999999999


Q ss_pred             HHHHHHHHHH
Q 011508          461 AQLLSFRNKL  470 (484)
Q Consensus       461 ~~L~~i~~~~  470 (484)
                      +++.++..-.
T Consensus       498 eR~~~l~~~~  507 (534)
T KOG3653|consen  498 ERMAELMMLW  507 (534)
T ss_pred             HHHHHHhccC
Confidence            9998875444

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.6e-40  Score=311.23  Aligned_cols=257  Identities=30%  Similarity=0.485  Sum_probs=204.7

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ...+|++.+.||+|+||.||+|....   +..+++|.+..........+.+|+.+++.++|+||+++++++.     ...
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~---~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~   75 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN---RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGE   75 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC---CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCC
Confidence            34568889999999999999999653   6789999988665545678899999999999999999999854     344


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++....  ...+++..++.++.|++.||+|||   +++++|+||+|+||++++++.+||+|||.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~  150 (261)
T cd05148          76 PVYIITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGL  150 (261)
T ss_pred             CeEEEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccc
Confidence            7899999999999999997532  345899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.......       .......++..|+|||......++.++||||||+++|+|++ |+.||......  .......   
T Consensus       151 ~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~---  218 (261)
T cd05148         151 ARLIKEDV-------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQIT---  218 (261)
T ss_pred             hhhcCCcc-------ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHH---
Confidence            97653321       11112346778999999988889999999999999999998 89998653211  0000000   


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                              . ....                   ..+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       219 --------~-~~~~-------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         219 --------A-GYRM-------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             --------h-CCcC-------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                    0 0000                   00123356789999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.7e-40  Score=313.45  Aligned_cols=266  Identities=24%  Similarity=0.388  Sum_probs=204.9

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeee
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSV  230 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  230 (484)
                      ...++|++.+.||+|+||.||++.....   .....+|+|.+..... .....+.+|++++.++ +|+||+++++++.  
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--   86 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT--   86 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc--
Confidence            3446788899999999999999986532   2346899999875432 2335688999999999 8999999999853  


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNR------------DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKP  298 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~  298 (484)
                         .+...+++|||+++|+|.++++...            .....+++..++.++.|++.||+|||   +++|+||||||
T Consensus        87 ---~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp  160 (293)
T cd05053          87 ---QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAA  160 (293)
T ss_pred             ---CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccce
Confidence               3447899999999999999997532            23456899999999999999999999   89999999999


Q ss_pred             CCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCC
Q 011508          299 SNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPT  377 (484)
Q Consensus       299 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~  377 (484)
                      +||+++.++.+||+|||.++.+......     .......++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  235 (293)
T cd05053         161 RNVLVTEDHVMKIADFGLARDIHHIDYY-----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY  235 (293)
T ss_pred             eeEEEcCCCeEEeCccccccccccccce-----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCC
Confidence            9999999999999999999876432210     01111235678999999988889999999999999999998 99998


Q ss_pred             CCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                      .....     .+....         +......                   ..+..+...+.+++.+|++.||++|||+.
T Consensus       236 ~~~~~-----~~~~~~---------~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~  282 (293)
T cd05053         236 PGIPV-----EELFKL---------LKEGYRM-------------------EKPQNCTQELYHLMRDCWHEVPSQRPTFK  282 (293)
T ss_pred             CCCCH-----HHHHHH---------HHcCCcC-------------------CCCCCCCHHHHHHHHHHcccCcccCcCHH
Confidence            64311     111110         0000000                   00122356789999999999999999999


Q ss_pred             HHHHHHHHHH
Q 011508          458 EVAAQLLSFR  467 (484)
Q Consensus       458 evl~~L~~i~  467 (484)
                      |+++.|+++.
T Consensus       283 eil~~l~~~~  292 (293)
T cd05053         283 QLVEDLDRML  292 (293)
T ss_pred             HHHHHHHHhh
Confidence            9999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.8e-40  Score=312.47  Aligned_cols=263  Identities=25%  Similarity=0.401  Sum_probs=201.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||.||+|.+...+....+|+|.++... ......+.+|++++.++ +|+||+++++++     ..+.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCCC
Confidence            4678889999999999999997654444567888776432 22345788999999999 899999999985     3445


Q ss_pred             eeeEEeecccCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 011508          237 FEALVYELMVNGSLEEWLHLNRD------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD  304 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~  304 (484)
                      ..++||||+++++|.++++....            ....+++.+++.++.|++.|++|||   +++++||||||+||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~  158 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG  158 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEec
Confidence            78999999999999999975431            1235889999999999999999999   89999999999999999


Q ss_pred             CCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccC
Q 011508          305 GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTG  383 (484)
Q Consensus       305 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~  383 (484)
                      .++.+||+|||++.......        ......++..|+|||+..+..++.++|||||||++|||+| |..||......
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  230 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  230 (303)
T ss_pred             CCCcEEeCccccCcccchhh--------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence            99999999999986431110        0111224667999999888889999999999999999998 99998643211


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                           +.... .+.        .....                   .+..++..+.+++.+||+.+|++||++.++++.|
T Consensus       231 -----~~~~~-~~~--------~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l  277 (303)
T cd05088         231 -----ELYEK-LPQ--------GYRLE-------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  277 (303)
T ss_pred             -----HHHHH-Hhc--------CCcCC-------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence                 11110 000        00000                   0111245688999999999999999999999999


Q ss_pred             HHHHHHH
Q 011508          464 LSFRNKL  470 (484)
Q Consensus       464 ~~i~~~~  470 (484)
                      +++...-
T Consensus       278 ~~~~~~~  284 (303)
T cd05088         278 NRMLEER  284 (303)
T ss_pred             HHHHHhh
Confidence            8876543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.4e-40  Score=324.31  Aligned_cols=195  Identities=27%  Similarity=0.397  Sum_probs=165.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ..+|++.+.||+|+||.||++.  +..+++.||+|...      ...+.+|++++++++||||+++++++.     .+..
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~--d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~  157 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACI--DNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFT-----YNKF  157 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEE--ECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCe
Confidence            3679999999999999999998  44567889999753      235678999999999999999999853     3457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++|+|++ .++|.+++...    ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus       158 ~~lv~e~~-~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a  229 (391)
T PHA03212        158 TCLILPRY-KTDLYCYLAAK----RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAA  229 (391)
T ss_pred             eEEEEecC-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence            89999999 57898888643    35889999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      .......      ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       230 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        230 CFPVDIN------ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             ccccccc------ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            7542211      1112235699999999999998999999999999999999999988753

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-40  Score=306.32  Aligned_cols=255  Identities=33%  Similarity=0.485  Sum_probs=200.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|++|.||+|.+.   .++.||+|.++... ...+++.+|++++++++|+|++++++++.     ....
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~---~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   75 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN---NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEP   75 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec---CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCC
Confidence            456889999999999999999854   34679999987543 23567899999999999999999999853     3447


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++....  ...+++..+..++.|++.|+.|||   +++++||||||+||++++++.+||+|||++
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~  150 (261)
T cd05068          76 IYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLA  150 (261)
T ss_pred             eeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceE
Confidence            899999999999999997433  345899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      .......      .........+..|+|||+..+..++.++||||||+++|||++ |+.||......  .....+     
T Consensus       151 ~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~-----  217 (261)
T cd05068         151 RVIKEDI------YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--EVLQQV-----  217 (261)
T ss_pred             EEccCCc------ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH-----
Confidence            8764221      011111223468999999988899999999999999999999 99998653211  000000     


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                             +......                   .+..++..+.+++.+|++.+|++||++.++++.|++
T Consensus       218 -------~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         218 -------DQGYRMP-------------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -------HcCCCCC-------------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence                   0000000                   011225678999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-39  Score=303.78  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=195.9

Q ss_pred             ccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEeec
Q 011508          166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYEL  244 (484)
Q Consensus       166 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  244 (484)
                      .||+|+||.||+|.+.....+..||+|++...... ..+.+.+|+.++++++|+||+++++++.      ....++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEe
Confidence            38999999999998765555677999998755332 2356889999999999999999999752      2357899999


Q ss_pred             ccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccccccc
Q 011508          245 MVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAA  324 (484)
Q Consensus       245 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  324 (484)
                      +++++|.+++...   ...+++..++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||++.......
T Consensus        76 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  149 (257)
T cd05115          76 ASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD  149 (257)
T ss_pred             CCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence            9999999998743   235899999999999999999999   8999999999999999999999999999997653322


Q ss_pred             ccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhhhc
Q 011508          325 NNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAEIV  403 (484)
Q Consensus       325 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (484)
                      ...    .......++..|+|||.+....++.++|||||||++||+++ |+.||......  .....+..          
T Consensus       150 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~----------  213 (257)
T cd05115         150 SYY----KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--EVMSFIEQ----------  213 (257)
T ss_pred             cce----eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--HHHHHHHC----------
Confidence            110    11111234578999999888889999999999999999996 99999754211  11111100          


Q ss_pred             CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          404 DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       404 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                        ....                   ..+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       214 --~~~~-------------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         214 --GKRL-------------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             --CCCC-------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence              0000                   00223366789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=9.9e-40  Score=310.69  Aligned_cols=263  Identities=26%  Similarity=0.394  Sum_probs=201.8

Q ss_pred             CCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      +|++.+.||+|+||.||+|+....   .....+++|.+..... .....+.+|+.+++.++||||+++++.|.     .+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            477889999999999999986422   2335788998865432 23457889999999999999999999854     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRD--------------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCD  295 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d  295 (484)
                      +..++|+||+.+++|.+++.....                    ....+++..++.++.|++.||+|||   +.+++|||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhh
Confidence            478999999999999999864321                    1235889999999999999999999   89999999


Q ss_pred             CCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CC
Q 011508          296 LKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GK  374 (484)
Q Consensus       296 lk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~  374 (484)
                      |||+||++++++.+||+|||+++........     .......++..|+|||...+..++.++||||||+++|||++ |.
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~  227 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG  227 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCC
Confidence            9999999999999999999998765332211     01112345678999999888889999999999999999998 99


Q ss_pred             CCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC
Q 011508          375 GPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM  454 (484)
Q Consensus       375 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  454 (484)
                      .||......              .+.+.+........                   +..+...+.+++..|++.+|++||
T Consensus       228 ~p~~~~~~~--------------~~~~~~~~~~~~~~-------------------~~~~~~~~~~~i~~cl~~~P~~Rp  274 (290)
T cd05045         228 NPYPGIAPE--------------RLFNLLKTGYRMER-------------------PENCSEEMYNLMLTCWKQEPDKRP  274 (290)
T ss_pred             CCCCCCCHH--------------HHHHHHhCCCCCCC-------------------CCCCCHHHHHHHHHHccCCcccCC
Confidence            998653111              11111111110000                   122356788999999999999999


Q ss_pred             CHHHHHHHHHHHHH
Q 011508          455 NMEEVAAQLLSFRN  468 (484)
Q Consensus       455 t~~evl~~L~~i~~  468 (484)
                      ++.|+++.|+++-.
T Consensus       275 ~~~~i~~~l~~~~~  288 (290)
T cd05045         275 TFADISKELEKMMV  288 (290)
T ss_pred             CHHHHHHHHHHHHh
Confidence            99999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.8e-40  Score=309.61  Aligned_cols=249  Identities=25%  Similarity=0.328  Sum_probs=192.4

Q ss_pred             cccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       167 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      ||+|+||+||++..  ..+++.||+|.+.....   ...+.+..|+++++.++|+||+++.+++     ..+...++|||
T Consensus         1 lg~G~~g~Vy~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e   73 (280)
T cd05608           1 LGKGGFGEVSACQM--RATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMT   73 (280)
T ss_pred             CCCCCceeEEEEEE--ccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEe
Confidence            79999999999984  34578899999874322   2235677899999999999999998874     44557899999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccc
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA  323 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  323 (484)
                      |+++|+|.+++.........+++..++.++.|++.||+|||   +++|+||||||+||+++.++.++|+|||.+..+...
T Consensus        74 ~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  150 (280)
T cd05608          74 IMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG  150 (280)
T ss_pred             CCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence            99999999888654444456899999999999999999999   899999999999999999999999999998765332


Q ss_pred             cccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhc
Q 011508          324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIV  403 (484)
Q Consensus       324 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (484)
                      .       .......|+..|+|||.+.+..++.++|||||||++|||++|+.||....... .......        .+.
T Consensus       151 ~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~--------~~~  214 (280)
T cd05608         151 Q-------SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQ--------RIL  214 (280)
T ss_pred             C-------ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch-hHHHHHH--------hhc
Confidence            1       11223468999999999999999999999999999999999999997532111 0001110        011


Q ss_pred             CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHH
Q 011508          404 DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQ  462 (484)
Q Consensus       404 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  462 (484)
                      ......                     +..++..+.+++.+||+.||++||     +++++++.
T Consensus       215 ~~~~~~---------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         215 NDSVTY---------------------PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             ccCCCC---------------------cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            100000                     112356788999999999999999     67777753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.3e-39  Score=308.23  Aligned_cols=268  Identities=25%  Similarity=0.428  Sum_probs=208.1

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCC--CeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDD--HETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      ..++|.+.+.||+|+||.||+|......  .+..|++|++..... .....+.+|+.++++++|+|++++++++.    .
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~----~   79 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCI----E   79 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe----c
Confidence            3467889999999999999999975422  367899998864432 23466889999999999999999999874    3


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDA----PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA  309 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~  309 (484)
                      .+...++++||+++++|.+++......    ...+++..++.++.|++.||+|||   +++++||||||+||++++++.+
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~  156 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQV  156 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcE
Confidence            345778999999999999999754322    146899999999999999999999   8999999999999999999999


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHh
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH  388 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~  388 (484)
                      ||+|||+++.+.......     ......++..|+|||++.+..++.++|||||||++||+++ |+.||.....  ..+.
T Consensus       157 kl~d~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~  229 (280)
T cd05043         157 KITDNALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMA  229 (280)
T ss_pred             EECCCCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHH
Confidence            999999998653322110     1112245778999999988889999999999999999999 9999865311  1111


Q ss_pred             HHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          389 NFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                      .+.....        .  +..                     ...++.++.+++.+||+.||++|||+.||++.|+++..
T Consensus       230 ~~~~~~~--------~--~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         230 AYLKDGY--------R--LAQ---------------------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             HHHHcCC--------C--CCC---------------------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            1111100        0  000                     11235678999999999999999999999999999865


Q ss_pred             H
Q 011508          469 K  469 (484)
Q Consensus       469 ~  469 (484)
                      +
T Consensus       279 ~  279 (280)
T cd05043         279 Q  279 (280)
T ss_pred             c
Confidence            4

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-40  Score=321.77  Aligned_cols=257  Identities=25%  Similarity=0.331  Sum_probs=200.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|.+.+.||+|+||.||+|+..  .+++.||+|+++...   ......+.+|++++..++|+||+++++++     .++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~   73 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDK--DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDE   73 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEEC--CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecC
Confidence            46889999999999999999843  457889999997542   23446788999999999999999999884     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++++|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg  146 (350)
T cd05573          74 EHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFG  146 (350)
T ss_pred             CeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCC
Confidence            6899999999999999999744    35889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccC----------------------CCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhC
Q 011508          316 LAKFLPEAANNL----------------------SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG  373 (484)
Q Consensus       316 ~a~~~~~~~~~~----------------------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg  373 (484)
                      ++..........                      ...........||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g  226 (350)
T cd05573         147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG  226 (350)
T ss_pred             CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence            998664332000                      0000112235689999999999999999999999999999999999


Q ss_pred             CCCCCCCccCCccHhHHHHhhcchhhhhhcC--cccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcC
Q 011508          374 KGPTNEMFTGNLTLHNFVKEALPERLAEIVD--PVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPR  451 (484)
Q Consensus       374 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  451 (484)
                      +.||......     ....        .+..  ..+..              +.     ...++..+.+++..|+. ||.
T Consensus       227 ~~Pf~~~~~~-----~~~~--------~i~~~~~~~~~--------------p~-----~~~~~~~~~~li~~ll~-dp~  273 (350)
T cd05573         227 FPPFYSDTLQ-----ETYN--------KIINWKESLRF--------------PP-----DPPVSPEAIDLICRLLC-DPE  273 (350)
T ss_pred             CCCCCCCCHH-----HHHH--------HHhccCCcccC--------------CC-----CCCCCHHHHHHHHHHcc-Chh
Confidence            9999753211     0000        1111  00000              00     00125678899999997 999


Q ss_pred             CCCC-HHHHHHH
Q 011508          452 ERMN-MEEVAAQ  462 (484)
Q Consensus       452 ~RPt-~~evl~~  462 (484)
                      +||+ ++|+++.
T Consensus       274 ~R~~s~~~ll~h  285 (350)
T cd05573         274 DRLGSFEEIKSH  285 (350)
T ss_pred             hcCCCHHHHhcC
Confidence            9999 9999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.4e-40  Score=315.66  Aligned_cols=244  Identities=25%  Similarity=0.311  Sum_probs=190.9

Q ss_pred             CccccccceeEEEEEEcC-CCCeeEEEEEEeeccC----ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          165 NLIGAGSFGSVYKGIFDH-DDHETLVAVKVLNLQH----RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      +.||+|+||.||+++... ...++.||+|+++...    ......+.+|+.+++.++||||+++++++     ..++..+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeEE
Confidence            679999999999998542 2457889999987532    22335677899999999999999999885     3445889


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      +||||+++++|.+++...    ..+.+..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus        77 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (323)
T cd05584          77 LILEYLSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKE  149 (323)
T ss_pred             EEEeCCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence            999999999999998743    34778888999999999999999   89999999999999999999999999999874


Q ss_pred             cccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhh
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERL  399 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  399 (484)
                      .....       .......|++.|+|||++.+..++.++|||||||++|||++|+.||.....     .....       
T Consensus       150 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-----~~~~~-------  210 (323)
T cd05584         150 SIHEG-------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-----KKTID-------  210 (323)
T ss_pred             cccCC-------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-----HHHHH-------
Confidence            32111       112234689999999999988899999999999999999999999965311     11111       


Q ss_pred             hhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHH
Q 011508          400 AEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAA  461 (484)
Q Consensus       400 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~  461 (484)
                       .+.......                     +..+...+.+++.+||+.||++||     +++++++
T Consensus       211 -~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         211 -KILKGKLNL---------------------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             -HHHcCCCCC---------------------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence             111111100                     112245688999999999999999     7888776

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.8e-40  Score=319.37  Aligned_cols=243  Identities=23%  Similarity=0.289  Sum_probs=190.6

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALV  241 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  241 (484)
                      +.||+|+||.||++..  ..++..||+|+++...   ......+.+|++++..++||||+++++++     ..++..++|
T Consensus         1 ~~lG~G~~g~V~~~~~--~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv   73 (325)
T cd05594           1 KLLGKGTFGKVILVKE--KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFV   73 (325)
T ss_pred             CeeeeCCCEEEEEEEE--CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEE
Confidence            4699999999999984  4467899999997542   22345677899999999999999999874     445588999


Q ss_pred             eecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          242 YELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCE-TPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       242 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      |||+++|+|.+++...    ..+++..+..++.||+.||+|||   + .+|+||||||+||+++.++.+||+|||+++..
T Consensus        74 ~E~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~  146 (325)
T cd05594          74 MEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG  146 (325)
T ss_pred             EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence            9999999999988643    35899999999999999999999   6 79999999999999999999999999998753


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ....       .......||..|+|||++.+..++.++|||||||++|||++|+.||.....     ......       
T Consensus       147 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~~~~~~-------  207 (325)
T cd05594         147 IKDG-------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFEL-------  207 (325)
T ss_pred             CCCC-------cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----HHHHHH-------
Confidence            2211       111234689999999999988999999999999999999999999965311     111110       


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQ  462 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  462 (484)
                       +.......                     +.....++.+++.+||+.||++|+     ++.++++.
T Consensus       208 -i~~~~~~~---------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         208 -ILMEEIRF---------------------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -HhcCCCCC---------------------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence             00000000                     111255688999999999999996     89998854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.7e-40  Score=321.83  Aligned_cols=264  Identities=25%  Similarity=0.356  Sum_probs=202.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCC-CCCceeEeeeeeeecc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIR-HRNLVKIITSCVSVDF  232 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  232 (484)
                      .++|.+.+.||+|+||.||+|++..   ...+..||+|+++..... ..+.+.+|++++.++. ||||++++++|..   
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~---  112 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK---  112 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc---
Confidence            3457788999999999999998642   234568999999754332 2346889999999997 9999999998643   


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCC-----------------------------------------------------
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRD-----------------------------------------------------  259 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------------------------------------------------  259 (484)
                        +...++||||+++|+|.++++....                                                     
T Consensus       113 --~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         113 --GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             --CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence              3478999999999999999975321                                                     


Q ss_pred             -----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011508          260 -----------------------------------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKP  298 (484)
Q Consensus       260 -----------------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~  298 (484)
                                                               ....+++..++.++.|++.||+|||   +++++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCc
Confidence                                                     1124678889999999999999999   89999999999


Q ss_pred             CCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCC
Q 011508          299 SNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPT  377 (484)
Q Consensus       299 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~  377 (484)
                      +||++++++.+||+|||+++........     .......++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~  342 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY  342 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999865322111     11112346788999999988889999999999999999998 88898


Q ss_pred             CCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                      ........ ..            ..+......                   ..+..+..++.+++..||+.+|.+||+++
T Consensus       343 ~~~~~~~~-~~------------~~~~~~~~~-------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~  390 (401)
T cd05107         343 PELPMNEQ-FY------------NAIKRGYRM-------------------AKPAHASDEIYEIMQKCWEEKFEIRPDFS  390 (401)
T ss_pred             CCCCchHH-HH------------HHHHcCCCC-------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence            65321110 00            000000000                   00122356789999999999999999999


Q ss_pred             HHHHHHHHH
Q 011508          458 EVAAQLLSF  466 (484)
Q Consensus       458 evl~~L~~i  466 (484)
                      ||++.|+++
T Consensus       391 ell~~L~~~  399 (401)
T cd05107         391 QLVHLVGDL  399 (401)
T ss_pred             HHHHHHHHH
Confidence            999999876

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.3e-40  Score=322.39  Aligned_cols=255  Identities=21%  Similarity=0.268  Sum_probs=196.2

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      ..++|++.+.||+|+||.||+|+.  ..++..||+|+++...   ......+.+|+.+++.++||||+++++++     .
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~  113 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRH--KSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----Q  113 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEE--CCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence            456799999999999999999984  4467889999986432   22334577899999999999999999874     4


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      ++...++||||+++|+|.+++...     .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~D  185 (370)
T cd05596         114 DDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD  185 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEe
Confidence            455899999999999999998632     3788888999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCC----CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS----EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHN  389 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~  389 (484)
                      ||++.......      ........||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....     ..
T Consensus       186 fG~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~  254 (370)
T cd05596         186 FGTCMKMDANG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VG  254 (370)
T ss_pred             ccceeeccCCC------cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-----HH
Confidence            99987653221      1111234689999999987653    478999999999999999999999975321     11


Q ss_pred             HHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCC--CCCHHHHHHH
Q 011508          390 FVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRE--RMNMEEVAAQ  462 (484)
Q Consensus       390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  462 (484)
                      ..        ..+.+..-......                 ....+.++.+++..|++.+|++  |||++|+++.
T Consensus       255 ~~--------~~i~~~~~~~~~~~-----------------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         255 TY--------SKIMDHKNSLTFPD-----------------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HH--------HHHHcCCCcCCCCC-----------------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            11        11111000000000                 0112557889999999999988  9999999764

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7e-40  Score=327.92  Aligned_cols=281  Identities=23%  Similarity=0.281  Sum_probs=197.2

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC---
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ---  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---  233 (484)
                      ...+|.+.+.||+|+||.||+|+..  .+++.||||++....    ....+|+.+++.++||||+++++++....+.   
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~--~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICI--DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEEC--CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            3467999999999999999999854  356789999885432    2345799999999999999999876543222   


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVS  312 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~  312 (484)
                      ...+.++||||++ ++|.+++.........+++..++.++.||+.||+|||   +++|+||||||+|||++.++ .+||+
T Consensus       138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeee
Confidence            2235679999996 5788877654444567999999999999999999999   89999999999999998665 79999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      |||+++.+....        ......||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.... ..+....
T Consensus       214 DFGla~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~  284 (440)
T PTZ00036        214 DFGSAKNLLAGQ--------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRII  284 (440)
T ss_pred             ccccchhccCCC--------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence            999998653221        1123468999999998765 46899999999999999999999999753221 1111111


Q ss_pred             Hhhcch--hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          392 KEALPE--RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       392 ~~~~~~--~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ......  .......+....    .......  ........+...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus       285 ~~~~~p~~~~~~~~~~~~~~----~~~~~~~--~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        285 QVLGTPTEDQLKEMNPNYAD----IKFPDVK--PKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHhCCCCHHHHHHhchhhhc----ccCCccC--chhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            111000  000001110000    0000000  0000000012235678999999999999999999999854

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-39  Score=315.59  Aligned_cols=243  Identities=23%  Similarity=0.316  Sum_probs=186.4

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||.||+|+..  .+++.||+|+++...   ......+.+|+.++.++ +||||+++++++.     .+...++
T Consensus         1 ~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~l   73 (329)
T cd05618           1 RVIGRGSYAKVLLVRLK--KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFF   73 (329)
T ss_pred             CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEE
Confidence            46999999999999844  457889999997542   22335577888888877 8999999999853     3458899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++|+|..++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        74 v~E~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~  146 (329)
T cd05618          74 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence            99999999999888643    35899999999999999999999   899999999999999999999999999998753


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCC---ccHhHHHHhhcch
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN---LTLHNFVKEALPE  397 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~  397 (484)
                      ....       .......||..|+|||++.+..++.++|||||||++|||++|+.||.......   .....+....   
T Consensus       147 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---  216 (329)
T cd05618         147 LRPG-------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV---  216 (329)
T ss_pred             cCCC-------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH---
Confidence            2111       11223568999999999999999999999999999999999999996432111   1111111110   


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM  456 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  456 (484)
                          +......                     .+..+...+.+++.+||+.||++||++
T Consensus       217 ----i~~~~~~---------------------~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         217 ----ILEKQIR---------------------IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ----HhcCCCC---------------------CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                0000000                     012225568899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.4e-40  Score=310.45  Aligned_cols=261  Identities=25%  Similarity=0.408  Sum_probs=200.0

Q ss_pred             CCCCccCccccccceeEEEEEEc--CCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .+|++.+.||+|+||.||+|.+.  +...+..+++|.+..... .....+.+|++++++++||||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QE   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cC
Confidence            45788899999999999999853  223567899999874332 23357889999999999999999999853     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRD-------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVL  302 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIl  302 (484)
                      ...++||||+++++|.+++.....             ....+++.+++.++.|++.||+|||   +++++||||||+||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nil  156 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNIL  156 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEE
Confidence            478999999999999999863321             1234789999999999999999999   899999999999999


Q ss_pred             ecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCc
Q 011508          303 LDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMF  381 (484)
Q Consensus       303 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~  381 (484)
                      +++++.+||+|||+++.......     ........++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADY-----YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS  231 (283)
T ss_pred             EcCCCcEEeccccccccccCCcc-----eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999999999999976532211     111122335678999999988889999999999999999998 998986531


Q ss_pred             cCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          382 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .  ....+.+....          .+ .                    .+..++..+.+++..|++.||++||++.+|.+
T Consensus       232 ~--~~~~~~~~~~~----------~~-~--------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  278 (283)
T cd05090         232 N--QEVIEMVRKRQ----------LL-P--------------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHT  278 (283)
T ss_pred             H--HHHHHHHHcCC----------cC-C--------------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            1  11111111000          00 0                    01223567889999999999999999999999


Q ss_pred             HHHH
Q 011508          462 QLLS  465 (484)
Q Consensus       462 ~L~~  465 (484)
                      +|..
T Consensus       279 ~l~~  282 (283)
T cd05090         279 RLRS  282 (283)
T ss_pred             Hhhc
Confidence            8864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=315.55  Aligned_cols=264  Identities=24%  Similarity=0.350  Sum_probs=208.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccch-HHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS-KSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ....+.++||+|-||.|..+...   ....||||.++....... .+|.+|+++|.+|+||||++++|.|...+     .
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve---g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----P  609 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE---GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----P  609 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec---CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----c
Confidence            44677899999999999999866   468999999987665444 78999999999999999999999996544     7


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      +++|+|||++|+|.+|+..+...  .+.-....+|+.||+.|++||.   +.++|||||.++|+|+++++++||+|||++
T Consensus       610 icmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgms  684 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMS  684 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccc
Confidence            89999999999999999866432  2455667789999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh--CCCCCCCCccCCccHhHHHHhhc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT--GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +-+-....     .......+-+.+|||||.+.-++++.++|||+||+++||+++  ...||.+..++.          .
T Consensus       685 R~lysg~y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~----------v  749 (807)
T KOG1094|consen  685 RNLYSGDY-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ----------V  749 (807)
T ss_pred             cccccCCc-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH----------H
Confidence            86533221     111223456789999999999999999999999999999865  788987643321          1


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                      -+....+.+..-...                --..+.-|+.++.+++.+||..|-++||+++++...|++.
T Consensus       750 ven~~~~~~~~~~~~----------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  750 VENAGEFFRDQGRQV----------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HHhhhhhcCCCCcce----------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            111222221110000                0011556789999999999999999999999999888764

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.8e-40  Score=317.03  Aligned_cols=245  Identities=27%  Similarity=0.339  Sum_probs=189.0

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHH---HcCCCCCceeEeeeeeeeccCC
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQAL---RSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      |++.+.||+|+||.||+|...  .+++.||||+++...   ....+.+.+|++++   +.++||||+++++++     ..
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~   73 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYK--KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QT   73 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----Ec
Confidence            667889999999999999854  457889999997542   22234566666554   567899999999985     34


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+++++|..+++.     ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        74 ~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Df  145 (324)
T cd05589          74 EDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADF  145 (324)
T ss_pred             CCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcc
Confidence            5588999999999999988862     35899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |+++.....       ........|++.|+|||.+.+..++.++|||||||++|||++|+.||......     ..... 
T Consensus       146 g~~~~~~~~-------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~-  212 (324)
T cd05589         146 GLCKEGMGF-------GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDS-  212 (324)
T ss_pred             cCCccCCCC-------CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHH-
Confidence            998643211       11122356899999999999989999999999999999999999999653111     11110 


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~  461 (484)
                             +.......                     +..++..+.+++.+||+.||++||     ++.++++
T Consensus       213 -------i~~~~~~~---------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         213 -------IVNDEVRY---------------------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -------HHhCCCCC---------------------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                   10000000                     112255688999999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.5e-39  Score=321.08  Aligned_cols=207  Identities=24%  Similarity=0.309  Sum_probs=170.2

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .|++.+.||+|+||+||+|+.  ..+++.||+|++....   ......+.+|++++.+++|+||+++++++.     +.+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~--~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~   74 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACK--VDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKD   74 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEE--CCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCC
Confidence            578889999999999999984  4467899999997542   223456889999999999999999999853     455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++|+|.+++...    ..+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl  147 (381)
T cd05626          75 NLYFVMDYIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGL  147 (381)
T ss_pred             EEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcC
Confidence            899999999999999998743    34888999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCC----------------------------------------CCccccccccccccccCccccCCCCCCc
Q 011508          317 AKFLPEAANNLS----------------------------------------SNQSSSVGVKGTVGYAAPEYGMGSEVST  356 (484)
Q Consensus       317 a~~~~~~~~~~~----------------------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~  356 (484)
                      +..+........                                        ..........||..|+|||++.+..++.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (381)
T cd05626         148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ  227 (381)
T ss_pred             CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence            764421110000                                        0000012346999999999998888999


Q ss_pred             ccceehhhHHHHHHHhCCCCCCCC
Q 011508          357 SGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       357 ~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ++|||||||++|||+||+.||...
T Consensus       228 ~~DiwSlG~il~elltG~~Pf~~~  251 (381)
T cd05626         228 LCDWWSVGVILFEMLVGQPPFLAP  251 (381)
T ss_pred             ccceeehhhHHHHHHhCCCCCcCC
Confidence            999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.2e-39  Score=307.97  Aligned_cols=279  Identities=23%  Similarity=0.259  Sum_probs=196.5

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcC---CCCCceeEeeeeeeeccCC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSI---RHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~  234 (484)
                      +|++.+.||+|+||.||+|+.  ..+++.||+|.++....  .....+.+|+.+++.+   +||||+++++++.......
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~   78 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARD--PHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR   78 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEE--CCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence            478889999999999999984  44678899999875432  2234566777777665   7999999999876544444


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||++ ++|.+++....  ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        79 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~df  152 (288)
T cd07863          79 ETKVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADF  152 (288)
T ss_pred             CceEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcc
Confidence            567899999996 58999887432  234899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |++.......        ......++..|+|||++.+..++.++||||+||++|||++|++||...... ..+.+.....
T Consensus       153 g~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~  223 (288)
T cd07863         153 GLARIYSCQM--------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLI  223 (288)
T ss_pred             CccccccCcc--------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHh
Confidence            9998653221        112245789999999998889999999999999999999999998653211 1111111110


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....... ....... ... .....   ..........++...+.+++.+|++.||++|||+.|++.
T Consensus       224 ~~~~~~~-~~~~~~~-~~~-~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         224 GLPPEDD-WPRDVTL-PRG-AFSPR---GPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CCCChhh-Ccccccc-ccc-ccCCC---CCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000000 0000000 000 00000   000000001123566889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.3e-39  Score=315.05  Aligned_cols=248  Identities=23%  Similarity=0.317  Sum_probs=190.4

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||.||+|+..  .++..||+|+++...   ......+..|..++..+ +||||+++++++     ..+...++
T Consensus         1 ~~lG~G~~g~V~~~~~~--~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~l   73 (329)
T cd05588           1 RVIGRGSYAKVLLVELK--KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFF   73 (329)
T ss_pred             CeEeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEE
Confidence            46999999999999844  457889999997542   22335678899999988 799999999985     34458899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        74 v~e~~~~g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  146 (329)
T cd05588          74 VIEFVSGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  146 (329)
T ss_pred             EEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence            99999999999988633    35899999999999999999999   899999999999999999999999999998743


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCC---ccHhHHHHhhcch
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN---LTLHNFVKEALPE  397 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~  397 (484)
                      ...       ........||..|+|||++.+..++.++|||||||++|||++|+.||.......   ....++....   
T Consensus       147 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~---  216 (329)
T cd05588         147 IRP-------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV---  216 (329)
T ss_pred             ccC-------CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH---
Confidence            111       111223568999999999999999999999999999999999999996432111   1111111111   


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC------HHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN------MEEVAA  461 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt------~~evl~  461 (484)
                          +......                     .+..+..++.+++.+||+.||.+||+      ++|+++
T Consensus       217 ----~~~~~~~---------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         217 ----ILEKQIR---------------------IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ----HHcCCCC---------------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence                1110000                     01122556889999999999999997      567764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.3e-39  Score=319.32  Aligned_cols=207  Identities=26%  Similarity=0.334  Sum_probs=171.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||+||+|..  ..+++.||+|+++...   ......+.+|+.++.+++|+||+++++.+     .++
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~   73 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQK--KDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDK   73 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEE--CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence            4688999999999999999984  4457899999997532   22335678899999999999999999884     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        74 ~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFG  146 (363)
T cd05628          74 LNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFG  146 (363)
T ss_pred             CeEEEEEcCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeecc
Confidence            5889999999999999999743    35899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCC----------------------------CCccccccccccccccCccccCCCCCCcccceehhhHHH
Q 011508          316 LAKFLPEAANNLS----------------------------SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILL  367 (484)
Q Consensus       316 ~a~~~~~~~~~~~----------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl  367 (484)
                      +++.+........                            ..........||+.|+|||++.+..++.++|||||||++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil  226 (363)
T cd05628         147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (363)
T ss_pred             CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence            9876532110000                            000011235799999999999998999999999999999


Q ss_pred             HHHHhCCCCCCC
Q 011508          368 LEMFTGKGPTNE  379 (484)
Q Consensus       368 ~elltg~~p~~~  379 (484)
                      |||++|+.||..
T Consensus       227 ~ell~G~~Pf~~  238 (363)
T cd05628         227 YEMLIGYPPFCS  238 (363)
T ss_pred             HHHHhCCCCCCC
Confidence            999999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-39  Score=303.83  Aligned_cols=252  Identities=27%  Similarity=0.433  Sum_probs=196.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|.+.+.||+|+||.||.|.+.+   +..+|+|.+.... ...+.+.+|+.++++++||||+++++++.     .....
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~---~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   74 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG---QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPI   74 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC---CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCc
Confidence            457888999999999999998652   3459999887443 23467899999999999999999999864     33467


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+.+|+|.+++....   ..+++..++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||.++
T Consensus        75 ~lv~e~~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~  148 (256)
T cd05113          75 YIVTEYMSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR  148 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccce
Confidence            99999999999999997432   25899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ......      ........++..|+|||...+..++.++|||||||++|+|++ |+.||......     .....    
T Consensus       149 ~~~~~~------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~----  213 (256)
T cd05113         149 YVLDDE------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVEK----  213 (256)
T ss_pred             ecCCCc------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHH----
Confidence            653221      111112335678999999988889999999999999999999 99998643211     01000    


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                          +.......                    .+......+.+++.+||+.+|.+||++.++++.|+
T Consensus       214 ----~~~~~~~~--------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         214 ----VSQGLRLY--------------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ----HhcCCCCC--------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                00000000                    00111457899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.4e-39  Score=315.66  Aligned_cols=255  Identities=24%  Similarity=0.296  Sum_probs=194.5

Q ss_pred             CCCccCccccccceeEEEEEEcC-CCCeeEEEEEEeeccC----ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDH-DDHETLVAVKVLNLQH----RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  233 (484)
                      +|++.+.||+|+||.||+++... ..++..||+|++....    ....+.+..|+.++..+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            47889999999999999997532 3457889999987432    22335678899999999 599999998874     4


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .+...++||||+++|+|.+++...    ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~D  148 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTD  148 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEee
Confidence            556889999999999999998743    34889999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||+++......      ........||..|+|||++.+. .++.++|||||||++|||+||+.||....... .......
T Consensus       149 fG~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~~  221 (332)
T cd05614         149 FGLSKEFLSEE------KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVSR  221 (332)
T ss_pred             CcCCccccccC------CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHHH
Confidence            99987643221      1112235689999999998765 47889999999999999999999996432211 1111111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  462 (484)
                      ..     .. .++.+                       +......+.+++.+||+.||++||     +++|+++.
T Consensus       222 ~~-----~~-~~~~~-----------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         222 RI-----LK-CDPPF-----------------------PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             HH-----hc-CCCCC-----------------------CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            00     00 00000                       111255678999999999999999     77788753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.2e-39  Score=307.31  Aligned_cols=272  Identities=26%  Similarity=0.370  Sum_probs=202.3

Q ss_pred             CCCccCccccccceeEEEEEEc--CCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          160 GFSLENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      -|.+.+.||+|+||.||.+.+.  ...++..||+|.++.... .....+.+|+++++.++|||++++++++...   +..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CCC
Confidence            4678899999999999999864  234578899999875432 3346789999999999999999999986432   234


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++...   ...+++..++.++.|++.||+|||   +++++||||||+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~  155 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGL  155 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCcc
Confidence            678999999999999998643   235899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc-
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL-  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-  395 (484)
                      ++.+......    ........++..|+|||.+.+..++.++|||||||++|||+|++.|+......   ..+...... 
T Consensus       156 ~~~~~~~~~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~~~~~~~~~~  228 (284)
T cd05079         156 TKAIETDKEY----YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL---FLKMIGPTHG  228 (284)
T ss_pred             ccccccCccc----eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch---hhhhcccccc
Confidence            9866432211    11112244677899999988888999999999999999999988765332110   000000000 


Q ss_pred             ---chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          396 ---PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       396 ---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                         .......+....                   ....+..++..+.+++.+|++.+|++|||++++++.|+++
T Consensus       229 ~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         229 QMTVTRLVRVLEEGK-------------------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cccHHHHHHHHHcCc-------------------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence               000000000000                   0000223467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-39  Score=316.61  Aligned_cols=267  Identities=23%  Similarity=0.349  Sum_probs=201.9

Q ss_pred             cCCCCccCccccccceeEEEEEEc---CCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeeecc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSVDF  232 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  232 (484)
                      .++|++.+.||+|+||.||+|...   ...+++.||||+++.... .....+.+|+.++.++ +|+||++++++|..   
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---   82 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---   82 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec---
Confidence            357999999999999999999843   223467899999975432 2345688999999999 68999999998743   


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCC----------------------------------------------------
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDA----------------------------------------------------  260 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------------------------  260 (484)
                       .+...++||||+++|+|.+++......                                                    
T Consensus        83 -~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          83 -PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             -CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence             334678999999999999998743210                                                    


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccccccCCC
Q 011508          261 -----------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSS  329 (484)
Q Consensus       261 -----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  329 (484)
                                 ...+++.++..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++.........   
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---  235 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY---  235 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch---
Confidence                       123688889999999999999999   899999999999999999999999999998765322110   


Q ss_pred             CccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccc
Q 011508          330 NQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLL  408 (484)
Q Consensus       330 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  408 (484)
                        .......++..|+|||.+.+..++.++||||||+++|||++ |..||....... .......    ..       ...
T Consensus       236 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~----~~-------~~~  301 (343)
T cd05103         236 --VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLK----EG-------TRM  301 (343)
T ss_pred             --hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHh----cc-------CCC
Confidence              11112235678999999988889999999999999999997 999986532111 0000000    00       000


Q ss_pred             cccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          409 VEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                      .                    .+..+..++.+++..||+.||++|||+.||++.|+.+.+
T Consensus       302 ~--------------------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         302 R--------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             C--------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            0                    001114468899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.5e-39  Score=304.74  Aligned_cols=255  Identities=29%  Similarity=0.479  Sum_probs=199.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||.||+|++..   ...||+|.++.... ..+.+.+|++++++++|+||+++++.+.      ...
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~   74 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEP   74 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecC---CceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC------CCC
Confidence            3568999999999999999998542   24599999875332 3467899999999999999999988742      235


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++|+|.+++....  ...+++..++.++.|++.||+|||   +.+++||||||+||++++++.++|+|||.+
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~  149 (262)
T cd05071          75 IYIVTEYMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA  149 (262)
T ss_pred             cEEEEEcCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCce
Confidence            689999999999999997432  335789999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ........      .......++..|+|||+..+..++.++||||||+++|||+| |+.||.......     ....   
T Consensus       150 ~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-----~~~~---  215 (262)
T cd05071         150 RLIEDNEY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQ---  215 (262)
T ss_pred             eecccccc------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-----HHHH---
Confidence            76643221      11112346778999999988889999999999999999999 888886532110     0000   


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                        +.......                       ...+++..+.+++.+|++.+|++||++.++++.|++.
T Consensus       216 --~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         216 --VERGYRMP-----------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             --HhcCCCCC-----------------------CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence              00000000                       0122356789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-39  Score=309.58  Aligned_cols=270  Identities=23%  Similarity=0.279  Sum_probs=206.9

Q ss_pred             ccHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeee
Q 011508          149 VSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSC  227 (484)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  227 (484)
                      +.++.+....++|++.+.||+|+||.||+|...  .+++.+|+|+++... .....+.+|+.+++++ +|+|++++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   84 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNK--KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY   84 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEEC--CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence            344555667889999999999999999999854  356789999876432 2335688899999999 799999999988


Q ss_pred             eeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 011508          228 VSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL  307 (484)
Q Consensus       228 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~  307 (484)
                      .......+...++||||+++++|.+++.........+++..+..++.|++.||.|||   +.+++||||||+||+++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~  161 (286)
T cd06638          85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEG  161 (286)
T ss_pred             eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCC
Confidence            655545566889999999999999988754333456889999999999999999999   89999999999999999999


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCC-----CCCCcccceehhhHHHHHHHhCCCCCCCCcc
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-----SEVSTSGDVYSFGILLLEMFTGKGPTNEMFT  382 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~  382 (484)
                      .++|+|||++.......       .......|+..|+|||++..     ..++.++||||+||++|||++|+.||.....
T Consensus       162 ~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~  234 (286)
T cd06638         162 GVKLVDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP  234 (286)
T ss_pred             CEEEccCCceeecccCC-------CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence            99999999987653211       11122358899999998753     4578899999999999999999999865311


Q ss_pred             CCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          383 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .    ..... .     .....+.+.                     .+..+...+.+++.+||+.||++|||+.||++.
T Consensus       235 ~----~~~~~-~-----~~~~~~~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         235 M----RALFK-I-----PRNPPPTLH---------------------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             h----HHHhh-c-----cccCCCccc---------------------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            1    00000 0     000000000                     011124568899999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-39  Score=308.76  Aligned_cols=276  Identities=27%  Similarity=0.406  Sum_probs=206.9

Q ss_pred             CCCCccCccccccceeEEEEEEcC--CCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDH--DDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      +.|.+.+.||+|+||.||+|++..  ..++..+|+|+++..... ..+.+.+|+++++.++|+||+++++++..   .+.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            457778999999999999998652  345788999999865543 45689999999999999999999988643   235


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++++|.+++....   ..+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccc
Confidence            57899999999999999997432   25899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH-hh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK-EA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~  394 (484)
                      .+.........    ........++..|+|||...+..++.++||||||+++|||++|+.|+............... ..
T Consensus       155 ~~~~~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~  230 (284)
T cd05038         155 LAKVLPEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM  230 (284)
T ss_pred             cccccccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccc
Confidence            99876422211    01111223556799999998889999999999999999999999998653221111000000 00


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                      ....+.+.+.....                   ...+..|+.++.+++.+||+.+|++|||+.||+++|+.+
T Consensus       231 ~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         231 IVTRLLELLKEGER-------------------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cHHHHHHHHHcCCc-------------------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            00001111111000                   001233467899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.3e-39  Score=308.24  Aligned_cols=260  Identities=27%  Similarity=0.429  Sum_probs=201.3

Q ss_pred             CCCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .+|...+.||+|+||.||++...+   ..++..+|+|.+..........+.+|+++++.++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence            457788999999999999997532   2346689999887665555678999999999999999999999854     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRD-----------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD  304 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~  304 (484)
                      ...+++|||+++++|.+++.....           ....+++..++.++.|++.|++|||   +.+++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEc
Confidence            478999999999999999975431           1135889999999999999999999   89999999999999999


Q ss_pred             CCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccC
Q 011508          305 GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTG  383 (484)
Q Consensus       305 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~  383 (484)
                      +++.+||+|||++........     ........+++.|+|||...+..++.++|||||||++|||++ |+.||......
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  231 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT  231 (280)
T ss_pred             CCCCEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence            999999999999875532110     011112235678999999988899999999999999999998 89998653211


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      .     ...        .+..... .                   ..+..++..+.+++.+||+.||++||+++||++.|
T Consensus       232 ~-----~~~--------~~~~~~~-~-------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l  278 (280)
T cd05092         232 E-----AIE--------CITQGRE-L-------------------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL  278 (280)
T ss_pred             H-----HHH--------HHHcCcc-C-------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence            0     000        0000000 0                   00122356789999999999999999999999988


Q ss_pred             H
Q 011508          464 L  464 (484)
Q Consensus       464 ~  464 (484)
                      +
T Consensus       279 ~  279 (280)
T cd05092         279 Q  279 (280)
T ss_pred             h
Confidence            6

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.3e-39  Score=319.24  Aligned_cols=258  Identities=22%  Similarity=0.277  Sum_probs=195.5

Q ss_pred             HHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeee
Q 011508          154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSV  230 (484)
Q Consensus       154 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  230 (484)
                      +....++|++.+.||+|+||.||+++..  .+++.+|+|++....   ......+.+|+.+++.++||||+++++++   
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~---  112 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHK--SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF---  112 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE---
Confidence            3445578999999999999999999954  457889999986422   22335678899999999999999999884   


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH  310 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k  310 (484)
                        .++...++||||+++|+|.+++...     .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+|
T Consensus       113 --~~~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~k  182 (370)
T cd05621         113 --QDDKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLK  182 (370)
T ss_pred             --EcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEE
Confidence              4456899999999999999999632     3788899999999999999999   89999999999999999999999


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCCC----CCCcccceehhhHHHHHHHhCCCCCCCCccCCcc
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS----EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLT  386 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~  386 (484)
                      |+|||++.......      ........||+.|+|||++.+.    .++.++||||+||++|||++|+.||.....    
T Consensus       183 L~DFG~a~~~~~~~------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~----  252 (370)
T cd05621         183 LADFGTCMKMDETG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL----  252 (370)
T ss_pred             EEecccceecccCC------ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH----
Confidence            99999998653221      1111235699999999988653    378899999999999999999999975311    


Q ss_pred             HhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCC--CCCHHHHHHH
Q 011508          387 LHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRE--RMNMEEVAAQ  462 (484)
Q Consensus       387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  462 (484)
                       ...        ...+.+.........                 .......+.+++..|+..+|.+  |||+.|+++.
T Consensus       253 -~~~--------~~~i~~~~~~~~~p~-----------------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         253 -VGT--------YSKIMDHKNSLNFPE-----------------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             -HHH--------HHHHHhCCcccCCCC-----------------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence             111        111111100000000                 0112456778888888755543  8999999876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.2e-39  Score=308.05  Aligned_cols=267  Identities=22%  Similarity=0.356  Sum_probs=199.1

Q ss_pred             CCCCccCccccccceeEEEEEEcC--------------CCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeE
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDH--------------DDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKI  223 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~--------------~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~  223 (484)
                      ++|++.+.||+|+||.||++...+              ..+...+|+|++..... .....+.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            468999999999999999986432              22345799999875432 234678999999999999999999


Q ss_pred             eeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 011508          224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA-------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDL  296 (484)
Q Consensus       224 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl  296 (484)
                      ++++.     .++..++||||+++++|.+++......       ...+++.+++.++.|++.||+|||   +.+++||||
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl  156 (296)
T cd05095          85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDL  156 (296)
T ss_pred             EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccC
Confidence            99853     344789999999999999999754321       134788899999999999999999   899999999


Q ss_pred             CCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh--CC
Q 011508          297 KPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT--GK  374 (484)
Q Consensus       297 k~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt--g~  374 (484)
                      ||+||+++.++.++|+|||++..+.....     ........++..|+|||....+.++.++|||||||++|||++  |.
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~  231 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE  231 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcc-----eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCC
Confidence            99999999999999999999876532211     011112234678999998888889999999999999999998  67


Q ss_pred             CCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC
Q 011508          375 GPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM  454 (484)
Q Consensus       375 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  454 (484)
                      .||......     +.+...     ............                ...+..|+..+.+++.+||+.||++||
T Consensus       232 ~p~~~~~~~-----~~~~~~-----~~~~~~~~~~~~----------------~~~~~~~~~~~~~li~~cl~~~p~~Rp  285 (296)
T cd05095         232 QPYSQLSDE-----QVIENT-----GEFFRDQGRQVY----------------LPKPALCPDSLYKLMLSCWRRNAKERP  285 (296)
T ss_pred             CCccccChH-----HHHHHH-----HHHHhhcccccc----------------CCCCCCCCHHHHHHHHHHcCCCcccCC
Confidence            787643211     111100     000000000000                000123456789999999999999999


Q ss_pred             CHHHHHHHHH
Q 011508          455 NMEEVAAQLL  464 (484)
Q Consensus       455 t~~evl~~L~  464 (484)
                      ++.||++.|+
T Consensus       286 ~~~~i~~~l~  295 (296)
T cd05095         286 SFQEIHATLL  295 (296)
T ss_pred             CHHHHHHHHh
Confidence            9999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-39  Score=314.54  Aligned_cols=243  Identities=24%  Similarity=0.310  Sum_probs=189.6

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||.||+|+..  .+++.||+|+++...   ......+..|.+++..+ +||||+++++++     ..+...++
T Consensus         1 ~~lG~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~l   73 (321)
T cd05591           1 KVLGKGSFGKVMLAELK--GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFF   73 (321)
T ss_pred             CccccCCCeEEEEEEEC--CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEE
Confidence            46999999999999854  456789999987532   22335677888888866 899999999985     44558899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++|+|..++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++...
T Consensus        74 v~E~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~  146 (321)
T cd05591          74 VMEYVNGGDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEG  146 (321)
T ss_pred             EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceec
Confidence            99999999999988643    35889999999999999999999   899999999999999999999999999998754


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ....       .......|+..|+|||++.+..++.++|||||||++|||++|+.||......     .....       
T Consensus       147 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~~~~-------  207 (321)
T cd05591         147 ILNG-------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DLFES-------  207 (321)
T ss_pred             ccCC-------ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HHHHH-------
Confidence            2211       1122346899999999999889999999999999999999999999753211     11111       


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-------CHHHHHHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-------NMEEVAAQ  462 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------t~~evl~~  462 (484)
                       +.......                     +..+..++.+++..||+.||++||       +++++++.
T Consensus       208 -i~~~~~~~---------------------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         208 -ILHDDVLY---------------------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             -HHcCCCCC---------------------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence             11000000                     111245688999999999999999       77887754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.4e-40  Score=314.76  Aligned_cols=237  Identities=25%  Similarity=0.310  Sum_probs=186.0

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||.||+|+.  ..+++.||+|+++...   ....+.+..|..++..+ +||||+++++++     ...+..++
T Consensus         1 ~~lg~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~i   73 (320)
T cd05590           1 RVLGKGSFGKVMLARL--KESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFF   73 (320)
T ss_pred             CeeeeCCCeEEEEEEE--cCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEE
Confidence            4699999999999984  4457889999987432   23345677888888876 799999999884     44558899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        74 v~Ey~~~g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~  146 (320)
T cd05590          74 VMEFVNGGDLMFHIQKS----RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG  146 (320)
T ss_pred             EEcCCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence            99999999999988743    35889999999999999999999   899999999999999999999999999998753


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ...       ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .......      
T Consensus       147 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i------  208 (320)
T cd05590         147 IFN-------GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAI------  208 (320)
T ss_pred             CcC-------CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHH------
Confidence            211       1112234689999999999988999999999999999999999999975321     1111111      


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM  456 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  456 (484)
                        .......                     +.....++.+++.+|++.||++||++
T Consensus       209 --~~~~~~~---------------------~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         209 --LNDEVVY---------------------PTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             --hcCCCCC---------------------CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence              0000000                     11124568899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1e-39  Score=315.30  Aligned_cols=242  Identities=24%  Similarity=0.290  Sum_probs=188.0

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCC-CceeEeeeeeeeccCCC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHR-NLVKIITSCVSVDFQGN  235 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~  235 (484)
                      +|++.+.||+|+||.||+|+..  .+++.||+|++....   ....+.+..|.+++..++|+ +|+++++++     ...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~   73 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERK--GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTM   73 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcC
Confidence            4788899999999999999844  456789999987532   23345678899999999765 477777764     344


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        74 ~~~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05587          74 DRLYFVMEYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFG  146 (324)
T ss_pred             CEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecC
Confidence            5889999999999999998743    34889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++......       ........||..|+|||++.+..++.++||||+||++|||+||+.||......     ....   
T Consensus       147 ~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~---  211 (324)
T cd05587         147 MCKENIFG-------GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-----ELFQ---  211 (324)
T ss_pred             cceecCCC-------CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHH---
Confidence            98643111       11122346899999999999999999999999999999999999999753211     1111   


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM  456 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  456 (484)
                           .+.......                     +.....++.+++.+||+.||.+|++.
T Consensus       212 -----~i~~~~~~~---------------------~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         212 -----SIMEHNVSY---------------------PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -----HHHcCCCCC---------------------CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                 111100000                     11124567899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.6e-39  Score=311.88  Aligned_cols=204  Identities=23%  Similarity=0.338  Sum_probs=163.9

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      .++||+|+||.||+|+..+..+++.||+|.+....  ....+.+|+.++++++||||+++++++..   ..+...++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEec---CCCcEEEEEEe
Confidence            46899999999999997665567889999986432  33567899999999999999999988643   23456899999


Q ss_pred             cccCCCHHHHHhhcCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCCceEEccc
Q 011508          244 LMVNGSLEEWLHLNRD-----APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL----DGELTAHVSDF  314 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Df  314 (484)
                      |+ +++|.+++.....     ....+++..+..++.|++.||+|||   +++|+||||||+|||+    +.++.+||+||
T Consensus        81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            99 5688888764321     1235889999999999999999999   8999999999999999    45678999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      |+++.......    .........+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus       157 G~a~~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         157 GFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             CceeccCCCCc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            99986533211    1111223568999999998876 45899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-39  Score=306.23  Aligned_cols=256  Identities=23%  Similarity=0.320  Sum_probs=197.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||.||+|+..  .+++.||+|++..........+.+|+.++++++||||+++++++..     +..
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~--~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~   80 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNL--HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REK   80 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEEC--CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCE
Confidence            357899999999999999999853  3568899999976554455678899999999999999999998643     347


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.++++..    ..+++..+..++.|++.||+|||   +.+|+||||+|+||+++.++.++|+|||++
T Consensus        81 ~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~  153 (267)
T cd06646          81 LWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVA  153 (267)
T ss_pred             EEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccc
Confidence            89999999999999998632    35889999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccC---CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM---GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      .......       .......++..|+|||.+.   ...++.++|||||||++|||++|+.||........ ...+... 
T Consensus       154 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~-  224 (267)
T cd06646         154 AKITATI-------AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKS-  224 (267)
T ss_pred             eeecccc-------cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecC-
Confidence            8653211       1112345788999999874   34578899999999999999999999854321100 0000000 


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                            ....+....                     ....+..+.+++.+||+.+|++|||++++++.|
T Consensus       225 ------~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         225 ------NFQPPKLKD---------------------KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ------CCCCCCCcc---------------------ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                  000000000                     011245788999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=307.24  Aligned_cols=253  Identities=28%  Similarity=0.323  Sum_probs=196.0

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      +|++.+.||+|+||.||++..  ..+++.||+|++.....   .....+.+|+.+++.++|+||+++++.+     ..++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~   73 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQV--RATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKD   73 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEE--cCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCC
Confidence            477889999999999999984  34578899999865322   2234577899999999999999999885     3445


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++|+|.+++....  ...+++..+..++.|++.||.|||   +.+++||||||+||++++++.++|+|||+
T Consensus        74 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~  148 (285)
T cd05605          74 ALCLVLTLMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGL  148 (285)
T ss_pred             eEEEEEeccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCC
Confidence            8899999999999998886432  345899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.......        ......|+..|+|||++.+..++.++||||+||++|||++|+.||...... ..... +...  
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~-~~~~--  216 (285)
T cd05605         149 AVEIPEGE--------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREE-VERR--  216 (285)
T ss_pred             ceecCCCC--------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHH-HHHH--
Confidence            87653211        112235889999999998888999999999999999999999999753211 00000 1000  


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQ  462 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  462 (484)
                            +......                    .+...+..+.+++..||+.||++||     +++++++.
T Consensus       217 ------~~~~~~~--------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         217 ------VKEDQEE--------------------YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ------hhhcccc--------------------cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                  0000000                    0112255688999999999999999     88888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-39  Score=301.69  Aligned_cols=250  Identities=30%  Similarity=0.428  Sum_probs=195.3

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      +|++.+.||+|+||.||+|.+.   .+..+|+|.+.... .....+.+|++++++++|+||+++++++.     .....+
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~---~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR---GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIF   75 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec---CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceE
Confidence            4788899999999999999864   34679999886432 23457889999999999999999999853     445789


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      +||||+++++|.+++....   ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||.++.
T Consensus        76 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~  149 (256)
T cd05059          76 IVTEYMANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARY  149 (256)
T ss_pred             EEEecCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCccccee
Confidence            9999999999999997433   25899999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchh
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      ......      .......++..|+|||...+..++.++||||||+++||+++ |+.||......  ......       
T Consensus       150 ~~~~~~------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~-------  214 (256)
T cd05059         150 VLDDQY------TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESV-------  214 (256)
T ss_pred             cccccc------cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHH-------
Confidence            532110      11111224567999999988899999999999999999999 89998653211  000000       


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                       .......                       .+..++.++.+++.+||+.+|++|||+.|+++.|
T Consensus       215 -~~~~~~~-----------------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         215 -SAGYRLY-----------------------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -HcCCcCC-----------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence             0000000                       0112366799999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.2e-40  Score=317.85  Aligned_cols=254  Identities=22%  Similarity=0.253  Sum_probs=195.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|.+.+.||+|+||.||+|+.  ..+++.||+|+++....   ...+.+.+|+.+++.++|+||+++++++     ..+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~   73 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVRE--KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDK   73 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEE--CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecC
Confidence            4688999999999999999984  44578899999975432   2345678899999999999999999874     345


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++....   ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        74 ~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg  147 (330)
T cd05601          74 DNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFG  147 (330)
T ss_pred             CeEEEEECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCC
Confidence            58899999999999999997542   35899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccC------CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhH
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM------GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHN  389 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~  389 (484)
                      ++..+.....      .......||+.|+|||++.      ...++.++|||||||++|||++|+.||......     .
T Consensus       148 ~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~  216 (330)
T cd05601         148 SAARLTANKM------VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-----K  216 (330)
T ss_pred             CCeECCCCCc------eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-----H
Confidence            9986633211      1112346899999999876      456789999999999999999999999653211     1


Q ss_pred             HHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          390 FVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ...        .+...........                 .......+.+++..|++ +|++|||++++++.
T Consensus       217 ~~~--------~i~~~~~~~~~~~-----------------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         217 TYN--------NIMNFQRFLKFPE-----------------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HHH--------HHHcCCCccCCCC-----------------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            111        1110000000000                 01124567889999998 99999999999853

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.5e-39  Score=305.68  Aligned_cols=248  Identities=23%  Similarity=0.318  Sum_probs=189.6

Q ss_pred             cccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       167 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      ||+|+||.||++...  .+++.||+|.+....   ......+..|++++++++||||+++++++     ..+...++|||
T Consensus         1 lg~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e   73 (277)
T cd05607           1 LGKGGFGEVCAVQVK--NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMS   73 (277)
T ss_pred             CCCCCceEEEEEEEc--cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEe
Confidence            799999999999854  357889999986432   12234556799999999999999998874     44568899999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccc
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA  323 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  323 (484)
                      |+++++|.+++....  ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||++......
T Consensus        74 ~~~g~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~  148 (277)
T cd05607          74 LMNGGDLKYHIYNVG--ERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG  148 (277)
T ss_pred             cCCCCCHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence            999999998886432  234889999999999999999999   899999999999999999999999999998765322


Q ss_pred             cccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhc
Q 011508          324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIV  403 (484)
Q Consensus       324 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (484)
                      .        ......|+..|+|||++.+..++.++||||+||++|||++|+.||...... .........        ..
T Consensus       149 ~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~-~~~~~~~~~--------~~  211 (277)
T cd05607         149 K--------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK-VAKEELKRR--------TL  211 (277)
T ss_pred             c--------eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch-hhHHHHHHH--------hh
Confidence            1        112235889999999998888999999999999999999999998653211 111111111        11


Q ss_pred             CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          404 DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       404 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      ......                    .......++.+++..||+.||++||+++|+++.+
T Consensus       212 ~~~~~~--------------------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         212 EDEVKF--------------------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             cccccc--------------------ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            000000                    0011255688999999999999999998776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=308.02  Aligned_cols=261  Identities=26%  Similarity=0.390  Sum_probs=201.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      .++|++.+.||+|+||.||+|.....   .....||+|.+..... .....+.+|+.+++.++|+||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence            35788899999999999999986532   2457899999865432 23457889999999999999999999853     


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDA------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL  307 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~  307 (484)
                      .....++||||+++++|.+++......      ...+++..++.++.|++.||.|||   +.+++||||||+||+++.++
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~  156 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDL  156 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCC
Confidence            345789999999999999999754321      224788999999999999999999   89999999999999999999


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCcc
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT  386 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~  386 (484)
                      .+||+|||+++........     .......++..|+|||.+.+..++.++|||||||++||+++ |+.||......  .
T Consensus       157 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~  229 (277)
T cd05032         157 TVKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--E  229 (277)
T ss_pred             CEEECCcccchhhccCccc-----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--H
Confidence            9999999998765332210     11122346788999999988889999999999999999998 99998642111  1


Q ss_pred             HhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          387 LHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      ..+...           +.....                    .+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       230 ~~~~~~-----------~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         230 VLKFVI-----------DGGHLD--------------------LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHHHh-----------cCCCCC--------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111110           000000                    01223567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2e-39  Score=309.23  Aligned_cols=252  Identities=22%  Similarity=0.300  Sum_probs=199.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ..+|++.+.||+|+||.||+|+.  ..++..|++|.+........+.+.+|+.+++.++|+|++++++.+..     +..
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~--~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~   91 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMD--VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDE   91 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEE--CCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCE
Confidence            35789999999999999999984  34567899999987665556788999999999999999999998643     448


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++..     ..+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+
T Consensus        92 ~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~  163 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (296)
T ss_pred             EEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccc
Confidence            8999999999999999863     23788999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......       .......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......    .+.. ....
T Consensus       164 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~-~~~~  231 (296)
T cd06654         164 AQITPEQ-------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYL-IATN  231 (296)
T ss_pred             hhccccc-------cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHH-HhcC
Confidence            7653221       11122358889999999988889999999999999999999999996532111    0100 0000


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .     .+.+..                     +......+.+++.+||..+|++|||+.|+++.
T Consensus       232 ~-----~~~~~~---------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         232 G-----TPELQN---------------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             C-----CCCCCC---------------------ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0     000000                     11224568899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.7e-39  Score=301.19  Aligned_cols=249  Identities=26%  Similarity=0.379  Sum_probs=191.9

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      +.||+|+||.||+|+..  .+++.+|+|.+..... .....+.+|++++++++||||++++++|.     .....++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e   73 (252)
T cd05084           1 ERIGRGNFGEVFSGRLR--ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVME   73 (252)
T ss_pred             CccCcccCccEEEEEEe--cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEe
Confidence            46999999999999854  3567899998764432 23457899999999999999999999864     3447899999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccc
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA  323 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  323 (484)
                      |+++++|.+++...   ...+++..++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||.+......
T Consensus        74 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  147 (252)
T cd05084          74 LVQGGDFLTFLRTE---GPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG  147 (252)
T ss_pred             eccCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccc
Confidence            99999999999632   235889999999999999999999   899999999999999999999999999998754321


Q ss_pred             cccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhhh
Q 011508          324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAEI  402 (484)
Q Consensus       324 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (484)
                      ..     .........+..|+|||.+.+..++.++||||||+++|||++ |..||......  .            ....
T Consensus       148 ~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~------------~~~~  208 (252)
T cd05084         148 VY-----ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--Q------------TREA  208 (252)
T ss_pred             cc-----cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--H------------HHHH
Confidence            10     000011123467999999988889999999999999999998 88888643111  0            0000


Q ss_pred             cCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          403 VDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       403 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      +......                   ..+..++..+.+++.+|++.+|++|||+.||+++|+
T Consensus       209 ~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         209 IEQGVRL-------------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             HHcCCCC-------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            0000000                   001223567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-39  Score=301.70  Aligned_cols=254  Identities=26%  Similarity=0.381  Sum_probs=194.8

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCceeeEEe
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDFEALVY  242 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  242 (484)
                      +.||+|+||.||+|+..+++....+++|.++... ....+.+.+|++++.++ +||||+++++++..     ....++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceEEE
Confidence            4699999999999997654444568888887432 23346788999999999 89999999998643     44789999


Q ss_pred             ecccCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 011508          243 ELMVNGSLEEWLHLNRD------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH  310 (484)
Q Consensus       243 e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k  310 (484)
                      ||+++|+|.+++.....            ....+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEE
Confidence            99999999999975431            1234789999999999999999999   89999999999999999999999


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhH
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHN  389 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~  389 (484)
                      |+|||++.......        .......+..|+|||++....++.++|||||||++|||++ |..||.....     ..
T Consensus       153 l~dfgl~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~  219 (270)
T cd05047         153 IADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AE  219 (270)
T ss_pred             ECCCCCccccchhh--------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HH
Confidence            99999886322110        0111224567999999988889999999999999999997 9999865311     11


Q ss_pred             HHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          390 FVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                      .....         ......+                   .+..+..++.+++.+|++.+|.+|||+.|++..|+.+.
T Consensus       220 ~~~~~---------~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         220 LYEKL---------PQGYRLE-------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHHH---------hCCCCCC-------------------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            11110         0000000                   01122557889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.7e-39  Score=305.61  Aligned_cols=262  Identities=28%  Similarity=0.427  Sum_probs=200.0

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCC---CeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDD---HETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      .+++|.+.+.||+|++|.||+|.+....   .+..||+|.+...... ....+.+|+.++++++|+||+++++++..   
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---   80 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE---   80 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc---
Confidence            3467899999999999999999975422   4678999988644332 33568999999999999999999998543   


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC--
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRD---APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL--  307 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~--  307 (484)
                        ....++||||+++++|.+++.....   ....+++..++.++.||+.||+|||   +++++||||||+||+++.++  
T Consensus        81 --~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~  155 (277)
T cd05036          81 --RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPG  155 (277)
T ss_pred             --CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCC
Confidence              3467899999999999999975432   1235899999999999999999999   88999999999999998754  


Q ss_pred             -ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCc
Q 011508          308 -TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNL  385 (484)
Q Consensus       308 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~  385 (484)
                       .+||+|||+++........     ........+..|+|||++.+..++.++|||||||++|||++ |..||......  
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--  228 (277)
T cd05036         156 RVAKIADFGMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--  228 (277)
T ss_pred             cceEeccCccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence             6999999999866322110     00111223568999999988899999999999999999997 99998653211  


Q ss_pred             cHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          386 TLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      .+.+.+.            ......                   .+..++..+.+++.+|++.+|++|||+.+|++.|+
T Consensus       229 ~~~~~~~------------~~~~~~-------------------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         229 EVMEFVT------------GGGRLD-------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHHHH------------cCCcCC-------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1111110            000000                   01223567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.3e-39  Score=302.47  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=193.1

Q ss_pred             CccccccceeEEEEEEcCC-CCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEe
Q 011508          165 NLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVY  242 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  242 (484)
                      +.||+|+||.||+|.+.+. .....+|+|.+.... ....+.+.+|+.+++.++|||++++++++.    ..+...++|+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----~~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICL----PSEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEee----cCCCCcEEEE
Confidence            4689999999999986532 345789999885432 233467889999999999999999999764    2334578999


Q ss_pred             ecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccccc
Q 011508          243 ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE  322 (484)
Q Consensus       243 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  322 (484)
                      ||+.+|+|.+++....   ...++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        77 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~  150 (262)
T cd05058          77 PYMKHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD  150 (262)
T ss_pred             ecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccC
Confidence            9999999999997432   34677888999999999999999   89999999999999999999999999999875532


Q ss_pred             ccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhC-CCCCCCCccCCccHhHHHHhhcchhhhh
Q 011508          323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG-KGPTNEMFTGNLTLHNFVKEALPERLAE  401 (484)
Q Consensus       323 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~  401 (484)
                      .....   ........++..|+|||.+.+..++.++|||||||++|||++| .+||....     ..+.....       
T Consensus       151 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-----~~~~~~~~-------  215 (262)
T cd05058         151 KEYYS---VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD-----SFDITVYL-------  215 (262)
T ss_pred             Cccee---ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHH-------
Confidence            21000   0111123456789999999888899999999999999999995 55554321     11111100       


Q ss_pred             hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          402 IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       402 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                       .......                    .+..++..+.+++..||+.+|++||++.||++.|+++.
T Consensus       216 -~~~~~~~--------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         216 -LQGRRLL--------------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -hcCCCCC--------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence             0000000                    01122457889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=320.42  Aligned_cols=207  Identities=24%  Similarity=0.312  Sum_probs=169.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||++..  ..+++.||+|++....   ....+.+.+|++++++++||||+++++++     .++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~   73 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDA   73 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEE--CCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcC
Confidence            4688999999999999999984  4467889999986432   22345678899999999999999999985     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      .+.++||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        74 ~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfG  146 (377)
T cd05629          74 QYLYLIMEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFG  146 (377)
T ss_pred             CeeEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecc
Confidence            5899999999999999999743    35888999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccC------CC--Cc--------------------------------cccccccccccccCccccCCCCCC
Q 011508          316 LAKFLPEAANNL------SS--NQ--------------------------------SSSVGVKGTVGYAAPEYGMGSEVS  355 (484)
Q Consensus       316 ~a~~~~~~~~~~------~~--~~--------------------------------~~~~~~~g~~~y~aPE~~~~~~~~  355 (484)
                      +++.+.......      ..  ..                                .......||+.|+|||++.+..++
T Consensus       147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  226 (377)
T cd05629         147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG  226 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence            986432111000      00  00                                000124699999999999988999


Q ss_pred             cccceehhhHHHHHHHhCCCCCCC
Q 011508          356 TSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       356 ~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      .++|||||||++|||++|+.||..
T Consensus       227 ~~~DiwSlGvil~elltG~~Pf~~  250 (377)
T cd05629         227 QECDWWSLGAIMFECLIGWPPFCS  250 (377)
T ss_pred             CceeeEecchhhhhhhcCCCCCCC
Confidence            999999999999999999999965

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.9e-39  Score=337.28  Aligned_cols=269  Identities=24%  Similarity=0.324  Sum_probs=202.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||+|++.....   ...+.+.+|++++++++||||+++++++.     ++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d--~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~   74 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYD--PVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DG   74 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEE--CCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eC
Confidence            5789999999999999999984  44578899999875432   22357889999999999999999999864     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRD-------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT  308 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~  308 (484)
                      +..++||||+++|+|.+++.....       ....+++..++.++.||++||+|||   +++|+||||||+||+++.++.
T Consensus        75 ~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~  151 (932)
T PRK13184         75 DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGE  151 (932)
T ss_pred             CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCC
Confidence            578999999999999999874321       1234677888999999999999999   899999999999999999999


Q ss_pred             eEEcccCcccccccccccC-----------CCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCC
Q 011508          309 AHVSDFGLAKFLPEAANNL-----------SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPT  377 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~-----------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~  377 (484)
                      +||+|||+++.........           ...........||+.|+|||++.+..++.++|||||||++|||+||+.||
T Consensus       152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF  231 (932)
T PRK13184        152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY  231 (932)
T ss_pred             EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence            9999999998762211000           00011112346999999999999999999999999999999999999999


Q ss_pred             CCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-CH
Q 011508          378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-NM  456 (484)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~  456 (484)
                      ..........    ..       .+.++.-..                    ...+++..+.+++.+|++.||++|| ++
T Consensus       232 ~~~~~~ki~~----~~-------~i~~P~~~~--------------------p~~~iP~~L~~LI~rcL~~DP~kR~ss~  280 (932)
T PRK13184        232 RRKKGRKISY----RD-------VILSPIEVA--------------------PYREIPPFLSQIAMKALAVDPAERYSSV  280 (932)
T ss_pred             CCcchhhhhh----hh-------hccChhhcc--------------------ccccCCHHHHHHHHHHccCChhhCcCHH
Confidence            6521111000    00       000000000                    0112356788999999999999996 67


Q ss_pred             HHHHHHHHHHHH
Q 011508          457 EEVAAQLLSFRN  468 (484)
Q Consensus       457 ~evl~~L~~i~~  468 (484)
                      +++.+.|+.+.+
T Consensus       281 eeLl~~Le~~lq  292 (932)
T PRK13184        281 QELKQDLEPHLQ  292 (932)
T ss_pred             HHHHHHHHHHHh
Confidence            777787877654

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.9e-39  Score=312.14  Aligned_cols=241  Identities=24%  Similarity=0.338  Sum_probs=185.6

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||.||+|+..  .+++.||+|+++...   ....+.+..|..++..+ +||||+++++++     ..+...++
T Consensus         1 ~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~l   73 (316)
T cd05592           1 KVLGKGSFGKVMLAELK--GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFF   73 (316)
T ss_pred             CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEE
Confidence            46999999999999854  456789999997542   22334556677777654 899999999884     44558899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        74 v~e~~~gg~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~  146 (316)
T cd05592          74 VMEYLNGGDLMFHIQSS----GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence            99999999999998743    35889999999999999999999   899999999999999999999999999998754


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ....       .......||..|+|||++.+..++.++|||||||++|||++|+.||.....     .+........   
T Consensus       147 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~---  211 (316)
T cd05592         147 MNGE-------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILND---  211 (316)
T ss_pred             CCCC-------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcC---
Confidence            2211       122234689999999999988999999999999999999999999975321     1111110000   


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH-HHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME-EVA  460 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl  460 (484)
                         .+.+                       +..+..++.+++..||+.||++||++. +++
T Consensus       212 ---~~~~-----------------------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         212 ---RPHF-----------------------PRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ---CCCC-----------------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence               0000                       111245678999999999999999976 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.5e-39  Score=301.23  Aligned_cols=250  Identities=30%  Similarity=0.415  Sum_probs=197.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      .+|.+.+.||+|+||.||++...    +..+|+|.++...  ..+.+.+|+.++++++|+|++++++++.    ..+...
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~----~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~   75 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGL   75 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc----CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCce
Confidence            46888999999999999999754    5678999886432  3467889999999999999999998753    334567


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++|+||+++++|.++++...  ...+++..++.++.|++.||+|||   +++++||||||+||++++++.+||+|||++.
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~  150 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK  150 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccce
Confidence            99999999999999997533  234889999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ......          ....++..|+|||++.+..++.++|||||||++|||++ |+.||...     .........   
T Consensus       151 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~-----~~~~~~~~~---  212 (256)
T cd05082         151 EASSTQ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRV---  212 (256)
T ss_pred             eccccC----------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHH---
Confidence            542211          11234568999999988889999999999999999998 99998642     111111110   


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                            ......                   ..+..++..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus       213 ------~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         213 ------EKGYKM-------------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ------hcCCCC-------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                  000000                   00123366789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.2e-39  Score=309.83  Aligned_cols=269  Identities=25%  Similarity=0.378  Sum_probs=205.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcC-----CCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDH-----DDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSV  230 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  230 (484)
                      .++|.+.+.||+|+||.||+|+...     ......+|+|.++.... .....+.+|+.+++++ +||||++++++|.  
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT--   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc--
Confidence            3578889999999999999997531     12346799998875432 2345688999999999 6999999999864  


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRD------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKP  298 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~  298 (484)
                         .+...++||||+++|+|.+++.....            ....+++.++..++.|++.||+|||   +++++||||||
T Consensus        89 ---~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp  162 (314)
T cd05099          89 ---QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAA  162 (314)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccc
Confidence               34478999999999999999975431            1235899999999999999999999   89999999999


Q ss_pred             CCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCC
Q 011508          299 SNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPT  377 (484)
Q Consensus       299 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~  377 (484)
                      +||++++++.+||+|||.++........     .......++..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~  237 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYY-----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY  237 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccc-----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999865432110     00111224567999999988889999999999999999999 88888


Q ss_pred             CCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                      .....     .......        ..... .                   ..+..++.++.+++.+||+.+|++|||+.
T Consensus       238 ~~~~~-----~~~~~~~--------~~~~~-~-------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~  284 (314)
T cd05099         238 PGIPV-----EELFKLL--------REGHR-M-------------------DKPSNCTHELYMLMRECWHAVPTQRPTFK  284 (314)
T ss_pred             CCCCH-----HHHHHHH--------HcCCC-C-------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence            64311     1111100        00000 0                   00122356788999999999999999999


Q ss_pred             HHHHHHHHHHHHHhh
Q 011508          458 EVAAQLLSFRNKLVK  472 (484)
Q Consensus       458 evl~~L~~i~~~~~~  472 (484)
                      |+++.|+++......
T Consensus       285 ~ll~~l~~~~~~~~~  299 (314)
T cd05099         285 QLVEALDKVLAAVSE  299 (314)
T ss_pred             HHHHHHHHHHHHhcC
Confidence            999999998776544

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.3e-39  Score=304.58  Aligned_cols=260  Identities=25%  Similarity=0.444  Sum_probs=200.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCC-CeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|+..+.||+|+||.||+|+..... ....+|+|.++... ....+.+.+|++++++++|+|++++.+++.     ..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCC
Confidence            46788899999999999999975432 23579999887543 223467889999999999999999999853     445


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++....   ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.+||+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          80 PAMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCcc
Confidence            7899999999999999997432   35899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.........    .........+..|+|||++....++.++|||||||++||+++ |+.||.....     .+..... 
T Consensus       154 ~~~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~i-  223 (268)
T cd05063         154 SRVLEDDPEG----TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAI-  223 (268)
T ss_pred             ceeccccccc----ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHH-
Confidence            8766432111    001111223467999999988889999999999999999998 9999864321     1111110 


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                             ... ...                   ....+++.++.+++.+|++.+|++||++.+|++.|+++
T Consensus       224 -------~~~-~~~-------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         224 -------NDG-FRL-------------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -------hcC-CCC-------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                   000 000                   00122356789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.8e-39  Score=306.96  Aligned_cols=268  Identities=22%  Similarity=0.336  Sum_probs=201.5

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCC--------------CeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCcee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDD--------------HETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVK  222 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~--------------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~  222 (484)
                      ..+|++.+.||+|+||.||+|......              .+..||+|.+..... ...+.+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            457899999999999999999865322              235689999875543 23467889999999999999999


Q ss_pred             EeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 011508          223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD-------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCD  295 (484)
Q Consensus       223 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d  295 (484)
                      +++++.     .+...++||||+++++|.+++.....       ....+++..++.++.|++.||+|||   +.+++|||
T Consensus        84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~d  155 (296)
T cd05051          84 LLGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRD  155 (296)
T ss_pred             EEEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccc
Confidence            999864     33578999999999999999975431       1225899999999999999999999   89999999


Q ss_pred             CCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh--C
Q 011508          296 LKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT--G  373 (484)
Q Consensus       296 lk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt--g  373 (484)
                      |||+||+++.++.++|+|||.+........     ........++..|+|||++.+..++.++|||||||++|||++  |
T Consensus       156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  230 (296)
T cd05051         156 LATRNCLVGKNYTIKIADFGMSRNLYSSDY-----YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR  230 (296)
T ss_pred             cchhceeecCCCceEEccccceeecccCcc-----eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCC
Confidence            999999999999999999999876532211     111123346778999999888889999999999999999998  6


Q ss_pred             CCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCC
Q 011508          374 KGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRER  453 (484)
Q Consensus       374 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  453 (484)
                      ..||......  .............     +.....                   ..+..++.++.+++.+|++.||++|
T Consensus       231 ~~p~~~~~~~--~~~~~~~~~~~~~-----~~~~~~-------------------~~~~~~~~~l~~li~~cl~~~p~~R  284 (296)
T cd05051         231 EQPYEHLTDQ--QVIENAGHFFRDD-----GRQIYL-------------------PRPPNCPKDIYELMLECWRRDEEDR  284 (296)
T ss_pred             CCCCCCcChH--HHHHHHHhccccc-----cccccC-------------------CCccCCCHHHHHHHHHHhccChhcC
Confidence            7777543211  0100110000000     000000                   0012235679999999999999999


Q ss_pred             CCHHHHHHHHH
Q 011508          454 MNMEEVAAQLL  464 (484)
Q Consensus       454 Pt~~evl~~L~  464 (484)
                      ||+.||++.|+
T Consensus       285 pt~~el~~~L~  295 (296)
T cd05051         285 PTFREIHLFLQ  295 (296)
T ss_pred             CCHHHHHHHhc
Confidence            99999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=4.2e-39  Score=301.40  Aligned_cols=254  Identities=29%  Similarity=0.483  Sum_probs=198.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||.||+|...   .+..+|+|.++.... ..+.+.+|+.++++++|+|++++++++.      ...
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~---~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~   74 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWN---GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEP   74 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEec---CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCC
Confidence            356889999999999999999855   345699999875433 3467899999999999999999998742      235


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .+++|||+++++|.++++...  ...+++..++.++.|++.||+|||   +++++||||||+||++++++.++|+|||.+
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~  149 (260)
T cd05070          75 IYIVTEYMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLA  149 (260)
T ss_pred             cEEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceee
Confidence            689999999999999997432  345899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ........      .......++..|+|||...+..++.++||||||+++|||++ |..||......  ......     
T Consensus       150 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~-----  216 (260)
T cd05070         150 RLIEDNEY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQV-----  216 (260)
T ss_pred             eeccCccc------ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHH-----
Confidence            76533211      11112235678999999988889999999999999999999 88998653211  111110     


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                             .......                   .+..++..+.+++.+|++.+|++|||+.++.+.|++
T Consensus       217 -------~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         217 -------ERGYRMP-------------------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -------HcCCCCC-------------------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                   0000000                   011225678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.7e-39  Score=310.23  Aligned_cols=265  Identities=25%  Similarity=0.377  Sum_probs=203.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCC-----CeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeeec
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDD-----HETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSVD  231 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  231 (484)
                      ++|.+.+.||+|+||.||+|......     ....+|+|.++.... .....+.+|+++++.+ +|+||++++++|.   
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~---   94 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT---   94 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe---
Confidence            57899999999999999999853221     235699999875432 2345688899999999 8999999999864   


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRD------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPS  299 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~  299 (484)
                        .++..++||||+++|+|.+++.....            ....+++.+++.++.|++.||+|||   +++++||||||+
T Consensus        95 --~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~  169 (307)
T cd05098          95 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR  169 (307)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHH
Confidence              33478999999999999999975432            1235889999999999999999999   899999999999


Q ss_pred             CeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCC
Q 011508          300 NVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN  378 (484)
Q Consensus       300 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~  378 (484)
                      ||+++.++.+||+|||.+.........     .......++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchh-----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999998765322100     01111224568999999988889999999999999999998 888885


Q ss_pred             CCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHH
Q 011508          379 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEE  458 (484)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  458 (484)
                      ...     ..+....         +......                   ..+..+..++.+++.+||+.+|++|||+.|
T Consensus       245 ~~~-----~~~~~~~---------~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  291 (307)
T cd05098         245 GVP-----VEELFKL---------LKEGHRM-------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQ  291 (307)
T ss_pred             cCC-----HHHHHHH---------HHcCCCC-------------------CCCCcCCHHHHHHHHHHcccChhhCcCHHH
Confidence            421     1111110         0000000                   001223567889999999999999999999


Q ss_pred             HHHHHHHHHHH
Q 011508          459 VAAQLLSFRNK  469 (484)
Q Consensus       459 vl~~L~~i~~~  469 (484)
                      |++.|+++.+.
T Consensus       292 vl~~l~~~~~~  302 (307)
T cd05098         292 LVEDLDRILAL  302 (307)
T ss_pred             HHHHHHHHHHH
Confidence            99999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.9e-39  Score=307.44  Aligned_cols=266  Identities=23%  Similarity=0.364  Sum_probs=204.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcC-----CCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcC-CCCCceeEeeeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDH-----DDHETLVAVKVLNLQH-RGASKSFIAECQALRSI-RHRNLVKIITSCVSV  230 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  230 (484)
                      .++|.+.+.||+|+||.||+|+...     ...+..||+|.+.... ......+.+|+.+++.+ +||||+++++++.  
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--
Confidence            4568889999999999999997531     2234579999886443 23346788999999999 8999999999854  


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRD------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKP  298 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~  298 (484)
                         .....++||||+++|+|.+++.....            ....+++.+++.++.|++.||+|||   +++++||||||
T Consensus        92 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp  165 (304)
T cd05101          92 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAA  165 (304)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeeccccc
Confidence               34578999999999999999975432            1235788999999999999999999   89999999999


Q ss_pred             CCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCC
Q 011508          299 SNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPT  377 (484)
Q Consensus       299 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~  377 (484)
                      +||++++++.+||+|||.++........     .......++..|+|||++.+..++.++||||||+++|||++ |..||
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  240 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  240 (304)
T ss_pred             ceEEEcCCCcEEECCCccceeccccccc-----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence            9999999999999999999866432211     11112335678999999988889999999999999999998 78887


Q ss_pred             CCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                      ....     ..+........         ...                   ..+..++..+.+++.+||+.+|++|||+.
T Consensus       241 ~~~~-----~~~~~~~~~~~---------~~~-------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~  287 (304)
T cd05101         241 PGIP-----VEELFKLLKEG---------HRM-------------------DKPANCTNELYMMMRDCWHAIPSHRPTFK  287 (304)
T ss_pred             ccCC-----HHHHHHHHHcC---------CcC-------------------CCCCCCCHHHHHHHHHHcccChhhCCCHH
Confidence            5431     11111110000         000                   00123466789999999999999999999


Q ss_pred             HHHHHHHHHHHH
Q 011508          458 EVAAQLLSFRNK  469 (484)
Q Consensus       458 evl~~L~~i~~~  469 (484)
                      ||++.|+++..-
T Consensus       288 e~l~~l~~~~~~  299 (304)
T cd05101         288 QLVEDLDRILTL  299 (304)
T ss_pred             HHHHHHHHHHHh
Confidence            999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1e-39  Score=316.92  Aligned_cols=197  Identities=30%  Similarity=0.446  Sum_probs=169.4

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-C-----CCceeEeeeeeeeccC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-H-----RNLVKIITSCVSVDFQ  233 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~  233 (484)
                      +|.+.+.||+|+||.|.+|.  +..+++.||||+++... ....+...|+.+|..|+ |     -|+|++++++     .
T Consensus       187 rY~V~e~LGkGtFGQVvk~~--d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~  258 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAY--DHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----Y  258 (586)
T ss_pred             EEEEEEEecccccceeEEEE--ecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----c
Confidence            78999999999999999999  55678999999998653 34466778999999996 4     3799999995     4


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC--CceEE
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE--LTAHV  311 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl  311 (484)
                      ..++.|||+|.+ ..+|.++++.+..  ..++...+..++.||+.||.+||   ..+|||+||||+||||.+.  ..+||
T Consensus       259 fr~HlciVfELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKV  332 (586)
T KOG0667|consen  259 FRNHLCIVFELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKV  332 (586)
T ss_pred             cccceeeeehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeE
Confidence            455999999999 6799999997654  35899999999999999999999   9999999999999999643  38999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      +|||.|.......          .....+..|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.
T Consensus       333 IDFGSSc~~~q~v----------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~  391 (586)
T KOG0667|consen  333 IDFGSSCFESQRV----------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD  391 (586)
T ss_pred             EecccccccCCcc----------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence            9999998753221          2456788999999999999999999999999999999998888764

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.7e-39  Score=304.23  Aligned_cols=251  Identities=26%  Similarity=0.350  Sum_probs=194.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|++.+.||+|+||.||+|+.  ..++..||+|.+..... .....+.+|++++++++||||+++++++..     ...
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~   73 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYH--LLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENR   73 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEE--cCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCE
Confidence            3578889999999999999984  34578899999875432 234578899999999999999999998654     347


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|..+.        .+++..+..++.|++.||+|||   +.+|+|+||||+||+++.++.++|+|||++
T Consensus        74 ~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~  142 (279)
T cd06619          74 ISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVS  142 (279)
T ss_pred             EEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence            78999999999997653        2678889999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ......         ......++..|+|||++.+..++.++||||||+++|+|++|+.||...........       +.
T Consensus       143 ~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~-------~~  206 (279)
T cd06619         143 TQLVNS---------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM-------PL  206 (279)
T ss_pred             eecccc---------cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc-------hH
Confidence            765321         11224688999999999988899999999999999999999999975332211100       00


Q ss_pred             h-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          398 R-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       398 ~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      . ...+.+.....                   ........++.+++.+|++.+|++||+++|+++.
T Consensus       207 ~~~~~~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         207 QLLQCIVDEDPPV-------------------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHHHHhccCCCC-------------------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            0 00000000000                   0001114568899999999999999999999865

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=4.1e-39  Score=304.70  Aligned_cols=262  Identities=24%  Similarity=0.398  Sum_probs=201.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCC--eeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDH--ETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ..+|++.+.||+|+||+||+|++...+.  ...||+|+++.... .....+.+|+.++..++|+||++++++|..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----   80 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-----   80 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-----
Confidence            3568889999999999999998654332  23589999875433 234678899999999999999999998742     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                       ...++++||+++|+|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||++++++.+||+||
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~df  153 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDF  153 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCC
Confidence             2467999999999999999743   235899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |+++........     .......++..|+|||...+..++.++|||||||++|||++ |..||......  .+..++..
T Consensus       154 G~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~  226 (279)
T cd05109         154 GLARLLDIDETE-----YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLEK  226 (279)
T ss_pred             Cceeecccccce-----eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHC
Confidence            999876432211     01111235678999999988889999999999999999998 89998653211  11111110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                      .            ...                   ..+..++..+.+++..||+.||++||++.|+++.|+++...
T Consensus       227 ~------------~~~-------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         227 G------------ERL-------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             C------------CcC-------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            0            000                   00112356788999999999999999999999998877544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-39  Score=299.96  Aligned_cols=252  Identities=29%  Similarity=0.436  Sum_probs=197.0

Q ss_pred             CccccccceeEEEEEEcCCC-CeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEe
Q 011508          165 NLIGAGSFGSVYKGIFDHDD-HETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVY  242 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  242 (484)
                      +.||+|+||.||+|++.... ....+|+|.+..... ...+.+.+|+++++.++|+|++++++++.      ....++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence            47999999999999865443 447899999875543 23467889999999999999999998752      23568999


Q ss_pred             ecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccccc
Q 011508          243 ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE  322 (484)
Q Consensus       243 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  322 (484)
                      ||+++++|.+++....    .+++..++.++.|++.||+|||   ..+++|+||||+||+++.++.+||+|||.++....
T Consensus        75 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~  147 (257)
T cd05060          75 ELAPLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGA  147 (257)
T ss_pred             EeCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeec
Confidence            9999999999997432    5899999999999999999999   89999999999999999999999999999986643


Q ss_pred             ccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhh
Q 011508          323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAE  401 (484)
Q Consensus       323 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  401 (484)
                      .....    .......++..|+|||...+..++.++||||||+++||+++ |+.||.....  ..+...+....+     
T Consensus       148 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~-----  216 (257)
T cd05060         148 GSDYY----RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGER-----  216 (257)
T ss_pred             CCccc----ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCc-----
Confidence            22111    11111224568999999988899999999999999999998 9999865321  111111111000     


Q ss_pred             hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          402 IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       402 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                           .                     ..+..++..+.+++.+||+.+|++||++.++++.|+++
T Consensus       217 -----~---------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         217 -----L---------------------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -----C---------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence                 0                     00222356789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=288.95  Aligned_cols=253  Identities=24%  Similarity=0.343  Sum_probs=200.6

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++.|++.+.||+|.|+.||+..  +..+++.+|+|+++...  ....+.+.+|+++.+.|+||||+++...     +..
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~--~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t-----i~~   81 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCV--HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQE   81 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHH--hccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh-----hcc
Confidence            45678889999999999999988  66678889999886432  2355788999999999999999999987     556


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEE
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHV  311 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl  311 (484)
                      ..+.++|+|+|.|++|..-+-..    ...++..+-...+||+.+|.|+|   .++|||||+||+|+++..   .-.+||
T Consensus        82 ~~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL  154 (355)
T KOG0033|consen   82 ESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKL  154 (355)
T ss_pred             cceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceee
Confidence            66899999999999997655422    23678888889999999999999   999999999999999943   347999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      +|||+|..+.        ......+..||++|+|||++...+|+..+|||+.||+||-|+.|.+||.+....  .+   .
T Consensus       155 ~~FGvAi~l~--------~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--rl---y  221 (355)
T KOG0033|consen  155 ADFGLAIEVN--------DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RL---Y  221 (355)
T ss_pred             cccceEEEeC--------CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--HH---H
Confidence            9999998764        244556788999999999999999999999999999999999999999763221  11   1


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....    ...+|    .+..                 .+....++..+|+++||..||.+|.|+.|.+.
T Consensus       222 e~I~----~g~yd----~~~~-----------------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  222 EQIK----AGAYD----YPSP-----------------EWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHh----ccccC----CCCc-----------------ccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            1100    00011    0000                 02223556789999999999999999999874

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-38  Score=300.20  Aligned_cols=258  Identities=25%  Similarity=0.343  Sum_probs=190.5

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      +.||+|+||.||+|.+.++.+...+|+|.++..... ....+.+|+.++++++||||+++++++.     .....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            368999999999998766666778999988755432 3357889999999999999999999854     3346899999


Q ss_pred             cccCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccccc
Q 011508          244 LMVNGSLEEWLHLNRD-APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE  322 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  322 (484)
                      |+++|+|.+++..... .....++..+..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||.+.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~  152 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK  152 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccC
Confidence            9999999999975432 2234677888899999999999999   89999999999999999999999999999875422


Q ss_pred             ccccCCCCccccccccccccccCccccCCC-------CCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGS-------EVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       323 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ...     ........++..|+|||++...       .++.++||||||+++|||++ |+.||........ .. .   .
T Consensus       153 ~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~-~---~  222 (269)
T cd05087         153 EDY-----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LT-Y---T  222 (269)
T ss_pred             cce-----eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HH-H---H
Confidence            110     0111224567889999987542       35789999999999999996 9999965322110 00 0   0


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      .........++.+.                       ..+...+.+++..|+ .+|++|||++||+..|+
T Consensus       223 ~~~~~~~~~~~~~~-----------------------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         223 VREQQLKLPKPRLK-----------------------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             hhcccCCCCCCccC-----------------------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00000111111110                       011445778999998 58999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.4e-39  Score=307.75  Aligned_cols=261  Identities=24%  Similarity=0.375  Sum_probs=201.3

Q ss_pred             CCCCccCccccccceeEEEEEEc---CCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  233 (484)
                      ++|.+.+.||+|+||.||+|...   .......||+|.++.... ...+.+.+|+.+++++ +|+||+++++++..    
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~----  110 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI----  110 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec----
Confidence            46888999999999999999752   233456899998875432 2345788999999999 79999999998643    


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                       .+..++||||+++|+|.++++...  ...+++.+++.++.|++.||+|||   +++|+|+||||+||+++.++.++|+|
T Consensus       111 -~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         111 -GGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             -CCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECC
Confidence             347899999999999999997433  233899999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||.++........     .......++..|+|||.+.+..++.++||||+||++|||++ |..||....... .+..   
T Consensus       185 fg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~---  255 (302)
T cd05055         185 FGLARDIMNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYK---  255 (302)
T ss_pred             CcccccccCCCce-----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHH---
Confidence            9998865332110     01112345778999999988889999999999999999998 999986532211 0111   


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                               .++.......                   +...+.++.+++.+|++.+|++|||+.|+++.|+++
T Consensus       256 ---------~~~~~~~~~~-------------------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         256 ---------LIKEGYRMAQ-------------------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             ---------HHHcCCcCCC-------------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                     1110000000                   011145689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.2e-39  Score=303.96  Aligned_cols=260  Identities=24%  Similarity=0.396  Sum_probs=203.0

Q ss_pred             CCCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|.+.+.||+|+||.||+|...+. .....||+|...... ....+.+.+|+.++++++|+||+++++++..      .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence            4578889999999999999986543 334579999887554 2344678999999999999999999998532      3


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++....   ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~  153 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGL  153 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCce
Confidence            4689999999999999997432   35899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++.......      .......++..|+|||.+....++.++||||||+++||+++ |..||.......  .......  
T Consensus       154 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~~~~~~--  223 (270)
T cd05056         154 SRYLEDESY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--VIGRIEN--  223 (270)
T ss_pred             eeecccccc------eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHc--
Confidence            876543211      00112234568999999888889999999999999999986 999996542211  0000000  


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                            -  ...                     ..+..++.++.+++.+|+..+|++|||+.++++.|++++.+
T Consensus       224 ------~--~~~---------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         224 ------G--ERL---------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             ------C--CcC---------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                  0  000                     00223466789999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.1e-39  Score=305.36  Aligned_cols=260  Identities=23%  Similarity=0.371  Sum_probs=199.8

Q ss_pred             CCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      +|.+.+.||+|+||.||+|.....   ..+..||+|+++..... ..+.+.+|+.++..++||||+++++++.     ..
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----KE   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC
Confidence            467788999999999999986432   24578999999755432 2356889999999999999999999853     33


Q ss_pred             ceeeEEeecccCCCHHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 011508          236 DFEALVYELMVNGSLEEWLHLNR------------DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL  303 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll  303 (484)
                      ...++++||+++++|.+++....            .....+++..++.++.|++.||+|||   +++|+||||||+||++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~  157 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLV  157 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEe
Confidence            47899999999999999985321            11235888999999999999999999   8999999999999999


Q ss_pred             cCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCcc
Q 011508          304 DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFT  382 (484)
Q Consensus       304 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~  382 (484)
                      ++++.+||+|||+++.......     ........+++.|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus       158 ~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  232 (283)
T cd05091         158 FDKLNVKISDLGLFREVYAADY-----YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  232 (283)
T ss_pred             cCCCceEecccccccccccchh-----eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            9999999999999886533211     111122345778999999988889999999999999999998 8888865311


Q ss_pred             CCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          383 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                           .++...        +.+....                    ..+.+|+..+.+++..||+.+|++||+++||++.
T Consensus       233 -----~~~~~~--------i~~~~~~--------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         233 -----QDVIEM--------IRNRQVL--------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             -----HHHHHH--------HHcCCcC--------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence                 111111        1111000                    0023346778999999999999999999999999


Q ss_pred             HHH
Q 011508          463 LLS  465 (484)
Q Consensus       463 L~~  465 (484)
                      |+.
T Consensus       280 l~~  282 (283)
T cd05091         280 LRT  282 (283)
T ss_pred             hhC
Confidence            864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.5e-39  Score=303.45  Aligned_cols=261  Identities=26%  Similarity=0.453  Sum_probs=200.5

Q ss_pred             CCCccCccccccceeEEEEEEcCCC-CeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .|++.+.||+|+||.||+|.....+ ....||+|.++... ......+..|+.+++.++||||+++++++     ..+..
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~~   79 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSRP   79 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCCc
Confidence            4778899999999999999975433 24579999987543 23346799999999999999999999985     44557


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++...   ...+++.+++.++.|++.||+|||   +++++|+||||+||+++.++.+||+|||.+
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~  153 (269)
T cd05065          80 VMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLS  153 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccc
Confidence            89999999999999998743   235899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ...........  .........+..|+|||.+.+..++.++|||||||++||+++ |..||......  .....+...  
T Consensus       154 ~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~--  227 (269)
T cd05065         154 RFLEDDTSDPT--YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQD--  227 (269)
T ss_pred             cccccCccccc--cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcC--
Confidence            76543221100  000111112457999999998899999999999999999887 99998653211  111111100  


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                            .  .+.                     .+.+++..+.+++..||+.+|++||++++|++.|+.+
T Consensus       228 ------~--~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 ------Y--RLP---------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------C--cCC---------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  0  000                     0223456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-39  Score=306.28  Aligned_cols=267  Identities=24%  Similarity=0.359  Sum_probs=197.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCC------------CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHD------------DHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIIT  225 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~------------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~  225 (484)
                      ++|++.+.||+|+||.||+++....            .....||+|.++.... .....+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5789999999999999999875321            1234689999875432 23356889999999999999999999


Q ss_pred             eeeeeccCCCceeeEEeecccCCCHHHHHhhcCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 011508          226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD--------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLK  297 (484)
Q Consensus       226 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk  297 (484)
                      ++.     .....++||||+++++|.+++.....        ....+++..++.++.|++.||+|||   +.+++|||||
T Consensus        85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlk  156 (295)
T cd05097          85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLA  156 (295)
T ss_pred             EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccC
Confidence            864     34578999999999999999864321        1124788999999999999999999   8999999999


Q ss_pred             CCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh--CCC
Q 011508          298 PSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT--GKG  375 (484)
Q Consensus       298 ~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt--g~~  375 (484)
                      |+||++++++.+||+|||++........     ........++..|+|||......++.++|||||||++|+|++  |..
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~  231 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQ  231 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999876532210     111112335678999999988889999999999999999998  566


Q ss_pred             CCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC
Q 011508          376 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN  455 (484)
Q Consensus       376 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt  455 (484)
                      ||......  .............     .......                   .+..++..+.+++.+|++.||++|||
T Consensus       232 p~~~~~~~--~~~~~~~~~~~~~-----~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~RPs  285 (295)
T cd05097         232 PYSLLSDE--QVIENTGEFFRNQ-----GRQIYLS-------------------QTPLCPSPVFKLMMRCWSRDIKDRPT  285 (295)
T ss_pred             CCcccChH--HHHHHHHHhhhhc-----cccccCC-------------------CCCCCCHHHHHHHHHHcCCCchhCcC
Confidence            77543211  1111000000000     0000000                   01112567999999999999999999


Q ss_pred             HHHHHHHHH
Q 011508          456 MEEVAAQLL  464 (484)
Q Consensus       456 ~~evl~~L~  464 (484)
                      +.+|++.|+
T Consensus       286 ~~~i~~~l~  294 (295)
T cd05097         286 FNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHh
Confidence            999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.1e-39  Score=303.55  Aligned_cols=259  Identities=24%  Similarity=0.339  Sum_probs=199.9

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  234 (484)
                      .+++.|++.+.||+|+||.||+|...  .+++.||+|++.... .....+.+|+.++.++ +|+|++++++++.......
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~--~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHV--KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEc--CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            45678899999999999999999854  457889999987553 3346788999999998 7999999999976543221


Q ss_pred             -CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          235 -NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       235 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                       ....++||||+++++|.+++....  ...+++..+..++.|++.|++|||   +++|+|+||||+||++++++.++|+|
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEcc
Confidence             346889999999999999987532  245889999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccC-----CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH  388 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~  388 (484)
                      ||++.......       .......|+..|+|||++.     ...++.++|||||||++|||++|+.||......    .
T Consensus       155 fg~~~~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~  223 (272)
T cd06637         155 FGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----R  223 (272)
T ss_pred             CCCceeccccc-------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----H
Confidence            99987653221       1122345889999999875     345788999999999999999999998643211    0


Q ss_pred             HHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          389 NFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....      ......+..                      ....++.++.+++.+||+.+|.+|||+.|+++
T Consensus       224 ~~~~------~~~~~~~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         224 ALFL------IPRNPAPRL----------------------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHHH------HhcCCCCCC----------------------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0000      000000000                      01123557889999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2e-39  Score=313.07  Aligned_cols=242  Identities=24%  Similarity=0.294  Sum_probs=188.2

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  235 (484)
                      +|.+.+.||+|+||.||+|+.  ..++..||+|+++...   ......+..|..++..+ +|++|+++++++     ...
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~   73 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAER--KGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTM   73 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEE--CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecC
Confidence            478889999999999999984  4457889999987542   22234567788888777 578888888874     344


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        74 ~~~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG  146 (323)
T cd05616          74 DRLYFVMEYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             CEEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCC
Confidence            5889999999999999998643    34889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +++......       .......||+.|+|||++.+..++.++|||||||++|||+||+.||......     ....   
T Consensus       147 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-----~~~~---  211 (323)
T cd05616         147 MCKENMWDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQ---  211 (323)
T ss_pred             CceecCCCC-------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-----HHHH---
Confidence            987532111       1122346899999999999999999999999999999999999999753211     1111   


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM  456 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  456 (484)
                           .+.......                     +.....++.+++.+|++.||++|++.
T Consensus       212 -----~i~~~~~~~---------------------p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         212 -----SIMEHNVAY---------------------PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -----HHHhCCCCC---------------------CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                 111100000                     11124567899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.4e-39  Score=320.92  Aligned_cols=208  Identities=25%  Similarity=0.307  Sum_probs=170.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .+|++.+.||+|+||.||+|+..  .+++.||+|++....   ......+.+|++++++++|+||+++++.+     .++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~   73 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKV--DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDK   73 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC--CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcC
Confidence            36889999999999999999844  457899999986432   22345678999999999999999999884     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|.+++...    ..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        74 ~~~~lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG  146 (376)
T cd05598          74 DNLYFVMDYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFG  146 (376)
T ss_pred             CEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCC
Confidence            6899999999999999999743    34788889999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccC------------------------------------CCCccccccccccccccCccccCCCCCCcccc
Q 011508          316 LAKFLPEAANNL------------------------------------SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGD  359 (484)
Q Consensus       316 ~a~~~~~~~~~~------------------------------------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~D  359 (484)
                      ++..+.......                                    ...........||+.|+|||++.+..++.++|
T Consensus       147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  226 (376)
T cd05598         147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD  226 (376)
T ss_pred             CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence            975432100000                                    00000012346999999999999999999999


Q ss_pred             eehhhHHHHHHHhCCCCCCCC
Q 011508          360 VYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       360 vws~Gvvl~elltg~~p~~~~  380 (484)
                      ||||||++|||++|+.||...
T Consensus       227 iwSlGvilyell~G~~Pf~~~  247 (376)
T cd05598         227 WWSVGVILYEMLVGQPPFLAD  247 (376)
T ss_pred             eeeccceeeehhhCCCCCCCC
Confidence            999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=6.4e-39  Score=301.34  Aligned_cols=260  Identities=26%  Similarity=0.437  Sum_probs=201.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCC-CeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .+|.+.+.||+|+||.||+|+....+ ....+|+|.++.... ...+.+.+|+.++++++||||+++++++.     .++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            46888999999999999999864332 345799998865432 23457889999999999999999999853     445


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++....   ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||.
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~  152 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGL  152 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCc
Confidence            7899999999999999997432   35899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.........    ........++..|+|||.+.+..++.++||||||+++||+++ |+.||......  .....+... 
T Consensus       153 ~~~~~~~~~~----~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~-  225 (267)
T cd05066         153 SRVLEDDPEA----AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEG-  225 (267)
T ss_pred             ccccccccce----eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCC-
Confidence            9876432211    011111223568999999998889999999999999999887 99998653211  111111100 


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                             ..  ...                     ...++..+.+++.+|++.+|++||++.++++.|+++
T Consensus       226 -------~~--~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 -------YR--LPA---------------------PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------Cc--CCC---------------------CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                   00  000                     112255788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.4e-39  Score=311.73  Aligned_cols=243  Identities=24%  Similarity=0.313  Sum_probs=190.1

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||.||+|+..  .++..||+|+++...   ......+..|..++..+ +||||+++++++     ...+..++
T Consensus         1 ~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~l   73 (318)
T cd05570           1 KVLGKGSFGKVLLAELK--GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFF   73 (318)
T ss_pred             CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEE
Confidence            46999999999999854  456789999997542   23345677888999888 799999999985     34558899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++|+|..++...    ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        74 v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  146 (318)
T cd05570          74 VMEYVNGGDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEG  146 (318)
T ss_pred             EEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence            99999999999988743    35899999999999999999999   899999999999999999999999999998643


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ....       .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.....     ......       
T Consensus       147 ~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~-------  207 (318)
T cd05570         147 ILGG-------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQS-------  207 (318)
T ss_pred             CcCC-------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHH-------
Confidence            2111       111234589999999999999999999999999999999999999965321     111110       


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH-----HHHHHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM-----EEVAAQ  462 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~~  462 (484)
                       +.......                     +..++..+.+++.+||+.||++|||+     .++++.
T Consensus       208 -i~~~~~~~---------------------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         208 -ILEDEVRY---------------------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             -HHcCCCCC---------------------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence             10000000                     11225578899999999999999999     777653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.4e-39  Score=305.80  Aligned_cols=269  Identities=26%  Similarity=0.280  Sum_probs=205.3

Q ss_pred             cHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeee
Q 011508          150 SYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCV  228 (484)
Q Consensus       150 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~  228 (484)
                      ...++..++++|.+.+.||+|+||.||+|...  .+++.+|+|++.... .....+.+|+.++.++ +|||++++++++.
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~--~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNK--KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEEC--CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            34555667889999999999999999999843  457889999986432 2345678899999999 8999999999986


Q ss_pred             eeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 011508          229 SVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT  308 (484)
Q Consensus       229 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~  308 (484)
                      ..+.......++||||+++++|.++++........+++..++.++.|++.||+|||   +.+++||||||+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCC
Confidence            54433445789999999999999998754434456899999999999999999999   899999999999999999999


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCC-----CCCcccceehhhHHHHHHHhCCCCCCCCccC
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-----EVSTSGDVYSFGILLLEMFTGKGPTNEMFTG  383 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~  383 (484)
                      +||+|||++.......       .......++..|+|||.+...     .++.++|||||||++|||++|+.||......
T Consensus       167 ~kl~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~  239 (291)
T cd06639         167 VKLVDFGVSAQLTSTR-------LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV  239 (291)
T ss_pred             EEEeecccchhccccc-------ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence            9999999987653221       111223578899999987543     3688999999999999999999998653211


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      . .+.++...         ..+.+..                     ++.....+.+++.+|++.+|++||++.|+++.
T Consensus       240 ~-~~~~~~~~---------~~~~~~~---------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         240 K-TLFKIPRN---------PPPTLLH---------------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             H-HHHHHhcC---------CCCCCCc---------------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0 00000000         0000000                     11124568899999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=318.86  Aligned_cols=245  Identities=26%  Similarity=0.375  Sum_probs=199.6

Q ss_pred             ccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEeecc
Q 011508          166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELM  245 (484)
Q Consensus       166 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  245 (484)
                      +||+|.||+||.|+  +..+...+|||-+........+.+..|+.+-++|+|.|||+++|.|     ..+++.-|.||.+
T Consensus       582 VLGKGTYG~VYA~R--D~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqV  654 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAAR--DMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQV  654 (1226)
T ss_pred             EeecCceeEEEeec--cccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecC
Confidence            59999999999998  5667889999999877766777899999999999999999999995     4455888999999


Q ss_pred             cCCCHHHHHhhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee-cCCCceEEcccCccccccc
Q 011508          246 VNGSLEEWLHLNRDAPRNL--NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL-DGELTAHVSDFGLAKFLPE  322 (484)
Q Consensus       246 ~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll-~~~~~~kl~Dfg~a~~~~~  322 (484)
                      +||+|.++++...   .++  .+..+-.+.+||++||.|||   .+.|||||||-+|+|+ +-.|.+||+|||.++.+..
T Consensus       655 PGGSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  655 PGGSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             CCCcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            9999999998544   334  67777888999999999999   9999999999999999 4678999999999987632


Q ss_pred             ccccCCCCccccccccccccccCccccCCC--CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGS--EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       323 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                             -.+....+.||..|||||++..+  .|+.++|||||||++.||.||++||..........   .+    -.+.
T Consensus       729 -------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---Fk----VGmy  794 (1226)
T KOG4279|consen  729 -------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---FK----VGMY  794 (1226)
T ss_pred             -------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---hh----hcce
Confidence                   23455567799999999998765  58899999999999999999999997653322110   00    0000


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .+ .|.                       .+++...+...++++|+.+||.+||+++++++
T Consensus       795 Kv-HP~-----------------------iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  795 KV-HPP-----------------------IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ec-CCC-----------------------CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            00 000                       14455778889999999999999999999985

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.6e-39  Score=313.89  Aligned_cols=238  Identities=28%  Similarity=0.323  Sum_probs=183.7

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHH-HHHcCCCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQ-ALRSIRHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||+||+|+.  ..+++.||+|++....   ......+..|.. +++.++||||+++++.+     ..++..++
T Consensus         1 ~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~l   73 (323)
T cd05575           1 KVIGKGSFGKVLLAKH--KADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYF   73 (323)
T ss_pred             CeeeeCCCeEEEEEEE--CCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEE
Confidence            4699999999999994  4467889999987532   122234555554 56789999999999885     34558899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++|+|.+++...    ..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++...
T Consensus        74 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~  146 (323)
T cd05575          74 VLDYVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (323)
T ss_pred             EEcCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence            99999999999998743    35889999999999999999999   899999999999999999999999999998753


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ...       ........||+.|+|||++.+..++.++|||||||++|||++|+.||....     ..+....       
T Consensus       147 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~~-------  207 (323)
T cd05575         147 IEH-------SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----TAEMYDN-------  207 (323)
T ss_pred             ccC-------CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-----HHHHHHH-------
Confidence            211       111223468999999999999999999999999999999999999996531     1111111       


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                       +.......                     ....+..+.+++.+|++.||++||++.
T Consensus       208 -i~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         208 -ILNKPLRL---------------------KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -HHcCCCCC---------------------CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             11110000                     011245688999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.4e-39  Score=320.48  Aligned_cols=278  Identities=20%  Similarity=0.235  Sum_probs=196.0

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|++.+.||+|+||.||+|..  ..+++.||+|.+....  ....+.+.+|+++++.++|+||+++++++...+......
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTD--PRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEE--CCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence            478889999999999999984  3457889999986432  223467889999999999999999999865433222236


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++|+||+. ++|.+++..    ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        79 ~~lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a  150 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLA  150 (372)
T ss_pred             EEEEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccce
Confidence            799999995 688887753    345899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.......      .......++..|+|||++.+. .++.++||||+||++|||++|+.||....... .+. .+.....
T Consensus       151 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~-~i~~~~g  222 (372)
T cd07853         151 RVEEPDES------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLD-LITDLLG  222 (372)
T ss_pred             eecccCcc------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHH-HHHHHcC
Confidence            86532211      111223578899999988764 57899999999999999999999997542211 111 1111000


Q ss_pred             hh-hhhh---cC---cccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          397 ER-LAEI---VD---PVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       397 ~~-~~~~---~d---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .. ..++   .+   ..+.........  .    .. ..........++.+++.+||+.||++|||+.|+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~----~~-~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         223 TPSLEAMRSACEGARAHILRGPHKPPS--L----PV-LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             CCCHHHHHHhhHHHHHHHHhCCCCCCc--h----HH-hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            00 0000   00   000000000000  0    00 000011225678899999999999999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-38  Score=298.13  Aligned_cols=253  Identities=26%  Similarity=0.396  Sum_probs=198.2

Q ss_pred             CccccccceeEEEEEEcCC-CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEe
Q 011508          165 NLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVY  242 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  242 (484)
                      +.||+|++|.||+|.+... .....||+|.+..... ...+.+.+|+.++++++|+||+++++.+..      ...++|+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            4689999999999997653 2334799999986655 455789999999999999999999998643      5789999


Q ss_pred             ecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccccc
Q 011508          243 ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE  322 (484)
Q Consensus       243 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  322 (484)
                      ||+++++|.+++.....  ..+++..++.++.|++.||+|||   +++++|+||+|+||+++.++.+||+|||++..+..
T Consensus        75 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~  149 (257)
T cd05040          75 ELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQ  149 (257)
T ss_pred             EecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccc
Confidence            99999999999975432  46899999999999999999999   89999999999999999999999999999987643


Q ss_pred             ccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhh
Q 011508          323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAE  401 (484)
Q Consensus       323 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  401 (484)
                      ....    ........++..|+|||++.+..++.++|||||||++|||++ |+.||......     +.....     ..
T Consensus       150 ~~~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~-----~~  215 (257)
T cd05040         150 NEDH----YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKKI-----DK  215 (257)
T ss_pred             cccc----eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH-----Hh
Confidence            2211    011112446788999999988889999999999999999999 99998643111     111100     00


Q ss_pred             hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          402 IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       402 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      . .....                     .+..++..+.+++.+|++.+|++|||+.||++.|.
T Consensus       216 ~-~~~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         216 E-GERLE---------------------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             c-CCcCC---------------------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            0 00000                     01123567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.5e-40  Score=284.43  Aligned_cols=252  Identities=25%  Similarity=0.368  Sum_probs=200.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc--------hHHHHHHHHHHHcC-CCCCceeEeeeeee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA--------SKSFIAECQALRSI-RHRNLVKIITSCVS  229 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~e~~~l~~l-~h~niv~~~~~~~~  229 (484)
                      ..|...+.||.|..++|-+..  +..++..+|+|++.......        .+.-.+|+.+|+++ .||+|+++.++   
T Consensus        17 ~~y~pkeilgrgvss~vrRci--~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~---   91 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCI--HKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDV---   91 (411)
T ss_pred             hhcChHHHhcccchhhhhhhh--hcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeee---
Confidence            457777899999999999988  55567889999987443211        24566899999998 79999999998   


Q ss_pred             eccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 011508          230 VDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA  309 (484)
Q Consensus       230 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~  309 (484)
                        ++.+.+.++|+|.|+.|.|.++|..    ...+++....+|++|+..|++|||   .++||||||||+|||++++.++
T Consensus        92 --yes~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i  162 (411)
T KOG0599|consen   92 --YESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNI  162 (411)
T ss_pred             --ccCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccce
Confidence              5666789999999999999999973    346999999999999999999999   9999999999999999999999


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCC------CCCCcccceehhhHHHHHHHhCCCCCCCCccC
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG------SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG  383 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~  383 (484)
                      ||+|||++..+.+..        .....+||++|.|||.+..      ..|+...|+|++||+||.|+.|.+||..-  .
T Consensus       163 ~isDFGFa~~l~~Ge--------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR--k  232 (411)
T KOG0599|consen  163 KISDFGFACQLEPGE--------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR--K  232 (411)
T ss_pred             EEeccceeeccCCch--------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH--H
Confidence            999999999875433        3345789999999998654      35788999999999999999999998531  0


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ...   +        +.-+..-...                 ..+..+.+......+|+.+||+.||.+|.|++|+++.
T Consensus       233 Qml---M--------LR~ImeGkyq-----------------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  233 QML---M--------LRMIMEGKYQ-----------------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHH---H--------HHHHHhcccc-----------------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            000   0        0111111110                 1111144556778999999999999999999999965

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.2e-39  Score=299.01  Aligned_cols=251  Identities=25%  Similarity=0.357  Sum_probs=198.9

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|++.+.||+|++|.||+|+..  .++..|++|.+....  ......+.+|+++++.++|||++++++++.     .++.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   73 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRK--ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGK   73 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEc--CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCE
Confidence            4778899999999999999854  356889999987432  234567889999999999999999999853     3458


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++....  ...+++..++.++.|++.||.|||   +.+++|+||||+||++++++.++|+|||.+
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          74 LNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             EEEEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccc
Confidence            899999999999999998542  345889999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......       .......++..|+|||+..+..++.++||||||+++|+|++|+.||.....     ......    
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~----  212 (256)
T cd08529         149 KLLSDNT-------NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILK----  212 (256)
T ss_pred             eeccCcc-------chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH----
Confidence            8664321       111223578899999999988899999999999999999999999965321     111110    


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                          +.......                    ....+...+.+++.+||+.+|++||++.++++.
T Consensus       213 ----~~~~~~~~--------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         213 ----IIRGVFPP--------------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ----HHcCCCCC--------------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                00000000                    011225678999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.8e-39  Score=307.27  Aligned_cols=265  Identities=25%  Similarity=0.364  Sum_probs=201.3

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeec
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVD  231 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  231 (484)
                      ...++|++.+.||+|+||.||+|...+.   ..+..||+|.++.... .....+.+|+..++.++|+||+++++++.   
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---   79 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS---   79 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc---
Confidence            3567899999999999999999975432   2345799998764432 22346788999999999999999999853   


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDA------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG  305 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~  305 (484)
                        .+...++||||+++|+|.+++......      ....++..+..++.|++.||+|||   +++|+||||||+||++++
T Consensus        80 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~  154 (288)
T cd05061          80 --KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAH  154 (288)
T ss_pred             --CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcC
Confidence              344789999999999999999753211      234577888999999999999999   899999999999999999


Q ss_pred             CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCC
Q 011508          306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGN  384 (484)
Q Consensus       306 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~  384 (484)
                      ++.++|+|||+++.......     ........++..|+|||.+.+..++.++|||||||++|||++ |..||.....  
T Consensus       155 ~~~~~L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--  227 (288)
T cd05061         155 DFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--  227 (288)
T ss_pred             CCcEEECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            99999999999876532211     011111235678999999988889999999999999999999 7888865311  


Q ss_pred             ccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          385 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                         .+...        .+.+.....                    .+..++..+.+++.+|++.||++|||+.|+++.|+
T Consensus       228 ---~~~~~--------~~~~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~  276 (288)
T cd05061         228 ---EQVLK--------FVMDGGYLD--------------------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK  276 (288)
T ss_pred             ---HHHHH--------HHHcCCCCC--------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence               11111        111110000                    01223567899999999999999999999998887


Q ss_pred             HH
Q 011508          465 SF  466 (484)
Q Consensus       465 ~i  466 (484)
                      +.
T Consensus       277 ~~  278 (288)
T cd05061         277 DD  278 (288)
T ss_pred             hh
Confidence            64

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.4e-39  Score=318.86  Aligned_cols=207  Identities=23%  Similarity=0.304  Sum_probs=169.6

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .|++.+.||+|+||.||+|+.  ..+++.||+|++....   ......+.+|+.++++++|+||+++++.+.     +++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~--~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~   74 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARK--VDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKD   74 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEE--CCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCC
Confidence            588899999999999999984  4467889999987532   223456889999999999999999999853     455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++|+|.+++...    ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGl  147 (382)
T cd05625          75 NLYFVMDYIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL  147 (382)
T ss_pred             EEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCC
Confidence            899999999999999998743    34788899999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccC----------------------------------------CCCccccccccccccccCccccCCCCCCc
Q 011508          317 AKFLPEAANNL----------------------------------------SSNQSSSVGVKGTVGYAAPEYGMGSEVST  356 (484)
Q Consensus       317 a~~~~~~~~~~----------------------------------------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~  356 (484)
                      +..+.......                                        ...........||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~  227 (382)
T cd05625         148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ  227 (382)
T ss_pred             CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence            75432110000                                        00000112346899999999999989999


Q ss_pred             ccceehhhHHHHHHHhCCCCCCCC
Q 011508          357 SGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       357 ~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ++||||+||++|||++|+.||...
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~  251 (382)
T cd05625         228 LCDWWSVGVILYEMLVGQPPFLAQ  251 (382)
T ss_pred             eeeEEechHHHHHHHhCCCCCCCC
Confidence            999999999999999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.7e-39  Score=311.04  Aligned_cols=241  Identities=24%  Similarity=0.304  Sum_probs=186.7

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||.||+|+..  .++..||+|+++...   .........|..++... +||||+++++++     ..++..++
T Consensus         1 ~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~l   73 (316)
T cd05620           1 KVLGKGSFGKVLLAELK--GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFF   73 (316)
T ss_pred             CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEE
Confidence            46999999999999954  457889999997542   22335567788888754 899999999885     44558999


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        74 v~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05620          74 VMEFLNGGDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKEN  146 (316)
T ss_pred             EECCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence            99999999999998643    35889999999999999999999   899999999999999999999999999998643


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ...       ........||..|+|||++.+..++.++||||+||++|||++|+.||.....     .......     .
T Consensus       147 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~~-----~  209 (316)
T cd05620         147 VFG-------DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFESI-----R  209 (316)
T ss_pred             ccC-------CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHH-----H
Confidence            211       1112335689999999999999999999999999999999999999965321     1111100     0


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH-HHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME-EVA  460 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl  460 (484)
                      . ..+.+                       +..+..++.+++.+||+.||++||++. ++.
T Consensus       210 ~-~~~~~-----------------------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         210 V-DTPHY-----------------------PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             h-CCCCC-----------------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            0 00000                       111245678999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-39  Score=339.46  Aligned_cols=260  Identities=20%  Similarity=0.289  Sum_probs=198.8

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      ...++|.+.+.||+|+||.||+|...  .++..+|+|.+.....  .....+..|+.++++++||||+++++++..   .
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk--~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d---e   84 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHK--RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN---K   84 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEEC--CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe---c
Confidence            34568999999999999999999954  4678899999875432  234678899999999999999999998643   2


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeeecCCCCCCeeecCC---
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC----ETPIVHCDLKPSNVLLDGE---  306 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~dlk~~NIll~~~---  306 (484)
                      .....++||||+++|+|.+++.........+++..++.|+.||+.||+|||+..    .++|+||||||+||||+.+   
T Consensus        85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~  164 (1021)
T PTZ00266         85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH  164 (1021)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence            345789999999999999999765444456999999999999999999999431    1569999999999999642   


Q ss_pred             --------------CceEEcccCcccccccccccCCCCccccccccccccccCccccCC--CCCCcccceehhhHHHHHH
Q 011508          307 --------------LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG--SEVSTSGDVYSFGILLLEM  370 (484)
Q Consensus       307 --------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~el  370 (484)
                                    ..+||+|||++..+....        ......||+.|+|||++.+  ..++.++|||||||++|||
T Consensus       165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYEL  236 (1021)
T PTZ00266        165 IGKITAQANNLNGRPIAKIGDFGLSKNIGIES--------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL  236 (1021)
T ss_pred             cccccccccccCCCCceEEccCCccccccccc--------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHH
Confidence                          358999999997653221        1123468999999998754  4588999999999999999


Q ss_pred             HhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCc
Q 011508          371 FTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELP  450 (484)
Q Consensus       371 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  450 (484)
                      +||+.||....    ....++.....     .  +.+.                      ....+.++.+|+..||+.+|
T Consensus       237 LTGk~PF~~~~----~~~qli~~lk~-----~--p~lp----------------------i~~~S~eL~dLI~~~L~~dP  283 (1021)
T PTZ00266        237 CSGKTPFHKAN----NFSQLISELKR-----G--PDLP----------------------IKGKSKELNILIKNLLNLSA  283 (1021)
T ss_pred             HHCCCCCCcCC----cHHHHHHHHhc-----C--CCCC----------------------cCCCCHHHHHHHHHHhcCCh
Confidence            99999996421    11111111000     0  0000                      01124578899999999999


Q ss_pred             CCCCCHHHHHH
Q 011508          451 RERMNMEEVAA  461 (484)
Q Consensus       451 ~~RPt~~evl~  461 (484)
                      .+||++.|++.
T Consensus       284 eeRPSa~QlL~  294 (1021)
T PTZ00266        284 KERPSALQCLG  294 (1021)
T ss_pred             hHCcCHHHHhc
Confidence            99999999985

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.4e-38  Score=297.58  Aligned_cols=257  Identities=23%  Similarity=0.344  Sum_probs=188.0

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      +.||+|+||.||+|..........+++|.+..... ...+.+.+|+.+++.++||||+++++.|..     ....++|||
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-----~~~~~lv~e   75 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-----AIPYLLVFE   75 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-----CCccEEEEe
Confidence            36999999999999865544455677787764432 344688999999999999999999998643     447899999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccc
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA  323 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  323 (484)
                      |+++|+|.+++..........++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~  152 (268)
T cd05086          76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE  152 (268)
T ss_pred             cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcc
Confidence            99999999999864433345677888899999999999999   899999999999999999999999999987643211


Q ss_pred             cccCCCCccccccccccccccCccccCC-------CCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          324 ANNLSSNQSSSVGVKGTVGYAAPEYGMG-------SEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       324 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      .     .........++..|+|||++..       ..++.++|||||||++|||++ |..||.....     ........
T Consensus       153 ~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~  222 (268)
T cd05086         153 D-----YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVI  222 (268)
T ss_pred             h-----hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHH
Confidence            1     0111123457889999998743       245789999999999999997 5667754211     11111111


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      .+......++.+..                       .....+.+++..|| .+|++||+++||++.|
T Consensus       223 ~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         223 KDQQVKLFKPQLEL-----------------------PYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             hhcccccCCCccCC-----------------------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            11111222222211                       11445777888899 6799999999999877

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6e-39  Score=314.49  Aligned_cols=204  Identities=25%  Similarity=0.292  Sum_probs=167.6

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeec-cC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVD-FQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~  233 (484)
                      ..++|++.+.||+|+||.||+++.  ..++..||+|++....  ......+.+|+.+++.++||||+++++++.... ..
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFD--TVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEE--cCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            347899999999999999999984  4467889999986432  233467889999999999999999999864322 11


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||++ ++|.+.+.      ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|
T Consensus        97 ~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~D  166 (359)
T cd07876          97 EFQDVYLVMELMD-ANLCQVIH------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  166 (359)
T ss_pred             ccceeEEEEeCCC-cCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEec
Confidence            2235789999995 56776664      23788889999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ||+++.....        .......+|..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus       167 fg~a~~~~~~--------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~  225 (359)
T cd07876         167 FGLARTACTN--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT  225 (359)
T ss_pred             CCCccccccC--------ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence            9998754221        1112346889999999999999999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-39  Score=299.39  Aligned_cols=254  Identities=24%  Similarity=0.298  Sum_probs=197.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-----cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-----GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      ++|.+.+.||+|++|.||+|..  ..++..+|+|.+.....     .....+.+|++++++++||||+++++++     .
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~--~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~   74 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYD--VDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----R   74 (263)
T ss_pred             CcccccceecCCCceEEEEEEE--cCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----c
Confidence            5789999999999999999984  34578899998864422     1235688899999999999999999985     3


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .+...++|+||+++++|.+++...    ..+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|
T Consensus        75 ~~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~d  147 (263)
T cd06625          75 DDETLSIFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGD  147 (263)
T ss_pred             cCCeEEEEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEee
Confidence            445899999999999999998743    34788999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||.++........    ........++..|+|||.+.+..++.++||||+|+++|||++|+.||.....    ...... 
T Consensus       148 fg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~-  218 (263)
T cd06625         148 FGASKRLQTICSS----GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFK-  218 (263)
T ss_pred             cccceeccccccc----cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHH-
Confidence            9998765332110    1111223577899999999998899999999999999999999999865311    110000 


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                              ........                   ..+..+...+.+++..||+.+|++|||+.|+++.
T Consensus       219 --------~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         219 --------IATQPTNP-------------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --------HhccCCCC-------------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                    00000000                   0012235678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=309.26  Aligned_cols=253  Identities=26%  Similarity=0.322  Sum_probs=206.5

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---chHHHHHHHHHHHcCC-CCCceeEeeeeeeecc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAECQALRSIR-HRNLVKIITSCVSVDF  232 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  232 (484)
                      ....|++.+.||+|.||.||+++  +..+++.+|+|++.+....   ..+.+.+|+.+|+++. ||||+.+.+.     +
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~--~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~-----~  105 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCR--EKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA-----F  105 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEE--ecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE-----E
Confidence            34678899999999999999999  4456889999999765432   3368899999999998 9999999999     4


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC----Cc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE----LT  308 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~----~~  308 (484)
                      +.....++|||++.||.|.+.+...     .+++..+..++.|++.+++|||   +.+|+||||||+|+|+...    +.
T Consensus       106 e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~  177 (382)
T KOG0032|consen  106 EDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGR  177 (382)
T ss_pred             EcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCc
Confidence            5556899999999999999999754     3899999999999999999999   8999999999999999543    47


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHh
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH  388 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~  388 (484)
                      +|++|||++.....        .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... 
T Consensus       178 ik~~DFGla~~~~~--------~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-  248 (382)
T KOG0032|consen  178 IKLIDFGLAKFIKP--------GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-  248 (382)
T ss_pred             EEEeeCCCceEccC--------CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-
Confidence            99999999997643        233455789999999999999999999999999999999999999998753322211 


Q ss_pred             HHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          389 NFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                                  .+....+...                 ...+......+.+++..|+..||.+|+|+.++++.
T Consensus       249 ------------~i~~~~~~f~-----------------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  249 ------------AILRGDFDFT-----------------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ------------HHHcCCCCCC-----------------CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                        1111111110                 00123346678899999999999999999999984

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.9e-39  Score=299.18  Aligned_cols=254  Identities=26%  Similarity=0.451  Sum_probs=199.5

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.++||+|+||.||+|...   ++..||+|.+..... ....+.+|+.++++++|+|++++++++.      .+.
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~---~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~   74 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN---GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT------QEP   74 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC---CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCC
Confidence            357889999999999999999854   456799999875433 3467899999999999999999998731      235


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .+++|||+++++|.+++....  ...+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||.+
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  149 (260)
T cd05067          75 IYIITEYMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLA  149 (260)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcce
Confidence            799999999999999987433  345889999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ........      .......++..|+|||++....++.++||||||+++||+++ |+.||......  .......    
T Consensus       150 ~~~~~~~~------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~----  217 (260)
T cd05067         150 RLIEDNEY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLE----  217 (260)
T ss_pred             eecCCCCc------ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHH----
Confidence            76542211      11112345678999999988889999999999999999999 99999653211  0110000    


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                              ......                   .+..++.++.+++.+|++.+|++|||++++.+.|+.
T Consensus       218 --------~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         218 --------RGYRMP-------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --------cCCCCC-------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                    000000                   011125578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.6e-39  Score=303.08  Aligned_cols=253  Identities=23%  Similarity=0.313  Sum_probs=195.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|.+.+.||+|+||.||+|+.  ..+++.||+|.++.........+.+|+.+++.++||||+++++.+.     ..+..
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~   81 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARN--VNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKL   81 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEE--cCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEE
Confidence            4678889999999999999984  4457889999988665445567889999999999999999999854     34578


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++++|.+++...    ..+++.+++.++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||.+.
T Consensus        82 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd06645          82 WICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSA  154 (267)
T ss_pred             EEEEeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeee
Confidence            9999999999999998643    35889999999999999999999   8899999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccC---CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM---GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ......       .......|+..|+|||++.   ...++.++|||||||++|+|++|+.||........ .......  
T Consensus       155 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~--  224 (267)
T cd06645         155 QITATI-------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKS--  224 (267)
T ss_pred             EccCcc-------cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhcc--
Confidence            653211       1112346889999999874   45688999999999999999999999864321110 0000000  


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                           ....+....                     ...++..+.+++.+|++.+|++||++++|++
T Consensus       225 -----~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         225 -----NFQPPKLKD---------------------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             -----CCCCCcccc---------------------cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                 000000000                     0012346789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.1e-39  Score=309.63  Aligned_cols=242  Identities=24%  Similarity=0.353  Sum_probs=187.0

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||.||+|+..  .+++.||+|+++...   ......+..|..++... +||||+++++++.     .++..++
T Consensus         1 ~~lG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~l   73 (316)
T cd05619           1 KMLGKGSFGKVFLAELK--GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFF   73 (316)
T ss_pred             CeeeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEE
Confidence            46999999999999844  456889999997542   22335567788888764 9999999999853     4458899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++|+|.+++...    ..+++.++..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++...
T Consensus        74 v~ey~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  146 (316)
T cd05619          74 VMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKEN  146 (316)
T ss_pred             EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence            99999999999998743    34889999999999999999999   899999999999999999999999999998743


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ...       ........||..|+|||++.+..++.++|||||||++|||++|+.||.....     .+......     
T Consensus       147 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~i~-----  209 (316)
T cd05619         147 MLG-------DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQSIR-----  209 (316)
T ss_pred             CCC-------CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH-----
Confidence            211       1112234689999999999988999999999999999999999999975321     11111000     


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH-HHHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME-EVAA  461 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  461 (484)
                       ...+..                       +..+..++.+++.+||+.||++||++. ++.+
T Consensus       210 -~~~~~~-----------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         210 -MDNPCY-----------------------PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             -hCCCCC-----------------------CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence             000000                       111245678999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-39  Score=295.61  Aligned_cols=258  Identities=27%  Similarity=0.337  Sum_probs=204.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      +.|++.+.||.|.-|+||++.+..  ++..+|+|++.+..   .....+...|-+||+.++||.+..+|..     ++.+
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~--t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-----fet~  149 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRG--TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-----FETD  149 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecC--CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-----eecc
Confidence            346778899999999999999654  45899999998653   3344677889999999999999999998     6677


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ++.|+|||||+||+|..+++.+  ..+.+++..+.-++..++-||+|||   ..|||.|||||+||||.++|++.|+||.
T Consensus       150 ~~~cl~meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFD  224 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFD  224 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeecc
Confidence            7999999999999999998854  4567999999999999999999999   8999999999999999999999999999


Q ss_pred             ccccccccccc-----------------------------C--------------------CCCccccccccccccccCc
Q 011508          316 LAKFLPEAANN-----------------------------L--------------------SSNQSSSVGVKGTVGYAAP  346 (484)
Q Consensus       316 ~a~~~~~~~~~-----------------------------~--------------------~~~~~~~~~~~g~~~y~aP  346 (484)
                      ++.........                             .                    ......+..++||-.|.||
T Consensus       225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP  304 (459)
T KOG0610|consen  225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP  304 (459)
T ss_pred             ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence            87543210000                             0                    0011223457899999999


Q ss_pred             cccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccc
Q 011508          347 EYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRT  426 (484)
Q Consensus       347 E~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~  426 (484)
                      |++.+...+.+.|.|+|||++|||+.|..||.+..... .            +..++-+.+..-.               
T Consensus       305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~-T------------l~NIv~~~l~Fp~---------------  356 (459)
T KOG0610|consen  305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE-T------------LRNIVGQPLKFPE---------------  356 (459)
T ss_pred             eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh-h------------HHHHhcCCCcCCC---------------
Confidence            99999999999999999999999999999998854332 2            2223322221100               


Q ss_pred             cccchhHHHHHHHhHhhccCCCCcCCCCC----HHHHH
Q 011508          427 RSFGGKECLVSVLGIGVICSSELPRERMN----MEEVA  460 (484)
Q Consensus       427 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl  460 (484)
                          ..+....+.+||++.|..||++|-.    +.||-
T Consensus       357 ----~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  357 ----EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             ----CCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence                1123567899999999999999998    66654

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-39  Score=313.22  Aligned_cols=241  Identities=26%  Similarity=0.282  Sum_probs=188.6

Q ss_pred             CccccccceeEEEEEEc-CCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEE
Q 011508          165 NLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALV  241 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~-~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  241 (484)
                      +.||+|+||.||+++.. +..+++.||+|++.....  .....+.+|++++++++||||+++++++     ..+...++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence            57999999999998753 234678999999975432  2234577899999999999999999885     345588999


Q ss_pred             eecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccc
Q 011508          242 YELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP  321 (484)
Q Consensus       242 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~  321 (484)
                      |||+++|+|.+++...    ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        77 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  149 (318)
T cd05582          77 LDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  149 (318)
T ss_pred             EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccC
Confidence            9999999999998643    35899999999999999999999   8999999999999999999999999999987543


Q ss_pred             cccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhh
Q 011508          322 EAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAE  401 (484)
Q Consensus       322 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  401 (484)
                      ...       .......|+..|+|||.+.+..++.++|||||||++|||++|+.||.....     .....        .
T Consensus       150 ~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~--------~  209 (318)
T cd05582         150 DHE-------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-----KETMT--------M  209 (318)
T ss_pred             CCC-------CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-----HHHHH--------H
Confidence            221       112235689999999999888899999999999999999999999965311     11111        1


Q ss_pred             hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHH
Q 011508          402 IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEE  458 (484)
Q Consensus       402 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  458 (484)
                      +.......                     +..+...+.+++..||+.||++||++.+
T Consensus       210 i~~~~~~~---------------------p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         210 ILKAKLGM---------------------PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             HHcCCCCC---------------------CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            11000000                     1122456889999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.4e-39  Score=302.78  Aligned_cols=242  Identities=23%  Similarity=0.342  Sum_probs=185.0

Q ss_pred             ccccccceeEEEEEEcC----------------------CCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeE
Q 011508          166 LIGAGSFGSVYKGIFDH----------------------DDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKI  223 (484)
Q Consensus       166 ~lg~G~~g~Vy~~~~~~----------------------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  223 (484)
                      .||+|+||.||+|.+..                      ......|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998532                      12235689999876544445678899999999999999999


Q ss_pred             eeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 011508          224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL  303 (484)
Q Consensus       224 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll  303 (484)
                      +++|...     ...++||||+++|+|..++...   ...+++..+..++.|+++||+|||   +++|+||||||+||++
T Consensus        82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill  150 (274)
T cd05076          82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILL  150 (274)
T ss_pred             EEEEEeC-----CceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEE
Confidence            9997543     3779999999999999998642   235889999999999999999999   8999999999999999


Q ss_pred             cCCC-------ceEEcccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHH-hCC
Q 011508          304 DGEL-------TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMF-TGK  374 (484)
Q Consensus       304 ~~~~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~ell-tg~  374 (484)
                      +..+       .+|++|||.+......           ....++..|+|||.+.+ ..++.++|||||||++||++ +|+
T Consensus       151 ~~~~~~~~~~~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~  219 (274)
T cd05076         151 ARLGLAEGTSPFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE  219 (274)
T ss_pred             eccCcccCccceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            7643       3799999987643211           11246788999998765 56899999999999999995 699


Q ss_pred             CCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC
Q 011508          375 GPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM  454 (484)
Q Consensus       375 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  454 (484)
                      .||.......  ...+.            +.....                     +......+.+++.+||+.+|++||
T Consensus       220 ~p~~~~~~~~--~~~~~------------~~~~~~---------------------~~~~~~~~~~li~~cl~~~p~~Rp  264 (274)
T cd05076         220 VPLKERTPSE--KERFY------------EKKHRL---------------------PEPSCKELATLISQCLTYEPTQRP  264 (274)
T ss_pred             CCccccChHH--HHHHH------------HhccCC---------------------CCCCChHHHHHHHHHcccChhhCc
Confidence            9986532111  00110            000000                     000134688999999999999999


Q ss_pred             CHHHHHHHHH
Q 011508          455 NMEEVAAQLL  464 (484)
Q Consensus       455 t~~evl~~L~  464 (484)
                      |+.+|++.|+
T Consensus       265 s~~~il~~L~  274 (274)
T cd05076         265 SFRTILRDLT  274 (274)
T ss_pred             CHHHHHHhhC
Confidence            9999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=298.00  Aligned_cols=250  Identities=33%  Similarity=0.469  Sum_probs=199.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||.|+||.||+|...    ++.||+|.++.... ..+++.+|+.+++.++|+|++++++++.     ....
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~----~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~   74 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR----GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNP   74 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec----CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCC
Confidence            356888999999999999999854    57799999976544 4578899999999999999999999853     3457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++....  ...+++..++.++.|++.||.|||   .++++|+||||+||+++.++.+||+|||.+
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~  149 (256)
T cd05039          75 LYIVTEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLA  149 (256)
T ss_pred             eEEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccc
Confidence            899999999999999997433  235899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.......          ....+..|+|||.+....++.++||||||+++||+++ |+.||......  .+...+..   
T Consensus       150 ~~~~~~~~----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~---  214 (256)
T cd05039         150 KEASQGQD----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPHVEK---  214 (256)
T ss_pred             cccccccc----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhc---
Confidence            86632210          1234567999999988889999999999999999997 99998643111  01000000   


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                               ....                   ..+..++..+.+++.+||+.+|++|||+.|++++|+.
T Consensus       215 ---------~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         215 ---------GYRM-------------------EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ---------CCCC-------------------CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence                     0000                   0012235678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-39  Score=318.21  Aligned_cols=281  Identities=19%  Similarity=0.185  Sum_probs=198.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ..+|.+.+.||+|+||.||++...+...+..||+|.+...     ....+|++++++++||||+++++++     .....
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAY-----RWKST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeE-----eeCCE
Confidence            4579999999999999999998666566788999987643     3456899999999999999999885     34458


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++|||++ .++|.+++..    ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.++|+|||++
T Consensus       161 ~~lv~e~~-~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a  232 (392)
T PHA03207        161 VCMVMPKY-KCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA  232 (392)
T ss_pred             EEEEehhc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccc
Confidence            89999999 5789888842    245899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCC--ccHhHHHHhhc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN--LTLHNFVKEAL  395 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~  395 (484)
                      ........     ........||..|+|||++.+..++.++|||||||++|||++|+.||.......  ..+........
T Consensus       233 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~  307 (392)
T PHA03207        233 CKLDAHPD-----TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ  307 (392)
T ss_pred             cccCcccc-----cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhc
Confidence            76543221     111224568999999999999999999999999999999999999997643221  11111111100


Q ss_pred             chhh--hhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 PERL--AEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~~~~--~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ....  ..-....+.............. ...............+.+++..||..||++|||+.|++..
T Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        308 VHPLEFPQNGSTNLCKHFKQYAIVLRPP-YTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cCccccCCccchhHHHHHHhhcccccCC-ccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000  0000000000000000000000 0000000011124567889999999999999999999875

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-38  Score=296.59  Aligned_cols=254  Identities=29%  Similarity=0.468  Sum_probs=200.5

Q ss_pred             CccccccceeEEEEEEcCC-CCeeEEEEEEeeccCccc-hHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEe
Q 011508          165 NLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHRGA-SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVY  242 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  242 (484)
                      +.||+|+||.||+|..... ..+..|++|.++...... .+.+.+|++.+..++|+|++++++++..     ....++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4699999999999997543 336789999997654433 5788999999999999999999998643     55889999


Q ss_pred             ecccCCCHHHHHhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          243 ELMVNGSLEEWLHLNRDA-----PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       243 e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      ||+++++|.+++......     ...+++..++.++.|++.||+|||   +++++||||+|+||+++.++.+||+|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccc
Confidence            999999999999854211     356899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ........     ........++..|+|||.+....++.++||||+|+++|||++ |..||.....     .....    
T Consensus       153 ~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~----  218 (262)
T cd00192         153 RDVYDDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-----EEVLE----  218 (262)
T ss_pred             cccccccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH----
Confidence            87644321     111223457889999999888889999999999999999999 6999876411     11111    


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                          .+.+....                    ..+..++.++.+++.+|++.+|++|||+.|+++.|+
T Consensus       219 ----~~~~~~~~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         219 ----YLRKGYRL--------------------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ----HHHcCCCC--------------------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                01100000                    002223567899999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-38  Score=301.28  Aligned_cols=265  Identities=23%  Similarity=0.266  Sum_probs=201.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|+..+.||.|++|.||+|...  .+++.+|+|.+..... .....+.+|++++++++||||+++++++...   ....
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~   75 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLK--NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSS   75 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEEC--CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCe
Confidence            46788899999999999999954  3578899999875433 3346789999999999999999999987532   3446


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++.........+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccc
Confidence            79999999999999988754444456889999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......         .....++..|+|||.+.+..++.++||||+||++|+|++|+.||...........+......  
T Consensus       153 ~~~~~~~---------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--  221 (287)
T cd06621         153 GELVNSL---------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV--  221 (287)
T ss_pred             ccccccc---------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh--
Confidence            7542211         11234778899999998889999999999999999999999999754221111111111000  


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                         ..-.+.+......                 .......+.+++..||+.+|++|||+.||++.
T Consensus       222 ---~~~~~~~~~~~~~-----------------~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         222 ---NMPNPELKDEPGN-----------------GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             ---cCCchhhccCCCC-----------------CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence               0000000000000                 01124578899999999999999999999874

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.6e-39  Score=313.75  Aligned_cols=206  Identities=23%  Similarity=0.328  Sum_probs=171.6

Q ss_pred             hHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeee
Q 011508          153 NLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVS  229 (484)
Q Consensus       153 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  229 (484)
                      ++....++|++.+.||+|+||.||+++.  ..+++.+|+|++....   ......+.+|+.+++.++||||+++++.+  
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~--~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~--  112 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRH--KSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF--  112 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEE--CCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE--
Confidence            3445568999999999999999999984  4467889999986422   22334577899999999999999999885  


Q ss_pred             eccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 011508          230 VDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA  309 (484)
Q Consensus       230 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~  309 (484)
                         ..+...++||||+++|+|.+++...     .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+
T Consensus       113 ---~~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~i  181 (371)
T cd05622         113 ---QDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL  181 (371)
T ss_pred             ---EcCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCE
Confidence               4455899999999999999998632     3788889999999999999999   8999999999999999999999


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCCC----CCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS----EVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      ||+|||++.......      ........||+.|+|||++...    .++.++|||||||++|||++|+.||..
T Consensus       182 kL~DfG~a~~~~~~~------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~  249 (371)
T cd05622         182 KLADFGTCMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA  249 (371)
T ss_pred             EEEeCCceeEcCcCC------cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence            999999998653221      1111235699999999988653    378999999999999999999999975

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.3e-38  Score=299.51  Aligned_cols=258  Identities=24%  Similarity=0.311  Sum_probs=196.4

Q ss_pred             HHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       155 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      +.+++++.....||+|+||.||+|+..  .++..||+|.+........+.+.+|+.++++++|+||+++++++.     .
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~--~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~   76 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDL--STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----E   76 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEec--CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----c
Confidence            345666667789999999999999854  356789999987665555678999999999999999999999864     3


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEcc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG-ELTAHVSD  313 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~D  313 (484)
                      ++..++|+||+++++|.+++..... ....++..+..++.|++.||+|||   +++|+||||||+||+++. ++.++|+|
T Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~d  152 (268)
T cd06624          77 NGFFKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISD  152 (268)
T ss_pred             CCEEEEEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEec
Confidence            4588999999999999999974321 111278888999999999999999   899999999999999976 67999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCC--CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS--EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      ||.+.......       .......++..|+|||++...  .++.++||||||+++|+|++|+.||.........  .+.
T Consensus       153 fg~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~~~  223 (268)
T cd06624         153 FGTSKRLAGIN-------PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--MFK  223 (268)
T ss_pred             chhheecccCC-------CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--Hhh
Confidence            99987653211       111223478899999987654  3788999999999999999999998643211100  000


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..     ... ..+.                       .+..+..++.+++.+||+.+|++|||+.|+++
T Consensus       224 ~~-----~~~-~~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         224 VG-----MFK-IHPE-----------------------IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hh-----hhc-cCCC-----------------------CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            00     000 0000                       01223557889999999999999999999976

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.5e-39  Score=307.84  Aligned_cols=275  Identities=21%  Similarity=0.289  Sum_probs=195.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|.+.+.||+|+||.||+|+.  ..++..||+|.++.... .....+.+|++++++++||||+++++++.     .++.
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~   78 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRS--KLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKS   78 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEe--cCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCe
Confidence            6789999999999999999984  34567899999875432 23356788999999999999999999854     3457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||++ ++|.+++...   ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  151 (309)
T cd07872          79 LTLVFEYLD-KDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLA  151 (309)
T ss_pred             EEEEEeCCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccc
Confidence            899999996 5888887643   234788999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh--
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA--  394 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~--  394 (484)
                      .......       .......++..|+|||.+.+ ..++.++|||||||++|||+||+.||....... .+.......  
T Consensus       152 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~  223 (309)
T cd07872         152 RAKSVPT-------KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGT  223 (309)
T ss_pred             eecCCCc-------cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCC
Confidence            7542211       11122357889999998765 568899999999999999999999997542211 111111100  


Q ss_pred             -cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 -LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 -~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                       .++....+.+..-.............. ..     ....+..++.+++.+|++.||.+|||+.|+++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         224 PTEETWPGISSNDEFKNYNFPKYKPQPL-IN-----HAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CCHHHHhhhcchhhhhhhhcCccCCCch-hh-----hccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             000011111000000000000000000 00     01123557889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-38  Score=297.76  Aligned_cols=253  Identities=28%  Similarity=0.470  Sum_probs=197.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|.+...||+|++|.||+|.+..   ...+|+|.+.... ...+.+.+|++++++++|+|++++++++.      ....
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~   75 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNG---TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPI   75 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcC---CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCc
Confidence            568888999999999999998653   3458999876443 23467889999999999999999988742      2357


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++++|.++++...  ...+++..+..++.|++.||+|||   +.+++|+||||+||++++++.++|+|||.+.
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~  150 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLAR  150 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccce
Confidence            89999999999999997532  345789999999999999999999   8999999999999999999999999999997


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......      .......++..|+|||...+..++.++||||||+++|||+| |+.||......  .........   
T Consensus       151 ~~~~~~~------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~---  219 (260)
T cd05069         151 LIEDNEY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--EVLEQVERG---  219 (260)
T ss_pred             EccCCcc------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC---
Confidence            6532211      11112235678999999988889999999999999999999 89998653211  010110000   


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                           ....                       .+...+..+.+++.+||+.||++||++++|++.|++
T Consensus       220 -----~~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         220 -----YRMP-----------------------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -----CCCC-----------------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                 0000                       011225678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.7e-38  Score=301.88  Aligned_cols=262  Identities=26%  Similarity=0.431  Sum_probs=200.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      .++|++.+.||+|+||.||+|....   ..++..||+|++..... .....+.+|+.++++++|||++++++++.     
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-----   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-----   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence            4678999999999999999998642   23567899999875433 22356889999999999999999999854     


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRD------------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCD  295 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d  295 (484)
                      .+...++||||+++|+|.+++.....                  ....+++..++.++.|++.||+|||   .++++|||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~d  155 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRD  155 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence            34478999999999999999974321                  1234788999999999999999999   89999999


Q ss_pred             CCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CC
Q 011508          296 LKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GK  374 (484)
Q Consensus       296 lk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~  374 (484)
                      |||+||++++++.++|+|||.+........     .........+..|+|||...+..++.++|||||||++|||++ |.
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~  230 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM  230 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCC
Confidence            999999999999999999999875532211     011112234667999999888899999999999999999998 88


Q ss_pred             CCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC
Q 011508          375 GPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM  454 (484)
Q Consensus       375 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  454 (484)
                      .||.....     .+....        +.+.....                    .+..++.++.+++.+|++.+|++||
T Consensus       231 ~p~~~~~~-----~~~~~~--------~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rp  277 (288)
T cd05050         231 QPYYGMAH-----EEVIYY--------VRDGNVLS--------------------CPDNCPLELYNLMRLCWSKLPSDRP  277 (288)
T ss_pred             CCCCCCCH-----HHHHHH--------HhcCCCCC--------------------CCCCCCHHHHHHHHHHcccCcccCC
Confidence            88864311     111111        10100000                    0112356789999999999999999


Q ss_pred             CHHHHHHHHHH
Q 011508          455 NMEEVAAQLLS  465 (484)
Q Consensus       455 t~~evl~~L~~  465 (484)
                      |+.|+++.|++
T Consensus       278 t~~el~~~l~~  288 (288)
T cd05050         278 SFASINRILQR  288 (288)
T ss_pred             CHHHHHHHhhC
Confidence            99999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-38  Score=301.58  Aligned_cols=261  Identities=25%  Similarity=0.417  Sum_probs=203.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCC--eeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDH--ETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .+|++.+.||+|+||.||+|.+...+.  ...+|+|.+..... .....+.+|+.++++++|+|+++++++|..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            567888999999999999998754332  34689998875543 234678899999999999999999998753      


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++....   ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg  154 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFG  154 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCc
Confidence            36789999999999999997433   34899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      .++.........     ......++..|+|||......++.++||||||+++||+++ |+.||......  .+.+.+.. 
T Consensus       155 ~~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~-  226 (279)
T cd05057         155 LAKLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--EIPDLLEK-  226 (279)
T ss_pred             ccccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--HHHHHHhC-
Confidence            998764322111     0111224578999999888889999999999999999999 99998653211  11111110 


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                                .....                    .+..+...+.+++.+||..+|++||++.++++.|+++...
T Consensus       227 ----------~~~~~--------------------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         227 ----------GERLP--------------------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             ----------CCCCC--------------------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence                      00000                    0112245688999999999999999999999999988543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-38  Score=296.99  Aligned_cols=242  Identities=23%  Similarity=0.367  Sum_probs=185.7

Q ss_pred             CccccccceeEEEEEEcCCC----------CeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          165 NLIGAGSFGSVYKGIFDHDD----------HETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~----------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      +.||+|+||.||+|++..+.          ....|++|.+..........+.+|+.+++.++||||+++++++..     
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-----   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-----   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            46899999999999864321          234689998876555555678899999999999999999998643     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc------
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT------  308 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~------  308 (484)
                      +...++||||+++++|..++...   ...+++..++.++.||+.||+|||   +++|+||||||+||+++.++.      
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~  149 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGP  149 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCc
Confidence            34678999999999999988643   235899999999999999999999   899999999999999987654      


Q ss_pred             -eEEcccCcccccccccccCCCCccccccccccccccCccccC-CCCCCcccceehhhHHHHHHH-hCCCCCCCCccCCc
Q 011508          309 -AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-GSEVSTSGDVYSFGILLLEMF-TGKGPTNEMFTGNL  385 (484)
Q Consensus       309 -~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gvvl~ell-tg~~p~~~~~~~~~  385 (484)
                       ++++|||.+......           ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......  
T Consensus       150 ~~~l~d~g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--  216 (262)
T cd05077         150 FIKLSDPGIPITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA--  216 (262)
T ss_pred             eeEeCCCCCCccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh--
Confidence             899999988654211           1234778899999876 467899999999999999998 488887542110  


Q ss_pred             cHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          386 TLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                         ...         .........                     ......++.+++.+||+.||.+||++.+|++.+
T Consensus       217 ---~~~---------~~~~~~~~~---------------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         217 ---EKE---------RFYEGQCML---------------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ---HHH---------HHHhcCccC---------------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence               000         000000000                     000145688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-38  Score=307.64  Aligned_cols=206  Identities=20%  Similarity=0.237  Sum_probs=163.7

Q ss_pred             ccCccccc--cceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          163 LENLIGAG--SFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       163 ~~~~lg~G--~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      +.++||+|  +|++||+++  +..++..||+|+++....  ...+.+.+|+++++.++||||+++++++..     ++..
T Consensus         2 ~~~~ig~G~~~~~~v~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~   74 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLAR--YKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNEL   74 (327)
T ss_pred             hhhhccccccceEEEEEEe--ecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEE
Confidence            45789999  788999998  445678999999875432  233567789999999999999999998643     4478


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++|+|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.++++||+...
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          75 WVVTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             EEEEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence            99999999999999996432  234889999999999999999999   8999999999999999999999999998754


Q ss_pred             ccccccccCCCCccccccccccccccCccccCC--CCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG--SEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ....................++..|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  213 (327)
T cd08227         150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  213 (327)
T ss_pred             ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            432211100000011122346788999999875  45899999999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.6e-39  Score=315.33  Aligned_cols=204  Identities=24%  Similarity=0.291  Sum_probs=168.6

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeec-cC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVD-FQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~  233 (484)
                      ..++|.+.+.||+|+||.||+|..  ...++.||||++....  ......+.+|+.+++.++||||+++++++.... +.
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYD--AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEE--CCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence            457899999999999999999984  4457789999987532  233457889999999999999999998764322 12


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||++ ++|.+++..      .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~D  169 (364)
T cd07875         100 EFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  169 (364)
T ss_pred             ccCeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEe
Confidence            3346799999995 578777742      3788899999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ||+++......        ......+|..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       170 fG~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  228 (364)
T cd07875         170 FGLARTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT  228 (364)
T ss_pred             CCCccccCCCC--------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCC
Confidence            99997653211        112346899999999999999999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.9e-39  Score=311.40  Aligned_cols=242  Identities=28%  Similarity=0.313  Sum_probs=184.5

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHH-HHHHcCCCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAEC-QALRSIRHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||.||+|+..  .++..||+|++....   ......+..|. .+++.++|+||+++++++     ..++..++
T Consensus         1 ~~lg~G~fg~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~l   73 (325)
T cd05602           1 KVIGKGSFGKVLLARHK--AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYF   73 (325)
T ss_pred             CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEE
Confidence            46999999999999844  456789999987532   11223444444 356788999999999885     34558899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++|+|.+++...    ..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        74 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~  146 (325)
T cd05602          74 VLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  146 (325)
T ss_pred             EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence            99999999999998743    34778888899999999999999   899999999999999999999999999998753


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ....       .......||+.|+|||++.+..++.++||||+||++|||++|+.||.....     ......       
T Consensus       147 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~-------  207 (325)
T cd05602         147 IEHN-------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDN-------  207 (325)
T ss_pred             ccCC-------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHHHH-------
Confidence            2211       112235689999999999999999999999999999999999999965321     111111       


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                       +.......                     .......+.+++.+|++.||.+||++.+.+.
T Consensus       208 -i~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         208 -ILNKPLQL---------------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             -HHhCCcCC---------------------CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence             11100000                     1112556889999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.3e-38  Score=301.75  Aligned_cols=251  Identities=23%  Similarity=0.319  Sum_probs=194.6

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeE
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      |++.+.||+|+||.||+|...  .++..+++|.+........+.+.+|+++++.++|+|++++++++..     +...++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~   79 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNK--ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI   79 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEEC--CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEE
Confidence            567789999999999999844  4567899999876555556778899999999999999999998643     347899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      |+||+++++|..++...   ...+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        80 v~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~  153 (282)
T cd06643          80 LIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKN  153 (282)
T ss_pred             EEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccc
Confidence            99999999999987632   235899999999999999999999   899999999999999999999999999998754


Q ss_pred             ccccccCCCCccccccccccccccCccccC-----CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ....       .......++..|+|||++.     +..++.++|||||||++|||++|+.||.......     ......
T Consensus       154 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~  221 (282)
T cd06643         154 TRTI-------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-----VLLKIA  221 (282)
T ss_pred             cccc-------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-----HHHHHh
Confidence            3211       1112345889999999874     3457889999999999999999999986532110     000000


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..     ..+.+..                     +..++.++.+++..||+.||.+||++.++++.
T Consensus       222 ~~-----~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         222 KS-----EPPTLAQ---------------------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             hc-----CCCCCCC---------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00     0000000                     11225578999999999999999999998754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.9e-38  Score=297.23  Aligned_cols=257  Identities=25%  Similarity=0.340  Sum_probs=187.4

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      +.||+|+||.||+|..........+++|.+..... .....+.+|+..++.++|+||+++++.+.     .....++|||
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLE   75 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEE
Confidence            36999999999999865554566789998764432 22356889999999999999999999864     3447899999


Q ss_pred             cccCCCHHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccccc
Q 011508          244 LMVNGSLEEWLHLNRDA-PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE  322 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  322 (484)
                      |+++|+|.+++...... ....++...+.++.|++.||+|||   +++|+||||||+||++++++.+||+|||++.....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~  152 (269)
T cd05042          76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYP  152 (269)
T ss_pred             eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEecccccccccc
Confidence            99999999999765432 233567888899999999999999   89999999999999999999999999999865422


Q ss_pred             ccccCCCCccccccccccccccCccccC-------CCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          323 AANNLSSNQSSSVGVKGTVGYAAPEYGM-------GSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       323 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ....     .......++..|+|||+..       ...++.++|||||||++|||++ |..||....... .+.....  
T Consensus       153 ~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~--  224 (269)
T cd05042         153 EDYY-----ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVR--  224 (269)
T ss_pred             chhe-----eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhh--
Confidence            2100     0112234567899999864       2456889999999999999999 788886432110 1111111  


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                        .....+.++.+                       ...+...+.+++..|+ .||++|||++||++.|
T Consensus       225 --~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         225 --EQDIKLPKPQL-----------------------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             --ccCccCCCCcc-----------------------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence              00001111111                       1122455677888888 5999999999999987

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.4e-39  Score=299.50  Aligned_cols=256  Identities=29%  Similarity=0.484  Sum_probs=200.5

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ..++|++.+.||+|+||.||+|...   +...+|+|.+.... ...+.+.+|+.++++++|+|++++++++     ....
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~---~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   74 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN---GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEE   74 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc---CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCC
Confidence            3467899999999999999999854   34679999987543 3346789999999999999999999984     3345


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++....  ...+++..+..++.|++.|++|||   +++++|+||||+||++++++.+||+|||.
T Consensus        75 ~~~~v~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~  149 (261)
T cd05034          75 PIYIVTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGL  149 (261)
T ss_pred             ceEEEEeccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECcccc
Confidence            7899999999999999997532  345899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.......      .........+..|+|||.+.+..++.++||||+|+++|++++ |+.||......     .....  
T Consensus       150 ~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~~--  216 (261)
T cd05034         150 ARLIEDDE------YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-----EVLEQ--  216 (261)
T ss_pred             ceeccchh------hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH--
Confidence            88664321      011112234568999999988889999999999999999999 99998643111     01110  


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                            +.. ....                   ..+.+++..+.+++.+|++.+|++||+++++.+.|+.
T Consensus       217 ------~~~-~~~~-------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         217 ------VER-GYRM-------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ------HHc-CCCC-------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                  000 0000                   0011225578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=314.10  Aligned_cols=257  Identities=26%  Similarity=0.382  Sum_probs=208.4

Q ss_pred             CCccCccccccceeEEEEEEcCCC-CeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ..+.++||+|.||.|++|.|..-. +...||||.++..... ...+|.+|+.+|.+|+|+|++++||...+      ...
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~------qp~  185 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD------QPA  185 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc------chh
Confidence            456689999999999999997532 2346999999866544 56799999999999999999999998543      357


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      .+|||.++.|+|.+.|+.  .....+-......++.|||.|+.||.   .+++|||||..+|+++-..-.+||+|||+.+
T Consensus       186 mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             hHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeeccccee
Confidence            899999999999999986  23445788888999999999999999   9999999999999999988899999999999


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .+.........    .....-.+.|+|||.+....++.++|||+|||++|||+| |+.||.+...              .
T Consensus       261 aLg~ned~Yvm----~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------------~  322 (1039)
T KOG0199|consen  261 ALGENEDMYVM----APQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------------I  322 (1039)
T ss_pred             ccCCCCcceEe----cCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------------H
Confidence            88665433221    122345788999999999999999999999999999999 8999976311              1


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                      .+.+.+|..                   .+-..++.|+..+.+++..||..+|++|||+..+.+.+-.
T Consensus       323 qIL~~iD~~-------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  323 QILKNIDAG-------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             HHHHhcccc-------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            122222211                   0111267889999999999999999999999999865533

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=5.1e-39  Score=300.67  Aligned_cols=253  Identities=31%  Similarity=0.448  Sum_probs=195.4

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchH--HHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      |++.+.||+|+||+||++...  .++..+|+|++.........  ...+|+.++++++||||+++++++..     ....
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~   73 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNK--KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYL   73 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEET--TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEE
T ss_pred             CEEeEEEEeCCCEEEEEEEEC--CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccc
Confidence            567889999999999999954  45678999999876543322  34569999999999999999998644     5588


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++++|.+++...    ..+++..++.++.|+++||++||   +.+++|+||||+||+++.++.++|+|||.+.
T Consensus        74 ~~v~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   74 YIVMEYCPGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSV  146 (260)
T ss_dssp             EEEEEEETTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred             ccccccccccccccccccc----ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            9999999999999999832    34899999999999999999999   8899999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccC-CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ....       .........++..|+|||+.. +..++.++||||+|+++|+|++|..||.....  .............
T Consensus       147 ~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~  217 (260)
T PF00069_consen  147 KLSE-------NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS--DDQLEIIEKILKR  217 (260)
T ss_dssp             ESTS-------TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH--HHHHHHHHHHHHT
T ss_pred             cccc-------cccccccccccccccccccccccccccccccccccccccccccccccccccccc--hhhhhhhhhcccc
Confidence            5411       112223456889999999988 78899999999999999999999999976410  0111111111100


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ......    ..                     .......+.+++..||+.||++||++.|+++
T Consensus       218 ~~~~~~----~~---------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  218 PLPSSS----QQ---------------------SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHT----TS---------------------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccccc----cc---------------------cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000    00                     0001367999999999999999999999975

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.9e-39  Score=312.34  Aligned_cols=243  Identities=28%  Similarity=0.312  Sum_probs=185.7

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHH-HHHcCCCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQ-ALRSIRHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||.||+|+.  ..+++.||+|++....   ......+..|.. +++.++||||+++++++     ..++..++
T Consensus         1 ~~lG~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~l   73 (325)
T cd05604           1 KVIGKGSFGKVLLAKR--KLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYF   73 (325)
T ss_pred             CceeeCCCeEEEEEEE--CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEE
Confidence            4699999999999984  4457889999987542   122344555554 46778999999999885     34558899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++|+|..++...    ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        74 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~  146 (325)
T cd05604          74 VLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (325)
T ss_pred             EEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence            99999999999888632    35889999999999999999999   899999999999999999999999999998753


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ...       ........|+..|+|||++.+..++.++|||||||++|||++|+.||....     ..+....       
T Consensus       147 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~~~~~~-------  207 (325)
T cd05604         147 IAQ-------SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----VAEMYDN-------  207 (325)
T ss_pred             CCC-------CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----HHHHHHH-------
Confidence            211       111223568999999999999999999999999999999999999996531     1111111       


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                       +....+..                     .......+.+++..|++.+|.+||++.+.++.
T Consensus       208 -~~~~~~~~---------------------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~  247 (325)
T cd05604         208 -ILHKPLVL---------------------RPGASLTAWSILEELLEKDRQRRLGAKEDFLE  247 (325)
T ss_pred             -HHcCCccC---------------------CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence             11111100                     01124567899999999999999998644433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=297.72  Aligned_cols=255  Identities=25%  Similarity=0.340  Sum_probs=200.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||.||+|....  +++.+++|.+........+.+.+|++++++++|||++++++++.     .+..
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~   74 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIA--TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL-----RRDK   74 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecC--CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE-----eCCE
Confidence            3578899999999999999998543  45789999998765556678999999999999999999999853     3457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .+++|||+++++|.+++....   ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||.+
T Consensus        75 ~~l~~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~  148 (262)
T cd06613          75 LWIVMEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVS  148 (262)
T ss_pred             EEEEEeCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccc
Confidence            899999999999999987432   35889999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCC---CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS---EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      .......       .......++..|+|||.....   .++.++||||||+++|||++|+.||........ ......  
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~--  218 (262)
T cd06613         149 AQLTATI-------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISK--  218 (262)
T ss_pred             hhhhhhh-------hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHh--
Confidence            7653221       111224578889999998776   789999999999999999999999865321110 000000  


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                           .......+..                     ....+.++.+++.+||+.+|.+|||+.+|+.
T Consensus       219 -----~~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         219 -----SNFPPPKLKD---------------------KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -----ccCCCccccc---------------------hhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                 0000000000                     1223567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.4e-38  Score=307.65  Aligned_cols=244  Identities=23%  Similarity=0.311  Sum_probs=187.1

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||.||+|...  .+++.||+|+++....   ...+.+.+|+.++.++ +||||+++++++     ......++
T Consensus         1 ~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~l   73 (327)
T cd05617           1 RVIGRGSYAKVLLVRLK--KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFL   73 (327)
T ss_pred             CeeeeCCCeEEEEEEEC--CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEE
Confidence            46999999999999854  4578899999975432   2335678899999888 699999999884     34458899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++|+|..++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        74 v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~  146 (327)
T cd05617          74 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEG  146 (327)
T ss_pred             EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence            99999999999988633    35899999999999999999999   899999999999999999999999999998743


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCC-ccHhHHHHhhcchhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN-LTLHNFVKEALPERL  399 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~  399 (484)
                      ...       ........||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....++.....    
T Consensus       147 ~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~----  215 (327)
T cd05617         147 LGP-------GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI----  215 (327)
T ss_pred             cCC-------CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH----
Confidence            211       111223568999999999999999999999999999999999999996432211 11111111111    


Q ss_pred             hhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          400 AEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       400 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                         .......                     +...+..+.+++.+||+.||++||++.
T Consensus       216 ---~~~~~~~---------------------p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         216 ---LEKPIRI---------------------PRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             ---HhCCCCC---------------------CCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence               0000000                     111245678999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=8.2e-39  Score=305.20  Aligned_cols=250  Identities=23%  Similarity=0.298  Sum_probs=198.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      .+|++.+.||+|+||.||+|+.  ..++..||+|.+........+.+.+|+.+++.++|+|++++++++.     .+...
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~   91 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAID--IATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDEL   91 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEE--CCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEE
Confidence            6789999999999999999984  3457789999998665555677889999999999999999999864     34588


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++++|.+++..     ..+++.++..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||.+.
T Consensus        92 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~  163 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (297)
T ss_pred             EEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccce
Confidence            999999999999999863     24788999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      ......       .......++..|+|||.+.+..++.++|||||||++|++++|+.||........... ...    ..
T Consensus       164 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~----~~  231 (297)
T cd06656         164 QITPEQ-------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IAT----NG  231 (297)
T ss_pred             EccCCc-------cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-ecc----CC
Confidence            653221       111223578899999999888899999999999999999999999965321110000 000    00


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                           .+.+.                     .+......+.+++.+||+.+|++||+++++++
T Consensus       232 -----~~~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         232 -----TPELQ---------------------NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             -----CCCCC---------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 00000                     01122456789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.5e-38  Score=305.09  Aligned_cols=204  Identities=23%  Similarity=0.342  Sum_probs=163.6

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      ..+||+|+||.||+|+..+..++..||+|.+....  ....+.+|++++++++||||+++++++..   ..+...++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~---~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLS---HSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEec---cCCCeEEEEEe
Confidence            35799999999999997666667889999886432  33567899999999999999999998753   23457899999


Q ss_pred             cccCCCHHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCCceEEccc
Q 011508          244 LMVNGSLEEWLHLNR-----DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL----DGELTAHVSDF  314 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Df  314 (484)
                      |+. ++|.+++....     .....+++..++.++.|++.||+|||   +.+|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            985 58888875322     12235889999999999999999999   8999999999999999    55679999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      |+++........    ........+|..|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus       157 G~a~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         157 GFARLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             cceeccCCCccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            999866432211    111223468899999998876 45899999999999999999999999653

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.1e-39  Score=299.36  Aligned_cols=251  Identities=21%  Similarity=0.286  Sum_probs=197.4

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      +|++.+.||+|+||.||++...  .++..+|+|.++... ....+.+.+|+.+++.++|+|++++++.+     ..+...
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   73 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHV--NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHL   73 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEc--CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEE
Confidence            4778899999999999999843  457889999986433 23446788999999999999999999985     344588


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++++|.+++....  ...+++..++.++.|++.||.|||   +++|+|+||||+||++++++.++|+|||.+.
T Consensus        74 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~  148 (255)
T cd08219          74 YIVMEYCDGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSAR  148 (255)
T ss_pred             EEEEeeCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcce
Confidence            99999999999999886432  335789999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      ......       .......++..|+|||++.+..++.++||||||+++|+|++|+.||....     ............
T Consensus       149 ~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~~~~~~~~~~~~  216 (255)
T cd08219         149 LLTSPG-------AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----WKNLILKVCQGS  216 (255)
T ss_pred             eecccc-------cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----HHHHHHHHhcCC
Confidence            653221       11123458889999999988889999999999999999999999996521     111111100000


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                          ..+                        .+..+...+.+++.+||+.||++|||+.|++..
T Consensus       217 ----~~~------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         217 ----YKP------------------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----CCC------------------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                000                        011224567899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=6.4e-39  Score=313.90  Aligned_cols=205  Identities=23%  Similarity=0.290  Sum_probs=168.9

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeec-c
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVD-F  232 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~  232 (484)
                      ...++|++.+.||+|+||.||++.  +...++.||+|++.....  .....+.+|+.+++.++||||+++++++.... .
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEE--ecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            345789999999999999999998  444678899999875432  23456788999999999999999999865332 1


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                      ......++||||++ +++.+.+..      .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+
T Consensus        92 ~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          92 EEFQDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             cccceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEe
Confidence            22345789999995 577777642      3788899999999999999999   8999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      |||+++......        ......+|..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus       162 Dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  221 (355)
T cd07874         162 DFGLARTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_pred             eCcccccCCCcc--------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            999997643211        112346899999999999889999999999999999999999999753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.9e-39  Score=308.75  Aligned_cols=242  Identities=24%  Similarity=0.294  Sum_probs=187.5

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  235 (484)
                      +|+..+.||+|+||.||+|..  ..+++.||+|+++...   ....+.+..|..++..+. |++|+++++++     ...
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~   73 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAER--KGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTV   73 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEE--CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecC
Confidence            367789999999999999984  4457889999987532   223356778899998886 46677777763     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|.+++...    ..+++.+++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        74 ~~~~lv~Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg  146 (323)
T cd05615          74 DRLYFVMEYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFG  146 (323)
T ss_pred             CEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccc
Confidence            5889999999999999998643    34899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +++......       .......||..|+|||++.+..++.++||||+||++|||++|+.||......     ....   
T Consensus       147 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~~~~---  211 (323)
T cd05615         147 MCKEHMVDG-------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-----ELFQ---  211 (323)
T ss_pred             cccccCCCC-------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----HHHH---
Confidence            987532211       1122345899999999999889999999999999999999999999753211     1111   


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM  456 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  456 (484)
                           .+.......                     +..+..++.+++.+|++.+|.+|++.
T Consensus       212 -----~i~~~~~~~---------------------p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         212 -----SIMEHNVSY---------------------PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -----HHHhCCCCC---------------------CccCCHHHHHHHHHHcccCHhhCCCC
Confidence                 111100000                     11124567899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.8e-38  Score=304.52  Aligned_cols=281  Identities=22%  Similarity=0.298  Sum_probs=199.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|++.+.||+|+||.||++..  ..++..+|+|.+..... ....++.+|++++++++||||+++++++.     .++.
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~--~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~   73 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLH--RPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGE   73 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEE--cCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCE
Confidence            3688999999999999999984  44567899998875432 22356889999999999999999999864     3458


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++...    ..+++..+..++.|++.||+|||+  ..+++|+||||+||+++.++.+||+|||++
T Consensus        74 ~~lv~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  147 (308)
T cd06615          74 ISICMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS  147 (308)
T ss_pred             EEEEeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCc
Confidence            89999999999999999743    358899999999999999999993  258999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......         .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.....  .....+.......
T Consensus       148 ~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~  216 (308)
T cd06615         148 GQLIDSM---------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSE  216 (308)
T ss_pred             ccccccc---------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCcccc
Confidence            7542211         1224588999999998888899999999999999999999999864321  1111111110000


Q ss_pred             hh-hhhcCcccccccccccch---hh-hh-hhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          398 RL-AEIVDPVLLVEREEGETS---EA-NA-HKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       398 ~~-~~~~d~~l~~~~~~~~~~---~~-~~-~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      .. ..................   .. .. ............+..++.+++.+||+.+|++|||++||++.-
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         217 GEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             ccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            00 000000000000000000   00 00 000000001112356789999999999999999999998774

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.7e-38  Score=301.16  Aligned_cols=252  Identities=23%  Similarity=0.307  Sum_probs=196.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      +.|++.+.||+|+||.||+|...  .++..+++|.+........+.+.+|+.+++.++|+|++++++.+..     +...
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   84 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNK--ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKL   84 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEEC--CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeE
Confidence            56889999999999999999843  4568899999986655556788999999999999999999998643     3478


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++++|..++...   ...+++..++.++.|++.+++|||   +.+++||||||+||+++.++.++|+|||.+.
T Consensus        85 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~  158 (292)
T cd06644          85 WIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA  158 (292)
T ss_pred             EEEEecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccce
Confidence            9999999999999887633   235899999999999999999999   8999999999999999999999999999886


Q ss_pred             ccccccccCCCCccccccccccccccCccccC-----CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ......       .......++..|+|||++.     ...++.++|||||||++|||++|+.||......     .....
T Consensus       159 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~  226 (292)
T cd06644         159 KNVKTL-------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLK  226 (292)
T ss_pred             eccccc-------cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHH
Confidence            542211       1112345788999999874     345788999999999999999999998653210     00000


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...     ...+...                     .+..+..++.+++.+||+.+|++||+++|+++
T Consensus       227 ~~~-----~~~~~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         227 IAK-----SEPPTLS---------------------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             Hhc-----CCCccCC---------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000     0000000                     01122456889999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.2e-38  Score=304.94  Aligned_cols=264  Identities=27%  Similarity=0.434  Sum_probs=201.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCC--eeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDH--ETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|+..+.||+|+||.||+|.+...+.  ...+|+|.+..... .....+.+|+.+++.++||||++++++|..     
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-----   80 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-----   80 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-----
Confidence            3567888999999999999998654332  23689998865432 223468899999999999999999998742     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                       ...++++||+++|+|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        81 -~~~~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Df  153 (303)
T cd05110          81 -PTIQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDF  153 (303)
T ss_pred             -CCceeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccc
Confidence             1357999999999999998743   235889999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |+++........     .......++..|+|||.+.+..++.++|||||||++|||++ |+.||......  ...++...
T Consensus       154 g~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~~~~  226 (303)
T cd05110         154 GLARLLEGDEKE-----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDLLEK  226 (303)
T ss_pred             cccccccCcccc-----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHC
Confidence            999866432211     11112345678999999988899999999999999999997 89998653211  11111110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHh
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV  471 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  471 (484)
                      .          .....                     +..+...+.+++..||..+|++||+++++++.|+++.....
T Consensus       227 ~----------~~~~~---------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         227 G----------ERLPQ---------------------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             C----------CCCCC---------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            0          00000                     11224568899999999999999999999999998865554

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.6e-39  Score=313.76  Aligned_cols=208  Identities=26%  Similarity=0.337  Sum_probs=171.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+++..  .+++.||+|+++...   ......+.+|+.++..++|+||+++++.+     .++
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~   73 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKK--DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDK   73 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEEC--CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence            46888999999999999999844  457889999997432   23345678899999999999999999884     455


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        74 ~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG  146 (360)
T cd05627          74 RNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFG  146 (360)
T ss_pred             CEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeecc
Confidence            6899999999999999999743    35889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCC----------------------------CCccccccccccccccCccccCCCCCCcccceehhhHHH
Q 011508          316 LAKFLPEAANNLS----------------------------SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILL  367 (484)
Q Consensus       316 ~a~~~~~~~~~~~----------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl  367 (484)
                      ++..+........                            ..........||+.|+|||++.+..++.++|||||||++
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  226 (360)
T cd05627         147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM  226 (360)
T ss_pred             CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence            9875532110000                            000011235699999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCC
Q 011508          368 LEMFTGKGPTNEM  380 (484)
Q Consensus       368 ~elltg~~p~~~~  380 (484)
                      |||++|+.||...
T Consensus       227 yel~tG~~Pf~~~  239 (360)
T cd05627         227 YEMLIGYPPFCSE  239 (360)
T ss_pred             eecccCCCCCCCC
Confidence            9999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.3e-38  Score=303.50  Aligned_cols=251  Identities=23%  Similarity=0.322  Sum_probs=199.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      .+|++.+.||.|++|.||+|+  +..++..|++|.+........+.+.+|+.+++.++|+|++++++++.     .+...
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~--~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~   91 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAI--DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDEL   91 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEE--EcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceE
Confidence            468999999999999999998  44467889999997665555678889999999999999999999864     34588


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++|+||+++++|.+++..     ..+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        92 ~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~  163 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA  163 (296)
T ss_pred             EEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccch
Confidence            999999999999998863     24889999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      ......       .......++..|+|||.+.+..++.++|||||||++|+|++|+.||........ .. ....   . 
T Consensus       164 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~-~~~~---~-  230 (296)
T cd06655         164 QITPEQ-------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY-LIAT---N-  230 (296)
T ss_pred             hccccc-------ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH-HHHh---c-
Confidence            653321       111223578899999999888899999999999999999999999965321100 00 0000   0 


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                          ..+.+..                     +..++..+.+++.+||..||++|||+.+++..
T Consensus       231 ----~~~~~~~---------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         231 ----GTPELQN---------------------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ----CCcccCC---------------------cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                0000000                     12235568899999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.8e-39  Score=309.24  Aligned_cols=238  Identities=28%  Similarity=0.324  Sum_probs=182.6

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHH-HHHcCCCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQ-ALRSIRHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||.||+|+.  ..++..||+|++....   ......+..|.. +++.++||||+++++++     ...+..++
T Consensus         1 ~~lg~G~~g~Vy~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~l   73 (321)
T cd05603           1 KVIGKGSFGKVLLAKR--KSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYF   73 (321)
T ss_pred             CeeeeCCCEEEEEEEE--CCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEE
Confidence            4699999999999984  3457889999987432   122234555554 57889999999999884     34558899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++++|..++...    ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        74 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~  146 (321)
T cd05603          74 VLDYVNGGELFFHLQRE----RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG  146 (321)
T ss_pred             EEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence            99999999999888632    34788899999999999999999   899999999999999999999999999998753


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ....       .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....     .......       
T Consensus       147 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~-------  207 (321)
T cd05603         147 VEPE-------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-----VSQMYDN-------  207 (321)
T ss_pred             CCCC-------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-----HHHHHHH-------
Confidence            2111       11223468999999999998899999999999999999999999996531     1111111       


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                       +....+..                     +......+.+++.+|++.||.+||++.
T Consensus       208 -i~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         208 -ILHKPLQL---------------------PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -HhcCCCCC---------------------CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             11111100                     111245688999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-38  Score=322.17  Aligned_cols=203  Identities=23%  Similarity=0.353  Sum_probs=163.1

Q ss_pred             hHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCC------CceeEeee
Q 011508          153 NLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR------NLVKIITS  226 (484)
Q Consensus       153 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~  226 (484)
                      ++...+++|++.+.||+|+||+||+|...  ..+..||||+++... .....+..|++++..++|.      ++++++++
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~--~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDR--KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEc--CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            33445688999999999999999999843  457889999986432 2234556677777777544      57888877


Q ss_pred             eeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCeeecC
Q 011508          227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCE-TPIVHCDLKPSNVLLDG  305 (484)
Q Consensus       227 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~NIll~~  305 (484)
                      +.    ....+.++|||++ +++|.+++...    ..+++..+..|+.||+.||+|||   . .+|+||||||+|||++.
T Consensus       200 ~~----~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~  267 (467)
T PTZ00284        200 FQ----NETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMET  267 (467)
T ss_pred             EE----cCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEec
Confidence            53    2345789999998 88999988643    35899999999999999999999   6 59999999999999987


Q ss_pred             CC----------------ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHH
Q 011508          306 EL----------------TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLE  369 (484)
Q Consensus       306 ~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~e  369 (484)
                      ++                .+||+|||.+.....          ......||..|+|||++.+..++.++|||||||++||
T Consensus       268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~e  337 (467)
T PTZ00284        268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERH----------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYE  337 (467)
T ss_pred             CCcccccccccccCCCCceEEECCCCccccCcc----------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHH
Confidence            65                499999998753211          1223568999999999999999999999999999999


Q ss_pred             HHhCCCCCCCC
Q 011508          370 MFTGKGPTNEM  380 (484)
Q Consensus       370 lltg~~p~~~~  380 (484)
                      |++|+.||...
T Consensus       338 lltG~~pf~~~  348 (467)
T PTZ00284        338 LYTGKLLYDTH  348 (467)
T ss_pred             HHhCCCCCCCC
Confidence            99999999753

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.1e-38  Score=305.51  Aligned_cols=267  Identities=24%  Similarity=0.365  Sum_probs=203.5

Q ss_pred             cCCCCccCccccccceeEEEEEEcCC-----CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHD-----DHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSV  230 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  230 (484)
                      ..+|.+.+.||+|+||.||+|.....     .....||+|.++.... ...+.+.+|+++++++ +|+||++++++|.  
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence            34688999999999999999975321     1234689998875432 2346788999999999 8999999999864  


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRD------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKP  298 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~  298 (484)
                         .+...++++||+++|+|.+++.....            ....+++.+++.++.|++.||+|||   +++++||||||
T Consensus        89 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp  162 (334)
T cd05100          89 ---QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAA  162 (334)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeecccccc
Confidence               34478999999999999999975421            1235889999999999999999999   89999999999


Q ss_pred             CCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCC
Q 011508          299 SNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPT  377 (484)
Q Consensus       299 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~  377 (484)
                      +||++++++.+||+|||+++........     .......++..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  237 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY  237 (334)
T ss_pred             ceEEEcCCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence            9999999999999999998765332110     01111234567999999998899999999999999999998 88888


Q ss_pred             CCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                      ....     ..+......        .. ...                   ..+..+..++.+++.+||+.+|++|||+.
T Consensus       238 ~~~~-----~~~~~~~~~--------~~-~~~-------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~  284 (334)
T cd05100         238 PGIP-----VEELFKLLK--------EG-HRM-------------------DKPANCTHELYMIMRECWHAVPSQRPTFK  284 (334)
T ss_pred             CCCC-----HHHHHHHHH--------cC-CCC-------------------CCCCCCCHHHHHHHHHHcccChhhCcCHH
Confidence            6531     111111100        00 000                   00122356788999999999999999999


Q ss_pred             HHHHHHHHHHHHH
Q 011508          458 EVAAQLLSFRNKL  470 (484)
Q Consensus       458 evl~~L~~i~~~~  470 (484)
                      |+++.|+.+....
T Consensus       285 ell~~l~~~~~~~  297 (334)
T cd05100         285 QLVEDLDRVLTVT  297 (334)
T ss_pred             HHHHHHHHHhhhc
Confidence            9999999887433

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.1e-38  Score=299.44  Aligned_cols=252  Identities=27%  Similarity=0.328  Sum_probs=193.7

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      |+..+.||+|+||+||+|...  .+++.+|+|.+.....   .....+.+|+++++.++|+|++++.+.+     ..++.
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~   74 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVR--ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDA   74 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEC--CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCE
Confidence            667789999999999999854  3578899999875432   2234577899999999999999998874     34558


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++....  ...+++..+..++.|++.||.|||   +++|+||||||+||++++++.++|+|||++
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~  149 (285)
T cd05632          75 LCLVLTIMNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             EEEEEEeccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcc
Confidence            899999999999998886432  235899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......        ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .... +......
T Consensus       150 ~~~~~~~--------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~-~~~~~~~  219 (285)
T cd05632         150 VKIPEGE--------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREE-VDRRVLE  219 (285)
T ss_pred             eecCCCC--------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhhhc
Confidence            7543211        1123458999999999988899999999999999999999999997532110 0000 1100000


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-----HHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-----MEEVAAQ  462 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  462 (484)
                          .. ...                       ...+...+.+++..|++.||++||+     +.++++.
T Consensus       220 ----~~-~~~-----------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         220 ----TE-EVY-----------------------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ----cc-ccc-----------------------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                00 000                       1122456789999999999999999     6666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3e-38  Score=299.46  Aligned_cols=252  Identities=28%  Similarity=0.350  Sum_probs=195.4

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      |+..+.||+|+||.||++...  .+++.||+|.+......   ....+.+|+.++++++|++++++++.+.     .++.
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~   74 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDA   74 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEc--CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCE
Confidence            677789999999999999854  45789999998754321   2345778999999999999999998853     3458


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++....  ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLA  149 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccce
Confidence            899999999999999986432  235889999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......        ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ... ...     
T Consensus       150 ~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~~~-~~~-----  214 (285)
T cd05630         150 VHVPEGQ--------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KRE-EVE-----  214 (285)
T ss_pred             eecCCCc--------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-hHH-HHH-----
Confidence            7543221        1122358999999999998899999999999999999999999997532110 000 000     


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-----HHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-----MEEVAAQ  462 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  462 (484)
                         ...+... ..                   .+..+...+.+++..||+.||++|||     ++|+++.
T Consensus       215 ---~~~~~~~-~~-------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         215 ---RLVKEVQ-EE-------------------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             ---hhhhhhh-hh-------------------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence               0000000 00                   01122456889999999999999999     8898873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.7e-38  Score=291.93  Aligned_cols=247  Identities=28%  Similarity=0.410  Sum_probs=191.3

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      ++||+|+||.||+|...   ++..+|+|.++..... ....+.+|++++++++||||+++++++..     ....++|||
T Consensus         1 ~~ig~g~~g~vy~~~~~---~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e   72 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK---DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVME   72 (250)
T ss_pred             CccCCCCCceEEEEEec---CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEE
Confidence            36999999999999854   4678999988754432 23468899999999999999999998643     347899999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccc
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA  323 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  323 (484)
                      |+++++|.+++....   ..+++..++.++.|++.+|.|||   +++++||||||+||+++.++.+||+|||++......
T Consensus        73 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  146 (250)
T cd05085          73 LVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG  146 (250)
T ss_pred             CCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccc
Confidence            999999999986432   34789999999999999999999   899999999999999999999999999998754321


Q ss_pred             cccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhhh
Q 011508          324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAEI  402 (484)
Q Consensus       324 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (484)
                      .      ........++..|+|||+..+..++.++||||||+++|++++ |..||......     .....     +...
T Consensus       147 ~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-----~~~~~-----~~~~  210 (250)
T cd05085         147 I------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-----QAREQ-----VEKG  210 (250)
T ss_pred             c------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHH-----HHcC
Confidence            1      011111234577999999988889999999999999999998 99998653111     10000     0000


Q ss_pred             cCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          403 VDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       403 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      .....                       +..++..+.+++.+|++.+|++||++.|++++|.
T Consensus       211 ~~~~~-----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         211 YRMSC-----------------------PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCC-----------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            00000                       1123567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-38  Score=310.54  Aligned_cols=281  Identities=20%  Similarity=0.247  Sum_probs=197.3

Q ss_pred             HHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       155 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      ....++|.+.+.||+|+||.||+|..  ..++..||+|++.....  .....+.+|+.++++++|+||+++++++.....
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYD--TRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEE--CCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            44568899999999999999999984  44578899999864322  233567789999999999999999987643221


Q ss_pred             -CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEE
Q 011508          233 -QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV  311 (484)
Q Consensus       233 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl  311 (484)
                       ......++++|++ +++|.+++..     ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl  159 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRI  159 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEE
Confidence             1224578999998 8899888752     34899999999999999999999   899999999999999999999999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      +|||+++.....          .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+..+
T Consensus       160 ~Dfg~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~  228 (343)
T cd07878         160 LDFGLARQADDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRI  228 (343)
T ss_pred             cCCccceecCCC----------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHH
Confidence            999999865321          123458899999999876 56899999999999999999999999653211 011111


Q ss_pred             HHhh---cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          391 VKEA---LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       391 ~~~~---~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ....   .++....+....... ...... ... ......  ........+.+++.+|++.||.+|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~-~~~~~~--~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         229 MEVVGTPSPEVLKKISSEHARK-YIQSLP-HMP-QQDLKK--IFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHhCCCCHHHHHhcchhhHHH-Hhhccc-ccc-chhHHH--hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1100   000000000000000 000000 000 000000  001123457899999999999999999999965

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-38  Score=297.51  Aligned_cols=262  Identities=26%  Similarity=0.336  Sum_probs=202.7

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeecc-C
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDF-Q  233 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~  233 (484)
                      ..+++|++.+.||+|++|.||+|...  .++..+++|++..... ..+.+.+|+.+++++ +|+||+++++++..... .
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHK--KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEEC--CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            35689999999999999999999954  3567899999875543 346789999999999 79999999999765442 3


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||+++++|.+++.........+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.++|+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECC
Confidence            355689999999999999998754433456899999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCC-----CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-----SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH  388 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~  388 (484)
                      ||.+.......       .......++..|+|||.+..     ..++.++|||||||++|+|++|+.||....... .+.
T Consensus       157 ~~~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~  228 (275)
T cd06608         157 FGVSAQLDSTL-------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALF  228 (275)
T ss_pred             Cccceecccch-------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHH
Confidence            99987653221       11123458889999998653     346789999999999999999999996431110 010


Q ss_pred             HHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          389 NFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      +..         ....+.+..                     ...+...+.+++.+||..||++|||+.|+++
T Consensus       229 ~~~---------~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         229 KIP---------RNPPPTLKS---------------------PENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             Hhh---------ccCCCCCCc---------------------hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            000         000000000                     1223567889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.2e-38  Score=297.13  Aligned_cols=260  Identities=23%  Similarity=0.346  Sum_probs=200.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ++|++...||+|+||.||+|+....   .....|++|.+...... ....+.+|++++++++|+||+++++++.     +
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR-----E   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----C
Confidence            5688899999999999999996532   23567999988754433 3467899999999999999999999853     3


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDA-----PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA  309 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~  309 (484)
                      ....++||||+++|+|.+++......     ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcE
Confidence            45789999999999999999754422     125899999999999999999999   8999999999999999999999


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHh
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH  388 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~  388 (484)
                      +++|||++.......      ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......     
T Consensus       157 ~l~~~~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-----  225 (275)
T cd05046         157 KVSLLSLSKDVYNSE------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----  225 (275)
T ss_pred             EEcccccccccCccc------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH-----
Confidence            999999987542211      111122346778999999888888999999999999999999 78888643211     


Q ss_pred             HHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          389 NFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      ......        ....+..                   .....++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus       226 ~~~~~~--------~~~~~~~-------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         226 EVLNRL--------QAGKLEL-------------------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHHHH--------HcCCcCC-------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            111110        0000000                   001123567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-38  Score=305.76  Aligned_cols=202  Identities=26%  Similarity=0.334  Sum_probs=168.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+++..  .+++.||+|++....   ....+.+.+|..++..++|+||+++++++     ..+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~   73 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMK--NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDE   73 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEEC--CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecC
Confidence            46889999999999999999844  457889999987422   22345688899999999999999999885     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|.+++...   ...+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg  147 (331)
T cd05597          74 NNLYLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFG  147 (331)
T ss_pred             CeEEEEEecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECC
Confidence            5899999999999999999742   235889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC-----CCCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-----SEVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      ++.......      ........||+.|+|||++..     ..++.++|||||||++|||++|+.||..
T Consensus       148 ~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         148 SCLRLLADG------TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             ceeecCCCC------CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            987653221      111122458999999998763     4578899999999999999999999965

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-40  Score=292.33  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=205.7

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeE
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      |.+.++||+|+||.||+|.  +..+|..+|||.+...  .+..++.+|+.++++++.|++|++||.++.     +...|+
T Consensus        35 FDi~~KLGEGSYGSV~KAI--H~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-----~sDLWI  105 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAI--HRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFK-----HSDLWI  105 (502)
T ss_pred             HHHHHHhcCCcchHHHHHH--HhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhcc-----CCceEe
Confidence            5677899999999999999  6668899999998754  356789999999999999999999998643     337899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      |||||..|++.+.++..   .+++++.++..+++..++||+|||   ...-+|||||+.|||+..+|.+||+|||.|..+
T Consensus       106 VMEYCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQL  179 (502)
T KOG0574|consen  106 VMEYCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQL  179 (502)
T ss_pred             ehhhcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchh
Confidence            99999999999999854   356999999999999999999999   677899999999999999999999999999876


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      .+.       -.......||+.|||||++..-.|..++||||+|++..||..|++||.+...-...        +     
T Consensus       180 TDT-------MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------F-----  239 (502)
T KOG0574|consen  180 TDT-------MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------F-----  239 (502)
T ss_pred             hhh-------HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------E-----
Confidence            432       23344567999999999999889999999999999999999999998763211000        0     


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                       ++                 ...+......++....++.++++.||-..|++|-|+.++++.
T Consensus       240 -MI-----------------PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  240 -MI-----------------PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             -ec-----------------cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence             00                 001112222366668899999999999999999999999864

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.3e-38  Score=296.05  Aligned_cols=257  Identities=25%  Similarity=0.399  Sum_probs=198.5

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC----------ccchHHHHHHHHHHHc-CCCCCceeEeeeee
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH----------RGASKSFIAECQALRS-IRHRNLVKIITSCV  228 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~  228 (484)
                      +|++.+.||+|+||.||+|..... .+..+|+|.+....          ......+.+|+.++.+ ++|+||+++++++.
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNN-GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCC-CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc
Confidence            478889999999999999996542 46789999876322          1223457788888875 79999999999853


Q ss_pred             eeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 011508          229 SVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT  308 (484)
Q Consensus       229 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~  308 (484)
                           .++..++||||+++++|.+++.........+++..++.++.|++.||.|||+  ..+++|+||+|+||+++.++.
T Consensus        80 -----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~  152 (269)
T cd08528          80 -----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDK  152 (269)
T ss_pred             -----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCc
Confidence                 4458899999999999999986544445568999999999999999999993  268999999999999999999


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHh
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH  388 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~  388 (484)
                      +||+|||.+.......        ......++..|+|||...+..++.++||||||+++|||++|+.||....     ..
T Consensus       153 ~~l~dfg~~~~~~~~~--------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~~  219 (269)
T cd08528         153 VTITDFGLAKQKQPES--------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----ML  219 (269)
T ss_pred             EEEecccceeeccccc--------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----HH
Confidence            9999999998653321        1223458889999999998889999999999999999999999986421     11


Q ss_pred             HHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          389 NFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      ....        .+.+.......                   ...+...+.+++.+||+.||++||++.||.++++
T Consensus       220 ~~~~--------~~~~~~~~~~~-------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         220 SLAT--------KIVEAVYEPLP-------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             HHHH--------HHhhccCCcCC-------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1111        11111000000                   0112457889999999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.7e-38  Score=294.28  Aligned_cols=254  Identities=26%  Similarity=0.457  Sum_probs=198.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|.+.+.||+|+||.||+|...   .+..+|+|.+.... .....+.+|++++++++|+|++++.+.+..      ..
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~---~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~   74 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN---KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EP   74 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec---CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CC
Confidence            467899999999999999999854   34569999876432 234678899999999999999999988532      46


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .+++|||+++++|.+++....  ...+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||.+
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~  149 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLA  149 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcce
Confidence            789999999999999997532  345788999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      .......      ........++..|+|||++....++.++|||||||++|+++| |+.||......  .......... 
T Consensus       150 ~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~-  220 (260)
T cd05073         150 RVIEDNE------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGY-  220 (260)
T ss_pred             eeccCCC------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCC-
Confidence            7653221      111112335678999999988889999999999999999999 89998653111  1111110000 


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                               ....                     ....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus       221 ---------~~~~---------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         221 ---------RMPR---------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---------CCCC---------------------cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                     0000                     11125578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5e-38  Score=295.31  Aligned_cols=254  Identities=25%  Similarity=0.369  Sum_probs=196.1

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc---------hHHHHHHHHHHHcCCCCCceeEeeeeeee
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA---------SKSFIAECQALRSIRHRNLVKIITSCVSV  230 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~  230 (484)
                      +|.+...||+|++|.||+|...  .++..+|+|.+.......         .+.+.+|+.++++++||||+++++++.  
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--   76 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNA--SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL--   76 (267)
T ss_pred             CccccceeecCCCeEEEEEEec--CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--
Confidence            4778899999999999999843  356789999886543221         246788999999999999999999854  


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH  310 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k  310 (484)
                         .....++|+||+++++|.+++...    ..+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++
T Consensus        77 ---~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~  146 (267)
T cd06628          77 ---DADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIK  146 (267)
T ss_pred             ---eCCccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEE
Confidence               345789999999999999999743    34788899999999999999999   89999999999999999999999


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      |+|||.++......... ..........++..|+|||.+.+..++.++||||+||++|+|++|+.||......    .. 
T Consensus       147 l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~-  220 (267)
T cd06628         147 ISDFGISKKLEANSLST-KTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QA-  220 (267)
T ss_pred             ecccCCCcccccccccC-CccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HH-
Confidence            99999998764321110 0011112245788999999998888999999999999999999999999753110    00 


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      +..     ......+.+                       +..++..+.+++.+||+.||++||++.||++
T Consensus       221 ~~~-----~~~~~~~~~-----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         221 IFK-----IGENASPEI-----------------------PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHH-----HhccCCCcC-----------------------CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            000     000000000                       1122567889999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.6e-38  Score=294.94  Aligned_cols=258  Identities=21%  Similarity=0.272  Sum_probs=202.2

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|++.+.||.|+||.||+|...  .++..+|+|.+....  ....+.+.+|++++++++|+|++++++++..   ..+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~   75 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRK--SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQT   75 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeec--CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCE
Confidence            4788899999999999999843  456789999987543  2234568889999999999999999987642   23456


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC--ETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      .+++|||+++++|.+++.........+++..++.++.|++.||+|||..+  +.+++|+||+|+||++++++.+||+|||
T Consensus        76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g  155 (265)
T cd08217          76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG  155 (265)
T ss_pred             EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccc
Confidence            78999999999999999865544567999999999999999999999554  6789999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++........       ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....     ........ 
T Consensus       156 ~~~~~~~~~~-------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~-  222 (265)
T cd08217         156 LAKILGHDSS-------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASKI-  222 (265)
T ss_pred             ccccccCCcc-------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHHH-
Confidence            9987643221       1122358899999999988889999999999999999999999997532     11111110 


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                             .+.....                    .+...+..+.+++.+|++.+|++||+++||++.
T Consensus       223 -------~~~~~~~--------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         223 -------KEGKFRR--------------------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -------hcCCCCC--------------------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                   0000000                    011225678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2e-38  Score=295.97  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=198.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|++.+.||+|+||.||+|....  ++..+++|.+.....  .+.+.+|++++++++|+|++++++++.     .+...
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~   73 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKE--TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDL   73 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcC--CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcE
Confidence            678999999999999999999653  467899999875432  578999999999999999999999854     34588


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++++||+++++|.+++...   ...+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.
T Consensus        74 ~l~~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~  147 (256)
T cd06612          74 WIVMEYCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSG  147 (256)
T ss_pred             EEEEecCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccch
Confidence            9999999999999998643   245899999999999999999999   8899999999999999999999999999988


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      ......       .......++..|+|||++.+..++.++||||||+++|+|++|+.||.........     ..     
T Consensus       148 ~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-----~~-----  210 (256)
T cd06612         148 QLTDTM-------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-----FM-----  210 (256)
T ss_pred             hcccCc-------cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-----hh-----
Confidence            663321       0112234788999999998888999999999999999999999998753211100     00     


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ......+.+.                     .+..+...+.+++.+|++.||++|||+.||++
T Consensus       211 ~~~~~~~~~~---------------------~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         211 IPNKPPPTLS---------------------DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hccCCCCCCC---------------------chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0000000000                     01223457899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=301.47  Aligned_cols=254  Identities=22%  Similarity=0.316  Sum_probs=199.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||.|+||.||+|....  ++..+|+|++........+.+.+|++++++++|+|++++++.+.     .+..
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKE--TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENK   76 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcC--CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCe
Confidence            4568899999999999999998543  56889999998665555678899999999999999999999854     3457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++...   ...+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.++|+|||.+
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~  150 (280)
T cd06611          77 LWILIEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVS  150 (280)
T ss_pred             EEEEeeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccc
Confidence            89999999999999998743   235899999999999999999999   899999999999999999999999999988


Q ss_pred             cccccccccCCCCccccccccccccccCccccC-----CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      .......       .......++..|+|||.+.     ...++.++||||||+++|||++|+.||....... .+..+. 
T Consensus       151 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~-  221 (280)
T cd06611         151 AKNKSTL-------QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKIL-  221 (280)
T ss_pred             hhhcccc-------cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHh-
Confidence            7543211       1122345888999999864     3457889999999999999999999986532110 000000 


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                              ....+.+..                     +..+..++.+++..||+.+|++||++.+|++.
T Consensus       222 --------~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         222 --------KSEPPTLDQ---------------------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             --------cCCCCCcCC---------------------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                    000000000                     12235578899999999999999999999865

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.1e-38  Score=299.65  Aligned_cols=275  Identities=22%  Similarity=0.277  Sum_probs=194.3

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|++.+.||+|++|.||+|+..  .++..||+|.++....  ...+.+.+|+.++++++|||++++++++.     .+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   73 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNK--KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESR   73 (285)
T ss_pred             CceEeeEecccCceEEEEEEEC--CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCe
Confidence            4788899999999999999843  4567899999865432  23467889999999999999999999854     3458


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||++ ++|.+++..... ...+++..++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||++
T Consensus        74 ~~~v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  148 (285)
T cd07861          74 LYLIFEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLA  148 (285)
T ss_pred             EEEEEecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccce
Confidence            899999996 689988864332 346899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      .......       .......++..|+|||.+.+ ..++.++|||||||++|+|+||+.||....... ...........
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~-~~~~~~~~~~~  220 (285)
T cd07861         149 RAFGIPV-------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID-QLFRIFRILGT  220 (285)
T ss_pred             eecCCCc-------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCC
Confidence            7543211       11122346889999998765 457889999999999999999999997532111 00000000000


Q ss_pred             --hh-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 --ER-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 --~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                        +. .....+  + .+....    ...............+..++.+++.+||+.||++|||+.+|++
T Consensus       221 ~~~~~~~~~~~--~-~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         221 PTEDVWPGVTS--L-PDYKNT----FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             CChhhhhcchh--h-HHHHhh----ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence              00 000000  0 000000    0000000000001123567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.7e-38  Score=301.31  Aligned_cols=266  Identities=23%  Similarity=0.289  Sum_probs=201.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|++.+.||+|+||+||++...  .+++.||+|++..... ...+.+.+|+++++.++||||+++++++..     ...
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~   77 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHI--PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-----ENN   77 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEc--CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-----CCE
Confidence            46788899999999999999854  3567899998865432 334678899999999999999999999643     358


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++...    ..+++..+..++.+++.+|.|||+  ..+++||||+|+||++++++.++|+|||++
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~  151 (284)
T cd06620          78 ICMCMEFMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS  151 (284)
T ss_pred             EEEEEecCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence            89999999999999988642    358899999999999999999994  368999999999999999999999999988


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......         .....++..|+|||++.+..++.++|||||||++|++++|+.||.........      ...+.
T Consensus       152 ~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~------~~~~~  216 (284)
T cd06620         152 GELINSI---------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG------QDDPM  216 (284)
T ss_pred             cchhhhc---------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh------hhhhh
Confidence            6542211         11245889999999988888999999999999999999999999764322110      00000


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                      .+.+.+........               ......+++..+.+++.+|++.||++|||+.||++...-++
T Consensus       217 ~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         217 GILDLLQQIVQEPP---------------PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             HHHHHHHHHhhccC---------------CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            01111111000000               00001224567899999999999999999999998754443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.7e-38  Score=302.48  Aligned_cols=278  Identities=22%  Similarity=0.283  Sum_probs=196.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|.+.+.||+|+||.||+|+..  .++..||+|.++.... .....+.+|+.+++.++|+||+++++++.     ....
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~   78 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSK--LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKS   78 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEc--CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCe
Confidence            57899999999999999999843  4568899999875432 23456788999999999999999999853     4457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||++ ++|.+++...   ...+++..+..++.|++.||+|||   +.+|+|+||||+||+++.++.+||+|||++
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  151 (301)
T cd07873          79 LTLVFEYLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLA  151 (301)
T ss_pred             EEEEEeccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcch
Confidence            899999996 6999888643   235789999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      .......       .......++..|+|||.+.+ ..++.++|||||||++|||+||+.||......  .....+.....
T Consensus       152 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~--~~~~~~~~~~~  222 (301)
T cd07873         152 RAKSIPT-------KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE--EQLHFIFRILG  222 (301)
T ss_pred             hccCCCC-------CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcC
Confidence            7543211       11122346889999998765 45788999999999999999999999753211  11111111111


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..........+..+.....  ................+...+.+++.+|++.||.+|||++|+++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         223 TPTEETWPGILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             CCChhhchhhhcccccccc--ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            1111111000000000000  00000000000001223557889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.2e-38  Score=292.09  Aligned_cols=252  Identities=25%  Similarity=0.310  Sum_probs=197.3

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|++.+.||+|++|.||++...  .+++.||+|.+.....  ...+.+.+|++++++++|+|++++++.+.    ..+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHR--TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEc--CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCE
Confidence            4888999999999999999954  3467899999875432  23456889999999999999999988642    23346


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++....  ...+++.+++.++.|++.|+++||   +.+++||||||+||+++.++.++|+|||++
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~  149 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIA  149 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccce
Confidence            789999999999999997532  345899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......       .......++..|+|||+..+..++.++||||||+++++|++|+.||....     ...........
T Consensus       150 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~~  217 (257)
T cd08223         150 RVLENQC-------DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRIIEG  217 (257)
T ss_pred             EEecccC-------CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHhc
Confidence            7653221       11223457889999999999899999999999999999999999986421     11111111000


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .    .. .+                       +.....++.+++.+|++.+|++|||+.++++.
T Consensus       218 ~----~~-~~-----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         218 K----LP-PM-----------------------PKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             C----CC-CC-----------------------ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0    00 00                       11225678899999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-38  Score=297.04  Aligned_cols=250  Identities=28%  Similarity=0.368  Sum_probs=198.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|++.+.||.|++|.||+|+..  .++..||+|.+.... ......+.+|+++++.++|+|++++++++..     +..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   73 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDK--RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSK   73 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEEC--CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCe
Confidence            36888899999999999999854  357889999987553 2334678899999999999999999998543     358


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++|+||+++++|.+++...     .+++..++.++.|++.|+.|||   +++++|+||+|+||++++++.++|+|||.+
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~  145 (274)
T cd06609          74 LWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVS  145 (274)
T ss_pred             EEEEEEeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccc
Confidence            89999999999999998742     5899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      +......       .......++..|+|||++.+..++.++||||||+++|+|+||+.||......     ..... .  
T Consensus       146 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~~~-~--  210 (274)
T cd06609         146 GQLTSTM-------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVLFL-I--  210 (274)
T ss_pred             eeecccc-------cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHHHH-h--
Confidence            8764321       1112245788899999998888999999999999999999999999653211     00000 0  


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                        .....+.+.                      ...++..+.+++.+||..+|++|||++++++.
T Consensus       211 --~~~~~~~~~----------------------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         211 --PKNNPPSLE----------------------GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             --hhcCCCCCc----------------------ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              000000000                      00024568899999999999999999999763

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=5.3e-38  Score=296.10  Aligned_cols=265  Identities=27%  Similarity=0.440  Sum_probs=199.9

Q ss_pred             CCccCccccccceeEEEEEEcC-CCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC-Cc
Q 011508          161 FSLENLIGAGSFGSVYKGIFDH-DDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG-ND  236 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~-~~  236 (484)
                      |.+.+.||+|+||.||+|.+.. ..++..||+|++....  ....+++.+|++++++++|||++++++++......+ ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5677899999999999998653 3456889999987543  223467889999999999999999999865432111 12


Q ss_pred             eeeEEeecccCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          237 FEALVYELMVNGSLEEWLHLNR--DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ..++++||+.+|+|.+++....  .....+++...+.++.|++.||+|||   +.+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            3478899999999998875332  12235789999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |.++.......     ........++..|++||.+....++.++|||||||++|||++ |+.||......  ....++..
T Consensus       158 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~  230 (273)
T cd05074         158 GLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLIK  230 (273)
T ss_pred             cccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHHc
Confidence            99886532211     011112335678999999988889999999999999999999 88888643211  11111110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                      .          ..+..                     +..++..+.+++.+|++.+|++||++.|+++.|+.+
T Consensus       231 ~----------~~~~~---------------------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 G----------NRLKQ---------------------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             C----------CcCCC---------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0          00000                     112256789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-38  Score=309.74  Aligned_cols=194  Identities=25%  Similarity=0.391  Sum_probs=161.6

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ....+|++.+.||+|+||.||+|+..  .++..||+|+....      ....|+.++++++|+||+++++++..     .
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  129 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKP--GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS-----G  129 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEEC--CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe-----C
Confidence            34467999999999999999999954  35678999975322      23569999999999999999998643     3


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++|+|++ .++|.+++...   ...+++..++.|+.||+.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus       130 ~~~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG  202 (357)
T PHA03209        130 AITCMVLPHY-SSDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLG  202 (357)
T ss_pred             CeeEEEEEcc-CCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCc
Confidence            4789999999 57898888643   345899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCC
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPT  377 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~  377 (484)
                      .++.....        .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       203 ~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        203 AAQFPVVA--------PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccC--------cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            98753211        1122346899999999999999999999999999999999965544

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.6e-38  Score=297.61  Aligned_cols=254  Identities=28%  Similarity=0.439  Sum_probs=194.2

Q ss_pred             CccccccceeEEEEEEcCC----CCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          165 NLIGAGSFGSVYKGIFDHD----DHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      +.||+|+||.||+|+..+.    ..+..+|+|.+.... ......+.+|+.+++.++||||+++++++.     .....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence            4699999999999986532    233679999876543 234567889999999999999999999864     344789


Q ss_pred             EEeecccCCCHHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-----ceEE
Q 011508          240 LVYELMVNGSLEEWLHLNRD---APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-----TAHV  311 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-----~~kl  311 (484)
                      +||||+++++|.+++.....   ....+++.+++.++.|++.||+|||   +.+++|+||||+||+++.+.     .++|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEE
Confidence            99999999999999975432   2234789999999999999999999   89999999999999999877     8999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  390 (484)
                      +|||++.........     .......++..|+|||++.+..++.++|||||||++|||++ |+.||......  .....
T Consensus       153 ~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~  225 (269)
T cd05044         153 GDFGLARDIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQH  225 (269)
T ss_pred             CCccccccccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHH
Confidence            999998765322110     11112245678999999999999999999999999999998 99998643111  11111


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      +..   .       ....                     .+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus       226 ~~~---~-------~~~~---------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         226 VTA---G-------GRLQ---------------------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             Hhc---C-------CccC---------------------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            000   0       0000                     01223567899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-38  Score=316.29  Aligned_cols=196  Identities=28%  Similarity=0.388  Sum_probs=164.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ..+|.+.+.||+|+||.||+|...  ..++.||||...      ...+.+|++++++++|+||+++++++..     +..
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~--~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~  234 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHP--DYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV-----GGL  234 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEEC--CCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCE
Confidence            457999999999999999999854  356789999642      2346789999999999999999998643     347


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++|||++ .++|.+++...   ...+++.+++.|+.|++.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       235 ~~lv~e~~-~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla  307 (461)
T PHA03211        235 TCLVLPKY-RSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAA  307 (461)
T ss_pred             EEEEEEcc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCc
Confidence            89999999 57999888643   235899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCC
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN  378 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~  378 (484)
                      +.......     ........||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus       308 ~~~~~~~~-----~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf  363 (461)
T PHA03211        308 CFARGSWS-----TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF  363 (461)
T ss_pred             eecccccc-----cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence            86533211     111223569999999999999999999999999999999999887653

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=7.2e-38  Score=294.04  Aligned_cols=254  Identities=24%  Similarity=0.292  Sum_probs=191.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-----cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-----GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      .+|+..+.||+|+||.||+|...  .++..|++|.+.....     .....+.+|+.++++++||||+++++++..   .
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~   76 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDV--DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---R   76 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEc--CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---C
Confidence            46889999999999999999843  4577899998864321     223568889999999999999999987532   2


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .+...++++||+++++|.+++...    ..+++..++.++.|++.||+|||   +.+|+||||+|+||+++.++.+||+|
T Consensus        77 ~~~~~~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~d  149 (266)
T cd06651          77 AEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGD  149 (266)
T ss_pred             CCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence            235678999999999999999743    24789999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||++.........    ........++..|+|||++.+..++.++|||||||++|||++|+.||......     ..+..
T Consensus       150 fg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~~~~  220 (266)
T cd06651         150 FGASKRLQTICMS----GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AAIFK  220 (266)
T ss_pred             CCCcccccccccc----CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HHHHH
Confidence            9998765321110    11112245788999999998888999999999999999999999999653111     00100


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...    ....+.+                       +..+...+.+++ .||..+|++||+++||++
T Consensus       221 ~~~----~~~~~~~-----------------------~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         221 IAT----QPTNPQL-----------------------PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             Hhc----CCCCCCC-----------------------chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            000    0000000                       111133455566 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5e-38  Score=297.94  Aligned_cols=253  Identities=25%  Similarity=0.317  Sum_probs=191.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHH-HHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQA-LRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||+|+++.... .....+..|+.. ++.++|||++++++++.     .+.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~   73 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRH--VPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REG   73 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEE--cCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCC
Confidence            4688899999999999999984  44678999999875432 223455566665 56679999999999864     344


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCeeecCCCceEEcccC
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCET-PIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ..++||||++ |+|.+++.........+++..++.++.|++.||+|||   ++ +++||||||+||+++.++.+||+|||
T Consensus        74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg  149 (283)
T cd06617          74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFG  149 (283)
T ss_pred             cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecc
Confidence            7899999995 7898888754444456899999999999999999999   76 99999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC----CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG----SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      .+.......        ......++..|+|||.+.+    ..++.++|+|||||++|+|++|+.||.........+....
T Consensus       150 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  221 (283)
T cd06617         150 ISGYLVDSV--------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV  221 (283)
T ss_pred             ccccccccc--------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH
Confidence            987653211        1112357888999998765    4568899999999999999999999864221111111100


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .         -..+.+.                      ...++.++.+++..||..+|++||++.++++
T Consensus       222 ~---------~~~~~~~----------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         222 E---------EPSPQLP----------------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             h---------cCCCCCC----------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0         0000000                      1112567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=7.8e-38  Score=295.59  Aligned_cols=248  Identities=24%  Similarity=0.323  Sum_probs=197.4

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      .|+..+.||.|+||.||+|...  .++..||+|.+.... ......+.+|+.+++.++|+||+++++++..     +...
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDN--RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----GTKL   77 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEc--cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCEE
Confidence            4677889999999999999844  356889999987543 2344678899999999999999999998643     4588


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++++|.+++..     ..+++.++..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.
T Consensus        78 ~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~  149 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAG  149 (277)
T ss_pred             EEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccce
Confidence            999999999999999863     24788999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      ......       .......++..|+|||++.+..++.++|+|||||++|||+||+.||........     .       
T Consensus       150 ~~~~~~-------~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~-------  210 (277)
T cd06640         150 QLTDTQ-------IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----L-------  210 (277)
T ss_pred             eccCCc-------cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----h-------
Confidence            653221       111223578889999999888899999999999999999999999865321110     0       


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                        ..+......                   .....++..+.+++..||+.+|++||++.+++..
T Consensus       211 --~~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         211 --FLIPKNNPP-------------------TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             --hhhhcCCCC-------------------CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence              000000000                   0023346778999999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-39  Score=302.81  Aligned_cols=254  Identities=22%  Similarity=0.326  Sum_probs=195.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  234 (484)
                      ...|++.++||.||.+.||++...   +.+.+|+|++....  ......|.+|+..|.+| .|.+||++++|-.     .
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s---~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-----~  431 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNS---DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-----T  431 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecC---CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-----c
Confidence            356899999999999999999844   34667877665332  33456799999999999 6999999999954     3


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      +++.|+||||- ..+|..+|+.....   +....+..+..|++.++.++|   .++|||.||||.|+|+- .|.+||+||
T Consensus       432 d~~lYmvmE~G-d~DL~kiL~k~~~~---~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDF  503 (677)
T KOG0596|consen  432 DGYLYMVMECG-DIDLNKILKKKKSI---DPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDF  503 (677)
T ss_pred             CceEEEEeecc-cccHHHHHHhccCC---CchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeee
Confidence            56999999987 67999999865432   332378889999999999999   99999999999999987 468999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCC-----------CCCcccceehhhHHHHHHHhCCCCCCCCccC
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-----------EVSTSGDVYSFGILLLEMFTGKGPTNEMFTG  383 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~  383 (484)
                      |.|..+..+....     .....+||+.||+||.+...           +.+.++||||+|||||+|+.|+.||..... 
T Consensus       504 GIA~aI~~DTTsI-----~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-  577 (677)
T KOG0596|consen  504 GIANAIQPDTTSI-----VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-  577 (677)
T ss_pred             chhcccCccccce-----eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-
Confidence            9999886654332     23346899999999976543           256899999999999999999999975211 


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                           .|      .++..+.|+.-.-++....               .   ..++++++..||++||++|||..|+++.
T Consensus       578 -----~~------aKl~aI~~P~~~Iefp~~~---------------~---~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  578 -----QI------AKLHAITDPNHEIEFPDIP---------------E---NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -----HH------HHHHhhcCCCccccccCCC---------------C---chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                 11      2244555553322221100               0   3348999999999999999999999853

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.4e-38  Score=292.66  Aligned_cols=251  Identities=29%  Similarity=0.459  Sum_probs=195.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      .+|++.+.||+|+||.||+|.+.   .+..+|+|.+.... .....+.+|++++++++|||++++++++     ......
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~---~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   74 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL---EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPI   74 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe---CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCce
Confidence            46788899999999999999865   34679999886433 2346789999999999999999999985     344578


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++++|.+++....   ..+++..++.++.|++.+++|||   +.+++|+||||+||+++.++.++|+|||.+.
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~  148 (256)
T cd05112          75 CLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTR  148 (256)
T ss_pred             EEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCccee
Confidence            99999999999999987432   34789999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ......      ........++..|+|||...+..++.++||||||+++|||++ |+.||.....     .......   
T Consensus       149 ~~~~~~------~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~---  214 (256)
T cd05112         149 FVLDDQ------YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVETI---  214 (256)
T ss_pred             ecccCc------ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHHH---
Confidence            553221      011112235678999999988889999999999999999998 9999865321     1111110   


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                        .+.... .                      .+...+..+.+++.+||+.+|++|||+.|++++|
T Consensus       215 --~~~~~~-~----------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         215 --NAGFRL-Y----------------------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             --hCCCCC-C----------------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence              000000 0                      0011145789999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-39  Score=314.15  Aligned_cols=259  Identities=28%  Similarity=0.432  Sum_probs=210.2

Q ss_pred             CccCccccccceeEEEEEEcCCCC--eeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          162 SLENLIGAGSFGSVYKGIFDHDDH--ETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       162 ~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ...++||+|+||+||+|.|--++.  ..+||+|++.... .....++.+|+-+|.+++|||+++++++|...      ..
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~~  772 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------TL  772 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------hH
Confidence            445789999999999999854432  3579999986443 34567899999999999999999999998643      36


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      .||++||+.|+|.+|++.+++   ++.....+.|..|||+|+.|||   .+++|||||..+|||+.....+||.|||+++
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~  846 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAK  846 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhh
Confidence            799999999999999997553   5888999999999999999999   9999999999999999999999999999999


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .+..+......     ....-.+.|+|=|.+....++.++|||||||++||++| |..|+++...++             
T Consensus       847 ll~~d~~ey~~-----~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------------  908 (1177)
T KOG1025|consen  847 LLAPDEKEYSA-----PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------------  908 (1177)
T ss_pred             ccCcccccccc-----cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------------
Confidence            98765533222     12335678999999999999999999999999999999 999987642221             


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                       +.+++..-                   .+-..++-|...+..++.+||..|+..||+++++.++..++....
T Consensus       909 -I~dlle~g-------------------eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  909 -IPDLLEKG-------------------ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             -hhHHHhcc-------------------ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence             11111100                   011116678889999999999999999999999999998875443

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=6.8e-38  Score=294.04  Aligned_cols=255  Identities=23%  Similarity=0.331  Sum_probs=195.3

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc------cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR------GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      +|.+.+.||+|+||.||+|...   ++..+|+|.+.....      .....+.+|++++++++|+||+++++++.     
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   72 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN---QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----   72 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc---CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----
Confidence            4778899999999999999753   567899998875432      12246888999999999999999999864     


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++|+||+++++|.+++...    ..+++..+..++.|++.||+|||   +.+|+|+||+|+||++++++.++|+|
T Consensus        73 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d  145 (265)
T cd06631          73 DDNTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLID  145 (265)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEecc
Confidence            345889999999999999999743    24789999999999999999999   88999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||.+........... .........++..|+|||+..+..++.++||||||+++|+|++|+.||......    ......
T Consensus       146 fg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~~~  220 (265)
T cd06631         146 FGCARRLAWVGLHGT-HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAMFYI  220 (265)
T ss_pred             chhhHhhhhcccccc-ccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHHHHh
Confidence            999876532111110 111122345889999999999888999999999999999999999999653111    000000


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...   .. ..+.+                       +..+..++.+++.+||+.+|++||++.|+++
T Consensus       221 ~~~---~~-~~~~~-----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         221 GAH---RG-LMPRL-----------------------PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             hhc---cC-CCCCC-----------------------CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000   00 00000                       1122557889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.6e-38  Score=298.01  Aligned_cols=266  Identities=23%  Similarity=0.307  Sum_probs=203.6

Q ss_pred             ccHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeee
Q 011508          149 VSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSC  227 (484)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  227 (484)
                      .+..++....+.|++.+.||+|+||.||+|...  .++..+|+|++.... .....+..|+.+++++ +|+|++++++++
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   82 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHV--KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAF   82 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEc--CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence            345566667789999999999999999999954  356789999986543 2335688899999998 799999999987


Q ss_pred             eeecc-CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 011508          228 VSVDF-QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE  306 (484)
Q Consensus       228 ~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~  306 (484)
                      ..... ......+++|||+++|+|.+++....  ...+++..++.++.|++.||+|||   +.+|+|+||+|+||+++++
T Consensus        83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~  157 (282)
T cd06636          83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             hcccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCC
Confidence            54321 23457899999999999999997543  234788889999999999999999   8999999999999999999


Q ss_pred             CceEEcccCcccccccccccCCCCccccccccccccccCccccC-----CCCCCcccceehhhHHHHHHHhCCCCCCCCc
Q 011508          307 LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEMF  381 (484)
Q Consensus       307 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~  381 (484)
                      +.++|+|||.+.......       .......++..|+|||.+.     ...++.++|||||||++|||++|+.||....
T Consensus       158 ~~~~l~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~  230 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH  230 (282)
T ss_pred             CCEEEeeCcchhhhhccc-------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence            999999999987553211       1122345889999999875     3467889999999999999999999996532


Q ss_pred             cCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          382 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....    ...      ......+.                      .....++.++.+++.+||+.||.+|||+.|+++
T Consensus       231 ~~~~----~~~------~~~~~~~~----------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         231 PMRA----LFL------IPRNPPPK----------------------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HHhh----hhh------HhhCCCCC----------------------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            1100    000      00000000                      001223567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=291.22  Aligned_cols=272  Identities=24%  Similarity=0.342  Sum_probs=207.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC--CCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI--RHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ....+.+.||+|.||.||+|.|+    |..||||++...   +.+.+.+|.++.+..  +|+||+.+++.-.... ..-.
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wr----Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~T  282 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWR----GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWT  282 (513)
T ss_pred             heeEEEEEecCccccceeecccc----CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceE
Confidence            45678899999999999999998    678999999743   446788888888765  9999999998633221 2224


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeeecCCCceEE
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY-----CETPIVHCDLKPSNVLLDGELTAHV  311 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl  311 (484)
                      +.|||++|.+.|||.|||..+     .++....++++..+|.||++||..     .+..|.|||||+.|||+..++.+.|
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence            789999999999999999843     488999999999999999999953     2577999999999999999999999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCC------CCcccceehhhHHHHHHHhC----------CC
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE------VSTSGDVYSFGILLLEMFTG----------KG  375 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dvws~Gvvl~elltg----------~~  375 (484)
                      +|+|+|...+...+...   ......+||.+|||||++....      .-..+||||||.|+||+.-.          +.
T Consensus       358 ADLGLAv~h~~~t~~id---i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~  434 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTID---IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL  434 (513)
T ss_pred             eeceeeEEecccCCccc---CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence            99999987766543332   2234567999999999976532      12368999999999999653          35


Q ss_pred             CCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC
Q 011508          376 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN  455 (484)
Q Consensus       376 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt  455 (484)
                      ||.+..+.+-.+.++..-.--+++...++..+                      ...++...+.++|+.||..+|.-|-|
T Consensus       435 Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW----------------------~s~~~l~~m~klMkeCW~~Np~aRlt  492 (513)
T KOG2052|consen  435 PYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW----------------------KSDPALRVMAKLMKECWYANPAARLT  492 (513)
T ss_pred             CcccCCCCCCCHHHHhcceeecccCCCCCccc----------------------ccCHHHHHHHHHHHHhhcCCchhhhH
Confidence            66665444444333322221111222222111                      13455888999999999999999999


Q ss_pred             HHHHHHHHHHHHH
Q 011508          456 MEEVAAQLLSFRN  468 (484)
Q Consensus       456 ~~evl~~L~~i~~  468 (484)
                      +--+-+.|.++.+
T Consensus       493 ALriKKtl~~l~~  505 (513)
T KOG2052|consen  493 ALRIKKTLAKLSN  505 (513)
T ss_pred             HHHHHHHHHHHhc
Confidence            9999999988764

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.3e-37  Score=290.56  Aligned_cols=252  Identities=21%  Similarity=0.278  Sum_probs=199.3

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|+..+.||.|+||.||.++.  ..++..+++|.+....  ......+.+|++++++++|+||+++++++.     ++..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~   73 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRR--TEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNT   73 (256)
T ss_pred             CceEeeEecccCCceEEEEEE--cCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCe
Confidence            578899999999999999884  4457789999887543  233467889999999999999999999954     3458


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .+++|||+++++|.+++....  ...+++.++..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||.+
T Consensus        74 ~~~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~  148 (256)
T cd08221          74 LLIEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGIS  148 (256)
T ss_pred             EEEEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcce
Confidence            899999999999999997543  345899999999999999999999   889999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ........       ......++..|+|||...+..++.++||||||+++|||++|..||.....     .+....    
T Consensus       149 ~~~~~~~~-------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~----  212 (256)
T cd08221         149 KILGSEYS-------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVK----  212 (256)
T ss_pred             EEcccccc-------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH----
Confidence            76533221       11234588999999999888889999999999999999999999865211     111111    


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                          +.......                    ....++..+.+++..||+.+|++||+++|+++.+
T Consensus       213 ----~~~~~~~~--------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         213 ----IVQGNYTP--------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----HHcCCCCC--------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                11000000                    0112255688999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-39  Score=305.30  Aligned_cols=245  Identities=27%  Similarity=0.359  Sum_probs=195.6

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc---hHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA---SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      |+-.+.||.|+||.||-|+  +..+...||||.+.......   -.++..|+..|.+++|||+|.+.|++...     ..
T Consensus        28 f~dLrEIGHGSFGAVYfAr--d~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----~T  100 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFAR--DVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----HT  100 (948)
T ss_pred             HHHHHHhcCCccceeEEee--ccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----ch
Confidence            4556789999999999998  55678899999998654433   35788999999999999999999986543     37


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .|+||||| -||-.+++.-..   +++.+-++..|..+.++||+|||   +.+.||||||+.|||+++.|.|||+|||.|
T Consensus       101 aWLVMEYC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSA  173 (948)
T KOG0577|consen  101 AWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSA  173 (948)
T ss_pred             HHHHHHHH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccch
Confidence            79999999 678888876543   46888999999999999999999   999999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccC---CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM---GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ....+.           ..++||+.|||||++.   .+.|+-|+||||+|++..||.-.++|...+..- ..+.....  
T Consensus       174 si~~PA-----------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-SALYHIAQ--  239 (948)
T KOG0577|consen  174 SIMAPA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ--  239 (948)
T ss_pred             hhcCch-----------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-HHHHHHHh--
Confidence            876433           2467999999999865   478999999999999999999999997543110 00111111  


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                             --.|.+.                      ..+....+..++..||+.-|++|||.++++..
T Consensus       240 -------NesPtLq----------------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  240 -------NESPTLQ----------------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             -------cCCCCCC----------------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence                   0111111                      22336778999999999999999999998753

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-38  Score=297.27  Aligned_cols=243  Identities=25%  Similarity=0.371  Sum_probs=185.5

Q ss_pred             CccccccceeEEEEEEcCCC-----CeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          165 NLIGAGSFGSVYKGIFDHDD-----HETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      +.||+|+||.||+|......     ....+++|.+........+.+.+|+.+++.++|||++++++++..     +...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-----GDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-----CCCcE
Confidence            46999999999999864322     234588888865544455678899999999999999999998643     34678


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc--------eEE
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT--------AHV  311 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~--------~kl  311 (484)
                      +||||+++|+|.++++...   ..+++..++.++.||+.||+|||   +++|+||||||+||+++.++.        +++
T Consensus        76 lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l  149 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL  149 (258)
T ss_pred             EEEecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEe
Confidence            9999999999999997432   25889999999999999999999   899999999999999987765        689


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCC-CCCCCCccCCccHhH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK-GPTNEMFTGNLTLHN  389 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~-~p~~~~~~~~~~~~~  389 (484)
                      +|||.+......           ....++..|+|||++.+ ..++.++|||||||++|||++|. .||......     .
T Consensus       150 ~d~g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-----~  213 (258)
T cd05078         150 SDPGISITVLPK-----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-----K  213 (258)
T ss_pred             cccccccccCCc-----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-----H
Confidence            999987654211           12347788999999876 45799999999999999999985 554331110     0


Q ss_pred             HHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          390 FVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      ..         .........                     +.....++.+++.+||+.||++|||++++++.|+
T Consensus       214 ~~---------~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         214 KL---------QFYEDRHQL---------------------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HH---------HHHHccccC---------------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00         000000000                     1111456889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.5e-38  Score=297.98  Aligned_cols=247  Identities=25%  Similarity=0.353  Sum_probs=195.3

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      |+..+.||+|+||.||+|...  .++..||+|.+.... ....+.+.+|++++++++|+||+++++++.     .+...+
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   78 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDN--RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLW   78 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEc--CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceE
Confidence            556688999999999999854  356789999987443 233457889999999999999999999853     455789


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      +||||+++++|.+++..     ..+++..+..++.|++.|+.|||   .++++|+||+|+||++++++.++|+|||++..
T Consensus        79 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06642          79 IIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQ  150 (277)
T ss_pred             EEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEcccccccc
Confidence            99999999999998862     34889999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhh
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERL  399 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  399 (484)
                      +....       .......++..|+|||++.+..++.++|||||||++|||++|+.||........  ....        
T Consensus       151 ~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~--------  213 (277)
T cd06642         151 LTDTQ-------IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLI--------  213 (277)
T ss_pred             ccCcc-------hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhhh--------
Confidence            53221       111223578899999999988899999999999999999999999865321110  0000        


Q ss_pred             hhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          400 AEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       400 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..-..+.+                       ...++..+.+++.+|++.+|++||++.+|++.
T Consensus       214 ~~~~~~~~-----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         214 PKNSPPTL-----------------------EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             hcCCCCCC-----------------------CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            00000000                       11235678899999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7.7e-38  Score=303.18  Aligned_cols=202  Identities=25%  Similarity=0.336  Sum_probs=167.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+++..  .+++.+|+|++....   ......+.+|+.++..++|++|+++++++     .+.
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~   73 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLK--NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDE   73 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC--CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecC
Confidence            46889999999999999999854  356789999986421   22234578899999999999999999885     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++....   ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        74 ~~~~lv~ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG  147 (332)
T cd05623          74 NNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFG  147 (332)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecc
Confidence            58899999999999999997432   35889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccC-----CCCCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      ++.......      ........||+.|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       148 ~a~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         148 SCLKLMEDG------TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             hheecccCC------cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence            987543221      11112346899999999875     34688999999999999999999999965

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.3e-38  Score=304.69  Aligned_cols=202  Identities=26%  Similarity=0.347  Sum_probs=168.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|.+.+.||+|+||.||+++..  .+++.||+|++....   ......+.+|..++..++|+||+++++++     ..+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~   73 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMK--HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDE   73 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence            47899999999999999999844  457789999986422   22334578899999999999999999885     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|.+++....   ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        74 ~~~~lv~Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG  147 (331)
T cd05624          74 NYLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFG  147 (331)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEecc
Confidence            68899999999999999997432   35889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC-----CCCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-----SEVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      ++.......      ........|++.|+|||++.+     ..++.++|||||||++|||++|+.||..
T Consensus       148 ~a~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         148 SCLKMNQDG------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             ceeeccCCC------ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence            987653221      111122468999999998765     4678899999999999999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.3e-38  Score=291.92  Aligned_cols=247  Identities=29%  Similarity=0.478  Sum_probs=194.0

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|++.+.||+|+||.||++..    .+..||+|.++...  ....+.+|+.++++++|||++++++++..      +..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~----~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~   73 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY----TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGL   73 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc----CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCc
Confidence            4578899999999999999863    35679999886432  34678899999999999999999998532      236


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++++|.+++....  ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||.+.
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~  148 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR  148 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccce
Confidence            89999999999999997532  335889999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ......          .....+..|+|||.+.+..++.++||||||+++|||++ |+.||.....     ......    
T Consensus       149 ~~~~~~----------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~----  209 (254)
T cd05083         149 VGSMGV----------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKEC----  209 (254)
T ss_pred             eccccC----------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHH----
Confidence            542211          11224567999999988889999999999999999998 9999865321     111100    


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                           +.......                   .+..++..+.+++.+||+.+|++||+++++++.|++
T Consensus       210 -----~~~~~~~~-------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         210 -----VEKGYRME-------------------PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -----HhCCCCCC-------------------CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                 00000000                   012235678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=296.74  Aligned_cols=271  Identities=21%  Similarity=0.257  Sum_probs=189.1

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCC-eeEEEEEEeeccCccch-----------HHHHHHHHHHHcCCCCCceeEee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDH-ETLVAVKVLNLQHRGAS-----------KSFIAECQALRSIRHRNLVKIIT  225 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~  225 (484)
                      .++|.+.+.||+|+||.||+|...++.. ...+|+|+.........           .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3679999999999999999998654311 34567776443321110           11223444566779999999998


Q ss_pred             eeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 011508          226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG  305 (484)
Q Consensus       226 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~  305 (484)
                      ++.... ......++++|++ ..++.+.+...    ...++..+..++.|++.||+|||   +++|+||||||+||+++.
T Consensus        91 ~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~  161 (294)
T PHA02882         91 CGSFKR-CRMYYRFILLEKL-VENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDG  161 (294)
T ss_pred             eeeEec-CCceEEEEEEehh-ccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcC
Confidence            754322 1223457888887 44676666532    22567888999999999999999   899999999999999999


Q ss_pred             CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCc
Q 011508          306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNL  385 (484)
Q Consensus       306 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~  385 (484)
                      ++.++|+|||+++.+..................||+.|+|||+..+..++.++|||||||++|||++|+.||........
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            99999999999987643221111111122234699999999999999999999999999999999999999976532221


Q ss_pred             cHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          386 TLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      ... .....+   +..+....+                      ....++..+.+++..|++.+|++||++.++.+.+
T Consensus       242 ~~~-~~~~~~---~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        242 LIH-AAKCDF---IKRLHEGKI----------------------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHH-HhHHHH---HHHhhhhhh----------------------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            111 111000   111111100                      0122356789999999999999999999998876

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-38  Score=305.75  Aligned_cols=241  Identities=25%  Similarity=0.253  Sum_probs=181.1

Q ss_pred             cccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcC---CCCCceeEeeeeeeeccCCCceeeE
Q 011508          167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSI---RHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       167 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      ||+|+||+||+|+.  ..++..||+|++.....   .....+..|..++...   +||||+++++.+     ..+...++
T Consensus         1 lG~G~~g~Vy~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~l   73 (330)
T cd05586           1 IGKGTFGQVYQVRK--KDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYL   73 (330)
T ss_pred             CCCCCceEEEEEEE--CCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEE
Confidence            79999999999984  44578899999864321   1223455666777655   699999999884     44558899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++|+|.+++...    ..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++...
T Consensus        74 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~  146 (330)
T cd05586          74 VTDYMSGGELFWHLQKE----GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKAN  146 (330)
T ss_pred             EEcCCCCChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence            99999999999988742    35889999999999999999999   899999999999999999999999999998753


Q ss_pred             ccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERL  399 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  399 (484)
                      ....       .......||..|+|||++.+. .++.++|||||||++|||++|+.||.....     .+........  
T Consensus       147 ~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~--  212 (330)
T cd05586         147 LTDN-------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFG--  212 (330)
T ss_pred             CCCC-------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcC--
Confidence            2211       112234689999999988654 479999999999999999999999965311     1111110000  


Q ss_pred             hhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC----HHHHHH
Q 011508          400 AEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN----MEEVAA  461 (484)
Q Consensus       400 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~evl~  461 (484)
                          +..+.                      .......+.+++.+||+.||++||+    +.|+++
T Consensus       213 ----~~~~~----------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         213 ----KVRFP----------------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ----CCCCC----------------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence                00000                      0011456788999999999999984    556554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.2e-38  Score=299.44  Aligned_cols=249  Identities=23%  Similarity=0.329  Sum_probs=194.1

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeE
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      |.....||+|+||.||++..  ..++..||||.+........+.+.+|+.+++.++|+|++++++.+.     .++..++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~l   96 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATE--KHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWV   96 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEE--CCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEE
Confidence            34456799999999999984  3456789999987655555567889999999999999999999854     3458899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||||+++++|.+++..     ..+++..++.++.||+.||+|||   +++|+||||||+||++++++.++|+|||++...
T Consensus        97 v~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (292)
T cd06658          97 VMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV  168 (292)
T ss_pred             EEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence            9999999999998852     24789999999999999999999   899999999999999999999999999998754


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ....       .......++..|+|||...+..++.++||||||+++|||++|+.||......    . ...     .+.
T Consensus       169 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~-~~~-----~~~  231 (292)
T cd06658         169 SKEV-------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----Q-AMR-----RIR  231 (292)
T ss_pred             cccc-------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----H-HHH-----HHH
Confidence            3221       1112245889999999998888999999999999999999999998642110    0 000     011


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ....+.+..                     .......+.+++..|+..||++|||++|+++.
T Consensus       232 ~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         232 DNLPPRVKD---------------------SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             hcCCCcccc---------------------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111111100                     01114467889999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.6e-38  Score=293.71  Aligned_cols=255  Identities=27%  Similarity=0.354  Sum_probs=199.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|+..+.||+|++|.||++...  .++..+|+|.+..... .....+.+|++++++++||||+++++.+..     +..
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~   73 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHR--PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGD   73 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEc--CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCE
Confidence            35778899999999999999853  4578899999876543 334678899999999999999999998643     358


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCE-TPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      .++++||+++++|.+++....   ..+++..+..++.|++.|++|||   + .+++|+||||+||++++++.++|+|||.
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~  147 (265)
T cd06605          74 ISICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGV  147 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            899999999999999997542   45889999999999999999999   7 9999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +........         ....++..|+|||.+.+..++.++||||||+++|+|++|+.||...................
T Consensus       148 ~~~~~~~~~---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  218 (265)
T cd06605         148 SGQLVNSLA---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVN  218 (265)
T ss_pred             chhhHHHHh---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhc
Confidence            876532110         11457889999999988899999999999999999999999997543211111111111100


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .     ..+.+                      ....+..++.+++..||..||++|||+.|++..
T Consensus       219 ~-----~~~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         219 E-----PPPRL----------------------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             C-----CCCCC----------------------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            0     00000                      011135678999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-37  Score=290.63  Aligned_cols=241  Identities=26%  Similarity=0.417  Sum_probs=187.3

Q ss_pred             CccccccceeEEEEEEcCCCC--------eeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          165 NLIGAGSFGSVYKGIFDHDDH--------ETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      +.||+|+||.||+|.......        ...+++|.+...... ...+.+|+.+++.++|+||+++++++..      .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence            469999999999999764321        145788877654433 5788999999999999999999998743      3


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-------ce
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-------TA  309 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-------~~  309 (484)
                      ..++||||+++|+|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++       .+
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~  147 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFI  147 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeE
Confidence            5689999999999999997543   25889999999999999999999   89999999999999999887       79


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCCC--CCCcccceehhhHHHHHHHh-CCCCCCCCccCCcc
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS--EVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT  386 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~  386 (484)
                      ||+|||++......           ....++..|+|||++.+.  .++.++||||||+++|||++ |..||......  .
T Consensus       148 kl~Dfg~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~--~  214 (259)
T cd05037         148 KLSDPGIPITVLSR-----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--E  214 (259)
T ss_pred             EeCCCCcccccccc-----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch--h
Confidence            99999998865321           113466789999998876  78999999999999999999 57777553211  0


Q ss_pred             HhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          387 LHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      ...+..           ......                      ......+.+++.+||+.+|++|||+.||++.|+
T Consensus       215 ~~~~~~-----------~~~~~~----------------------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         215 KERFYQ-----------DQHRLP----------------------MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHHHHh-----------cCCCCC----------------------CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000000           000000                      000256889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-38  Score=295.08  Aligned_cols=249  Identities=23%  Similarity=0.352  Sum_probs=204.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      +=|.+.+.||+|.|+.|-+|+  +--+|..||||++.+..-.  ....+.+|++-|+-++|||||++|.+     .....
T Consensus        18 GLYDLekTlG~GHFAVVKLAr--HVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-----iDTQT   90 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLAR--HVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-----IDTQT   90 (864)
T ss_pred             eeehhhhhhcCCceehhhhhh--hhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-----hcccc
Confidence            457888999999999999998  5567899999999865433  23578899999999999999999998     45556


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee-cCCCceEEcccC
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL-DGELTAHVSDFG  315 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll-~~~~~~kl~Dfg  315 (484)
                      ..|+|+|.-.+|+|.+|+....   ..+.+.-..+++.||+.|+.|+|   ...+|||||||+|+.+ ..-|-+||.|||
T Consensus        91 KlyLiLELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFG  164 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFG  164 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeecc
Confidence            8999999999999999998544   45889999999999999999999   7889999999999877 556899999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCC-cccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVS-TSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ++..+.+.        ......+|+..|.|||++.+..|+ ++.||||+|||||-|++|+.||+...+.+          
T Consensus       165 FSNkf~PG--------~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------  226 (864)
T KOG4717|consen  165 FSNKFQPG--------KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------  226 (864)
T ss_pred             ccccCCCc--------chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----------
Confidence            99766432        233456899999999999998875 68999999999999999999998753322          


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                         .+.-++|-....                     +.....+..+||..||..||++|.+.+||+..
T Consensus       227 ---TLTmImDCKYtv---------------------PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  227 ---TLTMIMDCKYTV---------------------PSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ---hhhhhhcccccC---------------------chhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence               233344433322                     33446677899999999999999999998753

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2e-37  Score=289.28  Aligned_cols=251  Identities=21%  Similarity=0.268  Sum_probs=197.9

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|++.+.||+|+||.+|++...  .+++.||+|.+....  ....+++.+|+.++++++|+||+++++++     .....
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~   73 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSK--EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGN   73 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEc--CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCe
Confidence            4788999999999999999844  457789999987532  22345788999999999999999999984     44568


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++|+||+++++|.+++....  ...+++.+++.++.|++.|++|||   +.+++|+||+|+||+++.++.++|+|||.+
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~  148 (256)
T cd08218          74 LYIVMDYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIA  148 (256)
T ss_pred             EEEEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccce
Confidence            899999999999999987432  234789999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......       .......++..|+|||+..+..++.++|+|||||++++|++|+.||....     ....+...   
T Consensus       149 ~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~---  213 (256)
T cd08218         149 RVLNSTV-------ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKI---  213 (256)
T ss_pred             eecCcch-------hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHH---
Confidence            7653321       11122347888999999988889999999999999999999999986421     11111111   


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                           .......                    .+..+..++.+++.+||+.+|++||++.||++.
T Consensus       214 -----~~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         214 -----IRGSYPP--------------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             -----hcCCCCC--------------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                 1000000                    012235678999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.1e-37  Score=289.15  Aligned_cols=249  Identities=22%  Similarity=0.346  Sum_probs=195.9

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|+..+.||+|++|.||++...  .++..+|+|.+....  ......+.+|++++++++|||++++++.+     ..+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~   73 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRK--ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKA   73 (256)
T ss_pred             CceEEEEecccCceEEEEEEEc--CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCE
Confidence            4788899999999999999854  357889999987543  22346788999999999999999999874     34558


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEcccCc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVSDFGL  316 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~  316 (484)
                      .++||||+++++|.+++....  ...+++..++.++.|++.+++|||   +++++|+||+|+||+++++ +.+||+|||.
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~  148 (256)
T cd08220          74 LMIVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGI  148 (256)
T ss_pred             EEEEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence            899999999999999997533  335889999999999999999999   8999999999999999865 4689999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.......        ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......     ........
T Consensus       149 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~  215 (256)
T cd08220         149 SKILSSKS--------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIMS  215 (256)
T ss_pred             ceecCCCc--------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHHHh
Confidence            98663321        112245788999999998888999999999999999999999998653211     11111000


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .....+                            +..+...+.+++..||+.+|++|||+.|+++
T Consensus       216 ~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         216 GTFAPI----------------------------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             cCCCCC----------------------------CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            000000                            1122567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.1e-38  Score=298.03  Aligned_cols=271  Identities=20%  Similarity=0.244  Sum_probs=193.3

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|++.+.||+|+||.||+|+..  .++..+|+|.++....  .....+.+|++++++++|+|++++++++     .+...
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~--~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~   73 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNR--ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKK   73 (284)
T ss_pred             CceeEEEecccCCeEEEEEEEC--CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCc
Confidence            4788899999999999999954  4567899999875432  2235678899999999999999999984     44558


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++|+||++ ++|.+++...   ...+++..++.++.||++||.|||   .++|+||||||+||+++.++.+||+|||.+
T Consensus        74 ~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  146 (284)
T cd07839          74 LTLVFEYCD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLA  146 (284)
T ss_pred             eEEEEecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchh
Confidence            899999995 6888887643   235899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +......       .......++..|+|||.+.+. .++.++|||||||++|||+||..|+.........+.........
T Consensus       147 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  219 (284)
T cd07839         147 RAFGIPV-------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGT  219 (284)
T ss_pred             hccCCCC-------CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCC
Confidence            7653221       111223468899999987664 47899999999999999999998864432211111111110000


Q ss_pred             hh------hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ER------LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..      +....+.........     ..   ..  ......+..++.+++.+||+.||.+|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~-----~~---~~--~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         220 PTEESWPGVSKLPDYKPYPMYPA-----TT---SL--VNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CChHHhHHhhhcccccccCCCCC-----cc---hh--hhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00      001111000000000     00   00  0001123567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.9e-37  Score=294.40  Aligned_cols=255  Identities=24%  Similarity=0.310  Sum_probs=195.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|++.+.||+|+||.||+|...  .++..||+|.++.... .....+.+|++++++++|+||+++++.+.     .+..
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~   73 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHR--PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGA   73 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEc--CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCe
Confidence            36888999999999999999854  4578899998875422 23467889999999999999999999854     3458


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++.... ....+++..+..++.|++.||.|||+  +.+|+|+||||+||+++.++.+||+|||.+
T Consensus        74 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  150 (286)
T cd06622          74 VYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS  150 (286)
T ss_pred             EEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence            899999999999999987432 13368999999999999999999993  359999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCC------CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      ..+....         .....++..|+|||.+.+.      .++.++|||||||++|+|++|+.||.......  .... 
T Consensus       151 ~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~-  218 (286)
T cd06622         151 GNLVASL---------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQ-  218 (286)
T ss_pred             ccccCCc---------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHH-
Confidence            7552211         1123478899999987554      35889999999999999999999996531110  0000 


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                             +..+.+.....                    .+..+..++.+++.+|++.+|++||+++++++.
T Consensus       219 -------~~~~~~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         219 -------LSAIVDGDPPT--------------------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -------HHHHhhcCCCC--------------------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                   11111100000                    012235678899999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-37  Score=287.76  Aligned_cols=248  Identities=28%  Similarity=0.425  Sum_probs=192.8

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      ++||+|+||.||+|...  . ++.||+|.+...... ..+.+.+|++++++++|+||+++++++.     .....++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~--~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e   72 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK--G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVME   72 (251)
T ss_pred             CccccCCCceEEEEEEe--C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEE
Confidence            46999999999999854  2 678999988765443 4467899999999999999999999854     3447899999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccc
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA  323 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  323 (484)
                      |+++++|.+++....   ..+++..++.++.+++.+|+|||   +++++||||+|+||+++.++.+||+|||.+......
T Consensus        73 ~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          73 LVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             cCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            999999999996432   35789999999999999999999   899999999999999999999999999998765321


Q ss_pred             cccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhhh
Q 011508          324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAEI  402 (484)
Q Consensus       324 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (484)
                      ...     ........+..|+|||.+.+..++.++|||||||++|||+| |..||......  .....+           
T Consensus       147 ~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~~~~~~-----------  208 (251)
T cd05041         147 IYT-----VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--QTRERI-----------  208 (251)
T ss_pred             cce-----eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--HHHHHH-----------
Confidence            100     00011224567999999988889999999999999999999 88888653211  111110           


Q ss_pred             cCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          403 VDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       403 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                       ......                   ..+..++.++.+++.+|++.+|++|||+.||++.|+
T Consensus       209 -~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         209 -ESGYRM-------------------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             -hcCCCC-------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence             000000                   001223567899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.5e-37  Score=295.92  Aligned_cols=204  Identities=26%  Similarity=0.422  Sum_probs=166.3

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++.+|.+.+.||+|+||.||+|...  .++..||+|++..... .....+.+|+.+++.++|+||+++++++.     .
T Consensus         2 ~~~~~y~~~~~ig~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~   74 (291)
T cd07870           2 GAATSYLNLEKLGEGSYATVYKGISR--INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----T   74 (291)
T ss_pred             CccceeEEEEEEEecCCEEEEEEEEc--CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----c
Confidence            35678999999999999999999843  3567899999875433 22346788999999999999999999853     4


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      +...++|+||+. +++.+++...   ...+++..+..++.|++.||+|||   +.+|+|+||||+||+++.++.+||+||
T Consensus        75 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Df  147 (291)
T cd07870          75 KETLTFVFEYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADF  147 (291)
T ss_pred             CCeEEEEEeccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEecc
Confidence            457899999994 7888777532   234778889999999999999999   889999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      |+++......       .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       148 g~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~  207 (291)
T cd07870         148 GLARAKSIPS-------QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV  207 (291)
T ss_pred             ccccccCCCC-------CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence            9987542211       11122346889999998865 35788999999999999999999999754

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.5e-37  Score=295.90  Aligned_cols=251  Identities=24%  Similarity=0.309  Sum_probs=197.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|.+.+.||+|+||.||+|...  .++..||+|.+........+.+.+|+.+++.++|||++++++++..     ....
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~   91 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDV--ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDEL   91 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEc--CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcE
Confidence            67889999999999999999843  3467899999876555555778999999999999999999998643     4478


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++|+||+++++|.+++...     .+++..+..++.|++.||+|||   +++++|+||+|+||+++.++.++|+|||.+.
T Consensus        92 ~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~  163 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA  163 (293)
T ss_pred             EEEEecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCccee
Confidence            9999999999999998632     3788999999999999999999   8999999999999999999999999999887


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      ......       .......++..|+|||.+....++.++||||||+++|++++|+.||......... .....    ..
T Consensus       164 ~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~~~~~----~~  231 (293)
T cd06647         164 QITPEQ-------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIAT----NG  231 (293)
T ss_pred             cccccc-------cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-eehhc----CC
Confidence            553221       1112235888999999988888999999999999999999999999653211100 00000    00


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                           .+...                     .+......+.+++..||+.+|++||++.+++..
T Consensus       232 -----~~~~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         232 -----TPELQ---------------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             -----CCCCC---------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00000                     011124568899999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4e-37  Score=287.47  Aligned_cols=254  Identities=31%  Similarity=0.497  Sum_probs=197.3

Q ss_pred             CCccCccccccceeEEEEEEcCCC--CeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDD--HETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +++.+.||.|+||.||+++.....  ....||+|.+...... ..+.+.+|+..+..++|+|++++++++..     .+.
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCe
Confidence            456789999999999999975432  2478999999755433 45688999999999999999999998543     357


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .+++|||+++++|.+++.....  ..+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.++|+|||.+
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~  150 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLS  150 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCc
Confidence            8999999999999999974331  12899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ..........      .....++..|+|||...+..++.++||||+|+++++|++ |+.||....     ......... 
T Consensus       151 ~~~~~~~~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~~-  218 (258)
T smart00219      151 RDLYDDDYYK------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS-----NEEVLEYLK-  218 (258)
T ss_pred             eecccccccc------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHh-
Confidence            8764331110      001236789999999988889999999999999999998 788876521     111111100 


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                             ......                    .+..++.++.+++.+|+..+|++|||+.|+++.|
T Consensus       219 -------~~~~~~--------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      219 -------KGYRLP--------------------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------cCCCCC--------------------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                   000000                    0111356789999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=298.35  Aligned_cols=211  Identities=24%  Similarity=0.369  Sum_probs=170.7

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      +|++.+.||+|++|.||+|+......+..||+|.+....   ....+.+.+|+.+++.++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            478889999999999999996543367899999998633   34456788999999999999999999997532   235


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC----CCceEE
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAP-RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG----ELTAHV  311 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~----~~~~kl  311 (484)
                      ..++||||++ ++|.+++....... ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.    ++.+||
T Consensus        78 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl  153 (316)
T cd07842          78 SVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKI  153 (316)
T ss_pred             eEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence            7899999995 57877775443332 36899999999999999999999   899999999999999999    899999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCc
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMF  381 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~  381 (484)
                      +|||++.........    ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....
T Consensus       154 ~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~  220 (316)
T cd07842         154 GDLGLARLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE  220 (316)
T ss_pred             CCCccccccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence            999999876432211    111223457889999998765 457899999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.5e-37  Score=297.78  Aligned_cols=261  Identities=22%  Similarity=0.251  Sum_probs=195.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||++..  ...++.|++|.+.....   .....+.+|+++++.++||||+++++.+     ..+
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~--~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~   73 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRH--KETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETK   73 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEE--CCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecC
Confidence            3688899999999999999984  44578899999875432   2335678999999999999999999885     345


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++++|.+++...    ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||
T Consensus        74 ~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg  146 (305)
T cd05609          74 RHLCMVMEYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFG  146 (305)
T ss_pred             CEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCC
Confidence            5889999999999999999643    35889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccC--------CCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          316 LAKFLPEAANNL--------SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       316 ~a~~~~~~~~~~--------~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      .++.........        ...........++..|+|||.+....++.++|||||||++|||++|+.||.+...     
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----  221 (305)
T cd05609         147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----  221 (305)
T ss_pred             CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----
Confidence            886421110000        0000011124578899999999888899999999999999999999999864211     


Q ss_pred             hHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          388 HNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      .++........   ...+..                       ...++..+.+++.+||+.||++||++.++.+.|+
T Consensus       222 ~~~~~~~~~~~---~~~~~~-----------------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         222 EELFGQVISDD---IEWPEG-----------------------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHHHHHHHhcc---cCCCCc-----------------------cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            11111100000   000000                       0112567899999999999999999655555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.5e-37  Score=289.65  Aligned_cols=256  Identities=22%  Similarity=0.309  Sum_probs=196.2

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc------cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR------GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      +|+..+.||+|++|.||+|..  ..++..||+|++.....      ...+.+.+|++++++++|+|++++++++     .
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~--~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~   73 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARD--VKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----C   73 (268)
T ss_pred             CccccceecCcCceEEEEEEE--cCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----c
Confidence            477889999999999999984  44678899999875431      1235788999999999999999999985     3


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVS  312 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~  312 (484)
                      +++..++|+||+++++|.+++...    ..+++..++.++.|++.||+|||   +++++|+||+|+||+++.++ .+||+
T Consensus        74 ~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~  146 (268)
T cd06630          74 EDSHFNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIA  146 (268)
T ss_pred             cCCeEEEEEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEc
Confidence            445889999999999999999743    35889999999999999999999   89999999999999998775 69999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||.+.........   .........++..|+|||.+.+..++.++||||+|+++|+|++|+.||......  .......
T Consensus       147 dfg~~~~~~~~~~~---~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~  221 (268)
T cd06630         147 DFGAAARLAAKGTG---AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHLALIF  221 (268)
T ss_pred             cccccccccccccc---CCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chHHHHH
Confidence            99998776433111   111112345788999999998888999999999999999999999998642211  1011110


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                              .........                   ..+.....++.+++..|++.+|++|||+.|+++
T Consensus       222 --------~~~~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         222 --------KIASATTAP-------------------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --------HHhccCCCC-------------------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                    000000000                   001223567889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.4e-37  Score=288.53  Aligned_cols=254  Identities=23%  Similarity=0.267  Sum_probs=192.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-----cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-----GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      .+|++.+.||+|+||.||+|...  .++..||+|.+.....     ...+.+.+|+.++++++||||+++++++..   .
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~   76 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDA--DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---P   76 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEc--CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---C
Confidence            57889999999999999999843  4578899998864321     123567889999999999999999997532   1


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||+++++|.+++...    ..+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~D  149 (265)
T cd06652          77 MERTLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGD  149 (265)
T ss_pred             CCceEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECc
Confidence            234678999999999999998743    24788889999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||.+.........    ........++..|+|||.+.+..++.++|||||||++|||++|+.||......    ... ..
T Consensus       150 fg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~-~~  220 (265)
T cd06652         150 FGASKRLQTICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAI-FK  220 (265)
T ss_pred             Ccccccccccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHH-HH
Confidence            9998765321110    11112245888999999998888999999999999999999999998642110    000 00


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...    ....+.                       .+......+.+++.+|+. +|++||+++||++
T Consensus       221 ~~~----~~~~~~-----------------------~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         221 IAT----QPTNPV-----------------------LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             Hhc----CCCCCC-----------------------CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            000    000000                       012224567788888884 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.9e-37  Score=293.14  Aligned_cols=276  Identities=22%  Similarity=0.292  Sum_probs=195.9

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|++|.||+|+..  .++..||+|++.....  ...+.+.+|+.++++++|+|++++++++.     ...
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   73 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNR--ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKR   73 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEEC--CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCC
Confidence            46888999999999999999854  3578899998864432  23356789999999999999999999854     345


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|..++..    ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||+
T Consensus        74 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  146 (286)
T cd07847          74 KLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGF  146 (286)
T ss_pred             EEEEEEeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECcccc
Confidence            78999999999888877652    235899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH---H
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV---K  392 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~---~  392 (484)
                      +........       ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ +....   .
T Consensus       147 ~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~  218 (286)
T cd07847         147 ARILTGPGD-------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLG  218 (286)
T ss_pred             ceecCCCcc-------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhC
Confidence            987643221       1122347788999998765 4578999999999999999999999975432111 11110   0


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...+ ......+..-............   ....+ ......+..+.+++.+||+.+|++|||+.|++.
T Consensus       219 ~~~~-~~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         219 DLIP-RHQQIFSTNQFFKGLSIPEPET---REPLE-SKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCCh-HHhhhcccccccccccCCCccc---ccCHH-HHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            1111 0011111000000000000000   00000 000112467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.3e-37  Score=289.77  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=193.1

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc----------chHHHHHHHHHHHcCCCCCceeEeeeeee
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG----------ASKSFIAECQALRSIRHRNLVKIITSCVS  229 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~  229 (484)
                      +|.+.+.||+|+||.||+|..  ..+++.+|+|.++.....          ..+.+.+|+.+++.++|+|++++++++. 
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~--~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-   78 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALN--VTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET-   78 (272)
T ss_pred             ceeecceecccCceEEEEEee--cCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec-
Confidence            467789999999999999984  345778999988642110          1245788999999999999999999853 


Q ss_pred             eccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 011508          230 VDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA  309 (484)
Q Consensus       230 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~  309 (484)
                          .....++||||+++++|.+++...    ..+++..+..++.|++.||.|||   +++++||||+|+||+++.++.+
T Consensus        79 ----~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~  147 (272)
T cd06629          79 ----TEEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGIC  147 (272)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeE
Confidence                345789999999999999999743    35889999999999999999999   8999999999999999999999


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCCCC--CCcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE--VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      +|+|||++........     ........++..|+|||......  ++.++|+||||+++|++++|..||.....    .
T Consensus       148 ~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~  218 (272)
T cd06629         148 KISDFGISKKSDDIYD-----NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----I  218 (272)
T ss_pred             EEeecccccccccccc-----ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----H
Confidence            9999999876532110     11122345788999999877654  78999999999999999999999854211    1


Q ss_pred             hHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          388 HNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..... .........+....                       ..+++..+.+++..|++.+|++|||++||++
T Consensus       219 ~~~~~-~~~~~~~~~~~~~~-----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         219 AAMFK-LGNKRSAPPIPPDV-----------------------SMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHHHH-hhccccCCcCCccc-----------------------cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            11110 00000000000000                       1123567899999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.2e-37  Score=288.93  Aligned_cols=261  Identities=26%  Similarity=0.344  Sum_probs=200.9

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|++.+.||.|+||.||+|....  ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+.     .+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~   73 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLP--NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDE   73 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcC--CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCE
Confidence            468899999999999999998543  56789999987543 234567899999999999999999998853     3457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++|+|++++++|.+++..... ...+++..+..++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++
T Consensus        74 ~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~  149 (267)
T cd06610          74 LWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVS  149 (267)
T ss_pred             EEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence            8999999999999999975332 235899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ..+.......   ........++..|+|||++... .++.++|+|||||++|+|++|+.||...... ....+....   
T Consensus       150 ~~~~~~~~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~-~~~~~~~~~---  222 (267)
T cd06610         150 ASLADGGDRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-KVLMLTLQN---  222 (267)
T ss_pred             HHhccCcccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh-hhHHHHhcC---
Confidence            7764432111   0112234588999999988776 7899999999999999999999999653221 111111110   


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                            ..+.+....                  ....++..+.+++..|++.||++||+++|+++
T Consensus       223 ------~~~~~~~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         223 ------DPPSLETGA------------------DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ------CCCCcCCcc------------------ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                  000000000                  01223567899999999999999999999975

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-38  Score=305.39  Aligned_cols=247  Identities=28%  Similarity=0.455  Sum_probs=196.3

Q ss_pred             ccCccccccceeEEEEEEcCCCCeeEEEEEEeec----cCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNL----QHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       163 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ....||+|+|-+||+|.  +..++..||=-.++.    ......+.|..|+.+|+.|+|+||++++.++.+..   +...
T Consensus        44 ~~evLGrGafKtVYka~--De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~i  118 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAF--DEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTI  118 (632)
T ss_pred             hhhhcccccceeeeecc--ccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Ccee
Confidence            34689999999999998  555566565332221    22334578999999999999999999999976543   4567


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEcccCcc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVSDFGLA  317 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~a  317 (484)
                      -+|+|.|..|+|..|+++.+    .++...+..|++||++||.|||+. ..+|+|||||.+||+|+++ |.|||+|+|+|
T Consensus       119 n~iTEL~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA  193 (632)
T KOG0584|consen  119 NFITELFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA  193 (632)
T ss_pred             eeeeecccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHH
Confidence            89999999999999998665    377889999999999999999976 7899999999999999765 79999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......         .....||+.|||||... ..|.+..||||||+.++||+|+..||..-......+.+......|.
T Consensus       194 tl~r~s~---------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~  263 (632)
T KOG0584|consen  194 TLLRKSH---------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA  263 (632)
T ss_pred             HHhhccc---------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH
Confidence            9874322         22367999999999866 7899999999999999999999999976433333333333333344


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .+..+-|                               +++.++|.+|+.. .++|||+.|++.
T Consensus       264 sl~kV~d-------------------------------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  264 ALSKVKD-------------------------------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HhhccCC-------------------------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence            3444333                               3578899999999 999999999985

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.4e-38  Score=297.80  Aligned_cols=249  Identities=23%  Similarity=0.300  Sum_probs=194.6

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeE
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      |.....||+|+||.||+|...  .++..||+|.+........+.+.+|+.++..++|||++++++++.     .++..++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~i   95 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREK--HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWV   95 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEc--CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEE
Confidence            344567999999999999843  356789999987655555567889999999999999999999854     3457899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      |+||+++++|.+++..     ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        96 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~  167 (297)
T cd06659          96 LMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI  167 (297)
T ss_pred             EEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence            9999999999998753     34889999999999999999999   899999999999999999999999999998754


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ....       .......++..|+|||++.+..++.++|||||||++|||++|+.||......  ........       
T Consensus       168 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~-------  231 (297)
T cd06659         168 SKDV-------PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRD-------  231 (297)
T ss_pred             cccc-------ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhc-------
Confidence            3221       1112345889999999998888999999999999999999999998642111  00000000       


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                       ........                     .......+.+++..|++.+|++||+++|+++.
T Consensus       232 -~~~~~~~~---------------------~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         232 -SPPPKLKN---------------------AHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             -cCCCCccc---------------------cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             00000000                     01124568899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-37  Score=288.50  Aligned_cols=248  Identities=27%  Similarity=0.330  Sum_probs=194.2

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-----cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-----GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      +|+..+.||+|++|.||+|...  .++..|++|.+.....     ...+.+.+|+.+++.++|+|++++++++.     .
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~   73 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNL--DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----E   73 (258)
T ss_pred             CccccceeeecCCceEEEEEEc--CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----c
Confidence            4677889999999999999854  3567899999875432     23467889999999999999999999853     4


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      +...++|+||+++++|.+++...    ..+++..++.++.|++.|++|||   +.+++|+||+|+||+++.++.+||+||
T Consensus        74 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~  146 (258)
T cd06632          74 EDNLYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADF  146 (258)
T ss_pred             CCeEEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccC
Confidence            45789999999999999999743    24889999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCC-CCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |.+.......        ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||......    . ....
T Consensus       147 ~~~~~~~~~~--------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~----~-~~~~  213 (258)
T cd06632         147 GMAKQVVEFS--------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV----A-AVFK  213 (258)
T ss_pred             ccceeccccc--------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH----H-HHHH
Confidence            9987653221        112345788999999887766 899999999999999999999999753210    0 0000


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .     .....  ..                    ..+..+...+.+++.+||+.+|++||++.+++.
T Consensus       214 ~-----~~~~~--~~--------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         214 I-----GRSKE--LP--------------------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             H-----Hhccc--CC--------------------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            0     00000  00                    001122456889999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=6.5e-37  Score=287.13  Aligned_cols=253  Identities=26%  Similarity=0.344  Sum_probs=201.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|++.+.||+|++|.||+|+..  .++..|++|++..... .....+.+|+..+.+++|+|++++++++.     ....
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~--~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~   73 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHK--PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGE   73 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEc--CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCe
Confidence            36888899999999999999854  3578899999876543 34567999999999999999999999854     3458


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCE-TPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      .++||||+++++|.+++...    ..+++..++.++.|+++|++|||   + .+++||||+|+||+++.++.++|+|||.
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~  146 (264)
T cd06623          74 ISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGI  146 (264)
T ss_pred             EEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCcc
Confidence            89999999999999999743    45899999999999999999999   8 9999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +........       ......++..|+|||.+....++.++||||||+++|+|+||+.||......  ...+...    
T Consensus       147 ~~~~~~~~~-------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~----  213 (264)
T cd06623         147 SKVLENTLD-------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQ----  213 (264)
T ss_pred             ceecccCCC-------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHH----
Confidence            886633221       112345788999999998888999999999999999999999999764321  1111111    


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhH-HHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKE-CLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                          .+........                    ... ++..+.+++..|++.+|++||++.|+++.
T Consensus       214 ----~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         214 ----AICDGPPPSL--------------------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ----HHhcCCCCCC--------------------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                1111000000                    011 35678999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-37  Score=294.37  Aligned_cols=202  Identities=27%  Similarity=0.415  Sum_probs=166.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      -++|++.+.||+|++|.||+|...  .+++.||+|.+..... .....+.+|++++++++|+||+++++++     ..++
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~   76 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSK--LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKK   76 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEc--CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCC
Confidence            367899999999999999999843  3567899999875432 2234577899999999999999999985     3455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+. ++|.+++....   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||.
T Consensus        77 ~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  149 (291)
T cd07844          77 TLTLVFEYLD-TDLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGL  149 (291)
T ss_pred             eEEEEEecCC-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECcccc
Confidence            8899999996 59999887432   35889999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ++......       .......++..|+|||...+ ..++.++||||+|+++|+|++|+.||...
T Consensus       150 ~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~  207 (291)
T cd07844         150 ARAKSVPS-------KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS  207 (291)
T ss_pred             ccccCCCC-------ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            87542111       11112246788999998765 45789999999999999999999999654

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-37  Score=296.13  Aligned_cols=259  Identities=27%  Similarity=0.304  Sum_probs=198.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|++|.||+|...  .++..||+|.+......   ..+.+.+|+++++.++|+||+++++.+     ..+
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   73 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLK--GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTE   73 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEc--CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecC
Confidence            36888899999999999999854  35788999998754322   345688999999999999999999885     345


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+.+++|.+++....  ...+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||
T Consensus        74 ~~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg  148 (316)
T cd05574          74 TYLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFD  148 (316)
T ss_pred             CEEEEEEEecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecc
Confidence            58899999999999999987432  345899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCC----------------------CccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhC
Q 011508          316 LAKFLPEAANNLSS----------------------NQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG  373 (484)
Q Consensus       316 ~a~~~~~~~~~~~~----------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg  373 (484)
                      ++............                      .........|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g  228 (316)
T cd05574         149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG  228 (316)
T ss_pred             hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence            98765332111000                      00111234678899999999988899999999999999999999


Q ss_pred             CCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCC
Q 011508          374 KGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRER  453 (484)
Q Consensus       374 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  453 (484)
                      +.||....... .            ...+.+.......                   ....+..+.+++.+|++.||++|
T Consensus       229 ~~pf~~~~~~~-~------------~~~~~~~~~~~~~-------------------~~~~~~~~~~li~~~l~~~p~~R  276 (316)
T cd05574         229 TTPFKGSNRDE-T------------FSNILKKEVTFPG-------------------SPPVSSSARDLIRKLLVKDPSKR  276 (316)
T ss_pred             CCCCCCCchHH-H------------HHHHhcCCccCCC-------------------ccccCHHHHHHHHHHccCCHhHC
Confidence            99996532110 0            1111111110000                   00125678999999999999999


Q ss_pred             CC----HHHHHH
Q 011508          454 MN----MEEVAA  461 (484)
Q Consensus       454 Pt----~~evl~  461 (484)
                      ||    ++|++.
T Consensus       277 ~s~~~~~~~ll~  288 (316)
T cd05574         277 LGSKRGAAEIKQ  288 (316)
T ss_pred             CCchhhHHHHHc
Confidence            99    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=302.58  Aligned_cols=288  Identities=22%  Similarity=0.247  Sum_probs=203.6

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .+++|++.+.||+|+||.||+|+.  ..++..||+|.++... ......+.+|+.++++++|+||+++++++....+...
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATH--KPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEE--cCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            357899999999999999999984  4457889999986432 2334568889999999999999999998766555555


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++|+||+. ++|.+++..     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          81 NDVYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             ceEEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECccc
Confidence            67899999995 588887752     35899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ++.........    ........++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.....  ..........
T Consensus       152 ~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~--~~~~~~~~~~  225 (336)
T cd07849         152 LARIADPEHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY--LHQLNLILGV  225 (336)
T ss_pred             ceeeccccccc----cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHH
Confidence            98765332211    111223468899999998654 5689999999999999999999999965311  1111111111


Q ss_pred             c----chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH--HHHH
Q 011508          395 L----PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ--LLSF  466 (484)
Q Consensus       395 ~----~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i  466 (484)
                      .    ++....+.+..............     .............++.+++.+||+.+|++|||+.|+++.  ++..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         226 LGTPSQEDLNCIISLRARNYIKSLPFKP-----KVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             cCCCCHHHHHHhhchhhhhHHhhcCcCC-----cccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            1    11122222111100000000000     000000001125568899999999999999999999886  4444

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=5.9e-37  Score=287.46  Aligned_cols=255  Identities=28%  Similarity=0.371  Sum_probs=197.2

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|.+.+.||+|+||.||+|...  .++..|++|.++.....  ..+.+.+|++++++++|+||+++++.+     ...+.
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~   73 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNL--DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREK   73 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEEC--CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCE
Confidence            5788899999999999999843  35688999998765443  457889999999999999999999984     34457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++|+||+++++|.+++...    ..+++..+..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||.+
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~  146 (264)
T cd06626          74 VYIFMEYCSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCA  146 (264)
T ss_pred             EEEEEecCCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccc
Confidence            89999999999999999742    34788899999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCC---CCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE---VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ...........   .......++..|+|||++.+..   ++.++||||||+++|++++|+.||....... .......  
T Consensus       147 ~~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-~~~~~~~--  220 (264)
T cd06626         147 VKLKNNTTTMG---EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-QIMFHVG--  220 (264)
T ss_pred             cccCCCCCccc---ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-HHHHHHh--
Confidence            87644321111   1011245788999999988766   8899999999999999999999996532110 0000000  


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                            ....+.+..                     ...+...+.+++.+||+.+|++|||+.|++.
T Consensus       221 ------~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         221 ------AGHKPPIPD---------------------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             ------cCCCCCCCc---------------------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                  000000000                     1112556789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=304.99  Aligned_cols=251  Identities=24%  Similarity=0.328  Sum_probs=200.9

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      -|.++..||.|+||.||+|..  ..++...|.|++........++|.-|++||..++||+||++++.|+     .++.+|
T Consensus        33 ~WeIiGELGDGAFGKVyKA~n--ket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkLw  105 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVN--KETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKLW  105 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhc--ccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCceE
Confidence            356778899999999999984  4566778889998877778889999999999999999999999853     344789


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      ++.|||.||-.+..+-..   .+.+++.++..+++|++.||.|||   +++|||||||+.|||++-+|.++|+|||.+..
T Consensus       106 iliEFC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAK  179 (1187)
T KOG0579|consen  106 ILIEFCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAK  179 (1187)
T ss_pred             EEEeecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeeccccccc
Confidence            999999999999887643   456999999999999999999999   99999999999999999999999999998865


Q ss_pred             cccccccCCCCccccccccccccccCcccc-----CCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYG-----MGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ...       .......+.||+.|||||+.     ...+|+.++||||||++|.||..+.+|-.....- ..+.+.....
T Consensus       180 n~~-------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-RVllKiaKSe  251 (1187)
T KOG0579|consen  180 NKS-------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSE  251 (1187)
T ss_pred             chh-------HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-HHHHHHhhcC
Confidence            422       22333457899999999974     4568999999999999999999999997553211 0111111100


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                               .|.+..                     +......+.+++..||..||..||++.++++
T Consensus       252 ---------PPTLlq---------------------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  252 ---------PPTLLQ---------------------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ---------CCcccC---------------------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence                     011111                     2233667899999999999999999999985

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.9e-37  Score=294.03  Aligned_cols=275  Identities=20%  Similarity=0.205  Sum_probs=195.3

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-----chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-----ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      +|++.+.||+|++|.||+|...  .+++.||+|.+......     ....+..|++++++++|+||+++++++..     
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----   73 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDK--ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----   73 (298)
T ss_pred             CceeeeeeeeccccEEEEEEEC--CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----
Confidence            4778899999999999999943  34678999999755432     23457789999999999999999998643     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      +...++||||+ +++|.+++....   ..+++..++.++.|+++||+|||   +++++|+||+|+||+++.++.++|+||
T Consensus        74 ~~~~~lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~df  146 (298)
T cd07841          74 KSNINLVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADF  146 (298)
T ss_pred             CCEEEEEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccc
Confidence            45889999999 999999997432   35899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |++.......       .......++..|+|||.+.+ ..++.++|||||||++|||++|.+||...... ..+.+....
T Consensus       147 g~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~  218 (298)
T cd07841         147 GLARSFGSPN-------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEA  218 (298)
T ss_pred             eeeeeccCCC-------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHH
Confidence            9998664321       11112346788999998754 46789999999999999999998777643211 111111111


Q ss_pred             hcchhhhhhcCc-ccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 ALPERLAEIVDP-VLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~~~~~~~~~d~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..........+. .+.........      ...............+.+++.+||+.||++|||++||++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         219 LGTPTEENWPGVTSLPDYVEFKPF------PPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cCCCchhhhhhccccccccccccc------CCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            000000000000 00000000000      0000000012235678999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5e-37  Score=291.49  Aligned_cols=273  Identities=22%  Similarity=0.249  Sum_probs=197.5

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|++.+.||+|++|.||+|...  .+++.||+|++....  ....+.+.+|+.++++++|+|++++++++.     .+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~   73 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDR--ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSG   73 (286)
T ss_pred             CceEEeecccCCCcEEEEEEEC--CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCe
Confidence            4788899999999999999854  357889999987654  233467899999999999999999999853     3558


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++|+||+ +++|.+++....   ..+++.+++.++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||.+
T Consensus        74 ~~~v~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~  146 (286)
T cd07832          74 FVLVMEYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLA  146 (286)
T ss_pred             eEEEeccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence            89999999 999999987433   45899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc-
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL-  395 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-  395 (484)
                      ........      .......++..|+|||.+.+. .++.++||||+|+++|||++|++||..... ...+........ 
T Consensus       147 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~  219 (286)
T cd07832         147 RLFSEEEP------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGT  219 (286)
T ss_pred             ccccCCCC------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCC
Confidence            86643221      112234588899999987654 468999999999999999999887754321 111111111000 


Q ss_pred             --chhhhhhcC---cccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 --PERLAEIVD---PVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 --~~~~~~~~d---~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                        +....+..+   ............       . ... ...+....+.+++.+|++.+|++|||++++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~-~~~-~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         220 PNEETWPGLTSLPDYNKITFPESKPI-------P-LEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CChHHHhhccCcchhhcccCCCCCcc-------h-HHH-hCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence              000000000   000000000000       0 000 011225678999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=7e-37  Score=291.86  Aligned_cols=281  Identities=22%  Similarity=0.236  Sum_probs=196.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|...  .+++.||+|.++....  .....+.+|+.+++.++ |+||+++++++...+....
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~--~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDK--NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEEC--CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            46889999999999999999954  4578899998765432  23357888999999995 6999999998765443333


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEcc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDA-PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG-ELTAHVSD  313 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~D  313 (484)
                      ...++||||+++ +|.+++...... ...+++..++.++.||+.||+|||   +++|+||||+|+||+++. ++.+||+|
T Consensus        79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEee
Confidence            457999999975 899988754332 346899999999999999999999   899999999999999998 88999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||.+..+....       .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....... .+.+...
T Consensus       155 fg~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~  226 (295)
T cd07837         155 LGLGRAFSIPV-------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFK  226 (295)
T ss_pred             cccceecCCCc-------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHH
Confidence            99987653211       11112246788999998765 457899999999999999999999996532111 0111111


Q ss_pred             hhc-chh--hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          393 EAL-PER--LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       393 ~~~-~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ... +..  .....+.........        ..+.......+....++.+++.+||+.||++||++.|++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         227 LLGTPTEQVWPGVSKLRDWHEFPQ--------WKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HhCCCChhhCcchhhccchhhcCc--------ccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000 000  000000000000000        0000000001223567899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=4.7e-37  Score=300.39  Aligned_cols=285  Identities=19%  Similarity=0.198  Sum_probs=198.9

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeec-cC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVD-FQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~  233 (484)
                      ..++|++.+.||+|+||.||+|..  ..+++.||+|.+....  ......+.+|+.++++++|+||+++++++.... +.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYD--TVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEE--CCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence            457899999999999999999984  4457889999986432  223456778999999999999999999864322 12


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      +....++||||+ .++|.+.+..      .++...+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|
T Consensus        92 ~~~~~~lv~e~~-~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~D  161 (353)
T cd07850          92 EFQDVYLVMELM-DANLCQVIQM------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  161 (353)
T ss_pred             ccCcEEEEEecc-CCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEcc
Confidence            334579999999 4688888752      2788899999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||.++......        ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+......
T Consensus       162 fg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~  232 (353)
T cd07850         162 FGLARTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQ  232 (353)
T ss_pred             CccceeCCCCC--------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHh
Confidence            99998653221        112235788999999999989999999999999999999999999653211 111111110


Q ss_pred             hc--chhhhhhcCcccccccccccchhh----hh----hhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 AL--PERLAEIVDPVLLVEREEGETSEA----NA----HKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~--~~~~~~~~d~~l~~~~~~~~~~~~----~~----~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..  +....+.++...............    ..    ..+............++.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         233 LGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             cCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00  001111111111000000000000    00    00000000011235678899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=8.2e-37  Score=290.01  Aligned_cols=255  Identities=26%  Similarity=0.318  Sum_probs=201.2

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ..++.|+..+.||+|++|.||+|....  ++..+++|++..... ..+.+.+|+++++.++|+|++++++++..     +
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~   87 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRA--TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-----G   87 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEcc--CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-----C
Confidence            355678889999999999999998543  467899999976544 45678899999999999999999998654     3


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++|+||+++++|.+++....   ..+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~  161 (286)
T cd06614          88 DELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFG  161 (286)
T ss_pred             CEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccc
Confidence            48899999999999999998543   35899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      .+.......       .......++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ....      
T Consensus       162 ~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-~~~~------  227 (286)
T cd06614         162 FAAQLTKEK-------SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-ALFL------  227 (286)
T ss_pred             hhhhhccch-------hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-HHHH------
Confidence            887553221       11122347789999999988889999999999999999999999986431110 0000      


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                            +.......                  ......++..+.+++.+|++.+|.+|||+.++++.
T Consensus       228 ------~~~~~~~~------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         228 ------ITTKGIPP------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             ------HHhcCCCC------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                  00000000                  00012235678999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2e-37  Score=294.28  Aligned_cols=271  Identities=24%  Similarity=0.321  Sum_probs=195.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||.||+|...  .+++.||+|++.....  ...+.+.+|+++++.++||||+++++++     ..+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   73 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHK--ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKK   73 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEEC--CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCC
Confidence            46888999999999999999954  3467899998764332  2345788999999999999999999985     4455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++|+||+++++|..+...    ...+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||+
T Consensus        74 ~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~  146 (286)
T cd07846          74 RLYLVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGF  146 (286)
T ss_pred             eEEEEEecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeee
Confidence            88999999999988887652    234899999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH--h
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK--E  393 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--~  393 (484)
                      +.......       .......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ..+.....  .
T Consensus       147 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~  218 (286)
T cd07846         147 ARTLAAPG-------EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLG  218 (286)
T ss_pred             eeeccCCc-------cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhC
Confidence            87653321       11122457889999998765 45788999999999999999999998643210 00111000  0


Q ss_pred             hcchhhhhhcCc------ccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDP------VLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~------~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..........+.      ....+....     ....     .....++..+.+++.+||+.+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         219 NLIPRHQEIFQKNPLFAGMRLPEVKEI-----EPLE-----KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             CCchhhHHHhccchHhhccccccccCc-----chHH-----HhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            001111111110      000000000     0000     001233567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7.6e-37  Score=289.93  Aligned_cols=248  Identities=23%  Similarity=0.300  Sum_probs=194.6

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeE
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      |...+.||+|++|.||++...  .++..+++|++........+.+.+|+.+++.++|+|++++++++.     ..+..++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~   93 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDK--STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWV   93 (285)
T ss_pred             hhcceEeccCCCeEEEEEEEC--CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEE
Confidence            445579999999999999843  356789999987655445567889999999999999999999854     3457899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      |+||+++++|.+++..     ..+++..+..++.|++.||+|||   +++++||||+|+||+++.++.++|+|||.+...
T Consensus        94 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~  165 (285)
T cd06648          94 VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV  165 (285)
T ss_pred             EEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence            9999999999999874     34889999999999999999999   899999999999999999999999999987754


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ....       .......|+..|+|||...+..++.++|||||||++|||++|+.||.....     ......     +.
T Consensus       166 ~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~-----~~  228 (285)
T cd06648         166 SKEV-------PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKR-----IR  228 (285)
T ss_pred             ccCC-------cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHH-----HH
Confidence            3221       111224588999999999888899999999999999999999999864211     111110     00


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....+.+..                     ...++..+.+++.+||+.+|++|||+.++++
T Consensus       229 ~~~~~~~~~---------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         229 DNLPPKLKN---------------------LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             hcCCCCCcc---------------------cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            000000000                     1112557899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.8e-37  Score=291.36  Aligned_cols=273  Identities=22%  Similarity=0.261  Sum_probs=193.4

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|+..+.||.|++|.||+|+..  .++..||||.++....  .....+.+|++++++++||||+++++++     .+++.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~   73 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNK--LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENK   73 (284)
T ss_pred             CceeeeeecCCCceEEEEEEEC--CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCc
Confidence            4788899999999999999853  4567899998875432  2235788999999999999999999985     34558


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+. ++|.+++....  ...+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||.+
T Consensus        74 ~~~v~e~~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          74 LYLVFEFLH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             EEEEeeccc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccch
Confidence            899999995 68999886432  345899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCC-CCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      .......       .......++..|+|||...+.. ++.++||||||+++|||+||+.||...... ....+.......
T Consensus       148 ~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~  219 (284)
T cd07860         148 RAFGVPV-------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGT  219 (284)
T ss_pred             hhcccCc-------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCC
Confidence            7653221       1112234678899999876644 688999999999999999999999653211 111111111000


Q ss_pred             h-h-hhhhcCc--ccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 E-R-LAEIVDP--VLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~-~-~~~~~d~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      . . .......  ..........  .     ...... ......++.+++.+|++.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~--~-----~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         220 PDEVVWPGVTSLPDYKPSFPKWA--R-----QDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             CChhhhhhhhHHHHHHhhccccc--c-----cCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0 0 0000000  0000000000  0     000000 0112456789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=292.34  Aligned_cols=277  Identities=23%  Similarity=0.307  Sum_probs=197.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|++|.||+|+..  .++..||+|+++...  ....+.+.+|++++++++|+||+++++++..     ++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~--~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~   73 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNK--ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KG   73 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeC--CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CC
Confidence            36889999999999999999854  346789999887543  2234678999999999999999999998643     44


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||++++.+..+...    ...+++.+++.++.|++.||+|||   ..+++|+||+|+||++++++.+||+|||.
T Consensus        74 ~~~iv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~  146 (288)
T cd07833          74 RLYLVFEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGF  146 (288)
T ss_pred             EEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeec
Confidence            78999999988766665542    234899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH--h
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK--E  393 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~--~  393 (484)
                      +........      .......++..|+|||++.+. .++.++||||||+++|+|++|+.||....... .+.....  .
T Consensus       147 ~~~~~~~~~------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~  219 (288)
T cd07833         147 ARALRARPA------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID-QLYLIQKCLG  219 (288)
T ss_pred             ccccCCCcc------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence            887643321      111234578889999998887 88999999999999999999999986532111 0000000  0


Q ss_pred             hcchhhhhhc--CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIV--DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~--d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..+.......  ++.....    ........ .......+..++.++.+++.+||+.+|++|||++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         220 PLPPSHQELFSSNPRFAGV----AFPEPSQP-ESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CCCHHHhhhcccCcccccc----ccCCCCCc-HHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0111100000  0000000    00000000 00000001223677999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.8e-37  Score=291.60  Aligned_cols=245  Identities=27%  Similarity=0.313  Sum_probs=194.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|++|.||++....  +++.+|+|++....   ....+.+.+|++++++++||||+++++++     ..+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   73 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKG--SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDD   73 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcC--CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcC
Confidence            468899999999999999999543  56889999987532   22346788999999999999999999985     344


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++++|.+++...    ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||
T Consensus        74 ~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg  146 (290)
T cd05580          74 SNLYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFG  146 (290)
T ss_pred             CeEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCC
Confidence            5889999999999999999743    35889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++......          .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.....     .....   
T Consensus       147 ~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~---  208 (290)
T cd05580         147 FAKRVKGR----------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQIYE---  208 (290)
T ss_pred             CccccCCC----------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH---
Confidence            98765322          1223588999999998888889999999999999999999999865321     00000   


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~  461 (484)
                           .+.......                     +......+.+++.+||+.||.+||     +++|+++
T Consensus       209 -----~~~~~~~~~---------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         209 -----KILEGKVRF---------------------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -----HHhcCCccC---------------------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                 011000000                     111145678999999999999999     7777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=288.06  Aligned_cols=249  Identities=25%  Similarity=0.360  Sum_probs=194.1

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCC---CCCceeEeeeeeeeccCCC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIR---HRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~  235 (484)
                      .|+..+.||+|+||.||+|...  .++..||+|.++... ....+.+.+|+.++++++   |||++++++++.     .+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~   74 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHV--PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KG   74 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEc--CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eC
Confidence            4777889999999999999953  357889999987543 234467889999999996   999999999864     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++++|.+++...     .+++..++.++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg  146 (277)
T cd06917          75 PRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFG  146 (277)
T ss_pred             CEEEEEEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCC
Confidence            5789999999999999998632     5889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      .+.......       .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||......     ..... 
T Consensus       147 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~~-  213 (277)
T cd06917         147 VAALLNQNS-------SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMML-  213 (277)
T ss_pred             ceeecCCCc-------cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhhc-
Confidence            988664322       11223458889999998765 45689999999999999999999999653111     11000 


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                          +.....+.+.                      ....+.++.+++.+||+.||++||++.|+++.
T Consensus       214 ----~~~~~~~~~~----------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         214 ----IPKSKPPRLE----------------------DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ----cccCCCCCCC----------------------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                0000000000                      01125578899999999999999999999864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-36  Score=291.94  Aligned_cols=248  Identities=25%  Similarity=0.338  Sum_probs=192.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ...|...+.||+|+||.||+|+..  .++..||+|.+.....   .....+.+|+++++.++|||+++++++|..     
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-----   86 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDV--RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-----   86 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEc--CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-----
Confidence            356888899999999999999854  3567899998864432   223568899999999999999999999654     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      +...++|+||+. |++.+++....   ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+||
T Consensus        87 ~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~df  159 (307)
T cd06607          87 EHTAWLVMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADF  159 (307)
T ss_pred             CCeEEEEHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeec
Confidence            347899999995 67877775332   35899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccC---CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM---GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      |++......           ....++..|+|||++.   ...++.++||||||+++|||+||+.||......     ...
T Consensus       160 g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~  223 (307)
T cd06607         160 GSASLVSPA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SAL  223 (307)
T ss_pred             CcceecCCC-----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHH
Confidence            998754321           1234778899999874   456889999999999999999999998643110     000


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .        .+....    .               .......+...+.+++.+||+.+|++||++.+|+..
T Consensus       224 ~--------~~~~~~----~---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         224 Y--------HIAQND----S---------------PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             H--------HHhcCC----C---------------CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0        000000    0               000012345678999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.2e-36  Score=287.43  Aligned_cols=247  Identities=26%  Similarity=0.368  Sum_probs=194.6

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      |++.+.||+|+||.||+|...  .++..||+|.+.... ......+.+|+.++.+++||||+++++++.     .+...+
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~   78 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDN--RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLW   78 (277)
T ss_pred             hhhheeEeecCCeEEEEEEEC--CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEE
Confidence            667789999999999999843  356889999886433 233457889999999999999999999854     345789


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      +||||+++++|.+++..     ..+++..+..++.|++.++.|||   +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        79 lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06641          79 IIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ  150 (277)
T ss_pred             EEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeeccccee
Confidence            99999999999999863     24889999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhh
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERL  399 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  399 (484)
                      .....       .......++..|+|||.+.+..++.++|||||||++|+|++|..||......     ..... .... 
T Consensus       151 ~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-~~~~-  216 (277)
T cd06641         151 LTDTQ-------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVLFL-IPKN-  216 (277)
T ss_pred             cccch-------hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHHHH-HhcC-
Confidence            53221       1112235788999999998888899999999999999999999998653211     01110 0000 


Q ss_pred             hhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          400 AEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       400 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                         ..+.+                       ...++.++.+++.+|++.+|++||++.++++.
T Consensus       217 ---~~~~~-----------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         217 ---NPPTL-----------------------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---CCCCC-----------------------CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               00000                       11225568899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=302.64  Aligned_cols=288  Identities=25%  Similarity=0.290  Sum_probs=206.3

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeec-cCCCcee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVD-FQGNDFE  238 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~  238 (484)
                      +...+.||+|+||.||+|+  ++.+|+.||||.++.... ...+...+|+++|++++|+|||++.+.-.... .--....
T Consensus        15 W~~~e~LG~Ga~g~V~rgr--nketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGR--NKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeec--ccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            4456789999999999998  667899999999986442 34467889999999999999999988632111 0113456


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee--cC--CCceEEccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL--DG--ELTAHVSDF  314 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll--~~--~~~~kl~Df  314 (484)
                      .+|||||.+|||...+..-. ....+++.+.+.++.++..||.|||   .++|+||||||.||++  .+  ....||+||
T Consensus        93 vlvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecc
Confidence            79999999999999997533 4557999999999999999999999   9999999999999998  23  336899999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccC-CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |.|+.+++.        ......+||..|.+||... ...|+..+|.|||||++|+..||..||........ ..+....
T Consensus       169 G~Arel~d~--------s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~-~~~~~~~  239 (732)
T KOG4250|consen  169 GAARELDDN--------SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKN-NKEIMWH  239 (732)
T ss_pred             cccccCCCC--------CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccc-cchhhhh
Confidence            999987543        2445578999999999988 48899999999999999999999999976533321 1111111


Q ss_pred             hc---chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC--CHHHHHHHHHHHHH
Q 011508          394 AL---PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM--NMEEVAAQLLSFRN  468 (484)
Q Consensus       394 ~~---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP--t~~evl~~L~~i~~  468 (484)
                      ..   +..+.-..++......+....-..+.+.       .......+-+.+..++..+|++|-  ...+....+..|..
T Consensus       240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~L-------s~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  240 IITKKPSGVAIGAQEEENGPVEWSSTLPQPNHL-------SRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             hhccCCCceeEeeecccCCceeeeccCCCcccc-------cHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            11   1111111111111111000000001111       112245566777888899999999  88888888877755


Q ss_pred             HH
Q 011508          469 KL  470 (484)
Q Consensus       469 ~~  470 (484)
                      ..
T Consensus       313 ~~  314 (732)
T KOG4250|consen  313 LK  314 (732)
T ss_pred             hh
Confidence            43

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.3e-36  Score=292.05  Aligned_cols=211  Identities=23%  Similarity=0.357  Sum_probs=168.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC--
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ--  233 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~--  233 (484)
                      -++|++.+.||+|+||.||+|..  ..++..||+|.+.....  .....+.+|++++++++||||++++++|......  
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~--~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARH--KKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEE--CCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            35799999999999999999984  44678999998865432  2234567899999999999999999987654321  


Q ss_pred             -CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          234 -GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       234 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                       .....++||||+. ++|.+++...   ...+++.+++.++.|++.||+|||   +++++|+||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          89 RYKGSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             CCCceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEEC
Confidence             2345699999995 5888887632   235899999999999999999999   8899999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      |||.+..........   ........++..|+|||.+.+. .++.++||||||+++|||++|+.||...
T Consensus       162 dfg~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         162 DFGLARAFSLSKNSK---PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             cCCCcccccCCcccC---CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            999998664322111   1111234578899999987664 4788999999999999999999998653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.1e-37  Score=286.40  Aligned_cols=248  Identities=25%  Similarity=0.345  Sum_probs=196.3

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      +|++.+.||.|+||.||+|..  ..++..||+|++.....   ...+.+.+|++++++++||||+++++.+     .++.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~--~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   73 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQK--RDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEE   73 (258)
T ss_pred             CceEEEEeccCCCceEEEEEE--ccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCC
Confidence            478889999999999999984  34577899999975432   3356789999999999999999999884     4556


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++|+||+.+++|.+++...    ..+++..+..++.|+++||.|||   .++++|+||+|+||++++++.++|+|||.
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~  146 (258)
T cd05578          74 NMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNI  146 (258)
T ss_pred             eEEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeeccc
Confidence            899999999999999999743    35889999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.......        ......++..|+|||.+....++.++|+||||+++|+|++|+.||......  .......    
T Consensus       147 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~----  212 (258)
T cd05578         147 ATKVTPDT--------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRA----  212 (258)
T ss_pred             ccccCCCc--------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHH----
Confidence            87653321        112245788999999998888999999999999999999999999754221  1111111    


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH--HHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM--EEVA  460 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~evl  460 (484)
                           .......                    ..+...+..+.+++.+||+.||.+||++  +|++
T Consensus       213 -----~~~~~~~--------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         213 -----KQETADV--------------------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             -----Hhccccc--------------------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                 0000000                    0012225678899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.5e-36  Score=292.26  Aligned_cols=281  Identities=21%  Similarity=0.246  Sum_probs=190.9

Q ss_pred             ccCccccccceeEEEEEEcCCCCeeEEEEEEeecc--CccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeE
Q 011508          163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       163 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.+.+|.|+++.||++.  .  +++.||+|+++..  .....+.+.+|+++++.++|+||+++++++     ..++..++
T Consensus         6 i~~~~~~~~~v~~~~~~--~--~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~   76 (314)
T cd08216           6 IGKCFEDLMIVHLAKHK--P--TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYV   76 (314)
T ss_pred             hhHhhcCCceEEEEEec--C--CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEE
Confidence            34445555555555543  2  5788999998765  233446789999999999999999999985     34457899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      +|||+++++|.+++....  ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||.+..+
T Consensus        77 ~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~  151 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM  151 (314)
T ss_pred             EEeccCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceee
Confidence            999999999999997543  234889999999999999999999   899999999999999999999999999988765


Q ss_pred             ccccccCCCCccccccccccccccCccccCC--CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMG--SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      ..................++..|+|||++..  ..++.++|||||||++|||++|+.||........ ..+......+  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~--  228 (314)
T cd08216         152 IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVP--  228 (314)
T ss_pred             ccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCc--
Confidence            3322111111111223457788999998865  3588999999999999999999999975322111 1111111111  


Q ss_pred             hhhhcCcccccccccccc-----hhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGET-----SEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                        ..++............     .....................+.+++..||+.||++|||++|+++.
T Consensus       229 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         229 --CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             --cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence              1111000000000000     0000000001111122335678899999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.1e-36  Score=284.55  Aligned_cols=251  Identities=24%  Similarity=0.328  Sum_probs=195.8

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|++.+.||+|+||.||+|....  ++..+|+|.+.....  ...+.+.+|+++++.++|+|++++++.+     ..+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~   73 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKS--DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGR   73 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcC--CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCe
Confidence            47788999999999999999543  467799999875421  2345788999999999999999999985     34458


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcccCc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVSDFGL  316 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~  316 (484)
                      .++|+||+++++|.+++....  ...+++..+..++.|++.||+|||   +.+++|+||||+||++++++ .+||+|||.
T Consensus        74 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~  148 (257)
T cd08225          74 LFIVMEYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGI  148 (257)
T ss_pred             EEEEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEeccccc
Confidence            899999999999999997433  235789999999999999999999   89999999999999998885 569999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.......       .......|+..|+|||+..+..++.++||||||+++|||++|+.||....     ..+.+.....
T Consensus       149 ~~~~~~~~-------~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~  216 (257)
T cd08225         149 ARQLNDSM-------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQ  216 (257)
T ss_pred             chhccCCc-------ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhc
Confidence            87653221       11122358889999999888889999999999999999999999986421     1122211111


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..    ..+.                        .......+.+++.+|++.+|++|||+.|+++.
T Consensus       217 ~~----~~~~------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         217 GY----FAPI------------------------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             cc----CCCC------------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            10    0000                        01114568899999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.6e-37  Score=295.17  Aligned_cols=292  Identities=20%  Similarity=0.263  Sum_probs=194.4

Q ss_pred             Cccccc--cceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAG--SFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G--~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      ..||+|  +||+||++.  +..+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++.     .++..++
T Consensus         4 ~~ig~g~~~~~~v~~a~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~   76 (328)
T cd08226           4 VEIGRGFCNLTSVYLAR--HTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWV   76 (328)
T ss_pred             HHhCCcccCceeEEEEE--EcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEE
Confidence            456766  999999998  445678999999875432  23467889999999999999999999954     3457899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      |+||+.+++|.+++....  ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||+.+...
T Consensus        77 v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~  151 (328)
T cd08226          77 ISPFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSL  151 (328)
T ss_pred             EEecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence            999999999999987543  235889999999999999999999   899999999999999999999999999865433


Q ss_pred             ccccccCCCCccccccccccccccCccccCCC--CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh----
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS--EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA----  394 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~----  394 (484)
                      ..................++..|+|||++.+.  .++.++|||||||++|||++|+.||.................    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd08226         152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPL  231 (328)
T ss_pred             hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCc
Confidence            22110000000001112356679999998763  478999999999999999999999976432211111000000    


Q ss_pred             ----cchhhhhhcCcccccccc--cccch---hhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH--H
Q 011508          395 ----LPERLAEIVDPVLLVERE--EGETS---EANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ--L  463 (484)
Q Consensus       395 ----~~~~~~~~~d~~l~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L  463 (484)
                          .+.......+.....+..  +....   ................+...+.+++.+||+.||++|||+.|+++.  +
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~  311 (328)
T cd08226         232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF  311 (328)
T ss_pred             cccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence                000000000000000000  00000   000000000111134457789999999999999999999999854  4


Q ss_pred             HHHHH
Q 011508          464 LSFRN  468 (484)
Q Consensus       464 ~~i~~  468 (484)
                      ..+++
T Consensus       312 ~~~~~  316 (328)
T cd08226         312 KQVKE  316 (328)
T ss_pred             HHHHH
Confidence            44443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.4e-36  Score=289.47  Aligned_cols=279  Identities=22%  Similarity=0.253  Sum_probs=195.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||.||+|...  .+++.+|+|.++....  .....+.+|+.++.+++||||+++++++...   +..
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~   79 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDK--KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLD   79 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEEC--CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCC
Confidence            46888999999999999999954  3567899999875432  2234567899999999999999999986532   135


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+. ++|.+++....   ..+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||.
T Consensus        80 ~~~lv~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~  152 (293)
T cd07843          80 KIYMVMEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGL  152 (293)
T ss_pred             cEEEEehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCc
Confidence            8899999996 59999887432   25899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.......       .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... ...........
T Consensus       153 ~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~  224 (293)
T cd07843         153 AREYGSPL-------KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLG  224 (293)
T ss_pred             eeeccCCc-------cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhC
Confidence            88664321       111223468889999987654 4689999999999999999999999753211 11111111000


Q ss_pred             ---chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 ---PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 ---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                         +.......+  +...... ...... .......+........+.+++.+||+.+|++|||+.|+++
T Consensus       225 ~~~~~~~~~~~~--~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         225 TPTEKIWPGFSE--LPGAKKK-TFTKYP-YNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             CCchHHHHHhhc--cchhccc-cccccc-chhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence               000000000  0000000 000000 0000000001112556889999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=326.30  Aligned_cols=256  Identities=28%  Similarity=0.358  Sum_probs=199.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      +-++.-...||.|.||.||.|.  +..+|...|+|-++.+..  ...+...+|+.++..++|||+|+++|+-.+.     
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtav--N~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR----- 1306 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAV--NLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR----- 1306 (1509)
T ss_pred             eeeeccccccCCcceeeeEEee--cCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-----
Confidence            4466778899999999999999  555788899998875443  3346788999999999999999999985443     


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..+|.||||++|+|.+.+...+    ..++.....+..|++.|++|||   +++||||||||.||+|+.+|.+|++|||
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeeccc
Confidence            47899999999999999997433    3566666778899999999999   9999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCC---CCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE---VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      .|..+.......   ...-....||+.|||||++.+..   -..+.||||+|||+.||+||+.||.....+-....+...
T Consensus      1380 sa~ki~~~~~~~---~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTM---PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA 1456 (1509)
T ss_pred             ceeEecCchhcC---CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc
Confidence            998875442111   12234568999999999987643   466899999999999999999999765433222221111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ...|+-                                |+....+-.+++..|++.||++|.++.|+++.
T Consensus      1457 gh~Pq~--------------------------------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GHKPQI--------------------------------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             cCCCCC--------------------------------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            111110                                22235556789999999999999999887653

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.3e-37  Score=296.78  Aligned_cols=280  Identities=21%  Similarity=0.252  Sum_probs=200.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|++|.||+|..  ..++..||+|++.....  .....+.+|+.++++++||||+++++++.... ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~--~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~   80 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAID--TRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADF   80 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEE--cCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCC
Confidence            47899999999999999999984  44578899999875432  33466788999999999999999998764332 334


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+ +++|.+++..    ...+++..++.++.|++.||+|||   .++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~~lv~e~~-~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          81 KDVYVVMDLM-ESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             ceEEEEEehh-hhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccc
Confidence            5789999999 4689998863    234899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ++.........   .........++..|+|||.+.+ ..++.++|||||||++|||++|+.||......  .....+...
T Consensus       153 ~~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~--~~~~~~~~~  227 (334)
T cd07855         153 MARGLSSSPTE---HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV--HQLKLILSV  227 (334)
T ss_pred             cceeecccCcC---CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH--HHHHHHHHH
Confidence            98765332211   1111223468899999998765 46889999999999999999999999653211  111111111


Q ss_pred             cc---hh-hhhhcCcccccccccccchhhhhhhcccccc----chhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LP---ER-LAEIVDPVLLVEREEGETSEANAHKQRTRSF----GGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~---~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..   .. +....+..+......         .+.....    .....+..+.+++.+||+.+|++|||+.+++..
T Consensus       228 ~g~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         228 LGSPSEEVLNRIGSDRVRKYIQN---------LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hCCChhHhhhhhchhhHHHHHhh---------cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            10   00 111110000000000         0000000    011235678999999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=287.92  Aligned_cols=272  Identities=23%  Similarity=0.279  Sum_probs=193.2

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      |++.+.||.|++|.||+|....  ++..||+|++.....  .....+.+|+++++.++|+|++++++++.     ++...
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~   73 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKL--TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKL   73 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcC--CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeE
Confidence            5678899999999999998543  578899999875432  23356889999999999999999999853     34588


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      +++|||+ +++|.+++.....  ..+++..++.++.|++.||+|||   +++++||||+|+||+++.++.++|+|||.+.
T Consensus        74 ~iv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          74 YLVFEFL-DLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             EEEEecc-CcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            9999999 5799999874432  35899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc-c
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL-P  396 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~  396 (484)
                      ......       .......++..|+|||++.+. .++.++||||||+++|+|++|+.||....... .+.+...... +
T Consensus       148 ~~~~~~-------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~  219 (283)
T cd07835         148 AFGVPV-------RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTP  219 (283)
T ss_pred             ccCCCc-------cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence            553211       111122467889999987654 57889999999999999999999996532111 1111111100 0


Q ss_pred             hh-hhhhc--CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ER-LAEIV--DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~-~~~~~--d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .. .....  .+..........        ..............+.+++.+|++.||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         220 DEDVWPGVTSLPDYKPTFPKWA--------RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             ChHHhhhhhhchhhhhhccccc--------ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00 00000  000000000000        00000001112457889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.2e-36  Score=285.72  Aligned_cols=243  Identities=25%  Similarity=0.293  Sum_probs=181.9

Q ss_pred             ccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHH---cCCCCCceeEeeeeeeeccCCCceee
Q 011508          166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALR---SIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       166 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      .||+|+||.||++...  .+++.+|+|.+.....   .....+.+|..++.   ..+|+|++.+++++.     .++..+
T Consensus         1 ~lg~G~~g~Vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~   73 (279)
T cd05633           1 IIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLC   73 (279)
T ss_pred             CcccCCCeEEEEEEEC--CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEE
Confidence            4899999999999854  4578899998865432   11223444544333   347999999988853     344789


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      +||||+++++|.+++...    ..+++..+..++.|++.||+|||   +.+|+||||||+||++++++.++|+|||++..
T Consensus        74 lv~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~  146 (279)
T cd05633          74 FILDLMNGGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD  146 (279)
T ss_pred             EEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence            999999999999988643    35899999999999999999999   89999999999999999999999999999875


Q ss_pred             cccccccCCCCccccccccccccccCccccC-CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      .....         .....|+..|+|||... +..++.++||||+||++|||++|+.||........  . ......   
T Consensus       147 ~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~-~~~~~~---  211 (279)
T cd05633         147 FSKKK---------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--H-EIDRMT---  211 (279)
T ss_pred             ccccC---------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--H-HHHHHh---
Confidence            42211         11235899999999876 45688999999999999999999999975422111  0 010000   


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQ  462 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  462 (484)
                        ...+..+                       +..++.++.+++..||+.||++||     |++|+++.
T Consensus       212 --~~~~~~~-----------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         212 --LTVNVEL-----------------------PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             --hcCCcCC-----------------------ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence              0000000                       122356788999999999999999     59998875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4e-36  Score=280.58  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=200.9

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|++.+.||.|++|.||++...  .++..+++|++.....  ...+.+.+|+++++.++|+|++++++.+.     ....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~   73 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRK--SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGK   73 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEc--CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCE
Confidence            4788899999999999999954  3567899999876543  34567889999999999999999998853     3458


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++|+||+++++|.+++.........+++..++.++.+++.||+|||   +.+++|+||+|+||++++++.++|+|||.+
T Consensus        74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~  150 (258)
T cd08215          74 LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGIS  150 (258)
T ss_pred             EEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccce
Confidence            89999999999999999865433467999999999999999999999   889999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......       .......++..|+|||...+..++.++||||+|+++++|++|+.||....     ..+.....   
T Consensus       151 ~~~~~~~-------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~~~~~~~~---  215 (258)
T cd08215         151 KVLSSTV-------DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----LLELALKI---  215 (258)
T ss_pred             eecccCc-------ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----HHHHHHHH---
Confidence            7653321       11122357889999999888889999999999999999999999986532     11111111   


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                           .......                    .+..+...+.+++.+||..+|++|||+.|+++
T Consensus       216 -----~~~~~~~--------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         216 -----LKGQYPP--------------------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -----hcCCCCC--------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 1000000                    01122567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.4e-37  Score=291.09  Aligned_cols=257  Identities=25%  Similarity=0.293  Sum_probs=189.6

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|...+.||+|+||.||++...  .++..+|+|.+..... .....+.+|+.++.++. |+||+++++++.     .+..
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~   77 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHK--PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGD   77 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEEC--CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCc
Confidence            4556688999999999999844  4578899999875432 23457889999999996 999999999854     3447


Q ss_pred             eeEEeecccCCCHHHHHhhc-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          238 EALVYELMVNGSLEEWLHLN-RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      .+++|||+. +++.++.... ......+++..+..++.|++.||+|||+  ..+++||||||+||+++.++.+||+|||+
T Consensus        78 ~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  154 (288)
T cd06616          78 CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGI  154 (288)
T ss_pred             EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecch
Confidence            789999984 5665544321 1123468999999999999999999993  35999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCC---CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS---EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      +.......        ......++..|+|||.+.+.   .++.++|||||||++|||++|+.||....    ........
T Consensus       155 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~----~~~~~~~~  222 (288)
T cd06616         155 SGQLVDSI--------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN----SVFDQLTQ  222 (288)
T ss_pred             hHHhccCC--------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc----hHHHHHhh
Confidence            87553211        11123478899999998766   68999999999999999999999986531    01011110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ....     ..+.+..+                   ....++.++.+++.+||+.+|++|||++||++.
T Consensus       223 ~~~~-----~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         223 VVKG-----DPPILSNS-------------------EEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             hcCC-----CCCcCCCc-------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000     00011000                   011236678999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-36  Score=294.58  Aligned_cols=287  Identities=23%  Similarity=0.237  Sum_probs=203.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeecc--CccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ..+|.+.+.||+|+||+||+|+  +..++..||+|.+...  .......+.+|+.+++.++|+||+++++++........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAK--NSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEE--ecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            4679999999999999999998  4456789999988643  22234567789999999999999999998654433333


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++|+||+ +++|.+++..    ...+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg  153 (337)
T cd07858          82 NDVYIVYELM-DTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFG  153 (337)
T ss_pred             CcEEEEEeCC-CCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCc
Confidence            4679999999 4789988863    235899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ++.......       .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||......  .........
T Consensus       154 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~  224 (337)
T cd07858         154 LARTTSEKG-------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV--HQLKLITEL  224 (337)
T ss_pred             cccccCCCc-------ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH--HHHHHHHHH
Confidence            998653321       11122357889999998764 46889999999999999999999999653110  001111110


Q ss_pred             ----cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH--HHHHHH
Q 011508          395 ----LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ--LLSFRN  468 (484)
Q Consensus       395 ----~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~  468 (484)
                          .++....+.+...............    .... .....++..+.+++.+||+.+|++|||++|+++.  ++.++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         225 LGSPSEEDLGFIRNEKARRYIRSLPYTPR----QSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             hCCCChHHhhhcCchhhhHHHHhcCcccc----cCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence                0011111111110000000000000    0000 0012346778999999999999999999999977  655543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.9e-36  Score=280.46  Aligned_cols=250  Identities=27%  Similarity=0.384  Sum_probs=198.2

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      .|+..+.||+|++|.||++....  ++..+++|++..........+.+|++++++++|+|++++++.+.     .+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   73 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKR--TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELW   73 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECC--CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEE
Confidence            37788999999999999999543  56789999997665445678999999999999999999999853     335789


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      +++||+++++|.+++....   ..+++..+..++.|++.+|++||   ..+++||||+|+||++++++.++|+|||.+..
T Consensus        74 l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~  147 (253)
T cd05122          74 IVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQ  147 (253)
T ss_pred             EEEecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccc
Confidence            9999999999999987432   46899999999999999999999   89999999999999999999999999999876


Q ss_pred             cccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhh
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERL  399 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  399 (484)
                      ......        .....++..|+|||.+.+..++.++||||||+++|+|++|+.||......     ...........
T Consensus       148 ~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~  214 (253)
T cd05122         148 LSDTKA--------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----KALFKIATNGP  214 (253)
T ss_pred             cccccc--------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHHHHhcCC
Confidence            643211        22345788999999998888999999999999999999999998653111     00000000000


Q ss_pred             hhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          400 AEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       400 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....+                          ...+...+.+++.+|++.||++|||+.|+++
T Consensus       215 ~~~~~--------------------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         215 PGLRN--------------------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CCcCc--------------------------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000                          1111456889999999999999999999975

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.3e-36  Score=285.62  Aligned_cols=274  Identities=21%  Similarity=0.268  Sum_probs=196.4

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      +|++.+.||.|++|.||+|+.  ..++..||+|.++.... .....+.+|++++++++|+|++++++++..     .+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   73 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRN--RTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKL   73 (284)
T ss_pred             CceEeeeeccCCceEEEEEEE--CCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcE
Confidence            478889999999999999995  34578899999876543 234567889999999999999999998643     3478


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||++ ++|.+++..... ...+++..+..++.|++.||+|||   +.+++||||||+||++++++.++|+|||.+.
T Consensus        74 ~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~  148 (284)
T cd07836          74 MLVFEYMD-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLAR  148 (284)
T ss_pred             EEEEecCC-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence            99999997 589988875432 345899999999999999999999   8899999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh---
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA---  394 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~---  394 (484)
                      ......       .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+ .........   
T Consensus       149 ~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~  220 (284)
T cd07836         149 AFGIPV-------NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTP  220 (284)
T ss_pred             hhcCCc-------cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Confidence            553221       11122346888999998765 457889999999999999999999997542211 111111100   


Q ss_pred             cchhhhhhcCc-ccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 LPERLAEIVDP-VLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .......+.+. .+.......        ...........++..+.+++.+|++.||.+||++.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         221 TESTWPGISQLPEYKPTFPRY--------PPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ChhhHHHHhcCchhcccccCC--------ChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00001111100 000000000        000000001223567889999999999999999999975

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.8e-36  Score=282.69  Aligned_cols=250  Identities=24%  Similarity=0.287  Sum_probs=198.5

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|++.+.||+|++|.||+++..  .++..+++|.+....  ......+.+|++++++++|+||+++++++.     ....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~   73 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRL--SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNK   73 (256)
T ss_pred             CceEeeeecCCCceeEEEEEEC--CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCE
Confidence            4788899999999999999843  456789999987543  223456788999999999999999998853     3468


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++|+||+++++|.+++.........+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||++
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~  150 (256)
T cd08530          74 LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGIS  150 (256)
T ss_pred             EEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccch
Confidence            89999999999999999764444456899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......         .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||......  .+...+.     
T Consensus       151 ~~~~~~~---------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~-----  214 (256)
T cd08530         151 KVLKKNM---------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--DLRYKVQ-----  214 (256)
T ss_pred             hhhccCC---------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHh-----
Confidence            8764321         11234788999999999888999999999999999999999999653211  0110000     


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                            ......                    .+..+..++.+++.+|++.+|++||++.|+++
T Consensus       215 ------~~~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         215 ------RGKYPP--------------------IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ------cCCCCC--------------------CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                  000000                    01123567899999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-36  Score=280.43  Aligned_cols=254  Identities=23%  Similarity=0.274  Sum_probs=194.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-----ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-----RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      .+|++.+.||+|+||.||+|+..  .++..||+|.+....     ......+.+|++++++++|+||+++++++...   
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---   76 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDA--DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---   76 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEc--CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---
Confidence            47899999999999999999843  457889999875321     12335788999999999999999999986332   


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++|+||+++++|.+++...    ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|
T Consensus        77 ~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          77 EEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECc
Confidence            234678999999999999998743    24788999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||.++.......    .........++..|+|||++.+..++.++|||||||++|+|++|+.||.....    .... ..
T Consensus       150 fg~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~  220 (264)
T cd06653         150 FGASKRIQTICM----SGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAI-FK  220 (264)
T ss_pred             cccccccccccc----cCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHH-HH
Confidence            999986532110    01111234588999999999888899999999999999999999999965311    1111 10


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ......    .+.+                       +.....++.+++.+|++ +|.+||++.+++.
T Consensus       221 ~~~~~~----~~~~-----------------------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         221 IATQPT----KPML-----------------------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             HHcCCC----CCCC-----------------------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            000000    0000                       12225678899999999 5799999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.4e-36  Score=281.21  Aligned_cols=247  Identities=23%  Similarity=0.277  Sum_probs=188.0

Q ss_pred             HHhcCCCCccCcc--ccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeec
Q 011508          155 FKATDGFSLENLI--GAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVD  231 (484)
Q Consensus       155 ~~~~~~~~~~~~l--g~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  231 (484)
                      ....++|++.+.+  |+|+||.||+++  +..++..+|+|.+........     |+.....+ +|+|++++++++..  
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~--   80 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLK--HKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT--   80 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEE--EcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec--
Confidence            3445677777776  999999999998  444578899999875432211     22222222 79999999998543  


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceE
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAH  310 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~k  310 (484)
                         ++..++||||+++++|.+++....    .+++.+++.++.|+++||+|||   +.+++||||||+||+++.++ .++
T Consensus        81 ---~~~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~  150 (267)
T PHA03390         81 ---LKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIY  150 (267)
T ss_pred             ---CCeeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEE
Confidence               448899999999999999997432    6899999999999999999999   89999999999999999998 999


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      |+|||.+......           ....++..|+|||++.+..++.++||||||+++|||++|+.||............+
T Consensus       151 l~dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~  219 (267)
T PHA03390        151 LCDYGLCKIIGTP-----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL  219 (267)
T ss_pred             EecCccceecCCC-----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH
Confidence            9999998765321           12347889999999998889999999999999999999999997543332222222


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-HHHHHH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-MEEVAA  461 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~  461 (484)
                      ....         ......                     ...++..+.+++.+||+.+|.+||+ ++|+++
T Consensus       220 ~~~~---------~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        220 LKRQ---------QKKLPF---------------------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             HHhh---------cccCCc---------------------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            2111         000000                     1122567899999999999999996 588874

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3e-36  Score=285.55  Aligned_cols=272  Identities=20%  Similarity=0.224  Sum_probs=190.6

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCCcee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      |++.+.||+|+||.||+|...  .++..||+|+++.... .......+|+.++.++. |+|++++++++...   ..+..
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~--~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~   75 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSR--KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRL   75 (282)
T ss_pred             CceEeeccccccceEEEEEEc--CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcE
Confidence            567889999999999999843  4568899999875432 22234557889999885 99999999986532   22578


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++|+||++ ++|.+++....   ..+++.+++.++.|++.||+|||   +.+++||||+|+||+++. +.+||+|||.+.
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~  147 (282)
T cd07831          76 ALVFELMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCR  147 (282)
T ss_pred             EEEEecCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccc
Confidence            99999995 68888886432   35899999999999999999999   899999999999999999 999999999998


Q ss_pred             ccccccccCCCCccccccccccccccCccccC-CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ......        ......++..|+|||.+. +..++.++|||||||++|||++|+.||.....  .............
T Consensus       148 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~  217 (282)
T cd07831         148 GIYSKP--------PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGT  217 (282)
T ss_pred             ccccCC--------CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCC
Confidence            653221        111234788999999764 45578899999999999999999999965321  1111111111111


Q ss_pred             ---hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          398 ---RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       398 ---~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                         .+.......-......  .....   ..... ....++.++.+++.+||+.+|++|||++++++
T Consensus       218 ~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         218 PDAEVLKKFRKSRHMNYNF--PSKKG---TGLRK-LLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CCHHHHHhhcccccccccC--ccccc---ccHHH-HcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence               0100000000000000  00000   00000 01133678999999999999999999999975

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=271.19  Aligned_cols=258  Identities=24%  Similarity=0.282  Sum_probs=200.6

Q ss_pred             hcCCCCcc-CccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCC
Q 011508          157 ATDGFSLE-NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       157 ~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  234 (484)
                      .+++|++. ++||-|-.|.|-.+.  ++.++..+|+|++..     .....+|+++--.. .|||||.+++++.. .+.+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~--~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCV--HKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYEN-SYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEE--eccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhh-hccC
Confidence            45667665 479999999999998  556788999999853     24567888876655 79999999998643 3566


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEE
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHV  311 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl  311 (484)
                      .....+|||.|+||.|.+.++...+  ..+++.++-.|..||..|+.|||   +.+|.||||||+|+|.+.   |-.+||
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEe
Confidence            7788899999999999999986553  45999999999999999999999   999999999999999964   458999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      +|||+|+.-...        ......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||......  .     
T Consensus       206 tDfGFAK~t~~~--------~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--a-----  270 (400)
T KOG0604|consen  206 TDFGFAKETQEP--------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--A-----  270 (400)
T ss_pred             cccccccccCCC--------ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--c-----
Confidence            999999865321        2223457899999999999999999999999999999999999999764221  1     


Q ss_pred             Hhhcchhhhh-hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          392 KEALPERLAE-IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       392 ~~~~~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                         ++..... +.......              +   +..+...+....++++.+|..+|.+|.|+.|+++.
T Consensus       271 ---ispgMk~rI~~gqy~F--------------P---~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  271 ---ISPGMKRRIRTGQYEF--------------P---EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ---CChhHHhHhhccCccC--------------C---ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence               1111111 11111000              1   11144556778899999999999999999999853

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-37  Score=312.12  Aligned_cols=278  Identities=19%  Similarity=0.202  Sum_probs=186.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEE------------------EeeccCccchHHHHHHHHHHHcCCCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVK------------------VLNLQHRGASKSFIAECQALRSIRHRN  219 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~n  219 (484)
                      .++|++.+.||+|+||+||++.++... +...++|                  .+.. .......+.+|+.++++++|+|
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRAST-EEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccc-hhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence            468999999999999999998754321 1111211                  1111 1122356789999999999999


Q ss_pred             ceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011508          220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA-PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKP  298 (484)
Q Consensus       220 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~  298 (484)
                      |+++++++.     ..+..++|+|++ +++|.+++...... ........+..++.|++.||+|||   +++|+||||||
T Consensus       225 Iv~l~~~~~-----~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP  295 (501)
T PHA03210        225 ILKIEEILR-----SEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKL  295 (501)
T ss_pred             cCcEeEEEE-----ECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            999999854     344789999998 56788877533211 122345677889999999999999   89999999999


Q ss_pred             CCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCC-C
Q 011508          299 SNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-T  377 (484)
Q Consensus       299 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p-~  377 (484)
                      +|||++.++.+||+|||+++.+....      ........||..|+|||++.+..++.++|||||||++|||++|..+ +
T Consensus       296 ~NILl~~~~~vkL~DFGla~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~  369 (501)
T PHA03210        296 ENIFLNCDGKIVLGDFGTAMPFEKER------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI  369 (501)
T ss_pred             HHEEECCCCCEEEEeCCCceecCccc------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence            99999999999999999998764321      1112235689999999999999999999999999999999998754 4


Q ss_pred             CCCccC-CccHhHHHHh------hcchh---hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCC
Q 011508          378 NEMFTG-NLTLHNFVKE------ALPER---LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSS  447 (484)
Q Consensus       378 ~~~~~~-~~~~~~~~~~------~~~~~---~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~  447 (484)
                      ...... ...+.+.+..      .+++.   +.+.++.....   .... ..   ....+   .......+.+++.+||+
T Consensus       370 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~---~~~~-~~---~~~~~---~~~~~~~~~~li~kmL~  439 (501)
T PHA03210        370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEID---HAGH-SV---PPLIR---NLGLPADFEYPLVKMLT  439 (501)
T ss_pred             cCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcc---cCcc-ch---hhHHH---hcCCChHHHHHHHHHhc
Confidence            332111 1111111111      01110   11111100000   0000 00   00000   01123457788999999


Q ss_pred             CCcCCCCCHHHHHHH
Q 011508          448 ELPRERMNMEEVAAQ  462 (484)
Q Consensus       448 ~dP~~RPt~~evl~~  462 (484)
                      .||++|||+.|+++.
T Consensus       440 ~DP~~Rpsa~elL~h  454 (501)
T PHA03210        440 FDWHLRPGAAELLAL  454 (501)
T ss_pred             cCcccCcCHHHHhhC
Confidence            999999999999864

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.4e-37  Score=274.77  Aligned_cols=210  Identities=24%  Similarity=0.366  Sum_probs=174.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCee--EEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ..|+....||+|.||.||+|+-.+....+  .+|+|.++...  .+......+|+.+++.++|||++.+..++.    ..
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl----~~   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFL----SH   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHh----cc
Confidence            56889999999999999999766555533  89999997553  355678899999999999999999998874    33


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC----Cce
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRD-APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE----LTA  309 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~----~~~  309 (484)
                      +...++++||.+ -+|.+.++-.+. ..+.++...+.+|+.||+.|+.|||   ++=|+||||||.||++..+    |.+
T Consensus       100 d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen  100 DKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             CceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCee
Confidence            568899999995 589998875443 2346888999999999999999999   8999999999999999887    899


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ||+|||+++.+...-.    ........+-|..|+|||.+.+ ..||.+.|||++||++.||+|-++.|.+.
T Consensus       176 KIaDlGlaR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             EeecccHHHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            9999999998754321    1222334678999999998877 46999999999999999999999888764

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.3e-36  Score=280.47  Aligned_cols=254  Identities=27%  Similarity=0.339  Sum_probs=199.6

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|...+.||+|++|.||+|...  .+++.|++|++.....  ...+.+.+|+.++++++|+||+++++.+....   ...
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~   75 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDK--DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNT   75 (260)
T ss_pred             CceeeeEeeecCceEEEEEEEC--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCe
Confidence            4777899999999999999854  3578899999876543  34567899999999999999999999864321   257


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++|+||+++++|.+++....    .+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||.+
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~  148 (260)
T cd06606          76 LNIFLEYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCA  148 (260)
T ss_pred             EEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccE
Confidence            899999999999999997433    6899999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .........     .......++..|+|||.......+.++||||||+++++|++|+.||.....    .....      
T Consensus       149 ~~~~~~~~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~------  213 (260)
T cd06606         149 KRLGDIETG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAAL------  213 (260)
T ss_pred             Eeccccccc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHH------
Confidence            876443210     012234588899999999888899999999999999999999999976431    00000      


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                        ..+.......                   ..+...+..+.+++.+|++.+|++||++.|++.
T Consensus       214 --~~~~~~~~~~-------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         214 --YKIGSSGEPP-------------------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             --HhccccCCCc-------------------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence              0010000000                   001222567899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.7e-36  Score=294.59  Aligned_cols=275  Identities=24%  Similarity=0.327  Sum_probs=197.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|++.+.||+|+||.||+|...  .++..+|+|++....  ......+.+|+.+++++ +|+||+++++++..   .+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~   80 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDR--RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---EN   80 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEc--CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CC
Confidence            467889999999999999999854  356889999885422  22335677899999999 99999999998642   23


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||++ ++|.+++...     .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~  151 (337)
T cd07852          81 DKDIYLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADF  151 (337)
T ss_pred             CceEEEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeec
Confidence            446799999996 6999988632     5788999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |.+..........  .........++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ........
T Consensus       152 g~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~  228 (337)
T cd07852         152 GLARSLSELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEV  228 (337)
T ss_pred             cchhccccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence            9998764332111  1112233468899999998754 567889999999999999999999996532211 11111100


Q ss_pred             h--cchh---------hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 A--LPER---------LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~--~~~~---------~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .  .+..         ...+++.....    ..        ...... ...++.++.+++..||+.||++|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~--------~~~~~~-~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         229 IGPPSAEDIESIKSPFAATMLDSLPSR----PR--------KPLDEL-LPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hCCCCHHHHHHHHhhhHHHhhhhcccc----cc--------cchhhh-ccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0  0000         00011100000    00        000000 11136778999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-37  Score=270.42  Aligned_cols=272  Identities=20%  Similarity=0.301  Sum_probs=205.7

Q ss_pred             HHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeee
Q 011508          151 YQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVS  229 (484)
Q Consensus       151 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  229 (484)
                      ++++.+-|+     +.||+|+|+.|..++  +-.++..+|||++.++......+..+|++++.+. .|+||++++++   
T Consensus        75 F~d~YkLt~-----e~LGeGAyasVqtcv--~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLief---  144 (463)
T KOG0607|consen   75 FEDMYKLTS-----ELLGEGAYASVQTCV--SIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEF---  144 (463)
T ss_pred             HHHHHHhHH-----HHhcCccceeeeeee--eeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHH---
Confidence            555555554     689999999999887  4456788999999988666677899999999999 69999999999   


Q ss_pred             eccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC--
Q 011508          230 VDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL--  307 (484)
Q Consensus       230 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~--  307 (484)
                        |+++...|+|||.|.||+|.+++++.    ..+++.++-++.++|+.||.|||   .++|.||||||+|||-....  
T Consensus       145 --FEdd~~FYLVfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~v  215 (463)
T KOG0607|consen  145 --FEDDTRFYLVFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKV  215 (463)
T ss_pred             --hcccceEEEEEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCc
Confidence              67777999999999999999999854    35899999999999999999999   99999999999999996543  


Q ss_pred             -ceEEcccCcccccccccccCCCCccccccccccccccCccccC-----CCCCCcccceehhhHHHHHHHhCCCCCCCCc
Q 011508          308 -TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEMF  381 (484)
Q Consensus       308 -~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~  381 (484)
                       .+||+||.+..-......-.....+.....+|+..|||||+..     ...|+.++|.||+|||+|-|++|.+||.+.-
T Consensus       216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~C  295 (463)
T KOG0607|consen  216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHC  295 (463)
T ss_pred             CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCcc
Confidence             7899999987655333222222233345678999999999643     2458899999999999999999999998764


Q ss_pred             cCCccHhHHHHhhcch----h-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH
Q 011508          382 TGNLTLHNFVKEALPE----R-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM  456 (484)
Q Consensus       382 ~~~~~~~~~~~~~~~~----~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  456 (484)
                      ..+-.+   -+...-.    . ...+.+-....                 ....+...+.+..+++...+..||.+|-++
T Consensus       296 g~dCGW---drGe~Cr~CQ~~LFesIQEGkYeF-----------------PdkdWahIS~eakdlisnLlvrda~~rlsa  355 (463)
T KOG0607|consen  296 GADCGW---DRGEVCRVCQNKLFESIQEGKYEF-----------------PDKDWAHISSEAKDLISNLLVRDAKQRLSA  355 (463)
T ss_pred             CCcCCc---cCCCccHHHHHHHHHHHhccCCcC-----------------ChhhhHHhhHHHHHHHHHHHhccHHhhhhh
Confidence            432211   1111100    0 11111111110                 001133446677888888999999999999


Q ss_pred             HHHHH
Q 011508          457 EEVAA  461 (484)
Q Consensus       457 ~evl~  461 (484)
                      .+++.
T Consensus       356 ~~vln  360 (463)
T KOG0607|consen  356 AQVLN  360 (463)
T ss_pred             hhccC
Confidence            99886

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5e-36  Score=287.85  Aligned_cols=278  Identities=24%  Similarity=0.245  Sum_probs=195.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|...  .++..||+|.++.....  ....+.+|+.++++++|+|++++++++...   ..
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   80 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDT--TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HL   80 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEEC--CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CC
Confidence            467999999999999999999954  45788999998754322  234567899999999999999999986432   22


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+. ++|.+++....   ..+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||
T Consensus        81 ~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg  153 (309)
T cd07845          81 DSIFLVMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFG  153 (309)
T ss_pred             CeEEEEEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccc
Confidence            46799999995 58988887432   45899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      .+.......       .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||......  .....+...
T Consensus       154 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~--~~~~~~~~~  224 (309)
T cd07845         154 LARTYGLPA-------KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI--EQLDLIIQL  224 (309)
T ss_pred             eeeecCCcc-------CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHh
Confidence            998663321       11112235778999998765 55789999999999999999999999753211  111111111


Q ss_pred             cchhhhh----hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LPERLAE----IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~~~~~~----~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .......    ..+............ ........     .......+.+++.+|++.||++|||++|+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         225 LGTPNESIWPGFSDLPLVGKFTLPKQ-PYNNLKHK-----FPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cCCCChhhchhhhcccccccccccCC-CCCchHHh-----ccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            1000000    000000000000000 00000000     01124567899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.5e-36  Score=286.80  Aligned_cols=246  Identities=25%  Similarity=0.336  Sum_probs=190.4

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      |...+.||+|+||.||+|+..  .++..+|+|.+.....   .....+.+|++++++++|+|++++++++..     +..
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~   99 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDV--RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHT   99 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEc--CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCe
Confidence            667789999999999999854  3568899999874432   223568899999999999999999998643     347


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+. |+|.+.+...   ...+++.++..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||++
T Consensus       100 ~~lv~e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~  172 (317)
T cd06635         100 AWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSA  172 (317)
T ss_pred             EEEEEeCCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCc
Confidence            899999996 5888877532   235899999999999999999999   899999999999999999999999999988


Q ss_pred             cccccccccCCCCccccccccccccccCccccC---CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM---GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ......           ....++..|+|||++.   ...++.++|||||||++|||++|+.||...... ..+..+..  
T Consensus       173 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~--  238 (317)
T cd06635         173 SIASPA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQ--  238 (317)
T ss_pred             cccCCc-----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHh--
Confidence            754221           1235788999999873   456889999999999999999999998653111 00111100  


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                                .....                   .....+...+.+++.+|++.+|++||++.+|++.+
T Consensus       239 ----------~~~~~-------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         239 ----------NESPT-------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             ----------ccCCC-------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                      00000                   00112255788999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5e-36  Score=283.27  Aligned_cols=245  Identities=26%  Similarity=0.322  Sum_probs=187.7

Q ss_pred             cccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       167 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      ||+|+||+||++...  .+++.||+|.+....   ......+.+|++++++++|||++++++.+     ...+..++|||
T Consensus         1 lg~g~~g~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e   73 (277)
T cd05577           1 LGKGGFGEVCACQVK--ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMT   73 (277)
T ss_pred             CCCCCceeEEEEEEc--CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEe
Confidence            699999999999844  357889999986432   22234567899999999999999999884     34458899999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccc
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA  323 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  323 (484)
                      |+++++|.+++.....  ..+++..++.++.|++.||.|||   +.+++||||+|+||++++++.++|+|||.+......
T Consensus        74 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~  148 (277)
T cd05577          74 LMNGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG  148 (277)
T ss_pred             cCCCCcHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence            9999999999975432  35899999999999999999999   899999999999999999999999999998765321


Q ss_pred             cccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhc
Q 011508          324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIV  403 (484)
Q Consensus       324 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (484)
                      .        ......++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ........        ..
T Consensus       149 ~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~--------~~  211 (277)
T cd05577         149 K--------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRR--------TL  211 (277)
T ss_pred             C--------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhc--------cc
Confidence            1        1122347789999999888889999999999999999999999996532210 00100000        00


Q ss_pred             CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHH
Q 011508          404 DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAA  461 (484)
Q Consensus       404 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~  461 (484)
                      ....                     ..+......+.+++.+||+.||++||     ++.++++
T Consensus       212 ~~~~---------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         212 EMAV---------------------EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cccc---------------------cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            0000                     00112255788999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.5e-36  Score=286.15  Aligned_cols=245  Identities=25%  Similarity=0.347  Sum_probs=191.6

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEeec
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYEL  244 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  244 (484)
                      ..||+|+||.||++...  .++..||+|.+..........+.+|+.+++.++|+|++++++++.     .++..++||||
T Consensus        26 ~~lg~g~~g~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~   98 (292)
T cd06657          26 IKIGEGSTGIVCIATVK--SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEF   98 (292)
T ss_pred             HHcCCCCCeEEEEEEEc--CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEEec
Confidence            57999999999999854  357889999886554445567889999999999999999999854     34588999999


Q ss_pred             ccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccccccc
Q 011508          245 MVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAA  324 (484)
Q Consensus       245 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~  324 (484)
                      +++++|.+++..     ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.++|+|||.+.......
T Consensus        99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~  170 (292)
T cd06657          99 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  170 (292)
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc
Confidence            999999998752     24789999999999999999999   8999999999999999999999999999887553221


Q ss_pred             ccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcC
Q 011508          325 NNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVD  404 (484)
Q Consensus       325 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  404 (484)
                             .......++..|+|||...+..++.++||||+|+++|+|++|+.||.....  ...........+        
T Consensus       171 -------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--~~~~~~~~~~~~--------  233 (292)
T cd06657         171 -------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRDNLP--------  233 (292)
T ss_pred             -------ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhhCC--------
Confidence                   111224578899999998888889999999999999999999999864211  111111111111        


Q ss_pred             cccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          405 PVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       405 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..+..                     ...+...+.+++.+||+.+|.+||++.++++.
T Consensus       234 ~~~~~---------------------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         234 PKLKN---------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             cccCC---------------------cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            00000                     01124567889999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-36  Score=292.77  Aligned_cols=251  Identities=23%  Similarity=0.305  Sum_probs=201.2

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc--hHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA--SKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      .....|.+...||+|.|+.|..|+  +..++..||||.+++..-..  ...+.+|+++|+.++|||||+++.+.     .
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~--~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~  125 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLAR--HILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----E  125 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeE--ecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----e
Confidence            345778999999999999999999  44567889999998654332  24588999999999999999999984     4


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||+.+|.+.+++..+.    .+.+..+..++.|+..|++|+|   ++.|||||||++||||+.+.++||+|
T Consensus       126 t~~~lylV~eya~~ge~~~yl~~~g----r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaD  198 (596)
T KOG0586|consen  126 TEATLYLVMEYASGGELFDYLVKHG----RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIAD  198 (596)
T ss_pred             ecceeEEEEEeccCchhHHHHHhcc----cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeec
Confidence            4558999999999999999998554    3556888889999999999999   99999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||++.++...        ......+|++.|.|||+..+..| ++++|+||+|+++|-|+.|..||++..-..        
T Consensus       199 fgfS~~~~~~--------~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--------  262 (596)
T KOG0586|consen  199 FGFSTFFDYG--------LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--------  262 (596)
T ss_pred             cccceeeccc--------ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc--------
Confidence            9999987532        23345689999999999998766 689999999999999999999998642111        


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                               .-++.+...+             +.    +.-...+..+++++++-.+|.+|++++++.+.
T Consensus       263 ---------Lr~rvl~gk~-------------rI----p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  263 ---------LRPRVLRGKY-------------RI----PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ---------ccchheeeee-------------cc----cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                     1111111100             00    00013345788899999999999999999864

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=281.98  Aligned_cols=277  Identities=22%  Similarity=0.248  Sum_probs=195.3

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcC---CCCCceeEeeeeeeeccCCC
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSI---RHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~  235 (484)
                      |++.+.||+|+||.||+|+...  ++..||+|+++....  .....+.+|+.+++++   +|+|++++++++...+....
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLN--TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             CeEEEEecccCceEEEEEEECC--CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence            5678899999999999999653  578899999874432  2234566787777666   69999999999876553333


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...+++|||+. ++|.+++....  ...+++..++.++.|+++||+|||   +.+++|+||+|+||+++.++.+||+|||
T Consensus        79 ~~~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg  152 (287)
T cd07838          79 LKLTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFG  152 (287)
T ss_pred             ceeEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccC
Confidence            45899999996 58999887533  235899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      .+.......        ......++..|+|||.+.+..++.++|||||||++|||++|+.||..... ...+..+.....
T Consensus       153 ~~~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~  223 (287)
T cd07838         153 LARIYSFEM--------ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE-ADQLDKIFDVIG  223 (287)
T ss_pred             cceeccCCc--------ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh-HHHHHHHHHHcC
Confidence            987763321        11123478889999999988899999999999999999999999875321 111222211111


Q ss_pred             chhhhhhc-CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 PERLAEIV-DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~-d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ........ ........       ..............+....+.+++.+||+.||++||+++|++.
T Consensus       224 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         224 LPSEEEWPRNVSLPRSS-------FPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCChHhcCCCcccchhh-------cccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            00000000 00000000       0000000000001223567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.6e-36  Score=285.34  Aligned_cols=284  Identities=24%  Similarity=0.289  Sum_probs=197.5

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeec--
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVD--  231 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--  231 (484)
                      ...++|++.+.||+|+||.||+|+...  +++.||+|.++....  .....+.+|++++++++|||++++++++....  
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKD--TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECC--CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            345789999999999999999999643  467899999875432  23356788999999999999999999875432  


Q ss_pred             ---cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 011508          232 ---FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT  308 (484)
Q Consensus       232 ---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~  308 (484)
                         ..++...++|+||+++ ++.+++...   ...+++..++.++.|++.||+|||   +.+|+|+||||+||++++++.
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~  154 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQ  154 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCc
Confidence               1123478999999965 777777532   335899999999999999999999   899999999999999999999


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      +||+|||.+........      .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+
T Consensus       155 ~kl~dfg~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-~~~~  227 (302)
T cd07864         155 IKLADFGLARLYNSEES------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-LAQL  227 (302)
T ss_pred             EEeCcccccccccCCcc------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-HHHH
Confidence            99999999986643221      11112245778999998754 4578899999999999999999999965321 1111


Q ss_pred             hHHHHh---hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          388 HNFVKE---ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       388 ~~~~~~---~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ......   ..+....++.............    . ...... .....++..+.+++..||+.||++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         228 ELISRLCGSPCPAVWPDVIKLPYFNTMKPKK----Q-YRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHHhCCCChhhccccccccccccccccc----c-cccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111110   0010011111000000000000    0 000000 001123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-36  Score=284.45  Aligned_cols=277  Identities=23%  Similarity=0.296  Sum_probs=195.3

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      |++.+.||+|++|.||+|+...  ++..+|+|.+....  ......+.+|++++++++|+|++++++++....   ....
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~   75 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKK--TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSI   75 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECC--CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcE
Confidence            5678899999999999999543  46789999998653  333467889999999999999999999864321   3578


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++|+||++ ++|.+++...   ...+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||.+.
T Consensus        76 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~  148 (287)
T cd07840          76 YMVFEYMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLAR  148 (287)
T ss_pred             EEEecccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEcccccee
Confidence            99999996 5898888633   246899999999999999999999   8899999999999999999999999999998


Q ss_pred             ccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc--
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL--  395 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--  395 (484)
                      .......      .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+........  
T Consensus       149 ~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~  221 (287)
T cd07840         149 PYTKRNS------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSP  221 (287)
T ss_pred             eccCCCc------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Confidence            6643321      11122346788999997654 45789999999999999999999999753211 11111111000  


Q ss_pred             -chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 -PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 -~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                       ........+..............     ..........++..+.+++.+||+.+|++||+++++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         222 TDENWPGVSKLPWFENLKPKKPYK-----RRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             chhhccccccchhhhhccccccch-----hHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             00000000000000000000000     00000001113667899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.6e-36  Score=287.87  Aligned_cols=290  Identities=21%  Similarity=0.214  Sum_probs=196.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeecc---
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDF---  232 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  232 (484)
                      .++|++.+.||+|+||.||+|+..  .++..+|+|++.....  .....+.+|++++++++|+||+++++++.....   
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQI--KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEEC--CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence            478999999999999999999944  3567899998865432  223467889999999999999999987654321   


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                      ......++|+||+. +++.+.+...   ...+++..+..++.|+++||+|||   +.+|+|+||||+||++++++.++|+
T Consensus        85 ~~~~~~~lv~~~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~  157 (311)
T cd07866          85 RKRGSVYMVTPYMD-HDLSGLLENP---SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIA  157 (311)
T ss_pred             ccCceEEEEEecCC-cCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEC
Confidence            22346789999995 5777777532   345899999999999999999999   8999999999999999999999999


Q ss_pred             ccCcccccccccccCCC----CccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          313 DFGLAKFLPEAANNLSS----NQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      |||++............    .........++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~  236 (311)
T cd07866         158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQL  236 (311)
T ss_pred             cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHH
Confidence            99999866433211111    1111223457888999998765 45789999999999999999999998653221 111


Q ss_pred             hHHHHhhcchhhhhhcCcc-cccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          388 HNFVKEALPERLAEIVDPV-LLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       388 ~~~~~~~~~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ................+.. +.............   .... .........+.+++.+|++.||++|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYP---RTLE-ERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCC---ccHH-HHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            1111100000000000000 00000000000000   0000 000112356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-36  Score=278.61  Aligned_cols=248  Identities=28%  Similarity=0.414  Sum_probs=197.1

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|++.+.||+|++|.||+|+..  ..+..|++|.+.....  ...+.+.+|++++.+++|+|++++++++.     ....
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~   73 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNL--ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDS   73 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEc--CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCE
Confidence            4788899999999999999854  3467899999876543  34467899999999999999999999854     3457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++...    ..+++..++.++.|++.||.|||   +.+|+||||+|+||+++.++.++|+|||.+
T Consensus        74 ~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~  146 (254)
T cd06627          74 LYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVA  146 (254)
T ss_pred             EEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccc
Confidence            89999999999999998743    35899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ........       ......++..|+|||...+..++.++||||+|+++|+|++|+.||.....    ........ ..
T Consensus       147 ~~~~~~~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~-~~  214 (254)
T cd06627         147 TKLNDVSK-------DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIV-QD  214 (254)
T ss_pred             eecCCCcc-------cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHh-cc
Confidence            87643221       11224578899999998887889999999999999999999999865321    11111000 00


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                           ..+.+                       +......+.+++.+||+.+|++|||+.|++.
T Consensus       215 -----~~~~~-----------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         215 -----DHPPL-----------------------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -----CCCCC-----------------------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                 00000                       1122557889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.5e-35  Score=277.66  Aligned_cols=243  Identities=25%  Similarity=0.305  Sum_probs=189.6

Q ss_pred             cccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       167 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      ||.|++|.||+|+..  .++..+|+|++.....   ...+.+.+|+.+++.++||||+++++.+.     ++...++|+|
T Consensus         1 lg~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e   73 (262)
T cd05572           1 LGVGGFGRVELVKVK--SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLME   73 (262)
T ss_pred             CCCCCceEEEEEEEC--CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEe
Confidence            799999999999954  3578899999875432   23467889999999999999999999853     4457899999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccc
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA  323 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  323 (484)
                      |+++++|.+++...    ..+++..+..++.|++.||+|||   +++++|+||+|+||+++.++.++|+|||.+......
T Consensus        74 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~  146 (262)
T cd05572          74 YCLGGELWTILRDR----GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG  146 (262)
T ss_pred             cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence            99999999999743    24889999999999999999999   899999999999999999999999999998866332


Q ss_pred             cccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhc
Q 011508          324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIV  403 (484)
Q Consensus       324 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (484)
                      .        ......++..|+|||.+....++.++|+||+|+++|+|++|..||.....+.   .+...        .+.
T Consensus       147 ~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~--------~~~  207 (262)
T cd05572         147 Q--------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYN--------DIL  207 (262)
T ss_pred             c--------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHH--------HHh
Confidence            1        1122357889999999888889999999999999999999999997543211   11111        111


Q ss_pred             CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-----HHHHHH
Q 011508          404 DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-----MEEVAA  461 (484)
Q Consensus       404 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~  461 (484)
                      +.....                   ..+..+..++.+++.+||+.+|++||+     ++|+++
T Consensus       208 ~~~~~~-------------------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         208 KGNGKL-------------------EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ccCCCC-------------------CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            100000                   001122567899999999999999999     666554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.5e-35  Score=279.91  Aligned_cols=243  Identities=23%  Similarity=0.282  Sum_probs=182.0

Q ss_pred             ccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---chHHHHHHH---HHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAEC---QALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       166 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      .||+|+||.||+|...  .+++.||+|.+......   ....+..|.   ..++...||+|+++++++     ..++..+
T Consensus         1 ~ig~g~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~   73 (278)
T cd05606           1 IIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLS   73 (278)
T ss_pred             CcccCCCeEEEEEEEe--cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEE
Confidence            4899999999999843  45788999998754321   112233443   344455899999998874     4455889


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      +||||+++++|.+++...    ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+..
T Consensus        74 ~v~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~  146 (278)
T cd05606          74 FILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD  146 (278)
T ss_pred             EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence            999999999999988632    35899999999999999999999   89999999999999999999999999999875


Q ss_pred             cccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      .....         .....|+..|+|||.+.++ .++.++||||+||++|||++|+.||........  ......     
T Consensus       147 ~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~--~~~~~~-----  210 (278)
T cd05606         147 FSKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRM-----  210 (278)
T ss_pred             cCccC---------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch--HHHHHH-----
Confidence            43211         1123588999999998754 689999999999999999999999975422111  000000     


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQ  462 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  462 (484)
                       ....+..+                       +..++.++.+++.+|+..+|.+||     ++.|+++.
T Consensus       211 -~~~~~~~~-----------------------~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         211 -TLTMAVEL-----------------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             -hhccCCCC-----------------------CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence             00000000                       111256788999999999999999     99999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=8.3e-36  Score=284.28  Aligned_cols=278  Identities=21%  Similarity=0.245  Sum_probs=191.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|++|.||+|+.  ..+++.||+|.+.....  ...+.+.+|++++++++|+|++++++++.     .+.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~--~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   74 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARD--RVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEK   74 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEe--cCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCC
Confidence            4688999999999999999984  34577899998865432  23357889999999999999999999853     445


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEcccC
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG-ELTAHVSDFG  315 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg  315 (484)
                      ..++||||++ ++|.+++....  ...+++..+..++.||+.||+|||   +++++|+||+|+||+++. ++.+||+|||
T Consensus        75 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         75 RLYLVFEYLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             eEEEEEeccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccc
Confidence            8899999995 68888875332  233678888899999999999999   899999999999999985 4579999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ++.......       .......++..|+|||++.+ ..++.++||||+||++|+|+||+.||......+ .+.+... .
T Consensus       149 ~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~-~  219 (294)
T PLN00009        149 LARAFGIPV-------RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFR-I  219 (294)
T ss_pred             cccccCCCc-------cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-H
Confidence            997543211       11122346889999998765 457899999999999999999999996532111 1111100 0


Q ss_pred             cchhhhhhcCccc-ccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LPERLAEIVDPVL-LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~~~~~~~~d~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .........+... ..+....    ..................++.+++.+|++.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        220 LGTPNEETWPGVTSLPDYKSA----FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hCCCChhhccccccchhhhhh----cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000000000000 0000000    00000000000011124568899999999999999999999863

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.9e-36  Score=289.27  Aligned_cols=289  Identities=21%  Similarity=0.235  Sum_probs=204.0

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|.+.+.||+|++|.||+|+..  .++..||+|.+....  ....+.+.+|+.+++.++|+||+++++++..........
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDK--RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeC--CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence            5788899999999999999943  357889999987543  334467899999999999999999999865433223346


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||++ ++|.+++...    ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||.+
T Consensus        79 ~~lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~  150 (330)
T cd07834          79 VYIVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLA  150 (330)
T ss_pred             eEEEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCce
Confidence            799999996 5898888632    26899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      .........    ........++..|+|||.+.+. .++.++||||||+++|+|++|+.||.......  ....+.....
T Consensus       151 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~  224 (330)
T cd07834         151 RGVDPDEDE----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID--QLNLIVEVLG  224 (330)
T ss_pred             Eeecccccc----cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHhcC
Confidence            876433210    0112234578899999998887 78999999999999999999999997643211  0011111000


Q ss_pred             h----hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH--HHHHHHH
Q 011508          397 E----RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ--LLSFRNK  469 (484)
Q Consensus       397 ~----~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~~  469 (484)
                      .    ................     ..............+.+..+.+++.+||+.+|.+|||+++++..  ++.++..
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         225 TPSEEDLKFITSEKARNYLKS-----LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             CCChhHhhhccccchhhHHhh-----cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            0    0000000000000000     00000000000011235678999999999999999999999975  5555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.1e-37  Score=312.60  Aligned_cols=264  Identities=27%  Similarity=0.359  Sum_probs=189.5

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc----
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDF----  232 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  232 (484)
                      ..+|+..+.||+||||.||+++  ++-+|+.||||++.... ........+|+..|++|+|||||+++....+...    
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVR--NKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVR--NKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEe--ecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            3567888999999999999999  55678999999997653 2234568899999999999999998754332100    


Q ss_pred             --------------------------------------------------------------------------------
Q 011508          233 --------------------------------------------------------------------------------  232 (484)
Q Consensus       233 --------------------------------------------------------------------------------  232 (484)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -C---------------------CC--------ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 011508          233 -Q---------------------GN--------DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY  282 (484)
Q Consensus       233 -~---------------------~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~  282 (484)
                       +                     .+        ...||=||||+..++.++++.+.-..   .....|+++++|+.||+|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence             0                     00        24578899999988888887543211   356789999999999999


Q ss_pred             HHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccccc-----------ccccCCCCccccccccccccccCccccCC
Q 011508          283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE-----------AANNLSSNQSSSVGVKGTVGYAAPEYGMG  351 (484)
Q Consensus       283 LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~-----------~~~~~~~~~~~~~~~~g~~~y~aPE~~~~  351 (484)
                      +|   +++||||||||.||+++++..|||+|||+|.....           ..+.........+..+||.-|+|||++.+
T Consensus       713 IH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99   89999999999999999999999999999987321           01111122223456789999999999876


Q ss_pred             C---CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccc
Q 011508          352 S---EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRS  428 (484)
Q Consensus       352 ~---~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~  428 (484)
                      .   .|+.|+|+||+|||++||+.   ||.........+...-...+|.. .++.++.                      
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-~~f~~~~----------------------  843 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-ADFFDPE----------------------  843 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-ccccccc----------------------
Confidence            5   49999999999999999986   45432111111111111111111 1111111                      


Q ss_pred             cchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          429 FGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       429 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                            ...-.++++++++.||.+|||+.|++.
T Consensus       844 ------~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  844 ------HPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ------chHHHHHHHHHhcCCCccCCCHHHHhh
Confidence                  334568999999999999999999984

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-37  Score=265.22  Aligned_cols=250  Identities=23%  Similarity=0.299  Sum_probs=192.2

Q ss_pred             CccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCceee
Q 011508          162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       162 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      .....||.|+.|.|++++++.  ++..+|||.+..... ...+++...+.++..- ++|.||+.+||+..     +...+
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs--~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-----n~dV~  167 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRS--TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-----NTDVF  167 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcc--cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-----CchHH
Confidence            456779999999999999654  578999999976543 3446777788777666 58999999999653     33678


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      +.||.| ...++.+++..   ..++++..+-++...+.+||.||.+  .++|+|||+||+|||+|+.|++||||||.+..
T Consensus       168 IcMelM-s~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  168 ICMELM-STCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             HHHHHH-HHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccce
Confidence            999998 44566666533   2458888888999999999999987  78999999999999999999999999999987


Q ss_pred             cccccccCCCCccccccccccccccCccccCC---CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG---SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.++.        ......|-+.|||||.+..   ..|+.++||||||++++||.||+.||..-..+-..+.+.... .|
T Consensus       242 lvdSk--------AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~-eP  312 (391)
T KOG0983|consen  242 LVDSK--------AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE-EP  312 (391)
T ss_pred             eeccc--------ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-CC
Confidence            64432        2233468899999998764   468889999999999999999999998743332222222221 11


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                              +.+..                     ...+...+.+++..||..|+.+||...++++.
T Consensus       313 --------P~L~~---------------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  313 --------PLLPG---------------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             --------CCCCc---------------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence                    11111                     11136678899999999999999999999854

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-36  Score=307.72  Aligned_cols=271  Identities=27%  Similarity=0.403  Sum_probs=211.2

Q ss_pred             HHHhcCCCCccCccccccceeEEEEEEcCCC-----CeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeee
Q 011508          154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDD-----HETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITS  226 (484)
Q Consensus       154 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~  226 (484)
                      ++...++..+.+.||+|.||.|++|......     ....||||.++.... ...+.+..|+++|+.+ +|+||+.++|+
T Consensus       291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            3344455567779999999999999864322     256799999885543 3456899999999999 69999999999


Q ss_pred             eeeeccCCCceeeEEeecccCCCHHHHHhhcC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 011508          227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---D-------AP--RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHC  294 (484)
Q Consensus       227 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  294 (484)
                      |..     ....++|+||+..|+|.++++..+   .       ..  ..++..+.+.++.|||.|++||+   +.+++||
T Consensus       371 ~t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHR  442 (609)
T KOG0200|consen  371 CTQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHR  442 (609)
T ss_pred             ecc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccch
Confidence            865     457899999999999999998766   1       11  13899999999999999999999   8999999


Q ss_pred             CCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-C
Q 011508          295 DLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-G  373 (484)
Q Consensus       295 dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g  373 (484)
                      ||.++|||++++..+||+|||+|+.............   ... -...|||||.+....++.++|||||||+|||++| |
T Consensus       443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~---~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG  518 (609)
T KOG0200|consen  443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSS---AGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLG  518 (609)
T ss_pred             hhhhhhEEecCCCEEEEccccceeccCCCCceEecCC---CCc-cceeecCHHHhccCcccccchhhHHHHHHHHHhhCC
Confidence            9999999999999999999999996544332211100   001 3456999999999999999999999999999999 8


Q ss_pred             CCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCC
Q 011508          374 KGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRER  453 (484)
Q Consensus       374 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  453 (484)
                      ..||.+.... ..+.++++                               +..+...+..|..++.++|+.||+.+|++|
T Consensus       519 ~~PYp~~~~~-~~l~~~l~-------------------------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~R  566 (609)
T KOG0200|consen  519 GTPYPGIPPT-EELLEFLK-------------------------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDR  566 (609)
T ss_pred             CCCCCCCCcH-HHHHHHHh-------------------------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccC
Confidence            9998752111 01111111                               111222367788899999999999999999


Q ss_pred             CCHHHHHHHHHHHHH
Q 011508          454 MNMEEVAAQLLSFRN  468 (484)
Q Consensus       454 Pt~~evl~~L~~i~~  468 (484)
                      |++.|+.+.++....
T Consensus       567 P~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  567 PTFSECVEFFEKHLQ  581 (609)
T ss_pred             CCHHHHHHHHHHHHH
Confidence            999999999998543

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1e-35  Score=283.97  Aligned_cols=255  Identities=23%  Similarity=0.296  Sum_probs=190.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  235 (484)
                      -++|++.+.||+|++|.||+|....  ++..||||.++.... .....+..|+.++.+. .|+||++++++|..     .
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~   86 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKK--TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----D   86 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECC--CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----C
Confidence            3668889999999999999999543  468899999875432 2335567788777666 59999999999643     4


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+ ++++.+++....   ..+++..+..++.|++.|++|||+  ..+|+||||+|+||++++++.+||+|||
T Consensus        87 ~~~~~v~e~~-~~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg  160 (296)
T cd06618          87 SDVFICMELM-STCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFG  160 (296)
T ss_pred             CeEEEEeecc-CcCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccc
Confidence            4789999998 557877775422   368999999999999999999993  2599999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCC----CCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE----VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      .+..+....        ......++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.........+.   
T Consensus       161 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---  229 (296)
T cd06618         161 ISGRLVDSK--------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLT---  229 (296)
T ss_pred             cchhccCCC--------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHH---
Confidence            987653221        111234778899999987553    78899999999999999999999864211110011   


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                               .+.+.......             .     ...+..++.+++.+||+.||++||+++++++.-
T Consensus       230 ---------~~~~~~~~~~~-------------~-----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         230 ---------KILQEEPPSLP-------------P-----NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             ---------HHhcCCCCCCC-------------C-----CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence                     11111000000             0     011255789999999999999999999998663

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-35  Score=287.41  Aligned_cols=277  Identities=23%  Similarity=0.273  Sum_probs=196.6

Q ss_pred             HHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeec
Q 011508          154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVD  231 (484)
Q Consensus       154 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  231 (484)
                      +...+++|++.+.||+|+||.||+|.  +..++..||+|.+....  ....+.+.+|++++++++|||++++++++..  
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--   80 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSAR--DQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS--   80 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEE--ECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec--
Confidence            44577899999999999999999998  44467889999875432  2234678899999999999999999998632  


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEE
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV  311 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl  311 (484)
                        .....++|+||+ +++|.+++..     ..+++..+..++.|++.||+|||   +.+|+||||+|+||++++++.++|
T Consensus        81 --~~~~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l  149 (328)
T cd07856          81 --PLEDIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKI  149 (328)
T ss_pred             --CCCcEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEe
Confidence              234678999999 6789888862     24788888899999999999999   899999999999999999999999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      +|||.+......          .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......  .....
T Consensus       150 ~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~--~~~~~  217 (328)
T cd07856         150 CDFGLARIQDPQ----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV--NQFSI  217 (328)
T ss_pred             CccccccccCCC----------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence            999998754221          112346788999998765 56899999999999999999999999653211  00000


Q ss_pred             HHhhc---chh-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          391 VKEAL---PER-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       391 ~~~~~---~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .....   ++. ...+.+.........     ...............+...+.+++.+|++.+|++|||+.+++..
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         218 ITDLLGTPPDDVINTICSENTLRFVQS-----LPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHHhCCCCHHHHHhccchhhHHHHhh-----ccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11110   111 111111000000000     00000000000011235678999999999999999999998765

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=276.95  Aligned_cols=244  Identities=23%  Similarity=0.248  Sum_probs=183.3

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHH-HcCCCCCceeEeeeeeeeccCCCceeeE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQAL-RSIRHRNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.||+|+||.||+|..  ..+++.||+|.+.....   .....+..|..++ ...+|+|++++++++.     .++..++
T Consensus         2 ~~l~~g~~~~v~~a~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~l   74 (260)
T cd05611           2 KPISKGAFGSVYLAKK--RSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYL   74 (260)
T ss_pred             ccCCcCCCeeEEEEEe--cCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEE
Confidence            5699999999999984  34567899999865432   1122344554444 4558999999999853     4458899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      |+||+++++|.+++...    ..+++..+..++.|++.||.|||   +.+++||||+|+||+++.++.++|+|||++...
T Consensus        75 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  147 (260)
T cd05611          75 VMEYLNGGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG  147 (260)
T ss_pred             EEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence            99999999999999743    34889999999999999999999   899999999999999999999999999988754


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA  400 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  400 (484)
                      ..           .....++..|+|||.+.+..++.++||||||+++|+|++|..||......     .......     
T Consensus       148 ~~-----------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~-----  206 (260)
T cd05611         148 LE-----------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-----AVFDNIL-----  206 (260)
T ss_pred             cc-----------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHH-----
Confidence            22           11234788999999988888899999999999999999999999653211     1111000     


Q ss_pred             hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       401 ~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                         .......                 ......++..+.+++.+||+.+|++||++.++.+.|
T Consensus       207 ---~~~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         207 ---SRRINWP-----------------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             ---hcccCCC-----------------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence               0000000                 000112356789999999999999999876654443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.1e-36  Score=291.66  Aligned_cols=279  Identities=21%  Similarity=0.254  Sum_probs=194.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeec------
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVD------  231 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  231 (484)
                      ..+|.+.+.||.|+||.||+|+.  ..++..||+|.+........+.+.+|++++++++||||+++++++....      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~--~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVD--SDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEE--CCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence            36899999999999999999984  4467889999987666555677889999999999999999988754321      


Q ss_pred             ---cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CC
Q 011508          232 ---FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG-EL  307 (484)
Q Consensus       232 ---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~  307 (484)
                         +......++||||++ ++|.+++..     ..+++..++.++.||+.||.|||   +.+|+||||||+||+++. ++
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~  152 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCc
Confidence               111235789999996 689888752     24889999999999999999999   899999999999999974 56


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCcc
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLT  386 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~  386 (484)
                      .+||+|||.+.........    ........++..|+|||.+.. ..++.++|||||||++|+|++|+.||....... .
T Consensus       153 ~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~  227 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSH----KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-Q  227 (342)
T ss_pred             eEEECCcccceecCCcccc----ccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence            7899999998765322110    111112347889999997654 567889999999999999999999996532111 0


Q ss_pred             HhHHHHhhcchh----hhhh---cCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHH
Q 011508          387 LHNFVKEALPER----LAEI---VDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEV  459 (484)
Q Consensus       387 ~~~~~~~~~~~~----~~~~---~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev  459 (484)
                      ....... .+..    ....   ....+.......   ..    +...  .......++.+++.+|++.||++|||+.|+
T Consensus       228 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~----~~~~--~~~~~~~~~~~li~~~L~~dP~~R~t~~el  297 (342)
T cd07854         228 MQLILES-VPVVREEDRNELLNVIPSFVRNDGGEP---RR----PLRD--LLPGVNPEALDFLEQILTFNPMDRLTAEEA  297 (342)
T ss_pred             HHHHHHh-cCCCChHHhhhhhhhhhhhhhhccccc---CC----CHHH--HccCCCHHHHHHHHHHhCCCchhccCHHHH
Confidence            1111100 0000    0000   000000000000   00    0000  001124578899999999999999999999


Q ss_pred             HHH
Q 011508          460 AAQ  462 (484)
Q Consensus       460 l~~  462 (484)
                      +..
T Consensus       298 l~h  300 (342)
T cd07854         298 LMH  300 (342)
T ss_pred             hCC
Confidence            853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=280.07  Aligned_cols=271  Identities=21%  Similarity=0.272  Sum_probs=192.1

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCCcee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      |++.+.||+|++|.||+|+...  +++.|++|.+...... ......+|+..+.+++ |+|++++++++.     .++..
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~   73 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKE--TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDEL   73 (283)
T ss_pred             CeeheeeccCCceEEEEEEECC--CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcE
Confidence            5678899999999999999543  4678999998654322 2234567999999998 999999999853     35688


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+ +|+|.+++....  ...+++..++.++.|++.+|.|||   +++++|+||+|+||++++++.++|+|||.+.
T Consensus        74 ~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~  147 (283)
T cd07830          74 YFVFEYM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR  147 (283)
T ss_pred             EEEEecC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccce
Confidence            9999999 889999887443  245899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccC-CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ......        ......++..|+|||.+. ...++.++||||||+++|||++|+.||....... ...+ .......
T Consensus       148 ~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~-~~~~-~~~~~~~  217 (283)
T cd07830         148 EIRSRP--------PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID-QLYK-ICSVLGT  217 (283)
T ss_pred             eccCCC--------CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH-HHHH-HHHhcCC
Confidence            653221        112235788999999774 4567899999999999999999999986532111 0100 0000000


Q ss_pred             h----hhh--hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          398 R----LAE--IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       398 ~----~~~--~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .    ..+  ..+............       .......+. ....+.+++.+||+.+|++|||++|+++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         218 PTKQDWPEGYKLASKLGFRFPQFAP-------TSLHQLIPN-ASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             CChhhhhhHhhhhcccccccccccc-------ccHHHHccc-CCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0    000  000000000000000       000000001 14568899999999999999999999753

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.2e-35  Score=281.72  Aligned_cols=245  Identities=27%  Similarity=0.369  Sum_probs=188.0

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      |...+.||+|+||.||+|+.  ..++..|++|.+.....   .....+.+|+++++.++|+|++++++++..     ...
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~--~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~   95 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATN--SHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHT   95 (313)
T ss_pred             hhcceeeccCCCeEEEEEEE--CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCE
Confidence            55667899999999999984  34578899999875432   223567889999999999999999998644     347


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+. |++.+++...   ...+++.+++.++.|++.+++|||   +.+++|+||+|+||+++.++.+||+|||.+
T Consensus        96 ~~lv~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~  168 (313)
T cd06633          96 AWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSA  168 (313)
T ss_pred             EEEEEecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCC
Confidence            899999994 6888877632   235899999999999999999999   899999999999999999999999999987


Q ss_pred             cccccccccCCCCccccccccccccccCccccC---CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM---GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      .....           .....++..|+|||++.   ...++.++|||||||++|+|++|..||....... .......  
T Consensus       169 ~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~--  234 (313)
T cd06633         169 SKSSP-----------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQ--  234 (313)
T ss_pred             cccCC-----------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHh--
Confidence            64311           11235788999999874   4568889999999999999999999986531110 0000000  


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                        ...     +...                      .......+.+++.+||+.+|.+||++.+++..
T Consensus       235 --~~~-----~~~~----------------------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         235 --NDS-----PTLQ----------------------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             --cCC-----CCCC----------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              000     0000                      11124468899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-35  Score=279.93  Aligned_cols=270  Identities=22%  Similarity=0.256  Sum_probs=195.9

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      |++.+.||+|++|.||+|..  ..++..+++|.++.....  ....+.+|++++++++|+||+++++++.     .+...
T Consensus         1 y~~~~~i~~g~~~~v~~~~~--~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   73 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARD--KLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDL   73 (283)
T ss_pred             CccceeeecCCCceEEEEEc--CCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCE
Confidence            56778999999999999984  445788999998754332  3467889999999999999999999853     34588


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++|+||++ ++|.+++....   ..+++..++.++.|++.||+|||   ..+|+|+||+|+||+++.++.++|+|||.+.
T Consensus        74 ~~v~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~  146 (283)
T cd05118          74 YLVFEFMD-TDLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLAR  146 (283)
T ss_pred             EEEEeccC-CCHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence            99999996 58888886432   45899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ......       .......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||......+ .+.. .......
T Consensus       147 ~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~-~~~~~~~  217 (283)
T cd05118         147 SFGSPV-------RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFK-IFRTLGT  217 (283)
T ss_pred             ecCCCc-------ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHHcCC
Confidence            664322       011223577889999988776 78999999999999999999999986532110 1111 1111100


Q ss_pred             ----hhhhhcCcccc--cccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          398 ----RLAEIVDPVLL--VEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       398 ----~~~~~~d~~l~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                          ......+....  .......        .........+++.++.+++.+||+.||.+||++.+++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         218 PDPEVWPKFTSLARNYKFSFPKKA--------GMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             CchHhcccchhhhhhhhhhhcccc--------ccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                00111000000  0000000        00000012345678999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-35  Score=288.06  Aligned_cols=284  Identities=20%  Similarity=0.225  Sum_probs=196.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-CC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDF-QG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~  234 (484)
                      .++|.+.+.||+|+||.||+|+..  .++..||+|++....  ......+.+|+.++++++|+||+++++++..... ..
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDK--RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeC--CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            478999999999999999999843  357889999886432  2223568899999999999999999998654321 12


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++|+||+. .+|.++..      ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+||
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          92 FQDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             CceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeC
Confidence            235689999995 47776652      24889999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |+++.....          .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+......
T Consensus       162 g~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~  230 (342)
T cd07879         162 GLARHADAE----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKV  230 (342)
T ss_pred             CCCcCCCCC----------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence            998754221          112357888999998766 468899999999999999999999997532110 11111100


Q ss_pred             --hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH--HHHHHH
Q 011508          394 --ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ--LLSFRN  468 (484)
Q Consensus       394 --~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~~  468 (484)
                        .......+..+.........    ....................+.+++.+||+.||++||+++|++..  ++.+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         231 TGVPGPEFVQKLEDKAAKSYIK----SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cCCCCHHHHHHhcccchHHHHh----hcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence              00000111110000000000    000000000000001124568899999999999999999999954  666654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.7e-35  Score=287.04  Aligned_cols=285  Identities=21%  Similarity=0.222  Sum_probs=195.7

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCc
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  236 (484)
                      +|++.+.||+|+||.||+++......+..||+|.+.....  ...+.+.+|+++++++ +|+||+++++.+.... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            4778899999999999999965443377899999864322  2245688899999999 5999999998754321 2334


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++++||+ +++|.+++..    ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.
T Consensus        80 ~~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          80 ELYLYEELM-EADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             cEEEEEecc-cCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence            578899998 4789998863    345899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh-
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA-  394 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-  394 (484)
                      ++.+......   .........|+..|+|||...+ ..++.++||||+||++|+|++|+.||...... ..+....... 
T Consensus       152 a~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~  227 (332)
T cd07857         152 ARGFSENPGE---NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLG  227 (332)
T ss_pred             ceeccccccc---ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhC
Confidence            9866432211   1111123468899999998665 56899999999999999999999998653211 0011111100 


Q ss_pred             -cch-hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 -LPE-RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 -~~~-~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                       .++ ....+.++..............    .... .....+...+.+++.+|++.||++|||+.|++..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         228 TPDEETLSRIGSPKAQNYIRSLPNIPK----KPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             CCCHHHHHhhhhhhHHHHHHhccccCC----cchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             000 0111111100000000000000    0000 0001125678999999999999999999998743

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.5e-35  Score=281.72  Aligned_cols=258  Identities=22%  Similarity=0.263  Sum_probs=195.3

Q ss_pred             CCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccC----ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQH----RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  233 (484)
                      +|++.+.||+|++|.||+++.... .+++.||+|+++...    ....+.+.+|+.++.++ +|+||+++++.+     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            477889999999999999985432 356789999987432    12335678999999999 699999999874     4


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .+...++||||+++++|.+++...    ..+++..+..++.|++++|+|||   +.+++||||+|+||+++.++.++|+|
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~d  148 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTD  148 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEE
Confidence            455789999999999999998632    34889999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCC--CCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE--VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      ||+++.......      .......++..|+|||...+..  .+.++||||||+++|||++|..||...... .......
T Consensus       149 fg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~  221 (288)
T cd05583         149 FGLSKEFLAEEE------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEIS  221 (288)
T ss_pred             Cccccccccccc------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHH
Confidence            999876533211      1112245788999999987654  788999999999999999999998642111 0111111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                      ..        +......                     .+..+...+.+++.+||+.||++|||+.+|.+.|+.
T Consensus       222 ~~--------~~~~~~~---------------------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         222 RR--------ILKSKPP---------------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HH--------HHccCCC---------------------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            10        0000000                     011124568899999999999999999888776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.1e-35  Score=278.86  Aligned_cols=249  Identities=23%  Similarity=0.323  Sum_probs=190.1

Q ss_pred             cccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       167 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      ||.|+||.||+++..  .++..+++|++.....   ...+.+.+|++++++++|+|++++++.+     ..+...++|+|
T Consensus         1 lg~g~~~~vy~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e   73 (265)
T cd05579           1 ISKGAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVME   73 (265)
T ss_pred             CCCCCceEEEEEEEC--CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEe
Confidence            689999999999954  3568899999875433   3446788999999999999999998874     44568899999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccc
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA  323 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  323 (484)
                      |+++++|.+++....    .+++..++.++.|++.||+|||   +.+++|+||+|+||++++++.++|+|||++......
T Consensus        74 ~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~  146 (265)
T cd05579          74 YLPGGDLASLLENVG----SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR  146 (265)
T ss_pred             cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence            999999999997432    5899999999999999999999   899999999999999999999999999998754322


Q ss_pred             cccC-CCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhh
Q 011508          324 ANNL-SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEI  402 (484)
Q Consensus       324 ~~~~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (484)
                      .... ...........++..|+|||.......+.++||||||+++|++++|+.||.....     ......        +
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~--------~  213 (265)
T cd05579         147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQN--------I  213 (265)
T ss_pred             cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH--------H
Confidence            1100 0001112234578899999998888899999999999999999999999865321     111110        0


Q ss_pred             cCcccccccccccchhhhhhhccccccchhH--HHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          403 VDPVLLVEREEGETSEANAHKQRTRSFGGKE--CLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       403 ~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      .......                     +..  .+..+.+++.+|++.+|++|||+.++.+.|
T Consensus       214 ~~~~~~~---------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         214 LNGKIEW---------------------PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             hcCCcCC---------------------CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            0000000                     011  156788999999999999999996555544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.6e-35  Score=277.13  Aligned_cols=251  Identities=22%  Similarity=0.254  Sum_probs=191.1

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-----ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-----RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      +|.+.+.||+|+||.||+++....  +..+++|+++...     .....++..|+.+++.++|||++++++++     ..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~   73 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKA--VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASF-----LE   73 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCC--CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHH-----hc
Confidence            478889999999999999985433  3335555544211     22334577899999999999999999985     34


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++|+||+++++|.+++.........+++..++.++.|++.||.|||   +.+++|+||+|+||+++. +.++|+||
T Consensus        74 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~  149 (260)
T cd08222          74 RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDF  149 (260)
T ss_pred             CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeeccc
Confidence            45789999999999999999765545567999999999999999999999   899999999999999975 56999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |.+.......       .......++..|+|||...+..++.++|+||||+++|+|++|..||....     ........
T Consensus       150 g~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-----~~~~~~~~  217 (260)
T cd08222         150 GVSRLLMGSC-------DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-----FLSVVLRI  217 (260)
T ss_pred             CceeecCCCc-------ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHH
Confidence            9987653221       11122457889999999888888999999999999999999999986421     11111110


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...     ..+.+                       +..++.++.+++.+||+.+|++||++.|+++
T Consensus       218 ~~~-----~~~~~-----------------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         218 VEG-----PTPSL-----------------------PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HcC-----CCCCC-----------------------cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            000     00000                       1233567899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3e-35  Score=282.09  Aligned_cols=248  Identities=25%  Similarity=0.340  Sum_probs=189.9

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .|+..+.||+|+||.||+|+..  .++..+|+|.+....   .....++.+|+++++.++|+|++++++++..     ..
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   88 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDV--RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH   88 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEc--CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CC
Confidence            3666789999999999999954  356789999886432   2233567889999999999999999998643     34


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+. |++.+++...   ...+++.++..++.|++.|+.|||   +.+++||||+|+||+++.++.++|+|||.
T Consensus        89 ~~~lv~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~  161 (308)
T cd06634          89 TAWLVMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGS  161 (308)
T ss_pred             eeEEEEEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCccc
Confidence            7899999995 6888877533   234889999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccC---CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM---GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      +......           ....++..|+|||.+.   ...++.++|||||||++|+|++|+.||....... ....+...
T Consensus       162 ~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~  229 (308)
T cd06634         162 ASIMAPA-----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN  229 (308)
T ss_pred             ceeecCc-----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhc
Confidence            8765321           1234788999999864   3567889999999999999999999986531110 00000000


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                      .         .+..                      ....+...+.+++.+||+.+|++||++.++++.-.
T Consensus       230 ~---------~~~~----------------------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~  269 (308)
T cd06634         230 E---------SPAL----------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  269 (308)
T ss_pred             C---------CCCc----------------------CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence            0         0000                      01123567889999999999999999999986643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-35  Score=287.23  Aligned_cols=286  Identities=19%  Similarity=0.226  Sum_probs=200.8

Q ss_pred             cHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeee
Q 011508          150 SYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSC  227 (484)
Q Consensus       150 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~  227 (484)
                      ...++...+++|.+.+.||+|+||.||+|..  ..++..||+|++.....  ...+.+.+|+.++++++|+||+++++++
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFD--TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEE--cCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            3456677889999999999999999999984  34578899999875322  2245678899999999999999999886


Q ss_pred             eeec-cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 011508          228 VSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE  306 (484)
Q Consensus       228 ~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~  306 (484)
                      .... +......+++++++ +++|.+++..     ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~  156 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNED  156 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCC
Confidence            5332 12233567888887 8899888762     24889999999999999999999   8999999999999999999


Q ss_pred             CceEEcccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCc
Q 011508          307 LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNL  385 (484)
Q Consensus       307 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~  385 (484)
                      +.+||+|||++......          .....++..|+|||...+ ..++.++|||||||++|||++|+.||...... .
T Consensus       157 ~~~kl~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~  225 (345)
T cd07877         157 CELKILDFGLARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-D  225 (345)
T ss_pred             CCEEEeccccccccccc----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H
Confidence            99999999998754221          122357889999998765 56888999999999999999999999643211 1


Q ss_pred             cHhHHHHhh--cchh-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          386 TLHNFVKEA--LPER-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       386 ~~~~~~~~~--~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .+.......  .+.. ...+.+... ...    ...........-..........+.+++.+|++.||.+||++.++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         226 QLKLILRLVGTPGAELLKKISSESA-RNY----IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHHHhCCCCHHHHhhcccHhH-HHH----HHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            111111110  0011 111110000 000    00000000000000000124568899999999999999999999865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.3e-35  Score=280.84  Aligned_cols=255  Identities=25%  Similarity=0.363  Sum_probs=197.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  234 (484)
                      ++|.+.+.||+|++|.||+|+..  .++..||+|++....   ....+.+.+|.+++++++ |+||+++++++     .+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~   73 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEK--ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QD   73 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEc--CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cC
Confidence            46888999999999999999854  357889999987532   223456888999999998 99999999884     45


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ++..++||||+++++|.+++...    ..+++..++.++.|++.||+|||   +.+++|+||+|+||+++.++.++|+||
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df  146 (280)
T cd05581          74 EENLYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDF  146 (280)
T ss_pred             CceEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCC
Confidence            56889999999999999999743    25899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCC-------------CCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCc
Q 011508          315 GLAKFLPEAANNLS-------------SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMF  381 (484)
Q Consensus       315 g~a~~~~~~~~~~~-------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~  381 (484)
                      |++...........             ..........++..|+|||......++.++||||||++++++++|+.||....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence            99886643321100             00122233457889999999888889999999999999999999999997532


Q ss_pred             cCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH----H
Q 011508          382 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM----E  457 (484)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~----~  457 (484)
                      ..     ...        ..+.+.....                     +...+..+.+++.+||+.+|++||++    +
T Consensus       227 ~~-----~~~--------~~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  272 (280)
T cd05581         227 EY-----LTF--------QKILKLEYSF---------------------PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYD  272 (280)
T ss_pred             HH-----HHH--------HHHHhcCCCC---------------------CCccCHHHHHHHHHHhcCCHhhCCCcccCHH
Confidence            10     000        0010000000                     11124568899999999999999999    6


Q ss_pred             HHHH
Q 011508          458 EVAA  461 (484)
Q Consensus       458 evl~  461 (484)
                      |+++
T Consensus       273 ~ll~  276 (280)
T cd05581         273 ELKA  276 (280)
T ss_pred             HHhc
Confidence            6654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-35  Score=288.15  Aligned_cols=282  Identities=19%  Similarity=0.215  Sum_probs=196.8

Q ss_pred             HHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeec
Q 011508          154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVD  231 (484)
Q Consensus       154 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  231 (484)
                      +....++|++.+.||+|+||.||+|..  ..++..||+|++.....  .....+.+|+.++++++|+||+++++++....
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALD--RRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEE--CCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            344567899999999999999999984  44578899999864322  22356789999999999999999999864322


Q ss_pred             c-CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 011508          232 F-QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH  310 (484)
Q Consensus       232 ~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k  310 (484)
                      . ......++||||+ +++|.+++..     ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.++
T Consensus        88 ~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~k  158 (343)
T cd07880          88 SLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELK  158 (343)
T ss_pred             cccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence            1 1113468999999 7899988862     34889999999999999999999   89999999999999999999999


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhH
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHN  389 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~  389 (484)
                      |+|||.+......          .....++..|+|||.+.+ ..++.++||||+|+++|++++|+.||....... ...+
T Consensus       159 l~dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~  227 (343)
T cd07880         159 ILDFGLARQTDSE----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLME  227 (343)
T ss_pred             EeecccccccccC----------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH
Confidence            9999998755321          112356889999998765 458899999999999999999999997532110 1111


Q ss_pred             HHHhh--cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          390 FVKEA--LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       390 ~~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .....  .+....+.+...-......    .........-......+...+.+++.+|++.||++|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         228 IMKVTGTPSKEFVQKLQSEDAKNYVK----KLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHhcCCCCHHHHHhhcchhHHHHHH----hccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11100  0001111110000000000    00000000000001233557889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.7e-35  Score=285.13  Aligned_cols=280  Identities=21%  Similarity=0.259  Sum_probs=192.8

Q ss_pred             cCCCC-ccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc--------------hHHHHHHHHHHHcCCCCCcee
Q 011508          158 TDGFS-LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA--------------SKSFIAECQALRSIRHRNLVK  222 (484)
Q Consensus       158 ~~~~~-~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~  222 (484)
                      .++|. +.+.||+|+||.||+|..  ...++.||+|.++......              ...+.+|+++++.++|+||++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   84 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYD--TLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG   84 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEE--CCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence            35565 457799999999999984  3457889999986543211              124778999999999999999


Q ss_pred             EeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 011508          223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVL  302 (484)
Q Consensus       223 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIl  302 (484)
                      +++++.     .+...++||||+. |+|.+++...    ..+++.....++.|++.||+|||   +.+++|+||+|+||+
T Consensus        85 ~~~~~~-----~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nil  151 (335)
T PTZ00024         85 LVDVYV-----EGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIF  151 (335)
T ss_pred             eeEEEe-----cCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeE
Confidence            999854     3458899999995 6999988632    34889999999999999999999   899999999999999


Q ss_pred             ecCCCceEEcccCcccccccccccC------C-CCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCC
Q 011508          303 LDGELTAHVSDFGLAKFLPEAANNL------S-SNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGK  374 (484)
Q Consensus       303 l~~~~~~kl~Dfg~a~~~~~~~~~~------~-~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~  374 (484)
                      ++.++.++|+|||.+..........      . ..........++..|+|||.+.+. .++.++|||||||++|||++|+
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~  231 (335)
T PTZ00024        152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK  231 (335)
T ss_pred             ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999999987654111000      0 001111223467889999988764 4689999999999999999999


Q ss_pred             CCCCCCccCCccHhHHHHhhcchh----hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCc
Q 011508          375 GPTNEMFTGNLTLHNFVKEALPER----LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELP  450 (484)
Q Consensus       375 ~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  450 (484)
                      .||....... .+. .+.......    .....+-..........  .     .... .....+...+.+++..|++.+|
T Consensus       232 ~p~~~~~~~~-~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-----~~~~-~~~~~~~~~~~~li~~~l~~~P  301 (335)
T PTZ00024        232 PLFPGENEID-QLG-RIFELLGTPNEDNWPQAKKLPLYTEFTPRK--P-----KDLK-TIFPNASDDAIDLLQSLLKLNP  301 (335)
T ss_pred             CCCCCCCHHH-HHH-HHHHHhCCCchhhCcchhhcccccccCcCC--c-----ccHH-HhCcCCChHHHHHHHHHcCCCc
Confidence            9997542211 111 111100000    00000000000000000  0     0000 0011225678899999999999


Q ss_pred             CCCCCHHHHHHH
Q 011508          451 RERMNMEEVAAQ  462 (484)
Q Consensus       451 ~~RPt~~evl~~  462 (484)
                      ++|||++|++..
T Consensus       302 ~~R~s~~~~l~~  313 (335)
T PTZ00024        302 LERISAKEALKH  313 (335)
T ss_pred             hhccCHHHHhcC
Confidence            999999999863

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1e-34  Score=276.29  Aligned_cols=255  Identities=24%  Similarity=0.318  Sum_probs=192.2

Q ss_pred             CCCccCccccccceeEEEEEEcC-CCCeeEEEEEEeeccC----ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDH-DDHETLVAVKVLNLQH----RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  233 (484)
                      +|++.+.||+|+||.||+|+... ..++..||+|+++...    ....+.+.+|++++.++ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            47888999999999999998532 2357889999987532    12335678899999999 699999998874     4


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .+...++||||+++++|.+++...    ..+++..+..++.|++.||+|||   +.+++||||+|+||+++.++.+||+|
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d  148 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTD  148 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEee
Confidence            455789999999999999999743    34788999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCC--CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS--EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      ||++.......      ........|+..|+|||.+...  .++.++||||||+++|+|++|+.||..... ......+.
T Consensus       149 fg~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~  221 (290)
T cd05613         149 FGLSKEFHEDE------VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEIS  221 (290)
T ss_pred             Cccceeccccc------ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHH
Confidence            99987653321      1111234588899999987653  467899999999999999999999864211 11111111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQ  462 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  462 (484)
                      ......      .+..                       +..+...+.+++.+|++.||++||     +++++++.
T Consensus       222 ~~~~~~------~~~~-----------------------~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         222 RRILKS------EPPY-----------------------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             HHhhcc------CCCC-----------------------CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            110000      0000                       111245688999999999999997     67777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-35  Score=275.49  Aligned_cols=271  Identities=23%  Similarity=0.261  Sum_probs=194.5

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      |+..+.||+|++|.||+|+..  .+++.+|+|++....  ....+.+.+|+.++++++|+|++++++++.     .....
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~   73 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDK--KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKL   73 (282)
T ss_pred             CeeehcccccCcceEEEeeec--CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCce
Confidence            566788999999999999944  457889999987653  333467889999999999999999999854     34588


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++|+||++ ++|.+++....   ..+++..++.++.|++.||+|||   +.+|+||||+|+||++++++.++|+|||.+.
T Consensus        74 ~~v~e~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~  146 (282)
T cd07829          74 YLVFEYCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLAR  146 (282)
T ss_pred             EEEecCcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCccc
Confidence            99999996 69999997542   35899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh---
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA---  394 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~---  394 (484)
                      .......       ......++..|+|||.+.+. .++.++|||||||++||+++|+.||...... ..+.......   
T Consensus       147 ~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~  218 (282)
T cd07829         147 AFGIPLR-------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTP  218 (282)
T ss_pred             ccCCCcc-------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCC
Confidence            6533221       11123456789999988766 7899999999999999999999998653211 0111111000   


Q ss_pred             cchhhhhhcCcc-cccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 LPERLAEIVDPV-LLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .+.....+.+-. .........        ..............+.+++.+||+.||++||++.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         219 TEESWPGVTKLPDYKPTFPKFP--------PKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cHHHHHhhcccccccccccccC--------ccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000011110000 000000000        00000000111557899999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-36  Score=279.13  Aligned_cols=249  Identities=29%  Similarity=0.350  Sum_probs=197.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      +.|+.-++||+|+||.||-+..++  +|+.+|.|.+.+..   +.......+|-.+|.+++.+.||.+-..     ++..
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvra--TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTk  257 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRA--TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETK  257 (591)
T ss_pred             cceeeeEEEecccccceeEEEEec--chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCC
Confidence            567888999999999999998554  68899999886432   2334567889999999999999887655     5667


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++|+..|.||+|.-+|....  ...+++..+..++.+|+.||++||   ..+||.|||||+|||+|+.|+++|+|+|
T Consensus       258 d~LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  258 DALCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             CceEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccc
Confidence            79999999999999988887543  356999999999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +|..+++..        .....+||.+|||||++.+..|+...|.||+||++|||+.|+.||.......           
T Consensus       333 LAvei~~g~--------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv-----------  393 (591)
T KOG0986|consen  333 LAVEIPEGK--------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV-----------  393 (591)
T ss_pred             eEEecCCCC--------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh-----------
Confidence            999775432        2223479999999999999999999999999999999999999996531110           


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                         -.+-+|++...+.++                -++..+.+..++....|+.||.+|-.-.
T Consensus       394 ---k~eEvdrr~~~~~~e----------------y~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  394 ---KREEVDRRTLEDPEE----------------YSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ---hHHHHHHHHhcchhh----------------cccccCHHHHHHHHHHHccCHHHhccCC
Confidence               011222222221111                0233356778888889999999996443

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-36  Score=275.49  Aligned_cols=264  Identities=23%  Similarity=0.360  Sum_probs=203.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--c-----chHHHHHHHHHHHcCCCCCceeEeeeeeeec
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--G-----ASKSFIAECQALRSIRHRNLVKIITSCVSVD  231 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  231 (484)
                      ++|-+.++||+|||+.||+|.  +-...+.||+|+-.....  +     -.+...+|.++-+.|+||.||++|+++.   
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAF--Dl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs---  537 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAF--DLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS---  537 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhc--ccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee---
Confidence            467888999999999999998  555678999998654321  1     1245678999999999999999999973   


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCc
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELT  308 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~  308 (484)
                       -+.+..|-|+|||+|.+|+-||+.++    .+++.++..|+.||+.||.||.+. +.+|+|-||||.|||+..   .|.
T Consensus       538 -lDtdsFCTVLEYceGNDLDFYLKQhk----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  538 -LDTDSFCTVLEYCEGNDLDFYLKQHK----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             -eccccceeeeeecCCCchhHHHHhhh----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccce
Confidence             34557899999999999999998544    489999999999999999999977 889999999999999943   478


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCC----CCCCcccceehhhHHHHHHHhCCCCCCCCccCC
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG----SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN  384 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~  384 (484)
                      +||.|||++++++.+...............||++|++||++.-    .+.+.|.||||+||++|..+.|+.||...... 
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ-  690 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ-  690 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH-
Confidence            9999999999998776655555556667789999999997653    35788999999999999999999999753211 


Q ss_pred             ccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          385 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                         .+.....      .++...-...+                  .-+....+...+|++||+..-++|....|+..
T Consensus       691 ---QdILqeN------TIlkAtEVqFP------------------~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  691 ---QDILQEN------TILKATEVQFP------------------PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             ---HHHHhhh------chhcceeccCC------------------CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence               1111110      01110000000                  01112556788999999999999988888764

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-36  Score=267.10  Aligned_cols=202  Identities=28%  Similarity=0.369  Sum_probs=174.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|...++||+|.||+|-+++  .+.+++.+|+|++++.-   ......-..|-++|+..+||.+..+-..     |+.
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~r--EKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt  239 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCR--EKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQT  239 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEe--ecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hcc
Confidence            4678899999999999999998  66688999999998653   2334556789999999999998877655     677


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ++..|.||||..||.|.-+|..    .+.+++.....+-..|..||.|||   +++||.||||.+|.++|.+|++||+||
T Consensus       240 ~drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDF  312 (516)
T KOG0690|consen  240 QDRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDF  312 (516)
T ss_pred             CceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeec
Confidence            7899999999999999888864    345888888888999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      |+++.--       ........++||+.|.|||++....|+.+.|.|.+|||+|||++|+.||...
T Consensus       313 GLCKE~I-------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  313 GLCKEEI-------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             ccchhcc-------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence            9998532       2234455689999999999999999999999999999999999999999753

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-35  Score=288.18  Aligned_cols=282  Identities=20%  Similarity=0.242  Sum_probs=195.9

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDF-  232 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-  232 (484)
                      ...++|++.+.||+|++|.||+|+..  .++..||+|++....  ....+.+.+|+.++++++|+|++++++++...+. 
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDT--KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL   89 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEEC--CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence            45678999999999999999999954  356789999886432  2233567789999999999999999887543221 


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                      ......++|+||+ +++|.+++..     ..+++..++.++.|++.||+|||   +.+|+||||||+||++++++.++|+
T Consensus        90 ~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~  160 (343)
T cd07851          90 EDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKIL  160 (343)
T ss_pred             cccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEc
Confidence            2223479999999 7799998863     35899999999999999999999   8999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      |||++......          .....++..|+|||.+.+ ..++.++|||||||++||+++|+.||...... ..+....
T Consensus       161 dfg~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~-~~~~~i~  229 (343)
T cd07851         161 DFGLARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI-DQLKRIM  229 (343)
T ss_pred             ccccccccccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence            99998765321          122357888999998755 46789999999999999999999999653211 0011110


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhh-ccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHK-QRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                       .........+..... .+............. .... .........+.+++.+|++.||++|||+.||++.
T Consensus       230 -~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         230 -NLVGTPDEELLQKIS-SESARNYIQSLPQMPKKDFK-EVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             -HhcCCCCHHHHhhcc-chhHHHHHHhccccCCCCHH-HHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence             000000000000000 000000000000000 0000 0001125678999999999999999999999763

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=267.94  Aligned_cols=277  Identities=24%  Similarity=0.377  Sum_probs=218.1

Q ss_pred             HHhHHHhcCCCCccCccccccceeEEEEEEcCCCC---eeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeee
Q 011508          151 YQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDH---ETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITS  226 (484)
Q Consensus       151 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~  226 (484)
                      .+++.....++++..++-+|.||.||.|.|++.++   .+.|-+|.++.... -....+..|--.+..+.|||+.++.+.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            44555666788889999999999999998875433   23466676654332 233567888889999999999999999


Q ss_pred             eeeeccCCCceeeEEeecccCCCHHHHHhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 011508          227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNR----DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVL  302 (484)
Q Consensus       227 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIl  302 (484)
                      +.+    +....+.++.++.-|+|..|+...+    ...+.++..+...++.|++.|++|||   ++++||.||..+|.+
T Consensus       356 ~ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCv  428 (563)
T KOG1024|consen  356 SIE----DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCV  428 (563)
T ss_pred             Eee----ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcce
Confidence            854    4457789999999999999998433    23456888889999999999999999   999999999999999


Q ss_pred             ecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCc
Q 011508          303 LDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMF  381 (484)
Q Consensus       303 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~  381 (484)
                      +|+..++||+|=.+++.+-+.+...-++.     ...+..||+||.+....|+.++|||||||+||||+| |+.|+.+..
T Consensus       429 Idd~LqVkltDsaLSRDLFP~DYhcLGDn-----EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID  503 (563)
T KOG1024|consen  429 IDDQLQVKLTDSALSRDLFPGDYHCLGDN-----ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID  503 (563)
T ss_pred             ehhheeEEeccchhccccCcccccccCCC-----CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence            99999999999999987755443322221     235788999999999999999999999999999999 999986532


Q ss_pred             cCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          382 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      +.  ....+..           |                    ..+-..+..|+++|..++.-||+.+|++||+.+|+..
T Consensus       504 Pf--Em~~ylk-----------d--------------------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  504 PF--EMEHYLK-----------D--------------------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             HH--HHHHHHh-----------c--------------------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            11  1111111           1                    1111226789999999999999999999999999999


Q ss_pred             HHHHHHHHHhh
Q 011508          462 QLLSFRNKLVK  472 (484)
Q Consensus       462 ~L~~i~~~~~~  472 (484)
                      -|.++-.++.+
T Consensus       551 cLseF~~qlt~  561 (563)
T KOG1024|consen  551 CLSEFHTQLTR  561 (563)
T ss_pred             HHHHHHHHHhh
Confidence            99999877653

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=268.92  Aligned_cols=276  Identities=23%  Similarity=0.312  Sum_probs=199.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-C-CC----ceeEeeeeeeec
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-H-RN----LVKIITSCVSVD  231 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~n----iv~~~~~~~~~~  231 (484)
                      +.+|.+...+|+|.||.|-.+...  ..+..||||+++.... -.+...-|+++|.++. + |+    ++.+.++     
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~--~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----  159 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDR--ETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDW-----  159 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeec--CCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----
Confidence            688999999999999999999843  3478999999975532 2345677999999993 2 22    6667676     


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC------
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG------  305 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~------  305 (484)
                      |+..++.+||+|.+ |.|+.+++..+.  -.+++...+..++.|++++++|||   +.+++|-||||+|||+.+      
T Consensus       160 FdyrghiCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~  233 (415)
T KOG0671|consen  160 FDYRGHICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKT  233 (415)
T ss_pred             hhccCceEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEE
Confidence            56667999999999 889999998544  345888999999999999999999   999999999999999931      


Q ss_pred             --------------CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHH
Q 011508          306 --------------ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMF  371 (484)
Q Consensus       306 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ell  371 (484)
                                    +..++++|||.|+.-.+..          ...+.|..|+|||++.+-.++.++||||+||||+|+.
T Consensus       234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely  303 (415)
T KOG0671|consen  234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY  303 (415)
T ss_pred             eccCCccceeccCCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence                          3468999999998754332          3456899999999999999999999999999999999


Q ss_pred             hCCCCCCCCccCC-ccHhHHHHhhcchh-hhhh-----cCc-ccccccccccc--------hhhhhhhccccccchhHHH
Q 011508          372 TGKGPTNEMFTGN-LTLHNFVKEALPER-LAEI-----VDP-VLLVEREEGET--------SEANAHKQRTRSFGGKECL  435 (484)
Q Consensus       372 tg~~p~~~~~~~~-~~~~~~~~~~~~~~-~~~~-----~d~-~l~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~  435 (484)
                      ||...|....+.+ ..+.+.+-+.+|.. +...     ... .+.. ++....        ...+.....   .......
T Consensus       304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw-~e~~~~~~~k~v~~~ckpl~~~~---~~~d~e~  379 (415)
T KOG0671|consen  304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDW-PEVSSKGKSKYVFEPCKPLKKYM---LQDDLEH  379 (415)
T ss_pred             ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccC-ccccccccchhhhcCCccHHHHh---ccCcHHH
Confidence            9999987643221 11222222333332 1111     000 0000 000000        000000011   0123336


Q ss_pred             HHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          436 VSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       436 ~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .+|.+|+..||..||.+|+|+.|++.
T Consensus       380 ~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  380 VQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             hHHHHHHHHHHccCccccccHHHHhc
Confidence            78999999999999999999999875

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-34  Score=268.25  Aligned_cols=237  Identities=30%  Similarity=0.336  Sum_probs=187.5

Q ss_pred             cccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       167 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      ||+|+||.||++...  .+++.+|+|++......   ....+..|+.++++++|+|++++++.+     ..+...++|||
T Consensus         1 lg~G~~~~v~~~~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e   73 (250)
T cd05123           1 LGKGSFGKVLLVRKK--DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLE   73 (250)
T ss_pred             CCCCCceEEEEEEEC--CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEe
Confidence            699999999999854  35678999998754322   345788999999999999999999874     45668899999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccc
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA  323 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  323 (484)
                      |+++++|.+++....    .+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        74 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  146 (250)
T cd05123          74 YAPGGELFSHLSKEG----RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE  146 (250)
T ss_pred             cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence            999999999997432    4899999999999999999999   899999999999999999999999999998765332


Q ss_pred             cccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhc
Q 011508          324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIV  403 (484)
Q Consensus       324 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (484)
                      .       .......++..|+|||...+...+.++|+||||+++|++++|+.||.....     ......        +.
T Consensus       147 ~-------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~--------~~  206 (250)
T cd05123         147 G-------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEK--------IL  206 (250)
T ss_pred             C-------CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHH--------Hh
Confidence            1       112234578899999999888889999999999999999999999965321     111111        11


Q ss_pred             CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHH
Q 011508          404 DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEE  458 (484)
Q Consensus       404 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  458 (484)
                      ...+..                     +...+..+.+++.+||..||++||++.+
T Consensus       207 ~~~~~~---------------------~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         207 KDPLRF---------------------PEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             cCCCCC---------------------CCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            100000                     1111456889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-37  Score=264.94  Aligned_cols=253  Identities=28%  Similarity=0.319  Sum_probs=188.6

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCceeeEE
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDFEALV  241 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  241 (484)
                      ...||.|+||+|++-.  ++.+++..|||+++.... ...+++..|.+...+- +.||||+++|.++..+     ..|+.
T Consensus        69 lg~iG~G~fG~V~KM~--hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG-----dcWiC  141 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKML--HKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-----DCWIC  141 (361)
T ss_pred             HHHhcCCcchhhhhhh--cCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-----ceeee
Confidence            4679999999999987  677899999999986654 4456788888765544 8999999999974433     56999


Q ss_pred             eecccCCCHHHHHhh-cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          242 YELMVNGSLEEWLHL-NRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       242 ~e~~~~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||.| ..||+.+.+. +.-....+++...-.|......||.||-.  ...|+|||+||+|||++..|.+||||||.+..+
T Consensus       142 MELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  142 MELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            9999 6677765432 11223458888888889999999999987  689999999999999999999999999999876


Q ss_pred             ccccccCCCCccccccccccccccCccccCCC--CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS--EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      ..+.        ....-.|-..|||||.+...  .|+.+|||||+|++|+|+.||+.|+.....--..+.+.+       
T Consensus       219 v~Si--------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv-------  283 (361)
T KOG1006|consen  219 VDSI--------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVV-------  283 (361)
T ss_pred             HHHH--------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHH-------
Confidence            4332        11223588899999987653  488899999999999999999999875321101111111       


Q ss_pred             hhhhcCcc-cccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          399 LAEIVDPV-LLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       399 ~~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                         .-|+- +..+.+                  ..+....+.+++..|+..|-..||...++.++
T Consensus       284 ---~gdpp~l~~~~~------------------~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  284 ---IGDPPILLFDKE------------------CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ---cCCCCeecCccc------------------ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence               11111 111110                  11225678999999999999999999988653

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=287.42  Aligned_cols=265  Identities=23%  Similarity=0.287  Sum_probs=214.7

Q ss_pred             HHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeee
Q 011508          151 YQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVS  229 (484)
Q Consensus       151 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  229 (484)
                      ++.+-..++-|++.+.||.|.+|.||+++.  ..+++..|+|++..... ..++...|.++|+.+ .|||++.++|++..
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~--~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRH--VKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEee--eecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            344445677899999999999999999994  44677888888876544 346777889999888 79999999999998


Q ss_pred             eccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 011508          230 VDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA  309 (484)
Q Consensus       230 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~  309 (484)
                      .+...++.+|+|||||.+||.-++++...  +..+.|..+..|++.++.|+.+||   .+.++|||||-.|||++.++.+
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~V  162 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEV  162 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcE
Confidence            88888899999999999999999998655  567999999999999999999999   9999999999999999999999


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCCC-----CCCcccceehhhHHHHHHHhCCCCCCCCccCC
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-----EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN  384 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~  384 (484)
                      ||+|||.+..++..       ........||+.|||||++...     .|+.++|+||+|++..||.-|.+|+.++....
T Consensus       163 KLvDFGvSaQldsT-------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr  235 (953)
T KOG0587|consen  163 KLVDFGVSAQLDST-------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR  235 (953)
T ss_pred             EEeeeeeeeeeecc-------cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence            99999999876432       3334456799999999987653     47789999999999999999999987653211


Q ss_pred             ccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          385 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .        .+.  +..-                     +..+...+.....++.++|..||..|-.+||++.++++
T Consensus       236 a--------LF~--IpRN---------------------PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  236 A--------LFL--IPRN---------------------PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             h--------hcc--CCCC---------------------CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            0        000  0000                     11111124444788999999999999999999999874

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-35  Score=282.01  Aligned_cols=242  Identities=25%  Similarity=0.302  Sum_probs=191.0

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++.|.+...+|.|+|+.|-.+.  +..+....++|++....    .+..+|+.++... +||||+++.+.     +.++
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~--~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v-----~~~~  388 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCE--SSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDV-----YEDG  388 (612)
T ss_pred             cchhhccccccCCCCccceeeee--ccccccchhheeccccc----cccccccchhhhhcCCCcceeecce-----ecCC
Confidence            36778888999999999999988  55567789999997652    2334577666655 89999999998     4566


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee-cCCCceEEccc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL-DGELTAHVSDF  314 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll-~~~~~~kl~Df  314 (484)
                      .+.++|||.+.++-+.+.+....     ....++..|+.+|+.|+.|||   .++++||||||+|||+ ++.++++|+||
T Consensus       389 ~~~~~v~e~l~g~ell~ri~~~~-----~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyF  460 (612)
T KOG0603|consen  389 KEIYLVMELLDGGELLRRIRSKP-----EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYF  460 (612)
T ss_pred             ceeeeeehhccccHHHHHHHhcc-----hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEe
Confidence            69999999999998877776332     222667789999999999999   8999999999999999 58899999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |.++.....          ....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+ ..+...+   
T Consensus       461 G~a~~~~~~----------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i---  526 (612)
T KOG0603|consen  461 GFWSELERS----------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRI---  526 (612)
T ss_pred             chhhhCchh----------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhh---
Confidence            999876433          22345788999999999999999999999999999999999999764333 1111111   


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                              ..+..                       .+..+....+|+..||+.||.+||+|.|+...
T Consensus       527 --------~~~~~-----------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  527 --------QMPKF-----------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             --------cCCcc-----------------------ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence                    11100                       01225677899999999999999999998764

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-35  Score=299.51  Aligned_cols=208  Identities=28%  Similarity=0.374  Sum_probs=178.9

Q ss_pred             HhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeec---cCccchHHHHHHHHHHHcCCCCCceeEeeeee
Q 011508          152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNL---QHRGASKSFIAECQALRSIRHRNLVKIITSCV  228 (484)
Q Consensus       152 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  228 (484)
                      .++....++|.+.++||+|+||.|..++  ...+++.||+|++++   -.+.....|..|-.+|..-+.+=|+.+...  
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr--~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA--  143 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVR--HKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA--  143 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEE--eeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH--
Confidence            4445556789999999999999999998  455789999999976   335556778999999998888888887765  


Q ss_pred             eeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 011508          229 SVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT  308 (484)
Q Consensus       229 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~  308 (484)
                         |+++.+.|+|||||+||+|..++....    ++++..+..++..|.-||.-||   +.|+|||||||+|||+|..|+
T Consensus       144 ---FQD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GH  213 (1317)
T KOG0612|consen  144 ---FQDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGH  213 (1317)
T ss_pred             ---hcCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCc
Confidence               788899999999999999999997543    5888999999999999999999   899999999999999999999


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccC----C-CCCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM----G-SEVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      +||+|||.+-.+..++      .-.+...+|||.|.+||++.    + +.|++.+|.||+||++|||+.|..||..
T Consensus       214 ikLADFGsClkm~~dG------~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  214 IKLADFGSCLKMDADG------TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             EeeccchhHHhcCCCC------cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence            9999999998775443      22334567999999999865    2 6799999999999999999999999965

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.4e-34  Score=299.99  Aligned_cols=147  Identities=31%  Similarity=0.454  Sum_probs=127.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|.+.+.||+|+||.||+|...  .+++.||+|+++....   .....+..|+.++..++|+||+++++++.     ..
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~--~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~   76 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKK--NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SA   76 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEEC--CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----EC
Confidence            57899999999999999999954  4578899999875432   22357888999999999999999998753     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+.+++|.+++...    ..+++..++.++.||+.||+|||   .++|+||||||+|||++.++.+||+|||
T Consensus        77 ~~~~lVmEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFG  149 (669)
T cd05610          77 NNVYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFG  149 (669)
T ss_pred             CEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCC
Confidence            5889999999999999999743    24788999999999999999999   8899999999999999999999999999


Q ss_pred             cccc
Q 011508          316 LAKF  319 (484)
Q Consensus       316 ~a~~  319 (484)
                      +++.
T Consensus       150 ls~~  153 (669)
T cd05610         150 LSKV  153 (669)
T ss_pred             CCcc
Confidence            9863

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=276.51  Aligned_cols=246  Identities=26%  Similarity=0.380  Sum_probs=194.2

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEE
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALV  241 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  241 (484)
                      .+.||+|.||+||-|+  +..+|+.||||++.+..  .....++.+|+.+|+++.||.||.+..-     ++..+..++|
T Consensus       569 devLGSGQFG~VYgg~--hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M-----~ET~ervFVV  641 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGK--HRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECM-----FETPERVFVV  641 (888)
T ss_pred             HhhccCCcceeeecce--ecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEe-----ecCCceEEEE
Confidence            3689999999999999  55578999999997644  2344789999999999999999998876     4556699999


Q ss_pred             eecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC---CceEEcccCccc
Q 011508          242 YELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAK  318 (484)
Q Consensus       242 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfg~a~  318 (484)
                      ||.+ .|+..+.+-.  .+..++++..-..++.||+.||.|||   .++|+|+||||+|||+...   .++||||||+|+
T Consensus       642 MEKl-~GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  642 MEKL-HGDMLEMILS--SEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             ehhh-cchHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeecccccee
Confidence            9999 5666665542  23456888888889999999999999   8999999999999999643   389999999999


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      ++.+.        ......+||+.|.|||++....|...-|+||.||++|--++|..||.+.    .++.+.++.+    
T Consensus       716 iIgEk--------sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIndQIQNA----  779 (888)
T KOG4236|consen  716 IIGEK--------SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDINDQIQNA----  779 (888)
T ss_pred             ecchh--------hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhHHhhcc----
Confidence            88543        3334568999999999999999999999999999999999999999652    2222222211    


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                             .+..              +.   ..+.+...+.+++|...|+..-.+|-|.++-+..
T Consensus       780 -------aFMy--------------Pp---~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  780 -------AFMY--------------PP---NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             -------cccc--------------CC---CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence                   1111              00   0134446677889999999999999998876643

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.2e-34  Score=263.53  Aligned_cols=222  Identities=21%  Similarity=0.177  Sum_probs=172.5

Q ss_pred             ccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEeecccCCC
Q 011508          170 GSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGS  249 (484)
Q Consensus       170 G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gs  249 (484)
                      |.+|.||+++  +..+++.+|+|.+....     .+.+|...+....|||++++++++     ...+..++||||+++|+
T Consensus         4 g~~~~v~~~~--~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~   71 (237)
T cd05576           4 GVIDKVLLVM--DTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGK   71 (237)
T ss_pred             cccceEEEEE--EccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCC
Confidence            8899999998  44567889999986542     233455555666799999999984     34558899999999999


Q ss_pred             HHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccccccCCC
Q 011508          250 LEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSS  329 (484)
Q Consensus       250 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  329 (484)
                      |.+++...    ..+++..+..++.|++.||+|||   +++++||||||+||+++.++.++++|||.+.......     
T Consensus        72 L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----  139 (237)
T cd05576          72 LWSHISKF----LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----  139 (237)
T ss_pred             HHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----
Confidence            99998743    24899999999999999999999   8999999999999999999999999999876543211     


Q ss_pred             CccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCccccc
Q 011508          330 NQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLV  409 (484)
Q Consensus       330 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  409 (484)
                           ....++..|+|||...+..++.++||||+|+++|||++|+.|+......               ........+  
T Consensus       140 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~~~~~~~~~--  197 (237)
T cd05576         140 -----DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------INTHTTLNI--  197 (237)
T ss_pred             -----ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------cccccccCC--
Confidence                 1123567799999998888999999999999999999999886432110               000000000  


Q ss_pred             ccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHH
Q 011508          410 EREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEE  458 (484)
Q Consensus       410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  458 (484)
                                           +..+...+.+++.+|++.||++||++.+
T Consensus       198 ---------------------~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         198 ---------------------PEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             ---------------------cccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence                                 1112456889999999999999999743

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-34  Score=232.84  Aligned_cols=200  Identities=25%  Similarity=0.403  Sum_probs=168.1

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +|.-.++||+|.||+||+|+  +..+.+.||+|.++.+.  .+......+|+-+|+.++|.|||++++.     ...+..
T Consensus         3 ~ydkmekigegtygtvfkar--n~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dv-----lhsdkk   75 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKAR--NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV-----LHSDKK   75 (292)
T ss_pred             chHHHHhhcCCcceeeEecc--cCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhh-----hccCce
Confidence            45566899999999999998  55678899999987654  3445678999999999999999999998     445567


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      ..+|+||| ..+|..+....   ...++...+..++.|+++||.+.|   ++++.||||||.|.++..+|+.|++|||++
T Consensus        76 ltlvfe~c-dqdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfgla  148 (292)
T KOG0662|consen   76 LTLVFEFC-DQDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLA  148 (292)
T ss_pred             eEEeHHHh-hHHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchh
Confidence            89999999 56888888743   345889999999999999999999   999999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHh-CCCCCCCC
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFT-GKGPTNEM  380 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~ellt-g~~p~~~~  380 (484)
                      +.+.-.       .......+-|..|++|.++.+. -|+...|+||-||++.|+.. |++.|.+.
T Consensus       149 rafgip-------vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~  206 (292)
T KOG0662|consen  149 RAFGIP-------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_pred             hhcCCc-------eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence            876322       2233344679999999998875 58999999999999999988 77667653

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-36  Score=255.92  Aligned_cols=283  Identities=20%  Similarity=0.277  Sum_probs=200.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeec--cCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC---
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ---  233 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---  233 (484)
                      ..|.-..+||+|.||.||+|+  .+.+++.||+|++-.  ...+......+|+++|..++|+|++.++..|....-.   
T Consensus        17 ~~yek~~kigqGtfgeVFkAr--~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKAR--SKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHh--hcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            345666889999999999998  555677899886533  3345556788999999999999999999988664322   


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||.+|+ -+|..++..   ...+++..++.++..++..||.|+|   ...|+|||+|+.|+|++.++.+||+|
T Consensus        95 ~r~t~ylVf~~ce-hDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   95 DRATFYLVFDFCE-HDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             ccceeeeeHHHhh-hhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeec
Confidence            2234789999994 588888862   3356899999999999999999999   99999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||+++.+....+...   +.....+-|..|++||.+.+ ..|+++.|||.-||++.||+||.+-+.+...  ......+.
T Consensus       168 FGlar~fs~~~n~~k---prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte--qqql~~Is  242 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVK---PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE--QQQLHLIS  242 (376)
T ss_pred             cccccceecccccCC---CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH--HHHHHHHH
Confidence            999987755443221   22345567999999998766 6799999999999999999999988765322  11112222


Q ss_pred             hhc----chhhhhhcCcccccccccccchhhh------hhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EAL----PERLAEIVDPVLLVEREEGETSEAN------AHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~----~~~~~~~~d~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ...    ++-+..+..-.+....+..+.....      ..++..+       .++..+|+..++..||.+|+++.+++..
T Consensus       243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~k-------d~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVK-------DDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccC-------ChhHHHHHHHHhccCcccCcchHhhhch
Confidence            111    1111111111111100000000000      0011111       3467889999999999999999999854

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=263.94  Aligned_cols=202  Identities=28%  Similarity=0.357  Sum_probs=170.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  233 (484)
                      ..+|....+||+|+||.|-+|.  .+++...+|||+++++-   ..+.+--+.|-++|..- +-|.++++..+     ++
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLae--rkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-----FQ  420 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAE--RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-----FQ  420 (683)
T ss_pred             ecccceEEEeccCccceeeeec--ccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-----hh
Confidence            3468899999999999999998  56678899999998643   23334455677777766 56778888776     55


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .-+..|.||||+.||+|--.+++..    .+.+..+.-++..|+-||-+||   +++|+.||||.+||++|.+|++||+|
T Consensus       421 TmDRLyFVMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~D  493 (683)
T KOG0696|consen  421 TMDRLYFVMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIAD  493 (683)
T ss_pred             hhhheeeEEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeee
Confidence            5569999999999999998887544    3677788889999999999999   99999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ||+++.--       .........+||+.|+|||++...+|+...|.|||||+||||+.|++||++.
T Consensus       494 FGmcKEni-------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe  553 (683)
T KOG0696|consen  494 FGMCKENI-------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE  553 (683)
T ss_pred             cccccccc-------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence            99997431       2234455689999999999999999999999999999999999999999874

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.8e-33  Score=285.89  Aligned_cols=274  Identities=20%  Similarity=0.185  Sum_probs=170.0

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCC--CCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeec-cC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHD--DHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVD-FQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~  233 (484)
                      ..++|++.+.||+|+||.||+|++..+  ..+..||+|++....  ..+....+  .+....+.++..++..+.... ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            567899999999999999999996532  116789999875432  11222211  122222333333222211111 13


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDA----------------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLK  297 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk  297 (484)
                      .+...++|+||+++++|.+++......                ........+..++.|++.||+|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            456789999999999999998743210                001123445679999999999999   8999999999


Q ss_pred             CCCeeecC-CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCC----------------------CC
Q 011508          298 PSNVLLDG-ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS----------------------EV  354 (484)
Q Consensus       298 ~~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~  354 (484)
                      |+|||++. ++.+||+|||+++.+.....      .......+++.|+|||.+...                      .+
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~  356 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL  356 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence            99999986 57999999999986533221      112235688999999964322                      23


Q ss_pred             CcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc-----hhhhhhcCcccccccccccchhhhhhhcccccc
Q 011508          355 STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP-----ERLAEIVDPVLLVEREEGETSEANAHKQRTRSF  429 (484)
Q Consensus       355 ~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~  429 (484)
                      +.++|||||||++|||+++..+++..      +..+......     ..+...+.+....+...           .... 
T Consensus       357 ~~k~DVwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~-  418 (566)
T PLN03225        357 PDRFDIYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRR-----------GFEV-  418 (566)
T ss_pred             CCCcccHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhh-----------hhhh-
Confidence            45679999999999999987665431      1111110000     00111111110000000           0000 


Q ss_pred             chhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          430 GGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       430 ~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                       .........+|+.+||+.||++|||++|+++.
T Consensus       419 -~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~H  450 (566)
T PLN03225        419 -LDLDGGAGWELLKSMMRFKGRQRISAKAALAH  450 (566)
T ss_pred             -ccccchHHHHHHHHHccCCcccCCCHHHHhCC
Confidence             00012345689999999999999999999864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-34  Score=237.37  Aligned_cols=221  Identities=24%  Similarity=0.290  Sum_probs=176.8

Q ss_pred             HHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeeec
Q 011508          154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSVD  231 (484)
Q Consensus       154 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  231 (484)
                      +....+...-+..||+|++|.|-+-+  +..++...|+|.+...-. ...++..+|+.+..+. .+|.+|.++|..    
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmr--h~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~----  114 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMR--HIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL----  114 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhhee--eccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh----
Confidence            44445555667789999999998776  666789999999975543 3346778888877665 799999999974    


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEE
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV  311 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl  311 (484)
                       ..+...++.||.| ..||+.+-++--+.+..+++..+-+|+..+..||.|||+  ...++|||+||+|||++.+|++|+
T Consensus       115 -~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKi  190 (282)
T KOG0984|consen  115 -FREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKI  190 (282)
T ss_pred             -hccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEE
Confidence             4445789999999 679988877666667789999999999999999999997  789999999999999999999999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCC----CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG----SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      ||||.+..+.++...        .-..|-..|+|||.+..    ..|+-|+||||+|+++.||.+++.||+.....-..+
T Consensus       191 CDFGIsG~L~dSiAk--------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qL  262 (282)
T KOG0984|consen  191 CDFGISGYLVDSIAK--------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQL  262 (282)
T ss_pred             cccccceeehhhhHH--------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHH
Confidence            999999877443211        11347788999998654    468999999999999999999999998765544444


Q ss_pred             hHHHH
Q 011508          388 HNFVK  392 (484)
Q Consensus       388 ~~~~~  392 (484)
                      .+.+.
T Consensus       263 kqvVe  267 (282)
T KOG0984|consen  263 KQVVE  267 (282)
T ss_pred             HHHhc
Confidence            44433

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.8e-33  Score=275.53  Aligned_cols=214  Identities=21%  Similarity=0.304  Sum_probs=155.7

Q ss_pred             hcCCCCccCccccccceeEEEEEEcC--------------CCCeeEEEEEEeeccCccchHH--------------HHHH
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDH--------------DDHETLVAVKVLNLQHRGASKS--------------FIAE  208 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--------------~~~~~~vavK~~~~~~~~~~~~--------------~~~e  208 (484)
                      ..++|++.++||+|+||.||+|....              ...++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            35789999999999999999997421              2234679999987543322223              3446


Q ss_pred             HHHHHcCCCCCc-----eeEeeeeeeec---cCCCceeeEEeecccCCCHHHHHhhcCC--------------------C
Q 011508          209 CQALRSIRHRNL-----VKIITSCVSVD---FQGNDFEALVYELMVNGSLEEWLHLNRD--------------------A  260 (484)
Q Consensus       209 ~~~l~~l~h~ni-----v~~~~~~~~~~---~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~  260 (484)
                      +.++.+++|.++     ++++++|....   .......++||||+++++|.++++....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766654     66777765421   1123467999999999999999874221                    0


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccccccCCCCcccccccccc
Q 011508          261 PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT  340 (484)
Q Consensus       261 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~  340 (484)
                      ...+++..+..++.|++.+|.|||   +.+|+||||||+||+++.++.+||+|||++........      .......++
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~------~~~~~g~~t  373 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN------FNPLYGMLD  373 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc------cCccccCCC
Confidence            123567888999999999999999   88999999999999999999999999999875432211      111112357


Q ss_pred             ccccCccccCCCC--------------------C--CcccceehhhHHHHHHHhCCC-CCCC
Q 011508          341 VGYAAPEYGMGSE--------------------V--STSGDVYSFGILLLEMFTGKG-PTNE  379 (484)
Q Consensus       341 ~~y~aPE~~~~~~--------------------~--~~~~Dvws~Gvvl~elltg~~-p~~~  379 (484)
                      +.|+|||.+....                    +  ..+.||||+||++++|++|.. ||..
T Consensus       374 p~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        374 PRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             cceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            8999999865432                    1  134799999999999999875 6643

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=279.66  Aligned_cols=265  Identities=28%  Similarity=0.379  Sum_probs=196.7

Q ss_pred             CCccCcccccccee-EEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCcee
Q 011508          161 FSLENLIGAGSFGS-VYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       161 ~~~~~~lg~G~~g~-Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      |.-.+.+|.|+.|+ ||+|.+.    ++.||||++-..   ...-..+|+..|+.- +|||||++++.     .++..+.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye----~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~-----E~d~qF~  578 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE----GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCS-----EQDRQFL  578 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC----CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEee-----ccCCceE
Confidence            34446789998875 6999976    678999987532   335667999999988 79999999877     5667799


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---C--CceEEcc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---E--LTAHVSD  313 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---~--~~~kl~D  313 (484)
                      ||..|.| ..+|.+++...............+.+..|++.||++||   +.+||||||||.||||+.   +  ..++|+|
T Consensus       579 YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSD  654 (903)
T KOG1027|consen  579 YIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISD  654 (903)
T ss_pred             EEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecc
Confidence            9999999 67999999863111111222455778899999999999   899999999999999975   2  4899999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||+++.+........    ......||-+|+|||++....-+.++||||+|||+|+.++ |.+||.+....+..+.   .
T Consensus       655 fglsKkl~~~~sS~~----r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl---~  727 (903)
T KOG1027|consen  655 FGLSKKLAGGKSSFS----RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL---T  727 (903)
T ss_pred             cccccccCCCcchhh----cccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh---c
Confidence            999999866543322    2345679999999999999888889999999999999999 5999987432211110   0


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHH------------
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVA------------  460 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl------------  460 (484)
                      ..     ..+.  .+.                     ...+|  +..+||.+|++++|..||++.+|+            
T Consensus       728 ~~-----~~L~--~L~---------------------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL  777 (903)
T KOG1027|consen  728 GN-----YTLV--HLE---------------------PLPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRL  777 (903)
T ss_pred             Cc-----ccee--eec---------------------cCchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHH
Confidence            00     0000  000                     01222  678999999999999999999997            


Q ss_pred             HHHHHHHHHHhhccCCCc
Q 011508          461 AQLLSFRNKLVKNVRGQP  478 (484)
Q Consensus       461 ~~L~~i~~~~~~~~~~~~  478 (484)
                      +.|++..++.....+..|
T Consensus       778 ~Fl~dvSDRvE~e~r~~~  795 (903)
T KOG1027|consen  778 SFLRDVSDRVEKENRDSP  795 (903)
T ss_pred             HHHHhhhhhhhhhhccCc
Confidence            456666666665555544

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.1e-32  Score=252.83  Aligned_cols=239  Identities=29%  Similarity=0.359  Sum_probs=187.8

Q ss_pred             cceeEEEEEEcCCCCeeEEEEEEeeccCccc-hHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEeecccCCC
Q 011508          171 SFGSVYKGIFDHDDHETLVAVKVLNLQHRGA-SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGS  249 (484)
Q Consensus       171 ~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gs  249 (484)
                      +||.||+|+...  ++..+|+|++....... .+.+.+|++.+++++|+|++++++++..     ....++++||+++++
T Consensus         1 ~~g~v~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~   73 (244)
T smart00220        1 SFGKVYLARDKK--TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGD   73 (244)
T ss_pred             CceEEEEEEECC--CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCC
Confidence            589999999643  46789999997665444 6789999999999999999999998643     347899999999999


Q ss_pred             HHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccccccCCC
Q 011508          250 LEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSS  329 (484)
Q Consensus       250 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  329 (484)
                      |.+++....    .+++..++.++.+++.++.+||   ..+++|+||+|+||++++++.++|+|||.+.......     
T Consensus        74 L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----  141 (244)
T smart00220       74 LFDLLKKRG----RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----  141 (244)
T ss_pred             HHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----
Confidence            999987432    2889999999999999999999   8899999999999999999999999999998764331     


Q ss_pred             CccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCccccc
Q 011508          330 NQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLV  409 (484)
Q Consensus       330 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  409 (484)
                         ......++..|+|||......++.++||||||++++++++|..||....... ...+...           ......
T Consensus       142 ---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~~~~~~-----------~~~~~~  206 (244)
T smart00220      142 ---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-ELFKKIG-----------KPKPPF  206 (244)
T ss_pred             ---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHh-----------ccCCCC
Confidence               1123457889999999988888999999999999999999999986531110 1111100           000000


Q ss_pred             ccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          410 EREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       410 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...                  ...+..++.+++.+|+..+|++||++.++++
T Consensus       207 ~~~------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      207 PPP------------------EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ccc------------------cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            000                  0002567899999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.8e-32  Score=244.67  Aligned_cols=202  Identities=27%  Similarity=0.356  Sum_probs=172.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  234 (484)
                      .+|.+..+||+|+|++|..+++.  .+.+.+|+|++++...   .+..-.+.|..+..+- +||.+|.+..+     |+.
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~--~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-----fqt  322 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLK--KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-----FQT  322 (593)
T ss_pred             ccceeeeeecCcchhhhhheehc--ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-----hcc
Confidence            56899999999999999999844  4678999999986532   3334466777777766 79999999887     667


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      +...++|.||++||+|--+++..    +.+++..+..+...|.-||.|||   ++||+.||||.+|+|+|..|++||.|+
T Consensus       323 esrlffvieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdy  395 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDY  395 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeeccc
Confidence            77999999999999998777643    35899999999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCc
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMF  381 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~  381 (484)
                      |+++.--       ........++||+.|.|||++.+..|+...|.|++||+++||+.|+.||+-..
T Consensus       396 gmcke~l-------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg  455 (593)
T KOG0695|consen  396 GMCKEGL-------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG  455 (593)
T ss_pred             chhhcCC-------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence            9998532       22344556899999999999999999999999999999999999999997543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-31  Score=250.58  Aligned_cols=137  Identities=26%  Similarity=0.448  Sum_probs=117.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-----C---CCceeEeeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-----H---RNLVKIITSCVS  229 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~~~  229 (484)
                      .++|.+.++||-|.|++||++.  +....+.||+|+.+... .-.+....|+++|++++     |   .+||++++.|..
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLaw--Dtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAW--DTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             CceEEEEEeccccccceeEEEe--eccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            3689999999999999999998  66778999999987442 23466789999999983     3   359999999876


Q ss_pred             eccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 011508          230 VDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL  303 (484)
Q Consensus       230 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll  303 (484)
                      .+ .++.+.++|+|++ |-+|..+|....  -+.++...+..|++||+.||.|||.  ..+|||-||||+|||+
T Consensus       154 sG-pNG~HVCMVfEvL-GdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  154 SG-PNGQHVCMVFEVL-GDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             cC-CCCcEEEEEehhh-hhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence            65 6778999999999 889999998543  4568999999999999999999998  6799999999999999

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=7.3e-33  Score=234.83  Aligned_cols=277  Identities=19%  Similarity=0.265  Sum_probs=198.8

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  234 (484)
                      ...++|++.+++|+|.++.||.|.  +-.+...++||+++...   .+.+.+|+.+|..|. ||||+++++...+.   .
T Consensus        35 g~~ddYeivrk~GRGKYSEVFeg~--~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~  106 (338)
T KOG0668|consen   35 GNQDDYEIVRKVGRGKYSEVFEGI--NITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDP---E  106 (338)
T ss_pred             cccchHHHHHHHcCccHhhHhccc--ccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCc---c
Confidence            455789999999999999999998  44456789999997543   367889999999996 99999999985433   2


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEcc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVSD  313 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~D  313 (484)
                      .....+|+||+.+.+...+..       .++..++...+.+++.||.|+|   +.||+|||+||.|+++|.. -..+|+|
T Consensus       107 SktpaLiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlID  176 (338)
T KOG0668|consen  107 SKTPSLIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLID  176 (338)
T ss_pred             ccCchhHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeee
Confidence            445679999999888776553       4777889999999999999999   9999999999999999865 4899999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      +|+|.++....        .....+.+..|.-||.+-. ..|+..-|+|||||++..|+..+.||....+....+.+.+.
T Consensus       177 WGLAEFYHp~~--------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIak  248 (338)
T KOG0668|consen  177 WGLAEFYHPGK--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAK  248 (338)
T ss_pred             cchHhhcCCCc--------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHH
Confidence            99998874322        1122346677889998765 56888999999999999999999998654433333443333


Q ss_pred             hhcchhhhhh-------cCccccccccc-ccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALPERLAEI-------VDPVLLVEREE-GETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~-------~d~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      -.-.+.+...       +|+.+..--.. .......+..+..+..    ..++.++++...|..|-++|||++|.++.
T Consensus       249 VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl----~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  249 VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHL----VSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCcccccc----CChHHHHHHHHHHhhccccccchHHHhcC
Confidence            2222221111       22221110000 0000000001111111    14678899999999999999999998864

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.3e-33  Score=261.00  Aligned_cols=199  Identities=25%  Similarity=0.381  Sum_probs=172.6

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++..+..||-|+||.|-++...+.  ...+|+|++++..   ....+....|-.+|...+.|.||++|..     |.++.
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~--~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT-----frd~k  493 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQ--KATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT-----FRDSK  493 (732)
T ss_pred             hhhhhhhcccCccceEEEEEeccc--chHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH-----hccch
Confidence            456677899999999999986532  2358888887543   3445678899999999999999999987     67788


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      +.|+.||-|-||.|...++...    .++......++..+.+|++|||   +++||.|||||+|.+++.+|-+||.|||+
T Consensus       494 yvYmLmEaClGGElWTiLrdRg----~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGF  566 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDRG----SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGF  566 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhcC----CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhh
Confidence            9999999999999999997443    4778888889999999999999   99999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      |+.+..        ...+..++||+.|.|||++.....+.++|.||+|+++|||++|.+||.+.
T Consensus       567 AKki~~--------g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~  622 (732)
T KOG0614|consen  567 AKKIGS--------GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV  622 (732)
T ss_pred             HHHhcc--------CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence            998732        34556789999999999999999999999999999999999999999764

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.1e-33  Score=241.20  Aligned_cols=203  Identities=25%  Similarity=0.329  Sum_probs=163.6

Q ss_pred             CccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       162 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      +-.+.||-|+||.||.++  +-.+++.||+|++.....  ...+.+.+|+++|..++|.|++..++...-....--.+.|
T Consensus        56 ~PDRPIGYGAFGVVWsVT--DPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVT--DPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             CCCCcccccceeEEEecc--CCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            345789999999999998  555789999998864332  3457899999999999999999888764322222223567


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      +++|.| ..+|...+-    .+..++...+.-+.+||++||+|||   +.+|.||||||.|.|++.+...||+|||+++.
T Consensus       134 V~TELm-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHH-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccc
Confidence            889988 567777664    4567888899999999999999999   99999999999999999999999999999997


Q ss_pred             cccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      .+.+....      ....+-|..|+|||++.+ ..|+.+.||||.||++.||+..+..|...
T Consensus       206 ee~d~~~h------MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq  261 (449)
T KOG0664|consen  206 WDQRDRLN------MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA  261 (449)
T ss_pred             cchhhhhh------hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence            65433211      122346889999999887 46899999999999999999999888653

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=8e-31  Score=251.58  Aligned_cols=211  Identities=25%  Similarity=0.314  Sum_probs=172.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .-|..++.||-|+||.|.++.  ..++...||.|.+.+.+   +........|-.||..-+.+=||++|..     |+++
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~--KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS-----FQDk  701 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVR--KVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS-----FQDK  701 (1034)
T ss_pred             cceEEEeeecccccceeEEEe--ecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE-----eccC
Confidence            447778899999999999998  44457889999987553   3344567789999999999999999977     6778


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +.+|+||+|++||++-.+|-..    .-+.+.-+..++..+..|+++.|   ..|+|||||||+|||||.+|++||.|||
T Consensus       702 dnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFG  774 (1034)
T KOG0608|consen  702 DNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFG  774 (1034)
T ss_pred             CceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeecc
Confidence            8999999999999999988633    23777777888899999999999   9999999999999999999999999999


Q ss_pred             cccccccccccC----------C--CCc-----------------------cccccccccccccCccccCCCCCCcccce
Q 011508          316 LAKFLPEAANNL----------S--SNQ-----------------------SSSVGVKGTVGYAAPEYGMGSEVSTSGDV  360 (484)
Q Consensus       316 ~a~~~~~~~~~~----------~--~~~-----------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv  360 (484)
                      ++.-+....+..          +  ...                       ......+||..|+|||++....++..+|.
T Consensus       775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw  854 (1034)
T KOG0608|consen  775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW  854 (1034)
T ss_pred             ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence            986543221100          0  000                       00113469999999999999999999999


Q ss_pred             ehhhHHHHHHHhCCCCCCCCccC
Q 011508          361 YSFGILLLEMFTGKGPTNEMFTG  383 (484)
Q Consensus       361 ws~Gvvl~elltg~~p~~~~~~~  383 (484)
                      ||.|||||||+.|+.||......
T Consensus       855 ws~gvil~em~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  855 WSVGVILYEMLVGQPPFLADTPG  877 (1034)
T ss_pred             hHhhHHHHHHhhCCCCccCCCCC
Confidence            99999999999999999775544

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=5e-31  Score=250.81  Aligned_cols=197  Identities=25%  Similarity=0.389  Sum_probs=166.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--------cchHHHHHHHHHHHcCC---CCCceeEeeee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--------GASKSFIAECQALRSIR---HRNLVKIITSC  227 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~~~~~~  227 (484)
                      .+|+..+.+|+|+||.|+.|+.+  .+...|+||.+.+..-        ...-..-.|+++|..++   |+||++++++ 
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K--~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf-  637 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHK--ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF-  637 (772)
T ss_pred             ccceeeeeccccccceEEEeeec--ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe-
Confidence            46889999999999999999954  4467799998865431        11122456999999997   9999999999 


Q ss_pred             eeeccCCCceeeEEeeccc-CCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 011508          228 VSVDFQGNDFEALVYELMV-NGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE  306 (484)
Q Consensus       228 ~~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~  306 (484)
                          |++++++||+||-.. +.+|.+++..    ...+++.+...|++|++.|+++||   +.+|||||||-+|+.++.+
T Consensus       638 ----FEddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~  706 (772)
T KOG1152|consen  638 ----FEDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSN  706 (772)
T ss_pred             ----eecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecC
Confidence                778889999999763 5589999973    346999999999999999999999   9999999999999999999


Q ss_pred             CceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCC
Q 011508          307 LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTN  378 (484)
Q Consensus       307 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~  378 (484)
                      |-+||+|||.+.....         .....++||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus       707 g~~klidfgsaa~~ks---------gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  707 GFVKLIDFGSAAYTKS---------GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             CeEEEeeccchhhhcC---------CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999999876522         22334679999999999999887 567899999999999999999985

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-30  Score=223.88  Aligned_cols=257  Identities=20%  Similarity=0.290  Sum_probs=191.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .+.|.+.+.||+|.||.+-+++  +.++.+.+++|-+.... ...++|.+|...--.| .|.||+..|+..    |+..+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~e--Hr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d   95 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAE--HRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSD   95 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeee--ccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHH----hhcCc
Confidence            3568999999999999999998  66678899999887553 3457899998776666 689999988764    66677


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee-c-CCCceEEccc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL-D-GELTAHVSDF  314 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll-~-~~~~~kl~Df  314 (484)
                      .++.++||++.|+|.+-+..     ..+.+.....++.|++.|+.|||   ++++||||||.+|||+ + +...+|||||
T Consensus        96 ~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDF  167 (378)
T KOG1345|consen   96 AYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDF  167 (378)
T ss_pred             eEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeec
Confidence            88999999999999987752     34778888999999999999999   9999999999999999 3 3348999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCC-----CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhH
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-----EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHN  389 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~  389 (484)
                      |..+......          .....+..|.+||.....     ...+.+|||.||++++..+||+.||............
T Consensus       168 G~t~k~g~tV----------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~  237 (378)
T KOG1345|consen  168 GLTRKVGTTV----------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWE  237 (378)
T ss_pred             ccccccCcee----------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHH
Confidence            9987542211          112345678999964432     3577899999999999999999999865444444444


Q ss_pred             HHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          390 FVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                      |..-..  +..    +.+...                    .......+.++.++-+.++|++|-...++..+...
T Consensus       238 ~~~w~~--rk~----~~~P~~--------------------F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~  287 (378)
T KOG1345|consen  238 WEQWLK--RKN----PALPKK--------------------FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC  287 (378)
T ss_pred             HHHHhc--ccC----ccCchh--------------------hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence            332111  100    000000                    01114467788888999999999776666665544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=3.5e-31  Score=255.82  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=200.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|.+...+|.|.||.||+++  +..+++..|+|+++........-.++|+-+++..+||||+.++|.+..     .+.
T Consensus        14 ~ddyellqrvgsgTygdvyKaR--d~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-----~dk   86 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKAR--DKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-----RDK   86 (829)
T ss_pred             ccchhheeeecCCcccchhhhc--ccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-----hcC
Confidence            4678999999999999999998  666789999999998877777888999999999999999999998543     448


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .|+.||||.+|+|++.-+    ...++++.++....+..++|++|||   +.+-+|||||-.||++++.+.+|++|||.+
T Consensus        87 lwicMEycgggslQdiy~----~TgplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvs  159 (829)
T KOG0576|consen   87 LWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVS  159 (829)
T ss_pred             cEEEEEecCCCcccceee----ecccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCch
Confidence            899999999999998776    3456999999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCcccc---CCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYG---MGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ..+..       .......+.||+.|||||+.   ..+.|...+|||+.|++..|+---++|..+...-. .+--...  
T Consensus       160 aqita-------ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-~l~LmTk--  229 (829)
T KOG0576|consen  160 AQITA-------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-ALFLMTK--  229 (829)
T ss_pred             hhhhh-------hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-HHHHhhc--
Confidence            75532       23344557899999999974   45679999999999999999988887743321100 0000000  


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                            .-.++--..+                    .......+.++++.|+..+|++|||++.++.
T Consensus       230 ------S~~qpp~lkD--------------------k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  230 ------SGFQPPTLKD--------------------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ------cCCCCCcccC--------------------CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                  0001100000                    0111456788999999999999999998774

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=2.3e-30  Score=243.42  Aligned_cols=283  Identities=20%  Similarity=0.248  Sum_probs=203.0

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC------CCCceeEeeeeeee
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR------HRNLVKIITSCVSV  230 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~  230 (484)
                      -..+|.+....|+|-|++|.+|..  ...+..||||++..... ..+.=+.|+++|++|+      --|+++++..    
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D--~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~----  502 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARD--QARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRH----  502 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccc--cCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH----
Confidence            456889999999999999999984  44456899999986542 2345678999999994      3467777776    


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-Cce
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LTA  309 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~  309 (484)
                       |...+++|+|||-+ ..+|.+.|+.+.. ...|....+..++.|+.-||..|-   ..+|+|.||||+|||+.+. ..+
T Consensus       503 -F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  503 -FKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             -hhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCccee
Confidence             55667999999998 6799999997764 345888899999999999999999   8999999999999999875 478


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCc-cHh
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNL-TLH  388 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~-~~~  388 (484)
                      ||||||.|....+..         ...+..+..|.|||++.+.+|+...|+||.||+||||.||+..|.+..+... .+.
T Consensus       577 KLCDfGSA~~~~ene---------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~  647 (752)
T KOG0670|consen  577 KLCDFGSASFASENE---------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF  647 (752)
T ss_pred             eeccCcccccccccc---------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence            999999998764322         1223456789999999999999999999999999999999999987543321 111


Q ss_pred             HHHHhhcchh-------hhhhcCcccccccccc-cchhh---------------hhhhccccccc--hhHHHHHHHhHhh
Q 011508          389 NFVKEALPER-------LAEIVDPVLLVEREEG-ETSEA---------------NAHKQRTRSFG--GKECLVSVLGIGV  443 (484)
Q Consensus       389 ~~~~~~~~~~-------~~~~~d~~l~~~~~~~-~~~~~---------------~~~~~~~~~~~--~~~~~~~l~~l~~  443 (484)
                      .-+...+|..       ..+-.|..+..-+.+. ...+.               .......+.+.  ......++.+|+.
T Consensus       648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd  727 (752)
T KOG0670|consen  648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD  727 (752)
T ss_pred             HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence            1122222322       1122222221111100 00000               00000000011  1234678899999


Q ss_pred             ccCCCCcCCCCCHHHHHH
Q 011508          444 ICSSELPRERMNMEEVAA  461 (484)
Q Consensus       444 ~cl~~dP~~RPt~~evl~  461 (484)
                      .|+..||++|.|..|++.
T Consensus       728 kml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  728 KMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHhccChhhcCCHHHHhc
Confidence            999999999999999875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.1e-28  Score=222.64  Aligned_cols=211  Identities=30%  Similarity=0.472  Sum_probs=177.2

Q ss_pred             cccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEeecc
Q 011508          167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELM  245 (484)
Q Consensus       167 lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  245 (484)
                      ||+|++|.||++....  ++..+++|++...... ..+.+.+|++.++.++|++++++++++.     .....++++|++
T Consensus         1 l~~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~   73 (215)
T cd00180           1 LGEGGFGTVYLARDKK--TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYC   73 (215)
T ss_pred             CCcCCceEEEEEEecC--CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecC
Confidence            6899999999998543  4688999998755432 3467899999999999999999999854     335789999999


Q ss_pred             cCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEcccCccccccccc
Q 011508          246 VNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG-ELTAHVSDFGLAKFLPEAA  324 (484)
Q Consensus       246 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~a~~~~~~~  324 (484)
                      ++++|.+++....   ..+++..++.++.++++++++||   ..+++|+||+|.||+++. ++.++|+|||.+.......
T Consensus        74 ~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~  147 (215)
T cd00180          74 EGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK  147 (215)
T ss_pred             CCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence            9999999987432   35889999999999999999999   889999999999999999 8999999999998664322


Q ss_pred             ccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhc
Q 011508          325 NNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIV  403 (484)
Q Consensus       325 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  403 (484)
                      .       ......+...|++||..... ..+.++|+|++|++++++                                 
T Consensus       148 ~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------  187 (215)
T cd00180         148 S-------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------  187 (215)
T ss_pred             c-------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------
Confidence            1       12224477889999998877 788999999999999999                                 


Q ss_pred             CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          404 DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       404 d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                                                      ..+.+++..|++.+|++||++.++++.
T Consensus       188 --------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 --------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             --------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                                            035678899999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=1.9e-29  Score=232.82  Aligned_cols=290  Identities=23%  Similarity=0.311  Sum_probs=204.7

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  233 (484)
                      ...+.|..+++||+|.|++||+++.... .....||+|.+....  ......+|+++|..+ .+.||+++.++     +.
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~-----~r  105 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGC-----FR  105 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhh-----hc
Confidence            3446788999999999999999986542 246789999886543  346789999999999 69999999998     67


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVS  312 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~  312 (484)
                      .++...+|+||++.-+..++..       .++..++..+++.+..||+++|   .+|||||||||+|++.+.. +.-.|.
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~Lv  175 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLV  175 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEE
Confidence            7889999999999988888875       3678899999999999999999   9999999999999999754 578999


Q ss_pred             ccCccccccccc------c------cC-------------------------CCCccccccccccccccCccccCC-CCC
Q 011508          313 DFGLAKFLPEAA------N------NL-------------------------SSNQSSSVGVKGTVGYAAPEYGMG-SEV  354 (484)
Q Consensus       313 Dfg~a~~~~~~~------~------~~-------------------------~~~~~~~~~~~g~~~y~aPE~~~~-~~~  354 (484)
                      |||+|...+...      .      ..                         ...........||++|+|||++.. ..-
T Consensus       176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q  255 (418)
T KOG1167|consen  176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ  255 (418)
T ss_pred             echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence            999997321111      0      00                         000011124569999999998776 456


Q ss_pred             CcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhh---hhcCcccccc-------------cccccchh
Q 011508          355 STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA---EIVDPVLLVE-------------REEGETSE  418 (484)
Q Consensus       355 ~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~d~~l~~~-------------~~~~~~~~  418 (484)
                      ++++||||.|||++-+++++.||....++-..+.+.+.-.-...+.   ...+..+..+             ++......
T Consensus       256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~  335 (418)
T KOG1167|consen  256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES  335 (418)
T ss_pred             CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence            8899999999999999999999977666555555544322221111   1111100000             00000000


Q ss_pred             hhhhhc-cccccchhHH-HHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          419 ANAHKQ-RTRSFGGKEC-LVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       419 ~~~~~~-~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .....+ ..+.....++ +..+.+++.+|+..||.+|.|++|.+..
T Consensus       336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            000000 0011112233 3478999999999999999999999853

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=225.25  Aligned_cols=202  Identities=23%  Similarity=0.294  Sum_probs=164.0

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeecc--CccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-C
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHRNLVKIITSCVSVDF-Q  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~  233 (484)
                      ...+|.-...+|.|.- .|..|.  +.-.++.||+|.+...  .....++..+|+..+..++|+|+++++.++.-... .
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~--D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAF--DQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecc--hhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            3456777788999988 666665  5556788999987543  23445778899999999999999999988653221 1


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .-...|+|||+| ..+|.+.+..      .++-..+..|+.|++.|++|||   +.+|+||||||+||++..+..+||.|
T Consensus        92 ~~~e~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   92 EFQEVYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             HHHhHHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeecc
Confidence            123578999999 7799998872      2667788899999999999999   99999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      ||+|+.-...        -.....+.|..|+|||++.+..+.+.+||||+||++.||++|+..|.+
T Consensus       162 fg~ar~e~~~--------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g  219 (369)
T KOG0665|consen  162 FGLARTEDTD--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG  219 (369)
T ss_pred             chhhcccCcc--------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC
Confidence            9999854322        123446789999999999998899999999999999999999988763

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=2.7e-28  Score=222.69  Aligned_cols=200  Identities=33%  Similarity=0.473  Sum_probs=168.2

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      |.+.+.||+|++|.||++....  ++..+++|.+...... ..+.+.+|++.+.+++|+|++++++++..     ....+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~--~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~   73 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKG--TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLY   73 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcC--CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceE
Confidence            5677899999999999998543  4678999999866544 56788999999999999999999998543     34789


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      +++|++++++|.+++.....   .+++..+..++.+++.++.+||   ..+++|+||+|+||+++.++.++|+|||.+..
T Consensus        74 ~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~  147 (225)
T smart00221       74 LVMEYCEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARF  147 (225)
T ss_pred             EEEeccCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence            99999999999999974332   1789999999999999999999   88999999999999999999999999999887


Q ss_pred             cccccccCCCCccccccccccccccCcccc-CCCCCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYG-MGSEVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      .....      ........++..|++||.. ....++.++|||+||+++++|++|+.||..
T Consensus       148 ~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      148 IHRDL------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ecCcc------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            64332      0011234577889999988 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=6.1e-27  Score=205.44  Aligned_cols=170  Identities=22%  Similarity=0.240  Sum_probs=126.6

Q ss_pred             CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccccccC
Q 011508          248 GSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL  327 (484)
Q Consensus       248 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  327 (484)
                      |+|.++++..   ...+++.+++.|+.|++.||+|||   +++      ||+||+++.++.+|+  ||.+.......   
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc---
Confidence            6899999743   345999999999999999999999   555      999999999999999  99987653211   


Q ss_pred             CCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCccc
Q 011508          328 SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVL  407 (484)
Q Consensus       328 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  407 (484)
                               ..|++.|+|||++.+..++.++|||||||++|||+||+.||.........+..+.....+           
T Consensus        64 ---------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------  123 (176)
T smart00750       64 ---------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA-----------  123 (176)
T ss_pred             ---------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc-----------
Confidence                     147899999999999999999999999999999999999986532211111111111000           


Q ss_pred             ccccccccchhhhhhhccccccchhHHH--HHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          408 LVEREEGETSEANAHKQRTRSFGGKECL--VSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       408 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                       .......              ......  .++.+++.+||+.+|++||++.|+++.+..+...
T Consensus       124 -~~~~~~~--------------~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      124 -DDPRDRS--------------NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             -CCccccc--------------cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence             0000000              011112  2689999999999999999999999999877543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=2e-27  Score=255.07  Aligned_cols=207  Identities=18%  Similarity=0.256  Sum_probs=138.1

Q ss_pred             cCCC-CCceeEeeeeeeecc--CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 011508          214 SIRH-RNLVKIITSCVSVDF--QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP  290 (484)
Q Consensus       214 ~l~h-~niv~~~~~~~~~~~--~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  290 (484)
                      .++| +||.+++++|.....  ......+.++|++ +++|.+++...   ...+++.+++.++.||++||+|||   +++
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH---~~g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAH---SQG  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHH---hCC
Confidence            3445 577777776522111  1223567788988 77999999732   345899999999999999999999   899


Q ss_pred             eeecCCCCCCeeecCC-------------------CceEEcccCccccccccccc----C-----CCCcccccccccccc
Q 011508          291 IVHCDLKPSNVLLDGE-------------------LTAHVSDFGLAKFLPEAANN----L-----SSNQSSSVGVKGTVG  342 (484)
Q Consensus       291 ivH~dlk~~NIll~~~-------------------~~~kl~Dfg~a~~~~~~~~~----~-----~~~~~~~~~~~g~~~  342 (484)
                      |+||||||+||||+..                   +.+|++|||+++........    .     ...........||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            9999999999999654                   44556666665432110000    0     000001112458889


Q ss_pred             ccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhh
Q 011508          343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAH  422 (484)
Q Consensus       343 y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~  422 (484)
                      |+|||++.+..++.++|||||||+||||++|..|+.....   .+.....        ....+..               
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~~~~~~--------~~~~~~~---------------  234 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TMSSLRH--------RVLPPQI---------------  234 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HHHHHHH--------hhcChhh---------------
Confidence            9999999999999999999999999999999888643110   0000000        0010000               


Q ss_pred             hccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          423 KQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       423 ~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                               .........++..||+++|.+||++.||++.
T Consensus       235 ---------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        235 ---------LLNWPKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             ---------hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence                     0002335678889999999999999999853

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=5e-24  Score=204.73  Aligned_cols=270  Identities=24%  Similarity=0.300  Sum_probs=197.6

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCC----CCceeEeeeeeeeccCCC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH----RNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~~~~~~~~~  235 (484)
                      +|.+.+.||+|+||.||.+...... ...+|+|............+..|..++..+..    +++..+++...    ..+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~-~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK-NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC-CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCC
Confidence            7999999999999999999854333 46788888776543333367788888888863    57778777631    355


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-----CceE
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-----LTAH  310 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~-----~~~k  310 (484)
                      .+.++||+.+ |.+|.++.....  .+.++..+++.|+.|++.+|++||   +.|++||||||+|+.+...     ..+.
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~  167 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLY  167 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEE
Confidence            6889999998 999999886544  467999999999999999999999   9999999999999999754     4699


Q ss_pred             EcccCcccccc--cccccC-CCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          311 VSDFGLAKFLP--EAANNL-SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       311 l~Dfg~a~~~~--~~~~~~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      |.|||+++...  ...+.. ...........||..|.++....+...+.+.|+||++.++.|++.|..||........ .
T Consensus       168 llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~  246 (322)
T KOG1164|consen  168 LLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-K  246 (322)
T ss_pred             EEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-H
Confidence            99999998332  222111 1111112446699999999999999999999999999999999999999965432211 1


Q ss_pred             hHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          388 HNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                      .+.....    ....... .                       ...++.++.++...+-..+..++|....+.+.++...
T Consensus       247 ~~~~~~~----~~~~~~~-~-----------------------~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~  298 (322)
T KOG1164|consen  247 SKFEKDP----RKLLTDR-F-----------------------GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF  298 (322)
T ss_pred             HHHHHHh----hhhcccc-c-----------------------cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence            1111100    0001100 0                       0111445666666666689999999999999987765


Q ss_pred             HH
Q 011508          468 NK  469 (484)
Q Consensus       468 ~~  469 (484)
                      ..
T Consensus       299 ~~  300 (322)
T KOG1164|consen  299 DS  300 (322)
T ss_pred             Hh
Confidence            54

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=4.4e-26  Score=198.52  Aligned_cols=249  Identities=24%  Similarity=0.312  Sum_probs=187.5

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ..+..+|.+...|..|+|+|+.    ..+++|+++....  ....+|..|.-.|+.+.||||+++++.|....     ..
T Consensus       192 lnl~tkl~e~hsgelwrgrwqg----ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-----nl  262 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQG----NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-----NL  262 (448)
T ss_pred             hhhhhhhccCCCcccccccccC----cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-----Cc
Confidence            3455678999999999999973    3477788765432  33468999999999999999999999986543     78


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc--ccCc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS--DFGL  316 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~--Dfg~  316 (484)
                      .++..||+.|+|...++...  ....+..++.+++.++++|++|||+. ..-|.---|.+..+++|++.+++|+  |--+
T Consensus       263 v~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kf  339 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKF  339 (448)
T ss_pred             eEeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheeccccee
Confidence            89999999999999998543  34577788999999999999999976 4455555799999999999988874  3222


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCC---CcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV---STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      +..-              .+..-.+.|++||.++..+-   -.++|+|||.+++|||.|...||.+..+-+....-..  
T Consensus       340 sfqe--------------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial--  403 (448)
T KOG0195|consen  340 SFQE--------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL--  403 (448)
T ss_pred             eeec--------------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh--
Confidence            2110              11235688999999887653   3579999999999999999999987543221111000  


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                         +.+.                           ...+++....+.+|+.-|+..||.+||.+..|+-.|++++
T Consensus       404 ---eglr---------------------------v~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  404 ---EGLR---------------------------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ---cccc---------------------------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence               0011                           1113344667889999999999999999999999998764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.3e-24  Score=207.94  Aligned_cols=174  Identities=21%  Similarity=0.162  Sum_probs=128.7

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-----ccchHHHHHHHHHHHcCCCCCceeEeeeeeee
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-----RGASKSFIAECQALRSIRHRNLVKIITSCVSV  230 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  230 (484)
                      ...++|.+.+.||+|+||+||+|..... ++..||||++....     ......+.+|+++|++++|+|+++.+..+   
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGD-PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCC-CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            3457899999999999999999985432 35678999875321     11245689999999999999998643221   


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeeecCCCce
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDL-KPSNVLLDGELTA  309 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-k~~NIll~~~~~~  309 (484)
                           ...++||||+++++|.. +.   .    ..   ...++.|++++|+|||   +++|+|||| ||+||+++.++.+
T Consensus        91 -----~~~~LVmE~~~G~~L~~-~~---~----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~i  151 (365)
T PRK09188         91 -----GKDGLVRGWTEGVPLHL-AR---P----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEA  151 (365)
T ss_pred             -----CCcEEEEEccCCCCHHH-hC---c----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCE
Confidence                 24689999999999963 21   0    11   1457889999999999   899999999 9999999999999


Q ss_pred             EEcccCcccccccccccCCC-CccccccccccccccCccccCCC
Q 011508          310 HVSDFGLAKFLPEAANNLSS-NQSSSVGVKGTVGYAAPEYGMGS  352 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~  352 (484)
                      ||+|||+++.+........- ....-....+++.|.|||.+...
T Consensus       152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99999999977543211100 00111345688899999987643

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=1.2e-22  Score=182.08  Aligned_cols=208  Identities=23%  Similarity=0.357  Sum_probs=171.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .-.|.++++||+|+||.++.|+  +--++..||||.-...+  ...++..|.+..+.| ..++|..++.+     -+.+.
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~--Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYF-----GqeG~   97 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGK--NLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYF-----GQEGK   97 (449)
T ss_pred             cccceeccccccCcceeeeccc--ccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeee-----ccccc
Confidence            3478999999999999999998  44567899999765433  346788898888888 56888887765     34455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-----ceEE
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-----TAHV  311 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-----~~kl  311 (484)
                      +-.+|+|.+ |.||++++.-.   ++.++..++..+|.|++.-++|+|   ++.+|.|||||+|+||...+     .+.+
T Consensus        98 ~NiLVidLL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~Ihi  170 (449)
T KOG1165|consen   98 YNILVIDLL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHI  170 (449)
T ss_pred             hhhhhhhhh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEE
Confidence            778999999 99999998743   457999999999999999999999   99999999999999996543     6899


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCc
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMF  381 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~  381 (484)
                      +|||+|+.+.+......-.........||.+||+-....+.+-+.+.|+-|+|-++.+.+-|..||.+..
T Consensus       171 iDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  171 IDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             EeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            9999999885544333333334455679999999998889999999999999999999999999998753

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.2e-22  Score=174.27  Aligned_cols=210  Identities=26%  Similarity=0.377  Sum_probs=169.0

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCC-CCceeEeeeeeeeccCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH-RNLVKIITSCVSVDFQG  234 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~  234 (484)
                      ...+.|.++++||.|+||.+|.|.  .-.++..||||+-+....  ..++..|..+...|++ ..|..+..+     ..+
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~--~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y-----~~e   82 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGI--SITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHY-----GTE   82 (341)
T ss_pred             eeccceEEEEeecCCchhheeeee--eccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhh-----ccc
Confidence            345789999999999999999998  555788999998764432  3567788888888865 445555444     345


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC---CceEE
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHV  311 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl  311 (484)
                      ..+-.+||+.+ |.||++++.-.   .+.++..+++-++-|++.-++|+|   .++++||||||+|+|..-+   ..+.+
T Consensus        83 ~~ynvlVMdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~L  155 (341)
T KOG1163|consen   83 KDYNVLVMDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYL  155 (341)
T ss_pred             cccceeeeecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEE
Confidence            56778999999 99999998743   346899999999999999999999   9999999999999999543   47899


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCc
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMF  381 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~  381 (484)
                      +|||+|+.+.+......-.........||..|.+-....+..-+.+.|+-|+|.+|.++.-|..||.+..
T Consensus       156 IDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglk  225 (341)
T KOG1163|consen  156 IDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLK  225 (341)
T ss_pred             EeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccc
Confidence            9999999875544333333334455679999999887777788899999999999999999999998753

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=2.6e-21  Score=187.37  Aligned_cols=264  Identities=31%  Similarity=0.404  Sum_probs=192.8

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---chHHHHHHHHHHHcCCCC-CceeEeeeeeeeccCCCc
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAECQALRSIRHR-NLVKIITSCVSVDFQGND  236 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~  236 (484)
                      |.+...||.|+||.||++...     ..+++|.+......   ....+.+|+.++..+.|+ +++++++.+     ....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~   71 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEG   71 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCC
Confidence            667789999999999999854     67899988765443   356799999999999988 799999885     2333


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcccC
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVSDFG  315 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg  315 (484)
                      ..+++++++.++++.+++...... ..+.......+..|++.+++|+|   ..+++|||+||+||+++... .++++|||
T Consensus        72 ~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg  147 (384)
T COG0515          72 SLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFG  147 (384)
T ss_pred             EEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccC
Confidence            479999999999999777643211 35888999999999999999999   88999999999999999988 79999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC---CCCCcccceehhhHHHHHHHhCCCCCCCCccC--CccHhHH
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG---SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG--NLTLHNF  390 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~--~~~~~~~  390 (484)
                      .+............. .......|+..|+|||.+.+   ..++...|+||+|++++++++|..||......  .......
T Consensus       148 ~~~~~~~~~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~  226 (384)
T COG0515         148 LAKLLPDPGSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI  226 (384)
T ss_pred             cceecCCCCcccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence            998554332111000 12345679999999999887   57889999999999999999999997653221  0111111


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      +......        ..........               .......+.+++..|+..+|..|.++.+....
T Consensus       227 ~~~~~~~--------~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         227 ILELPTP--------SLASPLSPSN---------------PELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHhcCCc--------ccccccCccc---------------cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111000        0000000000               01113467889999999999999999988765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=2.8e-23  Score=211.70  Aligned_cols=258  Identities=20%  Similarity=0.202  Sum_probs=179.1

Q ss_pred             CccCccccccceeEEEEEEcCCCCeeEEEEEEeecc--Cccch----HHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGAS----KSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       162 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ...+.+|.|++|.|+......  .....+.|.+...  .....    ..+..|+-+-..+.|+|++..+..+....    
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~--~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~----  394 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRS--DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID----  394 (601)
T ss_pred             CccceeeecccCceEEEEecC--CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc----
Confidence            356789999999777766322  2222333322210  11111    22556777777889999988777643322    


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                       ...-+||||++ +|..++...    ..++..++..++.|+..|++|||   ..+|.|||+|++|++++.++.+||+|||
T Consensus       395 -~~~~~mE~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg  465 (601)
T KOG0590|consen  395 -GILQSMEYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFG  465 (601)
T ss_pred             -cchhhhhcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecC
Confidence             33344999999 999999743    34788889999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCc-ccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVST-SGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      .+..+.-...   .........+|+..|+|||.+.+..|.+ ..||||.|+++..|.+|+.||.........+   ....
T Consensus       466 ~~~vf~~~~e---~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~  539 (601)
T KOG0590|consen  466 AASVFRYPWE---KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNN  539 (601)
T ss_pred             cceeeccCcc---hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhc
Confidence            9876633221   1123445678999999999999998876 5899999999999999999997654333221   0000


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .........               .       ........+..-..++.++|+.||.+|.|+++|++.
T Consensus       540 ~~~~~~~~~---------------~-------~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  540 YSDQRNIFE---------------G-------PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccccccccc---------------C-------hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            000000000               0       000012225566789999999999999999999863

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=3e-22  Score=183.58  Aligned_cols=207  Identities=21%  Similarity=0.222  Sum_probs=146.4

Q ss_pred             CCCCceeEeeeeeee----------------------ccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHH
Q 011508          216 RHRNLVKIITSCVSV----------------------DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA  273 (484)
Q Consensus       216 ~h~niv~~~~~~~~~----------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~  273 (484)
                      +|||||++.+++.+.                      ....+...|+||..+ ..+|.+++..+     ..+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-----~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-----HRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-----CCchHHHHHHH
Confidence            599999998876542                      122345678999888 55899998633     35667777899


Q ss_pred             HHHHHHHHHHHhcCCCCeeecCCCCCCeee--cCCC--ceEEcccCcccccccccccCCCCccccccccccccccCcccc
Q 011508          274 VDVASTLEYLHHYCETPIVHCDLKPSNVLL--DGEL--TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYG  349 (484)
Q Consensus       274 ~~i~~~l~~LH~~~~~~ivH~dlk~~NIll--~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~  349 (484)
                      .|+++|+.|||   .++|.|||+|++|||+  |+|.  ...|+|||++---+. ....-....-.....|.-..||||+.
T Consensus       348 aQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~-hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  348 AQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDN-HGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccc-cccccccccccccCCCcceecchhhh
Confidence            99999999999   9999999999999999  4443  678899998743221 11111122223345688889999987


Q ss_pred             CCCC------CCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhh
Q 011508          350 MGSE------VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHK  423 (484)
Q Consensus       350 ~~~~------~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~  423 (484)
                      ...+      .-.|+|.|+.|.+.||+++...||.....-..+...+-....|.                          
T Consensus       424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPa--------------------------  477 (598)
T KOG4158|consen  424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPA--------------------------  477 (598)
T ss_pred             hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCC--------------------------
Confidence            6532      23589999999999999999999976322222222211111110                          


Q ss_pred             ccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHH
Q 011508          424 QRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLL  464 (484)
Q Consensus       424 ~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~  464 (484)
                            .++.|+..+.+++...++.||++|++..-....|.
T Consensus       478 ------lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  478 ------LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             ------CcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence                  13455777889999999999999999887766654

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=4.5e-23  Score=210.23  Aligned_cols=250  Identities=20%  Similarity=0.208  Sum_probs=176.9

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHH--HHcCCCCCceeEeeeeeeeccCCCc
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQA--LRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      +|...+.||++.|=+|.+|+.+   .| .|+||++-+... -..+.|.++++-  ...++|||.+++...     ...+.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~---eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~-----~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR---EG-LVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKV-----LVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC---Cc-eEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHH-----HHhhH
Confidence            5677789999999999999744   23 489999876553 233444444333  444599999988765     34455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..|+|-+|. .-+|.|.+.    ...-+...+...|+.|++.||..+|   ..+|+|||||.+|||++.-.-+.|+||..
T Consensus        95 AAylvRqyv-khnLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAs  166 (1431)
T KOG1240|consen   95 AAYLVRQYV-KHNLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFAS  166 (1431)
T ss_pred             HHHHHHHHH-hhhhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccc
Confidence            678888888 558888886    3334778888899999999999999   99999999999999999999999999987


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC----------CC-CCcccceehhhHHHHHHHh-CCCCCCCCccCC
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG----------SE-VSTSGDVYSFGILLLEMFT-GKGPTNEMFTGN  384 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~----------~~-~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~  384 (484)
                      .+..--..++.....-.........+|.|||.+..          .. .+++.||||+||++.||++ |++||.-.    
T Consensus       167 FKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----  242 (1431)
T KOG1240|consen  167 FKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----  242 (1431)
T ss_pred             cCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----
Confidence            65432222222222222233445678999996443          12 6789999999999999998 89888531    


Q ss_pred             ccHhHHHHh--hcchh-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          385 LTLHNFVKE--ALPER-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       385 ~~~~~~~~~--~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                       .+-.+...  ..++. +..+-                               ...+..++..|++.||++|-++++.++
T Consensus       243 -QL~aYr~~~~~~~e~~Le~Ie-------------------------------d~~~Rnlil~Mi~rdPs~RlSAedyL~  290 (1431)
T KOG1240|consen  243 -QLLAYRSGNADDPEQLLEKIE-------------------------------DVSLRNLILSMIQRDPSKRLSAEDYLQ  290 (1431)
T ss_pred             -HHHhHhccCccCHHHHHHhCc-------------------------------CccHHHHHHHHHccCchhccCHHHHHH
Confidence             01111110  00111 11111                               224678999999999999999999997


Q ss_pred             H
Q 011508          462 Q  462 (484)
Q Consensus       462 ~  462 (484)
                      .
T Consensus       291 ~  291 (1431)
T KOG1240|consen  291 K  291 (1431)
T ss_pred             h
Confidence            7

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.87  E-value=2.6e-22  Score=178.45  Aligned_cols=175  Identities=10%  Similarity=0.079  Sum_probs=132.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHH---------HHHHHHHHHcCCCCCceeEeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS---------FIAECQALRSIRHRNLVKIITSCV  228 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~~~  228 (484)
                      .++|+..++||.|+||.||.+..    ++..+|+|++..........         +.+|+..+.++.|++|..+..++.
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~----~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT----DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec----CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            57899999999999999999642    24579999997554333222         678999999999999999988755


Q ss_pred             eecc---CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 011508          229 SVDF---QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG  305 (484)
Q Consensus       229 ~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~  305 (484)
                      ....   ......++||||++|.+|.++..        ++.    ....+++.++..+|   ..+++|||++|+||+++.
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~  170 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSK  170 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeC
Confidence            3321   12346789999999999988742        222    24569999999999   999999999999999999


Q ss_pred             CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHH
Q 011508          306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMF  371 (484)
Q Consensus       306 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ell  371 (484)
                      ++ ++|+|||......+....                   ..+.....+..++|+||||+++..+.
T Consensus       171 ~g-i~liDfg~~~~~~e~~a~-------------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        171 NG-LRIIDLSGKRCTAQRKAK-------------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CC-EEEEECCCcccccchhhH-------------------HHHHHHhHhcccccccceeEeehHHH
Confidence            88 999999988755221100                   01233445667999999999987654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.87  E-value=9.8e-22  Score=191.27  Aligned_cols=218  Identities=28%  Similarity=0.435  Sum_probs=160.8

Q ss_pred             HHcCCCCCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011508          212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPI  291 (484)
Q Consensus       212 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  291 (484)
                      |+.+.|.|+.+++|.+...     ...++|.+||..|+|.+.+..   ....+++.....+.++|+.||+|||   ..+|
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i   69 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLH---NSPI   69 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHh---cCcc
Confidence            4578999999999998654     478999999999999999974   3456999999999999999999999   4454


Q ss_pred             -eecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCC-------CCCcccceehh
Q 011508          292 -VHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-------EVSTSGDVYSF  363 (484)
Q Consensus       292 -vH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dvws~  363 (484)
                       .|+.++++|+++|....+||+|||+........     .........-..-|.|||.+...       ..+.+.|||||
T Consensus        70 ~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~-----~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~  144 (484)
T KOG1023|consen   70 GYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETA-----EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF  144 (484)
T ss_pred             eeeeeeccccceeeeeEEEEechhhhcccccccc-----cccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence             999999999999999999999999988764311     01111122345679999987763       14678999999


Q ss_pred             hHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhh
Q 011508          364 GILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGV  443 (484)
Q Consensus       364 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~  443 (484)
                      |++++|+++.+.||+........ .+.+..... .-.....|.+..                     ..+....+..++.
T Consensus       145 ~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~-~~~~~~rP~i~~---------------------~~e~~~~l~~l~~  201 (484)
T KOG1023|consen  145 GIIMYEILFRSGPFDLRNLVEDP-DEIILRVKK-GGSNPFRPSIEL---------------------LNELPPELLLLVA  201 (484)
T ss_pred             HHHHHHHHhccCccccccccCCh-HHHHHHHHh-cCCCCcCcchhh---------------------hhhcchHHHHHHH
Confidence            99999999999999875433322 111111000 001111111110                     0123447899999


Q ss_pred             ccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          444 ICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       444 ~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                      .||..+|.+||++++|-..++.+..
T Consensus       202 ~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  202 RCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             HhcccChhhCccHHHHHhhhhhhcc
Confidence            9999999999999999988877654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=3.1e-21  Score=169.93  Aligned_cols=139  Identities=15%  Similarity=0.100  Sum_probs=105.7

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--c-------hH-----------------HHHHHHHHHHcCCC
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--A-------SK-----------------SFIAECQALRSIRH  217 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~-------~~-----------------~~~~e~~~l~~l~h  217 (484)
                      ...||+|++|.||+|...   +++.||||+++.....  .       ..                 ....|++.+.++.+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~---~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   78 (190)
T cd05147           2 NGCISTGKEANVYHATTA---NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVT   78 (190)
T ss_pred             CCccccccceEEEEEECC---CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHH
Confidence            468999999999999853   5789999999754221  1       01                 12349999999988


Q ss_pred             CCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecCC
Q 011508          218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL-HHYCETPIVHCDL  296 (484)
Q Consensus       218 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dl  296 (484)
                      +++.....+.    . .  ..++||||++++++......    ...++......++.|++.+|.++ |   +.+|+||||
T Consensus        79 ~~v~~p~~~~----~-~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDl  144 (190)
T cd05147          79 AGIPCPEPIL----L-K--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADL  144 (190)
T ss_pred             CCCCCCcEEE----e-c--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCC
Confidence            7764322221    1 1  23799999988777654321    23588899999999999999999 6   789999999


Q ss_pred             CCCCeeecCCCceEEcccCccccc
Q 011508          297 KPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       297 k~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ||+||+++ ++.++|+|||+|...
T Consensus       145 kP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         145 SEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CHHHEEEE-CCcEEEEEccccccC
Confidence            99999998 478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.84  E-value=6.4e-21  Score=174.63  Aligned_cols=237  Identities=19%  Similarity=0.214  Sum_probs=147.2

Q ss_pred             CccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCC----------CCceeEeeeee
Q 011508          162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRH----------RNLVKIITSCV  228 (484)
Q Consensus       162 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h----------~niv~~~~~~~  228 (484)
                      ...+.||.|+++.||.++  +..++..+|+|++.....   ...+++.+|.-....+.+          -.++.-++...
T Consensus        15 ~~~~~i~~g~~~~v~~v~--d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   15 VRGRIIGKGGFSIVFEVT--DVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEETTEEEEEEE--ETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEccccccCCceEEEEEE--EccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            456789999999999999  555788999999865442   233566666655544322          11111111111


Q ss_pred             --------eeccCCCc-----eeeEEeecccCCCHHHHHhh---cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011508          229 --------SVDFQGND-----FEALVYELMVNGSLEEWLHL---NRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIV  292 (484)
Q Consensus       229 --------~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  292 (484)
                              ... .+..     ..+++|+-+ .+||.+++..   .......+....++.+..|+.+.+++||   ..|++
T Consensus        93 i~~~~~~~~~~-~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlV  167 (288)
T PF14531_consen   93 IPGKPPFFERG-PGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLV  167 (288)
T ss_dssp             ETTS-SEEEEC-ETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             EcCCCcceecC-CCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceE
Confidence                    000 0011     235678877 6788887642   2222233556666778899999999999   89999


Q ss_pred             ecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCC--------CCCCcccceehhh
Q 011508          293 HCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG--------SEVSTSGDVYSFG  364 (484)
Q Consensus       293 H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dvws~G  364 (484)
                      |+||+|+|++++.+|.++|+||+.........         .. ...+..|.|||....        -.++.+.|.|++|
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---------~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG  237 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---------RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLG  237 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEE---------EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCcee---------ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHH
Confidence            99999999999999999999998776543221         11 234577999996533        2578899999999


Q ss_pred             HHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhc
Q 011508          365 ILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVI  444 (484)
Q Consensus       365 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  444 (484)
                      +++|.|++|..||+..........             .....                        . +.+..+..|+..
T Consensus       238 ~~ly~lWC~~lPf~~~~~~~~~~~-------------~f~~C------------------------~-~~Pe~v~~LI~~  279 (288)
T PF14531_consen  238 ITLYSLWCGRLPFGLSSPEADPEW-------------DFSRC------------------------R-DMPEPVQFLIRG  279 (288)
T ss_dssp             HHHHHHHHSS-STCCCGGGSTSGG-------------GGTTS------------------------S----HHHHHHHHH
T ss_pred             HHHHHHHHccCCCCCCCccccccc-------------cchhc------------------------C-CcCHHHHHHHHH
Confidence            999999999999976432211100             00000                        0 226678899999


Q ss_pred             cCCCCcCCC
Q 011508          445 CSSELPRER  453 (484)
Q Consensus       445 cl~~dP~~R  453 (484)
                      +|+++|.+|
T Consensus       280 lL~~~~~~R  288 (288)
T PF14531_consen  280 LLQRNPEDR  288 (288)
T ss_dssp             HT-SSGGGS
T ss_pred             HccCCcccC
Confidence            999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=3.6e-20  Score=163.92  Aligned_cols=139  Identities=18%  Similarity=0.128  Sum_probs=107.8

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc--------------------------hHHHHHHHHHHHcCCC
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA--------------------------SKSFIAECQALRSIRH  217 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h  217 (484)
                      ...||+|++|.||+|+..   +++.||||+++......                          ...+..|.+.+.++.|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~---~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~   78 (190)
T cd05145           2 NGCISTGKEANVYHARTG---DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYE   78 (190)
T ss_pred             CceeecCCCcEEEEEEcC---CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHh
Confidence            468999999999999844   67899999998643210                          1123578999999999


Q ss_pred             CCceeEeeeeeeeccCCCceeeEEeecccCCCHHHH-HhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecC
Q 011508          218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEW-LHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCE-TPIVHCD  295 (484)
Q Consensus       218 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~d  295 (484)
                      +++.....+..    .   ..++||||++++++... +..     ..++..+...++.|++.++.++|   . .+|+|||
T Consensus        79 ~~i~~p~~~~~----~---~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrD  143 (190)
T cd05145          79 AGVPVPEPILL----K---KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGD  143 (190)
T ss_pred             CCCCCceEEEe----c---CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCC
Confidence            98744333311    1   24799999988755433 321     24678889999999999999999   6 9999999


Q ss_pred             CCCCCeeecCCCceEEcccCcccccc
Q 011508          296 LKPSNVLLDGELTAHVSDFGLAKFLP  321 (484)
Q Consensus       296 lk~~NIll~~~~~~kl~Dfg~a~~~~  321 (484)
                      |||+||+++ ++.++|+|||++...+
T Consensus       144 lkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         144 LSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CChhhEEEE-CCCEEEEEcccceecC
Confidence            999999999 7899999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=7.1e-20  Score=159.17  Aligned_cols=192  Identities=16%  Similarity=0.027  Sum_probs=134.7

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc----hHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCC
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA----SKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  235 (484)
                      +.+...|++|+||+||.+.-    .+.+++.+.+.....-.    ...+.+|+++|++|. |+++.+++++.        
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~----~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~--------   71 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG----GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD--------   71 (218)
T ss_pred             cccceeecCCCcceEEEeec----CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc--------
Confidence            34567899999999997642    35677777776443211    124789999999995 57888888751        


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC-CCCCeeecCCCceEEccc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDL-KPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-k~~NIll~~~~~~kl~Df  314 (484)
                       ..+++|||+.|.+|.+.+..           ....++.|++++|+++|   ..+|+|||| ||+||+++.++.++|+||
T Consensus        72 -~~~lvmeyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDF  136 (218)
T PRK12274         72 -GRHLDRSYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDF  136 (218)
T ss_pred             -CEEEEEeeecCccHHhhhhh-----------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEEC
Confidence             45899999999998754320           11347789999999999   999999999 799999999999999999


Q ss_pred             Cccccccccccc---CC-CCcc--ccccccccccccCccccCC--CCCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          315 GLAKFLPEAANN---LS-SNQS--SSVGVKGTVGYAAPEYGMG--SEVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       315 g~a~~~~~~~~~---~~-~~~~--~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      |++.........   .. .+..  .......++.|++|+...-  ..--...+.++-|+-+|.++|+..+.-+
T Consensus       137 G~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        137 QLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             CCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            999865432210   00 0000  0011224666777764221  1222567889999999999999888644

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=6.2e-20  Score=190.90  Aligned_cols=198  Identities=24%  Similarity=0.301  Sum_probs=153.3

Q ss_pred             HHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC---CCCceeEeeeeeeec
Q 011508          155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR---HRNLVKIITSCVSVD  231 (484)
Q Consensus       155 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~  231 (484)
                      ....+.|.+.+.||+|+||+||+|+..  + ++.||+|+-+....   .+|.--.+++.+|+   -+.|+.+...+.   
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~--~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~---  764 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHS--N-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHV---  764 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecC--C-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHc---
Confidence            334467888999999999999999844  2 89999998764432   23333344555555   233444444432   


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-------
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD-------  304 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~-------  304 (484)
                      +.  +.-++|+||.+.|+|.+++.    ..+.++|.-++.++.|+++.++.||   ..+||||||||+|.+|.       
T Consensus       765 ~~--~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~  835 (974)
T KOG1166|consen  765 FQ--NASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADS  835 (974)
T ss_pred             cC--CcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCC
Confidence            22  24579999999999999997    3456899999999999999999999   99999999999999993       


Q ss_pred             CCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCC
Q 011508          305 GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG  375 (484)
Q Consensus       305 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~  375 (484)
                      +..-++|+|||.+..+.--     ..........+|-.+-.+|...+.+++..+|.|.++.+++-||.|+.
T Consensus       836 ~~~~l~lIDfG~siDm~lf-----p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  836 DSKGLYLIDFGRSIDMKLF-----PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceEEEecccceeeeEc-----CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            2346899999998765322     22334455678899999999999999999999999999999999984

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=4.2e-19  Score=157.64  Aligned_cols=139  Identities=17%  Similarity=0.236  Sum_probs=104.3

Q ss_pred             CccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-----CCCCceeEeeeeeeeccCCCc
Q 011508          162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-----RHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       162 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .-.+.||+|+||.||.  .++  +... +||++........+.+.+|+.+++.+     +||||++++|++....  +..
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~--~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g   77 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPE--DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTG   77 (210)
T ss_pred             CCcceecCCCceEEEE--CCC--CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCe
Confidence            3457899999999995  332  3333 68988765445567899999999999     6799999999864321  112


Q ss_pred             e-eeEEeec--ccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeecCCCCCCeeecC----CCc
Q 011508          237 F-EALVYEL--MVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL-EYLHHYCETPIVHCDLKPSNVLLDG----ELT  308 (484)
Q Consensus       237 ~-~~lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~dlk~~NIll~~----~~~  308 (484)
                      . ..+|+||  +.+|+|.+++...     .+++.  ..++.+++.++ +|||   +++|+||||||+||+++.    +..
T Consensus        78 ~v~~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~  147 (210)
T PRK10345         78 YVYDVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVI  147 (210)
T ss_pred             EEEEEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCc
Confidence            3 3478999  5579999999642     24444  35677888777 9999   999999999999999974    348


Q ss_pred             eEEcccCcc
Q 011508          309 AHVSDFGLA  317 (484)
Q Consensus       309 ~kl~Dfg~a  317 (484)
                      ++|+||+.+
T Consensus       148 ~~LiDg~G~  156 (210)
T PRK10345        148 PVVCDNIGE  156 (210)
T ss_pred             EEEEECCCC
Confidence            999995443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.3e-20  Score=183.41  Aligned_cols=189  Identities=29%  Similarity=0.314  Sum_probs=152.3

Q ss_pred             ccccccceeEEEEEE-cCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCCceeeEE
Q 011508          166 LIGAGSFGSVYKGIF-DHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGNDFEALV  241 (484)
Q Consensus       166 ~lg~G~~g~Vy~~~~-~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv  241 (484)
                      .+|+|+||.|+.+.- .....+..+|+|+.++...  ........|-.++...+ ||.++++...     ++.+...+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhya-----fqt~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYA-----FQTDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeee-----eccccchhHh
Confidence            379999999997642 1223467789998865432  11124556778888886 9999998776     5566688999


Q ss_pred             eecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccc
Q 011508          242 YELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP  321 (484)
Q Consensus       242 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~  321 (484)
                      +++..+|.|...+...    ..+++.........++-+++++|   +.+|+|||+|++||+++.+|++++.|||.++..-
T Consensus        76 ld~~rgg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v  148 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKE----VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV  148 (612)
T ss_pred             hhhcccchhhhccccC----CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhH
Confidence            9999999998887632    34677777888889999999999   9999999999999999999999999999998763


Q ss_pred             cccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          322 EAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       322 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      ...           ..+||..|||||+..  ......|.||||++++||+||..||..
T Consensus       149 ~~~-----------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  149 KEK-----------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hhh-----------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            322           117999999999987  567899999999999999999999975

>smart00090 RIO RIO-like kinase

Probab=99.76  E-value=5.4e-18  Score=154.48  Aligned_cols=150  Identities=18%  Similarity=0.135  Sum_probs=111.8

Q ss_pred             hHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc------------------------chHHHHHH
Q 011508          153 NLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG------------------------ASKSFIAE  208 (484)
Q Consensus       153 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~e  208 (484)
                      .+.....-|.+.+.||+|++|.||+|+. +..+++.||+|+++.....                        ....+..|
T Consensus        22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~-~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E  100 (237)
T smart00090       22 SLLNRGILSAIGGCISTGKEANVYHALD-FDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKE  100 (237)
T ss_pred             HHHhcCchHHhCCeeccCcceeEEEEEe-cCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHH
Confidence            3444445688899999999999999972 1225788999998754211                        01235689


Q ss_pred             HHHHHcCCCCC--ceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 011508          209 CQALRSIRHRN--LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY  286 (484)
Q Consensus       209 ~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~  286 (484)
                      +..+.++.+..  +.+++++         ...++||||+++.+|......    ...+.......++.|++.++++||  
T Consensus       101 ~~~L~~L~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH--  165 (237)
T smart00090      101 FRNLQRLYEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLY--  165 (237)
T ss_pred             HHHHHHHHhcCCCCCeeeEe---------cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHH--
Confidence            99999997533  3344432         134799999998888765421    123556667889999999999999  


Q ss_pred             CCCC-eeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          287 CETP-IVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       287 ~~~~-ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                       ..+ ++||||||+||+++ ++.++|+|||.+...
T Consensus       166 -~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      166 -KEGELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -hcCCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence             889 99999999999999 789999999988754

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.76  E-value=2.1e-19  Score=171.74  Aligned_cols=129  Identities=28%  Similarity=0.481  Sum_probs=108.7

Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      .+.++.|++|...+|.+|+...+ .....++...+.++.|++.|+.|      ++.+|+|+||.||++..+..+||+|||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence            36789999999999999997443 34457888899999999999998      688999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT  372 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt  372 (484)
                      +........ .............||..||+||.+.+..|+.|+||||+|++|+|+++
T Consensus       402 l~ts~~~~~-~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  402 LVTSQDKDE-TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             heeecccCC-cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            987765443 11112234456789999999999999999999999999999999988

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.74  E-value=1.2e-17  Score=148.95  Aligned_cols=144  Identities=22%  Similarity=0.185  Sum_probs=110.0

Q ss_pred             HhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc----------------------chHHHHHHH
Q 011508          152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG----------------------ASKSFIAEC  209 (484)
Q Consensus       152 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~  209 (484)
                      +++.....-|.+.+.||+|+||.||++...   +++.||||++......                      ....+..|+
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   84 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDP---DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEF   84 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcC---CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHH
Confidence            344444445888899999999999999854   5788999987643210                      012356788


Q ss_pred             HHHHcCCCCC--ceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011508          210 QALRSIRHRN--LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC  287 (484)
Q Consensus       210 ~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  287 (484)
                      .++..+.|++  +.+.++.         ...++||||+++++|......          .....++.+++.++.++|   
T Consensus        85 ~~l~~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh---  142 (198)
T cd05144          85 AALKALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAY---  142 (198)
T ss_pred             HHHHHHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHH---
Confidence            8999887774  4444332         245899999999998765420          234578899999999999   


Q ss_pred             CCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          288 ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       288 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ..+++||||||+||++++++.++|+|||.+...
T Consensus       143 ~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         143 KHGIIHGDLSEFNILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             HCCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence            899999999999999999999999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=1.9e-17  Score=149.59  Aligned_cols=134  Identities=22%  Similarity=0.305  Sum_probs=107.6

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--------chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--------ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      +.||+|++|.||+|.+.    +..+++|+.......        ....+.+|++++..+.|+++.....++..     ..
T Consensus         2 ~~l~~G~~~~vy~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~   72 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL----GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-----PE   72 (211)
T ss_pred             cccccCceEEEEEEeeC----CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-----CC
Confidence            57999999999999853    456888876533221        11357789999999999988766655432     23


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||++|++|.+++...       .. .+..++.+++.+|.++|   ..+++|||++|.||+++ ++.++|+|||.
T Consensus        73 ~~~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~  140 (211)
T PRK14879         73 NFIIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGL  140 (211)
T ss_pred             CCEEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCc
Confidence            568999999999999998632       12 78889999999999999   89999999999999999 78899999998


Q ss_pred             ccc
Q 011508          317 AKF  319 (484)
Q Consensus       317 a~~  319 (484)
                      +..
T Consensus       141 a~~  143 (211)
T PRK14879        141 AEF  143 (211)
T ss_pred             ccC
Confidence            764

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.73  E-value=2.1e-17  Score=169.53  Aligned_cols=140  Identities=22%  Similarity=0.265  Sum_probs=108.1

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeecc--Cc------cchHHHHHHHHHHHcCCCCCceeEeeee
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HR------GASKSFIAECQALRSIRHRNLVKIITSC  227 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~  227 (484)
                      .....|...+.||+|+||.||+|.+...    .+++|+....  ..      ...+.+.+|++++..++|++++....++
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~----~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~  405 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGR----DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYD  405 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCc----cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEE
Confidence            3344566789999999999999986532    2333332111  11      1124688999999999999988776664


Q ss_pred             eeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 011508          228 VSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL  307 (484)
Q Consensus       228 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~  307 (484)
                      ..     ....++||||+++++|.+++.            ....++.+++++|.+||   +.+++||||||+||++ +++
T Consensus       406 ~~-----~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~  464 (535)
T PRK09605        406 VD-----PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDD  464 (535)
T ss_pred             Ee-----CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECC
Confidence            32     235689999999999999885            34678999999999999   8999999999999999 577


Q ss_pred             ceEEcccCccccc
Q 011508          308 TAHVSDFGLAKFL  320 (484)
Q Consensus       308 ~~kl~Dfg~a~~~  320 (484)
                      .++|+|||+++..
T Consensus       465 ~~~liDFGla~~~  477 (535)
T PRK09605        465 RLYLIDFGLGKYS  477 (535)
T ss_pred             cEEEEeCcccccC
Confidence            9999999998753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=3.3e-17  Score=146.52  Aligned_cols=130  Identities=22%  Similarity=0.291  Sum_probs=101.2

Q ss_pred             ccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--------chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--------ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       166 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .||+|+||.||+|.+.    +..+++|........        ....+.+|++++..+.|+++.....++..     ...
T Consensus         1 ~ig~G~~~~vy~~~~~----~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-----~~~   71 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL----GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-----PDN   71 (199)
T ss_pred             CCCCCceEEEEEeecC----CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-----CCC
Confidence            4899999999999843    467888886532211        12457789999999988875444333322     235


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||++|++|.+++....        .   .++.+++.+|++||   ..+++|||++|.||+++ ++.++++|||++
T Consensus        72 ~~lv~e~~~g~~l~~~~~~~~--------~---~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a  136 (199)
T TIGR03724        72 KTIVMEYIEGKPLKDVIEEGN--------D---ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLG  136 (199)
T ss_pred             CEEEEEEECCccHHHHHhhcH--------H---HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCC
Confidence            689999999999999875211        0   78999999999999   89999999999999999 789999999988


Q ss_pred             cc
Q 011508          318 KF  319 (484)
Q Consensus       318 ~~  319 (484)
                      ..
T Consensus       137 ~~  138 (199)
T TIGR03724       137 KY  138 (199)
T ss_pred             cC
Confidence            64

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.69  E-value=1.1e-17  Score=171.04  Aligned_cols=216  Identities=26%  Similarity=0.345  Sum_probs=141.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ..+|..+++|..|+||.||.++  ++.+.+.+|+|+ +++.     .      +++     ||..+-+         +  
T Consensus        82 e~df~~IklisngAygavylvr--h~~trqrfa~ki-Nkq~-----l------ilR-----nilt~a~---------n--  131 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVR--HKETRQRFAMKI-NKQN-----L------ILR-----NILTFAG---------N--  131 (1205)
T ss_pred             ccccceeEeeccCCCCceeeee--ccccccchhhcc-cccc-----h------hhh-----ccccccC---------C--
Confidence            3678899999999999999998  555667888843 2221     0      111     1222211         1  


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .+.|      |+-...++..    ..++.        +++.+++|||   +.+|+|||+||+|.+|+.-|++|+.|||++
T Consensus       132 pfvv------gDc~tllk~~----g~lPv--------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLs  190 (1205)
T KOG0606|consen  132 PFVV------GDCATLLKNI----GPLPV--------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLS  190 (1205)
T ss_pred             ccee------chhhhhcccC----CCCcc--------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhh
Confidence            1222      3333334321    12222        2278899999   999999999999999999999999999998


Q ss_pred             ccccccccc------CC--CCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhH
Q 011508          318 KFLPEAANN------LS--SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHN  389 (484)
Q Consensus       318 ~~~~~~~~~------~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~  389 (484)
                      +..-.....      +.  ..+-.....+||+.|+|||++....|+...|.|++|+++||.+-|+.||.+...++ .+.+
T Consensus       191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lfg~  269 (1205)
T KOG0606|consen  191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQ  269 (1205)
T ss_pred             hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HHhh
Confidence            754221110      00  00111124589999999999999999999999999999999999999997742221 1111


Q ss_pred             HHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC
Q 011508          390 FVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN  455 (484)
Q Consensus       390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt  455 (484)
                      .+...+            .. +++                 .+....+..+++...|+.+|..|--
T Consensus       270 visd~i------------~w-pE~-----------------dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  270 VISDDI------------EW-PEE-----------------DEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hhhhhc------------cc-ccc-----------------CcCCCHHHHHHHHHHHHhChHhhcc
Confidence            111110            00 000                 1112567788999999999999963

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=1.2e-15  Score=135.04  Aligned_cols=135  Identities=22%  Similarity=0.218  Sum_probs=94.6

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccch--HH----------------------HHHHHHHHHcCCCCC
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KS----------------------FIAECQALRSIRHRN  219 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~--~~----------------------~~~e~~~l~~l~h~n  219 (484)
                      .+.||+|+||+||+|...   ++..||||++........  ..                      ...|.+.+.++.+..
T Consensus         2 ~~~lg~G~~g~Vy~a~~~---~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   78 (187)
T cd05119           2 GGPIGTGKEADVYLALDG---DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAG   78 (187)
T ss_pred             CcccccccceeEEEEECC---CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcC
Confidence            468999999999999854   567899999875432111  11                      124555555554332


Q ss_pred             --ceeEeeeeeeeccCCCceeeEEeecccCCCHHH-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecC
Q 011508          220 --LVKIITSCVSVDFQGNDFEALVYELMVNGSLEE-WLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCE-TPIVHCD  295 (484)
Q Consensus       220 --iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~d  295 (484)
                        +.+.++.         ...++||||++++++.. .+....     .. .+...++.+++.++.++|   . .+|+|+|
T Consensus        79 ~~~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~D  140 (187)
T cd05119          79 VPVPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLY---REAGLVHGD  140 (187)
T ss_pred             CCCCceEec---------CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHh---hccCcCcCC
Confidence              3333332         13589999999854321 111100     11 567789999999999999   7 9999999


Q ss_pred             CCCCCeeecCCCceEEcccCccccc
Q 011508          296 LKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       296 lk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      |||+||+++ ++.++|+|||.+...
T Consensus       141 l~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         141 LSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CChhhEEEE-CCcEEEEECcccccc
Confidence            999999999 889999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=2e-15  Score=128.51  Aligned_cols=136  Identities=21%  Similarity=0.240  Sum_probs=109.6

Q ss_pred             ccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCC--CCceeEeeeeeeeccCCCceeeE
Q 011508          163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH--RNLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       163 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      +.+.||+|.++.||++...    +..+++|.......  ...+.+|+.++..++|  .++.+++++.     ...+..++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~----~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~   70 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK----DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYL   70 (155)
T ss_pred             cceecccccccceEEEEec----CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEE
Confidence            4578999999999999854    25689998865433  4578899999999976  4888887763     33357899


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ++||++++.+..+           +......++.++++++++||.....+++|+|++|+||++++.+.+++.|||.+...
T Consensus        71 v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          71 LMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             EEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            9999988776543           45567778999999999999554468999999999999999899999999988754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=1e-15  Score=137.82  Aligned_cols=163  Identities=23%  Similarity=0.362  Sum_probs=126.9

Q ss_pred             HHHHHcCCCCCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 011508          209 CQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCE  288 (484)
Q Consensus       209 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~  288 (484)
                      ..-|-++.|.||+++..|..+..+.+.....++.|||.-|++.++|++.......+......+|+.||..||.|||+. +
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            344556689999999999877766677778899999999999999998777777788888999999999999999987 8


Q ss_pred             CCeeecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHH
Q 011508          289 TPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLL  368 (484)
Q Consensus       289 ~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~  368 (484)
                      ..|+|+++..+-|++..++-+|++--.-..... ..+  ...........+-++|.|||+-.....+..+|||+||...+
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~-s~~--~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHP-SVN--STREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL  273 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccch-hhh--hhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence            999999999999999999988884321111110 000  00111112234678999999887778888999999999999


Q ss_pred             HHHhCCC
Q 011508          369 EMFTGKG  375 (484)
Q Consensus       369 elltg~~  375 (484)
                      ||..+..
T Consensus       274 emailEi  280 (458)
T KOG1266|consen  274 EMAILEI  280 (458)
T ss_pred             HHHHhee
Confidence            9988764

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.61  E-value=6.2e-15  Score=134.66  Aligned_cols=139  Identities=17%  Similarity=0.132  Sum_probs=102.7

Q ss_pred             Cccc-cccceeEEEEEEcCCCCeeEEEEEEeeccC-------------ccchHHHHHHHHHHHcCCCCCc--eeEeeeee
Q 011508          165 NLIG-AGSFGSVYKGIFDHDDHETLVAVKVLNLQH-------------RGASKSFIAECQALRSIRHRNL--VKIITSCV  228 (484)
Q Consensus       165 ~~lg-~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~  228 (484)
                      ..|| .|+.|+||.+...    +..++||.+....             ......+.+|++++.++.|+++  ++.+++..
T Consensus        37 ~~lg~~~g~gtv~~v~~~----~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~  112 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP----GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV  112 (239)
T ss_pred             ceeecCCCCccEEEEEeC----CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence            5677 8888999988753    4568888875321             0122467889999999998875  66666543


Q ss_pred             eeccCCCceeeEEeecccC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 011508          229 SVDFQGNDFEALVYELMVN-GSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL  307 (484)
Q Consensus       229 ~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~  307 (484)
                      ... ......++|||++++ .+|.+++...     .++..    .+.+++.++.+||   ..||+||||||.|||++.++
T Consensus       113 ~~~-~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~  179 (239)
T PRK01723        113 VRH-GLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDG  179 (239)
T ss_pred             eec-CcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCC
Confidence            211 111123599999997 6999888631     24443    3578999999999   99999999999999999988


Q ss_pred             ceEEcccCccccc
Q 011508          308 TAHVSDFGLAKFL  320 (484)
Q Consensus       308 ~~kl~Dfg~a~~~  320 (484)
                      .++|+|||.+...
T Consensus       180 ~v~LIDfg~~~~~  192 (239)
T PRK01723        180 KFWLIDFDRGELR  192 (239)
T ss_pred             CEEEEECCCcccC
Confidence            9999999988753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=1.2e-16  Score=163.25  Aligned_cols=259  Identities=25%  Similarity=0.267  Sum_probs=187.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  235 (484)
                      ..|.+.+.||+|+|+.|-...... .....+|+|.+....  ....+....|..+-..+. |+|++.+++.     ..+.
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~-~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~-----~~~~   93 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSR-DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEP-----SSSP   93 (601)
T ss_pred             ccccccccccccccchhhhhhhcC-CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCc-----cCCC
Confidence            457778889999999998876432 234567777765443  222344556777777776 9999999987     4556


Q ss_pred             ceeeEEeecccCCCHHHHH-hhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcc
Q 011508          236 DFEALVYELMVNGSLEEWL-HLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVSD  313 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~D  313 (484)
                      ...+++.+|..++++.+.+ ....   ...+....-.++.|+..++.|+|.  ..++.|+|+||+|.+++..+ ..+++|
T Consensus        94 ~~~~~~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~d  168 (601)
T KOG0590|consen   94 RSYLLSLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIAD  168 (601)
T ss_pred             cccccccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCC
Confidence            6889999999999998877 3211   135566677889999999999996  67899999999999999999 999999


Q ss_pred             cCcccccccccccCCCCccccccccc-cccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKG-TVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      ||+|..+....    +........+| ++.|.|||...+. ...+..|+||.|+++.-+++|..||............|.
T Consensus       169 f~~At~~~~~~----g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~  244 (601)
T KOG0590|consen  169 FGLATAYRNKN----GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK  244 (601)
T ss_pred             chhhccccccC----CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec
Confidence            99998775421    12223334567 9999999998874 557789999999999999999999976544433322222


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ......          .                   ............++...++..+|..|.+.+++-.
T Consensus       245 ~~~~~~----------~-------------------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  245 SNKGRF----------T-------------------QLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccccc----------c-------------------cCccccCChhhhhcccccccCCchhccccccccc
Confidence            211000          0                   0001112445678888899999999999888753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.47  E-value=2.3e-13  Score=135.10  Aligned_cols=143  Identities=22%  Similarity=0.230  Sum_probs=97.9

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccch----------------------------------------H
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS----------------------------------------K  203 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~  203 (484)
                      .+.||.|++|.||+|++.   +|+.||||+.+.......                                        -
T Consensus       122 ~~plasaSigQVh~A~l~---~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~El  198 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV---DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRREL  198 (437)
T ss_pred             CcceeeeehhheEEEEec---CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHH
Confidence            368999999999999976   468899999864321100                                        0


Q ss_pred             HHHHHHHHHHcC----CCCCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHH-
Q 011508          204 SFIAECQALRSI----RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS-  278 (484)
Q Consensus       204 ~~~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-  278 (484)
                      +|.+|.+.+.++    +|.+-+.+-..+.    ......++||||++|++|.++......   ..   .+..++.+++. 
T Consensus       199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~----~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~  268 (437)
T TIGR01982       199 DLRREAANASELGENFKNDPGVYVPEVYW----DRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARS  268 (437)
T ss_pred             CHHHHHHHHHHHHHhcCCCCCEEeCCEeh----hhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHH
Confidence            244455555544    2333333333321    122346899999999999887653211   12   23456666665 


Q ss_pred             HHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccccc
Q 011508          279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE  322 (484)
Q Consensus       279 ~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  322 (484)
                      .+..+|   ..+++|+|++|.||++++++.++++|||++..++.
T Consensus       269 ~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       269 FLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            467788   89999999999999999999999999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN03150 hypothetical protein; Provisional

Probab=99.44  E-value=8.7e-14  Score=144.49  Aligned_cols=81  Identities=40%  Similarity=0.658  Sum_probs=48.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc--cccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK--GVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+|+|.+|.++++|++|+.|||++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..  ..+.++..+++.+|+.+
T Consensus       449 Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l  528 (623)
T PLN03150        449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGL  528 (623)
T ss_pred             CCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccc
Confidence            3556666666666666666666666666666666666666666666666666666666643  11223445566666666


Q ss_pred             cCC
Q 011508           79 CGG   81 (484)
Q Consensus        79 ~g~   81 (484)
                      ||.
T Consensus       529 c~~  531 (623)
T PLN03150        529 CGI  531 (623)
T ss_pred             cCC
Confidence            664

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.42  E-value=2.7e-13  Score=132.67  Aligned_cols=204  Identities=28%  Similarity=0.339  Sum_probs=153.8

Q ss_pred             CCCccCcccc--ccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCC
Q 011508          160 GFSLENLIGA--GSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       160 ~~~~~~~lg~--G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  234 (484)
                      .|.+...+|.  |.+|.||.+......+...+|+|.-+....  .....=.+|+....++ .|+|.++....     +.+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~  189 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG  189 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence            4566788999  999999999864455677899987443322  2233445666666666 58898885555     566


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeecCCCCCCeeecCC-Cce
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS----TLEYLHHYCETPIVHCDLKPSNVLLDGE-LTA  309 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~  309 (484)
                      .+..++-+|++ +.+|.++.+...   ..++....+.+..+..+    ||.++|   ...++|-|+||.||+...+ ...
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheeccccccee
Confidence            77889999998 678888876332   23667777888888888    999999   9999999999999999999 899


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCC
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN  378 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~  378 (484)
                      +++|||+...+....-  ...........|...|++||...+ .++..+|||++|.+..+..++..+..
T Consensus       263 ~~~df~~v~~i~~~~~--~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~  328 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNF--SSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS  328 (524)
T ss_pred             ecCCcceeEEccCCcc--ccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence            9999999887754431  111111223357888999998654 67899999999999999999877653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.37  E-value=1e-11  Score=122.83  Aligned_cols=166  Identities=19%  Similarity=0.193  Sum_probs=122.9

Q ss_pred             CeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCC
Q 011508          185 HETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNL  264 (484)
Q Consensus       185 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l  264 (484)
                      ++.+|.|...+...........+.++.|+.++||||++++..     +..+...|+|+|.+.  -|..+++.       +
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t-----~e~~~~~ylvTErV~--Pl~~~lk~-------l  101 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDT-----TEEEGTLYLVTERVR--PLETVLKE-------L  101 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhh-----hcccCceEEEeeccc--cHHHHHHH-------h
Confidence            456788887776554445667888999999999999999988     455558999999984  46777763       3


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccccccCCCCcccccccccccccc
Q 011508          265 NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYA  344 (484)
Q Consensus       265 ~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~  344 (484)
                      ....+...+.||+.||.|||+  +.+++|++|.-+.|++++.|..||++|.++...+....       ......--..|.
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-------~~~~~~~~~s~~  172 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-------PAKSLYLIESFD  172 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-------ccccchhhhccc
Confidence            356677788999999999986  78999999999999999999999999988764422110       000111223355


Q ss_pred             CccccCCCCCCcccceehhhHHHHHHHhCCC
Q 011508          345 APEYGMGSEVSTSGDVYSFGILLLEMFTGKG  375 (484)
Q Consensus       345 aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~  375 (484)
                      .|+.+....  -..|.|.|||+++|++.|..
T Consensus       173 ~P~~~~~s~--~s~D~~~Lg~li~el~ng~~  201 (690)
T KOG1243|consen  173 DPEEIDPSE--WSIDSWGLGCLIEELFNGSL  201 (690)
T ss_pred             ChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence            666433322  34699999999999999943

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.32  E-value=5.4e-12  Score=109.68  Aligned_cols=128  Identities=17%  Similarity=0.145  Sum_probs=93.2

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCcee-EeeeeeeeccCCCceeeEEe
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK-IITSCVSVDFQGNDFEALVY  242 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~~~~~~lv~  242 (484)
                      .+.|+.|.++.||++...    +..+++|+...... ....+.+|+.+++.+.+.++++ ++.+.       ....++||
T Consensus         3 ~~~l~~G~~~~vy~~~~~----~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~   70 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA----NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLIT   70 (170)
T ss_pred             eeecCCcccCceEEEEEC----CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEE
Confidence            357899999999999854    56799998754322 2235678999999886555443 44331       11347999


Q ss_pred             ecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeecCCCCCCeeecCCCceEEcccCcc
Q 011508          243 ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP-----IVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       243 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      ||+++.++.+.-         .   ....++.+++++|+.||   ..+     ++|+|++|.||+++ ++.++++||+.+
T Consensus        71 e~i~G~~l~~~~---------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a  134 (170)
T cd05151          71 EFIEGSELLTED---------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYA  134 (170)
T ss_pred             EecCCCcccccc---------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccc
Confidence            999998775420         1   11235678999999999   555     59999999999999 568999999987


Q ss_pred             cc
Q 011508          318 KF  319 (484)
Q Consensus       318 ~~  319 (484)
                      ..
T Consensus       135 ~~  136 (170)
T cd05151         135 GM  136 (170)
T ss_pred             cC
Confidence            63

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.28  E-value=6.6e-11  Score=103.29  Aligned_cols=139  Identities=19%  Similarity=0.161  Sum_probs=96.9

Q ss_pred             cCccccccceeEEEEEEcCCC----CeeEEEEEEeeccCc----------------------cchHHHH----HHHHHHH
Q 011508          164 ENLIGAGSFGSVYKGIFDHDD----HETLVAVKVLNLQHR----------------------GASKSFI----AECQALR  213 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~----~~~~vavK~~~~~~~----------------------~~~~~~~----~e~~~l~  213 (484)
                      ...||.|--+.||.|.-.+..    .+..+|||+.+....                      ...+.+.    +|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            357999999999999743211    346899999863210                      0012233    7999999


Q ss_pred             cCCC--CCceeEeeeeeeeccCCCceeeEEeecccCCCHHH-HHhhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCC
Q 011508          214 SIRH--RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEE-WLHLNRDAPRNLNLLQRLSIAVDVASTLEYL-HHYCET  289 (484)
Q Consensus       214 ~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~  289 (484)
                      ++..  -++.+.+++         ...++||||+.+..+.. .++.     ..++..+...+..+++.+|..| |   ..
T Consensus        82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H---~~  144 (197)
T cd05146          82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYK---EC  144 (197)
T ss_pred             HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHH---hC
Confidence            8843  355555543         14589999996643321 2221     1244556677889999999998 7   88


Q ss_pred             CeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          290 PIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       290 ~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      +++||||++.||++++ +.+.|+|||.+...
T Consensus       145 glVHGDLs~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         145 NLVHADLSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             CeecCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence            9999999999999974 67999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.28  E-value=1.1e-11  Score=124.54  Aligned_cols=148  Identities=16%  Similarity=0.223  Sum_probs=92.0

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc----------------------------------hH--
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA----------------------------------SK--  203 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~--  203 (484)
                      .|+. +.||+|++|.||+|++.+  +|+.||||+.+......                                  .+  
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~--~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKD--NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECC--CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            4665 789999999999999763  37889999997442100                                  01  


Q ss_pred             ----HHHHHHHHHHcCC----CCCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 011508          204 ----SFIAECQALRSIR----HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD  275 (484)
Q Consensus       204 ----~~~~e~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~  275 (484)
                          ++.+|...+.+++    +.+.+.+-..+    .+-....++||||++|+.+.++-....   ...+.   ..++..
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~----~d~st~~VLvmE~i~G~~l~d~~~l~~---~g~d~---~~la~~  267 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVY----WDYCSETVMVMERMYGIPVSDVAALRA---AGTDM---KLLAER  267 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceee----cccCCCceEEEeeecCccHHhHHHHHh---cCCCH---HHHHHH
Confidence                1334444444442    33333322222    111335689999999999987532111   11111   112222


Q ss_pred             HHHH-HHHHHhcCCCCeeecCCCCCCeeecCCC----ceEEcccCcccccccc
Q 011508          276 VAST-LEYLHHYCETPIVHCDLKPSNVLLDGEL----TAHVSDFGLAKFLPEA  323 (484)
Q Consensus       276 i~~~-l~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg~a~~~~~~  323 (484)
                      .+.. +..++   ..|++|+|+||.||+++.++    .+++.|||++..++..
T Consensus       268 ~v~~~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        268 GVEVFFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             HHHHHHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence            2221 22234   68999999999999999888    9999999999887554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.26  E-value=2.9e-10  Score=106.60  Aligned_cols=280  Identities=15%  Similarity=0.135  Sum_probs=169.8

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeee--eccCCCce
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVS--VDFQGNDF  237 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~--~~~~~~~~  237 (484)
                      ......||+|+-+.+|..-     .-...+.|++.........   +.+..|... .||-+-.-+.+-..  .+-.....
T Consensus        13 i~~gr~LgqGgea~ly~l~-----e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~   84 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLG-----EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV   84 (637)
T ss_pred             cCCCccccCCccceeeecc-----hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence            3556889999999999643     1222455777654432222   223334444 55543321111000  00122233


Q ss_pred             eeEEeecccCC-CHHHHHhh--cCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          238 EALVYELMVNG-SLEEWLHL--NRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       238 ~~lv~e~~~~g-sL~~~l~~--~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ..+.|+.+++. -...+...  .+..-....|...++.++.++.+.+.||   ..|.+-||+.++|+|+++++.+.|.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcc
Confidence            67788887664 22222221  1222345789999999999999999999   899999999999999999999999986


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccC-----CCCCCcccceehhhHHHHHHHhC-CCCCCCCccCCccHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-----GSEVSTSGDVYSFGILLLEMFTG-KGPTNEMFTGNLTLH  388 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg-~~p~~~~~~~~~~~~  388 (484)
                      ..-...        .+.......+|...|.+||.-.     +-.-+...|.|.+|+++++++.| ++||.+......   
T Consensus       162 Dsfqi~--------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~---  230 (637)
T COG4248         162 DSFQIN--------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD---  230 (637)
T ss_pred             cceeec--------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC---
Confidence            543332        1122334457889999999643     33457789999999999999885 999987532211   


Q ss_pred             HHHHhhcchhhh-hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCC--CcCCCCCHHHHHHHHHH
Q 011508          389 NFVKEALPERLA-EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSE--LPRERMNMEEVAAQLLS  465 (484)
Q Consensus       389 ~~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~--dP~~RPt~~evl~~L~~  465 (484)
                            .+.... ++..-.+....+.     ....++...+....-.+..+..+..+|+..  +|.-|||++.++..|..
T Consensus       231 ------ap~p~E~~Ia~g~f~ya~~~-----~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         231 ------APNPLETDIAHGRFAYASDQ-----RRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             ------CCCcchhhhhcceeeechhc-----cCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence                  000011 1111111000000     000111112222233356677788888775  36799999999999999


Q ss_pred             HHHHHhhc
Q 011508          466 FRNKLVKN  473 (484)
Q Consensus       466 i~~~~~~~  473 (484)
                      +++++.+=
T Consensus       300 l~~~L~~C  307 (637)
T COG4248         300 LRQQLKKC  307 (637)
T ss_pred             HHHhhhhh
Confidence            99888643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.20  E-value=2.3e-11  Score=119.26  Aligned_cols=252  Identities=19%  Similarity=0.155  Sum_probs=169.0

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHH--HHHHHHHHHcC-CCCCceeEeeeeeeeccC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS--FIAECQALRSI-RHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  233 (484)
                      -..+|..+..||.|.|+.|+.... ...++..|++|.+.........+  -..|+.+...+ .|.+++.....     +.
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~-r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~-----W~  336 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSK-RPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSS-----WS  336 (524)
T ss_pred             ecCCcceeEEccCCccccceeeee-cCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCC-----cc
Confidence            345788899999999999999873 33457789999876554333222  23455555555 57777776554     23


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVS  312 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~  312 (484)
                      .....++=-|||+++++...+.    ....+++..++++..|++.++.++|   ++.++|+|+||+||++..+ +..+++
T Consensus       337 ~~r~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~  409 (524)
T KOG0601|consen  337 QLRQGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLG  409 (524)
T ss_pred             ccccccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcc
Confidence            3345678889999998876652    2334777888999999999999999   9999999999999999886 788999


Q ss_pred             ccCcccccccccccCCCCccccccccccccc-cCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGY-AAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y-~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      |||++..+.-..         ......+..| .+|+......+..+.|+||||..+.|..++..--... ..      |.
T Consensus       410 ~~~~~t~~~~~~---------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~~------~~  473 (524)
T KOG0601|consen  410 DFGCWTRLAFSS---------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-VQ------SL  473 (524)
T ss_pred             ccccccccceec---------ccccccccccccchhhccccccccccccccccccccccccCcccCccc-cc------ce
Confidence            999986432111         0011123333 3555666677889999999999999999987532210 00      00


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                               .+.......                     ......++..+...+..+++..||.+.+.....+..+
T Consensus       474 ---------~i~~~~~p~---------------------~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  474 ---------TIRSGDTPN---------------------LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             ---------eeecccccC---------------------CCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                     000000000                     0011245666777788899999999888766555443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.18  E-value=2.5e-10  Score=96.03  Aligned_cols=129  Identities=26%  Similarity=0.311  Sum_probs=92.8

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccc-------hHHHHHHHHHHHcCCCCCc--eeEeeeeeeeccCC
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGA-------SKSFIAECQALRSIRHRNL--VKIITSCVSVDFQG  234 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~-------~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~  234 (484)
                      ..+++|+-+.+|.+.+.    +..+++|.-.... ...       ...-.+|.+++.+++--.|  ..++.+       +
T Consensus         2 ~~i~~GAEa~i~~~~~~----g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-------D   70 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL----GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-------D   70 (204)
T ss_pred             chhhCCcceeEEeeecc----CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-------c
Confidence            46889999999999764    3346666432221 111       1346689999988854333  233332       2


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      .+...|+|||++|..|.+.+...           ...++..+-.-+.-||   ..+|+|+||.++||+++++. +.++||
T Consensus        71 ~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDf  135 (204)
T COG3642          71 PDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDF  135 (204)
T ss_pred             CCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEEC
Confidence            23557999999999999888632           2456777888888999   99999999999999998764 999999


Q ss_pred             Ccccc
Q 011508          315 GLAKF  319 (484)
Q Consensus       315 g~a~~  319 (484)
                      |++..
T Consensus       136 GLg~~  140 (204)
T COG3642         136 GLGEF  140 (204)
T ss_pred             Ccccc
Confidence            99874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.12  E-value=7.5e-10  Score=92.69  Aligned_cols=143  Identities=20%  Similarity=0.245  Sum_probs=98.0

Q ss_pred             ccCccccccceeEEEEEEcCCCCeeEEEEEE-eeccCcc-------chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKV-LNLQHRG-------ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       163 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~-~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ....|-+|+-+.|+++.+.    ++...||. +.+.-+.       ...+..+|.++|.++.--.|.-..-++.     +
T Consensus        11 ~l~likQGAEArv~~~~~~----Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~-----D   81 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS----GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI-----D   81 (229)
T ss_pred             cceeeeccceeeEeeeccC----CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE-----e
Confidence            4578899999999999875    55566663 3322111       1245678999998885333322111221     2


Q ss_pred             CceeeEEeecccC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC---ceE
Q 011508          235 NDFEALVYELMVN-GSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL---TAH  310 (484)
Q Consensus       235 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~---~~k  310 (484)
                      ...-.|+|||+++ .++.+++.......  ........++..|-+.+.-||   ..+|+||||..+||++..++   .+.
T Consensus        82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~  156 (229)
T KOG3087|consen   82 TYGGQIYMEFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPI  156 (229)
T ss_pred             cCCCeEEEEeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceE
Confidence            2245799999966 48888887543221  222333678889999999999   99999999999999996554   568


Q ss_pred             EcccCcccc
Q 011508          311 VSDFGLAKF  319 (484)
Q Consensus       311 l~Dfg~a~~  319 (484)
                      ++|||++..
T Consensus       157 lIdfgls~~  165 (229)
T KOG3087|consen  157 LIDFGLSSV  165 (229)
T ss_pred             EEeecchhc
Confidence            999998864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.10  E-value=8.8e-10  Score=100.20  Aligned_cols=146  Identities=20%  Similarity=0.182  Sum_probs=105.8

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCC--CceeEeeeeeeeccCCCceeeEE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHR--NLVKIITSCVSVDFQGNDFEALV  241 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv  241 (484)
                      +.|+.|.++.||+++..+   +..+++|....... .....+.+|.++++.+.+.  ++.+++.+.....  ..+..++|
T Consensus         4 ~~l~~G~~n~~~~v~~~~---g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v   78 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG---GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYV   78 (223)
T ss_pred             eecCCCccceEEEEEecC---CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEE
Confidence            568999999999998542   46789998764332 1345788999999999653  3566666532211  11245899


Q ss_pred             eecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 011508          242 YELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC----------------------------------  287 (484)
Q Consensus       242 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------  287 (484)
                      |||++|.++.+.+..     ..++..+...++.+++++|+.||+..                                  
T Consensus        79 ~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          79 MERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            999999888765421     23667777788888888888888421                                  


Q ss_pred             -------------------CCCeeecCCCCCCeeecC--CCceEEcccCccccc
Q 011508          288 -------------------ETPIVHCDLKPSNVLLDG--ELTAHVSDFGLAKFL  320 (484)
Q Consensus       288 -------------------~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~a~~~  320 (484)
                                         ...++|+|+++.||+++.  ++.+.|+||+.+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g  207 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG  207 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence                               245799999999999998  567899999987653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.09  E-value=6.1e-11  Score=122.55  Aligned_cols=210  Identities=26%  Similarity=0.306  Sum_probs=140.6

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      ..+.+.+.+.+-+|+++.++.+.  ....+...++|+.....   ....+....+-.++-..++|-++.....     +.
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~--pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~  874 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPAS--PAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FP  874 (1205)
T ss_pred             CCccceecccccCCCCcccccCC--ccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CC
Confidence            45677888889999999999876  33334344444433211   1112222222222222334444433222     23


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      -....+++++|..+++|...++.-.    ..+..-.......+.+++++||   ...+.|+|++|.|++...++..+++|
T Consensus       875 ~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~  947 (1205)
T KOG0606|consen  875 CRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTD  947 (1205)
T ss_pred             CCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCc
Confidence            3446789999999999999887433    2343344455667888999999   77799999999999999999999999


Q ss_pred             cCcccccccccc--------c---------------C-CCCccccccccccccccCccccCCCCCCcccceehhhHHHHH
Q 011508          314 FGLAKFLPEAAN--------N---------------L-SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLE  369 (484)
Q Consensus       314 fg~a~~~~~~~~--------~---------------~-~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~e  369 (484)
                      ||..........        .               . ...........+|+.|.+||...+......+|.|++|++++|
T Consensus       948 ~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e 1027 (1205)
T KOG0606|consen  948 FGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFE 1027 (1205)
T ss_pred             cccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhh
Confidence            984332211100        0               0 000012234578999999999999999999999999999999


Q ss_pred             HHhCCCCCCCC
Q 011508          370 MFTGKGPTNEM  380 (484)
Q Consensus       370 lltg~~p~~~~  380 (484)
                      .++|..||...
T Consensus      1028 ~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1028 VLTGIPPFNAE 1038 (1205)
T ss_pred             hhcCCCCCCCc
Confidence            99999999864

>PLN03150 hypothetical protein; Provisional

Probab=99.07  E-value=1.1e-10  Score=121.42  Aligned_cols=82  Identities=33%  Similarity=0.662  Sum_probs=76.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|+|.+|.++++|++|+.|+|++|+|+|.+|..+++|++|+.|||++|+|+|.+|.. +.+.+|+.+++++| .+.
T Consensus       425 L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N-~l~  503 (623)
T PLN03150        425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN-SLS  503 (623)
T ss_pred             CCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC-ccc
Confidence            6789999999999999999999999999999999999999999999999999999999874 78899999999999 566


Q ss_pred             CCCc
Q 011508           80 GGIS   83 (484)
Q Consensus        80 g~~~   83 (484)
                      |..|
T Consensus       504 g~iP  507 (623)
T PLN03150        504 GRVP  507 (623)
T ss_pred             ccCC
Confidence            6554

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.04  E-value=6.4e-09  Score=100.25  Aligned_cols=175  Identities=19%  Similarity=0.225  Sum_probs=130.6

Q ss_pred             cceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEeecccC-CC
Q 011508          171 SFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVN-GS  249 (484)
Q Consensus       171 ~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gs  249 (484)
                      -..+.|++.  ...+|..|++|+++............-+++++++.|.|+|++..++.... .++.-.++||+|.++ ++
T Consensus       288 ~~~Ttyk~~--s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKAT--SNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeee--eccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCch
Confidence            446788988  45567889999995443333333445678999999999999999876443 345568899999986 57


Q ss_pred             HHHHHhhcC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          250 LEEWLHLNR-----------DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       250 L~~~l~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      |.++-....           ..+...++...|.++.|+..||.++|   +.|+.-+-|.+.+|+++++.+++|+..|...
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEeccccee
Confidence            777653221           22345788999999999999999999   8999999999999999999999998888776


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCC
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG  375 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~  375 (484)
                      .+..+.                   .  |-+   .--.+-|.=.||.+++.|.||..
T Consensus       442 vl~~d~-------------------~--~~l---e~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  442 VLQEDP-------------------T--EPL---ESQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             eecCCC-------------------C--cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence            653321                   0  001   11246788899999999999964

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.00  E-value=3.9e-09  Score=91.91  Aligned_cols=125  Identities=22%  Similarity=0.222  Sum_probs=79.1

Q ss_pred             eEEEEEEcCCCCeeEEEEEEeeccCc-------------c---------c----hHHHHHHHHHHHcCCCC--CceeEee
Q 011508          174 SVYKGIFDHDDHETLVAVKVLNLQHR-------------G---------A----SKSFIAECQALRSIRHR--NLVKIIT  225 (484)
Q Consensus       174 ~Vy~~~~~~~~~~~~vavK~~~~~~~-------------~---------~----~~~~~~e~~~l~~l~h~--niv~~~~  225 (484)
                      .||.|...   ++..+|+|+.+....             .         .    .....+|.+.|.++...  ++.+.+.
T Consensus         1 ~Vy~~~~~---~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~   77 (188)
T PF01163_consen    1 DVYHAIDP---DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYD   77 (188)
T ss_dssp             EEEEEEEC---TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEE
T ss_pred             CEEEEECC---CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEE
Confidence            38888754   467899998863210             0         0    13467899999999765  4556654


Q ss_pred             eeeeeccCCCceeeEEeeccc--CCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCCee
Q 011508          226 SCVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY-LHHYCETPIVHCDLKPSNVL  302 (484)
Q Consensus       226 ~~~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~dlk~~NIl  302 (484)
                      +-         ...+||||++  |..+..+....      ++......++.+++..+.. +|   ..+|+||||.+.||+
T Consensus        78 ~~---------~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIl  139 (188)
T PF01163_consen   78 YN---------RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNIL  139 (188)
T ss_dssp             EE---------TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEE
T ss_pred             Ee---------CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEE
Confidence            41         3479999998  54444433211      1123445677788885555 57   899999999999999


Q ss_pred             ecCCCceEEcccCccccc
Q 011508          303 LDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       303 l~~~~~~kl~Dfg~a~~~  320 (484)
                      ++++ .+.|+|||.+...
T Consensus       140 v~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  140 VDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             EETT-CEEE--GTTEEET
T ss_pred             eecc-eEEEEecCcceec
Confidence            9988 9999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=98.99  E-value=4e-10  Score=125.03  Aligned_cols=82  Identities=37%  Similarity=0.650  Sum_probs=68.3

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+++|.+|.++++|++|+.|+|++|+++|.+|..+.++++|+.|+|++|+++|.+|.. ..+.+++.+++++| .+.
T Consensus       506 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N-~l~  584 (968)
T PLN00113        506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN-HLH  584 (968)
T ss_pred             CcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCC-cce
Confidence            5788888888888888899999999999999889988888999999999999998888864 56778888899988 455


Q ss_pred             CCCc
Q 011508           80 GGIS   83 (484)
Q Consensus        80 g~~~   83 (484)
                      |..|
T Consensus       585 ~~~p  588 (968)
T PLN00113        585 GSLP  588 (968)
T ss_pred             eeCC
Confidence            5443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.98  E-value=1.4e-08  Score=93.92  Aligned_cols=145  Identities=14%  Similarity=0.022  Sum_probs=97.3

Q ss_pred             ccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-----------chHHHHHHHHHHHcCCCCC--ceeEeeeeeeecc
Q 011508          166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-----------ASKSFIAECQALRSIRHRN--LVKIITSCVSVDF  232 (484)
Q Consensus       166 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~  232 (484)
                      .+-.-....|++..+.    ++.+.||........           ....+.+|...+.++...+  ..+.+++......
T Consensus        29 ~v~~~~~rrvvr~~~~----g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~  104 (268)
T PRK15123         29 VFRELEGRRTLRFELA----GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSN  104 (268)
T ss_pred             EEecCCCceEEEEEEC----CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCC
Confidence            3333344456676654    467999976432211           1114778888888884333  3334444322111


Q ss_pred             CCCceeeEEeecccCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC------
Q 011508          233 QGNDFEALVYELMVNG-SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG------  305 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~------  305 (484)
                      ......++|+|++++. +|.+++....  ....+...+..++.+++..++-||   ..||+|+|++++|||++.      
T Consensus       105 ~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~  179 (268)
T PRK15123        105 PATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGRE  179 (268)
T ss_pred             CccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCC
Confidence            1123568999999876 8999885322  123456677789999999999999   999999999999999975      


Q ss_pred             -CCceEEcccCcccc
Q 011508          306 -ELTAHVSDFGLAKF  319 (484)
Q Consensus       306 -~~~~kl~Dfg~a~~  319 (484)
                       +..+.++||+.+..
T Consensus       180 ~~~~~~LIDl~r~~~  194 (268)
T PRK15123        180 EDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCceEEEEECCcccc
Confidence             46899999997753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.86  E-value=1.7e-08  Score=90.37  Aligned_cols=135  Identities=24%  Similarity=0.186  Sum_probs=98.0

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc----------------c------chHHHHHHHHHHHcCCCC
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR----------------G------ASKSFIAECQALRSIRHR  218 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~----------------~------~~~~~~~e~~~l~~l~h~  218 (484)
                      ..+++.||-|--+.||.|..+   .+..+|||.=+....                .      ......+|.++|.+|...
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~---~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~  169 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP---KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPE  169 (304)
T ss_pred             HhhccccccCccceEEEEECC---CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhc
Confidence            456789999999999999854   578899996542210                0      013467899999999654


Q ss_pred             --CceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 011508          219 --NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDL  296 (484)
Q Consensus       219 --niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl  296 (484)
                        .+.+.+++         +...+|||+++|--|...-         ++....-.++..|+.-+..+-   ..||||||+
T Consensus       170 G~~VP~P~~~---------nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~---~~GiVHGDl  228 (304)
T COG0478         170 GVKVPKPIAW---------NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAY---RRGIVHGDL  228 (304)
T ss_pred             CCCCCCcccc---------ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHH---HcCccccCC
Confidence              56665554         3568999999886554321         123344456666776666666   689999999


Q ss_pred             CCCCeeecCCCceEEcccCcccc
Q 011508          297 KPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       297 k~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      ++-||++++||.+.++||-.+..
T Consensus       229 SefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         229 SEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             chheEEEecCCCEEEEeCccccc
Confidence            99999999999999999976653

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.84  E-value=6.6e-10  Score=91.44  Aligned_cols=77  Identities=26%  Similarity=0.420  Sum_probs=70.5

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      ||+|+|+ .+|+.|+.|.+|+.|++++|+++ .+|.+++.|+.|+.|+++-|+|.-.+-..+.|+-++.+++..| +|..
T Consensus        40 LSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldltyn-nl~e  116 (264)
T KOG0617|consen   40 LSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYN-NLNE  116 (264)
T ss_pred             cccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhcccc-cccc
Confidence            6899999 99999999999999999999999 9999999999999999999999977777799999999999999 5543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.81  E-value=8.1e-08  Score=85.90  Aligned_cols=110  Identities=23%  Similarity=0.265  Sum_probs=82.6

Q ss_pred             HHHHHHHHHHHcCCCC--CceeEeeeeeeeccCCCceeeEEeecccCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 011508          203 KSFIAECQALRSIRHR--NLVKIITSCVSVDFQGNDFEALVYELMVNG-SLEEWLHLNRDAPRNLNLLQRLSIAVDVAST  279 (484)
Q Consensus       203 ~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~  279 (484)
                      ....+|...+..+...  ...+.+++..... ......++|+|++++. +|.+++.....    .+......++.+++..
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~  130 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL  130 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence            4577888887777433  3445555543322 1124568999999874 89999874322    4556778899999999


Q ss_pred             HHHHHhcCCCCeeecCCCCCCeeecCCC---ceEEcccCccccc
Q 011508          280 LEYLHHYCETPIVHCDLKPSNVLLDGEL---TAHVSDFGLAKFL  320 (484)
Q Consensus       280 l~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfg~a~~~  320 (484)
                      ++-||   ..+|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       131 i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  131 IAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99999   99999999999999998886   8999999977653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.80  E-value=2.2e-07  Score=81.43  Aligned_cols=158  Identities=15%  Similarity=0.111  Sum_probs=107.9

Q ss_pred             HhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC------ccchHHHHHHHHHHHcCCCCC--ceeE
Q 011508          152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH------RGASKSFIAECQALRSIRHRN--LVKI  223 (484)
Q Consensus       152 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~n--iv~~  223 (484)
                      +.+......+-..---|+||-+.|++..+.    +..+-+|.-....      +.....|.+|+..|.++..-+  +.+.
T Consensus        11 ~~~w~~~~~wve~pN~~rgG~SgV~r~~~~----g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~p   86 (216)
T PRK09902         11 NHWWATEGDWVEEPNYRRNGMSGVQCVERN----GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKI   86 (216)
T ss_pred             HHHHhCCCceecCCCcCCCCcceEEEEEeC----CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCcc
Confidence            333333333333333567899999997754    2357777654211      223467999999999984322  4444


Q ss_pred             eeeeeeeccCCCceeeEEeecccC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 011508          224 ITSCVSVDFQGNDFEALVYELMVN-GSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVL  302 (484)
Q Consensus       224 ~~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIl  302 (484)
                      + ++...........+||+|-+++ -+|.+++....  ..+.+...+..++.++++.++-||   ..++.|+|+.+.||+
T Consensus        87 v-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIl  160 (216)
T PRK09902         87 V-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIY  160 (216)
T ss_pred             c-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhhee
Confidence            4 3322222334456899998854 58999886432  224577778899999999999999   999999999999999


Q ss_pred             ecCCCc--eEEcccCcccc
Q 011508          303 LDGELT--AHVSDFGLAKF  319 (484)
Q Consensus       303 l~~~~~--~kl~Dfg~a~~  319 (484)
                      ++.++.  ++++||.-++.
T Consensus       161 l~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        161 VKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             ecCCCCeeEEEEEhhccch
Confidence            986666  99999986653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.78  E-value=3.6e-09  Score=105.58  Aligned_cols=101  Identities=22%  Similarity=0.456  Sum_probs=77.4

Q ss_pred             HHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccccccCCCCc--cccccccccccccCccccCCC
Q 011508          275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQ--SSSVGVKGTVGYAAPEYGMGS  352 (484)
Q Consensus       275 ~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~  352 (484)
                      +++.|+.|+|.  +.++||++|.|++|.++.++..||+.|+++..............  .......-...|.|||++...
T Consensus       107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            44589999997  78999999999999999999999999998866544222111111  111223356779999999998


Q ss_pred             CCCcccceehhhHHHHHHHh-CCCCC
Q 011508          353 EVSTSGDVYSFGILLLEMFT-GKGPT  377 (484)
Q Consensus       353 ~~~~~~Dvws~Gvvl~ellt-g~~p~  377 (484)
                      ..+.++|+||+||++|.+.. |+.-+
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~  210 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSII  210 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchh
Confidence            88999999999999999984 55444

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.59  E-value=2.8e-08  Score=69.80  Aligned_cols=57  Identities=35%  Similarity=0.522  Sum_probs=36.8

Q ss_pred             CCCCEEeCcCCccccccC-ccccCCCCCCeeeccccceecccccc-cccccCcccccCCC
Q 011508           18 RGIENLDLSQNNLSGRIP-KYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus        18 ~~l~~l~ls~N~l~g~~p-~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      ++|+.|+|++|+|+ .|| ..+.++++|+.|++++|+++...|.. ..+++++.+++++|
T Consensus         1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N   59 (61)
T PF13855_consen    1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN   59 (61)
T ss_dssp             TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred             CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence            35667777777777 444 45666777777777777776655543 55666666677666

...

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.56  E-value=8.8e-07  Score=77.91  Aligned_cols=141  Identities=13%  Similarity=0.120  Sum_probs=91.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHH---------HHHHHHHHHcC---CCCCceeEee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS---------FIAECQALRSI---RHRNLVKIIT  225 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~e~~~l~~l---~h~niv~~~~  225 (484)
                      ..+|...+.+-......|.+....    +..+++|..+.......+.         ..+++..+.++   .......++.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei~----~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEID----GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEEC----CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            466777778877777777776644    5678888876543222211         22333333333   2333333333


Q ss_pred             eeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 011508          226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG  305 (484)
Q Consensus       226 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~  305 (484)
                      +.....+.-....+++|||++|..|.+...        ++.    .++..+.+++.-||   ..|++|+|..|.|+++++
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~  170 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSN  170 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEEC
Confidence            322222222345679999999988766542        222    24566778899999   999999999999999996


Q ss_pred             CCceEEcccCccc
Q 011508          306 ELTAHVSDFGLAK  318 (484)
Q Consensus       306 ~~~~kl~Dfg~a~  318 (484)
                      ++ +++.||+..+
T Consensus       171 ~~-i~iID~~~k~  182 (229)
T PF06176_consen  171 NG-IRIIDTQGKR  182 (229)
T ss_pred             Cc-EEEEECcccc
Confidence            54 9999998665

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.53  E-value=2.5e-08  Score=82.33  Aligned_cols=73  Identities=27%  Similarity=0.502  Sum_probs=61.8

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceec-ccccc-cccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEG-EVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g-~~p~~-~~~~~~~~~~~~~n   75 (484)
                      +++|+|+ .+|.++++|++|+.|+++-|+|. .+|..|+.++-|++|||++|+|.. .+|.. -.+..+..+.+++|
T Consensus        63 ~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dn  137 (264)
T KOG0617|consen   63 LSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDN  137 (264)
T ss_pred             cccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCC
Confidence            5789999 99999999999999999999999 999999999999999999999964 44542 23455666777777

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.51  E-value=7.7e-08  Score=67.52  Aligned_cols=53  Identities=42%  Similarity=0.631  Sum_probs=47.1

Q ss_pred             CCCCcccccCc-hhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccce
Q 011508            1 MNGNFFQGNIP-SSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHF   54 (484)
Q Consensus         1 l~~n~l~g~~p-~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l   54 (484)
                      |++|+|+ .|| ..|..+++|+.|+|++|+++..-|..|.++++|+.|++++|+|
T Consensus         8 l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    8 LSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             ETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5789999 566 5789999999999999999966667899999999999999986

...

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.48  E-value=9.9e-08  Score=61.42  Aligned_cols=38  Identities=42%  Similarity=0.677  Sum_probs=33.7

Q ss_pred             CCCCEEeCcCCccccccCccccCCCCCCeeeccccceec
Q 011508           18 RGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEG   56 (484)
Q Consensus        18 ~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g   56 (484)
                      ++|++|+|++|+|+ .||+.+++|++|+.|+|++|+|+.
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~   38 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD   38 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence            47999999999999 899989999999999999999984

...

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.46  E-value=3.1e-06  Score=74.11  Aligned_cols=106  Identities=22%  Similarity=0.163  Sum_probs=81.9

Q ss_pred             HHHHHHHHcCCC-CCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 011508          206 IAECQALRSIRH-RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH  284 (484)
Q Consensus       206 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  284 (484)
                      ..|.-+++.+.+ +++.+++|+|.         .++|.||...+++...-. .-..-...+|..+.+||.++++.+.+++
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHh
Confidence            357888888865 69999999983         368999998765532100 0001113689999999999999999999


Q ss_pred             hcCCCCeeecCCCCCCeeecCCCceEEcccCcccccc
Q 011508          285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP  321 (484)
Q Consensus       285 ~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~  321 (484)
                      +.....+.-.|++++|+-+++++++|++|...+...+
T Consensus        77 ~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   77 HGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             cCCCCcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            7655668889999999999999999999998776543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.45  E-value=5.9e-08  Score=90.54  Aligned_cols=73  Identities=25%  Similarity=0.326  Sum_probs=66.6

Q ss_pred             CCCCcccccCchhhh-CCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCc
Q 011508            1 MNGNFFQGNIPSSLS-SLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNV   76 (484)
Q Consensus         1 l~~n~l~g~~p~~~~-~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~   76 (484)
                      ++.|+|+ .+|.+++ +|.+|.+|||..|++. ++|+++.-+++|+.||||+|.+++.+++.+.+ .+..+.+.|||
T Consensus       235 ~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP  308 (565)
T KOG0472|consen  235 VGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP  308 (565)
T ss_pred             hcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence            3578887 9999988 8999999999999999 99999999999999999999999999998888 78888999996

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=5.4e-07  Score=90.41  Aligned_cols=142  Identities=19%  Similarity=0.226  Sum_probs=90.8

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCccch----------------------------------------HH
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS----------------------------------------KS  204 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~  204 (484)
                      +.|+.++-|.||+|++.   +|+.||||+.+..-....                                        -+
T Consensus       131 ~PiAsASIaQVH~A~L~---sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElD  207 (517)
T COG0661         131 EPIASASIAQVHRAVLK---SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELD  207 (517)
T ss_pred             CchhhhhHhhheeEEec---CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhC
Confidence            68999999999999988   478999999864321110                                        01


Q ss_pred             HHHHHHHHHcCC-----CCCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 011508          205 FIAECQALRSIR-----HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST  279 (484)
Q Consensus       205 ~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~  279 (484)
                      +.+|...+.+++     .++ +.+=..+    .+-.....++|||++|-.+.+......   ...+.   ..++..++++
T Consensus       208 y~~EA~n~~~~~~nf~~~~~-v~VP~V~----we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~---k~ia~~~~~~  276 (517)
T COG0661         208 YRREAANAERFRENFKDDPD-VYVPKVY----WEYTTRRVLTMEWIDGIKISDIAALKS---AGIDR---KELAELLVRA  276 (517)
T ss_pred             HHHHHHHHHHHHHHcCCCCC-eEeceee----hhccCCcEEEEEeeCCEecccHHHHHh---cCCCH---HHHHHHHHHH
Confidence            334444444441     222 1111111    222345689999999988888743222   12332   2333333332


Q ss_pred             -HHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccc
Q 011508          280 -LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA  323 (484)
Q Consensus       280 -l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~  323 (484)
                       +..+-   ..++.|.|..|.||+++.++.+.+.|||+...+++.
T Consensus       277 f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         277 FLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence             22222   569999999999999999999999999998877543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.40  E-value=4.1e-06  Score=75.91  Aligned_cols=139  Identities=17%  Similarity=0.214  Sum_probs=79.7

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCc--eeEeeeeeeeccCCCceeeEEe
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL--VKIITSCVSVDFQGNDFEALVY  242 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~  242 (484)
                      ..||+|..+.||+..      +..+++|......  ......+|.++++.+..-.+  .+.++++     ...+...+||
T Consensus         7 ~~i~~G~t~~~y~~~------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~   73 (226)
T TIGR02172         7 TQTGEGGNGESYTHK------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIY   73 (226)
T ss_pred             eeecCCCCcceeEec------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeee
Confidence            578999999999842      2346788876432  33557889999988854333  4455543     2233567899


Q ss_pred             ecccCCC-HHHHH---------------------hhcCCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhc-C
Q 011508          243 ELMVNGS-LEEWL---------------------HLNRDAPRNLNLLQRLS-IAV----------DVAS-TLEYLHHY-C  287 (484)
Q Consensus       243 e~~~~gs-L~~~l---------------------~~~~~~~~~l~~~~~~~-i~~----------~i~~-~l~~LH~~-~  287 (484)
                      |+++|.+ +...+                     +.....  ......... +..          .+.. ..++|... .
T Consensus        74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~  151 (226)
T TIGR02172        74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD  151 (226)
T ss_pred             eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence            9998863 21111                     111000  111111110 000          0111 11222211 1


Q ss_pred             CCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          288 ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       288 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      ...++|+|+.|.||++++++ +.++||+.+..
T Consensus       152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            34578999999999999888 99999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.36  E-value=1.5e-07  Score=87.87  Aligned_cols=52  Identities=40%  Similarity=0.570  Sum_probs=34.6

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeecccccee
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFE   55 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~   55 (484)
                      ++|.++ -+|..+..+++|..|+|++|-|. .+|.+++.+..|+.||+|+|+|.
T Consensus       420 snn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr  471 (565)
T KOG0472|consen  420 SNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR  471 (565)
T ss_pred             hcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc
Confidence            444444 66666777777777777777666 67777766666777777766664

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.34  E-value=9.1e-08  Score=94.12  Aligned_cols=75  Identities=29%  Similarity=0.319  Sum_probs=54.8

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccc-cCCCCCCeeeccccceecccccccccccCcccccCCCcc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYL-ENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVN   77 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~-~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~   77 (484)
                      ||+|+|. +.|..+-.-.++-.|+||+|++. +||..+ .+|.-|-+||||+|+|...+|....+..++.+.+++||.
T Consensus       110 LShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL  185 (1255)
T KOG0444|consen  110 LSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPL  185 (1255)
T ss_pred             cchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChh
Confidence            4666666 66666666666677777777776 677553 567777777888888887777777778888888888873

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.31  E-value=1.1e-05  Score=71.79  Aligned_cols=152  Identities=20%  Similarity=0.184  Sum_probs=97.4

Q ss_pred             ccHHhHHHhcCCCCccCc---cccccceeEEEEEEcCCCCeeEEEEEEeeccCccc-------------------hH---
Q 011508          149 VSYQNLFKATDGFSLENL---IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA-------------------SK---  203 (484)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-------------------~~---  203 (484)
                      .+...+.....+..+...   |++|--+.||+|.-   .++..+|+|+++......                   ..   
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~---~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAET---GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc---CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            344444455555555444   56677778999863   357889999987432111                   01   


Q ss_pred             --HHHHHHHHHHcCC--CCCceeEeeeeeeeccCCCceeeEEeecccCCC-HHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 011508          204 --SFIAECQALRSIR--HRNLVKIITSCVSVDFQGNDFEALVYELMVNGS-LEEWLHLNRDAPRNLNLLQRLSIAVDVAS  278 (484)
Q Consensus       204 --~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~i~~  278 (484)
                        -..+|..-|.++.  +-.+.+-+++.         .-.|||||+.... -.-.|+     ..++...+...+..++++
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~  177 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVE  177 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHH
Confidence              1346777777773  33444444431         3479999995431 111111     111233356677888888


Q ss_pred             HHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       279 ~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      .+.-|-.  ..++||+||+.-|||+. ++.+.|+|||.|...
T Consensus       178 ~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         178 YMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             HHHHHHH--hcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence            8888873  48999999999999999 789999999988755

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.23  E-value=6.1e-07  Score=76.94  Aligned_cols=71  Identities=30%  Similarity=0.407  Sum_probs=22.7

Q ss_pred             CCCCcccccCchhhh-CCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLS-SLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~-~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      |++|+|+ .|. .++ .|.+|+.||||+|.++ .|+ .+..+++|+.|+|++|+++...+.. ..+++++.+++++|
T Consensus        26 L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N   98 (175)
T PF14580_consen   26 LRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNN   98 (175)
T ss_dssp             ------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS
T ss_pred             ccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCC
Confidence            4566666 554 355 4677777777777777 665 3666777777777777777543322 24667777777777

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.15  E-value=5.9e-07  Score=89.14  Aligned_cols=185  Identities=18%  Similarity=0.159  Sum_probs=127.5

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCC-ceeEeeeeeeeccCCCceee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN-LVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~  239 (484)
                      +...+-+++|++++++|.+  ...+ +....+.+...     ....-++++|.+++||| .+..++.     .+.+++.+
T Consensus       244 s~~fh~fvK~altknpKkR--ptae-klL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~  310 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKR--PTAE-KLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLW  310 (829)
T ss_pred             hHHHHHHHHHHhcCCCccC--CChh-hheeceeeccc-----hhhHHHHHHHHHccCCCCccccccc-----CCcccccc
Confidence            3444568899999999976  3322 22334544322     44556889999999999 4444443     45667889


Q ss_pred             EEeecccCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          240 LVYELMVNG-SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       240 lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++++++.++ +......   .....+...+...+.+.-.++++++|   +..=+|+|    ||+.++ +..+..||+...
T Consensus       311 i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~  379 (829)
T KOG0576|consen  311 IPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPP  379 (829)
T ss_pred             hhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCc
Confidence            999999877 2221111   01112334444556667778999999   55458888    777765 578999999988


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCC
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPT  377 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~  377 (484)
                      .+....        ......+++.++|||+.....+..+.|+|+.|+-..++.-|-+|-
T Consensus       380 ~L~~~~--------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  380 QLTRTM--------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccCccc--------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            764432        223456899999999999999999999999998777777777664

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.13  E-value=2.8e-05  Score=71.11  Aligned_cols=147  Identities=20%  Similarity=0.239  Sum_probs=82.5

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCC--CceeEeeeeeeeccCCCceeeEEe
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR--NLVKIITSCVSVDFQGNDFEALVY  242 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~  242 (484)
                      +.|+.|..+.||+....   + ..+++|.....  .....+.+|..++..+...  .+.+++.++...  ......+++|
T Consensus         3 ~~l~~G~~n~~~~v~~~---~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~~   74 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTD---D-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLLM   74 (239)
T ss_dssp             EEEEESSSSEEEEEEET---T-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEEE
T ss_pred             ccCCCCCeeeEEEEEEC---C-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEEE
Confidence            56899999999999854   2 47889986543  3446778888888888433  345566543221  2233478999


Q ss_pred             ecccCCCHHH----------------HH---hhcCCCCCCCCHHHH---------HHH------------HHHHHH-HHH
Q 011508          243 ELMVNGSLEE----------------WL---HLNRDAPRNLNLLQR---------LSI------------AVDVAS-TLE  281 (484)
Q Consensus       243 e~~~~gsL~~----------------~l---~~~~~~~~~l~~~~~---------~~i------------~~~i~~-~l~  281 (484)
                      +++++..+..                .+   +..............         ...            ...+.+ .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999887777                11   111001111111110         000            011222 233


Q ss_pred             HHHh----cCCCCeeecCCCCCCeeec-CCCceEEcccCcccc
Q 011508          282 YLHH----YCETPIVHCDLKPSNVLLD-GELTAHVSDFGLAKF  319 (484)
Q Consensus       282 ~LH~----~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~a~~  319 (484)
                      .++.    .....++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            3332    1256799999999999999 556668999987753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.13  E-value=1.7e-05  Score=66.68  Aligned_cols=129  Identities=19%  Similarity=0.202  Sum_probs=89.2

Q ss_pred             CccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCcee-EeeeeeeeccCCCceeeE
Q 011508          162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK-IITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       162 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~~~~~~l  240 (484)
                      ...+.|++|.+|.||++.|.    +..+|+|+-..++  ....+..|.++|..+.-.++-+ ++.|       +  ..++
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~----~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y-------g--~~~i   89 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR----GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY-------G--EDFI   89 (201)
T ss_pred             hhhhhhhcccccEEEEeecc----CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe-------c--hhhh
Confidence            44578999999999999987    4578888865443  3467889999999997766644 3333       1  3356


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC-CCCeeecCCCceEEcccCcccc
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLK-PSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk-~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      .|||+.|-.|.++-..       .+-..    ...++..---|-   ..||-|+.|. |..+++..+..+.|+||..|+.
T Consensus        90 ~me~i~G~~L~~~~~~-------~~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          90 RMEYIDGRPLGKLEIG-------GDRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhcCcchhhhhhc-------ccHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            6999988888776531       11222    233444433344   7889999987 5555555556999999998874

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.13  E-value=2.9e-05  Score=71.60  Aligned_cols=142  Identities=15%  Similarity=0.073  Sum_probs=80.0

Q ss_pred             ccccccc-eeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCCceeeEEee
Q 011508          166 LIGAGSF-GSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       166 ~lg~G~~-g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      .|..|.+ ..||+....    +..+.+|+.....   .....+|+++++.+. +--+.+++++..     .++..++|||
T Consensus         5 ~~~~g~~~~~v~~~~~~----~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv~e   72 (244)
T cd05150           5 RVTEGQSGATVYRLDGK----NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGS-----DDGRAWLLTS   72 (244)
T ss_pred             ecCCCCCcCeEEEEcCC----CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEe-----cCCccEEEEE
Confidence            3445555 788998632    2467888775432   345678888888873 333445565532     2235689999


Q ss_pred             cccCCCHHHHH-------------------hhcCCCCCCCCH--HHHHHHHH--------------------HHHHHHHH
Q 011508          244 LMVNGSLEEWL-------------------HLNRDAPRNLNL--LQRLSIAV--------------------DVASTLEY  282 (484)
Q Consensus       244 ~~~~gsL~~~l-------------------~~~~~~~~~l~~--~~~~~i~~--------------------~i~~~l~~  282 (484)
                      +++|.++.+..                   +.......+...  ........                    .+...+..
T Consensus        73 ~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T cd05150          73 AVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAE  152 (244)
T ss_pred             eeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHH
Confidence            99988776432                   111000001110  00000000                    01111222


Q ss_pred             HHh----cCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          283 LHH----YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       283 LH~----~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      |-.    .....++|+|+.|.||+++++....|+||+.+..
T Consensus       153 l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         153 LEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            211    0134589999999999999987788999997764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.04  E-value=9.7e-05  Score=64.98  Aligned_cols=133  Identities=20%  Similarity=0.274  Sum_probs=89.5

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccC----------------ccchHHHHHHHHHHHcCC------CCCce
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH----------------RGASKSFIAECQALRSIR------HRNLV  221 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv  221 (484)
                      ...||+|+.-.||.-  +   ......||+.....                .....+..+|+.....+.      +.+|.
T Consensus         6 ~~~i~~G~~R~cy~H--P---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~   80 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--P---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP   80 (199)
T ss_pred             CcccccCCCceEEEC--C---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence            468999999999962  2   23457789887655                122456677777666665      78899


Q ss_pred             eEeeeeeeeccCCCceeeEEeecccC------CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 011508          222 KIITSCVSVDFQGNDFEALVYELMVN------GSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCD  295 (484)
Q Consensus       222 ~~~~~~~~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d  295 (484)
                      +++|+     .+.+.-..+|+|.+.+      .+|.+++...     .++. ..   ...+-+-..||-   ...|+.+|
T Consensus        81 r~~G~-----veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~---~~~L~~f~~~l~---~~~Iv~~d  143 (199)
T PF10707_consen   81 RFYGF-----VETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-EL---RQALDEFKRYLL---DHHIVIRD  143 (199)
T ss_pred             cEeEE-----EecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HH---HHHHHHHHHHHH---HcCCeecC
Confidence            99998     4455567889888753      2688888522     2444 33   333344455666   77899999


Q ss_pred             CCCCCeeecCCC----ceEEcc-cCccc
Q 011508          296 LKPSNVLLDGEL----TAHVSD-FGLAK  318 (484)
Q Consensus       296 lk~~NIll~~~~----~~kl~D-fg~a~  318 (484)
                      ++|+||++..+.    .+.|+| ||...
T Consensus       144 l~~~NIv~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  144 LNPHNIVVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             CCcccEEEEecCCCceEEEEEeCCCCcc
Confidence            999999995432    567777 45433

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.02  E-value=5.3e-07  Score=88.89  Aligned_cols=73  Identities=22%  Similarity=0.291  Sum_probs=37.4

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      ||.|+|. .+|..+-++++|+.|+||+|+|+ .+-...+...+|+.|+||.|+|+..+...-.++++..+...+|
T Consensus       229 lS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~N  301 (1255)
T KOG0444|consen  229 LSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNN  301 (1255)
T ss_pred             ccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccC
Confidence            4556665 55666666666666655555555 4444444455555555555555533333333444444444333

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.02  E-value=8.8e-05  Score=64.66  Aligned_cols=130  Identities=25%  Similarity=0.396  Sum_probs=90.8

Q ss_pred             CCCCccCccccccc-eeEEEEEEcCCCCeeEEEEEEeec---cCc------------------cchHHHHHHHHHHHcCC
Q 011508          159 DGFSLENLIGAGSF-GSVYKGIFDHDDHETLVAVKVLNL---QHR------------------GASKSFIAECQALRSIR  216 (484)
Q Consensus       159 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~  216 (484)
                      .+++..+.||.|.. |.||++...    +..+|+|++..   ...                  .....|..|.+...+|+
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~----g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk  112 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID----GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK  112 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC----CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence            67888999999999 999999976    57899999431   110                  11235788998888884


Q ss_pred             ---CCCc--eeEeeeeeeec---c----------CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHH
Q 011508          217 ---HRNL--VKIITSCVSVD---F----------QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS  278 (484)
Q Consensus       217 ---h~ni--v~~~~~~~~~~---~----------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~  278 (484)
                         +.++  ++.+||..-..   .          .......||.||.+...             .+...    -+.+|.+
T Consensus       113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~----~~~~~~~  175 (207)
T PF13095_consen  113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR----DIPQMLR  175 (207)
T ss_pred             hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----HHHHHHH
Confidence               4456  88888864331   0          12233467888775432             12222    2456666


Q ss_pred             HHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       279 ~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      -+..+|   ..+|+-+|+++.|..     .-||+|||.+
T Consensus       176 dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  176 DLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            677888   999999999999987     5689999864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.02  E-value=3.7e-05  Score=77.11  Aligned_cols=140  Identities=19%  Similarity=0.237  Sum_probs=88.0

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCccch-------------------------------H------HHHH
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS-------------------------------K------SFIA  207 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~-------------------------------~------~~~~  207 (484)
                      +.||.-+.|.||+|++++   |+.||||+-+..-....                               +      +|.+
T Consensus       167 ~piaaASlaQVhrA~L~~---G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~  243 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN---GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK  243 (538)
T ss_pred             chhhhcchhheEEEEecC---CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence            679999999999999884   78899998764321110                               1      1334


Q ss_pred             HHHHHHcC----CCCC------ceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHH
Q 011508          208 ECQALRSI----RHRN------LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA  277 (484)
Q Consensus       208 e~~~l~~l----~h~n------iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~  277 (484)
                      |.+-..+.    .|-+      |.+++-.       -.....|+||||+|..+.+.-....   ..++...   ++..+.
T Consensus       244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~-------~st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~---i~~~l~  310 (538)
T KOG1235|consen  244 EAKNAERFRENFKDFSLLTYVLVPKVYWD-------LSTKRVLTMEYVDGIKINDLDAIDK---RGISPHD---ILNKLV  310 (538)
T ss_pred             HHHhHHHHHHHHHhcccccceeCCeehhh-------cCcceEEEEEecCCccCCCHHHHHH---cCCCHHH---HHHHHH
Confidence            44333222    3444      3333322       2235689999999986655432111   1244443   444444


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCCeeecC----CCceEEcccCccccccc
Q 011508          278 STLEYLHHYCETPIVHCDLKPSNVLLDG----ELTAHVSDFGLAKFLPE  322 (484)
Q Consensus       278 ~~l~~LH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Dfg~a~~~~~  322 (484)
                      ++.  ++.....|++|+|=.|.||+++.    ++.+.+-|||+...+..
T Consensus       311 ~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  311 EAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            432  22223678999999999999983    67899999999876643

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.00  E-value=6.7e-07  Score=71.25  Aligned_cols=73  Identities=25%  Similarity=0.425  Sum_probs=57.8

Q ss_pred             CCCCcccccCchhhhCC-CCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSL-RGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l-~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      |++|.|. .+|..|... +-++.|+|++|.|+ .+|.+++.|+.|+.|++++|.|.-.+-....+.++-.|+..+|
T Consensus        60 ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~~~p~vi~~L~~l~~Lds~~n  133 (177)
T KOG4579|consen   60 LSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLNAEPRVIAPLIKLDMLDSPEN  133 (177)
T ss_pred             cccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccccchHHHHHHHhHHHhcCCCC
Confidence            5788887 777777654 58888999999998 8898888899999999999988876655555777777777666

>PLN02876 acyl-CoA dehydrogenase

Probab=97.96  E-value=0.00011  Score=79.73  Aligned_cols=84  Identities=12%  Similarity=0.127  Sum_probs=55.8

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCC-CCCc--eeEeeeeeeeccCCCceee
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR-HRNL--VKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~  239 (484)
                      ...++.|.++.+|+...........+++|+...... .....+.+|.++++.+. |.++  .+++.+|.+..  .....+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~--v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS--VIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC--cCCCce
Confidence            467899999999998765432224577776543221 22356889999999995 6664  67777664322  123468


Q ss_pred             EEeecccCCC
Q 011508          240 LVYELMVNGS  249 (484)
Q Consensus       240 lv~e~~~~gs  249 (484)
                      +||||++|..
T Consensus       121 lVME~v~G~~  130 (822)
T PLN02876        121 YIMEYLEGRI  130 (822)
T ss_pred             EEEEecCCcc
Confidence            9999998754

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=97.92  E-value=2.3e-06  Score=88.26  Aligned_cols=75  Identities=28%  Similarity=0.456  Sum_probs=50.4

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceec-ccccccccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEG-EVPIKGVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g-~~p~~~~~~~~~~~~~~~n~~l   78 (484)
                      ||+|.|+ .||.++.+|..|++|...+|+|. .+| ++.+++.|+++|||.|+|+- .+|....-++|++++++||..+
T Consensus       414 LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  414 LSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             cccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            4556665 66666666666666666666666 666 67777888888888888864 3444333378889999999753

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=97.88  E-value=5.9e-06  Score=70.89  Aligned_cols=73  Identities=32%  Similarity=0.423  Sum_probs=27.6

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccc-cCCCCCCeeeccccceecccc--cccccccCcccccCCCc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYL-ENFPFLQNLNLSFNHFEGEVP--IKGVFSNSSAISLDGNV   76 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~-~~l~~L~~l~ls~N~l~g~~p--~~~~~~~~~~~~~~~n~   76 (484)
                      ||+|+|+ .++. +..|++|+.|+|++|+++ .++..+ ..+++|+.|+|++|++...-.  ....+++|..+++.+||
T Consensus        49 Ls~N~I~-~l~~-l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NP  124 (175)
T PF14580_consen   49 LSNNQIT-KLEG-LPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNP  124 (175)
T ss_dssp             -TTS--S---TT-----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-G
T ss_pred             CCCCCCc-cccC-ccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCc
Confidence            5677777 5653 667777788888888877 565444 357777888888777754221  22456677777777774

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.85  E-value=0.00011  Score=67.42  Aligned_cols=32  Identities=31%  Similarity=0.428  Sum_probs=26.9

Q ss_pred             CCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          288 ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       288 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      ...++|+|+.+.||+++++...-|+||+.+..
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            44589999999999999776667999998764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=97.85  E-value=5.1e-06  Score=75.01  Aligned_cols=72  Identities=29%  Similarity=0.338  Sum_probs=47.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      ||+|.|+ .|..++--++.++.|+||+|.++ .+- .+..|++|+.||||+|.|+...--...+.++..+.+++|
T Consensus       291 LS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N  362 (490)
T KOG1259|consen  291 LSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQN  362 (490)
T ss_pred             ccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhh
Confidence            5667776 77777777777777777777777 553 366777777777777777643333345556666666666

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.83  E-value=1e-05  Score=52.01  Aligned_cols=33  Identities=36%  Similarity=0.628  Sum_probs=29.4

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIP   35 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p   35 (484)
                      |++|+|+ .+|+++++|++|+.|+|++|+|+ .+|
T Consensus         8 l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~-~i~   40 (44)
T PF12799_consen    8 LSNNQIT-DLPPELSNLPNLETLNLSNNPIS-DIS   40 (44)
T ss_dssp             ETSSS-S-SHGGHGTTCTTSSEEEETSSCCS-BEG
T ss_pred             ccCCCCc-ccCchHhCCCCCCEEEecCCCCC-CCc
Confidence            5799999 89999999999999999999999 665

...

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=97.69  E-value=8.9e-06  Score=79.92  Aligned_cols=74  Identities=26%  Similarity=0.167  Sum_probs=35.1

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCC
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      +.|+++..=-.++..|+.|+.||||+|.++..-++++.-+.+|+.|+||+|+++...+.. ..+..|+.|++++|
T Consensus       277 ~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~N  351 (873)
T KOG4194|consen  277 ETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHN  351 (873)
T ss_pred             ccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccccc
Confidence            344444333344455555555555555555444455555555555555555555444432 22333444444443

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.63  E-value=0.0001  Score=78.58  Aligned_cols=200  Identities=22%  Similarity=0.241  Sum_probs=132.0

Q ss_pred             HHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 011508          205 FIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH  284 (484)
Q Consensus       205 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  284 (484)
                      ...|+..+.++.|+|++.++.|....-..+ -...+..+++..-++...++.    ...++....+.+..++..|++|+|
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHH
Confidence            345777888889999999988865433211 122344577878788877763    334778888889999999999999


Q ss_pred             hcCCCCeeecCCCCC---CeeecCCCceEEc--ccCcccccccccccCCCCccccccccccccccCccccCCCCCCc--c
Q 011508          285 HYCETPIVHCDLKPS---NVLLDGELTAHVS--DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVST--S  357 (484)
Q Consensus       285 ~~~~~~ivH~dlk~~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~--~  357 (484)
                         +....|.-+..+   +--.+..+.+.++  ||+.+..++......        ....+..+.+||......+..  .
T Consensus       304 ---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--------~~~~~~~~~~~e~~~~~~~~~~r~  372 (1351)
T KOG1035|consen  304 ---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--------SDLLAEIRNADEDLKENTAKKSRL  372 (1351)
T ss_pred             ---HhccceeEEecccccccccCccceeecchhhhcccccCCCcccch--------hhcCccccccccccccccchhhhh
Confidence               555555545444   4444566667776  888887664432211        123455677888776655544  4


Q ss_pred             cceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHH
Q 011508          358 GDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVS  437 (484)
Q Consensus       358 ~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  437 (484)
                      .|+|.+|.....+..|..+-...             .   ....+++..                           +...
T Consensus       373 ~dL~~lgll~~~~~~~~~i~~~~-------------~---~~~~~l~~~---------------------------~~~~  409 (1351)
T KOG1035|consen  373 TDLWCLGLLLLQLSQGEDISEKS-------------A---VPVSLLDVL---------------------------STSE  409 (1351)
T ss_pred             hHHHHHHHHHhhhhhcCcccccc-------------c---chhhhhccc---------------------------cchh
Confidence            79999999999999887653210             0   001111110                           1124


Q ss_pred             HHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          438 VLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       438 l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      +.+....|+..++++|+++.+++...
T Consensus       410 ~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  410 LLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhhhhhcchhhhhccchhhhhhch
Confidence            56777889999999999999998764

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.62  E-value=0.00045  Score=63.22  Aligned_cols=75  Identities=20%  Similarity=0.264  Sum_probs=45.8

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCce-eEeeeeeeeccCCCceeeEEee
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV-KIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      +.|..|-...+|+....+. .+..|++|+...... ......+|+.+++.+...+++ ++++.     ..    ..+|||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~-~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~-----~~----~~~l~e   72 (235)
T cd05157           4 KRFTGGITNKLVKVSNKED-NQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYAT-----FQ----NGLIYE   72 (235)
T ss_pred             EEcCCcccceEEEEEcCCC-CCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEE-----eC----CcEEEE
Confidence            4677888899999863310 135688887653322 112334788888888544443 33332     11    248999


Q ss_pred             cccCCCH
Q 011508          244 LMVNGSL  250 (484)
Q Consensus       244 ~~~~gsL  250 (484)
                      |++|.++
T Consensus        73 ~i~G~~l   79 (235)
T cd05157          73 FIPGRTL   79 (235)
T ss_pred             eeCCCcC
Confidence            9988765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.58  E-value=0.0011  Score=62.86  Aligned_cols=80  Identities=9%  Similarity=-0.008  Sum_probs=54.0

Q ss_pred             ccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCC---CCceeEeeeeeeeccCCCceee
Q 011508          163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH---RNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       163 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      -.+.||.|..+.||+....   ++ .+.+|..+..  .....+..|.+.|+.+.-   -.+.++++.|...  ...+..+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~---~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~   89 (297)
T PRK10593         18 RVECISEQPYAALWALYDS---QG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDV   89 (297)
T ss_pred             eeeecCCccceeEEEEEcC---CC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeE
Confidence            3467999999999998632   22 3666764321  123578899999998843   3577778765432  1234579


Q ss_pred             EEeecccCCCH
Q 011508          240 LVYELMVNGSL  250 (484)
Q Consensus       240 lv~e~~~~gsL  250 (484)
                      +|||++++.++
T Consensus        90 LVmE~i~G~~~  100 (297)
T PRK10593         90 LLLERLRGVSV  100 (297)
T ss_pred             EEEeccCCEec
Confidence            99999988754

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=97.57  E-value=1.1e-05  Score=79.31  Aligned_cols=55  Identities=27%  Similarity=0.259  Sum_probs=30.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeecccccee
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFE   55 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~   55 (484)
                      ||.|.|+...+.++..+++|+.||||+|+|+.--|.+|..|..|+.|+||+|.+.
T Consensus       300 lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~  354 (873)
T KOG4194|consen  300 LSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID  354 (873)
T ss_pred             cchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH
Confidence            4566666556666666666666666666666222233444444444444444443

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=97.49  E-value=5.3e-05  Score=79.85  Aligned_cols=51  Identities=27%  Similarity=0.337  Sum_probs=28.1

Q ss_pred             CCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508           18 RGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus        18 ~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      ++|+.|+|++|+|+ .+|..   .++|+.|+||+|+|++ +|..  ..++..+++++|
T Consensus       382 ~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Lss-IP~l--~~~L~~L~Ls~N  432 (788)
T PRK15387        382 SGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLTS-LPML--PSGLLSLSVYRN  432 (788)
T ss_pred             cccceEEecCCccc-CCCCc---ccCCCEEEccCCcCCC-CCcc--hhhhhhhhhccC
Confidence            35667777777777 46643   2456666666666664 3321  223444555555

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=97.46  E-value=1.4e-05  Score=63.86  Aligned_cols=75  Identities=23%  Similarity=0.325  Sum_probs=60.4

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l   78 (484)
                      |++|.|+ .+|.+++.++.|+.|++++|.|. ..|..+..|.+|..||..+|.+. .+|.....+.+..+.-.+|..+
T Consensus        84 l~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl  158 (177)
T KOG4579|consen   84 LANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPL  158 (177)
T ss_pred             cchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcc
Confidence            6789999 99999999999999999999999 89999999999999999999987 5555444444444433355333

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.45  E-value=0.0016  Score=60.51  Aligned_cols=140  Identities=14%  Similarity=0.045  Sum_probs=77.4

Q ss_pred             ccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCce-eEeeeeeeeccCCCceeeEEeec
Q 011508          166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV-KIITSCVSVDFQGNDFEALVYEL  244 (484)
Q Consensus       166 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~  244 (484)
                      .+..|-.+.+|+...    ++..+++|..........-...+|.++++.+....+. +++..+         ..++||||
T Consensus         3 ~~~~G~tn~~y~~~~----~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~---------~~~~v~e~   69 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH----PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN---------EHWLLVEW   69 (256)
T ss_pred             cCCCcCcCCeEEEEe----CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe---------CCEEEEEe
Confidence            456788889998862    2456778875433222112357788888888544333 333321         13689999


Q ss_pred             ccCCCHHHH-----------------HhhcCCCCCCCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCCee
Q 011508          245 MVNGSLEEW-----------------LHLNRDAPRNLNLLQR-LSIAVD---------VASTLEYLHHY-----CETPIV  292 (484)
Q Consensus       245 ~~~gsL~~~-----------------l~~~~~~~~~l~~~~~-~~i~~~---------i~~~l~~LH~~-----~~~~iv  292 (484)
                      ++|..+...                 ++.......+++.... .....+         +...+..+-..     ....++
T Consensus        70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  149 (256)
T TIGR02721        70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL  149 (256)
T ss_pred             ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence            988654321                 1111111112222211 111111         11112222111     123589


Q ss_pred             ecCCCCCCeeecCCCceEEcccCcccc
Q 011508          293 HCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       293 H~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      |+|+.|.||++++++ +.|+||..+..
T Consensus       150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       150 HMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            999999999999877 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=97.45  E-value=2.5e-05  Score=76.63  Aligned_cols=72  Identities=28%  Similarity=0.433  Sum_probs=53.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      |+.|.+. .||..+++|..|++|||+.|+++ .+|..+..|+ |++|-+++|+++..++..+....+..++++.|
T Consensus       105 Ly~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~~lp~~ig~~~tl~~ld~s~n  176 (722)
T KOG0532|consen  105 LYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKN  176 (722)
T ss_pred             HHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccccCCcccccchhHHHhhhhhh
Confidence            3456666 77777888888888888888888 7777777775 77788888887766666665566666777666

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.41  E-value=0.003  Score=61.86  Aligned_cols=76  Identities=17%  Similarity=0.083  Sum_probs=50.9

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC-------ccchHHHHHHHHHHHcCC---CCCceeEeeeeeeeccCC
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-------RGASKSFIAECQALRSIR---HRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~  234 (484)
                      +.||.|.+..||++...+  .++.++||.-....       .-..+....|.+.|..+.   ..++.+++.+       +
T Consensus        32 ~elggGn~N~VyrV~~~~--g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~-------D  102 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTE--GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY-------D  102 (401)
T ss_pred             eEcCCCceEEEEEEEeCC--CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-------C
Confidence            579999999999998542  22478999753111       123456777888888762   3456667765       2


Q ss_pred             CceeeEEeecccCCC
Q 011508          235 NDFEALVYELMVNGS  249 (484)
Q Consensus       235 ~~~~~lv~e~~~~gs  249 (484)
                      ....++||||+++..
T Consensus       103 ~~~~~lVME~L~~~~  117 (401)
T PRK09550        103 EELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCCEEEEecCCCcc
Confidence            234689999998643

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=97.39  E-value=6.2e-05  Score=70.75  Aligned_cols=79  Identities=18%  Similarity=0.157  Sum_probs=38.0

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCccccC
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~g   80 (484)
                      ++|+|++.-+.+|..+++|+.|.|..|+|.-.--..|.++..|+.|+|..|+++-.-|.. ..+.++..+++..||..|.
T Consensus       282 snN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn  361 (498)
T KOG4237|consen  282 SNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN  361 (498)
T ss_pred             CCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCc
Confidence            344444333444444444444444444444222233445555666666666666555543 3344555566666655543

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.39  E-value=0.00013  Score=67.34  Aligned_cols=135  Identities=19%  Similarity=0.204  Sum_probs=89.7

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-----------------cc-----hHHHHHHHHHHHcCC-
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-----------------GA-----SKSFIAECQALRSIR-  216 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-----------------~~-----~~~~~~e~~~l~~l~-  216 (484)
                      =+++++.||-|.-+.||.+...   .++..++|.-.....                 +.     .-...+|...|+.|. 
T Consensus        93 v~svGnqIGVGKESDIY~v~d~---~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e  169 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE---EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYE  169 (465)
T ss_pred             hhhhccccccccccceEEEecC---CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHH
Confidence            4678899999999999999744   567788875432110                 00     012456777777773 


Q ss_pred             CC-CceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 011508          217 HR-NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCD  295 (484)
Q Consensus       217 h~-niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d  295 (484)
                      |- -+.+.++         .+..++|||++.+..|.+.-+.       .+...   +...+..-+--|-   .+|+||+|
T Consensus       170 ~gfpVPkpiD---------~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~---ly~~lm~~Iv~la---~~GlIHgD  227 (465)
T KOG2268|consen  170 RGFPVPKPID---------HNRHCVVMELVDGYPLRQVRHV-------EDPPT---LYDDLMGLIVRLA---NHGLIHGD  227 (465)
T ss_pred             cCCCCCCccc---------ccceeeHHHhhcccceeeeeec-------CChHH---HHHHHHHHHHHHH---HcCceecc
Confidence            22 2333333         3367899999988877654321       12222   3333444444565   88999999


Q ss_pred             CCCCCeeecCCCceEEcccCcccc
Q 011508          296 LKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       296 lk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      ..--||++++++.++++||-....
T Consensus       228 FNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  228 FNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             cchheeEEecCCCEEEeechHhhc
Confidence            999999999999999999976543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.38  E-value=0.00098  Score=63.57  Aligned_cols=145  Identities=21%  Similarity=0.190  Sum_probs=81.2

Q ss_pred             CccccccceeEEEEEEcCC----CCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCce-eEeeeeeeeccCCCceee
Q 011508          165 NLIGAGSFGSVYKGIFDHD----DHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV-KIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~  239 (484)
                      +.+..|-...+|+....+.    ..+..+++|+..... .......+|.+++..+....+. ++++++     .    -.
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~----~~   73 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIF-----P----NG   73 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEe-----C----CC
Confidence            4566777789998874321    124678889865432 2224567788888888543333 344432     1    14


Q ss_pred             EEeecccCCCHHHH-----------------HhhcCCC--CC---CCC--HHHHHH------------------------
Q 011508          240 LVYELMVNGSLEEW-----------------LHLNRDA--PR---NLN--LLQRLS------------------------  271 (484)
Q Consensus       240 lv~e~~~~gsL~~~-----------------l~~~~~~--~~---~l~--~~~~~~------------------------  271 (484)
                      +|+||++|.++...                 ++.....  ..   ..+  +.....                        
T Consensus        74 ~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (302)
T cd05156          74 RIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVEL  153 (302)
T ss_pred             chhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhH
Confidence            68999887765321                 1111111  00   011  111101                        


Q ss_pred             --HHHHHHHHHHHHHh------cCCCCeeecCCCCCCeeecCC----CceEEcccCcccc
Q 011508          272 --IAVDVASTLEYLHH------YCETPIVHCDLKPSNVLLDGE----LTAHVSDFGLAKF  319 (484)
Q Consensus       272 --i~~~i~~~l~~LH~------~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfg~a~~  319 (484)
                        +...+...+..+..      .....++|+|+.+.||+++++    +.++++||..+..
T Consensus       154 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         154 SLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence              11122222333431      125678999999999999985    7899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.35  E-value=0.00099  Score=63.32  Aligned_cols=149  Identities=21%  Similarity=0.162  Sum_probs=84.0

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCC--ceeEeeeeeeec-cCCCceeeE
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN--LVKIITSCVSVD-FQGNDFEAL  240 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~-~~~~~~~~l  240 (484)
                      .+.|..|....+|+....    +..+++|+...   ........|++++..+.+.+  +.+++....... ...++..+.
T Consensus        19 i~~i~~G~~n~~y~v~~~----~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~   91 (296)
T cd05153          19 FEGISAGIENTNYFVTTD----SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA   91 (296)
T ss_pred             eecccCccccceEEEEeC----CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence            456888888899998643    23588888754   23355667888888774332  344443211000 112335689


Q ss_pred             EeecccCCCHHH----H----------Hhhc----CCC---CCCCCHHHHH----------HHHHHHHHHHHHHHh----
Q 011508          241 VYELMVNGSLEE----W----------LHLN----RDA---PRNLNLLQRL----------SIAVDVASTLEYLHH----  285 (484)
Q Consensus       241 v~e~~~~gsL~~----~----------l~~~----~~~---~~~l~~~~~~----------~i~~~i~~~l~~LH~----  285 (484)
                      |+++++|..+..    .          ++..    ...   .....|....          .....+..++.++..    
T Consensus        92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~  171 (296)
T cd05153          92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS  171 (296)
T ss_pred             EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence            999998865421    0          1110    000   0111222111          011122334444442    


Q ss_pred             cCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          286 YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       286 ~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      ....+++|+|+.|.||+++++..+.|.||+.+..
T Consensus       172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            1135799999999999999987778999997753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	484
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-33
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-31
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-22
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-21
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		6e-21
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-21
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-20
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-17
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		7e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-17
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		9e-17
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-16
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-16
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-16
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-16
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-16
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-16
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		7e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		9e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		9e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		4e-15
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		5e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		7e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		8e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		8e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		9e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-14
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-14
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-14
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-14
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-14
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-14
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-14
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-13
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-13
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-13
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-13
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-13
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-13
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-13
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-12
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		3e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		8e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		9e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		9e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-12
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		5e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-10
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		7e-10
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-10
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-10
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-10
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-10
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		9e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-09
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-09
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-09
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-09
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-09
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-09
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		5e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		6e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-09
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		7e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		7e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		7e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-09
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-08
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-08
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-08
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		2e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-08
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-08
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		5e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-08
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		6e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-08
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		7e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-08
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		8e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		8e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-08
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		9e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-07
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-07
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-07
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-07
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-07
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-07
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-07
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-07
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-07
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-07
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-07
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-07
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-07
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		4e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-07
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-07
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-07
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-07
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		6e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		6e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		6e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		6e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		6e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-07
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-07
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-07
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-06
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-06
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-06
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-06
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-06
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-06
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-06
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-06
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-06
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-06
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		4e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		6e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-06
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-06
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-05
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-05
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-05
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		1e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-05
4hgl_A	330	Crystal Structure Of Ck1g3 With Compound 1 Length =		2e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-05
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-05
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-05
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		3e-05
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-05
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-05
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		5e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-05
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-05
3soa_A	444	Full-Length Human Camkii Length = 444		6e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		7e-05
2izr_A	330	Structure Of Casein Kinase Gamma 3 In Complex With		7e-05
2chl_A	351	Structure Of Casein Kinase 1 Gamma 3 Length = 351		8e-05
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		8e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-05
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		9e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-04
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-04
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		2e-04
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-04
2lav_A	361	Nmr Solution Structure Of Human Vaccinia-Related Ki		2e-04
2kty_A	368	Solution Structure Of Human Vaccinia Related Kinase		2e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-04
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		3e-04
3op5_A	364	Human Vaccinia-Related Kinase 1 Length = 364		3e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		4e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-04
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		6e-04
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 106/329 (32%), Positives = 158/329 (48%), Gaps = 36/329 (10%)
Query: 139 PSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH 198
           P   L  + R S + L  A+D FS +N++G G FG VYKG        TLVAVK L  + 
Sbjct: 18  PEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG---TLVAVKRLKEER 74
Query: 199 -RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN 257
            +G    F  E + +    HRNL+++   C++   +      LVY  M NGS+   L   
Sbjct: 75  XQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER-----LLVYPYMANGSVASCLRER 129
Query: 258 RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA 317
            ++   L+  +R  IA+  A  L YLH +C+  I+H D+K +N+LLD E  A V DFGLA
Sbjct: 130 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 189
Query: 318 KFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPT 377
           K +                V+GT+G+ APEY    + S   DV+ +G++LLE+ TG+   
Sbjct: 190 KLM------DYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 243
Query: 378 NEMFTGN---LTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKEC 434
           +     N   + L ++VK  L E+  E +  V L    + E  E                
Sbjct: 244 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVE---------------- 287
Query: 435 LVSVLGIGVICSSELPRERMNMEEVAAQL 463
              ++ + ++C+   P ER  M EV   L
Sbjct: 288 --QLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 103/329 (31%), Positives = 155/329 (47%), Gaps = 36/329 (10%)
Query: 139 PSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH 198
           P   L  + R S + L  A+D F  +N++G G FG VYKG         LVAVK L  + 
Sbjct: 10  PEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADG---XLVAVKRLKEER 66
Query: 199 -RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN 257
            +G    F  E + +    HRNL+++   C++   +      LVY  M NGS+   L   
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER-----LLVYPYMANGSVASCLRER 121
Query: 258 RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA 317
            ++   L+  +R  IA+  A  L YLH +C+  I+H D+K +N+LLD E  A V DFGLA
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
Query: 318 KFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPT 377
           K +                V+G +G+ APEY    + S   DV+ +G++LLE+ TG+   
Sbjct: 182 KLM------DYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
Query: 378 NEMFTGN---LTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKEC 434
           +     N   + L ++VK  L E+  E +  V L    + E  E                
Sbjct: 236 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVE---------------- 279
Query: 435 LVSVLGIGVICSSELPRERMNMEEVAAQL 463
              ++ + ++C+   P ER  M EV   L
Sbjct: 280 --QLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 129/264 (48%), Gaps = 22/264 (8%)
Query: 148 RVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA 207
           RV   +L +AT+ F  + LIG G FG VYKG+         VA+K    +     + F  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG---AKVALKRRTPESSQGIEEFET 84
Query: 208 ECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL 267
           E + L   RH +LV +I  C     + N+   L+Y+ M NG+L+  L+ +     +++  
Sbjct: 85  EIETLSFCRHPHLVSLIGFCD----ERNEM-ILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXX 327
           QRL I +  A  L YLH      I+H D+K  N+LLD      ++DFG++K   E     
Sbjct: 140 QRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTH 196
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL 387
                    VKGT+GY  PEY +   ++   DVYSFG++L E+   +    +     +  
Sbjct: 197 LXXV-----VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV- 250
Query: 388 HNFVKEALPE----RLAEIVDPVL 407
            N  + A+      +L +IVDP L
Sbjct: 251 -NLAEWAVESHNNGQLEQIVDPNL 273

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 85/264 (32%), Positives = 129/264 (48%), Gaps = 22/264 (8%)
Query: 148 RVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA 207
           RV   +L +AT+ F  + LIG G FG VYKG+         VA+K    +     + F  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG---AKVALKRRTPESSQGIEEFET 84
Query: 208 ECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL 267
           E + L   RH +LV +I  C     + N+   L+Y+ M NG+L+  L+ +     +++  
Sbjct: 85  EIETLSFCRHPHLVSLIGFCD----ERNEM-ILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXX 327
           QRL I +  A  L YLH      I+H D+K  N+LLD      ++DFG++K   E     
Sbjct: 140 QRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL 387
                    VKGT+GY  PEY +   ++   DVYSFG++L E+   +    +     +  
Sbjct: 197 LXXV-----VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV- 250
Query: 388 HNFVKEALPE----RLAEIVDPVL 407
            N  + A+      +L +IVDP L
Sbjct: 251 -NLAEWAVESHNNGQLEQIVDPNL 273

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/218 (34%), Positives = 111/218 (50%), Gaps = 20/218 (9%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHR 218
            +++  IGAGSFG+V++  +    H + VAVK+L  Q  H      F+ E   ++ +RH 
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+V  + +      Q  +  ++V E +  GSL   LH    A   L+  +RLS+A DVA 
Sbjct: 95  NIVLFMGAVT----QPPNL-SIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAK 148
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + YLH+    PIVH DLK  N+L+D + T  V DFGL++                    
Sbjct: 149 GMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-------KASXFLXSKXAA 200
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           GT  + APE       +   DVYSFG++L E+ T + P
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 76/219 (34%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVL----NLQHRGASKSFIAECQALRSIRHRNL 220
           N +G G FG VYKG  ++    T VAVK L    ++      + F  E + +   +H NL
Sbjct: 37  NKMGEGGFGVVYKGYVNN----TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V+++         G+D   LVY  M NGSL + L      P  L+   R  IA   A+ +
Sbjct: 93  VELL----GFSSDGDDL-CLVYVYMPNGSLLDRLSCLDGTPP-LSWHMRCKIAQGAANGI 146
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            +LH   E   +H D+K +N+LLD   TA +SDFGLA+     A            + GT
Sbjct: 147 NFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR-----ASEKFAQTVMXXRIVGT 198
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
             Y APE  +  E++   D+YSFG++LLE+ TG    +E
Sbjct: 199 TAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 77/219 (35%), Positives = 110/219 (50%), Gaps = 23/219 (10%)
Query: 165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVL----NLQHRGASKSFIAECQALRSIRHRNL 220
           N +G G FG VYKG  ++    T VAVK L    ++      + F  E + +   +H NL
Sbjct: 31  NKMGEGGFGVVYKGYVNN----TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 86
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V+++         G+D   LVY  M NGSL + L      P  L+   R  IA   A+ +
Sbjct: 87  VELL----GFSSDGDDL-CLVYVYMPNGSLLDRLSCLDGTPP-LSWHMRCKIAQGAANGI 140
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            +LH   E   +H D+K +N+LLD   TA +SDFGLA+     A            + GT
Sbjct: 141 NFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR-----ASEKFAQXVMXXRIVGT 192
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
             Y APE  +  E++   D+YSFG++LLE+ TG    +E
Sbjct: 193 TAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 230

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 76/219 (34%), Positives = 109/219 (49%), Gaps = 23/219 (10%)
Query: 165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVL----NLQHRGASKSFIAECQALRSIRHRNL 220
           N +G G FG VYKG  ++    T VAVK L    ++      + F  E + +   +H NL
Sbjct: 37  NKMGEGGFGVVYKGYVNN----TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V+++         G+D   LVY  M NGSL + L      P  L+   R  IA   A+ +
Sbjct: 93  VELL----GFSSDGDDL-CLVYVYMPNGSLLDRLSCLDGTPP-LSWHMRCKIAQGAANGI 146
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            +LH   E   +H D+K +N+LLD   TA +SDFGLA+     A            + GT
Sbjct: 147 NFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR-----ASEKFAQTVMXSRIVGT 198
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
             Y APE  +  E++   D+YSFG++LLE+ TG    +E
Sbjct: 199 TAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 109/218 (50%), Gaps = 20/218 (9%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHR 218
            +++  IGAGSFG+V++  +    H + VAVK+L  Q  H      F+ E   ++ +RH 
Sbjct: 39  LNIKEKIGAGSFGTVHRAEW----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+V  + +      Q  +  ++V E +  GSL   LH    A   L+  +RLS+A DVA 
Sbjct: 95  NIVLFMGAVT----QPPNL-SIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAK 148
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + YLH+    PIVH +LK  N+L+D + T  V DFGL++                    
Sbjct: 149 GMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-------KASTFLSSKSAA 200
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           GT  + APE       +   DVYSFG++L E+ T + P
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/219 (35%), Positives = 108/219 (49%), Gaps = 23/219 (10%)
Query: 165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVL----NLQHRGASKSFIAECQALRSIRHRNL 220
           N  G G FG VYKG  ++    T VAVK L    ++      + F  E +     +H NL
Sbjct: 28  NKXGEGGFGVVYKGYVNN----TTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENL 83
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V+++         G+D   LVY    NGSL + L      P  L+   R  IA   A+ +
Sbjct: 84  VELL----GFSSDGDDL-CLVYVYXPNGSLLDRLSCLDGTPP-LSWHXRCKIAQGAANGI 137
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            +LH   E   +H D+K +N+LLD   TA +SDFGLA+     A            + GT
Sbjct: 138 NFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLAR-----ASEKFAQXVXXSRIVGT 189
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
             Y APE  +  E++   D+YSFG++LLE+ TG    +E
Sbjct: 190 TAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 227

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL E+L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 81  GVCYSA---GRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTS---QICKGMEYL- 133
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 187
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 96  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 148
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 149 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 202
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 77  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 129
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 130 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 183
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 184 APESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 76  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 128
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 129 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 182
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 183 APESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 81  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 133
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 187
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 85  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 137
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 138 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 191
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 192 APESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 130
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 184
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 84  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 136
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 137 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 190
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 191 APESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 83  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 135
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 136 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 189
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 190 APESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 96  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 148
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 149 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 202
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 203 APESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 109 GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 161
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 162 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 215
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 82  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 134
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 135 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 188
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 189 APESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 130
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 184
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 78  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 130
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG----ESPIFWY 184
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  + +   ++ LLQ  S    +   +EYL 
Sbjct: 81  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTS---QICKGMEYL- 133
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H DL   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPG----ESPIFWY 187
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 188 APESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+VK  
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C S    G     L+ E +  GSL ++L  +++   ++ LLQ  S    +   +EYL 
Sbjct: 79  GVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS---QICKGMEYL- 131
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  +H +L   N+L++ E    + DFGL K LP+               +  + + 
Sbjct: 132 --GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPG----ESPIFWY 185
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT 372
           APE    S+ S + DV+SFG++L E+FT
Sbjct: 186 APESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 163 LENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNL 220
           +E +IGAG FG V +G        E+ VA+K L   +     + F++E   +    H N+
Sbjct: 18  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 77
Query: 221 VK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           ++   ++T+ + V         ++ E M NG+L+ +L LN        ++Q + +   +A
Sbjct: 78  IRLEGVVTNSMPV--------MILTEFMENGALDSFLRLNDG---QFTVIQLVGMLRGIA 126
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
           S + YL    E   VH DL   N+L++  L   VSDFGL++FL E +          +G 
Sbjct: 127 SGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENS--SDPTYTSSLGG 181
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
           K  + + APE     + +++ D +S+GI++ E+ + G+ P  +M
Sbjct: 182 KIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDM 225

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 22/224 (9%)
Query: 163 LENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNL 220
           +E +IGAG FG V +G        E+ VA+K L   +     + F++E   +    H N+
Sbjct: 20  IEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNI 79
Query: 221 VK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           ++   ++T+ + V         ++ E M NG+L+ +L LN        ++Q + +   +A
Sbjct: 80  IRLEGVVTNSMPV--------MILTEFMENGALDSFLRLNDG---QFTVIQLVGMLRGIA 128
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
           S + YL    E   VH DL   N+L++  L   VSDFGL++FL E +          +G 
Sbjct: 129 SGMRYL---AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENS--SDPTETSSLGG 183
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
           K  + + APE     + +++ D +S+GI++ E+ + G+ P  +M
Sbjct: 184 KIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDM 227

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 109/223 (48%), Gaps = 22/223 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ IRH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHE 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 74  KLVQLY-AVVS-----EEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIAS 125
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 176
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             + + APE  +    +   DV+SFGILL E+ T G+ P   M
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 109/219 (49%), Gaps = 22/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 8   ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 63
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 64  KLVQLY-AVVS-----EEPIXIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIAS 115
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 116 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQ------GAK 166
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             + + APE  +    +   DV+SFGILL E+ T G+ P
Sbjct: 167 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 111/250 (44%), Gaps = 29/250 (11%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +E ++G G+FG V K  +   D    VA+K   ++     K+FI E + L  + H N+VK
Sbjct: 12  VEEVVGRGAFGVVCKAKWRAKD----VAIK--QIESESERKAFIVELRQLSRVNHPNIVK 65
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +  +C++          LV E    GSL   LH     P        +S  +  +  + Y
Sbjct: 66  LYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAY 117
Query: 283 LHHYCETPIVHCDLKPSNVLL-DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           LH      ++H DLKP N+LL  G     + DFG A                    KG+ 
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----------CDIQTHMTNNKGSA 167
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM----FTGNLTLHNFVKEALPE 397
            + APE   GS  S   DV+S+GI+L E+ T + P +E+    F     +HN  +  L +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK 227
Query: 398 RLAEIVDPVL 407
            L + ++ ++
Sbjct: 228 NLPKPIESLM 237

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 111/250 (44%), Gaps = 29/250 (11%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +E ++G G+FG V K  +   D    VA+K   ++     K+FI E + L  + H N+VK
Sbjct: 13  VEEVVGRGAFGVVCKAKWRAKD----VAIK--QIESESERKAFIVELRQLSRVNHPNIVK 66
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +  +C++          LV E    GSL   LH     P        +S  +  +  + Y
Sbjct: 67  LYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAY 118
Query: 283 LHHYCETPIVHCDLKPSNVLL-DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           LH      ++H DLKP N+LL  G     + DFG A                    KG+ 
Sbjct: 119 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----------CDIQTHMTNNKGSA 168
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM----FTGNLTLHNFVKEALPE 397
            + APE   GS  S   DV+S+GI+L E+ T + P +E+    F     +HN  +  L +
Sbjct: 169 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK 228
Query: 398 RLAEIVDPVL 407
            L + ++ ++
Sbjct: 229 NLPKPIESLM 238

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 22/223 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 11  ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 66
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 67  KLVQLY-AVVS-----EEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIAS 118
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 119 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 169
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             + + APE  +    +   DV+SFGILL E+ T G+ P   M
Sbjct: 170 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 212

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 239
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 240 KLVQLY-AVVS-----EEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIAS 291
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 292 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 342
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             + + APE  +    +   DV+SFGILL E+ T G+ P
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 239
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 240 KLVQLY-AVVS-----EEPIYIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIAS 291
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 292 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 342
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             + + APE  +    +   DV+SFGILL E+ T G+ P
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 22/223 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 7   ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 62
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 63  KLVQLY-AVVS-----EEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIAS 114
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 115 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 165
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             + + APE  +    +   DV+SFGILL E+ T G+ P   M
Sbjct: 166 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 208

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 110/223 (49%), Gaps = 22/223 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 74  KLVQLY-AVVS-----EEPIYIVIEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIAS 125
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQ------GAK 176
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             + + APE  +    +   DV+SFGILL E+ T G+ P   M
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 22/223 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 9   ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 64
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 65  KLVQLY-AVVS-----EEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIAS 116
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 117 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 167
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             + + APE  +    +   DV+SFGILL E+ T G+ P   M
Sbjct: 168 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 22/223 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 74  KLVQLY-AVVS-----EEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIAS 125
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 176
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             + + APE  +    +   DV+SFGILL E+ T G+ P   M
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 22/223 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 74  KLVQLY-AVVS-----EEPIYIVIEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIAS 125
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 176
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             + + APE  +    +   DV+SFGILL E+ T G+ P   M
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 27/219 (12%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNL 220
           L   IG+GSFG+VYKG +  D     VAVK+L +      +  +F  E   LR  RH N+
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGD-----VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNI 94
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           +      + + +   D  A+V +     SL + LH+         + Q + IA   A  +
Sbjct: 95  L------LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGM 145
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           +YLH      I+H D+K +N+ L   LT  + DFGLA      +              G+
Sbjct: 146 DYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT-----GS 197
Query: 341 VGYAAPEYGMGSE---VSTSGDVYSFGILLLEMFTGKGP 376
           V + APE     +    S   DVYS+GI+L E+ TG+ P
Sbjct: 198 VLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 109/223 (48%), Gaps = 22/223 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 74  KLVQLY-AVVS-----EEPIYIVCEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIAS 125
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 176
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             + + APE  +    +   DV+SFGILL E+ T G+ P   M
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHE 322
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++                +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 323 KLVQLYAVVSEEPIY------IVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIAS 374
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 375 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 425
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
             + + APE  +    +   DV+SFGILL E+ T
Sbjct: 426 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 239
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 240 KLVQLY-AVVS-----EEPIYIVGEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIAS 291
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 292 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 342
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             + + APE  +    +   DV+SFGILL E+ T G+ P
Sbjct: 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 22/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 70
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL +   L  +  + L L Q + ++  +AS
Sbjct: 71  KLVQLY-AVVS-----EEPIYIVTEYMNKGSLLD--FLKGETGKYLRLPQLVDMSAQIAS 122
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 123 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQ------GAK 173
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             + + APE  +    +   DV+SFGILL E+ T G+ P
Sbjct: 174 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKII 224
           IG+GSFG+VYKG +  D     VAVK+LN+      +  +F  E   LR  RH N++  +
Sbjct: 16  IGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
               +         A+V +     SL   LH+         +++ + IA   A  ++YLH
Sbjct: 71  GYSTAPQL------AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 121
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 I+H DLK +N+ L  +LT  + DFGLA      +            + G++ + 
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSILWM 173
Query: 345 APEYGMGSE---VSTSGDVYSFGILLLEMFTGKGP 376
           APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 22/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L   +  + ++F+ E Q ++ +RH 
Sbjct: 185 ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLKPGNM-SPEAFLQEAQVMKKLRHE 240
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 241 KLVQLY-AVVS-----EEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIAS 292
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGL + + +             G K
Sbjct: 293 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQ------GAK 343
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             + + APE  +    +   DV+SFGILL E+ T G+ P
Sbjct: 344 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 124/267 (46%), Gaps = 37/267 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS----FIAECQALRSIR 216
           F +E  IG GSF +VYKG+    D ET V V    LQ R  +KS    F  E + L+ ++
Sbjct: 30  FDIE--IGRGSFKTVYKGL----DTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQ 83
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N+V+   S  S   +G     LV EL  +G+L+   +L R     + +L+  S    +
Sbjct: 84  HPNIVRFYDSWEST-VKGKKCIVLVTELXTSGTLK--TYLKRFKVXKIKVLR--SWCRQI 138
Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
              L++LH     PI+H DLK  N+ + G   +  + D GLA  L  A+           
Sbjct: 139 LKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAK-------- 188
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE---------MFTGNLT 386
            V GT  + APE     +   S DVY+FG   LE  T + P +E           T  + 
Sbjct: 189 AVIGTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVK 247
Query: 387 LHNFVKEALPERLAEIVDPVLLVEREE 413
             +F K A+PE + EI++  +   ++E
Sbjct: 248 PASFDKVAIPE-VKEIIEGCIRQNKDE 273

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 22/223 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 15  ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 70
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + ++  +AS
Sbjct: 71  KLVQLY-AVVS-----EEPIYIVTEYMNKGSLLDFL--KGETGKYLRLPQLVDMSAQIAS 122
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 123 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 173
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             + + APE  +    +   DV+SFGILL E+ T G+ P   M
Sbjct: 174 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 216

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKII 224
           IG+GSFG+VYKG +  D     VAVK+LN+      +  +F  E   LR  RH N++  +
Sbjct: 43  IGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 97
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                         A+V +     SL   LH+         +++ + IA   A  ++YLH
Sbjct: 98  GYSTKPQL------AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 148
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 I+H DLK +N+ L  +LT  + DFGLA      +            + G++ + 
Sbjct: 149 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSILWM 200
Query: 345 APEYGMGSE---VSTSGDVYSFGILLLEMFTGKGP 376
           APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 201 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKII 224
           IG+GSFG+VYKG +  D     VAVK+LN+      +  +F  E   LR  RH N++  +
Sbjct: 18  IGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 72
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                         A+V +     SL   LH+         +++ + IA   A  ++YLH
Sbjct: 73  GYSTKPQL------AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 123
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 I+H DLK +N+ L  +LT  + DFGLA      +            + G++ + 
Sbjct: 124 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSILWM 175
Query: 345 APEYGMGSE---VSTSGDVYSFGILLLEMFTGKGP 376
           APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 176 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 108/223 (48%), Gaps = 22/223 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  GSL ++L    +  + L L Q + +A  +AS
Sbjct: 74  KLVQLY-AVVS-----EEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIAS 125
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL  +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 126 GMAYVER---MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 176
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             + + APE  +    +   DV+SFGILL E+ T G+ P   M
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKII 224
           IG+GSFG+VYKG +  D     VAVK+LN+      +  +F  E   LR  RH N++  +
Sbjct: 44  IGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                         A+V +     SL   LH+         +++ + IA   A  ++YLH
Sbjct: 99  GYSTKPQL------AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 149
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 I+H DLK +N+ L  +LT  + DFGLA      +            + G++ + 
Sbjct: 150 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSILWM 201
Query: 345 APEYGMGSE---VSTSGDVYSFGILLLEMFTGKGP 376
           APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 202 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKII 224
           IG+GSFG+VYKG +  D     VAVK+LN+      +  +F  E   LR  RH N++  +
Sbjct: 21  IGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                         A+V +     SL   LH+         +++ + IA   A  ++YLH
Sbjct: 76  GYSTKPQL------AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 126
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 I+H DLK +N+ L  +LT  + DFGLA      +            + G++ + 
Sbjct: 127 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSILWM 178
Query: 345 APEYGMGSE---VSTSGDVYSFGILLLEMFTGKGP 376
           APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 179 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKII 224
           IG+GSFG+VYKG +  D     VAVK+LN+      +  +F  E   LR  RH N++  +
Sbjct: 21  IGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 75
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                         A+V +     SL   LH+         +++ + IA   A  ++YLH
Sbjct: 76  GYSTKPQL------AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 126
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 I+H DLK +N+ L  +LT  + DFGLA      +            + G++ + 
Sbjct: 127 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSILWM 178
Query: 345 APEYGMGSE---VSTSGDVYSFGILLLEMFTGKGP 376
           APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 179 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 22/223 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  G L ++L    +  + L L Q + +A  +AS
Sbjct: 74  KLVQLY-AVVS-----EEPIYIVMEYMSKGCLLDFL--KGEMGKYLRLPQLVDMAAQIAS 125
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 176
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             + + APE  +    +   DV+SFGILL E+ T G+ P   M
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKII 224
           IG+GSFG+VYKG +  D     VAVK+LN+      +  +F  E   LR  RH N++  +
Sbjct: 16  IGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                         A+V +     SL   LH+         +++ + IA   A  ++YLH
Sbjct: 71  GYSTKPQL------AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 121
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 I+H DLK +N+ L  +LT  + DFGLA      +            + G++ + 
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSILWM 173
Query: 345 APEYGMGSE---VSTSGDVYSFGILLLEMFTGKGP 376
           APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 108/223 (48%), Gaps = 22/223 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 18  ESLRLEVKLGQGCFGEVWMGTWNGT---TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++  + VS      +   +V E M  G L ++L    +  + L L Q + +A  +AS
Sbjct: 74  KLVQLY-AVVS-----EEPIYIVTEYMSKGCLLDFL--KGEMGKYLRLPQLVDMAAQIAS 125
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +             G K
Sbjct: 126 GMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ------GAK 176
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             + + APE  +    +   DV+SFGILL E+ T G+ P   M
Sbjct: 177 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 219

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKII 224
           IG+GSFG+VYKG +  D     VAVK+LN+      +  +F  E   LR  RH N++  +
Sbjct: 36  IGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 90
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                         A+V +     SL   LH+         +++ + IA   A  ++YLH
Sbjct: 91  GYSTKPQL------AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 141
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 I+H DLK +N+ L  +LT  + DFGLA                   + G++ + 
Sbjct: 142 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA-----TEKSRWSGSHQFEQLSGSILWM 193
Query: 345 APEYGMGSE---VSTSGDVYSFGILLLEMFTGKGP 376
           APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 194 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG+G FG V+ G + + D    VA+K +  +   + + FI E + +  + H  LV++   
Sbjct: 18  IGSGQFGLVHLGYWLNKDK---VAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
           C+           LV+E M +G L ++L   R       LL    + +DV   + YL   
Sbjct: 74  CLE-----QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL---GMCLDVCEGMAYLEEA 125
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
           C   ++H DL   N L+       VSDFG+ +F+ +             G K  V +A+P
Sbjct: 126 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD------DQYTSSTGTKFPVKWASP 176
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E    S  S+  DV+SFG+L+ E+F+ GK P
Sbjct: 177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG+G FG V+ G + + D    VA+K +  +   + + FI E + +  + H  LV++   
Sbjct: 13  IGSGQFGLVHLGYWLNKDK---VAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
           C+           LV+E M +G L ++L   R       LL    + +DV   + YL   
Sbjct: 69  CLE-----QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL---GMCLDVCEGMAYLEEA 120
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
           C   ++H DL   N L+       VSDFG+ +F+ +             G K  V +A+P
Sbjct: 121 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD------DQYTSSTGTKFPVKWASP 171
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E    S  S+  DV+SFG+L+ E+F+ GK P
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 202

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG+G FG V+ G + + D    VA+K +  +   + + FI E + +  + H  LV++   
Sbjct: 15  IGSGQFGLVHLGYWLNKDK---VAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
           C+           LV+E M +G L ++L   R       LL    + +DV   + YL   
Sbjct: 71  CLE-----QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL---GMCLDVCEGMAYLEEA 122
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
           C   ++H DL   N L+       VSDFG+ +F+ +             G K  V +A+P
Sbjct: 123 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD------DQYTSSTGTKFPVKWASP 173
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E    S  S+  DV+SFG+L+ E+F+ GK P
Sbjct: 174 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 204

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKII 224
           IG+GSFG+VYKG +  D     VAVK+LN+      +  +F  E   LR  RH N++  +
Sbjct: 44  IGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 98
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                         A+V +     SL   LH+         +++ + IA   A  ++YLH
Sbjct: 99  GYSTKPQL------AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 149
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 I+H DLK +N+ L  +LT  + DFGLA                   + G++ + 
Sbjct: 150 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA-----TEKSRWSGSHQFEQLSGSILWM 201
Query: 345 APEYGMGSE---VSTSGDVYSFGILLLEMFTGKGP 376
           APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 202 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  ++YL
Sbjct: 116 LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL 168
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 169 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKW 222
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 223 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 268

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 27/215 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKII 224
           IG+GSFG+VYKG +  D     VAVK+LN+      +  +F  E   LR  RH N++  +
Sbjct: 16  IGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                         A+V +     SL   LH+         +++ + IA   A  ++YLH
Sbjct: 71  GYSTKPQL------AIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 121
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 I+H DLK +N+ L  +LT  + DFGLA                   + G++ + 
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLA-----TEKSRWSGSHQFEQLSGSILWM 173
Query: 345 APEYGMGSE---VSTSGDVYSFGILLLEMFTGKGP 376
           APE     +    S   DVY+FGI+L E+ TG+ P
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 111/224 (49%), Gaps = 25/224 (11%)
Query: 164 ENLIGAGSFGSVYKGIFDHD--DHETLVAVKVLNLQHRGASK-SFIAECQALRSIRHRNL 220
           + +IGAG FG VYKG+        E  VA+K L   +    +  F+ E   +    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           +++    V   ++      ++ E M NG+L+++L   R+     ++LQ + +   +A+ +
Sbjct: 109 IRL--EGVISKYKPM---MIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGM 160
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXXXXVGV 337
           +YL        VH DL   N+L++  L   VSDFGL++ L   PEA            G 
Sbjct: 161 KYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-------GG 210
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
           K  + + APE     + +++ DV+SFGI++ E+ T G+ P  E+
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 109/226 (48%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  ++YL
Sbjct: 96  LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 149 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEXXSVHNKTGAKLPVKW 202
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 248

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  ++YL
Sbjct: 89  LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL 141
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 142 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKW 195
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 196 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 241

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  ++YL
Sbjct: 97  LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKW 203
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 249

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            S++ ++GAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+++   ++T    V         +V E M NGSL+ +L   R       ++Q + +   
Sbjct: 107 NIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRG 155
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +AS ++YL    +   VH DL   N+L++  L   VSDFGLA+ L   PEAA        
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTR---- 208
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P  EM
Sbjct: 209 ---GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  ++YL
Sbjct: 95  LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL 147
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 148 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKW 201
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 247

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  ++YL
Sbjct: 96  LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 149 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKW 202
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 203 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 248

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  ++YL
Sbjct: 92  LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 145 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKW 198
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 244

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  ++YL
Sbjct: 94  LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL 146
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 147 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKW 200
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 246

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  ++YL
Sbjct: 97  LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKW 203
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 249

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  ++YL
Sbjct: 115 LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYL 167
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 168 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKW 221
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 222 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 267

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG+G FG V+ G + + D    VA+K +  +   +   FI E + +  + H  LV++   
Sbjct: 35  IGSGQFGLVHLGYWLNKDK---VAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
           C+           LV+E M +G L ++L   R       LL    + +DV   + YL   
Sbjct: 91  CLE-----QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL---GMCLDVCEGMAYLEEA 142
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
           C   ++H DL   N L+       VSDFG+ +F+ +             G K  V +A+P
Sbjct: 143 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD------DQYTSSTGTKFPVKWASP 193
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E    S  S+  DV+SFG+L+ E+F+ GK P
Sbjct: 194 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 224

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 29  LGAGQFGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 84
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 85  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 134
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H DL+ +N+L+   L+  ++DFGLA+ + +             G K  + + AP
Sbjct: 135 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE------GAKFPIKWTAP 187
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 188 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 27  LGAGQFGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 83  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 132
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H DL+ +N+L+   L+  ++DFGLA+ + +             G K  + + AP
Sbjct: 133 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE------GAKFPIKWTAP 185
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 27  LGAGQFGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 83  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 132
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H DL+ +N+L+   L+  ++DFGLA+ + +             G K  + + AP
Sbjct: 133 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE------GAKFPIKWTAP 185
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 186 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 21  LGAGQFGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 77  VTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 126
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H DL+ +N+L+   L+  ++DFGLA+ + +             G K  + + AP
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE------GAKFPIKWTAP 179
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 31  LGAGQFGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 86
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 87  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 136
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H DL+ +N+L+   L+  ++DFGLA+ + +             G K  + + AP
Sbjct: 137 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE------GAKFPIKWTAP 189
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 190 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 26  LGAGQFGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 81
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 82  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 131
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H DL+ +N+L+   L+  ++DFGLA+ + +             G K  + + AP
Sbjct: 132 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE------GAKFPIKWTAP 184
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 185 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 22  LGAGQFGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 77
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 78  VTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 127
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H DL+ +N+L+   L+  ++DFGLA+ + +             G K  + + AP
Sbjct: 128 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE------GAKFPIKWTAP 180
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 181 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 211

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 21  LGAGQFGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 77  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 126
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H DL+ +N+L+   L+  ++DFGLA+ + +             G K  + + AP
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE------GAKFPIKWTAP 179
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 30  LGAGQFGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 85
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 86  VTQEPI------YIITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 135
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H DL+ +N+L+   L+  ++DFGLA+ + +             G K  + + AP
Sbjct: 136 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE------GAKFPIKWTAP 188
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 189 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 23  LGAGQFGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 78
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 79  VTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 128
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H DL+ +N+L+   L+  ++DFGLA+ + +             G K  + + AP
Sbjct: 129 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTARE------GAKFPIKWTAP 181
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 182 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 21  LGAGQFGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 77  VTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 126
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H DL+ +N+L+   L+  ++DFGLA+ + +             G K  + + AP
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE------GAKFPIKWTAP 179
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 16  LGAGQFGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 71
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 72  VTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 121
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H DL+ +N+L+   L+  ++DFGLA+ + +             G K  + + AP
Sbjct: 122 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE------GAKFPIKWTAP 174
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 175 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 205

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            S++ ++GAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+++   ++T    V         +V E M NGSL+ +L   R       ++Q + +   
Sbjct: 107 NIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRG 155
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +AS ++YL    +   VH DL   N+L++  L   VSDFGL++ L   PEAA        
Sbjct: 156 IASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR---- 208
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P  EM
Sbjct: 209 ---GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 124/257 (48%), Gaps = 33/257 (12%)
Query: 134 EPSTPP-SALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIF--DHDDHETLVA 190
           EP TP  +A   + LR+  +   K         ++G+G+FG+VYKGI+  + +  +  VA
Sbjct: 18  EPLTPSGTAPNQAQLRILKETELKRV------KVLGSGAFGTVYKGIWVPEGETVKIPVA 71
Query: 191 VKVLN-LQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGS 249
           +K+LN      A+  F+ E   + S+ H +LV+++  C+S   Q      LV +LM +G 
Sbjct: 72  IKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQ------LVTQLMPHGC 125
Query: 250 LEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA 309
           L E++H ++D   N+     L+  V +A  + YL    E  +VH DL   NVL+      
Sbjct: 126 LLEYVHEHKD---NIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHV 179
Query: 310 HVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLE 369
            ++DFGLA+ L               G K  + + A E     + +   DV+S+G+ + E
Sbjct: 180 KITDFGLARLL-----EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWE 234
Query: 370 MFTGKG------PTNEM 380
           + T  G      PT E+
Sbjct: 235 LMTFGGKPYDGIPTREI 251

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 31/231 (13%)
Query: 167 IGAGSFGSV----YKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G FG V    ++G +D       VA+K++  +   +   FI E + + ++ H  LV+
Sbjct: 16  LGTGQFGVVKYGKWRGQYD-------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 67
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +   C     Q   F  ++ E M NG L   L+  R+        Q L +  DV   +EY
Sbjct: 68  LYGVCTK---QRPIF--IITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEY 119
Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
           L        +H DL   N L++ +    VSDFGL++++ +            VG K  V 
Sbjct: 120 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS------VGSKFPVR 170
Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVK 392
           ++ PE  M S+ S+  D+++FG+L+ E+++ GK P  E FT + T  +  +
Sbjct: 171 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQ 220

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG+G FG V+ G + + D    VA+K +  +   + + FI E + +  + H  LV++   
Sbjct: 15  IGSGQFGLVHLGYWLNKDK---VAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
           C+           LV+E M +G L ++L   R       LL    + +DV   + YL   
Sbjct: 71  CLE-----QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL---GMCLDVCEGMAYLE-- 120
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E  ++H DL   N L+       VSDFG+ +F+ +             G K  V +A+P
Sbjct: 121 -EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD------DQYTSSTGTKFPVKWASP 173
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E    S  S+  DV+SFG+L+ E+F+ GK P
Sbjct: 174 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 204

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G FG V  G    D     VAVK +  ++   +++F+AE   +  +RH NLV+++  
Sbjct: 14  IGKGEFGDVMLG----DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLG- 66
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
            V V+ +G  +  +V E M  GSL ++L     +    + L + S+  DV   +EYL   
Sbjct: 67  -VIVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEG- 120
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
                VH DL   NVL+  +  A VSDFGL K   EA+             K  V + AP
Sbjct: 121 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG-------KLPVKWTAP 168
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E     + ST  DV+SFGILL E+++ G+ P
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVP 199

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            S++ ++GAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+++   ++T    V         +V E M NGSL+ +L   R       ++Q + +   
Sbjct: 78  NIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRG 126
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +AS ++YL    +   VH DL   N+L++  L   VSDFGL++ L   PEAA        
Sbjct: 127 IASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR---- 179
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P  EM
Sbjct: 180 ---GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 225

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            S++ ++GAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+++   ++T    V         +V E M NGSL+ +L   R       ++Q + +   
Sbjct: 107 NIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRG 155
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +AS ++YL    +   VH DL   N+L++  L   VSDFGL++ L   PEAA        
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR---- 208
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P  EM
Sbjct: 209 ---GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 31/225 (13%)
Query: 167 IGAGSFGSV----YKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G FG V    ++G +D       VA+K++  +   +   FI E + + ++ H  LV+
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +   C     Q   F  ++ E M NG L  +L   R+        Q L +  DV   +EY
Sbjct: 64  LYGVCTK---QRPIF--IITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEY 115
Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
           L        +H DL   N L++ +    VSDFGL++++ +            VG K  V 
Sbjct: 116 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS------VGSKFPVR 166
Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           ++ PE  M S+ S+  D+++FG+L+ E+++ GK P  E FT + T
Sbjct: 167 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSET 210

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            S++ ++GAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+++   ++T    V         +V E M NGSL+ +L   R       ++Q + +   
Sbjct: 107 NIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRG 155
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +AS ++YL    +   VH DL   N+L++  L   VSDFGL++ L   PEAA        
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR---- 208
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P  EM
Sbjct: 209 ---GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            S++ ++GAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+++   ++T    V         +V E M NGSL+ +L   R       ++Q + +   
Sbjct: 107 NIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRG 155
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +AS ++YL    +   VH DL   N+L++  L   VSDFGL++ L   PEAA        
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR---- 208
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P  EM
Sbjct: 209 ---GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            S++ ++GAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+++   ++T    V         +V E M NGSL+ +L   R       ++Q + +   
Sbjct: 78  NIIRLEGVVTKSKPV--------MIVTEXMENGSLDSFL---RKHDAQFTVIQLVGMLRG 126
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +AS ++YL    +   VH DL   N+L++  L   VSDFGL++ L   PEAA        
Sbjct: 127 IASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR---- 179
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P  EM
Sbjct: 180 ---GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 225

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            S++ ++GAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 35  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 94
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+++   ++T    V         +V E M NGSL+ +L   R       ++Q + +   
Sbjct: 95  NIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRG 143
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +AS ++YL    +   VH DL   N+L++  L   VSDFGL++ L   PEAA        
Sbjct: 144 IASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR---- 196
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P  EM
Sbjct: 197 ---GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 242

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 112/225 (49%), Gaps = 26/225 (11%)
Query: 165 NLIGAGSFGSVYKGIF--DHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLV 221
            ++G+G+FG+VYKGI+  + +  +  VA+K+LN      A+  F+ E   + S+ H +LV
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           +++  C+S   Q      LV +LM +G L E++H ++D   N+     L+  V +A  + 
Sbjct: 81  RLLGVCLSPTIQ------LVTQLMPHGCLLEYVHEHKD---NIGSQLLLNWCVQIAKGMM 131
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           YL    E  +VH DL   NVL+       ++DFGLA+ L               G K  +
Sbjct: 132 YLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----EGDEKEYNADGGKMPI 183
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG------PTNEM 380
            + A E     + +   DV+S+G+ + E+ T  G      PT E+
Sbjct: 184 KWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 228

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G FG V  G    D     VAVK +  ++   +++F+AE   +  +RH NLV+++  
Sbjct: 29  IGKGEFGDVMLG----DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLG- 81
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
            V V+ +G  +  +V E M  GSL ++L     +    + L + S+  DV   +EYL   
Sbjct: 82  -VIVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEG- 135
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
                VH DL   NVL+  +  A VSDFGL K   EA+             K  V + AP
Sbjct: 136 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG-------KLPVKWTAP 183
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E     + ST  DV+SFGILL E+++ G+ P
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/217 (33%), Positives = 106/217 (48%), Gaps = 26/217 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
             L   IG G FG V  G    D     VAVK +  ++   +++F+AE   +  +RH NL
Sbjct: 195 LKLLQTIGKGEFGDVMLG----DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNL 248
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V+++   V V+ +G  +  +V E M  GSL ++L     +    + L + S+  DV   +
Sbjct: 249 VQLLG--VIVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAM 302
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL        VH DL   NVL+  +  A VSDFGL K   EA+             K  
Sbjct: 303 EYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG-------KLP 349
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           V + APE     + ST  DV+SFGILL E+++ G+ P
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            S++ ++GAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+++   ++T    V         +V E M NGSL+ +L   R       ++Q + +   
Sbjct: 107 NIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRG 155
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +AS ++YL    +   VH DL   N+L++  L   VSDFGL++ L   PEAA        
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR---- 208
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P  EM
Sbjct: 209 ---GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            S++ ++GAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 45  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 104
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+++   ++T    V         +V E M NGSL+ +L   R       ++Q + +   
Sbjct: 105 NIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRG 153
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +AS ++YL    +   VH DL   N+L++  L   VSDFGL++ L   PEAA        
Sbjct: 154 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR---- 206
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P  EM
Sbjct: 207 ---GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 252

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 31/225 (13%)
Query: 167 IGAGSFGSV----YKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G FG V    ++G +D       VA+K++  +   +   FI E + + ++ H  LV+
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +   C     Q   F  ++ E M NG L   L+  R+        Q L +  DV   +EY
Sbjct: 69  LYGVCTK---QRPIF--IITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
           L        +H DL   N L++ +    VSDFGL++++ +            VG K  V 
Sbjct: 121 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS------VGSKFPVR 171
Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           ++ PE  M S+ S+  D+++FG+L+ E+++ GK P  E FT + T
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSET 215

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            S++ ++GAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+++   ++T    V         +V E M NGSL+ +L   R       ++Q + +   
Sbjct: 107 NIIRLEGVVTKSKPV--------MIVTEXMENGSLDSFL---RKHDAQFTVIQLVGMLRG 155
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +AS ++YL    +   VH DL   N+L++  L   VSDFGL++ L   PEAA        
Sbjct: 156 IASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR---- 208
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P  EM
Sbjct: 209 ---GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 109/229 (47%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            S++ ++GAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+++   ++T    V         +V E M NGSL+ +L   R       ++Q + +   
Sbjct: 107 NIIRLEGVVTKSKPV--------MIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRG 155
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +AS ++YL    +   VH DL   N+L++  L   VSDFGL + L   PEAA        
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR---- 208
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P  EM
Sbjct: 209 ---GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            S++ ++GAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+++   ++T    V         +V E M NGSL+ +L   R       ++Q + +   
Sbjct: 107 NIIRLEGVVTKSKPV--------MIVTEXMENGSLDSFL---RKHDAQFTVIQLVGMLRG 155
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +AS ++YL    +   VH DL   N+L++  L   VSDFGL++ L   PEAA        
Sbjct: 156 IASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR---- 208
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P  EM
Sbjct: 209 ---GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 31/231 (13%)
Query: 167 IGAGSFGSV----YKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G FG V    ++G +D       VA+K++  +   +   FI E + + ++ H  LV+
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +   C     Q   F  ++ E M NG L   L+  R+        Q L +  DV   +EY
Sbjct: 84  LYGVCTK---QRPIF--IITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
           L        +H DL   N L++ +    VSDFGL++++ +            VG K  V 
Sbjct: 136 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSS------VGSKFPVR 186
Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVK 392
           ++ PE  M S+ S+  D+++FG+L+ E+++ GK P  E FT + T  +  +
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQ 236

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 105/211 (49%), Gaps = 26/211 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G FG V  G    D     VAVK +  ++   +++F+AE   +  +RH NLV+++  
Sbjct: 20  IGKGEFGDVMLG----DYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLG- 72
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
            V V+ +G  +  +V E M  GSL ++L     +    + L + S+  DV   +EYL   
Sbjct: 73  -VIVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEG- 126
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
                VH DL   NVL+  +  A VSDFGL K   EA+             K  V + AP
Sbjct: 127 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG-------KLPVKWTAP 174
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E    +  ST  DV+SFGILL E+++ G+ P
Sbjct: 175 EALREAAFSTKSDVWSFGILLWEIYSFGRVP 205

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 31/231 (13%)
Query: 167 IGAGSFGSV----YKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G FG V    ++G +D       VA+K++  +   +   FI E + + ++ H  LV+
Sbjct: 23  LGTGQFGVVKYGKWRGQYD-------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 74
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +   C     Q   F  ++ E M NG L   L+  R+        Q L +  DV   +EY
Sbjct: 75  LYGVCTK---QRPIF--IITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEY 126
Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
           L        +H DL   N L++ +    VSDFGL++++ +            VG K  V 
Sbjct: 127 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS------VGSKFPVR 177
Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVK 392
           ++ PE  M S+ S+  D+++FG+L+ E+++ GK P  E FT + T  +  +
Sbjct: 178 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQ 227

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 110/231 (47%), Gaps = 31/231 (13%)
Query: 167 IGAGSFGSV----YKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G FG V    ++G +D       VA+K++  +   +   FI E + + ++ H  LV+
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +   C     Q   F  ++ E M NG L   L+  R+        Q L +  DV   +EY
Sbjct: 84  LYGVCTK---QRPIF--IITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
           L        +H DL   N L++ +    VSDFGL++++ +            VG K  V 
Sbjct: 136 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS------VGSKFPVR 186
Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVK 392
           ++ PE  M S+ S+  D+++FG+L+ E+++ GK P  E FT + T  +  +
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQ 236

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG+G FG V+ G + + D    VA+K +  +   + + FI E + +  + H  LV++   
Sbjct: 16  IGSGQFGLVHLGYWLNKDK---VAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
           C+           LV E M +G L ++L   R       LL    + +DV   + YL   
Sbjct: 72  CLE-----QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLL---GMCLDVCEGMAYLEEA 123
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
           C   ++H DL   N L+       VSDFG+ +F+ +             G K  V +A+P
Sbjct: 124 C---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD------DQYTSSTGTKFPVKWASP 174
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E    S  S+  DV+SFG+L+ E+F+ GK P
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGAS-KSFIAECQALRSIRHRNLVKI 223
           +G G FG V    +D +   T   VAVK L  +  G        E + LR++ H N+VK 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
              C      G +   L+ E + +GSL+E+L  N++    +NL Q+L  AV +   ++YL
Sbjct: 89  KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYL 142
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   NVL++ E    + DFGL K    A                 V +
Sbjct: 143 G---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK----AIETDKEXXTVKDDRDSPVFW 195
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            APE  M S+   + DV+SFG+ L E+ T
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGAS-KSFIAECQALRSIRHRNLVKI 223
           +G G FG V    +D +   T   VAVK L  +  G        E + LR++ H N+VK 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
              C      G +   L+ E + +GSL+E+L  N++    +NL Q+L  AV +   ++YL
Sbjct: 77  KGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYL 130
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   NVL++ E    + DFGL K    A                 V +
Sbjct: 131 G---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK----AIETDKEXXTVKDDRDSPVFW 183
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            APE  M S+   + DV+SFG+ L E+ T
Sbjct: 184 YAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  +++L
Sbjct: 97  LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKW 203
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 249

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG  G V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 21  LGAGQAGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 77  VTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 126
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H DL+ +N+L+   L+  ++DFGLA+ + +A            G K  + + AP
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTARE------GAKFPIKWTAP 179
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  +++L
Sbjct: 98  LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 151 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKW 204
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 250

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  +++L
Sbjct: 98  LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 151 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMLDKEFDSVHNKTGAKLPVKW 204
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 250

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  +++L
Sbjct: 156 LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 209 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKW 262
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  +++L
Sbjct: 95  LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL 147
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 148 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKW 201
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 247

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  +++L
Sbjct: 102 LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL 154
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 155 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKW 208
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 209 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 254

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 16/226 (7%)
Query: 166 LIGAGSFGSVYKG-IFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLVKI 223
           +IG G FG VY G + D+D  +   AVK LN +   G    F+ E   ++   H N++ +
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +  C+    +G+    L Y  M +G L  ++   R+   N  +   +   + VA  +++L
Sbjct: 97  LGICLRS--EGSPLVVLPY--MKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
                   VH DL   N +LD + T  V+DFGLA+   +             G K  V +
Sbjct: 150 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKW 203
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
            A E     + +T  DV+SFG+LL E+ T G  P  ++ T ++T++
Sbjct: 204 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 249

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 22/224 (9%)
Query: 163 LENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNL 220
           +E +IGAG FG V  G        E  VA+K L   +     + F++E   +    H N+
Sbjct: 37  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 96
Query: 221 VK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           +    ++T    V         ++ E M NGSL+ +L  N        ++Q + +   +A
Sbjct: 97  IHLEGVVTKSTPV--------MIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIA 145
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
           + ++YL    +   VH DL   N+L++  L   VSDFGL++FL +            +G 
Sbjct: 146 AGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT--SDPTYTSALGG 200
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
           K  + + APE     + +++ DV+S+GI++ E+ + G+ P  +M
Sbjct: 201 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 244

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G ++     T VAVK L  Q   +  +F+AE   ++ ++H+ LV++   
Sbjct: 17  LGAGQFGEVWMGYYNG---HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 72
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        ++ E M NGSL ++L         +N L  L +A  +A  + ++   
Sbjct: 73  VTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKL--LDMAAQIAEGMAFIE-- 122
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
            E   +H +L+ +N+L+   L+  ++DFGLA+ + +             G K  + + AP
Sbjct: 123 -ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTARE------GAKFPIKWTAP 175
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   DV+SFGILL E+ T G+ P
Sbjct: 176 EAINYGTFTIKSDVWSFGILLTEIVTHGRIP 206

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 111/234 (47%), Gaps = 14/234 (5%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETL-VAVKVLNLQHRGASK--SFIAECQALRSIRHRN 219
           L  ++G G FGSV +G    +D  +L VAVK + L +    +   F++E   ++   H N
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR--DAPRNLNLLQRLSIAVDVA 277
           +++++  C+ +  QG     ++   M  G L  +L  +R    P+++ L   L   VD+A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
             +EYL +      +H DL   N +L  ++T  V+DFGL+K +                 
Sbjct: 158 LGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI-----A 209
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV 391
           K  V + A E       ++  DV++FG+ + E+ T +G T      N  +++++
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT-RGMTPYPGVQNHEMYDYL 262

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 27/224 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
            +LE +IG G FG VY+  +  D+     A    +       ++   E +    ++H N+
Sbjct: 9   LTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI 68
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           + +   C+    + N    LV E    G L   L   R  P  L     ++ AV +A  +
Sbjct: 69  IALRGVCLK---EPN--LCLVMEFARGGPLNRVLSGKRIPPDIL-----VNWAVQIARGM 118
Query: 281 EYLHHYCETPIVHCDLKPSNVLL-----DGELT---AHVSDFGLAKFLPEAAXXXXXXXX 332
            YLH     PI+H DLK SN+L+     +G+L+     ++DFGLA+              
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---------EWHRT 169
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             +   G   + APE    S  S   DV+S+G+LL E+ TG+ P
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQHRGASK-SFIAECQALRSIRHR 218
             +E +IG G FG V  G        E  VA+K L   +    +  F++E   +    H 
Sbjct: 31  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 90
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N++    ++T C  V         ++ E M NGSL+ +L  N        ++Q + +   
Sbjct: 91  NIIHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDG---RFTVIQLVGMLRG 139
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           + S ++YL    +   VH DL   N+L++  L   VSDFG+++ L   PEAA        
Sbjct: 140 IGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR---- 192
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + APE     + +++ DV+S+GI++ E+ + G+ P  +M
Sbjct: 193 ---GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 238

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQHRGASK-SFIAECQALRSIRHR 218
             +E +IG G FG V  G        E  VA+K L   +    +  F++E   +    H 
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N++    ++T C  V         ++ E M NGSL+ +L  N        ++Q + +   
Sbjct: 76  NIIHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDG---RFTVIQLVGMLRG 124
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           + S ++YL    +   VH DL   N+L++  L   VSDFG+++ L   PEAA        
Sbjct: 125 IGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR---- 177
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + APE     + +++ DV+S+GI++ E+ + G+ P  +M
Sbjct: 178 ---GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 223

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 107/229 (46%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQHRGASK-SFIAECQALRSIRHR 218
             +E +IG G FG V  G        E  VA+K L   +    +  F++E   +    H 
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N++    ++T C  V         ++ E M NGSL+ +L  N        ++Q + +   
Sbjct: 70  NIIHLEGVVTKCKPV--------MIITEYMENGSLDAFLRKNDG---RFTVIQLVGMLRG 118
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           + S ++YL    +   VH DL   N+L++  L   VSDFG+++ L   PEAA        
Sbjct: 119 IGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTR---- 171
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + APE     + +++ DV+S+GI++ E+ + G+ P  +M
Sbjct: 172 ---GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 217

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 115/248 (46%), Gaps = 33/248 (13%)
Query: 131 TKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVA 190
           T  +PS+P           +Y          ++++ +G G +G VY+G++    +   VA
Sbjct: 1   TSMDPSSP-----------NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK--KYSLTVA 47
Query: 191 VKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL 250
           VK L  +     + F+ E   ++ I+H NLV+++  C     +   F  ++ E M  G+L
Sbjct: 48  VKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT----REPPFYIII-EFMTYGNL 101
Query: 251 EEWLH-LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA 309
            ++L   NR   + +N +  L +A  ++S +EYL    +   +H DL   N L+      
Sbjct: 102 LDYLRECNR---QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 155
Query: 310 HVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLE 369
            V+DFGL++ +               G K  + + APE    ++ S   DV++FG+LL E
Sbjct: 156 KVADFGLSRLM------TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 370 MFT-GKGP 376
           + T G  P
Sbjct: 210 IATYGMSP 217

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 117/263 (44%), Gaps = 38/263 (14%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKII 224
           IG+GSFG+VYKG +  D     VAVK+LN+      +  +F  E   LR  RH N++  +
Sbjct: 20  IGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                         A+V +     SL   LH +        + + + IA   A  ++YLH
Sbjct: 75  GYSTKPQL------AIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLH 125
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 I+H DLK +N+ L  + T  + DFGLA      +            + G++ + 
Sbjct: 126 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQ-----LSGSILWM 177
Query: 345 APE---YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM--------FTGNLTLH---NF 390
           APE       +  S   DVY+FGI+L E+ TG+ P + +          G  +L    + 
Sbjct: 178 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 237
Query: 391 VKEALPERLAEIVDPVLLVEREE 413
           V+   P+R+  ++   L  +R+E
Sbjct: 238 VRSNCPKRMKRLMAECLKKKRDE 260

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G G FG V+ G ++ +   T VA+K L      + +SF+ E Q ++ ++H  LV++   
Sbjct: 17  LGNGQFGEVWMGTWNGN---TKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAV 72
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                        +V E M  GSL ++L       R L L   + +A  VA+ + Y+   
Sbjct: 73  VSEEPI------YIVTEYMNKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM 124
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
                +H DL+ +N+L+   L   ++DFGLA+ + +             G K  + + AP
Sbjct: 125 N---YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQ------GAKFPIKWTAP 175
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E  +    +   DV+SFGILL E+ T G+ P
Sbjct: 176 EAALYGRFTIKSDVWSFGILLTELVTKGRVP 206

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 115/248 (46%), Gaps = 33/248 (13%)
Query: 131 TKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVA 190
           T  +PS+P           +Y          ++++ +G G +G VY+G++    +   VA
Sbjct: 1   TSMDPSSP-----------NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK--KYSLTVA 47
Query: 191 VKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL 250
           VK L  +     + F+ E   ++ I+H NLV+++  C     +   F  ++ E M  G+L
Sbjct: 48  VKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT----REPPF-YIITEFMTYGNL 101
Query: 251 EEWLH-LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA 309
            ++L   NR   + +N +  L +A  ++S +EYL    +   +H DL   N L+      
Sbjct: 102 LDYLRECNR---QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLV 155
Query: 310 HVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLE 369
            V+DFGL++ +               G K  + + APE    ++ S   DV++FG+LL E
Sbjct: 156 KVADFGLSRLM------TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 370 MFT-GKGP 376
           + T G  P
Sbjct: 210 IATYGMSP 217

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 31/225 (13%)
Query: 167 IGAGSFGSV----YKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G FG V    ++G +D       VA+K++  +   +   FI E + + ++ H  LV+
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-------VAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQ 68
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +   C     Q   F  ++ E M NG L   L+  R+        Q L +  DV   +EY
Sbjct: 69  LYGVCTK---QRPIF--IITEYMANGCL---LNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
           L        +H DL   N L++ +    VSDFGL++++ +             G K  V 
Sbjct: 121 LE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSR------GSKFPVR 171
Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           ++ PE  M S+ S+  D+++FG+L+ E+++ GK P  E FT + T
Sbjct: 172 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSET 215

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 73
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + +N +  L +A  ++S +
Sbjct: 74  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAM 125
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 126 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAPAGAKFP 176
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + + APE    ++ S   DV++FG+LL E+ T
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 117/263 (44%), Gaps = 38/263 (14%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKII 224
           IG+GSFG+VYKG +  D     VAVK+LN+      +  +F  E   LR  RH N++  +
Sbjct: 32  IGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
               +         A+V +     SL   LH +        + + + IA   A  ++YLH
Sbjct: 87  GYSTAPQL------AIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLH 137
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 I+H DLK +N+ L  + T  + DFGLA                   + G++ + 
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA-----TEKSRWSGSHQFEQLSGSILWM 189
Query: 345 APE---YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM--------FTGNLTLH---NF 390
           APE       +  S   DVY+FGI+L E+ TG+ P + +          G  +L    + 
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 391 VKEALPERLAEIVDPVLLVEREE 413
           V+   P+R+  ++   L  +R+E
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDE 272

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + +N +  L +A  ++S +
Sbjct: 78  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAM 129
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 130 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 180
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + + APE    ++ S   DV++FG+LL E+ T
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 17  TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 73
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + +N +  L +A  ++S +
Sbjct: 74  QLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAM 125
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 126 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTXTAHAGAKFP 176
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + + APE    ++ S   DV++FG+LL E+ T
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 16  TMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + +N +  L +A  ++S +
Sbjct: 73  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAM 124
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 175
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + + APE    ++ S   DV++FG+LL E+ T G  P
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 20  TMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + +N +  L +A  ++S +
Sbjct: 77  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAM 128
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 129 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 179
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + + APE    ++ S   DV++FG+LL E+ T G  P
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + +N +  L +A  ++S +
Sbjct: 78  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAM 129
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 130 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTXTAHAGAKFP 180
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + + APE    ++ S   DV++FG+LL E+ T G  P
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 217

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +GAG FG V+   ++     T VAVK +        ++F+AE   +++++H 
Sbjct: 15  ESLKLEKKLGAGQFGEVWMATYNK---HTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHD 70
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LVK+                ++ E M  GSL ++L  +  + + L  L  +  +  +A 
Sbjct: 71  KLVKLHAVVTKEPIY------IITEFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAE 122
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + ++    +   +H DL+ +N+L+   L   ++DFGLA+ + +             G K
Sbjct: 123 GMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE------GAK 173
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             + + APE       +   DV+SFGILL+E+ T G+ P
Sbjct: 174 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 16  TMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + +N +  L +A  ++S +
Sbjct: 73  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAM 124
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 175
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + + APE    ++ S   DV++FG+LL E+ T G  P
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + +N +  L +A  ++S +
Sbjct: 75  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAM 126
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 127 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAPAGAKFP 177
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + + APE    ++ S   DV++FG+LL E+ T
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 18  TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + +N +  L +A  ++S +
Sbjct: 75  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAM 126
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 127 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 177
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + + APE    ++ S   DV++FG+LL E+ T G  P
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +GAG FG V+   ++     T VAVK +        ++F+AE   +++++H 
Sbjct: 182 ESLKLEKKLGAGQFGEVWMATYNK---HTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHD 237
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LVK+                ++ E M  GSL ++L  +  + + L  L  +  +  +A 
Sbjct: 238 KLVKLHAVVTKEPI------YIITEFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAE 289
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + ++    +   +H DL+ +N+L+   L   ++DFGLA+                VG K
Sbjct: 290 GMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLAR----------------VGAK 330
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             + + APE       +   DV+SFGILL+E+ T G+ P
Sbjct: 331 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 116/263 (44%), Gaps = 38/263 (14%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSIRHRNLVKII 224
           IG+GSFG+VYKG +  D     VAVK+LN+      +  +F  E   LR  RH N++  +
Sbjct: 32  IGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                         A+V +     SL   LH +        + + + IA   A  ++YLH
Sbjct: 87  GYSTKPQL------AIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLH 137
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 I+H DLK +N+ L  + T  + DFGLA                   + G++ + 
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLA-----TEKSRWSGSHQFEQLSGSILWM 189
Query: 345 APE---YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM--------FTGNLTLH---NF 390
           APE       +  S   DVY+FGI+L E+ TG+ P + +          G  +L    + 
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249
Query: 391 VKEALPERLAEIVDPVLLVEREE 413
           V+   P+R+  ++   L  +R+E
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDE 272

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 29  TMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 85
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + +N +  L +A  ++S +
Sbjct: 86  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAM 137
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 138 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 188
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + + APE    ++ S   DV++FG+LL E+ T G  P
Sbjct: 189 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 225

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 18  TMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 74
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + +N +  L +A  ++S +
Sbjct: 75  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAM 126
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 127 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 177
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + + APE    ++ S   DV++FG+LL E+ T G  P
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 214

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +GAG FG V+   ++     T VAVK +        ++F+AE   +++++H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNK---HTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHD 243
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LVK+                ++ E M  GSL ++L  +  + + L  L  +  +  +A 
Sbjct: 244 KLVKLHAVVTKEPIY------IITEFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAE 295
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + ++    +   +H DL+ +N+L+   L   ++DFGLA+ + +             G K
Sbjct: 296 GMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE------GAK 346
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             + + APE       +   DV+SFGILL+E+ T G+ P
Sbjct: 347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G FG VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 14  TMKHKLGGGQFGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + ++ +  L +A  ++S +
Sbjct: 71  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAM 122
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 123 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTXTAHAGAKFP 173
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + + APE    ++ S   DV++FG+LL E+ T
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 109/229 (47%), Gaps = 30/229 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHR 218
            ++E +IGAG FG V  G        E  VA+K L + +     + F+ E   +    H 
Sbjct: 24  ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 83
Query: 219 NLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N++    ++T    V         +V E M NGSL+ +L  N        ++Q + +   
Sbjct: 84  NIIHLEGVVTKSKPV--------MIVTEYMENGSLDTFLKKNDG---QFTVIQLVGMLRG 132
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXX 332
           +++ ++YL    +   VH DL   N+L++  L   VSDFGL++ L   PEAA        
Sbjct: 133 ISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTR---- 185
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              G K  + + APE     + +++ DV+S+GI++ E+ + G+ P  EM
Sbjct: 186 ---GGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEM 231

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 32/218 (14%)
Query: 167 IGAGSFGSV----YKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G+G FG V    +KG +D       VAVK++  +   +   F  E Q +  + H  LVK
Sbjct: 16  LGSGQFGVVKLGKWKGQYD-------VAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVK 67
Query: 223 IITSCVSVDFQGNDFE-ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
               C        ++   +V E + NG L  +L   R   + L   Q L +  DV   + 
Sbjct: 68  FYGVC------SKEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMA 118
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           +L  +     +H DL   N L+D +L   VSDFG+ +++ +            VG K  V
Sbjct: 119 FLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS------VGTKFPV 169
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
            ++APE     + S+  DV++FGIL+ E+F+ GK P +
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 28/224 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSI 215
           D F +   IG GSFG V   I   +D + + A+K +N Q    R   ++   E Q ++ +
Sbjct: 15  DHFEILRAIGKGSFGKV--CIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
            H  LV +  S     FQ  +   +V +L++ G L    HL ++       + +L I  +
Sbjct: 73  EHPFLVNLWYS-----FQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKEETV-KLFIC-E 123
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +   L+YL +     I+H D+KP N+LLD     H++DF +A  LP              
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--------QIT 172
Query: 336 GVKGTVGYAAPEY---GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE      G+  S + D +S G+   E+  G+ P
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 102/230 (44%), Gaps = 41/230 (17%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETL----VAVKVLNLQHRGAS---KSFIAECQALR 213
           + + + +G G   +VY         +T+    VA+K + +  R      K F  E     
Sbjct: 13  YKIVDKLGGGGMSTVYLA------EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS 66
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
            + H+N+V    S + VD + +D   LV E +   +L E++  +   P          ++
Sbjct: 67  QLSHQNIV----SMIDVD-EEDDCYYLVMEYIEGPTLSEYIESH--GP----------LS 109
Query: 274 VDVA-----STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXX 328
           VD A       L+ + H  +  IVH D+KP N+L+D   T  + DFG+AK L E +    
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169
Query: 329 XXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
                   V GTV Y +PE   G       D+YS GI+L EM  G+ P N
Sbjct: 170 NH------VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFN 213

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + ++ +  L +A  ++S +
Sbjct: 73  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAM 124
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 175
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + + APE    ++ S   DV++FG+LL E+ T
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNL----QHRGASKSFIAECQALRSIRHRNL 220
           +G G FG V    +D  +D    +VAVK L      QHR   K    E   LR++ H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHI 78
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN-LNLLQRLSIAVDVAST 279
           +K    C   + QG     LV E +  GSL ++L      PR+ + L Q L  A  +   
Sbjct: 79  IKYKGCC---EDQGEKSLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEG 129
Query: 280 LEYLH--HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
           + YLH  HY     +H +L   NVLLD +    + DFGLAK +PE               
Sbjct: 130 MAYLHAQHY-----IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG---- 180
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
              V + APE     +   + DV+SFG+ L E+ T
Sbjct: 181 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNL----QHRGASKSFIAECQALRSIRHRNL 220
           +G G FG V    +D  +D    +VAVK L      QHR   K    E   LR++ H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHI 78
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN-LNLLQRLSIAVDVAST 279
           +K    C   + QG     LV E +  GSL ++L      PR+ + L Q L  A  +   
Sbjct: 79  IKYKGCC---EDQGEKSLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEG 129
Query: 280 LEYLH--HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
           + YLH  HY     +H +L   NVLLD +    + DFGLAK +PE               
Sbjct: 130 MAYLHSQHY-----IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG---- 180
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
              V + APE     +   + DV+SFG+ L E+ T
Sbjct: 181 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 108/217 (49%), Gaps = 22/217 (10%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + ++ +  L +A  ++S +
Sbjct: 71  QLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAM 122
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 123 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTXTAHAGAKFP 173
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + + APE    ++ S   DV++FG+LL E+ T G  P
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 210

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 21  TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 77
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + ++ +  L +A  ++S +
Sbjct: 78  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAM 129
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 130 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 180
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + + APE    ++ S   DV++FG+LL E+ T
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 22/224 (9%)
Query: 163 LENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNL 220
           +E +IGAG FG V  G        E  VA+K L   +     + F++E   +    H N+
Sbjct: 11  IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 70
Query: 221 VK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           +    ++T    V         ++ E M NGSL+ +L  N        ++Q + +   +A
Sbjct: 71  IHLEGVVTKSTPV--------MIITEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIA 119
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
           + ++YL    +   VH  L   N+L++  L   VSDFGL++FL +            +G 
Sbjct: 120 AGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDT--SDPTYTSALGG 174
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
           K  + + APE     + +++ DV+S+GI++ E+ + G+ P  +M
Sbjct: 175 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 218

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + ++ +  L +A  ++S +
Sbjct: 73  QLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAM 124
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 175
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + + APE    ++ S   DV++FG+LL E+ T
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 16  TMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + ++ +  L +A  ++S +
Sbjct: 73  QLLGVCT----REPPF-YIIIEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAM 124
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 175
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + + APE    ++ S   DV++FG+LL E+ T G  P
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 22/217 (10%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 72
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + ++ +  L +A  ++S +
Sbjct: 73  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAM 124
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 125 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 175
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + + APE    ++ S   DV++FG+LL E+ T G  P
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 14  TMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 70
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + ++ +  L +A  ++S +
Sbjct: 71  QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAM 122
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H DL   N L+       V+DFGL++ +               G K  
Sbjct: 123 EYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM------TGDTFTAHAGAKFP 173
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + + APE    ++ S   DV++FG+LL E+ T
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 205

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 262 TMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 318
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + +N +  L +A  ++S +
Sbjct: 319 QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAM 370
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H +L   N L+       V+DFGL++ +               G K  
Sbjct: 371 EYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 421
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + + APE    ++ S   DV++FG+LL E+ T
Sbjct: 422 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDH-ETLVAVKVLNLQHRGASKSFIAECQALR-- 213
           AT  +     IG G++G+VYK    H  H   L +V+V N +  G   S + E   LR  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEE-GLPISTVREVALLRRL 60
Query: 214 -SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
            +  H N+V+++  C +          LV+E  V+  L  +L  ++  P  L       +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYL--DKAPPPGLPAETIKDL 117
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
                  L++LH  C   IVH DLKP N+L+    T  ++DFGLA+              
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--------SYQM 166
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
               V  T+ Y APE  + S  +T  D++S G +  EMF  K     +F GN
Sbjct: 167 ALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFCGN 214

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDH-ETLVAVKVLNLQHRGASKSFIAECQALR-- 213
           AT  +     IG G++G+VYK    H  H   L +V+V N +  G   S + E   LR  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEE-GLPISTVREVALLRRL 60
Query: 214 -SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
            +  H N+V+++  C +          LV+E  V+  L  +L  ++  P  L       +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYL--DKAPPPGLPAETIKDL 117
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
                  L++LH  C   IVH DLKP N+L+    T  ++DFGLA+              
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--------SYQM 166
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
               V  T+ Y APE  + S  +T  D++S G +  EMF  K     +F GN
Sbjct: 167 ALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFCGN 214

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/215 (32%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNL----QHRGASKSFIAECQALRSIRHRNL 220
           +G G FG V    +D  +D    +VAVK L      QHR   K    E   LR++ H ++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---EIDILRTLYHEHI 95
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN-LNLLQRLSIAVDVAST 279
           +K    C      G     LV E +  GSL ++L      PR+ + L Q L  A  +   
Sbjct: 96  IKYKGCCEDA---GAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEG 146
Query: 280 LEYLH--HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
           + YLH  HY     +H DL   NVLLD +    + DFGLAK +PE               
Sbjct: 147 MAYLHAQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDG---- 197
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
              V + APE     +   + DV+SFG+ L E+ T
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 101/234 (43%), Gaps = 29/234 (12%)
Query: 163 LENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
           L+  +G G+FG V+            + LVAVK L      A K F  E + L +++H +
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN------------RDAPRNLNLL 267
           +VK    C        D   +V+E M +G L ++L  +            R A   L L 
Sbjct: 79  IVKFYGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXX 327
           Q L IA  +AS + YL        VH DL   N L+   L   + DFG+++ +       
Sbjct: 134 QMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR 190
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
                        + +  PE  M  + +T  DV+SFG++L E+FT GK P  ++
Sbjct: 191 VGGHTML-----PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/244 (32%), Positives = 109/244 (44%), Gaps = 26/244 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETL-VAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVK 222
           +G GSFG V +G +D    +T+ VAVK L    L    A   FI E  A+ S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS-IAVDVASTLE 281
           +    ++   +      +V EL   GSL + L  ++       LL  LS  AV VA  + 
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMG 135
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           YL        +H DL   N+LL       + DFGL + LP+            V      
Sbjct: 136 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV----PF 188
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLA 400
            + APE       S + D + FG+ L EMFT G+ P   +  G+  LH   KE   ERL 
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEG--ERLP 245
Query: 401 EIVD 404
              D
Sbjct: 246 RPED 249

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 108/244 (44%), Gaps = 26/244 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETL-VAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVK 222
           +G GSFG V +G +D    +T+ VAVK L    L    A   FI E  A+ S+ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS-IAVDVASTLE 281
           +    ++   +      +V EL   GSL + L  ++       LL  LS  AV VA  + 
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMG 129
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           YL        +H DL   N+LL       + DFGL + LP+            V      
Sbjct: 130 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV----PF 182
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLA 400
            + APE       S + D + FG+ L EMFT G+ P   +  G+  LH   KE   ERL 
Sbjct: 183 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEG--ERLP 239
Query: 401 EIVD 404
              D
Sbjct: 240 RPED 243

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 108/244 (44%), Gaps = 26/244 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETL-VAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVK 222
           +G GSFG V +G +D    +T+ VAVK L    L    A   FI E  A+ S+ HRNL++
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS-IAVDVASTLE 281
           +    ++   +      +V EL   GSL + L  ++       LL  LS  AV VA  + 
Sbjct: 86  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMG 135
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           YL        +H DL   N+LL       + DFGL + LP+            V      
Sbjct: 136 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV----PF 188
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLA 400
            + APE       S + D + FG+ L EMFT G+ P   +  G+  LH   KE   ERL 
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEG--ERLP 245
Query: 401 EIVD 404
              D
Sbjct: 246 RPED 249

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 103/232 (44%), Gaps = 23/232 (9%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDH-ETLVAVKVLNLQHRGASKSFIAECQALR-- 213
           AT  +     IG G++G+VYK    H  H   L +V+V N +  G   S + E   LR  
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEE-GLPISTVREVALLRRL 60
Query: 214 -SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
            +  H N+V+++  C +          LV+E  V+  L  +L  ++  P  L       +
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYL--DKAPPPGLPAETIKDL 117
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
                  L++LH  C   IVH DLKP N+L+    T  ++DFGLA+              
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--------SYQM 166
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
               V  T+ Y APE  + S  +T  D++S G +  EMF  K     +F GN
Sbjct: 167 ALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFCGN 214

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 108/244 (44%), Gaps = 26/244 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETL-VAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVK 222
           +G GSFG V +G +D    +T+ VAVK L    L    A   FI E  A+ S+ HRNL++
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS-IAVDVASTLE 281
           +    ++   +      +V EL   GSL + L  ++       LL  LS  AV VA  + 
Sbjct: 80  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMG 129
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           YL        +H DL   N+LL       + DFGL + LP+            V      
Sbjct: 130 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV----PF 182
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLA 400
            + APE       S + D + FG+ L EMFT G+ P   +  G+  LH   KE   ERL 
Sbjct: 183 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEG--ERLP 239
Query: 401 EIVD 404
              D
Sbjct: 240 RPED 243

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/244 (32%), Positives = 109/244 (44%), Gaps = 26/244 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETL-VAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVK 222
           +G GSFG V +G +D    +T+ VAVK L    L    A   FI E  A+ S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS-IAVDVASTLE 281
           +    ++   +      +V EL   GSL + L  ++       LL  LS  AV VA  + 
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMG 125
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           YL        +H DL   N+LL       + DFGL + LP+            V      
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV----PF 178
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLA 400
            + APE       S + D + FG+ L EMFT G+ P   +  G+  LH   KE   ERL 
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEG--ERLP 235
Query: 401 EIVD 404
              D
Sbjct: 236 RPED 239

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 108/244 (44%), Gaps = 26/244 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETL-VAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVK 222
           +G GSFG V +G +D    +T+ VAVK L    L    A   FI E  A+ S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS-IAVDVASTLE 281
           +    ++   +      +V EL   GSL + L  ++       LL  LS  AV VA  + 
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMG 125
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           YL        +H DL   N+LL       + DFGL + LP+            V      
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV----PF 178
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLA 400
            + APE       S + D + FG+ L EMFT G+ P   +  G+  LH   KE   ERL 
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEG--ERLP 235
Query: 401 EIVD 404
              D
Sbjct: 236 RPED 239

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 39/252 (15%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALR--- 213
           A +    E  IG G FG V+KG    D  +++VA+K L L         I + Q  +   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKD--KSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 214 ----SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
               ++ H N+VK+           ++   +V E +  G L   L L++  P   ++  +
Sbjct: 75  FIMSNLNHPNIVKLYGLM-------HNPPRMVMEFVPCGDLYHRL-LDKAHPIKWSV--K 124
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL-----DGELTAHVSDFGLAKFLPEAA 324
           L + +D+A  +EY+ +    PIVH DL+  N+ L     +  + A V+DFGL++      
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ------ 177
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSE---VSTSGDVYSFGILLLEMFTGKGPTNEMF 381
                      G+ G   + APE  +G+E    +   D YSF ++L  + TG+GP +E  
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232
Query: 382 TGNLTLHNFVKE 393
            G +   N ++E
Sbjct: 233 YGKIKFINMIRE 244

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/244 (31%), Positives = 108/244 (44%), Gaps = 26/244 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETL-VAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVK 222
           +G GSFG V +G +D    +T+ VAVK L    L    A   FI E  A+ S+ HRNL++
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS-IAVDVASTLE 281
           +    ++   +      +V EL   GSL + L  ++       LL  LS  AV VA  + 
Sbjct: 76  LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMG 125
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           YL        +H DL   N+LL       + DFGL + LP+            V      
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV----PF 178
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLA 400
            + APE       S + D + FG+ L EMFT G+ P   +  G+  LH   KE   ERL 
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEG--ERLP 235
Query: 401 EIVD 404
              D
Sbjct: 236 RPED 239

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 108/241 (44%), Gaps = 22/241 (9%)
Query: 140 SALLASV--LRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIF-DHDDHETLVAVKVLN- 195
           SALLA V  + + ++ +   +D      +IG G FG VY G + D   +    A+K L+ 
Sbjct: 5   SALLAEVKDVLIPHERVVTHSD-----RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR 59
Query: 196 LQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH 255
           +      ++F+ E   +R + H N++ +I   + +  +G     L Y  M +G L   L 
Sbjct: 60  ITEMQQVEAFLREGLLMRGLNHPNVLALIG--IMLPPEGLPHVLLPY--MCHGDL---LQ 112
Query: 256 LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG 315
             R   RN  +   +S  + VA  +EYL    E   VH DL   N +LD   T  V+DFG
Sbjct: 113 FIRSPQRNPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFG 169
Query: 316 LAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG 375
           LA+   +               +  V + A E       +T  DV+SFG+LL E+ T   
Sbjct: 170 LAR---DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA 226
Query: 376 P 376
           P
Sbjct: 227 P 227

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NLV
Sbjct: 223 TMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 279
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVDVASTL 280
           +++  C     +   F  ++ E M  G+L ++L   NR   + ++ +  L +A  ++S +
Sbjct: 280 QLLGVCT----REPPF-YIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAM 331
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           EYL    +   +H +L   N L+       V+DFGL++ +               G K  
Sbjct: 332 EYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM------TGDTYTAHAGAKFP 382
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + + APE    ++ S   DV++FG+LL E+ T
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 99/230 (43%), Gaps = 30/230 (13%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRS--IR 216
           D   L  LIG G +G+VYKG  D    E  VAVKV +  +R   ++FI E    R   + 
Sbjct: 13  DNLKLLELIGRGRYGAVYKGSLD----ERPVAVKVFSFANR---QNFINEKNIYRVPLME 65
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N+ + I     V   G     LV E   NGSL ++L L+       + +    +A  V
Sbjct: 66  HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSV 120
Query: 277 ASTLEYLH-------HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA-KFLPEAAXXXX 328
              L YLH       HY +  I H DL   NVL+  + T  +SDFGL+ +          
Sbjct: 121 TRGLAYLHTELPRGDHY-KPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 329 XXXXXXVGVKGTVGYAAPEYGMGS-------EVSTSGDVYSFGILLLEMF 371
                 +   GT+ Y APE   G+             D+Y+ G++  E+F
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 30/228 (13%)
Query: 162 SLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRN 219
            +E +IGAG FG V  G        +  VA+K L + +     + F+ E   +    H N
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPN 105
Query: 220 LVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           +V    ++T    V         +V E M NG+L+ +L   R       ++Q + +   +
Sbjct: 106 VVHLEGVVTRGKPV--------MIVIEFMENGALDAFL---RKHDGQFTVIQLVGMLRGI 154
Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXXX 333
           A+ + YL    +   VH DL   N+L++  L   VSDFGL++ +   PEA          
Sbjct: 155 AAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAV-------YT 204
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
             G K  V + APE     + +++ DV+S+GI++ E+ + G+ P  +M
Sbjct: 205 TTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 252

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 30/227 (13%)
Query: 155 FKATDGFSLENL-------IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA 207
           F++ D + +E         +G G +G VY G++    +   VAVK L  +     + F+ 
Sbjct: 21  FQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWK--KYSLTVAVKTLK-EDTMEVEEFLK 77
Query: 208 ECQALRSIRHRNLVKIITSC-VSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLN 265
           E   ++ I+H NLV+++  C +   F       +V E M  G+L ++L   NR+    + 
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFY------IVTEYMPYGNLLDYLRECNREEVTAVV 131
Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAX 325
           LL    +A  ++S +EYL    +   +H DL   N L+       V+DFGL++ +     
Sbjct: 132 LLY---MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLM----- 180
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                     G K  + + APE    +  S   DV++FG+LL E+ T
Sbjct: 181 -TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/234 (28%), Positives = 101/234 (43%), Gaps = 24/234 (10%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDH-ETLVAVKVLNLQHRGASKSF-----IAECQ 210
           AT  +     IG G++G+VYK    H  H   L +V+V N    G          +A  +
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
            L +  H N+V+++  C +          LV+E  V+  L  +L  ++  P  L      
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFE-HVDQDLRTYL--DKAPPPGLPAETIK 123
Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXX 330
            +       L++LH  C   IVH DLKP N+L+    T  ++DFGLA+            
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--------SY 172
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                 V  T+ Y APE  + S  +T  D++S G +  EMF  K     +F GN
Sbjct: 173 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK----PLFCGN 222

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 119/272 (43%), Gaps = 38/272 (13%)
Query: 158 TDGFSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLNLQ-HRGAS--KSFIAECQAL 212
           +D + L  ++G G    V+  + + DH D    VAVKVL     R  S    F  E Q  
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRD----VAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
            ++ H  +V +  +    +        +V E +   +L + +H   + P  +   + + +
Sbjct: 67  AALNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT--EGP--MTPKRAIEV 121
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
             D    L + H   +  I+H D+KP+N+L+       V DFG+A+ + ++         
Sbjct: 122 IADACQALNFSH---QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT-- 176
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL---HN 389
               V GT  Y +PE   G  V    DVYS G +L E+ TG+ P    FTG+  +   + 
Sbjct: 177 --AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQ 230
Query: 390 FVKEALPERLAEIVDPVLLVEREEGETSEANA 421
            V+E          DP+    R EG +++ +A
Sbjct: 231 HVRE----------DPIPPSARHEGLSADLDA 252

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           F +   +G GSFG V+     H+      A+KVL        K  +     L+ + H N 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGR--YYAMKVL-------KKEIVVR---LKQVEHTND 55
Query: 221 VKIITSCVSVDF---QGNDFEALVYELMVNGSLE--EWLHLNRDAPRNLNLLQRLSIAVD 275
            +++ S V+  F       F+      M+   +E  E   L R + R  N + +   A +
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAE 114
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           V   LEYLH      I++ DLKP N+LLD      ++DFG AK++P+             
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----------Y 161
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE       + S D +SFGIL+ EM  G  P
Sbjct: 162 XLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 38/272 (13%)
Query: 158 TDGFSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLNLQ-HRGAS--KSFIAECQAL 212
           +D + L  ++G G    V+  + + DH D    VAVKVL     R  S    F  E Q  
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRD----VAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
            ++ H  +V +  +    +        +V E +   +L + +H   + P  +   + + +
Sbjct: 67  AALNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT--EGP--MTPKRAIEV 121
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
             D    L + H   +  I+H D+KP+N+++       V DFG+A+ + ++         
Sbjct: 122 IADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT-- 176
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL---HN 389
               V GT  Y +PE   G  V    DVYS G +L E+ TG+ P    FTG+  +   + 
Sbjct: 177 --AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQ 230
Query: 390 FVKEALPERLAEIVDPVLLVEREEGETSEANA 421
            V+E          DP+    R EG +++ +A
Sbjct: 231 HVRE----------DPIPPSARHEGLSADLDA 252

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 37/276 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G++G VYK     D    +VA+K + L  +  G   + I E   L+ + H N+V +I
Sbjct: 29  VGEGTYGVVYKA---KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
               S          LV+E M    L++ L  N+        LQ   I + +   L  + 
Sbjct: 86  DVIHS-----ERCLTLVFEFM-EKDLKKVLDENKTG------LQDSQIKIYLYQLLRGVA 133
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
           H  +  I+H DLKP N+L++ +    ++DFGLA+                     T+ Y 
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-------TLWYR 186
Query: 345 APEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIV 403
           AP+  MGS + STS D++S G +  EM TGK     +F G         + LP+  + + 
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK----PLFPGVTD-----DDQLPKIFSILG 237
Query: 404 DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVL 439
            P     RE  +  E    KQRT     K+   S++
Sbjct: 238 TP---NPREWPQVQELPLWKQRTFQVFEKKPWSSII 270

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 120/276 (43%), Gaps = 37/276 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           +G G++G VYK     D    +VA+K + L  +  G   + I E   L+ + H N+V +I
Sbjct: 29  VGEGTYGVVYKA---KDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
               S          LV+E M    L++ L  N+        LQ   I + +   L  + 
Sbjct: 86  DVIHS-----ERCLTLVFEFM-EKDLKKVLDENKTG------LQDSQIKIYLYQLLRGVA 133
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
           H  +  I+H DLKP N+L++ +    ++DFGLA+                     T+ Y 
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-------TLWYR 186
Query: 345 APEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIV 403
           AP+  MGS + STS D++S G +  EM TGK     +F G         + LP+  + + 
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITGK----PLFPGVTD-----DDQLPKIFSILG 237
Query: 404 DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVL 439
            P     RE  +  E    KQRT     K+   S++
Sbjct: 238 TP---NPREWPQVQELPLWKQRTFQVFEKKPWSSII 270

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 117/272 (43%), Gaps = 38/272 (13%)
Query: 158 TDGFSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLNLQ-HRGAS--KSFIAECQAL 212
           +D + L  ++G G    V+  + + DH D    VAVKVL     R  S    F  E Q  
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRD----VAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
            ++ H  +V +  +    +        +V E +   +L + +H   + P  +   + + +
Sbjct: 67  AALNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT--EGP--MTPKRAIEV 121
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
             D    L + H   +  I+H D+KP+N+++       V DFG+A+ + ++         
Sbjct: 122 IADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT-- 176
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG---NLTLHN 389
               V GT  Y +PE   G  V    DVYS G +L E+ TG+ P    FTG   +   + 
Sbjct: 177 --AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPDSVAYQ 230
Query: 390 FVKEALPERLAEIVDPVLLVEREEGETSEANA 421
            V+E          DP+    R EG +++ +A
Sbjct: 231 HVRE----------DPIPPSARHEGLSADLDA 252

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 118/250 (47%), Gaps = 28/250 (11%)
Query: 134 EPSTPP-SALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVK 192
           EP TP   A   ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V 
Sbjct: 29  EPLTPSGEAPNQALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVA 82
Query: 193 VLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGS 249
           ++ L+      A+K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G 
Sbjct: 83  IMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGC 136
Query: 250 LEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA 309
           L +++  ++D   N+     L+  V +A  + YL    +  +VH DL   NVL+      
Sbjct: 137 LLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV 190
Query: 310 HVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLE 369
            ++DFGLAK L               G K  + + A E  +    +   DV+S+G+ + E
Sbjct: 191 KITDFGLAKLL-----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 245
Query: 370 MFT-GKGPTN 378
           + T G  P +
Sbjct: 246 LMTFGSKPYD 255

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 110/252 (43%), Gaps = 39/252 (15%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALR--- 213
           A +    E  IG G FG V+KG    D  +++VA+K L L         I + Q  +   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKD--KSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 214 ----SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
               ++ H N+VK+           ++   +V E +  G L    H   D    +    +
Sbjct: 75  FIMSNLNHPNIVKLYGLM-------HNPPRMVMEFVPCGDL---YHRLLDKAHPIKWSVK 124
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL-----DGELTAHVSDFGLAKFLPEAA 324
           L + +D+A  +EY+ +    PIVH DL+  N+ L     +  + A V+DFG ++      
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ------ 177
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSE---VSTSGDVYSFGILLLEMFTGKGPTNEMF 381
                      G+ G   + APE  +G+E    +   D YSF ++L  + TG+GP +E  
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232
Query: 382 TGNLTLHNFVKE 393
            G +   N ++E
Sbjct: 233 YGKIKFINMIRE 244

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 110/252 (43%), Gaps = 39/252 (15%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALR--- 213
           A +    E  IG G FG V+KG    D  +++VA+K L L         I + Q  +   
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKD--KSVVAIKSLILGDSEGETEMIEKFQEFQREV 74
Query: 214 ----SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
               ++ H N+VK+           ++   +V E +  G L    H   D    +    +
Sbjct: 75  FIMSNLNHPNIVKLYGLM-------HNPPRMVMEFVPCGDL---YHRLLDKAHPIKWSVK 124
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL-----DGELTAHVSDFGLAKFLPEAA 324
           L + +D+A  +EY+ +    PIVH DL+  N+ L     +  + A V+DF L++      
Sbjct: 125 LRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ------ 177
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSE---VSTSGDVYSFGILLLEMFTGKGPTNEMF 381
                      G+ G   + APE  +G+E    +   D YSF ++L  + TG+GP +E  
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232
Query: 382 TGNLTLHNFVKE 393
            G +   N ++E
Sbjct: 233 YGKIKFINMIRE 244

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 26/231 (11%)
Query: 163 LENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
           L+  +G G+FG V+     +   +  + LVAVK L      A K F  E + L +++H +
Sbjct: 17  LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 76
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN---------RDAPRNLNLLQRL 270
           +VK    CV       D   +V+E M +G L ++L  +          + P  L   Q L
Sbjct: 77  IVKFYGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML 131
Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXX 330
            IA  +A+ + YL        VH DL   N L+   L   + DFG+++ +          
Sbjct: 132 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG 188
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
                     + +  PE  M  + +T  DV+S G++L E+FT GK P  ++
Sbjct: 189 HTML-----PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 234

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 21/219 (9%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   L   +GAG FG V+ G +++    T VAVK L      + ++F+ E   +++++H 
Sbjct: 13  ESIKLVKRLGAGQFGEVWMGYYNNS---TKVAVKTLK-PGTMSVQAFLEEANLMKTLQHD 68
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++            +   ++ E M  GSL +   L  D    + L + +  +  +A 
Sbjct: 69  KLVRLYAVVTR-----EEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQIAE 121
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            + Y+        +H DL+ +NVL+   L   ++DFGLA+ + +             G K
Sbjct: 122 GMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE------GAK 172
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             + + APE       +   DV+SFGILL E+ T GK P
Sbjct: 173 FPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLVKI 223
           +G G FG V    +D  +D    +VAVK L        +S +  E + LR++ H ++VK 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN-LNLLQRLSIAVDVASTLEY 282
              C   + QG     LV E +  GSL ++L      PR+ + L Q L  A  +   + Y
Sbjct: 77  KGCC---EDQGEKSVQLVMEYVPLGSLRDYL------PRHCVGLAQLLLFAQQICEGMAY 127
Query: 283 LH--HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           LH  HY     +H  L   NVLLD +    + DFGLAK +PE                  
Sbjct: 128 LHAQHY-----IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG----DSP 178
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           V + APE     +   + DV+SFG+ L E+ T
Sbjct: 179 VFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 167 IGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLVKI 223
           +G G FG V    +D  +D    +VAVK L        +S +  E + LR++ H ++VK 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN-LNLLQRLSIAVDVASTLEY 282
              C   + QG     LV E +  GSL ++L      PR+ + L Q L  A  +   + Y
Sbjct: 76  KGCC---EDQGEKSVQLVMEYVPLGSLRDYL------PRHCVGLAQLLLFAQQICEGMAY 126
Query: 283 LH--HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           LH  HY     +H  L   NVLLD +    + DFGLAK +PE                  
Sbjct: 127 LHAQHY-----IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG----DSP 177
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           V + APE     +   + DV+SFG+ L E+ T
Sbjct: 178 VFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 24/224 (10%)
Query: 163 LENLIGAGSFGSV-YKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNL 220
           +E +IG+G  G V Y  +      +  VA+K L   +     + F++E   +    H N+
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           +++      V  +G     +V E M NGSL+ +L   R       ++Q + +   V + +
Sbjct: 113 IRL----EGVVTRGR-LAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGM 164
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXXXXVGV 337
            YL    +   VH DL   NVL+D  L   VSDFGL++ L   P+AA           G 
Sbjct: 165 RYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-------XTTTGG 214
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
           K  + + APE       S++ DV+SFG+++ E+   G+ P   M
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 24/224 (10%)
Query: 163 LENLIGAGSFGSV-YKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNL 220
           +E +IG+G  G V Y  +      +  VA+K L   +     + F++E   +    H N+
Sbjct: 53  IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           +++      V  +G     +V E M NGSL+ +L   R       ++Q + +   V + +
Sbjct: 113 IRL----EGVVTRGR-LAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGM 164
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAAXXXXXXXXXXVGV 337
            YL    +   VH DL   NVL+D  L   VSDFGL++ L   P+AA           G 
Sbjct: 165 RYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-------YTTTGG 214
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
           K  + + APE       S++ DV+SFG+++ E+   G+ P   M
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L  +        F+ E   +  + H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A+            
Sbjct: 168 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-- 222
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 223 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L  +        F+ E   +  + H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A+            
Sbjct: 154 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-- 208
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 209 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASK-SFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L   +    +  F+ E   +    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 113 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A+            
Sbjct: 168 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-- 222
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 223 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 21/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +GAG FG V+ G +++    T VAVK L      + ++F+ E   +++++H  LV++   
Sbjct: 20  LGAGQFGEVWMGYYNNS---TKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                    +   ++ E M  GSL ++L    D    + L + +  +  +A  + Y+   
Sbjct: 76  VTK-----EEPIYIITEFMAKGSLLDFL--KSDEGGKVLLPKLIDFSAQIAEGMAYIER- 127
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAP 346
                +H DL+ +NVL+   L   ++DFGLA+ + +             G K  + + AP
Sbjct: 128 --KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE------GAKFPIKWTAP 179
Query: 347 EYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           E       +   +V+SFGILL E+ T GK P
Sbjct: 180 EAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLVKIIT 225
           IG G+FG V+ G    D+  TLVAVK          K+ F+ E + L+   H N+V++I 
Sbjct: 122 IGRGNFGEVFSGRLRADN--TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
            C            +V EL+  G    +L       R   LLQ +    D A+ +EYL  
Sbjct: 180 VCTQ-----KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG---DAAAGMEYLES 231
Query: 286 YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAA 345
            C    +H DL   N L+  +    +SDFG+++   E A            V   V + A
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVXAASGGLRQV--PVKWTA 283
Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           PE       S+  DV+SFGILL E F+ G  P
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L  +        F+ E   +    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 98  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A+            
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-- 207
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 208 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L  +        F+ E   +    H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 98  ----CIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A+            
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-- 207
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 208 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 94/212 (44%), Gaps = 20/212 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLVKIIT 225
           IG G+FG V+ G    D+  TLVAVK          K+ F+ E + L+   H N+V++I 
Sbjct: 122 IGRGNFGEVFSGRLRADN--TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
            C            +V EL+  G    +L       R   LLQ +    D A+ +EYL  
Sbjct: 180 VCTQ-----KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG---DAAAGMEYLES 231
Query: 286 YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAA 345
            C    +H DL   N L+  +    +SDFG+++   E A            V   V + A
Sbjct: 232 KC---CIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVYAASGGLRQV--PVKWTA 283
Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           PE       S+  DV+SFGILL E F+ G  P
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L  +        F+ E   +    H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 90  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 144
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A+            
Sbjct: 145 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-- 199
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 200 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L  +        F+ E   +    H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 113 ----CIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A+            
Sbjct: 168 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-- 222
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 223 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L  +        F+ E   +    H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 115 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 169
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A+            
Sbjct: 170 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-- 224
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 225 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L  +        F+ E   +    H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 105 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 159
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A+            
Sbjct: 160 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-- 214
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 215 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L  +        F+ E   +    H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 125 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 179
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A+            
Sbjct: 180 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-- 234
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 235 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L  +        F+ E   +    H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 139 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A             
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML-- 248
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 249 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L  +        F+ E   +    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A+            
Sbjct: 154 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAML-- 208
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 209 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L  +        F+ E   +    H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 116 ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 170
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A             
Sbjct: 171 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAML-- 225
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 226 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 23/216 (10%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG VY+G      +D     VAVK L  +        F+ E   +    H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAVDVAST 279
               C+ V  Q      ++ ELM  G L+ +L   R     P +L +L  L +A D+A  
Sbjct: 99  ----CIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +YL    E   +H D+   N LL        A + DFG+A+ +  A+            
Sbjct: 154 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAML-- 208
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
               V +  PE  M    ++  D +SFG+LL E+F+
Sbjct: 209 ---PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 34/232 (14%)
Query: 167 IGAGSFGSVY----KGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG V+      +    D + LVAVK L      A + F  E + L  ++H+++V+
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQD-KMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD-----------APRNLNLLQRLS 271
               C     +G     +V+E M +G L  +L  +             AP  L L Q L+
Sbjct: 108 FFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
           +A  VA+ + YL        VH DL   N L+   L   + DFG+++ +           
Sbjct: 163 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-------YSTD 212
Query: 332 XXXVGVKGT--VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              VG +    + +  PE  +  + +T  DV+SFG++L E+FT GK P  ++
Sbjct: 213 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 34/232 (14%)
Query: 167 IGAGSFGSVY----KGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG V+      +    D + LVAVK L      A + F  E + L  ++H+++V+
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQD-KMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD-----------APRNLNLLQRLS 271
               C     +G     +V+E M +G L  +L  +             AP  L L Q L+
Sbjct: 79  FFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 133
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
           +A  VA+ + YL        VH DL   N L+   L   + DFG+++ +           
Sbjct: 134 VASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-------YSTD 183
Query: 332 XXXVGVKGT--VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
              VG +    + +  PE  +  + +T  DV+SFG++L E+FT GK P  ++
Sbjct: 184 YYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 235

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 38/234 (16%)
Query: 167 IGAGSFGSVY----KGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +G G+FG V+      +    D + LVAVK L      A + F  E + L  ++H+++V+
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQD-KMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD-----------APRNLNLLQRLS 271
               C     +G     +V+E M +G L  +L  +             AP  L L Q L+
Sbjct: 85  FFGVCT----EGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 139
Query: 272 IAVDVASTLEYLH--HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
           +A  VA+ + YL   H+     VH DL   N L+   L   + DFG+++ +         
Sbjct: 140 VASQVAAGMVYLAGLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSRDI-------YS 187
Query: 330 XXXXXVGVKGT--VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
                VG +    + +  PE  +  + +T  DV+SFG++L E+FT GK P  ++
Sbjct: 188 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 241

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 167 IGAGSFGSVYKGIFDH--DDHETLVAVKVLNLQHRGA--SKSFIAECQALRSIRHRNLVK 222
           +G G+FGSV    +D   D+   LVAVK   LQH G    + F  E Q L+++    +VK
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 223 IITSCVSVDF-QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
                  V +  G     LV E + +G L ++L  +R     L+  + L  +  +   +E
Sbjct: 89  Y----RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGME 141
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           YL        VH DL   N+L++ E    ++DFGLAK LP                +  +
Sbjct: 142 YLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG----QSPI 194
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            + APE    +  S   DV+SFG++L E+FT
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 167 IGAGSFGSVYKGIFDH--DDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVK 222
           +G G+FGSV    +D   D+   LVAVK   LQH G    + F  E Q L+++    +VK
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 223 IITSCVSVDF-QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
                  V +  G     LV E + +G L ++L  +R     L+  + L  +  +   +E
Sbjct: 73  Y----RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGME 125
Query: 282 YL-HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           YL    C    VH DL   N+L++ E    ++DFGLAK LP                +  
Sbjct: 126 YLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPG----QSP 177
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           + + APE    +  S   DV+SFG++L E+FT
Sbjct: 178 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 167 IGAGSFGSVYKGIFDH--DDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVK 222
           +G G+FGSV    +D   D+   LVAVK   LQH G    + F  E Q L+++    +VK
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 223 IITSCVSVDF-QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
                  V +  G     LV E + +G L ++L  +R     L+  + L  +  +   +E
Sbjct: 77  Y----RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGME 129
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           YL        VH DL   N+L++ E    ++DFGLAK LP                +  +
Sbjct: 130 YLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG----QSPI 182
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            + APE    +  S   DV+SFG++L E+FT
Sbjct: 183 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 167 IGAGSFGSVYKGIFDH--DDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVK 222
           +G G+FGSV    +D   D+   LVAVK   LQH G    + F  E Q L+++    +VK
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 223 IITSCVSVDF-QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
                  V +  G     LV E + +G L ++L  +R     L+  + L  +  +   +E
Sbjct: 76  Y----RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGME 128
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           YL        VH DL   N+L++ E    ++DFGLAK LP                +  +
Sbjct: 129 YLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG----QSPI 181
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            + APE    +  S   DV+SFG++L E+FT
Sbjct: 182 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 22/212 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ-HRGASKSFIAECQALRSIRHRNLVKIIT 225
           +G G++ +VYKG+  +      VA+K + L    G   + I E   ++ ++H N+V++  
Sbjct: 13  LGNGTYATVYKGL--NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRL-- 68
Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR--DAPRNLNLLQRLSIAVDVASTLEYL 283
               V    N    LV+E M N  L++++      + PR L L         +   L + 
Sbjct: 69  --YDVIHTENKL-TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
           H   E  I+H DLKP N+L++      + DFGLA+                     T+ Y
Sbjct: 125 H---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-------TLWY 174
Query: 344 AAPEYGMGSEV-STSGDVYSFGILLLEMFTGK 374
            AP+  MGS   STS D++S G +L EM TGK
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 38/272 (13%)
Query: 158 TDGFSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLNLQ-HRGAS--KSFIAECQAL 212
           +D + L  ++G G    V+  + +  H D    VAVKVL     R  S    F  E Q  
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRD----VAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
            ++ H  +V +  +    +        +V E +   +L + +H   + P  +   + + +
Sbjct: 67  AALNHPAIVAVYATG-EAETPAGPLPYIVMEYVDGVTLRDIVHT--EGP--MTPKRAIEV 121
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
             D    L + H   +  I+H D+KP+N+++       V DFG+A+ + ++         
Sbjct: 122 IADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT-- 176
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL---HN 389
               V GT  Y +PE   G  V    DVYS G +L E+ TG+ P    FTG+  +   + 
Sbjct: 177 --AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQ 230
Query: 390 FVKEALPERLAEIVDPVLLVEREEGETSEANA 421
            V+E          DP+    R EG +++ +A
Sbjct: 231 HVRE----------DPIPPSARHEGLSADLDA 252

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 38/272 (13%)
Query: 158 TDGFSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLNLQ-HRGAS--KSFIAECQAL 212
           +D + L  ++G G    V+  + +  H D    VAVKVL     R  S    F  E Q  
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRD----VAVKVLRADLARDPSFYLRFRREAQNA 66
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
            ++ H  +V +  +    +        +V E +   +L + +H   + P  +   + + +
Sbjct: 67  AALNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT--EGP--MTPKRAIEV 121
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
             D    L + H   +  I+H D+KP+N+++       V DFG+A+ + ++         
Sbjct: 122 IADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT-- 176
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL---HN 389
               V GT  Y +PE   G  V    DVYS G +L E+ TG+ P    FTG+  +   + 
Sbjct: 177 --AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQ 230
Query: 390 FVKEALPERLAEIVDPVLLVEREEGETSEANA 421
            V+E          DP+    R EG +++ +A
Sbjct: 231 HVRE----------DPIPPSARHEGLSADLDA 252

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 11  ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 64
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 65  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-- 116
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 117 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 171
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 172 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 10  ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-- 115
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 116 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 170
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 171 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 8   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 61
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 62  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-- 113
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 114 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 168
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 169 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 8   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 61
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 62  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGXLLDYVREHKD-- 113
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 114 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 168
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 169 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRH 217
           + L + +G G+FG V  G  +   H+  VAVK+LN Q             E Q L+  RH
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHK--VAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 218 RNLVKI--ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN--RDAPRNLNLLQRLSIA 273
            +++K+  + S  S  F       +V E +  G L +++  N   D   +  L Q++   
Sbjct: 76  PHIIKLYQVISTPSDIF-------MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
           VD      Y H +    +VH DLKP NVLLD  + A ++DFGL+  + +           
Sbjct: 129 VD------YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC--- 176
Query: 334 XVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNE 379
                G+  YAAPE   G        D++S G++L  +  G  P ++
Sbjct: 177 -----GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 84/200 (42%), Gaps = 21/200 (10%)
Query: 208 ECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL 267
           E Q L  +  R +V +  +     ++  D   LV  LM  G L+   H+           
Sbjct: 234 EKQILEKVNSRFVVSLAYA-----YETKDALCLVLTLMNGGDLK--FHIYHMGQAGFPEA 286
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXX 327
           + +  A ++   LE LH      IV+ DLKP N+LLD      +SD GLA  +PE     
Sbjct: 287 RAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFT--GNL 385
                   G  GTVGY APE       + S D ++ G LL EM  G+ P  +        
Sbjct: 344 --------GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395
Query: 386 TLHNFVKEALPERLAEIVDP 405
            +   VKE +PE  +E   P
Sbjct: 396 EVERLVKE-VPEEYSERFSP 414

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 9   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-- 114
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 115 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 169
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 170 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 7   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-- 112
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 113 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 167
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 168 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 85/202 (42%), Gaps = 21/202 (10%)
Query: 206 IAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLN 265
           + E Q L  +  R +V +  +     ++  D   LV  LM  G L+   H+         
Sbjct: 232 LNEKQILEKVNSRFVVSLAYA-----YETKDALCLVLTLMNGGDLK--FHIYHMGQAGFP 284
Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAX 325
             + +  A ++   LE LH      IV+ DLKP N+LLD      +SD GLA  +PE   
Sbjct: 285 EARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFT--G 383
                     G  GTVGY APE       + S D ++ G LL EM  G+ P  +      
Sbjct: 342 IK--------GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 393
Query: 384 NLTLHNFVKEALPERLAEIVDP 405
              +   VKE +PE  +E   P
Sbjct: 394 REEVERLVKE-VPEEYSERFSP 414

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 17  ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 70
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 71  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 122
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 123 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 177
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 178 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 10  ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 115
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 116 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 170
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 171 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 7   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 112
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 113 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 169 AEEKEYHAE-----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 10  ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 115
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 116 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 170
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 171 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 14  ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 119
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 120 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 174
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 175 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/269 (24%), Positives = 120/269 (44%), Gaps = 20/269 (7%)
Query: 147 LRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETL-VAVKVLNLQHRGAS--K 203
           L+   +++      F+L  ++G G FGSV +     +D   + VAVK+L      +S  +
Sbjct: 11  LKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE 70
Query: 204 SFIAECQALRSIRHRNLVKIITSCVSVDFQGN-DFEALVYELMVNGSLEEWLHLNR--DA 260
            F+ E   ++   H ++ K++   +    +G      ++   M +G L  +L  +R  + 
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130
Query: 261 PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
           P NL L   +   VD+A  +EYL        +H DL   N +L  ++T  V+DFGL++ +
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI 187
Query: 321 PEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
                            K  V + A E    +  +   DV++FG+ + E+ T +G T   
Sbjct: 188 -----YSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT-RGQTPYA 241
Query: 381 FTGNLTLHNFV-----KEALPERLAEIVD 404
              N  ++N++      +  PE + E+ D
Sbjct: 242 GIENAEIYNYLIGGNRLKQPPECMEEVYD 270

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 9   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 114
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 115 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 169
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 170 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVKII 224
           +G+G+FG+V KG +        VAVK+L  +    +     +AE   ++ + +  +V++I
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C +  +       LV E+   G L ++L  NR   ++ N+++   +   V+  ++YL 
Sbjct: 437 GICEAESWM------LVMEMAELGPLNKYLQQNRHV-KDKNIIE---LVHQVSMGMKYLE 486
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
              E+  VH DL   NVLL  +  A +SDFGL+K    A              K  V + 
Sbjct: 487 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRADENYYKAQTHGKWPVKWY 539
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           APE     + S+  DV+SFG+L+ E F+ G+ P   M    +T
Sbjct: 540 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 582

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 10  ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 63
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 64  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 115
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 116 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 170
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 171 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 7   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 112
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 113 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 167
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 168 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 7   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGXLLDYVREHKD-- 112
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 113 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 167
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 168 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVKII 224
           +G+G+FG+V KG +        VAVK+L  +    +     +AE   ++ + +  +V++I
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C +  +       LV E+   G L ++L  NR   ++ N+++   +   V+  ++YL 
Sbjct: 93  GICEAESWM------LVMEMAELGPLNKYLQQNRHV-KDKNIIE---LVHQVSMGMKYLE 142
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
              E+  VH DL   NVLL  +  A +SDFGL+K    A              K  V + 
Sbjct: 143 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRADENYYKAQTHGKWPVKWY 195
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           APE     + S+  DV+SFG+L+ E F+ G+ P   M    +T
Sbjct: 196 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 238

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVKII 224
           +G+G+FG+V KG +        VAVK+L  +    +     +AE   ++ + +  +V++I
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C +  +       LV E+   G L ++L  NR   ++ N+++   +   V+  ++YL 
Sbjct: 438 GICEAESWM------LVMEMAELGPLNKYLQQNRHV-KDKNIIE---LVHQVSMGMKYLE 487
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
              E+  VH DL   NVLL  +  A +SDFGL+K    A              K  V + 
Sbjct: 488 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRADENYYKAQTHGKWPVKWY 540
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           APE     + S+  DV+SFG+L+ E F+ G+ P   M    +T
Sbjct: 541 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 583

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVKII 224
           +G+G+FG+V KG +        VAVK+L  +    +     +AE   ++ + +  +V++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C +  +       LV E+   G L ++L  NR   ++ N+++   +   V+  ++YL 
Sbjct: 95  GICEAESWM------LVMEMAELGPLNKYLQQNRHV-KDKNIIE---LVHQVSMGMKYLE 144
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
              E+  VH DL   NVLL  +  A +SDFGL+K    A              K  V + 
Sbjct: 145 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRADENYYKAQTHGKWPVKWY 197
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           APE     + S+  DV+SFG+L+ E F+ G+ P   M    +T
Sbjct: 198 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVKII 224
           +G+G+FG+V KG +        VAVK+L  +    +     +AE   ++ + +  +V++I
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C +  +       LV E+   G L ++L  NR   ++ N+++   +   V+  ++YL 
Sbjct: 95  GICEAESWM------LVMEMAELGPLNKYLQQNRHV-KDKNIIE---LVHQVSMGMKYLE 144
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
              E+  VH DL   NVLL  +  A +SDFGL+K    A              K  V + 
Sbjct: 145 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRADENYYKAQTHGKWPVKWY 197
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           APE     + S+  DV+SFG+L+ E F+ G+ P   M    +T
Sbjct: 198 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 240

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 32  ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 85
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 86  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 137
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 138 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 192
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 193 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 13  ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 66
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 67  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 118
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 119 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 173
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 174 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 4   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 57
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 58  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 109
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 110 -NIGSQYLLNWCVQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 164
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 165 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVKII 224
           +G+G+FG+V KG +        VAVK+L  +    +     +AE   ++ + +  +V++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C +  +       LV E+   G L ++L  NR   ++ N+++   +   V+  ++YL 
Sbjct: 85  GICEAESWM------LVMEMAELGPLNKYLQQNRHV-KDKNIIE---LVHQVSMGMKYLE 134
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
              E+  VH DL   NVLL  +  A +SDFGL+K    A              K  V + 
Sbjct: 135 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRADENYYKAQTHGKWPVKWY 187
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           APE     + S+  DV+SFG+L+ E F+ G+ P   M    +T
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 230

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 38/272 (13%)
Query: 158 TDGFSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLNLQ-HRGAS--KSFIAECQAL 212
           +D + L  ++G G    V+  + +  H D    VAVKVL     R  S    F  E Q  
Sbjct: 28  SDRYELGEILGFGGMSEVHLARDLRLHRD----VAVKVLRADLARDPSFYLRFRREAQNA 83
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
            ++ H  +V +  +    +        +V E +   +L + +H   + P  +   + + +
Sbjct: 84  AALNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT--EGP--MTPKRAIEV 138
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
             D    L + H   +  I+H D+KP+N+++       V DFG+A+ + ++         
Sbjct: 139 IADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT-- 193
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL---HN 389
               V GT  Y +PE   G  V    DVYS G +L E+ TG+ P    FTG+  +   + 
Sbjct: 194 --AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAYQ 247
Query: 390 FVKEALPERLAEIVDPVLLVEREEGETSEANA 421
            V+E          DP+    R EG +++ +A
Sbjct: 248 HVRE----------DPIPPSARHEGLSADLDA 269

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 30/225 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRH 217
           + L + +G G+FG V  G      H+  VAVK+LN Q             E Q L+  RH
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHK--VAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL--HLNRDAPRNLNLLQRLSIAVD 275
            +++K+      V     DF  +V E +  G L +++  H   +      L Q++  AVD
Sbjct: 71  PHIIKL----YQVISTPTDF-FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
                 Y H +    +VH DLKP NVLLD  + A ++DFGL+  + +             
Sbjct: 126 ------YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----- 171
Query: 336 GVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNE 379
              G+  YAAPE   G        D++S G++L  +  G  P ++
Sbjct: 172 ---GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 152 QNLFKATDGFSLENL-IGAGSFGSVYKGIFDHDDHETLVAVKVLNL-QHRGASKSFIAEC 209
           + LF   D   + ++ +G G+FGSV +G++     +  VA+KVL     +  ++  + E 
Sbjct: 2   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
           Q +  + +  +V++I  C +          LV E+   G L ++L   R+     N+ + 
Sbjct: 62  QIMHQLDNPYIVRLIGVCQAEALM------LVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
           L     V+  ++YL    E   VH DL   NVLL     A +SDFGL+K L         
Sbjct: 116 LH---QVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL---GADDSY 166
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
                 G K  + + APE     + S+  DV+S+G+ + E  + G+ P  +M
Sbjct: 167 YTARSAG-KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVKII 224
           +G+G+FG+V KG +        VAVK+L  +    +     +AE   ++ + +  +V++I
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C +  +       LV E+   G L ++L  NR   ++ N+++   +   V+  ++YL 
Sbjct: 75  GICEAESWM------LVMEMAELGPLNKYLQQNRHV-KDKNIIE---LVHQVSMGMKYLE 124
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
              E+  VH DL   NVLL  +  A +SDFGL+K    A              K  V + 
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRADENYYKAQTHGKWPVKWY 177
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           APE     + S+  DV+SFG+L+ E F+ G+ P   M    +T
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 108/223 (48%), Gaps = 20/223 (8%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVKII 224
           +G+G+FG+V KG +        VAVK+L  +    +     +AE   ++ + +  +V++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C +  +       LV E+   G L ++L  NR   ++ N+++   +   V+  ++YL 
Sbjct: 79  GICEAESWM------LVMEMAELGPLNKYLQQNRHV-KDKNIIE---LVHQVSMGMKYLE 128
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
              E+  VH DL   NVLL  +  A +SDFGL+K    A              K  V + 
Sbjct: 129 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRADENXYKAQTHGKWPVKWY 181
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           APE     + S+  DV+SFG+L+ E F+ G+ P   M    +T
Sbjct: 182 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVKII 224
           +G+G+FG+V KG +        VAVK+L  +    +     +AE   ++ + +  +V++I
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C +  +       LV E+   G L ++L  NR   ++ N+++   +   V+  ++YL 
Sbjct: 79  GICEAESWM------LVMEMAELGPLNKYLQQNRHV-KDKNIIE---LVHQVSMGMKYLE 128
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
              E+  VH DL   NVLL  +  A +SDFGL+K    A              K  V + 
Sbjct: 129 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRADENYYKAQTHGKWPVKWY 181
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           APE     + S+  DV+SFG+L+ E F+ G+ P   M    +T
Sbjct: 182 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 224

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 1   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 54
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 55  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 106
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 107 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 163 AEEKEYHAE-----GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVKII 224
           +G+G+FG+V KG +        VAVK+L  +    +     +AE   ++ + +  +V++I
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             C +  +       LV E+   G L ++L  NR   ++ N+++   +   V+  ++YL 
Sbjct: 73  GICEAESWM------LVMEMAELGPLNKYLQQNRHV-KDKNIIE---LVHQVSMGMKYLE 122
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
              E+  VH DL   NVLL  +  A +SDFGL+K    A              K  V + 
Sbjct: 123 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSK----ALRADENYYKAQTHGKWPVKWY 175
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT 386
           APE     + S+  DV+SFG+L+ E F+ G+ P   M    +T
Sbjct: 176 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 218

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASK-SFIAECQAL 212
           A +  ++   +G GSFG VY+G+      D+ ET VA+K +N       +  F+ E   +
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL----- 267
           +     ++V+++     V  QG     ++ ELM  G L+ +L   R A  N  +L     
Sbjct: 73  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 268 -QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
            + + +A ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E    
Sbjct: 128 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 327 XXXXXXXXVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                    G KG   V + +PE       +T  DV+SFG++L E+ T
Sbjct: 185 RK-------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 105/228 (46%), Gaps = 27/228 (11%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASK-SFIAECQAL 212
           A +  ++   +G GSFG VY+G+      D+ ET VA+K +N       +  F+ E   +
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL----- 267
           +     ++V+++     V  QG     ++ ELM  G L+ +L   R A  N  +L     
Sbjct: 83  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 268 -QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
            + + +A ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E    
Sbjct: 138 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 327 XXXXXXXXVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                    G KG   V + +PE       +T  DV+SFG++L E+ T
Sbjct: 195 RK-------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASK-SFIAECQAL 212
           A +  ++   +G GSFG VY+G+      D+ ET VA+K +N       +  F+ E   +
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL----- 267
           +     ++V+++     V  QG     ++ ELM  G L+ +L   R    N  +L     
Sbjct: 68  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 268 -QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
            + + +A ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E    
Sbjct: 123 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 327 XXXXXXXXVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                    G KG   V + +PE       +T  DV+SFG++L E+ T
Sbjct: 180 RK-------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 100/225 (44%), Gaps = 30/225 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRH 217
           + L + +G G+FG V  G      H+  VAVK+LN Q             E Q L+  RH
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHK--VAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL--HLNRDAPRNLNLLQRLSIAVD 275
            +++K+      V     DF  +V E +  G L +++  H   +      L Q++  AVD
Sbjct: 71  PHIIKL----YQVISTPTDF-FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD 125
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
                 Y H +    +VH DLKP NVLLD  + A ++DFGL+  + +             
Sbjct: 126 ------YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC----- 171
Query: 336 GVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNE 379
              G+  YAAPE   G        D++S G++L  +  G  P ++
Sbjct: 172 ---GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 27/228 (11%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASK-SFIAECQAL 212
           A +  ++   +G GSFG VY+G+      D+ ET VA+K +N       +  F+ E   +
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL----- 267
           +     ++V+++     V  QG     ++ ELM  G L+ +L   R    N  +L     
Sbjct: 77  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 268 -QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
            + + +A ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E    
Sbjct: 132 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 327 XXXXXXXXVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                    G KG   V + +PE       +T  DV+SFG++L E+ T
Sbjct: 189 RK-------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 110/240 (45%), Gaps = 21/240 (8%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRH 217
           D + L+ +IG+G+  +V +  +     E  VA+K +NL+  + +    + E QA+    H
Sbjct: 10  DDYELQEVIGSGA-TAVVQAAYCAPKKEK-VAIKRINLEKCQTSMDELLKEIQAMSQCHH 67
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL-HLNRDAPRNLNLLQRLSIAV-- 274
            N+V   TS     F   D   LV +L+  GS+ + + H+         +L   +IA   
Sbjct: 68  PNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 275 -DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
            +V   LEYLH   +   +H D+K  N+LL  + +  ++DFG++ FL  A          
Sbjct: 123 REVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL--ATGGDITRNKV 177
Query: 334 XVGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNE---MFTGNLTLHN 389
                GT  + APE            D++SFGI  +E+ TG  P ++   M    LTL N
Sbjct: 178 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 237

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 110/240 (45%), Gaps = 21/240 (8%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRH 217
           D + L+ +IG+G+  +V +  +     E  VA+K +NL+  + +    + E QA+    H
Sbjct: 15  DDYELQEVIGSGA-TAVVQAAYCAPKKEK-VAIKRINLEKCQTSMDELLKEIQAMSQCHH 72
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL-HLNRDAPRNLNLLQRLSIAV-- 274
            N+V   TS     F   D   LV +L+  GS+ + + H+         +L   +IA   
Sbjct: 73  PNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 275 -DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
            +V   LEYLH   +   +H D+K  N+LL  + +  ++DFG++ FL  A          
Sbjct: 128 REVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFL--ATGGDITRNKV 182
Query: 334 XVGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNE---MFTGNLTLHN 389
                GT  + APE            D++SFGI  +E+ TG  P ++   M    LTL N
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASK-SFIAECQAL 212
           A +  ++   +G GSFG VY+G+      D+ ET VA+K +N       +  F+ E   +
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL----- 267
           +     ++V+++     V  QG     ++ ELM  G L+ +L   R    N  +L     
Sbjct: 70  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 268 -QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
            + + +A ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E    
Sbjct: 125 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 327 XXXXXXXXVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                    G KG   V + +PE       +T  DV+SFG++L E+ T
Sbjct: 182 RK-------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASK-SFIAECQAL 212
           A +  ++   +G GSFG VY+G+      D+ ET VA+K +N       +  F+ E   +
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL----- 267
           +     ++V+++     V  QG     ++ ELM  G L+ +L   R    N  +L     
Sbjct: 74  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 268 -QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
            + + +A ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E    
Sbjct: 129 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 185
Query: 327 XXXXXXXXVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                    G KG   V + +PE       +T  DV+SFG++L E+ T
Sbjct: 186 RK-------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASK-SFIAECQAL 212
           A +  ++   +G GSFG VY+G+      D+ ET VA+K +N       +  F+ E   +
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL----- 267
           +     ++V+++     V  QG     ++ ELM  G L+ +L   R    N  +L     
Sbjct: 76  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 268 -QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
            + + +A ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E    
Sbjct: 131 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 327 XXXXXXXXVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                    G KG   V + +PE       +T  DV+SFG++L E+ T
Sbjct: 188 RK-------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 111/238 (46%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 9   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-- 114
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFG AK L 
Sbjct: 115 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL- 169
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 170 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASK-SFIAECQAL 212
           A +  ++   +G GSFG VY+G+      D+ ET VA+K +N       +  F+ E   +
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL----- 267
           +     ++V+++     V  QG     ++ ELM  G L+ +L   R    N  +L     
Sbjct: 77  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 268 -QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
            + + +A ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E    
Sbjct: 132 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 188
Query: 327 XXXXXXXXVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                    G KG   V + +PE       +T  DV+SFG++L E+ T
Sbjct: 189 RK-------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASK-SFIAECQAL 212
           A +  ++   +G GSFG VY+G+      D+ ET VA+K +N       +  F+ E   +
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL----- 267
           +     ++V+++     V  QG     ++ ELM  G L+ +L   R    N  +L     
Sbjct: 76  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 268 -QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
            + + +A ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E    
Sbjct: 131 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 327 XXXXXXXXVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                    G KG   V + +PE       +T  DV+SFG++L E+ T
Sbjct: 188 RK-------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 111/238 (46%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 9   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-- 114
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFG AK L 
Sbjct: 115 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL- 169
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 170 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASK-SFIAECQAL 212
           A +  ++   +G GSFG VY+G+      D+ ET VA+K +N       +  F+ E   +
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL----- 267
           +     ++V+++     V  QG     ++ ELM  G L+ +L   R    N  +L     
Sbjct: 83  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 268 -QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
            + + +A ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E    
Sbjct: 138 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 327 XXXXXXXXVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                    G KG   V + +PE       +T  DV+SFG++L E+ T
Sbjct: 195 RK-------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 111/238 (46%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 11  ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 64
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 65  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-- 116
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFG AK L 
Sbjct: 117 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL- 171
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 172 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASK-SFIAECQAL 212
           A +  ++   +G GSFG VY+G+      D+ ET VA+K +N       +  F+ E   +
Sbjct: 45  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 104
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL----- 267
           +     ++V+++     V  QG     ++ ELM  G L+ +L   R    N  +L     
Sbjct: 105 KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 268 -QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
            + + +A ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E    
Sbjct: 160 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 216
Query: 327 XXXXXXXXVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                    G KG   V + +PE       +T  DV+SFG++L E+ T
Sbjct: 217 RK-------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 111/238 (46%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++ +G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 14  ALLRILKETEFKKI------KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LIMQLMPFGCLLDYVREHKD-- 119
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 120 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 174
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 175 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 111/238 (46%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 9   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 62
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 63  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 114
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFG AK L 
Sbjct: 115 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL- 169
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 170 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 111/238 (46%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 7   ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 112
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFG AK L 
Sbjct: 113 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL- 167
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 168 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 161 FSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           F L  ++G GSFG V+  K I    D   L A+KVL        K+ +     +R+   R
Sbjct: 26  FELLKVLGQGSFGKVFLVKKI-SGSDARQLYAMKVLK-------KATLKVRDRVRTKMER 77
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---- 274
           +++  +     V         L Y     G L    +L  D  R  +L  RLS  V    
Sbjct: 78  DILVEVNHPFIV--------KLHYAFQTEGKL----YLILDFLRGGDLFTRLSKEVMFTE 125
Query: 275 --------DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
                   ++A  L++LH      I++ DLKP N+LLD E    ++DFGL+K        
Sbjct: 126 EDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-------E 175
Query: 327 XXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                       GTV Y APE       + S D +SFG+L+ EM TG  P
Sbjct: 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 111/238 (46%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++G+G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 14  ALLRILKETEFKKI------KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 119
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFG AK L 
Sbjct: 120 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL- 174
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 175 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 111/238 (46%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++ +G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 14  ALLRILKETEFKKI------KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 67
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 68  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 119
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 120 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 174
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 175 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 111/238 (46%), Gaps = 27/238 (11%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GA 201
           ++LR+  +  FK         ++ +G+FG+VYKG++  +  +  + V +  L+      A
Sbjct: 7   ALLRILKETEFKKI------KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 60
Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++D  
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD-- 112
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL    +  +VH DL   NVL+       ++DFGLAK L 
Sbjct: 113 -NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL- 167
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
                         G K  + + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 168 ----GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           F +   +G GS+GSVYK I  H +   +VA+K + ++     +  I E   ++     ++
Sbjct: 31  FDVLEKLGEGSYGSVYKAI--HKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHV 86
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK   S     F+  D   +V E    GS+ + + L     RN  L +   IA  + STL
Sbjct: 87  VKYYGSY----FKNTDL-WIVMEYCGAGSVSDIIRL-----RNKTLTED-EIATILQSTL 135
Query: 281 ---EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
              EYLH   +   +H D+K  N+LL+ E  A ++DFG+A  L +              V
Sbjct: 136 KGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX-------V 185
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            GT  + APE       +   D++S GI  +EM  GK P
Sbjct: 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 107/232 (46%), Gaps = 19/232 (8%)
Query: 152 QNLFKATDGFSLENL-IGAGSFGSVYKGIFDHDDHETLVAVKVLNL-QHRGASKSFIAEC 209
           + LF   D   + ++ +G G+FGSV +G++     +  VA+KVL     +  ++  + E 
Sbjct: 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 387
Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
           Q +  + +  +V++I  C +          LV E+   G L ++L   R+     N+ + 
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEALM------LVMEMAGGGPLHKFLVGKREEIPVSNVAEL 441
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
           L     V+  ++YL    E   VH +L   NVLL     A +SDFGL+K L         
Sbjct: 442 LH---QVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL---GADDSY 492
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM 380
                 G K  + + APE     + S+  DV+S+G+ + E  + G+ P  +M
Sbjct: 493 YTARSAG-KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 161 FSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           F L  ++G GSFG V+  K I    D   L A+KVL        K+ +     +R+   R
Sbjct: 27  FELLKVLGQGSFGKVFLVKKI-SGSDARQLYAMKVLK-------KATLKVRDRVRTKMER 78
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---- 274
           +++  +     V         L Y     G L    +L  D  R  +L  RLS  V    
Sbjct: 79  DILVEVNHPFIV--------KLHYAFQTEGKL----YLILDFLRGGDLFTRLSKEVMFTE 126
Query: 275 --------DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
                   ++A  L++LH      I++ DLKP N+LLD E    ++DFGL+K        
Sbjct: 127 EDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-------E 176
Query: 327 XXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                       GTV Y APE       + S D +SFG+L+ EM TG  P
Sbjct: 177 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 97/230 (42%), Gaps = 44/230 (19%)
Query: 161 FSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           F L  ++G GSFG V+  K I    D   L A+KVL        K+ +     +R+   R
Sbjct: 26  FELLKVLGQGSFGKVFLVKKI-SGSDARQLYAMKVLK-------KATLKVRDRVRTKMER 77
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---- 274
           +++  +     V         L Y     G L    +L  D  R  +L  RLS  V    
Sbjct: 78  DILVEVNHPFIV--------KLHYAFQTEGKL----YLILDFLRGGDLFTRLSKEVMFTE 125
Query: 275 --------DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
                   ++A  L++LH      I++ DLKP N+LLD E    ++DFGL+K        
Sbjct: 126 EDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-------E 175
Query: 327 XXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                       GTV Y APE       + S D +SFG+L+ EM TG  P
Sbjct: 176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASK-SFIAECQAL 212
           A +  ++   +G GSFG VY+G+      D+ ET VA+K +N       +  F+ E   +
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL----- 267
           +     ++V+++     V  QG     ++ ELM  G L+ +L   R    N  +L     
Sbjct: 70  KEFNCHHVVRLL----GVVSQGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 268 -QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
            + + +A ++A  + YL+       VH DL   N  +  + T  + DFG+ + + E    
Sbjct: 125 SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 327 XXXXXXXXVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                    G KG   V + +PE       +T  DV+SFG++L E+ T
Sbjct: 182 RK-------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 95/234 (40%), Gaps = 19/234 (8%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHE-TLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
           F +E  IG G F  VY+     D     L  V++ +L    A    I E   L+ + H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           ++K   S +    + N+   +V EL   G L   +   +   R +         V + S 
Sbjct: 94  VIKYYASFI----EDNELN-IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           LE++H      ++H D+KP+NV +       + D GL +F                 + G
Sbjct: 149 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-------SLVG 198
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE 393
           T  Y +PE    +  +   D++S G LL EM   + P    +   + L++  K+
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKK 249

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 101/227 (44%), Gaps = 23/227 (10%)
Query: 152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQA 211
             +F+ +D    E ++G G FG   K +   +  E +V  +++        ++F+ E + 
Sbjct: 4   HRIFRPSDLIHGE-VLGKGCFGQAIK-VTHRETGEVMVMKELIRFDEE-TQRTFLKEVKV 60
Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRL 270
           +R + H N++K I   +  D + N     + E +  G+L   +  ++   P +    QR+
Sbjct: 61  MRCLEHPNVLKFI-GVLYKDKRLN----FITEYIKGGTLRGIIKSMDSQYPWS----QRV 111
Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL------PEA- 323
           S A D+AS + YLH      I+H DL   N L+       V+DFGLA+ +      PE  
Sbjct: 112 SFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 324 AXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEM 370
                        V G   + APE   G       DV+SFGI+L E+
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI 215

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 43/237 (18%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA---ECQALRSIRH 217
           + +   +G GSFG V   +  H   +  VA+K ++ Q    S   +    E   L+ +RH
Sbjct: 11  YIIRETLGEGSFGKV--KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 218 RNLVK---IITS----CVSVDFQGND-FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
            +++K   +IT+     + +++ G + F+ +V          E   +  D  R     Q+
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYAGGELFDYIV----------EKKRMTEDEGRRF--FQQ 116
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
           +  A+      EY H +    IVH DLKP N+LLD  L   ++DFGL+  + +       
Sbjct: 117 IICAI------EYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS 167
Query: 330 XXXXXVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNL 385
                    G+  YAAPE   G        DV+S GI+L  M  G+ P ++ F  NL
Sbjct: 168 C--------GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 19/221 (8%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRN 219
           + ++  +G G FG V + I  H D    VA+K    +    ++  +  E Q ++ + H N
Sbjct: 16  WEMKERLGTGGFGYVLRWI--HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 73
Query: 220 LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           +V        +     ND   L  E    G L ++L+   +    L      ++  D++S
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISS 132
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLD---GELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
            L YLH   E  I+H DLKP N++L      L   + D G AK L +             
Sbjct: 133 ALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV----- 184
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              GT+ Y APE     + + + D +SFG L  E  TG  P
Sbjct: 185 ---GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 19/221 (8%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRN 219
           + ++  +G G FG V + I  H D    VA+K    +    ++  +  E Q ++ + H N
Sbjct: 17  WEMKERLGTGGFGYVLRWI--HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPN 74
Query: 220 LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           +V        +     ND   L  E    G L ++L+   +    L      ++  D++S
Sbjct: 75  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-GLKEGPIRTLLSDISS 133
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLD---GELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
            L YLH   E  I+H DLKP N++L      L   + D G AK L +             
Sbjct: 134 ALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV----- 185
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              GT+ Y APE     + + + D +SFG L  E  TG  P
Sbjct: 186 ---GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 100/235 (42%), Gaps = 31/235 (13%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQAL 212
           K +D F    +IG GSFG V   +  H   E   AVKVL  +    +   K  ++E   L
Sbjct: 36  KPSD-FHFLKVIGKGSFGKVL--LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL 92
Query: 213 -RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
            ++++H  LV +  S     FQ  D    V + +  G L  + HL R+  R     +   
Sbjct: 93  LKNVKHPFLVGLHFS-----FQTADKLYFVLDYINGGEL--FYHLQRE--RCFLEPRARF 143
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
            A ++AS L YLH      IV+ DLKP N+LLD +    ++DFGL K             
Sbjct: 144 YAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-------ENIEHN 193
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMF 381
                  GT  Y APE         + D +  G +L EM  G  P     T EM+
Sbjct: 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+ G+VY  +      E  VA++ +NLQ +   +  I E   +R  ++ N+V  + S
Sbjct: 28  IGQGASGTVYTAMDVATGQE--VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E +  GSL + +         ++  Q  ++  +    LE+LH  
Sbjct: 86  -----YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS- 134
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGL-AKFLPEAAXXXXXXXXXXVGVKGTVGYAA 345
               ++H D+K  N+LL  + +  ++DFG  A+  PE +              GT  + A
Sbjct: 135 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--------GTPYWMA 184
Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           PE           D++S GI+ +EM  G+ P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+ G+VY  +      E  VA++ +NLQ +   +  I E   +R  ++ N+V  + S
Sbjct: 28  IGQGASGTVYTAMDVATGQE--VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E +  GSL + +         ++  Q  ++  +    LE+LH  
Sbjct: 86  -----YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS- 134
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGL-AKFLPEAAXXXXXXXXXXVGVKGTVGYAA 345
               ++H D+K  N+LL  + +  ++DFG  A+  PE +              GT  + A
Sbjct: 135 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV--------GTPYWMA 184
Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           PE           D++S GI+ +EM  G+ P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+ G+VY  +      E  VA++ +NLQ +   +  I E   +R  ++ N+V  + S
Sbjct: 28  IGQGASGTVYTAMDVATGQE--VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E +  GSL + +         ++  Q  ++  +    LE+LH  
Sbjct: 86  -----YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS- 134
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGL-AKFLPEAAXXXXXXXXXXVGVKGTVGYAA 345
               ++H D+K  N+LL  + +  ++DFG  A+  PE +              GT  + A
Sbjct: 135 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV--------GTPYWMA 184
Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           PE           D++S GI+ +EM  G+ P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 167 IGAGSFGSVYKG---IFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRSIRHRN 219
           +G GSFG VY+G        + ET VAVK +N    L+ R     F+ E   ++     +
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHH 81
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN------LNLLQRLSIA 273
           +V+++     V  +G     +V ELM +G L+ +L   R    N        L + + +A
Sbjct: 82  VVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
            ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E A         
Sbjct: 137 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRK----- 188
Query: 334 XVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEM 370
             G KG   V + APE       +TS D++SFG++L E+
Sbjct: 189 --GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 110/241 (45%), Gaps = 26/241 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRH 217
           D F   + +GAG+ G V+K    H     ++A K+++L+ + A ++  I E Q L     
Sbjct: 9   DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 66
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             +V    +     F  +   ++  E M  GSL++ L      P  +  L ++SIAV   
Sbjct: 67  PYIVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIAV--I 117
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA-KFLPEAAXXXXXXXXXXVG 336
             L YL    +  I+H D+KPSN+L++      + DFG++ + + E A            
Sbjct: 118 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFV-------- 167
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP 396
             GT  Y +PE   G+  S   D++S G+ L+EM  G+ P   M    L L   V E  P
Sbjct: 168 --GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFEL-LDYIVNEPPP 224
Query: 397 E 397
           +
Sbjct: 225 K 225

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+ G+VY  +      E  VA++ +NLQ +   +  I E   +R  ++ N+V  + S
Sbjct: 29  IGQGASGTVYTAMDVATGQE--VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E +  GSL + +         ++  Q  ++  +    LE+LH  
Sbjct: 87  -----YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS- 135
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGL-AKFLPEAAXXXXXXXXXXVGVKGTVGYAA 345
               ++H D+K  N+LL  + +  ++DFG  A+  PE +              GT  + A
Sbjct: 136 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV--------GTPYWMA 185
Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           PE           D++S GI+ +EM  G+ P
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 51/101 (50%), Gaps = 10/101 (9%)
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           + S LE+LH   +  I++ DLKP NVLLD +    +SD GLA  L               
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK------- 347
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           G  GT G+ APE  +G E   S D ++ G+ L EM   +GP
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 165 NLIGAGSFGSVYKGIF--DHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLV 221
            ++G+G+FG+VYKGI+  D ++ +  VA+KVL       A+K  + E   +  +    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           +++  C++   Q      LV +LM  G L + +  NR    + +L   L+  + +A  + 
Sbjct: 83  RLLGICLTSTVQ------LVTQLMPYGCLLDHVRENRGRLGSQDL---LNWCMQIAKGMS 133
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           YL    +  +VH DL   NVL+       ++DFGLA+ L               G K  +
Sbjct: 134 YLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLL-----DIDETEYHADGGKVPI 185
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN 378
            + A E  +    +   DV+S+G+ + E+ T G  P +
Sbjct: 186 KWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 51/101 (50%), Gaps = 10/101 (9%)
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           + S LE+LH   +  I++ DLKP NVLLD +    +SD GLA  L               
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK------- 347
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           G  GT G+ APE  +G E   S D ++ G+ L EM   +GP
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 51/101 (50%), Gaps = 10/101 (9%)
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           + S LE+LH   +  I++ DLKP NVLLD +    +SD GLA  L               
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK------- 347
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           G  GT G+ APE  +G E   S D ++ G+ L EM   +GP
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 51/101 (50%), Gaps = 10/101 (9%)
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           + S LE+LH   +  I++ DLKP NVLLD +    +SD GLA  L               
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK------- 347
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           G  GT G+ APE  +G E   S D ++ G+ L EM   +GP
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G VYK   ++ +   L  ++ L  +  G   + I E   L+ ++H N+VK+   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH- 285
                        LV+E           HL++D  + L++ +    +V   S L  L + 
Sbjct: 69  -----IHTKKRLVLVFE-----------HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 286 --YC-ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
             YC +  ++H DLKP N+L++ E    ++DFGLA+                     T+ 
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-------TLW 165
Query: 343 YAAPEYGMGS-EVSTSGDVYSFGILLLEMFTG 373
           Y AP+  MGS + ST+ D++S G +  EM  G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 153 NLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQ-- 210
            +FK T+   L+ ++G+G FG+V+KG++  +     + V +  ++ +   +SF A     
Sbjct: 26  RIFKETELRKLK-VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM 84
Query: 211 -ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA--PRNLNLL 267
            A+ S+ H ++V+++  C     Q      LV + +  GSL + +  +R A  P+ L   
Sbjct: 85  LAIGSLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGALGPQLL--- 135
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXX 327
             L+  V +A  + YL    E  +VH +L   NVLL       V+DFG+A  LP      
Sbjct: 136 --LNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 190
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                     K  + + A E     + +   DV+S+G+ + E+ T
Sbjct: 191 LYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G VYK   ++ +   L  ++ L  +  G   + I E   L+ ++H N+VK+   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH- 285
                        LV+E           HL++D  + L++ +    +V   S L  L + 
Sbjct: 69  -----IHTKKRLVLVFE-----------HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 286 --YC-ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
             YC +  ++H DLKP N+L++ E    ++DFGLA+                     T+ 
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-------TLW 165
Query: 343 YAAPEYGMGS-EVSTSGDVYSFGILLLEMFTG 373
           Y AP+  MGS + ST+ D++S G +  EM  G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 29/212 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G VYK   ++ +   L  ++ L  +  G   + I E   L+ ++H N+VK+   
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH- 285
                        LV+E           HL++D  + L++ +    +V   S L  L + 
Sbjct: 69  -----IHTKKRLVLVFE-----------HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112
Query: 286 --YC-ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
             YC +  ++H DLKP N+L++ E    ++DFGLA+                     T+ 
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-------TLW 165
Query: 343 YAAPEYGMGS-EVSTSGDVYSFGILLLEMFTG 373
           Y AP+  MGS + ST+ D++S G +  EM  G
Sbjct: 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 25/225 (11%)
Query: 153 NLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQ-- 210
            +FK T+   L+ ++G+G FG+V+KG++  +     + V +  ++ +   +SF A     
Sbjct: 8   RIFKETELRKLK-VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM 66
Query: 211 -ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA--PRNLNLL 267
            A+ S+ H ++V+++  C     Q      LV + +  GSL + +  +R A  P+ L   
Sbjct: 67  LAIGSLDHAHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGALGPQLL--- 117
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXX 327
             L+  V +A  + YL    E  +VH +L   NVLL       V+DFG+A  LP      
Sbjct: 118 --LNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQL 172
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                     K  + + A E     + +   DV+S+G+ + E+ T
Sbjct: 173 LYSE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRH 217
           D F   + +GAG+ G V+K    H     ++A K+++L+ + A ++  I E Q L     
Sbjct: 25  DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 82
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             +V    +     F  +   ++  E M  GSL++ L      P  +  L ++SIAV   
Sbjct: 83  PYIVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIAV--I 133
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
             L YL    +  I+H D+KPSN+L++      + DFG++  L ++              
Sbjct: 134 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-------- 183
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            GT  Y +PE   G+  S   D++S G+ L+EM  G+ P
Sbjct: 184 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 97/229 (42%), Gaps = 42/229 (18%)
Query: 161 FSLENLIGAGSFGSVY-KGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
           F L  ++G GSFG V+        D   L A+KVL        K+ +     +R+   R+
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLK-------KATLKVRDRVRTKMERD 82
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV----- 274
           ++  +     V         L Y     G L    +L  D  R  +L  RLS  V     
Sbjct: 83  ILADVNHPFVV--------KLHYAFQTEGKL----YLILDFLRGGDLFTRLSKEVMFTEE 130
Query: 275 -------DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXX 327
                  ++A  L++LH      I++ DLKP N+LLD E    ++DFGL+K   EA    
Sbjct: 131 DVKFYLAELALGLDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHE 184
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                      GTV Y APE       S S D +S+G+L+ EM TG  P
Sbjct: 185 KKAYSFC----GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 102/249 (40%), Gaps = 40/249 (16%)
Query: 159 DGFSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQA 211
           D  +L   +G G+FG V      GI D D  +  V V V  L+     K     ++E + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGI-DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 93
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNR 258
           ++ I +H+N++ ++ +C     Q      +V E    G+L E+L             +NR
Sbjct: 94  MKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                +     +S    +A  +EYL        +H DL   NVL+       ++DFGLA+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR 205
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
            +                 +  V + APE       +   DV+SFG+L+ E+FT  G   
Sbjct: 206 DI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 261 PGIPVEELF 269

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 99/221 (44%), Gaps = 23/221 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSI 215
           + F + NL+G GSF  VY+    H   E  VA+K+++   +   G  +    E +    +
Sbjct: 11  EDFKVGNLLGKGSFAGVYRAESIHTGLE--VAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           +H +++++        F+ +++  LV E+  NG +  +L  NR  P + N  +       
Sbjct: 69  KHPSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLK-NRVKPFSEN--EARHFMHQ 120
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           + + + YLH +    I+H DL  SN+LL   +   ++DFGLA  L               
Sbjct: 121 IITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL-------KMPHEKHY 170
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y +PE    S      DV+S G +   +  G+ P
Sbjct: 171 TLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 104/249 (41%), Gaps = 40/249 (16%)
Query: 159 DGFSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQA 211
           D  +L   +G G+FG V      GI D D  +  V V V  L+     K     ++E + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGI-DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 93
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNR 258
           ++ I +H+N++ ++ +C     Q      +V E    G+L E+L             +NR
Sbjct: 94  MKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEXSYDINR 148
Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                +     +S    +A  +EYL        +H DL   NVL+       ++DFGLA+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
            +                 +  V + APE       +   DV+SFG+L+ E+FT  G   
Sbjct: 206 DI-----NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 261 PGIPVEELF 269

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRH 217
           D F   + +GAG+ G V+K    H     ++A K+++L+ + A ++  I E Q L     
Sbjct: 6   DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             +V    +     F  +   ++  E M  GSL++ L      P  +  L ++SIAV   
Sbjct: 64  PYIVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIAV--I 114
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
             L YL    +  I+H D+KPSN+L++      + DFG++  L ++              
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-------- 164
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            GT  Y +PE   G+  S   D++S G+ L+EM  G+ P
Sbjct: 165 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRH 217
           D F   + +GAG+ G V+K    H     ++A K+++L+ + A ++  I E Q L     
Sbjct: 33  DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 90
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             +V    +     F  +   ++  E M  GSL++ L      P  +  L ++SIAV   
Sbjct: 91  PYIVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIAV--I 141
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
             L YL    +  I+H D+KPSN+L++      + DFG++  L ++              
Sbjct: 142 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-------- 191
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            GT  Y +PE   G+  S   D++S G+ L+EM  G+ P
Sbjct: 192 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 104/249 (41%), Gaps = 40/249 (16%)
Query: 159 DGFSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQA 211
           D  +L   +G G+FG V      GI D D  +  V V V  L+     K     ++E + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGI-DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 93
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNR 258
           ++ I +H+N++ ++ +C     Q      +V E    G+L E+L             +NR
Sbjct: 94  MKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                +     +S    +A  +EYL        +H DL   NVL+       ++DFGLA+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
            +                 +  V + APE       +   DV+SFG+L+ E+FT  G   
Sbjct: 206 DI-----NNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 261 PGIPVEELF 269

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 167 IGAGSFGSVYKG---IFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRSIRHRN 219
           +G GSFG VY+G        + ET VAVK +N    L+ R     F+ E   ++     +
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHH 78
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN------LNLLQRLSIA 273
           +V+++     V  +G     +V ELM +G L+ +L   R    N        L + + +A
Sbjct: 79  VVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 133
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
            ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E           
Sbjct: 134 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK----- 185
Query: 334 XVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEM 370
             G KG   V + APE       +TS D++SFG++L E+
Sbjct: 186 --GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 222

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 98/227 (43%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 62  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G  E + HL R        + R S    
Sbjct: 120 NFPFLVKLEFS-----FKDNSNLYMVMEYVAGG--EMFSHLRR--------IGRFSEPHA 164
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK +  A      
Sbjct: 165 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT--- 218
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 219 -------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRH 217
           D F   + +GAG+ G V+K    H     ++A K+++L+ + A ++  I E Q L     
Sbjct: 6   DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             +V    +     F  +   ++  E M  GSL++ L      P  +  L ++SIAV   
Sbjct: 64  PYIVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIAV--I 114
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
             L YL    +  I+H D+KPSN+L++      + DFG++  L ++              
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-------- 164
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            GT  Y +PE   G+  S   D++S G+ L+EM  G+ P
Sbjct: 165 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRH 217
           D F   + +GAG+ G V+K    H     ++A K+++L+ + A ++  I E Q L     
Sbjct: 6   DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             +V    +     F  +   ++  E M  GSL++ L      P  +  L ++SIAV   
Sbjct: 64  PYIVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIAV--I 114
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
             L YL    +  I+H D+KPSN+L++      + DFG++  L ++              
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-------- 164
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            GT  Y +PE   G+  S   D++S G+ L+EM  G+ P
Sbjct: 165 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 167 IGAGSFGSVYKG---IFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRSIRHRN 219
           +G GSFG VY+G        + ET VAVK +N    L+ R     F+ E   ++     +
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHH 81
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN------LNLLQRLSIA 273
           +V+++     V  +G     +V ELM +G L+ +L   R    N        L + + +A
Sbjct: 82  VVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
            ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E           
Sbjct: 137 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK----- 188
Query: 334 XVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEM 370
             G KG   V + APE       +TS D++SFG++L E+
Sbjct: 189 --GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 167 IGAGSFGSVYKG---IFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRSIRHRN 219
           +G GSFG VY+G        + ET VAVK +N    L+ R     F+ E   ++     +
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHH 81
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN------LNLLQRLSIA 273
           +V+++     V  +G     +V ELM +G L+ +L   R    N        L + + +A
Sbjct: 82  VVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
            ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E           
Sbjct: 137 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRK----- 188
Query: 334 XVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEM 370
             G KG   V + APE       +TS D++SFG++L E+
Sbjct: 189 --GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRH 217
           D F   + +GAG+ G V+K    H     ++A K+++L+ + A ++  I E Q L     
Sbjct: 6   DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             +V    +     F  +   ++  E M  GSL++ L      P  +  L ++SIAV   
Sbjct: 64  PYIVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIAV--I 114
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
             L YL    +  I+H D+KPSN+L++      + DFG++  L ++              
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-------- 164
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            GT  Y +PE   G+  S   D++S G+ L+EM  G+ P
Sbjct: 165 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 29/222 (13%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           D F   + +GAG+ G V+K    H     ++A K+++L+ + A ++ I        IR  
Sbjct: 68  DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQI--------IREL 117
Query: 219 NLVKIITSCVSVDFQG---NDFE-ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
            ++    S   V F G   +D E ++  E M  GSL++ L      P  +  L ++SIAV
Sbjct: 118 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIAV 175
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                L YL    +  I+H D+KPSN+L++      + DFG++  L ++           
Sbjct: 176 --IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 226
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
               GT  Y +PE   G+  S   D++S G+ L+EM  G+ P
Sbjct: 227 ----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 102/249 (40%), Gaps = 40/249 (16%)
Query: 159 DGFSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQA 211
           D  +L   +G G+FG V      GI D D  +  V V V  L+     K     ++E + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGI-DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 93
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNR 258
           ++ I +H+N++ ++ +C     Q      +V E    G+L E+L             +NR
Sbjct: 94  MKMIGKHKNIITLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                +     +S    +A  +EYL        +H DL   NVL+       ++DFGLA+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
            +                 +  V + APE       +   DV+SFG+L+ E+FT  G   
Sbjct: 206 DI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 261 PGIPVEELF 269

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRH 217
           D F   + +GAG+ G V+K    H     ++A K+++L+ + A ++  I E Q L     
Sbjct: 6   DDFEKISELGAGNGGVVFK--VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             +V    +     F  +   ++  E M  GSL++ L      P  +  L ++SIAV   
Sbjct: 64  PYIVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIAV--I 114
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
             L YL    +  I+H D+KPSN+L++      + DFG++  L ++              
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-------- 164
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            GT  Y +PE   G+  S   D++S G+ L+EM  G+ P
Sbjct: 165 -GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 102/249 (40%), Gaps = 40/249 (16%)
Query: 159 DGFSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQA 211
           D  +L   +G G+FG V      GI D D  +  V V V  L+     K     ++E + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGI-DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 93
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNR 258
           ++ I +H+N++ ++ +C     Q      +V E    G+L E+L             +NR
Sbjct: 94  MKMIGKHKNIIHLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                +     +S    +A  +EYL        +H DL   NVL+       ++DFGLA+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
            +                 +  V + APE       +   DV+SFG+L+ E+FT  G   
Sbjct: 206 DI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 261 PGIPVEELF 269

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 32/226 (14%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALRSI 215
           D F +   +G G FG+VY  +     ++ ++A+KVL    L+  G       E +    +
Sbjct: 14  DDFDIVRPLGKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 71
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL--HLNRDAPRNLNLLQRLSIA 273
           RH N++++        F       L+ E    G L + L  H   D  R+   ++ L+ A
Sbjct: 72  RHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 126
Query: 274 VDVASTLEYLHHYC-ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           +          HYC E  ++H D+KP N+L+  +    ++DFG +   P           
Sbjct: 127 L----------HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC--- 173
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
                 GT+ Y  PE   G       D++  G+L  E   G  P +
Sbjct: 174 ------GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/248 (24%), Positives = 99/248 (39%), Gaps = 38/248 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKSF---IAECQAL 212
           D  +L   +G G FG V        D D  +  V V V  L+     K     ++E + +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 213 RSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNRD 259
           + I +H+N++ ++ +C     Q      +V E    G+L E+L             +NR 
Sbjct: 141 KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
               +     +S    +A  +EYL        +H DL   NVL+       ++DFGLA+ 
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 320 LPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG---- 375
           +                 +  V + APE       +   DV+SFG+L+ E+FT  G    
Sbjct: 253 I-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 307
Query: 376 --PTNEMF 381
             P  E+F
Sbjct: 308 GIPVEELF 315

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETL-VAVKVL-NLQHRGASKSFIAECQALRSIRHRNL 220
           L   IG G FG V++GI+   ++  L VA+K   N       + F+ E   +R   H ++
Sbjct: 42  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 101
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK+I               ++ EL   G L  +L + +    +L+L   +  A  +++ L
Sbjct: 102 VKLIGVITENPVW------IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTAL 152
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            YL        VH D+   NVL+       + DFGL++++ ++              K  
Sbjct: 153 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG------KLP 203
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
           + + APE       +++ DV+ FG+ + E+ 
Sbjct: 204 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 16/223 (7%)
Query: 154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA-SKSFIAECQAL 212
           ++  +  F L++L+G G++G V      H     +VA+K +    +   +   + E + L
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSAT--HKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           +  +H N++ I        F+  +   ++ ELM          L+R    +  +L    I
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-------LHRVI--STQMLSDDHI 114
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
              +  TL  +     + ++H DLKPSN+L++      V DFGLA+ + E+A        
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 333 XXVGVKGTVG---YAAPEYGMGS-EVSTSGDVYSFGILLLEMF 371
              G+   V    Y APE  + S + S + DV+S G +L E+F
Sbjct: 175 QQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 32/226 (14%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALRSI 215
           D F +   +G G FG+VY  +     ++ ++A+KVL    L+  G       E +    +
Sbjct: 15  DDFDIGRPLGKGKFGNVY--LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL 72
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL--HLNRDAPRNLNLLQRLSIA 273
           RH N++++        F       L+ E    G L + L  H   D  R+   ++ L+ A
Sbjct: 73  RHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA 127
Query: 274 VDVASTLEYLHHYC-ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           +          HYC E  ++H D+KP N+L+  +    ++DFG +   P           
Sbjct: 128 L----------HYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC--- 174
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
                 GT+ Y  PE   G       D++  G+L  E   G  P +
Sbjct: 175 ------GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETL-VAVKVL-NLQHRGASKSFIAECQALRSIRHRNL 220
           L   IG G FG V++GI+   ++  L VA+K   N       + F+ E   +R   H ++
Sbjct: 19  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK+I               ++ EL   G L  +L + +    +L+L   +  A  +++ L
Sbjct: 79  VKLIGVITENPVW------IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTAL 129
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            YL        VH D+   NVL+       + DFGL++++ ++              K  
Sbjct: 130 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG------KLP 180
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
           + + APE       +++ DV+ FG+ + E+ 
Sbjct: 181 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 38/248 (15%)
Query: 159 DGFSLENLIGAGSFGSVY--KGI-FDHDDHETLVAVKVLNLQHRGASKSF---IAECQAL 212
           D   L   +G G+FG V   + I  D D    +  V V  L+     K     I+E + +
Sbjct: 17  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 76
Query: 213 RSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------D 259
           + I +H+N++ ++ +C     Q      +V E    G+L E+L   R            +
Sbjct: 77  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHN 131
Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
               L+    +S A  VA  +EYL        +H DL   NVL+  +    ++DFGLA+ 
Sbjct: 132 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 188
Query: 320 LPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG---- 375
           +                 +  V + APE       +   DV+SFG+LL E+FT  G    
Sbjct: 189 I-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 243
Query: 376 --PTNEMF 381
             P  E+F
Sbjct: 244 GVPVEELF 251

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRH 217
           D F   + +GAG+ G V K    H     ++A K+++L+ + A ++  I E Q L     
Sbjct: 16  DDFERISELGAGNGGVVTK--VQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS 73
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             +V    +     F  +   ++  E M  GSL++ L   +  P  +  L ++SIAV   
Sbjct: 74  PYIVGFYGA-----FYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI--LGKVSIAV--L 124
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
             L YL    +  I+H D+KPSN+L++      + DFG++  L ++              
Sbjct: 125 RGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-------- 174
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            GT  Y APE   G+  S   D++S G+ L+E+  G+ P
Sbjct: 175 -GTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+ G+VY  +      E  VA++ +NLQ +   +  I E   +R  ++ N+V  + S
Sbjct: 29  IGQGASGTVYTAMDVATGQE--VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 86
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E +  GSL + +         ++  Q  ++  +    LE+LH  
Sbjct: 87  -----YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHS- 135
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGL-AKFLPEAAXXXXXXXXXXVGVKGTVGYAA 345
               ++H ++K  N+LL  + +  ++DFG  A+  PE +              GT  + A
Sbjct: 136 --NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--------GTPYWMA 185
Query: 346 PEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           PE           D++S GI+ +EM  G+ P
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 102/249 (40%), Gaps = 40/249 (16%)
Query: 159 DGFSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQA 211
           D  +L   +G G+FG V      GI D D  +  V V V  L+     K     ++E + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGI-DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 93
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNR 258
           ++ I +H+N++ ++ +C     Q      +V E    G+L E+L             +NR
Sbjct: 94  MKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                +     +S    +A  +EYL        +H DL   NVL+       ++DFGLA+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
            +                 +  V + APE       +   DV+SFG+L+ E+FT  G   
Sbjct: 206 DI-----NNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 261 PGIPVEELF 269

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 38/248 (15%)
Query: 159 DGFSLENLIGAGSFGSVY--KGI-FDHDDHETLVAVKVLNLQHRGASKSF---IAECQAL 212
           D   L   +G G+FG V   + I  D D    +  V V  L+     K     I+E + +
Sbjct: 21  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 80
Query: 213 RSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------D 259
           + I +H+N++ ++ +C     Q      +V E    G+L E+L   R            +
Sbjct: 81  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHN 135
Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
               L+    +S A  VA  +EYL        +H DL   NVL+  +    ++DFGLA+ 
Sbjct: 136 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 192
Query: 320 LPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG---- 375
           +                 +  V + APE       +   DV+SFG+LL E+FT  G    
Sbjct: 193 I-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 247
Query: 376 --PTNEMF 381
             P  E+F
Sbjct: 248 GVPVEELF 255

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 40/244 (16%)
Query: 153 NLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQAL 212
           N+    + FS+  +IG G FG VY       D   + A+K L+       K    +    
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLD------KKRIKMKQGET 234
Query: 213 RSIRHRNLVKIITS-------CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLN 265
            ++  R ++ ++++       C+S  F   D  + + +LM  G L    HL++    +  
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEA 292
Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA----KFLP 321
            ++    A ++   LE++H+     +V+ DLKP+N+LLD      +SD GLA    K  P
Sbjct: 293 DMR--FYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPE-YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
            A+              GT GY APE    G    +S D +S G +L ++  G  P  + 
Sbjct: 348 HASV-------------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394
Query: 381 FTGN 384
            T +
Sbjct: 395 KTKD 398

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 40/244 (16%)
Query: 153 NLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQAL 212
           N+    + FS+  +IG G FG VY       D   + A+K L+       K    +    
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLD------KKRIKMKQGET 234
Query: 213 RSIRHRNLVKIITS-------CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLN 265
            ++  R ++ ++++       C+S  F   D  + + +LM  G L    HL++    +  
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEA 292
Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA----KFLP 321
            ++    A ++   LE++H+     +V+ DLKP+N+LLD      +SD GLA    K  P
Sbjct: 293 DMR--FYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPE-YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
            A+              GT GY APE    G    +S D +S G +L ++  G  P  + 
Sbjct: 348 HASV-------------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394
Query: 381 FTGN 384
            T +
Sbjct: 395 KTKD 398

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 109/244 (44%), Gaps = 40/244 (16%)
Query: 153 NLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQAL 212
           N+    + FS+  +IG G FG VY       D   + A+K L+       +  + + + L
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLD-----KKRIKMKQGETL 234
Query: 213 RSIRHRNLVKIITS-------CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLN 265
            ++  R ++ ++++       C+S  F   D  + + +LM  G L    HL++    +  
Sbjct: 235 -ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEA 291
Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA----KFLP 321
            ++    A ++   LE++H+     +V+ DLKP+N+LLD      +SD GLA    K  P
Sbjct: 292 DMR--FYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 346
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPE-YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
            A+              GT GY APE    G    +S D +S G +L ++  G  P  + 
Sbjct: 347 HASV-------------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 393
Query: 381 FTGN 384
            T +
Sbjct: 394 KTKD 397

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 38/248 (15%)
Query: 159 DGFSLENLIGAGSFGSVY--KGI-FDHDDHETLVAVKVLNLQHRGASKSF---IAECQAL 212
           D   L   +G G+FG V   + I  D D    +  V V  L+     K     I+E + +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 213 RSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------D 259
           + I +H+N++ ++ +C     Q      +V E    G+L E+L   R            +
Sbjct: 73  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHN 127
Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
               L+    +S A  VA  +EYL        +H DL   NVL+  +    ++DFGLA+ 
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 320 LPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG---- 375
           +                 +  V + APE       +   DV+SFG+LL E+FT  G    
Sbjct: 185 I-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239
Query: 376 --PTNEMF 381
             P  E+F
Sbjct: 240 GVPVEELF 247

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 104/248 (41%), Gaps = 38/248 (15%)
Query: 159 DGFSLENLIGAGSFGSVY--KGI-FDHDDHETLVAVKVLNLQHRGASKSF---IAECQAL 212
           D   L   +G G+FG V   + I  D D    +  V V  L+     K     I+E + +
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 213 RSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------D 259
           + I +H+N++ ++ +C     Q      +V E    G+L E+L   R            +
Sbjct: 88  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEFSFNPSHN 142
Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
               L+    +S A  VA  +EYL        +H DL   NVL+  +    ++DFGLA+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 320 LPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG---- 375
           +                 +  V + APE       +   DV+SFG+LL E+FT  G    
Sbjct: 200 I-----HHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254
Query: 376 --PTNEMF 381
             P  E+F
Sbjct: 255 GVPVEELF 262

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 99/235 (42%), Gaps = 30/235 (12%)
Query: 148 RVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN----LQHRGASK 203
           R S Q   K  D F L  ++G GSFG V+   F   +     A+K L     L       
Sbjct: 8   RPSLQIKLKIED-FELHKMLGKGSFGKVFLAEFKKTNQ--FFAIKALKKDVVLMDDDVEC 64
Query: 204 SFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN 263
           + + +     +  H  L  +  +     FQ  +    V E +  G L    H+   +   
Sbjct: 65  TMVEKRVLSLAWEHPFLTHMFCT-----FQTKENLFFVMEYLNGGDL--MYHIQ--SCHK 115
Query: 264 LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK--FLP 321
            +L +    A ++   L++LH      IV+ DLK  N+LLD +    ++DFG+ K   L 
Sbjct: 116 FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 172
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           +A               GT  Y APE  +G + + S D +SFG+LL EM  G+ P
Sbjct: 173 DAKTNEFC---------GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 106/244 (43%), Gaps = 40/244 (16%)
Query: 153 NLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQAL 212
           N+    + FS+  +IG G FG VY       D   + A+K L+       K    +    
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLD------KKRIKMKQGET 234
Query: 213 RSIRHRNLVKIITS-------CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLN 265
            ++  R ++ ++++       C+S  F   D  + + +LM  G L    HL++    +  
Sbjct: 235 LALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGVFSEA 292
Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA----KFLP 321
            ++    A ++   LE++H+     +V+ DLKP+N+LLD      +SD GLA    K  P
Sbjct: 293 DMR--FYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPE-YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
            A+              GT GY APE    G    +S D +S G +L ++  G  P  + 
Sbjct: 348 HASV-------------GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394
Query: 381 FTGN 384
            T +
Sbjct: 395 KTKD 398

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 38/248 (15%)
Query: 159 DGFSLENLIGAGSFGSVY--KGI-FDHDDHETLVAVKVLNLQHRGASKSF---IAECQAL 212
           D   L   +G G+FG V   + I  D D    +  V V  L+     K     I+E + +
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 213 RSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------D 259
           + I +H+N++ ++ +C     Q      +V E    G+L E+L   R            +
Sbjct: 88  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHN 142
Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
               L+    +S A  VA  +EYL        +H DL   NVL+  +    ++DFGLA+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 320 LPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG---- 375
           +                 +  V + APE       +   DV+SFG+LL E+FT  G    
Sbjct: 200 I-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254
Query: 376 --PTNEMF 381
             P  E+F
Sbjct: 255 GVPVEELF 262

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 167 IGAGSFGSVYKG---IFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRSIRHRN 219
           +G GSFG VY+G        + ET VAVK +N    L+ R     F+ E   ++     +
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHH 80
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN------LNLLQRLSIA 273
           +V+++     V  +G     +V ELM +G L+ +L   R    N        L + + +A
Sbjct: 81  VVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 135
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
            ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E           
Sbjct: 136 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----- 187
Query: 334 XVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEM 370
             G KG   V + APE       +TS D++SFG++L E+
Sbjct: 188 --GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 224

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 40/249 (16%)
Query: 159 DGFSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQA 211
           D  +L   +G G FG V      GI D D  +  V V V  L+     K     ++E + 
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGI-DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 80
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNR 258
           ++ I +H+N++ ++ +C     Q      +V E    G+L E+L             +NR
Sbjct: 81  MKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINR 135
Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                +     +S    +A  +EYL        +H DL   NVL+       ++DFGLA+
Sbjct: 136 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR 192
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
            +                 +  V + APE       +   DV+SFG+L+ E+FT  G   
Sbjct: 193 DI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 247
Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 248 PGIPVEELF 256

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETL-VAVKVL-NLQHRGASKSFIAECQALRSIRHRNL 220
           L   IG G FG V++GI+   ++  L VA+K   N       + F+ E   +R   H ++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK+I               ++ EL   G L  +L + +    +L+L   +  A  +++ L
Sbjct: 74  VKLIGVITENPVW------IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTAL 124
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            YL        VH D+   NVL+       + DFGL++++ ++              K  
Sbjct: 125 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG------KLP 175
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
           + + APE       +++ DV+ FG+ + E+ 
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETL-VAVKVL-NLQHRGASKSFIAECQALRSIRHRNL 220
           L   IG G FG V++GI+   ++  L VA+K   N       + F+ E   +R   H ++
Sbjct: 11  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK+I               ++ EL   G L  +L + +    +L+L   +  A  +++ L
Sbjct: 71  VKLIGVITENPVW------IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTAL 121
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            YL        VH D+   NVL+       + DFGL++++ ++              K  
Sbjct: 122 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG------KLP 172
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
           + + APE       +++ DV+ FG+ + E+ 
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 40/249 (16%)
Query: 159 DGFSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQA 211
           D  +L   +G G FG V      GI D D  +  V V V  L+     K     ++E + 
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGI-DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 82
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNR 258
           ++ I +H+N++ ++ +C     Q      +V E    G+L E+L             +NR
Sbjct: 83  MKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINR 137
Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                +     +S    +A  +EYL        +H DL   NVL+       ++DFGLA+
Sbjct: 138 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 194
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
            +                 +  V + APE       +   DV+SFG+L+ E+FT  G   
Sbjct: 195 DI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 249
Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 250 PGIPVEELF 258

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETL-VAVKVL-NLQHRGASKSFIAECQALRSIRHRNL 220
           L   IG G FG V++GI+   ++  L VA+K   N       + F+ E   +R   H ++
Sbjct: 17  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 76
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK+I               ++ EL   G L  +L + +    +L+L   +  A  +++ L
Sbjct: 77  VKLIGVITENPVW------IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTAL 127
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            YL        VH D+   NVL+       + DFGL++++ ++              K  
Sbjct: 128 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG------KLP 178
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
           + + APE       +++ DV+ FG+ + E+ 
Sbjct: 179 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 38/248 (15%)
Query: 159 DGFSLENLIGAGSFGSVY--KGI-FDHDDHETLVAVKVLNLQHRGASKSF---IAECQAL 212
           D   L   +G G+FG V   + I  D D    +  V V  L+     K     I+E + +
Sbjct: 69  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 213 RSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------D 259
           + I +H+N++ ++ +C     Q      +V E    G+L E+L   R            +
Sbjct: 129 KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
               L+    +S A  VA  +EYL        +H DL   NVL+  +    ++DFGLA+ 
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 320 LPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG---- 375
           +                 +  V + APE       +   DV+SFG+LL E+FT  G    
Sbjct: 241 I-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295
Query: 376 --PTNEMF 381
             P  E+F
Sbjct: 296 GVPVEELF 303

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 38/248 (15%)
Query: 159 DGFSLENLIGAGSFGSVY--KGI-FDHDDHETLVAVKVLNLQHRGASKSF---IAECQAL 212
           D   L   +G G+FG V   + I  D D    +  V V  L+     K     I+E + +
Sbjct: 20  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 79
Query: 213 RSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------D 259
           + I +H+N++ ++ +C     Q      +V E    G+L E+L   R            +
Sbjct: 80  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHN 134
Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
               L+    +S A  VA  +EYL        +H DL   NVL+  +    ++DFGLA+ 
Sbjct: 135 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 191
Query: 320 LPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG---- 375
           +                 +  V + APE       +   DV+SFG+LL E+FT  G    
Sbjct: 192 I-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 246
Query: 376 --PTNEMF 381
             P  E+F
Sbjct: 247 GVPVEELF 254

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 29/221 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G G+FG VYK    + +   L A KV++ +     + ++ E   L S  H N+VK++ +
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +  N+   L+ E    G+++  + L  + P     L    I V    TL+ L++ 
Sbjct: 103 F----YYENNLWILI-EFCAGGAVDA-VMLELERP-----LTESQIQVVCKQTLDALNYL 151
Query: 287 CETPIVHCDLKPSNVL--LDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +  I+H DLK  N+L  LDG++   ++DFG+       +              GT  + 
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDI--KLADFGV-------SAKNTRTIQRRDSFIGTPYWM 202
Query: 345 APEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           APE  M             DV+S GI L+EM   + P +E+
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETL-VAVKVL-NLQHRGASKSFIAECQALRSIRHRNL 220
           L   IG G FG V++GI+   ++  L VA+K   N       + F+ E   +R   H ++
Sbjct: 16  LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 75
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK+I               ++ EL   G L  +L + +    +L+L   +  A  +++ L
Sbjct: 76  VKLIGVITENPVW------IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTAL 126
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            YL        VH D+   NVL+       + DFGL++++ ++              K  
Sbjct: 127 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG------KLP 177
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
           + + APE       +++ DV+ FG+ + E+ 
Sbjct: 178 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 36/234 (15%)
Query: 154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQA 211
           L +A   +     IG G++G V+K   D  +    VA+K + +Q    G   S I E   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKA-RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV 64
Query: 212 LR---SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQ 268
           LR   +  H N+V++   C            LV+E           H+++D    L+ + 
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-----------HVDQDLTTYLDKVP 113
Query: 269 RLSIAVDVAST--------LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
              +  +            L++LH +    +VH DLKP N+L+       ++DFGLA+  
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 321 PEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
                           V  T+ Y APE  + S  +T  D++S G +  EMF  K
Sbjct: 171 --------SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 16/223 (7%)
Query: 154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA-SKSFIAECQAL 212
           ++  +  F L++L+G G++G V      H     +VA+K +    +   +   + E + L
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSAT--HKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           +  +H N++ I        F+  +   ++ ELM          L+R    +  +L    I
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-------LHRVI--STQMLSDDHI 114
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
              +  TL  +     + ++H DLKPSN+L++      V DFGLA+ + E+A        
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 333 XXVGVK---GTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMF 371
              G+     T  Y APE  + S + S + DV+S G +L E+F
Sbjct: 175 QQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 102/248 (41%), Gaps = 38/248 (15%)
Query: 159 DGFSLENLIGAGSFGSVY--KGI-FDHDDHETLVAVKVLNLQHRGASKSF---IAECQAL 212
           D   L   +G G+FG V   + I  D D    +  V V  L+     K     I+E + +
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 213 RSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------D 259
           + I +H+N++ ++ +C     Q      +V E    G+L E+L   R            +
Sbjct: 88  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHN 142
Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
               L+    +S A  VA  +EYL        +H DL   NVL+  +    ++DFGLA+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 320 LPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG---- 375
           +                 +  V + APE       +   DV+SFG+LL E+FT  G    
Sbjct: 200 I-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 254
Query: 376 --PTNEMF 381
             P  E+F
Sbjct: 255 GVPVEELF 262

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 100/224 (44%), Gaps = 49/224 (21%)
Query: 165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-----GASKSFIAECQALRSIRHRN 219
           + +G G F +VYK      +   +VA+K + L HR     G +++ + E + L+ + H N
Sbjct: 16  DFLGEGQFATVYKA--RDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 73
Query: 220 LVKIITS-------CVSVDFQGNDFEALVYE--LMVNGSLEEWLHLNRDAPRNLNLLQRL 270
           ++ ++ +        +  DF   D E ++ +  L++  S     H+              
Sbjct: 74  IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS-----HIK------------- 115
Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL--PEAAXXXX 328
           +  +     LEYLH +    I+H DLKP+N+LLD      ++DFGLAK    P  A    
Sbjct: 116 AYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQ 172
Query: 329 XXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMF 371
                      T  Y APE   G+ +   G D+++ G +L E+ 
Sbjct: 173 VV---------TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 167 IGAGSFGSVYKGIF----DHDD-HETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           +G G+F  ++KG+     D+   HET V +KVL+  HR  S+SF      +  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
                CV       D   LV E +  GSL+ +L  N++    +N+L +L +A  +A+ + 
Sbjct: 76  LNYGVCVC-----GDENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAAAMH 127
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           +L    E  ++H ++   N+LL  E        G   F+  +             ++  +
Sbjct: 128 FLE---ENTLIHGNVCAKNILLIREEDRKT---GNPPFIKLSDPGISITVLPKDILQERI 181
Query: 342 GYAAPE-YGMGSEVSTSGDVYSFGILLLEMFTG 373
            +  PE       ++ + D +SFG  L E+ +G
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 29/221 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G G+FG VYK    + +   L A KV++ +     + ++ E   L S  H N+VK++ +
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +  N+   L+ E    G+++  + L  + P     L    I V    TL+ L++ 
Sbjct: 103 F----YYENNLWILI-EFCAGGAVDA-VMLELERP-----LTESQIQVVCKQTLDALNYL 151
Query: 287 CETPIVHCDLKPSNVL--LDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +  I+H DLK  N+L  LDG++   ++DFG+       +              GT  + 
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDI--KLADFGV-------SAKNTRXIQRRDSFIGTPYWM 202
Query: 345 APEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           APE  M             DV+S GI L+EM   + P +E+
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 167 IGAGSFGSVYKG---IFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRSIRHRN 219
           +G GSFG VY+G        + ET VAVK +N    L+ R     F+ E   ++     +
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHH 81
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN------LNLLQRLSIA 273
           +V+++     V  +G     +V ELM +G L+ +L   R    N        L + + +A
Sbjct: 82  VVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
            ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E           
Sbjct: 137 AEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----- 188
Query: 334 XVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEM 370
             G KG   V + APE       +TS D++SFG++L E+
Sbjct: 189 --GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 40/249 (16%)
Query: 159 DGFSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQA 211
           D  +L   +G G FG V      GI D D  +  V V V  L+     K     ++E + 
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGI-DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 85
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNR 258
           ++ I +H+N++ ++ +C     Q      +V E    G+L E+L             +NR
Sbjct: 86  MKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINR 140
Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                +     +S    +A  +EYL        +H DL   NVL+       ++DFGLA+
Sbjct: 141 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 197
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
            +                 +  V + APE       +   DV+SFG+L+ E+FT  G   
Sbjct: 198 DI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 252
Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 253 PGIPVEELF 261

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 110/241 (45%), Gaps = 34/241 (14%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG GS G V      H   +  VAVK ++L+ +   +    E   +R   H N+V + +S
Sbjct: 53  IGEGSTGIVCIATEKHTGKQ--VAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSS 110
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E +  G+L + +   R     +N  Q  ++ + V   L YLH+ 
Sbjct: 111 -----YLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLSVLRALSYLHNQ 160
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFG----LAKFLPEAAXXXXXXXXXXVGVKGTVG 342
               ++H D+K  ++LL  +    +SDFG    ++K +P+              + GT  
Sbjct: 161 G---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKX-----------LVGTPY 206
Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPT-NEMFTGNLTLHNFVKEALPERLAE 401
           + APE        T  D++S GI+++EM  G+ P  NE     L     ++++LP R+ +
Sbjct: 207 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE---PPLQAMRRIRDSLPPRVKD 263
Query: 402 I 402
           +
Sbjct: 264 L 264

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 36/234 (15%)
Query: 154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQA 211
           L +A   +     IG G++G V+K   D  +    VA+K + +Q    G   S I E   
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKAR-DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV 64
Query: 212 LR---SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQ 268
           LR   +  H N+V++   C            LV+E           H+++D    L+ + 
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFE-----------HVDQDLTTYLDKVP 113
Query: 269 RLSIAVDVAST--------LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
              +  +            L++LH +    +VH DLKP N+L+       ++DFGLA+  
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 321 PEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
                           V  T+ Y APE  + S  +T  D++S G +  EMF  K
Sbjct: 171 --------SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 105/231 (45%), Gaps = 41/231 (17%)
Query: 170 GSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVS 229
           G FG V+K    +D     VAVK+  LQ + + +S   E  +   ++H NL++ I +   
Sbjct: 26  GRFGCVWKAQLMND----FVAVKIFPLQDKQSWQSE-REIFSTPGMKHENLLQFIAA--- 77
Query: 230 VDFQGNDFEA---LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH- 285
            + +G++ E    L+      GSL ++L  N      +   +   +A  ++  L YLH  
Sbjct: 78  -EKRGSNLEVELWLITAFHDKGSLTDYLKGN-----IITWNELCHVAETMSRGLSYLHED 131
Query: 286 --YC-----ETPIVHCDLKPSNVLLDGELTAHVSDFGLA-KFLPEAAXXXXXXXXXXVGV 337
             +C     +  I H D K  NVLL  +LTA ++DFGLA +F P              G 
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTH------GQ 185
Query: 338 KGTVGYAAPEYGMGS-----EVSTSGDVYSFGILLLEMFT----GKGPTNE 379
            GT  Y APE   G+     +     D+Y+ G++L E+ +      GP +E
Sbjct: 186 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDE 236

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETL-VAVKVL-NLQHRGASKSFIAECQALRSIRHRNL 220
           L   IG G FG V++GI+   ++  + VA+K   N       + F+ E   +R   H ++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK+I               ++ EL   G L  +L + +    +L+L   +  A  +++ L
Sbjct: 74  VKLIGVITENPVW------IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTAL 124
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            YL        VH D+   NVL+       + DFGL++++ ++              K  
Sbjct: 125 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG------KLP 175
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
           + + APE       +++ DV+ FG+ + E+ 
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHR 218
           + +  +IG GSFG V K  +DH  H+ +    V N +  HR A++  I   + LR     
Sbjct: 99  YEVLKVIGKGSFGQVVKA-YDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKD 156
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N + +I    +  F+ +    + +EL+ + +L E +  N+    +L L+++   A  +  
Sbjct: 157 NTMNVIHMLENFTFRNHI--CMTFELL-SMNLYELIKKNKFQGFSLPLVRKF--AHSILQ 211
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            L+ LH   +  I+HCDLKP N+LL   G     V DFG + +  +              
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF---- 264
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
                 Y APE  +G+      D++S G +L E+ TG
Sbjct: 265 ------YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETL-VAVKVL-NLQHRGASKSFIAECQALRSIRHRNL 220
           L   IG G FG V++GI+   ++  + VA+K   N       + F+ E   +R   H ++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK+I               ++ EL   G L  +L + + +   L+L   +  A  +++ L
Sbjct: 74  VKLIGVITENPVW------IIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTAL 124
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            YL        VH D+   NVL+       + DFGL++++ ++              K  
Sbjct: 125 AYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKG------KLP 175
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
           + + APE       +++ DV+ FG+ + E+ 
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 36/221 (16%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALR---SIRHRNLV 221
           IG G++G V+K   D  +    VA+K + +Q    G   S I E   LR   +  H N+V
Sbjct: 19  IGEGAYGKVFKAR-DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST-- 279
           ++   C            LV+E           H+++D    L+ +    +  +      
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFE-----------HVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 280 ------LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
                 L++LH +    +VH DLKP N+L+       ++DFGLA+               
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--------SFQMA 175
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
              V  T+ Y APE  + S  +T  D++S G +  EMF  K
Sbjct: 176 LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHR 218
           + +  +IG GSFG V K  +DH  H+ +    V N +  HR A++  I   + LR     
Sbjct: 99  YEVLKVIGKGSFGQVVKA-YDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKD 156
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N + +I    +  F+ +    + +EL+ + +L E +  N+    +L L+++   A  +  
Sbjct: 157 NTMNVIHMLENFTFRNHI--CMTFELL-SMNLYELIKKNKFQGFSLPLVRKF--AHSILQ 211
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            L+ LH   +  I+HCDLKP N+LL   G     V DFG + +  +              
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF---- 264
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
                 Y APE  +G+      D++S G +L E+ TG
Sbjct: 265 ------YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 16/223 (7%)
Query: 154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA-SKSFIAECQAL 212
           ++  +  F L++L+G G++G V      H     +VA+K +    +   +   + E + L
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSAT--HKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           +  +H N++ I        F+  +   ++ ELM          L+R    +  +L    I
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-------LHRVI--STQMLSDDHI 114
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
              +  TL  +     + ++H DLKPSN+L++      V DFGLA+ + E+A        
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 333 XXVGV---KGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMF 371
              G+     T  Y APE  + S + S + DV+S G +L E+F
Sbjct: 175 QQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 29/221 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G G+FG VYK    + +   L A KV++ +     + ++ E   L S  H N+VK++ +
Sbjct: 45  LGDGAFGKVYKA--QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 102
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +  N+   L+ E    G+++  + L  + P     L    I V    TL+ L++ 
Sbjct: 103 F----YYENNLWILI-EFCAGGAVDA-VMLELERP-----LTESQIQVVCKQTLDALNYL 151
Query: 287 CETPIVHCDLKPSNVL--LDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +  I+H DLK  N+L  LDG++   ++DFG+      +A            + GT  + 
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDI--KLADFGV------SAKNTRXIQRRDXFI-GTPYWM 202
Query: 345 APEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           APE  M             DV+S GI L+EM   + P +E+
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 243

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 102/249 (40%), Gaps = 40/249 (16%)
Query: 159 DGFSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQA 211
           D  +L   +G G+FG V      GI D D  +  V V V  L+     K     ++E + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGI-DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 93
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNR 258
           ++ I +H+N++ ++ +C      G  +  + Y     G+L E+L             +NR
Sbjct: 94  MKMIGKHKNIINLLGACTQ---DGPLYVIVAYA--SKGNLREYLRARRPPGMEYSYDINR 148
Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                +     +S    +A  +EYL        +H DL   NVL+       ++DFGLA+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
            +                 +  V + APE       +   DV+SFG+L+ E+FT  G   
Sbjct: 206 DI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 261 PGIPVEELF 269

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 104/231 (45%), Gaps = 39/231 (16%)
Query: 167 IGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLV 221
           IG G+FG V++    G+  ++   T+VAVK+L  +     ++ F  E   +    + N+V
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPF-TMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--------------------LNRDAP 261
           K++  C      G     L++E M  G L E+L                     ++   P
Sbjct: 114 KLLGVCAV----GKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 168
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
             L+  ++L IA  VA+ + YL    E   VH DL   N L+   +   ++DFGL++ + 
Sbjct: 169 PPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI- 224
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            +A          + ++    +  PE    +  +T  DV+++G++L E+F+
Sbjct: 225 YSADYYKADGNDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 113/262 (43%), Gaps = 53/262 (20%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLV---K 222
           +G G++ +VYKG     D+  LVA+K + L+H  GA  + I E   L+ ++H N+V    
Sbjct: 10  LGEGTYATVYKGKSKLTDN--LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           II +  S+         LV+E + +  L+++L    D    +N+         +   L Y
Sbjct: 68  IIHTEKSL--------TLVFEYL-DKDLKQYLD---DCGNIINMHNVKLFLFQLLRGLAY 115
Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL--AKFLPEAAXXXXXXXXXXVGVKGT 340
            H      ++H DLKP N+L++      ++DFGL  AK +P                  T
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV---------T 163
Query: 341 VGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGK--------------------GPTNE 379
           + Y  P+  +GS + ST  D++  G +  EM TG+                     PT E
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE 223
Query: 380 MFTGNLTLHNFVKEALPERLAE 401
            + G L+   F     P+  AE
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAE 245

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 83
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI---RKIGSFDETCTRFYTA- 139
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV- 195
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE       S S D+++ G ++ ++  G  P
Sbjct: 196 -----GTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 26/226 (11%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI 215
           K  + F    ++G GSF +V          E   A+K+L  +H       I E +     
Sbjct: 7   KRPEDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVT 58
Query: 216 RHRNLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLS 271
           R R+++  +     V + F   D E L + L    NG L +++   R          R  
Sbjct: 59  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFY 115
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXX 330
            A ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+       
Sbjct: 116 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 171
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                   GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 172 FV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     IG GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTIGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E M  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYMPGGDM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETL-VAVKVL-NLQHRGASKSFIAECQALRSIRHRNL 220
           L   IG G FG V++GI+   ++  + VA+K   N       + F+ E   +R   H ++
Sbjct: 14  LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 73
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK+I               ++ EL   G L  +L + + +   L+L   +  A  +++ L
Sbjct: 74  VKLIGVITENPVW------IIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTAL 124
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            YL        VH D+   NVL+       + DFGL++++ ++              K  
Sbjct: 125 AYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG------KLP 175
Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
           + + APE       +++ DV+ FG+ + E+ 
Sbjct: 176 IKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 100/235 (42%), Gaps = 30/235 (12%)
Query: 148 RVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN----LQHRGASK 203
           R S Q   K  D F L  ++G GSFG V+   F   +     A+K L     L       
Sbjct: 7   RPSLQIKLKIED-FILHKMLGKGSFGKVFLAEFKKTNQ--FFAIKALKKDVVLMDDDVEC 63
Query: 204 SFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN 263
           + + +     +  H  L  +  +     FQ  +    V E +  G L    H+   +   
Sbjct: 64  TMVEKRVLSLAWEHPFLTHMFCT-----FQTKENLFFVMEYLNGGDL--MYHIQ--SCHK 114
Query: 264 LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK--FLP 321
            +L +    A ++   L++LH      IV+ DLK  N+LLD +    ++DFG+ K   L 
Sbjct: 115 FDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           +A               GT  Y APE  +G + + S D +SFG+LL EM  G+ P
Sbjct: 172 DAKTNXFC---------GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     IG GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTIGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E M  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYMPGGDM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 26/226 (11%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI 215
           K  + F    ++G GSF +V          E   A+K+L  +H       I E +     
Sbjct: 4   KRPEDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVT 55
Query: 216 RHRNLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLS 271
           R R+++  +     V + F   D E L + L    NG L +++   R          R  
Sbjct: 56  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFY 112
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXX 330
            A ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+       
Sbjct: 113 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 168
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                   GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 169 FV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 26/226 (11%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI 215
           K  + F    ++G GSF +V          E   A+K+L  +H       I E +     
Sbjct: 6   KRPEDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVT 57
Query: 216 RHRNLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLS 271
           R R+++  +     V + F   D E L + L    NG L +++   R          R  
Sbjct: 58  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFY 114
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXX 330
            A ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+       
Sbjct: 115 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 170
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                   GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 171 FV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 26/226 (11%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI 215
           K  + F    ++G GSF +V          E   A+K+L  +H       I E +     
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVT 56
Query: 216 RHRNLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLS 271
           R R+++  +     V + F   D E L + L    NG L +++   R          R  
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFY 113
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXX 330
            A ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+       
Sbjct: 114 TA-EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANX 169
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                   GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 170 FV------GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG GSFG V+KGI   +  + +VA+K+++L+                    +  + +++ 
Sbjct: 31  IGKGSFGEVFKGI--DNRTQQVVAIKIIDLE-----------EAEDEIEDIQQEITVLSQ 77
Query: 227 CVS---VDFQGNDFEA----LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           C S     + G+  +     ++ E +  GS    L L R  P   +  Q  ++  ++   
Sbjct: 78  CDSSYVTKYYGSYLKGSKLWIIMEYLGGGSA---LDLLRAGP--FDEFQIATMLKEILKG 132
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+YLH   +   +H D+K +NVLL  +    ++DFG+A  L +                G
Sbjct: 133 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-------G 182
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           T  + APE    S   +  D++S GI  +E+  G+ P ++M
Sbjct: 183 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 223

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 103/249 (41%), Gaps = 40/249 (16%)
Query: 159 DGFSLENLIGAGSFGSVY--KGI-FDHDDHETLVAVKVLNLQHRGASKSF---IAECQAL 212
           D   L   +G G+FG V   + I  D D    +  V V  L+     K     I+E + +
Sbjct: 28  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 87
Query: 213 RSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP---------- 261
           + I +H+N++ ++ +C     Q      +V E    G+L E+L   R+ P          
Sbjct: 88  KMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLQA-REPPGLEYSYNPSH 141
Query: 262 ---RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                L+    +S A  VA  +EYL        +H DL   NVL+  +    ++DFGLA+
Sbjct: 142 NPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 198
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
            +                 +  V + APE       +   DV+SFG+LL E+FT  G   
Sbjct: 199 DI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253
Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 254 PGVPVEELF 262

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               LVK+  S     F+ N    +V E +  G +  + HL R   R      R   A  
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRRIG-RFXEPHARF-YAAQ 149
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +  T EYLH      +++ DLKP N+L+D +    V+DFG AK                 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTW 196
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 102/249 (40%), Gaps = 40/249 (16%)
Query: 159 DGFSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQA 211
           D  +L   +G G+FG V      GI D D  +  V V V  L+     +     ++E + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGI-DKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEM 93
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNR 258
           ++ I +H+N++ ++ +C     Q      +V E    G+L E+L             +NR
Sbjct: 94  MKMIGKHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                +     +S    +A  +EYL        +H DL   NVL+       ++DFGLA+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
            +                 +  V + APE       +   DV+SFG+L+ E+FT  G   
Sbjct: 206 DI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 261 PGIPVEELF 269

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 42  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 100 NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRR--------IGRFSEPHA 144
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 191
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 192 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 32/238 (13%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS 204
           S+++  ++N  + TDG+ ++  IG GS+    + I    + E   AVK+++   R  ++ 
Sbjct: 8   SIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNME--FAVKIIDKSKRDPTEE 65
Query: 205 FIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNL 264
                  LR  +H N++ +        +    +  +V ELM  G L + +       R  
Sbjct: 66  IEI---LLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGELLDKIL------RQK 111
Query: 265 NLLQRLSIAV--DVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL----TAHVSDFGLAK 318
              +R + AV   +  T+EYLH      +VH DLKPSN+L   E     +  + DFG AK
Sbjct: 112 FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            L                   T  + APE         + D++S G+LL  M TG  P
Sbjct: 169 QLRAENGLLMTPCY-------TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 36  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 93
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               LVK+  S     F+ N    +V E +  G +  + HL R   R      R   A  
Sbjct: 94  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRRIG-RFXEPHARF-YAAQ 144
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +  T EYLH      +++ DLKP N+L+D +    V+DFG AK                 
Sbjct: 145 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTW 191
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 192 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               LVK+  S     F+ N    +V E +  G +  + HL R   R      R   A  
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRRIG-RFXEPHARF-YAAQ 149
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +  T EYLH      +++ DLKP N+L+D +    V+DFG AK                 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTW 196
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 62  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               LVK+  S     F+ N    +V E +  G  E + HL R   R      R   A  
Sbjct: 120 NFPFLVKLEFS-----FKDNSNLYMVMEYVAGG--EMFSHLRRIG-RFXEPHARF-YAAQ 170
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +  T EYLH      +++ DLKP N+L+D +    V+DFG AK                 
Sbjct: 171 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTW 217
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 218 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               LVK+  S     F+ N    +V E +  G +  + HL R   R      R   A  
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRRIG-RFXEPHARF-YAAQ 149
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +  T EYLH      +++ DLKP N+L+D +    V+DFG AK                 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTW 196
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 28  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 85
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G  E + HL R        + R S    
Sbjct: 86  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGG--EMFSHLRR--------IGRFSEPHA 130
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 131 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAK----------R 177
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 178 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 101/245 (41%), Gaps = 38/245 (15%)
Query: 142 LLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDH-ETLVAVKVLNLQH-R 199
           +L +V    ++      D +   +++G G+F  V   I   D   + LVA+K +  +   
Sbjct: 1   MLGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALE 57
Query: 200 GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-----EEWL 254
           G   S   E   L  I+H N+V +        ++      L+ +L+  G L     E+  
Sbjct: 58  GKEGSMENEIAVLHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEKGF 112
Query: 255 HLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVL---LDGELTAHV 311
           +  RDA R         +   V   ++YLH   +  IVH DLKP N+L   LD +    +
Sbjct: 113 YTERDASR---------LIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 312 SDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
           SDFGL+K     +              GT GY APE       S + D +S G++   + 
Sbjct: 161 SDFGLSKMEDPGSVLSTAC--------GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 212
Query: 372 TGKGP 376
            G  P
Sbjct: 213 CGYPP 217

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               LVK+  S     F+ N    +V E +  G +  + HL R   R      R   A  
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRRIG-RFAEPHARF-YAAQ 149
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +  T EYLH      +++ DLKP N+L+D +    V+DFG AK                 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTW 196
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETL-VAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G FG V++GI+   ++  + VA+K   N       + F+ E   +R   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                          ++ EL   G L  +L + + +   L+L   +  A  +++ L YL 
Sbjct: 458 GVITENPVW------IIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLE 508
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  VH D+   NVL+       + DFGL++++ ++              K  + + 
Sbjct: 509 ---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKG------KLPIKWM 559
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMF 371
           APE       +++ DV+ FG+ + E+ 
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 101/245 (41%), Gaps = 38/245 (15%)
Query: 142 LLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDH-ETLVAVKVLNLQH-R 199
           +L +V    ++      D +   +++G G+F  V   I   D   + LVA+K +  +   
Sbjct: 1   MLGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALE 57
Query: 200 GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-----EEWL 254
           G   S   E   L  I+H N+V +        ++      L+ +L+  G L     E+  
Sbjct: 58  GKEGSMENEIAVLHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEKGF 112
Query: 255 HLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVL---LDGELTAHV 311
           +  RDA R         +   V   ++YLH   +  IVH DLKP N+L   LD +    +
Sbjct: 113 YTERDASR---------LIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 312 SDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
           SDFGL+K     +              GT GY APE       S + D +S G++   + 
Sbjct: 161 SDFGLSKMEDPGSVLSTAC--------GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 212
Query: 372 TGKGP 376
            G  P
Sbjct: 213 CGYPP 217

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETL-VAVKVL-NLQHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G FG V++GI+   ++  + VA+K   N       + F+ E   +R   H ++VK+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                          ++ EL   G L  +L + + +   L+L   +  A  +++ L YL 
Sbjct: 458 GVITENPVW------IIMELCTLGELRSFLQVRKFS---LDLASLILYAYQLSTALAYLE 508
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                  VH D+   NVL+       + DFGL++++ ++              K  + + 
Sbjct: 509 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG------KLPIKWM 559
Query: 345 APEYGMGSEVSTSGDVYSFGILLLEMF 371
           APE       +++ DV+ FG+ + E+ 
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 106/241 (43%), Gaps = 43/241 (17%)
Query: 148 RVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK---- 203
           RV  + LF   D       IG GSFG VYKGI +H   + +VA+K+++L+          
Sbjct: 14  RVDPEELFTKLDR------IGKGSFGEVYKGIDNHT--KEVVAIKIIDLEEAEDEIEDIQ 65
Query: 204 ---SFIAECQALRSIRH-RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD 259
              + +++C +    R+  + +K     + +++ G        +L+  G LEE       
Sbjct: 66  QEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGG---GSALDLLKPGPLEE------- 115
Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
                      +I  ++   L+YLH   +   +H D+K +NVLL  +    ++DFG+A  
Sbjct: 116 -------TYIATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQ 165
Query: 320 LPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
           L +                GT  + APE    S      D++S GI  +E+  G+ P ++
Sbjct: 166 LTDTQIKRNXFV-------GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 218
Query: 380 M 380
           +
Sbjct: 219 L 219

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/245 (26%), Positives = 101/245 (41%), Gaps = 38/245 (15%)
Query: 142 LLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDH-ETLVAVKVLNLQH-R 199
           +L +V    ++      D +   +++G G+F  V   I   D   + LVA+K +  +   
Sbjct: 1   MLGAVEGPRWKQAEDIRDIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALE 57
Query: 200 GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-----EEWL 254
           G   S   E   L  I+H N+V +        ++      L+ +L+  G L     E+  
Sbjct: 58  GKEGSMENEIAVLHKIKHPNIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEKGF 112
Query: 255 HLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVL---LDGELTAHV 311
           +  RDA R         +   V   ++YLH   +  IVH DLKP N+L   LD +    +
Sbjct: 113 YTERDASR---------LIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 312 SDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
           SDFGL+K     +              GT GY APE       S + D +S G++   + 
Sbjct: 161 SDFGLSKMEDPGSVLSTAC--------GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 212
Query: 372 TGKGP 376
            G  P
Sbjct: 213 CGYPP 217

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 38/228 (16%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDH-ETLVAVKVLNLQH-RGASKSFIAECQALRSIR 216
           D +   +++G G+F  V   I   D   + LVA+K +  +   G   S   E   L  I+
Sbjct: 18  DIYDFRDVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 74
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-----EEWLHLNRDAPRNLNLLQRLS 271
           H N+V +        ++      L+ +L+  G L     E+  +  RDA R         
Sbjct: 75  HPNIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--------- 120
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVL---LDGELTAHVSDFGLAKFLPEAAXXXX 328
           +   V   ++YLH   +  IVH DLKP N+L   LD +    +SDFGL+K     +    
Sbjct: 121 LIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST 177
Query: 329 XXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                     GT GY APE       S + D +S G++   +  G  P
Sbjct: 178 AC--------GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEYS-----FKDNSNLYMVMEYVPGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 40/233 (17%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSI-RHRN 219
             +++IG G+FG V K     D      A+K +     +   + F  E + L  +  H N
Sbjct: 18  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 77
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------DAPRNLNLL 267
           ++ ++ +C     +   +  L  E   +G+L ++L  +R                 L+  
Sbjct: 78  IINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 132
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXX 327
           Q L  A DVA  ++YL    +   +H DL   N+L+     A ++DFGL++         
Sbjct: 133 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------- 180
Query: 328 XXXXXXXVGVKGTVG-----YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG 375
                  V VK T+G     + A E    S  +T+ DV+S+G+LL E+ +  G
Sbjct: 181 ----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 229

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 102/249 (40%), Gaps = 40/249 (16%)
Query: 159 DGFSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQA 211
           D  +L   +G G+FG V      GI D D  +  V V V  L+     K     ++E + 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGI-DKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM 93
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------------LNR 258
           ++ I +H+N++ ++ +C      G  +  + Y     G+L E+L             +NR
Sbjct: 94  MKMIGKHKNIINLLGACTQ---DGPLYVIVGYA--SKGNLREYLRARRPPGMEYSYDINR 148
Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                +     +S    +A  +EYL        +H DL   NVL+       ++DFGLA+
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG--- 375
            +                 +  V + APE       +   DV+SFG+L+ E+FT  G   
Sbjct: 206 DI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 376 ---PTNEMF 381
              P  E+F
Sbjct: 261 PGIPVEELF 269

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 167 IGAGSFGSVYKG---IFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRSIRHRN 219
           +G GSFG VY+G        + ET VAVK +N    L+ R     F+ E   ++     +
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHH 81
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN------LNLLQRLSIA 273
           +V+++     V  +G     +V ELM +G L+ +L   R    N        L + + +A
Sbjct: 82  VVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 136
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
            ++A  + YL+       VH +L   N ++  + T  + DFG+ + + E           
Sbjct: 137 AEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----- 188
Query: 334 XVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEM 370
             G KG   V + APE       +TS D++SFG++L E+
Sbjct: 189 --GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 225

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 33/219 (15%)
Query: 167 IGAGSFGSVYKG---IFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRSIRHRN 219
           +G GSFG VY+G        + ET VAVK +N    L+ R     F+ E   ++     +
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER---IEFLNEASVMKGFTCHH 82
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN------LNLLQRLSIA 273
           +V+++     V  +G     +V ELM +G L+ +L   R    N        L + + +A
Sbjct: 83  VVRLL----GVVSKGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 137
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
            ++A  + YL+       VH +L   N ++  + T  + DFG+ + + E           
Sbjct: 138 AEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK----- 189
Query: 334 XVGVKG--TVGYAAPEYGMGSEVSTSGDVYSFGILLLEM 370
             G KG   V + APE       +TS D++SFG++L E+
Sbjct: 190 --GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 226

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 42  DQFERIKTLGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 100 NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRR--------IGRFSEPHA 144
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 191
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 192 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 40/233 (17%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSI-RHRN 219
             +++IG G+FG V K     D      A+K +     +   + F  E + L  +  H N
Sbjct: 28  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------DAPRNLNLL 267
           ++ ++ +C     +   +  L  E   +G+L ++L  +R                 L+  
Sbjct: 88  IINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXX 327
           Q L  A DVA  ++YL    +   +H DL   N+L+     A ++DFGL++         
Sbjct: 143 QLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------- 190
Query: 328 XXXXXXXVGVKGTVG-----YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG 375
                  V VK T+G     + A E    S  +T+ DV+S+G+LL E+ +  G
Sbjct: 191 ----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 239

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 81
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 137
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN---- 190
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 191 --AFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEYS-----FKDNSNLYMVMEYVPGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEYS-----FKDNSNLYMVMEYVPGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 65
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 66  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 121
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 122 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 177
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 178 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 42  DQFERIKTLGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 100 NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRR--------IGRFSEPHA 144
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 191
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 192 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 80
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 81  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 136
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 137 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV- 192
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 193 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+++D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 84
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 85  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 140
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 141 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV- 196
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 197 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 24/217 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHR 218
           + +  +IG G FG V K  +DH  H+ +    V N +  HR A++  I   + LR     
Sbjct: 99  YEVLKVIGKGXFGQVVKA-YDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKD 156
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N + +I    +  F+ +    + +EL+ + +L E +  N+    +L L+++   A  +  
Sbjct: 157 NTMNVIHMLENFTFRNHI--CMTFELL-SMNLYELIKKNKFQGFSLPLVRKF--AHSILQ 211
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            L+ LH   +  I+HCDLKP N+LL   G     V DFG + +  +              
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRF---- 264
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
                 Y APE  +G+      D++S G +L E+ TG
Sbjct: 265 ------YRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 95/218 (43%), Gaps = 19/218 (8%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIIT 225
           +G G FG V++     DD     A+K + L +R  A +  + E +AL  + H  +V+   
Sbjct: 13  LGRGGFGVVFEAKNKVDDCN--YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 226 SCVSVD----FQGNDFEALVY---ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           + +  +     Q +  +  +Y   +L    +L++W++  R           L I + +A 
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHIFLQIAE 129
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-----PEAAXXXXXXXXX 333
            +E+LH      ++H DLKPSN+    +    V DFGL   +      +           
Sbjct: 130 AVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
             G  GT  Y +PE   G+  S   D++S G++L E+ 
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 42  DQFERIKTLGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 100 NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRR--------IGRFSEPHA 144
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 191
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 192 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 34  DQFERIKTLGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 91
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G  E + HL R        + R S    
Sbjct: 92  NFPFLVKLEFS-----FKDNSNLYMVMEYVPGG--EMFSHLRR--------IGRFSEPHA 136
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 137 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 183
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 184 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 84
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 85  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 140
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 141 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 196
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 197 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 41/233 (17%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLN---LQHRGASKSFIAECQALR 213
           +D +  + ++G GSFG V   I   D       AVKV++   ++ +   +S + E Q L+
Sbjct: 31  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR----DAPRNLNLLQ 268
            + H N++K+        F+   +  LV E+   G L +E +   R    DA R      
Sbjct: 88  QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR------ 136
Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSDFGLAKFLPEAAX 325
              I   V S + Y+H   +  IVH DLKP N+LL+    +    + DFGL+    EA+ 
Sbjct: 137 ---IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASK 189
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
                        GT  Y APE   G+      DV+S G++L  + +G  P N
Sbjct: 190 KMKDKI-------GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN 234

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ +M  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 83
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 139
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 195
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 196 -----GTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 62  DQFERIKTLGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 119
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 120 NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRR--------IGRFSEPHA 164
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 165 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 211
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 212 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 34  DQFERIKTLGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 91
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               LVK+  S     F+ N    +V E +  G +  + HL R   R      R   A  
Sbjct: 92  NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRRIG-RFXEPHARF-YAAQ 142
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +  T EYLH      +++ DLKP N+L+D +    V+DFG AK                 
Sbjct: 143 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTW 189
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 190 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 167 IGAGSFGSVYKGIF----DHDD-HETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           +G G+F  ++KG+     D+   HET V +KVL+  HR  S+SF      +  + H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
                C    F G D   LV E +  GSL+ +L  N++    +N+L +L +A  +A  + 
Sbjct: 76  LNYGVC----FCG-DENILVQEFVKFGSLDTYLKKNKNC---INILWKLEVAKQLAWAMH 127
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           +L    E  ++H ++   N+LL  E        G   F+  +             ++  +
Sbjct: 128 FLE---ENTLIHGNVCAKNILLIREEDRKT---GNPPFIKLSDPGISITVLPKDILQERI 181
Query: 342 GYAAPE-YGMGSEVSTSGDVYSFGILLLEMFTG 373
            +  PE       ++ + D +SFG  L E+ +G
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 81
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 137
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 193
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 194 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 83
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 139
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 195
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 196 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 81
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 137
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 193
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 194 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 91/226 (40%), Gaps = 48/226 (21%)
Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIIT 225
           LIG+G FG V+K    H        +K +   +  A +    E +AL  + H N+V    
Sbjct: 18  LIGSGGFGQVFKA--KHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVHY-N 70
Query: 226 SCVSVDFQGNDFEA----------------LVYELMVNGSLEEWLHLNR----DAPRNLN 265
            C    + G D++                 +  E    G+LE+W+   R    D    L 
Sbjct: 71  GC----WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAX 325
           L ++++  VD      Y+H      +++ DLKPSN+ L       + DFGL   L     
Sbjct: 127 LFEQITKGVD------YIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 177
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
                       KGT+ Y +PE     +     D+Y+ G++L E+ 
Sbjct: 178 RXRS--------KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 83
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 139
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 195
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 196 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 83
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 139
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 195
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 196 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 83
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 84  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 139
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 140 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 195
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 196 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 80
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 81  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 136
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 137 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 192
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 193 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 51/234 (21%)
Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIIT 225
           LIG+G FG V+K    H        ++ +   +  A +    E +AL  + H N+V    
Sbjct: 19  LIGSGGFGQVFKA--KHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVHYNG 72
Query: 226 SCVSVDF---------QGNDFEA---------------LVYELMVNGSLEEWLHLNR--- 258
                D+         + +D++                +  E    G+LE+W+   R   
Sbjct: 73  CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 132
Query: 259 -DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA 317
            D    L L ++++  VD      Y+H      ++H DLKPSN+ L       + DFGL 
Sbjct: 133 LDKVLALELFEQITKGVD------YIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLV 183
Query: 318 KFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
             L                 KGT+ Y +PE     +     D+Y+ G++L E+ 
Sbjct: 184 TSLKNDGKRTRS--------KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 28/226 (12%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI 215
           K  D + +++LIG GSFG V K  +D  + E  VA+K++        K+F+ + Q    +
Sbjct: 51  KWMDRYEIDSLIGKGSFGQVVKA-YDRVEQE-WVAIKIIK-----NKKAFLNQAQIEVRL 103
Query: 216 -----RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
                +H   +K     +   F   +   LV+E M++ +L + L        +LNL ++ 
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKF 162
Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAAXXXX 328
             A  + + L +L    E  I+HCDLKP N+LL         + DFG +  L +      
Sbjct: 163 --AQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQXI 219
Query: 329 XXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
                         Y +PE  +G     + D++S G +L+EM TG+
Sbjct: 220 QSRF----------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 86
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 87  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 142
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 143 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 198
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 199 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     IG GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTIGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 30/214 (14%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG GS G V      H   +  VAVK+++L+ +   +    E   +R  +H N+V++  S
Sbjct: 53  IGEGSTGIVCLAREKHSGRQ--VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
            +     G +   L+ E +  G+L + +   R     LN  Q  ++   V   L YLH  
Sbjct: 111 YLV----GEELWVLM-EFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLH-- 158
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFG----LAKFLPEAAXXXXXXXXXXVGVKGTVG 342
               ++H D+K  ++LL  +    +SDFG    ++K +P+              + GT  
Sbjct: 159 -AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKX-----------LVGTPY 206
Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           + APE    S  +T  D++S GI+++EM  G+ P
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G + +E   L++ D  R    +    
Sbjct: 69  HLRHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI---- 119
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 120 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 166
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 167 -RRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 42  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 100 NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRR--------IGRFSEPHA 144
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 191
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 192 VKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG GSFG V+KGI   +  + +VA+K+++L+                    +  + +++ 
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLE-----------EAEDEIEDIQQEITVLSQ 61
Query: 227 CVS---VDFQGNDFEA----LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           C S     + G+  +     ++ E +  GS  + L      P  L+  Q  +I  ++   
Sbjct: 62  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKG 116
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+YLH   +   +H D+K +NVLL       ++DFG+A  L +                G
Sbjct: 117 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-------G 166
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           T  + APE    S   +  D++S GI  +E+  G+ P +E+
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 101/223 (45%), Gaps = 21/223 (9%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIF-DHDDHETLVAVKVLNLQHRGASK-SFIAECQALRS 214
           A +   L  ++G G FG VY+G++ +H   +  VAVK         +K  F++E   +++
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H ++VK+I           +   ++ EL   G L  +L  N+++   L +L  +  ++
Sbjct: 82  LDHPHIVKLIG------IIEEEPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSL 132
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   + YL        VH D+   N+L+       + DFGL++++ +            
Sbjct: 133 QICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV---- 185
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
              +  + + +PE       +T+ DV+ F + + E+ + GK P
Sbjct: 186 --TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG GSFG V+KGI   +  + +VA+K+++L+                    +  + +++ 
Sbjct: 15  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLE-----------EAEDEIEDIQQEITVLSQ 61
Query: 227 CVS---VDFQGNDFEA----LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           C S     + G+  +     ++ E +  GS  + L      P  L+  Q  +I  ++   
Sbjct: 62  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKG 116
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+YLH   +   +H D+K +NVLL       ++DFG+A  L +                G
Sbjct: 117 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-------G 166
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           T  + APE    S   +  D++S GI  +E+  G+ P +E+
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG GSFG V+KGI   +  + +VA+K+++L+                    +  + +++ 
Sbjct: 35  IGKGSFGEVFKGI--DNRTQKVVAIKIIDLE-----------EAEDEIEDIQQEITVLSQ 81
Query: 227 CVS---VDFQGNDFEA----LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           C S     + G+  +     ++ E +  GS  + L      P  L+  Q  +I  ++   
Sbjct: 82  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKG 136
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+YLH   +   +H D+K +NVLL       ++DFG+A  L +                G
Sbjct: 137 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-------G 186
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           T  + APE    S   +  D++S GI  +E+  G+ P +E+
Sbjct: 187 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 118/278 (42%), Gaps = 37/278 (13%)
Query: 133 REPSTPPSALLASVLRVSYQNLFKATDGFS-LENLI--GAGSFGSVYKGIFDHDDHETLV 189
           R P   P  +     R + Q +    D  S L+N I  G GS G V   I        LV
Sbjct: 122 RSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVC--IATVRSSGKLV 179
Query: 190 AVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGS 249
           AVK ++L+ +   +    E   +R  +H N+V++  S     +   D   +V E +  G+
Sbjct: 180 AVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-----YLVGDELWVVMEFLEGGA 234
Query: 250 LEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA 309
           L + +   R     +N  Q  ++ + V   L  LH      ++H D+K  ++LL  +   
Sbjct: 235 LTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 286
Query: 310 HVSDFG----LAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGI 365
            +SDFG    ++K +P               + GT  + APE           D++S GI
Sbjct: 287 KLSDFGFCAQVSKEVPRRKX-----------LVGTPYWMAPELISRLPYGPEVDIWSLGI 335
Query: 366 LLLEMFTGKGPT-NEMFTGNLTLHNFVKEALPERLAEI 402
           +++EM  G+ P  NE     L     +++ LP RL  +
Sbjct: 336 MVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPRLKNL 370

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRH 217
           + +   +G GSFG V   +  H      VA+K++N   L           E   LR +RH
Sbjct: 16  YQIVKTLGEGSFGKV--KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 73
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            +++K+     S D      E ++        L +++ + RD    ++  +       + 
Sbjct: 74  PHIIKLYDVIKSKD------EIIMVIEYAGNELFDYI-VQRD---KMSEQEARRFFQQII 123
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
           S +EY H +    IVH DLKP N+LLD  L   ++DFGL+  + +               
Sbjct: 124 SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC------- 173
Query: 338 KGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNE 379
            G+  YAAPE   G        DV+S G++L  M   + P ++
Sbjct: 174 -GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 101/223 (45%), Gaps = 21/223 (9%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIF-DHDDHETLVAVKVLNLQHRGASK-SFIAECQALRS 214
           A +   L  ++G G FG VY+G++ +H   +  VAVK         +K  F++E   +++
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H ++VK+I           +   ++ EL   G L  +L  N+++   L +L  +  ++
Sbjct: 66  LDHPHIVKLIG------IIEEEPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSL 116
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   + YL        VH D+   N+L+       + DFGL++++ +            
Sbjct: 117 QICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV---- 169
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
              +  + + +PE       +T+ DV+ F + + E+ + GK P
Sbjct: 170 --TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 35/221 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG GSFG V+KGI +    + +VA+K+++L+                    +  + +++ 
Sbjct: 30  IGKGSFGEVFKGIDNRT--QKVVAIKIIDLE-----------EAEDEIEDIQQEITVLSQ 76
Query: 227 CVS---VDFQGNDFEA----LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           C S     + G+  +     ++ E +  GS  + L      P  L+  Q  +I  ++   
Sbjct: 77  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKG 131
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+YLH   +   +H D+K +NVLL       ++DFG+A  L +                G
Sbjct: 132 LDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-------G 181
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           T  + APE    S   +  D++S GI  +E+  G+ P +E+
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/223 (22%), Positives = 101/223 (45%), Gaps = 21/223 (9%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIF-DHDDHETLVAVKVLNLQHRGASK-SFIAECQALRS 214
           A +   L  ++G G FG VY+G++ +H   +  VAVK         +K  F++E   +++
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H ++VK+I           +   ++ EL   G L  +L  N+++   L +L  +  ++
Sbjct: 70  LDHPHIVKLIG------IIEEEPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSL 120
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   + YL        VH D+   N+L+       + DFGL++++ +            
Sbjct: 121 QICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV---- 173
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
              +  + + +PE       +T+ DV+ F + + E+ + GK P
Sbjct: 174 --TRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 109/250 (43%), Gaps = 44/250 (17%)
Query: 152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQA 211
           +NL+  +    L  +   G FG V+K    ++     VAVK+  +Q + + ++   E  +
Sbjct: 17  ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE----YVAVKIFPIQDKQSWQNEY-EVYS 71
Query: 212 LRSIRHRNLVKIIT-----SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNL 266
           L  ++H N+++ I      + V VD        L+      GSL ++L  N  +   L  
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLW------LITAFHEKGSLSDFLKANVVSWNEL-- 123
Query: 267 LQRLSIAVDVASTLEYLHHYC-------ETPIVHCDLKPSNVLLDGELTAHVSDFGLA-K 318
                IA  +A  L YLH          +  I H D+K  NVLL   LTA ++DFGLA K
Sbjct: 124 ---CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGS-----EVSTSGDVYSFGILLLEMFT- 372
           F  EA            G  GT  Y APE   G+     +     D+Y+ G++L E+ + 
Sbjct: 181 F--EAGKSAGDTH----GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234
Query: 373 ---GKGPTNE 379
                GP +E
Sbjct: 235 CTAADGPVDE 244

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRH 217
           + +   +G GSFG V   +  H      VA+K++N   L           E   LR +RH
Sbjct: 15  YQIVKTLGEGSFGKV--KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 72
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            +++K+     S D      E ++        L +++ + RD    ++  +       + 
Sbjct: 73  PHIIKLYDVIKSKD------EIIMVIEYAGNELFDYI-VQRD---KMSEQEARRFFQQII 122
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
           S +EY H +    IVH DLKP N+LLD  L   ++DFGL+  + +               
Sbjct: 123 SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC------- 172
Query: 338 KGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNE 379
            G+  YAAPE   G        DV+S G++L  M   + P ++
Sbjct: 173 -GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 42  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 100 NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRR--------IGRFSEPHA 144
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 191
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 192 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +V          E   A+K+L  +H       I E +     R R
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 88
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 89  DVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 144
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 145 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 200
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 201 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               LVK+  S     F+ N    +V E +  G +  + HL R   R      R   A  
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRRIG-RFXEPHARF-YAAQ 149
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +  T EYLH      +++ DLKP N+L+D +    V+DFG AK                 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTW 196
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               LVK+  S     F+ N    +V E +  G +  + HL R   R      R   A  
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRRIG-RFXEPHARF-YAAQ 149
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +  T EYLH      +++ DLKP N+L+D +    V+DFG AK                 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTW 196
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 27/221 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 42  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               LVK+  S     F+ N    +V E +  G +  + HL R   R      R   A  
Sbjct: 100 NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRRIG-RFXEPHARF-YAAQ 150
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +  T EYLH      +++ DLKP N+L+D +    V+DFG AK                 
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------RVKGRTW 197
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +    + + ++A+KVL    L+  G       E +   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F  +    L+ E    G++  E   L++ D  R    +    
Sbjct: 64  HLRHPNILRLYGY-----FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 114
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 115 --TELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 161
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 162 -RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 118/278 (42%), Gaps = 37/278 (13%)
Query: 133 REPSTPPSALLASVLRVSYQNLFKATDGFS-LENLI--GAGSFGSVYKGIFDHDDHETLV 189
           R P   P  +     R + Q +    D  S L+N I  G GS G V   I        LV
Sbjct: 45  RSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVC--IATVRSSGKLV 102
Query: 190 AVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGS 249
           AVK ++L+ +   +    E   +R  +H N+V++  S     +   D   +V E +  G+
Sbjct: 103 AVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-----YLVGDELWVVMEFLEGGA 157
Query: 250 LEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA 309
           L + +   R     +N  Q  ++ + V   L  LH      ++H D+K  ++LL  +   
Sbjct: 158 LTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRV 209
Query: 310 HVSDFG----LAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGI 365
            +SDFG    ++K +P               + GT  + APE           D++S GI
Sbjct: 210 KLSDFGFCAQVSKEVPRRKX-----------LVGTPYWMAPELISRLPYGPEVDIWSLGI 258
Query: 366 LLLEMFTGKGPT-NEMFTGNLTLHNFVKEALPERLAEI 402
           +++EM  G+ P  NE     L     +++ LP RL  +
Sbjct: 259 MVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPRLKNL 293

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVPGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E    G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYAPGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+++D +    V+DFGLAK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRH 217
           + +   +G GSFG V   +  H      VA+K++N   L           E   LR +RH
Sbjct: 6   YQIVKTLGEGSFGKV--KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 63
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            +++K+     S D      E ++        L +++ + RD    ++  +       + 
Sbjct: 64  PHIIKLYDVIKSKD------EIIMVIEYAGNELFDYI-VQRD---KMSEQEARRFFQQII 113
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
           S +EY H +    IVH DLKP N+LLD  L   ++DFGL+  + +               
Sbjct: 114 SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC------- 163
Query: 338 KGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNE 379
            G+  YAAPE   G        DV+S G++L  M   + P ++
Sbjct: 164 -GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y AP   +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 28/226 (12%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI 215
           K  D + +++LIG GSFG V K  +D  + E  VA+K++        K+F+ + Q    +
Sbjct: 51  KWMDRYEIDSLIGKGSFGQVVKA-YDRVEQE-WVAIKIIK-----NKKAFLNQAQIEVRL 103
Query: 216 -----RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
                +H   +K     +   F   +   LV+E M++ +L + L        +LNL ++ 
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKF 162
Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAAXXXX 328
             A  + + L +L    E  I+HCDLKP N+LL         + DFG +  L +      
Sbjct: 163 --AQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXI 219
Query: 329 XXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
                         Y +PE  +G     + D++S G +L+EM TG+
Sbjct: 220 QSRF----------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 41/233 (17%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLN---LQHRGASKSFIAECQALR 213
           +D +  + ++G GSFG V   I   D       AVKV++   ++ +   +S + E Q L+
Sbjct: 25  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR----DAPRNLNLLQ 268
            + H N++K+        F+   +  LV E+   G L +E +   R    DA R      
Sbjct: 82  QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR------ 130
Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSDFGLAKFLPEAAX 325
              I   V S + Y+H   +  IVH DLKP N+LL+    +    + DFGL+    EA+ 
Sbjct: 131 ---IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASK 183
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
                        GT  Y APE   G+      DV+S G++L  + +G  P N
Sbjct: 184 KMKDKI-------GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 27  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 84
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G  E + HL R        + R S    
Sbjct: 85  NFPFLVKLEFS-----FKDNSNLYMVMEYVPGG--EMFSHLRR--------IGRFSEPHA 129
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 130 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 176
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 177 VKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 32  IGSGAQGIVVAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 222 ---KIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
               + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++ + +   
Sbjct: 87  GLLNVFTPQKSLEEFQDV---YIVMELM-DANLSQVIQMELDHERMSYLLYQMLVGI--- 139
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
                  H     I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 140 ------KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR----TAGTSFMMTPYVV-- 187
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
             T  Y APE  +G     + D++S G+++ EM  G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 25/221 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           D + +   +G G+FG V++ + +        A K +   H    ++   E Q +  +RH 
Sbjct: 51  DHYDIHEELGTGAFGVVHR-VTERATGNNFAA-KFVMTPHESDKETVRKEIQTMSVLRHP 108
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV +  +     F+ ++   ++YE M  G L E +    D    ++  + +     V  
Sbjct: 109 TLVNLHDA-----FEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCK 160
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS--DFGLAKFL-PEAAXXXXXXXXXXV 335
            L ++H   E   VH DLKP N++   + +  +   DFGL   L P+ +           
Sbjct: 161 GLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-------- 209
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              GT  +AAPE   G  V    D++S G+L   + +G  P
Sbjct: 210 -TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 25/221 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           D + +   +G G+FG V++ + +        A K +   H    ++   E Q +  +RH 
Sbjct: 157 DHYDIHEELGTGAFGVVHR-VTERATGNNFAA-KFVMTPHESDKETVRKEIQTMSVLRHP 214
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV +  +     F+ ++   ++YE M  G L E +    D    ++  + +     V  
Sbjct: 215 TLVNLHDA-----FEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCK 266
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS--DFGLAKFL-PEAAXXXXXXXXXXV 335
            L ++H   E   VH DLKP N++   + +  +   DFGL   L P+ +           
Sbjct: 267 GLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-------- 315
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              GT  +AAPE   G  V    D++S G+L   + +G  P
Sbjct: 316 -TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++ + +   
Sbjct: 87  GLLNVFTPQKSLEEFQDV---YIVMELM-DANLSQVIQMELDHERMSYLLYQMLVGI--- 139
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
                  H     I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 140 ------KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR----TAGTSFMMTPYVV-- 187
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
             T  Y APE  +G     + D++S G+++ EM  G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 28/226 (12%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI 215
           K  D + +++LIG GSFG V K  +D  + E  VA+K++        K+F+ + Q    +
Sbjct: 32  KWMDRYEIDSLIGKGSFGQVVKA-YDRVEQE-WVAIKIIK-----NKKAFLNQAQIEVRL 84
Query: 216 -----RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
                +H   +K     +   F   +   LV+E M++ +L + L        +LNL ++ 
Sbjct: 85  LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKF 143
Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAAXXXX 328
             A  + + L +L    E  I+HCDLKP N+LL         + DFG +  L +      
Sbjct: 144 --AQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQXI 200
Query: 329 XXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
                         Y +PE  +G     + D++S G +L+EM TG+
Sbjct: 201 QSRF----------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 236

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G + +E   L++ D  R    +    
Sbjct: 69  HLRHPNILRLYGY-----FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYI---- 119
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 120 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 166
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 167 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRH 217
           + +   +G GSFG V   +  H      VA+K++N   L           E   LR +RH
Sbjct: 10  YQIVKTLGEGSFGKV--KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH 67
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            +++K+     S D      E ++        L +++ + RD    ++  +       + 
Sbjct: 68  PHIIKLYDVIKSKD------EIIMVIEYAGNELFDYI-VQRD---KMSEQEARRFFQQII 117
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
           S +EY H +    IVH DLKP N+LLD  L   ++DFGL+  + +               
Sbjct: 118 SAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC------- 167
Query: 338 KGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNE 379
            G+  YAAPE   G        DV+S G++L  M   + P ++
Sbjct: 168 -GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 45/235 (19%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNL--------QHRGASKSFIAECQAL 212
           +  +++IG G    V + +     HE   AVK++ +        Q     ++   E   L
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHE--FAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 213 RSIR-HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           R +  H +++ +I S     ++ + F  LV++LM  G L ++L         L+  +  S
Sbjct: 154 RQVAGHPHIITLIDS-----YESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETRS 204
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
           I   +   + +LH      IVH DLKP N+LLD  +   +SDFG +  L           
Sbjct: 205 IMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--- 258
Query: 332 XXXVGVKGTVGYAAPEY----------GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT GY APE           G G EV    D+++ G++L  +  G  P
Sbjct: 259 -----LCGTPGYLAPEILKCSMDETHPGYGKEV----DLWACGVILFTLLAGSPP 304

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 99/242 (40%), Gaps = 26/242 (10%)
Query: 162 SLENL--IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
            LENL  +G+G+ G V+K  F    H  ++AVK   ++  G  +        L  +   +
Sbjct: 26  DLENLGEMGSGTCGQVWKMRFRKTGH--VIAVK--QMRRSGNKEENKRILMDLDVVLKSH 81
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
               I  C    F  N    +  ELM  G+  E L      P    +L ++++A+     
Sbjct: 82  DCPYIVQCFGT-FITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAI--VKA 136
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L YL    +  ++H D+KPSN+LLD      + DFG++  L +                G
Sbjct: 137 LYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--------G 186
Query: 340 TVGYAAPEY-----GMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA 394
              Y APE          +     DV+S GI L+E+ TG+ P     T    L   ++E 
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE 246
Query: 395 LP 396
            P
Sbjct: 247 PP 248

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E    G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYAPGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+++D +    V+DFGLAK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + F    ++G GSF +           E   A+K+L  +H       I E +     R R
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSRE--YAIKILEKRH------IIKENKVPYVTRER 81
Query: 219 NLVKIITS--CVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +++  +     V + F   D E L + L    NG L +++   R          R   A 
Sbjct: 82  DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTA- 137
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
           ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK L PE+          
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV- 193
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 194 -----GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 22/228 (9%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           F L   IG+GSFG +Y G     + E  VA+K+ N++ +          Q L   +   +
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKTK--------HPQLLYESKIYRI 58
Query: 221 VKIITSCVSVDFQG--NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           ++  T   +V + G   D+  LV +L+   SLE+  +      R L+L   L +A  + +
Sbjct: 59  LQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTA---HVSDFGLAKFLPEAAXXXXXXXXXXV 335
            +E++H       +H D+KP N L+     A   ++ DFGLAK   + +           
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG 383
            + GT  YA+    +G E S   D+ S G +L+    G  P   +  G
Sbjct: 172 NLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 42  DQFERIKTLGTGSFGRVM--LVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E    G +  + HL R        + R S    
Sbjct: 100 NFPFLVKLEFS-----FKDNSNLYMVMEYAPGGEM--FSHLRR--------IGRFSEPHA 144
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+++D +    V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----------R 191
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 192 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 166 LIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           ++G G++G VY G    D  ++  +A+K +  +    S+    E    + ++H+N+V+ +
Sbjct: 29  VLGKGTYGIVYAG---RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
            S     F  N F  +  E +  GSL   L  ++  P   N     +I       LE L 
Sbjct: 86  GS-----FSENGFIKIFMEQVPGGSLSALLR-SKWGPLKDN---EQTIGFYTKQILEGLK 136
Query: 285 HYCETPIVHCDLKPSNVLLD---GELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           +  +  IVH D+K  NVL++   G L   +SDFG +K L                  GT+
Sbjct: 137 YLHDNQIVHRDIKGDNVLINTYSGVLK--ISDFGTSKRLAGINPCTET-------FTGTL 187
Query: 342 GYAAPEY------GMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
            Y APE       G G     + D++S G  ++EM TGK P  E+
Sbjct: 188 QYMAPEIIDKGPRGYGK----AADIWSLGCTIIEMATGKPPFYEL 228

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 41/233 (17%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLN---LQHRGASKSFIAECQALR 213
           +D +  + ++G GSFG V   I   D       AVKV++   ++ +   +S + E Q L+
Sbjct: 48  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 104
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR----DAPRNLNLLQ 268
            + H N++K+        F+   +  LV E+   G L +E +   R    DA R      
Sbjct: 105 QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR------ 153
Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSDFGLAKFLPEAAX 325
              I   V S + Y+H   +  IVH DLKP N+LL+    +    + DFGL+    EA+ 
Sbjct: 154 ---IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASK 206
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
                        GT  Y APE   G+      DV+S G++L  + +G  P N
Sbjct: 207 KMKDKI-------GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN 251

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 40/233 (17%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSI-RHRN 219
             +++IG G+FG V K     D      A+K +     +   + F  E + L  +  H N
Sbjct: 25  KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 84
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------DAPRNLNLL 267
           ++ ++ +C     +   +  L  E   +G+L ++L  +R                 L+  
Sbjct: 85  IINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 139
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXX 327
           Q L  A DVA  ++YL    +   +H +L   N+L+     A ++DFGL++         
Sbjct: 140 QLLHFAADVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR--------- 187
Query: 328 XXXXXXXVGVKGTVG-----YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG 375
                  V VK T+G     + A E    S  +T+ DV+S+G+LL E+ +  G
Sbjct: 188 ----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 236

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 41/233 (17%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLN---LQHRGASKSFIAECQALR 213
           +D +  + ++G GSFG V   I   D       AVKV++   ++ +   +S + E Q L+
Sbjct: 49  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 105
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR----DAPRNLNLLQ 268
            + H N++K+        F+   +  LV E+   G L +E +   R    DA R      
Sbjct: 106 QLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR------ 154
Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSDFGLAKFLPEAAX 325
              I   V S + Y+H   +  IVH DLKP N+LL+    +    + DFGL+    EA+ 
Sbjct: 155 ---IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASK 207
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
                        GT  Y APE   G+      DV+S G++L  + +G  P N
Sbjct: 208 KMKDKI-------GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN 252

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 166 LIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           ++G G++G VY G    D  ++  +A+K +  +    S+    E    + ++H+N+V+ +
Sbjct: 15  VLGKGTYGIVYAG---RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
            S     F  N F  +  E +  GSL   L  ++  P   N     +I       LE L 
Sbjct: 72  GS-----FSENGFIKIFMEQVPGGSLSALLR-SKWGPLKDN---EQTIGFYTKQILEGLK 122
Query: 285 HYCETPIVHCDLKPSNVLLD---GELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           +  +  IVH D+K  NVL++   G L   +SDFG +K L                  GT+
Sbjct: 123 YLHDNQIVHRDIKGDNVLINTYSGVLK--ISDFGTSKRLAGINPCTET-------FTGTL 173
Query: 342 GYAAPEY------GMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
            Y APE       G G     + D++S G  ++EM TGK P  E+
Sbjct: 174 QYMAPEIIDKGPRGYGK----AADIWSLGCTIIEMATGKPPFYEL 214

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 67  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 117
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 118 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 164
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 165 -RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 98/223 (43%), Gaps = 24/223 (10%)
Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL--NLQHRGASKSFIAECQAL 212
           F++ + +    L+G GS+G V K    + D   +VA+K    +   +   K  + E + L
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKC--RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLL 78
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           + +RH NLV ++  C     +      LV+E + +  L++ L L    P  L+       
Sbjct: 79  KQLRHENLVNLLEVC-----KKKKRWYLVFEFVDHTILDD-LEL---FPNGLDYQVVQKY 129
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
              + + + + H +    I+H D+KP N+L+       + DFG A+ L            
Sbjct: 130 LFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV- 185
Query: 333 XXVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGK 374
                  T  Y APE  +G  +   + DV++ G L+ EMF G+
Sbjct: 186 ------ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 100/214 (46%), Gaps = 34/214 (15%)
Query: 161 FSLENLIGAGSFGS-VYKGIFDHDDHETLVAVK-VLNLQHRGASKSFIAECQALR-SIRH 217
           F  ++++G G+ G+ VY+G+FD+ D    VAVK +L      A +    E Q LR S  H
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRD----VAVKRILPECFSFADR----EVQLLRESDEH 77
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            N+++    C   D Q   F+ +  EL    +L+E++     A   L   + +++     
Sbjct: 78  PNVIRYF--CTEKDRQ---FQYIAIELCA-ATLQEYVEQKDFAHLGL---EPITLLQQTT 128
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLD-----GELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           S L +LH      IVH DLKP N+L+      G++ A +SDFGL K L            
Sbjct: 129 SGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL----AVGRHSFS 181
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGIL 366
              GV GT G+ APE  M SE       Y+  I 
Sbjct: 182 RRSGVPGTEGWIAPE--MLSEDCKENPTYTVDIF 213

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSI-RHRNLV 221
           +GAG+FG V +        +D    VAVK+L +  H    ++ ++E + +  + +H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------LNRDAPRNLNLLQRLSIAVD 275
            ++ +C      G     ++ E    G L  +L       L+++  R L L   L  +  
Sbjct: 106 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 160
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           VA  + +L        +H D+   NVLL     A + DFGLA+ +   +           
Sbjct: 161 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-------- 209
Query: 336 GVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            VKG     V + APE       +   DV+S+GILL E+F+
Sbjct: 210 -VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 65  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 115
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 116 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSS-------- 162
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 163 -RRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 69  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 119
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 120 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 166
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 167 -RRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 115/265 (43%), Gaps = 48/265 (18%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIR-HR 218
           + L   +G G++G V+K I D    E +   K+ +  Q+   ++    E   L  +  H 
Sbjct: 11  YELVKKLGKGAYGIVWKSI-DRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 219 NLVKIITSCVSVDFQGNDFEA-LVYELMVNGSLEEWLHLNRDAPRNLNLLQ---RLSIAV 274
           N+V ++    +V    ND +  LV++ M     E  LH    A    N+L+   +  +  
Sbjct: 70  NIVNLL----NVLRADNDRDVYLVFDYM-----ETDLH----AVIRANILEPVHKQYVVY 116
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK--------------FL 320
            +   ++YLH      ++H D+KPSN+LL+ E    V+DFGL++               +
Sbjct: 117 QLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSI 173
Query: 321 PEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
            E                 T  Y APE  +GS   T G D++S G +L E+  GK     
Sbjct: 174 NENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP---- 229
Query: 380 MFTGNLTLHNFVKEALPERLAEIVD 404
           +F G+ T++        ER+  ++D
Sbjct: 230 IFPGSSTMNQL------ERIIGVID 248

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 97/225 (43%), Gaps = 36/225 (16%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSI-RHRNLV 221
           +GAG+FG V +        +D    VAVK+L +  H    ++ ++E + +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            ++ +C      G     ++ E    G L   L+  R   R L      +IA   AST +
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDL---LNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 282 YLHHYCETP----------IVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
            LH   +             +H D+   NVLL     A + DFGLA+ +   +       
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---- 221
Query: 332 XXXVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                VKG     V + APE       +   DV+S+GILL E+F+
Sbjct: 222 -----VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E +  G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT    APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSI-RHRNLV 221
           +GAG+FG V +        +D    VAVK+L +  H    ++ ++E + +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------LNRDAPRNLNLLQRLSIAVD 275
            ++ +C      G     ++ E    G L  +L       L+++  R L L   L  +  
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQ 168
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           VA  + +L        +H D+   NVLL     A + DFGLA+ +   +           
Sbjct: 169 VAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-------- 217
Query: 336 GVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            VKG     V + APE       +   DV+S+GILL E+F+
Sbjct: 218 -VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 39/231 (16%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSI-RHRNLV 221
           +GAG+FG V +        +D    VAVK+L +  H    ++ ++E + +  + +H N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 222 KIITSCVS----------------VDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLN 265
            ++ +C                  ++F     EA++   +  G   E   L+++  R L 
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPE--GLDKEDGRPLE 156
Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAX 325
           L   L  +  VA  + +L        +H D+   NVLL     A + DFGLA+ +   + 
Sbjct: 157 LRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 213
Query: 326 XXXXXXXXXVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                      VKG     V + APE       +   DV+S+GILL E+F+
Sbjct: 214 YI---------VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 23  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 81  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 131
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 132 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 178
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 179 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E    G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYAPGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+++D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRH 217
           F    L+G G+FG V   +          A+K+L  +    +      + E + L++ RH
Sbjct: 153 FEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             L     + +   FQ +D    V E    G L  + HL+R+  R  +  +      ++ 
Sbjct: 211 PFL-----TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARFYGAEIV 261
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAAXXXXXXXXXXVG 336
           S L+YLH   E  +V+ DLK  N++LD +    ++DFGL K  + + A            
Sbjct: 262 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC------ 313
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 314 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 32  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 90  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 140
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 141 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 187
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 188 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 64  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 114
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 115 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 161
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 162 -RRAALCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 97/229 (42%), Gaps = 36/229 (15%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSI 215
           TD + L   +G G+F  V + +      E   A K++N +   A   +    E +  R +
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQE--YAAKIINTKKLSARDHQKLEREARICRLL 87
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           +H N+V++  S   +  +G  F  LV++L+  G L E            +++ R   +  
Sbjct: 88  KHPNIVRLHDS---ISEEG--FHYLVFDLVTGGELFE------------DIVAREYYSEA 130
Query: 276 VAS-----TLEYLHHYCETPIVHCDLKPSNVLLDGEL---TAHVSDFGLAKFLPEAAXXX 327
            AS      LE ++H  +  IVH DLKP N+LL  +       ++DFGL       A   
Sbjct: 131 DASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGL-------AIEV 183
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                   G  GT GY +PE           D+++ G++L  +  G  P
Sbjct: 184 QGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 67  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 117
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 118 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 164
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 165 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 65  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 115
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 116 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 162
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 31/229 (13%)
Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRS 214
           F     ++    IG G++G V    +DH     +   K+   +H+   +  + E Q L  
Sbjct: 39  FDVGPRYTQLQYIGEGAYGMV-SSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLR 97
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
            RH N++ I         + +  EA+    +V   +E  L+          LL+   ++ 
Sbjct: 98  FRHENVIGIRDI-----LRASTLEAMRDVYIVQDLMETDLY---------KLLKSQQLSN 143
Query: 275 D--------VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXX 326
           D        +   L+Y+H      ++H DLKPSN+L++      + DFGLA+     A  
Sbjct: 144 DHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARI----ADP 196
Query: 327 XXXXXXXXVGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
                        T  Y APE  + S+  + S D++S G +L EM + +
Sbjct: 197 EHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRH 217
           F    L+G G+FG V   +          A+K+L  +    +      + E + L++ RH
Sbjct: 150 FEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             L     + +   FQ +D    V E    G L  + HL+R+  R  +  +      ++ 
Sbjct: 208 PFL-----TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARFYGAEIV 258
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAAXXXXXXXXXXVG 336
           S L+YLH   E  +V+ DLK  N++LD +    ++DFGL K  + + A            
Sbjct: 259 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC------ 310
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 311 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 64  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 114
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 115 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 161
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 162 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 69  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 119
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 120 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 166
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 167 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 64  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 114
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 115 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 161
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 162 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 64  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 114
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 115 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 161
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 162 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 11  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 69  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 119
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 120 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 166
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 167 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 27/221 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               LVK+  S     F+ N    +V E    G +  + HL R   R      R   A  
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYAPGGEM--FSHLRRIG-RFXEPHARF-YAAQ 149
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +  T EYLH      +++ DLKP N+++D +    V+DFG AK                 
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----------RVKGRTW 196
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 197 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 21/155 (13%)
Query: 165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVK 222
            LIG G FG VY G +  +     VA+++++++       K+F  E  A R  RH N+V 
Sbjct: 39  ELIGKGRFGQVYHGRWHGE-----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL 93
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
            + +C+S         A++  L    +L     + RDA   L++ +   IA ++   + Y
Sbjct: 94  FMGACMSPPHL-----AIITSLCKGRTL---YSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 283 LHHYCETPIVHCDLKPSNVLLD-GELTAHVSDFGL 316
           LH      I+H DLK  NV  D G++   ++DFGL
Sbjct: 146 LH---AKGILHKDLKSKNVFYDNGKVV--ITDFGL 175

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 64  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 114
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 115 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 161
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 162 -RRTELCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               LVK+  S     F+ N    +V E    G +  + HL R        + R S    
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYAPGGEM--FSHLRR--------IGRFSEPHA 143
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+++D +    V+DFG AK           
Sbjct: 144 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----------R 190
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 3   ALEDFEIGRPLGKGKFGNVY--LAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 61  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 111
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 112 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 158
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 159 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 36/229 (15%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSI 215
           TD + L   IG G+F  V + +     HE   A K++N +   A   +    E +  R +
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHE--YAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           +H N+V++  S          F  LV++L+  G L E            +++ R   +  
Sbjct: 61  KHSNIVRLHDS-----ISEEGFHYLVFDLVTGGELFE------------DIVAREYYSEA 103
Query: 276 VAS-----TLEYLHHYCETPIVHCDLKPSNVLLDGEL---TAHVSDFGLAKFLPEAAXXX 327
            AS      LE + H  +  +VH DLKP N+LL  +       ++DFGL       A   
Sbjct: 104 DASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGL-------AIEV 156
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                   G  GT GY +PE           D+++ G++L  +  G  P
Sbjct: 157 QGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 8   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 66  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 116
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 117 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 163
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 164 -RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 14/207 (6%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLVKIIT 225
           IG GS+G   K I    D + LV  ++       A K   ++E   LR ++H N+V+   
Sbjct: 14  IGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
             +    + N    +V E    G L   +       + L+    L +   +   L+  H 
Sbjct: 73  RIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 286 YCE--TPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
             +    ++H DLKP+NV LDG+    + DFGLA+ L                  GT  Y
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK-------AFVGTPYY 182
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEM 370
            +PE       +   D++S G LL E+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 14/207 (6%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLVKIIT 225
           IG GS+G   K I    D + LV  ++       A K   ++E   LR ++H N+V+   
Sbjct: 14  IGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
             +    + N    +V E    G L   +       + L+    L +   +   L+  H 
Sbjct: 73  RIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 286 YCE--TPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
             +    ++H DLKP+NV LDG+    + DFGLA+ L                  GT  Y
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-------GTPYY 182
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEM 370
            +PE       +   D++S G LL E+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 40/241 (16%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRS 214
           + D +     +G G++G VYK I D   +ET VA+K + L+H   G   + I E   L+ 
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAI-DTVTNET-VAIKRIRLEHEEEGVPGTAIREVSLLKE 89
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNL--NLLQRLSI 272
           ++HRN++++ +         N    L++E   N  L++++  N D    +  + L +L  
Sbjct: 90  LQHRNIIELKSV-----IHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTA--HVSDFGLAKFLPEAAXXX 327
            V+   +   LH          DLKP N+LL   D   T    + DFGLA+         
Sbjct: 144 GVNFCHSRRCLHR---------DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEM------FTGKGPTNEM 380
                       T+ Y  PE  +GS   STS D++S   +  EM      F G    +++
Sbjct: 195 THEII-------TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL 247
Query: 381 F 381
           F
Sbjct: 248 F 248

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII 86
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++         
Sbjct: 87  SLL-NVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQM--------- 135
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L  + H     I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR----TAGTSFMMTPYVV---- 187
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 67  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 117
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 118 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 164
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 165 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 116/273 (42%), Gaps = 37/273 (13%)
Query: 135 PSTPPSALLASVLRVSYQNLFKATDGFS-LENLI--GAGSFGSVYKGIFDHDDHETLVAV 191
           P   P  +     R + Q +    D  S L+N I  G GS G V   I        LVAV
Sbjct: 4   PQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIV--CIATVRSSGKLVAV 61
Query: 192 KVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLE 251
           K ++L+ +   +    E   +R  +H N+V++  S     +   D   +V E +  G+L 
Sbjct: 62  KKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-----YLVGDELWVVMEFLEGGALT 116
Query: 252 EWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV 311
           + +   R     +N  Q  ++ + V   L  LH      ++H D+K  ++LL  +    +
Sbjct: 117 DIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 168
Query: 312 SDFG----LAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILL 367
           SDFG    ++K +P               + GT  + APE           D++S GI++
Sbjct: 169 SDFGFCAQVSKEVPRRKX-----------LVGTPYWMAPELISRLPYGPEVDIWSLGIMV 217
Query: 368 LEMFTGKGPT-NEMFTGNLTLHNFVKEALPERL 399
           +EM  G+ P  NE     L     +++ LP RL
Sbjct: 218 IEMVDGEPPYFNE---PPLKAMKMIRDNLPPRL 247

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 32  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 90  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 140
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 141 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----- 190
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 191 ----DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 7   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 65  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 115
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 116 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT---- 166
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 167 -----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 5   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 63  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 113
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 114 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 160
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 161 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++ + +   
Sbjct: 87  GLLNVFTPQKSLEEFQDV---YIVMELM-DANLSQVIQMELDHERMSYLLYQMLVGI--- 139
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
                  H     I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 140 ------KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR----TAGTSFMMTPYVV-- 187
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
             T  Y APE  +G     + D++S G ++ EM  G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 116/273 (42%), Gaps = 37/273 (13%)
Query: 135 PSTPPSALLASVLRVSYQNLFKATDGFS-LENLI--GAGSFGSVYKGIFDHDDHETLVAV 191
           P   P  +     R + Q +    D  S L+N I  G GS G V   I        LVAV
Sbjct: 2   PQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIV--CIATVRSSGKLVAV 59
Query: 192 KVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLE 251
           K ++L+ +   +    E   +R  +H N+V++  S     +   D   +V E +  G+L 
Sbjct: 60  KKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS-----YLVGDELWVVMEFLEGGALT 114
Query: 252 EWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV 311
           + +   R     +N  Q  ++ + V   L  LH      ++H D+K  ++LL  +    +
Sbjct: 115 DIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 166
Query: 312 SDFG----LAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILL 367
           SDFG    ++K +P               + GT  + APE           D++S GI++
Sbjct: 167 SDFGFCAQVSKEVPRRKX-----------LVGTPYWMAPELISRLPYGPEVDIWSLGIMV 215
Query: 368 LEMFTGKGPT-NEMFTGNLTLHNFVKEALPERL 399
           +EM  G+ P  NE     L     +++ LP RL
Sbjct: 216 IEMVDGEPPYFNE---PPLKAMKMIRDNLPPRL 245

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 10  ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 68  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 118
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 119 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 165
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 166 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 64  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 114
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 115 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 161
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 162 -RRTXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 70/144 (48%), Gaps = 19/144 (13%)
Query: 240 LVYELMVNGSL----EEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCD 295
           ++YE M N S+    E +  L+++    + +     I   V ++  Y+H+  E  I H D
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRD 177
Query: 296 LKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVS 355
           +KPSN+L+D      +SDFG ++++ +             G +GT  +  PE+   +E S
Sbjct: 178 VKPSNILMDKNGRVKLSDFGESEYMVDKKIK---------GSRGTYEFMPPEF-FSNESS 227
Query: 356 TSG---DVYSFGILLLEMFTGKGP 376
            +G   D++S GI L  MF    P
Sbjct: 228 YNGAKVDIWSLGICLYVMFYNVVP 251

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALR 213
           K +D + ++  +G G+F  V + +  H       A K++N +   A   +    E +  R
Sbjct: 26  KFSDNYDVKEELGKGAFSVVRRCV--HKTTGLEFAAKIINTKKLSARDFQKLEREARICR 83
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
            ++H N+V++  S      Q   F  LV++L+  G L E + + R+             +
Sbjct: 84  KLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDI-VARE------FYSEADAS 131
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL---TAHVSDFGLAKFLPEAAXXXXXX 330
             +   LE + +     IVH +LKP N+LL  +       ++DFGLA  + ++       
Sbjct: 132 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 188
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                G  GT GY +PE       S   D+++ G++L  +  G  P
Sbjct: 189 -----GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++         
Sbjct: 80  SLL-NVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQM--------- 128
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L  + H     I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 129 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR----TAGTSFMMTPYVV---- 180
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++         
Sbjct: 87  SLL-NVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQM--------- 135
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L  + H     I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 136 LXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLAR----TAGTSFMMTPYVV---- 187
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 20/220 (9%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           + L   IG+GSFG +Y G       E  + ++ +  +H         E +  + ++    
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVG 66
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           +  I  C +      D+  +V EL+   SLE+  +      R  +L   L +A  + S +
Sbjct: 67  IPTIRWCGAE----GDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRI 118
Query: 281 EYLHHYCETPIVHCDLKPSNVLL----DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
           EY+H       +H D+KP N L+     G L  ++ DFGLAK   +A             
Sbjct: 119 EYIH---SKNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYRENKN 174
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           + GT  YA+    +G E S   D+ S G +L+    G  P
Sbjct: 175 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 67  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 117
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 118 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 164
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 165 -RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 88/221 (39%), Gaps = 23/221 (10%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSI 215
           D F    ++G GSFG V        +   L AVKVL    +      +  + E + L   
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVK--ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           R+   +  +  C    FQ  D    V E +  G L    H+ +   R  +  +    A +
Sbjct: 81  RNHPFLTQLFCC----FQTPDRLFFVMEFVNGGDL--MFHIQKS--RRFDEARARFYAAE 132
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           + S L +LH   +  I++ DLK  NVLLD E    ++DFG+ K                 
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-------EGICNGVTTA 182
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              GT  Y APE         + D ++ G+LL EM  G  P
Sbjct: 183 TFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 6   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 64  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 114
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 115 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-------- 161
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 162 -RRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 91/232 (39%), Gaps = 49/232 (21%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           D F     +G GSFG V   +  H +     A+K+L+ Q          +   L+ I H 
Sbjct: 42  DQFERIRTLGTGSFGRVM--LVKHKETGNHYAMKILDKQ----------KVVKLKQIEHT 89
Query: 219 NLVKIITSCVSV--------DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
              K I   V+          F+ N    +V E    G +  + HL R        + R 
Sbjct: 90  LNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM--FSHLRR--------IGRF 139
Query: 271 S------IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAA 324
           S       A  +  T EYLH      +++ DLKP N+L+D +    V+DFG AK      
Sbjct: 140 SEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK------ 190
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                       + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 191 ----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 103/233 (44%), Gaps = 41/233 (17%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLN---LQHRGASKSFIAECQALR 213
           +D +  + ++G GSFG V   I   D       AVKV++   ++ +   +S + E Q L+
Sbjct: 25  SDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR----DAPRNLNLLQ 268
            + H N+ K+        F+   +  LV E+   G L +E +   R    DA R      
Sbjct: 82  QLDHPNIXKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR------ 130
Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSDFGLAKFLPEAAX 325
              I   V S + Y H   +  IVH DLKP N+LL+    +    + DFGL+    EA+ 
Sbjct: 131 ---IIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASK 183
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
                        GT  Y APE   G+      DV+S G++L  + +G  P N
Sbjct: 184 KXKDKI-------GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN 228

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRH 217
           F    L+G G+FG V   +          A+K+L  +    +      + E + L++ RH
Sbjct: 12  FEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             L     + +   FQ +D    V E    G L  + HL+R+  R  +  +      ++ 
Sbjct: 70  PFL-----TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARFYGAEIV 120
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAAXXXXXXXXXXVG 336
           S L+YLH   E  +V+ DLK  N++LD +    ++DFGL K  + + A            
Sbjct: 121 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC------ 172
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 173 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 67  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 117
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P +        
Sbjct: 118 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----- 167
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 168 ----DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 20/220 (9%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           + L   IG+GSFG +Y G       E  + ++ +  +H         E +  + ++    
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVG 64
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           +  I  C +      D+  +V EL+   SLE+  +      R  +L   L +A  + S +
Sbjct: 65  IPTIRWCGAE----GDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRI 116
Query: 281 EYLHHYCETPIVHCDLKPSNVLL----DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
           EY+H       +H D+KP N L+     G L  ++ DFGLAK   +A             
Sbjct: 117 EYIH---SKNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           + GT  YA+    +G E S   D+ S G +L+    G  P
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 212

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALR 213
           K +D + ++  +G G+F  V + +  H       A K++N +   A   +    E +  R
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCV--HKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
            ++H N+V++  S      Q   F  LV++L+  G L E + + R+             +
Sbjct: 61  KLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDI-VARE------FYSEADAS 108
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL---TAHVSDFGLAKFLPEAAXXXXXX 330
             +   LE + +     IVH +LKP N+LL  +       ++DFGLA  + ++       
Sbjct: 109 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 165
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                G  GT GY +PE       S   D+++ G++L  +  G  P
Sbjct: 166 -----GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 26/227 (11%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN----LQHRGASKSFIAECQA 211
           K TD F+   ++G GSFG V   + D    E L A+K+L     +Q      + + E + 
Sbjct: 17  KLTD-FNFLMVLGKGSFGKVM--LADRKGTEELYAIKILKKDVVIQDDDVECTMV-EKRV 72
Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           L  +     +  + SC    FQ  D    V E +  G L    H+ +         Q + 
Sbjct: 73  LALLDKPPFLTQLHSC----FQTVDRLYFVMEYVNGGDL--MYHIQQVG--KFKEPQAVF 124
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
            A +++  L +LH   +  I++ DLK  NV+LD E    ++DFG+ K             
Sbjct: 125 YAAEISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------EHMMDG 174
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
                  GT  Y APE         S D +++G+LL EM  G+ P +
Sbjct: 175 VTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 85/207 (41%), Gaps = 14/207 (6%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLVKIIT 225
           IG GS+G   K I    D + LV  ++       A K   ++E   LR ++H N+V+   
Sbjct: 14  IGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
             +    + N    +V E    G L   +       + L+    L +   +   L+  H 
Sbjct: 73  RIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 286 YCE--TPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
             +    ++H DLKP+NV LDG+    + DFGLA+ L                  GT  Y
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV-------GTPYY 182
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEM 370
            +PE       +   D++S G LL E+
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII 86
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++   +     
Sbjct: 87  SLL-NVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYLLYQMLCGI----- 139
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
            ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 140 -KHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR----TAGTSFMMTPYVV---- 187
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRH 217
           F    L+G G+FG V   +          A+K+L  +    +      + E + L++ RH
Sbjct: 10  FEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             L     + +   FQ +D    V E    G L  + HL+R+  R  +  +      ++ 
Sbjct: 68  PFL-----TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARFYGAEIV 118
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAAXXXXXXXXXXVG 336
           S L+YLH   E  +V+ DLK  N++LD +    ++DFGL K  + + A            
Sbjct: 119 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC------ 170
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 171 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 20/225 (8%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI 215
           +  + + L   IG+GSFG +Y G       E  + ++ +  +H         E +  + +
Sbjct: 6   RVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKH----PQLHIESKFYKMM 61
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           +    +  I  C +      D+  +V EL+   SLE+  +      R  +L   L +A  
Sbjct: 62  QGGVGIPSIKWCGAE----GDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQ 113
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLL----DGELTAHVSDFGLAKFLPEAAXXXXXXX 331
           + S +EY+H       +H D+KP N L+     G L  ++ DFGLAK   +A        
Sbjct: 114 MISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLV-YIIDFGLAKKYRDARTHQHIPY 169
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT  YA+    +G E S   D+ S G +L+    G  P
Sbjct: 170 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALR 213
           K +D + ++  +G G+F  V + +  H       A K++N +   A   +    E +  R
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCV--HKTTGLEFAAKIINTKKLSARDFQKLEREARICR 59
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
            ++H N+V++  S      Q   F  LV++L+  G L E + + R+             +
Sbjct: 60  KLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDI-VARE------FYSEADAS 107
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL---TAHVSDFGLAKFLPEAAXXXXXX 330
             +   LE + +     IVH +LKP N+LL  +       ++DFGLA  + ++       
Sbjct: 108 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 164
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                G  GT GY +PE       S   D+++ G++L  +  G  P
Sbjct: 165 -----GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 107/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 59
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 60  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLF 111
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 112 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-- 166
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 167 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 208

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 25/220 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRH 217
           F    L+G G+FG V   +          A+K+L  +    +      + E + L++ RH
Sbjct: 11  FEYLKLLGKGTFGKVI--LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             L     + +   FQ +D    V E    G L  + HL+R+  R  +  +      ++ 
Sbjct: 69  PFL-----TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFSEDRARFYGAEIV 119
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAAXXXXXXXXXXVG 336
           S L+YLH   E  +V+ DLK  N++LD +    ++DFGL K  + + A            
Sbjct: 120 SALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFC------ 171
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 172 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 66/261 (25%), Positives = 113/261 (43%), Gaps = 51/261 (19%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN------------------------- 195
           ++L++ IG GS+G V K  ++ +D+ T  A+KVL+                         
Sbjct: 15  YTLKDEIGKGSYG-VVKLAYNENDN-TYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 196 -LQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL 254
            +Q RG  +    E   L+ + H N+VK++     +D    D   +V+EL+  G + E  
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVP 129
Query: 255 HLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF 314
            L     + L+  Q      D+   +EYLH+     I+H D+KPSN+L+  +    ++DF
Sbjct: 130 TL-----KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADF 181
Query: 315 GLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSG---DVYSFGILLLEMF 371
           G++     +               GT  + APE    +    SG   DV++ G+ L    
Sbjct: 182 GVSNEFKGSDALLSNTV-------GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234
Query: 372 TGKGPTNEMFTGNLTLHNFVK 392
            G+ P   M    + LH+ +K
Sbjct: 235 FGQCPF--MDERIMCLHSKIK 253

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 27/226 (11%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALR 213
           K +D + ++  +G G+F  V + +  H       A K++N +   A   +    E +  R
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCV--HKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
            ++H N+V++  S      Q   F  LV++L+  G L E + + R+             +
Sbjct: 61  KLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDI-VARE------FYSEADAS 108
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL---TAHVSDFGLAKFLPEAAXXXXXX 330
             +   LE + +     IVH +LKP N+LL  +       ++DFGLA  + ++       
Sbjct: 109 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 165
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                G  GT GY +PE       S   D+++ G++L  +  G  P
Sbjct: 166 -----GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 91/227 (40%), Gaps = 22/227 (9%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRN 219
           F L  L+G G++G VYKG   H     L A+KV+++      +    E   L+    HRN
Sbjct: 26  FELVELVGNGTYGQVYKG--RHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRN 82
Query: 220 LVKIITSCVSVDFQGNDFE-ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           +     + +  +  G D +  LV E    GS+ + +   +      N L+   IA     
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWIAYICRE 137
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            L  L H  +  ++H D+K  NVLL       + DFG++  L                  
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI------- 190
Query: 339 GTVGYAAPEYGMGSE-----VSTSGDVYSFGILLLEMFTGKGPTNEM 380
           GT  + APE     E          D++S GI  +EM  G  P  +M
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 59  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLF 110
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 111 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 165
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 166 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 61  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLF 112
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 113 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 167
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 168 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 209

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 101/238 (42%), Gaps = 32/238 (13%)
Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS 204
           S+++  ++N  + TDG+ ++  IG GS+    + I    + E   AVK+++   R  ++ 
Sbjct: 8   SIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXE--FAVKIIDKSKRDPTEE 65
Query: 205 FIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNL 264
                  LR  +H N++ +        +    +  +V EL   G L + +       R  
Sbjct: 66  IEI---LLRYGQHPNIITLKDV-----YDDGKYVYVVTELXKGGELLDKIL------RQK 111
Query: 265 NLLQRLSIAV--DVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL----TAHVSDFGLAK 318
              +R + AV   +  T+EYLH      +VH DLKPSN+L   E     +  + DFG AK
Sbjct: 112 FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            L                   T  + APE         + D++S G+LL    TG  P
Sbjct: 169 QLRAENGLLXTPCY-------TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 59  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKDFMDASALTGIPLPLIK--SYLF 110
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 111 QLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 165
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 166 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 36/225 (16%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRN 219
           F  +  +G G+F  V   + +      L AVK +  +  +G   S   E   LR I+H N
Sbjct: 24  FEFKETLGTGAFSEVV--LAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHEN 81
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSL-----EEWLHLNRDAPRNLNLLQRLSIAV 274
           +V      +   ++  +   LV +L+  G L     E+  +  +DA          ++  
Sbjct: 82  IV-----ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAS---------TLIR 127
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAAXXXXXXX 331
            V   + YLH      IVH DLKP N+L    D E    +SDFGL+K   +         
Sbjct: 128 QVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTAC- 183
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  GT GY APE       S + D +S G++   +  G  P
Sbjct: 184 -------GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 59  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLF 110
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 111 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 165
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 166 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 59  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLF 110
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 111 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 165
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 166 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 63  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLF 114
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 115 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 169
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 170 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 211

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 59
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 60  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLF 111
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 112 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 166
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 167 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 208

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E  V+  L++++  +      L L++  S   
Sbjct: 62  LNHPNIVKLL----DVIHTENKL-YLVFE-HVDQDLKKFMDASALTGIPLPLIK--SYLF 113
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 114 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 169 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 61  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLF 112
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 113 QLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 167
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 168 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 209

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 62  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLF 113
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 114 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 169 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 62  LNHPNIVKLL----DVIHTENKL-YLVFEFL-SMDLKDFMDASALTGIPLPLIK--SYLF 113
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 114 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 169 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 61  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLF 112
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 113 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 167
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 168 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 209

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ + H N+VK++
Sbjct: 11  IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V    N    LV+E + +  L++++  +      L L++  S    +   L + H
Sbjct: 69  ----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLSFCH 120
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y 
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYR 170
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
            ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 74
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DV 276
           +V++     S    G   + +   L+++   E    + R   R    L  + + +    +
Sbjct: 75  IVRLRYFFYS---SGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXV 335
             +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNV 180
Query: 336 GVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
               +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ + H N+VK++
Sbjct: 18  IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                      +   LV+E + +  L++++  +      L L++  S    +   L + H
Sbjct: 76  DVI-----HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 127
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y 
Sbjct: 128 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYR 177
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 178 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 214

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 62  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLF 113
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 114 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 169 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 59
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 60  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLF 111
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 112 QLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 166
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 167 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 208

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E +   S++    ++  A   + L    S   
Sbjct: 62  LNHPNIVKLL----DVIHTENKL-YLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLF 113
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 114 QLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 169 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 119/277 (42%), Gaps = 33/277 (11%)
Query: 136 STPPSALLA-SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL 194
           STPP  L + + + +  QN     D       +G G++G V K    H     ++AVK +
Sbjct: 27  STPPRDLDSKACISIGNQNFEVKADDLEPIMELGRGAYGVVEK--MRHVPSGQIMAVKRI 84
Query: 195 NLQHRGASKSFIAECQALRSIRHRNLVKIITSC-VSVDFQGNDFEA----LVYELMVNGS 249
                   ++ +   +  R +   ++      C  +V F G  F      +  ELM + S
Sbjct: 85  --------RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTS 135
Query: 250 LEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA 309
           L+++     D  + +       IAV +   LE+LH   +  ++H D+KPSNVL++     
Sbjct: 136 LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQV 193
Query: 310 HVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFG 364
            + DFG++ +L ++               G   Y APE  +  E++  G     D++S G
Sbjct: 194 KMCDFGISGYLVDSVAKTIDA--------GCKPYMAPER-INPELNQKGYSVKSDIWSLG 244
Query: 365 ILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAE 401
           I ++E+   + P +   T    L   V+E  P+  A+
Sbjct: 245 ITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 281

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ + H N+VK++
Sbjct: 18  IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 75
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V    N    LV+E + +  L++++  +      L L++  S    +   L + H
Sbjct: 76  ----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 127
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y 
Sbjct: 128 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYR 177
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 178 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 214

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ + H N+VK++
Sbjct: 11  IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                      +   LV+E + +  L++++  +      L L++  S    +   L + H
Sbjct: 69  DVI-----HTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 120
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y 
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYR 170
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 171 APEILLGXKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 61  LNHPNIVKLL----DVIHTENKL-YLVFEFL-SMDLKDFMDASALTGIPLPLIK--SYLF 112
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 113 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 167
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 168 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 209

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNI 109
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 110 VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 215
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 268

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 28/228 (12%)
Query: 161 FSLENLIGAGSFGSVYK-GIFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRSI 215
           F L  ++G G +G V++       +   + A+KVL     +++   +    AE   L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           +H  +V +I +     FQ      L+ E +  G L  ++ L R+      +    +    
Sbjct: 79  KHPFIVDLIYA-----FQTGGKLYLILEYLSGGEL--FMQLEREG-----IFMEDTACFY 126
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +A     L H  +  I++ DLKP N++L+ +    ++DFGL K                 
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK-------ESIHDGTVTH 179
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG 383
              GT+ Y APE  M S  + + D +S G L+ +M TG  P    FTG
Sbjct: 180 XFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTG 223

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 25/220 (11%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKV-LNLQHRGASKSFIAECQALRSIRHRNLVKIIT 225
           IG G++G VYK   +    E +   K+ L+ +  G   + I E   L+ + H N+VK++ 
Sbjct: 11  IGEGTYGVVYKAR-NKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL- 68
Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
               V    N    LV+E + +  L++++  +      L L++  S    +   L + H 
Sbjct: 69  ---DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 121
Query: 286 YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAA 345
           +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y A
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYRA 171
Query: 346 PEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           PE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N+
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNI 111
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 112 VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 169 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 217
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 218 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 270

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 25/220 (11%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKV-LNLQHRGASKSFIAECQALRSIRHRNLVKIIT 225
           IG G++G VYK   +    E +   K+ L+ +  G   + I E   L+ + H N+VK++ 
Sbjct: 10  IGEGTYGVVYKAR-NKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL- 67
Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
               V    N    LV+E + +  L++++  +      L L++  S    +   L + H 
Sbjct: 68  ---DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCHS 120
Query: 286 YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAA 345
           +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y A
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYRA 170
Query: 346 PEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           PE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 58
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L++++  +      L L++  S   
Sbjct: 59  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLF 110
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 111 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 165
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 166 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNI 113
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 114 VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 171 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 219
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 220 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 272

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRH 217
           F    L+G G+FG V   +          A+K+L  +    +      + E + L++ RH
Sbjct: 7   FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             L     + +   FQ +D    V E    G L  + HL+R+  R     +      ++ 
Sbjct: 65  PFL-----TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFTEERARFYGAEIV 115
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAAXXXXXXXXXXVG 336
           S LEYLH      +V+ D+K  N++LD +    ++DFGL K  + + A            
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC------ 166
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 167 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ + H N+VK++
Sbjct: 11  IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V    N    LV+E + +  L++++  +      L L++  S    +   L + H
Sbjct: 69  ----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 120
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y 
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYR 170
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRH 217
           F    L+G G+FG V   +          A+K+L  +    +      + E + L++ RH
Sbjct: 7   FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             L     + +   FQ +D    V E    G L  + HL+R+  R     +      ++ 
Sbjct: 65  PFL-----TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFTEERARFYGAEIV 115
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAAXXXXXXXXXXVG 336
           S LEYLH      +V+ D+K  N++LD +    ++DFGL K  + + A            
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC------ 166
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 167 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 28/228 (12%)
Query: 161 FSLENLIGAGSFGSVYK-GIFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRSI 215
           F L  ++G G +G V++       +   + A+KVL     +++   +    AE   L  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           +H  +V +I +     FQ      L+ E +  G L  ++ L R+      +    +    
Sbjct: 79  KHPFIVDLIYA-----FQTGGKLYLILEYLSGGEL--FMQLEREG-----IFMEDTACFY 126
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +A     L H  +  I++ DLKP N++L+ +    ++DFGL K   E+            
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHTFC- 182
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG 383
              GT+ Y APE  M S  + + D +S G L+ +M TG  P    FTG
Sbjct: 183 ---GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP----FTG 223

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ + H N+VK++
Sbjct: 10  IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V    N    LV+E + +  L++++  +      L L++  S    +   L + H
Sbjct: 68  ----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 119
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y 
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYR 169
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 42  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               L K+  S     F+ N    +V E    G +  + HL R        + R S    
Sbjct: 100 NFPFLTKLEFS-----FKDNSNLYMVMEYAPGGEM--FSHLRR--------IGRFSEPHA 144
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+++D +    V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----------R 191
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 192 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNI 109
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 110 VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 215
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 216 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 268

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 39/227 (17%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 42  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS---- 271
               L K+  S     F+ N    +V E    G +  + HL R        + R S    
Sbjct: 100 NFPFLTKLEFS-----FKDNSNLYMVMEYAPGGEM--FSHLRR--------IGRFSEPHA 144
Query: 272 --IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
              A  +  T EYLH      +++ DLKP N+++D +    V+DFG AK           
Sbjct: 145 RFYAAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----------R 191
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 192 VKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNI 87
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 88  VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 193
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 246

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 27/221 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 42  DQFERIKTLGTGSFGRVM--LVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 99
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               L K+  S     F+ N    +V E    G +  + HL R   R      R   A  
Sbjct: 100 NFPFLTKLEFS-----FKDNSNLYMVMEYAPGGEM--FSHLRRIG-RFXEPHARF-YAAQ 150
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +  T EYLH      +++ DLKP N+++D +    V+DFG AK                 
Sbjct: 151 IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----------RVKGRTW 197
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  Y APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 198 XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 105/231 (45%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 59
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E +   S++    ++  A   + L    S   
Sbjct: 60  LNHPNIVKLL----DVIHTENKL-YLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLF 111
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 112 QLLQGLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 166
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 167 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 208

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N+
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNI 103
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 104 VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 161 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 209
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 210 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 262

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ + H N+VK++
Sbjct: 11  IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V    N    LV+E + +  L++++  +      L L++  S    +   L + H
Sbjct: 69  ----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 120
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y 
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYR 170
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 171 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 207

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ + H N+VK++
Sbjct: 10  IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V    N    LV+E + +  L++++  +      L L++  S    +   L + H
Sbjct: 68  ----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 119
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y 
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYR 169
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
            ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 74
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DV 276
           +V++     S    G   + +   L+++   E    + R   R    L  + + +    +
Sbjct: 75  IVRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXV 335
             +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNV 180
Query: 336 GVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
               +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 26/220 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRH 217
           F    L+G G+FG V   +          A+K+L  +    +      + E + L++ RH
Sbjct: 10  FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             L     + +   FQ +D    V E    G L  + HL+R+  R     +      ++ 
Sbjct: 68  PFL-----TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFTEERARFYGAEIV 118
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAAXXXXXXXXXXVG 336
           S LEYLH      +V+ D+K  N++LD +    ++DFGL K  + + A            
Sbjct: 119 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC------ 169
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 170 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N+
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNI 87
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 88  VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 193
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 194 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 246

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 8   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 66  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 116
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       +++FG +   P +        
Sbjct: 117 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS-------- 163
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 164 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 37/234 (15%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHE---TLVAVKVLNLQHRGAS-KSFIAECQALRSIRHR 218
           L   +G G FG V K    H       T VAVK+L      +  +  ++E   L+ + H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------------DA 260
           +++K+  +C       +    L+ E    GSL  +L  +R                  D 
Sbjct: 87  HVIKLYGACSQ-----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 261 P--RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
           P  R L +   +S A  ++  ++YL    E  +VH DL   N+L+       +SDFGL++
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            + E               +  V + A E       +T  DV+SFG+LL E+ T
Sbjct: 199 DVYEEDSYVKRSQG-----RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHE---TLVAVKVLNLQHRGAS-KSFIAECQALRSIRHR 218
           L   +G G FG V K    H       T VAVK+L      +  +  ++E   L+ + H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------------DA 260
           +++K+  +C       +    L+ E    GSL  +L  +R                  D 
Sbjct: 87  HVIKLYGACSQ-----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 261 P--RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
           P  R L +   +S A  ++  ++YL    E  +VH DL   N+L+       +SDFGL++
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            + E               +  V + A E       +T  DV+SFG+LL E+ T
Sbjct: 199 DVYEEDSXVKRSQG-----RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 95/236 (40%), Gaps = 31/236 (13%)
Query: 146 VLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF 205
           V R S+ NL   +DG+ ++  IG GS+    + +    + E   AVKV++   R  S+  
Sbjct: 15  VPRGSHMNLV-FSDGYVVKETIGVGSYSECKRCVHKATNME--YAVKVIDKSKRDPSEEI 71
Query: 206 IAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNRDAPRNL 264
                 LR  +H N++ +        +       LV ELM  G L ++ L     + R  
Sbjct: 72  EI---LLRYGQHPNIITLKDV-----YDDGKHVYLVTELMRGGELLDKILRQKFFSEREA 123
Query: 265 NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL----TAHVSDFGLAKFL 320
           +      +   +  T+EYLH      +VH DLKPSN+L   E        + DFG AK L
Sbjct: 124 SF-----VLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQL 175
Query: 321 PEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                              T  + APE           D++S GILL  M  G  P
Sbjct: 176 RAENGLLMTPCY-------TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N+
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNI 83
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 84  VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 140
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 141 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 189
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 190 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 242

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
            ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 75
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DV 276
           +V++     S    G   + +   L+++   E    + R   R    L  + + +    +
Sbjct: 76  IVRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 132
Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXV 335
             +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V
Sbjct: 133 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNV 181
Query: 336 GVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
               +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 182 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 235

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
            ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 74
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DV 276
           +V++     S    G   + +   L+++   E    + R   R    L  + + +    +
Sbjct: 75  IVRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXV 335
             +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNV 180
Query: 336 GVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
               +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 36/225 (16%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSI-RHRNLV 221
           +GAG+FG V +        +D    VAVK+L +  H    ++ ++E + +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            ++ +C      G     ++ E    G L   L+  R   R L      +IA    ST +
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDL---LNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 282 YLHHYCETP----------IVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
            LH   +             +H D+   NVLL     A + DFGLA+ +   +       
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---- 221
Query: 332 XXXVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                VKG     V + APE       +   DV+S+GILL E+F+
Sbjct: 222 -----VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 27/221 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ + H N+VK++
Sbjct: 15  IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 72
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V    N    LV+E + +  L++++  +      L L++  S    +   L + H
Sbjct: 73  ----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 124
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y 
Sbjct: 125 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYR 174
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 175 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 211

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N+
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNI 94
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 95  VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 151
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 152 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 200
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 201 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 253

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRH 217
           F    L+G G+FG V   +          A+K+L  +    +      + E + L++ RH
Sbjct: 7   FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             L     + +   FQ +D    V E    G L  + HL+R+  R     +      ++ 
Sbjct: 65  PFL-----TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFTEERARFYGAEIV 115
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAAXXXXXXXXXXVG 336
           S LEYLH      +V+ D+K  N++LD +    ++DFGL K  + + A            
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC------ 166
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 167 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNI 154
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 155 VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 212 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 260
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 261 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 313

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 27/209 (12%)
Query: 173 GSVYKGIFDHDDHETLVAVKVLNLQHRGASKS--FIAECQALRSIRHRNLVKIITSCVSV 230
           G ++KG +  +D    + VKVL ++     KS  F  EC  LR   H N++ ++ +C S 
Sbjct: 24  GELWKGRWQGND----IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS- 78
Query: 231 DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP 290
                    L+   M  GSL   LH   +    ++  Q +  A+D+A  + +L H  E  
Sbjct: 79  --PPAPHPTLITHWMPYGSLYNVLHEGTNF--VVDQSQAVKFALDMARGMAFL-HTLEPL 133
Query: 291 IVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGM 350
           I    L   +V++D ++TA +S     KF                G      + APE   
Sbjct: 134 IPRHALNSRSVMIDEDMTARIS-MADVKF-----------SFQSPGRMYAPAWVAPEALQ 181
Query: 351 GSEVST---SGDVYSFGILLLEMFTGKGP 376
                T   S D++SF +LL E+ T + P
Sbjct: 182 KKPEDTNRRSADMWSFAVLLWELVTREVP 210

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN 219
            ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCN 74
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DV 276
           +V++     S    G   + +   L+++   E    + R   R    L  + + +    +
Sbjct: 75  IVRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXV 335
             +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNV 180
Query: 336 GVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
               +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 181 SXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 27/221 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ + H N+VK++
Sbjct: 10  IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V    N    LV+E + +  L++++  +      L L++  S    +   L + H
Sbjct: 68  ----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 119
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y 
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-------TLWYR 169
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHE---TLVAVKVLNLQHRGAS-KSFIAECQALRSIRHR 218
           L   +G G FG V K    H       T VAVK+L      +  +  ++E   L+ + H 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------------DA 260
           +++K+  +C       +    L+ E    GSL  +L  +R                  D 
Sbjct: 87  HVIKLYGACSQ-----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 261 P--RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
           P  R L +   +S A  ++  ++YL    E  +VH DL   N+L+       +SDFGL++
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            + E               +  V + A E       +T  DV+SFG+LL E+ T
Sbjct: 199 DVYEEDSXVKRSQG-----RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N+
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNI 88
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 89  VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 145
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 146 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 194
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 195 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 247

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 27/221 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ + H N+VK++
Sbjct: 10  IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V    N    LV+E + +  L++++  +      L L++  S    +   L + H
Sbjct: 68  ----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 119
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y 
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-------TLWYR 169
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++   +   
Sbjct: 87  GLLNVFTPQKSLEEFQDV---YIVMELM-DANLSQVIQMELDHERMSYLLYQMLCGI--- 139
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
              ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 140 ---KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV-- 187
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
             T  Y APE  +G     + D++S G ++ EM  G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N+
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNI 79
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 80  VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 137 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 185
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 186 XICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 238

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRH 217
           F    L+G G+FG V   +          A+K+L  +    +      + E + L++ RH
Sbjct: 7   FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             L     + +   FQ +D    V E    G L  + HL+R+  R     +      ++ 
Sbjct: 65  PFL-----TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFTEERARFYGAEIV 115
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAAXXXXXXXXXXVG 336
           S LEYLH      +V+ D+K  N++LD +    ++DFGL K  + + A            
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC------ 166
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 167 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R  ++    E Q +R + H N+
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNI 80
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 81  VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 138 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 186
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 187 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 239

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 35/216 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++   +   
Sbjct: 87  GLLNVFTPQKSLEEFQDV---YIVMELM-DANLSQVIQMELDHERMSYLLYQMLCGI--- 139
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
                  H     I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 140 ------KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR----TAGTSFMMTPYVV-- 187
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
             T  Y APE  +G     + D++S G ++ EM  G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 34/238 (14%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG GS G V   I        LVAVK ++L+ +   +    E   +R  +H N+V++  S
Sbjct: 28  IGEGSTGIV--CIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E +  G+L + +   R     +N  Q  ++ + V   L  LH  
Sbjct: 86  -----YLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQ 135
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFG----LAKFLPEAAXXXXXXXXXXVGVKGTVG 342
               ++H D+K  ++LL  +    +SDFG    ++K +P               + GT  
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX-----------LVGTPY 181
Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPT-NEMFTGNLTLHNFVKEALPERL 399
           + APE           D++S GI+++EM  G+ P  NE     L     +++ LP RL
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPRL 236

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRH 217
           F    L+G G+FG V   +          A+K+L  +    +      + E + L++ RH
Sbjct: 7   FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             L     + +   FQ +D    V E    G L  + HL+R+  R     +      ++ 
Sbjct: 65  PFL-----TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFTEERARFYGAEIV 115
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAAXXXXXXXXXXVG 336
           S LEYLH      +V+ D+K  N++LD +    ++DFGL K  + + A            
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC------ 166
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 167 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 34/238 (14%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG GS G V   I        LVAVK ++L+ +   +    E   +R  +H N+V++  S
Sbjct: 32  IGEGSTGIV--CIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 89
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
                +   D   +V E +  G+L + +   R     +N  Q  ++ + V   L  LH  
Sbjct: 90  -----YLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQ 139
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFG----LAKFLPEAAXXXXXXXXXXVGVKGTVG 342
               ++H D+K  ++LL  +    +SDFG    ++K +P               + GT  
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX-----------LVGTPY 185
Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPT-NEMFTGNLTLHNFVKEALPERL 399
           + APE           D++S GI+++EM  G+ P  NE     L     +++ LP RL
Sbjct: 186 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPRL 240

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRH 217
           F    L+G G+FG V   +          A+K+L  +    +      + E + L++ RH
Sbjct: 12  FDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             L     + +   FQ +D    V E    G L  + HL+R+  R     +      ++ 
Sbjct: 70  PFL-----TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRE--RVFTEERARFYGAEIV 120
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF-LPEAAXXXXXXXXXXVG 336
           S LEYLH      +V+ D+K  N++LD +    ++DFGL K  + + A            
Sbjct: 121 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFC------ 171
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 172 --GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII 86
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++   +     
Sbjct: 87  SLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI----- 139
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
            ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 140 -KHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLAR----TAGTSFMMTPYVV---- 187
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 32/231 (13%)
Query: 162 SLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRS 214
           S+EN      IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H N+VK++     V    N    LV+E + +  L+ ++  +      L L++  S   
Sbjct: 62  LNHPNIVKLL----DVIHTENKL-YLVFEFL-HQDLKTFMDASALTGIPLPLIK--SYLF 113
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
            +   L + H +    ++H DLKP N+L++ E    ++DFGLA+                
Sbjct: 114 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 335 VGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                T+ Y APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 169 -----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 210

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 30/225 (13%)
Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALR 213
           A + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +   
Sbjct: 9   ALEDFEIGRPLGKGKFGNVY--LAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLS 271
            +RH N++++        F       L+ E    G++  E   L++ D  R    +    
Sbjct: 67  HLRHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYI---- 117
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
              ++A+ L Y H      ++H D+KP N+LL       +++FG +   P +        
Sbjct: 118 --TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSS-------- 164
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 165 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 27/221 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ + H N+VK++
Sbjct: 12  IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 69
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V    N    LV+E + +  L++++  +      L L++  S    +   L + H
Sbjct: 70  ----DVIHTENKL-YLVFEFL-HQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 121
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y 
Sbjct: 122 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-------TLWYR 171
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 208

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 90/223 (40%), Gaps = 28/223 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           F    ++G+G+F  V+  +        L A+K +         S   E   L+ I+H N+
Sbjct: 11  FIFMEVLGSGAFSEVF--LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD-VAST 279
           V +        ++      LV +L+  G L      +R   R +   +  S+ +  V S 
Sbjct: 69  VTL-----EDIYESTTHYYLVMQLVSGGEL-----FDRILERGVYTEKDASLVIQQVLSA 118
Query: 280 LEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
           ++YLH   E  IVH DLKP N+L    +      ++DFGL+K                  
Sbjct: 119 VKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC------- 168
Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
             GT GY APE       S + D +S G++   +  G  P  E
Sbjct: 169 --GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L + RH N++ I   
Sbjct: 33  IGEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDI 91
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 143
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 196
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 35/216 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII 86
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++   +   
Sbjct: 87  GLLNVFTPQKSLEEFQDV---YIVMELM-DANLSQVIQMELDHERMSYLLYQMLCGI--- 139
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
                  H     I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 140 ------KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLAR----TAGTSFMMTPYVV-- 187
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
             T  Y APE  +G     + D++S G ++ EM  G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 80
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++   +     
Sbjct: 81  SLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI----- 133
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
            ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 134 -KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV---- 181
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 182 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 222 KIITSCVSVDFQGNDFEA--LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++   +     
Sbjct: 125 SLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI----- 177
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
            ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 178 -KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV---- 225
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++   +     
Sbjct: 87  SLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI----- 139
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
            ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 140 -KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV---- 187
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 25  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++   +     
Sbjct: 80  SLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI----- 132
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
            ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 133 -KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV---- 180
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKII 224
           IG G++G VYK    +     +VA+K + L  +  G   + I E   L+ + H N+VK++
Sbjct: 10  IGEGTYGVVYKA--RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V    N    LV+E  V+  L+ ++  +      L L++  S    +   L + H
Sbjct: 68  ----DVIHTENKL-YLVFE-HVHQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 119
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
            +    ++H DLKP N+L++ E    ++DFGLA+                     T+ Y 
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-------TLWYR 169
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           APE  +G +  ST+ D++S G +  EM T +     +F G+
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRA----LFPGD 206

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++   +     
Sbjct: 87  SLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI----- 139
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
            ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 140 -KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV---- 187
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++   +     
Sbjct: 88  SLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI----- 140
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
            ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 141 -KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV---- 188
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 31  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 85
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++   +     
Sbjct: 86  SLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI----- 138
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
            ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 139 -KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV---- 186
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 187 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 33  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++   +     
Sbjct: 88  SLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI----- 140
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
            ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 141 -KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV---- 188
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 101/252 (40%), Gaps = 43/252 (17%)
Query: 136 STPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN 195
           + P +A L     +   N    +D F +E+ +G G+   VY+        +   A+KVL 
Sbjct: 30  AAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRC--KQKGTQKPYALKVLK 87
Query: 196 LQHRGASKSFI-AECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL---- 250
              +   K  +  E   L  + H N++K+        F+     +LV EL+  G L    
Sbjct: 88  ---KTVDKKIVRTEIGVLLRLSHPNIIKLKEI-----FETPTEISLVLELVTGGELFDRI 139
Query: 251 -EEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL-----D 304
            E+  +  RDA            A  V   LE + +  E  IVH DLKP N+L      D
Sbjct: 140 VEKGYYSERDA------------ADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPD 187
Query: 305 GELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFG 364
             L   ++DFGL+K +                V GT GY APE   G       D++S G
Sbjct: 188 APL--KIADFGLSKIVEHQVLMKT--------VCGTPGYCAPEILRGCAYGPEVDMWSVG 237
Query: 365 ILLLEMFTGKGP 376
           I+   +  G  P
Sbjct: 238 IITYILLCGFEP 249

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 34  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 88
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++   +   
Sbjct: 89  GLLNVFTPQKSLEEFQDV---YIVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI--- 141
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
              ++LH      I+H DLKPSN+++  + T  + DFGLA+                V  
Sbjct: 142 ---KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAGTSFMMVPF 187
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
             T  Y APE  +G     + D++S G ++ EM  G
Sbjct: 188 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 92/189 (48%), Gaps = 23/189 (12%)
Query: 189 VAVKVLN--LQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE--ALVYEL 244
           VAVK L+   Q++  +K    E   L+ + H+N++ ++ +  +      +F+   LV EL
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMEL 110
Query: 245 MVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD 304
           M + +L + +H+  D  R   LL ++   +      ++LH      I+H DLKPSN+++ 
Sbjct: 111 M-DANLCQVIHMELDHERMSYLLYQMLCGI------KHLH---SAGIIHRDLKPSNIVVK 160
Query: 305 GELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFG 364
            + T  + DFGLA+     A          V    T  Y APE  +G   + + D++S G
Sbjct: 161 SDCTLKILDFGLAR----TACTNFMMTPYVV----TRYYRAPEVILGMGYAANVDIWSVG 212
Query: 365 ILLLEMFTG 373
            ++ E+  G
Sbjct: 213 CIMGELVKG 221

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 26  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 80
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++   +     
Sbjct: 81  SLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI----- 133
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
            ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 134 -KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV---- 181
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 182 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLV 221
           IG+G+ G V   Y  + D +     VA+K L+   Q++  +K    E   ++ + H+N++
Sbjct: 70  IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 222 KIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
            ++ +  +      +F+   LV ELM + +L + + +  D  R   LL ++   +     
Sbjct: 125 SLL-NVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI----- 177
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
            ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V    
Sbjct: 178 -KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV---- 225
Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 35  IGEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSND--------HICYFLYQILRGLKYIH 145
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 198
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 31  IGEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 141
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 194
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKI--I 224
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I  I
Sbjct: 31  IGEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 225 TSCVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
               +++   + +  +V +LM      L +  HL+ D                +   L+Y
Sbjct: 90  IRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKY 139
Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
           +H      ++H DLKPSN+LL+      + DFGLA+     A               T  
Sbjct: 140 IH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR----VADPDHDHTGFLTEYVATRW 192
Query: 343 YAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           Y APE  + S+  + S D++S G +L EM + +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 33  IGEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 91
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 143
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 196
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 51  IGEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 109
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 110 IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 161
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 162 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 214
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 36  IGEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 146
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 147 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 199
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 37  IGEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 95
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 96  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 147
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 148 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 200
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 201 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 28  IGEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 86
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 87  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 138
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 139 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 191
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 192 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 35  IGEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 145
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 198
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++   +   
Sbjct: 87  GLLNVFTPQKSLEEFQD---VYIVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI--- 139
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
              ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 140 ---KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPEVV-- 187
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
             T  Y APE  +G     + D++S G ++ EM  G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 34/225 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALRSI 215
           + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +    +
Sbjct: 12  EDFDIGRPLGKGKFGNVY--LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHL 69
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLSIA 273
           RH N++++        F       L+ E    G++  E   L+R D  R    +      
Sbjct: 70  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI------ 118
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAAXXXXXXX 331
            ++A+ L Y H      ++H D+KP N+LL  +GEL   ++DFG +   P +        
Sbjct: 119 TELANALSYCH---SKRVIHRDIKPENLLLGSNGELK--IADFGWSVHAPSS-------- 165
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   G  P
Sbjct: 166 -RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 44/99 (44%), Gaps = 2/99 (2%)
Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
           N   G+IP  +  LRG+  LDLS N L GRIP+ +     L  ++LS N+  G +P  G 
Sbjct: 663 NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ 722
Query: 64  FSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRS 102
           F          N  LCG    L  C  S  +      RS
Sbjct: 723 FETFPPAKFLNNPGLCG--YPLPRCDPSNADGYAHHQRS 759

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKI--I 224
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I  I
Sbjct: 31  IGEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 225 TSCVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
               +++   + +  +V +LM      L +  HL+ D                +   L+Y
Sbjct: 90  IRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKY 139
Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
           +H      ++H DLKPSN+LL+      + DFGLA+     A               T  
Sbjct: 140 IH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR----VADPDHDHTGFLTEYVATRW 192
Query: 343 YAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           Y APE  + S+  + S D++S G +L EM + +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 29  IGEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 139
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 140 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 192
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 35  IGEGAYGMVCSA-YDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 145
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 198
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/342 (20%), Positives = 141/342 (41%), Gaps = 56/342 (16%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+FG V+K        +  +   ++  +  G   + + E + L+ ++H N+V +I  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 227 C---------------VSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           C               +  DF  +D   L+  ++V  +L E         R + +L    
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-------IKRVMQML---- 133
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
                 + L Y+H      I+H D+K +NVL+  +    ++DFGLA+    A        
Sbjct: 134 -----LNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 332 XXXVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF 390
              V    T+ Y  PE  +G  +     D++  G ++ EM+T + P   +  GN   H  
Sbjct: 186 XNRV---VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSP---IMQGNTEQHQL 238
Query: 391 VKEALPERLAEIVDPVL--------LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIG 442
              AL  +L   + P +        L E+ E    +    K R +++      + ++   
Sbjct: 239 ---ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 295
Query: 443 VICSSELPRERMNMEEVAAQLLSFRNKLVKNVRGQPATYVTA 484
           ++     P +R++ ++       + + +  +++G  +T++T+
Sbjct: 296 LVLD---PAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTS 334

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 35/224 (15%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           + L+  IG G+F  V   +  H      VAVK+++      +  +    E + ++ + H 
Sbjct: 17  YRLQKTIGKGNFAKV--KLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+VK+        F+  + E  +Y +M   S  E         R      R      + S
Sbjct: 75  NIVKL--------FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVS 125
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            ++Y H   +  IVH DLK  N+LLDG++   ++DFG +                 VG K
Sbjct: 126 AVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFSN-------------EFTVGNK 169
Query: 339 -----GTVGYAAPEYGMGSEVS-TSGDVYSFGILLLEMFTGKGP 376
                G+  YAAPE   G +      DV+S G++L  + +G  P
Sbjct: 170 LDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 29  IGEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 87
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 88  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 139
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 140 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 192
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 193 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 35  IGEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 145
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 198
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKI--I 224
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I  I
Sbjct: 35  IGEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDI 93
Query: 225 TSCVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
               +++   + +  +V +LM      L +  HL+ D                +   L+Y
Sbjct: 94  IRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKY 143
Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
           +H      ++H DLKPSN+LL+      + DFGLA+     A               T  
Sbjct: 144 IH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR----VADPDHDHTGFLTEYVATRW 196
Query: 343 YAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           Y APE  + S+  + S D++S G +L EM + +
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 133/290 (45%), Gaps = 59/290 (20%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH------RGASKSF--IAECQ 210
           D + +   +G+G+ G V K  F+    +  VA+K+++ +       R A  +     E +
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLL 267
            L+ + H  ++KI        F   D+  +V ELM  G L + +  N+   +A   L   
Sbjct: 68  ILKKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAA 324
           Q L +AV      +YLH   E  I+H DLKP NVLL   + +    ++DFG +K L E +
Sbjct: 122 QML-LAV------QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGPTNE 379
                       + GT  Y APE  +   V T+G     D +S G++L    +G  P +E
Sbjct: 172 LMRT--------LCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
Query: 380 MFTGNLTL--------HNFVKEA---LPERLAEIVDPVLLVEREEGETSE 418
             T  ++L        +NF+ E    + E+  ++V  +L+V+ +   T+E
Sbjct: 222 HRT-QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 270

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/342 (20%), Positives = 141/342 (41%), Gaps = 56/342 (16%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+FG V+K        +  +   ++  +  G   + + E + L+ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 227 CVS---------------VDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           C +                DF  +D   L+  ++V  +L E         R + +L    
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-------IKRVMQML---- 134
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
                 + L Y+H      I+H D+K +NVL+  +    ++DFGLA+    A        
Sbjct: 135 -----LNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 332 XXXVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF 390
              V    T+ Y  PE  +G  +     D++  G ++ EM+T + P   +  GN   H  
Sbjct: 187 XNRV---VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSP---IMQGNTEQHQL 239
Query: 391 VKEALPERLAEIVDPVL--------LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIG 442
              AL  +L   + P +        L E+ E    +    K R +++      + ++   
Sbjct: 240 ---ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 296
Query: 443 VICSSELPRERMNMEEVAAQLLSFRNKLVKNVRGQPATYVTA 484
           ++     P +R++ ++       + + +  +++G  +T++T+
Sbjct: 297 LVLD---PAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTS 335

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKI--I 224
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I  I
Sbjct: 31  IGEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 225 TSCVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
               +++   + +  +V +LM      L +  HL+ D                +   L+Y
Sbjct: 90  IRAPTIEQMKDVY--IVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKY 139
Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
           +H      ++H DLKPSN+LL+      + DFGLA+     A               T  
Sbjct: 140 IH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLAR----VADPDHDHTGFLTEYVATRW 192
Query: 343 YAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           Y APE  + S+  + S D++S G +L EM + +
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 39  IGEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 97
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 98  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 149
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 150 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 202
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 203 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 31  IGEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 89
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 90  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 141
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 142 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 194
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 195 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 31/223 (13%)
Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI--RHRN 219
           +L   +G G +G V++G++    H   VAVK+ + +     +S+  E +   ++  RH N
Sbjct: 11  ALVECVGKGRYGEVWRGLW----HGESVAVKIFSSRD---EQSWFRETEIYNTVLLRHDN 63
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           ++  I S ++          L+     +GSL ++L      P        L +AV  A  
Sbjct: 64  ILGFIASDMTSRNSSTQL-WLITHYHEHGSLYDFLQRQTLEPH-----LALRLAVSAACG 117
Query: 280 LEYLH-----HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
           L +LH        +  I H D K  NVL+   L   ++D GLA    + +          
Sbjct: 118 LAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR 177
Query: 335 VGVKGTVGYAAPEYGMGSEVSTS-------GDVYSFGILLLEM 370
           VG K    Y APE  +  ++ T         D+++FG++L E+
Sbjct: 178 VGTK---RYMAPEV-LDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 38/221 (17%)
Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHRNLVKI 223
           ++G GSFG V K        E   AVKV+N        + + + E + L+ + H N++K+
Sbjct: 29  MLGKGSFGEVLKCKDRITQQE--YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR----DAPRNLNLLQRLSIAVDVAS 278
                    + +    +V EL   G L +E +   R    DA R         I   V S
Sbjct: 87  FEI-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------IIKQVFS 132
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
            + Y+H +    IVH DLKP N+LL+    +    + DFGL+    +             
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI----- 184
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              GT  Y APE   G+      DV+S G++L  + +G  P
Sbjct: 185 ---GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 133/290 (45%), Gaps = 59/290 (20%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH------RGASKSF--IAECQ 210
           D + +   +G+G+ G V K  F+    +  VA+K+++ +       R A  +     E +
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLL 267
            L+ + H  ++KI        F   D+  +V ELM  G L + +  N+   +A   L   
Sbjct: 68  ILKKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAA 324
           Q L +AV      +YLH   E  I+H DLKP NVLL   + +    ++DFG +K L E +
Sbjct: 122 QML-LAV------QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGPTNE 379
                       + GT  Y APE  +   V T+G     D +S G++L    +G  P +E
Sbjct: 172 LMRT--------LCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
Query: 380 MFTGNLTL--------HNFVKEA---LPERLAEIVDPVLLVEREEGETSE 418
             T  ++L        +NF+ E    + E+  ++V  +L+V+ +   T+E
Sbjct: 222 HRT-QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 270

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K + LQ +        E Q +R + H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKV-LQGKAFKNR---ELQIMRKLDHCNI 75
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 76  VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 181
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 29/237 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K + LQ +        E Q +R + H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKV-LQGKAFKNR---ELQIMRKLDHCNI 75
Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVA 277
           V++     S    G   + +   L+++   E    + R   R    L  + + +    + 
Sbjct: 76  VRLRYFFYS---SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVG 336
            +L Y+H +    I H D+KP N+LLD +     + DFG AK L              V 
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVS 181
Query: 337 VKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
              +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 30/228 (13%)
Query: 159 DGFSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLN----LQHRGASKSFIAECQAL 212
           + F L  ++G G++G V+  + I  HD  + L A+KVL     +Q    ++    E Q L
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTGK-LYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
             IR    +  +       FQ      L+ + +  G L  + HL++   R       + I
Sbjct: 113 EHIRQSPFLVTLHYA----FQTETKLHLILDYINGGEL--FTHLSQ---RERFTEHEVQI 163
Query: 273 AV-DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK-FLPEAAXXXXXX 330
            V ++   LE+LH   +  I++ D+K  N+LLD      ++DFGL+K F+ +        
Sbjct: 164 YVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 220
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEV--STSGDVYSFGILLLEMFTGKGP 376
                   GT+ Y AP+   G +     + D +S G+L+ E+ TG  P
Sbjct: 221 C-------GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 133/290 (45%), Gaps = 59/290 (20%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH------RGASKSF--IAECQ 210
           D + +   +G+G+ G V K  F+    +  VA+K+++ +       R A  +     E +
Sbjct: 9   DEYIMSKTLGSGACGEV-KLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVETEIE 66
Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLL 267
            L+ + H  ++KI        F   D+  +V ELM  G L + +  N+   +A   L   
Sbjct: 67  ILKKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAA 324
           Q L +AV      +YLH   E  I+H DLKP NVLL   + +    ++DFG +K L E +
Sbjct: 121 QML-LAV------QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 170
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGPTNE 379
                       + GT  Y APE  +   V T+G     D +S G++L    +G  P +E
Sbjct: 171 LMRT--------LCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 220
Query: 380 MFTGNLTL--------HNFVKEA---LPERLAEIVDPVLLVEREEGETSE 418
             T  ++L        +NF+ E    + E+  ++V  +L+V+ +   T+E
Sbjct: 221 HRT-QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 269

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L + RH N++ I   
Sbjct: 33  IGEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDI 91
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 92  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 143
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 144 ---SANVLHRDLKPSNLLLNTTSDLKICDFGLAR----VADPDHDHTGFLTEYVATRWYR 196
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 197 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 133/290 (45%), Gaps = 59/290 (20%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH------RGASKSF--IAECQ 210
           D + +   +G+G+ G V K  F+    +  VA+K+++ +       R A  +     E +
Sbjct: 10  DEYIMSKTLGSGACGEV-KLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLL 267
            L+ + H  ++KI        F   D+  +V ELM  G L + +  N+   +A   L   
Sbjct: 68  ILKKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAA 324
           Q L +AV      +YLH   E  I+H DLKP NVLL   + +    ++DFG +K L E +
Sbjct: 122 QML-LAV------QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGPTNE 379
                       + GT  Y APE  +   V T+G     D +S G++L    +G  P +E
Sbjct: 172 LMRT--------LCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
Query: 380 MFTGNLTL--------HNFVKEA---LPERLAEIVDPVLLVEREEGETSE 418
             T  ++L        +NF+ E    + E+  ++V  +L+V+ +   T+E
Sbjct: 222 HRT-QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 270

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++   +   
Sbjct: 87  GLLNVFTPQKSLEEFQD---VYIVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI--- 139
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
              ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 140 ---KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV-- 187
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
             T  Y APE  +G     + D++S G ++ EM  G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 34/225 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALRSI 215
           + F +   +G G FG+VY  +      + ++A+KVL    L+  G       E +    +
Sbjct: 12  EDFDIGRPLGKGKFGNVY--LARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHL 69
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR-DAPRNLNLLQRLSIA 273
           RH N++++        F       L+ E    G++  E   L+R D  R    +      
Sbjct: 70  RHPNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYI------ 118
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAAXXXXXXX 331
            ++A+ L Y H      ++H D+KP N+LL  +GEL   ++DFG +   P +        
Sbjct: 119 TELANALSYCH---SKRVIHRDIKPENLLLGSNGELK--IADFGWSVHAPSSRRDT---- 169
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT+ Y  PE   G       D++S G+L  E   G  P
Sbjct: 170 -----LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 35  IGEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 93
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 94  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 145
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 146 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLXEXVATRWYR 198
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 91/189 (48%), Gaps = 23/189 (12%)
Query: 189 VAVKVLN--LQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE--ALVYEL 244
           VAVK L+   Q++  +K    E   L+ + H+N++ ++ +  +      +F+   LV EL
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMEL 108
Query: 245 MVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD 304
           M + +L + +H+  D  R   LL ++   +      ++LH      I+H DLKPSN+++ 
Sbjct: 109 M-DANLCQVIHMELDHERMSYLLYQMLCGI------KHLH---SAGIIHRDLKPSNIVVK 158
Query: 305 GELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFG 364
            + T  + DFGLA+     A          V    T  Y APE  +G     + D++S G
Sbjct: 159 SDCTLKILDFGLAR----TASTNFMMTPYVV----TRYYRAPEVILGMGYKENVDIWSVG 210
Query: 365 ILLLEMFTG 373
            ++ E+  G
Sbjct: 211 CIMGELVKG 219

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 36  IGEGAYGMVCSA-YDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 94
Query: 227 CVSVDFQGNDFEALVYELMVNG--SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
             +   +      +V +LM      L +  HL+ D                +   L+Y+H
Sbjct: 95  IRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSND--------HICYFLYQILRGLKYIH 146
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 ++H DLKPSN+LL+      + DFGLA+     A               T  Y 
Sbjct: 147 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR----VADPDHDHTGFLXEXVATRWYR 199
Query: 345 APEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
           APE  + S+  + S D++S G +L EM + +
Sbjct: 200 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 33  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 87
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++   +   
Sbjct: 88  GLLNVFTPQKSLEEFQDV---YIVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI--- 140
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
              ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 141 ---KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV-- 188
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
             T  Y APE  +G     + D++S G ++ EM  G
Sbjct: 189 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++   +   
Sbjct: 87  GLLNVFTPQKSLEEFQDV---YIVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI--- 139
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
              ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 140 ---KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV-- 187
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
             T  Y APE  +G     + D++S G ++ EM  G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 33/224 (14%)
Query: 167 IGAGSFGSVYKG-IFDHDDHETLVAVKVLNLQHRGA---SKSFIAECQALRSIRHRNLVK 222
           +G   FG VYKG +F     E   AV +  L+ +      + F  E      ++H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV- 92
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHL------------NRDAPRNLNLLQRL 270
               C+      +   ++++    +G L E+L +            +R     L     +
Sbjct: 93  ----CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 148
Query: 271 SIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXX 328
            +   +A+ +EYL  HH     +VH DL   NVL+  +L   +SD GL + +  AA    
Sbjct: 149 HLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV-YAADYYK 202
Query: 329 XXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                 + ++    + APE  M  + S   D++S+G++L E+F+
Sbjct: 203 LLGNSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 133/290 (45%), Gaps = 59/290 (20%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH------RGASKSF--IAECQ 210
           D + +   +G+G+ G V K  F+    +  VA+K+++ +       R A  +     E +
Sbjct: 16  DEYIMSKTLGSGACGEV-KLAFERKTCKK-VAIKIISKRKFAIGSAREADPALNVETEIE 73
Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLL 267
            L+ + H  ++KI        F   D+  +V ELM  G L + +  N+   +A   L   
Sbjct: 74  ILKKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAA 324
           Q L +AV      +YLH   E  I+H DLKP NVLL   + +    ++DFG +K L E +
Sbjct: 128 QML-LAV------QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 177
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGPTNE 379
                       + GT  Y APE  +   V T+G     D +S G++L    +G  P +E
Sbjct: 178 LMRT--------LCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 227
Query: 380 MFTGNLTL--------HNFVKEA---LPERLAEIVDPVLLVEREEGETSE 418
             T  ++L        +NF+ E    + E+  ++V  +L+V+ +   T+E
Sbjct: 228 HRT-QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 276

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 33/224 (14%)
Query: 167 IGAGSFGSVYKG-IFDHDDHETLVAVKVLNLQHRGAS---KSFIAECQALRSIRHRNLVK 222
           +G   FG VYKG +F     E   AV +  L+ +      + F  E      ++H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV- 75
Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHL------------NRDAPRNLNLLQRL 270
               C+      +   ++++    +G L E+L +            +R     L     +
Sbjct: 76  ----CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 271 SIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXX 328
            +   +A+ +EYL  HH     +VH DL   NVL+  +L   +SD GL + +  AA    
Sbjct: 132 HLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV-YAADYYK 185
Query: 329 XXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                 + ++    + APE  M  + S   D++S+G++L E+F+
Sbjct: 186 LLGNSLLPIR----WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/77 (37%), Positives = 38/77 (49%)
Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
           N   G+IP  +  LRG+  LDLS N L GRIP+ +     L  ++LS N+  G +P  G 
Sbjct: 666 NDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQ 725
Query: 64  FSNSSAISLDGNVNLCG 80
           F          N  LCG
Sbjct: 726 FETFPPAKFLNNPGLCG 742

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 89/224 (39%), Gaps = 30/224 (13%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH 217
           +DG+ ++  IG GS+    + +    + E   AVKV++   R  S+        LR  +H
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNME--YAVKVIDKSKRDPSEEIEI---LLRYGQH 80
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNRDAPRNLNLLQRLSIAVDV 276
            N++ +        +       LV ELM  G L ++ L     + R  +      +   +
Sbjct: 81  PNIITLKDV-----YDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTI 130
Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGEL----TAHVSDFGLAKFLPEAAXXXXXXXX 332
             T+EYLH      +VH DLKPSN+L   E        + DFG AK L            
Sbjct: 131 GKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY 187
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                  T  + APE           D++S GILL  M  G  P
Sbjct: 188 -------TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 116/263 (44%), Gaps = 54/263 (20%)
Query: 190 AVKVLNLQHRGA---------SKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGNDFEA 239
           AVK++++   G+          ++ + E   LR +  H N++++  +     ++ N F  
Sbjct: 33  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFF 87
Query: 240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPS 299
           LV++LM  G L ++L         + L ++ +  + + + LE +    +  IVH DLKP 
Sbjct: 88  LVFDLMKKGELFDYL------TEKVTLSEKETRKI-MRALLEVICALHKLNIVHRDLKPE 140
Query: 300 NVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEY----------G 349
           N+LLD ++   ++DFG +  L                V GT  Y APE           G
Sbjct: 141 NILLDDDMNIKLTDFGFSCQLDPGEKLRE--------VCGTPSYLAPEIIECSMNDNHPG 192
Query: 350 MGSEVSTSGDVYSFGILLLEMFTGKGP---------TNEMFTGNLTLHNFVKEALPERLA 400
            G EV    D++S G+++  +  G  P            + +GN    +   +   + + 
Sbjct: 193 YGKEV----DMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 248
Query: 401 EIVDPVLLVEREEGETS-EANAH 422
           ++V   L+V+ ++  T+ EA AH
Sbjct: 249 DLVSRFLVVQPQKRYTAEEALAH 271

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 116/263 (44%), Gaps = 54/263 (20%)
Query: 190 AVKVLNLQHRGA---------SKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGNDFEA 239
           AVK++++   G+          ++ + E   LR +  H N++++  +     ++ N F  
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFF 100
Query: 240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPS 299
           LV++LM  G L ++L         + L ++ +  + + + LE +    +  IVH DLKP 
Sbjct: 101 LVFDLMKKGELFDYL------TEKVTLSEKETRKI-MRALLEVICALHKLNIVHRDLKPE 153
Query: 300 NVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEY----------G 349
           N+LLD ++   ++DFG +  L                V GT  Y APE           G
Sbjct: 154 NILLDDDMNIKLTDFGFSCQLDPGEKLR--------SVCGTPSYLAPEIIECSMNDNHPG 205
Query: 350 MGSEVSTSGDVYSFGILLLEMFTGKGP---------TNEMFTGNLTLHNFVKEALPERLA 400
            G EV    D++S G+++  +  G  P            + +GN    +   +   + + 
Sbjct: 206 YGKEV----DMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK 261
Query: 401 EIVDPVLLVEREEGETS-EANAH 422
           ++V   L+V+ ++  T+ EA AH
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAH 284

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 21/212 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G++G V    +D+ +   +   K+   +H+   +  + E + L   RH N++ I   
Sbjct: 51  IGEGAYGMVCSA-YDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 109
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWL---HLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
             +   +      LV  LM    L + L   HL+ D                +   L+Y+
Sbjct: 110 IRAPTIEQMKDVYLVTHLM-GADLYKLLKTQHLSND--------HICYFLYQILRGLKYI 160
Query: 284 HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
           H      ++H DLKPSN+LL+      + DFGLA+     A               T  Y
Sbjct: 161 H---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR----VADPDHDHTGFLTEYVATRWY 213
Query: 344 AAPEYGMGSE-VSTSGDVYSFGILLLEMFTGK 374
            APE  + S+  + S D++S G +L EM + +
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 24/172 (13%)
Query: 208 ECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL 267
           E   L+S+ H N++K+        F+   +  LV E    G L E + +NR      +  
Sbjct: 96  EISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQI-INR---HKFDEC 146
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAA 324
              +I   + S + YLH +    IVH D+KP N+LL+ +   L   + DFGL+ F  +  
Sbjct: 147 DAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                         GT  Y APE  +  + +   DV+S G+++  +  G  P
Sbjct: 204 KLRDRL--------GTAYYIAPEV-LKKKYNEKCDVWSCGVIMYILLCGYPP 246

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 41/227 (18%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G G+FG VYK    + +   L A KV+  +     + +I E + L +  H  +VK++ +
Sbjct: 27  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 227 -------CVSVDF-QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
                   + ++F  G   +A++ EL                 R L   Q   +   +  
Sbjct: 85  YYHDGKLWIMIEFCPGGAVDAIMLEL----------------DRGLTEPQIQVVCRQMLE 128
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            L +LH      I+H DLK  NVL+  E    ++DFG+       +              
Sbjct: 129 ALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGV-------SAKNLKTLQKRDSFI 178
Query: 339 GTVGYAAPEYGMGSEVSTS-----GDVYSFGILLLEMFTGKGPTNEM 380
           GT  + APE  M   +  +      D++S GI L+EM   + P +E+
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 27/220 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G G+FG VYK    + +   L A KV+  +     + +I E + L +  H  +VK++ +
Sbjct: 19  LGDGAFGKVYKA--KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 76
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEE-WLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
                +  +    ++ E    G+++   L L+R        L    I V     LE L+ 
Sbjct: 77  -----YYHDGKLWIMIEFCPGGAVDAIMLELDRG-------LTEPQIQVVCRQMLEALNF 124
Query: 286 YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAA 345
                I+H DLK  NVL+  E    ++DFG+       +              GT  + A
Sbjct: 125 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGV-------SAKNLKTLQKRDSFIGTPYWMA 177
Query: 346 PEYGMGSEVSTS-----GDVYSFGILLLEMFTGKGPTNEM 380
           PE  M   +  +      D++S GI L+EM   + P +E+
Sbjct: 178 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 217

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI--RHR 218
            +L   +G G +G V++G +  ++    VAVK+ + +     KS+  E +   ++  RH 
Sbjct: 39  ITLLECVGKGRYGEVWRGSWQGEN----VAVKIFSSRD---EKSWFRETELYNTVMLRHE 91
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N++  I S ++          L+      GSL ++L L       L+ +  L I + +AS
Sbjct: 92  NILGFIASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIAS 145
Query: 279 TLEYLH-----HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
            L +LH        +  I H DLK  N+L+       ++D GLA    ++          
Sbjct: 146 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 205
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSG-------DVYSFGILLLEM 370
            VG K    Y APE  +   +           D+++FG++L E+
Sbjct: 206 RVGTK---RYMAPEV-LDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 166 LIGAGSFGSVYKGIFDHDDHET----LVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
            +G G F   ++ I D D  E     +V   +L   H+    S   E    RS+ H+++V
Sbjct: 28  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVV 84
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA---PRNLNLLQRLSIAVDVAS 278
                     F+ NDF  +V EL    SL E LH  R A   P     L+++ +      
Sbjct: 85  GFHGF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGC---- 134
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
             +YLH      ++H DLK  N+ L+ +L   + DFGL       A            + 
Sbjct: 135 --QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGL-------ATKVEYDGERKKTLC 182
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           GT  Y APE       S   DV+S G ++  +  GK P
Sbjct: 183 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 166 LIGAGSFGSVYKGIFDHDDHET----LVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
            +G G F   ++ I D D  E     +V   +L   H+    S   E    RS+ H+++V
Sbjct: 24  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVV 80
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA---PRNLNLLQRLSIAVDVAS 278
                     F+ NDF  +V EL    SL E LH  R A   P     L+++ +      
Sbjct: 81  GFHGF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGC---- 130
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
             +YLH      ++H DLK  N+ L+ +L   + DFGL       A            + 
Sbjct: 131 --QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGL-------ATKVEYDGERKKTLC 178
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           GT  Y APE       S   DV+S G ++  +  GK P
Sbjct: 179 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 166 LIGAGSFGSVYKGIFDHDDHET----LVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
            +G G F   ++ I D D  E     +V   +L   H+    S   E    RS+ H+++V
Sbjct: 24  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVV 80
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA---PRNLNLLQRLSIAVDVAS 278
                     F+ NDF  +V EL    SL E LH  R A   P     L+++ +      
Sbjct: 81  GFHGF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGC---- 130
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
             +YLH      ++H DLK  N+ L+ +L   + DFGL       A            + 
Sbjct: 131 --QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGL-------ATKVEYDGERKKTLC 178
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           GT  Y APE       S   DV+S G ++  +  GK P
Sbjct: 179 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 38/221 (17%)
Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHRNLVKI 223
           ++G GSFG V K        E   AVKV+N        + + + E + L+ + H N++K+
Sbjct: 29  MLGKGSFGEVLKCKDRITQQE--YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR----DAPRNLNLLQRLSIAVDVAS 278
                    + +    +V EL   G L +E +   R    DA R         I   V S
Sbjct: 87  FEI-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------IIKQVFS 132
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
            + Y+H +    IVH DLKP N+LL+    +    + DFGL+    +             
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI----- 184
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              GT  Y APE   G+      DV+S G++L  + +G  P
Sbjct: 185 ---GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 33/229 (14%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSI 215
           + F +  +IG G+FG V   +    + + + A+K+LN   +  R  +  F  E    R +
Sbjct: 74  EDFEILKVIGRGAFGEV--AVVKLKNADKVFAMKILNKWEMLKRAETACFREE----RDV 127
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA-PRNLN--LLQRLSI 272
                 K IT+ +   FQ ++   LV +  V G L   L    D  P  +    L  + I
Sbjct: 128 LVNGDSKWITT-LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           A+D    L Y+H          D+KP N+L+D      ++DFG    L E          
Sbjct: 187 AIDSVHQLHYVHR---------DIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQ 232
Query: 333 XXVGVKGTVGYAAPEY-----GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             V V GT  Y +PE      G         D +S G+ + EM  G+ P
Sbjct: 233 SSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI--RHR 218
            +L   +G G +G V++G +  ++    VAVK+ + +     KS+  E +   ++  RH 
Sbjct: 10  ITLLECVGKGRYGEVWRGSWQGEN----VAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N++  I S ++          L+      GSL ++L L       L+ +  L I + +AS
Sbjct: 63  NILGFIASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIAS 116
Query: 279 TLEYLH-----HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
            L +LH        +  I H DLK  N+L+       ++D GLA    ++          
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSG-------DVYSFGILLLEM 370
            VG K    Y APE  +   +           D+++FG++L E+
Sbjct: 177 RVGTK---RYMAPEV-LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 31/224 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI--RHR 218
            +L   +G G +G V++G +  ++    VAVK+ + +     KS+  E +   ++  RH 
Sbjct: 10  ITLLECVGKGRYGEVWRGSWQGEN----VAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N++  I S ++          L+      GSL ++L L       L+ +  L I + +AS
Sbjct: 63  NILGFIASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIAS 116
Query: 279 TLEYLH-----HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
            L +LH        +  I H DLK  N+L+       ++D GLA    ++          
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSG-------DVYSFGILLLEM 370
            VG K    Y APE  +   +           D+++FG++L E+
Sbjct: 177 RVGTK---RYMAPEV-LDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 42/240 (17%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+FG V+K        +  +   ++  +  G   + + E + L+ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 227 C---------------VSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           C               +  DF  +D   L+  ++V  +L E         R + +L    
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE-------IKRVMQML---- 134
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
                 + L Y+H      I+H D+K +NVL+  +    ++DFGLA+    A        
Sbjct: 135 -----LNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 332 XXXVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF 390
              V    T+ Y  PE  +G  +     D++  G ++ EM+T + P   +  GN   H  
Sbjct: 187 XNRV---VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSP---IMQGNTEQHQL 239

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 38/221 (17%)
Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALRSIRHRNLVKI 223
           ++G GSFG V K        E   AVKV+N        + + + E + L+ + H N++K+
Sbjct: 29  MLGKGSFGEVLKCKDRITQQE--YAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNR----DAPRNLNLLQRLSIAVDVAS 278
                    + +    +V EL   G L +E +   R    DA R         I   V S
Sbjct: 87  FEI-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR---------IIKQVFS 132
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
            + Y+H +    IVH DLKP N+LL+    +    + DFGL+    +             
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI----- 184
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              GT  Y APE   G+      DV+S G++L  + +G  P
Sbjct: 185 ---GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 42/240 (17%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG G+FG V+K        +  +   ++  +  G   + + E + L+ ++H N+V +I  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 227 C---------------VSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           C               +  DF  +D   L+  ++V  +L E         R + +L    
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-------IKRVMQML---- 134
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
                 + L Y+H      I+H D+K +NVL+  +    ++DFGLA+    A        
Sbjct: 135 -----LNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 332 XXXVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF 390
              V    T+ Y  PE  +G  +     D++  G ++ EM+T + P   +  GN   H  
Sbjct: 187 XNRV---VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSP---IMQGNTEQHQL 239

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 44/207 (21%)
Query: 190 AVKVLNLQHRGA---------SKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGNDFEA 239
           AVK++++   G+          ++ + E   LR +  H N++++  +     ++ N F  
Sbjct: 46  AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFF 100
Query: 240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPS 299
           LV++LM  G L ++L         + L ++ +  + + + LE +    +  IVH DLKP 
Sbjct: 101 LVFDLMKKGELFDYL------TEKVTLSEKETRKI-MRALLEVICALHKLNIVHRDLKPE 153
Query: 300 NVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEY----------G 349
           N+LLD ++   ++DFG +  L                V GT  Y APE           G
Sbjct: 154 NILLDDDMNIKLTDFGFSCQLDPGEKLRE--------VCGTPSYLAPEIIECSMNDNHPG 205
Query: 350 MGSEVSTSGDVYSFGILLLEMFTGKGP 376
            G EV    D++S G+++  +  G  P
Sbjct: 206 YGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 10/106 (9%)
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           + +++  L YLH   E  I++ DLK  NVLLD E    ++D+G+ K              
Sbjct: 127 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGD 176
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
                 GT  Y APE   G +   S D ++ G+L+ EM  G+ P +
Sbjct: 177 TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 32/218 (14%)
Query: 166 LIGAGSFGSVYKGIFDHDDHET----LVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
            +G G F   ++ I D D  E     +V   +L   H+    S   E    RS+ H+++V
Sbjct: 48  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVV 104
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA---PRNLNLLQRLSIAVDVAS 278
                     F+ NDF  +V EL    SL E LH  R A   P     L+++ +      
Sbjct: 105 GFHGF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGC---- 154
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
             +YLH      ++H DLK  N+ L+ +L   + DFGLA  +                + 
Sbjct: 155 --QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-------LC 202
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           GT  Y APE       S   DV+S G ++  +  GK P
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 32/218 (14%)
Query: 166 LIGAGSFGSVYKGIFDHDDHET----LVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
            +G G F   ++ I D D  E     +V   +L   H+    S   E    RS+ H+++V
Sbjct: 22  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVV 78
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA---PRNLNLLQRLSIAVDVAS 278
                     F+ NDF  +V EL    SL E LH  R A   P     L+++ +      
Sbjct: 79  GFHGF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGC---- 128
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
             +YLH      ++H DLK  N+ L+ +L   + DFGLA  +                + 
Sbjct: 129 --QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-------LC 176
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           GT  Y APE       S   DV+S G ++  +  GK P
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 32/218 (14%)
Query: 166 LIGAGSFGSVYKGIFDHDDHET----LVAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
            +G G F   ++ I D D  E     +V   +L   H+    S   E    RS+ H+++V
Sbjct: 46  FLGKGGFAKCFE-ISDADTKEVFAGKIVPKSLLLKPHQREKMSM--EISIHRSLAHQHVV 102
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA---PRNLNLLQRLSIAVDVAS 278
                     F+ NDF  +V EL    SL E LH  R A   P     L+++ +      
Sbjct: 103 GFHGF-----FEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGC---- 152
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
             +YLH      ++H DLK  N+ L+ +L   + DFGLA  +                + 
Sbjct: 153 --QYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-------LC 200
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           GT  Y APE       S   DV+S G ++  +  GK P
Sbjct: 201 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 36/239 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGAS----KSFIAECQA 211
           D   L   +G G+FG V +   F  D   T   VAVK+L     GA+    ++ ++E + 
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 74
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD-------APRN 263
           L  I  H N+V ++ +C      G     +V E    G+L  +L   R+       AP +
Sbjct: 75  LIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 264 L-----NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
           L      L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            + +               +  + + APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 188 DIXKDPDXVRKG-----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI--RHRNL 220
           L+  IG G FG V++G +  ++    VAVK+ + +     +S+  E +  +++  RH N+
Sbjct: 10  LQESIGKGRFGEVWRGKWRGEE----VAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 62
Query: 221 VKIITSCVSVDFQGNDFEA---LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           +  I +    D + N       LV +   +GSL +  +LNR     + +   + +A+  A
Sbjct: 63  LGFIAA----DNKDNGTWTQLWLVSDYHEHGSLFD--YLNR---YTVTVEGMIKLALSTA 113
Query: 278 STLEYLHHYC-----ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           S L +LH        +  I H DLK  N+L+    T  ++D GLA     A         
Sbjct: 114 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 173
Query: 333 XXVGVKGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEM 370
             VG K    Y APE    S      E     D+Y+ G++  E+
Sbjct: 174 HRVGTK---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI--RHRNL 220
           L+  IG G FG V++G +  ++    VAVK+ + +     +S+  E +  +++  RH N+
Sbjct: 8   LQESIGKGRFGEVWRGKWRGEE----VAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 60
Query: 221 VKIITSCVSVDFQGNDFEA---LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           +  I +    D + N       LV +   +GSL +  +LNR     + +   + +A+  A
Sbjct: 61  LGFIAA----DNKDNGTWTQLWLVSDYHEHGSLFD--YLNR---YTVTVEGMIKLALSTA 111
Query: 278 STLEYLHHYC-----ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           S L +LH        +  I H DLK  N+L+    T  ++D GLA     A         
Sbjct: 112 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 171
Query: 333 XXVGVKGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEM 370
             VG K    Y APE    S      E     D+Y+ G++  E+
Sbjct: 172 HRVGTK---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI--RHRNL 220
           L+  IG G FG V++G +  ++    VAVK+ + +     +S+  E +  +++  RH N+
Sbjct: 13  LQESIGKGRFGEVWRGKWRGEE----VAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 65
Query: 221 VKIITSCVSVDFQGNDFEA---LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           +  I +    D + N       LV +   +GSL +  +LNR     + +   + +A+  A
Sbjct: 66  LGFIAA----DNKDNGTWTQLWLVSDYHEHGSLFD--YLNR---YTVTVEGMIKLALSTA 116
Query: 278 STLEYLHHYC-----ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           S L +LH        +  I H DLK  N+L+    T  ++D GLA     A         
Sbjct: 117 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 176
Query: 333 XXVGVKGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEM 370
             VG K    Y APE    S      E     D+Y+ G++  E+
Sbjct: 177 HRVGTK---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI--RHRNL 220
           L+  IG G FG V++G +  ++    VAVK+ + +     +S+  E +  +++  RH N+
Sbjct: 46  LQESIGKGRFGEVWRGKWRGEE----VAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 98
Query: 221 VKIITSCVSVDFQGNDFEA---LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           +  I    + D + N       LV +   +GSL +  +LNR     + +   + +A+  A
Sbjct: 99  LGFI----AADNKDNGTWTQLWLVSDYHEHGSLFD--YLNR---YTVTVEGMIKLALSTA 149
Query: 278 STLEYLHHYC-----ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           S L +LH        +  I H DLK  N+L+    T  ++D GLA     A         
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209
Query: 333 XXVGVKGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEM 370
             VG K    Y APE    S      E     D+Y+ G++  E+
Sbjct: 210 HRVGTK---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 36/239 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGAS----KSFIAECQA 211
           D   L   +G G+FG V +   F  D   T   VAVK+L     GA+    ++ ++E + 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD-------APRN 263
           L  I  H N+V ++ +C      G     +V E    G+L  +L   R+       AP +
Sbjct: 84  LIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 264 L-----NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
           L      L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            + +               +  + + APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 197 DIXKDPDXVRKG-----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 59/290 (20%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH------RGASKSF--IAECQ 210
           D + +   +G+G+ G V K  F+    +  VA+++++ +       R A  +     E +
Sbjct: 149 DEYIMSKTLGSGACGEV-KLAFERKTCKK-VAIRIISKRKFAIGSAREADPALNVETEIE 206
Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLL 267
            L+ + H  ++KI        F   D+  +V ELM  G L + +  N+   +A   L   
Sbjct: 207 ILKKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAA 324
           Q L +AV      +YLH   E  I+H DLKP NVLL   + +    ++DFG +K L E +
Sbjct: 261 QML-LAV------QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 310
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGPTNE 379
                       + GT  Y APE  +   V T+G     D +S G++L    +G  P +E
Sbjct: 311 LMRT--------LCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 360
Query: 380 MFTGNLTL--------HNFVKEA---LPERLAEIVDPVLLVEREEGETSE 418
             T  ++L        +NF+ E    + E+  ++V  +L+V+ +   T+E
Sbjct: 361 HRT-QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 409

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI--RHRNL 220
           L+  IG G FG V++G +  ++    VAVK+ + +     +S+  E +  +++  RH N+
Sbjct: 33  LQESIGKGRFGEVWRGKWRGEE----VAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 85
Query: 221 VKIITSCVSVDFQGNDFEA---LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           +  I    + D + N       LV +   +GSL +  +LNR     + +   + +A+  A
Sbjct: 86  LGFI----AADNKDNGTWTQLWLVSDYHEHGSLFD--YLNR---YTVTVEGMIKLALSTA 136
Query: 278 STLEYLHHYC-----ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           S L +LH        +  I H DLK  N+L+    T  ++D GLA     A         
Sbjct: 137 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 196
Query: 333 XXVGVKGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEM 370
             VG K    Y APE    S      E     D+Y+ G++  E+
Sbjct: 197 HRVGTK---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 10/106 (9%)
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           + +++  L YLH   E  I++ DLK  NVLLD E    ++D+G+ K              
Sbjct: 112 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGD 161
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
                 GT  Y APE   G +   S D ++ G+L+ EM  G+ P +
Sbjct: 162 TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 25/235 (10%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K + LQ +        E Q +R + H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKV-LQGKAFKNR---ELQIMRKLDHCNI 75
Query: 221 VKIITSCVSVDFQGND-FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           V++     S   + ++ +  LV + +         H +R A + L ++        +  +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSR-AKQTLPVIYVKLYMYQLFRS 134
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTA-HVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
           L Y+H +    I H D+KP N+LLD +     + DFG AK L              V   
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--------VRGEPNVSXI 183
Query: 339 GTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
            +  Y APE   G ++ ++S DV+S G +L E+  G+     +F G+  +   V+
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ----PIFPGDSGVDQLVE 234

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 49/104 (47%), Gaps = 10/104 (9%)
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           + +++  L YLH   E  I++ DLK  NVLLD E    ++D+G+ K              
Sbjct: 159 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGD 208
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                 GT  Y APE   G +   S D ++ G+L+ EM  G+ P
Sbjct: 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 35/224 (15%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI--RHRNL 220
           L+  IG G FG V++G +  ++    VAVK+ + +     +S+  E +  +++  RH N+
Sbjct: 7   LQESIGKGRFGEVWRGKWRGEE----VAVKIFSSRE---ERSWFREAEIYQTVMLRHENI 59
Query: 221 VKIITSCVSVDFQGNDFEA---LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           +  I +    D + N       LV +   +GSL +  +LNR     + +   + +A+  A
Sbjct: 60  LGFIAA----DNKDNGTWTQLWLVSDYHEHGSLFD--YLNR---YTVTVEGMIKLALSTA 110
Query: 278 STLEYLHHYC-----ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           S L +LH        +  I H DLK  N+L+    T  ++D GLA     A         
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 170
Query: 333 XXVGVKGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEM 370
             VG K    Y APE    S      E     D+Y+ G++  E+
Sbjct: 171 HRVGTK---RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 10/106 (9%)
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           + +++  L YLH   E  I++ DLK  NVLLD E    ++D+G+ K              
Sbjct: 116 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-------EGLRPGD 165
Query: 333 XXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
                 GT  Y APE   G +   S D ++ G+L+ EM  G+ P +
Sbjct: 166 TTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF-IAECQALRSIRHRNLVKIIT 225
           IG GS+G V+K   + D  + +   K L  +     K   + E + L+ ++H NLV ++ 
Sbjct: 11  IGEGSYGVVFK-CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH- 284
                 F+      LV+E   +  L E     R  P +L      SI       + + H 
Sbjct: 70  V-----FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK----SITWQTLQAVNFCHK 120
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
           H C    +H D+KP N+L+       + DFG A+ L   +               T  Y 
Sbjct: 121 HNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-------ATRWYR 169
Query: 345 APEYGMG-SEVSTSGDVYSFGILLLEMFTG 373
           +PE  +G ++     DV++ G +  E+ +G
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 92/239 (38%), Gaps = 31/239 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALRSI 215
           D F +   +G G FG+VY  +        +VA+KVL    ++  G       E +    +
Sbjct: 23  DDFEIGRPLGKGKFGNVY--LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHL 80
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIA 273
            H N++++        F       L+ E    G L + L      D  R   +++ L   
Sbjct: 81  HHPNILRLYNY-----FYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEEL--- 132
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
              A  L Y H      ++H D+KP N+LL  +    ++DFG +   P            
Sbjct: 133 ---ADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC---- 182
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
                GT+ Y  PE   G   +   D++  G+L  E+  G  P  E  + N T    VK
Sbjct: 183 -----GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG-NPPFESASHNETYRRIVK 235

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 90/228 (39%), Gaps = 29/228 (12%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQAL 212
           KA D + +  +IG G+FG V   +  H   + + A+K+L+   +  R  S  F  E   +
Sbjct: 73  KAED-YDVVKVIGRGAFGEV--QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 129
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
                  +V++  +     FQ + +  +V E M  G L   L  N D P           
Sbjct: 130 AFANSPWVVQLFCA-----FQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKF----Y 179
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
             +V   L+ +H      ++H D+KP N+LLD      ++DFG    + E          
Sbjct: 180 TAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV 236
Query: 333 XXVGVKGTVGYAAPE----YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                 GT  Y +PE     G         D +S G+ L EM  G  P
Sbjct: 237 ------GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 64/136 (47%), Gaps = 16/136 (11%)
Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXX 330
            IAV +   LE+LH   +  ++H D+KPSNVL++      + DFG++ +L +        
Sbjct: 113 KIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA 170
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGPTNEMFTGNL 385
                   G   Y APE  +  E++  G     D++S GI ++E+   + P +   T   
Sbjct: 171 --------GCKPYMAPER-INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ 221
Query: 386 TLHNFVKEALPERLAE 401
            L   V+E  P+  A+
Sbjct: 222 QLKQVVEEPSPQLPAD 237

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/256 (23%), Positives = 106/256 (41%), Gaps = 38/256 (14%)
Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNL-QHRGASKSFIAECQALR 213
           ++  D + + +LIG GS+G V +  +D  +   +   K+L + +     K  + E   L 
Sbjct: 49  WQIPDRYEIRHLIGTGSYGHVCEA-YDKLEKRVVAIKKILRVFEDLIDCKRILREIAILN 107
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
            + H ++VK++   +  D +   F+ L   L +  S  ++  L R  P  L  L   ++ 
Sbjct: 108 RLNHDHVVKVLDIVIPKDVEK--FDELYVVLEIADS--DFKKLFR-TPVYLTELHIKTLL 162
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL--PEAAXX----- 326
            ++   ++Y+H      I+H DLKP+N L++ + +  V DFGLA+ +  PE         
Sbjct: 163 YNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 327 -------------XXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFT 372
                                 G   T  Y APE  +  E  T   DV+S G +  E+  
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279
Query: 373 GKGPTNEMFTGNLTLH 388
                  M   N+  H
Sbjct: 280 -------MIKENVAYH 288

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 28/214 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRNLVKIIT 225
           +G GSF    K +  H       AVK+++ +    ++    E  AL+    H N+VK+  
Sbjct: 19  LGEGSFSICRKCV--HKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHE 73
Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH 285
                 F       LV EL+  G L E +       ++ +  +   I   + S + ++H 
Sbjct: 74  V-----FHDQLHTFLVMELLNGGELFERI----KKKKHFSETEASYIMRKLVSAVSHMH- 123
Query: 286 YCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVG 342
             +  +VH DLKP N+L   E   L   + DFG A+  P                  T+ 
Sbjct: 124 --DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-------TLH 174
Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           YAAPE    +    S D++S G++L  M +G+ P
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 59/290 (20%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH------RGASKSF--IAECQ 210
           D + +   +G+G+ G V K  F+    +  VA+++++ +       R A  +     E +
Sbjct: 135 DEYIMSKTLGSGACGEV-KLAFERKTCKK-VAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLL 267
            L+ + H  ++KI        F   D+  +V ELM  G L + +  N+   +A   L   
Sbjct: 193 ILKKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 246
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAA 324
           Q L +AV      +YLH   E  I+H DLKP NVLL   + +    ++DFG +K L E +
Sbjct: 247 QML-LAV------QYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGPTNE 379
                       + GT  Y APE  +   V T+G     D +S G++L    +G  P +E
Sbjct: 297 LMRT--------LCGTPTYLAPEVLVS--VGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346
Query: 380 MFTGNLTL--------HNFVKEA---LPERLAEIVDPVLLVEREEGETSE 418
             T  ++L        +NF+ E    + E+  ++V  +L+V+ +   T+E
Sbjct: 347 HRT-QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTE 395

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 108/250 (43%), Gaps = 43/250 (17%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV    +D    +  VAVK L+   Q    ++    E + L+ ++H N   L+
Sbjct: 28  VGSGAYGSVCSA-YDARLRQK-VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS------IAVD 275
            + T   S++    DF  +     + G+      LN     N+   Q LS      +   
Sbjct: 86  DVFTPATSIE----DFSEVYLVTTLMGA-----DLN-----NIVKCQALSDEHVQFLVYQ 131
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           +   L+Y+H      I+H DLKPSNV ++ +    + DFGLA+   E             
Sbjct: 132 LLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADE----------EMT 178
Query: 336 GVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKG--PTNEMFTGNLTLHNFVK 392
           G   T  Y APE  +     + + D++S G ++ E+  GK   P ++       +   V 
Sbjct: 179 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVG 238
Query: 393 EALPERLAEI 402
              PE LA+I
Sbjct: 239 TPSPEVLAKI 248

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 103/239 (43%), Gaps = 36/239 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGAS----KSFIAECQA 211
           D   L   +G G+FG V +   F  D   T   VAVK+L     GA+    ++ ++E + 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD-------APRN 263
           L  I  H N+V ++ +C      G     +V E    G+L  +L   R+       AP +
Sbjct: 84  LIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 264 L-----NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
           L      L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            + +               +  + + APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 197 DIYKDPDXVRKG-----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 35/234 (14%)
Query: 159 DGFSLENLIGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGAS----KSFIAECQA 211
           D   L   +G G+FG V +   F  D   T   VAVK+L     GA+    ++ ++E + 
Sbjct: 64  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 120
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD-------APRN 263
           L  I  H N+V ++ +C      G     +V E    G+L  +L   R+       AP +
Sbjct: 121 LIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPED 176
Query: 264 L-----NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
           L      L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+
Sbjct: 177 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 233
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            + +               +  + + APE       +   DV+SFG+LL E+F+
Sbjct: 234 DIYKDPDYVRKG-----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 36/239 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGAS----KSFIAECQA 211
           D   L   +G G+FG V +   F  D   T   VAVK+L     GA+    ++ ++E + 
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 85
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR-------DAPRN 263
           L  I  H N+V ++ +C      G     +V E    G+L  +L   R       +AP +
Sbjct: 86  LIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKEAPED 141
Query: 264 L-----NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
           L      L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+
Sbjct: 142 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 198
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            + +               +  + + APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 199 DIYKDPDYVRKG-----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 252

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSI 215
           TD + L   +G G+F  V + +      E   A K++N +   A   +    E +  R +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQE--YAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           +H N+V++  S   +  +G  F  LV++L+  G L E            +++ R   +  
Sbjct: 61  KHPNIVRLHDS---ISEEG--FHYLVFDLVTGGELFE------------DIVAREYYSEA 103
Query: 276 VAS-----TLEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXX 327
            AS      LE ++H     IVH DLKP N+LL  +       ++DFGL       A   
Sbjct: 104 DASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGL-------AIEV 156
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                   G  GT GY +PE           D+++ G++L  +  G  P
Sbjct: 157 QGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 35/230 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSI 215
           + F +  +IG G+FG V   +    + E + A+K+LN   +  R  +  F  E    R +
Sbjct: 74  EDFEIIKVIGRGAFGEV--AVVKMKNTERIYAMKILNKWEMLKRAETACFREE----RDV 127
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA-PRNLN--LLQRLSI 272
                 + IT+ +   FQ  +   LV +  V G L   L    D  P ++    +  + +
Sbjct: 128 LVNGDCQWITA-LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 186
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           A+D    L Y         VH D+KP NVLLD      ++DFG    + +          
Sbjct: 187 AIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG-----TVQ 232
Query: 333 XXVGVKGTVGYAAPEY------GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             V V GT  Y +PE       GMG +     D +S G+ + EM  G+ P
Sbjct: 233 SSVAV-GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 102/239 (42%), Gaps = 36/239 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGAS----KSFIAECQA 211
           D   L   +G G+FG V +   F  D   T   VAVK+L     GA+    ++ ++E + 
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD-------APRN 263
           L  I  H N+V ++ +C      G     +V E    G+L  +L   R+       AP +
Sbjct: 84  LIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 264 L-----NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
           L      L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            + +               +  + + APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 197 DIYKDPDYVRKG-----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++   +   
Sbjct: 87  GLLNVFTPQKSLEEFQDV---YIVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI--- 139
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
              ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 140 ---KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMEPEVV-- 187
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
             T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 103/239 (43%), Gaps = 36/239 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGAS----KSFIAECQA 211
           D   L   +G G+FG V +   F  D   T   VAVK+L     GA+    ++ ++E + 
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 74
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD-------APRN 263
           L  I  H N+V ++ +C      G     ++ E    G+L  +L   R+       AP +
Sbjct: 75  LIHIGHHLNVVNLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 264 L-----NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
           L      L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            + +               +  + + APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 188 DIXKDPDXVRKG-----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 35/230 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSI 215
           + F +  +IG G+FG V   +    + E + A+K+LN   +  R  +  F  E    R +
Sbjct: 90  EDFEIIKVIGRGAFGEV--AVVKMKNTERIYAMKILNKWEMLKRAETACFREE----RDV 143
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA-PRNLN--LLQRLSI 272
                 + IT+ +   FQ  +   LV +  V G L   L    D  P ++    +  + +
Sbjct: 144 LVNGDCQWITA-LHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 202
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           A+D    L Y         VH D+KP NVLLD      ++DFG    + +          
Sbjct: 203 AIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDG-----TVQ 248
Query: 333 XXVGVKGTVGYAAPEY------GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             V V GT  Y +PE       GMG +     D +S G+ + EM  G+ P
Sbjct: 249 SSVAV-GTPDYISPEILQAMEDGMG-KYGPECDWWSLGVCMYEMLYGETP 296

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 30/226 (13%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR------GASKSFIAECQALRS 214
           + + +L+G GS+G V + +    D ETL    V  L+ +          +   E Q LR 
Sbjct: 7   YLMGDLLGEGSYGKVKEVL----DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +RH+N+++++    + + Q      +V E  V G  E    L+    +   + Q      
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKM---YMVMEYCVCGMQE---MLDSVPEKRFPVCQAHGYFC 116
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-PEAAXXXXXXXXX 333
            +   LEYLH      IVH D+KP N+LL    T  +S  G+A+ L P AA         
Sbjct: 117 QLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-- 171
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSG---DVYSFGILLLEMFTGKGP 376
               +G+  +  PE   G + + SG   D++S G+ L  + TG  P
Sbjct: 172 ----QGSPAFQPPEIANGLD-TFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 36/229 (15%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSI 215
           TD + L   +G G+F  V + +      E   A K++N +   A   +    E +  R +
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQE--YAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           +H N+V++  S   +  +G  F  LV++L+  G L E            +++ R   +  
Sbjct: 61  KHPNIVRLHDS---ISEEG--FHYLVFDLVTGGELFE------------DIVAREYYSEA 103
Query: 276 VAS-----TLEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAAXXX 327
            AS      LE ++H     IVH DLKP N+LL  +       ++DFGL       A   
Sbjct: 104 DASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGL-------AIEV 156
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                   G  GT GY +PE           D+++ G++L  +  G  P
Sbjct: 157 QGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 36/239 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGAS----KSFIAECQA 211
           D   L   +G G+FG V +   F  D   T   VAVK+L     GA+    ++ ++E + 
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 74
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD-------APRN 263
           L  I  H N+V ++ +C      G     ++ E    G+L  +L   R+       AP +
Sbjct: 75  LIHIGHHLNVVNLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 264 L-----NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
           L      L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            + +               +  + + APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 188 DIYKDPDYVRKG-----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 36/239 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGAS----KSFIAECQA 211
           D   L   +G G+FG V +   F  D   T   VAVK+L     GA+    ++ ++E + 
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 74
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD-------APRN 263
           L  I  H N+V ++ +C      G     ++ E    G+L  +L   R+       AP +
Sbjct: 75  LIHIGHHLNVVNLLGACTK---PGGPL-MVITEFCKFGNLSTYLRSKRNEFVPYKVAPED 130
Query: 264 L-----NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
           L      L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+
Sbjct: 131 LYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 319 FLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            + +               +  + + APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 188 DIYKDPDYVRKG-----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 241

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 26  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 80
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++   +   
Sbjct: 81  GLLNVFTPQKSLEEFQDV---YIVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI--- 133
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
              ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 134 ---KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV-- 181
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
             T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 182 --TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 37  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 91
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++   +   
Sbjct: 92  GLLNVFTPQKSLEEFQDV---YIVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI--- 144
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
              ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 145 ---KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMTPYVV-- 192
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
             T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 193 --TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV         H   VAVK L+   Q    +K    E + L+ ++H N   L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHR--VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            + T   S++ + ND   LV  LM    L   +   +    ++  L        +   L+
Sbjct: 88  DVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLK 139
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   T 
Sbjct: 140 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MAGFVATR 186
Query: 342 GYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
            Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 103/238 (43%), Gaps = 35/238 (14%)
Query: 159 DGFSLENLIGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGAS----KSFIAECQA 211
           D  +L   +G G+FG V +   F  D   T   VAVK+L     GA+    ++ ++E + 
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 84
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD------APRNL 264
           L  I  H N+V ++ +C      G     +V E    G+L  +L   R+       P +L
Sbjct: 85  LIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTPEDL 140
Query: 265 -----NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
                 L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+ 
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARD 197
Query: 320 LPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + +               +  + + APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 198 IXKDPDXVRKG-----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV         H   VAVK L+   Q    +K    E + L+ ++H N   L+
Sbjct: 40  VGSGAYGSVCAAFDTKTGHR--VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 97
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            + T   S++ + ND   LV  LM    L   +   +    ++  L        +   L+
Sbjct: 98  DVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLK 149
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   T 
Sbjct: 150 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVATR 196
Query: 342 GYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
            Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 197 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV         H   VAVK L+   Q    +K    E + L+ ++H N   L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHR--VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            + T   S++ + ND   LV  LM    L   +   +    ++  L        +   L+
Sbjct: 88  DVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLK 139
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   T 
Sbjct: 140 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVATR 186
Query: 342 GYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
            Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 100/232 (43%), Gaps = 33/232 (14%)
Query: 159 DGFSLENLIGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGAS----KSFIAECQA 211
           D   L   +G G+FG V +   F  D   T   VAVK+L     GA+    ++ ++E + 
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK---EGATHSEHRALMSELKI 85
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD-----APRNL- 264
           L  I  H N+V ++ +C      G     +V E    G+L  +L   R+      P +L 
Sbjct: 86  LIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKPEDLY 141
Query: 265 ----NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
                L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+ +
Sbjct: 142 KDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDI 198
Query: 321 PEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
            +               +  + + APE       +   DV+SFG+LL E+F+
Sbjct: 199 XKDPDXVRKG-----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV         H   VAVK L+   Q    +K    E + L+ ++H N   L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHR--VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            + T   S++ + ND   LV  LM    L   +   +    ++  L        +   L+
Sbjct: 88  DVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLK 139
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   T 
Sbjct: 140 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MAGFVATR 186
Query: 342 GYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
            Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 167 IGAGSFGSV---YKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN-- 219
           IG+G+ G V   Y  I + +     VA+K L+   Q++  +K    E   ++ + H+N  
Sbjct: 32  IGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 86
Query: 220 -LVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            L+ + T   S++ FQ      +V ELM + +L + + +  D  R   LL ++   +   
Sbjct: 87  GLLNVFTPQKSLEEFQDV---YIVMELM-DANLCQVIQMELDHERMSYLLYQMLCGI--- 139
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
              ++LH      I+H DLKPSN+++  + T  + DFGLA+     A          V  
Sbjct: 140 ---KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR----TAGTSFMMEPEVV-- 187
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
             T  Y APE  +G     + D++S G ++ EM   K
Sbjct: 188 --TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 106/245 (43%), Gaps = 33/245 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV    +D    +  VAVK L+   Q    ++    E + L+ ++H N   L+
Sbjct: 36  VGSGAYGSVCSA-YDARLRQK-VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 222 KIITSCVSVDFQGNDF-EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
            + T   S++    DF E  +   ++   L   +     +  ++  L        +   L
Sbjct: 94  DVFTPATSIE----DFSEVYLVTTLMGADLNNIVKCQALSDEHVQFL-----VYQLLRGL 144
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           +Y+H      I+H DLKPSNV ++ +    + DFGLA+   E             G   T
Sbjct: 145 KYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE----------EMTGYVAT 191
Query: 341 VGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKG--PTNEMFTGNLTLHNFVKEALPE 397
             Y APE  +     + + D++S G ++ E+  GK   P ++       +   V    PE
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 251
Query: 398 RLAEI 402
            LA+I
Sbjct: 252 VLAKI 256

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV         H   VAVK L+   Q    +K    E + L+ ++H N   L+
Sbjct: 26  VGSGAYGSVCAAFDTKTGHR--VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            + T   S++ + ND   LV  LM    L   +   +    ++  L        +   L+
Sbjct: 84  DVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLK 135
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   T 
Sbjct: 136 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MAGFVATR 182
Query: 342 GYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
            Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 32/235 (13%)
Query: 159 DGFSLENLIGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGAS----KSFIAECQA 211
           D  +L   +G G+FG V +   F  D   T   VAVK+L     GA+    ++ ++E + 
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD--APRN----- 263
           L  I  H N+V ++ +C      G     +V E    G+L  +L   R+   P       
Sbjct: 84  LIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKD 139
Query: 264 -LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE 322
            L L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+ + +
Sbjct: 140 FLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYK 196
Query: 323 AAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
                          +  + + APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 197 DPDYVRKG-----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV         H   VAVK L+   Q    +K    E + L+ ++H N   L+
Sbjct: 26  VGSGAYGSVCAAFDTKTGHR--VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            + T   S++ + ND   LV  LM    L   +   +    ++  L        +   L+
Sbjct: 84  DVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLK 135
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   T 
Sbjct: 136 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVATR 182
Query: 342 GYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
            Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV         H   VAVK L+   Q    +K    E + L+ ++H N   L+
Sbjct: 50  VGSGAYGSVCAAFDTKTGHR--VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            + T   S++ + ND   LV  LM    L   +   +    ++  L        +   L+
Sbjct: 108 DVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLK 159
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   T 
Sbjct: 160 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVATR 206
Query: 342 GYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
            Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 118/271 (43%), Gaps = 40/271 (14%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVA--VKVLNLQHRGASKSFIA-ECQALRSIRHRNLVKI 223
           +G G FG V++ + +    +T +A  VKV     +G  +  +  E   L   RHRN++ +
Sbjct: 13  LGRGEFGIVHRCV-ETSSKKTYMAKFVKV-----KGTDQVLVKKEISILNIARHRNILHL 66
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
             S     F+  +   +++E +    L+ +  +N  A   LN  + +S    V   L++L
Sbjct: 67  HES-----FESMEELVMIFEFI--SGLDIFERINTSAF-ELNEREIVSYVHQVCEALQFL 118
Query: 284 HHYCETPIVHCDLKPSNVLLDGEL--TAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           H +    I H D++P N++       T  + +FG A+ L                     
Sbjct: 119 HSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE------- 168
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP----TNEMFTGNL--TLHNFVKEAL 395
            Y APE      VST+ D++S G L+  + +G  P    TN+    N+    + F +EA 
Sbjct: 169 -YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227
Query: 396 PE---RLAEIVDPVLLVEREEGET-SEANAH 422
            E      + VD +L+ ER+   T SEA  H
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEALQH 258

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV         H   VAVK L+   Q    +K    E + L+ ++H N   L+
Sbjct: 49  VGSGAYGSVCAAFDTKTGHR--VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 106
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            + T   S++ + ND   LV  LM    L   +   +    ++  L        +   L+
Sbjct: 107 DVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLK 158
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   T 
Sbjct: 159 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVATR 205
Query: 342 GYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
            Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 206 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 111/272 (40%), Gaps = 33/272 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G GSFG V++     +D +T    AVK + L+   A +  +  C  L S R   L   +
Sbjct: 101 LGRGSFGEVHR----MEDKQTGFQCAVKKVRLEVFRAEE--LMACAGLTSPRIVPLYGAV 154
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V+        +  EL+  GSL + +      P +   L  L  A++    LEYLH
Sbjct: 155 REGPWVN--------IFMELLEGGSLGQLVKEQGCLPED-RALYYLGQALE---GLEYLH 202
Query: 285 HYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFL-PEAAXXXXXXXXXXVGVKGTV 341
                 I+H D+K  NVLL  DG   A + DFG A  L P+              + GT 
Sbjct: 203 ---SRRILHGDVKADNVLLSSDGSHAA-LCDFGHAVCLQPDGLGKSLLTGDY---IPGTE 255
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER-LA 400
            + APE  +G       DV+S   ++L M  G  P  + F G L L     E  P R + 
Sbjct: 256 THMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCL-KIASEPPPVREIP 314
Query: 401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGK 432
               P+     +EG   E   H+      GGK
Sbjct: 315 PSCAPLTAQAIQEGLRKEP-IHRVSAAELGGK 345

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 32/235 (13%)
Query: 159 DGFSLENLIGAGSFGSVYKG-IFDHDDHETL--VAVKVLNLQHRGAS----KSFIAECQA 211
           D  +L   +G G+FG V +   F  D   T   VAVK+L     GA+    ++ ++E + 
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD--APRN----- 263
           L  I  H N+V ++ +C      G     +V E    G+L  +L   R+   P       
Sbjct: 84  LIHIGHHLNVVNLLGACTK---PGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKDLYKD 139
Query: 264 -LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE 322
            L L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+ + +
Sbjct: 140 FLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYK 196
Query: 323 AAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
                          +  + + APE       +   DV+SFG+LL E+F+ G  P
Sbjct: 197 DPDYVRKG-----DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 246

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV         H   VAVK L+   Q    +K    E + L+ ++H N   L+
Sbjct: 50  VGSGAYGSVCAAFDTKTGHR--VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 107
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            + T   S++ + ND   LV  LM    L   +   +    ++  L        +   L+
Sbjct: 108 DVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLK 159
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   T 
Sbjct: 160 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MXGXVATR 206
Query: 342 GYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
            Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 207 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV         H   VAVK L+   Q    +K    E + L+ ++H N   L+
Sbjct: 36  VGSGAYGSVCAAFDTKTGHR--VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 93
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            + T   S++ + ND   LV  LM    L   +   +    ++  L        +   L+
Sbjct: 94  DVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLK 145
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   T 
Sbjct: 146 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVATR 192
Query: 342 GYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
            Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 29/231 (12%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFI-AECQALRSIRH 217
           D F  +  +G+G+FG V+  + +         +K +N          I AE + L+S+ H
Sbjct: 22  DLFIFKRKLGSGAFGDVH--LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            N++KI        F+      +V E    G L E +   +   + L+      +   + 
Sbjct: 80  PNIIKIFEV-----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAH----VSDFGLAKFLPEAAXXXXXXXXX 333
           + L Y H      +VH DLKP N+L   + + H    + DFGLA+               
Sbjct: 135 NALAYFH---SQHVVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELF--------KSDEH 182
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                GT  Y APE     +V+   D++S G+++  + TG  P    FTG 
Sbjct: 183 STNAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMYFLLTGCLP----FTGT 228

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 111/272 (40%), Gaps = 33/272 (12%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G GSFG V++     +D +T    AVK + L+   A +  +  C  L S R   L   +
Sbjct: 82  LGRGSFGEVHR----MEDKQTGFQCAVKKVRLEVFRAEE--LMACAGLTSPRIVPLYGAV 135
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                V+        +  EL+  GSL + +      P +   L  L  A++    LEYLH
Sbjct: 136 REGPWVN--------IFMELLEGGSLGQLVKEQGCLPED-RALYYLGQALE---GLEYLH 183
Query: 285 HYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFL-PEAAXXXXXXXXXXVGVKGTV 341
                 I+H D+K  NVLL  DG   A + DFG A  L P+              + GT 
Sbjct: 184 ---SRRILHGDVKADNVLLSSDGSHAA-LCDFGHAVCLQPDGLGKDLLTGDY---IPGTE 236
Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER-LA 400
            + APE  +G       DV+S   ++L M  G  P  + F G L L     E  P R + 
Sbjct: 237 THMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCL-KIASEPPPVREIP 295
Query: 401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGK 432
               P+     +EG   E   H+      GGK
Sbjct: 296 PSCAPLTAQAIQEGLRKEP-IHRVSAAELGGK 326

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  + +   + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 110/263 (41%), Gaps = 33/263 (12%)
Query: 165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKII 224
            +IG GSFG V++      D    VA+K +    R  ++    E Q +R ++H N+V + 
Sbjct: 46  KVIGNGSFGVVFQAKLVESDE---VAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLK 98
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
               S    G+  + +   L++    E     +R   +    +  L I + +   L  L 
Sbjct: 99  AFFYS---NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 285 HYCETPIVHCDLKPSNVLLDGEL-TAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGY 343
           +     I H D+KP N+LLD       + DFG AK L              V    +  Y
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--------IAGEPNVSXICSRYY 207
Query: 344 AAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEI 402
            APE   G +  +T+ D++S G ++ E+  G+     +F G         E+  ++L EI
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQ----PLFPG---------ESGIDQLVEI 254
Query: 403 VDPVLLVEREEGETSEANAHKQR 425
           +  +    RE+ +T   N  + +
Sbjct: 255 IKVLGTPSREQIKTMNPNYMEHK 277

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 48/107 (44%), Gaps = 8/107 (7%)
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL-----PEAA 324
           L I + +A  +E+LH      ++H DLKPSN+    +    V DFGL   +      +  
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMF 371
                      G  GT  Y +PE   G+  S   D++S G++L E+ 
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/245 (24%), Positives = 106/245 (43%), Gaps = 33/245 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV    +D    +  VAVK L+   Q    ++    E + L+ ++H N   L+
Sbjct: 36  VGSGAYGSVCSA-YDARLRQK-VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 222 KIITSCVSVDFQGNDF-EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
            + T   S++    DF E  +   ++   L   +     +  ++  L        +   L
Sbjct: 94  DVFTPATSIE----DFSEVYLVTTLMGADLNNIVKSQALSDEHVQFL-----VYQLLRGL 144
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
           +Y+H      I+H DLKPSNV ++ +    + DFGLA+   E             G   T
Sbjct: 145 KYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE----------EMTGYVAT 191
Query: 341 VGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKG--PTNEMFTGNLTLHNFVKEALPE 397
             Y APE  +     + + D++S G ++ E+  GK   P ++       +   V    PE
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPE 251
Query: 398 RLAEI 402
            LA+I
Sbjct: 252 VLAKI 256

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV         H   VAVK L+   Q    +K    E + L+ ++H N   L+
Sbjct: 26  VGSGAYGSVCAAFDTKTGHR--VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            + T   S++ + ND   LV  LM    L   +   +    ++  L        +   L+
Sbjct: 84  DVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCAKLTDDHVQFL-----IYQILRGLK 135
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   T 
Sbjct: 136 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVATR 182
Query: 342 GYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
            Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 38/227 (16%)
Query: 167 IGAGSFGSVYKGI---FDHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSI-RHRNLV 221
           +GAG+FG V +        +D    VAVK+L +  H    ++ ++E + +  + +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------DAPRNLNLLQR 269
            ++ +C      G     ++ E    G L  +L   R            +    L+    
Sbjct: 114 NLLGACT----HGGPV-LVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDL 168
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
           L  +  VA  + +L        +H D+   NVLL     A + DFGLA+ +   +     
Sbjct: 169 LHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-- 223
Query: 330 XXXXXVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                  VKG     V + APE       +   DV+S+GILL E+F+
Sbjct: 224 -------VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 62/135 (45%), Gaps = 16/135 (11%)
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
           IAV +   LE+LH   +  ++H D+KPSNVL++        DFG++ +L +         
Sbjct: 141 IAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDA- 197
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGPTNEMFTGNLT 386
                  G   Y APE  +  E++  G     D++S GI  +E+   + P +   T    
Sbjct: 198 -------GCKPYXAPER-INPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQ 249
Query: 387 LHNFVKEALPERLAE 401
           L   V+E  P+  A+
Sbjct: 250 LKQVVEEPSPQLPAD 264

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           IG+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 35  IGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 91  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 142
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----------MTGYVA 189
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 99/238 (41%), Gaps = 32/238 (13%)
Query: 157 ATDGFS---------LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA 207
           +TD FS          E+++G G+   V   I      E   AVK++  Q          
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQE--YAVKIIEKQPGHIRSRVFR 59
Query: 208 ECQALRSIR-HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNL 266
           E + L   + HRN++++I       F+  D   LV+E M  GS+   +H  R    + N 
Sbjct: 60  EVEMLYQCQGHRNVLELIEF-----FEEEDRFYLVFEKMRGGSILSHIHKRR----HFNE 110
Query: 267 LQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEA 323
           L+   +  DVAS L++LH+     I H DLKP N+L +         + DFGL   +   
Sbjct: 111 LEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLN 167
Query: 324 AXXXXXXXXXXVGVKGTVGYAAPEY--GMGSEVS---TSGDVYSFGILLLEMFTGKGP 376
                      +   G+  Y APE       E S      D++S G++L  + +G  P
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKXQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           + L   IG G+F  V   +  H      VA+K+++      +  +    E + ++ + H 
Sbjct: 14  YRLLKTIGKGNFAKV--KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 71
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELM---VNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+VK+        F+  + E  +Y +M     G + ++L     A   +   +  S    
Sbjct: 72  NIVKL--------FEVIETEKTLYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQ 119
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           + S ++Y H   +  IVH DLK  N+LLD ++   ++DFG +                 V
Sbjct: 120 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSN-------------EFTV 163
Query: 336 GVK-----GTVGYAAPEYGMGSEVS-TSGDVYSFGILLLEMFTGKGP 376
           G K     G+  YAAPE   G +      DV+S G++L  + +G  P
Sbjct: 164 GGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 210

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 91/228 (39%), Gaps = 24/228 (10%)
Query: 152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAE 208
           ++  K TD F+   ++G GSFG V   + +    + L AVK+L           +  + E
Sbjct: 335 RDRMKLTD-FNFLMVLGKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMVE 391
Query: 209 CQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQ 268
            + L        +  + SC    FQ  D    V E +  G L    H+ +          
Sbjct: 392 KRVLALPGKPPFLTQLHSC----FQTMDRLYFVMEYVNGGDL--MYHIQQVG--RFKEPH 443
Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXX 328
            +  A ++A  L +L       I++ DLK  NV+LD E    ++DFG+ K          
Sbjct: 444 AVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------ENI 493
Query: 329 XXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                     GT  Y APE         S D ++FG+LL EM  G+ P
Sbjct: 494 WDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 37  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 93  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 144
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----------MTGYVA 191
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           + L   IG G+F  V   +  H      VAVK+++     +S  +    E + ++ + H 
Sbjct: 16  YRLLKTIGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+VK+        F+  + E  +Y +M   S  E         R      R      + S
Sbjct: 74  NIVKL--------FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVS 124
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            ++Y H   +  IVH DLK  N+LLD ++   ++DFG +                     
Sbjct: 125 AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC-------- 173
Query: 339 GTVGYAAPEYGMGSEVS-TSGDVYSFGILLLEMFTGKGP 376
           G+  YAAPE   G +      DV+S G++L  + +G  P
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           + L   IG G+F  V   +  H      VAVK+++     +S  +    E + ++ + H 
Sbjct: 16  YRLLKTIGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+VK+        F+  + E  +Y +M   S  E         R      R      + S
Sbjct: 74  NIVKL--------FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVS 124
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            ++Y H   +  IVH DLK  N+LLD ++   ++DFG +                     
Sbjct: 125 AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC-------- 173
Query: 339 GTVGYAAPEYGMGSEVS-TSGDVYSFGILLLEMFTGKGP 376
           G+  YAAPE   G +      DV+S G++L  + +G  P
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 26/229 (11%)
Query: 152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN----LQHRGASKSFIA 207
           ++  K TD F+   ++G GSFG V   + +    + L AVK+L     +Q      + + 
Sbjct: 14  RDRMKLTD-FNFLMVLGKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMV- 69
Query: 208 ECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL 267
           E + L        +  + SC    FQ  D    V E +  G L    H+ +         
Sbjct: 70  EKRVLALPGKPPFLTQLHSC----FQTMDRLYFVMEYVNGGDL--MYHIQQVG--RFKEP 121
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXX 327
             +  A ++A  L +L       I++ DLK  NV+LD E    ++DFG+ K         
Sbjct: 122 HAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-------EN 171
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                      GT  Y APE         S D ++FG+LL EM  G+ P
Sbjct: 172 IWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKV-LNLQHRGASKSFIAECQALRSIRHRNLVKI-- 223
           IG G++G+V+K   + + HE +   +V L+    G   S + E   L+ ++H+N+V++  
Sbjct: 10  IGEGTYGTVFKAK-NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 224 ---ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
                  +++ F+  D +   Y    NG L+         P  +      S    +   L
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVK-----SFLFQLLKGL 114
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            + H      ++H DLKP N+L++      ++DFGLA+                     T
Sbjct: 115 GFCH---SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-------T 164
Query: 341 VGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           + Y  P+   G+++ STS D++S G +  E+     P   +F GN
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARP---LFPGN 206

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKXQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 104/230 (45%), Gaps = 31/230 (13%)
Query: 152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETL-VAVKVLN--LQHRGASKSFIAE 208
           + +++  + +   + +G+G++GSV      +D    L +AVK L+   Q    +K    E
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSS---YDVKSGLKIAVKKLSRPFQSIIHAKRTYRE 100
Query: 209 CQALRSIRHRN---LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLN 265
            + L+ ++H N   L+ + T   S++ + ND   LV  LM    L   +   +    ++ 
Sbjct: 101 LRLLKHMKHENVIGLLDVFTPATSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQ 157
Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAX 325
            L        +   L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +   
Sbjct: 158 FL-----IYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-- 207
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
                     G   T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 208 --------MTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 32  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 88  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 139
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 186
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           + L   IG G+F  V   +  H      VA+K+++      +  +    E + ++ + H 
Sbjct: 17  YRLLKTIGKGNFAKV--KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELM---VNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+VK+        F+  + E  +Y +M     G + ++L     A   +   +  S    
Sbjct: 75  NIVKL--------FEVIETEKTLYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQ 122
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
           + S ++Y H   +  IVH DLK  N+LLD ++   ++DFG +                 V
Sbjct: 123 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSN-------------EFTV 166
Query: 336 GVK-----GTVGYAAPEYGMGSEVS-TSGDVYSFGILLLEMFTGKGP 376
           G K     G   YAAPE   G +      DV+S G++L  + +G  P
Sbjct: 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 41  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 96
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 97  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 148
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 149 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----------MTGYVA 195
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 37  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 93  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 144
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----------MTGYVA 191
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 35  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 91  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 142
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE----------MTGYVA 189
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 104/234 (44%), Gaps = 42/234 (17%)
Query: 161 FSLENL-----IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI 215
           F+ E+L     IG G++GSV K +  H     ++AVK +        +S + E +  + +
Sbjct: 19  FTAEDLKDLGEIGRGAYGSVNKMV--HKPSGQIMAVKRI--------RSTVDEKEQKQLL 68
Query: 216 RHRNLVKIITSC-VSVDFQGNDFEA----LVYELMVNG--SLEEWLHLNRDAPRNLNLLQ 268
              ++V   + C   V F G  F      +  ELM        ++++   D      +L 
Sbjct: 69  MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 269 RLSIAVDVASTLEYLHHYCET-PIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXX 327
           ++++A     T++ L+H  E   I+H D+KPSN+LLD      + DFG++  L ++    
Sbjct: 129 KITLA-----TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT 183
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGP 376
                      G   Y APE  +    S  G     DV+S GI L E+ TG+ P
Sbjct: 184 RDA--------GCRPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 41  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 96
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 97  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 148
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 149 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 195
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 37  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 93  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 144
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 191
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 35  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 91  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 142
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 189
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 42  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 97
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 98  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 149
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 150 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 196
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 29  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 84
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 85  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 136
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 137 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 183
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 184 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 42  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 97
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 98  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 149
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 150 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 196
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 42  VGSGAYGSVCAAF----DTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIG 97
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 98  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 149
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 150 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 196
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 94/228 (41%), Gaps = 38/228 (16%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA--SKSFIAECQALRSI 215
           +D + L   IGAG+FG V + + D   +E LVAVK +    RG    ++   E    RS+
Sbjct: 18  SDRYELVKDIGAGNFG-VARLMRDKQANE-LVAVKYIE---RGEKIDENVKREIINHRSL 72
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLNRDAPRNLNLLQRLS 271
           RH N+V+     ++         A+V E    G L E +      + D  R     Q+L 
Sbjct: 73  RHPNIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFF--FQQLI 125
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH--VSDFGLAKFLPEAAXXXXX 329
             V  A  ++         + H DLK  N LLDG       ++DFG +K     A     
Sbjct: 126 SGVSYAHAMQ---------VAHRDLKLENTLLDGSPAPRLKIADFGYSK-----ASVLHS 171
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTS-GDVYSFGILLLEMFTGKGP 376
                V   GT  Y APE  +  E      DV+S G+ L  M  G  P
Sbjct: 172 QPKSAV---GTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 37  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 93  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 144
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE----------MTGYVA 191
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 36  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 92  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 143
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 144 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 190
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 27  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 82
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 83  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 134
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 135 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 181
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 53  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 108
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 109 LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 160
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 161 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 207
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 35  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 90
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 91  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 142
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 189
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 26  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 81
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 82  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 133
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 180
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 32  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 88  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 139
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 186
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 27  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 82
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 83  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 134
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 135 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 181
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGXVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 53  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 108
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 109 LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 160
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 161 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MXGYVA 207
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 28  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 83
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 84  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 135
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 136 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 182
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 32  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 88  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 139
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 186
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 50  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 105
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 106 LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 157
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 158 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 204
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 81/165 (49%), Gaps = 12/165 (7%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALR 213
           K  D + +++LIG GS+G VY   +D + ++  VA+K +N   +     K  + E   L 
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLA-YDKNANKN-VAIKKVNRMFEDLIDCKRILREITILN 82
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
            ++   ++++    +  D    D   +V E+  +  L++        P  L      +I 
Sbjct: 83  RLKSDYIIRLHDLIIPEDLLKFDELYIVLEI-ADSDLKKLFK----TPIFLTEQHVKTIL 137
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
            ++    +++H   E+ I+H DLKP+N LL+ + +  + DFGLA+
Sbjct: 138 YNLLLGEKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 62
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 63  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 118 ------VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 36  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 92  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 143
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 144 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 190
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 88/223 (39%), Gaps = 29/223 (13%)
Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK--- 222
           ++G G+FG V K     D      A+K +       S + ++E   L S+ H+ +V+   
Sbjct: 13  VLGQGAFGQVVKARNALDSR--YYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVVRYYA 69
Query: 223 -------IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
                   +    +V  +   F  + Y    NG+L + +H       NLN  QR      
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEY--CENGTLYDLIH-----SENLNQ-QRDEYWRL 121
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
               LE L +     I+H DLKP N+ +D      + DFGLAK +  +            
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 336 GVK-------GTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEM 370
           G         GT  Y A E   G+   +   D+YS GI+  EM
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 63
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 64  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 119 ------VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 165 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 25/219 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           + L   IG G+F  V   +  H      VAVK+++     +S  +    E + ++ + H 
Sbjct: 16  YRLLKTIGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+VK+        F+  + E  +Y +M   S  E         R      R      + S
Sbjct: 74  NIVKL--------FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVS 124
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            ++Y H   +  IVH DLK  N+LLD ++   ++DFG +                     
Sbjct: 125 AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSN--------EFTFGNKLDAFC 173
Query: 339 GTVGYAAPEYGMGSEVS-TSGDVYSFGILLLEMFTGKGP 376
           G   YAAPE   G +      DV+S G++L  + +G  P
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 49  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 104
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 105 LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 156
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 157 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----------MTGYVA 203
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 90/224 (40%), Gaps = 26/224 (11%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G GSFG V++      D +T     V  ++        +  C  L S R   L   +  
Sbjct: 66  VGRGSFGEVHR----MKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
              V+        +  EL+  GSL + +      P +   L  L  A++    LEYLH  
Sbjct: 122 GPWVN--------IFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALE---GLEYLH-- 167
Query: 287 CETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFL-PEAAXXXXXXXXXXVGVKGTVGY 343
               I+H D+K  NVLL  DG   A + DFG A  L P+              + GT  +
Sbjct: 168 -TRRILHGDVKADNVLLSSDGSRAA-LCDFGHALCLQPDGLGKSLLTGDY---IPGTETH 222
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL 387
            APE  MG       D++S   ++L M  G  P  + F G L L
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 266

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 32  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 87
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 88  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 139
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE----------MTGYVA 186
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 90/224 (40%), Gaps = 26/224 (11%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G GSFG V++      D +T     V  ++        +  C  L S R   L   +  
Sbjct: 82  VGRGSFGEVHR----MKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVRE 137
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
              V+        +  EL+  GSL + +      P +   L  L  A++    LEYLH  
Sbjct: 138 GPWVN--------IFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALE---GLEYLH-- 183
Query: 287 CETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFL-PEAAXXXXXXXXXXVGVKGTVGY 343
               I+H D+K  NVLL  DG   A + DFG A  L P+              + GT  +
Sbjct: 184 -TRRILHGDVKADNVLLSSDGSRAA-LCDFGHALCLQPDGLGKSLLTGDY---IPGTETH 238
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL 387
            APE  MG       D++S   ++L M  G  P  + F G L L
Sbjct: 239 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 282

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 102/244 (41%), Gaps = 34/244 (13%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLV 221
           L +++G G+  +V++G   H     L A+KV N +         + E + L+ + H+N+V
Sbjct: 13  LSDILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           K+         +    + L+ E    GSL   L    + P N   L      + +   + 
Sbjct: 71  KLFAIEEETTTR---HKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVG 123
Query: 282 YLHHYCETPIVHCDLKPSNVLL----DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
            ++H  E  IVH ++KP N++     DG+    ++DFG A+ L +            V +
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--------QFVSL 175
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE 397
            GT  Y  P            D+Y   +L  +     G T ++++  +T ++    +LP 
Sbjct: 176 YGTEEYLHP------------DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
Query: 398 RLAE 401
           R  E
Sbjct: 224 RPFE 227

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/244 (22%), Positives = 102/244 (41%), Gaps = 34/244 (13%)
Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNLV 221
           L +++G G+  +V++G   H     L A+KV N +         + E + L+ + H+N+V
Sbjct: 13  LSDILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           K+         +    + L+ E    GSL   L    + P N   L      + +   + 
Sbjct: 71  KLFAIEEETTTR---HKVLIMEFCPCGSLYTVL----EEPSNAYGLPESEFLIVLRDVVG 123
Query: 282 YLHHYCETPIVHCDLKPSNVLL----DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
            ++H  E  IVH ++KP N++     DG+    ++DFG A+ L +            V +
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED--------DEQFVXL 175
Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE 397
            GT  Y  P            D+Y   +L  +     G T ++++  +T ++    +LP 
Sbjct: 176 YGTEEYLHP------------DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
Query: 398 RLAE 401
           R  E
Sbjct: 224 RPFE 227

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 36  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 91
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 92  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 143
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+   +             G   
Sbjct: 144 LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE----------MTGYVA 190
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G+G++GSV   I D    E  VA+K L+   Q    +K    E   L+ ++H N++ ++
Sbjct: 32  VGSGAYGSVCSAI-DKRSGEK-VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                     N ++  +    +   L++ + L     +   L+ ++         L+Y+H
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM------LKGLKYIH 143
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 +VH DLKP N+ ++ +    + DFGLA+                 G   T  Y 
Sbjct: 144 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR----------HADAEMTGYVVTRWYR 190
Query: 345 APEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           APE  +     + + D++S G ++ EM TGK
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 90/224 (40%), Gaps = 26/224 (11%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G GSFG V++      D +T     V  ++        +  C  L S R   L   +  
Sbjct: 80  LGRGSFGEVHR----MKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVRE 135
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
              V+        +  EL+  GSL + +      P +   L  L  A++    LEYLH  
Sbjct: 136 GPWVN--------IFMELLEGGSLGQLIKQMGCLPED-RALYYLGQALE---GLEYLH-- 181
Query: 287 CETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFL-PEAAXXXXXXXXXXVGVKGTVGY 343
               I+H D+K  NVLL  DG   A + DFG A  L P+              + GT  +
Sbjct: 182 -TRRILHGDVKADNVLLSSDGSRAA-LCDFGHALCLQPDGLGKSLLTGDY---IPGTETH 236
Query: 344 AAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL 387
            APE  MG       D++S   ++L M  G  P  + F G L L
Sbjct: 237 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL 280

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 43/228 (18%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           + L   IG G+F  V   +  H      VAVK+++     +S  +    E + ++ + H 
Sbjct: 9   YRLLKTIGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHP 66
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEE---------WLHLNRDAPRNLNLLQR 269
           N+VK+        F+  + E  +Y +M   S  E         W+   ++A         
Sbjct: 67  NIVKL--------FEVIETEKTLYLVMEYASGGEVFDYLVAHGWMK-EKEARAKFR---- 113
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
                 + S ++Y H   +  IVH DLK  N+LLD ++   ++DFG +            
Sbjct: 114 -----QIVSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTF 165
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVS-TSGDVYSFGILLLEMFTGKGP 376
                    G+  YAAPE   G +      DV+S G++L  + +G  P
Sbjct: 166 C--------GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 205

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/245 (25%), Positives = 100/245 (40%), Gaps = 50/245 (20%)
Query: 161 FSLENL-----IGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASK-SFIAECQA 211
           F  ENL     +G+G+FG V                VAVK+L  +   + + + ++E + 
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA---------- 260
           +  +  H N+V ++ +C      G  +  L++E    G L  +L   R+           
Sbjct: 102 MTQLGSHENIVNLLGACT---LSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 261 ------PRNLNLL---QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV 311
                   +LN+L     L  A  VA  +E+L        VH DL   NVL+       +
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKI 213
Query: 312 SDFGLAKFLPEAAXXXXXXXXXXVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILL 367
            DFGLA+ +   +            V+G     V + APE       +   DV+S+GILL
Sbjct: 214 CDFGLARDIMSDSNYV---------VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
Query: 368 LEMFT 372
            E+F+
Sbjct: 265 WEIFS 269

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 25/219 (11%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           + L   IG G+F  V   +  H      VAV++++     +S  +    E + ++ + H 
Sbjct: 16  YRLLKTIGKGNFAKV--KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+VK+        F+  + E  +Y +M   S  E         R      R      + S
Sbjct: 74  NIVKL--------FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVS 124
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            ++Y H   +  IVH DLK  N+LLD ++   ++DFG +                     
Sbjct: 125 AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC-------- 173
Query: 339 GTVGYAAPEYGMGSEVS-TSGDVYSFGILLLEMFTGKGP 376
           G+  YAAPE   G +      DV+S G++L  + +G  P
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 36/226 (15%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           + L   +G G+F  V + +      E   A K++N +   A   +    E +  R ++H 
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQE--YAAKIINTKKLSARDHQKLEREARICRLLKHP 81
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+V++  S   +  +G+ +  L+++L+  G L E            +++ R   +   AS
Sbjct: 82  NIVRLHDS---ISEEGHHY--LIFDLVTGGELFE------------DIVAREYYSEADAS 124
Query: 279 -----TLEYLHHYCETPIVHCDLKPSNVLLDGEL---TAHVSDFGLAKFLPEAAXXXXXX 330
                 LE + H  +  +VH DLKP N+LL  +L      ++DFGL       A      
Sbjct: 125 HCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGL-------AIEVEGE 177
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                G  GT GY +PE           D+++ G++L  +  G  P
Sbjct: 178 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 35/224 (15%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           + L   IG G+F  V   +  H      VAV++++     +S  +    E + ++ + H 
Sbjct: 16  YRLLKTIGKGNFAKV--KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+VK+        F+  + E  +Y +M   S  E         R      R      + S
Sbjct: 74  NIVKL--------FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVS 124
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVK 338
            ++Y H   +  IVH DLK  N+LLD ++   ++DFG +                  G K
Sbjct: 125 AVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFSN-------------EFTFGNK 168
Query: 339 -----GTVGYAAPEYGMGSEVS-TSGDVYSFGILLLEMFTGKGP 376
                G+  YAAPE   G +      DV+S G++L  + +G  P
Sbjct: 169 LDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + D+GLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 91/235 (38%), Gaps = 58/235 (24%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK----------SFIAECQ 210
           ++LEN IG GS+G            E  +AV+      R A K           F  E +
Sbjct: 11  YTLENTIGRGSWG------------EVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIE 58
Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR-----DAPRNLN 265
            ++S+ H N++++  +     F+ N    LV EL   G L E +   R     DA R   
Sbjct: 59  IMKSLDHPNIIRLYET-----FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--- 110
Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGL-AKFLP 321
                 I  DV S + Y H   +  + H DLKP N L      +    + DFGL A+F P
Sbjct: 111 ------IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                            GT  Y +P+   G       D +S G+++  +  G  P
Sbjct: 162 GKMMRTKV---------GTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 206

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 91/235 (38%), Gaps = 58/235 (24%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK----------SFIAECQ 210
           ++LEN IG GS+G            E  +AV+      R A K           F  E +
Sbjct: 28  YTLENTIGRGSWG------------EVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIE 75
Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR-----DAPRNLN 265
            ++S+ H N++++  +     F+ N    LV EL   G L E +   R     DA R   
Sbjct: 76  IMKSLDHPNIIRLYET-----FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--- 127
Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGL-AKFLP 321
                 I  DV S + Y H   +  + H DLKP N L      +    + DFGL A+F P
Sbjct: 128 ------IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 178
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                            GT  Y +P+   G       D +S G+++  +  G  P
Sbjct: 179 GKMMRTKV---------GTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 223

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 62/145 (42%), Gaps = 12/145 (8%)
Query: 237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDL 296
           + A+V EL+   SLE+   L     R   L   L IA+ + S +EY+H      +++ D+
Sbjct: 71  YNAMVLELL-GPSLEDLFDL---CDRTFTLKTVLMIAIQLLSRMEYVH---SKNLIYRDV 123
Query: 297 KPSNVLL-----DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMG 351
           KP N L+       E   H+ DFGLAK   +              + GT  Y +    +G
Sbjct: 124 KPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG 183
Query: 352 SEVSTSGDVYSFGILLLEMFTGKGP 376
            E S   D+ + G + +    G  P
Sbjct: 184 KEQSRRDDLEALGHMFMYFLRGSLP 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 63  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 118 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN 62
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 63  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 118 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 111/273 (40%), Gaps = 49/273 (17%)
Query: 162 SLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQ-HRGASKSFIAECQALRSI- 215
           S    +GAG+FG V +    G+   D   T VAVK+L    H    ++ ++E + L  + 
Sbjct: 49  SFGKTLGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLG 107
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA--------------P 261
            H N+V ++ +C      G     ++ E    G L  +L   RD+               
Sbjct: 108 NHMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 162
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
             L+L   LS +  VA  + +L        +H DL   N+LL       + DFGLA+ + 
Sbjct: 163 LALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIK 219
Query: 322 EAAXXXXXXXXXXVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             +            VKG     V + APE       +   DV+S+GI L E+F+ G  P
Sbjct: 220 NDSNYV---------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 270
Query: 377 TNEMFTGNLTLHNFVKEAL----PERL-AEIVD 404
              M   +   +  +KE      PE   AE+ D
Sbjct: 271 YPGMPVDS-KFYKMIKEGFRMLSPEHAPAEMYD 302

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 110/252 (43%), Gaps = 49/252 (19%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR-- 218
           +S+   IG+G    V++ +   ++ + + A+K +NL+         A+ Q L S R+   
Sbjct: 11  YSILKQIGSGGSSKVFQVL---NEKKQIYAIKYVNLEE--------ADNQTLDSYRNEIA 59
Query: 219 NLVKIITSCVSV----DFQGNDFEALVYELMVNGSLE--EWLHLNRDAPRNLNLLQRLSI 272
            L K+      +    D++  D    +Y +M  G+++   WL       ++++  +R S 
Sbjct: 60  YLNKLQQHSDKIIRLYDYEITD--QYIYMVMECGNIDLNSWL----KKKKSIDPWERKSY 113
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLL-DGELTAHVSDFGLA-KFLPEAAXXXXXX 330
             ++   LE +H   +  IVH DLKP+N L+ DG L   + DFG+A +  P+        
Sbjct: 114 WKNM---LEAVHTIHQHGIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDS 168
Query: 331 XXXXVGVKGTVGYAAPE--YGMGSE---------VSTSGDVYSFGILLLEMFTGKGPTNE 379
                   GTV Y  PE    M S          +S   DV+S G +L  M  GK P  +
Sbjct: 169 QV------GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222
Query: 380 MFTGNLTLHNFV 391
           +      LH  +
Sbjct: 223 IINQISKLHAII 234

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 109/268 (40%), Gaps = 59/268 (22%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAV----KVLN---LQHRGASKSFIAECQALR 213
           +S  + +G+G+FG V+  +    + E +V      KVL    ++     K  + E   L 
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILS 84
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR----DAPRNLNLLQR 269
            + H N++K++       F+   F  LV E   +G L+ +  ++R    D P    + ++
Sbjct: 85  RVEHANIIKVLDI-----FENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
           L  AV       YL       I+H D+K  N+++  + T  + DFG A +L         
Sbjct: 139 LVSAVG------YLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF 189
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHN 389
                    GT+ Y APE  MG+                     +GP  EM++  +TL+ 
Sbjct: 190 C--------GTIEYCAPEVLMGNPY-------------------RGPELEMWSLGVTLYT 222
Query: 390 FVKEALP-----ERLAEIVDPVLLVERE 412
            V E  P     E +   + P  LV +E
Sbjct: 223 LVFEENPFCELEETVEAAIHPPYLVSKE 250

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 63  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 118 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 63  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 118 ------VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 164 NKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 88/218 (40%), Gaps = 33/218 (15%)
Query: 166 LIGAGSFGSVYKGIFDHDDHETL----VAVKVLNLQHRGASKSFIAECQALRSIRHRNLV 221
           ++G G FG V+K        ET     +A K++  +     +    E   +  + H NL+
Sbjct: 96  ILGGGRFGQVHKC------EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           ++  +     F+  +   LV E +  G L      +R    + NL + L   + +    E
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGGEL-----FDRIIDESYNLTE-LDTILFMKQICE 198
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVS--DFGLA-KFLPEAAXXXXXXXXXXVGVK 338
            + H  +  I+H DLKP N+L        +   DFGLA ++ P                 
Sbjct: 199 GIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF--------- 249
Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           GT  + APE      VS   D++S G++   + +G  P
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 29/228 (12%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQAL 212
           KA D + +  +IG G+FG V   +  H     + A+K+L+   +  R  S  F  E   +
Sbjct: 72  KAED-YEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 128
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
                  +V++  +     FQ + +  +V E M  G L   L  N D P       R   
Sbjct: 129 AFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKW---ARFYT 179
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           A +V   L+ +H       +H D+KP N+LLD      ++DFG    + +          
Sbjct: 180 A-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 333 XXVGVKGTVGYAAPE----YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                 GT  Y +PE     G         D +S G+ L EM  G  P
Sbjct: 236 ------GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 29/214 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRN---LV 221
           +G+G++GSV         H   VAVK L+   Q    +K    E + L+ ++H N   L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGHR--VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 87
Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
            + T   S++ + ND   LV  LM    L   +   +    ++  L        +   L+
Sbjct: 88  DVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRGLK 139
Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTV 341
           Y+H      I+H DLKPSN+ ++ +    + DF LA+   +             G   T 
Sbjct: 140 YIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE----------MTGYVATR 186
Query: 342 GYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
            Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 29/228 (12%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQAL 212
           KA D + +  +IG G+FG V   +  H     + A+K+L+   +  R  S  F  E   +
Sbjct: 72  KAED-YEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 128
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
                  +V++  +     FQ + +  +V E M  G L   L  N D P       R   
Sbjct: 129 AFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKW---ARFYT 179
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           A +V   L+ +H       +H D+KP N+LLD      ++DFG    + +          
Sbjct: 180 A-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 235
Query: 333 XXVGVKGTVGYAAPE----YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                 GT  Y +PE     G         D +S G+ L EM  G  P
Sbjct: 236 ------GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 110/252 (43%), Gaps = 49/252 (19%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR-- 218
           +S+   IG+G    V++ +   ++ + + A+K +NL+         A+ Q L S R+   
Sbjct: 58  YSILKQIGSGGSSKVFQVL---NEKKQIYAIKYVNLEE--------ADNQTLDSYRNEIA 106
Query: 219 NLVKIITSCVSV----DFQGNDFEALVYELMVNGSLE--EWLHLNRDAPRNLNLLQRLSI 272
            L K+      +    D++  D    +Y +M  G+++   WL       ++++  +R S 
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITD--QYIYMVMECGNIDLNSWLK----KKKSIDPWERKSY 160
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLL-DGELTAHVSDFGLA-KFLPEAAXXXXXX 330
             ++   LE +H   +  IVH DLKP+N L+ DG L   + DFG+A +  P+        
Sbjct: 161 WKNM---LEAVHTIHQHGIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDS 215
Query: 331 XXXXVGVKGTVGYAAPE--YGMGSE---------VSTSGDVYSFGILLLEMFTGKGPTNE 379
                   GTV Y  PE    M S          +S   DV+S G +L  M  GK P  +
Sbjct: 216 QV------GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
Query: 380 MFTGNLTLHNFV 391
           +      LH  +
Sbjct: 270 IINQISKLHAII 281

>pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDL 296
           + A+V EL+   SLE+   L     R  +L   L IA+ + S +EY+H      +++ D+
Sbjct: 79  YNAMVLELL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDV 131
Query: 297 KPSNVLL-----DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMG 351
           KP N L+       +   H+ DFGLAK   +              + GT  Y +    +G
Sbjct: 132 KPENFLIGRPGNKTQQVIHIIDFGLAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG 191
Query: 352 SEVSTSGDVYSFGILLLEMFTGKGP 376
            E S   D+ + G + +    G  P
Sbjct: 192 KEQSRRDDLEALGHMFMYFLRGSLP 216

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 90/228 (39%), Gaps = 29/228 (12%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQAL 212
           KA D + +  +IG G+FG V   +  H     + A+K+L+   +  R  S  F  E   +
Sbjct: 67  KAED-YEVVKVIGRGAFGEV--QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 123
Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
                  +V++  +     FQ + +  +V E M  G L   L  N D P       R   
Sbjct: 124 AFANSPWVVQLFYA-----FQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKW---ARFYT 174
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           A +V   L+ +H       +H D+KP N+LLD      ++DFG    + +          
Sbjct: 175 A-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 333 XXVGVKGTVGYAAPE----YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                 GT  Y +PE     G         D +S G+ L EM  G  P
Sbjct: 231 ------GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 109/252 (43%), Gaps = 49/252 (19%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR-- 218
           +S+   IG+G    V++ +   ++ + + A+K +NL+         A+ Q L S R+   
Sbjct: 58  YSILKQIGSGGSSKVFQVL---NEKKQIYAIKYVNLEE--------ADNQTLDSYRNEIA 106
Query: 219 NLVKIITSCVSV----DFQGNDFEALVYELMVNGSLE--EWLHLNRDAPRNLNLLQRLSI 272
            L K+      +    D++  D    +Y +M  G+++   WL       ++++  +R S 
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITD--QYIYMVMECGNIDLNSWLK----KKKSIDPWERKSY 160
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLL-DGELTAHVSDFGLA-KFLPEAAXXXXXX 330
                + LE +H   +  IVH DLKP+N L+ DG L   + DFG+A +  P+        
Sbjct: 161 W---KNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDS 215
Query: 331 XXXXVGVKGTVGYAAPE--YGMGSE---------VSTSGDVYSFGILLLEMFTGKGPTNE 379
                   GTV Y  PE    M S          +S   DV+S G +L  M  GK P  +
Sbjct: 216 QV------GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
Query: 380 MFTGNLTLHNFV 391
           +      LH  +
Sbjct: 270 IINQISKLHAII 281

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 33/227 (14%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHRGASKSF---IAECQALRSIR 216
           FS    IG GSFG+VY   F  D  +  +VA+K ++   + +++ +   I E + L+ +R
Sbjct: 56  FSDLREIGHGSFGAVY---FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N ++    C    +       LV E  + GS  + L +++        LQ + IA   
Sbjct: 113 HPNTIQY-RGC----YLREHTAWLVMEYCL-GSASDLLEVHKKP------LQEVEIAAVT 160
Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
              L+ L +     ++H D+K  N+LL       + DFG A  +  A             
Sbjct: 161 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV--------- 211
Query: 337 VKGTVGYAAPEYGMG---SEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
             GT  + APE  +     +     DV+S GI  +E+   K P   M
Sbjct: 212 --GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 111/274 (40%), Gaps = 49/274 (17%)
Query: 161 FSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQ-HRGASKSFIAECQALRSI 215
            S    +GAG+FG V +    G+   D   T VAVK+L    H    ++ ++E + L  +
Sbjct: 41  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYL 99
Query: 216 -RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA-------------- 260
             H N+V ++ +C      G     ++ E    G L  +L   RD+              
Sbjct: 100 GNHMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 154
Query: 261 PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
              L+L   LS +  VA  + +L        +H DL   N+LL       + DFGLA+ +
Sbjct: 155 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 211
Query: 321 PEAAXXXXXXXXXXVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKG 375
              +            VKG     V + APE       +   DV+S+GI L E+F+ G  
Sbjct: 212 KNDSNYV---------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 262
Query: 376 PTNEMFTGNLTLHNFVKEAL----PERL-AEIVD 404
           P   M   +   +  +KE      PE   AE+ D
Sbjct: 263 PYPGMPVDS-KFYKMIKEGFRMLSPEHAPAEMYD 295

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G+G++GSV   I D    E  VA+K L+   Q    +K    E   L+ ++H N++ ++
Sbjct: 50  VGSGAYGSVCSAI-DKRSGEK-VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLH 284
                     N ++  +    +   L++ + +     +   L+ ++         L+Y+H
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQM------LKGLKYIH 161
Query: 285 HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 +VH DLKP N+ ++ +    + DFGLA+                 G   T  Y 
Sbjct: 162 ---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR----------HADAEMTGYVVTRWYR 208
Query: 345 APEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           APE  +     + + D++S G ++ EM TGK
Sbjct: 209 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 109/252 (43%), Gaps = 49/252 (19%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR-- 218
           +S+   IG+G    V++ +   ++ + + A+K +NL+         A+ Q L S R+   
Sbjct: 30  YSILKQIGSGGSSKVFQVL---NEKKQIYAIKYVNLEE--------ADNQTLDSYRNEIA 78
Query: 219 NLVKIITSCVSV----DFQGNDFEALVYELMVNGSLE--EWLHLNRDAPRNLNLLQRLSI 272
            L K+      +    D++  D    +Y +M  G+++   WL       ++++  +R S 
Sbjct: 79  YLNKLQQHSDKIIRLYDYEITD--QYIYMVMECGNIDLNSWLK----KKKSIDPWERKSY 132
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLL-DGELTAHVSDFGLA-KFLPEAAXXXXXX 330
                + LE +H   +  IVH DLKP+N L+ DG L   + DFG+A +  P+        
Sbjct: 133 W---KNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDS 187
Query: 331 XXXXVGVKGTVGYAAPE--YGMGSE---------VSTSGDVYSFGILLLEMFTGKGPTNE 379
                   GTV Y  PE    M S          +S   DV+S G +L  M  GK P  +
Sbjct: 188 QV------GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
Query: 380 MFTGNLTLHNFV 391
           +      LH  +
Sbjct: 242 IINQISKLHAII 253

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 108/248 (43%), Gaps = 41/248 (16%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           +S+   IG+G    V++ +   ++ + + A+K +NL+        S+  E   L  ++  
Sbjct: 14  YSILKQIGSGGSSKVFQVL---NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 70
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLE--EWLHLNRDAPRNLNLLQRLSIAVDV 276
           +  KII      D++  D    +Y +M  G+++   WL       ++++  +R S     
Sbjct: 71  S-DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLK----KKKSIDPWERKSYW--- 117
Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLL-DGELTAHVSDFGLA-KFLPEAAXXXXXXXXXX 334
            + LE +H   +  IVH DLKP+N L+ DG L   + DFG+A +  P+            
Sbjct: 118 KNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQV-- 173
Query: 335 VGVKGTVGYAAPE--YGMGSE---------VSTSGDVYSFGILLLEMFTGKGPTNEMFTG 383
               GTV Y  PE    M S          +S   DV+S G +L  M  GK P  ++   
Sbjct: 174 ----GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 229
Query: 384 NLTLHNFV 391
              LH  +
Sbjct: 230 ISKLHAII 237

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 61
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 62  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 116
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 117 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 162
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 63  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 118 ------VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 64  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 119 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 37/218 (16%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRNLVK 222
           +G+G++G+V   +    D  T   VA+K L    Q    +K    E + L+ +RH N++ 
Sbjct: 33  VGSGAYGAVCSAV----DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIG 88
Query: 223 IITSCVSVDFQGNDFEA--LVYELMVN--GSLEEWLHLNRDAPRNLNLLQRLSIAV-DVA 277
           ++    + D   +DF    LV   M    G L +   L  D         R+   V  + 
Sbjct: 89  LL-DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED---------RIQFLVYQML 138
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
             L Y+H      I+H DLKP N+ ++ +    + DFGLA+                 G 
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----------QADSEMXGX 185
Query: 338 KGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
             T  Y APE  +     + + D++S G ++ EM TGK
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 64  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 119 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 64  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 119 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 64  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 119 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 64  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 119 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 98/238 (41%), Gaps = 32/238 (13%)
Query: 157 ATDGFS---------LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA 207
           +TD FS          E+++G G+   V   I      E   AVK++  Q          
Sbjct: 2   STDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQE--YAVKIIEKQPGHIRSRVFR 59
Query: 208 ECQALRSIR-HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNL 266
           E + L   + HRN++++I       F+  D   LV+E M  GS+   +H  R    + N 
Sbjct: 60  EVEMLYQCQGHRNVLELIEF-----FEEEDRFYLVFEKMRGGSILSHIHKRR----HFNE 110
Query: 267 LQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEA 323
           L+   +  DVAS L++LH+     I H DLKP N+L +         + DF L   +   
Sbjct: 111 LEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 324 AXXXXXXXXXXVGVKGTVGYAAPEY--GMGSEVS---TSGDVYSFGILLLEMFTGKGP 376
                      +   G+  Y APE       E S      D++S G++L  + +G  P
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 95/236 (40%), Gaps = 23/236 (9%)
Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVA---VKVLNLQHRGASKSFIAECQA 211
           F++ + +     IG GSFG         D  + ++    +  ++ + R  S+  +A    
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVA---V 76
Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           L +++H N+V+   S     F+ N    +V +    G L  +  +N          Q L 
Sbjct: 77  LANMKHPNIVQYRES-----FEENGSLYIVMDYCEGGDL--FKRINAQKGVLFQEDQILD 129
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXX 331
             V +   L+++H   +  I+H D+K  N+ L  + T  + DFG+A+ L           
Sbjct: 130 WFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI 186
Query: 332 XXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL 387
                  GT  Y +PE       +   D+++ G +L E+ T K         NL L
Sbjct: 187 -------GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 63  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 118 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 63  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 118 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 64  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 118
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 119 ------VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 164
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 63  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 118 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 61/250 (24%), Positives = 103/250 (41%), Gaps = 35/250 (14%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQALRSIR 216
           D + +++LIG GS+G VY   +D +  E  VA+K +N   +     K  + E   L  ++
Sbjct: 26  DNYIIKHLIGRGSYGYVYLA-YDKNT-EKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
              ++++    +  D    D   +V E+  +  L++        P  L      +I  ++
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEI-ADSDLKKLFK----TPIFLTEEHIKTILYNL 138
Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---------------P 321
                ++H   E+ I+H DLKP+N LL+ + +  V DFGLA+ +                
Sbjct: 139 LLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 322 EAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVST-SGDVYSFGILLLEMFTG-----KG 375
           E                 T  Y APE  +  E  T S D++S G +  E+          
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 376 PTNE--MFTG 383
           PTN   +F G
Sbjct: 256 PTNRFPLFPG 265

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/248 (25%), Positives = 108/248 (43%), Gaps = 41/248 (16%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           +S+   IG+G    V++ +   ++ + + A+K +NL+        S+  E   L  ++  
Sbjct: 10  YSILKQIGSGGSSKVFQVL---NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 66
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLE--EWLHLNRDAPRNLNLLQRLSIAVDV 276
           +  KII      D++  D    +Y +M  G+++   WL       ++++  +R S     
Sbjct: 67  S-DKIIRL---YDYEITD--QYIYMVMECGNIDLNSWLK----KKKSIDPWERKSYW--- 113
Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLL-DGELTAHVSDFGLA-KFLPEAAXXXXXXXXXX 334
            + LE +H   +  IVH DLKP+N L+ DG L   + DFG+A +  P+            
Sbjct: 114 KNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDSQV-- 169
Query: 335 VGVKGTVGYAAPE--YGMGSE---------VSTSGDVYSFGILLLEMFTGKGPTNEMFTG 383
               GTV Y  PE    M S          +S   DV+S G +L  M  GK P  ++   
Sbjct: 170 ----GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 225
Query: 384 NLTLHNFV 391
              LH  +
Sbjct: 226 ISKLHAII 233

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 63  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 118 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 111/273 (40%), Gaps = 49/273 (17%)
Query: 162 SLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQ-HRGASKSFIAECQALRSI- 215
           S    +GAG+FG V +    G+   D   T VAVK+L    H    ++ ++E + L  + 
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA--------------P 261
            H N+V ++ +C      G     ++ E    G L  +L   RD+               
Sbjct: 85  NHMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
             L+L   LS +  VA  + +L        +H DL   N+LL       + DFGLA+ + 
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 322 EAAXXXXXXXXXXVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             +            VKG     V + APE       +   DV+S+GI L E+F+ G  P
Sbjct: 197 NDSNYV---------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 377 TNEMFTGNLTLHNFVKEAL----PERL-AEIVD 404
              M   +   +  +KE      PE   AE+ D
Sbjct: 248 YPGMPVDS-KFYKMIKEGFRMLSPEHAPAEMYD 279

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 33/227 (14%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHRGASKSF---IAECQALRSIR 216
           FS    IG GSFG+VY   F  D  +  +VA+K ++   + +++ +   I E + L+ +R
Sbjct: 17  FSDLREIGHGSFGAVY---FARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N ++    C    +       LV E  + GS  + L +++        LQ + IA   
Sbjct: 74  HPNTIQY-RGC----YLREHTAWLVMEYCL-GSASDLLEVHKKP------LQEVEIAAVT 121
Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVG 336
              L+ L +     ++H D+K  N+LL       + DFG A  +  A             
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV--------- 172
Query: 337 VKGTVGYAAPEYGMG---SEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
             GT  + APE  +     +     DV+S GI  +E+   K P   M
Sbjct: 173 --GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 111/274 (40%), Gaps = 49/274 (17%)
Query: 161 FSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQ-HRGASKSFIAECQALRSI 215
            S    +GAG+FG V +    G+   D   T VAVK+L    H    ++ ++E + L  +
Sbjct: 48  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYL 106
Query: 216 -RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA-------------- 260
             H N+V ++ +C      G     ++ E    G L  +L   RD+              
Sbjct: 107 GNHMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 161
Query: 261 PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
              L+L   LS +  VA  + +L        +H DL   N+LL       + DFGLA+ +
Sbjct: 162 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 218
Query: 321 PEAAXXXXXXXXXXVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKG 375
              +            VKG     V + APE       +   DV+S+GI L E+F+ G  
Sbjct: 219 KNDSNYV---------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 269
Query: 376 PTNEMFTGNLTLHNFVKEAL----PERL-AEIVD 404
           P   M   +   +  +KE      PE   AE+ D
Sbjct: 270 PYPGMPVDS-KFYKMIKEGFRMLSPEHAPAEMYD 302

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 27/213 (12%)
Query: 173 GSVYKGIFDHDDHETLVAVKVLNLQHRGASKS--FIAECQALRSIRHRNLVKIITSCVSV 230
           G ++KG +  +D    + VKVL ++     KS  F  EC  LR   H N++ ++ +C S 
Sbjct: 24  GELWKGRWQGND----IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS- 78
Query: 231 DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP 290
                    L+      GSL   LH   +    ++  Q +  A+D A    +L H  E  
Sbjct: 79  --PPAPHPTLITHWXPYGSLYNVLHEGTNF--VVDQSQAVKFALDXARGXAFL-HTLEPL 133
Query: 291 IVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGM 350
           I    L   +V +D + TA +S   + KF                G      + APE   
Sbjct: 134 IPRHALNSRSVXIDEDXTARISXADV-KF-----------SFQSPGRXYAPAWVAPEALQ 181
Query: 351 GSEVST---SGDVYSFGILLLEMFTGKGPTNEM 380
                T   S D +SF +LL E+ T + P  ++
Sbjct: 182 KKPEDTNRRSADXWSFAVLLWELVTREVPFADL 214

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 91/226 (40%), Gaps = 25/226 (11%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIR 216
            + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + 
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH--LNRDAPRNLNLLQRLSIAV 274
           H N+VK          +GN  + L  E    G L + +   +    P       +L   V
Sbjct: 63  HENVVKFYGH----RREGN-IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGV 117
Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXX 334
                  YLH      I H D+KP N+LLD      +SDFGLA                 
Sbjct: 118 ------VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLL 163
Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             + GT+ Y APE     E      DV+S GI+L  M  G+ P ++
Sbjct: 164 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 111/274 (40%), Gaps = 49/274 (17%)
Query: 161 FSLENLIGAGSFGSVYK----GIFDHDDHETLVAVKVLNLQ-HRGASKSFIAECQALRSI 215
            S    +GAG+FG V +    G+   D   T VAVK+L    H    ++ ++E + L  +
Sbjct: 43  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMT-VAVKMLKPSAHLTEREALMSELKVLSYL 101
Query: 216 -RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA-------------- 260
             H N+V ++ +C      G     ++ E    G L  +L   RD+              
Sbjct: 102 GNHMNIVNLLGACT---IGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 156
Query: 261 PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
              L+L   LS +  VA  + +L        +H DL   N+LL       + DFGLA+ +
Sbjct: 157 ELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 213
Query: 321 PEAAXXXXXXXXXXVGVKGT----VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKG 375
              +            VKG     V + APE       +   DV+S+GI L E+F+ G  
Sbjct: 214 KNDSNYV---------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 264
Query: 376 PTNEMFTGNLTLHNFVKEAL----PERL-AEIVD 404
           P   M   +   +  +KE      PE   AE+ D
Sbjct: 265 PYPGMPVDS-KFYKMIKEGFRMLSPEHAPAEMYD 297

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/235 (22%), Positives = 98/235 (41%), Gaps = 28/235 (11%)
Query: 151 YQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQ 210
           +++++K T       L+G G++  V   +   +  E   AVK++  Q   +      E +
Sbjct: 10  FEDMYKLTS-----ELLGEGAYAKVQGAVSLQNGKE--YAVKIIEKQAGHSRSRVFREVE 62
Query: 211 ALRSIR-HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
            L   + ++N++++I       F+ +    LV+E +  GS+    H+ +   ++ N  + 
Sbjct: 63  TLYQCQGNKNILELIEF-----FEDDTRFYLVFEKLQGGSI--LAHIQKQ--KHFNEREA 113
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT---AHVSDFGLAKFLPEAAXX 326
             +  DVA+ L++LH      I H DLKP N+L +         + DF L   +      
Sbjct: 114 SRVVRDVAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSC 170
Query: 327 XXXXXXXXVGVKGTVGYAAPEY-----GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                       G+  Y APE         +      D++S G++L  M +G  P
Sbjct: 171 TPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 42/229 (18%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLV-KI 223
           +G G+FG V + + DH   ++ VA+K++    ++R A++    E   L+ I+ ++   K 
Sbjct: 27  LGEGTFGKVVECL-DHARGKSQVALKIIRNVGKYREAAR---LEINVLKKIKEKDKENKF 82
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +   +S  F  +    + +EL+   + E +L  N   P  L  ++ +  A  +   L +L
Sbjct: 83  LCVLMSDWFNFHGHMCIAFELLGKNTFE-FLKENNFQPYPLPHVRHM--AYQLCHALRFL 139
Query: 284 HHYCETPIVHCDLKPSNVL-LDGEL------------------TAHVSDFGLAKFLPEAA 324
           H   E  + H DLKP N+L ++ E                   +  V+DFG A F  E  
Sbjct: 140 H---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-- 194
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
                       +  T  Y  PE  +    +   DV+S G +L E + G
Sbjct: 195 --------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 63/148 (42%), Gaps = 20/148 (13%)
Query: 232 FQGNDFEALVYELMVNGSLEEWLHLNRDA---PRNLNLLQRLSIAVDVASTLEYLHHYCE 288
           F+ +DF  +V E+    SL E LH  R A   P     +++          ++YLH+   
Sbjct: 95  FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQ------TIQGVQYLHN--- 144
Query: 289 TPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEY 348
             ++H DLK  N+ L+ ++   + DFGL       A            + GT  Y APE 
Sbjct: 145 NRVIHRDLKLGNLFLNDDMDVKIGDFGL-------ATKIEFDGERKKDLCGTPNYIAPEV 197
Query: 349 GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                 S   D++S G +L  +  GK P
Sbjct: 198 LCKKGHSFEVDIWSLGCILYTLLVGKPP 225

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 35/225 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKV-LNLQHRGASKSFIAECQALRSIRHRNLVKI-- 223
           IG G++G+V+K   + + HE +   +V L+    G   S + E   L+ ++H+N+V++  
Sbjct: 10  IGEGTYGTVFKAK-NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 224 ---ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
                  +++ F+  D +   Y    NG L+         P  +      S    +   L
Sbjct: 69  VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---------PEIVK-----SFLFQLLKGL 114
Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            + H      ++H DLKP N+L++      +++FGLA+                     T
Sbjct: 115 GFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-------T 164
Query: 341 VGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           + Y  P+   G+++ STS D++S G +  E+     P   +F GN
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 42/229 (18%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLV-KI 223
           +G G+FG V + + DH   ++ VA+K++    ++R A++    E   L+ I+ ++   K 
Sbjct: 36  LGEGTFGKVVECL-DHARGKSQVALKIIRNVGKYREAAR---LEINVLKKIKEKDKENKF 91
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +   +S  F  +    + +EL+   + E +L  N   P  L  ++ +  A  +   L +L
Sbjct: 92  LCVLMSDWFNFHGHMCIAFELLGKNTFE-FLKENNFQPYPLPHVRHM--AYQLCHALRFL 148
Query: 284 HHYCETPIVHCDLKPSNVL-LDGEL------------------TAHVSDFGLAKFLPEAA 324
           H   E  + H DLKP N+L ++ E                   +  V+DFG A F  E  
Sbjct: 149 H---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-- 203
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
                       +  T  Y  PE  +    +   DV+S G +L E + G
Sbjct: 204 --------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 244

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 63/148 (42%), Gaps = 20/148 (13%)
Query: 232 FQGNDFEALVYELMVNGSLEEWLHLNRDA---PRNLNLLQRLSIAVDVASTLEYLHHYCE 288
           F+ +DF  +V E+    SL E LH  R A   P     +++    V      +YLH+   
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGV------QYLHN--- 160
Query: 289 TPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEY 348
             ++H DLK  N+ L+ ++   + DFGL       A            + GT  Y APE 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGL-------ATKIEFDGERKKDLCGTPNYIAPEV 213
Query: 349 GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                 S   D++S G +L  +  GK P
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 110/252 (43%), Gaps = 49/252 (19%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR-- 218
           +S+   IG+G    V++ +   ++ + + A+K +NL+         A+ Q L S R+   
Sbjct: 30  YSILKQIGSGGSSKVFQVL---NEKKQIYAIKYVNLEE--------ADNQTLDSYRNEIA 78
Query: 219 NLVKIITSCVSV----DFQGNDFEALVYELMVNGSLE--EWLHLNRDAPRNLNLLQRLSI 272
            L K+      +    D++  D    +Y +M  G+++   WL       ++++  +R S 
Sbjct: 79  YLNKLQQHSDKIIRLYDYEITD--QYIYMVMECGNIDLNSWLK----KKKSIDPWERKSY 132
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLL-DGELTAHVSDFGLA-KFLPEAAXXXXXX 330
                + LE +H   +  IVH DLKP+N L+ DG L   + DFG+A +  P+        
Sbjct: 133 W---KNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDXXXVVKDS 187
Query: 331 XXXXVGVKGTVGYAAPE--YGMGSE---------VSTSGDVYSFGILLLEMFTGKGPTNE 379
                   GTV Y  PE    M S          +S   DV+S G +L  M  GK P  +
Sbjct: 188 QV------GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241
Query: 380 MFTGNLTLHNFV 391
           +      LH  +
Sbjct: 242 IINQISKLHAII 253

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 15/220 (6%)
Query: 168 GAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSC 227
           G  S+  + +G+  HD H    A+K +    +   +    E    R   H N+++++  C
Sbjct: 40  GGFSYVDLVEGL--HDGH--FYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 228 VSVDFQGNDFEA-LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY 286
           +    +G   EA L+      G+L   +   +D    L   Q L + + +   LE +H  
Sbjct: 96  LRE--RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-- 151
Query: 287 CETPIVHCDLKPSNVLLDGELTAHVSDFGL--AKFLPEAAXXXXXXXXXXVGVKGTVGYA 344
                 H DLKP+N+LL  E    + D G      +                 + T+ Y 
Sbjct: 152 -AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 345 APE-YGMGSE--VSTSGDVYSFGILLLEMFTGKGPTNEMF 381
           APE + + S   +    DV+S G +L  M  G+GP + +F
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 42/229 (18%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAECQALRSIRHRNLV-KI 223
           +G G+FG V + + DH   ++ VA+K++    ++R A++    E   L+ I+ ++   K 
Sbjct: 59  LGEGTFGKVVECL-DHARGKSQVALKIIRNVGKYREAAR---LEINVLKKIKEKDKENKF 114
Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
           +   +S  F  +    + +EL+   + E +L  N   P  L  ++ +  A  +   L +L
Sbjct: 115 LCVLMSDWFNFHGHMCIAFELLGKNTFE-FLKENNFQPYPLPHVRHM--AYQLCHALRFL 171
Query: 284 HHYCETPIVHCDLKPSNVL-LDGEL------------------TAHVSDFGLAKFLPEAA 324
           H   E  + H DLKP N+L ++ E                   +  V+DFG A F  E  
Sbjct: 172 H---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-- 226
Query: 325 XXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
                       +  T  Y  PE  +    +   DV+S G +L E + G
Sbjct: 227 --------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 267

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 63/148 (42%), Gaps = 20/148 (13%)
Query: 232 FQGNDFEALVYELMVNGSLEEWLHLNRDA---PRNLNLLQRLSIAVDVASTLEYLHHYCE 288
           F+ +DF  +V E+    SL E LH  R A   P     +++          ++YLH+   
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQ------TIQGVQYLHN--- 160
Query: 289 TPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEY 348
             ++H DLK  N+ L+ ++   + DFGL       A            + GT  Y APE 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGL-------ATKIEFDGERKKXLCGTPNYIAPEV 213
Query: 349 GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                 S   D++S G +L  +  GK P
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 63/148 (42%), Gaps = 20/148 (13%)
Query: 232 FQGNDFEALVYELMVNGSLEEWLHLNRDA---PRNLNLLQRLSIAVDVASTLEYLHHYCE 288
           F+ +DF  +V E+    SL E LH  R A   P     +++    V      +YLH+   
Sbjct: 111 FEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGV------QYLHN--- 160
Query: 289 TPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEY 348
             ++H DLK  N+ L+ ++   + DFGL       A            + GT  Y APE 
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGL-------ATKIEFDGERKKTLCGTPNYIAPEV 213
Query: 349 GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                 S   D++S G +L  +  GK P
Sbjct: 214 LCKKGHSFEVDIWSLGCILYTLLVGKPP 241

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 91/221 (41%), Gaps = 37/221 (16%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI--RHRNLVKII 224
           IG G +G V+ G +  +     VAVKV          S+  E +  +++  RH N++  I
Sbjct: 45  IGKGRYGEVWMGKWRGEK----VAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFI 97
Query: 225 TSCVSVDFQGNDFEALVY---ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
               + D +G      +Y   +   NGSL ++L         L+    L +A    S L 
Sbjct: 98  ----AADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLC 148
Query: 282 YLHHYC-----ETPIVHCDLKPSNVLLDGELTAHVSDFGLA-KFLPEAAXXXXXXXXXXV 335
           +LH        +  I H DLK  N+L+    T  ++D GLA KF+ +             
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV- 207
Query: 336 GVKGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEM 370
              GT  Y  PE    S      +     D+YSFG++L E+
Sbjct: 208 ---GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 41/90 (45%), Gaps = 6/90 (6%)
Query: 291 IVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGM 350
           I H D+KP N+LLD      +SDFGLA                   + GT+ Y APE   
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLLNKMCGTLPYVAPELLK 179
Query: 351 GSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             E      DV+S GI+L  M  G+ P ++
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 209

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 38/231 (16%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHE---TLVAVKVLNLQHRGASKSFIA-ECQALRS 214
           D + +   +G+G F  V K        E     +  + L+   RG S+  I  E   LR 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           IRH N++      +   F+      L+ EL+  G L ++L             ++ S+  
Sbjct: 65  IRHPNII-----TLHDIFENKTDVVLILELVSGGELFDFL------------AEKESLTE 107
Query: 275 DVAST-----LEYLHHYCETPIVHCDLKPSNV-LLDGEL---TAHVSDFGLAKFLPEAAX 325
           D A+      L+ +H+     I H DLKP N+ LLD  +      + DFG+A  + EA  
Sbjct: 108 DEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGN 166
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                      + GT  + APE      +    D++S G++   + +G  P
Sbjct: 167 EFK-------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 18/215 (8%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           +G G  G V+  +   +D +  VA+K + L    + K  + E + +R + H N+VK+   
Sbjct: 19  LGCGGNGLVFSAV--DNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY---- 282
                 Q  D    + EL     ++E++  +       N+L++  +  + A    Y    
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEYMETDL-----ANVLEQGPLLEEHARLFMYQLLR 131
Query: 283 -LHHYCETPIVHCDLKPSNVLLDGE-LTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGT 340
            L +     ++H DLKP+N+ ++ E L   + DFGLA+ +              V    T
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV----T 187
Query: 341 VGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGK 374
             Y +P   +     T   D+++ G +  EM TGK
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/242 (22%), Positives = 98/242 (40%), Gaps = 15/242 (6%)
Query: 150 SYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAEC 209
           S+   F   D + +   IG G++G V          +  +            +K  + E 
Sbjct: 46  SFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLREL 105
Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
           + L+  +H N++ I    +       +F++ VY  +V   +E  LH    + + L L   
Sbjct: 106 KILKHFKHDNIIAI-KDILRPTVPYGEFKS-VY--VVLDLMESDLHQIIHSSQPLTLEHV 161
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
                 +   L+Y+H      ++H DLKPSN+L++      + DFG+A+ L  +      
Sbjct: 162 RYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 218
Query: 330 XXXXXVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH 388
                V    T  Y APE  +   E + + D++S G +  EM   +    ++F G   +H
Sbjct: 219 FMTEYV---ATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR----QLFPGKNYVH 271
Query: 389 NF 390
Sbjct: 272 QL 273

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 41/90 (45%), Gaps = 6/90 (6%)
Query: 291 IVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGM 350
           I H D+KP N+LLD      +SDFGLA                   + GT+ Y APE   
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRERLLNKMCGTLPYVAPELLK 180
Query: 351 GSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
             E      DV+S GI+L  M  G+ P ++
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 38/231 (16%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHE---TLVAVKVLNLQHRGASKSFIA-ECQALRS 214
           D + +   +G+G F  V K        E     +  + L+   RG S+  I  E   LR 
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           IRH N++      +   F+      L+ EL+  G L ++L             ++ S+  
Sbjct: 72  IRHPNII-----TLHDIFENKTDVVLILELVSGGELFDFL------------AEKESLTE 114
Query: 275 DVAST-----LEYLHHYCETPIVHCDLKPSNV-LLDGEL---TAHVSDFGLAKFLPEAAX 325
           D A+      L+ +H+     I H DLKP N+ LLD  +      + DFG+A  + EA  
Sbjct: 115 DEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGN 173
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                      + GT  + APE      +    D++S G++   + +G  P
Sbjct: 174 EFK-------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 62/267 (23%), Positives = 112/267 (41%), Gaps = 23/267 (8%)
Query: 131 TKREPSTPPSALLASVLRV----SYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHE 186
            K EP+   +++ A  L +    S+   F   D + +   IG G++G V          +
Sbjct: 22  VKAEPAHTAASVAAKNLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQ 81
Query: 187 TLVAVKVL--NLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYEL 244
             VA+K +         +K  + E + L+  +H N++ I    +       +F++ VY  
Sbjct: 82  --VAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI-KDILRPTVPYGEFKS-VY-- 135
Query: 245 MVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD 304
           +V   +E  LH    + + L L         +   L+Y+H      ++H DLKPSN+L++
Sbjct: 136 VVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVN 192
Query: 305 GELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMG-SEVSTSGDVYSF 363
                 + DFG+A+ L  +           V    T  Y APE  +   E + + D++S 
Sbjct: 193 ENCELKIGDFGMARGLCTSPAEHQYFMTEYV---ATRWYRAPELMLSLHEYTQAIDLWSV 249
Query: 364 GILLLEMFTGKGPTNEMFTGNLTLHNF 390
           G +  EM   +    ++F G   +H  
Sbjct: 250 GCIFGEMLARR----QLFPGKNYVHQL 272

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKSQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + DFGL +   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 87/223 (39%), Gaps = 29/223 (13%)
Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK--- 222
           ++G G+FG V K     D      A+K +       S + ++E   L S+ H+ +V+   
Sbjct: 13  VLGQGAFGQVVKARNALDSR--YYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVVRYYA 69
Query: 223 -------IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
                   +    +V  +   F  + Y    N +L + +H       NLN  QR      
Sbjct: 70  AWLERRNFVKPMTAVKKKSTLFIQMEY--CENRTLYDLIH-----SENLNQ-QRDEYWRL 121
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXV 335
               LE L +     I+H DLKP N+ +D      + DFGLAK +  +            
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 336 GVK-------GTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEM 370
           G         GT  Y A E   G+   +   D+YS GI+  EM
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 97/229 (42%), Gaps = 36/229 (15%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSI 215
           T+ + L   +G G+F  V + +      E   A  ++N +   A   +    E +  R +
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQE--YAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           +H N+V++  S   +  +G+ +  L+++L+  G L E            +++ R   +  
Sbjct: 68  KHPNIVRLHDS---ISEEGHHY--LIFDLVTGGELFE------------DIVAREYYSEA 110
Query: 276 VAS-----TLEYLHHYCETPIVHCDLKPSNVLLDGEL---TAHVSDFGLAKFLPEAAXXX 327
            AS      LE + H  +  +VH +LKP N+LL  +L      ++DFGL       A   
Sbjct: 111 DASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGL-------AIEV 163
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                   G  GT GY +PE           D+++ G++L  +  G  P
Sbjct: 164 EGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + D GLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 109/252 (43%), Gaps = 49/252 (19%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR-- 218
           +S+   IG+G    V++ +   ++ + + A+K +NL+         A+ Q L S R+   
Sbjct: 58  YSILKQIGSGGSSKVFQVL---NEKKQIYAIKYVNLEE--------ADNQTLDSYRNEIA 106
Query: 219 NLVKIITSCVSV----DFQGNDFEALVYELMVNGSLE--EWLHLNRDAPRNLNLLQRLSI 272
            L K+      +    D++  D    +Y +M  G+++   WL       ++++  +R S 
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITD--QYIYMVMECGNIDLNSWLK----KKKSIDPWERKSY 160
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLL-DGELTAHVSDFGLA-KFLPEAAXXXXXX 330
             ++   LE +H   +  IVH DLKP+N L+ DG L   + DFG+A +  P+        
Sbjct: 161 WKNM---LEAVHTIHQHGIVHSDLKPANFLIVDGMLK--LIDFGIANQMQPDTTSVVKDS 215
Query: 331 XXXXVGVKGTVGYAAPE--YGMGSE---------VSTSGDVYSFGILLLEMFTGKGPTNE 379
                   G V Y  PE    M S          +S   DV+S G +L  M  GK P  +
Sbjct: 216 QV------GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269
Query: 380 MFTGNLTLHNFV 391
           +      LH  +
Sbjct: 270 IINQISKLHAII 281

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 22/229 (9%)
Query: 156 KATDGFSLENL-IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRS 214
           +  D F  E   +G G++G VYK        +   A+K   ++  G S S   E   LR 
Sbjct: 17  RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK--QIEGTGISMSACREIALLRE 74
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEW----LHLNRDAPRNLNLLQRL 270
           ++H N++ +    +S        +  V+ L      + W     H    A +    L R 
Sbjct: 75  LKHPNVISLQKVFLS------HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT----AHVSDFGLAKFLPEAAXX 326
            +   +   L+ +H+     ++H DLKP+N+L+ GE        ++D G A+        
Sbjct: 129 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 327 XXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGK 374
                   V    T  Y APE  +G+   T   D+++ G +  E+ T +
Sbjct: 189 LADLDPVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + D GLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    +  FGLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 91/230 (39%), Gaps = 34/230 (14%)
Query: 154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALR 213
           +   +D + L   IG+G+FG V + + D   +E LVAVK +    + A+ +   E    R
Sbjct: 14  IMHDSDRYELVKDIGSGNFG-VARLMRDKQSNE-LVAVKYIERGEKIAA-NVKREIINHR 70
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLNRDAPRNLNLLQR 269
           S+RH N+V+     ++         A+V E    G L E +      + D  R     Q+
Sbjct: 71  SLRHPNIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFF--FQQ 123
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH--VSDFGLAKFLPEAAXXX 327
           L   V     ++         + H DLK  N LLDG       + DFG +K         
Sbjct: 124 LISGVSYCHAMQ---------VCHRDLKLENTLLDGSPAPRLKICDFGYSK--------S 166
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTS-GDVYSFGILLLEMFTGKGP 376
                      GT  Y APE  +  E      DV+S G+ L  M  G  P
Sbjct: 167 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 62/145 (42%), Gaps = 12/145 (8%)
Query: 237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDL 296
           + A+V EL+   SLE+   L     R  +L   L IA+ + S +EY+H      +++ D+
Sbjct: 79  YNAMVLELL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDV 131
Query: 297 KPSNVLL-----DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMG 351
           KP N L+       +   H+ DF LAK   +              + GT  Y +    +G
Sbjct: 132 KPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG 191
Query: 352 SEVSTSGDVYSFGILLLEMFTGKGP 376
            E S   D+ + G + +    G  P
Sbjct: 192 KEQSRRDDLEALGHMFMYFLRGSLP 216

>pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 62/145 (42%), Gaps = 12/145 (8%)
Query: 237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDL 296
           + A+V EL+   SLE+   L     R  +L   L IA+ + S +EY+H      +++ D+
Sbjct: 100 YNAMVLELL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDV 152
Query: 297 KPSNVLL-----DGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMG 351
           KP N L+       +   H+ DF LAK   +              + GT  Y +    +G
Sbjct: 153 KPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG 212
Query: 352 SEVSTSGDVYSFGILLLEMFTGKGP 376
            E S   D+ + G + +    G  P
Sbjct: 213 KEQSRRDDLEALGHMFMYFLRGSLP 237

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 58/253 (22%), Positives = 98/253 (38%), Gaps = 44/253 (17%)
Query: 146 VLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF 205
           ++  S++      + F +   +G G+FG V   +  H D++   AVKV+    +  ++S 
Sbjct: 22  IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVL--LCQHIDNKKYYAVKVVR-NIKKYTRSA 78
Query: 206 IAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLN 265
             E   L+ I++ ++           F   D   L++E +   SL E +  N     N N
Sbjct: 79  KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-----NYN 132
Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH--------------- 310
                 I +     L+ L++  +  + H DLKP N+LLD                     
Sbjct: 133 GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192
Query: 311 ----------VSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDV 360
                     + DFG A F  +              +  T  Y APE  +      S D+
Sbjct: 193 IYRTKSTGIKLIDFGCATFKSDYHG----------SIINTRQYRAPEVILNLGWDVSSDM 242
Query: 361 YSFGILLLEMFTG 373
           +SFG +L E++TG
Sbjct: 243 WSFGCVLAELYTG 255

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 88/220 (40%), Gaps = 27/220 (12%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           + L   IG G+F  V   +  H      VAVK+++     +S  +    E +  + + H 
Sbjct: 16  YRLLKTIGKGNFAKV--KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHP 73
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN-RDAPRNLNLLQRLSIAVDVA 277
           N+VK+         +      LV E    G + ++L  + R   +      R      + 
Sbjct: 74  NIVKLFEVI-----ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-----QIV 123
Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGV 337
           S ++Y H   +  IVH DLK  N+LLD +    ++DFG +                    
Sbjct: 124 SAVQYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFSN--------EFTFGNKLDAF 172
Query: 338 KGTVGYAAPEYGMGSEVS-TSGDVYSFGILLLEMFTGKGP 376
            G   YAAPE   G +      DV+S G++L  + +G  P
Sbjct: 173 CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 93/231 (40%), Gaps = 38/231 (16%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHE---TLVAVKVLNLQHRGASKSFIA-ECQALRS 214
           D + +   +G+G F  V K        E     +  + L    RG S+  I  E   LR 
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           IRH N++      +   F+      L+ EL+  G L ++L             ++ S+  
Sbjct: 86  IRHPNII-----TLHDIFENKTDVVLILELVSGGELFDFL------------AEKESLTE 128
Query: 275 DVAST-----LEYLHHYCETPIVHCDLKPSNV-LLDGEL---TAHVSDFGLAKFLPEAAX 325
           D A+      L+ +H+     I H DLKP N+ LLD  +      + DFG+A  + EA  
Sbjct: 129 DEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGN 187
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                      + GT  + APE      +    D++S G++   + +G  P
Sbjct: 188 EFK-------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 33/216 (15%)
Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALRSIRHRN--- 219
           +G+G++GSV        D +T   VAVK L+   Q    +K    E + L+ ++H N   
Sbjct: 30  VGSGAYGSVCAAF----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 85
Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           L+ + T   S++ + ND   LV  LM    L   +   +    ++  L        +   
Sbjct: 86  LLDVFTPARSLE-EFNDV-YLVTHLM-GADLNNIVKCQKLTDDHVQFL-----IYQILRG 137
Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKG 339
           L+Y+H      I+H DLKPSN+ ++ +    + D GLA+   +             G   
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE----------MTGYVA 184
Query: 340 TVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGK 374
           T  Y APE  +     + + D++S G ++ E+ TG+
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/106 (27%), Positives = 51/106 (48%), Gaps = 15/106 (14%)
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLD-----GELTAHVSDFGLAKFLPEAAXXXXXX 330
           +   LE +++  +  IVH DLKP N+LL      G++   + DFG+++ +  A       
Sbjct: 137 IKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK--IVDFGMSRKIGHACELRE-- 192
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                 + GT  Y APE      ++T+ D+++ GI+   + T   P
Sbjct: 193 ------IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 73/180 (40%), Gaps = 26/180 (14%)
Query: 201 ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-EEWLHLNRD 259
           ++   + E   L+ + H N++K+        F+      LV E    G L +E +H  + 
Sbjct: 79  SNSKLLEEVAVLKLLDHPNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHRMK- 132
Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSDFGL 316
                N +    I   V S + YLH +    IVH DLKP N+LL+    +    + DFGL
Sbjct: 133 ----FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGL 185
Query: 317 AKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           +                     GT  Y APE  +  +     DV+S G++L  +  G  P
Sbjct: 186 SAVFENQKKMKERL--------GTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 92/232 (39%), Gaps = 38/232 (16%)
Query: 154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA--SKSFIAECQA 211
           +   +D + L   IG+G+FG V + + D   +E LVAVK +    RG    ++   E   
Sbjct: 13  IMHDSDRYELVKDIGSGNFG-VARLMRDKQSNE-LVAVKYIE---RGEKIDENVKREIIN 67
Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLNRDAPRNLNLL 267
            RS+RH N+V+     ++         A+V E    G L E +      + D  R     
Sbjct: 68  HRSLRHPNIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEARFF--F 120
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH--VSDFGLAKFLPEAAX 325
           Q+L       S + Y H      + H DLK  N LLDG       + DFG +K       
Sbjct: 121 QQL------ISGVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------- 164
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTS-GDVYSFGILLLEMFTGKGP 376
                        GT  Y APE  +  E      DV+S G+ L  M  G  P
Sbjct: 165 -SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 92/232 (39%), Gaps = 38/232 (16%)
Query: 154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQA 211
           +   +D +     IG+G+FG V + + D    E LVAVK +    RGA+  ++   E   
Sbjct: 15  IMHDSDRYDFVKDIGSGNFG-VARLMRDKLTKE-LVAVKYIE---RGAAIDENVQREIIN 69
Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLNRDAPRNLNLL 267
            RS+RH N+V+     ++         A++ E    G L E +      + D  R     
Sbjct: 70  HRSLRHPNIVRFKEVILTPTHL-----AIIMEYASGGELYERICNAGRFSEDEARFF--F 122
Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH--VSDFGLAKFLPEAAX 325
           Q+L   V    +++         I H DLK  N LLDG       + DFG +K       
Sbjct: 123 QQLLSGVSYCHSMQ---------ICHRDLKLENTLLDGSPAPRLKICDFGYSK------- 166
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTS-GDVYSFGILLLEMFTGKGP 376
                        GT  Y APE  +  E      DV+S G+ L  M  G  P
Sbjct: 167 -SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/226 (21%), Positives = 88/226 (38%), Gaps = 21/226 (9%)
Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITS 226
           IG+G FG +Y     +   +    V  +  Q  G      +E +  + +  ++ +K    
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP---LFSELKFYQRVAKKDCIKKWIE 101
Query: 227 CVSVDFQG---------NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR--LSIAVD 275
              +D+ G          +F+   Y  MV   L   + L + + +N    +   L + + 
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLG--IDLQKISGQNGTFKKSTVLQLGIR 159
Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLPEAAXXXXXXXXX 333
           +   LEY+H   E   VH D+K +N+LL        +++D+GL+                
Sbjct: 160 MLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216
Query: 334 XVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
             G  GT+ + + +   G  +S   DV   G  +L    GK P  +
Sbjct: 217 RKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/72 (36%), Positives = 36/72 (50%), Gaps = 2/72 (2%)
Query: 18  RGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVN 77
           + +  LDL  N + G +P+ L    FL +LN+SFN+  GE+P  G        +   N  
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
Query: 78  LCGGISELHLCT 89
           LCG  S L  CT
Sbjct: 304 LCG--SPLPACT 313

>pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 112/274 (40%), Gaps = 37/274 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETL-----VAVKV-----------LNLQHRGASKSFIAECQ 210
           IG G FG +Y  + D +  E++       VKV           L    R A    I +  
Sbjct: 43  IGQGGFGCIY--LADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
             R +++  + K   S +  D  G  +  ++ +      L++    N        +LQ  
Sbjct: 101 RTRKLKYLGVPKYWGSGLH-DKNGKSYRFMIMD-RFGSDLQKIYEANAKRFSRKTVLQ-- 156
Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS--DFGLA-KFLPEAAXXX 327
            +++ +   LEY+H   E   VH D+K SN+LL+ +    V   D+GLA ++ PE     
Sbjct: 157 -LSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKE 212
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL 387
                      GT+ + + +   G   S  GD+   G  +++  TG  P    +  NL  
Sbjct: 213 YKEDPKRCH-DGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP----WEDNLKD 267
Query: 388 HNFVKEA---LPERLAEIVDPVLLVEREEGETSE 418
             +V+++     E +A ++D     + + GE ++
Sbjct: 268 PKYVRDSKIRYRENIASLMDKCFPEKNKPGEIAK 301

>pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 112/274 (40%), Gaps = 37/274 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETL-----VAVKV-----------LNLQHRGASKSFIAECQ 210
           IG G FG +Y  + D +  E++       VKV           L    R A    I +  
Sbjct: 43  IGQGGFGCIY--LADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
             R +++  + K   S +  D  G  +  ++ +      L++    N        +LQ  
Sbjct: 101 RTRKLKYLGVPKYWGSGLH-DKNGKSYRFMIMD-RFGSDLQKIYEANAKRFSRKTVLQ-- 156
Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS--DFGLA-KFLPEAAXXX 327
            +++ +   LEY+H   E   VH D+K SN+LL+ +    V   D+GLA ++ PE     
Sbjct: 157 -LSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKE 212
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL 387
                      GT+ + + +   G   S  GD+   G  +++  TG  P    +  NL  
Sbjct: 213 YKEDPKRCH-DGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP----WEDNLKD 267
Query: 388 HNFVKEA---LPERLAEIVDPVLLVEREEGETSE 418
             +V+++     E +A ++D     + + GE ++
Sbjct: 268 PKYVRDSKIRYRENIASLMDKCFPEKNKPGEIAK 301

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 90/229 (39%), Gaps = 28/229 (12%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHE---TLVAVKVLNLQHRGASKSFIA-ECQA 211
           K  D + +   +G+G F  V K        E     +  +      RG S+  I  E   
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           LR + H N++ +        ++      L+ EL+  G L ++L        +L+  +  S
Sbjct: 69  LRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFLA----QKESLSEEEATS 119
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNV-LLDGEL-TAHVS--DFGLAKFLPEAAXXX 327
               +   + YLH      I H DLKP N+ LLD  +   H+   DFGLA  + +     
Sbjct: 120 FIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                    + GT  + APE      +    D++S G++   + +G  P
Sbjct: 177 --------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 90/229 (39%), Gaps = 28/229 (12%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHE---TLVAVKVLNLQHRGASKSFIA-ECQA 211
           K  D + +   +G+G F  V K        E     +  +      RG S+  I  E   
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           LR + H N++ +        ++      L+ EL+  G L ++L        +L+  +  S
Sbjct: 69  LRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFLA----QKESLSEEEATS 119
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNV-LLDGEL-TAHVS--DFGLAKFLPEAAXXX 327
               +   + YLH      I H DLKP N+ LLD  +   H+   DFGLA  + +     
Sbjct: 120 FIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                    + GT  + APE      +    D++S G++   + +G  P
Sbjct: 177 --------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 90/229 (39%), Gaps = 28/229 (12%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHE---TLVAVKVLNLQHRGASKSFIA-ECQA 211
           K  D + +   +G+G F  V K        E     +  +      RG S+  I  E   
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           LR + H N++ +        ++      L+ EL+  G L ++L        +L+  +  S
Sbjct: 69  LRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFLA----QKESLSEEEATS 119
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNV-LLDGEL-TAHVS--DFGLAKFLPEAAXXX 327
               +   + YLH      I H DLKP N+ LLD  +   H+   DFGLA  + +     
Sbjct: 120 FIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                    + GT  + APE      +    D++S G++   + +G  P
Sbjct: 177 --------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 90/229 (39%), Gaps = 28/229 (12%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHE---TLVAVKVLNLQHRGASKSFIA-ECQA 211
           K  D + +   +G+G F  V K        E     +  +      RG S+  I  E   
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSI 68
Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           LR + H N++ +        ++      L+ EL+  G L ++L        +L+  +  S
Sbjct: 69  LRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFLA----QKESLSEEEATS 119
Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNV-LLDGEL-TAHVS--DFGLAKFLPEAAXXX 327
               +   + YLH      I H DLKP N+ LLD  +   H+   DFGLA  + +     
Sbjct: 120 FIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                    + GT  + APE      +    D++S G++   + +G  P
Sbjct: 177 --------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/250 (23%), Positives = 102/250 (40%), Gaps = 40/250 (16%)
Query: 151 YQNLFKATDGFSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQHRGASKSFIAEC 209
           Y+ + + ++ F +E+ IG G+F SVY          E  +A+K  +L          AE 
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALK--HLIPTSHPIRIAAEL 70
Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
           Q L     ++ V  +  C    F+ ND   +    + + S  + L+       +L+  + 
Sbjct: 71  QCLTVAGGQDNVMGVKYC----FRKNDHVVIAMPYLEHESFLDILN-------SLSFQEV 119
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH-VSDFGLA----------- 317
               +++   L+ +H +    IVH D+KPSN L +  L  + + DFGLA           
Sbjct: 120 REYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELL 176
Query: 318 KFLPEAAXXXX----------XXXXXXVGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGIL 366
           KF+   A                        GT G+ APE        T+  D++S G++
Sbjct: 177 KFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVI 236
Query: 367 LLEMFTGKGP 376
            L + +G+ P
Sbjct: 237 FLSLLSGRYP 246

>pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 62/274 (22%), Positives = 110/274 (40%), Gaps = 37/274 (13%)
Query: 167 IGAGSFGSVYKGIFDHDDHETL-----VAVKV-----------LNLQHRGASKSFIAECQ 210
           IG G FG +Y  + D +  E++       VKV           L    R A    I +  
Sbjct: 43  IGQGGFGCIY--LADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
             R +++  + K   S +  D  G  +  ++ +      L++    N        +LQ  
Sbjct: 101 RTRKLKYLGVPKYWGSGLH-DKNGKSYRFMIMD-RFGSDLQKIYEANAKRFSRKTVLQ-- 156
Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS--DFGLA-KFLPEAAXXX 327
            +++ +   LEY+H   E   VH D+K SN+LL+ +    V   D+GLA ++ PE     
Sbjct: 157 -LSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 328 XXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL 387
                      GT+ + + +   G   S  GD+   G  +++  TG  P    +  NL  
Sbjct: 213 YAADPKRCH-DGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP----WEDNLKD 267
Query: 388 HNFVKEA---LPERLAEIVDPVLLVEREEGETSE 418
             +V+++     E +A ++D         GE ++
Sbjct: 268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAK 301

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 76/183 (41%), Gaps = 25/183 (13%)
Query: 199 RGASKSFIA-ECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN 257
           RG S+  I  E   LR + H N++ +        ++      L+ EL+  G L ++L   
Sbjct: 55  RGVSREEIEREVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFLA-- 107
Query: 258 RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNV-LLDGEL-TAHVS--D 313
                +L+  +  S    +   + YLH      I H DLKP N+ LLD  +   H+   D
Sbjct: 108 --QKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 314 FGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
           FGLA  + +              + GT  + APE      +    D++S G++   + +G
Sbjct: 163 FGLAHEIEDGVEFK--------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
Query: 374 KGP 376
             P
Sbjct: 215 ASP 217

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 25/221 (11%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           D + +   +G+G+FG V++ + +       VA K +N  +     +   E   +  + H 
Sbjct: 51  DYYDILEELGSGAFGVVHRCV-EKATGRVFVA-KFINTPYPLDKYTVKNEISIMNQLHHP 108
Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            L+ +  +     F+      L+ E +  G L      +R A  +  + +   I   +  
Sbjct: 109 KLINLHDA-----FEDKYEMVLILEFLSGGEL-----FDRIAAEDYKMSEAEVINY-MRQ 157
Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS--DFGLA-KFLPEAAXXXXXXXXXXV 335
             E L H  E  IVH D+KP N++ + +  + V   DFGLA K  P+             
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT------ 211
Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
               T  +AAPE      V    D+++ G+L   + +G  P
Sbjct: 212 ---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 87/231 (37%), Gaps = 35/231 (15%)
Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSI 215
           D F +  +IG G+F  V   +        + A+K++N   +  RG    F  E   L + 
Sbjct: 61  DDFEILKVIGRGAFSEV--AVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118
Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL-HLNRDAPRNLN--LLQRLSI 272
             R + ++  +     FQ  ++  LV E  V G L   L       P  +    L  + +
Sbjct: 119 DRRWITQLHFA-----FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM 173
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXX 332
           A+D    L Y         VH D+KP N+LLD      ++DFG    L            
Sbjct: 174 AIDSVHRLGY---------VHRDIKPDNILLDRCGHIRLADFGSCLKL-----RADGTVR 219
Query: 333 XXVGVKGTVGYAAPE-------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             V V GT  Y +PE                  D ++ G+   EMF G+ P
Sbjct: 220 SLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 31/226 (13%)
Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDD----HETLVAVKVLNLQHRGASKSFIAECQALR 213
           +D +     +G+G++G V   +   D        +  +K  ++     S + + E   L+
Sbjct: 20  SDRYQRVKKLGSGAYGEV---LLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLK 76
Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
            + H N++K+        F+      LV E+   G L + + L +      + +    I 
Sbjct: 77  QLDHPNIMKLYEF-----FEDKRNYYLVMEVYRGGELFDEIILRQ----KFSEVDAAVIM 127
Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSDFGLAKFLPEAAXXXXXX 330
             V S   YLH +    IVH DLKP N+LL+    +    + DFGL+             
Sbjct: 128 KQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL 184
Query: 331 XXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                   GT  Y APE  +  +     DV+S G++L  +  G  P
Sbjct: 185 --------GTAYYIAPEV-LRKKYDEKCDVWSCGVILYILLCGYPP 221

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 32/231 (13%)
Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA------EC 209
           K  D + +   +G+G F  V K        E   A K +  +   AS+  +       E 
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLE--YAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
             LR + H N++ +        ++      L+ EL+  G L ++L        +L+  + 
Sbjct: 67  SILRQVLHPNIITLHDV-----YENRTDVVLILELVSGGELFDFLA----QKESLSEEEA 117
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNV-LLDGEL-TAHVS--DFGLAKFLPEAAX 325
            S    +   + YLH      I H DLKP N+ LLD  +   H+   DFGLA  + +   
Sbjct: 118 TSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 326 XXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                      + GT  + APE      +    D++S G++   + +G  P
Sbjct: 175 FK--------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 59/240 (24%), Positives = 101/240 (42%), Gaps = 52/240 (21%)
Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRS----IR 216
           + + + +G G+FG V + I DH      VAVK++        K+    C+A RS    + 
Sbjct: 16  YEIVDTLGEGAFGKVVECI-DHKAGGRHVAVKIV--------KNVDRYCEAARSEIQVLE 66
Query: 217 HRNLVKIITS--CVSV--DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           H N     ++  CV +   F+ +    +V+EL+   S  +++  N   P  L+ ++++  
Sbjct: 67  HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKM-- 123
Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVL-LDGELTA------------------HVSD 313
           A  +  ++ +LH      + H DLKP N+L +  + T                    V D
Sbjct: 124 AYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 314 FGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG 373
           FG A +  E              +  T  Y APE  +    S   DV+S G +L+E + G
Sbjct: 181 FGSATYDDEHHST----------LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 29/103 (28%), Positives = 47/103 (45%), Gaps = 8/103 (7%)
Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXX 329
           +S +  VA  +E+L        +H DL   N+LL       + DFGLA+ + +       
Sbjct: 202 ISYSFQVARGMEFLSS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRK 258
Query: 330 XXXXXVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                   +  + + APE       ST  DV+S+G+LL E+F+
Sbjct: 259 G-----DTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 25/84 (29%), Positives = 38/84 (45%), Gaps = 6/84 (7%)
Query: 293 HCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAXXXXXXXXXXVGVKGTVGYAAPEYGMGS 352
           H D+KP N+L+  +  A++ DFG+A    +                GT+ Y APE    S
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV------GTLYYXAPERFSES 210
Query: 353 EVSTSGDVYSFGILLLEMFTGKGP 376
             +   D+Y+   +L E  TG  P
Sbjct: 211 HATYRADIYALTCVLYECLTGSPP 234

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	484
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-85
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-80
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-71
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-61
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-58
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-57
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-54
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-54
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-53
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-50
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-49
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-49
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-48
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-48
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-47
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-46
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-46
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	4e-37
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	4e-37
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	5e-37
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-35
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-35
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-34
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-34
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-34
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-34
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	6e-34
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-34
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-34
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-34
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-33
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-33
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-33
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-31
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-30
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-29
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-29
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-29
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-29
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-29
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-29
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-29
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-14
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-14
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-12
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-11
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	7e-08
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-28
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	9e-12
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-11
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-11
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	5e-09
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-06
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-28
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-28
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-27
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-27
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-27
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-27
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-27
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-27
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-27
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-27
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-26
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-26
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-24
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-23
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-22
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-22
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-22
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-22
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-22
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-22
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-22
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-21
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-21
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-21
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-21
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-21
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-20
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-20
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-20
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-20
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-19
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-19
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-19
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	8e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-18
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-18
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-18
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-18
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-18
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-18
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-18
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	5e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-18
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-17
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-17
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-17
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-17
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-17
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-17
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-17
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-17
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-17
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-17
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-17
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-17
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-17
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-17
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-16
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-16
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-16
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-16
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-16
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-16
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-16
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-16
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	8e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	8e-16
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-15
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-15
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-15
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-15
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-15
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	7e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-15
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-14
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-14
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-13
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-13
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-13
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-13
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-08
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-11
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-09
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-06
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-06
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	9e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-06
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-05
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-05
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-05
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-05
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-04
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-04
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	9e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	7e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-04
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-05
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-05
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-05
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-04
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-05
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	8e-04
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	8e-05
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-04
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-04
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-04
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	6e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  264 bits (676), Expect = 4e-85
 Identities = 100/330 (30%), Positives = 156/330 (47%), Gaps = 38/330 (11%)

Query: 139 PSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ- 197
           P   L  + R S + L  A+D FS +N++G G FG VYKG        TLVAVK L  + 
Sbjct: 10  PEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADG---TLVAVKRLKEER 66

Query: 198 HRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN 257
            +G    F  E + +    HRNL+++   C+       +   LVY  M NGS+   L   
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCM----TPTE-RLLVYPYMANGSVASCLRER 121

Query: 258 RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA 317
            ++   L+  +R  IA+  A  L YLH +C+  I+H D+K +N+LLD E  A V DFGLA
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181

Query: 318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPT 377
           K +     ++++       V+GT+G+ APEY    + S   DV+ +G++LLE+ TG+   
Sbjct: 182 KLMDYKDTHVTT------AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235

Query: 378 NEMFTGNLTLHNFVKEALP----ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKE 433
           +     N      +         ++L  +VD  L     +G   +              E
Sbjct: 236 DLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL-----QGNYKD--------------E 276

Query: 434 CLVSVLGIGVICSSELPRERMNMEEVAAQL 463
            +  ++ + ++C+   P ER  M EV   L
Sbjct: 277 EVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  250 bits (642), Expect = 4e-80
 Identities = 92/342 (26%), Positives = 146/342 (42%), Gaps = 41/342 (11%)

Query: 126 SWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDH 185
           S  + +  +  +    +     RV   +L +AT+ F  + LIG G FG VYKG+      
Sbjct: 6   SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG-- 63

Query: 186 ETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELM 245
              VA+K    +     + F  E + L   RH +LV +I  C        +   L+Y+ M
Sbjct: 64  -AKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-----RNEMILIYKYM 117

Query: 246 VNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG 305
            NG+L+  L+ +     +++  QRL I +  A  L YLH      I+H D+K  N+LLD 
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDE 174

Query: 306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGI 365
                ++DFG++K   E           S  VKGT+GY  PEY +   ++   DVYSFG+
Sbjct: 175 NFVPKITDFGISKKGTEL-----DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229

Query: 366 LLLEMFTGKGPTNEMFTGNLTLHNFVKEALP----ERLAEIVDPVLLVEREEGETSEANA 421
           +L E+   +    +       + N  + A+      +L +IVDP L       +      
Sbjct: 230 VLFEVLCARSAIVQSLPRE--MVNLAEWAVESHNNGQLEQIVDPNL-----ADKIR---- 278

Query: 422 HKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL 463
                      E L       V C +    +R +M +V  +L
Sbjct: 279 ----------PESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  227 bits (580), Expect = 5e-71
 Identities = 85/329 (25%), Positives = 139/329 (42%), Gaps = 58/329 (17%)

Query: 150 SYQNLFKATDGFSLE------NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS- 202
           S+  L   T+ F         N +G G FG VYKG  +     T VAVK L       + 
Sbjct: 16  SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN----NTTVAVKKLAAMVDITTE 71

Query: 203 ---KSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD 259
              + F  E + +   +H NLV+++         G+D   LVY  M NGSL + L    D
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSS----DGDDL-CLVYVYMPNGSLLDRLS-CLD 125

Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
               L+   R  IA   A+ + +LH   E   +H D+K +N+LLD   TA +SDFGLA+ 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARA 182

Query: 320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
             + A  + +++     + GT  Y APE  +  E++   D+YSFG++LLE+ TG    +E
Sbjct: 183 SEKFAQTVMTSR-----IVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE 236

Query: 380 MFTGNLTLHNFVKEALP-----ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKEC 434
               +      +          + + + +D  +       +    +              
Sbjct: 237 ----HREPQLLLDIKEEIEDEEKTIEDYIDKKM------NDADSTSVEA----------- 275

Query: 435 LVSVLGIGVICSSELPRERMNMEEVAAQL 463
              +  +   C  E   +R ++++V   L
Sbjct: 276 ---MYSVASQCLHEKKNKRPDIKKVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  202 bits (515), Expect = 2e-61
 Identities = 63/249 (25%), Positives = 106/249 (42%), Gaps = 28/249 (11%)

Query: 144 ASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK 203
           +S + +  +NL+  +    L  +   G FG V+K    ++     VAVK+  +Q +  S 
Sbjct: 9   SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY----VAVKIFPIQDK-QSW 63

Query: 204 SFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN 263
               E  +L  ++H N+++ I +         D   L+      GSL ++L  N      
Sbjct: 64  QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW-LITAFHEKGSLSDFLKANV----- 117

Query: 264 LNLLQRLSIAVDVASTLEYLHH-------YCETPIVHCDLKPSNVLLDGELTAHVSDFGL 316
           ++  +   IA  +A  L YLH          +  I H D+K  NVLL   LTA ++DFGL
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177

Query: 317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-----EVSTSGDVYSFGILLLEMF 371
           A       +   ++     G  GT  Y APE   G+     +     D+Y+ G++L E+ 
Sbjct: 178 ALKFEAGKSAGDTH-----GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

Query: 372 TGKGPTNEM 380
           +     +  
Sbjct: 233 SRCTAADGP 241

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  194 bits (495), Expect = 2e-58
 Identities = 75/220 (34%), Positives = 113/220 (51%), Gaps = 20/220 (9%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNL 220
           ++  IGAGSFG+V++  +    H + VAVK+L  Q   A     F+ E   ++ +RH N+
Sbjct: 41  IKEKIGAGSFGTVHRAEW----HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V  + +      Q  +  ++V E +  GSL   LH    A   L+  +RLS+A DVA  +
Sbjct: 97  VLFMGAVT----QPPNL-SIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGM 150

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
            YLH+    PIVH +LK  N+L+D + T  V DFGL++         +S   SS    GT
Sbjct: 151 NYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-------KASTFLSSKSAAGT 202

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
             + APE       +   DVYSFG++L E+ T + P   +
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  191 bits (487), Expect = 2e-57
 Identities = 67/251 (26%), Positives = 106/251 (42%), Gaps = 33/251 (13%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
             +E ++G G+FG V K  +        VA+K +  +     K+FI E + L  + H N+
Sbjct: 10  IEVEEVVGRGAFGVVCKAKW----RAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNI 63

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK+  +C+      N    LV E    GSL   LH   +          +S  +  +  +
Sbjct: 64  VKLYGACL------NPV-CLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQCSQGV 115

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELT-AHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
            YLH      ++H DLKP N+LL    T   + DFG A  +          Q+     KG
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----------QTHMTNNKG 165

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL---- 395
           +  + APE   GS  S   DV+S+GI+L E+ T + P +E+      +   V        
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225

Query: 396 ----PERLAEI 402
               P+ +  +
Sbjct: 226 IKNLPKPIESL 236

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  181 bits (461), Expect = 5e-54
 Identities = 51/227 (22%), Positives = 89/227 (39%), Gaps = 33/227 (14%)

Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA--SKSFIAECQALRSIRHRN 219
           +    +     G ++KG +        + VKVL ++      S+ F  EC  LR   H N
Sbjct: 13  NFLTKLNENHSGELWKGRW----QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           ++ ++ +C S          L+   M  GSL   LH        ++  Q +  A+D+A  
Sbjct: 69  VLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARG 123

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           + +LH   E  I    L   +V++D ++TA +S   +                 S G   
Sbjct: 124 MAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF------------QSPGRMY 170

Query: 340 TVGYAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
              + APE             +   D++SF +LL E+ T + P  ++
Sbjct: 171 APAWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVPFADL 214

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  180 bits (460), Expect = 8e-54
 Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 35/230 (15%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH----RGASKSFIAECQALRSIRHR 218
           LE +IG G FG VY+  +        VAVK              ++   E +    ++H 
Sbjct: 11  LEEIIGIGGFGKVYRAFW----IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N++ +   C+    +  +   LV E    G L   L       + +     ++ AV +A 
Sbjct: 67  NIIALRGVCL----KEPNL-CLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIAR 116

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAH--------VSDFGLAKFLPEAANNLSSN 330
            + YLH     PI+H DLK SN+L+  ++           ++DFGLA+           +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---------H 167

Query: 331 QSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           +++ +   G   + APE    S  S   DV+S+G+LL E+ TG+ P   +
Sbjct: 168 RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  180 bits (458), Expect = 3e-53
 Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 37/234 (15%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS-------KSFIAECQALR 213
              E  IG G FG V+KG    D     VA+K L L             + F  E   + 
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSV--VAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
           ++ H N+VK+     +          +V E +  G L   L    D    +    +L + 
Sbjct: 79  NLNHPNIVKLYGLMHNPPR-------MVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLM 128

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLD-----GELTAHVSDFGLAKFLPEAANNLS 328
           +D+A  +EY+ +    PIVH DL+  N+ L        + A V+DFGL++          
Sbjct: 129 LDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--------- 178

Query: 329 SNQSSSVGVKGTVGYAAPE--YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
            +  S  G+ G   + APE         +   D YSF ++L  + TG+GP +E 
Sbjct: 179 -SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  181 bits (461), Expect = 4e-53
 Identities = 67/241 (27%), Positives = 101/241 (41%), Gaps = 28/241 (11%)

Query: 150 SYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAEC 209
           +        D   L  LIG G +G+VYKG  D       VAVKV +  +R   ++FI E 
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP----VAVKVFSFANR---QNFINEK 56

Query: 210 Q--ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL 267
               +  + H N+ + I     V   G     LV E   NGSL ++L L+       + +
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWV 111

Query: 268 QRLSIAVDVASTLEYLH------HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
               +A  V   L YLH       + +  I H DL   NVL+  + T  +SDFGL+  L 
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 322 EAANNLSSNQS-SSVGVKGTVGYAAPEYGMGS-------EVSTSGDVYSFGILLLEMFTG 373
                    +  +++   GT+ Y APE   G+             D+Y+ G++  E+F  
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

Query: 374 K 374
            
Sbjct: 232 C 232

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  172 bits (439), Expect = 1e-50
 Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 27/223 (12%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNL 220
           +   IG+GSFG+VYKG +  D     VAVK+LN+        ++F  E   LR  RH N+
Sbjct: 28  VGQRIGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           +  +    +         A+V +     SL   LH +        + + + IA   A  +
Sbjct: 83  LLFMGYSTAPQL------AIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGM 133

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
           +YLH      I+H DLK +N+ L  + T  + DFGLA        +  S       + G+
Sbjct: 134 DYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK-----SRWSGSHQFEQLSGS 185

Query: 341 VGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           + + APE       +  S   DVY+FGI+L E+ TG+ P + +
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  171 bits (435), Expect = 1e-49
 Identities = 53/229 (23%), Positives = 90/229 (39%), Gaps = 30/229 (13%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNL 220
           +  LIG G FG VY G + H +    VA+++++++       K+F  E  A R  RH N+
Sbjct: 37  IGELIGKGRFGQVYHGRW-HGE----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV 91

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V  + +C+          A++  L    +L   +   +     L++ +   IA ++   +
Sbjct: 92  VLFMGACM----SPPHL-AIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGM 143

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
            YLH      I+H DLK  NV  D      ++DFGL              +       G 
Sbjct: 144 GYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSI--SGVLQAGRREDKLRIQNGW 197

Query: 341 VGYAAPE---------YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           + + APE                S   DV++ G +  E+   + P    
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  167 bits (425), Expect = 3e-48
 Identities = 59/255 (23%), Positives = 95/255 (37%), Gaps = 28/255 (10%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
              ++G G FG   K    H +   ++ +K L        ++F+ E + +R + H N++K
Sbjct: 14  HGEVLGKGCFGQAIKVT--HRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
            I        +       + E +  G+L   +             QR+S A D+AS + Y
Sbjct: 72  FIGVLY----KDKRL-NFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAY 123

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS-------SSV 335
           LH      I+H DL   N L+       V+DFGLA+ + +        +S          
Sbjct: 124 LH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL 395
            V G   + APE   G       DV+SFGI+L E+        +     +     V+  L
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240

Query: 396 --------PERLAEI 402
                   P     I
Sbjct: 241 DRYCPPNCPPSFFPI 255

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  165 bits (421), Expect = 8e-48
 Identities = 57/231 (24%), Positives = 96/231 (41%), Gaps = 29/231 (12%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQ--ALRSIRHRNL 220
           L   +G G +G V++G +        VAVK+ + +     KS+  E +      +RH N+
Sbjct: 12  LLECVGKGRYGEVWRGSW----QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENI 64

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           +  I S ++          L+      GSL ++L L       L+ +  L I + +AS L
Sbjct: 65  LGFIASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGL 118

Query: 281 EYLH-----HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
            +LH        +  I H DLK  N+L+       ++D GLA    ++ N L    +  V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178

Query: 336 GVKGTVGYAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
              GT  Y APE           +     D+++FG++L E+         +
Sbjct: 179 ---GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  163 bits (414), Expect = 2e-46
 Identities = 57/225 (25%), Positives = 86/225 (38%), Gaps = 25/225 (11%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           +   IG G +G V+ G +        VAVKV       AS     E      +RH N++ 
Sbjct: 41  MVKQIGKGRYGEVWMGKW----RGEKVAVKVFFTTEE-ASWFRETEIYQTVLMRHENILG 95

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
            I + +           L+ +   NGSL ++L         L+    L +A    S L +
Sbjct: 96  FIAADIKGTGSWTQL-YLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCH 149

Query: 283 LH-----HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
           LH        +  I H DLK  N+L+    T  ++D GLA       N +    ++ V  
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-- 207

Query: 338 KGTVGYAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            GT  Y  PE           +     D+YSFG++L E+      
Sbjct: 208 -GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  163 bits (414), Expect = 3e-46
 Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 29/231 (12%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAEC--QALRSIRHRNL 220
           L+  IG G FG V++G +        VAVK+ + +     +S+  E        +RH N+
Sbjct: 46  LQESIGKGRFGEVWRGKW----RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENI 98

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           +  I +    +        LV +   +GSL ++L+        + +   + +A+  AS L
Sbjct: 99  LGFIAADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGL 152

Query: 281 EYLH-----HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
            +LH        +  I H DLK  N+L+    T  ++D GLA     A + +    +  V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212

Query: 336 GVKGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEMFTGKGPTNEM 380
              GT  Y APE    S      E     D+Y+ G++  E+          
Sbjct: 213 ---GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  138 bits (349), Expect = 2e-37
 Identities = 67/223 (30%), Positives = 99/223 (44%), Gaps = 25/223 (11%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETL-VAVKVLN---LQHRGASKSFIAECQALRSIR 216
             L   +G GSFG V +G +D    +T+ VAVK L    L    A   FI E  A+ S+ 
Sbjct: 20  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           HRNL+++    ++   +      +V EL   GSL + L  ++    +  L      AV V
Sbjct: 80  HRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQV 130

Query: 277 ASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
           A  + YL    +     +H DL   N+LL       + DFGL + LP+  ++    +   
Sbjct: 131 AEGMGYLESKRF-----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           V         APE       S + D + FG+ L EMFT G+ P
Sbjct: 186 VPFAWC----APESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  137 bits (346), Expect = 4e-37
 Identities = 67/245 (27%), Positives = 103/245 (42%), Gaps = 21/245 (8%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNLVKI 223
            IG GSF +VYKG  D +     VA   L  +    S  + F  E + L+ ++H N+V+ 
Sbjct: 33  EIGRGSFKTVYKG-LDTETTV-EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL 283
             S  S          LV ELM +G+L+ +L       + + +    S    +   L++L
Sbjct: 91  YDSWESTVKGKKCI-VLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFL 145

Query: 284 HHYCETPIVHCDLKPSNVLLDGEL-TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
           H     PI+H DLK  N+ + G   +  + D GLA              S +  V GT  
Sbjct: 146 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---------RASFAKAVIGTPE 195

Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEI 402
           + APE     +   S DVY+FG+ +LEM T + P +E                P    ++
Sbjct: 196 FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254

Query: 403 VDPVL 407
             P +
Sbjct: 255 AIPEV 259

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  137 bits (346), Expect = 4e-37
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 19/214 (8%)

Query: 163 LENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
               +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+
Sbjct: 14  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK    C S   +      L+ E +  GSL ++L  +++    ++ ++ L     +   +
Sbjct: 74  VKYKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGM 127

Query: 281 EYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
           EYL    Y     +H DL   N+L++ E    + DFGL K LP+        +     + 
Sbjct: 128 EYLGTKRY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                 APE    S+ S + DV+SFG++L E+FT
Sbjct: 183 WY----APESLTESKFSVASDVWSFGVVLYELFT 212

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  137 bits (348), Expect = 5e-37
 Identities = 61/219 (27%), Positives = 94/219 (42%), Gaps = 20/219 (9%)

Query: 163 LENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
             + +G G+FGSV    +D   D+   LVAVK L        + F  E Q L+++    +
Sbjct: 27  YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK           G     LV E + +G L ++L  +R     L+  + L  +  +   +
Sbjct: 87  VKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGM 140

Query: 281 EYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
           EYL          VH DL   N+L++ E    ++DFGLAK LP   +     +     + 
Sbjct: 141 EYLGSRRC-----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
                 APE    +  S   DV+SFG++L E+FT     
Sbjct: 196 WY----APESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  135 bits (342), Expect = 2e-36
 Identities = 66/215 (30%), Positives = 98/215 (45%), Gaps = 20/215 (9%)

Query: 163 LENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRN 219
               +G G FG V    +D   D+    VAVK L  +  G   +    E + LR++ H N
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           +VK    C      G +   L+ E + +GSL+E+L  N++    +NL Q+L  AV +   
Sbjct: 85  IVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKG 138

Query: 280 LEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
           ++YL    Y     VH DL   NVL++ E    + DFGL K +       +        V
Sbjct: 139 MDYLGSRQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPV 193

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                  APE  M S+   + DV+SFG+ L E+ T
Sbjct: 194 FWY----APECLMQSKFYIASDVWSFGVTLHELLT 224

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  135 bits (343), Expect = 3e-36
 Identities = 61/214 (28%), Positives = 100/214 (46%), Gaps = 19/214 (8%)

Query: 163 LENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
               +G G+FGSV    +D   D+   +VAVK L        + F  E + L+S++H N+
Sbjct: 45  FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           VK    C S   +      L+ E +  GSL ++L  +++    ++ ++ L     +   +
Sbjct: 105 VKYKGVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGM 158

Query: 281 EYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
           EYL    Y     +H DL   N+L++ E    + DFGL K LP+        +     + 
Sbjct: 159 EYLGTKRY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 213

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
                 APE    S+ S + DV+SFG++L E+FT
Sbjct: 214 WY----APESLTESKFSVASDVWSFGVVLYELFT 243

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  135 bits (342), Expect = 3e-36
 Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 31/225 (13%)

Query: 161 FSLENLIGAGSFGSVYKGIF--DHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRH 217
           F    ++G+G+FG+VYKG++  + +  +  VA+K L       +    + E   + S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            ++ +++  C++   Q      L+ +LM  G L +++  ++D   N+     L+  V +A
Sbjct: 77  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIA 127

Query: 278 STLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
             + YL          VH DL   NVL+       ++DFGLAK L          +  + 
Sbjct: 128 KGMNYLEDRRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----EEKEYHAE 177

Query: 336 GVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           G K  + + A E   + +    +   DV+S+G+ + E+ T G  P
Sbjct: 178 GGKVPIKWMALESILHRI---YTHQSDVWSYGVTVWELMTFGSKP 219

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  137 bits (346), Expect = 2e-35
 Identities = 56/217 (25%), Positives = 107/217 (49%), Gaps = 20/217 (9%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
            ++++ +G G +G VY+G++    +   VAVK L  +     + F+ E   ++ I+H NL
Sbjct: 222 ITMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNL 278

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V+++  C     +   F  ++ E M  G+L ++L       + ++ +  L +A  ++S +
Sbjct: 279 VQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAM 331

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
           EYL    +   +H +L   N L+       V+DFGL++ +           ++  G K  
Sbjct: 332 EYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG------DTYTAHAGAKFP 382

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + + APE    ++ S   DV++FG+LL E+ T G  P
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  133 bits (336), Expect = 2e-35
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 25/222 (11%)

Query: 161 FSLENLIGAGSFGSVYKGIF--DHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRH 217
                ++G+G FG+V+KG++  + +  +  V +KV+  +    S         A+ S+ H
Sbjct: 15  LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            ++V+++  C     Q      LV + +  GSL + +  +R     L     L+  V +A
Sbjct: 75  AHIVRLLGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIA 125

Query: 278 STLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
             + YL  H       VH +L   NVLL       V+DFG+A  LP         Q    
Sbjct: 126 KGMYYLEEHGM-----VHRNLAARNVLLKSPSQVQVADFGVADLLPP-----DDKQLLYS 175

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             K  + + A E     + +   DV+S+G+ + E+ T G  P
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  131 bits (333), Expect = 3e-35
 Identities = 55/221 (24%), Positives = 98/221 (44%), Gaps = 28/221 (12%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLV 221
            +  +G G+FGSV +G++     +  VA+KVL      A     + E Q +  + +  +V
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           ++I  C +          LV E+   G L ++L         + +     +   V+  ++
Sbjct: 74  RLIGVCQAEALM------LVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMK 124

Query: 282 YL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           YL   ++     VH DL   NVLL     A +SDFGL+K L    +  ++  +    +K 
Sbjct: 125 YLEEKNF-----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179

Query: 340 TVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
                APE   +    + S+  DV+S+G+ + E  + G+ P
Sbjct: 180 Y----APECINFR---KFSSRSDVWSYGVTMWEALSYGQKP 213

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  131 bits (333), Expect = 3e-35
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 30/218 (13%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVL--NLQHRGASKSFIAECQALRSIRHRNLVKII 224
           +G+G+FG+V KG +        VAVK+L             +AE   ++ + +  +V++I
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84

Query: 225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYL- 283
             C +  +       LV E+   G L ++L  N    R++     + +   V+  ++YL 
Sbjct: 85  GICEAESWM------LVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE 134

Query: 284 -HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG 342
             ++     VH DL   NVLL  +  A +SDFGL+K L    N   +       VK    
Sbjct: 135 ESNF-----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY-- 187

Query: 343 YAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             APE   Y    + S+  DV+SFG+L+ E F+ G+ P
Sbjct: 188 --APECINYY---KFSSKSDVWSFGVLMWEAFSYGQKP 220

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  132 bits (333), Expect = 5e-35
 Identities = 59/226 (26%), Positives = 107/226 (47%), Gaps = 24/226 (10%)

Query: 162 SLENLIGAGSFGSVYKGI-FDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
            L  ++G G FGSV +G     D     VAVK + L +      + F++E   ++   H 
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR--DAPRNLNLLQRLSIAVDV 276
           N+++++  C+ +  QG     ++   M  G L  +L  +R    P+++ L   L   VD+
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 277 ASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
           A  +EYL   ++     +H DL   N +L  ++T  V+DFGL+K +  + +     + + 
Sbjct: 157 ALGMEYLSNRNF-----LHRDLAARNCMLRDDMTVCVADFGLSKKI-YSGDYYRQGRIAK 210

Query: 335 VGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           + VK      A E     +    ++  DV++FG+ + E+ T G  P
Sbjct: 211 MPVKWI----AIESLADRV---YTSKSDVWAFGVTMWEIATRGMTP 249

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  137 bits (346), Expect = 6e-35
 Identities = 52/248 (20%), Positives = 91/248 (36%), Gaps = 31/248 (12%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLV 221
           ++  I  G  G +Y    D + +   V +K L       A    +AE Q L  + H ++V
Sbjct: 84  VKGCIAHGGLGWIYLA-LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNG-SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           +I       D  G+    +V E  V G SL+          + L + + ++  +++   L
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSKG------QKLPVAEAIAYLLEILPAL 195

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
            YLH      +V+ DLKP N++L  E    + D G    +         N    +   GT
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI---------NSFGYLY--GT 240

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA 400
            G+ APE         + D+Y+ G  L  +            G        ++    +  
Sbjct: 241 PGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPT----RNGRYVDG-LPEDDPVLKTY 294

Query: 401 EIVDPVLL 408
           +    +L 
Sbjct: 295 DSYGRLLR 302

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  133 bits (336), Expect = 6e-35
 Identities = 67/221 (30%), Positives = 94/221 (42%), Gaps = 26/221 (11%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS----FIAECQALRSIR 216
             L   IG G+FG V+ G    D   TLVAVK                F+ E + L+   
Sbjct: 116 LVLGEQIGRGNFGEVFSGRLRAD--NTLVAVKSCR---ETLPPDLKAKFLQEARILKQYS 170

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N+V++I  C     Q      +V EL+  G    +L   R     L +   L +  D 
Sbjct: 171 HPNIVRLIGVCT----QKQPI-YIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDA 222

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
           A+ +EYL        +H DL   N L+  +    +SDFG+++   +     +S     V 
Sbjct: 223 AAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA-ASGGLRQVP 278

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           VK T    APE       S+  DV+SFGILL E F+ G  P
Sbjct: 279 VKWT----APEALNYGRYSSESDVWSFGILLWETFSLGASP 315

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  130 bits (330), Expect = 1e-34
 Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 38/228 (16%)

Query: 163 LENLIGAGSFGSVYKGI-FDHDDHETLVAVKVLNLQHRGAS----KSFIAECQALRSIRH 217
            + +IG G FG VY G   D   +    A+K L+   R       ++F+ E   +R + H
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS---RITEMQQVEAFLREGLLMRGLNH 81

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            N++ +I               ++   M +G L +++   +   RN  +   +S  + VA
Sbjct: 82  PNVLALIGIM----LPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVA 134

Query: 278 STLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
             +EYL    +     VH DL   N +LD   T  V+DFGLA+ + +      S Q    
Sbjct: 135 RGMEYLAEQKF-----VHRDLAARNCMLDESFTVKVADFGLARDILD--REYYSVQQHRH 187

Query: 336 G---VKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
               VK T    A E          +T  DV+SFG+LL E+ T G  P
Sbjct: 188 ARLPVKWT----ALESLQTYR---FTTKSDVWSFGVLLWELLTRGAPP 228

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  134 bits (338), Expect = 1e-34
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 26/221 (11%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNG---TTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 239

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++                +V E M  GSL ++L       + L L Q + +A  +AS
Sbjct: 240 KLVQLYAVVSEEPIY------IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIAS 291

Query: 279 TLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
            + Y+   +Y     VH DL+ +N+L+   L   V+DFGLA+ + +      +  ++  G
Sbjct: 292 GMAYVERMNY-----VHRDLRAANILVGENLVCKVADFGLARLIED------NEYTARQG 340

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            K  + + APE  +    +   DV+SFGILL E+ T G+ P
Sbjct: 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (329), Expect = 2e-34
 Identities = 57/222 (25%), Positives = 105/222 (47%), Gaps = 25/222 (11%)

Query: 161 FSLENLIGAGSFGSVYKGIF--DHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRH 217
           F    ++G+G+FG+VYKG++  + +  +  VA+K L       A+K  + E   + S+ +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            ++ +++  C++   Q      L+ +LM  G L +++  ++D   N+     L+  V +A
Sbjct: 77  PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIA 127

Query: 278 STLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
             + YL          VH DL   NVL+       ++DFGLAK L          +  + 
Sbjct: 128 KGMNYLEDRRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----EEKEYHAE 177

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           G K  + + A E  +    +   DV+S+G+ + E+ T G  P
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  129 bits (327), Expect = 3e-34
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 38/229 (16%)

Query: 162 SLENLIGAGSFGSVYKGIF-DHDDHETLVAVKVLNLQHRGASKS----FIAECQALRSIR 216
               +IG G FG VY G   D+D  +   AVK LN   R         F+ E   ++   
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFS 84

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N++ ++   + +  +G+    +V   M +G L  ++        N  +   +   + V
Sbjct: 85  HPNVLSLLG--ICLRSEGSPL--VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 137

Query: 277 ASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
           A  ++YL    +     VH DL   N +LD + T  V+DFGLA+ + +      S  + +
Sbjct: 138 AKGMKYLASKKF-----VHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEYYSVHNKT 190

Query: 335 VG---VKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
                VK      A E          +T  DV+SFG+LL E+ T G  P
Sbjct: 191 GAKLPVKWM----ALESLQTQK---FTTKSDVWSFGVLLWELMTRGAPP 232

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  132 bits (335), Expect = 3e-34
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 26/221 (11%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +GAG FG V+   ++     T VAVK +      + ++F+AE   +++++H 
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNK---HTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHD 243

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LVK+                ++ E M  GSL ++L  +        L + +  +  +A 
Sbjct: 244 KLVKLHAVVTKEPIY------IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAE 295

Query: 279 TLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
            + ++   +Y     +H DL+ +N+L+   L   ++DFGLA+ + +      +  ++  G
Sbjct: 296 GMAFIEQRNY-----IHRDLRAANILVSASLVCKIADFGLARVIED------NEYTAREG 344

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            K  + + APE       +   DV+SFGILL+E+ T G+ P
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  128 bits (325), Expect = 3e-34
 Identities = 48/224 (21%), Positives = 99/224 (44%), Gaps = 31/224 (13%)

Query: 161 FSLENLIGAGSFGSVYKGIF-DHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHR 218
             L  ++G G FG VY+G++ +H   +  VAVK         +K  F++E   ++++ H 
Sbjct: 14  VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHP 73

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           ++VK+I               ++ EL   G L  +L        +L +L  +  ++ +  
Sbjct: 74  HIVKLIGIIEEEPTW------IIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICK 124

Query: 279 TLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
            + YL   +      VH D+   N+L+       + DFGL++++ +       +   +  
Sbjct: 125 AMAYLESINC-----VHRDIAVRNILVASPECVKLGDFGLSRYIED------EDYYKASV 173

Query: 337 VKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            +  + + +PE   +      +T+ DV+ F + + E+ + GK P
Sbjct: 174 TRLPIKWMSPESINFRR---FTTASDVWMFAVCMWEILSFGKQP 214

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  128 bits (325), Expect = 3e-34
 Identities = 63/226 (27%), Positives = 112/226 (49%), Gaps = 36/226 (15%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIR 216
           +   L   +GAG FG V+ G ++     T VAVK L    +G+    +F+AE   ++ ++
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNG---HTKVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H+ LV++            +   ++ E M NGSL ++L         L + + L +A  +
Sbjct: 67  HQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQI 118

Query: 277 ASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
           A  + ++   +Y     +H DL+ +N+L+   L+  ++DFGLA+ + +      +  ++ 
Sbjct: 119 AEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIED------NEYTAR 167

Query: 335 VGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            G K  + + APE   YG     +   DV+SFGILL E+ T G+ P
Sbjct: 168 EGAKFPIKWTAPEAINYGT---FTIKSDVWSFGILLTEIVTHGRIP 210

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  130 bits (328), Expect = 3e-34
 Identities = 60/229 (26%), Positives = 102/229 (44%), Gaps = 34/229 (14%)

Query: 159 DGFSLENLIGAGSFGSVYKGIF-DHDDHETLVAVKVLNLQHRGAS----KSFIAECQALR 213
               +E +IG+G  G V  G        +  VA+K L     G +    + F++E   + 
Sbjct: 49  SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMG 105

Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
              H N++++         +G     +V E M NGSL+ +L   R       ++Q + + 
Sbjct: 106 QFDHPNIIRLEGVVT----RGRLA-MIVTEYMENGSLDTFL---RTHDGQFTIMQLVGML 157

Query: 274 VDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQ 331
             V + + YL    Y     VH DL   NVL+D  L   VSDFGL++ L +  +   +  
Sbjct: 158 RGVGAGMRYLSDLGY-----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212

Query: 332 SSSVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
              + ++ T    APE   +      S++ DV+SFG+++ E+   G+ P
Sbjct: 213 GGKIPIRWT----APEAIAFR---TFSSASDVWSFGVVMWEVLAYGERP 254

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  132 bits (334), Expect = 4e-34
 Identities = 70/222 (31%), Positives = 101/222 (45%), Gaps = 32/222 (14%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS-KSFIAECQALRSIRH 217
               L   IG G FG V  G +        VAVK +      A+ ++F+AE   +  +RH
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDY----RGNKVAVKCIK---NDATAQAFLAEASVMTQLRH 245

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            NLV+++   V    +      +V E M  GSL ++L         L     L  ++DV 
Sbjct: 246 SNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVC 299

Query: 278 STLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
             +EYL  +++     VH DL   NVL+  +  A VSDFGL K             S+  
Sbjct: 300 EAMEYLEGNNF-----VHRDLAARNVLVSEDNVAKVSDFGLTKEA----------SSTQD 344

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             K  V + APE     + ST  DV+SFGILL E+++ G+ P
Sbjct: 345 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  134 bits (338), Expect = 5e-34
 Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 22/218 (10%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRNLV 221
            +  +G G+FGSV +G++     +  VA+KVL      A     + E Q +  + +  +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           ++I  C +          LV E+   G L ++L         + +     +   V+  ++
Sbjct: 400 RLIGVCQAEALM------LVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMK 450

Query: 282 YL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           YL   ++     VH +L   NVLL     A +SDFGL+K L    +  ++  +    +K 
Sbjct: 451 YLEEKNF-----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 505

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
                APE     + S+  DV+S+G+ + E  + G+ P
Sbjct: 506 Y----APECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  129 bits (327), Expect = 6e-34
 Identities = 63/228 (27%), Positives = 111/228 (48%), Gaps = 35/228 (15%)

Query: 161 FSLENLIGAGSFGSVYKGIF--DHDDHETLVAVKVLNLQHRGAS----KSFIAECQALRS 214
            + + +IGAG FG VYKG+        E  VA+K L     G +      F+ E   +  
Sbjct: 46  VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQ 102

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
             H N++++         +      ++ E M NG+L+++L   R+     ++LQ + +  
Sbjct: 103 FSHHNIIRLEGVIS----KYKPM-MIITEYMENGALDKFL---REKDGEFSVLQLVGMLR 154

Query: 275 DVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
            +A+ ++YL   +Y     VH DL   N+L++  L   VSDFGL++ L +          
Sbjct: 155 GIAAGMKYLANMNY-----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDD----PEATY 205

Query: 333 SSVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           ++ G K  + + APE   Y    + +++ DV+SFGI++ E+ T G+ P
Sbjct: 206 TTSGGKIPIRWTAPEAISYR---KFTSASDVWSFGIVMWEVMTYGERP 250

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  129 bits (326), Expect = 6e-34
 Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 25/227 (11%)

Query: 162 SLENLIGAGSFGSVYKGI-FDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           +L  ++G G FGSV +      D     VAVK+L      +S  + F+ E   ++   H 
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85

Query: 219 NLVKIITSCVSVDFQGNDFEAL-VYELMVNGSLEEWLHLNR--DAPRNLNLLQRLSIAVD 275
           ++ K++   +    +G     + +   M +G L  +L  +R  + P NL L   +   VD
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 276 VASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
           +A  +EYL   ++     +H DL   N +L  ++T  V+DFGL++ +  + +      +S
Sbjct: 146 IACGMEYLSSRNF-----IHRDLAARNCMLAEDMTVCVADFGLSRKI-YSGDYYRQGCAS 199

Query: 334 SVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            + VK      A E     +    +   DV++FG+ + E+ T G+ P
Sbjct: 200 KLPVKWL----ALESLADNL---YTVHSDVWAFGVTMWEIMTRGQTP 239

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  130 bits (329), Expect = 6e-34
 Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 38/229 (16%)

Query: 162 SLENLIGAGSFGSVYKGIF-DHDDHETLVAVKVLNLQHRGASKS----FIAECQALRSIR 216
               +IG G FG VY G   D+D  +   AVK LN   R         F+ E   ++   
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFS 148

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N++ ++   + +  +G+    +V   M +G L  ++        N  +   +   + V
Sbjct: 149 HPNVLSLLG--ICLRSEGSPL--VVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQV 201

Query: 277 ASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
           A  +++L    +     VH DL   N +LD + T  V+DFGLA+ + +      S  + +
Sbjct: 202 AKGMKFLASKKF-----VHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEFDSVHNKT 254

Query: 335 VG---VKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
                VK      A E          +T  DV+SFG+LL E+ T G  P
Sbjct: 255 GAKLPVKWM----ALESLQTQK---FTTKSDVWSFGVLLWELMTRGAPP 296

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  128 bits (323), Expect = 6e-34
 Identities = 53/227 (23%), Positives = 95/227 (41%), Gaps = 37/227 (16%)

Query: 161 FSLENLIGAGSFGSVYKGIF-DHDDHETLVAVKVLNLQHRGAS----KSFIAECQALRSI 215
             L   IG G FG V++GI+   ++    VA+K         S    + F+ E   +R  
Sbjct: 17  IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQF 73

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
            H ++VK+I               ++ EL   G L  +L   +    +L+L   +  A  
Sbjct: 74  DHPHIVKLIGVITENPVW------IIMELCTLGELRSFL---QVRKYSLDLASLILYAYQ 124

Query: 276 VASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
           +++ L YL    +     VH D+   NVL+       + DFGL++++ +      S    
Sbjct: 125 LSTALAYLESKRF-----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYK 173

Query: 334 SVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           +   K  + + APE   +      +++ DV+ FG+ + E+   G  P
Sbjct: 174 ASKGKLPIKWMAPESINFRR---FTSASDVWMFGVCMWEILMHGVKP 217

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  127 bits (322), Expect = 7e-34
 Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 30/221 (13%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
            +L   +G+G FG V  G +     +  VAVK++     G+     F  E Q +  + H 
Sbjct: 10  ITLLKELGSGQFGVVKLGKWKG---QYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHP 63

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LVK    C     +      +V E + NG L  +L   R   + L   Q L +  DV  
Sbjct: 64  KLVKFYGVC----SKEYPI-YIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCE 115

Query: 279 TLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
            + +L  H +     +H DL   N L+D +L   VSDFG+ +++ +          SSVG
Sbjct: 116 GMAFLESHQF-----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD------DQYVSSVG 164

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            K  V ++APE     + S+  DV++FGIL+ E+F+ GK P
Sbjct: 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  128 bits (325), Expect = 7e-34
 Identities = 63/219 (28%), Positives = 91/219 (41%), Gaps = 22/219 (10%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKS-FIAECQALRSI 215
                   +G G FG V    +D  +D    +VAVK L        +S +  E   LR++
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
            H +++K    C            LV E +  GSL ++L  +      + L Q L  A  
Sbjct: 91  YHEHIIKYKGCCEDAGAASL---QLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQ 142

Query: 276 VASTLEYLH--HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
           +   + YLH  HY     +H DL   NVLLD +    + DFGLAK +PE        +  
Sbjct: 143 ICEGMAYLHAQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 197

Query: 334 SVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
              V       APE     +   + DV+SFG+ L E+ T
Sbjct: 198 DSPVFWY----APECLKEYKFYYASDVWSFGVTLYELLT 232

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  133 bits (335), Expect = 8e-34
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 26/221 (11%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G ++     T VA+K L      + ++F+ E Q ++ +RH 
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNG---TTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHE 322

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++                +V E M  GSL ++L       + L L Q + +A  +AS
Sbjct: 323 KLVQLYAVVSEEPIY------IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIAS 374

Query: 279 TLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
            + Y+   +Y     VH DL+ +N+L+   L   V+DFGLA+ + +      +  ++  G
Sbjct: 375 GMAYVERMNY-----VHRDLRAANILVGENLVCKVADFGLARLIED------NEYTARQG 423

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            K  + + APE  +    +   DV+SFGILL E+ T G+ P
Sbjct: 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  127 bits (322), Expect = 9e-34
 Identities = 61/223 (27%), Positives = 105/223 (47%), Gaps = 30/223 (13%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIR 216
              +    +G G FG V  G +     +  VA+K++     G+     FI E + + ++ 
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRG---QYDVAIKMIK---EGSMSEDEFIEEAKVMMNLS 77

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H  LV++   C     +      ++ E M NG L  +L   R+        Q L +  DV
Sbjct: 78  HEKLVQLYGVC----TKQRPI-FIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDV 129

Query: 277 ASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
              +EYL    +     +H DL   N L++ +    VSDFGL++++ +         +SS
Sbjct: 130 CEAMEYLESKQF-----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLD------DEYTSS 178

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           VG K  V ++ PE  M S+ S+  D+++FG+L+ E+++ GK P
Sbjct: 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  127 bits (321), Expect = 2e-33
 Identities = 54/233 (23%), Positives = 96/233 (41%), Gaps = 41/233 (17%)

Query: 161 FSLENLIGAGSFGSVYKGIF-----DHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI 215
                 +G G+F  ++KG+          HET V +KVL+  HR  S+SF      +  +
Sbjct: 10  LIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL 69

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
            H++LV     CV     G++   LV E +  GSL+ +L   +     +N+L +L +A  
Sbjct: 70  SHKHLVLNYGVCV----CGDEN-ILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQ 121

Query: 276 VASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAH--------VSDFGLAKFLPEAAN 325
           +A+ + +L  +       +H ++   N+LL  E            +SD G++        
Sbjct: 122 LAAAMHFLEENTL-----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------ 170

Query: 326 NLSSNQSSSVGVKGTVGYAAPE-YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            +         +        PE       ++ + D +SFG  L E+ + G  P
Sbjct: 171 -VLPKDILQERIPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  126 bits (319), Expect = 2e-33
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 30/221 (13%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
            +    IG+G FG V+ G + +   +  VA+K +     GA   + FI E + +  + H 
Sbjct: 10  LTFVQEIGSGQFGLVHLGYWLN---KDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHP 63

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++   C     +      LV E M +G L ++L   R           L + +DV  
Sbjct: 64  KLVQLYGVC----LEQAPI-CLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCE 115

Query: 279 TLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
            + YL          +H DL   N L+       VSDFG+ +F+ +         +SS G
Sbjct: 116 GMAYLEEACV-----IHRDLAARNCLVGENQVIKVSDFGMTRFVLD------DQYTSSTG 164

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            K  V +A+PE    S  S+  DV+SFG+L+ E+F+ GK P
Sbjct: 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  126 bits (319), Expect = 3e-33
 Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 28/221 (12%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
            ++++ +G G +G VY+G++    +   VAVK L          + F+ E   ++ I+H 
Sbjct: 15  ITMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHP 69

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           NLV+++  C     +   F  ++ E M  G+L ++L       + ++ +  L +A  ++S
Sbjct: 70  NLVQLLGVCT----REPPF-YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISS 122

Query: 279 TLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
            +EYL   ++     +H DL   N L+       V+DFGL++ +           ++  G
Sbjct: 123 AMEYLEKKNF-----IHRDLAARNCLVGENHLVKVADFGLSRLMTG------DTYTAHAG 171

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            K  + + APE    ++ S   DV++FG+LL E+ T G  P
Sbjct: 172 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  126 bits (319), Expect = 3e-33
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 37/229 (16%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDH--ETLVAVKVLNLQHRG---ASKSFIAECQALRSIRH 217
           + + +G G   +VY       D      VA+K + +  R      K F  E      + H
Sbjct: 15  IVDKLGGGGMSTVYLAE----DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELM--VNG-SLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +N+V +I      D    + +   Y +M  + G +L E++      P  L++   ++   
Sbjct: 71  QNIVSMI------D-VDEE-DDCYYLVMEYIEGPTLSEYIE--SHGP--LSVDTAINFTN 118

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
            +   +++ H   +  IVH D+KP N+L+D   T  + DFG+AK    A +  S  Q++ 
Sbjct: 119 QILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAK----ALSETSLTQTNH 171

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG 383
           V   GTV Y +PE   G       D+YS GI+L EM  G+ P    F G
Sbjct: 172 V--LGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNG 214

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  127 bits (321), Expect = 7e-33
 Identities = 60/226 (26%), Positives = 104/226 (46%), Gaps = 28/226 (12%)

Query: 159 DGFSLENLIGAGSFGSVYKGIF-DHDDHETLVAVKVLNLQHRGAS----KSFIAECQALR 213
              S++ ++GAG FG V  G        E  VA+K L     G +    + F+ E   + 
Sbjct: 45  TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMG 101

Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
              H N++++         +      +V E M NGSL+ +L   R       ++Q + + 
Sbjct: 102 QFDHPNIIRLEGVVT----KSKPV-MIVTEYMENGSLDSFL---RKHDAQFTVIQLVGML 153

Query: 274 VDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQ 331
             +AS ++YL    Y     VH DL   N+L++  L   VSDFGL + L +         
Sbjct: 154 RGIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLGRVLEDD----PEAA 204

Query: 332 SSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            ++ G K  + + +PE     + +++ DV+S+GI+L E+ + G+ P
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  125 bits (315), Expect = 8e-33
 Identities = 70/220 (31%), Positives = 101/220 (45%), Gaps = 32/220 (14%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS-KSFIAECQALRSIRHRN 219
             L   IG G FG V  G +        VAVK +      A+ ++F+AE   +  +RH N
Sbjct: 23  LKLLQTIGKGEFGDVMLGDY----RGNKVAVKCIK---NDATAQAFLAEASVMTQLRHSN 75

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           LV+++   V    +      +V E M  GSL ++L         L     L  ++DV   
Sbjct: 76  LVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEA 129

Query: 280 LEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
           +EYL  +++     VH DL   NVL+  +  A VSDFGL K             S+    
Sbjct: 130 MEYLEGNNF-----VHRDLAARNVLVSEDNVAKVSDFGLTKEA----------SSTQDTG 174

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           K  V + APE     + ST  DV+SFGILL E+++ G+ P
Sbjct: 175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  123 bits (311), Expect = 5e-32
 Identities = 57/232 (24%), Positives = 94/232 (40%), Gaps = 41/232 (17%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETL---VAVKVLNLQHRGASKSFIA----ECQALRSI 215
           L  L+G G  G VY+      +       VA+K+++     +   F      E +    +
Sbjct: 38  LRRLVGRGGMGDVYEA-----EDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRL 91

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELM--VNG-SLEEWLHLNRDAPRNLNLLQRLSI 272
           +  ++V I       D  G   +  +Y  M  +NG  L   L   R  P  L   + ++I
Sbjct: 92  QEPHVVPIH------D-FGEI-DGQLYVDMRLINGVDLAAMLR--RQGP--LAPPRAVAI 139

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
              + S L+  H        H D+KP N+L+  +  A++ DFG+A     A  +    Q 
Sbjct: 140 VRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIAS----ATTDEKLTQL 192

Query: 333 SSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
            +    GT+ Y APE    S  +   D+Y+   +L E  TG  P    + G+
Sbjct: 193 GNT--VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (322), Expect = 8e-32
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 25/220 (11%)

Query: 162 SLENLIGAGSFGSVYKGIF-DHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSIRHRN 219
            L   IG G FG V++GI+   ++    VA+K        + +  F+ E   +R   H +
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           +VK+I               ++ EL   G L  +L + +    +L+L   +  A  +++ 
Sbjct: 453 IVKLIGVITENPVW------IIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTA 503

Query: 280 LEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
           L YL    +     VH D+   NVL+       + DFGL++++ +      S    +   
Sbjct: 504 LAYLESKRF-----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKG 552

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
           K  + + APE       +++ DV+ FG+ + E+   G  P
Sbjct: 553 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  122 bits (309), Expect = 1e-31
 Identities = 63/231 (27%), Positives = 101/231 (43%), Gaps = 35/231 (15%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAECQALRSIRHRN 219
           L  ++G G    V+    D  DH   VAVKVL             F  E Q   ++ H  
Sbjct: 16  LGEILGFGGMSEVHLAR-DLRDHRD-VAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73

Query: 220 LVKIITSCVSVDFQGNDFEA------LVYELMVNG-SLEEWLHLNRDAPRNLNLLQRLSI 272
           +V +       D  G           +V E  V+G +L + +H   + P  +   + + +
Sbjct: 74  IVAVY------D-TGEAETPAGPLPYIVMEY-VDGVTLRDIVH--TEGP--MTPKRAIEV 121

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
             D    L + H   +  I+H D+KP+N+++       V DFG+A+ + ++ N+++   +
Sbjct: 122 IADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178

Query: 333 SSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG 383
               V GT  Y +PE   G  V    DVYS G +L E+ TG+ P    FTG
Sbjct: 179 ----VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTG 221

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  121 bits (305), Expect = 3e-31
 Identities = 58/247 (23%), Positives = 94/247 (38%), Gaps = 20/247 (8%)

Query: 133 REPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVK 192
           +    PP         +     +     F +E  IG G F  VY+      D    VA+K
Sbjct: 6   QGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRA-ACLLDGV-PVALK 63

Query: 193 VLNLQHRGASK---SFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGS 249
            + +     +K     I E   L+ + H N++K   S     F  ++   +V EL   G 
Sbjct: 64  KVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS-----FIEDNELNIVLELADAGD 118

Query: 250 LEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA 309
           L   +   +   R +         V + S LE++H      ++H D+KP+NV +      
Sbjct: 119 LSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVV 175

Query: 310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLE 369
            + D GL +F         S       + GT  Y +PE    +  +   D++S G LL E
Sbjct: 176 KLGDLGLGRFFSSKTTAAHS-------LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228

Query: 370 MFTGKGP 376
           M   + P
Sbjct: 229 MAALQSP 235

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  120 bits (303), Expect = 1e-30
 Identities = 65/234 (27%), Positives = 103/234 (44%), Gaps = 40/234 (17%)

Query: 162 SLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKS----FIAECQALRS 214
           +L   +G G+FG VY+G      +D     VAVK L       S+     F+ E   +  
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISK 89

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLS 271
             H+N+V+ I        Q      ++ ELM  G L+ +L   R     P +L +L  L 
Sbjct: 90  FNHQNIVRCIGVS----LQSLPR-FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144

Query: 272 IAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAANN 326
           +A D+A   +YL  +H+     +H D+   N LL        A + DFG+A+ +  A + 
Sbjct: 145 VARDIACGCQYLEENHF-----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-SY 198

Query: 327 LSSNQSSSVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
                 + + VK       PE    G+    ++  D +SFG+LL E+F+ G  P
Sbjct: 199 YRKGGCAMLPVKWM----PPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMP 245

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  121 bits (304), Expect = 1e-30
 Identities = 34/284 (11%), Positives = 71/284 (25%), Gaps = 54/284 (19%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDG-----FSLENLIGAGSFGSVYKGIFDHD 183
            +  +EP+    A+ A+V   + +    +          L   +  G    V+       
Sbjct: 27  EEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVR---- 82

Query: 184 DHET--LVAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVKIITSC----------- 227
           D E     A+KV        R   +       A   +   +  +                
Sbjct: 83  DVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142

Query: 228 ------VSVDFQGNDFEA----LVYELMVNGSLEEWLHLNRDAPRN---LNLLQRLSIAV 274
                   +    +D+      L+        LE                 +L    +  
Sbjct: 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTA 201

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
            +      L       +VH    P N+ +  +    + D      +       S      
Sbjct: 202 QLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS------ 252

Query: 335 VGVKGTVGYAAPEYGMGSE--VSTSGDVYSFGILLLEMFTGKGP 376
                 V YA  E+   S    + + + +  G+ +  ++    P
Sbjct: 253 ----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  117 bits (295), Expect = 8e-30
 Identities = 63/282 (22%), Positives = 95/282 (33%), Gaps = 44/282 (15%)

Query: 120 SCLIITSWWSKTKREPS--TPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYK 177
             L   S      R  S     S  L S      +        F   + +G GS+G V+K
Sbjct: 16  ENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFK 75

Query: 178 GIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSI-RHRNLVKIITSCVSVDFQG 234
                D    L AVK      RG       +AE  +   + +H   V++  +     ++ 
Sbjct: 76  VRSKEDGR--LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-----WEE 128

Query: 235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHC 294
                L  EL    SL++          +L   Q      D    L +LH      +VH 
Sbjct: 129 GGILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHL 181

Query: 295 DLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE-----YG 349
           D+KP+N+ L       + DFGL   L            +    +G   Y APE     YG
Sbjct: 182 DVKPANIFLGPRGRCKLGDFGLLVEL--------GTAGAGEVQEGDPRYMAPELLQGSYG 233

Query: 350 MGSEVSTSGDVYSFGILLLEMFTGKGP------TNEMFTGNL 385
             +      DV+S G+ +LE+              ++  G L
Sbjct: 234 TAA------DVFSLGLTILEVACNMELPHGGEGWQQLRQGYL 269

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  116 bits (293), Expect = 1e-29
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 23/215 (10%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIIT 225
           ++G G++G VY G  D  +    +A+K +  +    S+    E    + ++H+N+V+ + 
Sbjct: 29  VLGKGTYGIVYAGR-DLSNQV-RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG 86

Query: 226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA-PRNLNLLQRLSIAVDVASTLEYLH 284
           S        N F  +  E +  GSL   L         N   +        +   L+YLH
Sbjct: 87  SFSE-----NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG--FYTKQILEGLKYLH 139

Query: 285 HYCETPIVHCDLKPSNVLLDGEL-TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGY 343
              +  IVH D+K  NVL++       +SDFG +K        L+     +    GT+ Y
Sbjct: 140 ---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK-------RLAGINPCTETFTGTLQY 189

Query: 344 AAPE--YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            APE           + D++S G  ++EM TGK P
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  118 bits (297), Expect = 1e-29
 Identities = 65/234 (27%), Positives = 102/234 (43%), Gaps = 40/234 (17%)

Query: 162 SLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKS----FIAECQALRS 214
           +L   +G G+FG VY+G      +D     VAVK L       S+     F+ E   +  
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISK 130

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLS 271
             H+N+V+ I        Q      ++ ELM  G L+ +L   R     P +L +L  L 
Sbjct: 131 FNHQNIVRCIGVS----LQSLPR-FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185

Query: 272 IAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGE---LTAHVSDFGLAKFLPEAANN 326
           +A D+A   +YL  +H+     +H D+   N LL        A + DFG+A+ +  A   
Sbjct: 186 VARDIACGCQYLEENHF-----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-GY 239

Query: 327 LSSNQSSSVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
                 + + VK       PE    G+    ++  D +SFG+LL E+F+ G  P
Sbjct: 240 YRKGGCAMLPVKWM----PPEAFMEGI---FTSKTDTWSFGVLLWEIFSLGYMP 286

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  116 bits (293), Expect = 2e-29
 Identities = 59/238 (24%), Positives = 103/238 (43%), Gaps = 50/238 (21%)

Query: 163 LENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKS----FIAECQALRSI 215
           +   +G GSFG VY+G+      D+ ET VA+K +N     AS      F+ E   ++  
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEF 85

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------DAPRNLNLLQR 269
              ++V+++        QG     ++ ELM  G L+ +L   R            +L + 
Sbjct: 86  NCHHVVRLLGVV----SQGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 270 LSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL 327
           + +A ++A  + YL  + +     VH DL   N ++  + T  + DFG+ + +       
Sbjct: 141 IQMAGEIADGMAYLNANKF-----VHRDLAARNCMVAEDFTVKIGDFGMTRDI------- 188

Query: 328 SSNQSSSVGVKGTVGY-----AAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
                +    KG  G       +PE    G+    +T  DV+SFG++L E+ T  + P
Sbjct: 189 ---YETDYYRKGGKGLLPVRWMSPESLKDGV---FTTYSDVWSFGVVLWEIATLAEQP 240

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  115 bits (291), Expect = 3e-29
 Identities = 58/247 (23%), Positives = 98/247 (39%), Gaps = 50/247 (20%)

Query: 162 SLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKS----FIAECQALRS 214
                +G   FG VYKG        +    VA+K L      A       F  E      
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEAMLRAR 68

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------DAPR 262
           ++H N+V ++        +     ++++    +G L E+L +                  
Sbjct: 69  LQHPNVVCLLGVV----TKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123

Query: 263 NLNLLQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
            L     + +   +A+ +EYL  HH      VH DL   NVL+  +L   +SD GL + +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDLGLFREV 178

Query: 321 PEAANNLSSNQSSSVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
             AA+      +S + ++      APE   YG     S   D++S+G++L E+F+ G  P
Sbjct: 179 -YAADYYKLLGNSLLPIRWM----APEAIMYGK---FSIDSDIWSYGVVLWEVFSYGLQP 230

Query: 377 ----TNE 379
               +N+
Sbjct: 231 YCGYSNQ 237

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  115 bits (290), Expect = 4e-29
 Identities = 53/242 (21%), Positives = 89/242 (36%), Gaps = 37/242 (15%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           F    ++G G+FG V K    +       A+K +         + ++E   L S+ H+ +
Sbjct: 8   FEEIAVLGQGAFGQVVKAR--NALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYV 64

Query: 221 VKIITSCVSVDFQGNDFEA--------LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           V+   + +          A        +  E   NG+L + +        N    +   +
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRL 121

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
              +   L Y+H      I+H DLKP N+ +D      + DFGLAK +  + + L  +  
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 333 SSVGVK-------GTVGYAAPE-------YGMGSEVSTSGDVYSFGILLLEMFTGKGPTN 378
           +  G         GT  Y A E       Y    ++    D+YS GI+  EM        
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHY--NEKI----DMYSLGIIFFEMIYPFSTGM 232

Query: 379 EM 380
           E 
Sbjct: 233 ER 234

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  114 bits (288), Expect = 6e-29
 Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 19/227 (8%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK-SFIAECQALRSIRH 217
             F     +G G FG V++     DD     A+K + L +R  ++   + E +AL  + H
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDC--NYAIKRIRLPNRELAREKVMREVKALAKLEH 62

Query: 218 RNLVKIITSCV----SVDFQGNDFEALVY---ELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
             +V+   + +    +   Q +  +  +Y   +L    +L++W++  R           L
Sbjct: 63  PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCL 121

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL---PEAANNL 327
            I + +A  +E+LH      ++H DLKPSN+    +    V DFGL   +    E    L
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 328 SSNQSSSVGVK--GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT 372
           +   + +      GT  Y +PE   G+  S   D++S G++L E+  
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  115 bits (291), Expect = 6e-29
 Identities = 53/232 (22%), Positives = 98/232 (42%), Gaps = 39/232 (16%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           +S+   IG+G    V++ +   ++ + + A+K +NL+        S+  E   L  ++  
Sbjct: 11  YSILKQIGSGGSSKVFQVL---NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 219 NL--VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           +   +++           + +  +V E   N  L  WL   +    +++  +R S   ++
Sbjct: 68  SDKIIRLYDY-----EITDQYIYMVMEC-GNIDLNSWLKKKK----SIDPWERKSYWKNM 117

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLD-GELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
              +  +H   +  IVH DLKP+N L+  G L   + DFG+A  +     ++  +     
Sbjct: 118 LEAVHTIH---QHGIVHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDS---- 168

Query: 336 GVKGTVGYAAPE-----------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              GTV Y  PE               S++S   DV+S G +L  M  GK P
Sbjct: 169 -QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  114 bits (287), Expect = 6e-29
 Identities = 54/231 (23%), Positives = 88/231 (38%), Gaps = 30/231 (12%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           F    LIG+G FG V+K     D       +K +   +  A +    E +AL  + H N+
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGK--TYVIKRVKYNNEKAER----EVKALAKLDHVNI 66

Query: 221 VKIITSCVSVDFQGNDFEA-----------LVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
           V         D+                  +  E    G+LE+W+   R     L+ +  
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVLA 124

Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSS 329
           L +   +   ++Y+H      +++ DLKPSN+ L       + DFGL   L         
Sbjct: 125 LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--------K 173

Query: 330 NQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           N       KGT+ Y +PE     +     D+Y+ G++L E+        E 
Sbjct: 174 NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  114 bits (289), Expect = 7e-29
 Identities = 25/91 (27%), Positives = 40/91 (43%), Gaps = 5/91 (5%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           +  N    ++   +   + +  LDL  N + G +P+ L    FL +LN+SFN+  GE+P 
Sbjct: 228 LAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

Query: 61  KGVFSNSSAISLDGNVNLCGGISELHLCTCS 91
            G        +   N  LCG      L  C+
Sbjct: 287 GGNLQRFDVSAYANNKCLCGS----PLPACT 313

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 22/84 (26%), Positives = 36/84 (42%), Gaps = 3/84 (3%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP- 59
           +      G IP  LS ++ +  LD S N LSG +P  + + P L  +    N   G +P 
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167

Query: 60  -IKGVFSNSSAISLDGNVNLCGGI 82
                    +++++  N  L G I
Sbjct: 168 SYGSFSKLFTSMTISRN-RLTGKI 190

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 25/82 (30%), Positives = 38/82 (46%), Gaps = 2/82 (2%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK 61
             N   G IP +++ L  +  L ++  N+SG IP +L     L  L+ S+N   G +P  
Sbjct: 85  GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144

Query: 62  -GVFSNSSAISLDGNVNLCGGI 82
                N   I+ DGN  + G I
Sbjct: 145 ISSLPNLVGITFDGN-RISGAI 165

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 19/82 (23%), Positives = 38/82 (46%), Gaps = 2/82 (2%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           ++ N   G IP + ++L  +  +DLS+N L G       +    Q ++L+ N    ++  
Sbjct: 181 ISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239

Query: 61  KGVFSNSSAISLDGNVNLCGGI 82
            G+  N + + L  N  + G +
Sbjct: 240 VGLSKNLNGLDLRNN-RIYGTL 260

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 4/85 (4%)

Query: 3   GNFFQGNIPSSLSSLRG-IENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK 61
           GN   G IP S  S      ++ +S+N L+G+IP    N   L  ++LS N  EG+  + 
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVL 216

Query: 62  -GVFSNSSAISLDGNVNLCGGISEL 85
            G   N+  I L  N +L   + ++
Sbjct: 217 FGSDKNTQKIHLAKN-SLAFDLGKV 240

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 52.9 bits (128), Expect = 7e-08
 Identities = 21/83 (25%), Positives = 34/83 (40%), Gaps = 5/83 (6%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGR--IPKYLENFPFLQNLNLS-FNHFEGEVPI 60
             + G +  + +    + NLDLS  NL     IP  L N P+L  L +   N+  G +P 
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95

Query: 61  K-GVFSNSSAISLDGNVNLCGGI 82
                +    + +    N+ G I
Sbjct: 96  AIAKLTQLHYLYITHT-NVSGAI 117

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  114 bits (287), Expect = 1e-28
 Identities = 69/238 (28%), Positives = 104/238 (43%), Gaps = 43/238 (18%)

Query: 162 SLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
            L+  +G G+FG V+            + LVAVK L      A K F  E + L +++H 
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE 77

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------DAPRNLNL 266
           ++VK    C      G+    +V+E M +G L ++L  +              A   L L
Sbjct: 78  HIVKFYGVC----GDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132

Query: 267 LQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAA 324
            Q L IA  +AS + YL   H+     VH DL   N L+   L   + DFG+++      
Sbjct: 133 SQMLHIASQIASGMVYLASQHF-----VHRDLATRNCLVGANLLVKIGDFGMSR------ 181

Query: 325 NNLSSNQSSSVGVKGT--VGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
            ++ S     VG      + +  PE   Y      +T  DV+SFG++L E+FT GK P
Sbjct: 182 -DVYSTDYYRVGGHTMLPIRWMPPESIMYRK---FTTESDVWSFGVILWEIFTYGKQP 235

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  114 bits (287), Expect = 1e-28
 Identities = 53/232 (22%), Positives = 98/232 (42%), Gaps = 39/232 (16%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
           +S+   IG+G    V++ +   ++ + + A+K +NL+        S+  E   L  ++  
Sbjct: 30  YSILKQIGSGGSSKVFQVL---NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86

Query: 219 NL--VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           +   +++           + +  +V E   N  L  WL   +    +++  +R S   ++
Sbjct: 87  SDKIIRLYDY-----EITDQYIYMVMEC-GNIDLNSWLKKKK----SIDPWERKSYWKNM 136

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLD-GELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
              +  +H   +  IVH DLKP+N L+  G L   + DFG+A  +     ++  +     
Sbjct: 137 LEAVHTIH---QHGIVHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDS---- 187

Query: 336 GVKGTVGYAAPE-----------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              GTV Y  PE               S++S   DV+S G +L  M  GK P
Sbjct: 188 -QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  116 bits (291), Expect = 1e-28
 Identities = 60/297 (20%), Positives = 114/297 (38%), Gaps = 41/297 (13%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDG--FSLENLIGAGSFGSVYKGIFDHDDHE 186
              ++   +P           S  N   +  G  +S+   IG+G    V++ +   ++ +
Sbjct: 24  KFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVL---NEKK 80

Query: 187 TLVAVKVLNLQHRGAS--KSFIAECQALRSIRHRNL--VKIITSCVSVDFQGNDFEALVY 242
            + A+K +NL+        S+  E   L  ++  +   +++           + +  +V 
Sbjct: 81  QIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY-----EITDQYIYMVM 135

Query: 243 ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVL 302
           E   N  L  WL   +    +++  +R S   ++   +  +H +    IVH DLKP+N L
Sbjct: 136 E-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFL 187

Query: 303 LD-GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE-----------YGM 350
           +  G L   + DFG+A  +     ++  +        G V Y  PE              
Sbjct: 188 IVDGML--KLIDFGIANQMQPDTTSVVKDS-----QVGAVNYMPPEAIKDMSSSRENGKS 240

Query: 351 GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVL 407
            S++S   DV+S G +L  M  GK P  ++      LH  +         +I +  L
Sbjct: 241 KSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDL 297

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  114 bits (288), Expect = 1e-28
 Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 42/242 (17%)

Query: 162 SLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
            L+  +G G+FG V+         +  + LVAVK L      A + F  E + L  ++H+
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR-----------DAPRNLNLL 267
           ++V+    C     +G     +V+E M +G L  +L  +             AP  L L 
Sbjct: 104 HIVRFFGVC----TEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158

Query: 268 QRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAAN 325
           Q L++A  VA+ + YL   H+     VH DL   N L+   L   + DFG+++ +    +
Sbjct: 159 QLLAVASQVAAGMVYLAGLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-D 212

Query: 326 NLSSNQSSSVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP----T 377
                  + + ++       PE   Y      +T  DV+SFG++L E+FT GK P    +
Sbjct: 213 YYRVGGRTMLPIRWM----PPESILYRK---FTTESDVWSFGVVLWEIFTYGKQPWYQLS 265

Query: 378 NE 379
           N 
Sbjct: 266 NT 267

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  118 bits (298), Expect = 2e-28
 Identities = 31/99 (31%), Positives = 43/99 (43%), Gaps = 3/99 (3%)

Query: 3   GNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKG 62
            N   G+IP  +  LRG+  LDLS N L GRIP+ +     L  ++LS N+  G +P  G
Sbjct: 665 HNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMG 724

Query: 63  VFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSR 101
            F          N  LCG    L  C   +     +  +
Sbjct: 725 QFETFPPAKFLNNPGLCGYP--LPRC-DPSNADGYAHHQ 760

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 78.0 bits (193), Expect = 2e-15
 Identities = 35/91 (38%), Positives = 47/91 (51%), Gaps = 3/91 (3%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           +  N F G IP +LS+   + +L LS N LSG IP  L +   L++L L  N  EGE+P 
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460

Query: 61  K-GVFSNSSAISLDGNVNLCGGI-SELHLCT 89
           +         + LD N +L G I S L  CT
Sbjct: 461 ELMYVKTLETLILDFN-DLTGEIPSGLSNCT 490

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 74.2 bits (183), Expect = 3e-14
 Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 3/92 (3%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           +  N  +G IP  L  ++ +E L L  N+L+G IP  L N   L  ++LS N   GE+P 
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508

Query: 61  K-GVFSNSSAISLDGNVNLCGGISELHLCTCS 91
             G   N + + L  N +  G I    L  C 
Sbjct: 509 WIGRLENLAILKLSNN-SFSGNIPA-ELGDCR 538

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 71.5 bits (176), Expect = 3e-13
 Identities = 31/126 (24%), Positives = 51/126 (40%), Gaps = 5/126 (3%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           ++ N   G IP  +  L  +  L LS N+ SG IP  L +   L  L+L+ N F G +P 
Sbjct: 497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP- 555

Query: 61  KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMS 120
             +F  S  I+ +    + G     ++     K+        L+        +  L+  +
Sbjct: 556 AAMFKQSGKIAAN---FIAGKRYV-YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN 611

Query: 121 CLIITS 126
              ITS
Sbjct: 612 PCNITS 617

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 70.3 bits (173), Expect = 5e-13
 Identities = 26/91 (28%), Positives = 40/91 (43%), Gaps = 3/91 (3%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           ++ N F   IP  L     +++LD+S N LSG   + +     L+ LN+S N F G +P 
Sbjct: 207 VSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP- 264

Query: 61  KGVFSNSSAISLDGNVNLCGGISELHLCTCS 91
                +   +SL  N    G I +     C 
Sbjct: 265 PLPLKSLQYLSLAEN-KFTGEIPDFLSGACD 294

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 7/96 (7%)

Query: 1   MNGNFFQGNIP-SSLSSLRGIENLDLSQNNLSGRIPKYLENFPF-LQNLNLSFNHFEGEV 58
           ++ N F G +P  +L  +RG++ LDLS N  SG +P+ L N    L  L+LS N+F G +
Sbjct: 325 LSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPI 384

Query: 59  P---IKGVFSNSSAISLDGNVNLCGGISELHLCTCS 91
                +   +    + L  N    G I    L  CS
Sbjct: 385 LPNLCQNPKNTLQELYLQNN-GFTGKIPPT-LSNCS 418

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 68.0 bits (167), Expect = 3e-12
 Identities = 13/58 (22%), Positives = 23/58 (39%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP 59
           N   FQG     L+ L      +++     G      +N   +  L++S+N   G +P
Sbjct: 592 NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIP 649

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 67.6 bits (166), Expect = 4e-12
 Identities = 29/94 (30%), Positives = 43/94 (45%), Gaps = 5/94 (5%)

Query: 1   MNGNFFQGNIPSSL--SSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEV 58
           ++ N F G I  +L  +    ++ L L  N  +G+IP  L N   L +L+LSFN+  G +
Sbjct: 375 LSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTI 434

Query: 59  PIK-GVFSNSSAISLDGNVNLCGGISELHLCTCS 91
           P   G  S    + L  N  L G I +  L    
Sbjct: 435 PSSLGSLSKLRDLKLWLN-MLEGEIPQ-ELMYVK 466

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 67.2 bits (165), Expect = 5e-12
 Identities = 27/85 (31%), Positives = 40/85 (47%), Gaps = 2/85 (2%)

Query: 2   NGNFFQGNIPSSLS-SLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
             N F G IP  LS +   +  LDLS N+  G +P +  +   L++L LS N+F GE+P+
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336

Query: 61  KGVFSNSSAISLD-GNVNLCGGISE 84
             +        LD       G + E
Sbjct: 337 DTLLKMRGLKVLDLSFNEFSGELPE 361

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 66.5 bits (163), Expect = 9e-12
 Identities = 24/91 (26%), Positives = 35/91 (38%), Gaps = 6/91 (6%)

Query: 3   GNFFQGNIP-SSLSSLRGIENLDLSQNNLSGRIPKYLE---NFPFLQNLNLSFNHFEGEV 58
            N        S    L  +E LDLS N++SG              L++L +S N   G+V
Sbjct: 135 SNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV 194

Query: 59  PIKGVFSNSSAISLDGNVNLCGGISELHLCT 89
            +     N   + +  N N   GI  L  C+
Sbjct: 195 DV-SRCVNLEFLDVSSN-NFSTGIPFLGDCS 223

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 65.7 bits (161), Expect = 2e-11
 Identities = 21/93 (22%), Positives = 38/93 (40%), Gaps = 7/93 (7%)

Query: 1   MNGNFFQGNIPSSL---SSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGE 57
           ++ N   G              +++L +S N +SG +   +     L+ L++S N+F   
Sbjct: 158 LSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTG 215

Query: 58  VPIKGVFSNSSAISLDGNVNLCGGI-SELHLCT 89
           +P  G  S    + + GN  L G     +  CT
Sbjct: 216 IPFLGDCSALQHLDISGN-KLSGDFSRAISTCT 247

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 65.7 bits (161), Expect = 2e-11
 Identities = 26/115 (22%), Positives = 39/115 (33%), Gaps = 5/115 (4%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           ++ N F GNIP+ L   R +  LDL+ N  +G IP  +          ++ N   G+  +
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYV 576

Query: 61  K-GVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGIL 114
                         GN+    GI    L   ST+      SR             
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNN 631

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 63.0 bits (154), Expect = 1e-10
 Identities = 22/93 (23%), Positives = 37/93 (39%), Gaps = 3/93 (3%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
              N     + SSL SL G+E+L LS ++++G +    +    L +L+LS N   G V  
Sbjct: 60  KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTT 118

Query: 61  KGVFSN-SSAISLD-GNVNLCGGISELHLCTCS 91
                + S    L+  +  L            +
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLN 151

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 63.0 bits (154), Expect = 1e-10
 Identities = 19/83 (22%), Positives = 35/83 (42%), Gaps = 4/83 (4%)

Query: 3   GNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLE--NFPFLQNLNLSFNHFEGEVPI 60
            +   G++         + +LDLS+N+LSG +       +   L+ LN+S N  +    +
Sbjct: 86  NSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKV 144

Query: 61  KGVFSNSSAISLD-GNVNLCGGI 82
            G    +S   LD    ++ G  
Sbjct: 145 SGGLKLNSLEVLDLSANSISGAN 167

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 61.8 bits (151), Expect = 3e-10
 Identities = 34/88 (38%), Positives = 43/88 (48%), Gaps = 9/88 (10%)

Query: 1   MNGNFFQGNIPSSLSSLRG-IENLDLSQNNLSGRIPKYLENFPF--LQNLNLSFNHFEGE 57
           ++ N F G +P SL++L   +  LDLS NN SG I   L   P   LQ L L  N F G+
Sbjct: 350 LSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409

Query: 58  VPIKGVFSNSSA---ISLDGNVNLCGGI 82
           +P     SN S    + L  N  L G I
Sbjct: 410 IPP--TLSNCSELVSLHLSFN-YLSGTI 434

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 57.6 bits (140), Expect = 5e-09
 Identities = 12/85 (14%), Positives = 24/85 (28%), Gaps = 4/85 (4%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQN--NLSGRIPKYLENFPFLQNLNLSFNHFEGEV 58
           +  NF  G     + +    +    + N     G   + L         N++   + G  
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624

Query: 59  PIK-GVFSNSSAISLDGNVNLCGGI 82
                   +   + +  N  L G I
Sbjct: 625 SPTFDNNGSMMFLDMSYN-MLSGYI 648

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 49.5 bits (119), Expect = 2e-06
 Identities = 19/73 (26%), Positives = 35/73 (47%), Gaps = 5/73 (6%)

Query: 23  LDLSQNNLS---GRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLC 79
           +DLS   L+     +   L +   L++L LS +H  G V      ++ +++ L  N +L 
Sbjct: 55  IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN-SLS 113

Query: 80  GGI-SELHLCTCS 91
           G + +   L +CS
Sbjct: 114 GPVTTLTSLGSCS 126

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  113 bits (286), Expect = 2e-28
 Identities = 62/242 (25%), Positives = 101/242 (41%), Gaps = 57/242 (23%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKS----FIAECQALRSI-RH 217
            +++IG G+FG V K     D      A+K +      ASK     F  E + L  +  H
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK---EYASKDDHRDFAGELEVLCKLGHH 85

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------DAPRNLN 265
            N++ ++ +C            L  E   +G+L ++L  +R                 L+
Sbjct: 86  PNIINLLGAC----EHRGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 266 LLQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEA 323
             Q L  A DVA  ++YL    +     +H DL   N+L+     A ++DFGL++     
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQF-----IHRDLAARNILVGENYVAKIADFGLSR----- 190

Query: 324 ANNLSSNQSSSVGVKGTVG-----YAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GK 374
                      V VK T+G     + A E   Y +    +T+ DV+S+G+LL E+ + G 
Sbjct: 191 --------GQEVYVKKTMGRLPVRWMAIESLNYSV---YTTNSDVWSYGVLLWEIVSLGG 239

Query: 375 GP 376
            P
Sbjct: 240 TP 241

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  114 bits (286), Expect = 2e-28
 Identities = 58/254 (22%), Positives = 91/254 (35%), Gaps = 32/254 (12%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHET- 187
            +   E       LL   L+       +     + +  +G GSFG V++      D +T 
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMK----DKQTG 83

Query: 188 -LVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMV 246
              AVK + L+          E  A   +    +V +  +      +   +  +  EL+ 
Sbjct: 84  FQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA-----VREGPWVNIFMELLE 133

Query: 247 NGSLEEWLHLNRDAPRNLNLLQRLSIAV---DVASTLEYLHHYCETPIVHCDLKPSNVLL 303
            GSL + +       + +  L               LEYLH      I+H D+K  NVLL
Sbjct: 134 GGSLGQLI-------KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLL 183

Query: 304 DGE-LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYS 362
             +   A + DFG A  L       S      +   GT  + APE  MG       D++S
Sbjct: 184 SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI--PGTETHMAPEVVMGKPCDAKVDIWS 241

Query: 363 FGILLLEMFTGKGP 376
              ++L M  G  P
Sbjct: 242 SCCMMLHMLNGCHP 255

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  115 bits (290), Expect = 3e-28
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 33/226 (14%)

Query: 161 FSLENLIGAGSFGS-VYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALR-SIRHR 218
           F  ++++G G+ G+ VY+G+FD+ D    VAVK +  +    +     E Q LR S  H 
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRD----VAVKRILPECFSFADR---EVQLLRESDEHP 78

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+++   +      +   F+ +  EL    +L+E++     A      L+ +++     S
Sbjct: 79  NVIRYFCT-----EKDRQFQYIAIEL-CAATLQEYVEQKDFA---HLGLEPITLLQQTTS 129

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLL-----DGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
            L +LH      IVH DLKP N+L+      G++ A +SDFGL K L         + S 
Sbjct: 130 GLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG----RHSFSR 182

Query: 334 SVGVKGTVGYAAPEY---GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GV GT G+ APE          + + D++S G +   + +    
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  112 bits (283), Expect = 4e-28
 Identities = 52/225 (23%), Positives = 85/225 (37%), Gaps = 19/225 (8%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           +     +G G F  V      HD H    A+K +    +   +    E    R   H N+
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHF--YALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 221 VKIITSCVSVDFQGNDFEA-LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           ++++     +  +G   EA L+      G+L   +   +D    L   Q L + + +   
Sbjct: 89  LRLVAY--CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS--VGV 337
           LE +H        H DLKP+N+LL  E    + D G                +       
Sbjct: 147 LEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203

Query: 338 KGTVGYAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           + T+ Y APE      + +  E +   DV+S G +L  M  G+GP
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGP 245

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  113 bits (285), Expect = 4e-28
 Identities = 41/251 (16%), Positives = 83/251 (33%), Gaps = 28/251 (11%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIF-DHDDHET--LVAVKVLNLQHRGASKSFIAECQALRS 214
           +    + +L+G G+F  VY+    D +D +      +KV    +           + L+ 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP-RNLNLLQRLSIA 273
                 +K  ++         +   LV EL   G+L   ++L ++ P + +     +S A
Sbjct: 124 SMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH-----------VSDFGLAKFLPE 322
           + +   +E +H   +  I+H D+KP N +L                  + D G +  +  
Sbjct: 179 MRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDM-- 233

Query: 323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFT 382
               L    +       T G+   E       +   D +     +  M  G     +   
Sbjct: 234 ---KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290

Query: 383 GNLTLHNFVKE 393
           G        + 
Sbjct: 291 GECKPEGLFRR 301

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  112 bits (282), Expect = 1e-27
 Identities = 49/220 (22%), Positives = 86/220 (39%), Gaps = 21/220 (9%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIR 216
           + +     IG GSFG         D       +K +N+    +   +    E   L +++
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGR--QYVIKEINISRMSSKEREESRREVAVLANMK 81

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N+V+   S     F+ N    +V +    G L +   +N          Q L   V +
Sbjct: 82  HPNIVQYRES-----FEENGSLYIVMDYCEGGDLFK--RINAQKGVLFQEDQILDWFVQI 134

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
              L+++H   +  I+H D+K  N+ L  + T  + DFG+A+ L        +       
Sbjct: 135 CLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA------- 184

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  Y +PE       +   D+++ G +L E+ T K  
Sbjct: 185 CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  111 bits (280), Expect = 1e-27
 Identities = 60/240 (25%), Positives = 96/240 (40%), Gaps = 43/240 (17%)

Query: 162 SLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKS-FIAECQALRSI-R 216
           S    +GAG+FG V +         D    VAVK+L        +   ++E + L  +  
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR--------------DAPR 262
           H N+V ++ +C      G     ++ E    G L  +L   R              D   
Sbjct: 86  HMNIVNLLGAC----TIGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 263 NLNLLQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
            L+L   LS +  VA  + +L   +      +H DL   N+LL       + DFGLA+ +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 321 PEAANNLSSNQSSSVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
               +N     ++ + VK      APE     +    +   DV+S+GI L E+F+ G  P
Sbjct: 196 KN-DSNYVVKGNARLPVKWM----APESIFNCV---YTFESDVWSYGIFLWELFSLGSSP 247

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  111 bits (279), Expect = 1e-27
 Identities = 63/247 (25%), Positives = 97/247 (39%), Gaps = 54/247 (21%)

Query: 163 LENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKS----FIAECQALRSI 215
           L   +G G FG V K            T VAVK+L      AS S     ++E   L+ +
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQV 83

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR----------------- 258
            H +++K+  +C     Q      L+ E    GSL  +L  +R                 
Sbjct: 84  NHPHVIKLYGAC----SQDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 259 ---DAPRNLNLLQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSD 313
                 R L +   +S A  ++  ++YL          VH DL   N+L+       +SD
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKL-----VHRDLAARNILVAEGRKMKISD 193

Query: 314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEM 370
           FGL++ + E  ++        + VK      A E     +    +T  DV+SFG+LL E+
Sbjct: 194 FGLSRDVYE-EDSYVKRSQGRIPVKWM----AIESLFDHI---YTTQSDVWSFGVLLWEI 245

Query: 371 FT-GKGP 376
            T G  P
Sbjct: 246 VTLGGNP 252

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  110 bits (277), Expect = 2e-27
 Identities = 53/230 (23%), Positives = 89/230 (38%), Gaps = 20/230 (8%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIR 216
           + + +   IG GS+G   K          ++  K L+      +  +  ++E   LR ++
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIR--RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 63

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N+V+     +  D        +V E    G L   +       + L+    L +   +
Sbjct: 64  HPNIVRYYDRII--DRTNTTL-YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120

Query: 277 ASTLEYLH--HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
              L+  H        ++H DLKP+NV LDG+    + DFGLA+ L    +   +     
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT----- 175

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
               GT  Y +PE       +   D++S G LL E+     P    FT  
Sbjct: 176 --FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF 219

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  111 bits (279), Expect = 2e-27
 Identities = 54/295 (18%), Positives = 98/295 (33%), Gaps = 67/295 (22%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA-ECQALRSIRHRN 219
           F     +G G FG V++     DD     A+K + L +R  ++  +  E +AL  + H  
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDC--NYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 220 LVKIITSCVSVDFQGNDFEALVY------------------------------------- 242
           +V+   + +    +    E                                         
Sbjct: 66  IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125

Query: 243 ---------------ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC 287
                          +L    +L++W++  R +  +      L I + +A  +E+LH   
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMN-RRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 288 ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK-----GTVG 342
              ++H DLKPSN+    +    V DFGL   + +     +               GT  
Sbjct: 185 ---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241

Query: 343 YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE 397
           Y +PE   G+  S   D++S G++L E+        E       + +      P 
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER---VRIITDVRNLKFPL 293

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  110 bits (277), Expect = 2e-27
 Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 36/234 (15%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRH 217
             + L +++G G+  +V++G   H     L A+KV N +         + E + L+ + H
Sbjct: 9   HLWLLSDILGQGATANVFRGR--HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL---QRLSIAV 274
           +N+VK+       +      + L+ E    GSL   L      P N   L   + L +  
Sbjct: 67  KNIVKLFA---IEEETTTRHKVLIMEFCPCGSLYTVLE----EPSNAYGLPESEFLIVLR 119

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLL----DGELTAHVSDFGLAKFLPEAANNLSSN 330
           DV   + +L    E  IVH ++KP N++     DG+    ++DFG A+ L +      S 
Sbjct: 120 DVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVS- 174

Query: 331 QSSSVGVKGTVGYAAPEYGMGSEVSTSG--------DVYSFGILLLEMFTGKGP 376
                 + GT  Y  P+    + +            D++S G+      TG  P
Sbjct: 175 ------LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  110 bits (277), Expect = 3e-27
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 46/241 (19%)

Query: 162 SLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKS----FIAECQALRS 214
            L   +G G+FG V +      D       VAVK+L     GA+ S     ++E + L  
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIH 86

Query: 215 I-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------DAP 261
           I  H N+V ++ +C     +      ++ E    G+L  +L   R               
Sbjct: 87  IGHHLNVVNLLGAC----TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 262 RNLNLLQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
             L L   +  +  VA  +E+L          +H DL   N+LL  +    + DFGLA+ 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLARD 197

Query: 320 LPEAANNLSSNQSSSVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKG 375
           + +   +      + + +K      APE     +    +   DV+SFG+LL E+F+ G  
Sbjct: 198 IYK-DPDYVRKGDARLPLKWM----APETIFDRV---YTIQSDVWSFGVLLWEIFSLGAS 249

Query: 376 P 376
           P
Sbjct: 250 P 250

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  110 bits (278), Expect = 5e-27
 Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 49/243 (20%)

Query: 162 SLENLIGAGSFGSVYKGI-----FDHDDHETLVAVKVLNLQHRGASKS----FIAECQAL 212
            L   +G G+FG V          D  +  T VAVK+L      A++      I+E + +
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMM 128

Query: 213 RSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------D 259
           + I +H+N++ ++ +C     Q      ++ E    G+L E+L   R            +
Sbjct: 129 KMIGKHKNIINLLGAC----TQDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183

Query: 260 APRNLNLLQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA 317
               L+    +S A  VA  +EYL          +H DL   NVL+  +    ++DFGLA
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLA 238

Query: 318 KFLPEAANNLSSNQSSSVG---VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-G 373
           + +    +++   + ++ G   VK      APE       +   DV+SFG+LL E+FT G
Sbjct: 239 RDI----HHIDYYKKTTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLG 290

Query: 374 KGP 376
             P
Sbjct: 291 GSP 293

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  110 bits (276), Expect = 6e-27
 Identities = 60/253 (23%), Positives = 96/253 (37%), Gaps = 64/253 (25%)

Query: 162 SLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKS----FIAECQALRS 214
                IG G+FG V++         +  T+VAVK+L      AS      F  E   +  
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAE 106

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---------------- 258
             + N+VK++  C      G     L++E M  G L E+L                    
Sbjct: 107 FDNPNIVKLLGVC----AVGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161

Query: 259 ----DAPRNLNLLQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVS 312
                 P  L+  ++L IA  VA+ + YL    +     VH DL   N L+   +   ++
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF-----VHRDLATRNCLVGENMVVKIA 216

Query: 313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGY-----AAPE---YGMGSEVSTSGDVYSFG 364
           DFGL++ +           S+                 PE   Y      +T  DV+++G
Sbjct: 217 DFGLSRNI----------YSADYYKADGNDAIPIRWMPPESIFYNR---YTTESDVWAYG 263

Query: 365 ILLLEMFT-GKGP 376
           ++L E+F+ G  P
Sbjct: 264 VVLWEIFSYGLQP 276

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  113 bits (283), Expect = 7e-27
 Identities = 61/229 (26%), Positives = 94/229 (41%), Gaps = 25/229 (10%)

Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA-ECQALRS 214
           +    + ++  +G G FG V + I  H D    VA+K    +    ++     E Q ++ 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWI--HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK 68

Query: 215 IRHRNLVKIITSCVSV-DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL---QRL 270
           + H N+V        +     ND   L  E    G L ++L+       N   L      
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN----QFENCCGLKEGPIR 124

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH---VSDFGLAKFLPEAANNL 327
           ++  D++S L YLH   E  I+H DLKP N++L          + D G AK L +     
Sbjct: 125 TLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ----- 176

Query: 328 SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
               +  V   GT+ Y APE     + + + D +SFG L  E  TG  P
Sbjct: 177 GELCTEFV---GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  109 bits (275), Expect = 8e-27
 Identities = 57/239 (23%), Positives = 95/239 (39%), Gaps = 45/239 (18%)

Query: 162 SLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGASKS----FIAECQALRS 214
                +GAG+FG V +        +D    VAVK+L      A        ++E + +  
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSH 105

Query: 215 I-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR----------DAPRN 263
           + +H N+V ++ +C      G     ++ E    G L  +L               A   
Sbjct: 106 LGQHENIVNLLGAC----THGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160

Query: 264 LNLLQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            +    L  +  VA  + +L   +      +H D+   NVLL     A + DFGLA+ + 
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDIM 215

Query: 322 EAANNLSSNQSSSVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GKGP 376
              +N     ++ + VK      APE     +    +   DV+S+GILL E+F+ G  P
Sbjct: 216 N-DSNYIVKGNARLPVKWM----APESIFDCV---YTVQSDVWSYGILLWEIFSLGLNP 266

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  109 bits (275), Expect = 8e-27
 Identities = 58/243 (23%), Positives = 100/243 (41%), Gaps = 49/243 (20%)

Query: 162 SLENLIGAGSFGSVYKGIF-----DHDDHETLVAVKVLNLQHRGASKS----FIAECQAL 212
           +L   +G G+FG V          D       VAVK+L      A++      ++E + +
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMM 94

Query: 213 RSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL------------HLNRD 259
           + I +H+N++ ++ +C     Q      ++ E    G+L E+L             +NR 
Sbjct: 95  KMIGKHKNIINLLGAC----TQDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149

Query: 260 APRNLNLLQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA 317
               +     +S    +A  +EYL          +H DL   NVL+       ++DFGLA
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLA 204

Query: 318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-G 373
           + +    +      +  + VK      APE     +    +   DV+SFG+L+ E+FT G
Sbjct: 205 RDINN-IDYYKKTTNGRLPVKWM----APEALFDRV---YTHQSDVWSFGVLMWEIFTLG 256

Query: 374 KGP 376
             P
Sbjct: 257 GSP 259

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  109 bits (275), Expect = 8e-27
 Identities = 48/228 (21%), Positives = 90/228 (39%), Gaps = 17/228 (7%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRN 219
             +  ++  G F  VY+        E   A+K L       +++ I E   ++ +  H N
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGRE--YALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           +V+  ++      + +  +A    L     G L E+L    ++   L+    L I     
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL-KKMESRGPLSCDTVLKIFYQTC 146

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS--- 334
             ++++H   + PI+H DLK  N+LL  + T  + DFG A  +    +   S Q  +   
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 335 --VGVKGTVGYAAPE----YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             +    T  Y  PE    Y     +    D+++ G +L  +   + P
Sbjct: 206 EEITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHP 252

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (276), Expect = 1e-26
 Identities = 46/290 (15%), Positives = 92/290 (31%), Gaps = 62/290 (21%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRH----- 217
           ++G     +  +   D +  E+   V V          A K    E   LR +R      
Sbjct: 85  VLGQEDPYAYLEAT-DQETGES-FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142

Query: 218 -----------RNLVKIITSCVSVDFQG--------NDFEALVYELMVNGSLEEWLHLNR 258
                       +LVK       +  +         + F           +  E L  + 
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202

Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
              ++L    RL + + V   L  LHHY    +VH  L+P +++LD      ++ F    
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259

Query: 319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEY----------GMGSEVSTSGDVYSFGILLL 368
                         +S       G+A PE              + ++ + D ++ G+ + 
Sbjct: 260 RD-----------GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308

Query: 369 EMFTGKGPTNEMFTGNLTLHNFVK-----EALPERLAEIVDPVLLVEREE 413
            ++    P     T +  L          + +P+ +  +++  L   +E+
Sbjct: 309 WIWCADLP----NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKED 354

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  110 bits (276), Expect = 2e-26
 Identities = 55/241 (22%), Positives = 97/241 (40%), Gaps = 44/241 (18%)

Query: 161 FSLENLIGAGSFGSV-YKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALR-SIRHR 218
              E ++G GS G+V ++G F        VAVK + +         + E + L  S  H 
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGRP----VAVKRMLIDF---CDIALMEIKLLTESDDHP 69

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL---HLNRDAPRNLNLLQRLSIAVD 275
           N+++    C       + F  +  EL  N +L++ +   +++ +  +       +S+   
Sbjct: 70  NVIRYY--CS---ETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH-------------VSDFGLAKFLPE 322
           +AS + +LH      I+H DLKP N+L+                    +SDFGL K L  
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSG-------DVYSFGILLLEMFTGKG 375
                SS +++     GT G+ APE    S    +        D++S G +   + +   
Sbjct: 181 ---GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237

Query: 376 P 376
            
Sbjct: 238 H 238

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  109 bits (275), Expect = 2e-26
 Identities = 55/234 (23%), Positives = 94/234 (40%), Gaps = 36/234 (15%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRH 217
             + L +++G G+  +V++G   H     L A+KV N +         + E + L+ + H
Sbjct: 9   HLWLLSDILGQGATANVFRGR--HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL---QRLSIAV 274
           +N+VK+       +      + L+ E    GSL   L      P N   L   + L +  
Sbjct: 67  KNIVKLFA---IEEETTTRHKVLIMEFCPCGSLYTVLE----EPSNAYGLPESEFLIVLR 119

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLL----DGELTAHVSDFGLAKFLPEAANNLSSN 330
           DV   + +L    E  IVH ++KP N++     DG+    ++DFG A+ L +        
Sbjct: 120 DVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-----DEQ 171

Query: 331 QSSSVGVKGTVGYAAPEYGMGSEVSTSG--------DVYSFGILLLEMFTGKGP 376
             S     GT  Y  P+    + +            D++S G+      TG  P
Sbjct: 172 FVSLY---GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  107 bits (270), Expect = 5e-26
 Identities = 59/248 (23%), Positives = 95/248 (38%), Gaps = 54/248 (21%)

Query: 162 SLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGAS----KSFIAECQALRS 214
               ++G+G+FG V                VAVK+L      A     ++ ++E + +  
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQ 104

Query: 215 I-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR--------------- 258
           +  H N+V ++ +C            L++E    G L  +L   R               
Sbjct: 105 LGSHENIVNLLGAC----TLSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159

Query: 259 ----DAPRNLNLLQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVS 312
               +    L     L  A  VA  +E+L          VH DL   NVL+       + 
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC-----VHRDLAARNVLVTHGKVVKIC 214

Query: 313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLE 369
           DFGLA+ +    +N     ++ + VK      APE    G+    +   DV+S+GILL E
Sbjct: 215 DFGLARDIMS-DSNYVVRGNARLPVKWM----APESLFEGI---YTIKSDVWSYGILLWE 266

Query: 370 MFT-GKGP 376
           +F+ G  P
Sbjct: 267 IFSLGVNP 274

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  107 bits (270), Expect = 6e-26
 Identities = 57/242 (23%), Positives = 96/242 (39%), Gaps = 49/242 (20%)

Query: 163 LENLIGAGSFGSVYKGIF-----DHDDHETLVAVKVLNLQHRGASKS----FIAECQALR 213
           L   +G G FG V          D       VAVK+L      A++      ++E + ++
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMK 141

Query: 214 SI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------DA 260
            I +H+N++ ++ +C     Q      ++ E    G+L E+L   R              
Sbjct: 142 MIGKHKNIINLLGAC----TQDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 261 PRNLNLLQRLSIAVDVASTLEYL--HHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
              +     +S    +A  +EYL          +H DL   NVL+       ++DFGLA+
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLAR 251

Query: 319 FLPEAANNLSSNQSSSVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILLLEMFT-GK 374
            +    +      +  + VK      APE     +    +   DV+SFG+L+ E+FT G 
Sbjct: 252 DINN-IDYYKKTTNGRLPVKWM----APEALFDRV---YTHQSDVWSFGVLMWEIFTLGG 303

Query: 375 GP 376
            P
Sbjct: 304 SP 305

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  105 bits (265), Expect = 9e-26
 Identities = 43/249 (17%), Positives = 88/249 (35%), Gaps = 26/249 (10%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSI-RH 217
           F     IG+G FGSV+K +    D   + A+K       G+   ++ + E  A   + +H
Sbjct: 13  FHELEKIGSGEFGSVFKCV-KRLDGC-IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            ++V+  ++     +  +D   +  E    GSL + +  N          +   + + V 
Sbjct: 71  SHVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANN--------LSS 329
             L Y+H      +VH D+KPSN+ +      + +     +    +             +
Sbjct: 126 RGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 330 NQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH 388
             SS    +G   + A E    +       D+++  + ++     +             H
Sbjct: 183 RISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL----PRNGDQWH 238

Query: 389 NFVKEALPE 397
              +  LP 
Sbjct: 239 EIRQGRLPR 247

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  107 bits (268), Expect = 1e-25
 Identities = 46/292 (15%), Positives = 93/292 (31%), Gaps = 59/292 (20%)

Query: 128 WSKTKREPSTPPSALLASVLRVSYQNLFKATDG-----FSLENLIGAGSFGSVYKGIFDH 182
            + ++   S   S +  S+         ++  G          ++G     +  +   D 
Sbjct: 37  RTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEAT-DQ 95

Query: 183 DDHETLVAVKVLNLQHRGAS------KSFIAECQALRSIRHRNLVKIITSC--------- 227
           +  E+   V V     R  S      K  +   + LR I+++   K+             
Sbjct: 96  ETGES-FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154

Query: 228 ------VSVDFQGNDFEA----LVYELMV--NGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
                 + V     D        +Y  M     +  E L  +    ++L    RL + + 
Sbjct: 155 PQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQ 214

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           V   L  LHHY    +VH  L+P +++LD      ++ F                  + V
Sbjct: 215 VIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD-----------GARV 260

Query: 336 GVKGTVGYAAPEY-----------GMGSEVSTSGDVYSFGILLLEMFTGKGP 376
               + G+  PE               + ++ S D ++ G+++  ++    P
Sbjct: 261 VSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  102 bits (257), Expect = 1e-24
 Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 30/230 (13%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA-ECQALRSIRH 217
           D + L+ +IG+G+   V          +  VA+K +NL+    S   +  E QA+    H
Sbjct: 15  DDYELQEVIGSGATAVVQAAY--CAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH 72

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL-HLNRDAPRNLNLLQRLSIAV-- 274
            N+V   TS     F   D   LV +L+  GS+ + + H+         +L   +IA   
Sbjct: 73  PNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127

Query: 275 -DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
            +V   LEYLH   +   +H D+K  N+LL  + +  ++DFG++ FL    +   +    
Sbjct: 128 REVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRK 184

Query: 334 SVGVKGTVGYAAPEYGMGSEVSTSG-------DVYSFGILLLEMFTGKGP 376
           +  V GT     P   M  EV           D++SFGI  +E+ TG  P
Sbjct: 185 TF-V-GT-----P-CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  100 bits (251), Expect = 9e-24
 Identities = 58/263 (22%), Positives = 95/263 (36%), Gaps = 44/263 (16%)

Query: 135 PSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL 194
              P +  L            +  D F    ++G GSF +V   +          A+K+L
Sbjct: 7   EPRPGAGSLQHAQPPPQPRKKRPED-FKFGKILGEGSFSTVV--LARELATSREYAIKIL 63

Query: 195 NLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLE 251
             +H            E   +  + H   VK+  +     FQ ++          NG L 
Sbjct: 64  EKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGEL- 117

Query: 252 EWLHLNRDAPRNLNLLQRLSIAV------DVASTLEYLHHYCETPIVHCDLKPSNVLLDG 305
              ++ +                      ++ S LEYLH      I+H DLKP N+LL+ 
Sbjct: 118 -LKYIRKI--------GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNE 165

Query: 306 ELTAHV--SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSF 363
           +   H+  +DFG AK L   +    +N  S VG   T  Y +PE         S D+++ 
Sbjct: 166 D--MHIQITDFGTAKVLSPESKQARAN--SFVG---TAQYVSPELLTEKSACKSSDLWAL 218

Query: 364 GILLLEMFTGKGP-----TNEMF 381
           G ++ ++  G  P        +F
Sbjct: 219 GCIIYQLVAGLPPFRAGNEYLIF 241

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  100 bits (251), Expect = 2e-23
 Identities = 44/236 (18%), Positives = 81/236 (34%), Gaps = 32/236 (13%)

Query: 158 TDGFSLENLIGAG--SFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALR 213
              + L  +IG G     +V      +      V V+ +NL+            E    +
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLAR--YKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK 81

Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
              H N+V    +     F  ++   +V   M  GS ++ +  +         +  L+IA
Sbjct: 82  LFNHPNIVPYRAT-----FIADNELWVVTSFMAYGSAKDLICTHFMDG-----MNELAIA 131

Query: 274 V---DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSN 330
                V   L+Y+HH      VH  +K S++L+  +   ++S       +          
Sbjct: 132 YILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188

Query: 331 QSSSVGVKGTVGYAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
                     + + +PE       G  ++     D+YS GI   E+  G  P  +M
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKS----DIYSVGITACELANGHVPFKDM 240

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 97.4 bits (243), Expect = 9e-23
 Identities = 52/216 (24%), Positives = 95/216 (43%), Gaps = 22/216 (10%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++    IG G+ G+VY  +         VA++ +NLQ +   +  I E   +R  ++ N+
Sbjct: 22  YTRFEKIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V  + S     +   D   +V E +  GSL + +         ++  Q  ++  +    L
Sbjct: 80  VNYLDS-----YLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQAL 129

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
           E+LH      ++H D+K  N+LL  + +  ++DFG           ++  QS    + GT
Sbjct: 130 EFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-------QITPEQSKRSTMVGT 179

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             + APE           D++S GI+ +EM  G+ P
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 38/225 (16%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRH 217
           F +   +G G FG+VY         + ++A+KVL    L+  G       E +    +RH
Sbjct: 11  FEIGRPLGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS------ 271
            N++++        F       L+ E    G++  +  L +          +        
Sbjct: 69  PNILRLYGY-----FHDATRVYLILEYAPLGTV--YRELQKL--------SKFDEQRTAT 113

Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQ 331
              ++A+ L Y H      ++H D+KP N+LL       ++DFG +   P      SS +
Sbjct: 114 YITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP------SSRR 164

Query: 332 SSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           +      GT+ Y  PE   G       D++S G+L  E   GK P
Sbjct: 165 TDLC---GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 98.0 bits (244), Expect = 2e-22
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 33/224 (14%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA-ECQALRSIRH 217
           D F   + +GAG+ G V+K    H     ++A K+++L+ + A ++ I  E Q L     
Sbjct: 33  DDFEKISELGAGNGGVVFKVS--HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 90

Query: 218 RNLVK-----IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
             +V           +S+            E M  GSL++ L      P  +  L +  +
Sbjct: 91  PYIVGFYGAFYSDGEISI----------CMEHMDGGSLDQVLKKAGRIPEQI--LGK--V 136

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           ++ V   L YL    +  I+H D+KPSN+L++      + DFG++  L      + S  +
Sbjct: 137 SIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMAN 188

Query: 333 SSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           S VG   T  Y +PE   G+  S   D++S G+ L+EM  G+ P
Sbjct: 189 SFVG---TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 55/251 (21%), Positives = 99/251 (39%), Gaps = 25/251 (9%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATD---GFSLENLIGAGSFGSVYKGIFDHDDH 185
                        +     + + + +    D          IG GS G V          
Sbjct: 12  DLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAR--EKHS 69

Query: 186 ETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELM 245
              VAVK+++L+ +   +    E   +R  +H N+V++  S     +   +   ++ E +
Sbjct: 70  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS-----YLVGEELWVLMEFL 124

Query: 246 VNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG 305
             G+L + +   R     LN  Q  ++   V   L YLH      ++H D+K  ++LL  
Sbjct: 125 QGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTL 176

Query: 306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGI 365
           +    +SDFG           +S +      + GT  + APE    S  +T  D++S GI
Sbjct: 177 DGRVKLSDFGFCA-------QISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229

Query: 366 LLLEMFTGKGP 376
           +++EM  G+ P
Sbjct: 230 MVIEMVDGEPP 240

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 99.1 bits (247), Expect = 2e-22
 Identities = 65/221 (29%), Positives = 91/221 (41%), Gaps = 27/221 (12%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRH 217
           F    ++G G FG V            + A K L    ++ R      + E Q L  +  
Sbjct: 186 FRQYRVLGKGGFGEVCAC--QVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           R +V +  +     ++  D   LV  LM  G L    H+           + +  A ++ 
Sbjct: 244 RFVVSLAYA-----YETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFYAAEIC 296

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSSSV 335
             LE LH      IV+ DLKP N+LLD     H+  SD GLA  +PE        Q+   
Sbjct: 297 CGLEDLH---RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPE-------GQTIKG 344

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            V GTVGY APE       + S D ++ G LL EM  G+ P
Sbjct: 345 RV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 95.8 bits (239), Expect = 4e-22
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 23/221 (10%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFI-AECQALRSIRHRN 219
           F+    IG GSFG V+KGI   +  + +VA+K+++L+        I  E   L       
Sbjct: 24  FTKLEKIGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           + K   S     +  +    ++ E +  GS  + L      P  L+  Q  +I  ++   
Sbjct: 82  VTKYYGS-----YLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKG 131

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           L+YLH       +H D+K +NVLL       ++DFG+A  L     +    +++ V   G
Sbjct: 132 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL----TDTQIKRNTFV---G 181

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM 380
           T  + APE    S   +  D++S GI  +E+  G+ P +E+
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 96.0 bits (239), Expect = 5e-22
 Identities = 47/239 (19%), Positives = 87/239 (36%), Gaps = 43/239 (17%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-----------------LQHRGASK 203
           + +   +  G F  +       D+     A+K                    +  +    
Sbjct: 33  YRIIRTLNQGKFNKIILCE--KDNK--FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88

Query: 204 SFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLNRD 259
            F  E Q +  I++   +              D   ++YE M N S+ ++      L+++
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGI-----ITNYDEVYIIYEYMENDSILKFDEYFFVLDKN 143

Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
               + +     I   V ++  Y+H+  E  I H D+KPSN+L+D      +SDFG +++
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201

Query: 320 LPEAANNLSSNQSSSVGVKGTVGYAAPE--YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           + +    +          +GT  +  PE      S      D++S GI L  MF    P
Sbjct: 202 MVD--KKIKG-------SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 55/228 (24%), Positives = 85/228 (37%), Gaps = 42/228 (18%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRH 217
           +     +G G F   ++      D + + A K++    L      +    E    RS+ H
Sbjct: 17  YVRGRFLGKGGFAKCFEIS--DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLNRDAPRNLNLLQRLSIA 273
           +++V          F+ NDF  +V EL    SL E       L     R   L Q     
Sbjct: 75  QHVVGFHGF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY-LRQ----- 123

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
             +    +YLH      ++H DLK  N+ L+ +L   + DFGL            + +  
Sbjct: 124 --IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGL------------ATKVE 166

Query: 334 SVGVK-----GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             G +     GT  Y APE       S   DV+S G ++  +  GK P
Sbjct: 167 YDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 95.9 bits (239), Expect = 8e-22
 Identities = 49/256 (19%), Positives = 106/256 (41%), Gaps = 43/256 (16%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR--------H 217
            +G G F +V+    D  ++   VA+K++         +   E + L+ +          
Sbjct: 26  KLGWGHFSTVWLA-KDMVNNT-HVAMKIVRGDKVYTEAAED-EIKLLQRVNDADNTKEDS 82

Query: 218 RNLVKIITSCVSVDFQGNDFE--ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
                I+      + +G +     +V+E++   +L   +         L  +++  I+  
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQ 139

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH------VSDFGLAKFLPEAANN-LS 328
           +   L+Y+H  C   I+H D+KP NVL++   +        ++D G A +  E   N + 
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH 388
           + +           Y +PE  +G+      D++S   L+ E+ TG      +F  +   H
Sbjct: 198 TRE-----------YRSPEVLLGAPWGCGADIWSTACLIFELITGD----FLFEPD-EGH 241

Query: 389 NFVKEALPERLAEIVD 404
           ++ K+   + +A+I++
Sbjct: 242 SYTKDD--DHIAQIIE 255

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 97.2 bits (242), Expect = 9e-22
 Identities = 66/239 (27%), Positives = 98/239 (41%), Gaps = 37/239 (15%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI 215
           D F    ++G G FG V+           L A K LN +    R   +  + E + L  +
Sbjct: 185 DWFLDFRVLGRGGFGEVFAC--QMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV 242

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI--A 273
             R +V +        F+      LV  +M  G +    H+      N    +  +I   
Sbjct: 243 HSRFIVSL-AYA----FETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYT 295

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQ 331
             + S LE+LH   +  I++ DLKP NVLLD +   +V  SD GLA  L          Q
Sbjct: 296 AQIVSGLEHLH---QRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKA-------GQ 343

Query: 332 SSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP---------TNEMF 381
           + + G  GT G+ APE  +G E   S D ++ G+ L EM   +GP           E+ 
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 94.4 bits (235), Expect = 2e-21
 Identities = 59/230 (25%), Positives = 94/230 (40%), Gaps = 28/230 (12%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRN 219
           F L  L+G G++G VYKG   H     L A+KV+++      +    E   L+    HRN
Sbjct: 26  FELVELVGNGTYGQVYKGR--HVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRN 82

Query: 220 LVKIITSCVSVDFQGNDFEA-LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV---D 275
           +     + +  +  G D +  LV E    GS+ + +   +        L+   IA    +
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-----LKEEWIAYICRE 137

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           +   L +LH   +  ++H D+K  NVLL       + DFG++         L        
Sbjct: 138 ILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-------QLDRTVGRRN 187

Query: 336 GVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGPTNEM 380
              GT  + APE     E   +      D++S GI  +EM  G  P  +M
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 51/225 (22%), Positives = 86/225 (38%), Gaps = 38/225 (16%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRH 217
           F +   +G G FG+VY        ++ ++A+KVL    L+  G       E +    +RH
Sbjct: 16  FDIGRPLGKGKFGNVYLAR--EKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS------ 271
            N++++        F       L+ E    G L  +  L +          R        
Sbjct: 74  PNILRMYNY-----FHDRKRIYLMLEFAPRGEL--YKELQKH--------GRFDEQRSAT 118

Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQ 331
              ++A  L Y H      ++H D+KP N+L+  +    ++DFG +   P      S  +
Sbjct: 119 FMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP------SLRR 169

Query: 332 SSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            +     GT+ Y  PE   G       D++  G+L  E   G  P
Sbjct: 170 RTMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 58/262 (22%), Positives = 92/262 (35%), Gaps = 44/262 (16%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDG--FSLENLIGAGSFGSVYKGIFDHDDHE 186
                  + P +   A   +   + L        +     +G G F   ++      D +
Sbjct: 9   KAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEIS--DADTK 66

Query: 187 TLVAVKVLN---LQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE 243
            + A K++    L      +    E    RS+ H+++V          F+ NDF  +V E
Sbjct: 67  EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLE 121

Query: 244 LMVNGSLEEWL----HLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPS 299
           L    SL E       L     R   L Q       +    +YLH      ++H DLK  
Sbjct: 122 LCRRRSLLELHKRRKALTEPEARYY-LRQ-------IVLGCQYLHRNR---VIHRDLKLG 170

Query: 300 NVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK-----GTVGYAAPEYGMGSEV 354
           N+ L+ +L   + DFGL            + +    G +     GT  Y APE       
Sbjct: 171 NLFLNEDLEVKIGDFGL------------ATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218

Query: 355 STSGDVYSFGILLLEMFTGKGP 376
           S   DV+S G ++  +  GK P
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPP 240

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 48/232 (20%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRH 217
           F +   IG GSFG V   I   +D + + A+K +N Q    R   ++   E Q ++ + H
Sbjct: 17  FEILRAIGKGSFGKVC--IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV--- 274
             LV +  S     FQ  +   +V +L++ G L    HL ++                  
Sbjct: 75  PFLVNLWYS-----FQDEEDMFMVVDLLLGGDL--RYHLQQN--------VHFKEETVKL 119

Query: 275 ---DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQ 331
              ++   L+YL +     I+H D+KP N+LLD     H++DF +A  LP      +   
Sbjct: 120 FICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--- 173

Query: 332 SSSVGVKGTVGYAAPE-------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                + GT  Y APE        G    V    D +S G+   E+  G+ P
Sbjct: 174 -----MAGTKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 25/228 (10%)

Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS-KSFIAECQ-AL 212
            KA D       +G G++G V K    H     ++AVK +         K  + +   ++
Sbjct: 4   VKADD-LEPIMELGRGAYGVVEKMR--HVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           R++     V    +     F+  D   +  ELM + SL+++     D  + +       I
Sbjct: 61  RTVDCPFTVTFYGAL----FREGDV-WICMELM-DTSLDKFYKQVIDKGQTIPEDILGKI 114

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           AV +   LE+LH   +  ++H D+KPSNVL++      + DFG++ +L +        + 
Sbjct: 115 AVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD-----DVAKD 167

Query: 333 SSVGVKGTVGYAAPE----YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                 G   Y APE           S   D++S GI ++E+   + P
Sbjct: 168 IDA---GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 55/238 (23%), Positives = 104/238 (43%), Gaps = 28/238 (11%)

Query: 151 YQNLFKATD---GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA 207
           Y+++ +  D    + +   +G G+FG VYK    + +   L A KV+  +     + +I 
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAK--NKETGALAAAKVIETKSEEELEDYIV 65

Query: 208 ECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL 267
           E + L +  H  +VK++ +     +  +    ++ E    G+++    +  +  R L   
Sbjct: 66  EIEILATCDHPYIVKLLGA-----YYHDGKLWIMIEFCPGGAVDA---IMLELDRGLTEP 117

Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL 327
           Q   +   +   L +LH      I+H DLK  NVL+  E    ++DFG++          
Sbjct: 118 QIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN----LKT 170

Query: 328 SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGPTNEM 380
              + S +   GT  + APE  M   +  +      D++S GI L+EM   + P +E+
Sbjct: 171 LQKRDSFI---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 92.2 bits (230), Expect = 3e-21
 Identities = 51/227 (22%), Positives = 92/227 (40%), Gaps = 39/227 (17%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRH 217
           F + NL+G GSF  VY+           VA+K+++   +   G  +    E +    ++H
Sbjct: 13  FKVGNLLGKGSFAGVYRAE--SIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---DAPRNLNLLQRLSIAV 274
            +++++        F+ +++  LV E+  NG +  +L             + + ++   +
Sbjct: 71  PSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
                  YLH +    I+H DL  SN+LL   +   ++DFGL            + Q   
Sbjct: 126 L------YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGL------------ATQLKM 164

Query: 335 VGVK-----GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              K     GT  Y +PE    S      DV+S G +   +  G+ P
Sbjct: 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 92.4 bits (230), Expect = 6e-21
 Identities = 68/255 (26%), Positives = 108/255 (42%), Gaps = 30/255 (11%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETL 188
           S    +   PP   L  +   S     +  + F +   +G GS+GSVYK I  H +   +
Sbjct: 1   SLETVQLRNPPRRQLKKLDEDSLTK--QPEEVFDVLEKLGEGSYGSVYKAI--HKETGQI 56

Query: 189 VAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNG 248
           VA+K + ++     +  I E   ++     ++VK   S     +  N    +V E    G
Sbjct: 57  VAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGS-----YFKNTDLWIVMEYCGAG 109

Query: 249 SLEEWLHLNRDAPRNLNLLQRLSIAVDVAST---LEYLHHYCETPIVHCDLKPSNVLLDG 305
           S+ + + L          L    IA  + ST   LEYLH       +H D+K  N+LL+ 
Sbjct: 110 SVSDIIRLRN------KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNT 160

Query: 306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGI 365
           E  A ++DFG+A         L+   +    V GT  + APE       +   D++S GI
Sbjct: 161 EGHAKLADFGVAG-------QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGI 213

Query: 366 LLLEMFTGKGPTNEM 380
             +EM  GK P  ++
Sbjct: 214 TAIEMAEGKPPYADI 228

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 91.9 bits (229), Expect = 7e-21
 Identities = 58/224 (25%), Positives = 88/224 (39%), Gaps = 44/224 (19%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGASKSFIAECQALRSI 215
              F    ++G+G+F  V+          T  L A+K +         S   E   L+ I
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVK----QRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI 63

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN-RDAPRNLNLLQRL 270
           +H N+V +        ++      LV +L+  G L + +        +DA          
Sbjct: 64  KHENIVTLEDI-----YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------- 110

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAANNL 327
            +   V S ++YLH   E  IVH DLKP N+L    +      ++DFGL+K        +
Sbjct: 111 -VIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIM 164

Query: 328 SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFG----ILL 367
           S+         GT GY APE       S + D +S G    ILL
Sbjct: 165 ST-------ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 57/240 (23%), Positives = 94/240 (39%), Gaps = 38/240 (15%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI 215
           D F +  +IG G+F  V   +        + A+K++N      RG    F  E   L + 
Sbjct: 61  DDFEILKVIGRGAFSEVA--VVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG 118

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
             R + ++  +     FQ  ++  LV E  V G L     L++   R    + R  +A +
Sbjct: 119 DRRWITQLHFA-----FQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEMARFYLA-E 170

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSS 333
           +   ++ +H       VH D+KP N+LLD     H+  +DFG      +   + +     
Sbjct: 171 IVMAIDSVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGSCL---KLRADGTVRSLV 222

Query: 334 SVGVKGTVGYAAPEYGMGSEVSTSGDVY-------SFGILLLEMFTGKGP-----TNEMF 381
           +V   GT  Y +PE             Y       + G+   EMF G+ P     T E +
Sbjct: 223 AV---GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 61/233 (26%), Positives = 99/233 (42%), Gaps = 36/233 (15%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSF---IAECQALRSI 215
           D F     +G GSFG V   +  H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVM--LVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               LVK+  S     F+ N    +V E +  G +  + HL R   R      R   A  
Sbjct: 99  NFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHL-RRIGRFSEPHARFYAA-Q 149

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSS 333
           +  T EYLH      +++ DLKP N+L+D +   ++  +DFG AK +      L      
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQ--GYIQVTDFGFAKRVKGRTWTLC----- 199

Query: 334 SVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMF 381
                GT    APE  +    + + D ++ G+L+ EM  G  P       +++
Sbjct: 200 -----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 92.1 bits (229), Expect = 3e-20
 Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 28/215 (13%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR---NLVK 222
           +IG GSFG V K  +DH  H+  VA+K++  + R   ++   E + L  +R +   N + 
Sbjct: 104 VIGKGSFGQVVKA-YDHKVHQ-HVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMN 160

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
           +I    +  F+ +    + +EL+ + +L E +  N+    +L L+++   A  +   L+ 
Sbjct: 161 VIHMLENFTFRNHIC--MTFELL-SMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDA 215

Query: 283 LHHYCETPIVHCDLKPSNVLLDGELTAH--VSDFGLAKFLPEAANNLSSN-QSSSVGVKG 339
           LH   +  I+HCDLKP N+LL  +  +   V DFG + +  +    + +  QS       
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRF----- 264

Query: 340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
              Y APE  +G+      D++S G +L E+ TG 
Sbjct: 265 ---YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 92.6 bits (230), Expect = 4e-20
 Identities = 66/256 (25%), Positives = 105/256 (41%), Gaps = 46/256 (17%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQAL---RS 214
           FS+  +IG G FG VY       D   + A+K L+   ++ +      + E   L    +
Sbjct: 191 FSVHRIIGRGGFGEVYGC--RKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
                +V +  +     F   D  + + +LM  G L    HL++      +       A 
Sbjct: 249 GDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDL--HYHLSQH--GVFSEADMRFYAA 299

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQS 332
           ++   LE++H      +V+ DLKP+N+LLD     HV  SD GLA    +   +      
Sbjct: 300 EIILGLEHMH---NRFVVYRDLKPANILLDEH--GHVRISDLGLACDFSKKKPH------ 348

Query: 333 SSVGVKGTVGYAAPE-YGMGSEVSTSGDVYSFGILLLEMFTGKGP--------TNEMFTG 383
           +SV   GT GY APE    G    +S D +S G +L ++  G  P         +E+   
Sbjct: 349 ASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-- 403

Query: 384 NLTLHNFVKEALPERL 399
            +TL       LP+  
Sbjct: 404 RMTLTM--AVELPDSF 417

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 88.7 bits (221), Expect = 9e-20
 Identities = 64/244 (26%), Positives = 97/244 (39%), Gaps = 62/244 (25%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFI----------AECQ 210
           F +   +G GSFG V+  +     +    A+KVL        K  +           E  
Sbjct: 8   FQILRTLGTGSFGRVH--LIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERL 58

Query: 211 ALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
            L  + H  ++++  +     FQ      ++ + +  G L  +  L +         QR 
Sbjct: 59  MLSIVTHPFIIRMWGT-----FQDAQQIFMIMDYIEGGEL--FSLLRKS--------QRF 103

Query: 271 SIAV------DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPE 322
              V      +V   LEYLH      I++ DLKP N+LLD     H+  +DFG AK++P+
Sbjct: 104 PNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAKYVPD 158

Query: 323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----T 377
               L           GT  Y APE       + S D +SFGIL+ EM  G  P     T
Sbjct: 159 VTYTLC----------GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208

Query: 378 NEMF 381
            + +
Sbjct: 209 MKTY 212

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 90.6 bits (225), Expect = 9e-20
 Identities = 57/236 (24%), Positives = 95/236 (40%), Gaps = 36/236 (15%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRH 217
           F +  +IG G+FG V   +    + + + A+K+LN      R  +  F  E   L +   
Sbjct: 76  FEILKVIGRGAFGEVA--VVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
           + +  +  +     FQ ++   LV +  V G L     L++   R    + R  +A ++ 
Sbjct: 134 KWITTLHYA-----FQDDNNLYLVMDYYVGGDL--LTLLSKFEDRLPEEMARFYLA-EMV 185

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSSSV 335
             ++ +H       VH D+KP N+L+D     H+  +DFG                 SSV
Sbjct: 186 IAIDSVHQLH---YVHRDIKPDNILMDMN--GHIRLADFGSCL-----KLMEDGTVQSSV 235

Query: 336 GVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILLLEMFTGKGP-----TNEMF 381
            V GT  Y +PE     E          D +S G+ + EM  G+ P       E +
Sbjct: 236 AV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY 290

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 54/225 (24%), Positives = 89/225 (39%), Gaps = 25/225 (11%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS-KSFIAECQ-ALRSIR 216
           +       IG G++GSV K +  H     ++AVK +         K  + +    +RS  
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMV--HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSD 79

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH-LNRDAPRNLNLLQRLSIAVD 275
              +V+   +     F+  D   +  ELM + S +++   +       +       I + 
Sbjct: 80  CPYIVQFYGAL----FREGDC-WICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLA 133

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
               L +L       I+H D+KPSN+LLD      + DFG++  L +     S  ++   
Sbjct: 134 TVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-----SIAKTRDA 186

Query: 336 GVKGTVGYAAPE----YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              G   Y APE               DV+S GI L E+ TG+ P
Sbjct: 187 ---GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 54/243 (22%), Positives = 89/243 (36%), Gaps = 53/243 (21%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRH 217
           + +  +IG G+FG V   +  H     + A+K+L+      R  S  F  E   +     
Sbjct: 71  YEVVKVIGRGAFGEVQ--LVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
             +V++  +     FQ + +  +V E M  G L             +NL+    +    A
Sbjct: 129 PWVVQLFYA-----FQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWA 170

Query: 278 --------STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNL 327
                     L+ +H       +H D+KP N+LLD     H+  +DFG    + +     
Sbjct: 171 RFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVR 225

Query: 328 SSNQSSSVGVKGTVGYAAPE----YGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TN 378
                ++V   GT  Y +PE     G         D +S G+ L EM  G  P       
Sbjct: 226 C---DTAV---GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 279

Query: 379 EMF 381
             +
Sbjct: 280 GTY 282

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 67/253 (26%), Positives = 100/253 (39%), Gaps = 49/253 (19%)

Query: 131 TKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVA 190
           +    + P +A L     +   N    +D F +E+ +G G+   VY+        +   A
Sbjct: 25  SVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCK--QKGTQKPYA 82

Query: 191 VKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL 250
           +KVL        K    E   L  + H N++K+        F+     +LV EL+  G L
Sbjct: 83  LKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI-----FETPTEISLVLELVTGGEL 135

Query: 251 EEWL----HLN-RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL-- 303
            + +    + + RDA               +   + YLH   E  IVH DLKP N+L   
Sbjct: 136 FDRIVEKGYYSERDAAD---------AVKQILEAVAYLH---ENGIVHRDLKPENLLYAT 183

Query: 304 -DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE----YGMGSEVSTSG 358
              +    ++DFGL+K +          Q     V GT GY APE       G EV    
Sbjct: 184 PAPDAPLKIADFGLSKIVEH--------QVLMKTVCGTPGYCAPEILRGCAYGPEV---- 231

Query: 359 DVYSFG----ILL 367
           D++S G    ILL
Sbjct: 232 DMWSVGIITYILL 244

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 55/235 (23%), Positives = 99/235 (42%), Gaps = 56/235 (23%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---------LQHRGASKSFIAE 208
            + +  + ++G G    V + I  H       AVK+++          + +   ++ + E
Sbjct: 16  YENYEPKEILGRGVSSVVRRCI--HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73

Query: 209 CQALRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN-RDAPR 262
              LR +  H N++++  +     ++ N F  LV++LM  G L ++L     L+ ++  +
Sbjct: 74  VDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK 128

Query: 263 NLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE 322
                    I   +   +  LH   +  IVH DLKP N+LLD ++   ++DFG +  L  
Sbjct: 129 ---------IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176

Query: 323 AANNLSSNQSSSVGVKGTVGYAAPE----------YGMGSEVSTSGDVYSFGILL 367
                         V GT  Y APE           G G EV    D++S G+++
Sbjct: 177 --------GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIM 219

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 89.4 bits (222), Expect = 3e-19
 Identities = 61/248 (24%), Positives = 97/248 (39%), Gaps = 52/248 (20%)

Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGA 201
             ++ S       +D +  + ++G GSFG V              AVKV++   ++ +  
Sbjct: 15  MFVQHSTAIF---SDRYKGQRVLGKGSFGEVILCK--DKITGQECAVKVISKRQVKQKTD 69

Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN 257
            +S + E Q L+ + H N++K+        F+   +  LV E+   G L + +      +
Sbjct: 70  KESLLREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRKRFS 124

Query: 258 -RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSD 313
             DA R         I   V S + Y+H      IVH DLKP N+LL     +    + D
Sbjct: 125 EVDAAR---------IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIID 172

Query: 314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE-----YGMGSEVSTSGDVYSFGILLL 368
           FGL+                     GT  Y APE     Y          DV+S G++L 
Sbjct: 173 FGLSTHF--------EASKKMKDKIGTAYYIAPEVLHGTYDEKC------DVWSTGVILY 218

Query: 369 EMFTGKGP 376
            + +G  P
Sbjct: 219 ILLSGCPP 226

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 86.7 bits (215), Expect = 4e-19
 Identities = 28/221 (12%), Positives = 54/221 (24%), Gaps = 61/221 (27%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETL---VAVKVLNLQHRGASKS---FIAECQALRSIR 216
           L    G       ++     D    L   VA+  ++ Q           ++    L  I 
Sbjct: 35  LLIFHGGVPPLQFWQA---LD--TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89

Query: 217 HRNLVKIITSCVSVDF-QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
              + +++      D         +V E +  GSL+E          + + +  +     
Sbjct: 90  KPGVARVL------DVVHTRAGGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQS 137

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           +A+  +  H      +      PS V         VS  G                    
Sbjct: 138 LAAAADAAH---RAGVALSIDHPSRVR--------VSIDGDVVL---------------- 170

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                              +   D+   G  L  +   + P
Sbjct: 171 ---AYPATMPD-------ANPQDDIRGIGASLYALLVNRWP 201

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 46/214 (21%), Positives = 86/214 (40%), Gaps = 27/214 (12%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH 217
            D + +   +G+G+FG V++ +        +   K +N  +     +   E   +  + H
Sbjct: 50  YDYYDILEELGSGAFGVVHRCV--EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV--D 275
             L+ +  +     F+      L+ E +  G L      +R A  +  + +   I     
Sbjct: 108 PKLINLHDA-----FEDKYEMVLILEFLSGGEL-----FDRIAAEDYKMSEAEVINYMRQ 157

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSS 333
               L+++H   E  IVH D+KP N++ + +  + V   DFGLA  L         ++  
Sbjct: 158 ACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-------DEIV 207

Query: 334 SVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILL 367
            V    T  +AAPE      V    D+++ G+L 
Sbjct: 208 KVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 88.6 bits (220), Expect = 5e-19
 Identities = 57/234 (24%), Positives = 87/234 (37%), Gaps = 48/234 (20%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK--SFIAECQALRSI 215
           ++ +     +G+G++G V              A+K++       S     + E   L+ +
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCR--DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN-RDAPRNLNLLQRL 270
            H N++K+        F+      LV E    G L + +      N  DA          
Sbjct: 94  DHPNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA---------A 139

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAANNL 327
            I   V S + YLH +    IVH DLKP N+LL   + +    + DFGL+          
Sbjct: 140 VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF------- 189

Query: 328 SSNQSSSVGVKGTVGYAAPE-----YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             NQ       GT  Y APE     Y          DV+S G++L  +  G  P
Sbjct: 190 -ENQKKMKERLGTAYYIAPEVLRKKYDEKC------DVWSIGVILFILLAGYPP 236

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 86.5 bits (215), Expect = 5e-19
 Identities = 52/241 (21%), Positives = 93/241 (38%), Gaps = 64/241 (26%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIA-ECQALRSIRHR 218
           + +L+G GS+G V + +    +     AVK+L    L+     ++ +  E Q LR +RH+
Sbjct: 9   MGDLLGEGSYGKVKEVL--DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 219 NLVK--------------IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNL 264
           N+++              ++             E  + + +              A    
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCV----CGMQE--MLDSVPEKRFPVC-----QAHG-- 113

Query: 265 NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAA 324
               +L   ++      YLH      IVH D+KP N+LL    T  +S  G+A+ L   A
Sbjct: 114 -YFCQLIDGLE------YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163

Query: 325 NN--LSSNQSSSVGVKGTVGYAAPE-------YGMGSEVSTSGDVYSFGILLLEMFTGKG 375
            +    ++Q       G+  +  PE       +  G +V    D++S G+ L  + TG  
Sbjct: 164 ADDTCRTSQ-------GSPAFQPPEIANGLDTFS-GFKV----DIWSAGVTLYNITTGLY 211

Query: 376 P 376
           P
Sbjct: 212 P 212

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 86.8 bits (215), Expect = 6e-19
 Identities = 53/273 (19%), Positives = 93/273 (34%), Gaps = 58/273 (21%)

Query: 149 VSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKV-----LNLQHRGASK 203
               +L +    + L+  IG GS+G V   I   +    + A+K+     +   +    +
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAI--ENQTRAIRAIKIMNKNKIRQINPKDVE 73

Query: 204 SFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN 263
               E + ++ + H N+ ++        ++   +  LV EL   G L + L++  D    
Sbjct: 74  RIKTEVRLMKKLHHPNIARLYEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128

Query: 264 LNLLQRL------------------------------------SIAVDVASTLEYLHHYC 287
              +  +                                    +I   + S L YLH   
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH--- 185

Query: 288 ETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAA 345
              I H D+KP N L     +  +   DFGL+K   +  N      ++     GT  + A
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA---GTPYFVA 242

Query: 346 PE--YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           PE             D +S G+LL  +  G  P
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 87.5 bits (217), Expect = 8e-19
 Identities = 65/271 (23%), Positives = 107/271 (39%), Gaps = 41/271 (15%)

Query: 125 TSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDD 184
            +        PS    A    V     ++     + F    L+G G+FG V   +     
Sbjct: 115 AAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNE-FEYLKLLGKGTFGKVI--LVKEKA 171

Query: 185 HETLVAVKVL---NLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALV 241
                A+K+L    +  +      + E + L++ RH  L  +  S     FQ +D    V
Sbjct: 172 TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS-----FQTHDRLCFV 226

Query: 242 YELMVNGSLEEWLHLNRDA----PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLK 297
            E    G L  + HL+R+      R      R   A ++ S L+YLH   E  +V+ DLK
Sbjct: 227 MEYANGGEL--FFHLSRERVFSEDR-----ARFYGA-EIVSALDYLHS--EKNVVYRDLK 276

Query: 298 PSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVS 355
             N++LD +   H+  +DFGL K        +    +      GT  Y APE    ++  
Sbjct: 277 LENLMLDKD--GHIKITDFGLCK------EGIKDGATMKT-FCGTPEYLAPEVLEDNDYG 327

Query: 356 TSGDVYSFGILLLEMFTGKGP-----TNEMF 381
            + D +  G+++ EM  G+ P       ++F
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 33/218 (15%)

Query: 164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRNLVK 222
           E+++G G+   V   I  +       AVK++  Q          E + L   + HRN+++
Sbjct: 18  EDVLGEGAHARVQTCI--NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSL----EEWLHLN-RDAPRNLNLLQRLSIAVDVA 277
           +I       F+  D   LV+E M  GS+     +  H N  +A           +  DVA
Sbjct: 76  LIEF-----FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---------VVQDVA 121

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
           S L++LH      I H DLKP N+L    +      + DF L   +    +    +    
Sbjct: 122 SALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG-----DVYSFGILL 367
           +   G+  Y APE         S      D++S G++L
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 56/241 (23%), Positives = 94/241 (39%), Gaps = 53/241 (21%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--------LQHRGASKSFIAEC 209
            D + +   +G+G+ G V             VA+++++         +    + +   E 
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAF--ERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191

Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLNRDAPRNLN 265
           + L+ + H  ++KI     + D+       +V ELM  G L + +     L     +   
Sbjct: 192 EILKKLNHPCIIKIKNFFDAEDYY------IVLELMEGGELFDKVVGNKRLKEATCKLY- 244

Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPE 322
             Q       +   ++YLH   E  I+H DLKP NVLL   + +    ++DFG +K L E
Sbjct: 245 FYQ-------MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294

Query: 323 AANNLSSNQSSSVGVKGTVGYAAPE-------YGMGSEVSTSGDVYSFGILLLEMFTGKG 375
                    S    + GT  Y APE        G    V    D +S G++L    +G  
Sbjct: 295 --------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYP 342

Query: 376 P 376
           P
Sbjct: 343 P 343

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 86.8 bits (215), Expect = 2e-18
 Identities = 54/218 (24%), Positives = 87/218 (39%), Gaps = 35/218 (16%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH 217
            D + +   +G G+FG V++            A K +   H    ++   E Q +  +RH
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVT--ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-----EEWLHLN-RDAPRNLNLLQRLS 271
             LV +  +     F+ ++   ++YE M  G L     +E   ++  +A           
Sbjct: 214 PTLVNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVE--------- 259

Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSS 329
               V   L ++H   E   VH DLKP N++   + +  +   DFGL   L         
Sbjct: 260 YMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP------- 309

Query: 330 NQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILL 367
            QS  V   GT  +AAPE   G  V    D++S G+L 
Sbjct: 310 KQSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 63/271 (23%), Positives = 102/271 (37%), Gaps = 63/271 (23%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDGFS----LENLIGAGSFGSVYKGIFDHDD 184
                +P    +    S+        + A   F      +++IG G    V + +  H  
Sbjct: 60  KLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCV--HRA 117

Query: 185 HETLVAVKVLNLQHRGASKSFIA--------ECQALRSIR-HRNLVKIITSCVSVDFQGN 235
                AVK++ +     S   +         E   LR +  H +++ +I S     ++ +
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS-----YESS 172

Query: 236 DFEALVYELMVNGSLEEWL----HLN-RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP 290
            F  LV++LM  G L ++L     L+ ++            I   +   + +LH      
Sbjct: 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRS---------IMRSLLEAVSFLH---ANN 220

Query: 291 IVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE--- 347
           IVH DLKP N+LLD  +   +SDFG +  L      L         + GT GY APE   
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLR-------ELCGTPGYLAPEILK 272

Query: 348 -------YGMGSEVSTSGDVYSFG----ILL 367
                   G G EV    D+++ G     LL
Sbjct: 273 CSMDETHPGYGKEV----DLWACGVILFTLL 299

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 55/233 (23%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--------LQHRGASKSFIAEC 209
            D + +   +G+G+ G V             VA+K+++         +    + +   E 
Sbjct: 9   RDEYIMSKTLGSGACGEVKLAF--ERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN-RDAPRNL 264
           + L+ + H  ++KI        F   D+  +V ELM  G L + +     L         
Sbjct: 67  EILKKLNHPCIIKIKNF-----FDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL-- 118

Query: 265 NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLP 321
                      +   ++YLH   E  I+H DLKP NVLL   + +    ++DFG +K L 
Sbjct: 119 -------YFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168

Query: 322 EAANNLSSNQSSSVGVKGTVGYAAPE-------YGMGSEVSTSGDVYSFGILL 367
           E         S    + GT  Y APE        G    V    D +S G++L
Sbjct: 169 E--------TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 53/241 (21%), Positives = 91/241 (37%), Gaps = 28/241 (11%)

Query: 143 LASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS 202
               L +  Q      +       +G+G+ G V+K          ++AVK +        
Sbjct: 9   QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMR--FRKTGHVIAVKQMRRSGNKEE 66

Query: 203 -KSFIAECQAL-RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA 260
            K  + +   + +S     +V+   +         D   +  ELM   + +  L      
Sbjct: 67  NKRILMDLDVVLKSHDCPYIVQCFGTF----ITNTDV-FIAMELMGTCAEK--LKKRMQG 119

Query: 261 PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
           P    +L +  + V +   L YL    +  ++H D+KPSN+LLD      + DFG++  L
Sbjct: 120 PIPERILGK--MTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175

Query: 321 PEAANNLSSNQSSSVGVKGTVGYAAPE-----YGMGSEVSTSGDVYSFGILLLEMFTGKG 375
            +        +  S    G   Y APE          +     DV+S GI L+E+ TG+ 
Sbjct: 176 VD-----DKAKDRSA---GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227

Query: 376 P 376
           P
Sbjct: 228 P 228

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 83.4 bits (207), Expect = 4e-18
 Identities = 58/230 (25%), Positives = 95/230 (41%), Gaps = 53/230 (23%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSI 215
           +D + ++  +G G+F  V + +  H       A K++N +   A   +    E +  R +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCV--HKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN-RDAPRNLNLLQRL 270
           +H N+V++  S      Q   F  LV++L+  G L E +      +  DA          
Sbjct: 63  QHPNIVRLHDS-----IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH-------- 109

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAHV--SDFGLAKFLPEAANNL 327
                +  ++ Y H      IVH +LKP N+LL  +   A V  +DFGLA  + +     
Sbjct: 110 -CIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND----- 160

Query: 328 SSNQSSSVGVKGTVGYAAPE------YGMGSEVSTSGDVYSFG----ILL 367
                +  G  GT GY +PE      Y     V    D+++ G    ILL
Sbjct: 161 ---SEAWHGFAGTPGYLSPEVLKKDPYSK--PV----DIWACGVILYILL 201

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 43/219 (19%), Positives = 84/219 (38%), Gaps = 38/219 (17%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA-ECQALRSIR 216
            + + +   +G G FG V++ +      +     K + +  +G  +  +  E   L   R
Sbjct: 4   YEKYMIAEDLGRGEFGIVHRCV--ETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIAR 59

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL-----EEWLHLN-RDAPRNLNLLQRL 270
           HRN++ +  S     F+  +   +++E +    +          LN R+           
Sbjct: 60  HRNILHLHES-----FESMEELVMIFEFISGLDIFERINTSAFELNEREIVS-------- 106

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLS 328
                V   L++LH      I H D++P N++     ++ +   +FG A+ L        
Sbjct: 107 -YVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP------ 156

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILL 367
              +  +       Y APE      VST+ D++S G L+
Sbjct: 157 -GDNFRLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 84.3 bits (209), Expect = 5e-18
 Identities = 59/247 (23%), Positives = 94/247 (38%), Gaps = 55/247 (22%)

Query: 137 TPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNL 196
           T     +   L  +       TDG+ ++  IG GS+    + I  H       AVK+++ 
Sbjct: 3   TVGVHSIVQQLHRNSIQF---TDGYEVKEDIGVGSYSVCKRCI--HKATNMEFAVKIIDK 57

Query: 197 QHRGASKSFIAECQAL-RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL- 254
             R  ++    E + L R  +H N++ +        +    +  +V ELM  G L + + 
Sbjct: 58  SKRDPTE----EIEILLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGELLDKIL 108

Query: 255 ---HLN-RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL----DGE 306
                + R+A           +   +  T+EYLH      +VH DLKPSN+L        
Sbjct: 109 RQKFFSEREASA---------VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNP 156

Query: 307 LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE------YGMGSEVSTSGDV 360
            +  + DFG AK L      L            T  + APE      Y          D+
Sbjct: 157 ESIRICDFGFAKQLRAENGLLM-------TPCYTANFVAPEVLERQGYDA--AC----DI 203

Query: 361 YSFGILL 367
           +S G+LL
Sbjct: 204 WSLGVLL 210

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 83.0 bits (206), Expect = 5e-18
 Identities = 55/231 (23%), Positives = 85/231 (36%), Gaps = 51/231 (22%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA-ECQALRSIRHRNLV 221
           L   +G G++G V   +  +   E  VAVK+++++        I  E    + + H N+V
Sbjct: 11  LVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 222 K---IITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLNRDAPRNLNLLQRLSIAV 274
           K                + + L  E    G L + +     +     +      +L   V
Sbjct: 69  KFYGHRRE--------GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGV 118

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
                  YLH      I H D+KP N+LLD      +SDFGLA         +    +  
Sbjct: 119 V------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRE 161

Query: 335 VGVKGTVG---YAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             +    G   Y APE      +     V    DV+S GI+L  M  G+ P
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP 207

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 83.0 bits (206), Expect = 5e-18
 Identities = 59/227 (25%), Positives = 85/227 (37%), Gaps = 50/227 (22%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH 217
              ++LEN IG GS+G V   +          A K +          F  E + ++S+ H
Sbjct: 8   NQYYTLENTIGRGSWGEVKIAV--QKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH 65

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN-RDAPRNLNLLQRLSI 272
            N++++  +     F+ N    LV EL   G L E +         DA R         I
Sbjct: 66  PNIIRLYET-----FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR---------I 111

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAANNLSS 329
             DV S + Y H   +  + H DLKP N L      +    + DFGLA            
Sbjct: 112 MKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-----GK 163

Query: 330 NQSSSVGVKGTVGYAAPE-----YGMGSEVSTSGDVYSFG----ILL 367
              + V   GT  Y +P+     Y  G E     D +S G    +LL
Sbjct: 164 MMRTKV---GTPYYVSPQVLEGLY--GPEC----DEWSAGVMMYVLL 201

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 84.8 bits (210), Expect = 8e-18
 Identities = 60/284 (21%), Positives = 99/284 (34%), Gaps = 68/284 (23%)

Query: 132 KREPSTPPSALLASVLRVSYQNLFKA-----TDGFSLENLIGAGSFGSVYKGIFDHDDHE 186
               S+    L    + ++     +       + +     +G+G++G V        +  
Sbjct: 4   HHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCK--EKNGH 61

Query: 187 TLVAVKVLN-------------LQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ 233
           +  A+KV+                     +    E   L+S+ H N++K+        F+
Sbjct: 62  SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FE 116

Query: 234 GNDFEALVYELMVNGSLEEWL----HLN-RDAPRNLNLLQRLSIAVDVASTLEYLHHYCE 288
              +  LV E    G L E +      +  DA          +I   + S + YLH +  
Sbjct: 117 DKKYFYLVTEFYEGGELFEQIINRHKFDECDA---------ANIMKQILSGICYLHKHN- 166

Query: 289 TPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAA 345
             IVH D+KP N+LL   +  L   + DFGL+ F         S         GT  Y A
Sbjct: 167 --IVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--------SKDYKLRDRLGTAYYIA 216

Query: 346 PE-----YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
           PE     Y          DV+S G+++  +  G  P    F G 
Sbjct: 217 PEVLKKKYNEKC------DVWSCGVIMYILLCGYPP----FGGQ 250

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 60/237 (25%), Positives = 93/237 (39%), Gaps = 65/237 (27%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRHRN 219
           L   IG G+F  V      H      VA+K+++   L      K F  E + ++ + H N
Sbjct: 19  LLKTIGKGNFAKVKLAR--HILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPN 75

Query: 220 LVKIITSCVSVDFQGNDFEA--------LVYELMVNGSLEEWL----HLNRDAPRNLNLL 267
           +VK+             FE         L+ E    G + ++L     +     R+    
Sbjct: 76  IVKL-------------FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK--F 120

Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL 327
           +++  AV       Y H      IVH DLK  N+LLD ++   ++DFG        +N  
Sbjct: 121 RQIVSAVQ------YCHQKR---IVHRDLKAENLLLDADMNIKIADFGF-------SNEF 164

Query: 328 SSNQ--SSSVGVKGTVGYAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           +      +     G   YAAPE      Y  G EV    DV+S G++L  + +G  P
Sbjct: 165 TVGGKLDAFC---GAPPYAAPELFQGKKY-DGPEV----DVWSLGVILYTLVSGSLP 213

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 83.5 bits (207), Expect = 9e-18
 Identities = 51/248 (20%), Positives = 89/248 (35%), Gaps = 42/248 (16%)

Query: 136 STPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKV 193
           S   S     +L ++  ++    D + L  +IG G F  V + I    + ET    AVK+
Sbjct: 2   SPGISGGGGGILDMADDDV-LFEDVYELCEVIGKGPFSVVRRCI----NRETGQQFAVKI 56

Query: 194 -----LNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNG 248
                       +++    E      ++H ++V+++ +     +  +    +V+E M   
Sbjct: 57  VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLET-----YSSDGMLYMVFEFMDGA 111

Query: 249 SLEEWLHLNRDAPRNLNLLQRLS------IAVDVASTLEYLHHYCETPIVHCDLKPSNVL 302
            L           R  +     S          +   L Y H   +  I+H D+KP  VL
Sbjct: 112 DL-----CFEIVKRA-DAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVL 162

Query: 303 L---DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGD 359
           L   +      +  FG+A  L E+            G  GT  + APE           D
Sbjct: 163 LASKENSAPVKLGGFGVAIQLGESGLVAG-------GRVGTPHFMAPEVVKREPYGKPVD 215

Query: 360 VYSFGILL 367
           V+  G++L
Sbjct: 216 VWGCGVIL 223

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 84.3 bits (209), Expect = 1e-17
 Identities = 50/230 (21%), Positives = 87/230 (37%), Gaps = 52/230 (22%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSI 215
           T+ + L   +G G+F  V + +          A  ++N +       +    E +  R +
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCV--KVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN-RDAPRNLNLLQRL 270
           +H N+V++  S             L+++L+  G L E +    + +  DA          
Sbjct: 68  KHPNIVRLHDS-----ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH-------- 114

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAANNL 327
                +   + + H   +  +VH +LKP N+LL          ++DFGLA  +       
Sbjct: 115 -CIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170

Query: 328 SSNQSSSVGVKGTVGYAAPE------YGMGSEVSTSGDVYSFG----ILL 367
                   G  GT GY +PE      YG    V    D+++ G    ILL
Sbjct: 171 F-------GFAGTPGYLSPEVLRKDPYGK--PV----DLWACGVILYILL 207

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 84.4 bits (209), Expect = 1e-17
 Identities = 59/242 (24%), Positives = 98/242 (40%), Gaps = 52/242 (21%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSI 215
            + +++  ++G GSFG V K        +   AVKV+N        + + + E + L+ +
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCK--DRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN-RDAPRNLNLLQRL 270
            H N++K+         + +    +V EL   G L + +      +  DA          
Sbjct: 79  DHPNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA---------A 124

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAANNL 327
            I   V S + Y+H +    IVH DLKP N+LL   + +    + DFGL+    +     
Sbjct: 125 RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ----- 176

Query: 328 SSNQSSSVGVKGTVGYAAPE-----YGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFT 382
               +      GT  Y APE     Y    +     DV+S G++L  + +G  P    F 
Sbjct: 177 ---NTKMKDRIGTAYYIAPEVLRGTY--DEKC----DVWSAGVILYILLSGTPP----FY 223

Query: 383 GN 384
           G 
Sbjct: 224 GK 225

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 55/231 (23%), Positives = 85/231 (36%), Gaps = 51/231 (22%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA-ECQALRSIRHRNLV 221
           L   +G G++G V   +  +   E  VAVK+++++        I  E    + + H N+V
Sbjct: 11  LVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 222 K---IITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLNRDAPRNLNLLQRLSIAV 274
           K                + + L  E    G L + +     +     +      +L   V
Sbjct: 69  KFYGHRRE--------GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAGV 118

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
                  YLH      I H D+KP N+LLD      +SDFGLA         +    +  
Sbjct: 119 V------YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLA--------TVFRYNNRE 161

Query: 335 VGVKGTVG---YAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             +    G   Y APE      +     V    DV+S GI+L  M  G+ P
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREF-HAEPV----DVWSCGIVLTAMLAGELP 207

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 50/235 (21%), Positives = 89/235 (37%), Gaps = 50/235 (21%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN----LQHRGASKSFIA----ECQAL 212
           +S  + +G+G+FG V+  +    +    V VK +     L+        +     E   L
Sbjct: 26  YSTMSPLGSGAFGFVWTAV--DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83

Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGS-----LEEWLHLNRDAPRNLNLL 267
             + H N++K++       F+   F  LV E   +G      ++    L+          
Sbjct: 84  SRVEHANIIKVLDI-----FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY---- 134

Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL 327
               I   + S + YL       I+H D+K  N+++  + T  + DFG        A  L
Sbjct: 135 ----IFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS-------AAYL 180

Query: 328 SSNQSSSVGVKGTVGYAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              +       GT+ Y APE      Y  G E+    +++S G+ L  +   + P
Sbjct: 181 ERGKLFYTFC-GTIEYCAPEVLMGNPYR-GPEL----EMWSLGVTLYTLVFEENP 229

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 81.5 bits (202), Expect = 2e-17
 Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 29/217 (13%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIR 216
            D F  +  +G+G+FG V+              +K +N  + +   +   AE + L+S+ 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVE--ERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N++KI        F+      +V E    G L E +   +   + L+      +   +
Sbjct: 79  HPNIIKIFEV-----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
            + L Y H      +VH DLKP N+L           + DFGLA+           + ++
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS-----DEHSTN 185

Query: 334 SVGVKGTVGYAAPE---YGMGSEVSTSGDVYSFGILL 367
           +    GT  Y APE     +  +     D++S G+++
Sbjct: 186 AA---GTALYMAPEVFKRDVTFKC----DIWSAGVVM 215

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 36/225 (16%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL--NLQHRGASKSFIAECQALRSIRHR 218
           + +++LIG GSFG V K  +D  + E  VA+K++         ++    E + L  +   
Sbjct: 56  YEIDSLIGKGSFGQVVKA-YDRVEQE-WVAIKIIKNKKAFLNQAQI---EVRLLELMNKH 110

Query: 219 ------NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
                  +V +        F   +   LV+E++ + +L + L        +LNL ++   
Sbjct: 111 DTEMKYYIVHLKRH-----FMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRK--F 162

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH--VSDFGLAKFLPEAANN-LSS 329
           A  + + L +L    E  I+HCDLKP N+LL     +   + DFG +  L +     + S
Sbjct: 163 AQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQS 221

Query: 330 NQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
                        Y +PE  +G     + D++S G +L+EM TG+
Sbjct: 222 RF-----------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 53/247 (21%), Positives = 93/247 (37%), Gaps = 32/247 (12%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETL 188
           S    +   PP+     ++      +       S   ++G G FG V+K           
Sbjct: 60  SALAVDIPAPPAPFDHRIVTAKQGAVNSFYT-VSKTEILGGGRFGQVHKCE--ETATGLK 116

Query: 189 VAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNG 248
           +A K++  +     +    E   +  + H NL+++  +     F+  +   LV E +  G
Sbjct: 117 LAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-----FESKNDIVLVMEYVDGG 171

Query: 249 SLEEWLHLNRDAPRNLNLLQRLSIAV--DVASTLEYLHHYCETPIVHCDLKPSNVLLDGE 306
            L      +R    + NL +  +I     +   + ++H   +  I+H DLKP N+L    
Sbjct: 172 EL-----FDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNR 223

Query: 307 LTAHV--SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFG 364
               +   DFGLA+            +   V   GT  + APE      VS   D++S G
Sbjct: 224 DAKQIKIIDFGLARR-------YKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVG 275

Query: 365 ----ILL 367
               +LL
Sbjct: 276 VIAYMLL 282

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 57/249 (22%), Positives = 95/249 (38%), Gaps = 41/249 (16%)

Query: 133 REPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVK 192
              S      +            K +D + ++  +G G+F  V + +  H       A K
Sbjct: 3   HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCV--HKTTGLEFAAK 60

Query: 193 VLNLQHRGAS--KSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL 250
           ++N +   A   +    E +  R ++H N+V++  S      Q   F  LV++L+  G L
Sbjct: 61  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS-----IQEESFHYLVFDLVTGGEL 115

Query: 251 EEWL----HLN-RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL-- 303
            E +      +  DA               +  ++ Y H      IVH +LKP N+LL  
Sbjct: 116 FEDIVAREFYSEADASH---------CIQQILESIAYCH---SNGIVHRNLKPENLLLAS 163

Query: 304 -DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYS 362
                   ++DFGLA  + +          +  G  GT GY +PE       S   D+++
Sbjct: 164 KAKGAAVKLADFGLAIEVND--------SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 215

Query: 363 FG----ILL 367
            G    ILL
Sbjct: 216 CGVILYILL 224

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 80/270 (29%), Positives = 113/270 (41%), Gaps = 47/270 (17%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETL 188
                 P+ PP+      L  S     K +D F    +IG GSFG V   +  H   E  
Sbjct: 9   ELMNANPAPPPAPSQQINLGPSSNPHAKPSD-FHFLKVIGKGSFGKVL--LARHKAEEVF 65

Query: 189 VAVKVL---NLQHRGASKSFIAECQAL-RSIRHRNLVKIITSCVSVDFQGNDFEALVYEL 244
            AVKVL    +  +   K  ++E   L ++++H  LV +  S     FQ  D    V + 
Sbjct: 66  YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFS-----FQTADKLYFVLDY 120

Query: 245 MVNGSLEEWLHLNRDAPRNLNLLQRLSI------AVDVASTLEYLHHYCETPIVHCDLKP 298
           +  G L  + HL R+        +          A ++AS L YLH      IV+ DLKP
Sbjct: 121 INGGEL--FYHLQRE--------RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKP 167

Query: 299 SNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVST 356
            N+LLD +   H+  +DFGL K       N+  N ++S    GT  Y APE         
Sbjct: 168 ENILLDSQ--GHIVLTDFGLCK------ENIEHNSTTSTFC-GTPEYLAPEVLHKQPYDR 218

Query: 357 SGDVYSFGILLLEMFTGKGP-----TNEMF 381
           + D +  G +L EM  G  P     T EM+
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 81.8 bits (203), Expect = 3e-17
 Identities = 57/242 (23%), Positives = 104/242 (42%), Gaps = 47/242 (19%)

Query: 159 DGFSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLN----LQHRGASKSFIAECQAL 212
           + F L  ++G G +G V+  + +   +  + + A+KVL     +++   +    AE   L
Sbjct: 17  ECFELLRVLGKGGYGKVFQVRKVTGANTGK-IFAMKVLKKAMIVRNAKDTAHTKAERNIL 75

Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
             ++H  +V +I +     FQ      L+ E +  G L  ++ L R+             
Sbjct: 76  EEVKHPFIVDLIYA-----FQTGGKLYLILEYLSGGEL--FMQLERE--------GIFME 120

Query: 273 ------AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAA 324
                   +++  L +LH   +  I++ DLKP N++L+ +   HV  +DFGL K      
Sbjct: 121 DTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCK------ 169

Query: 325 NNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNE 379
            ++     +     GT+ Y APE  M S  + + D +S G L+ +M TG  P       +
Sbjct: 170 ESIHDGTVTHTFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228

Query: 380 MF 381
             
Sbjct: 229 TI 230

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 82.1 bits (203), Expect = 3e-17
 Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 37/229 (16%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS---KSFIAECQALRSIRH 217
           FS    IG GSFG+VY        +  +VA+K ++   + ++   +  I E + L+ +RH
Sbjct: 56  FSDLREIGHGSFGAVYFAR--DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            N ++         +       LV E    GS  + L +++        LQ + IA    
Sbjct: 114 PNTIQYRGC-----YLREHTAWLVMEYC-LGSASDLLEVHK------KPLQEVEIAAVTH 161

Query: 278 ST---LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
                L YLH      ++H D+K  N+LL       + DFG A  +        +  +S 
Sbjct: 162 GALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM--------APANSF 210

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSG---DVYSFGILLLEMFTGKGPTNEM 380
           V   GT  + APE  +  +        DV+S GI  +E+   K P   M
Sbjct: 211 V---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 81.0 bits (201), Expect = 3e-17
 Identities = 57/232 (24%), Positives = 104/232 (44%), Gaps = 33/232 (14%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHR--GASKSFIAECQALRS 214
             +     IG G++G+V+K      + ET  +VA+K + L     G   S + E   L+ 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAK----NRETHEIVALKRVRLDDDDEGVPSSALREICLLKE 57

Query: 215 IRHRNLVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIA 273
           ++H+N+V++       D    +    LV+E   +  L+++         +L+     S  
Sbjct: 58  LKHKNIVRLH------DVLHSDKKLTLVFEFC-DQDLKKYF---DSCNGDLDPEIVKSFL 107

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
             +   L + H      ++H DLKP N+L++      +++FGLA+         S+    
Sbjct: 108 FQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE--- 161

Query: 334 SVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
            V V  T+ Y  P+   G+++ STS D++S G +  E+     P   +F GN
Sbjct: 162 -V-V--TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 54/238 (22%), Positives = 97/238 (40%), Gaps = 46/238 (19%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL--NLQHRGASKSFIAECQALRSIRHR 218
           + +   +G G+FG V +   DH   ++ VA+K++    ++R A++    E   L+ I+ +
Sbjct: 21  YEIVGNLGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEK 76

Query: 219 ---NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
              N    +      +F G+    + +EL+   +  E+L  N   P  L  ++   +A  
Sbjct: 77  DKENKFLCVLMSDWFNFHGHMC--IAFELL-GKNTFEFLKENNFQPYPLPHVRH--MAYQ 131

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH-------------------VSDFGL 316
           +   L +LH   E  + H DLKP N+L                           V+DFG 
Sbjct: 132 LCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS 188

Query: 317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           A F  E   + ++  ++         Y  PE  +    +   DV+S G +L E + G 
Sbjct: 189 ATFDHE---HHTTIVATRH-------YRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 81.4 bits (202), Expect = 4e-17
 Identities = 68/245 (27%), Positives = 105/245 (42%), Gaps = 55/245 (22%)

Query: 159 DGFSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLNLQHRGASKSFI---------A 207
             F L  ++G GSFG V+  K I   D  + L A+KVL        K+ +          
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQ-LYAMKVL-------KKATLKVRDRVRTKM 75

Query: 208 ECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR----DAPRN 263
           E   L  + H  +VK+  +     FQ      L+ + +  G L  +  L++         
Sbjct: 76  ERDILVEVNHPFIVKLHYA-----FQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEED- 127

Query: 264 LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLP 321
                +  +A ++A  L++LH      I++ DLKP N+LLD E   H+  +DFGL+K   
Sbjct: 128 ----VKFYLA-ELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSK--- 174

Query: 322 EAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP----- 376
               ++   + +     GTV Y APE       + S D +SFG+L+ EM TG  P     
Sbjct: 175 ---ESIDHEKKAYS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230

Query: 377 TNEMF 381
             E  
Sbjct: 231 RKETM 235

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 38/215 (17%)

Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRNL 220
             +  +G GSF    K +  H       AVK+++ +    ++    E  AL+    H N+
Sbjct: 14  LKDKPLGEGSFSICRKCV--HKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNI 68

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSL----EEWLHLN-RDAPRNLNLLQRLSIAVD 275
           VK+        F       LV EL+  G L    ++  H +  +A           I   
Sbjct: 69  VKLHEV-----FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY---------IMRK 114

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           + S + ++H   +  +VH DLKP N+L    +  L   + DFG A+  P     L +   
Sbjct: 115 LVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--- 168

Query: 333 SSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILL 367
                  T+ YAAPE    +    S D++S G++L
Sbjct: 169 ----PCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 61/249 (24%), Positives = 105/249 (42%), Gaps = 61/249 (24%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN----LQHRGASKSFIA----------- 207
           L++ IG GS+G V      +++  T  A+KVL+    ++  G  +               
Sbjct: 17  LKDEIGKGSYGVVKLAY--NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 208 -----------ECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHL 256
                      E   L+ + H N+VK++   V +D    D   +V+EL+  G +      
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLV--EV-LDDPNEDHLYMVFELVNQGPV------ 125

Query: 257 NRDAPRNLNLLQRLSIAV------DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH 310
             + P      + LS         D+   +EYLH+     I+H D+KPSN+L+  +    
Sbjct: 126 -MEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIK 177

Query: 311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSG---DVYSFGILL 367
           ++DFG++    + ++ L SN        GT  + APE    +    SG   DV++ G+ L
Sbjct: 178 IADFGVSN-EFKGSDALLSNTV------GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

Query: 368 LEMFTGKGP 376
                G+ P
Sbjct: 231 YCFVFGQCP 239

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 82.2 bits (203), Expect = 4e-17
 Identities = 53/230 (23%), Positives = 95/230 (41%), Gaps = 24/230 (10%)

Query: 156 KATDGFSLENL-IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRS 214
           +  D F  E   +G G++G VYK        +   A+K +     G S S   E   LR 
Sbjct: 17  RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRE 74

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN-----LNLLQR 269
           ++H N++ +    +S     +    L+++      L   +  +R +  N     L     
Sbjct: 75  LKHPNVISLQKVFLS---HADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMV 130

Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH----VSDFGLAKFLPEAAN 325
            S+   +   + YLH      ++H DLKP+N+L+ GE        ++D G A+       
Sbjct: 131 KSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187

Query: 326 NLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGK 374
            L+      V    T  Y APE  +G+   + + D+++ G +  E+ T +
Sbjct: 188 PLADLDPVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 80.3 bits (199), Expect = 6e-17
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 27/220 (12%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIR 216
           + +     +G G++G VYK     D    +VA+K + L     G   + I E   L+ + 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAK---DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELH 77

Query: 217 HRNLVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           H N+V +I      D         LV+E M    L++ L    +    L   Q       
Sbjct: 78  HPNIVSLI------DVIHSERCLTLVFEFM-EKDLKKVL---DENKTGLQDSQIKIYLYQ 127

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           +   + + H +    I+H DLKP N+L++ +    ++DFGLA+       + +      V
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE----V 180

Query: 336 GVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGK 374
            V  T+ Y AP+  MGS+  STS D++S G +  EM TGK
Sbjct: 181 -V--TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 80.3 bits (199), Expect = 7e-17
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 26/214 (12%)

Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKI 223
           +G G++ +VYKG+    +  T   VA+K + L    G   + I E   ++ ++H N+V++
Sbjct: 13  LGNGTYATVYKGL----NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWL--HLNRDAPRNLNLLQRLSIAVDVASTLE 281
                +   +      LV+E M +  L++++      + PR L L         +   L 
Sbjct: 69  YDVIHT---ENKLT--LVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           + H      I+H DLKP N+L++      + DFGLA+      N  SS     V V  T+
Sbjct: 123 FCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE----V-V--TL 172

Query: 342 GYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGK 374
            Y AP+  MGS   STS D++S G +L EM TGK
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 80.4 bits (199), Expect = 8e-17
 Identities = 61/267 (22%), Positives = 110/267 (41%), Gaps = 45/267 (16%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHET- 187
             T    +  P ++  S    +      + D +     +G G++G VYK I    D  T 
Sbjct: 9   MGTLEAQTQGPGSMSVSAAPSA-----TSIDRYRRITKLGEGTYGEVYKAI----DTVTN 59

Query: 188 -LVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVD-FQGNDFEALVYE 243
             VA+K + L+H   G   + I E   L+ ++HRN++++            N    L++E
Sbjct: 60  ETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK------SVIHHNHRLHLIFE 113

Query: 244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL 303
                 L++++    D   ++++    S    + + + + H       +H DLKP N+LL
Sbjct: 114 YA-ENDLKKYM----DKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLL 165

Query: 304 DGELTAH-----VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STS 357
                +      + DFGLA+         +      + +  T+ Y  PE  +GS   STS
Sbjct: 166 SVSDASETPVLKIGDFGLARAFGIPIRQFTHE----I-I--TLWYRPPEILLGSRHYSTS 218

Query: 358 GDVYSFGILLLEMFTGKGPTNEMFTGN 384
            D++S   +  EM     P   +F G+
Sbjct: 219 VDIWSIACIWAEMLMKT-P---LFPGD 241

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 32/221 (14%)

Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVK 222
           IG G+FG V+K        +T   VA+K + +++   G   + + E + L+ ++H N+V 
Sbjct: 25  IGQGTFGEVFKAR----HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVN 80

Query: 223 IITSCVSVDFQGNDFEA---LVYELM---VNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           +I  C +     N  +    LV++     + G L        +      L +   +   +
Sbjct: 81  LIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-------NVLVKFTLSEIKRVMQML 133

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLD--GELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
            + L Y+H      I+H D+K +NVL+   G L   ++DFGLA+    A N+  +  ++ 
Sbjct: 134 LNGLYYIHRNK---ILHRDMKAANVLITRDGVLK--LADFGLARAFSLAKNSQPNRYTNR 188

Query: 335 VGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGK 374
           V V  T+ Y  PE  +G        D++  G ++ EM+T  
Sbjct: 189 V-V--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 56/231 (24%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLN--LQHRGASKSFIAECQALR 213
            + +++  ++G GSFG V K      D  T    AVKV+N        + + + E + L+
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCK----DRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 214 SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN-RDAPRNLNLLQ 268
            + H N++K+         + +    +V EL   G L + +      +  DA R      
Sbjct: 77  KLDHPNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------ 125

Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAAN 325
              I   V S + Y+H   +  IVH DLKP N+LL   + +    + DFGL+    +   
Sbjct: 126 ---IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--- 176

Query: 326 NLSSNQSSSVGVKGTVGYAAPE-----YGMGSEVSTSGDVYSFG----ILL 367
             ++     +   GT  Y APE     Y    +     DV+S G    ILL
Sbjct: 177 --NTKMKDRI---GTAYYIAPEVLRGTY--DEKC----DVWSAGVILYILL 216

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 45/239 (18%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQALRSI 215
           + F    L+G G+FG V   +          A+K+L    +  +      + E + L++ 
Sbjct: 5   NDFDYLKLLGKGTFGKVI--LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI--- 272
           RH  L  +  +     FQ +D    V E    G L  + HL+R+        +  +    
Sbjct: 63  RHPFLTALKYA-----FQTHDRLCFVMEYANGGEL--FFHLSRE--------RVFTEERA 107

Query: 273 ---AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNL 327
                ++ S LEYLH      +V+ D+K  N++LD +   H+  +DFGL K        +
Sbjct: 108 RFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCK------EGI 156

Query: 328 SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMF 381
           S   +      GT  Y APE    ++   + D +  G+++ EM  G+ P        +F
Sbjct: 157 SDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 56/238 (23%), Positives = 96/238 (40%), Gaps = 45/238 (18%)

Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVK-VLNLQHRGASKSFIAECQA 211
            K  D F +E + G G+FG+V  G     +  T   VA+K V+  Q        +   Q 
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGK----EKSTGMSVAIKKVI--QDPRFRNRELQIMQD 72

Query: 212 LRSIRHRNLVKIITSCVSVDFQGND--FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
           L  + H N+V++ +   ++  +     +  +V E +      + LH  R           
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLH--RCCRNYYRRQVA 125

Query: 270 LSIAV------DVASTLEYLHHYCETPIVHCDLKPSNVLLD---GELTAHVSDFGLAKFL 320
               +       +  ++  LH      + H D+KP NVL++   G L   + DFG AK L
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLK--LCDFGSAKKL 182

Query: 321 PEAANNLSSNQSSSVGVKGTVG---YAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGK 374
             +  N++            +    Y APE   G+   +T+ D++S G +  EM  G+
Sbjct: 183 SPSEPNVA-----------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 37/225 (16%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHR-GASKSFIAECQALRSI 215
           + +   + +G G++ +VYKG        T  LVA+K + L+H  GA  + I E   L+ +
Sbjct: 2   ETYIKLDKLGEGTYATVYKGK----SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL 57

Query: 216 RHRNLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           +H N+V    II +  S+         LV+E + +  L+++L    D    +N+      
Sbjct: 58  KHANIVTLHDIIHTEKSL--------TLVFEYL-DKDLKQYL---DDCGNIINMHNVKLF 105

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLD--GELTAHVSDFGLAKFLPEAANNLSSN 330
              +   L Y H      ++H DLKP N+L++  GEL   ++DFGLA+          + 
Sbjct: 106 LFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELK--LADFGLARAKSIPTKTYDNE 160

Query: 331 QSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGK 374
               V V  T+ Y  P+  +GS   ST  D++  G +  EM TG+
Sbjct: 161 ----V-V--TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 49/231 (21%), Positives = 88/231 (38%), Gaps = 38/231 (16%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVL--NLQHRGASKSFIAECQALRSIRHR----- 218
            +G G+FG V       D+ +   AVKV+    ++  ++K    E   L+ I++      
Sbjct: 42  KMGDGTFGRVLLC-QHIDNKK-YYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNN 96

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+VK         +  +    L++E +   SL E +  N     ++  ++     +++  
Sbjct: 97  NIVKYHGK---FMYYDHMC--LIFEPL-GPSLYEIITRNNYNGFHIEDIK--LYCIEILK 148

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS------ 332
            L YL    +  + H DLKP N+LLD                 +      +  +      
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 333 --SSVGVKGTVG-------YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
              +       G       Y APE  +      S D++SFG +L E++TG 
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 37/246 (15%)

Query: 151 YQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAE 208
             + F     +     IG+G+ G V     D       VA+K L+   Q++  +K    E
Sbjct: 17  GDSTFTVLKRYQNLKPIGSGAQGIVCAAY-DAILERN-VAIKKLSRPFQNQTHAKRAYRE 74

Query: 209 CQALRSIRHRNLVK---IITSCVSVDFQGNDFEA--LVYELMVNGSLEEWLHLNRDAPRN 263
              ++ + H+N++    + T   S++    +F+   +V ELM + +L + + +  D  R 
Sbjct: 75  LVLMKCVNHKNIIGLLNVFTPQKSLE----EFQDVYIVMELM-DANLCQVIQMELDHERM 129

Query: 264 LNLL-QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE 322
             LL Q L         +++LH      I+H DLKPSN+++  + T  + DFGLA+    
Sbjct: 130 SYLLYQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---- 175

Query: 323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFT 382
                 ++   +  V  T  Y APE  +G     + D++S G ++ EM  G      +F 
Sbjct: 176 ---TAGTSFMMTPYV-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFP 227

Query: 383 GNLTLH 388
           G   + 
Sbjct: 228 GTDHID 233

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 52/236 (22%)

Query: 166 LIGAGSFGSVYKGIFDHDDHETLVAVKVL--NLQHRGASKSFIAECQALRSIRHR----- 218
            +G G+FG V +   DH      VAVK++    ++  A++S   E Q L  +        
Sbjct: 21  TLGEGAFGKVVEC-IDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNST 76

Query: 219 -NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
              V+++      +  G+    +V+EL+   S  +++  N   P  L+ +++  +A  + 
Sbjct: 77  FRCVQMLEW---FEHHGHIC--IVFELL-GLSTYDFIKENGFLPFRLDHIRK--MAYQIC 128

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLL-DGELTAHVS------------------DFGLAK 318
            ++ +LH      + H DLKP N+L    + T   +                  DFG A 
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185

Query: 319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           +  E   + S+  S+         Y APE  +    S   DV+S G +L+E + G 
Sbjct: 186 YDDE---HHSTLVSTRH-------YRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 79.3 bits (196), Expect = 3e-16
 Identities = 61/227 (26%), Positives = 82/227 (36%), Gaps = 46/227 (20%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA-ECQALRSIRHRNLV 221
               IG+G+FG            + LVAVK +           +  E    RS+RH N+V
Sbjct: 24  FVKDIGSGNFGVARLMR--DKLTKELVAVKYIERGAAIDEN--VQREIINHRSLRHPNIV 79

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLNRDAPRNLNLLQRLSIAVDVA 277
           +     ++         A++ E    G L E +      + D  R     Q+L   V   
Sbjct: 80  RFKEVILT-----PTHLAIIMEYASGGELYERICNAGRFSEDEAR--FFFQQLLSGVS-- 130

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAH--VSDFGLAKFLPEAANNLSSNQSSSV 335
               Y H      I H DLK  N LLDG       + DFG +K      +       S+V
Sbjct: 131 ----YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQP----KSTV 178

Query: 336 GVKGTVGYAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              GT  Y APE      Y  G       DV+S G+ L  M  G  P
Sbjct: 179 ---GTPAYIAPEVLLRQEYD-GKIA----DVWSCGVTLYVMLVGAYP 217

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 77.9 bits (193), Expect = 3e-16
 Identities = 59/222 (26%), Positives = 102/222 (45%), Gaps = 31/222 (13%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIR 216
           + +     IG G++G VYK     +++    A+K + L+    G   + I E   L+ ++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA---QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK 58

Query: 217 HRNLVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           H N+VK+       D         LV+E + +  L++ L         L  +   S  + 
Sbjct: 59  HSNIVKLY------DVIHTKKRLVLVFEHL-DQDLKKLL---DVCEGGLESVTAKSFLLQ 108

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLD--GELTAHVSDFGLAKFLPEAANNLSSNQSS 333
           + + + Y H      ++H DLKP N+L++  GEL   ++DFGLA+         +     
Sbjct: 109 LLNGIAYCHDRR---VLHRDLKPQNLLINREGELK--IADFGLARAFGIPVRKYTHE--- 160

Query: 334 SVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGK 374
            + V  T+ Y AP+  MGS+  ST+ D++S G +  EM  G 
Sbjct: 161 -I-V--TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 57/291 (19%), Positives = 95/291 (32%), Gaps = 63/291 (21%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETL 188
           S   +    PP+           ++       + L  L+G G FG+V+ G    D  +  
Sbjct: 1   SMLTKPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQ-- 58

Query: 189 VAVKVLN---LQHRGASKSFIA---ECQALRSIR----HRNLVKIITSCVSVDFQGNDFE 238
           VA+KV+    +         +    E   L  +     H  +++++      D+      
Sbjct: 59  VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL------DWFETQEG 112

Query: 239 A-LVYELMVNGS-LEEWLHLNRDAPRNLNLLQRLS------IAVDVASTLEYLHHYCETP 290
             LV E  +    L +++               L           V + +++ H      
Sbjct: 113 FMLVLERPLPAQDLFDYITEK----------GPLGEGPSRCFFGQVVAAIQHCHSRG--- 159

Query: 291 IVHCDLKPSNVLLDGE-LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE-- 347
           +VH D+K  N+L+D     A + DFG    L +                GT  Y+ PE  
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---------GTRVYSPPEWI 210

Query: 348 ----YGMGSEVSTSGDVYSFGILLLEMFTGKGP---TNEMFTGNLTLHNFV 391
               Y           V+S GILL +M  G  P     E+    L     V
Sbjct: 211 SRHQY-HALPA----TVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV 256

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 78.2 bits (193), Expect = 4e-16
 Identities = 56/274 (20%), Positives = 92/274 (33%), Gaps = 64/274 (23%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETL 188
               R     P   L +      +        + +  L+G+G FGSVY GI   D+    
Sbjct: 13  GLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLP-- 70

Query: 189 VAVKVLN---LQHRGASKSFIA---ECQALRSIRHR--NLVKIITSCVSVDFQGNDFEAL 240
           VA+K +    +   G   +      E   L+ +      +++++       F+  D   L
Sbjct: 71  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD----W-FERPDSFVL 125

Query: 241 VYE-----------LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCET 289
           + E           +   G+L+E       A               V   + + H+    
Sbjct: 126 ILERPEPVQDLFDFITERGALQE-----ELARS---------FFWQVLEAVRHCHNCG-- 169

Query: 290 PIVHCDLKPSNVLLDGE-LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE- 347
            ++H D+K  N+L+D       + DFG    L +                GT  Y+ PE 
Sbjct: 170 -VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---------GTRVYSPPEW 219

Query: 348 -----YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                Y  G        V+S GILL +M  G  P
Sbjct: 220 IRYHRY-HGRSA----AVWSLGILLYDMVCGDIP 248

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 77.2 bits (191), Expect = 5e-16
 Identities = 69/235 (29%), Positives = 103/235 (43%), Gaps = 60/235 (25%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRHRN 219
           L + +G G+FG V  G   H      VAVK+LN   ++          E Q L+  RH +
Sbjct: 15  LGDTLGVGTFGKVKIGE--HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72

Query: 220 LVK------------IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL 267
           ++K            ++   VS    G  F+ +      +G +EE      +A R   L 
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVS---GGELFDYICK----HGRVEE-----MEARR---LF 117

Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL 327
           Q++  AVD      Y H +    +VH DLKP NVLLD  + A ++DFGL+  +      L
Sbjct: 118 QQILSAVD------YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFL 167

Query: 328 SSNQSSSVGVKGTVGYAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            ++        G+  YAAPE      Y  G EV    D++S G++L  +  G  P
Sbjct: 168 RTSC-------GSPNYAAPEVISGRLYA-GPEV----DIWSCGVILYALLCGTLP 210

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 63/250 (25%), Positives = 106/250 (42%), Gaps = 42/250 (16%)

Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALR 213
           +  +  F L++L+G G++G V          E  VA+K +        +   + E + L+
Sbjct: 7   YNISSDFQLKSLLGEGAYGVVCSAT-HKPTGEI-VAIKKIEPFDKPLFALRTLREIKILK 64

Query: 214 SIRHRNLVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL--Q 268
             +H N++    I       +F  N+   ++ ELM     +  LH          ++  Q
Sbjct: 65  HFKHENIITIFNIQRPDSFENF--NEV-YIIQELM-----QTDLH---------RVISTQ 107

Query: 269 RLS------IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE 322
            LS              ++ LH    + ++H DLKPSN+L++      V DFGLA+ + E
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164

Query: 323 AANNLSSNQSSSVGVKGTVG---YAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTN 378
           +A + S       G+   V    Y APE  + S   +   DV+S G +L E+F  + P  
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-P-- 221

Query: 379 EMFTGNLTLH 388
            +F G    H
Sbjct: 222 -IFPGRDYRH 230

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 77.2 bits (191), Expect = 6e-16
 Identities = 48/214 (22%), Positives = 89/214 (41%), Gaps = 30/214 (14%)

Query: 167 IGAGSFGSVYKGIFDHDDHET--LVAVK--VLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           IG GS+G V+K      + +T  +VA+K  + +       K  + E + L+ ++H NLV 
Sbjct: 11  IGEGSYGVVFKCR----NRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVN 66

Query: 223 IITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           ++      + F+      LV+E   + ++   L       R +      SI       + 
Sbjct: 67  LL------EVFRRKRRLHLVFEYC-DHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVN 116

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           + H +     +H D+KP N+L+       + DFG A+ L   ++      +       T 
Sbjct: 117 FCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-------TR 166

Query: 342 GYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGK 374
            Y +PE  +G        DV++ G +  E+ +G 
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 77.8 bits (192), Expect = 8e-16
 Identities = 45/225 (20%), Positives = 80/225 (35%), Gaps = 42/225 (18%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN------LQHRGASKSFIAECQA 211
            D + +   +G+G F  V K            A K +        +     +    E   
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCR--EKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN-RDAPRNLNL 266
           LR + H N++ +        ++      L+ EL+  G L ++L     L+  +A      
Sbjct: 69  LRQVLHPNIITLHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATS---- 119

Query: 267 LQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTA-HVSDFGLAKFLPE 322
                    +   + YLH      I H DLKP N++L   +  +    + DFGLA  +  
Sbjct: 120 -----FIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-- 169

Query: 323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILL 367
                  +      + GT  + APE      +    D++S G++ 
Sbjct: 170 ------EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 78.1 bits (193), Expect = 8e-16
 Identities = 62/257 (24%), Positives = 110/257 (42%), Gaps = 39/257 (15%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETL 188
           +  K  P   P+ ++  VL    +   +    ++   +IG GSFG V++     +  E  
Sbjct: 11  NGVKLNPLDDPNKVI-KVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAK-LVESDE-- 66

Query: 189 VAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA--LVYELMV 246
           VA+K +    R  ++    E Q +R ++H N+V +  +    +    D     LV E + 
Sbjct: 67  VAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLK-AFFYSNGDKKDEVFLNLVLEYV- 120

Query: 247 NGSLEEWLHLNRDAPRNLNLLQRLSIAV------DVASTLEYLHHYCETPIVHCDLKPSN 300
                E ++  R +     L Q + + +       +  +L Y+H      I H D+KP N
Sbjct: 121 ----PETVY--RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQN 171

Query: 301 VLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STS 357
           +LLD   +  +   DFG AK L     N      S +    +  Y APE   G+   +T+
Sbjct: 172 LLLDPP-SGVLKLIDFGSAKILIAGEPN-----VSYI---CSRYYRAPELIFGATNYTTN 222

Query: 358 GDVYSFGILLLEMFTGK 374
            D++S G ++ E+  G+
Sbjct: 223 IDIWSTGCVMAELMQGQ 239

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 48/227 (21%), Positives = 83/227 (36%), Gaps = 46/227 (20%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGASKSFIA------EC 209
            D + +   +G+G F  V K      +  T    A K +  +   AS+  ++      E 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCR----EKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN-RDAPRNL 264
             LR + H N++ +        ++      L+ EL+  G L ++L     L+  +A    
Sbjct: 67  SILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATS-- 119

Query: 265 NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL----DGELTAHVSDFGLAKFL 320
                      +   + YLH      I H DLKP N++L           + DFGLA  +
Sbjct: 120 -------FIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169

Query: 321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILL 367
            +                GT  + APE      +    D++S G++ 
Sbjct: 170 ED-------GVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 64/237 (27%), Positives = 103/237 (43%), Gaps = 52/237 (21%)

Query: 161 FSLENLIGAGSFGSVY--KGIFDHDDHETLVAVKVLN----LQHRGASKSFIAECQALRS 214
           F L  ++G G++G V+  + I  HD  + L A+KVL     +Q    ++    E Q L  
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGK-LYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114

Query: 215 IRHRN-LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI- 272
           IR    LV +  +     FQ      L+ + +  G L  + HL++         +R +  
Sbjct: 115 IRQSPFLVTLHYA-----FQTETKLHLILDYINGGEL--FTHLSQR--------ERFTEH 159

Query: 273 -----AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAAN 325
                  ++   LE+LH   +  I++ D+K  N+LLD     HV  +DFGL+K   E   
Sbjct: 160 EVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSK---EFVA 211

Query: 326 NLSSNQSSSVGVKGTVGYAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           + +          GT+ Y AP+       G    V    D +S G+L+ E+ TG  P
Sbjct: 212 DETERAYDFC---GTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 62/235 (26%), Positives = 96/235 (40%), Gaps = 61/235 (25%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRHRN 219
           +   +G GSFG V      H   +  VA+K ++   L+          E   L+ +RH +
Sbjct: 13  IRETLGEGSFGKVKLAT--HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 220 LVK------------IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL 267
           ++K            ++         G  F+ +V        + E      +  R     
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAG----GELFDYIVE----KKRMTE-----DEGRR---FF 114

Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL 327
           Q++  A++      Y H +    IVH DLKP N+LLD  L   ++DFGL+  +    N L
Sbjct: 115 QQIICAIE------YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFL 164

Query: 328 SSNQSSSVGVKGTVGYAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            ++        G+  YAAPE      Y  G EV    DV+S GI+L  M  G+ P
Sbjct: 165 KTSC-------GSPNYAAPEVINGKLYA-GPEV----DVWSCGIVLYVMLVGRLP 207

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 68/235 (28%), Positives = 104/235 (44%), Gaps = 60/235 (25%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSIRHRN 219
           L + +G G+FG V  G   H+     VAVK+LN   ++          E Q L+  RH +
Sbjct: 20  LGDTLGVGTFGKVKVGK--HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 220 LVK------------IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL 267
           ++K            ++   VS    G  F+ +      NG L+E     +++ R   L 
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVS---GGELFDYICK----NGRLDE-----KESRR---LF 122

Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL 327
           Q++   VD      Y H +    +VH DLKP NVLLD  + A ++DFGL+  +      L
Sbjct: 123 QQILSGVD------YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFL 172

Query: 328 SSNQSSSVGVKGTVGYAAPE------YGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            ++        G+  YAAPE      Y  G EV    D++S G++L  +  G  P
Sbjct: 173 RTSC-------GSPNYAAPEVISGRLYA-GPEV----DIWSSGVILYALLCGTLP 215

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 28/230 (12%)

Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQH-RGASKSF------ 205
             AT  +     IG G++G+VYK      D  +   VA+K + + +  G           
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKAR----DPHSGHFVALKSVRVPNGGGGGGGLPISTVR 60

Query: 206 -IAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNL 264
            +A  + L +  H N+V+++  C +          LV+E + +  L  +L          
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPA 119

Query: 265 NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAA 324
             ++   +       L++LH  C   IVH DLKP N+L+    T  ++DFGLA+      
Sbjct: 120 ETIK--DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-----I 169

Query: 325 NNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
            +     +  V V  T+ Y APE  + S  +T  D++S G +  EMF  K
Sbjct: 170 YSYQMALTPVV-V--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 54/255 (21%), Positives = 96/255 (37%), Gaps = 50/255 (19%)

Query: 150 SYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAEC 209
           S+   +   D + L   +G G +  V++ I  +  +   V VK+L    +   K    E 
Sbjct: 27  SHVVEWGNQDDYQLVRKLGRGKYSEVFEAI--NITNNEKVVVKILKPVKK---KKIKREI 81

Query: 210 QALRSIR-HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQ 268
           + L ++R   N++ +    +  D        +   +                     L Q
Sbjct: 82  KILENLRGGPNIITLA--DIVKDPVSRTPALVFEHVN-----NTDFK---------QLYQ 125

Query: 269 RLSIAVDVAS-------TLEYLHHYCETPIVHCDLKPSNVLLD---GELTAHVSDFGLAK 318
            L+   D+          L+Y H      I+H D+KP NV++D    +L   + D+GLA+
Sbjct: 126 TLTDY-DIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLR--LIDWGLAE 179

Query: 319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPT 377
           F           Q  +V V  +  +  PE  +  ++   S D++S G +L  M   K P 
Sbjct: 180 F-------YHPGQEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP- 230

Query: 378 NEMFTGNLTLHNFVK 392
              F G+      V+
Sbjct: 231 --FFHGHDNYDQLVR 243

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 75.3 bits (186), Expect = 4e-15
 Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 30/226 (13%)

Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQH--RGASKSFIAECQ 210
           F++ + +    L+G GS+G V K      + +T  +VA+K        +   K  + E +
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCR----NKDTGRIVAIKKFLESDDDKMVKKIAMREIK 76

Query: 211 ALRSIRHRNLVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
            L+ +RH NLV ++      +  +      LV+E + + ++ + L      P  L+    
Sbjct: 77  LLKQLRHENLVNLL------EVCKKKKRWYLVFEFV-DHTILDDL---ELFPNGLDYQVV 126

Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSS 329
                 + + + + H +    I+H D+KP N+L+       + DFG A+ L         
Sbjct: 127 QKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183

Query: 330 NQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGK 374
             +       T  Y APE  +G      + DV++ G L+ EMF G+
Sbjct: 184 EVA-------TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 76.3 bits (188), Expect = 4e-15
 Identities = 68/276 (24%), Positives = 108/276 (39%), Gaps = 47/276 (17%)

Query: 115 FLTGMSCLIITSWWSKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGS 174
           F      +   S +   K       S +   V              ++   +IG GSFG 
Sbjct: 10  FAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGV 69

Query: 175 VYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG 234
           VY+     D  E  VA+K +    R  ++    E Q +R + H N+V++     S   + 
Sbjct: 70  VYQAK-LCDSGEL-VAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFFYSSGEKK 123

Query: 235 ND-FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV------DVASTLEYLHHYC 287
           ++ +  LV + +      E ++  R A       Q L +         +  +L Y+H + 
Sbjct: 124 DEVYLNLVLDYV-----PETVY--RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176

Query: 288 ETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYA- 344
              I H D+KP N+LLD + TA +   DFG AK L     N              V Y  
Sbjct: 177 ---ICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQLVRGEPN--------------VSYIC 218

Query: 345 -----APEYGMGSEV-STSGDVYSFGILLLEMFTGK 374
                APE   G+   ++S DV+S G +L E+  G+
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 75.7 bits (187), Expect = 4e-15
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 37/227 (16%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHR-----GASKSFIAECQA 211
             +   + +G G F +VYK      D  T  +VA+K + L HR     G +++ + E + 
Sbjct: 10  KRYEKLDFLGEGQFATVYKAR----DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65

Query: 212 LRSIRHRNLVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
           L+ + H N++ ++      D F      +LV++ M    LE  +   +D    L      
Sbjct: 66  LQELSHPNIIGLL------DAFGHKSNISLVFDFM-ETDLEVII---KDNSLVLTPSHIK 115

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD--GELTAHVSDFGLAKFLPEAANNLS 328
           +  +     LEYLH +    I+H DLKP+N+LLD  G L   ++DFGLAK         +
Sbjct: 116 AYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLK--LADFGLAKSFGSPNRAYT 170

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGK 374
                 V V  T  Y APE   G+ +     D+++ G +L E+    
Sbjct: 171 HQ----V-V--TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 54/278 (19%), Positives = 105/278 (37%), Gaps = 33/278 (11%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETL 188
           S+ + +      +   +       + ++  D + + +LIG GS+G V +        + +
Sbjct: 23  SQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAY--DKLEKRV 80

Query: 189 VAVKVLNL--QHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMV 246
           VA+K +    +     K  + E   L  + H ++VK++   +  D +  D   +V E+  
Sbjct: 81  VAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA- 139

Query: 247 NGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE 306
               +         P  L  L   ++  ++   ++Y+H      I+H DLKP+N L++ +
Sbjct: 140 ----DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQD 192

Query: 307 LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVG--------------------YAAP 346
            +  V DFGLA+ +    N  S    S       +                     Y AP
Sbjct: 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252

Query: 347 EYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTG 383
           E  +  E  + + DV+S G +  E+             
Sbjct: 253 ELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 24/226 (10%)

Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHR--GASKSFIAECQA 211
           +A   +     IG G++G V+K     D       VA+K + +Q    G   S I E   
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKAR---DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV 64

Query: 212 LRSIR---HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQ 268
           LR +    H N+V++   C            LV+E + +  L  +L    +       ++
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK 123

Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLS 328
              +   +   L++LH +    +VH DLKP N+L+       ++DFGLA+       +  
Sbjct: 124 --DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR-----IYSFQ 173

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
              +S V V  T+ Y APE  + S  +T  D++S G +  EMF  K
Sbjct: 174 MALTSVV-V--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 44/214 (20%), Positives = 76/214 (35%), Gaps = 40/214 (18%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR-NLVKI 223
           +G G F  V + I          A K L  + RG       + E   L   +    ++ +
Sbjct: 37  LGRGKFAVVRQCI--SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 224 ITSCVSVDFQGNDFEALVYELMVNGSL------EEWLHLN-RDAPRNLNLLQRLSIAVDV 276
                   ++      L+ E    G +      E    ++  D  R         +   +
Sbjct: 95  HEV-----YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR---------LIKQI 140

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH---VSDFGLAKFLPEAANNLSSNQSS 333
              + YLH   +  IVH DLKP N+LL          + DFG+++ +             
Sbjct: 141 LEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH-------ACEL 190

Query: 334 SVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILL 367
              + GT  Y APE      ++T+ D+++ GI+ 
Sbjct: 191 REIM-GTPEYLAPEILNYDPITTATDMWNIGIIA 223

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 74.1 bits (183), Expect = 6e-15
 Identities = 52/231 (22%), Positives = 85/231 (36%), Gaps = 50/231 (21%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGASKSFIA------EC 209
            D + +   +G+G F  V K         T    A K +  +   +S+  ++      E 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCR----QKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59

Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN-RDAPRNL 264
             LR IRH N++ +        F+      L+ EL+  G L ++L     L   +A +  
Sbjct: 60  NILREIRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ-- 112

Query: 265 NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH----VSDFGLAKFL 320
                      +   + YLH      I H DLKP N++L  +   +    + DFG+A  +
Sbjct: 113 -------FLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162

Query: 321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFG----ILL 367
                             GT  + APE      +    D++S G    ILL
Sbjct: 163 EA-------GNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILL 205

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 76.2 bits (187), Expect = 7e-15
 Identities = 60/234 (25%), Positives = 96/234 (41%), Gaps = 34/234 (14%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQAL-RS 214
             F+   ++G GSFG V   + +    + L AVK+L           +  + E + L   
Sbjct: 341 TDFNFLMVLGKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 398

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
            +   L ++ +      FQ  D    V E +  G L    H+ +           +  A 
Sbjct: 399 GKPPFLTQLHSC-----FQTMDRLYFVMEYVNGGDL--MYHIQQV--GRFKEPHAVFYAA 449

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQS 332
           ++A  L +L       I++ DLK  NV+LD E   H+  +DFG+ K       N+    +
Sbjct: 450 EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK------ENIWDGVT 498

Query: 333 SSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMF 381
           +     GT  Y APE         S D ++FG+LL EM  G+ P      +E+F
Sbjct: 499 TKTFC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 74.6 bits (184), Expect = 7e-15
 Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 34/232 (14%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQAL-RSIR 216
           F L  ++G GSFG V+  + +        A+K L    +      +  + E + L  +  
Sbjct: 19  FILHKMLGKGSFGKVF--LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H  L  +  +     FQ  +    V E +  G L    H+        +L +    A ++
Sbjct: 77  HPFLTHMFCT-----FQTKENLFFVMEYLNGGDL--MYHIQSC--HKFDLSRATFYAAEI 127

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSSS 334
              L++LH      IV+ DLK  N+LLD +   H+  +DFG+ K       N+  +  ++
Sbjct: 128 ILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCK------ENMLGDAKTN 176

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMF 381
               GT  Y APE  +G + + S D +SFG+LL EM  G+ P       E+F
Sbjct: 177 TFC-GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 74.7 bits (184), Expect = 8e-15
 Identities = 47/221 (21%), Positives = 82/221 (37%), Gaps = 52/221 (23%)

Query: 164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQAL-RSIRHRNLVK 222
           + ++G G  G V +    H       A+K+L       S     E     ++    ++V 
Sbjct: 34  KQVLGLGVNGKVLECF--HRRTGQKCALKLLY-----DSPKARQEVDHHWQASGGPHIVC 86

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSL----EEWLHLN---RDAPRNLNLLQRLSIAVD 275
           I+    ++         ++ E M  G L    +E        R+A           I  D
Sbjct: 87  ILDVYENMHHGKRCL-LIIMECMEGGELFSRIQERGDQAFTEREAAE---------IMRD 136

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           + + +++LH      I H D+KP N+L    + +    ++DFG AK   +  N L +   
Sbjct: 137 IGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQT--- 188

Query: 333 SSVGVKGTVGYAAPE------YGMGSEVSTSGDVYSFGILL 367
                  T  Y APE      Y        S D++S G+++
Sbjct: 189 ----PCYTPYYVAPEVLGPEKYD------KSCDMWSLGVIM 219

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 74.2 bits (183), Expect = 9e-15
 Identities = 56/257 (21%), Positives = 98/257 (38%), Gaps = 54/257 (21%)

Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGASKSFIAECQAL 212
           F     +     +G G  G V+  +    D++    VA+K + L    + K  + E + +
Sbjct: 7   FDLGSRYMDLKPLGCGGNGLVFSAV----DNDCDKRVAIKKIVLTDPQSVKHALREIKII 62

Query: 213 RSIRHRNLVKII-------TSCVSVDFQGNDFEA--LVYELMVNGSLEEWLH-------L 256
           R + H N+VK+        +          +  +  +V E M     E  L        L
Sbjct: 63  RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPL 117

Query: 257 NRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVSDFG 315
             +  R   + Q L         L+Y+H      ++H DLKP+N+ ++ E L   + DFG
Sbjct: 118 LEEHARLF-MYQLLR-------GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFG 166

Query: 316 LAKFLPEAANNLSSNQSSSVGVKGTVG---YAAPEYGMGSEVSTSG-DVYSFGILLLEMF 371
           LA+        +  + S    +   +    Y +P   +     T   D+++ G +  EM 
Sbjct: 167 LAR-------IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219

Query: 372 TGKGPTNEMFTGNLTLH 388
           TGK     +F G   L 
Sbjct: 220 TGK----TLFAGAHELE 232

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 74.2 bits (183), Expect = 9e-15
 Identities = 47/227 (20%), Positives = 82/227 (36%), Gaps = 46/227 (20%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGASKSFIA------EC 209
            D +     +G+G F  V K      +  T    A K +  +   +S+  ++      E 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCR----EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWL----HLN-RDAPRNL 264
             L+ I+H N++ +        ++      L+ EL+  G L ++L     L   +A    
Sbjct: 66  SILKEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE-- 118

Query: 265 NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH----VSDFGLAKFL 320
                      + + + YLH      I H DLKP N++L           + DFGLA  +
Sbjct: 119 -------FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168

Query: 321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILL 367
                             GT  + APE      +    D++S G++ 
Sbjct: 169 DF-------GNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 60/251 (23%), Positives = 102/251 (40%), Gaps = 43/251 (17%)

Query: 151 YQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVK-VLNLQHRGASKSFIAEC 209
              +F     ++  + IG G++G V     D+ +    VA+K +   +H+   +  + E 
Sbjct: 19  RGQVFDVGPRYTNLSYIGEGAYGMVCSAY-DNLNKVR-VAIKKISPFEHQTYCQRTLREI 76

Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL-- 267
           + L   RH N++ I     +   +      +V +LM     E  L+          LL  
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLY---------KLLKT 122

Query: 268 QRLS------IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
           Q LS          +   L+Y+H      ++H DLKPSN+LL+      + DFGLA+   
Sbjct: 123 QHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR--- 176

Query: 322 EAANNLSSNQSSSVGVKGTVG---YAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPT 377
                   +   +  +   V    Y APE  + S+  T   D++S G +L EM + +   
Sbjct: 177 ----VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR--- 229

Query: 378 NEMFTGNLTLH 388
             +F G   L 
Sbjct: 230 -PIFPGKHYLD 239

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 58/251 (23%), Positives = 103/251 (41%), Gaps = 47/251 (18%)

Query: 151 YQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAE 208
             + F     +     IG+G+ G V          +  VA+K L+   Q++  +K    E
Sbjct: 54  GDSTFTVLKRYQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRE 111

Query: 209 CQALRSIRHRNLVKIITSCVSVDFQGNDFEA--LVYELMVNGSLEEWLH------LNRDA 260
              ++ + H+N++ ++ +  +      +F+   LV ELM     +  L       L+ + 
Sbjct: 112 LVLMKCVNHKNIISLL-NVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 165

Query: 261 PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
              L L Q L         +++LH      I+H DLKPSN+++  + T  + DFGLA+  
Sbjct: 166 MSYL-LYQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 212

Query: 321 PEAANNLSSNQSSSVGVKGTVG---YAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPT 377
                       +S  +   V    Y APE  +G     + D++S G ++ EM   K   
Sbjct: 213 ---------TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK--- 260

Query: 378 NEMFTGNLTLH 388
             +F G   + 
Sbjct: 261 -ILFPGRDYID 270

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 42/235 (17%), Positives = 87/235 (37%), Gaps = 30/235 (12%)

Query: 161 FSLENLIGAGSFGSVYKGI------FDHDDHETLVAVKV----------LNLQHRGASKS 204
           + L++     + G +Y+         D    +   ++K+           N   R A   
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 205 FIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNG-SLEEWLHLNRDAPRN 263
            + + + L S     +   +   V      + +  LV   +  G SL+  L ++      
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGV----HQDKYRFLVLPSL--GRSLQSALDVSPK--HV 155

Query: 264 LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLP 321
           L+    L +A  +   LE+LH       VH ++   N+ +D E  + V  + +G A    
Sbjct: 156 LSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212

Query: 322 EAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            +  +++  + S    +G + + + +   G   S   D+ S G  +L+   G  P
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 58/249 (23%), Positives = 101/249 (40%), Gaps = 44/249 (17%)

Query: 151 YQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAE 208
            +  ++    +     +G+G++GSV   I D    E  VA+K L+   Q    +K    E
Sbjct: 16  NKTAWELPKTYVSPTHVGSGAYGSVCSAI-DKRSGEK-VAIKKLSRPFQSEIFAKRAYRE 73

Query: 209 CQALRSIRHRNLVKIITSCVSVDFQGNDFEA--LVYELMVNGSLEEWLH------LNRDA 260
              L+ ++H N++ ++    +      +F    LV   M     +  L        + + 
Sbjct: 74  LLLLKHMQHENVIGLL-DVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEK 127

Query: 261 PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
            + L + Q L         L+Y+H      +VH DLKP N+ ++ +    + DFGLA+  
Sbjct: 128 IQYL-VYQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR-- 174

Query: 321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKGPTNE 379
                +  +  +  V    T  Y APE  +         D++S G ++ EM TGK     
Sbjct: 175 -----HADAEMTGYV---VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK----T 222

Query: 380 MFTGNLTLH 388
           +F G   L 
Sbjct: 223 LFKGKDYLD 231

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 55/253 (21%), Positives = 91/253 (35%), Gaps = 40/253 (15%)

Query: 151 YQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAE 208
              L      ++++  I +GS+G+V  G+   D     VA+K +   +            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGV---DSEGIPVAIKRVFNTVSDGRTVNILSDS 70

Query: 209 CQALRSIR---------HRNLVKIITSCVSVDFQGNDFEA--LVYELMVNGSLEEWLH-L 256
               R +R         H N++ +    + V F+        LV ELM        L  +
Sbjct: 71  FLCKRVLREIRLLNHFHHPNILGLRD--IFVHFEEPAMHKLYLVTELM-----RTDLAQV 123

Query: 257 NRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL 316
             D    ++          +   L  LH   E  +VH DL P N+LL       + DF L
Sbjct: 124 IHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNL 180

Query: 317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSG-DVYSFGILLLEMFTGKG 375
           A+          +  ++         Y APE  M  +  T   D++S G ++ EMF  K 
Sbjct: 181 AR--------EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK- 231

Query: 376 PTNEMFTGNLTLH 388
               +F G+   +
Sbjct: 232 A---LFRGSTFYN 241

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 61/236 (25%), Positives = 97/236 (41%), Gaps = 42/236 (17%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQAL-RSIR 216
           F+   ++G GSFG V   + +    + L AVK+L    +      +  + E + L    +
Sbjct: 22  FNFLMVLGKGSFGKVM--LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR----DAPRNLNLLQRLSI 272
              L ++ +      FQ  D    V E +  G L    H+ +      P           
Sbjct: 80  PPFLTQLHSC-----FQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPH-----AVFYA 127

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSN 330
           A ++A  L +L       I++ DLK  NV+LD E   H+  +DFG+ K       N+   
Sbjct: 128 A-EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCK------ENIWDG 175

Query: 331 QSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMF 381
            ++     GT  Y APE         S D ++FG+LL EM  G+ P      +E+F
Sbjct: 176 VTTKTFC-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 51/256 (19%), Positives = 92/256 (35%), Gaps = 53/256 (20%)

Query: 129 SKTKREPSTPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETL 188
                 P   P   + S L++    +    D      ++G G  G V +    +   +  
Sbjct: 34  QPPPPPPQQFPQFHVKSGLQIKKNAIID--DYKVTSQVLGLGINGKVLQIF--NKRTQEK 89

Query: 189 VAVKVLNLQHRGASKSFIAECQAL-RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVN 247
            A+K+L             E +   R+ +  ++V+I+    +  + G     +V E +  
Sbjct: 90  FALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYEN-LYAGRKCLLIVMECLDG 143

Query: 248 GSL----EEWLHLN---RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSN 300
           G L    ++        R+A           I   +   ++YLH      I H D+KP N
Sbjct: 144 GELFSRIQDRGDQAFTEREASE---------IMKSIGEAIQYLH---SINIAHRDVKPEN 191

Query: 301 VLL---DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPE------YGMG 351
           +L           ++DFG AK    + N+L++          T  Y APE      Y   
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKET-TSHNSLTT-------PCYTPYYVAPEVLGPEKYD-- 241

Query: 352 SEVSTSGDVYSFGILL 367
                S D++S G+++
Sbjct: 242 ----KSCDMWSLGVIM 253

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 71.7 bits (176), Expect = 6e-14
 Identities = 50/231 (21%), Positives = 89/231 (38%), Gaps = 25/231 (10%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKV-----------LNLQHRGASKSFIAE 208
           + L   IG+G FG +Y     +  + +    VKV           L    R A K  I +
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 209 CQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNG-SLEEWLHLNRDAPRNLNLL 267
               + + +  +          +F+G  +  +V E +  G  L++    N          
Sbjct: 99  WIERKQLDYLGIPLFY-GSGLTEFKGRSYRFMVMERL--GIDLQKISGQN----GTFKKS 151

Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD--GELTAHVSDFGLAKFLPEAAN 325
             L + + +   LEY+H       VH D+K +N+LL        +++D+GL+       N
Sbjct: 152 TVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208

Query: 326 NLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           +    ++   G  GT+ + + +   G  +S   DV   G  +L    GK P
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 72.1 bits (177), Expect = 7e-14
 Identities = 46/233 (19%), Positives = 88/233 (37%), Gaps = 26/233 (11%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDH---ETLVAVKVLNLQH-----------RGASKSFI 206
           + +   IG G FG +Y    +  +    +    VKV    +           R A    I
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96

Query: 207 AECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNG-SLEEWLHLNRDAPRNLN 265
            +    R +++  + K        D  G  +  ++ +    G  L++    N    +  +
Sbjct: 97  QKWIRTRKLKYLGVPKYW-GSGLHDKNGKSYRFMIMDRF--GSDLQKIYEAN---AKRFS 150

Query: 266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD--GELTAHVSDFGLAKFLPEA 323
               L +++ +   LEY+H +     VH D+K SN+LL+       ++ D+GLA      
Sbjct: 151 RKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE 207

Query: 324 ANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             + +          GT+ + + +   G   S  GD+   G  +++  TG  P
Sbjct: 208 GVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 38/236 (16%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH- 217
           D F    ++G GSFG V   +    +   L AVKVL        K  I +   +      
Sbjct: 23  DNFEFIRVLGKGSFGKVM--LARVKETGDLYAVKVL-------KKDVILQDDDVECTMTE 73

Query: 218 RNLVKIITSC---VSVD--FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           + ++ +  +      +   FQ  D    V E +  G L    H+ +   R  +  +    
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKS--RRFDEARARFY 129

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSN 330
           A ++ S L +LH   +  I++ DLK  NVLLD E   H   +DFG+ K        + + 
Sbjct: 130 AAEIISALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCK------EGICNG 178

Query: 331 QSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMF 381
            +++    GT  Y APE         + D ++ G+LL EM  G  P      +++F
Sbjct: 179 VTTATFC-GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 54/259 (20%), Positives = 95/259 (36%), Gaps = 44/259 (16%)

Query: 151 YQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAE 208
                   D + +++LIG GS+G VY       + E  VA+K +N   +     K  + E
Sbjct: 18  GIKNVHVPDNYIIKHLIGRGSYGYVYLAY--DKNTEKNVAIKKVNRMFEDLIDCKRILRE 75

Query: 209 CQALRSIRHRNLVKIITSCVSVDFQGNDFEA--LVYELMVNGSLEEWLHLNRDAPRNLNL 266
              L  ++   ++++    +  D     F+   +V E+      +  L       +    
Sbjct: 76  ITILNRLKSDYIIRLYDLIIPDDL--LKFDELYIVLEIA-----DSDLK------KLFKT 122

Query: 267 LQRLS------IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
              L+      I  ++     ++H   E+ I+H DLKP+N LL+ + +  V DFGLA+ +
Sbjct: 123 PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179

Query: 321 PEAANNLSSNQSSSVGVKGTVG---------------YAAPEYGMGSEVSTSG-DVYSFG 364
               +    N        G                  Y APE  +  E  T   D++S G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239

Query: 365 ILLLEMFTGKGPTNEMFTG 383
            +  E+           T 
Sbjct: 240 CIFAELLNMLQSHINDPTN 258

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 63/266 (23%), Positives = 107/266 (40%), Gaps = 47/266 (17%)

Query: 136 STPPSALLASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN 195
           S+PP A      +   +  ++    +     +G+G++G+V   + D       VA+K L 
Sbjct: 2   SSPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAV-DGRTGAK-VAIKKLY 59

Query: 196 --LQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA--LVYELMVNGSLE 251
              Q    +K    E + L+ +RH N++ ++    + D   +DF    LV   M      
Sbjct: 60  RPFQSELFAKRAYRELRLLKHMRHENVIGLL-DVFTPDETLDDFTDFYLVMPFM-----G 113

Query: 252 EWLHLNRDAPRNLNLL--QRLS------IAVDVASTLEYLHHYCETPIVHCDLKPSNVLL 303
             L           L+  ++L       +   +   L Y+H      I+H DLKP N+ +
Sbjct: 114 TDLG---------KLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAV 161

Query: 304 DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSG-DVYS 362
           + +    + DFGLA+          S  +  V    T  Y APE  +     T   D++S
Sbjct: 162 NEDCELKILDFGLAR-------QADSEMTGYV---VTRWYRAPEVILNWMRYTQTVDIWS 211

Query: 363 FGILLLEMFTGKGPTNEMFTGNLTLH 388
            G ++ EM TGK     +F G+  L 
Sbjct: 212 VGCIMAEMITGK----TLFKGSDHLD 233

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 69.7 bits (171), Expect = 4e-13
 Identities = 57/252 (22%), Positives = 109/252 (43%), Gaps = 49/252 (19%)

Query: 151 YQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNL--QHRGASKSFIAE 208
            + +++  + +   + +G+G++GSV             VAVK L+   Q    +K    E
Sbjct: 21  NKTIWEVPERYQNLSPVGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRE 78

Query: 209 CQALRSIRHRNLVK---IITSCVSVDFQGNDFEA--LVYELMVNGSLEEWLHLNRDAPRN 263
            + L+ ++H N++    + T   S++    +F    LV  LM        L+       N
Sbjct: 79  LRLLKHMKHENVIGLLDVFTPARSLE----EFNDVYLVTHLM-----GADLN-------N 122

Query: 264 LNLLQRLS------IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA 317
           +   Q+L+      +   +   L+Y+H      I+H DLKPSN+ ++ +    + DFGLA
Sbjct: 123 IVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA 179

Query: 318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGP 376
           +       + +   +  V    T  Y APE  +     + + D++S G ++ E+ TG+  
Sbjct: 180 R-------HTADEMTGYV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-- 227

Query: 377 TNEMFTGNLTLH 388
              +F G   + 
Sbjct: 228 --TLFPGTDHID 237

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 45/232 (19%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH- 217
             F L  +IG GS+  V   +      + + A+KV+        K  + + + +  ++  
Sbjct: 9   QDFDLLRVIGRGSYAKVL--LVRLKKTDRIYAMKVV-------KKELVNDDEDIDWVQTE 59

Query: 218 RNLVKIITSC---VSVD--FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           +++ +  ++    V +   FQ       V E +  G L    H+ R         ++L  
Sbjct: 60  KHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQ--------RKLPE 109

Query: 273 ------AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAA 324
                 + +++  L YLH   E  I++ DLK  NVLLD E   H+  +D+G+ K      
Sbjct: 110 EHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK------ 158

Query: 325 NNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             L    ++S    GT  Y APE   G +   S D ++ G+L+ EM  G+ P
Sbjct: 159 EGLRPGDTTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 69.3 bits (170), Expect = 6e-13
 Identities = 61/225 (27%), Positives = 93/225 (41%), Gaps = 31/225 (13%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL---NLQHRGASKSFIAECQAL-RS 214
             F L  +IG GS+  V   +      + + A++V+    +           E     ++
Sbjct: 52  QDFDLLRVIGRGSYAKVL--LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA 109

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQ-RLSIA 273
             H  LV + +      FQ       V E +  G L    H+ R   R L     R   A
Sbjct: 110 SNHPFLVGLHSC-----FQTESRLFFVIEYVNGGDL--MFHMQRQ--RKLPEEHARFYSA 160

Query: 274 VDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQ 331
            +++  L YLH   E  I++ DLK  NVLLD E   H+  +D+G+ K        L    
Sbjct: 161 -EISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCK------EGLRPGD 208

Query: 332 SSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           ++S    GT  Y APE   G +   S D ++ G+L+ EM  G+ P
Sbjct: 209 TTST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 69.6 bits (170), Expect = 6e-13
 Identities = 51/285 (17%), Positives = 102/285 (35%), Gaps = 63/285 (22%)

Query: 167 IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-----HRNLV 221
           +G G F +V+   +D    +  VA+KV+         +   E + L+S+R       N  
Sbjct: 45  LGWGHFSTVWLS-WDIQGKK-FVAMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPNRE 101

Query: 222 KIITSCVSVDFQGND--FEALVYELMVNG-SLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            ++         G +     +V+E++  G  L +W+  +      L  ++++   V    
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG- 158

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
            L+YLH  C   I+H D+KP N+LL   +  +    ++    +       + S+  ++  
Sbjct: 159 -LDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 336 GVKG------------------------------------TVGYAAPEYGMGSEVSTSGD 359
                                                   T  Y + E  +GS  +T  D
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPAD 275

Query: 360 VYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVD 404
           ++S   +  E+ TG      +F  +        E   + +A I++
Sbjct: 276 IWSTACMAFELATGD----YLFEPHSGEEYTRDE---DHIALIIE 313

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 24/223 (10%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH-RN 219
           F +   IG G+FG +  G  +   +E  VA+K+  ++ R        E +  + +     
Sbjct: 11  FRVGKKIGCGNFGELRLGK-NLYTNEY-VAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNG-SLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           + ++             + A+V EL+  G SLE    L     R  +L   L IA+ + S
Sbjct: 67  IPQVYYFG-----PCGKYNAMVLELL--GPSLE---DLFDLCDRTFSLKTVLMIAIQLIS 116

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLL-----DGELTAHVSDFGLAKFLPEAANNLSSNQSS 333
            +EY+H      +++ D+KP N L+       +   H+ DF LAK   +           
Sbjct: 117 RMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173

Query: 334 SVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              + GT  Y +    +G E S   D+ + G + +    G  P
Sbjct: 174 HKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 68.8 bits (168), Expect = 7e-13
 Identities = 34/140 (24%), Positives = 58/140 (41%), Gaps = 10/140 (7%)

Query: 255 HLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF 314
                    L L   +  +  VA  +E+L        +H DL   N+LL  +    + DF
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 237

Query: 315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-G 373
           GLA+ + +  + +     + + +K      APE       +   DV+SFG+LL E+F+ G
Sbjct: 238 GLARDIYKDPDYVRK-GDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLG 292

Query: 374 KGPTNEMFTGNLTLHNFVKE 393
             P   +   +      +KE
Sbjct: 293 ASPYPGV-KIDEEFCRRLKE 311

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 35/170 (20%), Positives = 61/170 (35%), Gaps = 26/170 (15%)

Query: 159 DGFSLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHRGAS----KSFIAECQA 211
           D   L   +G G+FG V +      D       VAVK+L     GA+    ++ ++E + 
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 78

Query: 212 LRSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
           L  I  H N+V ++ +C     +      ++ E    G+L  +L   R+           
Sbjct: 79  LIHIGHHLNVVNLLGAC----TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTK--- 131

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
                     +Y+        +  DLK     +    ++  S F   K L
Sbjct: 132 --GARFRQGKDYVG------AIPVDLKRRLDSITSSQSSASSGFVEEKSL 173

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 68.6 bits (168), Expect = 9e-13
 Identities = 66/268 (24%), Positives = 107/268 (39%), Gaps = 68/268 (25%)

Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRGASKSFIAECQAL 212
                 + L   +G G++G V+K I    D  T  +VAVK +         +F     A 
Sbjct: 5   RHVLRKYELVKKLGKGAYGIVWKSI----DRRTGEVVAVKKI-------FDAFQNSTDAQ 53

Query: 213 RSIR----------HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLH------- 255
           R+ R          H N+V ++    + +    D   LV++ M     E  LH       
Sbjct: 54  RTFREIMILTELSGHENIVNLLNVLRADND--RDV-YLVFDYM-----ETDLHAVIRANI 105

Query: 256 LNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG 315
           L     + + + Q +         ++YLH      ++H D+KPSN+LL+ E    V+DFG
Sbjct: 106 LEPVHKQYV-VYQLIK-------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFG 154

Query: 316 LAKFLPEAANNLSSNQSSSVGVKGTVG--------------YAAPEYGMGSEVSTSG-DV 360
           L++         ++   S                       Y APE  +GS   T G D+
Sbjct: 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDM 214

Query: 361 YSFGILLLEMFTGKGPTNEMFTGNLTLH 388
           +S G +L E+  GK P   +F G+ T++
Sbjct: 215 WSLGCILGEILCGK-P---IFPGSSTMN 238

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 22/221 (9%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH-RN 219
           + L   IG+GSFG +Y G       E  VA+K+  ++ +        E +  + ++    
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEE--VAIKLECVKTK--HPQLHIESKIYKMMQGGVG 66

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNG-SLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           +  I            D+  +V EL+  G SLE    L     R  +L   L +A  + S
Sbjct: 67  IPTIRWCG-----AEGDYNVMVMELL--GPSLE---DLFNFCSRKFSLKTVLLLADQMIS 116

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAH---VSDFGLAKFLPEAANNLSSNQSSSV 335
            +EY+H       +H D+KP N L+      +   + DFGLAK   +A  +       + 
Sbjct: 117 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 173

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  YA+    +G E S   D+ S G +L+    G  P
Sbjct: 174 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 51/268 (19%), Positives = 100/268 (37%), Gaps = 59/268 (22%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVK-VLNLQHRGASKSFIAECQALRSIRHRN 219
           +SL   +G GSFG V +      +     A+K VL             E   ++ + H N
Sbjct: 9   YSLGKTLGTGSFGIVCEVF--DIESGKRFALKKVLQDPRYK-----NRELDIMKVLDHVN 61

Query: 220 LVK---IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN----LNL------ 266
           ++K      +    + +         +L    +     H +     +    LN+      
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 267 --LQRLSIAVDVAS-TLEYLHH------------YCETP-IVHCDLKPSNVLLDGELTAH 310
             L ++  +   +  ++                 +  +  I H D+KP N+L++ +    
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK-DNT 180

Query: 311 V--SDFGLAKFLPEAANNLSSNQSSSVGVKGTVG---YAAPEYGMGS-EVSTSGDVYSFG 364
           +   DFG AK L  +  +++            +    Y APE  +G+ E + S D++S G
Sbjct: 181 LKLCDFGSAKKLIPSEPSVA-----------YICSRFYRAPELMLGATEYTPSIDLWSIG 229

Query: 365 ILLLEMFTGKGPTNEMFTGNLTLHNFVK 392
            +  E+  GK P   +F+G  ++   V+
Sbjct: 230 CVFGELILGK-P---LFSGETSIDQLVR 253

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 65.8 bits (161), Expect = 4e-12
 Identities = 45/223 (20%), Positives = 86/223 (38%), Gaps = 24/223 (10%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH-RN 219
           + +   IG GSFG +++G  +  +++  VA+K    +    +     E +  + +     
Sbjct: 12  YKVGRRIGEGSFGVIFEGT-NLLNNQQ-VAIKFEPRRSD--APQLRDEYRTYKLLAGCTG 67

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNG-SLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           +  +         Q      LV +L+  G SLE    L     R  ++      A  + +
Sbjct: 68  IPNVYYFG-----QEGLHNVLVIDLL--GPSLE---DLLDLCGRKFSVKTVAMAAKQMLA 117

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTA-----HVSDFGLAKFLPEAANNLSSNQSS 333
            ++ +H      +V+ D+KP N L+    +      +V DFG+ KF  +           
Sbjct: 118 RVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174

Query: 334 SVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              + GT  Y +    +G E S   D+ + G + +    G  P
Sbjct: 175 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.5 bits (156), Expect = 2e-11
 Identities = 37/206 (17%), Positives = 60/206 (29%), Gaps = 53/206 (25%)

Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVL--------NLQHRGASKSFI 206
              T+       IG G FG V++ I DH    T VA+K++        N  H+   +  +
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIADH----TPVAIKIIAIEGPDLVNGSHQKTFEEIL 71

Query: 207 AECQALRSI---------RHRNLVKIITSCV-------------------------SVDF 232
            E    + +         R    + + +                              DF
Sbjct: 72  PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131

Query: 233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIV 292
             +D   +V E    G       L +   +  +L    SI   + ++L            
Sbjct: 132 FKDDQLFIVLEFEFGGID-----LEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FE 184

Query: 293 HCDLKPSNVLLDGELTAHVSDFGLAK 318
           H DL   NVLL       +      K
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGK 210

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 59/221 (26%), Positives = 99/221 (44%), Gaps = 22/221 (9%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           F L   IG+GSFG +Y G  +   +E  VA+K+ N++ +      + E +  R ++    
Sbjct: 9   FRLGRKIGSGSFGEIYLGT-NIQTNEE-VAIKLENVKTK--HPQLLYESKIYRILQGGTG 64

Query: 221 V-KIITSCVSVDFQGNDFEALVYELMVNG-SLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           +  +            D+  LV +L+  G SLE    L     R L+L   L +A  + +
Sbjct: 65  IPNVRWFG-----VEGDYNVLVMDLL--GPSLE---DLFNFCSRKLSLKTVLMLADQMIN 114

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAH---VSDFGLAKFLPEAANNLSSNQSSSV 335
            +E++H       +H D+KP N L+     A+   + DFGLAK   + + +       + 
Sbjct: 115 RVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT  YA+    +G E S   D+ S G +L+    G  P
Sbjct: 172 NLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 16/77 (20%), Positives = 34/77 (44%), Gaps = 2/77 (2%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP- 59
           ++    +   P++ +SL  ++ L++S NN         +    LQ L+ S NH       
Sbjct: 477 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQ 536

Query: 60  -IKGVFSNSSAISLDGN 75
            ++   S+ + ++L  N
Sbjct: 537 ELQHFPSSLAFLNLTQN 553

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 4/78 (5%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           + GN  Q     + S L  ++ L   + NL+      + +   L+ LN++ N  +    +
Sbjct: 83  LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS-FKL 141

Query: 61  KGVFSNSSA---ISLDGN 75
              FSN +    + L  N
Sbjct: 142 PEYFSNLTNLEHLDLSSN 159

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 13/79 (16%), Positives = 25/79 (31%), Gaps = 5/79 (6%)

Query: 1   MNGNFFQGNIPSS-LSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP 59
              +  +     S   SLR +  LD+S  +              L+ L ++ N F+    
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

Query: 60  IKGVFSNSSA---ISLDGN 75
              +F+       + L   
Sbjct: 463 -PDIFTELRNLTFLDLSQC 480

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 17/62 (27%), Positives = 27/62 (43%), Gaps = 1/62 (1%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFP-FLQNLNLSFNHFEGEVP 59
           M+ N F          L  ++ LD S N++     + L++FP  L  LNL+ N F     
Sbjct: 501 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560

Query: 60  IK 61
            +
Sbjct: 561 HQ 562

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 15/78 (19%), Positives = 28/78 (35%), Gaps = 5/78 (6%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           ++ N  +     S  S   ++ LDLS+  +        ++   L  L L+ N  +     
Sbjct: 35  LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL--A 92

Query: 61  KGVFSNSSA---ISLDGN 75
            G FS  S+   +     
Sbjct: 93  LGAFSGLSSLQKLVAVET 110

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 12/79 (15%), Positives = 27/79 (34%), Gaps = 6/79 (7%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKY-LENFPFLQNLNLSFNHFEGEVP 59
           ++    +       + L  +E L ++ N+               L  L+LS    E    
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL-- 485

Query: 60  IKGVFSNSSA---ISLDGN 75
               F++ S+   +++  N
Sbjct: 486 SPTAFNSLSSLQVLNMSHN 504

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 9/59 (15%), Positives = 16/59 (27%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP 59
           ++    Q     +  SL  +  L L+ N +             LQ L     +      
Sbjct: 59  LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 14/67 (20%), Positives = 26/67 (38%), Gaps = 2/67 (2%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK 61
           NG  F+G    S      ++ LDLS N +   +         L++L+   ++ +      
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF- 414

Query: 62  GVFSNSS 68
            VF +  
Sbjct: 415 SVFLSLR 421

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 25/78 (32%), Positives = 35/78 (44%), Gaps = 9/78 (11%)

Query: 1  MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
          M  NF++  IP +L      +NLDLS N L         +FP LQ L+LS    +     
Sbjct: 15 MELNFYK--IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED- 69

Query: 61 KGVFSNSSA---ISLDGN 75
           G + + S    + L GN
Sbjct: 70 -GAYQSLSHLSTLILTGN 86

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 18/74 (24%), Positives = 25/74 (33%), Gaps = 6/74 (8%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQN----LNLSFNHFEGEVP 59
                 +P   S+L  +E+LDLS N +       L     +      L+LS N      P
Sbjct: 135 LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP 194

Query: 60  IKGVFSNSSAISLD 73
             G F       L 
Sbjct: 195 --GAFKEIRLHKLT 206

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 43.9 bits (104), Expect = 9e-05
 Identities = 18/57 (31%), Positives = 24/57 (42%), Gaps = 2/57 (3%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLS--GRIPKYLENFPFLQNLNLSFNHFEG 56
                +G    S   L  +E LDLS+N LS  G   +       L+ L+LSFN    
Sbjct: 331 TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 16/76 (21%), Positives = 26/76 (34%), Gaps = 6/76 (7%)

Query: 1   MNGNFFQGNIPSSLSSLRGIEN----LDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEG 56
           ++ N  Q    + L  L  +      LDLS N ++   P   +    L  L L  N    
Sbjct: 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSL 214

Query: 57  EVPIKGVFSNSSAISL 72
            V  K      + + +
Sbjct: 215 NVM-KTCIQGLAGLEV 229

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 37/187 (19%), Positives = 69/187 (36%), Gaps = 33/187 (17%)

Query: 143 LASVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS 202
           + S L++    +    D      ++G G  G V +    +   +   A+K+L        
Sbjct: 4   VKSGLQIKKNAIID--DYKVTSQVLGLGINGKVLQIF--NKRTQEKFALKMLQ-----DC 54

Query: 203 KSFIAECQAL-RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSL----EEWLHLN 257
                E +   R+ +  ++V+I+    +  + G     +V E +  G L    ++     
Sbjct: 55  PKARREVELHWRASQCPHIVRIVDVYEN-LYAGRKCLLIVMECLDGGELFSRIQDRGDQA 113

Query: 258 ---RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHV 311
              R+A           I   +   ++YLH      I H D+KP N+L           +
Sbjct: 114 FTEREASE---------IMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKL 161

Query: 312 SDFGLAK 318
           +DFG AK
Sbjct: 162 TDFGFAK 168

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 17/77 (22%), Positives = 27/77 (35%), Gaps = 2/77 (2%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP- 59
           +  N F          L  ++ +DL  NNL+        N   L++LNL  N        
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK 602

Query: 60  -IKGVFSNSSAISLDGN 75
                F N + + +  N
Sbjct: 603 VFGPAFRNLTELDMRFN 619

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.4 bits (134), Expect = 3e-08
 Identities = 14/79 (17%), Positives = 19/79 (24%), Gaps = 4/79 (5%)

Query: 1   MNGNFFQGNIP-SSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP 59
           +  N     +       L  I  + LS N             P LQ L L     +    
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471

Query: 60  IKGVFSNSSA---ISLDGN 75
               F        + L  N
Sbjct: 472 SPSPFQPLRNLTILDLSNN 490

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 12/71 (16%), Positives = 25/71 (35%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK 61
           +          S   L+ +E+L++  N++ G           L+ L+LS +         
Sbjct: 313 SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTN 372

Query: 62  GVFSNSSAISL 72
             F + +   L
Sbjct: 373 ETFVSLAHSPL 383

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 15/78 (19%), Positives = 30/78 (38%), Gaps = 5/78 (6%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           +  N  +    ++ +    + +LD+  N +S   P+  +  P L+ LNL  N        
Sbjct: 32  LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ--LS 89

Query: 61  KGVFSNSSA---ISLDGN 75
              F+  +    + L  N
Sbjct: 90  DKTFAFCTNLTELHLMSN 107

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 13/81 (16%), Positives = 28/81 (34%), Gaps = 5/81 (6%)

Query: 1   MNGNFFQGNIPSSLSSLRG--IENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEV 58
           ++ +       ++   L+   +  LDLS NNL+          P L+   L +N+ +   
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288

Query: 59  PIKGVFSNSSAIS-LDGNVNL 78
                      +  L+   + 
Sbjct: 289 S--HSLHGLFNVRYLNLKRSF 307

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 12/78 (15%), Positives = 20/78 (25%), Gaps = 5/78 (6%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           +  N        + +    +  L L  N++             L  L+LS N        
Sbjct: 80  LQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS--TK 137

Query: 61  KGVFSNSSA---ISLDGN 75
            G          + L  N
Sbjct: 138 LGTQVQLENLQELLLSNN 155

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.9 bits (125), Expect = 3e-07
 Identities = 17/72 (23%), Positives = 23/72 (31%), Gaps = 2/72 (2%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           +  N  Q    +     + +  LDLS N LS            LQ L LS N  +     
Sbjct: 104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA--LK 161

Query: 61  KGVFSNSSAISL 72
                  +  SL
Sbjct: 162 SEELDIFANSSL 173

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.5 bits (124), Expect = 5e-07
 Identities = 16/57 (28%), Positives = 25/57 (43%), Gaps = 2/57 (3%)

Query: 1   MNGNFFQG--NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFE 55
           +     +   + PS    LR +  LDLS NN++      LE    L+ L+L  N+  
Sbjct: 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA 517

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 16/78 (20%), Positives = 23/78 (29%), Gaps = 5/78 (6%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           +  N      P     L  ++ L+L  N LS    K       L  L+L  N  +     
Sbjct: 56  VGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK--IK 113

Query: 61  KGVFSNSSA---ISLDGN 75
              F        + L  N
Sbjct: 114 NNPFVKQKNLITLDLSHN 131

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 23/86 (26%), Positives = 31/86 (36%), Gaps = 13/86 (15%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLS--------GRIPKYLENFPFLQNLNLSFN 52
           ++ N         L  L  +E LDL  NNL+        G    +L+    L  LNL  N
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESN 546

Query: 53  HFEGEVPIKGVFSNSSA---ISLDGN 75
            F+       VF +      I L  N
Sbjct: 547 GFDEI--PVEVFKDLFELKIIDLGLN 570

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 16/80 (20%), Positives = 28/80 (35%), Gaps = 7/80 (8%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENF--PFLQNLNLSFNHFEGEV 58
           ++ N        +   L  ++ L LS N +     + L+ F    L+ L LS N  +   
Sbjct: 128 LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE-- 185

Query: 59  PIKGVFSNSSA---ISLDGN 75
              G F        + L+  
Sbjct: 186 FSPGCFHAIGRLFGLFLNNV 205

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 12/74 (16%), Positives = 25/74 (33%), Gaps = 5/74 (6%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPF---LQNLNLSFNHFEGEV 58
           + N  +   P    ++  +  L L+   L   + + L        ++NL+LS +      
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST-- 236

Query: 59  PIKGVFSNSSAISL 72
                F      +L
Sbjct: 237 TSNTTFLGLKWTNL 250

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 47.7 bits (114), Expect = 7e-06
 Identities = 14/74 (18%), Positives = 29/74 (39%), Gaps = 3/74 (4%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           +  +   G     L  L  +  L+L  N       +  ++   L+ ++L  N+       
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL--P 576

Query: 61  KGVFSNSSAI-SLD 73
             VF+N  ++ SL+
Sbjct: 577 ASVFNNQVSLKSLN 590

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 47.3 bits (113), Expect = 9e-06
 Identities = 11/54 (20%), Positives = 18/54 (33%)

Query: 3   GNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEG 56
            N        S + L  +E   L  NN+       L     ++ LNL  +  + 
Sbjct: 257 YNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 13/82 (15%), Positives = 29/82 (35%), Gaps = 8/82 (9%)

Query: 1   MNGNFFQGNIPSSLS----SLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEG 56
           ++ +F      ++ +    +   +  L+L++N +S            L+ L+L  N    
Sbjct: 360 LSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQ 419

Query: 57  EVPIKGVFSNSSA---ISLDGN 75
           E+     +        I L  N
Sbjct: 420 ELT-GQEWRGLENIFEIYLSYN 440

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 12/57 (21%), Positives = 20/57 (35%), Gaps = 4/57 (7%)

Query: 10 IPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSN 66
          +P  L     I  L+L+ N L          +  L +L++ FN      P   +   
Sbjct: 19 VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP--ELCQK 71

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 12/72 (16%), Positives = 22/72 (30%), Gaps = 3/72 (4%)

Query: 3   GNFFQGNIPSSLSSL--RGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
            N  Q      L       ++ L+LS N +    P        L  L L+       +  
Sbjct: 154 NNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLT- 212

Query: 61  KGVFSNSSAISL 72
           + +    +  S+
Sbjct: 213 EKLCLELANTSI 224

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 16/95 (16%), Positives = 32/95 (33%), Gaps = 14/95 (14%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQN---------NLSGRIPKYLENFPFLQNLNLSF 51
           +  N  Q     SL  L  +  L+L ++         +L        +    L++LN+  
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338

Query: 52  NHFEGEVPIKGVFSNSSA---ISLDGNVNLCGGIS 83
           N   G      +F+       +SL  +      ++
Sbjct: 339 NDIPGIKS--NMFTGLINLKYLSLSNSFTSLRTLT 371

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 57.2 bits (138), Expect = 8e-09
 Identities = 14/65 (21%), Positives = 31/65 (47%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK 61
           +      N   S S+L+ + +++L       ++P +L + P LQ+LN++ N       +K
Sbjct: 475 DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLK 534

Query: 62  GVFSN 66
             ++ 
Sbjct: 535 ADWTR 539

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 12/73 (16%), Positives = 25/73 (34%), Gaps = 10/73 (13%)

Query: 3   GNFFQGNIPSSLSSLRGIENLDLSQNNLSG---------RIPKYLENFPFLQNLNLSFNH 53
                  +P  L  L  +++L+++ N             R+    +  P +Q   + +N+
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559

Query: 54  FEGEVPIKGVFSN 66
            E E P       
Sbjct: 560 LE-EFPASASLQK 571

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 47.6 bits (113), Expect = 8e-06
 Identities = 11/84 (13%), Positives = 28/84 (33%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
           + +       L +   +  L L+     GR+P  +     L+ L+   +       + G 
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368

Query: 64  FSNSSAISLDGNVNLCGGISELHL 87
              +  +S +    +     ++ L
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFL 392

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 13/91 (14%), Positives = 32/91 (35%), Gaps = 9/91 (9%)

Query: 1   MNGNFFQGNIPSSLSSLRGIE------NLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHF 54
           ++ N F    P+   +   ++        D   N +  + P  +   P L  L +  N  
Sbjct: 760 VSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI 818

Query: 55  EGEVPIKGVFSNSSAISLDGNVNLCGGISEL 85
             +V  + +      + +  N N+   ++ +
Sbjct: 819 R-KVD-EKLTPQLYILDIADNPNISIDVTSV 847

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 11/63 (17%), Positives = 21/63 (33%), Gaps = 7/63 (11%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLS-------GRIPKYLENFPFLQNLNLSFNH 53
           ++ N  Q       ++   I  + LS N ++              +N   L  ++L FN 
Sbjct: 680 LSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNK 739

Query: 54  FEG 56
              
Sbjct: 740 LTS 742

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 12/60 (20%), Positives = 20/60 (33%), Gaps = 5/60 (8%)

Query: 1   MNGNFFQG---NIPSSLSSLRGI--ENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFE 55
            + N       NI  S+   +GI    + LS N +     +       +  + LS N   
Sbjct: 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 42.6 bits (100), Expect = 3e-04
 Identities = 7/83 (8%), Positives = 23/83 (27%)

Query: 3   GNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKG 62
           G   +G +P ++  L  ++ L    ++ +     + +            +          
Sbjct: 332 GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMF 391

Query: 63  VFSNSSAISLDGNVNLCGGISEL 85
           +  +      D   +      E+
Sbjct: 392 LDYDQRLNLSDLLQDAINRNPEM 414

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 41.8 bits (98), Expect = 5e-04
 Identities = 10/51 (19%), Positives = 21/51 (41%), Gaps = 3/51 (5%)

Query: 8   GNIPSSLSSLRGIENLDLSQNNLSGRIPK--YLENFPFLQNLNLSFNHFEG 56
                +  +   +  +DL  N L+  +         P+L N+++S+N F  
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS 767

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 56.6 bits (137), Expect = 9e-09
 Identities = 8/72 (11%), Positives = 27/72 (37%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
                       +L+ + ++++       ++P +L+  P +Q +N++ N       +K  
Sbjct: 235 AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDD 294

Query: 64  FSNSSAISLDGN 75
           +   +   +   
Sbjct: 295 WQALADAPVGEK 306

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 16/91 (17%), Positives = 32/91 (35%), Gaps = 9/91 (9%)

Query: 1   MNGNFFQGNIPSSLSSLRGIE------NLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHF 54
           ++ N F    P+   +   ++        D   N      P+ +   P L  L +  N  
Sbjct: 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI 578

Query: 55  EGEVPIKGVFSNSSAISLDGNVNLCGGISEL 85
              V  + +  N S + +  N N+   +S +
Sbjct: 579 RK-VN-EKITPNISVLDIKDNPNISIDLSYV 607

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 15/75 (20%), Positives = 29/75 (38%), Gaps = 6/75 (8%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGV 63
           N     + +SL  ++ +  L+   N L G++P    +   L +LNL++N           
Sbjct: 316 NLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITE--IPANF 372

Query: 64  FSNSSA---ISLDGN 75
              +     +S   N
Sbjct: 373 CGFTEQVENLSFAHN 387

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 12/95 (12%), Positives = 27/95 (28%), Gaps = 7/95 (7%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLSG----RIPKYLENFPFLQNLNLSFNHFEGE 57
            G    G +P ++  L  +E L L  +          PK +      +       H++  
Sbjct: 89  EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKT 148

Query: 58  VP---IKGVFSNSSAISLDGNVNLCGGISELHLCT 89
                 +  FS+     ++ +           +  
Sbjct: 149 FVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITL 183

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 8/49 (16%), Positives = 18/49 (36%)

Query: 8   GNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEG 56
             +  +      + +++LS N +S    +       L ++NL  N    
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 20/107 (18%), Positives = 33/107 (30%), Gaps = 5/107 (4%)

Query: 13  SLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI---KGVFSNSSA 69
           SL+S   +  L L     SGR+P  +     L+ L L  +  +    +   KG+ +N S 
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 70  ISLDGNVNLCGG--ISELHLCTCSTKESKQSRSRSLKLIIPIVTGIL 114
                         +        S        S   +  I   + I 
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 12/95 (12%), Positives = 31/95 (32%), Gaps = 6/95 (6%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK 61
           N +  Q +I  S         +    NN++  + K +     L+   +  + F  E   +
Sbjct: 167 NSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICE 225

Query: 62  GVFS-----NSSAISLDGNVNLCGGISELHLCTCS 91
              +          + D   +    ++++ +  C 
Sbjct: 226 AWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP 260

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 10/98 (10%), Positives = 30/98 (30%), Gaps = 13/98 (13%)

Query: 3   GNFFQGNIPSSLSSLRGIENLDLSQNNL--------SGRIPKYLENFPFLQNLNLSFNHF 54
                  +P+ L +L  ++ ++++ N            +          +Q + + +N+ 
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317

Query: 55  EGEVPIKGVFSNSSA---ISLDGNVNLCGGISELHLCT 89
           +   P++           +    N  L G +       
Sbjct: 318 K-TFPVETSLQKMKKLGMLECLYN-QLEGKLPAFGSEI 353

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 13/64 (20%), Positives = 20/64 (31%), Gaps = 8/64 (12%)

Query: 3   GNFFQGNIPS-SLSSLRGIENLDLSQNNLSGRIP------KYLENFPFLQNLNLSFNHFE 55
            N           ++L  +  +DLS N+ S   P        L+ F      +   N   
Sbjct: 497 FNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL 555

Query: 56  GEVP 59
            E P
Sbjct: 556 REWP 559

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 14/73 (19%), Positives = 31/73 (42%), Gaps = 1/73 (1%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
              N  +G +P+   S   + +L+L+ N ++     +      ++NL+ + N  +    I
Sbjct: 337 CLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNI 395

Query: 61  KGVFSNSSAISLD 73
               S S   ++D
Sbjct: 396 FDAKSVSVMSAID 408

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 18/85 (21%), Positives = 31/85 (36%), Gaps = 11/85 (12%)

Query: 1   MNGNFFQGNIPSSLS--SLRGIENLDLSQNNLSGRIPKYLENFPF-------LQNLNLSF 51
              N  +  IP+     S+  +  +D S N +     K  +           + ++NLS 
Sbjct: 384 FAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSN 442

Query: 52  NHFEGEVP-IKGVFSNSSAISLDGN 75
           N        +    S  S+I+L GN
Sbjct: 443 NQISKFPKELFSTGSPLSSINLMGN 467

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 40.8 bits (96), Expect = 8e-04
 Identities = 9/74 (12%), Positives = 16/74 (21%), Gaps = 21/74 (28%)

Query: 1   MNGNFFQGNIPSSLSSLRG---------------------IENLDLSQNNLSGRIPKYLE 39
             GN      P  ++                         I  LD+  N        Y+ 
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIKDNPNISIDLSYVC 608

Query: 40  NFPFLQNLNLSFNH 53
            +       L ++ 
Sbjct: 609 PYIEAGMYMLFYDK 622

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 23/108 (21%), Positives = 38/108 (35%), Gaps = 9/108 (8%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           + GN  Q   P S S L  +ENL   +  L+      +     L+ LN++ N       +
Sbjct: 87  LTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKL 145

Query: 61  KGVFSNSSA---ISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKL 105
              FSN +    + L  N      I  + +            + SL +
Sbjct: 146 PAYFSNLTNLVHVDLSYNY-----IQTITVNDLQFLRENPQVNLSLDM 188

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 14/78 (17%), Positives = 28/78 (35%), Gaps = 5/78 (6%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           ++    +        +L  ++ L++S NNL      +      L  L+ SFN  E     
Sbjct: 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET--SK 537

Query: 61  KGVFSNSSAIS---LDGN 75
             +     +++   L  N
Sbjct: 538 GILQHFPKSLAFFNLTNN 555

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 15/79 (18%), Positives = 27/79 (34%), Gaps = 5/79 (6%)

Query: 1   MNGNFFQGNIP-SSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP 59
              +  +     S+  SL  +  LD+S  N              L  L ++ N F+    
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465

Query: 60  IKGVFSNSSA---ISLDGN 75
              VF+N++    + L   
Sbjct: 466 -SNVFANTTNLTFLDLSKC 483

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 16/78 (20%), Positives = 29/78 (37%), Gaps = 5/78 (6%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           ++ N  +     S S+   ++ LDLS+  +     K       L NL L+ N  +     
Sbjct: 39  LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS--FS 96

Query: 61  KGVFSNSSA---ISLDGN 75
            G FS  ++   +     
Sbjct: 97  PGSFSGLTSLENLVAVET 114

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 19/69 (27%), Positives = 26/69 (37%), Gaps = 7/69 (10%)

Query: 10 IPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSA 69
          +P  + S    +N+DLS N L         NF  LQ L+LS    E        +     
Sbjct: 26 VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI--EDKAWHGLHH 81

Query: 70 ---ISLDGN 75
             + L GN
Sbjct: 82 LSNLILTGN 90

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 12/79 (15%), Positives = 32/79 (40%), Gaps = 7/79 (8%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKY-LENFPFLQNLNLSFNHFEGEVP 59
           ++ N     + ++   L  +++LD   + L          +   L  L++S+ + +    
Sbjct: 383 LSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI--D 439

Query: 60  IKGVFSNSSAI---SLDGN 75
             G+F   +++    + GN
Sbjct: 440 FDGIFLGLTSLNTLKMAGN 458

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.0 bits (121), Expect = 7e-07
 Identities = 62/368 (16%), Positives = 125/368 (33%), Gaps = 88/368 (23%)

Query: 9   NIPSSLS-SLRGIENLDLSQNNLSGRIPKYLE-----NFPFLQNLNLSFNHFEGEVPIKG 62
               ++S +LR    L   Q  +   + K++E     N+ FL +            PIK 
Sbjct: 56  MSKDAVSGTLRLFWTLLSKQEEM---VQKFVEEVLRINYKFLMS------------PIKT 100

Query: 63  VFSNSSAIS---LDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGI------ 113
                S ++   ++    L                +K + SR L+  + +   +      
Sbjct: 101 EQRQPSMMTRMYIEQRDRLYNDNQVF---------AKYNVSR-LQPYLKLRQALLELRPA 150

Query: 114 --LFLTGM-----SCLIITS--------------WWSKTKREPSTPPSALLASVLRVSYQ 152
             + + G+     + + +                +W   K   S  P  +L  + ++ YQ
Sbjct: 151 KNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS--PETVLEMLQKLLYQ 208

Query: 153 ---NLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHET-LVAVKVL-NLQHRGASKSFIA 207
              N    +D  S   L    S  +  + +     +E  L+   VL N+Q+  A  +F  
Sbjct: 209 IDPNWTSRSDHSSNIKL-RIHSIQAELRRLLKSKPYENCLL---VLLNVQNAKAWNAFNL 264

Query: 208 ECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN-RDAPRNLNL 266
            C+ L + R + +   +++  +     +     +    V   L ++L    +D PR +  
Sbjct: 265 SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLT 324

Query: 267 LQRLSIAV------DVASTLEYLHHY-CE--TPIVHCDLKPSNVLLDGELTAHVSDFGLA 317
                +++      D  +T +   H  C+  T I+   L   NVL   E         + 
Sbjct: 325 TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSL---NVLEPAEYRKMFDRLSV- 380

Query: 318 KFLPEAAN 325
              P +A+
Sbjct: 381 --FPPSAH 386

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.8 bits (110), Expect = 1e-05
 Identities = 59/410 (14%), Positives = 117/410 (28%), Gaps = 124/410 (30%)

Query: 4   NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNL----NLS----FNHFE 55
                  P+  S      N+ L  +++   + + L++ P+   L    N+     +N F 
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFN 263

Query: 56  GEVPI------KGVF-----SNSSAISLDGNVNLCGGISE---LHLCTCSTKESKQSRSR 101
               I      K V      + ++ ISLD   +    ++      L         Q   R
Sbjct: 264 LSCKILLTTRFKQVTDFLSAATTTHISLD---HHSMTLTPDEVKSLLLKYLDCRPQDLPR 320

Query: 102 SLKLIIPIVTGIL--FLTGMSCLIITSW--WSKTKREPSTPPSALLASVLRVSYQNLFKA 157
            +    P    I+   +          W  W     +        L +++  S   L   
Sbjct: 321 EVLTTNPRRLSIIAESIRDGLAT----WDNWKHVNCDK-------LTTIIESSLNVL--- 366

Query: 158 TDGFSLENLIGAGSFGSVYK--GIFDHDDH---ETLVAV----------KVLNLQHRGAS 202
            +      +         +    +F    H     L  +           V+N  H+   
Sbjct: 367 -EPAEYRKM---------FDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK--- 413

Query: 203 KSFIAECQALRSIR------------------HRNLVKIITS-CVSVDFQGND------- 236
            S + +     +I                   HR    I+    +   F  +D       
Sbjct: 414 YSLVEKQPKESTISIPSIYLELKVKLENEYALHR---SIVDHYNIPKTFDSDDLIPPYLD 470

Query: 237 ---FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR--------LSIAVDVASTLEYLHH 285
              +  + + L      E    L R    +   L++         + +  + +TL+ L  
Sbjct: 471 QYFYSHIGHHLKNIEHPERM-TLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF 529

Query: 286 YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           Y +  I  CD  P       +    V+   +  FLP+   NL  ++ + +
Sbjct: 530 Y-KPYI--CDNDP-------KYERLVNA--ILDFLPKIEENLICSKYTDL 567

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.4 bits (121), Expect = 9e-07
 Identities = 18/79 (22%), Positives = 31/79 (39%), Gaps = 4/79 (5%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKY-LENFPFLQNLNLSFNHFEGEVP 59
           ++ N F+     S S+   + +L +  N     +    LEN   L+ L+LS +  E    
Sbjct: 308 LSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDC 367

Query: 60  IKGVFSNSSA---ISLDGN 75
                 N S    ++L  N
Sbjct: 368 CNLQLRNLSHLQSLNLSYN 386

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 21/77 (27%), Positives = 35/77 (45%), Gaps = 6/77 (7%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK 61
             ++F     ++     G++ LDL+  +LS  +P  L     L+ L LS N FE     +
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN--LCQ 318

Query: 62  GVFSNSSA---ISLDGN 75
              SN  +   +S+ GN
Sbjct: 319 ISASNFPSLTHLSIKGN 335

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 14/78 (17%), Positives = 26/78 (33%), Gaps = 5/78 (6%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           +  N       ++LS  + +++L   Q  +S      L N   L++L L  NH       
Sbjct: 88  LTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS--IK 145

Query: 61  KGVFSNSSA---ISLDGN 75
                 +     +    N
Sbjct: 146 LPKGFPTEKLKVLDFQNN 163

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 5/76 (6%)

Query: 1   MNGNFFQGNI---PSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGE 57
           + GN F        +SL +L  +E L LS  +LS        +   + +++LS N     
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515

Query: 58  VPIKGVFSNSSAISLD 73
                  S+   I L+
Sbjct: 516 SI--EALSHLKGIYLN 529

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 47.3 bits (113), Expect = 8e-06
 Identities = 14/77 (18%), Positives = 30/77 (38%), Gaps = 4/77 (5%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK 61
           +           L +L  +++L+LS N       +  +  P L+ L+L+F   +     +
Sbjct: 360 DDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQ 418

Query: 62  GVFSNSS---AISLDGN 75
             F N      ++L  +
Sbjct: 419 SPFQNLHLLKVLNLSHS 435

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 47.3 bits (113), Expect = 9e-06
 Identities = 17/58 (29%), Positives = 24/58 (41%), Gaps = 1/58 (1%)

Query: 9   NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSN 66
            +PS L  L  ++ L LS N           NFP L +L++  N    E+   G   N
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG-TGCLEN 348

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 16/91 (17%), Positives = 28/91 (30%), Gaps = 2/91 (2%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQN--LNLSFNHFEGEV 58
           +  N               ++ LD   N +     + + +     N  LNL+ N   G  
Sbjct: 136 LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIE 195

Query: 59  PIKGVFSNSSAISLDGNVNLCGGISELHLCT 89
           P     +   +++  G  NL      L   T
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNST 226

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 18/91 (19%), Positives = 31/91 (34%), Gaps = 10/91 (10%)

Query: 1   MNGNFFQGNIP-SSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP 59
           +     +     S   +L  ++ L+LS + L     +  +  P LQ+LNL  NHF     
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466

Query: 60  IK-GVFSNSSA---ISLDGNVNLCGGISELH 86
            K            + L         +S + 
Sbjct: 467 QKTNSLQTLGRLEILVLSFC-----DLSSID 492

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 44.6 bits (106), Expect = 5e-05
 Identities = 11/77 (14%), Positives = 18/77 (23%), Gaps = 5/77 (6%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK 61
                      +  S   ++ L L+ N L       L     L++L              
Sbjct: 65  TRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF-- 122

Query: 62  GVFSNSSA---ISLDGN 75
               N      + L  N
Sbjct: 123 IPLHNQKTLESLYLGSN 139

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 17/79 (21%), Positives = 31/79 (39%), Gaps = 6/79 (7%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKY-LENFPFLQNLNLSFNHFEGEVP 59
           ++ N        +      +E LDL+   L  +  +   +N   L+ LNLS +  +    
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442

Query: 60  IKGVFSNSSA---ISLDGN 75
              +F    A   ++L GN
Sbjct: 443 --QLFDGLPALQHLNLQGN 459

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 12/78 (15%), Positives = 24/78 (30%), Gaps = 5/78 (6%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
            + N       ++ S L  +  LDL++  +        ++   L  L L+ N        
Sbjct: 40  FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF--MA 97

Query: 61  KGVFSNSSA---ISLDGN 75
           +   S   A   +     
Sbjct: 98  ETALSGPKALKHLFFIQT 115

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 43.9 bits (104), Expect = 1e-04
 Identities = 14/69 (20%), Positives = 21/69 (30%), Gaps = 7/69 (10%)

Query: 10 IPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSA 69
          IP +L +    E L+ S N L             L  L+L+             F +   
Sbjct: 27 IPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHE--DTFQSQHR 82

Query: 70 ---ISLDGN 75
             + L  N
Sbjct: 83 LDTLVLTAN 91

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 45.0 bits (107), Expect = 4e-05
 Identities = 14/67 (20%), Positives = 26/67 (38%), Gaps = 3/67 (4%)

Query: 9   NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSS 68
            +      +  ++ LDLS N+L   + +    F  L+NL L  N     + +        
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-STHHTLK 342

Query: 69  AISLDGN 75
            ++L  N
Sbjct: 343 NLTLSHN 349

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 42.0 bits (99), Expect = 3e-04
 Identities = 17/77 (22%), Positives = 34/77 (44%), Gaps = 4/77 (5%)

Query: 9   NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSS 68
           ++  +      +ENL L  N++   +   L     L+NL LS N ++    ++ +F N +
Sbjct: 309 HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVA 364

Query: 69  AISLDGNVNLCGGISEL 85
             ++D     C    +L
Sbjct: 365 RPAVDDADQHCKIDYQL 381

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.8 bits (106), Expect = 5e-05
 Identities = 16/70 (22%), Positives = 24/70 (34%), Gaps = 6/70 (8%)

Query: 11  PSSLSSLRGIENLDLSQNNLSGRI--PKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSS 68
           P +   L  +  L L    LS  +    Y  N   L  L+LS N     + +   F   +
Sbjct: 90  PDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR-SLYLHPSFGKLN 148

Query: 69  A---ISLDGN 75
           +   I    N
Sbjct: 149 SLKSIDFSSN 158

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 14/88 (15%), Positives = 34/88 (38%), Gaps = 6/88 (6%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           ++ N       S+   L  +  +DL +N+++    +  +    LQ L+L  N       +
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN------AL 374

Query: 61  KGVFSNSSAISLDGNVNLCGGISELHLC 88
             +    S   +  + N    + +++L 
Sbjct: 375 TTIHFIPSIPDIFLSGNKLVTLPKINLT 402

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 41.3 bits (97), Expect = 7e-04
 Identities = 17/79 (21%), Positives = 26/79 (32%), Gaps = 4/79 (5%)

Query: 1   MNGNFFQGNI-PSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP 59
           +   +    I   +  +L  +  LDL  + +    P   +    L  L L F      V 
Sbjct: 55  LGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVL 114

Query: 60  IKGVFSNSSA---ISLDGN 75
             G F N  A   + L  N
Sbjct: 115 KDGYFRNLKALTRLDLSKN 133

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 44.7 bits (106), Expect = 5e-05
 Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 4/78 (5%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           + GN  Q     + S L  ++ L   + NL+      + +   L+ LN++ N  +    +
Sbjct: 83  LTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKL 141

Query: 61  KGVFSNSSA---ISLDGN 75
              FSN +    + L  N
Sbjct: 142 PEYFSNLTNLEHLDLSSN 159

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 14/65 (21%), Positives = 28/65 (43%), Gaps = 2/65 (3%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK 61
           NG  F+G    S      ++ LDLS N +   +         L++L+   ++ + ++   
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF 414

Query: 62  GVFSN 66
            VF +
Sbjct: 415 SVFLS 419

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 40.9 bits (96), Expect = 8e-04
 Identities = 15/78 (19%), Positives = 29/78 (37%), Gaps = 5/78 (6%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           ++ N  +     S  S   ++ LDLS+  +        ++   L  L L+ N  +  +  
Sbjct: 35  LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLA- 92

Query: 61  KGVFSNSSA---ISLDGN 75
            G FS  S+   +     
Sbjct: 93  LGAFSGLSSLQKLVAVET 110

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258

 Score = 43.1 bits (101), Expect = 8e-05
 Identities = 37/180 (20%), Positives = 62/180 (34%), Gaps = 37/180 (20%)

Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH---- 217
           ++  +I  G   +V+      D     +AVK+    +R  +  F    + L         
Sbjct: 50  AMGGVISTGKEANVFYADGVFDGKPVAMAVKI----YRIETSEFDKMDEYLYGDERFDMR 105

Query: 218 ----------------RNLVKIITSCVSV----DFQGNDFEALVYELMVNGSLEEWLHLN 257
                           RNL +   + VSV     +  N    L+ E +  G  E      
Sbjct: 106 RISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKN---VLLMEFI--GEDELPAPTL 160

Query: 258 RDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA 317
            +  R L  L    I  DV   ++ L+   E  +VH DL   N++   ++  +  D G A
Sbjct: 161 VELGRELKELDVEGIFNDVVENVKRLYQEAE--LVHADLSEYNIMYIDKV--YFIDMGQA 216

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 14/67 (20%), Positives = 26/67 (38%), Gaps = 3/67 (4%)

Query: 9   NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSS 68
            +      +  ++ LDLS N+L   + +    F  L+NL L  N     + +        
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-STHHTLK 348

Query: 69  AISLDGN 75
            ++L  N
Sbjct: 349 NLTLSHN 355

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 22/98 (22%), Positives = 41/98 (41%), Gaps = 4/98 (4%)

Query: 9   NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSS 68
           ++  +      +ENL L  N++   +   L     L+NL LS N ++    ++ +F N +
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVA 370

Query: 69  AISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLI 106
             ++D     C    +L    C  +  K    R L+ I
Sbjct: 371 RPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYI 408

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 43.3 bits (103), Expect = 1e-04
 Identities = 15/65 (23%), Positives = 24/65 (36%), Gaps = 1/65 (1%)

Query: 11  PSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAI 70
            S L++L  + +L L+ N L     + +     L  L LS NH     P+    S   + 
Sbjct: 280 ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLAS-LSKMDSA 338

Query: 71  SLDGN 75
                
Sbjct: 339 DFANQ 343

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 40.2 bits (95), Expect = 9e-04
 Identities = 13/53 (24%), Positives = 27/53 (50%), Gaps = 2/53 (3%)

Query: 10  IPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKG 62
             S LS++ G+  L ++++ +    P  + N   L +L+L++N  E   P+  
Sbjct: 147 DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLAS 197

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 41.5 bits (98), Expect = 2e-04
 Identities = 12/51 (23%), Positives = 23/51 (45%)

Query: 2   NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFN 52
            G     +   +LS L  +  LD+S +     I   +   P + +++LS+N
Sbjct: 96  MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN 146

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 17/62 (27%), Positives = 27/62 (43%)

Query: 1  MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
          +  +  +  + S   S   ++ LDLS N LS      L  F  L+ LNLS N     + +
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDL 76

Query: 61 KG 62
          + 
Sbjct: 77 ES 78

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 13/69 (18%), Positives = 21/69 (30%), Gaps = 1/69 (1%)

Query: 9   NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSS 68
            +     S  G+  + L  N L   I K L     L++ +L  N F           N  
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263

Query: 69  AISLDGNVN 77
             ++     
Sbjct: 264 VQTVAKQTV 272

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 17/53 (32%), Positives = 24/53 (45%)

Query: 1  MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNH 53
          +  +  +  + S   S   ++ LDLS N LS      L  F  L+ LNLS N 
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 13/69 (18%), Positives = 21/69 (30%), Gaps = 1/69 (1%)

Query: 9   NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSS 68
            +     S  G+  + L  N L   I K L     L++ +L  N F           N  
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263

Query: 69  AISLDGNVN 77
             ++     
Sbjct: 264 VQTVAKQTV 272

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 21/72 (29%), Positives = 28/72 (38%), Gaps = 8/72 (11%)

Query: 11  PSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFE-------GEVPIKGV 63
             SLS L  +  L L  N LS R+P  L +   LQ + L  N+           V     
Sbjct: 234 NGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVK 292

Query: 64  FSNSSAISLDGN 75
            +  + ISL  N
Sbjct: 293 RAYYNGISLFNN 304

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 41.6 bits (97), Expect = 4e-04
 Identities = 10/71 (14%), Positives = 20/71 (28%), Gaps = 6/71 (8%)

Query: 9  NIPSSLSSLRGIENLDLSQNNLSGRIPKY-LENFPFLQNLNLSFNHFEGEVPIKGVFSNS 67
          +    L     +  L +        +    L     L+NL +  +     V     F  +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVA-PDAFHFT 79

Query: 68 SA---ISLDGN 75
               ++L  N
Sbjct: 80 PRLSRLNLSFN 90

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 41.7 bits (97), Expect = 5e-04
 Identities = 21/69 (30%), Positives = 33/69 (47%), Gaps = 4/69 (5%)

Query: 9   NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSS 68
            +P +L++LR +E L  S N L   +   + N P LQ L L  N  +    I+ + S   
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534

Query: 69  --AISLDGN 75
              ++L GN
Sbjct: 535 LVLLNLQGN 543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 14/51 (27%), Positives = 24/51 (47%), Gaps = 1/51 (1%)

Query: 6   FQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPF-LQNLNLSFNHFE 55
             G   +  ++   ++ LDLS N+L         ++P  L +LNLSF   +
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 13/67 (19%), Positives = 26/67 (38%), Gaps = 3/67 (4%)

Query: 9   NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSS 68
                L +L+ + +LD+S+N     +P   +    ++ LNLS       V    +     
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVK-TCIPQTLE 434

Query: 69  AISLDGN 75
            + +  N
Sbjct: 435 VLDVSNN 441

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 40.7 bits (96), Expect = 8e-04
 Identities = 10/56 (17%), Positives = 21/56 (37%), Gaps = 2/56 (3%)

Query: 7   QGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKG 62
                  +  L  +  ++ S N L+   P  L+N   L ++ ++ N      P+  
Sbjct: 57  GIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLAN 110

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	484
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.94
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.43
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.25
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.21
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.17
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.17
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.15
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.13
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.01
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.99
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	98.97
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	98.97
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.93
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	98.92
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	98.92
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	98.91
3e6j_A	229	Variable lymphocyte receptor diversity region; var	98.91
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	98.9
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.9
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.89
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.88
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	98.87
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.86
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.85
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	98.85
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.85
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.84
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	98.82
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.82
3m19_A	251	Variable lymphocyte receptor A diversity region; a	98.81
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.81
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	98.81
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.81
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.81
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.8
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.79
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.75
3m19_A	251	Variable lymphocyte receptor A diversity region; a	98.75
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.72
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	98.72
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.72
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.72
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	98.71
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.71
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.7
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.7
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.69
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.69
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.69
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	98.68
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.67
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.67
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.66
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.64
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.64
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.64
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.63
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.63
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.62
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.62
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.59
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.58
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.58
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.58
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.58
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.57
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.57
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.56
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.56
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.55
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.55
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.54
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.54
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.54
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.54
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.53
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.53
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.53
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.53
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.52
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.52
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.52
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.52
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.51
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.51
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.51
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.51
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.49
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.47
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.47
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.47
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.46
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.45
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.45
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.44
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.42
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.42
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.41
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.41
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.41
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.4
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.36
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.36
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.35
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.34
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.33
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.33
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.33
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.32
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.32
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.31
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.28
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.26
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.23
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.22
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.21
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.2
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.14
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.13
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.09
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.07
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.06
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.04
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.02
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.01
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.0
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	97.97
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.94
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	97.94
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	97.93
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.87
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.86
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	97.74
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	97.63
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.51
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.48
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.41
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.39
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	97.28
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.26
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.23
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.19
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.08
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.08
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.96
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	96.93
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.9
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.84
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.81
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.71
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.62
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	96.58
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	96.43
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	96.42
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	96.39
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	96.24
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.18
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.17
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.11
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	95.68
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	95.48
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	95.05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	94.7
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.6
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.3
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	93.06
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	92.37
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	88.92
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	84.78
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	84.42
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	81.87
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	80.88

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.3e-58  Score=434.70  Aligned_cols=265  Identities=26%  Similarity=0.420  Sum_probs=211.9

Q ss_pred             CCCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|.+.+.||+|+||+||+|++..   ..++..||||+++.......++|.+|+++|++++|||||+++|+|..     +
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-----G   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----C
Confidence            467888999999999999998753   23578899999987655566789999999999999999999999743     4


Q ss_pred             ceeeEEeecccCCCHHHHHhhcC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNR---------DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE  306 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~  306 (484)
                      +..++|||||++|+|.++++...         .....++|.+++.|+.||+.||+|||   +++|+||||||+|||++++
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCC
Confidence            47899999999999999997542         23456999999999999999999999   8999999999999999999


Q ss_pred             CceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCc
Q 011508          307 LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNL  385 (484)
Q Consensus       307 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~  385 (484)
                      +.+||+|||+|+.......     ........||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+....  
T Consensus       165 ~~~Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--  237 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDY-----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--  237 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGC-----EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--
T ss_pred             CcEEECCcccceecCCCCc-----eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence            9999999999986643321     112223468999999999999999999999999999999999 99999764211  


Q ss_pred             cHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          386 TLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                         +......        ....                    ...+..|+.++.+|+.+||+.||++|||++||++.|+.
T Consensus       238 ---~~~~~i~--------~~~~--------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          238 ---EVIECIT--------QGRV--------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN  286 (299)
T ss_dssp             ---HHHHHHH--------HTCC--------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHHHHHH--------cCCC--------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               1111100        0000                    00134457789999999999999999999999999998


Q ss_pred             HHHH
Q 011508          466 FRNK  469 (484)
Q Consensus       466 i~~~  469 (484)
                      +.+.
T Consensus       287 ~~~~  290 (299)
T 4asz_A          287 LAKA  290 (299)
T ss_dssp             HHHH
T ss_pred             HHhc
Confidence            8654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.7e-57  Score=434.56  Aligned_cols=265  Identities=27%  Similarity=0.424  Sum_probs=206.3

Q ss_pred             CCCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|.+.+.||+|+||+||+|++..   ..+++.||||+++.......++|.+|+++|++++|||||+++|+|..     +
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-----~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-----G  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----S
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----C
Confidence            356778899999999999999753   34578999999986655556789999999999999999999999743     4


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRD-----------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD  304 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~  304 (484)
                      ...++|||||++|+|.++++....           ...+++|.+++.|+.||+.||+|||   +++|+||||||+||||+
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEEC
Confidence            478999999999999999985432           1246999999999999999999999   89999999999999999


Q ss_pred             CCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccC
Q 011508          305 GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTG  383 (484)
Q Consensus       305 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~  383 (484)
                      +++.+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||+| |+.||......
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~-----~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~  267 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT  267 (329)
T ss_dssp             TTTEEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred             CCCcEEEcccccceeccCCCc-----ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999987643221     112234569999999999999999999999999999999999 89999764211


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                        .+...+...        .  .+                     ..+..|+.++.+|+.+||+.||++|||++||++.|
T Consensus       268 --~~~~~i~~g--------~--~~---------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L  314 (329)
T 4aoj_A          268 --EAIDCITQG--------R--EL---------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL  314 (329)
T ss_dssp             --HHHHHHHHT--------C--CC---------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHH
T ss_pred             --HHHHHHHcC--------C--CC---------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence              111111100        0  00                     01344577899999999999999999999999999


Q ss_pred             HHHHHH
Q 011508          464 LSFRNK  469 (484)
Q Consensus       464 ~~i~~~  469 (484)
                      +.+.+.
T Consensus       315 ~~l~~~  320 (329)
T 4aoj_A          315 QALAQA  320 (329)
T ss_dssp             HHHHHS
T ss_pred             HHHhhC
Confidence            988653

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.1e-57  Score=424.00  Aligned_cols=264  Identities=29%  Similarity=0.424  Sum_probs=204.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .+++.+.+.||+|+||+||+|++.     ..||||+++....  ...+.|.+|++++++++|||||+++++|.      +
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~-----~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~------~  103 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH-----GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT------K  103 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS-----SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------S
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC-----CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------C
Confidence            456788999999999999999854     2489999875432  33467999999999999999999999863      2


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++|||||++|+|.++++..   ...+++.+++.|+.||+.||+|||   +++||||||||+||||++++.+||+|||
T Consensus       104 ~~~~iVmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFG  177 (307)
T 3omv_A          104 DNLAIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFG  177 (307)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred             CeEEEEEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeecc
Confidence            3578999999999999999743   245999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC---CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG---SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      +|+.......     ........||+.|+|||++.+   ..|+.++|||||||++|||+||+.||.+..... .+...+.
T Consensus       178 la~~~~~~~~-----~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~  251 (307)
T 3omv_A          178 LATVKSRWSG-----SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVG  251 (307)
T ss_dssp             SCBC-----------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHH
T ss_pred             CceecccCCc-----ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHh
Confidence            9987643221     112234579999999999853   468999999999999999999999997532211 1111111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHh
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV  471 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  471 (484)
                      .       ....+.+.                    ..+.+|+.++.+|+.+||+.||++||||.||++.|+.++..+.
T Consensus       252 ~-------~~~~p~~~--------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp  303 (307)
T 3omv_A          252 R-------GYASPDLS--------------------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP  303 (307)
T ss_dssp             T-------TCCCCCST--------------------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred             c-------CCCCCCcc--------------------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence            1       00111110                    0123457789999999999999999999999999998876543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.3e-57  Score=427.78  Aligned_cols=261  Identities=23%  Similarity=0.378  Sum_probs=207.1

Q ss_pred             CCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .+++.+.||+|+||+||+|++..   ..+++.||||+++.... ...++|.+|+.++++++|||||+++|+|..     +
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-----~  101 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-----D  101 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-----C
Confidence            35667899999999999999742   33567899999975443 334789999999999999999999999743     4


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRD------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL  303 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll  303 (484)
                      +..++|||||++|+|.++|.....            ....++|.+++.|+.||++||+|||   +++||||||||+||||
T Consensus       102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A          102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLV  178 (308)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEE
Confidence            478999999999999999975321            1235899999999999999999999   8999999999999999


Q ss_pred             cCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCcc
Q 011508          304 DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFT  382 (484)
Q Consensus       304 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~  382 (484)
                      ++++.+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+...
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~  253 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADY-----YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  253 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGC-----BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH
T ss_pred             CCCCCEEECCcccceeccCCCc-----eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999987643321     112234569999999999999999999999999999999999 8999976421


Q ss_pred             CCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          383 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .  .+...+.           +....                    ..+.+|+.++.+|+.+||+.||++||||.||++.
T Consensus       254 ~--~~~~~i~-----------~~~~~--------------------~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          254 Q--DVVEMIR-----------NRQVL--------------------PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             H--HHHHHHH-----------TTCCC--------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             H--HHHHHHH-----------cCCCC--------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            1  1111111           00000                    0134567789999999999999999999999999


Q ss_pred             HHHH
Q 011508          463 LLSF  466 (484)
Q Consensus       463 L~~i  466 (484)
                      |+.+
T Consensus       301 L~a~  304 (308)
T 4gt4_A          301 LRAW  304 (308)
T ss_dssp             HHTS
T ss_pred             HHhc
Confidence            9754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.1e-55  Score=419.43  Aligned_cols=250  Identities=24%  Similarity=0.311  Sum_probs=205.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      +.|++.+.||+|+||+||+|+.  ..+++.||||+++.......+.+.+|+++|++++|||||++++++.     .++..
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~  146 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATV--RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDEL  146 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEE--TTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEE--CCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence            4689999999999999999994  4467899999998766666677899999999999999999999954     44589


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      |+|||||++|+|.+++...     .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus       147 ~ivmEy~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~  218 (346)
T 4fih_A          147 WVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCA  218 (346)
T ss_dssp             EEEECCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCce
Confidence            9999999999999999742     4899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      .+....       ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+...  ......+..     
T Consensus       219 ~~~~~~-------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~-----  284 (346)
T 4fih_A          219 QVSKEV-------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRD-----  284 (346)
T ss_dssp             ECCSSS-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHH-----
T ss_pred             ecCCCC-------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHc-----
Confidence            764322       223346799999999999999999999999999999999999999975311  111111111     


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                         ...+.+..                     +..++.++.+|+.+||+.||++|||++|+++
T Consensus       285 ---~~~~~~~~---------------------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          285 ---NLPPRLKN---------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ---SSCCCCSC---------------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCCCCCCc---------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               11111100                     2233567899999999999999999999876

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.4e-55  Score=423.01  Aligned_cols=274  Identities=23%  Similarity=0.319  Sum_probs=217.3

Q ss_pred             HhHHHhcCCCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCC-CCceeEeee
Q 011508          152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQHR-GASKSFIAECQALRSIRH-RNLVKIITS  226 (484)
Q Consensus       152 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~~~~~  226 (484)
                      .+++...++|++.+.||+|+||+||+|++...   ...+.||||+++.... ...+.|.+|+++|.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            34445567899999999999999999987543   3457899999976543 234679999999999965 899999999


Q ss_pred             eeeeccCCCceeeEEeecccCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 011508          227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHC  294 (484)
Q Consensus       227 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~  294 (484)
                      |.    ..+...++|||||++|+|.++|+....            ....+++.+++.++.||+.||+|||   +++||||
T Consensus       137 ~~----~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHR  209 (353)
T 4ase_A          137 CT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  209 (353)
T ss_dssp             EC----CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EE----ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecC
Confidence            74    334568999999999999999975432            1345899999999999999999999   8999999


Q ss_pred             CCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-C
Q 011508          295 DLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-G  373 (484)
Q Consensus       295 dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g  373 (484)
                      ||||+|||+++++.+||+|||+|+.+.....     ........||+.|+|||++.+..|+.++|||||||++|||+| |
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~-----~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G  284 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG  284 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCC-----ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCC
Confidence            9999999999999999999999987643321     122234568999999999999999999999999999999998 9


Q ss_pred             CCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCC
Q 011508          374 KGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRER  453 (484)
Q Consensus       374 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  453 (484)
                      +.||.+..... .+...+....        .  +                     ..+..|+.++.+++..||+.||++|
T Consensus       285 ~~Pf~~~~~~~-~~~~~i~~g~--------~--~---------------------~~p~~~~~~~~~li~~c~~~dP~~R  332 (353)
T 4ase_A          285 ASPYPGVKIDE-EFCRRLKEGT--------R--M---------------------RAPDYTTPEMYQTMLDCWHGEPSQR  332 (353)
T ss_dssp             CCSSTTCCCSH-HHHHHHHHTC--------C--C---------------------CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             CCCCCCCCHHH-HHHHHHHcCC--------C--C---------------------CCCccCCHHHHHHHHHHcCcChhHC
Confidence            99997643221 1111111100        0  0                     0133446788999999999999999


Q ss_pred             CCHHHHHHHHHHHHHH
Q 011508          454 MNMEEVAAQLLSFRNK  469 (484)
Q Consensus       454 Pt~~evl~~L~~i~~~  469 (484)
                      ||+.||++.|+.+.+.
T Consensus       333 Pt~~eil~~L~~llq~  348 (353)
T 4ase_A          333 PTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHH
Confidence            9999999999988654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.4e-55  Score=414.00  Aligned_cols=283  Identities=23%  Similarity=0.252  Sum_probs=202.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      .+|.+.+.||+|+||+||+|++.    ++.||||+++.... ....+..|+..+.+++|||||+++++|...+ ......
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~----g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR----GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET----TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC----CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEE
Confidence            35778899999999999999864    67899999975422 1223345666677889999999999986543 223467


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY-----CETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      ++|||||++|+|.++++..     .++|..+++++.|++.||+|||+.     +..+|+||||||+|||++.++.+||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             EEEecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            9999999999999999743     489999999999999999999932     123999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCC------CCCcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      ||+|+.........   ........||+.|+|||++.+.      .++.++|||||||++|||+||+.||..........
T Consensus       152 FGla~~~~~~~~~~---~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~  228 (303)
T 3hmm_A          152 LGLAVRHDSATDTI---DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  228 (303)
T ss_dssp             CTTCEEEETTTTEE---SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred             CCCCccccCCCCce---eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence            99998764332111   1122345799999999998754      47789999999999999999998875433222111


Q ss_pred             hHHHHhhc-chh-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          388 HNFVKEAL-PER-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       388 ~~~~~~~~-~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                      ..+..... .+. ...+.+..+.....              ......+++..+.+|+.+||+.||++||||.||++.|++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p--------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          229 YDLVPSDPSVEEMRKVVCEQKLRPNIP--------------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             TTTSCSSCCHHHHHHHHTTSCCCCCCC--------------GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hhcccccchHHHHHHHHhcccCCCCCC--------------ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            11110000 000 11111111111000              001123457789999999999999999999999999999


Q ss_pred             HHHH
Q 011508          466 FRNK  469 (484)
Q Consensus       466 i~~~  469 (484)
                      +.++
T Consensus       295 l~~~  298 (303)
T 3hmm_A          295 LSQQ  298 (303)
T ss_dssp             HHHC
T ss_pred             HHHH
Confidence            8754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=6.6e-55  Score=414.81  Aligned_cols=260  Identities=24%  Similarity=0.261  Sum_probs=206.0

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      +.|.+.++||+|+||.||+|+.  ..+++.||||+++....     ..+|+.++++++|||||++++++.     +++..
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~--~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~  125 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKD--KQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVR-----EGPWV  125 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEE--TTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             hheEeCcEeccCCCeEEEEEEE--CCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence            4577888999999999999994  44678999999975432     247999999999999999999854     45588


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcccCcc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVSDFGLA  317 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~a  317 (484)
                      ++|||||+||+|.++++...    .+++.++..++.||+.||+|||   +++|+||||||+||||+.++ .+||+|||+|
T Consensus       126 ~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla  198 (336)
T 4g3f_A          126 NIFMELLEGGSLGQLIKQMG----CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA  198 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred             EEEEeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence            99999999999999998543    5999999999999999999999   99999999999999999987 6999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      +.+......  .........+||+.|||||++.+..|+.++|||||||++|||+||+.||........ +........+ 
T Consensus       199 ~~~~~~~~~--~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~~~-  274 (336)
T 4g3f_A          199 LCLQPDGLG--KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEPPP-  274 (336)
T ss_dssp             EEC--------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSCCG-
T ss_pred             eEccCCCcc--cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCCCC-
Confidence            877543211  111112335799999999999999999999999999999999999999976433221 1111111000 


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                       ..+                            .+..++..+.+++.+||+.||++|||+.|+++.|.......
T Consensus       275 -~~~----------------------------~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          275 -IRE----------------------------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             -GGG----------------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -chh----------------------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence             000                            02334667899999999999999999999999998877654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.7e-55  Score=419.31  Aligned_cols=251  Identities=21%  Similarity=0.288  Sum_probs=198.9

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||+||+|+.  ..+++.||||+++....  ...+.+.+|+++|++++|||||++++++.     +++
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~   96 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKS--TEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENG   96 (350)
T ss_dssp             CCEEEEEEC------CEEEEEE--TTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred             cceEEeEEEecCCCeEEEEEEE--CCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECC
Confidence            6899999999999999999994  44678999999976532  23467899999999999999999999853     455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..|+|||||+||+|.+++....  ...+++.+++.|+.||+.||+|||   +++|+||||||+||||+.++.+||+|||+
T Consensus        97 ~~yiVmEy~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGl  171 (350)
T 4b9d_A           97 SLYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGI  171 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEccccc
Confidence            8999999999999999997543  345789999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      |+.+....       ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||....     ..+.......
T Consensus       172 a~~~~~~~-------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-----~~~~~~~i~~  239 (350)
T 4b9d_A          172 ARVLNSTV-------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-----MKNLVLKIIS  239 (350)
T ss_dssp             ESCCCHHH-------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHH
T ss_pred             ceeecCCc-------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----HHHHHHHHHc
Confidence            98764321       12234579999999999999999999999999999999999999997532     1111111111


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...    .+ +                       +..++.++.+|+.+||+.||++|||++|+++
T Consensus       240 ~~~----~~-~-----------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          240 GSF----PP-V-----------------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             TCC----CC-C-----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC----CC-C-----------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000    00 0                       1223567899999999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-54  Score=405.37  Aligned_cols=249  Identities=29%  Similarity=0.399  Sum_probs=195.6

Q ss_pred             CccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       162 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      .+.+.||+|+||+||+|+..  .++..||+|++.....  ...+.|.+|+++|++++|||||++++++.... .++...+
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~  105 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDT--ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV  105 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEEC--CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEE
Confidence            56678999999999999954  4678999999975432  23467899999999999999999999875432 3345789


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeecC-CCceEEcccCc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP--IVHCDLKPSNVLLDG-ELTAHVSDFGL  316 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~NIll~~-~~~~kl~Dfg~  316 (484)
                      +|||||++|+|.+++...    ..+++..+..++.||+.||+|||   +++  |+||||||+|||++. ++.+||+|||+
T Consensus       106 lvmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGl  178 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcC
Confidence            999999999999999854    35899999999999999999999   777  999999999999974 78999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      |+....         ......+||+.|+|||++.+ .|+.++|||||||++|||+||+.||.+....    .........
T Consensus       179 a~~~~~---------~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~----~~~~~~i~~  244 (290)
T 3fpq_A          179 ATLKRA---------SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTS  244 (290)
T ss_dssp             GGGCCT---------TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTT
T ss_pred             CEeCCC---------CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH----HHHHHHHHc
Confidence            975422         12234579999999998865 6999999999999999999999999653211    111111000


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .     ..+..                      .+..++.++.+|+.+||+.||++|||++|+++
T Consensus       245 ~-----~~~~~----------------------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          245 G-----VKPAS----------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             T-----CCCGG----------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C-----CCCCC----------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0     00000                      01112456889999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.6e-55  Score=410.90  Aligned_cols=250  Identities=21%  Similarity=0.323  Sum_probs=204.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||+||+|+  +..+++.||||+++...   ....+.+.+|+++|++++|||||++++++     +++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~--~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~  104 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDD  104 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEE--ETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             cccEEEEEEecccCeEEEEEE--ECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeC
Confidence            569999999999999999999  44568899999997532   33457799999999999999999999984     556


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++|||||+||+|.+++....    .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus       105 ~~~yivmEy~~gG~L~~~i~~~~----~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFG  177 (311)
T 4aw0_A          105 EKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG  177 (311)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcC
Confidence            68999999999999999998543    5999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +|+.+....     ........+||+.|+|||++.+..|+.++||||+||++|||+||+.||.....     ....... 
T Consensus       178 la~~~~~~~-----~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i-  246 (311)
T 4aw0_A          178 TAKVLSPES-----KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----GLIFAKI-  246 (311)
T ss_dssp             TCEECCTTT-----TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH-
T ss_pred             CceecCCCC-----CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH-
Confidence            999774322     11223346899999999999999999999999999999999999999975311     1111111 


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                             .......                     +..++.++.+|+.+||+.||++|||++|++.
T Consensus       247 -------~~~~~~~---------------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          247 -------IKLEYDF---------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             -------HHTCCCC---------------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             -------HcCCCCC---------------------CcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence                   1000000                     1122556889999999999999999999754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.1e-54  Score=420.52  Aligned_cols=250  Identities=24%  Similarity=0.311  Sum_probs=206.0

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      +.|++.+.||+|+||.||+|+.  ..+++.||||++........+.+.+|+.+|++++|||||++++++.     .++..
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~  223 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATV--RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDEL  223 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEE--TTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEE--CCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCEE
Confidence            5699999999999999999994  4467899999998776666678999999999999999999999964     34589


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      |+|||||+||+|.++++..     .+++.++..++.||+.||+|||   +++|+||||||+||||+.++.+||+|||+|+
T Consensus       224 ~iVmEy~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~  295 (423)
T 4fie_A          224 WVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCA  295 (423)
T ss_dssp             EEEEECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccce
Confidence            9999999999999999742     4899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      .+....       ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+...  ......+..     
T Consensus       296 ~~~~~~-------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--~~~~~~i~~-----  361 (423)
T 4fie_A          296 QVSKEV-------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--LKAMKMIRD-----  361 (423)
T ss_dssp             ECCSSC-------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHH-----
T ss_pred             ECCCCC-------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--HHHHHHHHc-----
Confidence            764322       223346799999999999999999999999999999999999999975311  111111111     


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                         ...+.+..                     ...++.++.+|+.+||+.||++|||+.|+++
T Consensus       362 ---~~~~~~~~---------------------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          362 ---NLPPRLKN---------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ---SCCCCCSC---------------------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CCCCCCcc---------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               11111100                     1223567899999999999999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=8.7e-54  Score=396.87  Aligned_cols=247  Identities=25%  Similarity=0.366  Sum_probs=188.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||+||+|+  +..+++.||+|+++...   ....+.+.+|++++++++|||||++++++     .++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~--~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~   85 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAY--HTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSK   85 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEE--CTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             eCeEEEEEEecCcCeEEEEEE--ECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EEC
Confidence            689999999999999999998  55578999999997543   23346789999999999999999999984     455


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+ +|+|.+++...    ..+++.++..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||
T Consensus        86 ~~~~ivmEy~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFG  157 (275)
T 3hyh_A           86 DEIIMVIEYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFG  157 (275)
T ss_dssp             SEEEEEEECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSS
T ss_pred             CEEEEEEeCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecC
Confidence            6899999999 78999999753    35999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      +|+......        .....+||+.|+|||++.+..+ +.++||||+||++|||+||+.||.+..     ........
T Consensus       158 la~~~~~~~--------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-----~~~~~~~i  224 (275)
T 3hyh_A          158 LSNIMTDGN--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-----IPVLFKNI  224 (275)
T ss_dssp             CC-----------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH
T ss_pred             CCeecCCCC--------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-----HHHHHHHH
Confidence            998653321        2234579999999999988776 579999999999999999999997531     11111111


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .        ......                     +..++.++.+++.+||+.||++|||++|+++.
T Consensus       225 ~--------~~~~~~---------------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          225 S--------NGVYTL---------------------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             H--------HTCCCC---------------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             H--------cCCCCC---------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            0        000000                     11225568899999999999999999999863

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.4e-53  Score=400.88  Aligned_cols=250  Identities=26%  Similarity=0.291  Sum_probs=194.1

Q ss_pred             CCCCccCccccccceeEEEEEEc-CCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||+||+|+.. +..+++.||||+++...  ......+.+|+++|++++|||||++++++.     ++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----TE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----ET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----EC
Confidence            56999999999999999999853 23467899999997543  223356889999999999999999999854     45


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++|||||+||+|.+++....    .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFG  171 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFG  171 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccc
Confidence            58999999999999999998543    5899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +|+......       ......+||+.|+|||++.+..|+.++||||+||++|||+||+.||.+...     .+..... 
T Consensus       172 la~~~~~~~-------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i-  238 (304)
T 3ubd_A          172 LSKESIDHE-------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KETMTMI-  238 (304)
T ss_dssp             EEEC------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH-
T ss_pred             cceeccCCC-------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HHHHHHH-
Confidence            998653321       222346799999999999999999999999999999999999999975321     1111111 


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH-----HHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM-----EEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~  461 (484)
                             .......                     +..++.++.+|+.+||+.||++|||+     +|+++
T Consensus       239 -------~~~~~~~---------------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          239 -------LKAKLGM---------------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -------HHCCCCC---------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -------HcCCCCC---------------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                   1000000                     12235678899999999999999985     56654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2e-52  Score=394.82  Aligned_cols=261  Identities=21%  Similarity=0.319  Sum_probs=188.5

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeecc------
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDF------  232 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------  232 (484)
                      +|++.+.||+|+||+||+|+.  ..+++.||||+++..... ..+.+.+|+++|++++|||||++++++...+.      
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKN--KVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEE--TTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hCEEeeEEecCCCeEEEEEEE--CCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            588999999999999999994  446789999999765433 34678999999999999999999998765431      


Q ss_pred             -CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEE
Q 011508          233 -QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV  311 (484)
Q Consensus       233 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl  311 (484)
                       ....+.++|||||++|+|.+++..... ....++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEE
Confidence             123457899999999999999975432 233567778999999999999999   899999999999999999999999


Q ss_pred             cccCcccccccccccCCC-----CccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCcc
Q 011508          312 SDFGLAKFLPEAANNLSS-----NQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLT  386 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~-----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~  386 (484)
                      +|||+|+.+.........     ........+||+.|+|||++.+..|+.++|||||||++|||++   ||.....    
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----  232 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----  232 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----
Confidence            999999887543321110     1112234579999999999999999999999999999999996   7753210    


Q ss_pred             HhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          387 LHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....        +..+.+.....                    ........+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~--------~~~~~~~~~p~--------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          233 RVRT--------LTDVRNLKFPP--------------------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHHH--------HHHHHTTCCCH--------------------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHH--------HHHHhcCCCCC--------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0000        00111000000                    01122345678999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-49  Score=390.06  Aligned_cols=285  Identities=19%  Similarity=0.210  Sum_probs=202.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeec-cCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVD-FQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~  234 (484)
                      .++|++.+.||+|+||+||+|+  +..+++.||||+++....  ...+.+.+|+++|++++|||||++++++.... +.+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~--~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~  130 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSAR--RRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE  130 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEE--ETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred             CCCeEEEEEEecccCeEEEEEE--ECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence            3679999999999999999999  445688999999975432  23457889999999999999999999865432 345


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....|+|||||+ |+|.+++..    ...+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+||
T Consensus       131 ~~~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DF  202 (398)
T 4b99_A          131 FKSVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDF  202 (398)
T ss_dssp             CCCEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCC
T ss_pred             CCEEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeec
Confidence            567899999995 789999973    346999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |+|+.+.....   .........+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+..... .+......
T Consensus       203 Gla~~~~~~~~---~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~~  278 (398)
T 4b99_A          203 GMARGLCTSPA---EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMMV  278 (398)
T ss_dssp             TTCBCC----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHH
T ss_pred             ceeeecccCcc---ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHHh
Confidence            99987643221   112223456899999999998775 56999999999999999999999997632111 11111111


Q ss_pred             hcc--hhhhhhcCc-ccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALP--ERLAEIVDP-VLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~--~~~~~~~d~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...  ......+.. ........     .....+............++.+|+.+||+.||++|||++|+++
T Consensus       279 ~g~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          279 LGTPSPAVIQAVGAERVRAYIQS-----LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HCCCCGGGTC-----CHHHHHHS-----SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCCCChHHhhhhhhhhhhhhhhc-----CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            110  000000000 00000000     0000000000001122457889999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.6e-49  Score=380.36  Aligned_cols=208  Identities=26%  Similarity=0.369  Sum_probs=171.0

Q ss_pred             HhcCCCCccCccccccceeEEEEEEc-CCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFD-HDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  233 (484)
                      ...++|++.+.||+|+||+||+|+.+ +..+++.||+|++....  ....+.+|+++|+.+ +||||+++++++     .
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~   90 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCF-----R   90 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEE-----E
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEE-----E
Confidence            34678999999999999999999854 33467899999986543  346788999999998 699999999985     4


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVS  312 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~  312 (484)
                      .+++.++||||+++|+|.+++.       .+++.++..++.||+.||+|||   +++|+||||||+|||++.+ +.+||+
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~  160 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALV  160 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             ECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEEC
Confidence            4568999999999999999984       3889999999999999999999   8999999999999999877 799999


Q ss_pred             ccCcccccccccccCC---------------------CCccccccccccccccCccccCCC-CCCcccceehhhHHHHHH
Q 011508          313 DFGLAKFLPEAANNLS---------------------SNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEM  370 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~---------------------~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~el  370 (484)
                      |||+|+..........                     .........+||+.|+|||++.+. .|+.++||||+||++|||
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~el  240 (361)
T 4f9c_A          161 DFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSL  240 (361)
T ss_dssp             CCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHH
T ss_pred             cCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHH
Confidence            9999986543221100                     001112345799999999998775 589999999999999999


Q ss_pred             HhCCCCCCCC
Q 011508          371 FTGKGPTNEM  380 (484)
Q Consensus       371 ltg~~p~~~~  380 (484)
                      +||+.||...
T Consensus       241 l~G~~Pf~~~  250 (361)
T 4f9c_A          241 LSGRYPFYKA  250 (361)
T ss_dssp             HHTCSSSSCC
T ss_pred             HHCCCCCCCC
Confidence            9999999654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.6e-47  Score=366.97  Aligned_cols=286  Identities=32%  Similarity=0.471  Sum_probs=227.3

Q ss_pred             cccHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeee
Q 011508          148 RVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSC  227 (484)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  227 (484)
                      +++..++...+++|++.+.||+|+||.||+|++.   ++..||+|++........+.+.+|++++++++||||+++++++
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  104 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR---DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC  104 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT---TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEEC---CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4455566678899999999999999999999854   4678999998876666667899999999999999999999995


Q ss_pred             eeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 011508          228 VSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL  307 (484)
Q Consensus       228 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~  307 (484)
                           ...+..++||||+++|+|.+++.........+++..++.++.|++.||+|||   +++|+||||||+||+++.++
T Consensus       105 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~  176 (321)
T 2qkw_B          105 -----DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENF  176 (321)
T ss_dssp             -----CCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTC
T ss_pred             -----cCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCC
Confidence                 3455789999999999999999765544456999999999999999999999   89999999999999999999


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCC-cc
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN-LT  386 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~-~~  386 (484)
                      .+||+|||++........     ........||..|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus       177 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~  251 (321)
T 2qkw_B          177 VPKITDFGISKKGTELDQ-----THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN  251 (321)
T ss_dssp             CEEECCCTTCEECSSSSC-----CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC
T ss_pred             CEEEeecccccccccccc-----cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH
Confidence            999999999986532211     111223458999999999988899999999999999999999999997654322 22


Q ss_pred             HhHHHHhhcch-hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          387 LHNFVKEALPE-RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       387 ~~~~~~~~~~~-~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                      ...|....... .+..++++.+..                   ....+++..+.+++.+||+.||++|||+.||++.|+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  312 (321)
T 2qkw_B          252 LAEWAVESHNNGQLEQIVDPNLAD-------------------KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY  312 (321)
T ss_dssp             HHHHTHHHHTTTCCCSSSSSSCTT-------------------CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhhhccccccHHHhcChhhcc-------------------ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            33333222111 123333332211                   1134568889999999999999999999999999998


Q ss_pred             HHH
Q 011508          466 FRN  468 (484)
Q Consensus       466 i~~  468 (484)
                      +..
T Consensus       313 ~l~  315 (321)
T 2qkw_B          313 ALR  315 (321)
T ss_dssp             HHH
T ss_pred             Hhh
Confidence            864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.1e-48  Score=394.88  Aligned_cols=252  Identities=22%  Similarity=0.291  Sum_probs=204.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||+|++........+.+.+|+++|+.++|||||++++++     .++...
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~--~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~  229 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTE--RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEM  229 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE--TTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEE
T ss_pred             cccEEEEEEeeccCeEEEEEEE--CCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEE
Confidence            5799999999999999999994  456789999999876655567889999999999999999999984     456689


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC--CceEEcccCc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE--LTAHVSDFGL  316 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfg~  316 (484)
                      ++|||||+||+|.+++...   ...+++.++..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+
T Consensus       230 ~iv~E~~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~  303 (573)
T 3uto_A          230 VMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGL  303 (573)
T ss_dssp             EEEEECCCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSS
T ss_pred             EEEEeecCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccc
Confidence            9999999999999998632   245999999999999999999999   8999999999999999854  7999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      |+.+...        ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....     +...    
T Consensus       304 a~~~~~~--------~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-----~~~~----  366 (573)
T 3uto_A          304 TAHLDPK--------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD-----ETLR----  366 (573)
T ss_dssp             CEECCTT--------SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHH----
T ss_pred             eeEccCC--------CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----HHHH----
Confidence            9876432        1223457999999999999999999999999999999999999999763211     1111    


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                          .+.........                 .....++.++.+|+.+||+.||.+|||+.|+++
T Consensus       367 ----~i~~~~~~~~~-----------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          367 ----NVKSCDWNMDD-----------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             ----HHHTTCCCCCS-----------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----HHHhCCCCCCc-----------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                11110000000                 001223567889999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.8e-47  Score=368.94  Aligned_cols=288  Identities=35%  Similarity=0.550  Sum_probs=229.7

Q ss_pred             hhccccHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeE
Q 011508          145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKI  223 (484)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~  223 (484)
                      ....++..++....++|++.+.||+|+||.||+|+..   +++.||||++..... .....+.+|+++++.++||||+++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   92 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA---DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL   92 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS---SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec---CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence            3567899999999999999999999999999999743   478899999875442 223478999999999999999999


Q ss_pred             eeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 011508          224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL  303 (484)
Q Consensus       224 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll  303 (484)
                      ++++.     .....++||||+++|+|.+++.........+++..++.++.|++.||+|||+.+..+|+||||||+||++
T Consensus        93 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~  167 (326)
T 3uim_A           93 RGFCM-----TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL  167 (326)
T ss_dssp             CEEEC-----CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred             EEEEe-----cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence            99964     3447799999999999999998766556679999999999999999999994322399999999999999


Q ss_pred             cCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC---
Q 011508          304 DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM---  380 (484)
Q Consensus       304 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~---  380 (484)
                      +.++.+||+|||++.......      ........||+.|+|||++.+..++.++|||||||++|||++|+.||...   
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  241 (326)
T 3uim_A          168 DEEFEAVVGDFGLAKLMDYKD------THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA  241 (326)
T ss_dssp             CTTCCEEECCCSSCEECCSSS------SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred             CCCCCEEeccCccccccCccc------ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc
Confidence            999999999999998764322      12223345999999999998888999999999999999999999999632   


Q ss_pred             ccCCccHhHHHHhhcchh-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHH
Q 011508          381 FTGNLTLHNFVKEALPER-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEV  459 (484)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev  459 (484)
                      .........|+....... ...+.+..+...                   ...++...+.+++..||+.||++|||+.||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~el  302 (326)
T 3uim_A          242 NDDDVMLLDWVKGLLKEKKLEALVDVDLQGN-------------------YKDEEVEQLIQVALLCTQSSPMERPKMSEV  302 (326)
T ss_dssp             TTSCSBHHHHHTTTTSSCCSTTSSCTTCTTS-------------------CCHHHHHHHHHHHHHHTCSCGGGSCCHHHH
T ss_pred             cccchhHHHHHHHHhhchhhhhhcChhhccc-------------------cCHHHHHHHHHHHHHHhCcCCccCCCHHHH
Confidence            122334445554443332 333333332221                   134557889999999999999999999999


Q ss_pred             HHHHHH
Q 011508          460 AAQLLS  465 (484)
Q Consensus       460 l~~L~~  465 (484)
                      ++.|+.
T Consensus       303 l~~L~~  308 (326)
T 3uim_A          303 VRMLEG  308 (326)
T ss_dssp             HHHHHT
T ss_pred             HHHhcC
Confidence            999975

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.7e-47  Score=390.19  Aligned_cols=249  Identities=24%  Similarity=0.306  Sum_probs=196.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHH---HHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFI---AECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||||++++..   ........   .++.+++.++|||||+++++     +
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~--~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~-----f  261 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRK--ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA-----F  261 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE--TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE-----E
T ss_pred             HHeEEEEEEecccCeEEEEEEE--CCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE-----E
Confidence            5799999999999999999994  4568999999997432   12222333   44677778899999999998     4


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                      ++.+..|+|||||+||+|.+++....    .+++..+..++.||+.||+|||   +++||||||||+||||+.+|.+||+
T Consensus       262 ~~~~~lylVmEy~~GGdL~~~l~~~~----~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~  334 (689)
T 3v5w_A          262 HTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRIS  334 (689)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EECCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEec
Confidence            55668999999999999999998543    4899999999999999999999   9999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      |||+|+.+...         .....+||+.|+|||++.. ..|+.++||||+||++|||++|+.||.+.....  .....
T Consensus       335 DFGlA~~~~~~---------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~--~~~i~  403 (689)
T 3v5w_A          335 DLGLACDFSKK---------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEID  403 (689)
T ss_dssp             CCTTCEECSSC---------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC--HHHHH
T ss_pred             ccceeeecCCC---------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHH
Confidence            99999876332         1234579999999999864 579999999999999999999999997632221  11111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-----HHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-----MEEVAA  461 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~  461 (484)
                      ....        ......                     +..++.++.+|+.+||+.||.+|++     ++||++
T Consensus       404 ~~i~--------~~~~~~---------------------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          404 RMTL--------TMAVEL---------------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHH--------HCCCCC---------------------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             Hhhc--------CCCCCC---------------------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            1110        000000                     1223567899999999999999998     677764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.4e-47  Score=361.96  Aligned_cols=276  Identities=24%  Similarity=0.361  Sum_probs=216.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|.+.+.||+|+||.||+|+..  .++..||+|++........+.+.+|++++++++||||+++++++..     +..
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~   81 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHR--ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKR   81 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEET--TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTE
T ss_pred             hhHeeccceecCCCCEEEEEEEEC--CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCe
Confidence            357889999999999999999954  4578899999876555566789999999999999999999999643     447


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++|+|.+++...   ...+++.+++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  155 (310)
T 3s95_A           82 LNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLA  155 (310)
T ss_dssp             EEEEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred             eEEEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccc
Confidence            89999999999999999853   245899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCC-------CccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          318 KFLPEAANNLSS-------NQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       318 ~~~~~~~~~~~~-------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      ............       .........||+.|+|||++.+..++.++||||||+++|||++|..||.............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~  235 (310)
T 3s95_A          156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN  235 (310)
T ss_dssp             EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC
T ss_pred             eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh
Confidence            876443221110       0111124579999999999999999999999999999999999999987543322111110


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      ....        .+..                       .+..++..+.+++.+||+.||++|||+.|+++.|+.++..+
T Consensus       236 ~~~~--------~~~~-----------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          236 VRGF--------LDRY-----------------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             HHHH--------HHHT-----------------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hhcc--------cccc-----------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            0000        0000                       01223456889999999999999999999999999999888


Q ss_pred             hhccCCC
Q 011508          471 VKNVRGQ  477 (484)
Q Consensus       471 ~~~~~~~  477 (484)
                      ....+..
T Consensus       285 ~~~~~~~  291 (310)
T 3s95_A          285 AGHLPLG  291 (310)
T ss_dssp             HHCCCCH
T ss_pred             cCcccCC
Confidence            6655443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.9e-46  Score=356.96  Aligned_cols=281  Identities=23%  Similarity=0.284  Sum_probs=211.0

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ...++|++.+.||+|+||.||+|++.    ++.||||++.... ........|+.++++++||||+++++++.... ...
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~   94 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL----NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVD   94 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET----TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSS
T ss_pred             cchhhchhhheecccCceEEEEEEEC----CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCC
Confidence            34467999999999999999999864    5789999997543 23345667999999999999999999976543 223


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeeecCCCCCCeeecC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCET----------PIVHCDLKPSNVLLDG  305 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivH~dlk~~NIll~~  305 (484)
                      ...++||||+++|+|.++++..     .+++..++.++.|++.||+|||   +.          +|+||||||+||+++.
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~  166 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKN  166 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECT
T ss_pred             ceEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECC
Confidence            4579999999999999999743     3899999999999999999999   77          9999999999999999


Q ss_pred             CCceEEcccCcccccccccccCCCCccccccccccccccCccccCC-----CCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-----SEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       306 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ++.+||+|||+++.......     ........||+.|+|||++.+     ..++.++|||||||++|||+||+.||...
T Consensus       167 ~~~~kL~DFg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~  241 (322)
T 3soc_A          167 NLTACIADFGLALKFEAGKS-----AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP  241 (322)
T ss_dssp             TCCEEECCCTTCEEECTTSC-----CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred             CCeEEEccCCcccccccccC-----ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999987643321     112233569999999999876     35677899999999999999999999764


Q ss_pred             ccCCcc-HhHHHHhhc-chhhhhh-cCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          381 FTGNLT-LHNFVKEAL-PERLAEI-VDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       381 ~~~~~~-~~~~~~~~~-~~~~~~~-~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                      ...... +........ ...+.+. ........              .........++.++.+++.+||+.||++|||+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  307 (322)
T 3soc_A          242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPV--------------LRDYWQKHAGMAMLCETIEECWDHDAEARLSAG  307 (322)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCC--------------CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             cchhccchhhhhccCCchhhhhhhhhcccCCCC--------------ccccccccchHHHHHHHHHHHccCChhhCcCHH
Confidence            332211 111111000 0011111 11111000              000111234577899999999999999999999


Q ss_pred             HHHHHHHHHHHH
Q 011508          458 EVAAQLLSFRNK  469 (484)
Q Consensus       458 evl~~L~~i~~~  469 (484)
                      ||++.|+++++.
T Consensus       308 ell~~L~~l~~~  319 (322)
T 3soc_A          308 CVGERITQMQRL  319 (322)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHH
Confidence            999999999764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-45  Score=351.43  Aligned_cols=251  Identities=22%  Similarity=0.297  Sum_probs=204.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||+||+|.  +..+++.||+|++........+.+.+|+.++++++||||+++++++..     ++.
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~   91 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDE   91 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEE--BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             hhceeeeeeeccCCCeEEEEEE--ECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-----CCE
Confidence            4679999999999999999998  445678999999987766667789999999999999999999998643     447


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++|+|.+++...     .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  163 (297)
T 3fxz_A           92 LWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFC  163 (297)
T ss_dssp             EEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence            89999999999999999743     4889999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .......       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......    . ......  
T Consensus       164 ~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~-~~~~~~--  229 (297)
T 3fxz_A          164 AQITPEQ-------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----R-ALYLIA--  229 (297)
T ss_dssp             EECCSTT-------CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----H-HHHHHH--
T ss_pred             eecCCcc-------cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----H-HHHHHH--
Confidence            8664322       1223456999999999999999999999999999999999999999653211    0 000000  


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                         ....+.+.                     .+..++..+.+++.+||+.||++|||++|+++
T Consensus       230 ---~~~~~~~~---------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          230 ---TNGTPELQ---------------------NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             ---HHCSCCCS---------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---hCCCCCCC---------------------CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               00000000                     02233567899999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3e-46  Score=355.18  Aligned_cols=281  Identities=24%  Similarity=0.383  Sum_probs=210.3

Q ss_pred             cCCCCccCccccccceeEEEEEEc--CCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|++.  +..+++.||||++........+.+.+|++++++++||||+++++++...+   .
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~   85 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R   85 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence            367899999999999999999864  34467899999998665555678999999999999999999999875322   3


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             CceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCc
Confidence            45789999999999999997542   35899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++.........    ........++..|+|||.+.+..++.++||||||+++|||+||..||......   .........
T Consensus       160 ~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~  232 (295)
T 3ugc_A          160 LTKVLPQDKEF----FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDK  232 (295)
T ss_dssp             SCC-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH---HHHHHCTTC
T ss_pred             ccccccCCcce----eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH---HHhhhcCcc
Confidence            99876443211    11122345778899999998889999999999999999999999998653110   000000000


Q ss_pred             chh--hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          396 PER--LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       396 ~~~--~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      ...  ...+.+. +.               ...+...+..++.++.+++..||+.||++|||+.|+++.|+++++.+
T Consensus       233 ~~~~~~~~~~~~-~~---------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          233 QGQMIVFHLIEL-LK---------------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             CTHHHHHHHHHH-HH---------------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ccchhHHHHHHH-Hh---------------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            000  0000000 00               00001113445778999999999999999999999999999998765

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.6e-45  Score=360.66  Aligned_cols=284  Identities=19%  Similarity=0.237  Sum_probs=217.1

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCC---CeeEEEEEEeeccCccc-----------hHHHHHHHHHHHcCCCCCcee
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDD---HETLVAVKVLNLQHRGA-----------SKSFIAECQALRSIRHRNLVK  222 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~  222 (484)
                      ..++|.+.+.||+|+||.||+|.+..+.   .++.||||++.......           ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            4568999999999999999999875432   35789999987543211           123445666777888999999


Q ss_pred             EeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 011508          223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVL  302 (484)
Q Consensus       223 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIl  302 (484)
                      +++++.... .+..+.++||||+ +++|.+++...   ...+++..++.++.||+.||+|||   +++|+||||||+|||
T Consensus       113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nil  184 (364)
T 3op5_A          113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLL  184 (364)
T ss_dssp             EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred             EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEE
Confidence            999986542 3345789999999 99999999753   245999999999999999999999   889999999999999


Q ss_pred             ec--CCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          303 LD--GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       303 l~--~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ++  .++.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99  8899999999999877554322222222223456999999999999999999999999999999999999999764


Q ss_pred             ccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHH
Q 011508          381 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVA  460 (484)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  460 (484)
                      .... .............+.+++++.+..                      ..++.++.+++..||+.||++||++.+|+
T Consensus       265 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~li~~cl~~~p~~RP~~~~l~  321 (364)
T 3op5_A          265 LKDP-KYVRDSKIRYRENIASLMDKCFPA----------------------ANAPGEIAKYMETVKLLDYTEKPLYENLR  321 (364)
T ss_dssp             TTCH-HHHHHHHHHHHHCHHHHHHHHSCT----------------------TCCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred             ccCH-HHHHHHHHHhhhhHHHHHHHhccc----------------------ccCHHHHHHHHHHHhcCCCCCCCCHHHHH
Confidence            3221 222222222233344444333211                      22366789999999999999999999999


Q ss_pred             HHHHHHHHHHh
Q 011508          461 AQLLSFRNKLV  471 (484)
Q Consensus       461 ~~L~~i~~~~~  471 (484)
                      +.|+.+.....
T Consensus       322 ~~l~~~~~~~~  332 (364)
T 3op5_A          322 DILLQGLKAIG  332 (364)
T ss_dssp             HHHHHHHHHTT
T ss_pred             HHHHHHHHHcC
Confidence            99999887654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.2e-45  Score=358.72  Aligned_cols=267  Identities=23%  Similarity=0.376  Sum_probs=211.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcC-----CCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDH-----DDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSV  230 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  230 (484)
                      .++|.+.+.||+|+||.||+|+...     ...+..||||+++.... ...+.+.+|+.+++++ +||||++++++|.  
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence            3678899999999999999998642     23567899999976533 2346789999999999 8999999999853  


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRD------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKP  298 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~  298 (484)
                         ..+..++||||+++|+|.+++.....            ....+++.+++.++.||+.||+|||   +++|+||||||
T Consensus       158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp  231 (370)
T 2psq_A          158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA  231 (370)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred             ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccch
Confidence               44578999999999999999986532            1235899999999999999999999   89999999999


Q ss_pred             CCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCC
Q 011508          299 SNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPT  377 (484)
Q Consensus       299 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~  377 (484)
                      +|||++.++.+||+|||+++.......     ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~  306 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  306 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCT-----TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             hhEEECCCCCEEEccccCCcccCcccc-----eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999986643221     111223457889999999999999999999999999999999 99999


Q ss_pred             CCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                      ......  .+...+...        ...                       ..+..++.++.+++..||+.||++|||+.
T Consensus       307 ~~~~~~--~~~~~~~~~--------~~~-----------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~  353 (370)
T 2psq_A          307 PGIPVE--ELFKLLKEG--------HRM-----------------------DKPANCTNELYMMMRDCWHAVPSQRPTFK  353 (370)
T ss_dssp             TTCCGG--GHHHHHHTT--------CCC-----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCHH--HHHHHHhcC--------CCC-----------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence            753211  111111000        000                       00223466789999999999999999999


Q ss_pred             HHHHHHHHHHHHH
Q 011508          458 EVAAQLLSFRNKL  470 (484)
Q Consensus       458 evl~~L~~i~~~~  470 (484)
                      |+++.|+.+....
T Consensus       354 ell~~L~~il~~~  366 (370)
T 2psq_A          354 QLVEDLDRILTLT  366 (370)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHh
Confidence            9999999987654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.3e-46  Score=357.10  Aligned_cols=266  Identities=24%  Similarity=0.390  Sum_probs=208.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCC-CeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|++...+ .+..||||+++.... ...+.+.+|+.++++++||||+++++++     ..+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~  122 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----TRG  122 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CGG
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence            357889999999999999999975432 356799999976533 3346789999999999999999999995     344


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++...   ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  196 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFG  196 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred             CccEEEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCC
Confidence            5789999999999999999643   235899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      +++........    ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......     ......
T Consensus       197 ~a~~~~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-----~~~~~~  267 (325)
T 3kul_A          197 LSRVLEDDPDA----AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-----DVISSV  267 (325)
T ss_dssp             SCEECC----C----CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-----HHHHHH
T ss_pred             cccccccCccc----eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-----HHHHHH
Confidence            99876443211    111223346788999999988899999999999999999999 99999653211     111100


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHh
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV  471 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  471 (484)
                           ......                       ..+..++..+.+++..||+.||++|||+.||++.|+.+.....
T Consensus       268 -----~~~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          268 -----EEGYRL-----------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             -----HTTCCC-----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             -----HcCCCC-----------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence                 000000                       0022346678999999999999999999999999999876543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.7e-44  Score=343.67  Aligned_cols=283  Identities=30%  Similarity=0.448  Sum_probs=222.3

Q ss_pred             hccccHHhHHHhcCCCCcc------CccccccceeEEEEEEcCCCCeeEEEEEEeeccC----ccchHHHHHHHHHHHcC
Q 011508          146 VLRVSYQNLFKATDGFSLE------NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH----RGASKSFIAECQALRSI  215 (484)
Q Consensus       146 ~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l  215 (484)
                      ...+++.++..++++|...      +.||+|+||.||+|..    .++.||+|++....    ....+.+.+|+.+++++
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l   87 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV----NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC   87 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES----SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE----CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc
Confidence            4568889999999998877      8999999999999984    35789999986432    22346789999999999


Q ss_pred             CCCCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 011508          216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCD  295 (484)
Q Consensus       216 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d  295 (484)
                      +||||+++++++     ...+..++||||+++++|.+++..... ...+++..++.++.|++.||+|||   +++|+|||
T Consensus        88 ~h~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~d  158 (307)
T 2nru_A           88 QHENLVELLGFS-----SDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRD  158 (307)
T ss_dssp             CCTTBCCEEEEE-----CSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred             CCCCeEEEEEEE-----ecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCC
Confidence            999999999985     344578999999999999999975432 345899999999999999999999   89999999


Q ss_pred             CCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCC
Q 011508          296 LKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG  375 (484)
Q Consensus       296 lk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~  375 (484)
                      |||+||+++.++.+||+|||++........     ........|++.|+|||.+.+ .++.++||||||+++|+|++|+.
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~  232 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLP  232 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCSS-----CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCC
T ss_pred             CCHHHEEEcCCCcEEEeecccccccccccc-----cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCC
Confidence            999999999999999999999986543221     111223468999999998765 58899999999999999999999


Q ss_pred             CCCCCccCCccHhHHHHhhc--chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCC
Q 011508          376 PTNEMFTGNLTLHNFVKEAL--PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRER  453 (484)
Q Consensus       376 p~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  453 (484)
                      ||....... .+..+.....  ...+.+.+++.+..                    ....++..+.+++..||+.||.+|
T Consensus       233 p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~cl~~~p~~R  291 (307)
T 2nru_A          233 AVDEHREPQ-LLLDIKEEIEDEEKTIEDYIDKKMND--------------------ADSTSVEAMYSVASQCLHEKKNKR  291 (307)
T ss_dssp             SBCTTBSSS-BTTHHHHHHHTTSCCHHHHSCSSCSC--------------------CCHHHHHHHHHHHHHHTCSSTTTS
T ss_pred             CcccCcchH-HHHHHHHHhhhhhhhhhhhccccccc--------------------cchHHHHHHHHHHHHHcCCCcccC
Confidence            997643322 2222222111  11133444433211                    134457789999999999999999


Q ss_pred             CCHHHHHHHHHHHHH
Q 011508          454 MNMEEVAAQLLSFRN  468 (484)
Q Consensus       454 Pt~~evl~~L~~i~~  468 (484)
                      ||+.||++.|+++++
T Consensus       292 ps~~~l~~~L~~l~~  306 (307)
T 2nru_A          292 PDIKKVQQLLQEMTA  306 (307)
T ss_dssp             CCHHHHHHHHHHHC-
T ss_pred             cCHHHHHHHHHHHhc
Confidence            999999999998854

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.7e-45  Score=360.05  Aligned_cols=279  Identities=22%  Similarity=0.309  Sum_probs=217.3

Q ss_pred             cccHHhHHHhcCCCCccCccccccceeEEEEEEc---CCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCcee
Q 011508          148 RVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVK  222 (484)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~  222 (484)
                      .+....+....++|++.+.||+|+||.||+|++.   +..+++.||||+++.... ...+.+.+|++++.++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            3444555566788999999999999999999864   345678999999976433 2345789999999999 8999999


Q ss_pred             EeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCC------------------------------------------
Q 011508          223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA------------------------------------------  260 (484)
Q Consensus       223 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------  260 (484)
                      +++++.    ..+...++||||+++|+|.++++.....                                          
T Consensus        91 ~~~~~~----~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (359)
T 3vhe_A           91 LLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG  166 (359)
T ss_dssp             EEEEEC----STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred             eeeeee----cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence            999873    3344589999999999999999854321                                          


Q ss_pred             --------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          261 --------------------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       261 --------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                                          ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  243 (359)
T 3vhe_A          167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI  243 (359)
T ss_dssp             -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence                                112899999999999999999999   899999999999999999999999999999866


Q ss_pred             ccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhh
Q 011508          321 PEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERL  399 (484)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  399 (484)
                      .....     ........||..|+|||++.+..++.++|||||||++|||+| |+.||........ +.......     
T Consensus       244 ~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~~~~~~~~-----  312 (359)
T 3vhe_A          244 YKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEG-----  312 (359)
T ss_dssp             TSCTT-----CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-HHHHHHHT-----
T ss_pred             ccccc-----chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-HHHHHHcC-----
Confidence            33221     112233568899999999988899999999999999999998 9999976432211 11111100     


Q ss_pred             hhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          400 AEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       400 ~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                         .....                       +..++.++.+++..||+.||++|||+.||++.|+.+.+..
T Consensus       313 ---~~~~~-----------------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          313 ---TRMRA-----------------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             ---CCCCC-----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---CCCCC-----------------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence               00000                       1223567899999999999999999999999999987654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.1e-45  Score=345.88  Aligned_cols=271  Identities=24%  Similarity=0.381  Sum_probs=205.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHc--CCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRS--IRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|++.    ++.||||++...   ....+..|.+++..  ++||||+++++++.... ...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~   78 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQ----GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSS   78 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEET----TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEEC----CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCC
Confidence            467999999999999999999863    678999998643   33556667777766  79999999999876543 345


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeecCCCCCCeeecCCCceE
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC-----ETPIVHCDLKPSNVLLDGELTAH  310 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlk~~NIll~~~~~~k  310 (484)
                      ...++||||+++|+|.++++.     ..+++..++.++.|++.||+|||...     +++|+||||||+||+++.++.+|
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEE
T ss_pred             ceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEE
Confidence            578999999999999999963     35899999999999999999999321     57999999999999999999999


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCCC------CCCcccceehhhHHHHHHHhC----------C
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEMFTG----------K  374 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~Gvvl~elltg----------~  374 (484)
                      |+|||+++.........   ........||+.|+|||++.+.      .++.++|||||||++|||+||          +
T Consensus       154 l~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~  230 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQL---DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK  230 (301)
T ss_dssp             ECCCTTCEEEETTTTEE---ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred             EeeCCCeeecccccccc---cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence            99999997654332111   1112234699999999998876      556799999999999999999          7


Q ss_pred             CCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC
Q 011508          375 GPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM  454 (484)
Q Consensus       375 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  454 (484)
                      .||.....................    ..+.+.                  .......++..+.+++.+||+.||++||
T Consensus       231 ~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rp  288 (301)
T 3q4u_A          231 PPFYDVVPNDPSFEDMRKVVCVDQ----QRPNIP------------------NRWFSDPTLTSLAKLMKECWYQNPSARL  288 (301)
T ss_dssp             CTTTTTSCSSCCHHHHHHHHTTSC----CCCCCC------------------GGGGGSHHHHHHHHHHHHHCCSSGGGSC
T ss_pred             ccccccCCCCcchhhhhHHHhccC----CCCCCC------------------hhhccCccHHHHHHHHHHHhhcChhhCC
Confidence            787665443333322222111100    000000                  0011234578899999999999999999


Q ss_pred             CHHHHHHHHHHH
Q 011508          455 NMEEVAAQLLSF  466 (484)
Q Consensus       455 t~~evl~~L~~i  466 (484)
                      |+.||++.|+++
T Consensus       289 s~~~i~~~L~~i  300 (301)
T 3q4u_A          289 TALRIKKTLTKI  300 (301)
T ss_dssp             CHHHHHHHHHHH
T ss_pred             CHHHHHHHHhcc
Confidence            999999999876

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.7e-45  Score=348.75  Aligned_cols=263  Identities=30%  Similarity=0.380  Sum_probs=199.6

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      ...++|++.+.||+|+||+||+|+..    ++.||+|++.....  ...+.+.+|++++++++||||+++++++     .
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~  104 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWH----GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----T  104 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET----TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred             CChhHceeeeEeecCCCeEEEEEEEC----CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----E
Confidence            34467899999999999999999853    57799999875542  2335788999999999999999999985     4


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeecCCCceEE
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP--IVHCDLKPSNVLLDGELTAHV  311 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl  311 (484)
                      .....++||||+++|+|.+++.... ....+++..++.++.|++.||+|||   +++  |+||||||+||+++.++.+||
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL  180 (309)
T 3p86_A          105 QPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKV  180 (309)
T ss_dssp             STTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEE
T ss_pred             ECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEE
Confidence            4557899999999999999997432 1123899999999999999999999   888  999999999999999999999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      +|||+++......       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     +..
T Consensus       181 ~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-----~~~  248 (309)
T 3p86_A          181 CDFGLSRLKASTF-------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-----QVV  248 (309)
T ss_dssp             CCCC------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-----HHH
T ss_pred             CCCCCCccccccc-------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHH
Confidence            9999997543221       1123356899999999999999999999999999999999999999753211     111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      ...     .. .....                     ..+..++.++.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus       249 ~~~-----~~-~~~~~---------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          249 AAV-----GF-KCKRL---------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             HHH-----HH-SCCCC---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             HHH-----Hh-cCCCC---------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            100     00 00000                     002233567899999999999999999999999999887654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=361.05  Aligned_cols=277  Identities=27%  Similarity=0.375  Sum_probs=213.7

Q ss_pred             CCCCccCccccccceeEEEEEEc---CCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ++|++.+.||+|+||.||+|++.   +..++..||||+++.... .....+.+|+.++++++||||+++++++.     .
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~  145 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----Q  145 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----c
Confidence            56889999999999999999965   234567899999975432 33457889999999999999999999853     4


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC---c
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRD---APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL---T  308 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~---~  308 (484)
                      ....++||||+++|+|.+++.....   ....+++.+++.++.||+.||+|||   +++|+||||||+|||++.++   .
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCce
Confidence            4577999999999999999986542   2245899999999999999999999   89999999999999998555   5


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccH
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTL  387 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~  387 (484)
                      +||+|||+++.......     ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  .+
T Consensus       223 ~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~--~~  295 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--EV  295 (367)
T ss_dssp             EEECCCHHHHHHHHHSS-----CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HH
T ss_pred             EEECCCccccccccccc-----cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence            99999999986533221     112223457899999999988899999999999999999998 99999753211  11


Q ss_pred             hHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          388 HNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                      ...+..           .. ..                   ..+..++..+.+++..||+.||++|||+.||++.|+.+.
T Consensus       296 ~~~i~~-----------~~-~~-------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          296 LEFVTS-----------GG-RM-------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             HHHHHT-----------TC-CC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHc-----------CC-CC-------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            111100           00 00                   002233567899999999999999999999999999998


Q ss_pred             HHHhhccCCCccee
Q 011508          468 NKLVKNVRGQPATY  481 (484)
Q Consensus       468 ~~~~~~~~~~~~~~  481 (484)
                      +........-|..|
T Consensus       345 ~~~~~~~~~~p~~~  358 (367)
T 3l9p_A          345 QDPDVINTALPIEY  358 (367)
T ss_dssp             HCHHHHTCCCCCC-
T ss_pred             hChhhccCCCcccc
Confidence            77655555545443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.8e-45  Score=351.84  Aligned_cols=250  Identities=22%  Similarity=0.305  Sum_probs=201.2

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ..++|++.+.||+|+||.||+|+.  ..+++.||||++.....  ...+.+.+|+++++.++||||+++++++.     .
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~   85 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARH--ILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----T   85 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEE--TTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEE--CCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----E
Confidence            346899999999999999999984  44678999999975432  23467889999999999999999999853     4


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+++|+|.+++....    .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DF  158 (328)
T 3fe3_A           86 EKTLYLIMEYASGGEVFDYLVAHG----RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADF  158 (328)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECST
T ss_pred             CCEEEEEEECCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeec
Confidence            558899999999999999997543    4899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCC-cccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVS-TSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |++......        .......||+.|+|||++.+..+. .++||||+||++|||++|+.||....     .......
T Consensus       159 G~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~  225 (328)
T 3fe3_A          159 GFSNEFTVG--------GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----LKELRER  225 (328)
T ss_dssp             TCCGGGSSS--------CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHH
T ss_pred             cCceecCCC--------CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----HHHHHHH
Confidence            999765322        122345699999999998887764 79999999999999999999997632     1111111


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..        ......                     +..++.++.+++.+||+.||.+|||++|+++.
T Consensus       226 i~--------~~~~~~---------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          226 VL--------RGKYRI---------------------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HH--------HCCCCC---------------------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             HH--------hCCCCC---------------------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            10        000000                     11125568899999999999999999999763

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-44  Score=346.39  Aligned_cols=262  Identities=24%  Similarity=0.295  Sum_probs=208.4

Q ss_pred             cccHHhHHHhcCC----------CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCC
Q 011508          148 RVSYQNLFKATDG----------FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH  217 (484)
Q Consensus       148 ~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h  217 (484)
                      .++++++..+++.          |...+.||+|+||.||+|+..  .+++.||||++........+.+.+|+.++++++|
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK--HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC--CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            4566666655543          666779999999999999854  3578999999987666666789999999999999


Q ss_pred             CCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 011508          218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLK  297 (484)
Q Consensus       218 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk  297 (484)
                      |||+++++++..     ....++||||+++++|.+++..     ..+++..++.++.|++.||+|||   +.+|+|||||
T Consensus       102 ~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlk  168 (321)
T 2c30_A          102 FNVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIK  168 (321)
T ss_dssp             TTBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCS
T ss_pred             CCcceEEEEEEE-----CCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCC
Confidence            999999998654     3478999999999999999863     34899999999999999999999   8999999999


Q ss_pred             CCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCC
Q 011508          298 PSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPT  377 (484)
Q Consensus       298 ~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~  377 (484)
                      |+||+++.++.+||+|||++.......       .......||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus       169 p~NIll~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf  241 (321)
T 2c30_A          169 SDSILLTLDGRVKLSDFGFCAQISKDV-------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY  241 (321)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSSS-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             HHHEEECCCCcEEEeeeeeeeecccCc-------cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999998664321       1123356999999999999999999999999999999999999999


Q ss_pred             CCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                      .....     .....     .+.....+.+..                     ...++..+.+++.+||+.||++|||+.
T Consensus       242 ~~~~~-----~~~~~-----~~~~~~~~~~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~  290 (321)
T 2c30_A          242 FSDSP-----VQAMK-----RLRDSPPPKLKN---------------------SHKVSPVLRDFLERMLVRDPQERATAQ  290 (321)
T ss_dssp             TTSCH-----HHHHH-----HHHHSSCCCCTT---------------------GGGSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred             CCCCH-----HHHHH-----HHhcCCCCCcCc---------------------cccCCHHHHHHHHHHccCChhhCcCHH
Confidence            65311     11111     011111111100                     112255788999999999999999999


Q ss_pred             HHHHH
Q 011508          458 EVAAQ  462 (484)
Q Consensus       458 evl~~  462 (484)
                      |+++.
T Consensus       291 ell~h  295 (321)
T 2c30_A          291 ELLDH  295 (321)
T ss_dssp             HHHTS
T ss_pred             HHhcC
Confidence            99864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9e-45  Score=351.55  Aligned_cols=295  Identities=26%  Similarity=0.340  Sum_probs=207.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHH--HHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQA--LRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|+..    ++.||||++....   ...+..|.++  +..++||||+++++.+......+.
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD----ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET----TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             hHHhheeeecccCCCeEEEEEEEC----CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            467899999999999999999753    6889999997543   2344444444  455899999999987766656666


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeeecCCCCCCeeecCC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCET---------PIVHCDLKPSNVLLDGE  306 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivH~dlk~~NIll~~~  306 (484)
                      ...++||||+++|+|.+++....     .++..++.++.|++.||+|||   +.         +|+||||||+|||++.+
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~  156 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKND  156 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred             ceEEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCC
Confidence            77899999999999999997432     588999999999999999999   77         99999999999999999


Q ss_pred             CceEEcccCcccccccccccCC-CCccccccccccccccCccccCC-------CCCCcccceehhhHHHHHHHhCCCCCC
Q 011508          307 LTAHVSDFGLAKFLPEAANNLS-SNQSSSVGVKGTVGYAAPEYGMG-------SEVSTSGDVYSFGILLLEMFTGKGPTN  378 (484)
Q Consensus       307 ~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~Gvvl~elltg~~p~~  378 (484)
                      +.+||+|||++..+........ ..........||..|+|||++.+       ..++.++|||||||++|||++|..||.
T Consensus       157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~  236 (336)
T 3g2f_A          157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF  236 (336)
T ss_dssp             SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred             CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence            9999999999987643321110 11122234569999999999876       456789999999999999999977764


Q ss_pred             CCccCCccHhHHHHhhc--c--hhhhhhcC-cccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCC
Q 011508          379 EMFTGNLTLHNFVKEAL--P--ERLAEIVD-PVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRER  453 (484)
Q Consensus       379 ~~~~~~~~~~~~~~~~~--~--~~~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  453 (484)
                      ...........+.....  +  ......+. .........             .......++..+.+++.+||+.||++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~l~~li~~cl~~dP~~R  303 (336)
T 3g2f_A          237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE-------------AWKENSLAVRSLKETIEDCWDQDAEAR  303 (336)
T ss_dssp             TTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT-------------TCCCCSHHHHHHHHHHHHHSCSSGGGS
T ss_pred             CccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc-------------ccccccchHHHHHHHHHHHhcCChhhC
Confidence            43221111111110000  0  00111110 000000000             000023357789999999999999999


Q ss_pred             CCHHHHHHHHHHHHHHHhhccCCCcce
Q 011508          454 MNMEEVAAQLLSFRNKLVKNVRGQPAT  480 (484)
Q Consensus       454 Pt~~evl~~L~~i~~~~~~~~~~~~~~  480 (484)
                      ||++||++.|+++...+.++....|+.
T Consensus       304 ps~~e~l~~L~~ll~~~~~~~~~~~~~  330 (336)
T 3g2f_A          304 LTAQXAEERMAELMMIWERNKSVSPTA  330 (336)
T ss_dssp             CCHHHHHHHHHHHHHCCCC--------
T ss_pred             cchHHHHHHHHHHHHHHHhcccCCCcc
Confidence            999999999999999998887776654

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-44  Score=338.05  Aligned_cols=257  Identities=28%  Similarity=0.426  Sum_probs=206.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||.||+|+..   ++..||+|++..... ..+.+.+|++++++++||||+++++++     ..+..
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~   79 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAP   79 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET---TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSS
T ss_pred             hhhceeeheecCCCccEEEEEEec---CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCc
Confidence            357889999999999999999965   356799999975433 346799999999999999999999985     34457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  153 (269)
T 4hcu_A           80 ICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMT  153 (269)
T ss_dssp             EEEEEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred             eEEEEEeCCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccc
Confidence            89999999999999999743   235899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ........      .......++..|+|||.+.+..++.++||||+|+++|+|++ |+.||......     ......  
T Consensus       154 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~~~~~~--  220 (269)
T 4hcu_A          154 RFVLDDQY------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDI--  220 (269)
T ss_dssp             GGBCCHHH------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHH--
T ss_pred             cccccccc------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----HHHHHH--
Confidence            86643321      11223446788999999988899999999999999999999 99999753211     111110  


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                         .......                       .+..++..+.+++..||+.||++|||+.|+++.|+++.+
T Consensus       221 ---~~~~~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          221 ---STGFRLY-----------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             ---HTTCCCC-----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---hcCccCC-----------------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence               0000000                       011225578999999999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.9e-44  Score=346.97  Aligned_cols=271  Identities=20%  Similarity=0.273  Sum_probs=210.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .++|++.+.||+|+||.||+|+.  ..+++.||||++.....  .+.+.+|+++++++ +||||+++++++..     +.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~   78 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKN--LYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GK   78 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEE--TTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TT
T ss_pred             cCCeEEEEEeeccCCceEEEEEE--CCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CC
Confidence            46799999999999999999984  34678999999875432  34688999999999 99999999998543     45


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc-----eEE
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT-----AHV  311 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~-----~kl  311 (484)
                      ..++||||+ +++|.+++...   ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.     +||
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl  151 (330)
T 2izr_A           79 YNAMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHI  151 (330)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred             ccEEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEE
Confidence            789999999 99999999854   246999999999999999999999   889999999999999998887     999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      +|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .....
T Consensus       152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~--~~~~~  229 (330)
T 2izr_A          152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT--LKERY  229 (330)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS--HHHHH
T ss_pred             EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc--HHHHH
Confidence            9999998764432211111112245679999999999999999999999999999999999999998643221  11111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHh
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV  471 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  471 (484)
                      ............ ..+                       ...++ ++.+++..||+.||.+||++.+|.+.|+++.++..
T Consensus       230 ~~i~~~~~~~~~-~~~-----------------------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~  284 (330)
T 2izr_A          230 QKIGDTKRATPI-EVL-----------------------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG  284 (330)
T ss_dssp             HHHHHHHHHSCH-HHH-----------------------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHhhhccCCH-HHH-----------------------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            111000000000 000                       11124 78999999999999999999999999998877653

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.3e-45  Score=356.85  Aligned_cols=265  Identities=25%  Similarity=0.433  Sum_probs=197.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|+.... ..+..||||+++.... ...+.+.+|+.++++++||||+++++++.     ..
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~  118 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KS  118 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eC
Confidence            35789999999999999999986422 3467899999976533 23467899999999999999999999963     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.++++..   ...+++.+++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  192 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFG  192 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred             CceEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCc
Confidence            5789999999999999999743   345899999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      +++........    ........++..|+|||++.+..++.++|||||||++|||++ |+.||......     +...  
T Consensus       193 ~a~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-----~~~~--  261 (373)
T 2qol_A          193 LGRVLEDDPEA----AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----DVIK--  261 (373)
T ss_dssp             -------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-----HHHH--
T ss_pred             cccccccCCcc----ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH--
Confidence            99876433211    111122335778999999988899999999999999999998 99999653211     1111  


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                             .++.....                   ..+..++..+.+++..||+.||++||++.||++.|+.+....
T Consensus       262 -------~i~~~~~~-------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          262 -------AVDEGYRL-------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             -------HHHTTEEC-------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             -------HHHcCCCC-------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence                   00000000                   001233667899999999999999999999999999987653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2e-45  Score=361.43  Aligned_cols=262  Identities=27%  Similarity=0.408  Sum_probs=207.4

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ..++|.+.+.||+|+||.||+|++..  +++.||||+++.... ...+.+.+|++++++++||||++++++|.     .+
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~  184 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRA--DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QK  184 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT--TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEec--CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cC
Confidence            44678899999999999999999643  568899999875432 22346889999999999999999999963     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus       185 ~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          185 QPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCC
Confidence            57899999999999999997532   34899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      +++........     .......++..|+|||.+.+..++.++|||||||++|||+| |..||......  .....+...
T Consensus       259 ~s~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--~~~~~~~~~  331 (377)
T 3cbl_A          259 MSREEADGVYA-----ASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTREFVEKG  331 (377)
T ss_dssp             GCEECTTSEEE-----CCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--HHHHHHHTT
T ss_pred             CceecCCCcee-----ecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC
Confidence            99864322111     00111235778999999988889999999999999999998 99999763211  111111100


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                              .  .+                     ..+..|+.++.+++..||+.||++|||++||++.|+.++++
T Consensus       332 --------~--~~---------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          332 --------G--RL---------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             --------C--CC---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------C--CC---------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                    0  00                     00233466789999999999999999999999999999765

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.4e-44  Score=340.63  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=201.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|++.+.||+|+||.||+|+.  ..++..||+|++......   ..+.+.+|+.++++++||||+++++++     ..
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~   82 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAED--TILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EE   82 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEE--TTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----EC
T ss_pred             hccEEEEEEEccCCCEEEEEEEE--CCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----ee
Confidence            46799999999999999999984  446788999998654332   235788999999999999999999985     34


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ++..++||||+++++|.+++....    .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Df  155 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDF  155 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeC
Confidence            558899999999999999997543    4899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |++.......      ........||+.|+|||.+.+..++.++||||||+++|||+||+.||.......     .....
T Consensus       156 g~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~  224 (294)
T 4eqm_A          156 GIAKALSETS------LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS-----IAIKH  224 (294)
T ss_dssp             SSSTTC-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH-----HHHHH
T ss_pred             CCcccccccc------ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHH
Confidence            9998764322      111223468999999999999999999999999999999999999997632111     00000


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-CHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-NMEEVAAQLLSFR  467 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~  467 (484)
                      ....    .. ....                   ....+++..+.+++.+||+.||++|| +++++.+.|+.+.
T Consensus       225 ~~~~----~~-~~~~-------------------~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          225 IQDS----VP-NVTT-------------------DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HSSC----CC-CHHH-------------------HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             hhcc----CC-Ccch-------------------hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            0000    00 0000                   00122356789999999999999999 8999988887654

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.4e-44  Score=346.14  Aligned_cols=249  Identities=22%  Similarity=0.287  Sum_probs=201.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeecc---CccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||+|+++..   .......+.+|+.+++.++||||+++++++     ...
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~   77 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVRE--KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTH   77 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE--TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECS
T ss_pred             HHeEEEEEEecCCCeEEEEEEE--CCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeC
Confidence            5789999999999999999984  446789999999754   233456788999999999999999999985     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|.+++....    .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        78 ~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG  150 (337)
T 1o6l_A           78 DRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeecc
Confidence            58899999999999999997543    4899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +++.....       ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....... 
T Consensus       151 ~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i-  217 (337)
T 1o6l_A          151 LCKEGISD-------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELI-  217 (337)
T ss_dssp             TCBCSCCT-------TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH-
T ss_pred             chhhcccC-------CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHHHH-
Confidence            99854221       1122345799999999999999999999999999999999999999975311     1111111 


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  462 (484)
                             ....+..                     +..++.++.+++.+||+.||++||     +++|+++.
T Consensus       218 -------~~~~~~~---------------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          218 -------LMEEIRF---------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -------HHCCCCC---------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -------HcCCCCC---------------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                   0000000                     112255788999999999999999     89998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.9e-44  Score=348.86  Aligned_cols=252  Identities=21%  Similarity=0.271  Sum_probs=201.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc------chHHHHHHHHHHHcCCCCCceeEeeeeeeec
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG------ASKSFIAECQALRSIRHRNLVKIITSCVSVD  231 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  231 (484)
                      .+.|.+.+.||+|+||.||+|+.  ..++..||+|+++.....      ..+.+.+|+.++++++||||+++++++    
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~--~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~----   84 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCRE--KSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY----   84 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEE--TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             hhceEEeeEEeeCcCEEEEEEEE--CCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE----
Confidence            46799999999999999999994  446789999999765422      246789999999999999999999985    


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC----
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL----  307 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~----  307 (484)
                       ......++||||+++|+|.+++..    ...+++..+..++.||+.||+|||   +++|+||||||+||+++.++    
T Consensus        85 -~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~  156 (361)
T 2yab_A           85 -ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIP  156 (361)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSC
T ss_pred             -EeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCcc
Confidence             445588999999999999999963    235899999999999999999999   89999999999999998776    


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      .+||+|||++.......        ......||+.|+|||++.+..++.++|||||||++|+|++|..||......    
T Consensus       157 ~vkl~DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~----  224 (361)
T 2yab_A          157 HIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----  224 (361)
T ss_dssp             CEEECCCSSCEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----
T ss_pred             CEEEEecCCceEcCCCC--------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH----
Confidence            79999999998764321        122356999999999999989999999999999999999999999753211    


Q ss_pred             hHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          388 HNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                       ....        .+..........                 ....++..+.+++..||..||++|||+.|+++
T Consensus       225 -~~~~--------~i~~~~~~~~~~-----------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          225 -ETLA--------NITAVSYDFDEE-----------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -HHHH--------HHHTTCCCCCHH-----------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHH--------HHHhcCCCCCch-----------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             1111        111100000000                 01122557889999999999999999999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-44  Score=354.91  Aligned_cols=277  Identities=25%  Similarity=0.407  Sum_probs=204.1

Q ss_pred             CCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .|.+.+.||+|+||.||+|++... .....||+|.++... ....+.+.+|+.++++++||||++++++|.    ..+..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~~~~~  165 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEGS  165 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----CCSSC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----cCCCC
Confidence            466778999999999999987533 234679999987543 234568999999999999999999999863    34457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++|+|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a  239 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLA  239 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             eEEEEECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccc
Confidence            78999999999999999743   345889999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +........   .........++..|+|||.+.+..++.++|||||||++|||+| |.+||.......  ....+.... 
T Consensus       240 ~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~~~~~~~~~-  313 (373)
T 3c1x_A          240 RDMYDKEFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQGR-  313 (373)
T ss_dssp             ---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--HHHHHHTTC-
T ss_pred             ccccccccc---cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--HHHHHHcCC-
Confidence            866432211   1111223457889999999988899999999999999999999 677776532221  111111000 


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHhhccCC
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVKNVRG  476 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~~  476 (484)
                               ..                     ..+..++..+.+++..||+.||++|||+.|+++.|+.+...+......
T Consensus       314 ---------~~---------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~  363 (373)
T 3c1x_A          314 ---------RL---------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYV  363 (373)
T ss_dssp             ---------CC---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBC
T ss_pred             ---------CC---------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccccee
Confidence                     00                     002234667899999999999999999999999999998877544433


Q ss_pred             -Ccceee
Q 011508          477 -QPATYV  482 (484)
Q Consensus       477 -~~~~~~  482 (484)
                       -+++|+
T Consensus       364 ~~~~~~~  370 (373)
T 3c1x_A          364 HVNATYV  370 (373)
T ss_dssp             CCCTTTT
T ss_pred             eccceeE
Confidence             244554

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.8e-44  Score=360.17  Aligned_cols=255  Identities=30%  Similarity=0.402  Sum_probs=206.7

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ..++|++.+.||+|+||.||+|.+.    ++.||||+++...  ..+.+.+|++++++++||||+++++++.    ..+.
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~----~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~  260 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKG  260 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET----TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE----CTTS
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec----CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE----cCCC
Confidence            4467889999999999999999864    5689999997543  4578999999999999999999999874    3334


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++|+|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       261 ~~~iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~  335 (450)
T 1k9a_A          261 GLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGL  335 (450)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence            6899999999999999998653  234789999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++......          ....++..|+|||.+.+..++.++|||||||++|||+| |+.||.......  ....+... 
T Consensus       336 a~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~~~-  402 (450)
T 1k9a_A          336 TKEASSTQ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKG-  402 (450)
T ss_dssp             CEECC----------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--HHHHHHTT-
T ss_pred             cccccccc----------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcC-
Confidence            98542211          11246889999999999999999999999999999998 999997643221  11111100 


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                             ..  +                     ..+..|+..+.+++..||+.||++|||+.|+++.|+.++..
T Consensus       403 -------~~--~---------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          403 -------YK--M---------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             -------CC--C---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -------CC--C---------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                   00  0                     01234567899999999999999999999999999998754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6e-44  Score=337.88  Aligned_cols=253  Identities=27%  Similarity=0.439  Sum_probs=199.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc-------hHHHHHHHHHHHcCCCCCceeEeeeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA-------SKSFIAECQALRSIRHRNLVKIITSCVSV  230 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~  230 (484)
                      .++|++.+.||+|+||.||+|+..  .+++.||+|++.......       .+.+.+|+.++++++||||+++++++.  
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--   93 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLV--KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--   93 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEET--TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET--
T ss_pred             hccceehhccccCCceeEEEEEEc--CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec--
Confidence            467899999999999999999954  357889999986543322       167889999999999999999999852  


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeecCCCc
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP--IVHCDLKPSNVLLDGELT  308 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~NIll~~~~~  308 (484)
                         +.  .++||||+++|+|.+++...   ...+++..++.++.|++.||+|||   +++  |+||||||+||+++.++.
T Consensus        94 ---~~--~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~  162 (287)
T 4f0f_A           94 ---NP--PRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDE  162 (287)
T ss_dssp             ---TT--TEEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCT
T ss_pred             ---CC--CeEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCC
Confidence               22  26999999999999988632   346899999999999999999999   888  999999999999988776


Q ss_pred             -----eEEcccCcccccccccccCCCCccccccccccccccCccccC--CCCCCcccceehhhHHHHHHHhCCCCCCCCc
Q 011508          309 -----AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM--GSEVSTSGDVYSFGILLLEMFTGKGPTNEMF  381 (484)
Q Consensus       309 -----~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~  381 (484)
                           +||+|||+++....          ......||+.|+|||.+.  ...++.++|||||||++|||++|+.||....
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  232 (287)
T 4f0f_A          163 NAPVCAKVADFGLSQQSVH----------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS  232 (287)
T ss_dssp             TCSCCEEECCCTTCBCCSS----------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             CCceeEEeCCCCccccccc----------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence                 99999999875422          122346899999999983  4567899999999999999999999997643


Q ss_pred             cCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          382 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .............       -..+.                       .+..++..+.+++..||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~-------~~~~~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          233 YGKIKFINMIREE-------GLRPT-----------------------IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCHHHHHHHHHHS-------CCCCC-----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccHHHHHHHHhcc-------CCCCC-----------------------CCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            3221111111100       00000                       02233667899999999999999999999999


Q ss_pred             HHHH
Q 011508          462 QLLS  465 (484)
Q Consensus       462 ~L~~  465 (484)
                      .|++
T Consensus       283 ~L~~  286 (287)
T 4f0f_A          283 ELSE  286 (287)
T ss_dssp             HHHT
T ss_pred             HHHh
Confidence            9975

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.4e-44  Score=338.37  Aligned_cols=272  Identities=18%  Similarity=0.232  Sum_probs=212.1

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .++|++.+.||+|+||.||+|+.  ..+++.||+|++....  ..+.+.+|+.+++++ +|+|++++++++.     ...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~   79 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTN--LLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGL   79 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEE--TTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETT
T ss_pred             ccceEEEEEEeecCCEEEEEEEE--CCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCc
Confidence            46799999999999999999984  3467899999986443  335688899999999 8999999999853     345


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc-----eEE
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT-----AHV  311 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~-----~kl  311 (484)
                      ..++||||+ +++|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.     +||
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl  152 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYV  152 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             eeEEEEEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEE
Confidence            889999999 99999999754   235899999999999999999999   999999999999999987775     999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCcc--HhH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLT--LHN  389 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~--~~~  389 (484)
                      +|||++.....................||+.|+|||++.+..++.++||||||+++|||++|+.||.........  +..
T Consensus       153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (298)
T 1csn_A          153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  232 (298)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence            999999877543321111112234567999999999999999999999999999999999999999764322110  000


Q ss_pred             HHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          390 FVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                      ......+......                            ...++.++.+++..||+.||++|||+++|++.|+++.++
T Consensus       233 ~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          233 IGEKKQSTPLREL----------------------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HHHHHHHSCHHHH----------------------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHhhccCccHHHH----------------------------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence            0000000000000                            112356789999999999999999999999999999887


Q ss_pred             Hhhc
Q 011508          470 LVKN  473 (484)
Q Consensus       470 ~~~~  473 (484)
                      ....
T Consensus       285 ~~~~  288 (298)
T 1csn_A          285 LNTT  288 (298)
T ss_dssp             TTCC
T ss_pred             cCCC
Confidence            6443

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=351.73  Aligned_cols=270  Identities=25%  Similarity=0.400  Sum_probs=211.1

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeec
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVD  231 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  231 (484)
                      ...++|++.+.||+|+||.||+|+....   .+++.||+|+++.... ...+.+.+|+.++++++||||+++++++.   
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---  120 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA---  120 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC---
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc---
Confidence            3457899999999999999999997532   3568999999976543 23467899999999999999999999953   


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDA--------------------PRNLNLLQRLSIAVDVASTLEYLHHYCETPI  291 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  291 (484)
                        .++..++||||+++|+|.+++......                    ...+++.+++.++.||+.||+|||   +++|
T Consensus       121 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~i  195 (343)
T 1luf_A          121 --VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKF  195 (343)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             --cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence              455789999999999999999864321                    256899999999999999999999   8999


Q ss_pred             eecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHH
Q 011508          292 VHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMF  371 (484)
Q Consensus       292 vH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ell  371 (484)
                      +||||||+||+++.++.+||+|||++........     ........+|+.|+|||++.+..++.++||||||+++|||+
T Consensus       196 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  270 (343)
T 1luf_A          196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF  270 (343)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCcceEEECCCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence            9999999999999999999999999986643221     11122345789999999998888999999999999999999


Q ss_pred             h-CCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCc
Q 011508          372 T-GKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELP  450 (484)
Q Consensus       372 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  450 (484)
                      | |+.||.....     .+....        +.+.....                    .+..++..+.+++..||+.||
T Consensus       271 t~g~~p~~~~~~-----~~~~~~--------~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~~p  317 (343)
T 1luf_A          271 SYGLQPYYGMAH-----EEVIYY--------VRDGNILA--------------------CPENCPLELYNLMRLCWSKLP  317 (343)
T ss_dssp             TTTCCTTTTSCH-----HHHHHH--------HHTTCCCC--------------------CCTTCCHHHHHHHHHHTCSSG
T ss_pred             hcCCCcCCCCCh-----HHHHHH--------HhCCCcCC--------------------CCCCCCHHHHHHHHHHcccCc
Confidence            9 9999975321     111110        11100000                    012335678999999999999


Q ss_pred             CCCCCHHHHHHHHHHHHHHHh
Q 011508          451 RERMNMEEVAAQLLSFRNKLV  471 (484)
Q Consensus       451 ~~RPt~~evl~~L~~i~~~~~  471 (484)
                      ++|||+.||++.|+++.+++.
T Consensus       318 ~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          318 ADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             GGSCCHHHHHHHHHHTTC---
T ss_pred             ccCCCHHHHHHHHHHHHhhhh
Confidence            999999999999999876654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.6e-44  Score=347.34  Aligned_cols=255  Identities=23%  Similarity=0.316  Sum_probs=200.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .++|++.+.||+|+||.||+|+..  .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.     .+.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~   78 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNR--VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGN   78 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             hhhceeeeEEecCCCEEEEEEEEC--CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence            368999999999999999999844  4578899999875433 22356889999999999999999999854     445


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++|+|.+++..    ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~  151 (323)
T 3tki_A           79 IQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGL  151 (323)
T ss_dssp             EEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeec
Confidence            88999999999999999863    335899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +..+.....     ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||............+.....
T Consensus       152 a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~  226 (323)
T 3tki_A          152 ATVFRYNNR-----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT  226 (323)
T ss_dssp             CEECEETTE-----ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT
T ss_pred             cceeccCCc-----ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc
Confidence            986643221     111224569999999999887765 78999999999999999999999764333222222211100


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .      ..                         ....+...+.+++.+||+.||++|||+.|+++.
T Consensus       227 ~------~~-------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          227 Y------LN-------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             T------ST-------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             c------CC-------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            0      00                         012235568899999999999999999999764

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=341.52  Aligned_cols=284  Identities=19%  Similarity=0.242  Sum_probs=210.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .++|.+.+.||+|+||.||+|+..  .+++.||||+++... ....+.+.+|++++++++||||+++++++..   ....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~   82 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHK--KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTR   82 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTC
T ss_pred             CCCEEEEEEecCCCCeEEEEEEEC--CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeec---CCCc
Confidence            357899999999999999999954  357899999997543 2345678899999999999999999998642   2344


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCCceEEc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL----DGELTAHVS  312 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~  312 (484)
                      ..++||||+++++|.+++..... ...+++..++.++.|++.||+|||   +++|+||||||+||++    +.++.+||+
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred             eEEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence            77999999999999999985432 234899999999999999999999   8999999999999999    778889999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccC--------CCCCCcccceehhhHHHHHHHhCCCCCCCCccCC
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM--------GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN  384 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~  384 (484)
                      |||+++......        ......||..|+|||++.        +..++.++|||||||++|||++|+.||.......
T Consensus       159 Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  230 (319)
T 4euu_A          159 DFGAARELEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR  230 (319)
T ss_dssp             CCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred             cCCCceecCCCC--------ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence            999998764322        122346899999999875        5778999999999999999999999997543222


Q ss_pred             ccH---hHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          385 LTL---HNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       385 ~~~---~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...   ........+..+..+.+..-.. ..  ....     ..............+.+++..||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~-~~--~~~~-----~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~  302 (319)
T 4euu_A          231 RNKEVMYKIITGKPSGAISGVQKAENGP-ID--WSGD-----MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (319)
T ss_dssp             GCHHHHHHHHHHCCTTCCEEEECSTTCC-EE--EESS-----CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             hhHHHHHHHhcCCCcccchhhhcccCCc-cc--cCcc-----CCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhh
Confidence            111   1111111111111111000000 00  0000     00011123556788999999999999999999999999


Q ss_pred             HHHHH
Q 011508          462 QLLSF  466 (484)
Q Consensus       462 ~L~~i  466 (484)
                      ...+.
T Consensus       303 h~~d~  307 (319)
T 4euu_A          303 ETSDI  307 (319)
T ss_dssp             HHHHH
T ss_pred             ccHHH
Confidence            88754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.2e-44  Score=347.82  Aligned_cols=278  Identities=27%  Similarity=0.352  Sum_probs=210.6

Q ss_pred             CCccCccccccceeEEEEEEc--CCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          161 FSLENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      |++.+.||+|+||.||++.+.  +..+++.||||+++.... ...+.+.+|++++++++||||+++++++..   .+...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---~~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED---AGAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---TTTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEec---CCCce
Confidence            488899999999999998763  334678999999986543 234678999999999999999999998753   22457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++|+|.+++...     .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             EEEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccc
Confidence            89999999999999999743     3899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc-
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP-  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-  396 (484)
                      .........    ........++..|+|||++.+..++.++||||||+++|||+||+.||............+...... 
T Consensus       182 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  257 (318)
T 3lxp_A          182 KAVPEGHEY----YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV  257 (318)
T ss_dssp             EECCTTCSE----EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH
T ss_pred             ccccccccc----cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH
Confidence            876432211    111223457888999999988889999999999999999999999986531110000000000000 


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHhh
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVK  472 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~  472 (484)
                      ..+.+.++....                   ...+..++.++.+++..||+.||++|||+.|+++.|+.+.+++..
T Consensus       258 ~~~~~~~~~~~~-------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          258 LRLTELLERGER-------------------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             HHHHHHHHTTCC-------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhcccC-------------------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence            001111111100                   001233467899999999999999999999999999999988754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=8.5e-45  Score=340.17  Aligned_cols=259  Identities=29%  Similarity=0.443  Sum_probs=206.6

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ..++|++.+.||+|+||.||+|...   ++..||+|+++.... ..+.+.+|++++.+++||||+++++++     ..+.
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~   76 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK---GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEY   76 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred             chhheeeeeeeccCCCceEEEEEec---CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence            3467899999999999999999865   456799999975443 346789999999999999999999985     4455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++....   ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~  150 (268)
T 3sxs_A           77 PIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGM  150 (268)
T ss_dssp             SEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTC
T ss_pred             ceEEEEEccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCcc
Confidence            7899999999999999997542   35899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.......      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......     .....  
T Consensus       151 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~--  217 (268)
T 3sxs_A          151 TRYVLDDQ------YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVLK--  217 (268)
T ss_dssp             EEECCTTC------EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHH--
T ss_pred             ceecchhh------hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHHH--
Confidence            98664322      111223446788999999988889999999999999999999 99999653211     11100  


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                            +......                    ..+..++..+.+++..||+.||++|||+.|+++.|+.++++
T Consensus       218 ------~~~~~~~--------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          218 ------VSQGHRL--------------------YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ------HHTTCCC--------------------CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ------HHcCCCC--------------------CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                  0000000                    00112245788999999999999999999999999988654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-44  Score=342.87  Aligned_cols=253  Identities=20%  Similarity=0.282  Sum_probs=201.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||.||+|+.  ..++..||+|.+.... .....+.+|+.+++.++||||+++++++.     +.+.
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~   75 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVE--TSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEE   75 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTE
T ss_pred             hhceEeeeEEecCCCeEEEEEEE--CCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCE
Confidence            46899999999999999999994  4467899999987543 34467889999999999999999999864     3458


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC--CCceEEcccC
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG--ELTAHVSDFG  315 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfg  315 (484)
                      .++||||+++|+|.+++...   ...+++.+++.++.|++.||+|||   +++|+||||||+||+++.  ++.+||+|||
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg  149 (321)
T 1tki_A           76 LVMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFG  149 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred             EEEEEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence            89999999999999999632   235899999999999999999999   899999999999999987  7899999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++.......        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......     .....  
T Consensus       150 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~--  214 (321)
T 1tki_A          150 QARQLKPGD--------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIEN--  214 (321)
T ss_dssp             TCEECCTTC--------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH--
T ss_pred             CCeECCCCC--------ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHH--
Confidence            998764321        122356899999999999988999999999999999999999999753211     11111  


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                            +.........                 .....++.++.+++.+||+.||++|||+.|+++.
T Consensus       215 ------i~~~~~~~~~-----------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          215 ------IMNAEYTFDE-----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ------HHHTCCCCCH-----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------HHcCCCCCCh-----------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                  1100000000                 0011235678999999999999999999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=349.92  Aligned_cols=268  Identities=25%  Similarity=0.361  Sum_probs=211.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcC-----CCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDH-----DDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSV  230 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  230 (484)
                      .++|.+.+.||+|+||.||+|+...     ...+..||+|+++.... .....+.+|+++++++ +||||+++++++.  
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--  145 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--  145 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec--
Confidence            4678899999999999999998642     13457899999976543 2336788999999999 9999999999853  


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRDA------------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKP  298 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~  298 (484)
                         .++..++||||+++|+|.+++......            ...+++..++.++.|++.||+|||   +++|+||||||
T Consensus       146 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp  219 (382)
T 3tt0_A          146 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAA  219 (382)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred             ---cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCc
Confidence               445789999999999999999865421            245899999999999999999999   88999999999


Q ss_pred             CCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCC
Q 011508          299 SNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPT  377 (484)
Q Consensus       299 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~  377 (484)
                      +||+++.++.+||+|||+++.......     ........+|..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~  294 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  294 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCT-----TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ceEEEcCCCcEEEcccCcccccccccc-----cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999986643221     112223457889999999999999999999999999999999 99998


Q ss_pred             CCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                      .....     .+......     ......                       .+..++.++.+++..||+.||++|||++
T Consensus       295 ~~~~~-----~~~~~~~~-----~~~~~~-----------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~  341 (382)
T 3tt0_A          295 PGVPV-----EELFKLLK-----EGHRMD-----------------------KPSNCTNELYMMMRDCWHAVPSQRPTFK  341 (382)
T ss_dssp             TTCCH-----HHHHHHHH-----TTCCCC-----------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCH-----HHHHHHHH-----cCCCCC-----------------------CCccCCHHHHHHHHHHcCCChhhCcCHH
Confidence            65321     11111100     000000                       0122356789999999999999999999


Q ss_pred             HHHHHHHHHHHHHh
Q 011508          458 EVAAQLLSFRNKLV  471 (484)
Q Consensus       458 evl~~L~~i~~~~~  471 (484)
                      ||++.|+.+.....
T Consensus       342 ell~~L~~~~~~~~  355 (382)
T 3tt0_A          342 QLVEDLDRIVALTS  355 (382)
T ss_dssp             HHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHHHHh
Confidence            99999999976653

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.8e-44  Score=350.98  Aligned_cols=255  Identities=21%  Similarity=0.271  Sum_probs=201.0

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-----ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-----RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      +.|++.+.||+|+||.||+|+.  ..+++.||||++....     ....+.+.+|+.+++.++||||+++++++.     
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----   96 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCIN--RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----   96 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE--TTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             cceEEeeEEeeCCCEEEEEEEE--CCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----
Confidence            5689999999999999999984  4467899999986432     123567899999999999999999999864     


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---eE
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT---AH  310 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~---~k  310 (484)
                      .+...++||||+++++|.+++.........+++..++.++.||+.||+|||   +++|+||||||+||+++.++.   +|
T Consensus        97 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vk  173 (351)
T 3c0i_A           97 SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVK  173 (351)
T ss_dssp             ETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEE
T ss_pred             eCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEE
Confidence            345889999999999999888755444456899999999999999999999   899999999999999987654   99


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      |+|||++.......       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....      ..
T Consensus       174 l~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~  240 (351)
T 3c0i_A          174 LGGFGVAIQLGESG-------LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE------RL  240 (351)
T ss_dssp             ECCCTTCEECCTTS-------CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH------HH
T ss_pred             EecCcceeEecCCC-------eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH------HH
Confidence            99999998764321       112234699999999999999999999999999999999999999975311      11


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...        +..........                 ....++.++.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~--------i~~~~~~~~~~-----------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          241 FEG--------IIKGKYKMNPR-----------------QWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHH--------HHHTCCCCCHH-----------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHH--------HHcCCCCCCcc-----------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            110        00000000000                 01122567899999999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8e-44  Score=336.31  Aligned_cols=259  Identities=26%  Similarity=0.421  Sum_probs=204.8

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ..++|++.+.||+|+||.||+|.+.   ++..||+|+++.... ..+.+.+|++++.+++||||+++++++     ....
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~   92 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQR   92 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET---TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc---CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCC
Confidence            4467889999999999999999865   456799999975533 346799999999999999999999985     4455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~  166 (283)
T 3gen_A           93 PIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGL  166 (283)
T ss_dssp             SEEEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTG
T ss_pred             CeEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccc
Confidence            789999999999999999743   235899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +........      .......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||......     .....  
T Consensus       167 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-----~~~~~--  233 (283)
T 3gen_A          167 SRYVLDDEY------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-----ETAEH--  233 (283)
T ss_dssp             GGGBCCHHH------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHH--
T ss_pred             ccccccccc------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-----HHHHH--
Confidence            986643321      11223346788999999988889999999999999999998 99999753211     11100  


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                         +.......                       .+..++..+.+++..||+.||++|||++|+++.|+++.++
T Consensus       234 ---~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          234 ---IAQGLRLY-----------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             ---HHTTCCCC-----------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HhcccCCC-----------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence               00000000                       0112245788999999999999999999999999998754

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2e-44  Score=347.58  Aligned_cols=263  Identities=24%  Similarity=0.397  Sum_probs=201.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCC--eeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDH--ETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|++.+.||+|+||+||+|++..++.  ...||+|.+.... ....+.+.+|+.++++++||||++++++|..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   88 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES-----
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----
Confidence            3568899999999999999999643322  2357888876433 2345789999999999999999999999743     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                       ...++|+||+++|+|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        89 -~~~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Df  161 (327)
T 3poz_A           89 -STVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF  161 (327)
T ss_dssp             -SSEEEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCT
T ss_pred             -CCeEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccC
Confidence             23679999999999999997543   45899999999999999999999   889999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |+++.......     ........+|..|+|||++.+..++.++|||||||++|||+| |+.||......  .+...+..
T Consensus       162 g~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~  234 (327)
T 3poz_A          162 GLAKLLGAEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEK  234 (327)
T ss_dssp             THHHHHTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHT
T ss_pred             cceeEccCCcc-----cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--HHHHHHHc
Confidence            99987643321     111223456889999999999999999999999999999999 99999763221  11111110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      .            ...                   ..+..++..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       235 ~------------~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          235 G------------ERL-------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             T------------CCC-------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             C------------CCC-------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence            0            000                   001223567899999999999999999999999999987543

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.7e-44  Score=342.95  Aligned_cols=279  Identities=25%  Similarity=0.412  Sum_probs=205.9

Q ss_pred             HhHHHhcCCCCccCccccccceeEEEEEEcC-CCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeee
Q 011508          152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDH-DDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCV  228 (484)
Q Consensus       152 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~  228 (484)
                      .++....++|.+.+.||+|+||.||+|.... ..++..||+|+++....  ...+.+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            4444556789999999999999999998653 33567899999875532  23467889999999999999999999986


Q ss_pred             eeccCCCceeeEEeecccCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 011508          229 SVDFQGNDFEALVYELMVNGSLEEWLHLNR--DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE  306 (484)
Q Consensus       229 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~  306 (484)
                      ..........++||||+++++|.+++....  .....+++..++.++.|++.||.|||   +++|+||||||+||+++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCC
Confidence            544333345699999999999999985432  23456999999999999999999999   8999999999999999999


Q ss_pred             CceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCc
Q 011508          307 LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNL  385 (484)
Q Consensus       307 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~  385 (484)
                      +.+||+|||++........     ........+++.|+|||.+.+..++.++||||||+++|||++ |..||......  
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--  256 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDY-----YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--  256 (313)
T ss_dssp             SCEEECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--
T ss_pred             CcEEEeecCcceecccccc-----cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--
Confidence            9999999999986643221     111223457889999999999899999999999999999999 88898653221  


Q ss_pred             cHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          386 TLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       386 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                      .......           ......                    .+..++..+.+++.+||+.||++|||+.|+++.|++
T Consensus       257 ~~~~~~~-----------~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  305 (313)
T 3brb_A          257 EMYDYLL-----------HGHRLK--------------------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK  305 (313)
T ss_dssp             GHHHHHH-----------TTCCCC--------------------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHH-----------cCCCCC--------------------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1111110           000000                    012235678999999999999999999999999999


Q ss_pred             HHHHHh
Q 011508          466 FRNKLV  471 (484)
Q Consensus       466 i~~~~~  471 (484)
                      +.+.+.
T Consensus       306 l~~~lp  311 (313)
T 3brb_A          306 LLESLP  311 (313)
T ss_dssp             HHHHC-
T ss_pred             HHHhcC
Confidence            987654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-43  Score=339.61  Aligned_cols=272  Identities=24%  Similarity=0.336  Sum_probs=202.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC--CCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI--RHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|+..    ++.||||++...   ....+..|.+++..+  +||||+++++++.... ...
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~  107 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR----GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSW  107 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET----TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGG
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC----CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCC
Confidence            467999999999999999999864    678999998643   234455566666554  9999999999875432 222


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--------CeeecCCCCCCeeecCCC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCET--------PIVHCDLKPSNVLLDGEL  307 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~--------~ivH~dlk~~NIll~~~~  307 (484)
                      ...++||||+++|+|.++++..     .+++..++.++.|++.||+|||   +.        +|+||||||+||+++.++
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~  179 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNG  179 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             CceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCC
Confidence            5789999999999999999743     4899999999999999999999   77        999999999999999999


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcc------cceehhhHHHHHHHhC--------
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTS------GDVYSFGILLLEMFTG--------  373 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~------~Dvws~Gvvl~elltg--------  373 (484)
                      .+||+|||++..........   ........||+.|+|||++.+...+.+      +|||||||++|||+||        
T Consensus       180 ~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~  256 (337)
T 3mdy_A          180 TCCIADLGLAVKFISDTNEV---DIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE  256 (337)
T ss_dssp             CEEECCCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CEEEEeCCCceeeccccccc---cCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence            99999999997664332111   111123469999999999887766655      9999999999999999        


Q ss_pred             --CCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcC
Q 011508          374 --KGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPR  451 (484)
Q Consensus       374 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  451 (484)
                        +.||..................        ...+..              .........+|+.++.+++.+||+.||+
T Consensus       257 ~~~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dP~  314 (337)
T 3mdy_A          257 EYQLPYHDLVPSDPSYEDMREIVC--------IKKLRP--------------SFPNRWSSDECLRQMGKLMTECWAHNPA  314 (337)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHT--------TSCCCC--------------CCCGGGGGSHHHHHHHHHHHHHSCSSGG
T ss_pred             cccccHhhhcCCCCchhhhHHHHh--------hhccCc--------------cccccchhhHHHHHHHHHHHHhhhhChh
Confidence              5555443322222211111100        000000              0001111346788999999999999999


Q ss_pred             CCCCHHHHHHHHHHHHHHH
Q 011508          452 ERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       452 ~RPt~~evl~~L~~i~~~~  470 (484)
                      +|||+.||++.|+.+.+..
T Consensus       315 ~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          315 SRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             GSCCHHHHHHHHHHHHHTT
T ss_pred             hCCCHHHHHHHHHHHHhhc
Confidence            9999999999999987654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-44  Score=347.70  Aligned_cols=271  Identities=23%  Similarity=0.329  Sum_probs=208.0

Q ss_pred             hcCCCCccCccccccceeEEEEEEc---CCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeec
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSI-RHRNLVKIITSCVSVD  231 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  231 (484)
                      ..++|.+.+.||+|+||.||+|+..   ....+..||+|++.... ....+.+.+|+.+++++ +||||+++++++.   
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  119 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---  119 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence            4568899999999999999999963   23457789999997543 23446799999999999 9999999999853   


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDA-------------------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIV  292 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  292 (484)
                        ..+..++||||+++|+|.+++......                   ...+++..++.++.|++.||+|||   +++|+
T Consensus       120 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv  194 (344)
T 1rjb_A          120 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCV  194 (344)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             --eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence              345789999999999999999754321                   134899999999999999999999   89999


Q ss_pred             ecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh
Q 011508          293 HCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT  372 (484)
Q Consensus       293 H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt  372 (484)
                      ||||||+||+++.++.+||+|||++........     ........+|+.|+|||.+.+..++.++|||||||++|||+|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  269 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS  269 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCcc-----ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHc
Confidence            999999999999999999999999986643221     112233457889999999988889999999999999999998


Q ss_pred             -CCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcC
Q 011508          373 -GKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPR  451 (484)
Q Consensus       373 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  451 (484)
                       |..||....... .........        ....                       .+..++.++.+++.+||+.||.
T Consensus       270 ~g~~p~~~~~~~~-~~~~~~~~~--------~~~~-----------------------~~~~~~~~l~~li~~~l~~dp~  317 (344)
T 1rjb_A          270 LGVNPYPGIPVDA-NFYKLIQNG--------FKMD-----------------------QPFYATEEIYIIMQSCWAFDSR  317 (344)
T ss_dssp             TSCCSSTTCCCSH-HHHHHHHTT--------CCCC-----------------------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             CCCCCcccCCcHH-HHHHHHhcC--------CCCC-----------------------CCCCCCHHHHHHHHHHcCCCch
Confidence             999997643221 111111110        0000                       0122356789999999999999


Q ss_pred             CCCCHHHHHHHHHHHHHHHhh
Q 011508          452 ERMNMEEVAAQLLSFRNKLVK  472 (484)
Q Consensus       452 ~RPt~~evl~~L~~i~~~~~~  472 (484)
                      +|||+.||++.|+.+......
T Consensus       318 ~Rps~~~l~~~l~~~~~~~~~  338 (344)
T 1rjb_A          318 KRPSFPNLTSFLGCQLADAEE  338 (344)
T ss_dssp             GSCCHHHHHHHHHHHC-----
T ss_pred             hCcCHHHHHHHHHHHHHHHHH
Confidence            999999999999998766543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.3e-43  Score=335.31  Aligned_cols=273  Identities=22%  Similarity=0.306  Sum_probs=212.3

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ..++|++.+.||+|+||.||+|+.  ..+++.||+|++.....  .+.+.+|+.+++.++|++++..+.++.    ..+.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~   78 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTD--IAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGD   78 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEE--TTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEE----EETT
T ss_pred             eccEEEEEEEEccCCCeEEEEEEE--cCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCcccccc----CCCC
Confidence            357899999999999999999984  34678999999875432  356889999999999999888777663    3345


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEcc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSD  313 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~D  313 (484)
                      ..++||||+ +++|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||++   +.++.+||+|
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  151 (296)
T 3uzp_A           79 YNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIID  151 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             ceEEEEEec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEee
Confidence            789999999 999999997432   35899999999999999999999   8999999999999999   4788999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCC--ccHhHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN--LTLHNFV  391 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~--~~~~~~~  391 (484)
                      ||++.....................||..|+|||.+.+..++.++|||||||++|||++|+.||.......  ..+....
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  231 (296)
T 3uzp_A          152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  231 (296)
T ss_dssp             CTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred             CCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence            99998765433211111122344579999999999999999999999999999999999999997643221  1111111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHh
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV  471 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  471 (484)
                      ...........                            ...++.++.+++..||+.||++|||+.||++.|+.+..+..
T Consensus       232 ~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          232 EKKMSTPIEVL----------------------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHHSCHHHH----------------------------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccccCCchHHH----------------------------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence            11110000000                            11235678999999999999999999999999999987764


Q ss_pred             h
Q 011508          472 K  472 (484)
Q Consensus       472 ~  472 (484)
                      .
T Consensus       284 ~  284 (296)
T 3uzp_A          284 F  284 (296)
T ss_dssp             C
T ss_pred             C
Confidence            3

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.9e-43  Score=335.86  Aligned_cols=275  Identities=21%  Similarity=0.307  Sum_probs=209.5

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ...++|++.+.||+|+||.||+|+.  ..+++.||+|++.....  ...+.+|+.+++.++|++++..+..+.    ..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~   77 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTD--IAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEG   77 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEE--TTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEE----EET
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEE--cCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeec----CCC
Confidence            3457899999999999999999984  34678999998765432  245788999999999999888887763    344


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVS  312 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~  312 (484)
                      ...++||||+ +++|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||++   +.++.+||+
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~  150 (296)
T 4hgt_A           78 DYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred             CceEEEEEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEe
Confidence            5789999999 999999997432   35899999999999999999999   8999999999999999   788999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCc--cHhHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNL--TLHNF  390 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~--~~~~~  390 (484)
                      |||++.....................||..|+|||.+.+..++.++|||||||++|||++|+.||........  .+...
T Consensus       151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 4hgt_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence            9999987754332111111223346799999999999999999999999999999999999999976433211  11111


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      .....+......                            ...++.++.+++..||+.||++|||+.||++.|+.+..+.
T Consensus       231 ~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~  282 (296)
T 4hgt_A          231 SEKKMSTPIEVL----------------------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHHSCHHHH----------------------------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             hcccccchhhhh----------------------------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence            111110000000                            1122567899999999999999999999999999998876


Q ss_pred             hhc
Q 011508          471 VKN  473 (484)
Q Consensus       471 ~~~  473 (484)
                      ...
T Consensus       283 ~~~  285 (296)
T 4hgt_A          283 GFS  285 (296)
T ss_dssp             TCC
T ss_pred             CCC
Confidence            543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.3e-44  Score=344.47  Aligned_cols=248  Identities=25%  Similarity=0.352  Sum_probs=198.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|.+.+.||+|+||.||+|+.  ..+++.||+|++....   ......+.+|+.+++.++||||+++++++.     .
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~   80 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATH--YKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----T   80 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEE--TTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             cCCEEEEEEEecCCCeEEEEEEE--CCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----e
Confidence            36899999999999999999994  4467899999987432   223457899999999999999999999954     3


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+ +|+|.+++....    .+++.+++.++.|++.||+|||   +.+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~~lv~E~~-~g~l~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DF  152 (336)
T 3h4j_B           81 PTDIVMVIEYA-GGELFDYIVEKK----RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADF  152 (336)
T ss_dssp             SSEEEEEECCC-CEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCS
T ss_pred             CCEEEEEEECC-CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEe
Confidence            45789999999 789999987543    4899999999999999999999   889999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |++.......        ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........        
T Consensus       153 G~s~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------  216 (336)
T 3h4j_B          153 GLSNIMTDGN--------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--------  216 (336)
T ss_dssp             SCTBTTTTSB--------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--------
T ss_pred             ccceeccCCc--------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--------
Confidence            9998653321        1233469999999999988776 7899999999999999999999975322110        


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                           ...+.....                     ..+..++.++.+++.+||+.||.+|||++|+++.
T Consensus       217 -----~~~i~~~~~---------------------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          217 -----FKKVNSCVY---------------------VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             -----BCCCCSSCC---------------------CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             -----HHHHHcCCC---------------------CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                 000000000                     0012235678899999999999999999999864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=9.5e-44  Score=349.23  Aligned_cols=250  Identities=23%  Similarity=0.323  Sum_probs=195.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  233 (484)
                      .++|++.+.||+|+||.||+|+..  .+++.||+|+++...   ....+.+.+|..++.++ +||||+++++++     .
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~--~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~  123 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLK--KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q  123 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----E
Confidence            357899999999999999999954  457899999998543   22335688899999887 899999999985     4


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||+++|+|.+++....    .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus       124 ~~~~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~D  196 (396)
T 4dc2_A          124 TESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTD  196 (396)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEee
Confidence            4558999999999999999997543    4899999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCcc---HhHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLT---LHNF  390 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~---~~~~  390 (484)
                      ||+++.....       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ....
T Consensus       197 FGla~~~~~~-------~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~  269 (396)
T 4dc2_A          197 YGMCKEGLRP-------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY  269 (396)
T ss_dssp             CTTCBCCCCT-------TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHH
T ss_pred             cceeeecccC-------CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHH
Confidence            9999853221       12233467999999999999999999999999999999999999999653221110   0000


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM  456 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  456 (484)
                      ..       ..+....+..                     +..+..++.+++.+||+.||++||++
T Consensus       270 ~~-------~~i~~~~~~~---------------------p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          270 LF-------QVILEKQIRI---------------------PRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HH-------HHHHHCCCCC---------------------CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HH-------HHHhccccCC---------------------CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            10       0011100000                     12235678899999999999999996

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-44  Score=349.29  Aligned_cols=281  Identities=26%  Similarity=0.359  Sum_probs=212.1

Q ss_pred             cCCCCccCccccccceeEEEEEEc--CCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|++.  +..++..||+|++........+.+.+|++++++++||||+++++++..   .+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   98 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---PGR   98 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---SSS
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---CCC
Confidence            357899999999999999999863  334678999999987655556779999999999999999999998652   345


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++++|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGG
T ss_pred             ceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccc
Confidence            67899999999999999997543   24899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++.........    ........++..|+|||++.+..++.++||||||+++|+|++|+.||..................
T Consensus       173 ~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~  248 (327)
T 3lxl_A          173 LAKLLPLDKDY----YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP  248 (327)
T ss_dssp             GCEECCTTCSE----EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CC
T ss_pred             cceecccCCcc----ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccc
Confidence            99876433211    11122345888899999998888999999999999999999999998642111000000000000


Q ss_pred             -chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          396 -PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       396 -~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                       ...+.+.+....                   ....+..++..+.+++..||+.||++|||+.|+++.|+.+....
T Consensus       249 ~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          249 ALSRLLELLEEGQ-------------------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHHHHHHTTC-------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             cHHHHHHHhhccc-------------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence             000011110000                   00112344678999999999999999999999999999886544

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=339.40  Aligned_cols=258  Identities=29%  Similarity=0.410  Sum_probs=198.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|++.+.||+|+||.||+|++.    ++.||+|++...  ...+.+.+|++++++++||||+++++++.       +..
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~   74 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR----AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPV   74 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET----TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC----CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCc
Confidence            56888999999999999999864    577999998643  34567899999999999999999999853       246


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc-eEEcccCcc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT-AHVSDFGLA  317 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~-~kl~Dfg~a  317 (484)
                      ++||||+++|+|.+++.... ....+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||++
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~  153 (307)
T 2eva_A           75 CLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA  153 (307)
T ss_dssp             EEEEECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-
T ss_pred             EEEEEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccc
Confidence            89999999999999997433 1234789999999999999999999432389999999999999998886 799999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ......          .....||..|+|||++.+..++.++||||||+++|||++|+.||................    
T Consensus       154 ~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~----  219 (307)
T 2eva_A          154 CDIQTH----------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN----  219 (307)
T ss_dssp             ---------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT----
T ss_pred             cccccc----------cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc----
Confidence            755321          112358999999999999999999999999999999999999997542221111100000    


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHh
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV  471 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  471 (484)
                          -..+..                       ...++..+.+++.+||+.||++|||++|+++.|+.+...+.
T Consensus       220 ----~~~~~~-----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          220 ----GTRPPL-----------------------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             ----TCCCCC-----------------------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             ----CCCCCc-----------------------ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence                000000                       12235678899999999999999999999999999876553

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=340.68  Aligned_cols=251  Identities=20%  Similarity=0.246  Sum_probs=200.0

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc------chHHHHHHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG------ASKSFIAECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      +.|.+.+.||+|+||.||+|+.  ..++..||+|++......      ..+.+.+|+.++++++||||+++++++.    
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----   84 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCRE--KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----   84 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEE--TTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             cceEeceEEeeCCCeEEEEEEE--CCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence            4688999999999999999994  446788999999754321      3467899999999999999999999853    


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC----c
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL----T  308 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~----~  308 (484)
                       .....++||||+++++|.+++..    ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++    .
T Consensus        85 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~  156 (326)
T 2y0a_A           85 -NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPR  156 (326)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCC
T ss_pred             -eCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCC
Confidence             45588999999999999999963    245899999999999999999999   89999999999999998887    8


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHh
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH  388 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~  388 (484)
                      +||+|||++.......        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......     
T Consensus       157 ~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----  223 (326)
T 2y0a_A          157 IKIIDFGLAHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----  223 (326)
T ss_dssp             EEECCCTTCEECCTTS--------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----
T ss_pred             EEEEECCCCeECCCCC--------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-----
Confidence            9999999998764321        122346999999999999899999999999999999999999999653211     


Q ss_pred             HHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          389 NFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ......     ... ......                   .....++..+.+++.+||+.||++|||+.|+++
T Consensus       224 ~~~~~~-----~~~-~~~~~~-------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          224 ETLANV-----SAV-NYEFED-------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHH-----HHT-CCCCCH-------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHH-----Hhc-CCCcCc-------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111100     000 000000                   001122567889999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-43  Score=340.29  Aligned_cols=267  Identities=26%  Similarity=0.384  Sum_probs=210.4

Q ss_pred             hcCCCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      ..++|.+.+.||+|+||.||+|+...   ..++..||+|+++.... ...+.+.+|++++++++||||+++++++     
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   95 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-----   95 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----
Confidence            34678899999999999999998632   33568899999975432 3346788999999999999999999985     


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRD--------------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIV  292 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv  292 (484)
                      ..+...++||||+++++|.+++.....                    ....+++.+++.++.|++.||+|||   +++|+
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iv  172 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLV  172 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCc
Confidence            345578999999999999999986543                    1234899999999999999999999   89999


Q ss_pred             ecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh
Q 011508          293 HCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT  372 (484)
Q Consensus       293 H~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt  372 (484)
                      ||||||+||+++.++.+||+|||++.........     .......+++.|+|||.+.+..++.++||||||+++|||++
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  247 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT  247 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCE-----ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccc-----eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999866432211     11223457889999999988889999999999999999999


Q ss_pred             -CCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcC
Q 011508          373 -GKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPR  451 (484)
Q Consensus       373 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  451 (484)
                       |+.||......  .+...+....        ...                       .+..++..+.+++.+||+.||+
T Consensus       248 ~g~~p~~~~~~~--~~~~~~~~~~--------~~~-----------------------~~~~~~~~~~~li~~~l~~dp~  294 (314)
T 2ivs_A          248 LGGNPYPGIPPE--RLFNLLKTGH--------RME-----------------------RPDNCSEEMYRLMLQCWKQEPD  294 (314)
T ss_dssp             TSCCSSTTCCGG--GHHHHHHTTC--------CCC-----------------------CCTTCCHHHHHHHHHHTCSSGG
T ss_pred             CCCCCCCCCCHH--HHHHHhhcCC--------cCC-----------------------CCccCCHHHHHHHHHHccCChh
Confidence             99999754221  1111111000        000                       0122356789999999999999


Q ss_pred             CCCCHHHHHHHHHHHHHH
Q 011508          452 ERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       452 ~RPt~~evl~~L~~i~~~  469 (484)
                      +|||+.|+++.|+++..+
T Consensus       295 ~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          295 KRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GSCCHHHHHHHHHHHHHT
T ss_pred             hCcCHHHHHHHHHHHHhh
Confidence            999999999999988654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=344.43  Aligned_cols=274  Identities=19%  Similarity=0.232  Sum_probs=209.8

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ..++|++.+.||+|+||.||+|+.  ..+++.||+|++........+.+.+|+++++.++||||+++++++.... ....
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~  103 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEG--LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH  103 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEE--TTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEe--cCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence            346799999999999999999984  3457899999997765556678999999999999999999999976432 3345


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++|+|.+++.........+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||.
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence            789999999999999999865545567999999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccccccCCC--CccccccccccccccCccccCCCC---CCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          317 AKFLPEAANNLSS--NQSSSVGVKGTVGYAAPEYGMGSE---VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       317 a~~~~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      +............  .........||..|+|||++.+..   ++.++||||||+++|||++|+.||..............
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            8765322110000  000112345799999999987654   68899999999999999999999864322211111111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                      ..            .... +                  ....++..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus       261 ~~------------~~~~-~------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          261 QN------------QLSI-P------------------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HC------------C--C-C------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hc------------cCCC-C------------------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            10            0000 0                  01122567899999999999999999999999998764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.5e-44  Score=346.45  Aligned_cols=275  Identities=25%  Similarity=0.409  Sum_probs=196.9

Q ss_pred             HHhcCCCCccCccccccceeEEEEEEcCCCC-eeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeec
Q 011508          155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDH-ETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVD  231 (484)
Q Consensus       155 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  231 (484)
                      ....++|++.+.||+|+||.||+|+....+. ...||||+++...  ....+.+.+|++++++++||||+++++++....
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3455789999999999999999998543221 1379999997542  334578999999999999999999999875433


Q ss_pred             cCC-CceeeEEeecccCCCHHHHHhhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 011508          232 FQG-NDFEALVYELMVNGSLEEWLHLNRD--APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT  308 (484)
Q Consensus       232 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~  308 (484)
                      ..+ ....++||||+++|+|.+++.....  ....+++..++.++.|++.||+|||   +++|+||||||+||+++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCC
Confidence            111 1123899999999999999975432  2235899999999999999999999   899999999999999999999


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccH
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTL  387 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~  387 (484)
                      +||+|||+++.......     ........+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......  .
T Consensus       176 ~kl~Dfg~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~  248 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDY-----YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--I  248 (323)
T ss_dssp             EEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--H
T ss_pred             EEEeecccccccccccc-----ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH--H
Confidence            99999999986643221     111223446788999999988899999999999999999999 999997632211  1


Q ss_pred             hHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          388 HNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                      ...+           .......                    .+..++.++.+++.+||+.||++|||+.|+++.|+++.
T Consensus       249 ~~~~-----------~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l  297 (323)
T 3qup_A          249 YNYL-----------IGGNRLK--------------------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL  297 (323)
T ss_dssp             HHHH-----------HTTCCCC--------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH-----------hcCCCCC--------------------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111           0000000                    01223567899999999999999999999999999987


Q ss_pred             HHH
Q 011508          468 NKL  470 (484)
Q Consensus       468 ~~~  470 (484)
                      ...
T Consensus       298 ~~~  300 (323)
T 3qup_A          298 GHL  300 (323)
T ss_dssp             HC-
T ss_pred             HHh
Confidence            654

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.9e-44  Score=338.09  Aligned_cols=263  Identities=23%  Similarity=0.378  Sum_probs=198.3

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ..++|++.+.||+|+||.||+|+.... ..+..||+|++..... ...+.+.+|+.++++++||||+++++++.      
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------   86 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------   86 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------
Confidence            346789999999999999999987543 2356799999875433 23467889999999999999999999852      


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ++..++||||+++++|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df  160 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDF  160 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred             cCccEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcc
Confidence            235789999999999999997432   35899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |++........      .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......  ....+. 
T Consensus       161 g~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~~i~-  231 (281)
T 1mp8_A          161 GLSRYMEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRIE-  231 (281)
T ss_dssp             ------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHH-
T ss_pred             ccccccCcccc------cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHHHHH-
Confidence            99987643221      11122346788999999988889999999999999999997 999997642211  111110 


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                                ......                    .+..++..+.+++..||+.||++|||+.|+++.|+.+.+..
T Consensus       232 ----------~~~~~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          232 ----------NGERLP--------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             ----------TTCCCC--------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ----------cCCCCC--------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence                      000000                    01233667899999999999999999999999999987664

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=8.3e-44  Score=341.18  Aligned_cols=269  Identities=24%  Similarity=0.379  Sum_probs=212.4

Q ss_pred             hcCCCCccCccccccceeEEEEEEc---CCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeeec
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSVD  231 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  231 (484)
                      ..++|++.+.||+|+||.||+|++.   +..++..||+|+++.... ...+.+.+|+.+++++ +||||+++++++.   
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---   97 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT---   97 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe---
Confidence            3467899999999999999999863   344678999999975543 2346789999999999 9999999999853   


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDA--------------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLK  297 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk  297 (484)
                        .++..++||||+++|+|.+++......              ...+++..++.++.|++.||+|||   +++|+|||||
T Consensus        98 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlk  172 (313)
T 1t46_A           98 --IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLA  172 (313)
T ss_dssp             --SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             --cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCc
Confidence              445789999999999999999865321              235899999999999999999999   8999999999


Q ss_pred             CCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCC
Q 011508          298 PSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGP  376 (484)
Q Consensus       298 ~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p  376 (484)
                      |+||+++.++.+||+|||++........     ........+++.|+|||.+.+..++.++||||||+++|||+| |+.|
T Consensus       173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  247 (313)
T 1t46_A          173 ARNILLTHGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (313)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cceEEEcCCCCEEEcccccccccccccc-----ceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999987643321     111223457889999999988899999999999999999999 9999


Q ss_pred             CCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH
Q 011508          377 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM  456 (484)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  456 (484)
                      |....... .........        ....                       .+..++..+.+++.+||+.||.+|||+
T Consensus       248 ~~~~~~~~-~~~~~~~~~--------~~~~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~  295 (313)
T 1t46_A          248 YPGMPVDS-KFYKMIKEG--------FRML-----------------------SPEHAPAEMYDIMKTCWDADPLKRPTF  295 (313)
T ss_dssp             STTCCSSH-HHHHHHHHT--------CCCC-----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCcccchh-HHHHHhccC--------CCCC-----------------------CcccCCHHHHHHHHHHcCCCchhCcCH
Confidence            97643221 111111110        0000                       012235678999999999999999999


Q ss_pred             HHHHHHHHHHHHHH
Q 011508          457 EEVAAQLLSFRNKL  470 (484)
Q Consensus       457 ~evl~~L~~i~~~~  470 (484)
                      .|+++.|+++....
T Consensus       296 ~ell~~L~~~~~~~  309 (313)
T 1t46_A          296 KQIVQLIEKQISES  309 (313)
T ss_dssp             HHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHh
Confidence            99999999887654

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.7e-45  Score=365.08  Aligned_cols=262  Identities=25%  Similarity=0.443  Sum_probs=208.7

Q ss_pred             HHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       154 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      +....++|.+.+.||+|+||.||+|.+.   .+..||||+++... ...+.+.+|+.++++++||||+++++++.     
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-----  253 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYN---KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-----  253 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEET---TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEEC---CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-----
Confidence            3345567889999999999999999975   35779999997543 34678999999999999999999999853     


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                       ....++||||+++|+|.++++...  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus       254 -~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~D  327 (454)
T 1qcf_A          254 -KEPIYIITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIAD  327 (454)
T ss_dssp             -SSSCEEEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECS
T ss_pred             -CCccEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEee
Confidence             336799999999999999997432  124788999999999999999999   88999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||+++.......      .......++..|+|||++....++.++|||||||++|||+| |+.||......     +...
T Consensus       328 FG~a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----~~~~  396 (454)
T 1qcf_A          328 FGLARVIEDNEY------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----EVIR  396 (454)
T ss_dssp             TTGGGGBCCHHH------HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHH
T ss_pred             CCCceEcCCCce------eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHH
Confidence            999987643221      11122346788999999988899999999999999999999 99999753211     1111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                      ..     ..-..  +                     ..+..|+.++.+++.+||+.||++|||+++|++.|+.+...
T Consensus       397 ~i-----~~~~~--~---------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~  445 (454)
T 1qcf_A          397 AL-----ERGYR--M---------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA  445 (454)
T ss_dssp             HH-----HHTCC--C---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred             HH-----HcCCC--C---------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence            00     00000  0                     00233467899999999999999999999999999887543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.2e-44  Score=347.30  Aligned_cols=278  Identities=21%  Similarity=0.274  Sum_probs=204.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcC-CCCeeEEEEEEeeccCcc-----------chHHHHHHHHHHHcCCCCCceeEee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDH-DDHETLVAVKVLNLQHRG-----------ASKSFIAECQALRSIRHRNLVKIIT  225 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~  225 (484)
                      .++|.+.+.||+|+||.||+|+... ...+..+|+|++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3679999999999999999999643 124678999998755321           1134678889999999999999999


Q ss_pred             eeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 011508          226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG  305 (484)
Q Consensus       226 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~  305 (484)
                      ++... +.+....++||||+ +++|.+++....    .+++.+++.++.||+.||+|||   +++|+||||||+||+++.
T Consensus       116 ~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          116 SGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGY  186 (345)
T ss_dssp             EEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEES
T ss_pred             ccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEcc
Confidence            87653 24466889999999 999999997543    5899999999999999999999   889999999999999998


Q ss_pred             CC--ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccC
Q 011508          306 EL--TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG  383 (484)
Q Consensus       306 ~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~  383 (484)
                      ++  .+||+|||+++.+..................||..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            87  9999999999877544322221222224457999999999999989999999999999999999999999653222


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      .......... ....+...+....                      ....++.++.+++..||+.||++|||++||++.|
T Consensus       267 ~~~~~~~~~~-~~~~~~~~~~~~~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L  323 (345)
T 2v62_A          267 PVAVQTAKTN-LLDELPQSVLKWA----------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL  323 (345)
T ss_dssp             HHHHHHHHHH-HHHTTTHHHHHHS----------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred             cHHHHHHHHh-hcccccHHHHhhc----------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence            2111111111 1111110000000                      0112356799999999999999999999999999


Q ss_pred             HHHH
Q 011508          464 LSFR  467 (484)
Q Consensus       464 ~~i~  467 (484)
                      +.+.
T Consensus       324 ~~~~  327 (345)
T 2v62_A          324 NPHG  327 (345)
T ss_dssp             CTTC
T ss_pred             hccC
Confidence            8754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-43  Score=335.98  Aligned_cols=282  Identities=24%  Similarity=0.274  Sum_probs=201.5

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-----cchHHHHHHHHHHHcC---CCCCceeEeeeee
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-----GASKSFIAECQALRSI---RHRNLVKIITSCV  228 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~~~~~~~  228 (484)
                      ..++|++.+.||+|+||+||+|+  +..+++.||+|++.....     .....+.+|+.+++++   +||||+++++++.
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~   84 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKAR--DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA   84 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEE--CTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEE--ECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence            45789999999999999999998  555688999999874331     2235677788877776   4999999999986


Q ss_pred             eeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 011508          229 SVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT  308 (484)
Q Consensus       229 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~  308 (484)
                      ..........++||||+. ++|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.
T Consensus        85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~  158 (308)
T 3g33_A           85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGT  158 (308)
T ss_dssp             ECCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSC
T ss_pred             ccCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCC
Confidence            654333446799999995 69999997543  234899999999999999999999   899999999999999999999


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHh
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH  388 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~  388 (484)
                      +||+|||++......        .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+.
T Consensus       159 ~kl~Dfg~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~  229 (308)
T 3g33_A          159 VKLADFGLARIYSYQ--------MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLG  229 (308)
T ss_dssp             EEECSCSCTTTSTTC--------CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHH
T ss_pred             EEEeeCccccccCCC--------cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence            999999999865322        12234568999999999988899999999999999999999999997632211 111


Q ss_pred             HHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          389 NFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .............+ ....... .. .   ..............++...+.+++.+||+.||++|||+.|+++
T Consensus       230 ~i~~~~~~~~~~~~-~~~~~~~-~~-~---~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          230 KIFDLIGLPPEDDW-PRDVSLP-RG-A---FPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHCCCCTTTS-CSSCSSC-GG-G---SCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhCCCChhhc-cchhhcc-cc-c---cCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            11111100000000 0000000 00 0   0000000000001223567899999999999999999999985

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=336.57  Aligned_cols=252  Identities=23%  Similarity=0.328  Sum_probs=193.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--------------------------cchHHHHHHHHH
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--------------------------GASKSFIAECQA  211 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~  211 (484)
                      .++|++.+.||+|+||.||+|+.  ..+++.||||++.....                          ...+.+.+|+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYN--ENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEE--TTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEE--CCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            46899999999999999999984  44678999999875431                          113568899999


Q ss_pred             HHcCCCCCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011508          212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPI  291 (484)
Q Consensus       212 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  291 (484)
                      +++++||||+++++++..   ......++||||+++++|.+++.     ...+++..++.++.|++.||+|||   +++|
T Consensus        90 l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i  158 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLH---YQKI  158 (298)
T ss_dssp             HHTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence            999999999999998643   23557899999999999987653     245899999999999999999999   8899


Q ss_pred             eecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCC---CCcccceehhhHHHH
Q 011508          292 VHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE---VSTSGDVYSFGILLL  368 (484)
Q Consensus       292 vH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dvws~Gvvl~  368 (484)
                      +||||||+||+++.++.+||+|||++.......       .......||+.|+|||.+.+..   ++.++|||||||++|
T Consensus       159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~  231 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY  231 (298)
T ss_dssp             ECCCCCGGGEEECTTSCEEECCCTTCEECSSSS-------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHH
T ss_pred             eccCCCHHHEEECCCCCEEEecCCCcccccccc-------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHH
Confidence            999999999999999999999999998764321       1122346999999999987755   478899999999999


Q ss_pred             HHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCC
Q 011508          369 EMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSE  448 (484)
Q Consensus       369 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  448 (484)
                      ||++|+.||....     ..........        ..... +.                  ...++..+.+++.+||+.
T Consensus       232 ~l~~g~~pf~~~~-----~~~~~~~~~~--------~~~~~-~~------------------~~~~~~~l~~li~~~l~~  279 (298)
T 2zv2_A          232 CFVFGQCPFMDER-----IMCLHSKIKS--------QALEF-PD------------------QPDIAEDLKDLITRMLDK  279 (298)
T ss_dssp             HHHHSSCSSCCSS-----HHHHHHHHHH--------CCCCC-CS------------------SSCCCHHHHHHHHHHTCS
T ss_pred             HHHHCCCCCCCcc-----HHHHHHHHhc--------ccCCC-CC------------------ccccCHHHHHHHHHHhhc
Confidence            9999999997531     1111111000        00000 00                  011255789999999999


Q ss_pred             CcCCCCCHHHHHH
Q 011508          449 LPRERMNMEEVAA  461 (484)
Q Consensus       449 dP~~RPt~~evl~  461 (484)
                      ||++|||+.|+++
T Consensus       280 dp~~R~s~~e~l~  292 (298)
T 2zv2_A          280 NPESRIVVPEIKL  292 (298)
T ss_dssp             CTTTSCCHHHHTT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999875

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-43  Score=337.78  Aligned_cols=267  Identities=24%  Similarity=0.405  Sum_probs=204.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .+|.+.+.||+|+||.||+|+.... .....+|+|.+..... ...+.+.+|+.++++++||||++++++|.    ..+.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSEG  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CSSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cCCC
Confidence            4688889999999999999986533 2345689998875433 33467899999999999999999999863    4455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++|+|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  174 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGL  174 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred             ceEEEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccc
Confidence            779999999999999999742   345899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.........   .........+|+.|+|||.+.+..++.++||||||+++|||++ |.+||.......  ........ 
T Consensus       175 a~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~--~~~~~~~~-  248 (298)
T 3f66_A          175 ARDMYDKEYY---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQG-  248 (298)
T ss_dssp             GCCCSCGGGC---BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT--HHHHHHTT-
T ss_pred             cccccccchh---ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhcC-
Confidence            9876443211   1122234457889999999988899999999999999999999 555554432111  11111100 


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHh
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV  471 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  471 (484)
                                ..                    ...+..++..+.+++..||+.||++|||+.|+++.|+++...+.
T Consensus       249 ----------~~--------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          249 ----------RR--------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             ----------CC--------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             ----------CC--------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                      00                    00012235678999999999999999999999999999877653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.4e-43  Score=339.19  Aligned_cols=269  Identities=22%  Similarity=0.310  Sum_probs=200.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|++.+.||+|+||.||+|...  .+++.||+|++....   ......+.+|+.++++++||||+++++++..     
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----  103 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACL--LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----  103 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEET--TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----
T ss_pred             ccceEEEEeecCCCCceEEEEEEc--CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----
Confidence            357899999999999999999853  357889999997532   2234678899999999999999999998653     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ++..++||||+++++|.+++.........+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+||
T Consensus       104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Df  180 (310)
T 2wqm_A          104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDL  180 (310)
T ss_dssp             TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEec
Confidence            34789999999999999999765444556899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |++.......       .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.........+...+.. 
T Consensus       181 g~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-  252 (310)
T 2wqm_A          181 GLGRFFSSKT-------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-  252 (310)
T ss_dssp             -------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHT-
T ss_pred             cceeeecCCC-------ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhc-
Confidence            9987653321       11223468999999999999999999999999999999999999996532211111111100 


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHhhc
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVKN  473 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~  473 (484)
                             ...+..                      ....++.++.+++..||+.||++|||+.||++.|+++++.....
T Consensus       253 -------~~~~~~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          253 -------CDYPPL----------------------PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             -------TCSCCC----------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             -------ccCCCC----------------------cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence                   000000                      01123567899999999999999999999999999998876543

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-43  Score=338.99  Aligned_cols=245  Identities=26%  Similarity=0.327  Sum_probs=199.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||+|+++...   ....+.+.+|..+++.++||||+++++++     .+.
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~   78 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRS--RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDA   78 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECS
T ss_pred             HHcEEEEEEeeCCCEEEEEEEE--CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeC
Confidence            5688999999999999999984  4467899999997542   23446788999999999999999999985     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++...    ..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        79 ~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg  151 (318)
T 1fot_A           79 QQIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFG  151 (318)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecC
Confidence            5889999999999999999753    35899999999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +++.....          .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .....   
T Consensus       152 ~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~---  213 (318)
T 1fot_A          152 FAKYVPDV----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYE---  213 (318)
T ss_dssp             SCEECSSC----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHH---
T ss_pred             cceecCCc----------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHH---
Confidence            99865321          1235699999999999999999999999999999999999999975311     11111   


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~  461 (484)
                           .+....+..                     +.....++.+++.+||+.||++||     +++|+++
T Consensus       214 -----~i~~~~~~~---------------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          214 -----KILNAELRF---------------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -----HHHHCCCCC---------------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----HHHhCCCCC---------------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                 111111100                     111245688999999999999999     8888874

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.2e-43  Score=338.71  Aligned_cols=282  Identities=24%  Similarity=0.323  Sum_probs=189.1

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .++|++.+.||+|+||.||+|.  +..+++.||+|+++.... ...+.+.+|++++++++||||+++++++     ..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   76 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGL--NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTEN   76 (317)
T ss_dssp             ---------------CEEEEEE--CSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTT
T ss_pred             ccceeEeeEECCCCCEEEEEEE--ECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECC
Confidence            4679999999999999999998  455678999999975543 3346788999999999999999999985     4455


Q ss_pred             eeeEEeecccCCCHHHHHhhcC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          237 FEALVYELMVNGSLEEWLHLNR--DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ..++||||++ |+|.+++....  .....+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df  152 (317)
T 2pmi_A           77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDF  152 (317)
T ss_dssp             EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcC
Confidence            8899999997 69999987543  22345899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |++.......       .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+......
T Consensus       153 g~~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~  224 (317)
T 2pmi_A          153 GLARAFGIPV-------NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDI  224 (317)
T ss_dssp             SSCEETTSCC-------CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred             ccceecCCCc-------ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence            9998663221       11223468999999999876 468999999999999999999999997642211 11111111


Q ss_pred             hc--chhhhhhcCc--ccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 AL--PERLAEIVDP--VLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~--~~~~~~~~d~--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..  ++.....+..  ...............   ..........+..++.+++.+||+.||++|||++|+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          225 MGTPNESLWPSVTKLPKYNPNIQQRPPRDLR---QVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HCSCCTTTCGGGGGCTTCCTTCCCCCCCCSH---HHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hCCCChhHhhhhhhhhhcccccccccchhHH---HhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            00  0000000000  000000000000000   00000001123567899999999999999999999975

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.5e-43  Score=345.06  Aligned_cols=250  Identities=26%  Similarity=0.378  Sum_probs=198.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|.+.+.||+|+||.||+|..  ..+++.||+|++....   ......+.+|+++++.++||||+++++++     ...
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~--~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~   87 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQK--NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDE   87 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEE--TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             HHeEEEEEEeeCCCeEEEEEEE--CCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence            5689999999999999999984  4467899999987532   33456788999999999999999999985     345


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+.+|+|.+++...    ..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG  160 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFN  160 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccc
Confidence            5889999999999999999742    35899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC---CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG---SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      ++......        .......||+.|+|||++..   ..++.++|||||||++|||++|+.||.......  ......
T Consensus       161 ~a~~~~~~--------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~  230 (384)
T 4fr4_A          161 IAAMLPRE--------TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVH  230 (384)
T ss_dssp             TCEECCTT--------CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHH
T ss_pred             eeeeccCC--------CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHH
Confidence            99876322        12234579999999999864   458999999999999999999999997532221  111111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-HHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-MEEVAA  461 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~evl~  461 (484)
                      ...        ......                     +..++..+.+++.+||+.||++||+ +++|.+
T Consensus       231 ~~~--------~~~~~~---------------------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          231 TFE--------TTVVTY---------------------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHH--------HCCCCC---------------------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHh--------hcccCC---------------------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            100        000000                     1223567899999999999999998 666653

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.7e-43  Score=335.54  Aligned_cols=278  Identities=19%  Similarity=0.231  Sum_probs=198.0

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||+||+|+..  .+++.||+|++.....  .....+.+|+.++++++||||+++++++.     .+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~   74 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNR--ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred             CCceeeeEecCCCCeEEEEEEEC--CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCC
Confidence            47899999999999999999954  4578899999975543  23467889999999999999999999964     345


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++ ++.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus        75 ~~~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~  147 (292)
T 3o0g_A           75 KLTLVFEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEEEECCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEEEecCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            88999999965 666666532   245899999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCC-CCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.......       .......||..|+|||++.+.. ++.++|||||||++|||++|..||.........+........
T Consensus       148 ~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~  220 (292)
T 3o0g_A          148 ARAFGIPV-------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  220 (292)
T ss_dssp             CEECCSCC-------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred             ceecCCcc-------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC
Confidence            98663221       1223346899999999987765 799999999999999999988886443222111222211111


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...... ... ...............  ..........+...+.+++.+||+.||++|||++|+++
T Consensus       221 ~~~~~~-~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          221 TPTEEQ-WPS-MTKLPDYKPYPMYPA--TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCTTT-CTT-GGGSTTCCCCCCCCT--TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCChhh-hhh-hcccccccccccccC--CcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            100000 000 000000000000000  00000001233567889999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-43  Score=333.51  Aligned_cols=271  Identities=24%  Similarity=0.374  Sum_probs=211.9

Q ss_pred             cCCCCccC-ccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLEN-LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|.+.+ .||+|+||.||+|++.....+..||+|+++.... ...+.+.+|++++++++||||+++++++.      .
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~   81 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------A   81 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------S
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------C
Confidence            34566666 8999999999999876666778899999976432 34467899999999999999999999862      2


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++++|.+++...   ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg  155 (287)
T 1u59_A           82 EALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFG  155 (287)
T ss_dssp             SSEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCT
T ss_pred             CCcEEEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECccc
Confidence            3579999999999999999632   345899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ++.........    ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......  .....+...
T Consensus       156 ~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~i~~~  229 (287)
T 1u59_A          156 LSKALGADDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQG  229 (287)
T ss_dssp             TCEECTTCSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTT
T ss_pred             ceeeeccCcce----eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--HHHHHHhcC
Confidence            99876432211    111223346889999999988889999999999999999998 99999753211  111111100


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHhhcc
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVKNV  474 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~  474 (484)
                              ....                       .+..++..+.+++..||+.||++||++.|+++.|+.+..+.....
T Consensus       230 --------~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  278 (287)
T 1u59_A          230 --------KRME-----------------------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV  278 (287)
T ss_dssp             --------CCCC-----------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred             --------CcCC-----------------------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence                    0000                       012336678999999999999999999999999999988876555


Q ss_pred             CCC
Q 011508          475 RGQ  477 (484)
Q Consensus       475 ~~~  477 (484)
                      ...
T Consensus       279 ~~~  281 (287)
T 1u59_A          279 EGH  281 (287)
T ss_dssp             SSC
T ss_pred             cCC
Confidence            443

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1e-43  Score=341.08  Aligned_cols=278  Identities=22%  Similarity=0.309  Sum_probs=216.2

Q ss_pred             ccHHhHHHhcCCCCccCccccccceeEEEEEEc---CCCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcC-CCCCceeE
Q 011508          149 VSYQNLFKATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRG-ASKSFIAECQALRSI-RHRNLVKI  223 (484)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~  223 (484)
                      +....+....++|++.+.||+|+||.||+|++.   +..+++.||+|+++..... ..+.+.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            444455556688999999999999999999864   2346789999999765432 335788999999999 79999999


Q ss_pred             eeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011508          224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDA------------PRNLNLLQRLSIAVDVASTLEYLHHYCETPI  291 (484)
Q Consensus       224 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  291 (484)
                      ++++.    ..+...++||||+++++|.+++......            ...+++..++.++.|++.||+|||   +++|
T Consensus        97 ~~~~~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i  169 (316)
T 2xir_A           97 LGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKC  169 (316)
T ss_dssp             EEEEC----CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             EEEEe----cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence            99863    3344689999999999999999854321            123889999999999999999999   8999


Q ss_pred             eecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHH
Q 011508          292 VHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMF  371 (484)
Q Consensus       292 vH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ell  371 (484)
                      +||||||+||+++.++.+||+|||++........     ........+|+.|+|||++.+..++.++||||||+++|||+
T Consensus       170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~  244 (316)
T 2xir_A          170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF  244 (316)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             ccccCccceEEECCCCCEEECCCccccccccCcc-----ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHH
Confidence            9999999999999999999999999986643221     11222345788999999998889999999999999999999


Q ss_pred             h-CCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCc
Q 011508          372 T-GKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELP  450 (484)
Q Consensus       372 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP  450 (484)
                      | |+.||........ +.......        .....                       +..++..+.+++..||+.||
T Consensus       245 t~g~~p~~~~~~~~~-~~~~~~~~--------~~~~~-----------------------~~~~~~~l~~li~~~l~~dp  292 (316)
T 2xir_A          245 SLGASPYPGVKIDEE-FCRRLKEG--------TRMRA-----------------------PDYTTPEMYQTMLDCWHGEP  292 (316)
T ss_dssp             TTSCCSSTTCCCSHH-HHHHHHHT--------CCCCC-----------------------CTTCCHHHHHHHHHHTCSSG
T ss_pred             hCCCCCCcccchhHH-HHHHhccC--------ccCCC-----------------------CCCCCHHHHHHHHHHcCCCh
Confidence            8 9999976432211 11111100        00000                       11125578999999999999


Q ss_pred             CCCCCHHHHHHHHHHHHHHH
Q 011508          451 RERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       451 ~~RPt~~evl~~L~~i~~~~  470 (484)
                      .+|||+.||++.|+.+.+..
T Consensus       293 ~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          293 SQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             GGSCCHHHHHHHHHHHHHHH
T ss_pred             hhCcCHHHHHHHHHHHHhhh
Confidence            99999999999999987654

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-43  Score=346.46  Aligned_cols=254  Identities=18%  Similarity=0.235  Sum_probs=201.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||.||+|+..  .+++.||+|++..........+.+|+.++++++||||+++++++.     ....
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~  122 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEK--ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYE  122 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSE
T ss_pred             ccceEEEEEEecCCCEEEEEEEEC--CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCE
Confidence            357999999999999999999854  467899999998665445567899999999999999999999853     4558


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC--CCceEEcccC
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG--ELTAHVSDFG  315 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfg  315 (484)
                      .++||||+++|+|.+++...   ...+++..++.++.||+.||+|||   +++|+||||||+||+++.  ++.+||+|||
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG  196 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFG  196 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred             EEEEEEcCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecc
Confidence            89999999999999998632   335899999999999999999999   899999999999999974  4689999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++.......        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....... 
T Consensus       197 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~i-  262 (387)
T 1kob_A          197 LATKLNPDE--------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-----LETLQNV-  262 (387)
T ss_dssp             TCEECCTTS--------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-----HHHHHHH-
T ss_pred             cceecCCCc--------ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-----HHHHHHH-
Confidence            998763321        12234689999999999999999999999999999999999999975321     1111100 


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                             .........                 .....++.++.+++..||+.||++|||+.|+++.
T Consensus       263 -------~~~~~~~~~-----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          263 -------KRCDWEFDE-----------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             -------HHCCCCCCS-----------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -------HhCCCCCCc-----------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                   000000000                 0011235678999999999999999999999863

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.3e-43  Score=335.80  Aligned_cols=261  Identities=28%  Similarity=0.417  Sum_probs=194.0

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ..++|++.+.||+|+||.||+|+..     ..||+|+++....  ...+.+.+|+.++++++||||+++++++      .
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~   90 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH-----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------T   90 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS-----SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------C
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc-----CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------c
Confidence            4568999999999999999999843     3499999875543  2346789999999999999999999864      2


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+++++|.+++...   ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Df  164 (289)
T 3og7_A           91 APQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDF  164 (289)
T ss_dssp             SSSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCC
T ss_pred             CCccEEEEEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccc
Confidence            33578999999999999999633   345899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccC---CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM---GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      |++........     ........||..|+|||.+.   +..++.++||||||+++|||++|+.||....... .+...+
T Consensus       165 g~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~  238 (289)
T 3og7_A          165 GLATEKSRWSG-----SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIEMV  238 (289)
T ss_dssp             C-----------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-HHHHHH
T ss_pred             eeccccccccc-----cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-HHHHHh
Confidence            99976533211     11122346899999999886   5678899999999999999999999997642211 111111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                      ...       ...+.+..                    ....++..+.+++..||+.||++|||+.|+++.|+++.
T Consensus       239 ~~~-------~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          239 GRG-------SLSPDLSK--------------------VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             HHT-------SCCCCTTS--------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ccc-------ccCcchhh--------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            100       00000000                    01234667999999999999999999999999998864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=347.91  Aligned_cols=250  Identities=25%  Similarity=0.318  Sum_probs=196.2

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeecc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDF  232 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  232 (484)
                      ..++|++.+.||+|+||.||+|+..  .+++.||+|+++...   ....+.+.+|..++..+ +||||+++++++     
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~--~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----   93 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVK--ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----   93 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEc--CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----
Confidence            3468999999999999999999954  457899999997542   23446688999999988 799999999985     


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                      ......++||||+++|+|.+++....    .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+
T Consensus        94 ~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~  166 (353)
T 3txo_A           94 QTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLA  166 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEc
Confidence            44558999999999999999997543    4899999999999999999999   8999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||+++.....       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......     +...
T Consensus       167 DFG~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~~~~  234 (353)
T 3txo_A          167 DFGMCKEGICN-------GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-----DLFE  234 (353)
T ss_dssp             CCTTCBCSCC----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH
T ss_pred             cccceeecccC-------CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-----HHHH
Confidence            99999754221       12223457999999999998888999999999999999999999999753211     1111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH------HHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM------EEVAA  461 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~evl~  461 (484)
                      .        +.......                     +......+.+++.+||+.||++||++      +|+++
T Consensus       235 ~--------i~~~~~~~---------------------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          235 A--------ILNDEVVY---------------------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             H--------HHHCCCCC---------------------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             H--------HHcCCCCC---------------------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            1        11100000                     11124568899999999999999998      67764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=351.71  Aligned_cols=253  Identities=20%  Similarity=0.270  Sum_probs=199.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|..  ..++..+|+|++.....  ...+.+.+|+.++++++||||+++++++     ..+
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~--~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~   82 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVK--VLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEE   82 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEE--TTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECS
T ss_pred             cCCeEEEEEeccCCCeEEEEEEE--CCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EEC
Confidence            46799999999999999999984  44678999999976542  2345688999999999999999999985     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCceEEc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD---GELTAHVS  312 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~  312 (484)
                      +..++||||+++|+|.+++...    ..+++..+..++.||+.||+|||   +++|+||||||+||+++   .++.+||+
T Consensus        83 ~~~~lv~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~  155 (444)
T 3soa_A           83 GHHYLIFDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLA  155 (444)
T ss_dssp             SEEEEEECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred             CEEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEc
Confidence            5889999999999999999753    34899999999999999999999   89999999999999998   45789999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||++.......       .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.....     .....
T Consensus       156 DFG~a~~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~~~~~  223 (444)
T 3soa_A          156 DFGLAIEVEGEQ-------QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----HRLYQ  223 (444)
T ss_dssp             CCSSCBCCCTTC-------CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH
T ss_pred             cCceeEEecCCC-------ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----HHHHH
Confidence            999997664321       122345799999999999999999999999999999999999999965321     11111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..... ......+.                        ...++.++.+++..||+.||++|||+.|+++
T Consensus       224 ~i~~~-~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          224 QIKAG-AYDFPSPE------------------------WDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHT-CCCCCTTT------------------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhC-CCCCCccc------------------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            10000 00000000                        1123567899999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.4e-43  Score=336.09  Aligned_cols=268  Identities=26%  Similarity=0.394  Sum_probs=209.5

Q ss_pred             hcCCCCccC-ccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          157 ATDGFSLEN-LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       157 ~~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      ..++|.+.+ .||+|+||.||+|.+.....+..||||+++....  ...+.+.+|+++++.++||||+++++++.     
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   88 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-----   88 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-----
Confidence            345678887 9999999999999876777789999999975432  22467899999999999999999999861     


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                       .+..++||||+++++|.+++...    ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        89 -~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~D  160 (291)
T 1xbb_A           89 -AESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISD  160 (291)
T ss_dssp             -SSSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECC
T ss_pred             -CCCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEcc
Confidence             23678999999999999999753    34899999999999999999999   88999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||++.........    ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+.
T Consensus       161 fg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~  234 (291)
T 1xbb_A          161 FGLSKALRADENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLE  234 (291)
T ss_dssp             CTTCEECCTTCSE----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHH
T ss_pred             CCcceeeccCCCc----ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHH
Confidence            9999876433211    111122346788999999988889999999999999999999 99999753211  1111111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHhh
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVK  472 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~  472 (484)
                      ..        ....                       .+..++..+.+++..||+.||++|||+.||++.|+.+-.....
T Consensus       235 ~~--------~~~~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  283 (291)
T 1xbb_A          235 KG--------ERMG-----------------------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN  283 (291)
T ss_dssp             TT--------CCCC-----------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred             cC--------CCCC-----------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence            00        0000                       0122366789999999999999999999999999998777654


Q ss_pred             cc
Q 011508          473 NV  474 (484)
Q Consensus       473 ~~  474 (484)
                      ..
T Consensus       284 ~~  285 (291)
T 1xbb_A          284 EG  285 (291)
T ss_dssp             HH
T ss_pred             cc
Confidence            43

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.3e-43  Score=336.53  Aligned_cols=276  Identities=24%  Similarity=0.303  Sum_probs=199.0

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ..++|++.+.||+|+||+||+|+..   +++.||+|++.....  .....+.+|++++++++||||+++++++     ..
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~   90 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS---QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HS   90 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET---TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CC
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC---CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----cc
Confidence            3478999999999999999999864   478899999875432  2346788999999999999999999985     44


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      +...++||||++ ++|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Df  163 (311)
T 3niz_A           91 ERCLTLVFEFME-KDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADF  163 (311)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CCEEEEEEcCCC-CCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccC
Confidence            558899999996 5888888643   345899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |++.......       .......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||....... .+......
T Consensus       164 g~a~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~  235 (311)
T 3niz_A          164 GLARAFGIPV-------RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSI  235 (311)
T ss_dssp             TTCEETTSCC-------C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHH
T ss_pred             cCceecCCCc-------ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence            9998653221       11223468999999998876 568999999999999999999999997653332 12222111


Q ss_pred             hc---chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 AL---PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~---~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..   +.......+............ .     ..........+..++.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          236 LGTPNPREWPQVQELPLWKQRTFQVF-E-----KKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HCCCCTTTSGGGTTSHHHHSCCCCCC-C-----CCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HCCCChHHhhhhhccchhhhcccccc-c-----CCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11   100111100000000000000 0     00000001223567899999999999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.1e-43  Score=338.96  Aligned_cols=274  Identities=22%  Similarity=0.273  Sum_probs=197.1

Q ss_pred             cCCCCcc-CccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLE-NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  235 (484)
                      .+.|.+. +.||+|+||.||+|+  +..+++.||||++..........+.+|++++.++ +||||+++++++..     +
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~   83 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCI--NLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----E   83 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEE--CSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred             ceeEEecCceecCCceEEEEEEE--EcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----C
Confidence            3568874 789999999999998  4556789999999876655667899999999985 79999999999643     4


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---eEEc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT---AHVS  312 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~  312 (484)
                      +..++||||+++++|.+++....    .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.   +||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~  156 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRR----HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKIC  156 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred             CEEEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEE
Confidence            58899999999999999997543    4899999999999999999999   889999999999999988775   9999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCC-----CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-----SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      |||++.....................||..|+|||++..     ..++.++|||||||++|||++|+.||.........+
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  236 (316)
T 2ac3_A          157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW  236 (316)
T ss_dssp             CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred             EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence            999988664322111111112233569999999998764     458899999999999999999999997653322111


Q ss_pred             hHHHH-hhcchh-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          388 HNFVK-EALPER-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       388 ~~~~~-~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..... ...... ...+........              .   .....++..+.+++.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~i~~~~~~~~--------------~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          237 DRGEACPACQNMLFESIQEGKYEFP--------------D---KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             ----CCHHHHHHHHHHHHHCCCCCC--------------H---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccccchhHHHHHHHHHhccCcccC--------------c---hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            00000 000000 001110000000              0   0011235678999999999999999999999873

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.5e-43  Score=344.03  Aligned_cols=253  Identities=22%  Similarity=0.327  Sum_probs=200.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|+.  ..++..||+|++.....  ...+.+.+|+.++++++||||+++++++.     .+
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~  100 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVH--KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EE  100 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEE--TTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             ccCeEEeeEEecCCCeEEEEEEE--CCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eC
Confidence            45799999999999999999984  44678999999975532  23457889999999999999999999853     45


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC---ceEEc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL---TAHVS  312 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~  312 (484)
                      ...++||||+++|+|.+++...    ..+++..++.++.||+.||+|||   +++|+||||||+||+++.++   .+||+
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~  173 (362)
T 2bdw_A          101 SFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLA  173 (362)
T ss_dssp             SEEEEEECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred             CEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEe
Confidence            5889999999999999998732    35899999999999999999999   89999999999999997654   59999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||++.......        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....     .....
T Consensus       174 DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~~~~~  240 (362)
T 2bdw_A          174 DFGLAIEVNDSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYA  240 (362)
T ss_dssp             CCTTCBCCTTCC--------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred             ecCcceEecCCc--------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHH
Confidence            999998664221        12235699999999999998999999999999999999999999975321     11111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .....    ..+    ..                 ......++.++.+++.+||+.||++|||+.|+++.
T Consensus       241 ~i~~~----~~~----~~-----------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          241 QIKAG----AYD----YP-----------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHHT----CCC----CC-----------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHhC----CCC----CC-----------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            10000    000    00                 00012235678999999999999999999998754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=7.1e-44  Score=341.34  Aligned_cols=265  Identities=22%  Similarity=0.346  Sum_probs=196.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc---hHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA---SKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|++.+.||+|+||.||+|+.  ..+++.||||+++......   ...+.+|+.++++++||||+++++++.... ..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   87 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARD--LRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA   87 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TT
T ss_pred             cCcEEEEEEEccCCCEEEEEEEE--CCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CC
Confidence            46799999999999999999984  4467899999997653322   356889999999999999999999876543 22


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+++++|.+++....    .+++.+++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        88 ~~~~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           88 GPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             EEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCC
T ss_pred             CcccEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeec
Confidence            335599999999999999997543    4899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |++.........    ........||+.|+|||++.+..++.++||||||+++|||++|+.||.......     .....
T Consensus       161 g~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~-----~~~~~  231 (311)
T 3ork_A          161 GIARAIADSGNS----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQH  231 (311)
T ss_dssp             SCC----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHH
T ss_pred             cCcccccccccc----cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHH
Confidence            999876443211    112223568999999999999999999999999999999999999997532111     11100


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH-HHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA-QLLSF  466 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~-~L~~i  466 (484)
                      ....   ...+.                      .....++..+.+++.+||+.||++||++.+++. .+..+
T Consensus       232 ~~~~---~~~~~----------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          232 VRED---PIPPS----------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             HHCC---CCCHH----------------------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             hcCC---CCCcc----------------------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            0000   00000                      001123567899999999999999997766554 44433

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.2e-43  Score=332.98  Aligned_cols=263  Identities=21%  Similarity=0.369  Sum_probs=205.9

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ..++|.+.+.||+|+||.||+|++... ..+..||+|++..... ...+.+.+|+.++++++||||+++++++.     .
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~   84 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-----E   84 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-----S
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-----C
Confidence            346789999999999999999987533 3466799999876532 34467899999999999999999999852     2


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                       +..++||||+++++|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        85 -~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df  157 (281)
T 3cc6_A           85 -EPTWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDF  157 (281)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred             -CCCEEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCcc
Confidence             24589999999999999997543   35899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |++........      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......  .....+..
T Consensus       158 g~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~  229 (281)
T 3cc6_A          158 GLSRYIEDEDY------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEK  229 (281)
T ss_dssp             CGGGCC---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHH
T ss_pred             CCCcccccccc------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhc
Confidence            99987643221      11123457889999999988889999999999999999998 99999653221  11111110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      ..        .  ..                     .+..++..+.+++.+||+.||++|||+.|+++.|+.+.+.-
T Consensus       230 ~~--------~--~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          230 GD--------R--LP---------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             TC--------C--CC---------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CC--------C--CC---------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            00        0  00                     01123567899999999999999999999999999987653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.3e-44  Score=362.07  Aligned_cols=258  Identities=24%  Similarity=0.431  Sum_probs=208.1

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ...+|++.+.||+|+||.||+|++..  ++..||||+++... ...+.+.+|+.++++++||||++++++|.     ...
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~  289 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REP  289 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGG--GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcC--CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCC
Confidence            44568889999999999999999653  46889999997543 34578999999999999999999999964     344


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++|+|.+++....  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       290 ~~~lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~  364 (495)
T 1opk_A          290 PFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGL  364 (495)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred             cEEEEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeeccc
Confidence            7899999999999999997543  245899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++......      ........++..|+|||++....++.++|||||||++|||+| |+.||......  .+...+..  
T Consensus       365 a~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~~~~~~~~--  434 (495)
T 1opk_A          365 SRLMTGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEK--  434 (495)
T ss_dssp             EECCTTCC------EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHT--
T ss_pred             ceeccCCc------eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc--
Confidence            98764321      111223346789999999988899999999999999999999 99999764221  11111110  


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                                ....                   ..+..|+..+.+|+..||+.||++|||+.||++.|+.+
T Consensus       435 ----------~~~~-------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          435 ----------DYRM-------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             ----------TCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ----------CCCC-------------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence                      0000                   01234467889999999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.1e-43  Score=366.91  Aligned_cols=266  Identities=24%  Similarity=0.365  Sum_probs=207.7

Q ss_pred             CCccC-ccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          161 FSLEN-LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       161 ~~~~~-~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      +.+.+ .||+|+||.||+|.+.....+..||||+++.... ...+.+.+|+++|++++||||++++++|..      +..
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~~~  410 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------EAL  410 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------SSE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------CCe
Confidence            33334 7999999999999987666778899999976532 345789999999999999999999998632      257


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++|+|.+++...   ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       411 ~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             EEEEEeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence            9999999999999999743   345899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ........    ........+++.|+|||++.+..++.++|||||||++|||++ |+.||......  .+...+....  
T Consensus       485 ~~~~~~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~~~--  556 (613)
T 2ozo_A          485 ALGADDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGK--  556 (613)
T ss_dssp             TCC------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--HHHHHHHTTC--
T ss_pred             cccCCCce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCC--
Confidence            76432211    111122345689999999988899999999999999999998 99999764221  1111111000  


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHhhccC
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVKNVR  475 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~  475 (484)
                              .+                     ..+..|+.++.+++..||+.||++||++.+|++.|+.+.........
T Consensus       557 --------~~---------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~  605 (613)
T 2ozo_A          557 --------RM---------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  605 (613)
T ss_dssp             --------CC---------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCC
T ss_pred             --------CC---------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccC
Confidence                    00                     01234567899999999999999999999999999998877754443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.2e-43  Score=348.64  Aligned_cols=289  Identities=16%  Similarity=0.189  Sum_probs=204.4

Q ss_pred             hcCCCCccCccccc--cceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          157 ATDGFSLENLIGAG--SFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       157 ~~~~~~~~~~lg~G--~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      ..++|++.+.||+|  +||.||+|+..  .+++.||||+++....  ...+.+.+|+.++++++||||+++++++..   
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---   97 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYK--PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA---   97 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEET--TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEc--CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE---
Confidence            34679999999999  99999999954  4678999999976532  234678889999999999999999999643   


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                        +...++||||+++|+|.+++....  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+
T Consensus        98 --~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~  170 (389)
T 3gni_B           98 --DNELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLS  170 (389)
T ss_dssp             --TTEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             --CCEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEc
Confidence              458899999999999999997543  235899999999999999999999   8999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCC--CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG--SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      |||.+.....................||..|+|||++.+  ..++.++|||||||++|||++|+.||......... ...
T Consensus       171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~  249 (389)
T 3gni_B          171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEK  249 (389)
T ss_dssp             CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH-HHC
T ss_pred             ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHH
Confidence            999987653322111111222233468999999999887  57899999999999999999999999764332211 111


Q ss_pred             HHhhcchhhhhhcCcccccc------cc---------ccc--chhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCC
Q 011508          391 VKEALPERLAEIVDPVLLVE------RE---------EGE--TSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRER  453 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~------~~---------~~~--~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  453 (484)
                      .....+    .+.+......      ..         ...  ...............+..+...+.+|+.+||+.||++|
T Consensus       250 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  325 (389)
T 3gni_B          250 LNGTVP----CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR  325 (389)
T ss_dssp             ------------------------------------------------------------CCHHHHHHHHHHTCSCTTTS
T ss_pred             hcCCCC----ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccC
Confidence            111111    0000000000      00         000  00000000000000123346679999999999999999


Q ss_pred             CCHHHHHHH
Q 011508          454 MNMEEVAAQ  462 (484)
Q Consensus       454 Pt~~evl~~  462 (484)
                      ||+.|+++.
T Consensus       326 pta~ell~h  334 (389)
T 3gni_B          326 PSASTLLNH  334 (389)
T ss_dssp             CCHHHHTTS
T ss_pred             CCHHHHhcC
Confidence            999999854

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.6e-44  Score=340.63  Aligned_cols=277  Identities=26%  Similarity=0.361  Sum_probs=206.1

Q ss_pred             CCCCccCccccccceeEEEEEEc--CCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ..|++.+.||+|+||.||+|++.  +..+++.||+|++..... ...+.+.+|++++++++||||+++++++...   +.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            45788899999999999999863  334678999999975432 3447789999999999999999999987532   23


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++++|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             ceEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccc
Confidence            56789999999999999996543   34899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++.........    ........+|..|+|||.+.+..++.++||||||+++|||+||..|+......   .........
T Consensus       172 ~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~  244 (302)
T 4e5w_A          172 LTKAIETDKEY----YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL---FLKMIGPTH  244 (302)
T ss_dssp             TCEECCTTCCE----EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH---HHHHHCSCC
T ss_pred             ccccccCCCcc----eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH---HhhccCCcc
Confidence            99876433211    11223345888899999998888999999999999999999999986432100   000000000


Q ss_pred             chh-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          396 PER-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       396 ~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                      ... ...+... +.               .......+..++..+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus       245 ~~~~~~~~~~~-~~---------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          245 GQMTVTRLVNT-LK---------------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             GGGHHHHHHHH-HH---------------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccCHHHHHHH-Hh---------------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            000 0000000 00               00000012334678999999999999999999999999999874

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=339.45  Aligned_cols=278  Identities=25%  Similarity=0.390  Sum_probs=212.3

Q ss_pred             CCCCccCccccccceeEEEEEEc--CCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFD--HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||.||+|++.  +..+++.||+|++........+.+.+|++++++++||||+++++++...   +..
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~  117 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR  117 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-------
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---CCC
Confidence            56888999999999999999863  2346789999999876555567899999999999999999999986432   234


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             ceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence            6789999999999999997542   35899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.........    ........++..|+|||.+.+..++.++||||||+++|||+||..||......   ..........
T Consensus       192 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~---~~~~~~~~~~  264 (326)
T 2w1i_A          192 TKVLPQDKEY----YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE---FMRMIGNDKQ  264 (326)
T ss_dssp             CEECCSSCSE----EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH---HHHHHCTTCC
T ss_pred             hhhccccccc----cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH---HHHhhccccc
Confidence            9876433211    01112245778899999998888999999999999999999999987542100   0000000000


Q ss_pred             -----hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHh
Q 011508          397 -----ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV  471 (484)
Q Consensus       397 -----~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  471 (484)
                           ..+.+.+....                   +...+..++.++.+++..||+.||++|||+.||++.|+.+++++.
T Consensus       265 ~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          265 GQMIVFHLIELLKNNG-------------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             THHHHHHHHHHHHTTC-------------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             hhhhHHHHHHHhhcCC-------------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence                 00011110000                   000123346789999999999999999999999999999998763

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-43  Score=332.42  Aligned_cols=269  Identities=24%  Similarity=0.372  Sum_probs=207.4

Q ss_pred             CCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .|.+.+.||+|+||.||+|++... ..+..||+|++..... ...+.+.+|+.++++++||||+++++++..    .+..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CCCC
Confidence            456678999999999999986543 3345799999875433 334678899999999999999999998632    3344


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+.+|+|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~  171 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLA  171 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred             cEEEEecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCc
Confidence            58999999999999999742   345899999999999999999999   889999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      .........   .........++..|+|||.+.+..++.++||||||+++|+|++|..|+...... ......+..... 
T Consensus       172 ~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~-  246 (298)
T 3pls_A          172 RDILDREYY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLAQGRR-  246 (298)
T ss_dssp             CTTTTGGGG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHHTTCC-
T ss_pred             ccccCCccc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhhcCCC-
Confidence            866433211   111223346889999999999999999999999999999999966654332111 111111111000 


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHhhc
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVKN  473 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~  473 (484)
                             .                       ..+..++..+.+++..||+.||.+|||++|+++.|+++..++...
T Consensus       247 -------~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          247 -------L-----------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             -------C-----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             -------C-----------------------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence                   0                       001223567899999999999999999999999999998877543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=343.99  Aligned_cols=252  Identities=24%  Similarity=0.290  Sum_probs=185.9

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ..++|++.+.||+|+||.||+|+..  .+++.||||+++...  ..+.+.+|++++++++||||+++++++.     ...
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~  121 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQK--GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPT  121 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEEC--CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCC
Confidence            3567999999999999999999954  456889999997543  3456889999999999999999999964     345


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEEcc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSD  313 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~D  313 (484)
                      ..++||||+++|+|.+++...    ..+++.+++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~D  194 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIAD  194 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred             eEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEcc
Confidence            789999999999999999732    35899999999999999999999   889999999999999975   88999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||+++......        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........+..    
T Consensus       195 fg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----  262 (349)
T 2w4o_A          195 FGLSKIVEHQV--------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRR----  262 (349)
T ss_dssp             CC------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHH----
T ss_pred             CccccccCccc--------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHH----
Confidence            99998653221        122346899999999999999999999999999999999999999653221111111    


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                              +.........                 ....+++.++.+++.+||+.||++|||+.|+++
T Consensus       263 --------i~~~~~~~~~-----------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          263 --------ILNCEYYFIS-----------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             --------HHTTCCCCCT-----------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --------HHhCCCccCC-----------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    1110000000                 001123567899999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.7e-44  Score=334.19  Aligned_cols=251  Identities=26%  Similarity=0.387  Sum_probs=190.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc----cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR----GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      .++|++.+.||+|+||.||+|.+.    +..||+|+++....    ...+.+.+|+++++.++||||+++++++.     
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   76 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI----GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----   76 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET----TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc----CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----
Confidence            367899999999999999999854    57899999875432    22467889999999999999999999964     


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---eeecCCCCCCeeecC-----
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP---IVHCDLKPSNVLLDG-----  305 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~dlk~~NIll~~-----  305 (484)
                      .+...++||||+++++|.+++.     ...+++..++.++.|++.||+|||   +++   |+||||||+||+++.     
T Consensus        77 ~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~  148 (271)
T 3dtc_A           77 KEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENG  148 (271)
T ss_dssp             CC--CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSS
T ss_pred             cCCceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccc
Confidence            3457899999999999999986     235899999999999999999999   666   999999999999986     


Q ss_pred             ---CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCcc
Q 011508          306 ---ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFT  382 (484)
Q Consensus       306 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~  382 (484)
                         ++.+||+|||.+.......         .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....
T Consensus       149 ~~~~~~~kl~Dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  219 (271)
T 3dtc_A          149 DLSNKILKITDFGLAREWHRTT---------KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG  219 (271)
T ss_dssp             CCSSCCEEECCCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred             cccCcceEEccCCccccccccc---------ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence               6789999999998653321         1234689999999999888899999999999999999999999975321


Q ss_pred             CCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          383 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..     ...        .........                   ..+..++..+.+++.+||+.||++|||+.|+++.
T Consensus       220 ~~-----~~~--------~~~~~~~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          220 LA-----VAY--------GVAMNKLAL-------------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HH-----HHH--------HHHTSCCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HH-----HHH--------hhhcCCCCC-------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            10     000        000000000                   0012335678999999999999999999999999


Q ss_pred             HHHH
Q 011508          463 LLSF  466 (484)
Q Consensus       463 L~~i  466 (484)
                      |+.+
T Consensus       268 L~~l  271 (271)
T 3dtc_A          268 LTTI  271 (271)
T ss_dssp             HHC-
T ss_pred             HhcC
Confidence            9754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=9e-44  Score=346.64  Aligned_cols=277  Identities=15%  Similarity=0.168  Sum_probs=209.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCC------CeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeE--------
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDD------HETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKI--------  223 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~--------  223 (484)
                      .++|.+.+.||+|+||.||+|+...+.      .++.||+|++...     +.+.+|++++++++||||+++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            368999999999999999999965421      3678999998744     467899999999999999883        


Q ss_pred             -------eeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 011508          224 -------ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDL  296 (484)
Q Consensus       224 -------~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl  296 (484)
                             ++++.    ..+...++||||+ +++|.+++....  ...+++..++.++.||+.||+|||   +++|+||||
T Consensus       116 ~~~i~~~~~~~~----~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Di  185 (352)
T 2jii_A          116 LLAIPTCMGFGV----HQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLH---ENEYVHGNV  185 (352)
T ss_dssp             TCSCCCCCEEEE----ETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCC
T ss_pred             ccCccchhhccc----cCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCC
Confidence                   44432    2356789999999 999999998542  245999999999999999999999   889999999


Q ss_pred             CCCCeeecCCC--ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCC
Q 011508          297 KPSNVLLDGEL--TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK  374 (484)
Q Consensus       297 k~~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~  374 (484)
                      ||+||+++.++  .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  265 (352)
T 2jii_A          186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF  265 (352)
T ss_dssp             CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred             CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999998  9999999999877554322222222223457999999999999989999999999999999999999


Q ss_pred             CCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC
Q 011508          375 GPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM  454 (484)
Q Consensus       375 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  454 (484)
                      .||.........+....... ......+.+....                      ...++.++.+++..||+.||++||
T Consensus       266 ~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----------------------~~~~~~~l~~li~~~l~~dp~~Rp  322 (352)
T 2jii_A          266 LPWTNCLPNTEDIMKQKQKF-VDKPGPFVGPCGH----------------------WIRPSETLQKYLKVVMALTYEEKP  322 (352)
T ss_dssp             CTTGGGTTCHHHHHHHHHHH-HHSCCCEECTTSC----------------------EECCCHHHHHHHHHHHTCCTTCCC
T ss_pred             CCcccCCcCHHHHHHHHHhc-cCChhhhhhhccc----------------------cCCCcHHHHHHHHHHHhCChhhCC
Confidence            99976432222221111110 1111111110000                      111256789999999999999999


Q ss_pred             CHHHHHHHHHHHHHHHhh
Q 011508          455 NMEEVAAQLLSFRNKLVK  472 (484)
Q Consensus       455 t~~evl~~L~~i~~~~~~  472 (484)
                      |++||++.|+++.+....
T Consensus       323 s~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          323 PYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             CHHHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHHHHhcCC
Confidence            999999999999877643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-43  Score=335.99  Aligned_cols=263  Identities=24%  Similarity=0.414  Sum_probs=211.3

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ...++|++.+.||+|+||.||+|+..  .++..||+|++.... ...+.+.+|++++++++||||+++++++     ..+
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~   81 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWK--KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TRE   81 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEG--GGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSS
T ss_pred             ccccceeEEeecCCCCceeEEEeEec--CCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccC
Confidence            45677899999999999999999954  357889999987543 3457889999999999999999999985     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++++|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg  156 (288)
T 3kfa_A           82 PPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFG  156 (288)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             CCEEEEEEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCc
Confidence            57899999999999999997543  345899999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      .+.......      ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......  ........ 
T Consensus       157 ~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~--~~~~~~~~-  227 (288)
T 3kfa_A          157 LSRLMTGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEK-  227 (288)
T ss_dssp             GGGTSCSSS------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--GHHHHHHT-
T ss_pred             cceeccCCc------cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhc-
Confidence            998764321      122233457888999999988899999999999999999999 99998753211  11111110 


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                             ....                       ..+..++..+.+++..||+.||++|||+.|+++.|+.+....
T Consensus       228 -------~~~~-----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          228 -------DYRM-----------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             -------TCCC-----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -------cCCC-----------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence                   0000                       002233567899999999999999999999999999887654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.1e-43  Score=340.09  Aligned_cols=249  Identities=24%  Similarity=0.324  Sum_probs=195.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  234 (484)
                      ++|++.+.||+|+||.||+|+..  .+++.||+|+++....   ...+.+.+|..++.++ +||||+++++++     ..
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~   81 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLK--KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT   81 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred             hheEEEEEEEecCCeEEEEEEEC--CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----Ee
Confidence            56889999999999999999954  4578999999986532   2335678899999988 899999999985     44


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+++|+|.+++....    .+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        82 ~~~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DF  154 (345)
T 3a8x_A           82 ESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDY  154 (345)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCG
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEec
Confidence            558899999999999999997543    4899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCcc---HhHHH
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLT---LHNFV  391 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~---~~~~~  391 (484)
                      |+++.....       ........||+.|+|||++.+..++.++|||||||++|||++|+.||.........   .....
T Consensus       155 G~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  227 (345)
T 3a8x_A          155 GMCKEGLRP-------GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL  227 (345)
T ss_dssp             GGCBCSCCT-------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH
T ss_pred             cccccccCC-------CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH
Confidence            999854221       11223457999999999999999999999999999999999999999653221100   00000


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM  456 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  456 (484)
                      .       ..+.......                     +..++.++.+++.+||+.||++||++
T Consensus       228 ~-------~~i~~~~~~~---------------------p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          228 F-------QVILEKQIRI---------------------PRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             H-------HHHHHCCCCC---------------------CTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             H-------HHHHcCCCCC---------------------CCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            0       0011100000                     11225678899999999999999996

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-43  Score=349.97  Aligned_cols=260  Identities=20%  Similarity=0.269  Sum_probs=203.1

Q ss_pred             HhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeee
Q 011508          152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCV  228 (484)
Q Consensus       152 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  228 (484)
                      .++....++|++.+.||+|+||.||+|+..  .+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++ 
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~--~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-  138 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHK--STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-  138 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEEC--CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-
Confidence            445556788999999999999999999954  457899999997522   22335688999999999999999999985 


Q ss_pred             eeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 011508          229 SVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT  308 (484)
Q Consensus       229 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~  308 (484)
                          .++...++||||+++|+|.++++..     .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.
T Consensus       139 ----~~~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~  206 (410)
T 3v8s_A          139 ----QDDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGH  206 (410)
T ss_dssp             ----ECSSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSC
T ss_pred             ----EECCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCC
Confidence                4455899999999999999999743     3889999999999999999999   899999999999999999999


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCCC----CCcccceehhhHHHHHHHhCCCCCCCCccCC
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE----VSTSGDVYSFGILLLEMFTGKGPTNEMFTGN  384 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~  384 (484)
                      +||+|||+++......      .......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.....  
T Consensus       207 ikL~DFG~a~~~~~~~------~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--  278 (410)
T 3v8s_A          207 LKLADFGTCMKMNKEG------MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--  278 (410)
T ss_dssp             EEECCCTTCEECCTTS------EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--
T ss_pred             EEEeccceeEeeccCC------cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--
Confidence            9999999998664321      11223457999999999987654    88999999999999999999999975321  


Q ss_pred             ccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCC--CCCHHHHHHH
Q 011508          385 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRE--RMNMEEVAAQ  462 (484)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~evl~~  462 (484)
                         ........... ....-+.                        ...++.++.+|+.+||+.+|++  ||+++||++.
T Consensus       279 ---~~~~~~i~~~~-~~~~~p~------------------------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          279 ---VGTYSKIMNHK-NSLTFPD------------------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ---HHHHHHHHTHH-HHCCCCT------------------------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ---hhHHHHHHhcc-ccccCCC------------------------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence               11111111000 0000000                        0112557889999999999998  9999999864

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-43  Score=343.09  Aligned_cols=274  Identities=22%  Similarity=0.331  Sum_probs=212.9

Q ss_pred             HHhcCCCCccCccccccceeEEEEEEcCCC---CeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeee
Q 011508          155 FKATDGFSLENLIGAGSFGSVYKGIFDHDD---HETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVS  229 (484)
Q Consensus       155 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  229 (484)
                      ....++|.+.+.||+|+||.||+|.....+   ....||+|.+..... ...+.+.+|+.+++++ +||||+++++++. 
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-  120 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT-  120 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe-
Confidence            344578999999999999999999965432   235799999975543 2346788999999999 8999999999853 


Q ss_pred             eccCCCceeeEEeecccCCCHHHHHhhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 011508          230 VDFQGNDFEALVYELMVNGSLEEWLHLNRD----------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPS  299 (484)
Q Consensus       230 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~  299 (484)
                          ..+..++||||+++|+|.+++.....          ....+++..++.++.|++.||+|||   +++|+||||||+
T Consensus       121 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  193 (333)
T 2i1m_A          121 ----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAAR  193 (333)
T ss_dssp             ----SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccc
Confidence                44578999999999999999975321          1235899999999999999999999   889999999999


Q ss_pred             CeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCC
Q 011508          300 NVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTN  378 (484)
Q Consensus       300 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~  378 (484)
                      ||+++.++.+||+|||++........     ........++..|+|||.+.+..++.++|||||||++|||+| |..||.
T Consensus       194 NIl~~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  268 (333)
T 2i1m_A          194 NVLLTNGHVAKIGDFGLARDIMNDSN-----YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP  268 (333)
T ss_dssp             GCEEEGGGEEEBCCCGGGCCGGGCTT-----SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             eEEECCCCeEEECccccccccccccc-----eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence            99999999999999999986643221     111223457889999999888889999999999999999999 999987


Q ss_pred             CCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHH
Q 011508          379 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEE  458 (484)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e  458 (484)
                      ...... ..........        ...                       .+..++..+.+++..||+.||.+|||+.|
T Consensus       269 ~~~~~~-~~~~~~~~~~--------~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~  316 (333)
T 2i1m_A          269 GILVNS-KFYKLVKDGY--------QMA-----------------------QPAFAPKNIYSIMQACWALEPTHRPTFQQ  316 (333)
T ss_dssp             TCCSSH-HHHHHHHHTC--------CCC-----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             ccchhH-HHHHHHhcCC--------CCC-----------------------CCCCCCHHHHHHHHHHhccChhhCcCHHH
Confidence            642221 1111111100        000                       01122557889999999999999999999


Q ss_pred             HHHHHHHHHHHHhhc
Q 011508          459 VAAQLLSFRNKLVKN  473 (484)
Q Consensus       459 vl~~L~~i~~~~~~~  473 (484)
                      |++.|+++.....+.
T Consensus       317 l~~~L~~~~~~~~~~  331 (333)
T 2i1m_A          317 ICSFLQEQAQEDRRE  331 (333)
T ss_dssp             HHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhhcc
Confidence            999999998776543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3e-43  Score=330.03  Aligned_cols=254  Identities=24%  Similarity=0.339  Sum_probs=200.9

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|.+.+.||+|+||.||+|++.    ++.||+|+++....  ...+.+.+|+.++++++||||+++++++...   ...
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~   82 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ----GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP   82 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET----TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC----CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence            57899999999999999999964    67799999976542  2345789999999999999999999986432   235


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeecCCCceEEccc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP--IVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ..++||||+++|+|.+++....  ...+++..++.++.|++.||+|||   +++  |+||||||+||+++.++.++|+||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~  157 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMA  157 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred             CeEeeecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEec
Confidence            7899999999999999998432  235899999999999999999999   778  999999999999999999999998


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCc---ccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVST---SGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      |++.....            ....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||......     ...
T Consensus       158 ~~~~~~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~  220 (271)
T 3kmu_A          158 DVKFSFQS------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-----EIG  220 (271)
T ss_dssp             GSCCTTSC------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-----HHH
T ss_pred             cceeeecc------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-----HHH
Confidence            87654311            1235889999999988765544   799999999999999999999753211     111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                      ....    .....+.+                       +..++..+.+++..||+.||++|||++|+++.|+++++
T Consensus       221 ~~~~----~~~~~~~~-----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          221 MKVA----LEGLRPTI-----------------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHH----HSCCCCCC-----------------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHH----hcCCCCCC-----------------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1000    00000000                       12235678999999999999999999999999998753

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-43  Score=329.08  Aligned_cols=257  Identities=28%  Similarity=0.428  Sum_probs=205.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||.||+|...   ++..||+|++..... ..+.+.+|++++++++||||+++++++.     .+..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   77 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAP   77 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSS
T ss_pred             hhheeeeeEecCCCceeEEEEEec---CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCC
Confidence            357889999999999999999865   456899999976543 3468999999999999999999999853     3457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++....   ..+++..++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||++
T Consensus        78 ~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~  151 (267)
T 3t9t_A           78 ICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMT  151 (267)
T ss_dssp             CEEEECCCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred             eEEEEeCCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccc
Confidence            899999999999999997542   35889999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ........      .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.....     .......  
T Consensus       152 ~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~i--  218 (267)
T 3t9t_A          152 RFVLDDQY------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDI--  218 (267)
T ss_dssp             GGBCCHHH------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHH--
T ss_pred             cccccccc------cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHHH--
Confidence            86643221      11123457788999999988889999999999999999999 8999875311     1111110  


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                         ..-....                       .+..++..+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus       219 ---~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          219 ---STGFRLY-----------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ---HTTCCCC-----------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---hcCCcCC-----------------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence               0000000                       011225578899999999999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.7e-43  Score=341.88  Aligned_cols=246  Identities=23%  Similarity=0.271  Sum_probs=200.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|+..  .+++.||+|+++...   ....+.+.+|+.+++.++||||+++++++     .++
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~  113 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN  113 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             HHCEEEEEeecCcCcEEEEEEEC--CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence            57899999999999999999954  467899999997542   23446788999999999999999999985     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++....    .+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg  186 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccc
Confidence            58899999999999999998543    4899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +++.....          .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ......  
T Consensus       187 ~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~--  249 (350)
T 1rdq_E          187 FAKRVKGR----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYEK--  249 (350)
T ss_dssp             TCEECSSC----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH--
T ss_pred             cceeccCC----------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----HHHHHH--
Confidence            99865321          1235699999999999999999999999999999999999999975311     111111  


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-----HHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-----MEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~~  462 (484)
                            +....+..                     +..++.++.+++.+||+.||++||+     ++||++.
T Consensus       250 ------i~~~~~~~---------------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          250 ------IVSGKVRF---------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ------HHHCCCCC---------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------HHcCCCCC---------------------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                  11000000                     1122567899999999999999998     8888753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5e-43  Score=341.97  Aligned_cols=255  Identities=24%  Similarity=0.274  Sum_probs=192.1

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ..++|.+.+.||+|+||.||+|+.  ..+++.||+|++..... ..+.+.+|+.+++.++||||+++++++.     ...
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~   89 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRD--KLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVIL-----TPT   89 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEE--TTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEE--CCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCC
Confidence            457899999999999999999994  44678999999975432 3467889999999999999999999964     345


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc--eEEccc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT--AHVSDF  314 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Df  314 (484)
                      ..++||||+++|+|.+++....    .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.  +||+||
T Consensus        90 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Df  162 (361)
T 3uc3_A           90 HLAIIMEYASGGELYERICNAG----RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDF  162 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred             EEEEEEEeCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeec
Confidence            7899999999999999997533    4899999999999999999999   899999999999999987765  999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcc-cceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTS-GDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |+++.....        .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ........
T Consensus       163 g~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~~~~~  233 (361)
T 3uc3_A          163 GYSKSSVLH--------SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR-DYRKTIQR  233 (361)
T ss_dssp             CCC-----------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC-CHHHHHHH
T ss_pred             Ccccccccc--------CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH-HHHHHHHH
Confidence            998743221        11223469999999999888777655 899999999999999999997643221 12221111


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                              +.........                   ...++.++.+++.+||+.||++|||+.|+++.
T Consensus       234 --------~~~~~~~~~~-------------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          234 --------ILSVKYSIPD-------------------DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             --------HHTTCCCCCT-------------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             --------HhcCCCCCCC-------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                    1111100000                   01124578899999999999999999999865

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.5e-43  Score=338.28  Aligned_cols=262  Identities=21%  Similarity=0.320  Sum_probs=198.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-----
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDF-----  232 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  232 (484)
                      ++|++.+.||+|+||.||+|+..  .+++.||||+++.... ...+.+.+|++++++++||||+++++++.....     
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNK--VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEET--TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEc--CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            56889999999999999999954  4578899999975443 345679999999999999999999998754321     


Q ss_pred             -----------------------------------------------CCCceeeEEeecccCCCHHHHHhhcCCCCCCCC
Q 011508          233 -----------------------------------------------QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLN  265 (484)
Q Consensus       233 -----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~  265 (484)
                                                                     ..+.+.++||||+++++|.+++..... ....+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~  162 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDRE  162 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSC
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchh
Confidence                                                           112347999999999999999985442 33467


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccccccCCC-----Ccccccccccc
Q 011508          266 LLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSS-----NQSSSVGVKGT  340 (484)
Q Consensus       266 ~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~-----~~~~~~~~~g~  340 (484)
                      +..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...........     .........||
T Consensus       163 ~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            7789999999999999999   899999999999999999999999999999877543211110     01122345699


Q ss_pred             ccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhh
Q 011508          341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEAN  420 (484)
Q Consensus       341 ~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~  420 (484)
                      +.|+|||++.+..++.++|||||||++|||++|..|+...       .....        .........           
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~--------~~~~~~~~~-----------  293 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIIT--------DVRNLKFPL-----------  293 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHH--------HHHTTCCCH-----------
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHH--------HhhccCCCc-----------
Confidence            9999999999999999999999999999999987764221       00000        000000000           


Q ss_pred             hhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          421 AHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       421 ~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                               ....+...+.+++.+||+.||++|||++|+++
T Consensus       294 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          294 ---------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             ---------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             ---------ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence                     01233556789999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=339.52  Aligned_cols=263  Identities=23%  Similarity=0.392  Sum_probs=200.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCC--eeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDH--ETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|++.+.||+|+||.||+|++...+.  ..+||+|.+.... ....+.+.+|+.++++++||||+++++++..     
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----   88 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-----   88 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES-----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec-----
Confidence            4679999999999999999999654322  2346888775433 3445789999999999999999999998642     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                       ...++|+||+.+|+|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        89 -~~~~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~Df  161 (327)
T 3lzb_A           89 -STVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDF  161 (327)
T ss_dssp             -SSEEEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCT
T ss_pred             -CCceEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccC
Confidence             13689999999999999997543   35899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |+++.......     ........+|..|+|||.+.+..++.++|||||||++|||++ |+.||.......  +...+..
T Consensus       162 G~a~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~  234 (327)
T 3lzb_A          162 GLAKLLGAEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEK  234 (327)
T ss_dssp             TC---------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHT
T ss_pred             cceeEccCccc-----cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHc
Confidence            99987643321     111223456889999999999999999999999999999999 999997642221  1111110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      .            ...                   ..+..++.++.+++..||+.||++|||+.|+++.|+.+....
T Consensus       235 ~------------~~~-------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          235 G------------ERL-------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             T------------CCC-------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             C------------CCC-------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence            0            000                   001223567899999999999999999999999999987543

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.4e-43  Score=342.70  Aligned_cols=250  Identities=24%  Similarity=0.359  Sum_probs=199.3

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeec
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVD  231 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  231 (484)
                      ...++|.+.+.||+|+||.||+|+..  .+++.||+|+++...   ....+.+..|..++..+ +||||+++++++    
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~----   87 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFK--KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF----   87 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEET--TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE----
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE----
Confidence            34578999999999999999999954  467899999997542   23446778899999877 999999999985    


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEE
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV  311 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl  311 (484)
                       ......++||||+++|+|.+++....    .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||
T Consensus        88 -~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL  159 (345)
T 1xjd_A           88 -QTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKI  159 (345)
T ss_dssp             -ECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred             -EeCCEEEEEEeCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEE
Confidence             44558999999999999999997543    4899999999999999999999   899999999999999999999999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      +|||+++.....       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ....
T Consensus       160 ~DFG~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~  227 (345)
T 1xjd_A          160 ADFGMCKENMLG-------DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELF  227 (345)
T ss_dssp             CCCTTCBCCCCT-------TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH
T ss_pred             eEChhhhhcccC-------CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHH
Confidence            999999754221       1122345799999999999999999999999999999999999999975321     1111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH-HHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME-EVA  460 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl  460 (484)
                      ......      ...+                       +..+..++.+++.+||+.||++||++. |++
T Consensus       228 ~~i~~~------~~~~-----------------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          228 HSIRMD------NPFY-----------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHHHC------CCCC-----------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHHHhC------CCCC-----------------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            110000      0000                       111255788999999999999999997 664

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.3e-43  Score=344.46  Aligned_cols=247  Identities=21%  Similarity=0.231  Sum_probs=192.2

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEee
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      .+.||+|+||.||+|+..  .++..||+|+++.......+.+.+|++++++++||||+++++++.     .....++|||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~E  166 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEET--ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVME  166 (373)
T ss_dssp             EEECC-----CEEEEEET--TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEEE
T ss_pred             ceEEecCcCEEEEEEEEc--CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEEe
Confidence            568999999999999844  457889999998765555678999999999999999999999864     3457899999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee--cCCCceEEcccCcccccc
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL--DGELTAHVSDFGLAKFLP  321 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll--~~~~~~kl~Dfg~a~~~~  321 (484)
                      |+++++|.+++...   ...+++..++.++.||+.||+|||   +.+|+||||||+|||+  +.++.+||+|||+++...
T Consensus       167 ~~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          167 YVDGGELFDRIIDE---SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             CCTTCEEHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             CCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            99999999988643   235899999999999999999999   8999999999999999  567799999999998764


Q ss_pred             cccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhh
Q 011508          322 EAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAE  401 (484)
Q Consensus       322 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  401 (484)
                      ...        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ....        .
T Consensus       241 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~--------~  299 (373)
T 2x4f_A          241 PRE--------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-----ETLN--------N  299 (373)
T ss_dssp             TTC--------BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH--------H
T ss_pred             Ccc--------ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH--------H
Confidence            322        112346899999999999999999999999999999999999999753211     1111        1


Q ss_pred             hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          402 IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       402 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      +..........                 ....++.++.+++.+||+.||++|||+.|+++
T Consensus       300 i~~~~~~~~~~-----------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          300 ILACRWDLEDE-----------------EFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             HHHTCCCSCSG-----------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHhccCCCChh-----------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11000000000                 01123567899999999999999999999997

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.3e-43  Score=340.42  Aligned_cols=250  Identities=24%  Similarity=0.282  Sum_probs=199.6

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeecc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDF  232 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  232 (484)
                      ..++|++.+.||+|+||.||+|+.  ..+++.||+|+++...   ....+.+..|..++..+ +||||+++++++     
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~--~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----   90 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSER--KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----   90 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEE--CCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----
Confidence            346899999999999999999994  4468899999997542   23456788999999988 899999999984     


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                      ...+..++||||+++|+|.+++....    .+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+
T Consensus        91 ~~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           91 QTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEE
Confidence            44558999999999999999997543    4899999999999999999999   8999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||+++.....       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .....
T Consensus       164 DFG~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~  231 (353)
T 2i0e_A          164 DFGMCKENIWD-------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQ  231 (353)
T ss_dssp             CCTTCBCCCCT-------TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred             eCCcccccccC-------CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHHH
Confidence            99999854221       1122345799999999999999999999999999999999999999975321     11111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-----HHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-----MEEVAA  461 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~  461 (484)
                      .        +....+..                     +...+.++.+++.+||+.||++||+     ++|+++
T Consensus       232 ~--------i~~~~~~~---------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          232 S--------IMEHNVAY---------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             H--------HHHCCCCC---------------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             H--------HHhCCCCC---------------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1        11110000                     1122557889999999999999996     466654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.6e-44  Score=338.41  Aligned_cols=256  Identities=24%  Similarity=0.373  Sum_probs=200.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCC-----eeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDH-----ETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      .++|.+.+.||+|+||.||+|+....+.     +..||+|++........+.+.+|+.++++++||||+++++++.    
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----   82 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV----   82 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC----
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE----
Confidence            3578899999999999999998654322     2579999998766666688999999999999999999999964    


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc----
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT----  308 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~----  308 (484)
                       .++..++||||+++|+|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.    
T Consensus        83 -~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~  155 (289)
T 4fvq_A           83 -CGDENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTG  155 (289)
T ss_dssp             -CTTCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGT
T ss_pred             -eCCCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCccccc
Confidence             3457799999999999999997532   34899999999999999999999   899999999999999998886    


Q ss_pred             ----eEEcccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccC
Q 011508          309 ----AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG  383 (484)
Q Consensus       309 ----~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~  383 (484)
                          +||+|||.+......           ....++..|+|||++.+ ..++.++||||||+++|||++|..|+......
T Consensus       156 ~~~~~kl~Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~  224 (289)
T 4fvq_A          156 NPPFIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS  224 (289)
T ss_dssp             BCCEEEECCCCSCTTTSCH-----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ccceeeeccCcccccccCc-----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence                999999998754221           12347889999999887 67899999999999999999965554322111


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      .. .......          ...+                       +..++.++.+++..||+.||++|||+.|+++.|
T Consensus       225 ~~-~~~~~~~----------~~~~-----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  270 (289)
T 4fvq_A          225 QR-KLQFYED----------RHQL-----------------------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDL  270 (289)
T ss_dssp             HH-HHHHHHT----------TCCC-----------------------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             HH-HHHHhhc----------cCCC-----------------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            00 0000000          0000                       001133578899999999999999999999999


Q ss_pred             HHHHHH
Q 011508          464 LSFRNK  469 (484)
Q Consensus       464 ~~i~~~  469 (484)
                      +++...
T Consensus       271 ~~l~~p  276 (289)
T 4fvq_A          271 NSLFTP  276 (289)
T ss_dssp             HTCC--
T ss_pred             HHhcCC
Confidence            887543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-43  Score=339.86  Aligned_cols=266  Identities=26%  Similarity=0.428  Sum_probs=201.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCC--CeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDD--HETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ..+|.+.+.||+|+||.||+|+.....  .+..||+|+++.... .....+.+|+.++++++||||+++++++     ..
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~  117 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----SK  117 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----CS
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----ec
Confidence            356778899999999999999875432  246799999975433 2335788999999999999999999985     34


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+++++|.+++...   ...+++.+++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Df  191 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDF  191 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCC
Confidence            55789999999999999999753   245899999999999999999999   889999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |++.........    ........++..|+|||.+.+..++.++|||||||++|||++ |+.||......     .....
T Consensus       192 g~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~~~~~  262 (333)
T 1mqb_A          192 GLSRVLEDDPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVMKA  262 (333)
T ss_dssp             CC---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHH
T ss_pred             Ccchhhcccccc----ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH-----HHHHH
Confidence            999876432211    111122346788999999988899999999999999999999 99999653211     11110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHh
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV  471 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  471 (484)
                              +.+.....                    .+..++..+.+++.+||+.||++||++.|+++.|+.+.....
T Consensus       263 --------~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          263 --------INDGFRLP--------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             --------HHTTCCCC--------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             --------HHCCCcCC--------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence                    00000000                    012235678999999999999999999999999999876543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9.1e-43  Score=351.61  Aligned_cols=206  Identities=26%  Similarity=0.397  Sum_probs=159.1

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|+.  ..+++.||||++.....  ...+.+.+|+.+|++++||||+++++++...+....
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYD--KLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             CTTEEECCC-------CEEEEEE--CC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEE--CCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            47899999999999999999984  44678999999865332  234678899999999999999999999866555566


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+ +++|.+++..    ...+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFG  201 (458)
T 3rp9_A          130 DELYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFG  201 (458)
T ss_dssp             CCEEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccc
Confidence            7889999998 6799999873    245999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCC--------------------CccccccccccccccCcccc-CCCCCCcccceehhhHHHHHHHhC
Q 011508          316 LAKFLPEAANNLSS--------------------NQSSSVGVKGTVGYAAPEYG-MGSEVSTSGDVYSFGILLLEMFTG  373 (484)
Q Consensus       316 ~a~~~~~~~~~~~~--------------------~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dvws~Gvvl~elltg  373 (484)
                      +++...........                    ........+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            99876432211000                    00122345789999999975 566799999999999999999994

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.6e-43  Score=349.62  Aligned_cols=266  Identities=19%  Similarity=0.232  Sum_probs=205.7

Q ss_pred             ccHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEee
Q 011508          149 VSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIIT  225 (484)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~  225 (484)
                      ..+.++....++|++.+.||+|+||+||+|+..  .+++.||+|+++...   ......+.+|..++..++||||+++++
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  141 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLK--NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY  141 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEc--CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            345555667789999999999999999999954  457899999997532   222345889999999999999999999


Q ss_pred             eeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 011508          226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG  305 (484)
Q Consensus       226 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~  305 (484)
                      +|.     ++...++||||+++|+|.+++...   ...+++..+..++.|++.||+|||   +++|+||||||+|||++.
T Consensus       142 ~~~-----~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~  210 (437)
T 4aw2_A          142 AFQ-----DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDM  210 (437)
T ss_dssp             EEE-----CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECT
T ss_pred             EEe-----eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcC
Confidence            853     455899999999999999999742   245899999999999999999999   899999999999999999


Q ss_pred             CCceEEcccCcccccccccccCCCCccccccccccccccCccccC-----CCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       306 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ++.+||+|||+++......      .......+||+.|+|||++.     ...++.++|||||||++|||++|+.||...
T Consensus       211 ~g~vkL~DFGla~~~~~~~------~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~  284 (437)
T 4aw2_A          211 NGHIRLADFGSCLKLMEDG------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  284 (437)
T ss_dssp             TSCEEECCCTTCEECCTTS------CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             CCCEEEcchhhhhhcccCC------CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999997654322      11223357999999999986     567899999999999999999999999753


Q ss_pred             ccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCC--CCCHHH
Q 011508          381 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRE--RMNMEE  458 (484)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~e  458 (484)
                      ..     .+......... ....-+..                       ...++.++.+|+.+||..+|++  ||+++|
T Consensus       285 ~~-----~~~~~~i~~~~-~~~~~p~~-----------------------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~e  335 (437)
T 4aw2_A          285 SL-----VETYGKIMNHK-ERFQFPTQ-----------------------VTDVSENAKDLIRRLICSREHRLGQNGIED  335 (437)
T ss_dssp             SH-----HHHHHHHHTHH-HHCCCCSS-----------------------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHH
T ss_pred             Ch-----hHHHHhhhhcc-ccccCCcc-----------------------cccCCHHHHHHHHHHhcccccccCCCCHHH
Confidence            21     11111111000 00000000                       0112556889999999988888  999999


Q ss_pred             HHHH
Q 011508          459 VAAQ  462 (484)
Q Consensus       459 vl~~  462 (484)
                      +++.
T Consensus       336 il~H  339 (437)
T 4aw2_A          336 FKKH  339 (437)
T ss_dssp             HHTS
T ss_pred             HhCC
Confidence            9763

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.8e-43  Score=351.58  Aligned_cols=249  Identities=26%  Similarity=0.383  Sum_probs=200.5

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|.+.+.||+|+||.||+|+.  ..+++.||||++....   ......+.+|+.+++.++||||+++++++.     .
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~   87 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKH--ELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----T   87 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEE--TTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEE--CCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence            36799999999999999999984  4467899999997542   223467889999999999999999999854     3


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+++|+|.+++..    ...+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DF  160 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADF  160 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEec
Confidence            4588999999999999999973    245899999999999999999999   999999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |++.......        ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.....     ..... 
T Consensus       161 G~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~~~~-  226 (476)
T 2y94_A          161 GLSNMMSDGE--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PTLFK-  226 (476)
T ss_dssp             SSCEECCTTC--------CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HHHHH-
T ss_pred             cchhhccccc--------cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HHHHH-
Confidence            9998763321        1223469999999999988765 7899999999999999999999975321     11111 


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                             .+.+.....                     +..+..++.+++.+||+.||++|||++|+++.
T Consensus       227 -------~i~~~~~~~---------------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          227 -------KICDGIFYT---------------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             -------HHHTTCCCC---------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -------HHhcCCcCC---------------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                   111111000                     11124568899999999999999999999873

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.3e-43  Score=332.44  Aligned_cols=265  Identities=26%  Similarity=0.443  Sum_probs=207.4

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ...++|++.+.||+|+||.||+|...   ++..||+|++.... ...+.+.+|++++++++||||+++++++.      .
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~   79 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN---GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------Q   79 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------S
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc---CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc------C
Confidence            34467899999999999999999865   45679999987543 34578999999999999999999999852      2


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++++|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+||++++++.+||+|||
T Consensus        80 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg  154 (279)
T 1qpc_A           80 EPIYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFG  154 (279)
T ss_dssp             SSCEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CCcEEEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCc
Confidence            35789999999999999997432  125899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      .+........      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......     +.....
T Consensus       155 ~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~~~~~~  223 (279)
T 1qpc_A          155 LARLIEDNEY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNL  223 (279)
T ss_dssp             TCEECSSSCE------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHH
T ss_pred             ccccccCccc------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-----HHHHHH
Confidence            9987643221      11123346788999999988889999999999999999999 99998653211     111100


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHhhcc
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVKNV  474 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~  474 (484)
                           ..-....                       .+..++.++.+++..||+.||++|||+.++++.|+++........
T Consensus       224 -----~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~  275 (279)
T 1qpc_A          224 -----ERGYRMV-----------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQY  275 (279)
T ss_dssp             -----HTTCCCC-----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC----
T ss_pred             -----hcccCCC-----------------------CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCC
Confidence                 0000000                       012235678999999999999999999999999999987654433

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.4e-43  Score=337.33  Aligned_cols=268  Identities=23%  Similarity=0.361  Sum_probs=208.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcC-----CCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDH-----DDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSV  230 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  230 (484)
                      .++|++.+.||+|+||.||+|+...     ..++..||+|+++.... ...+.+.+|+++++++ +||||+++++++.  
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc--
Confidence            4678999999999999999998642     13467899999975533 2346788999999999 9999999999853  


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRDA------------PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKP  298 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~  298 (484)
                         .++..++||||+++|+|.+++......            ...+++..++.++.|++.||+|||   +++|+||||||
T Consensus       112 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp  185 (334)
T 2pvf_A          112 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA  185 (334)
T ss_dssp             ---SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred             ---cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCcc
Confidence               445789999999999999999854321            234899999999999999999999   89999999999


Q ss_pred             CCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCC
Q 011508          299 SNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPT  377 (484)
Q Consensus       299 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~  377 (484)
                      +||+++.++.+||+|||++........     ........+++.|+|||++.+..++.++||||||+++|||++ |+.||
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  260 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDY-----YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  260 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSS-----EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ceEEEcCCCCEEEcccccccccccccc-----ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence            999999999999999999986643221     111223457889999999988889999999999999999999 99999


Q ss_pred             CCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                      .....     .+.....     ..-....                       .+..++..+.+++..||+.||.+|||+.
T Consensus       261 ~~~~~-----~~~~~~~-----~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~  307 (334)
T 2pvf_A          261 PGIPV-----EELFKLL-----KEGHRMD-----------------------KPANCTNELYMMMRDCWHAVPSQRPTFK  307 (334)
T ss_dssp             TTCCH-----HHHHHHH-----HHTCCCC-----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CcCCH-----HHHHHHH-----hcCCCCC-----------------------CCccCCHHHHHHHHHHccCChhhCcCHH
Confidence            65321     1111100     0000000                       0122356789999999999999999999


Q ss_pred             HHHHHHHHHHHHHh
Q 011508          458 EVAAQLLSFRNKLV  471 (484)
Q Consensus       458 evl~~L~~i~~~~~  471 (484)
                      |+++.|+.+.....
T Consensus       308 ell~~L~~l~~~~~  321 (334)
T 2pvf_A          308 QLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHhccc
Confidence            99999999976553

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.2e-44  Score=358.80  Aligned_cols=260  Identities=29%  Similarity=0.464  Sum_probs=202.4

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ...++|++.+.||+|+||.||+|.+..   +..||||+++... ...+.+.+|++++++++||||+++++++..      
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------  250 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------  250 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT---TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC---CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------
Confidence            345678899999999999999999753   4669999997644 345789999999999999999999998632      


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++....  ...+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus       251 ~~~~iv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG  325 (452)
T 1fmk_A          251 EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG  325 (452)
T ss_dssp             SSCEEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             CceEEEehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCc
Confidence            35799999999999999997432  234889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      +++......      ........++..|+|||.+....++.++|||||||++|||+| |+.||......     +.....
T Consensus       326 ~a~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~~~~~i  394 (452)
T 1fmk_A          326 LARLIEDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQV  394 (452)
T ss_dssp             TTC--------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHH
T ss_pred             cceecCCCc------eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH
Confidence            998764321      111223346789999999988899999999999999999999 99999753211     111100


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                           ..-..  +                     ..+..|+..+.+++.+||+.||++|||+++|++.|+.+...
T Consensus       395 -----~~~~~--~---------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          395 -----ERGYR--M---------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             -----HTTCC--C---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -----HcCCC--C---------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence                 00000  0                     00233467789999999999999999999999999887543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=347.74  Aligned_cols=287  Identities=19%  Similarity=0.246  Sum_probs=211.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .++|.+.+.||+|+||.||+|+..  .+++.||||+++.... ...+.+.+|++++++++||||+++++++..   ....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~---~~~~   82 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHK--KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE---TTTR   82 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC---TTTC
T ss_pred             CCceEEEEEEEcCCCeEEEEEEEC--CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeecc---CCCC
Confidence            357899999999999999999954  4578999999975432 334678899999999999999999998642   2344


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCCceEEc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL----DGELTAHVS  312 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~  312 (484)
                      ..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||   +++|+||||||+||++    +.++.+||+
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             eeEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence            67999999999999999975432 233899999999999999999999   8999999999999999    777889999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCC--------CCCCcccceehhhHHHHHHHhCCCCCCCCccCC
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG--------SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN  384 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~  384 (484)
                      |||+++......        ......||..|+|||++.+        ..++.++|||||||++|||++|+.||.......
T Consensus       159 DFG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~  230 (396)
T 4eut_A          159 DFGAARELEDDE--------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR  230 (396)
T ss_dssp             CGGGCEECCCGG--------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT
T ss_pred             cCCCceEccCCC--------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc
Confidence            999998764322        1223468999999998754        467889999999999999999999997543322


Q ss_pred             ccHh---HHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          385 LTLH---NFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       385 ~~~~---~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....   .......+..+..+.... .....  ....     ..........+...+.+++..||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~--~~~~-----~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          231 RNKEVMYKIITGKPSGAISGVQKAE-NGPID--WSGD-----MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             TCHHHHHHHHHSCCTTCCEEEECST-TCCEE--EESS-----CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             chHHHHHHHhcCCCcccchhheecc-CCCcc--cCcc-----CCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            2111   111111111111110000 00000  0000     00011113556788999999999999999999999999


Q ss_pred             HHHHHHHH
Q 011508          462 QLLSFRNK  469 (484)
Q Consensus       462 ~L~~i~~~  469 (484)
                      .++++..+
T Consensus       303 ~l~~il~~  310 (396)
T 4eut_A          303 ETSDILHR  310 (396)
T ss_dssp             HHHHHHTC
T ss_pred             HHHHHhhc
Confidence            99887643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.5e-43  Score=338.64  Aligned_cols=262  Identities=23%  Similarity=0.349  Sum_probs=202.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCC--eeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDH--ETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|++...+.  ...||+|.+.... ......+.+|+.++++++||||+++++++.      +
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~   86 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------G   86 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------B
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence            578899999999999999999654322  2348888875433 233356788999999999999999999862      2


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg  160 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFG  160 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCS
T ss_pred             CccEEEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCC
Confidence            3578999999999999999743   235888999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      +++.......     ........++..|+|||++.+..++.++|||||||++|||+| |+.||......  .....+...
T Consensus       161 ~a~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~  233 (325)
T 3kex_A          161 VADLLPPDDK-----QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKG  233 (325)
T ss_dssp             GGGGSCCCTT-----CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTT
T ss_pred             cccccCcccc-----cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcC
Confidence            9987644321     112233457889999999998899999999999999999999 99999764221  111111110


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      ..        ..                       .+..++..+.+++..||+.||.+|||+.|+++.|+.+....
T Consensus       234 ~~--------~~-----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          234 ER--------LA-----------------------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             CB--------CC-----------------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             CC--------CC-----------------------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            00        00                       01112445778999999999999999999999999886543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.1e-43  Score=342.03  Aligned_cols=265  Identities=22%  Similarity=0.279  Sum_probs=198.8

Q ss_pred             HHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeecc-----CccchHHHHHHHHHHHcCCCCCceeEeeeee
Q 011508          154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ-----HRGASKSFIAECQALRSIRHRNLVKIITSCV  228 (484)
Q Consensus       154 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  228 (484)
                      +....++|++.+.||+|+||.||+|+.  ..++..||+|++...     .....+.+.+|++++++++||||+++++++.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   98 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIE--NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE   98 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEE--TTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEE--CCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence            345567899999999999999999984  446788999998753     2334568899999999999999999999963


Q ss_pred             eeccCCCceeeEEeecccCCCHHHHHhhcCCC------------------------------------CCCCCHHHHHHH
Q 011508          229 SVDFQGNDFEALVYELMVNGSLEEWLHLNRDA------------------------------------PRNLNLLQRLSI  272 (484)
Q Consensus       229 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i  272 (484)
                           .....++||||+++|+|.+++......                                    ...+++..++.+
T Consensus        99 -----~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  173 (345)
T 3hko_A           99 -----DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI  173 (345)
T ss_dssp             -----CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred             -----cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence                 445889999999999999998531111                                    112467788899


Q ss_pred             HHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC--ceEEcccCcccccccccccCCCCccccccccccccccCccccC
Q 011508          273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL--TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM  350 (484)
Q Consensus       273 ~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~--~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  350 (484)
                      +.|++.||+|||   +.+|+||||||+||+++.++  .+||+|||++..+......   .........||+.|+|||++.
T Consensus       174 ~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~  247 (345)
T 3hko_A          174 MRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG---EYYGMTTKAGTPYFVAPEVLN  247 (345)
T ss_dssp             HHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc---ccccccccCCCccccCchhhc
Confidence            999999999999   88999999999999998776  8999999999866432211   111123456999999999986


Q ss_pred             C--CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccc
Q 011508          351 G--SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRS  428 (484)
Q Consensus       351 ~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~  428 (484)
                      +  ..++.++|||||||++|||++|+.||......     ....        .+.........                 
T Consensus       248 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~--------~~~~~~~~~~~-----------------  297 (345)
T 3hko_A          248 TTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA-----DTIS--------QVLNKKLCFEN-----------------  297 (345)
T ss_dssp             CSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH--------HHHHCCCCTTS-----------------
T ss_pred             cCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH-----HHHH--------HHHhcccccCC-----------------
Confidence            5  67899999999999999999999999753211     1111        11111110000                 


Q ss_pred             cchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          429 FGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       429 ~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .....++..+.+++.+||+.||++|||+.|+++
T Consensus       298 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          298 PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            001123567899999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.7e-43  Score=339.41  Aligned_cols=243  Identities=22%  Similarity=0.339  Sum_probs=198.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--------chHHHHHHHHHHHcCCCCCceeEeeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--------ASKSFIAECQALRSIRHRNLVKIITSCVS  229 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~  229 (484)
                      .++|++.+.||+|+||.||+|+.  ..+++.||||+++.....        ....+.+|+.++++++||||+++++++  
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~--   98 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVD--KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF--   98 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEE--TTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE--
T ss_pred             ccceEEEeEEEecCCEEEEEEEE--CCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE--
Confidence            46799999999999999999984  446789999999765321        224577899999999999999999985  


Q ss_pred             eccCCCceeeEEeecccCC-CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 011508          230 VDFQGNDFEALVYELMVNG-SLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT  308 (484)
Q Consensus       230 ~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~  308 (484)
                         ......++||||+.+| +|.+++...    ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.
T Consensus        99 ---~~~~~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~  168 (335)
T 3dls_A           99 ---ENQGFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFT  168 (335)
T ss_dssp             ---ECSSEEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSC
T ss_pred             ---eeCCEEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCc
Confidence               3455889999999777 999999743    35899999999999999999999   899999999999999999999


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      +||+|||++.......        ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....     
T Consensus       169 ~kL~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----  235 (335)
T 3dls_A          169 IKLIDFGSAAYLERGK--------LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-----  235 (335)
T ss_dssp             EEECCCTTCEECCTTC--------CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----
T ss_pred             EEEeecccceECCCCC--------ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----
Confidence            9999999998764321        1223568999999999888776 8899999999999999999999964211     


Q ss_pred             hHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          388 HNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                                    ........                     +..++.++.+++.+||+.||++|||+.|+++.
T Consensus       236 --------------~~~~~~~~---------------------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 --------------TVEAAIHP---------------------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             --------------GTTTCCCC---------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             --------------HHhhccCC---------------------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                          00000000                     11125578999999999999999999999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-43  Score=332.79  Aligned_cols=253  Identities=24%  Similarity=0.302  Sum_probs=195.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|.+.+.||+|+||.||+|...  .++..+|+|++..... ...+.+.+|++++++++||||+++++++.     ....
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~   94 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEER--SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHN   94 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hheeecceeccCCCeEEEEEEEc--cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCe
Confidence            46889999999999999999843  4578899999876543 34578899999999999999999999953     4457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEccc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDF  314 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Df  314 (484)
                      .++||||+++|+|.+++.........+++..++.++.|++.||+|||   +++|+||||||+||++   +.++.+||+||
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEee
Confidence            89999999999999998754433456999999999999999999999   8999999999999999   45678999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |++.......        ......||..|+|||++. ..++.++||||||+++|||++|+.||......     ......
T Consensus       172 g~a~~~~~~~--------~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-----~~~~~~  237 (285)
T 3is5_A          172 GLAELFKSDE--------HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-----EVQQKA  237 (285)
T ss_dssp             CCCCC------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHH
T ss_pred             ecceecCCcc--------cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-----HHHhhh
Confidence            9998653321        122346899999999876 46899999999999999999999999753211     111100


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .      ...+.....                    ......++.+++.+||+.||++|||+.|+++
T Consensus       238 ~------~~~~~~~~~--------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          238 T------YKEPNYAVE--------------------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             H------HCCCCCCC----------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             c------cCCcccccc--------------------cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0      000000000                    0011456889999999999999999999975

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=2.5e-42  Score=327.31  Aligned_cols=252  Identities=27%  Similarity=0.384  Sum_probs=197.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ..|.+.+.||+|+||.||+|...  .++..||+|++....  ....+.+.+|+.++++++||||+++++++.... .+..
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~  102 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDT--ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK  102 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCE
T ss_pred             eeEEeeeeccCCCCeEEEEeEec--CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCc
Confidence            34778889999999999999844  467889999987543  233467889999999999999999999875432 4456


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeec-CCCceEEcc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP--IVHCDLKPSNVLLD-GELTAHVSD  313 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~D  313 (484)
                      ..++||||+++++|.+++...    ..+++..++.++.|++.||+|||   +.+  |+||||||+||+++ .++.+||+|
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             eEEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEee
Confidence            789999999999999999754    34889999999999999999999   777  99999999999997 788999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||++......         ......|++.|+|||++.+ .++.++||||||+++|+|++|+.||......    ......
T Consensus       176 fg~~~~~~~~---------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~  241 (290)
T 1t4h_A          176 LGLATLKRAS---------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRR  241 (290)
T ss_dssp             TTGGGGCCTT---------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHH
T ss_pred             CCCccccccc---------ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH----HHHHHH
Confidence            9999754221         1223468999999998764 5899999999999999999999999653221    111111


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....     ..+..                      .+..++.++.+++..||+.||.+|||+.|+++
T Consensus       242 ~~~~-----~~~~~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          242 VTSG-----VKPAS----------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HTTT-----CCCGG----------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Hhcc-----CCccc----------------------cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            0000     00000                      01112456899999999999999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=4e-43  Score=331.63  Aligned_cols=260  Identities=23%  Similarity=0.373  Sum_probs=204.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-----
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDF-----  232 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  232 (484)
                      ..+|++.+.||+|+||.||+|+..  .+++.||+|++....    +.+.+|++++++++||||+++++++....+     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHR--IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEET--TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             ccccceeeeeccCCceEEEEEEEc--CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            356889999999999999999954  357889999997543    456789999999999999999998754322     


Q ss_pred             ------CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 011508          233 ------QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE  306 (484)
Q Consensus       233 ------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~  306 (484)
                            ......++||||+++++|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+||+++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEET
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCC
Confidence                  12446799999999999999997543  235899999999999999999999   8899999999999999999


Q ss_pred             CceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCcc
Q 011508          307 LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLT  386 (484)
Q Consensus       307 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~  386 (484)
                      +.+||+|||++.......        ......+++.|+|||.+.+..++.++||||||+++|||++|..|+...      
T Consensus       159 ~~~kl~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------  224 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDG--------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------  224 (284)
T ss_dssp             TEEEECCCTTCEESSCCS--------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------
T ss_pred             CCEEECcchhheeccccc--------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------
Confidence            999999999998764321        122345899999999999889999999999999999999999886421      


Q ss_pred             HhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          387 LHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                       .....        .+.+..+                       +..++..+.+++..||+.||++|||+.|+++.|+.+
T Consensus       225 -~~~~~--------~~~~~~~-----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~  272 (284)
T 2a19_B          225 -SKFFT--------DLRDGII-----------------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW  272 (284)
T ss_dssp             -HHHHH--------HHHTTCC-----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHH--------Hhhcccc-----------------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             01110        1111111                       011245678999999999999999999999999999


Q ss_pred             HHHHhhcc
Q 011508          467 RNKLVKNV  474 (484)
Q Consensus       467 ~~~~~~~~  474 (484)
                      +....++.
T Consensus       273 ~~~~~~~~  280 (284)
T 2a19_B          273 KKSPEKNE  280 (284)
T ss_dssp             TC------
T ss_pred             hhCCCccc
Confidence            87665543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=8.4e-43  Score=336.33  Aligned_cols=263  Identities=25%  Similarity=0.381  Sum_probs=204.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||.||+|+...++....+|+|.++... ....+.+.+|+++++++ +||||+++++++..     .+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----~~   99 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG   99 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----CC
Confidence            5789999999999999999996654333356999887532 23446789999999999 99999999999643     45


Q ss_pred             eeeEEeecccCCCHHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 011508          237 FEALVYELMVNGSLEEWLHLNR------------DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD  304 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~  304 (484)
                      ..++||||+++++|.+++....            .....+++..++.++.|++.||+|||   +++|+||||||+||+++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG  176 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEc
Confidence            7899999999999999997543            22346899999999999999999999   89999999999999999


Q ss_pred             CCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccC
Q 011508          305 GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTG  383 (484)
Q Consensus       305 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~  383 (484)
                      .++.+||+|||+++......        ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... 
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-  247 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-  247 (327)
T ss_dssp             GGGCEEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-
T ss_pred             CCCeEEEcccCcCccccccc--------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-
Confidence            99999999999987442211        1122346789999999988889999999999999999998 9999965321 


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                          ....... ..    -....                       .+..++..+.+++.+||+.||++|||+.|+++.|
T Consensus       248 ----~~~~~~~-~~----~~~~~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L  295 (327)
T 1fvr_A          248 ----AELYEKL-PQ----GYRLE-----------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  295 (327)
T ss_dssp             ----HHHHHHG-GG----TCCCC-----------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ----HHHHHHh-hc----CCCCC-----------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence                1111110 00    00000                       0122356789999999999999999999999999


Q ss_pred             HHHHHHH
Q 011508          464 LSFRNKL  470 (484)
Q Consensus       464 ~~i~~~~  470 (484)
                      +.+....
T Consensus       296 ~~~~~~~  302 (327)
T 1fvr_A          296 NRMLEER  302 (327)
T ss_dssp             HHHHHSS
T ss_pred             HHHHHhh
Confidence            9987654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.9e-42  Score=342.34  Aligned_cols=255  Identities=20%  Similarity=0.242  Sum_probs=191.5

Q ss_pred             CCCCcc-CccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHc-CCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLE-NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRS-IRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|.+. +.||+|+||+||+|+.  ..+++.||||+++.     ...+.+|+.++.+ .+||||+++++++... +.+..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~--~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~  132 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFN--KRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRK  132 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEE--TTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEE
T ss_pred             ccceeccceeeeccCeEEEEEEE--CCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCc
Confidence            456665 6899999999999994  44678999999863     2467788888754 5899999999986542 23455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEEcc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSD  313 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~D  313 (484)
                      ..++||||+++|+|.+++....  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEe
Confidence            7899999999999999997432  245899999999999999999999   899999999999999987   78999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCcc--HhHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLT--LHNFV  391 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~--~~~~~  391 (484)
                      ||+++......        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ....+
T Consensus       208 FG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i  279 (400)
T 1nxk_A          208 FGFAKETTSHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI  279 (400)
T ss_dssp             CTTCEECC-------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH
T ss_pred             cccccccCCCC--------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH
Confidence            99998653221        122356899999999999999999999999999999999999999764322110  11111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..           ......                 ......++.++.+++.+||+.||++|||+.|+++.
T Consensus       280 ~~-----------~~~~~~-----------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          280 RM-----------GQYEFP-----------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HH-----------TCCCCC-----------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             Hc-----------CcccCC-----------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00           000000                 00012235678999999999999999999999874

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-42  Score=349.50  Aligned_cols=283  Identities=19%  Similarity=0.174  Sum_probs=197.5

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-C
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDF-Q  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~  233 (484)
                      ..++|++.+.||+|+||.||+|+.  ..+++.||||++....  ....+.+.+|+.+++.++||||+++++++..... .
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~--~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYD--AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEE--TTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEE--CCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence            357899999999999999999984  4467889999997542  2334678899999999999999999998754321 2


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||+++ +|.+.+.      ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus       138 ~~~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~D  207 (464)
T 3ttj_A          138 EFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  207 (464)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred             cCCeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEE
Confidence            33567999999965 5777664      23889999999999999999999   88999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||+++.....        .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+..... .+...+..
T Consensus       208 FG~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~  278 (464)
T 3ttj_A          208 FGLARTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQ  278 (464)
T ss_dssp             CCCC-----C--------CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred             EEeeeecCCC--------cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence            9999865322        12233578999999999999999999999999999999999999997632111 11111111


Q ss_pred             hc---c-------hhhhhhcCcccccccccccchhh-hhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 AL---P-------ERLAEIVDPVLLVEREEGETSEA-NAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~---~-------~~~~~~~d~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..   +       ......++.....  ........ .................++.+|+.+||+.||++|||++|+++.
T Consensus       279 lg~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          279 LGTPCPEFMKKLQPTVRNYVENRPKY--AGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HCSCCHHHHTTSCHHHHHHHTTSCCC--CCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCCCCHHHHHHcchhhhhHhhccccc--CCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00   0       0011111100000  00000000 0000000000112235678999999999999999999999863

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.3e-43  Score=337.19  Aligned_cols=278  Identities=27%  Similarity=0.377  Sum_probs=208.4

Q ss_pred             cCCCCccCccccccceeEEEEEEc---CCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      .++|.+.+.||+|+||.||+|++.   +..++..||||++..... .....+.+|+.++++++||||+++++++.     
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----  103 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----  103 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-----
Confidence            467999999999999999999854   234567899999974432 33457889999999999999999999853     


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CC
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDA---PRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---EL  307 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~  307 (484)
                      .....++||||+++++|.+++......   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.   +.
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTC
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcc
Confidence            445779999999999999999865422   245899999999999999999999   899999999999999984   44


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCcc
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT  386 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~  386 (484)
                      .+||+|||++........     ........+++.|+|||.+.+..++.++||||||+++|||+| |+.||......  .
T Consensus       181 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~  253 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASY-----YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--E  253 (327)
T ss_dssp             CEEECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--H
T ss_pred             eEEECccccccccccccc-----cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--H
Confidence            699999999875532221     111223457889999999988889999999999999999998 99998653111  1


Q ss_pred             HhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          387 LHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                      ....+...        ....                       .+..++..+.+++..||+.||.+|||+.||++.|+.+
T Consensus       254 ~~~~~~~~--------~~~~-----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          254 VLEFVTSG--------GRMD-----------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HHHHHHTT--------CCCC-----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcC--------CCCC-----------------------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11111000        0000                       0122356789999999999999999999999999999


Q ss_pred             HHHHhhccCCCccee
Q 011508          467 RNKLVKNVRGQPATY  481 (484)
Q Consensus       467 ~~~~~~~~~~~~~~~  481 (484)
                      ...........|..|
T Consensus       303 ~~~~~~~~~~~~~~~  317 (327)
T 2yfx_A          303 TQDPDVINTALPIEY  317 (327)
T ss_dssp             HHCHHHHTCCCCCC-
T ss_pred             hcCHHHhcccccccc
Confidence            876655444444444

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-42  Score=340.14  Aligned_cols=212  Identities=27%  Similarity=0.398  Sum_probs=179.6

Q ss_pred             hhccccHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-----CCC
Q 011508          145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-----HRN  219 (484)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~n  219 (484)
                      ....+++.+.....++|.+.+.||+|+||.||+|+..  .+++.||||+++.. ......+..|+.+++.+.     |||
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~   97 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI--DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNN   97 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEEC--CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence            3556677766677889999999999999999999954  45788999998643 233456788999999986     999


Q ss_pred             ceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 011508          220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPS  299 (484)
Q Consensus       220 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~  299 (484)
                      |+++++++..     .+..++||||+ +++|.+++....  ...+++..++.++.||+.||+|||   +++|+||||||+
T Consensus        98 iv~~~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~  166 (360)
T 3llt_A           98 IVKYHGKFMY-----YDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPE  166 (360)
T ss_dssp             BCCEEEEEEE-----TTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred             eecccceeeE-----CCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcc
Confidence            9999998644     34889999999 999999998543  235899999999999999999999   899999999999


Q ss_pred             CeeecC-------------------------CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCC
Q 011508          300 NVLLDG-------------------------ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV  354 (484)
Q Consensus       300 NIll~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  354 (484)
                      |||++.                         ++.+||+|||++......          .....||+.|+|||++.+..+
T Consensus       167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~  236 (360)
T 3llt_A          167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----------HGSIINTRQYRAPEVILNLGW  236 (360)
T ss_dssp             GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----------CCSCCSCGGGCCHHHHTTCCC
T ss_pred             cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----------CcCccCcccccCcHHHcCCCC
Confidence            999975                         789999999999864321          123468999999999999999


Q ss_pred             CcccceehhhHHHHHHHhCCCCCCCC
Q 011508          355 STSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       355 ~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      +.++|||||||++|||++|+.||...
T Consensus       237 ~~~~DiwslG~il~ell~g~~pf~~~  262 (360)
T 3llt_A          237 DVSSDMWSFGCVLAELYTGSLLFRTH  262 (360)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCccchHHHHHHHHHHHHCCCCCCCC
Confidence            99999999999999999999999763

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.3e-42  Score=328.88  Aligned_cols=268  Identities=23%  Similarity=0.303  Sum_probs=195.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||.||+|+..   +++.||+|++.....  ...+.+.+|++++++++||||+++++++.     ..+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~   73 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN---YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKK   73 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET---TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSS
T ss_pred             ccchhhhhcccCCCEEEEEEEcC---CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCC
Confidence            57889999999999999999853   568899999875432  23467889999999999999999999854     345


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++ +|.+++...   ...+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus        74 ~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  146 (288)
T 1ob3_A           74 RLVLVFEHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGL  146 (288)
T ss_dssp             CEEEEEECCSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             eEEEEEEecCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECcc
Confidence            88999999964 999998743   245899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.......       .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+........
T Consensus       147 ~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~  218 (288)
T 1ob3_A          147 ARAFGIPV-------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILG  218 (288)
T ss_dssp             HHHHCC----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred             ccccCccc-------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHC
Confidence            97653221       11223458999999999876 458999999999999999999999997642211 1111111100


Q ss_pred             ch---hhhh-----hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 PE---RLAE-----IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 ~~---~~~~-----~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..   ....     ..++.+....            +.........++.++.+++.+||+.||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          219 TPNSKNWPNVTELPKYDPNFTVYE------------PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCC------------CCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCChhhchhhhccccccccccccc------------CccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00   0000     0000000000            00000001223567899999999999999999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-42  Score=331.74  Aligned_cols=262  Identities=19%  Similarity=0.229  Sum_probs=196.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      -++|.+.+.||+|+||.||+|+..  .+++.||+|++......   ..+.+.+|+.++++++||||+++++++..     
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----  105 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDT--VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----  105 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEET--TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEc--CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----
Confidence            378999999999999999999844  45788999999754322   23678899999999999999999998643     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ++..++||||+++++|.+++....    .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Df  178 (309)
T 2h34_A          106 DGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDF  178 (309)
T ss_dssp             TTEEEEEEECCCCEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSC
T ss_pred             CCeEEEEEEecCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecC
Confidence            447899999999999999997542    4899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |++.......      ........|+..|+|||.+.+..++.++||||||+++|||++|+.||......      .....
T Consensus       179 g~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~  246 (309)
T 2h34_A          179 GIASATTDEK------LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS------VMGAH  246 (309)
T ss_dssp             CC----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH------HHHHH
T ss_pred             ccCccccccc------cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH------HHHHH
Confidence            9987654321      11122346899999999999999999999999999999999999999753211      11110


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-CHHHHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-NMEEVAAQLLSFRNKL  470 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~~~~  470 (484)
                      .    ........                     .....++..+.+++.+||+.||++|| |++++++.|+.+....
T Consensus       247 ~----~~~~~~~~---------------------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          247 I----NQAIPRPS---------------------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             H----HSCCCCGG---------------------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             h----ccCCCCcc---------------------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            0    00000000                     00122355788999999999999999 9999999998765444

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.2e-43  Score=364.87  Aligned_cols=256  Identities=27%  Similarity=0.391  Sum_probs=202.3

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEe
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVY  242 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  242 (484)
                      +.||+|+||.||+|.+.....++.||||+++....  ...+.+.+|++++++++||||++++++|.      .+..++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEEEE
Confidence            47999999999999887777789999999975432  23478999999999999999999999863      22478999


Q ss_pred             ecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccccc
Q 011508          243 ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE  322 (484)
Q Consensus       243 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  322 (484)
                      ||+++|+|.+++...    ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.+..
T Consensus       449 E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~  521 (635)
T 4fl3_A          449 EMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  521 (635)
T ss_dssp             ECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred             EccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence            999999999999743    35899999999999999999999   89999999999999999999999999999987644


Q ss_pred             ccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhh
Q 011508          323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAE  401 (484)
Q Consensus       323 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  401 (484)
                      ....    ........+|..|+|||++.+..++.++|||||||++|||++ |+.||......  .+...+..        
T Consensus       522 ~~~~----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~~~~~i~~--------  587 (635)
T 4fl3_A          522 DENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEK--------  587 (635)
T ss_dssp             -----------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHT--------
T ss_pred             Cccc----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHc--------
Confidence            3211    111223346789999999998899999999999999999998 99999764221  11111110        


Q ss_pred             hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          402 IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       402 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      ....                       ..+..|+.++.+++..||+.||++|||+.+|++.|+++...+
T Consensus       588 ~~~~-----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          588 GERM-----------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             TCCC-----------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCC-----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            0000                       002334678999999999999999999999999999887654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.6e-43  Score=334.98  Aligned_cols=245  Identities=25%  Similarity=0.282  Sum_probs=189.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--chHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--ASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.++||+|+||+||+|+..  .+++.||||++......  ....+..|+..+.++ +||||++++++|.     .+
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~  129 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSK--EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EG  129 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET--TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             hheeeeheeccCCCeEEEEEEEC--CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eC
Confidence            57899999999999999999954  35788999998654322  223455666666555 9999999999964     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+ +++|.+++....   ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus       130 ~~~~lv~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          130 GILYLQTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCT
T ss_pred             CEEEEEEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccce
Confidence            5889999999 789999987543   35999999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++.......        ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...    ...........
T Consensus       203 ~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~  269 (311)
T 3p1a_A          203 LLVELGTAG--------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYL  269 (311)
T ss_dssp             TCEECC--------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCC
T ss_pred             eeeecccCC--------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCC
Confidence            987653321        1223458999999998876 7899999999999999999997766431    01111100000


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      +.        .+                       +..++.++.+++.+||+.||++|||++|+++
T Consensus       270 ~~--------~~-----------------------~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 PP--------EF-----------------------TAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             CH--------HH-----------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Cc--------cc-----------------------ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            00        00                       1123567899999999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.4e-42  Score=332.26  Aligned_cols=252  Identities=21%  Similarity=0.269  Sum_probs=200.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc------chHHHHHHHHHHHcCCCCCceeEeeeeeeec
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG------ASKSFIAECQALRSIRHRNLVKIITSCVSVD  231 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  231 (484)
                      .++|++.+.||+|+||.||+|+..  .++..||+|+++.....      ..+.+.+|+.++++++||||+++++++.   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---   85 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREK--STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE---   85 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE---
T ss_pred             hccEEEeeEeeecCCEEEEEEEEC--CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe---
Confidence            356899999999999999999944  45788999999764322      2467899999999999999999999853   


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC----
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL----  307 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~----  307 (484)
                        .....++||||+++++|.+++...    ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++    
T Consensus        86 --~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~  156 (321)
T 2a2a_A           86 --NRTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIP  156 (321)
T ss_dssp             --CSSEEEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSC
T ss_pred             --cCCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcC
Confidence              445889999999999999999742    35899999999999999999999   89999999999999999887    


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      .+||+|||++.......        ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......    
T Consensus       157 ~~kl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  224 (321)
T 2a2a_A          157 HIKLIDFGLAHEIEDGV--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----  224 (321)
T ss_dssp             CEEECCCTTCEECCTTC--------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH----
T ss_pred             CEEEccCccceecCccc--------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH----
Confidence            79999999998664321        112346899999999999999999999999999999999999999653211    


Q ss_pred             hHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          388 HNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                       .....        +..........                 ....++..+.+++.+||+.||++|||+.|+++
T Consensus       225 -~~~~~--------i~~~~~~~~~~-----------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          225 -ETLAN--------ITSVSYDFDEE-----------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -HHHHH--------HHTTCCCCCHH-----------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -HHHHH--------HHhcccccChh-----------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             11110        00000000000                 01122557889999999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.6e-42  Score=326.33  Aligned_cols=252  Identities=23%  Similarity=0.279  Sum_probs=200.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||.||+|+..  .++..||+|++........+.+.+|++++++++||||+++++++.     .+..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~   80 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQK--GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTD   80 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeC--CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCe
Confidence            356899999999999999999854  456789999998766666788999999999999999999999854     4557


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEccc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDF  314 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Df  314 (484)
                      .++||||+++++|.+++....    .+++..++.++.|++.||+|||   +++|+||||||+||++   +.++.+||+||
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Df  153 (277)
T 3f3z_A           81 IYLVMELCTGGELFERVVHKR----VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDF  153 (277)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeccCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEec
Confidence            899999999999999987543    4899999999999999999999   8999999999999999   78889999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |++.......        ......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......     ..... 
T Consensus       154 g~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~-  218 (277)
T 3f3z_A          154 GLAARFKPGK--------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS-----EVMLK-  218 (277)
T ss_dssp             TTCEECCTTS--------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH-
T ss_pred             ccceeccCcc--------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH-----HHHHH-
Confidence            9998654321        12234689999999988654 899999999999999999999999753211     11100 


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                             +....... +.                .....++..+.+++.+||+.||++|||+.|+++.
T Consensus       219 -------~~~~~~~~-~~----------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          219 -------IREGTFTF-PE----------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             -------HHHCCCCC-CH----------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -------HHhCCCCC-Cc----------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   00000000 00                0011235678999999999999999999999863

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=335.90  Aligned_cols=271  Identities=20%  Similarity=0.232  Sum_probs=193.6

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-CCCceeEeeeeeeecc---
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRNLVKIITSCVSVDF---  232 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~---  232 (484)
                      ...+|++.+.||+|+||.||+|+..  .+++.||+|++........+.+.+|+.++.++. ||||+++++++.....   
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDV--GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEET--TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             cCceEEEEEEEccCCceEEEEEEEC--CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            3457899999999999999999953  457889999987666555678899999999995 9999999998753321   


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeecCCCceE
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP--IVHCDLKPSNVLLDGELTAH  310 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~NIll~~~~~~k  310 (484)
                      ......++||||+ +|+|.+++..... ...+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.+|
T Consensus       104 ~~~~~~~lv~e~~-~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~k  178 (337)
T 3ll6_A          104 TGQAEFLLLTELC-KGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIK  178 (337)
T ss_dssp             TSSEEEEEEEECC-SEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred             cCCceEEEEEEec-CCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEE
Confidence            3455689999999 5799999875332 335999999999999999999999   788  99999999999999999999


Q ss_pred             EcccCcccccccccccCCCC-----ccccccccccccccCcccc---CCCCCCcccceehhhHHHHHHHhCCCCCCCCcc
Q 011508          311 VSDFGLAKFLPEAANNLSSN-----QSSSVGVKGTVGYAAPEYG---MGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFT  382 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~  382 (484)
                      |+|||++.............     ........||+.|+|||++   .+..++.++|||||||++|||++|+.||.....
T Consensus       179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  258 (337)
T 3ll6_A          179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK  258 (337)
T ss_dssp             BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence            99999998765432111000     0111234589999999998   566789999999999999999999999965311


Q ss_pred             CCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          383 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..                 +.+.......                   ...+...+.+++..||+.||++|||+.|+++.
T Consensus       259 ~~-----------------~~~~~~~~~~-------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  302 (337)
T 3ll6_A          259 LR-----------------IVNGKYSIPP-------------------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ  302 (337)
T ss_dssp             ------------------------CCCCT-------------------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HH-----------------hhcCcccCCc-------------------ccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            10                 0000000000                   01113347789999999999999999999999


Q ss_pred             HHHHHHHH
Q 011508          463 LLSFRNKL  470 (484)
Q Consensus       463 L~~i~~~~  470 (484)
                      |+.+....
T Consensus       303 l~~~~~~~  310 (337)
T 3ll6_A          303 LQEIAAAR  310 (337)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHhcc
Confidence            99998764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.7e-43  Score=329.56  Aligned_cols=254  Identities=30%  Similarity=0.393  Sum_probs=197.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||.||+|...    ++.||+|+++...  ..+.+.+|++++++++||||+++++++.    ..+..
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~~~~   89 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGG   89 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET----TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--C
T ss_pred             hhhceEEeEEecCCCceEEEEEEc----CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEE----cCCCc
Confidence            467899999999999999999854    6789999987543  4577899999999999999999999863    33446


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~  164 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT  164 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             eEEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccc
Confidence            899999999999999997532  123788999999999999999999   899999999999999999999999999998


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      .......          ....++..|+|||.+.+..++.++||||||+++|||+| |+.||......     .....   
T Consensus       165 ~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-----~~~~~---  226 (278)
T 1byg_A          165 KEASSTQ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----DVVPR---  226 (278)
T ss_dssp             ---------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-----GHHHH---
T ss_pred             ccccccc----------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH---
Confidence            7553221          12347889999999988889999999999999999998 99999753211     11110   


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                        +..-....                       .+..++..+.+++..||+.||++|||+.|+++.|+.++..
T Consensus       227 --~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          227 --VEKGYKMD-----------------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             --HTTTCCCC-----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --HhcCCCCC-----------------------CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence              00000000                       0122356789999999999999999999999999999764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.1e-42  Score=334.52  Aligned_cols=276  Identities=23%  Similarity=0.321  Sum_probs=208.1

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHc--CCCCCceeEeeeeeeeccCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRS--IRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~  234 (484)
                      ..++|.+.+.||+|+||.||+|+..    ++.||||++...   ....+.+|.+++..  ++||||+++++++.... ..
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~  111 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKWR----GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GT  111 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET----TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SS
T ss_pred             ccccEEEEeeecCCCCcEEEEEEEc----CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cc
Confidence            3467999999999999999999863    678999998643   34667889998887  79999999999865332 11


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeeecCCCce
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY-----CETPIVHCDLKPSNVLLDGELTA  309 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~  309 (484)
                      ....++||||+++|+|.+++...     .+++..++.++.|++.||+|||..     ++.+|+||||||+||+++.++.+
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~  186 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  186 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCE
Confidence            23689999999999999999743     489999999999999999999932     14689999999999999999999


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCCC------CCCcccceehhhHHHHHHHhC----------
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEMFTG----------  373 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~Gvvl~elltg----------  373 (484)
                      ||+|||++..........   ........||..|+|||++.+.      .++.++|||||||++|||+||          
T Consensus       187 kL~Dfg~~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~  263 (342)
T 1b6c_B          187 CIADLGLAVRHDSATDTI---DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY  263 (342)
T ss_dssp             EECCCTTCEEEETTTTEE---EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             EEEECCCceecccccccc---ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence            999999997664322110   0012334699999999998765      344789999999999999999          


Q ss_pred             CCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCC
Q 011508          374 KGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRER  453 (484)
Q Consensus       374 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  453 (484)
                      +.||............+.......    ...+.+..                  .....++...+.+++.+||+.||++|
T Consensus       264 ~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~------------------~~~~~~~~~~l~~li~~cl~~dp~~R  321 (342)
T 1b6c_B          264 QLPYYDLVPSDPSVEEMRKVVCEQ----KLRPNIPN------------------RWQSCEALRVMAKIMRECWYANGAAR  321 (342)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTS----CCCCCCCG------------------GGGTSHHHHHHHHHHHHHCCSSGGGS
T ss_pred             ccCccccCcCcccHHHHHHHHHHH----HhCCCCcc------------------cccchhHHHHHHHHHHHHhccChhhC
Confidence            677765433333332222211110    01111100                  01123557889999999999999999


Q ss_pred             CCHHHHHHHHHHHHHHH
Q 011508          454 MNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       454 Pt~~evl~~L~~i~~~~  470 (484)
                      ||+.||++.|+.+.++.
T Consensus       322 ps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          322 LTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             CCHHHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHHHHHHh
Confidence            99999999999997653

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=345.93  Aligned_cols=265  Identities=21%  Similarity=0.267  Sum_probs=203.9

Q ss_pred             ccHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEee
Q 011508          149 VSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIIT  225 (484)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~  225 (484)
                      +...+.....++|++.+.||+|+||.||+|+..  .+++.||+|+++...   ....+.+.+|..++..++||||+++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~--~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  128 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMK--QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF  128 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence            344555566789999999999999999999954  467899999997532   223345889999999999999999999


Q ss_pred             eeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 011508          226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG  305 (484)
Q Consensus       226 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~  305 (484)
                      ++     .+....++||||+++|+|.+++....   ..+++..+..++.||+.||+|||   +++|+||||||+|||++.
T Consensus       129 ~~-----~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~  197 (412)
T 2vd5_A          129 AF-----QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDR  197 (412)
T ss_dssp             EE-----ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECT
T ss_pred             EE-----eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecC
Confidence            85     44558999999999999999997542   35899999999999999999999   899999999999999999


Q ss_pred             CCceEEcccCcccccccccccCCCCccccccccccccccCccccC-------CCCCCcccceehhhHHHHHHHhCCCCCC
Q 011508          306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-------GSEVSTSGDVYSFGILLLEMFTGKGPTN  378 (484)
Q Consensus       306 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~Dvws~Gvvl~elltg~~p~~  378 (484)
                      ++.+||+|||+++......      .......+||+.|+|||++.       ...++.++|||||||++|||++|+.||.
T Consensus       198 ~g~vkL~DFGla~~~~~~~------~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~  271 (412)
T 2vd5_A          198 CGHIRLADFGSCLKLRADG------TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY  271 (412)
T ss_dssp             TSCEEECCCTTCEECCTTS------CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCCEEEeechhheeccCCC------ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence            9999999999998764321      11122357999999999886       4578999999999999999999999997


Q ss_pred             CCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCC---CC
Q 011508          379 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRER---MN  455 (484)
Q Consensus       379 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt  455 (484)
                      .....     +......... ....-+..                       ...++.++.+++.+||. +|++|   |+
T Consensus       272 ~~~~~-----~~~~~i~~~~-~~~~~p~~-----------------------~~~~s~~~~dli~~lL~-~p~~Rlgr~~  321 (412)
T 2vd5_A          272 ADSTA-----ETYGKIVHYK-EHLSLPLV-----------------------DEGVPEEARDFIQRLLC-PPETRLGRGG  321 (412)
T ss_dssp             CSSHH-----HHHHHHHTHH-HHCCCC---------------------------CCCHHHHHHHHTTSS-CGGGCTTTTT
T ss_pred             CCCHH-----HHHHHHHhcc-cCcCCCcc-----------------------ccCCCHHHHHHHHHHcC-ChhhcCCCCC
Confidence            53211     1111110000 00000000                       11225678999999999 99998   58


Q ss_pred             HHHHHHH
Q 011508          456 MEEVAAQ  462 (484)
Q Consensus       456 ~~evl~~  462 (484)
                      ++|+++.
T Consensus       322 ~~ei~~H  328 (412)
T 2vd5_A          322 AGDFRTH  328 (412)
T ss_dssp             HHHHHTS
T ss_pred             HHHHhcC
Confidence            9888653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=326.73  Aligned_cols=249  Identities=22%  Similarity=0.355  Sum_probs=179.9

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|.+.+.||+|+||.||+|+..  .+++.||+|++....   ....+.+.+|+.++++++||||+++++++.     ..
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   83 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESI--HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DS   83 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CS
T ss_pred             ccceeeeeecCCCceEEEEEEEc--cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cC
Confidence            57899999999999999999843  357889999997432   223467899999999999999999999853     44


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++++|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg  157 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFG  157 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCT
T ss_pred             CeEEEEEecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeec
Confidence            5889999999999999999743   245899999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      .+.......       .......|++.|+|||.+.+..++.++||||||+++|||++|+.||........          
T Consensus       158 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----------  220 (278)
T 3cok_A          158 LATQLKMPH-------EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT----------  220 (278)
T ss_dssp             TCEECC-----------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------
T ss_pred             ceeeccCCC-------CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH----------
Confidence            998653221       111234689999999999988899999999999999999999999975321110          


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                         ...+.......                     +..++.++.+++.+||+.||++|||++|+++
T Consensus       221 ---~~~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          221 ---LNKVVLADYEM---------------------PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ------CCSSCCCC---------------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---HHHHhhcccCC---------------------ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence               00000000000                     1122557889999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.3e-43  Score=336.49  Aligned_cols=249  Identities=24%  Similarity=0.294  Sum_probs=176.7

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCCceeeEEe
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGNDFEALVY  242 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~  242 (484)
                      .+.||+|+||.||+|+..  .+++.||||++...   ....+.+|+.+++.+. ||||+++++++.     ++...++||
T Consensus        16 ~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~lv~   85 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHK--KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFLVM   85 (325)
T ss_dssp             SCCSEEETTEEEEEEEET--TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEE
T ss_pred             CCccccCCCeEEEEEEEC--CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEEEE
Confidence            478999999999999954  45789999999643   3467789999999996 999999999953     455889999


Q ss_pred             ecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC---ceEEcccCcccc
Q 011508          243 ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL---TAHVSDFGLAKF  319 (484)
Q Consensus       243 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfg~a~~  319 (484)
                      ||+++|+|.+++...    ..+++.+++.++.|++.||+|||   +++|+||||||+||+++.++   .+||+|||+++.
T Consensus        86 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           86 ELLNGGELFERIKKK----KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             CCCCSCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            999999999999753    35899999999999999999999   89999999999999997765   899999999986


Q ss_pred             cccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCC--ccHhHHHHhhcch
Q 011508          320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN--LTLHNFVKEALPE  397 (484)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~  397 (484)
                      .....       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ....+..      
T Consensus       159 ~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------  225 (325)
T 3kn6_A          159 KPPDN-------QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM------  225 (325)
T ss_dssp             CCC-----------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH------
T ss_pred             cCCCC-------CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH------
Confidence            54322       11223468999999999999999999999999999999999999997643211  1111111      


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                        ..+.........                 .....++.++.+++..||+.||++|||++|+++
T Consensus       226 --~~i~~~~~~~~~-----------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          226 --KKIKKGDFSFEG-----------------EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             --HHHTTTCCCCCS-----------------HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             --HHHHcCCCCCCc-----------------ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence              111111110000                 001233667899999999999999999999874

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.7e-43  Score=342.56  Aligned_cols=251  Identities=28%  Similarity=0.318  Sum_probs=190.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHH-HHcCCCCCceeEeeeeeeeccC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQA-LRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      .++|++.+.||+|+||.||+|+..  .++..||+|+++....   .....+.+|..+ ++.++||||+++++++     .
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~--~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~  109 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHK--AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----Q  109 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEET--TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----E
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEc--CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----E
Confidence            357899999999999999999954  4678999999976432   223456677776 5678999999999985     4


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      ..+..++||||+++|+|.+++....    .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~D  182 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTD  182 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEee
Confidence            4558999999999999999997543    4889999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||+++.....       .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ......
T Consensus       183 FG~a~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~  250 (373)
T 2r5t_A          183 FGLCKENIEH-------NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDN  250 (373)
T ss_dssp             CCBCGGGBCC-------CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHHHHH
T ss_pred             CccccccccC-------CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHH
Confidence            9999854221       1122345799999999999999999999999999999999999999975321     111111


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                              ++...+..                     +..+...+.+++.+||+.||++||++.+.++.+
T Consensus       251 --------i~~~~~~~---------------------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i  291 (373)
T 2r5t_A          251 --------ILNKPLQL---------------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI  291 (373)
T ss_dssp             --------HHHSCCCC---------------------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred             --------HHhcccCC---------------------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence                    11111100                     111245688999999999999999986544433

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.7e-42  Score=324.35  Aligned_cols=253  Identities=21%  Similarity=0.321  Sum_probs=200.1

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|...  .++..||+|++.....  ...+.+.+|+.++++++||||+++++++.     ..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   77 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHK--TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EE   77 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEc--CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cC
Confidence            578999999999999999999844  4578899999975432  23467889999999999999999999853     44


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---eEEc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT---AHVS  312 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~  312 (484)
                      ...++||||+++++|.+++...    ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             CEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence            5789999999999999988754    34899999999999999999999   899999999999999987655   9999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||.+.......        ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......     ....
T Consensus       151 Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~  217 (284)
T 3kk8_A          151 DFGLAIEVNDSE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYA  217 (284)
T ss_dssp             CCTTCEECCSSC--------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH
T ss_pred             eceeeEEcccCc--------cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-----HHHH
Confidence            999997653321        122356899999999999999999999999999999999999999653211     1111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ... ........+.                        ...++.++.+++..||+.||++|||+.|+++.
T Consensus       218 ~~~-~~~~~~~~~~------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          218 QIK-AGAYDYPSPE------------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             HHH-HTCCCCCTTT------------------------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHH-hccccCCchh------------------------hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            000 0000000000                        11225678899999999999999999999874

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.7e-42  Score=325.92  Aligned_cols=253  Identities=23%  Similarity=0.321  Sum_probs=200.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|++.+.||+|+||.||+|+..  .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++..     +..
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   79 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNR--VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNI   79 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTE
T ss_pred             cceEEEEEeecCCCcEEEEEEEC--CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCE
Confidence            56889999999999999999854  4578899999975432 344678999999999999999999998643     457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++++|.+++..    ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||.+
T Consensus        80 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  152 (276)
T 2yex_A           80 QYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLA  152 (276)
T ss_dssp             EEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCc
Confidence            8999999999999998863    235899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ........     ........|+..|+|||.+.+..+ +.++||||||+++|||++|+.||............+..... 
T Consensus       153 ~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  226 (276)
T 2yex_A          153 TVFRYNNR-----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-  226 (276)
T ss_dssp             EECEETTE-----ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT-
T ss_pred             cccCCCcc-----hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc-
Confidence            86543211     111223568999999999887665 78999999999999999999999764333222222211100 


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                           ...                         ....++..+.+++..||+.||++|||++|+++
T Consensus       227 -----~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          227 -----YLN-------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----TST-------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----ccC-------------------------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 000                         01122557889999999999999999999976

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.5e-42  Score=334.22  Aligned_cols=251  Identities=23%  Similarity=0.274  Sum_probs=190.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcC-CCCeeEEEEEEeeccC----ccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDH-DDHETLVAVKVLNLQH----RGASKSFIAECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      .++|++.+.||+|+||.||+|+... ..+++.||+|+++...    ......+.+|+.++++++||||+++++++.    
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----   91 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ----   91 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE----
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE----
Confidence            3678999999999999999998632 2467899999997542    223356788999999999999999999853    


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                       .++..++||||+++++|.+++....    .+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+
T Consensus        92 -~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~  163 (327)
T 3a62_A           92 -TGGKLYLILEYLSGGELFMQLEREG----IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLT  163 (327)
T ss_dssp             -CSSCEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEEC
T ss_pred             -cCCEEEEEEeCCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEE
Confidence             4458899999999999999997543    4889999999999999999999   8899999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||+++......       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .....
T Consensus       164 Dfg~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~  231 (327)
T 3a62_A          164 DFGLCKESIHDG-------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----KKTID  231 (327)
T ss_dssp             CCSCC-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHH
T ss_pred             eCCcccccccCC-------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----HHHHH
Confidence            999987543221       112235689999999999998999999999999999999999999975321     11111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAA  461 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~  461 (484)
                      .        +.......                     +..+..++.+++.+||+.||++||     ++.|+++
T Consensus       232 ~--------i~~~~~~~---------------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          232 K--------ILKCKLNL---------------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             H--------HHHTCCCC---------------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             H--------HHhCCCCC---------------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            1        11000000                     112255788999999999999999     7778765

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.6e-42  Score=326.70  Aligned_cols=249  Identities=22%  Similarity=0.335  Sum_probs=198.1

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      +.++|++.+.||+|+||.||+|...  .++..||+|++....   ......+.+|+.++++++||||+++++++.     
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----   79 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREK--QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----   79 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEc--cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----
Confidence            3467899999999999999999844  457789999986432   223467889999999999999999999953     


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||+++++|.+++....    .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|
T Consensus        80 ~~~~~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~D  152 (279)
T 3fdn_A           80 DATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIAD  152 (279)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECS
T ss_pred             cCCEEEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEe
Confidence            4457899999999999999997543    4899999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||++......         ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....     ......
T Consensus       153 fg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~  218 (279)
T 3fdn_A          153 FGWSVHAPSS---------RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKR  218 (279)
T ss_dssp             CCEESCC-----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH
T ss_pred             ccccccCCcc---------cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HHHHHH
Confidence            9988654322         11234689999999999999999999999999999999999999975311     111110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .     ... ....                       +..++..+.+++.+||+.||++|||++|+++.
T Consensus       219 ~-----~~~-~~~~-----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          219 I-----SRV-EFTF-----------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             H-----HHT-CCCC-----------------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             H-----HhC-CCCC-----------------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0     000 0000                       11125568899999999999999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.3e-42  Score=345.88  Aligned_cols=272  Identities=22%  Similarity=0.320  Sum_probs=207.5

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|.+.+.||+|+||.||+|+..  .+++.||||++.....  ...+.+|+++++.++|++.+..+.++.    .....
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~   77 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG----VEGDY   77 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEET--TTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEE----EETTE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEEC--CCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCE
Confidence            468999999999999999999843  4578899998875433  245889999999998866555554442    23457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEccc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDF  314 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Df  314 (484)
                      .++||||+ +++|.+++....   ..+++..++.|+.||+.||+|||   +++|+||||||+|||+   +.++.+||+||
T Consensus        78 ~~lvme~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DF  150 (483)
T 3sv0_A           78 NVLVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDF  150 (483)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEEEECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeC
Confidence            89999999 999999997432   35999999999999999999999   8999999999999999   68899999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |+++.+..................||..|+|||++.+..++.++|||||||++|||++|+.||........  ...+...
T Consensus       151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~--~~~~~~i  228 (483)
T 3sv0_A          151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK--KQKYEKI  228 (483)
T ss_dssp             TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH--HHHHHHH
T ss_pred             CcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH--HHHHHHH
Confidence            99987754332211111222356799999999999999999999999999999999999999986433211  1111111


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      ........+..                        ....++.++.+++..||+.||++||++.+|++.|+.+....
T Consensus       229 ~~~~~~~~~~~------------------------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          229 SEKKVATSIEA------------------------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHHHSCHHH------------------------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hhccccccHHH------------------------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            11111000000                        01223567899999999999999999999999999986643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-42  Score=343.56  Aligned_cols=210  Identities=25%  Similarity=0.386  Sum_probs=162.8

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  233 (484)
                      ..++|++.+.||+|+||.||+|..  ..+++.||||++....  ......+.+|+.++.++. ||||+++++++..   .
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~   81 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSID--RRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---D   81 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEE--TTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---T
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEE--CCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---C
Confidence            347899999999999999999984  4467899999986432  233467889999999997 9999999998643   2


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      +....++||||++ ++|.+++...     .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        82 ~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~D  152 (388)
T 3oz6_A           82 NDRDVYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVAD  152 (388)
T ss_dssp             TSSCEEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             CCCEEEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecC
Confidence            3457899999996 6999998742     4889999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccC--------------CCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCC
Q 011508          314 FGLAKFLPEAANNL--------------SSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTN  378 (484)
Q Consensus       314 fg~a~~~~~~~~~~--------------~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~  378 (484)
                      ||+++.+.......              ...........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus       153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  232 (388)
T 3oz6_A          153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP  232 (388)
T ss_dssp             CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence            99998764311100              011122334679999999998876 678999999999999999999999997


Q ss_pred             CC
Q 011508          379 EM  380 (484)
Q Consensus       379 ~~  380 (484)
                      +.
T Consensus       233 ~~  234 (388)
T 3oz6_A          233 GS  234 (388)
T ss_dssp             CS
T ss_pred             CC
Confidence            64

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.4e-42  Score=334.12  Aligned_cols=271  Identities=23%  Similarity=0.366  Sum_probs=210.4

Q ss_pred             HhHHHhcCCCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeee
Q 011508          152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSC  227 (484)
Q Consensus       152 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~  227 (484)
                      +++....++|++.+.||+|+||.||+|+...   ...+..||+|++..... .....+.+|+.++++++||||+++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   97 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   97 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence            3444566789999999999999999998642   23467899999975433 2335688999999999999999999985


Q ss_pred             eeeccCCCceeeEEeecccCCCHHHHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCe
Q 011508          228 VSVDFQGNDFEALVYELMVNGSLEEWLHLNR------DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNV  301 (484)
Q Consensus       228 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NI  301 (484)
                           ..+...++||||+++|+|.+++....      .....+++..++.++.|++.||+|||   +++|+||||||+||
T Consensus        98 -----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NI  169 (322)
T 1p4o_A           98 -----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNC  169 (322)
T ss_dssp             -----CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGE
T ss_pred             -----ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceE
Confidence                 34557899999999999999997532      11235789999999999999999999   88999999999999


Q ss_pred             eecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCC
Q 011508          302 LLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEM  380 (484)
Q Consensus       302 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~  380 (484)
                      +++.++.+||+|||++........     ........+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus       170 li~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  244 (322)
T 1p4o_A          170 MVAEDFTVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL  244 (322)
T ss_dssp             EECTTCCEEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             EEcCCCeEEECcCccccccccccc-----cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence            999999999999999986543221     111223457889999999988889999999999999999999 89998653


Q ss_pred             ccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHH
Q 011508          381 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVA  460 (484)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  460 (484)
                      ..     ......        +.......                    .+..++..+.+++..||+.||++|||+.|++
T Consensus       245 ~~-----~~~~~~--------~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l  291 (322)
T 1p4o_A          245 SN-----EQVLRF--------VMEGGLLD--------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEII  291 (322)
T ss_dssp             CH-----HHHHHH--------HHTTCCCC--------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CH-----HHHHHH--------HHcCCcCC--------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence            21     111111        11100000                    0122356789999999999999999999999


Q ss_pred             HHHHHHHH
Q 011508          461 AQLLSFRN  468 (484)
Q Consensus       461 ~~L~~i~~  468 (484)
                      +.|+++..
T Consensus       292 ~~L~~~~~  299 (322)
T 1p4o_A          292 SSIKEEME  299 (322)
T ss_dssp             HHHGGGSC
T ss_pred             HHHHHhhc
Confidence            99987643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.5e-43  Score=351.76  Aligned_cols=249  Identities=22%  Similarity=0.280  Sum_probs=191.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeecc---CccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|++.+.||+|+||.||+|+.  ..+++.||||+++..   .......+.+|+.+++.++||||+++++++..     
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----  219 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKE--KATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----  219 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEE--TTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEE--cCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----
Confidence            46799999999999999999984  446789999999753   22334567889999999999999999999643     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCeeecCCCceEEcc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCE-TPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .+..++||||+++|+|.+++....    .+++..+..++.||+.||+|||   + ++|+||||||+|||++.++.+||+|
T Consensus       220 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~D  292 (446)
T 4ejn_A          220 HDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITD  292 (446)
T ss_dssp             TTEEEEEECCCSSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECC
T ss_pred             CCEEEEEEeeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEcc
Confidence            447899999999999999997543    4899999999999999999999   6 8999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||+++......       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     ......
T Consensus       293 FG~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~  360 (446)
T 4ejn_A          293 FGLCKEGIKDG-------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFEL  360 (446)
T ss_dssp             CCCCCTTCC------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred             CCCceeccCCC-------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHH
Confidence            99997543221       122345799999999999999999999999999999999999999965321     111111


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~  461 (484)
                      ..        ......                     +..++.++.+++.+||+.||++||     |++|+++
T Consensus       361 i~--------~~~~~~---------------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          361 IL--------MEEIRF---------------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HH--------HCCCCC---------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HH--------hCCCCC---------------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            00        000000                     112255788999999999999999     9999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-42  Score=339.48  Aligned_cols=288  Identities=21%  Similarity=0.228  Sum_probs=202.7

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc---
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDF---  232 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  232 (484)
                      ...++|++.+.||+|+||.||+|+.  ..+++.||+|++.....    ...+|+++++.++||||+++++++.....   
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~--~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFD--IESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEE--TTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEE--CCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            4567899999999999999999984  44678999999865432    23479999999999999999998755321   


Q ss_pred             ------------------------------CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHH
Q 011508          233 ------------------------------QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY  282 (484)
Q Consensus       233 ------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~  282 (484)
                                                    ..+.+.++||||++ |+|.+.+.........+++..+..++.||+.||+|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                          33456889999997 58888887544445679999999999999999999


Q ss_pred             HHhcCCCCeeecCCCCCCeeec-CCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCC-CCCcccce
Q 011508          283 LHHYCETPIVHCDLKPSNVLLD-GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDV  360 (484)
Q Consensus       283 LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv  360 (484)
                      ||   +.+|+||||||+||+++ .++.+||+|||+++......        ......+|..|+|||++.+. .++.++||
T Consensus       157 LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  225 (383)
T 3eb0_A          157 IH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--------PSVAYICSRFYRAPELMLGATEYTPSIDL  225 (383)
T ss_dssp             HH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--------CCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred             HH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--------CCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence            99   99999999999999998 68899999999998663322        12234689999999988764 58999999


Q ss_pred             ehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhh--cCcccccccccccchhhhhhhccccccchhHHHHHH
Q 011508          361 YSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEI--VDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSV  438 (484)
Q Consensus       361 ws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  438 (484)
                      ||+||++|||++|+.||...... ..+...+..........+  .++.....    .....  .....+...+..++.++
T Consensus       226 wslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~g~p~~~~~~~~~~~~~~~----~~~~~--~~~~~~~~~~~~~~~~~  298 (383)
T 3eb0_A          226 WSIGCVFGELILGKPLFSGETSI-DQLVRIIQIMGTPTKEQMIRMNPHYTEV----RFPTL--KAKDWRKILPEGTPSLA  298 (383)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHHHCTTC--C----CCCCC--CCCCHHHHSCTTCCHHH
T ss_pred             hhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHHHhCcccccc----cCCcc--CcccHHhhCCCCCCHHH
Confidence            99999999999999999764221 112222211111100000  00000000    00000  00000000122346678


Q ss_pred             HhHhhccCCCCcCCCCCHHHHHH--HHHHHHH
Q 011508          439 LGIGVICSSELPRERMNMEEVAA--QLLSFRN  468 (484)
Q Consensus       439 ~~l~~~cl~~dP~~RPt~~evl~--~L~~i~~  468 (484)
                      .+++.+||+.||++|||+.|+++  .++.++.
T Consensus       299 ~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          299 IDLLEQILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             HHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence            99999999999999999999985  3455544

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9e-43  Score=338.26  Aligned_cols=252  Identities=24%  Similarity=0.383  Sum_probs=191.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCC--CCceeEeeeeeeeccC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRH--RNLVKIITSCVSVDFQ  233 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~  233 (484)
                      .++|++.+.||+|+||.||+|...   +++.||||++.....  ...+.+.+|+.++.+++|  +||+++++++.     
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----   79 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----   79 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT---TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC---CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----
Confidence            467999999999999999999853   478899999975533  233678899999999976  99999999854     


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .+...++|||+ .+++|.+++...    ..+++.++..++.|++.||+|||   +++|+||||||+|||++ ++.+||+|
T Consensus        80 ~~~~~~lv~e~-~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~D  150 (343)
T 3dbq_A           80 TDQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLID  150 (343)
T ss_dssp             CSSEEEEEECC-CSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECC
T ss_pred             eCCEEEEEEeC-CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEee
Confidence            34588999995 588999999853    35899999999999999999999   88999999999999997 57899999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCC-----------CCCCcccceehhhHHHHHHHhCCCCCCCCcc
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-----------SEVSTSGDVYSFGILLLEMFTGKGPTNEMFT  382 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~  382 (484)
                      ||+++.......     ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....
T Consensus       151 FG~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  225 (343)
T 3dbq_A          151 FGIANQMQPDTT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  225 (343)
T ss_dssp             CSSSCCC-----------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             cccccccCcccc-----cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh
Confidence            999987643221     111223569999999998754           6789999999999999999999999975322


Q ss_pred             CCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          383 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ....            +..++++......                   +..+...+.+++..||+.||++|||+.|+++.
T Consensus       226 ~~~~------------~~~~~~~~~~~~~-------------------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          226 QISK------------LHAIIDPNHEIEF-------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHH------------HHHHHCTTSCCCC-------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHH------------HHHHhcCCcccCC-------------------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            1100            1112221111100                   11124568899999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=339.64  Aligned_cols=261  Identities=15%  Similarity=0.157  Sum_probs=203.8

Q ss_pred             HhcCCCCccCccccccceeEEEEEEc---CCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC---CCCceeEeeeeee
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR---HRNLVKIITSCVS  229 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~  229 (484)
                      ...++|.+.+.||+|+||.||+|++.   +..+++.||+|+++..   ....+..|++++.+++   |+||+++++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            34577999999999999999999532   3345788999998754   3457788888888886   9999999998643


Q ss_pred             eccCCCceeeEEeecccCCCHHHHHhhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---
Q 011508          230 VDFQGNDFEALVYELMVNGSLEEWLHLNRD-APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---  305 (484)
Q Consensus       230 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---  305 (484)
                           ++..++||||+++|+|.+++..... ....+++..++.++.||+.||+|||   +++|+||||||+|||++.   
T Consensus       139 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          139 -----QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             -----SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGT
T ss_pred             -----CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEeccccc
Confidence                 4478999999999999999975432 2456999999999999999999999   899999999999999998   


Q ss_pred             --------CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCC
Q 011508          306 --------ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPT  377 (484)
Q Consensus       306 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~  377 (484)
                              ++.+||+|||+++.+....     .........||..|+|||++.+..++.++|||||||++|||+||+.||
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf  285 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFP-----KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK  285 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSC-----TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CccccccccCCEEEeeCchhhhhhccC-----CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcc
Confidence                    8999999999997653221     112233457999999999999999999999999999999999999998


Q ss_pred             CCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCC-CCH
Q 011508          378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRER-MNM  456 (484)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R-Pt~  456 (484)
                      .........                ++..+..                      ......+.+++..|++.+|.+| |++
T Consensus       286 ~~~~~~~~~----------------~~~~~~~----------------------~~~~~~~~~~~~~~l~~~p~~r~~~~  327 (365)
T 3e7e_A          286 VKNEGGECK----------------PEGLFRR----------------------LPHLDMWNEFFHVMLNIPDCHHLPSL  327 (365)
T ss_dssp             EEEETTEEE----------------ECSCCTT----------------------CSSHHHHHHHHHHHHCCCCTTCCCCH
T ss_pred             ccCCCCcee----------------echhccc----------------------cCcHHHHHHHHHHHcCCCCCCcchHH
Confidence            543221100                0000000                      0014456788899999999998 688


Q ss_pred             HHHHHHHHHHHHHH
Q 011508          457 EEVAAQLLSFRNKL  470 (484)
Q Consensus       457 ~evl~~L~~i~~~~  470 (484)
                      +++.+.|+++....
T Consensus       328 ~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          328 DLLRQKLKKVFQQH  341 (365)
T ss_dssp             HHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHh
Confidence            88888888876653

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2e-42  Score=344.39  Aligned_cols=254  Identities=24%  Similarity=0.313  Sum_probs=191.0

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--------cchHHHHHHHHHHHcCCCCCceeEeeeee
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--------GASKSFIAECQALRSIRHRNLVKIITSCV  228 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~  228 (484)
                      ..++|.+.+.||+|+||.||+|...  .+++.||+|++.....        .....+.+|+.++++++||||+++++++.
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFER--KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEEC--CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4578999999999999999999944  4678999999875421        11235789999999999999999999852


Q ss_pred             eeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-
Q 011508          229 SVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-  307 (484)
Q Consensus       229 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-  307 (484)
                            ....++||||+++|+|.+++..    ...+++..++.++.|++.||+|||   +++|+||||||+|||++.++ 
T Consensus       211 ------~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~  277 (419)
T 3i6u_A          211 ------AEDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEE  277 (419)
T ss_dssp             ------SSEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSS
T ss_pred             ------cCceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCC
Confidence                  2246899999999999998863    345899999999999999999999   88999999999999996544 


Q ss_pred             --ceEEcccCcccccccccccCCCCccccccccccccccCccccCC---CCCCcccceehhhHHHHHHHhCCCCCCCCcc
Q 011508          308 --TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG---SEVSTSGDVYSFGILLLEMFTGKGPTNEMFT  382 (484)
Q Consensus       308 --~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~  382 (484)
                        .+||+|||+++.....        .......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||.....
T Consensus       278 ~~~~kl~DFG~a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~  349 (419)
T 3i6u_A          278 DCLIKITDFGHSKILGET--------SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  349 (419)
T ss_dssp             SCCEEECCSSTTTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred             cceEEEeecccceecCCC--------ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence              5999999999876432        11223569999999999753   5788999999999999999999999976422


Q ss_pred             CCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          383 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .. .+...+.........+.                            ...++..+.+++.+||+.||++|||++|+++.
T Consensus       350 ~~-~~~~~i~~~~~~~~~~~----------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          350 QV-SLKDQITSGKYNFIPEV----------------------------WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             SC-CHHHHHHTTCCCCCHHH----------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hH-HHHHHHhcCCCCCCchh----------------------------hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            21 12211111100000000                            11235678999999999999999999999863

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1e-43  Score=349.34  Aligned_cols=259  Identities=16%  Similarity=0.152  Sum_probs=193.1

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeecc---CccchHHHHHHH---HHHHcCCCCCceeEeeeeeeec
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAEC---QALRSIRHRNLVKIITSCVSVD  231 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~  231 (484)
                      .++|.+.+.||+|+||.||+|+.  ..+++.||||++...   .....+.+.+|+   +++++++||||+++++.+....
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATD--QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC---CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CceEEEcceeecCCCEEEEEEEE--CCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            46788999999999999999994  446789999999743   233457788999   5555568999999985432100


Q ss_pred             --cCCC------------c-----eeeEEeecccCCCHHHHHhhcCCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 011508          232 --FQGN------------D-----FEALVYELMVNGSLEEWLHLNRDA---PRNLNLLQRLSIAVDVASTLEYLHHYCET  289 (484)
Q Consensus       232 --~~~~------------~-----~~~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  289 (484)
                        +...            .     ..++||||+ +|+|.+++......   ...+++..++.|+.||+.||+|||   ++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~  225 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HY  225 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hC
Confidence              1111            1     378999999 78999999854211   123556888899999999999999   88


Q ss_pred             CeeecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCC-----------CCCccc
Q 011508          290 PIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-----------EVSTSG  358 (484)
Q Consensus       290 ~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~  358 (484)
                      +|+||||||+|||++.++.+||+|||+++....          ......| +.|+|||++.+.           .++.++
T Consensus       226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~  294 (377)
T 3byv_A          226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----------RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSF  294 (377)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTC----------EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHH
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEechhheecCC----------cccCCCC-cCccChhhhcccccccccccccccCChhh
Confidence            999999999999999999999999999985422          1223457 999999998877           899999


Q ss_pred             ceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHH
Q 011508          359 DVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSV  438 (484)
Q Consensus       359 Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  438 (484)
                      |||||||++|||++|+.||........             ...+...                         ...++.++
T Consensus       295 DvwSlG~il~elltg~~Pf~~~~~~~~-------------~~~~~~~-------------------------~~~~~~~~  336 (377)
T 3byv_A          295 DAWALGLVIYWIWCADLPITKDAALGG-------------SEWIFRS-------------------------CKNIPQPV  336 (377)
T ss_dssp             HHHHHHHHHHHHHHSSCCC------CC-------------SGGGGSS-------------------------CCCCCHHH
T ss_pred             hHHHHHHHHHHHHHCCCCCcccccccc-------------hhhhhhh-------------------------ccCCCHHH
Confidence            999999999999999999965321110             0000000                         01125578


Q ss_pred             HhHhhccCCCCcCCCCCHHHHHH--HHHHHHHHHh
Q 011508          439 LGIGVICSSELPRERMNMEEVAA--QLLSFRNKLV  471 (484)
Q Consensus       439 ~~l~~~cl~~dP~~RPt~~evl~--~L~~i~~~~~  471 (484)
                      .+++.+||+.||++|||+.|+++  .++.++....
T Consensus       337 ~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~  371 (377)
T 3byv_A          337 RALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS  371 (377)
T ss_dssp             HHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHHH
Confidence            89999999999999999999996  5666665543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.4e-43  Score=328.96  Aligned_cols=258  Identities=22%  Similarity=0.293  Sum_probs=202.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|...  .+++.||+|++.....  ...+.+.+|+.++++++||||+++++++..   ..+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   79 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRK--SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTN   79 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGG
T ss_pred             hhheeeehhccCCCCcEEEEEEEC--CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCC
Confidence            467899999999999999999854  4578999999975432  234578899999999999999999998653   234


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeecCCCCCCeeecCCCceE
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP-----IVHCDLKPSNVLLDGELTAH  310 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dlk~~NIll~~~~~~k  310 (484)
                      ...++||||+++++|.+++.........+++..++.++.|++.||+|||   +.+     |+||||||+||+++.++.+|
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~k  156 (279)
T 2w5a_A           80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVK  156 (279)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEE
T ss_pred             ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEE
Confidence            5789999999999999999865544556999999999999999999999   666     99999999999999999999


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      |+|||.+.......       .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......  .+...
T Consensus       157 l~dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~  227 (279)
T 2w5a_A          157 LGDFGLARILNHDT-------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGK  227 (279)
T ss_dssp             ECCCCHHHHC---C-------HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH
T ss_pred             EecCchheeecccc-------ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--HHHHH
Confidence            99999998653221       1112345899999999999889999999999999999999999999753211  11111


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      +..   .     ..+.+                       +..++.++.+++.+||+.||++|||+.||++.+
T Consensus       228 i~~---~-----~~~~~-----------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          228 IRE---G-----KFRRI-----------------------PYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHH---T-----CCCCC-----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             Hhh---c-----ccccC-----------------------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            100   0     00000                       112356789999999999999999999998765

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.7e-42  Score=334.94  Aligned_cols=247  Identities=25%  Similarity=0.328  Sum_probs=195.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      +.|++.+.||+|+||.||+|+.  ..+++.||||++......   ..+.+.+|++++++++||||+++++++..     +
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~  126 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARD--VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----E  126 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----T
T ss_pred             hheeeeeEEccCCCEEEEEEEE--ccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----C
Confidence            4588889999999999999984  346789999999754322   23568899999999999999999998643     4


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+. |+|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus       127 ~~~~lv~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG  199 (348)
T 1u5q_A          127 HTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFG  199 (348)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred             CeEEEEEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeecc
Confidence            48899999996 68888886432   35899999999999999999999   8899999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccC---CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM---GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      ++......           ....||+.|+|||++.   ...++.++|||||||++|||++|+.||......     ....
T Consensus       200 ~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-----~~~~  263 (348)
T 1u5q_A          200 SASIMAPA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALY  263 (348)
T ss_dssp             TCBSSSSB-----------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHH
T ss_pred             CceecCCC-----------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHH
Confidence            99765321           1246899999999874   567899999999999999999999998653211     1111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ....     -..+.+.                      ...++..+.+++..||+.||++|||++|+++.
T Consensus       264 ~~~~-----~~~~~~~----------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          264 HIAQ-----NESPALQ----------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             HHHH-----SCCCCCC----------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHh-----cCCCCCC----------------------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0000     0000000                      11225568899999999999999999999854

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.3e-42  Score=349.94  Aligned_cols=257  Identities=24%  Similarity=0.335  Sum_probs=203.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|.+.+.||+|+||.||+|+..  .+++.||+|++....   ......+.+|+.++++++||||+++++++     ..
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~--~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  256 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMK--ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ET  256 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEC--CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ee
Confidence            367889999999999999999954  467899999997542   23346788999999999999999999985     44


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+++|+|.+++.........+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus       257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DF  333 (543)
T 3c4z_A          257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDL  333 (543)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeec
Confidence            55889999999999999999865544557999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |+++......       .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........
T Consensus       334 Gla~~~~~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~~~i  405 (543)
T 3c4z_A          334 GLAVELKAGQ-------TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELKQRV  405 (543)
T ss_dssp             TTCEECCTTC-------CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHHHHH
T ss_pred             ceeeeccCCC-------cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHHHHH
Confidence            9998764321       11223579999999999999999999999999999999999999997642211 111111111


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH-----HHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM-----EEVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~  461 (484)
                              .......                     +..++..+.+++.+||+.||++||++     +||++
T Consensus       406 --------~~~~~~~---------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          406 --------LEQAVTY---------------------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             --------HHCCCCC---------------------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             --------hhcccCC---------------------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                    1000000                     12225678899999999999999975     55553

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.6e-42  Score=333.43  Aligned_cols=286  Identities=19%  Similarity=0.252  Sum_probs=200.0

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeecc---C
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDF---Q  233 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~  233 (484)
                      ++|++.+.||+|+||.||+|+..  .+++.||+|++.....  .....+.+|+.+++.++||||+++++++.....   .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHR--KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEET--TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cceeEEEEEecCCCcEEEEEEEC--CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            67999999999999999999953  4678999999865432  234578899999999999999999998765321   1


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||++ ++|.+.+...   ...+++.+++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|
T Consensus        95 ~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~D  167 (351)
T 3mi9_A           95 CKGSIYLVFDFCE-HDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD  167 (351)
T ss_dssp             --CEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             CCceEEEEEeccC-CCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence            1456899999996 5788777633   245899999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||++.........   .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......  .....+.
T Consensus       168 fg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~i~  242 (351)
T 3mi9_A          168 FGLARAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALIS  242 (351)
T ss_dssp             CTTCEECCCCSSS---SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHH
T ss_pred             chhcccccccccc---cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHH
Confidence            9999876432211   1122234568999999998876 56899999999999999999999999764221  1111111


Q ss_pred             hh---cchh-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EA---LPER-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~---~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..   .+.. ....-+...............    ..............+.+|+.+||+.||++|||++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          243 QLCGSITPEVWPNVDNYELYEKLELVKGQKR----KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCC----CHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhCCCChhhccccccchhhccccccccccc----CHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            11   0111 000000000000000000000    000000001113568899999999999999999999863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=330.19  Aligned_cols=277  Identities=21%  Similarity=0.276  Sum_probs=195.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||.||+|+..  .+++.||+|++......  ..+.+.+|++++++++||||+++++++.     ...
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~   75 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNR--DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKR   75 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred             ccceEeeEEeecCCeEEEEEEeC--CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCC
Confidence            57899999999999999999954  45788999988654332  2356789999999999999999999964     345


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++...    ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||.
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  148 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGF  148 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eEEEEEEeCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCC
Confidence            789999999999999988633    35899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH---H
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV---K  392 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~---~  392 (484)
                      +.......       .......||..|+|||++.+ ..++.++||||||+++|+|++|+.||........ .....   .
T Consensus       149 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~  220 (311)
T 4agu_A          149 ARLLTGPS-------DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTLG  220 (311)
T ss_dssp             CEECC-------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHC
T ss_pred             chhccCcc-------cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhc
Confidence            98764322       11223468999999998865 6789999999999999999999999976422111 11100   0


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ...+.......................     .........++..+.+++.+||+.||++|||++|+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          221 DLIPRHQQVFSTNQYFSGVKIPDPEDM-----EPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             SCCHHHHHHHHTCGGGTTCCCCCCSSC-----CCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccCcCCCcccc-----chhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            001100000000000000000000000     00000012235678999999999999999999999853

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.3e-42  Score=331.83  Aligned_cols=278  Identities=21%  Similarity=0.237  Sum_probs=201.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  236 (484)
                      .++|++.+.||+|+||.||+|+.  ..+++.||+|+++..   ..+.+.+|+.++++++ ||||+++++++..   ....
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~  106 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAIN--ITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSR  106 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTC
T ss_pred             CCceEEEEEecccCCeEEEEEEE--CCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCC
Confidence            46799999999999999999984  345789999998743   3467899999999997 9999999998643   2245


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcccC
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVSDFG  315 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg  315 (484)
                      ..++||||+++++|.+++.       .+++..+..++.|++.||+|||   +++|+||||||+||+++.++ .+||+|||
T Consensus       107 ~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg  176 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWG  176 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred             ceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCC
Confidence            7899999999999999885       2789999999999999999999   89999999999999999776 89999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      +++......        ......++..|+|||++.+ ..++.++|||||||++|||++|+.||.........+.......
T Consensus       177 ~a~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~  248 (330)
T 3nsz_A          177 LAEFYHPGQ--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL  248 (330)
T ss_dssp             TCEECCTTC--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred             CceEcCCCC--------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhc
Confidence            998664322        1223468999999999877 6789999999999999999999999965433222222222221


Q ss_pred             cchhhhhhcCccc-cccccccc---chhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 LPERLAEIVDPVL-LVEREEGE---TSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~~l-~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ......+.++..- ...+....   ..................+..++.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          249 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1111111111000 00000000   0000000000011112234678999999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.4e-43  Score=359.53  Aligned_cols=258  Identities=29%  Similarity=0.467  Sum_probs=205.7

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ...++|++.+.||+|+||.||+|++..   +..||||+++... ...+.|.+|+++|++++|+||+++++++..      
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------  333 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------  333 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT---TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC---CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------
Confidence            345678889999999999999999753   4669999997644 345789999999999999999999998632      


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++|+|.+++....  ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus       334 ~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG  408 (535)
T 2h8h_A          334 EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG  408 (535)
T ss_dssp             SSCEEEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTT
T ss_pred             ccceEeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccc
Confidence            35799999999999999997432  234889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      +++.......      .......++..|+|||++....++.++|||||||++|||++ |+.||......     +.....
T Consensus       409 ~a~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~-----~~~~~i  477 (535)
T 2h8h_A          409 LARLIEDNEY------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQV  477 (535)
T ss_dssp             STTTCCCHHH------HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH-----HHHHHH
T ss_pred             cceecCCCce------ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHH
Confidence            9987643211      11122346789999999988899999999999999999999 99999753211     111100


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                           ..-..  +                     ..+..|+..+.+|+..||+.||++|||+++|++.|+.+.
T Consensus       478 -----~~~~~--~---------------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          478 -----ERGYR--M---------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             -----HTTCC--C---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -----HcCCC--C---------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                 00000  0                     002334667899999999999999999999999998764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.5e-42  Score=323.37  Aligned_cols=247  Identities=22%  Similarity=0.328  Sum_probs=199.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|.+.+.||+|+||.||+|+..  .++..||+|++....   ......+.+|++++++++||||+++++++.     ..
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   86 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREK--QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DR   86 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             hhceeeheecCCCCeEEEEEEEc--CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cC
Confidence            57899999999999999999854  457889999986432   223467899999999999999999999854     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++++|.+++....    .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg  159 (284)
T 2vgo_A           87 KRIYLMLEFAPRGELYKELQKHG----RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFG  159 (284)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEeccc
Confidence            58899999999999999997543    4899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++.......         .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||......     ....   
T Consensus       160 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~---  222 (284)
T 2vgo_A          160 WSVHAPSLR---------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHR---  222 (284)
T ss_dssp             TCEECSSSC---------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH---
T ss_pred             ccccCcccc---------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHH---
Confidence            987553211         12346899999999999999999999999999999999999999753211     1111   


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                           .+.......                     +..++..+.+++..||+.||.+|||++|+++.
T Consensus       223 -----~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          223 -----RIVNVDLKF---------------------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             -----HHHTTCCCC---------------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             -----HHhccccCC---------------------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                 111100000                     11124568899999999999999999999874

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.2e-42  Score=349.90  Aligned_cols=256  Identities=27%  Similarity=0.345  Sum_probs=202.9

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      ..++|++.+.||+|+||.||+|+..  .+++.||+|++....   ......+.+|+++|+.++||||+++++++     .
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~--~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~  254 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVR--ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----E  254 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             cccceEEEEEEeeCCCEEEEEEEEC--CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----e
Confidence            3467899999999999999999954  467899999997532   23446788999999999999999999985     4


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      ..+..++||||+++|+|.+++....  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus       255 ~~~~l~lVmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~D  329 (576)
T 2acx_A          255 TKDALCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISD  329 (576)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEe
Confidence            4558999999999999999997432  234899999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||+++......        ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........
T Consensus       330 FGla~~~~~~~--------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~~  400 (576)
T 2acx_A          330 LGLAVHVPEGQ--------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERL  400 (576)
T ss_dssp             CTTCEECCTTC--------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHHH
T ss_pred             cccceecccCc--------cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHHH
Confidence            99998764321        1223479999999999999999999999999999999999999997643211 11111110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQ  462 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  462 (484)
                      .     ... ...+                       +..++.++.+++.+||+.||++||     +++||++.
T Consensus       401 i-----~~~-~~~~-----------------------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          401 V-----KEV-PEEY-----------------------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             H-----HHC-CCCC-----------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             h-----hcc-cccC-----------------------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            0     000 0000                       112256789999999999999999     78888753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.2e-42  Score=329.43  Aligned_cols=254  Identities=23%  Similarity=0.276  Sum_probs=185.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc-h-HHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA-S-KSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|+.  ..+++.||+|+++...... . +.+.++...++.++||||+++++++.     .+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~   78 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRH--VPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----RE   78 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEe--cCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----cc
Confidence            46789999999999999999994  3467899999997543222 2 33445555678889999999999864     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCeeecCCCceEEccc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCET-PIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ...++||||++ |+|.+++.........+++..++.++.|++.||+|||   ++ +|+||||||+||+++.++.+||+||
T Consensus        79 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Df  154 (290)
T 3fme_A           79 GDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDF  154 (290)
T ss_dssp             SSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred             CCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeec
Confidence            47899999996 5998888754444557999999999999999999999   76 9999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCcccc----CCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYG----MGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      |++.......        ......||+.|+|||++    .+..++.++||||||+++|||++|+.||.........+...
T Consensus       155 g~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  226 (290)
T 3fme_A          155 GISGYLVDDV--------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV  226 (290)
T ss_dssp             -----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHH
T ss_pred             CCcccccccc--------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHH
Confidence            9998663321        11223589999999995    56678999999999999999999999997532211111111


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .....         +..                      ....++.++.+++.+||+.||++|||+.|+++
T Consensus       227 ~~~~~---------~~~----------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          227 VEEPS---------PQL----------------------PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHSCC---------CCC----------------------CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hccCC---------CCc----------------------ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            11000         000                      01223567899999999999999999999987

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=7.2e-42  Score=324.87  Aligned_cols=253  Identities=25%  Similarity=0.344  Sum_probs=195.1

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      +|.....||+|+||.||+|+.  ..++..||+|.+........+.+.+|+.+++.++||||+++++++..     .+..+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~   95 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRD--LSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIK   95 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEE--TTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEE--CCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEE
Confidence            455556899999999999994  34578899999987665566789999999999999999999998643     44789


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceEEcccCccc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG-ELTAHVSDFGLAK  318 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg~a~  318 (484)
                      +||||+++++|.+++.... ....+++..++.++.|++.||+|||   +++|+||||||+||+++. ++.+||+|||.+.
T Consensus        96 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~  171 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK  171 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred             EEEEeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeeccccc
Confidence            9999999999999997543 2335778999999999999999999   889999999999999987 8899999999998


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCC--CCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE--VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ......       .......|+..|+|||++.+..  ++.++||||||+++|+|++|+.||.........   ....   
T Consensus       172 ~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~---  238 (295)
T 2clq_A          172 RLAGIN-------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---MFKV---  238 (295)
T ss_dssp             ESCC------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---HHHH---
T ss_pred             ccCCCC-------CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---HHhh---
Confidence            653321       1122346899999999986643  789999999999999999999999643211100   0000   


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                       ... ...+.+                       +..++.++.+++.+||+.||++|||+.|+++
T Consensus       239 -~~~-~~~~~~-----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          239 -GMF-KVHPEI-----------------------PESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -HHH-CCCCCC-----------------------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -ccc-cccccc-----------------------cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             000 000000                       1223567889999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3e-42  Score=339.84  Aligned_cols=251  Identities=24%  Similarity=0.385  Sum_probs=191.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCC--CCCceeEeeeeeeeccCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIR--HRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~  234 (484)
                      .+|++.+.||+|+||.||+|...   .+..||||++.....  ...+.+.+|+.++++++  ||||+++++++..     
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-----  127 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-----  127 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT---TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----
T ss_pred             CceEEEEEEccCCCeEEEEEEcC---CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-----
Confidence            45999999999999999999843   378899999975432  23467899999999996  5999999998643     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ++..++||| +.+++|.+++....    .+++.+++.++.||+.||+|||   +++|+||||||+|||++ ++.+||+||
T Consensus       128 ~~~~~lv~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DF  198 (390)
T 2zmd_A          128 DQYIYMVME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDF  198 (390)
T ss_dssp             SSEEEEEEE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCC
T ss_pred             CCEEEEEEe-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEec
Confidence            447899999 56889999998542    5889999999999999999999   89999999999999996 579999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCC-----------CCCCcccceehhhHHHHHHHhCCCCCCCCccC
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-----------SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG  383 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~  383 (484)
                      |+++.+.....     ........||+.|+|||++.+           ..++.++|||||||++|||++|+.||......
T Consensus       199 G~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~  273 (390)
T 2zmd_A          199 GIANQMQPDTT-----SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ  273 (390)
T ss_dssp             SSSCCC--------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred             CccccccCCCc-----cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH
Confidence            99987643221     111223569999999998764           46889999999999999999999999653211


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .    ..        +..++++......                   +..+...+.+++..||+.||++|||+.|+++.
T Consensus       274 ~----~~--------~~~~~~~~~~~~~-------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          274 I----SK--------LHAIIDPNHEIEF-------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             H----HH--------HHHHHCTTSCCCC-------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             H----HH--------HHHHhCccccCCC-------------------CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            0    01        1122222111100                   11114568899999999999999999999864

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.1e-42  Score=342.43  Aligned_cols=212  Identities=25%  Similarity=0.340  Sum_probs=169.8

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ..++|.+.+.||+|+||.||+|+.  ..+++.||||++.....  ...+.+.+|+.++++++||||+++++++.......
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~--~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  101 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYD--KNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLK  101 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEE--TTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEE--CCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCc
Confidence            357899999999999999999994  44678999999975432  23467889999999999999999999976554444


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+. ++|.+++..    ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       102 ~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A          102 FDELYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             CCCEEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CCeEEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccC
Confidence            467899999995 699999973    245899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCC---------------CccccccccccccccCcccc-CCCCCCcccceehhhHHHHHHHhCCCCCC
Q 011508          315 GLAKFLPEAANNLSS---------------NQSSSVGVKGTVGYAAPEYG-MGSEVSTSGDVYSFGILLLEMFTGKGPTN  378 (484)
Q Consensus       315 g~a~~~~~~~~~~~~---------------~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dvws~Gvvl~elltg~~p~~  378 (484)
                      |+++...........               .........||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            999876443211000               00122456799999999985 56679999999999999999998766654

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.1e-41  Score=321.67  Aligned_cols=257  Identities=20%  Similarity=0.265  Sum_probs=200.0

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc------chHHHHHHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG------ASKSFIAECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      ++|++.+.||+|+||.||+|+..  .+++.||+|+++.....      ..+.+.+|+.++++++||||+++++++.    
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----   78 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQK--GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE----   78 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             hhhhhHHhhcccCceEEEEEEEc--CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec----
Confidence            46889999999999999999954  45788999998754321      3567899999999999999999999864    


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC----c
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL----T  308 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~----~  308 (484)
                       .....++||||+++++|.+++...    ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++    .
T Consensus        79 -~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~  150 (283)
T 3bhy_A           79 -NKTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPR  150 (283)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCC
T ss_pred             -CCCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCc
Confidence             345789999999999999999753    34899999999999999999999   89999999999999998877    8


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHh
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH  388 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~  388 (484)
                      +||+|||.+.......        ......+++.|+|||++.+..++.++||||||+++|+|++|+.||......     
T Consensus       151 ~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----  217 (283)
T 3bhy_A          151 IKLIDFGIAHKIEAGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-----  217 (283)
T ss_dssp             EEECCCTTCEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----
T ss_pred             eEEEecccceeccCCC--------cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-----
Confidence            9999999998653321        112345899999999999899999999999999999999999999753211     


Q ss_pred             HHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH--HHHHH
Q 011508          389 NFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA--QLLSF  466 (484)
Q Consensus       389 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~--~L~~i  466 (484)
                      .....        +.........                 .....++..+.+++.+||+.||++|||+.|+++  .++.+
T Consensus       218 ~~~~~--------~~~~~~~~~~-----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          218 ETLTN--------ISAVNYDFDE-----------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHH--------HHTTCCCCCH-----------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHH--------hHhcccCCcc-----------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            11100        0000000000                 001122557889999999999999999999997  34544


Q ss_pred             H
Q 011508          467 R  467 (484)
Q Consensus       467 ~  467 (484)
                      +
T Consensus       273 ~  273 (283)
T 3bhy_A          273 R  273 (283)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.8e-42  Score=326.55  Aligned_cols=251  Identities=24%  Similarity=0.290  Sum_probs=197.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|.+.+.||+|+||.||+|+..  .+++.||+|+++.......+.+.+|+.++++++||||+++++++.     ....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   80 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQR--LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTH   80 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             hccceeeeeccCCCCceEEEEEEC--CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCE
Confidence            356889999999999999999843  457889999998655445567889999999999999999999853     4458


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEccc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVSDF  314 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Df  314 (484)
                      .++||||+++++|.+++....    .+++..++.++.|++.||+|||   +.+|+||||||+||++   +.++.+||+||
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Df  153 (304)
T 2jam_A           81 YYLVMQLVSGGELFDRILERG----VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDF  153 (304)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred             EEEEEEcCCCccHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccC
Confidence            899999999999999987543    4889999999999999999999   8899999999999999   77889999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |++......         ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......     ......
T Consensus       154 g~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i  219 (304)
T 2jam_A          154 GLSKMEQNG---------IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES-----KLFEKI  219 (304)
T ss_dssp             STTCCCCCB---------TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHH
T ss_pred             CcceecCCC---------ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHH
Confidence            998754221         112345899999999999999999999999999999999999999753211     111100


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                              ........                 ......++..+.+++.+||+.||++|||+.|+++
T Consensus       220 --------~~~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          220 --------KEGYYEFE-----------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             --------HHCCCCCC-----------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             --------HcCCCCCC-----------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                    00000000                 0001223567899999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-41  Score=333.20  Aligned_cols=286  Identities=21%  Similarity=0.215  Sum_probs=205.8

Q ss_pred             HHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       155 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      +...++|++.+.||+|+||.||+|+.  ..++..||+|++..... ...+.+.+|++++++++||||+++++++......
T Consensus        23 ~~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           23 FDVGPRYTNLSYIGEGAYGMVCSAYD--NLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE  100 (364)
T ss_dssp             CCCTTTEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             ccccccEEEEEEeecCCCeEEEEEEE--CCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence            34457899999999999999999984  44678999999975432 2336788999999999999999999997665545


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||+. |+|.+++...     .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|
T Consensus       101 ~~~~~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~D  171 (364)
T 3qyz_A          101 QMKDVYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICD  171 (364)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             ccceEEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEe
Confidence            5567899999995 6999998742     4899999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||++.........    ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+.....
T Consensus       172 fg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~  246 (364)
T 3qyz_A          172 FGLARVADPDHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILG  246 (364)
T ss_dssp             CTTCEECCGGGCB----CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHH
T ss_pred             CcceEecCCCCCc----cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHH
Confidence            9999876543211    111233579999999997654 558999999999999999999999997643221 1111111


Q ss_pred             hhcc---hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          393 EALP---ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       393 ~~~~---~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....   +.+..+.+............     ............+..++.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          247 ILGSPSQEDLNCIINLKARNYLLSLPH-----KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHCSCCHHHHHTCCCHHHHHHHHTSCC-----CCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhCCCCHHHHHHhhhhhHHHHHHhcCC-----ccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1100   00111110000000000000     0000000001223567899999999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.5e-42  Score=325.57  Aligned_cols=250  Identities=22%  Similarity=0.255  Sum_probs=200.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|.+.+.||+|+||.||+|...  .+++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.     .
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~   86 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDA--DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----D   86 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             ccceEEEEEEeecCCEEEEEEEEC--CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----c
Confidence            357889999999999999999954  4578899999875432   23467889999999999999999999964     3


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ++..++||||+++++|.+++...    ..+++.+++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df  159 (294)
T 2rku_A           87 NDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDF  159 (294)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEec
Confidence            45789999999999999998753    24899999999999999999999   889999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |.+.......       .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......     +...  
T Consensus       160 g~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~--  225 (294)
T 2rku_A          160 GLATKVEYDG-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-----ETYL--  225 (294)
T ss_dssp             TTCEECCSTT-------CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHH--
T ss_pred             cCceecccCc-------cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHH--
Confidence            9998653221       1122346899999999999888999999999999999999999999753211     1111  


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                            .+.......                     +..+...+.+++.+||+.||++|||++|+++.
T Consensus       226 ------~~~~~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          226 ------RIKKNEYSI---------------------PKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ------HHHTTCCCC---------------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ------HHhhccCCC---------------------ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                  010000000                     11224568899999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.1e-42  Score=333.51  Aligned_cols=254  Identities=24%  Similarity=0.301  Sum_probs=196.1

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  235 (484)
                      ..++|++.+.||+|+||.||+|+.  ..+++.||+|+++....    ...+|++++.++ +||||+++++++     .++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~   88 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIH--KATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVY-----DDG   88 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEE-----ECS
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEE--CCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEE-----EcC
Confidence            346799999999999999999994  44678999999976543    235688888888 799999999985     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC----CceEE
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE----LTAHV  311 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~----~~~kl  311 (484)
                      ...++||||+++|+|.+++...    ..+++..+..++.||+.||+|||   +++|+||||||+||++.++    +.+||
T Consensus        89 ~~~~lv~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           89 KYVYVVTELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEE
Confidence            6889999999999999999743    35899999999999999999999   8999999999999998443    35999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      +|||++.......       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......  ......
T Consensus       162 ~Dfg~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~  232 (342)
T 2qr7_A          162 CDFGFAKQLRAEN-------GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEIL  232 (342)
T ss_dssp             CCCTTCEECBCTT-------CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHH
T ss_pred             EECCCcccCcCCC-------CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHH
Confidence            9999998764322       1223356899999999988878999999999999999999999999753211  111111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .....        .......                 ..+..++.++.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~i~~--------~~~~~~~-----------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          233 ARIGS--------GKFSLSG-----------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             HHHHH--------CCCCCCS-----------------TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHcc--------CCcccCc-----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11100        0000000                 0012235678999999999999999999999864

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.2e-43  Score=335.82  Aligned_cols=278  Identities=22%  Similarity=0.268  Sum_probs=192.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|.+.+.||+|+||.||+|+..  .+++.||+|++...... ....+.+|++++++++||||+++++++.     .+..
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~   74 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSK--LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKS   74 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSC
T ss_pred             CceEEEEEEcCCCCEEEEEEEEC--CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCE
Confidence            57889999999999999999954  45788999998754322 1224567999999999999999999853     4457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||++ |+|.+++...   ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  147 (324)
T 3mtl_A           75 LTLVFEYLD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLA  147 (324)
T ss_dssp             EEEEEECCS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred             EEEEecccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCccc
Confidence            899999996 6999998754   235899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      .......       .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||.......  ....+.....
T Consensus       148 ~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~  218 (324)
T 3mtl_A          148 RAKSIPT-------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILG  218 (324)
T ss_dssp             ECC-------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHC
T ss_pred             ccccCCc-------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence            7653221       11223468999999998876 568999999999999999999999997642211  1111111110


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..........+........  ................+..++.+++.+||+.||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          219 TPTEETWPGILSNEEFKTY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CCCTTTSTTGGGCHHHHHT--CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCChHhchhhhcchhhccc--ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0000000000000000000  00000000000001223567889999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.2e-42  Score=333.61  Aligned_cols=276  Identities=22%  Similarity=0.285  Sum_probs=191.5

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--chHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      ...++|++.+.||+|+||.||+|+.  ..+++.||+|+++.....  ..+.+.+|+.++++++||||+++++++.     
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----  103 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAID--TVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----  103 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEE--TTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEE--CCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----
Confidence            3446899999999999999999984  446789999999754322  2356789999999999999999999964     


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-----CCCc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD-----GELT  308 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~-----~~~~  308 (484)
                      .+...++||||++ |+|.+++....    .+++..++.++.||+.||+|||   +++|+||||||+||+++     .++.
T Consensus       104 ~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~  175 (329)
T 3gbz_A          104 HNHRLHLIFEYAE-NDLKKYMDKNP----DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPV  175 (329)
T ss_dssp             ETTEEEEEEECCS-EEHHHHHHHCT----TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCE
T ss_pred             cCCEEEEEEecCC-CCHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccce
Confidence            3458899999996 59999997543    4899999999999999999999   89999999999999994     4556


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      +||+|||++.......       .......+|..|+|||++.+. .++.++|||||||++|||++|+.||....... .+
T Consensus       176 ~kl~Dfg~a~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~  247 (329)
T 3gbz_A          176 LKIGDFGLARAFGIPI-------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QL  247 (329)
T ss_dssp             EEECCTTHHHHHC------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH
T ss_pred             EEECcCCCccccCCcc-------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HH
Confidence            9999999998653221       112234579999999998774 58999999999999999999999997632211 11


Q ss_pred             hHHHHhh-cchh--hhhhcC-cccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          388 HNFVKEA-LPER--LAEIVD-PVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       388 ~~~~~~~-~~~~--~~~~~d-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....... .+..  ...... +..........       ....+......+..++.+++.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          248 FKIFEVLGLPDDTTWPGVTALPDWKQSFPKFR-------GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCC-------CCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhCCCchhhhhhhhhhhhhhhhhhhhc-------cccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            1111110 0000  000000 00000000000       000000001223567899999999999999999999975

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.3e-41  Score=324.33  Aligned_cols=251  Identities=25%  Similarity=0.345  Sum_probs=202.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .+.|++.+.||+|+||.||+|+.  ..+++.||+|++..... ...+.+.+|+.++++++||||+++++++..     +.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   93 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGID--NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DT   93 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEE--TTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred             HHHHHHhhhhcccCCeEEEEEEE--CCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CC
Confidence            35688999999999999999984  34678899999976542 345789999999999999999999998643     34


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++..     ..+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~  165 (303)
T 3a7i_A           94 KLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGV  165 (303)
T ss_dssp             EEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeeccc
Confidence            78999999999999999863     35899999999999999999999   88999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.......       .......|+..|+|||++.+..++.++||||||+++|+|++|+.||......  .....+.    
T Consensus       166 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~----  232 (303)
T 3a7i_A          166 AGQLTDTQ-------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM--KVLFLIP----  232 (303)
T ss_dssp             CEECBTTB-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHH----
T ss_pred             ceecCccc-------cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH--HHHHHhh----
Confidence            98664321       1122346899999999999999999999999999999999999999653211  0000000    


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                          ....+.+                       ...++..+.+++..||+.||++|||+.|+++..
T Consensus       233 ----~~~~~~~-----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          233 ----KNNPPTL-----------------------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             ----HSCCCCC-----------------------CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             ----cCCCCCC-----------------------ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence                0000000                       112255689999999999999999999998754

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.7e-42  Score=335.95  Aligned_cols=284  Identities=21%  Similarity=0.211  Sum_probs=204.2

Q ss_pred             cccHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-----------chHHHHHHHHHHHcCC
Q 011508          148 RVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-----------ASKSFIAECQALRSIR  216 (484)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~  216 (484)
                      +....++....++|.+.+.||+|+||.||+|...   .+..||||++......           ..+.+.+|++++++++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~   87 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS---EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH   87 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECT---TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECC---CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC
Confidence            3445677888999999999999999999999843   3788999998643321           1267899999999999


Q ss_pred             CCCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCC
Q 011508          217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDL  296 (484)
Q Consensus       217 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl  296 (484)
                      ||||+++++++...+.......++||||++ |+|.+++...   ...+++..++.++.|++.||+|||   +++|+||||
T Consensus        88 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dl  160 (362)
T 3pg1_A           88 HPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDL  160 (362)
T ss_dssp             CTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCC
T ss_pred             CcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCC
Confidence            999999999986655455567899999996 6888888732   346899999999999999999999   889999999


Q ss_pred             CCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCC
Q 011508          297 KPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKG  375 (484)
Q Consensus       297 k~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~  375 (484)
                      ||+||+++.++.+||+|||++.......        ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus       161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  232 (362)
T 3pg1_A          161 HPGNILLADNNDITICDFNLAREDTADA--------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA  232 (362)
T ss_dssp             CGGGEEECTTCCEEECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ChHHEEEcCCCCEEEEecCccccccccc--------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence            9999999999999999999997543221        1223468999999998876 678999999999999999999999


Q ss_pred             CCCCCccCCccHhHHHHhhcch-----------hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhc
Q 011508          376 PTNEMFTGNLTLHNFVKEALPE-----------RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVI  444 (484)
Q Consensus       376 p~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  444 (484)
                      ||....... .+..........           ...+.+...+........            ......+...+.+++.+
T Consensus       233 pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~li~~  299 (362)
T 3pg1_A          233 LFRGSTFYN-QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW------------TAVVPTADPVALDLIAK  299 (362)
T ss_dssp             SCCCSSHHH-HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH------------HHHSTTSCHHHHHHHHH
T ss_pred             CCCCCCHHH-HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhH------------HhhCCCCCHHHHHHHHH
Confidence            997642111 111111111000           011111111111000000            00012235678999999


Q ss_pred             cCCCCcCCCCCHHHHHHH
Q 011508          445 CSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       445 cl~~dP~~RPt~~evl~~  462 (484)
                      ||+.||++|||+.|+++.
T Consensus       300 ~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          300 MLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HTCSSGGGSCCHHHHHTS
T ss_pred             HhcCChhhCCCHHHHHcC
Confidence            999999999999999863

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.6e-42  Score=325.52  Aligned_cols=264  Identities=28%  Similarity=0.384  Sum_probs=196.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      .++|++.+.||+|+||.||+|++... +....||+|+++...   ....+.+.+|++++++++||||+++++++..    
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   92 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----   92 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence            35789999999999999999986533 334579999987542   2344678999999999999999999998632    


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                       + ..++|+||+++++|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|
T Consensus        93 -~-~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~D  164 (291)
T 1u46_A           93 -P-PMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGD  164 (291)
T ss_dssp             -S-SCEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECC
T ss_pred             -C-CceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcc
Confidence             2 3789999999999999997542   35899999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||++.........    ........++..|+|||++.+..++.++||||||+++|+|++ |+.||.....     .....
T Consensus       165 fg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~  235 (291)
T 1u46_A          165 FGLMRALPQNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILH  235 (291)
T ss_dssp             CTTCEECCC-CCE----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHH
T ss_pred             ccccccccccccc----hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----HHHHH
Confidence            9999876433211    111223457888999999988889999999999999999999 9999975321     11111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                      .        +.......                   ..+..++..+.+++..||+.||++|||+.++++.|+++...
T Consensus       236 ~--------~~~~~~~~-------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          236 K--------IDKEGERL-------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             H--------HHTSCCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             H--------HHccCCCC-------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            1        00000000                   00122356789999999999999999999999999887654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-42  Score=335.42  Aligned_cols=279  Identities=19%  Similarity=0.220  Sum_probs=194.8

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeec-cC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVD-FQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~  233 (484)
                      ..++|++.+.||+|+||.||+|+.  ..+++.||||++.....  ...+.+.+|+++++.++||||+++++++.... ..
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~  100 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVD--GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD  100 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEE--TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred             ecceEEEeEEeeecCCeEEEEEEE--CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence            357899999999999999999984  44678999999864332  23467889999999999999999999875432 11


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||+ +++|.+++..     ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|
T Consensus       101 ~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~D  171 (367)
T 1cm8_A          101 DFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILD  171 (367)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             cCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEe
Confidence            224569999999 8899999974     24899999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||+++.....          .....+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+..... .+.....
T Consensus       172 fg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~  240 (367)
T 1cm8_A          172 FGLARQADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMK  240 (367)
T ss_dssp             CTTCEECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHH
T ss_pred             eecccccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence            9999865321          123468999999998876 679999999999999999999999997642111 1111111


Q ss_pred             hh--cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          393 EA--LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       393 ~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..  .+......+..........    .........-......+...+.+++.+||+.||++|||++|+++
T Consensus       241 ~~g~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          241 VTGTPPAEFVQRLQSDEAKNYMK----GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHCCCCHHHHHTCSCHHHHHHHH----HSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcCCCCHHHHHHhhhHHHHHHHH----hCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            10  0111100000000000000    00000000000001223567899999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.8e-42  Score=337.30  Aligned_cols=200  Identities=28%  Similarity=0.394  Sum_probs=171.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .++|++.+.||+|+||.||+|...  .++..||+|++..... ...+.+.+|+.++++++||||+++++++..     +.
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~  104 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHK--PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DG  104 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TT
T ss_pred             cccceeeeeecCCCCeEEEEEEEC--CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CC
Confidence            357899999999999999999954  4578999999976533 334678999999999999999999998643     44


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCeeecCCCceEEcccC
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCET-PIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ..++||||+++++|.+++....    .+++..+..++.|++.||+|||   +. +|+||||||+||+++.++.+||+|||
T Consensus       105 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  177 (360)
T 3eqc_A          105 EISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFG  177 (360)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred             EEEEEEECCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECC
Confidence            7899999999999999997543    4889999999999999999999   64 89999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ++.......         .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       178 ~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  233 (360)
T 3eqc_A          178 VSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  233 (360)
T ss_dssp             CCHHHHHHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred             CCccccccc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            987553221         12346899999999999999999999999999999999999999753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.7e-42  Score=332.10  Aligned_cols=250  Identities=22%  Similarity=0.252  Sum_probs=200.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|.+.+.||+|+||.||+++..  .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.     .
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~  112 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDA--DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----D  112 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEC--CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----c
Confidence            467899999999999999999954  457889999987543   223467889999999999999999999954     3


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ++..++||||+++++|.+++...    ..+++.+++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus       113 ~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Df  185 (335)
T 2owb_A          113 NDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDF  185 (335)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred             CCeEEEEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeec
Confidence            45889999999999999998754    34899999999999999999999   889999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |++.......       .......|+..|+|||++.+..++.++||||||+++|||++|+.||.....     .......
T Consensus       186 g~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~  253 (335)
T 2owb_A          186 GLATKVEYDG-------ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KETYLRI  253 (335)
T ss_dssp             TTCEECCSTT-------CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHH
T ss_pred             cCceecccCc-------ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----HHHHHHH
Confidence            9998763221       112234689999999999988899999999999999999999999975321     1111100


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                              .......                     +..+...+.+++.+||+.||++|||+.|+++.
T Consensus       254 --------~~~~~~~---------------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          254 --------KKNEYSI---------------------PKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             --------HHTCCCC---------------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --------hcCCCCC---------------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    0000000                     11224568899999999999999999999874

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.3e-42  Score=323.55  Aligned_cols=248  Identities=17%  Similarity=0.216  Sum_probs=195.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|++.+.||+|+||.||+|+..  .+++.||+|+++....  .....+.+|+..+..+ +||||+++++++..     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----   82 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKR--LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----   82 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----
T ss_pred             cchhhhhhhhcCCCceEEEEEEEc--CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----
Confidence            467899999999999999999954  4578999999986432  3346788999999999 99999999998643     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---------
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---------  305 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---------  305 (484)
                      ++..++||||+++++|.+++.........+++..++.++.|++.||+|||   +++|+||||||+||+++.         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~  159 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASE  159 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccc
Confidence            44889999999999999999865433356899999999999999999999   899999999999999984         


Q ss_pred             ----------CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCC
Q 011508          306 ----------ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGK  374 (484)
Q Consensus       306 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~  374 (484)
                                ...+||+|||.+.......           ...||..|+|||.+.+. .++.++|||||||++|+|++|.
T Consensus       160 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~  228 (289)
T 1x8b_A          160 EGDEDDWASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE  228 (289)
T ss_dssp             ----------CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCC
T ss_pred             ccccccccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCC
Confidence                      4479999999998653221           23489999999998765 6678999999999999999999


Q ss_pred             CCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC
Q 011508          375 GPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM  454 (484)
Q Consensus       375 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP  454 (484)
                      +|+...    ........            .....                    .+..++..+.+++.+||+.||++||
T Consensus       229 ~~~~~~----~~~~~~~~------------~~~~~--------------------~~~~~~~~~~~li~~~l~~dp~~Rp  272 (289)
T 1x8b_A          229 PLPRNG----DQWHEIRQ------------GRLPR--------------------IPQVLSQEFTELLKVMIHPDPERRP  272 (289)
T ss_dssp             CCCSSS----HHHHHHHT------------TCCCC--------------------CSSCCCHHHHHHHHHHTCSSGGGSC
T ss_pred             CCCcch----hHHHHHHc------------CCCCC--------------------CCcccCHHHHHHHHHHhCCCcccCC
Confidence            876431    11111110            00000                    0112256789999999999999999


Q ss_pred             CHHHHHHH
Q 011508          455 NMEEVAAQ  462 (484)
Q Consensus       455 t~~evl~~  462 (484)
                      |+.|+++.
T Consensus       273 s~~~ll~h  280 (289)
T 1x8b_A          273 SAMALVKH  280 (289)
T ss_dssp             CHHHHHTC
T ss_pred             CHHHHhhC
Confidence            99999763

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7e-42  Score=329.76  Aligned_cols=267  Identities=23%  Similarity=0.308  Sum_probs=199.5

Q ss_pred             cccHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeee
Q 011508          148 RVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITS  226 (484)
Q Consensus       148 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~  226 (484)
                      .++..++....++|++.+.||+|+||.||+|+..  .+++.||+|++.... ...+.+.+|+.+++++ +||||++++++
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~   89 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHV--KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGA   89 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEEC--CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeE
Confidence            3444555567789999999999999999999954  357889999997543 3447889999999999 89999999999


Q ss_pred             eeeeccC-CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 011508          227 CVSVDFQ-GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG  305 (484)
Q Consensus       227 ~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~  305 (484)
                      +...... .....++||||+++++|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+||+++.
T Consensus        90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~  164 (326)
T 2x7f_A           90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTE  164 (326)
T ss_dssp             EEECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECT
T ss_pred             EeeccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcC
Confidence            7653211 1457899999999999999997542  245899999999999999999999   889999999999999999


Q ss_pred             CCceEEcccCcccccccccccCCCCccccccccccccccCccccC-----CCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       306 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ++.+||+|||++.......       .......|+..|+|||++.     +..++.++|||||||++|+|++|+.||...
T Consensus       165 ~~~~kl~Dfg~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  237 (326)
T 2x7f_A          165 NAEVKLVDFGVSAQLDRTV-------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  237 (326)
T ss_dssp             TCCEEECCCTTTC--------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CCCEEEeeCcCceecCcCc-------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999988653321       1122346899999999986     567899999999999999999999999653


Q ss_pred             ccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHH
Q 011508          381 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVA  460 (484)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  460 (484)
                      ...     ......     .....+.+.                      ...++..+.+++.+||+.||++|||+.|++
T Consensus       238 ~~~-----~~~~~~-----~~~~~~~~~----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  285 (326)
T 2x7f_A          238 HPM-----RALFLI-----PRNPAPRLK----------------------SKKWSKKFQSFIESCLVKNHSQRPATEQLM  285 (326)
T ss_dssp             CHH-----HHHHHH-----HHSCCCCCS----------------------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             cHH-----HHHHHh-----hcCccccCC----------------------ccccCHHHHHHHHHHhccChhhCCCHHHHh
Confidence            211     000000     000000000                      112255789999999999999999999998


Q ss_pred             H
Q 011508          461 A  461 (484)
Q Consensus       461 ~  461 (484)
                      +
T Consensus       286 ~  286 (326)
T 2x7f_A          286 K  286 (326)
T ss_dssp             T
T ss_pred             h
Confidence            6

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.6e-41  Score=337.98  Aligned_cols=278  Identities=24%  Similarity=0.274  Sum_probs=197.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-CCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDF-QGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  237 (484)
                      .+|++.+.||+|+||.||+|+..  .+++.||||++.....    ...+|++++++++||||+++++++..... .+..+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~--~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEEC--CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            45888899999999999999954  3578899999865432    23479999999999999999998765432 22345


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-CceEEcccCc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVSDFGL  316 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~  316 (484)
                      .++||||+++ +|.+.+.........+++..++.++.||+.||+|||   +++|+||||||+|||++.+ +.+||+|||+
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchh
Confidence            6799999965 777776544334456999999999999999999999   8999999999999999965 5789999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++.+....        ......||..|+|||++.+. .++.++|||||||++|||++|+.||.+.... ..+.+.+....
T Consensus       204 a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg  274 (420)
T 1j1b_A          204 AKQLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLG  274 (420)
T ss_dssp             CEECCTTC--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred             hhhcccCC--------CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence            98763321        12234689999999998764 7899999999999999999999999763211 11222222111


Q ss_pred             c---hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 P---ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~---~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .   +.+... ++..... .   ..... ..++ ........+.++.+|+.+||+.||++|||+.|+++.
T Consensus       275 ~p~~~~~~~~-~~~~~~~-~---~p~~~-~~~~-~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          275 TPTREQIREM-NPNYTEF-K---FPQIK-AHPW-TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             SCCHHHHHHH-CSCCCCC-C---CCCCC-CCCH-HHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHhh-Chhhhhh-c---cCccC-CCCH-HHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            1   111111 1111000 0   00000 0000 000012235678999999999999999999999853

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2e-41  Score=344.17  Aligned_cols=252  Identities=23%  Similarity=0.304  Sum_probs=197.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||+||+|+.  ..+++.||||++....  ......+.+|++++++++||||+++++++.     ..
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~   93 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKD--RITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DS   93 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEE--TTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CS
T ss_pred             hcceEEeEEEeecCCEEEEEEEE--CCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cC
Confidence            35689999999999999999984  4467889999986432  234567899999999999999999999853     45


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCceEEc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD---GELTAHVS  312 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~  312 (484)
                      ...++||||+++|+|.+++....    .+++..++.++.||+.||+|||   +++|+||||||+||+++   .++.+||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  166 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKII  166 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEE
Confidence            58899999999999999987543    4899999999999999999999   89999999999999995   45689999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||++.......        ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....     .....
T Consensus       167 Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~  232 (486)
T 3mwu_A          167 DFGLSTCFQQNT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDILK  232 (486)
T ss_dssp             SCSCTTTBCCC------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred             ECCcCeECCCCC--------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH
Confidence            999998653321        1223469999999999876 589999999999999999999999975321     11111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..        .........                 .....++.++.+++.+||+.||++|||+.|+++.
T Consensus       233 ~i--------~~~~~~~~~-----------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          233 RV--------ETGKYAFDL-----------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HH--------HHTCCCSCS-----------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             HH--------HhCCCCCCC-----------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            10        000000000                 0012235678999999999999999999999874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6e-42  Score=326.56  Aligned_cols=254  Identities=22%  Similarity=0.313  Sum_probs=196.8

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ..++|++.+.||+|+||.||+|+..  .++..||+|++........+.+.+|+++++.++||||+++++++..     +.
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   89 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNK--ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DG   89 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEET--TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-
T ss_pred             CccceeecceeccCCCeEEEEEEEc--CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CC
Confidence            3467999999999999999999954  3578899999987666667889999999999999999999998643     44


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++....   ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+
T Consensus        90 ~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  163 (302)
T 2j7t_A           90 KLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGV  163 (302)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHH
T ss_pred             eEEEEEEeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCC
Confidence            7899999999999999987532   35899999999999999999999   88999999999999999999999999998


Q ss_pred             ccccccccccCCCCccccccccccccccCcccc-----CCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYG-----MGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      +.......       .......|+..|+|||++     ....++.++||||||+++|+|++|+.||......     ...
T Consensus       164 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~  231 (302)
T 2j7t_A          164 SAKNLKTL-------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVL  231 (302)
T ss_dssp             HHHHHHHH-------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHH
T ss_pred             Cccccccc-------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHH
Confidence            76432211       111234689999999987     4677899999999999999999999999753211     111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....     ....+..                     ..+..++..+.+++..||+.||++|||+.|+++
T Consensus       232 ~~~~-----~~~~~~~---------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          232 LKIA-----KSDPPTL---------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHHH-----HSCCCCC---------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             HHHh-----ccCCccc---------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1000     0000000                     002233567899999999999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.2e-42  Score=328.92  Aligned_cols=264  Identities=18%  Similarity=0.212  Sum_probs=201.3

Q ss_pred             ccHHhHHHhcCCCCcc-CccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcC-CCCCceeEe
Q 011508          149 VSYQNLFKATDGFSLE-NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSI-RHRNLVKII  224 (484)
Q Consensus       149 ~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~  224 (484)
                      +.++......+.|.+. +.||+|+||.||+|+..  .+++.||+|++.....  .....+.+|+.++.++ .||||++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISK--STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEEC--CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            3334444555677777 88999999999999854  4578999999875432  3356789999999999 569999999


Q ss_pred             eeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 011508          225 TSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD  304 (484)
Q Consensus       225 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~  304 (484)
                      +++     ......++||||+++|+|.+++...  ....+++..++.++.|++.||+|||   +++|+||||||+||+++
T Consensus        96 ~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~  165 (327)
T 3lm5_A           96 EVY-----ENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLS  165 (327)
T ss_dssp             EEE-----ECSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEES
T ss_pred             EEE-----EeCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEe
Confidence            985     3455789999999999999998632  2346899999999999999999999   89999999999999998


Q ss_pred             C---CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCc
Q 011508          305 G---ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMF  381 (484)
Q Consensus       305 ~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~  381 (484)
                      .   ++.+||+|||++.......        ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       166 ~~~~~~~~kL~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  237 (327)
T 3lm5_A          166 SIYPLGDIKIVDFGMSRKIGHAC--------ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED  237 (327)
T ss_dssp             CBTTBCCEEECCGGGCEEC-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCCCCcEEEeeCccccccCCcc--------ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            7   7899999999998764321        1123468999999999999999999999999999999999999996532


Q ss_pred             cCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          382 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...     ....     +.... .....                   .....+...+.+++..||+.||++|||++|+++
T Consensus       238 ~~~-----~~~~-----i~~~~-~~~~~-------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          238 NQE-----TYLN-----ISQVN-VDYSE-------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHH-----HHHH-----HHHTC-CCCCT-------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             chH-----HHHH-----HHhcc-cccCc-------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            110     0000     00000 00000                   001223567889999999999999999999986


Q ss_pred             H
Q 011508          462 Q  462 (484)
Q Consensus       462 ~  462 (484)
                      .
T Consensus       288 h  288 (327)
T 3lm5_A          288 H  288 (327)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.4e-41  Score=319.76  Aligned_cols=249  Identities=25%  Similarity=0.364  Sum_probs=192.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|.+.+.||+|+||.||+|+..  .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++.     .
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   82 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQ--LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----T   82 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             eccEEEEeeecCCCCeEEEEEEEC--CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----c
Confidence            467999999999999999999854  357889999987532   233467889999999999999999999854     3


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+++++|.+++....    .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~df  155 (276)
T 2h6d_A           83 PTDFFMVMEYVSGGELFDYICKHG----RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADF  155 (276)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeec
Confidence            458899999999999999997543    4899999999999999999999   889999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |++.......        ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.....     ......
T Consensus       156 g~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~  222 (276)
T 2h6d_A          156 GLSNMMSDGE--------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTLFKK  222 (276)
T ss_dssp             CGGGCCCC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred             ccccccCCCc--------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHHH
Confidence            9998653321        1123458999999999887765 6899999999999999999999965311     111110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .     ..   ....                     .+..+...+.+++.+||+.||++|||+.|+++.
T Consensus       223 ~-----~~---~~~~---------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          223 I-----RG---GVFY---------------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             H-----HH---CCCC---------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             h-----hc---Cccc---------------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            0     00   0000                     011224568899999999999999999999874

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=331.13  Aligned_cols=279  Identities=22%  Similarity=0.237  Sum_probs=194.3

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-----chHHHHHHHHHHHcCCCCCceeEeeeeeee
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-----ASKSFIAECQALRSIRHRNLVKIITSCVSV  230 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  230 (484)
                      ...++|.+.+.||+|+||.||+|+  +..+++.||+|++......     ..+.+.+|++++++++||||+++++++   
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---   81 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKAR--DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF---   81 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEE--CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred             HHhcccEEEeEEeecCCEEEEEEE--ECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE---
Confidence            345789999999999999999998  4446789999998753321     124688999999999999999999985   


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH  310 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k  310 (484)
                        ......++||||+++ +|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+|
T Consensus        82 --~~~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~k  152 (346)
T 1ua2_A           82 --GHKSNISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLK  152 (346)
T ss_dssp             --CCTTCCEEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             --eeCCceEEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEE
Confidence              345578999999965 899888643   345888899999999999999999   89999999999999999999999


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhH
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHN  389 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~  389 (484)
                      |+|||+++......       .......+|+.|+|||++.+. .++.++|||||||++|||++|..||...... ..+..
T Consensus       153 l~Dfg~a~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~-~~~~~  224 (346)
T 1ua2_A          153 LADFGLAKSFGSPN-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL-DQLTR  224 (346)
T ss_dssp             ECCCGGGSTTTSCC-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred             EEecccceeccCCc-------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHH
Confidence            99999998663321       122234689999999998664 5899999999999999999999998753211 11111


Q ss_pred             HHHhhcchhhhhhcCccccccc-ccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          390 FVKEALPERLAEIVDPVLLVER-EEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       390 ~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ............+.+..-..+. ..........      ......+..++.+++.+||+.||++|||+.|+++.
T Consensus       225 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPL------HHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             HHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCH------HHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHHHcCCCChhhhhhhccCcccccccccCCCCh------HHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            1111100000000000000000 0000000000      00012235679999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.6e-42  Score=338.96  Aligned_cols=208  Identities=23%  Similarity=0.333  Sum_probs=157.8

Q ss_pred             CCCc-cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          160 GFSL-ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       160 ~~~~-~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      .|.+ .++||+|+||.||+|+..+..++..||+|++....  ....+.+|+.+|++++||||+++++++..   ..+...
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~~~   95 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLS---HADRKV   95 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEE---TTTTEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEec---CCCCeE
Confidence            3555 45899999999999997766677899999996442  34678899999999999999999998743   335678


Q ss_pred             eEEeecccCCCHHHHHhhcC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee----cCCCce
Q 011508          239 ALVYELMVNGSLEEWLHLNR-----DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL----DGELTA  309 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll----~~~~~~  309 (484)
                      ++||||+. ++|.+++....     .....+++..++.++.||+.||+|||   +++|+||||||+|||+    +.++.+
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            99999995 68888876322     12234899999999999999999999   8999999999999999    677899


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ||+|||+++.......    .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus       172 kl~Dfg~a~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          172 KIADMGFARLFNSPLK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             EECCTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEEECCCceecCCCCc----ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            9999999987643211    1112234568999999999877 45899999999999999999999999754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.3e-42  Score=331.25  Aligned_cols=273  Identities=25%  Similarity=0.322  Sum_probs=196.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc--hHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA--SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|+..  .+++.||+|++.......  .+.+.+|+.++++++||||+++++++.     ..
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   96 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNK--DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KK   96 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEET--TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             hhhheeeeEEeecCCEEEEEEEEC--CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cC
Confidence            467999999999999999999954  457889999986544322  356789999999999999999999964     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+++++|.+++..    ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        97 ~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg  169 (331)
T 4aaa_A           97 KRWYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFG  169 (331)
T ss_dssp             TEEEEEEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCC
Confidence            578999999999999887653    235899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      ++.......       .......|+..|+|||++.+. .++.++|||||||++|+|++|+.||....... .+.......
T Consensus       170 ~~~~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~  241 (331)
T 4aaa_A          170 FARTLAAPG-------EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID-QLYHIMMCL  241 (331)
T ss_dssp             TC-------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHH
T ss_pred             CceeecCCc-------cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHh
Confidence            997653321       112234689999999998775 78999999999999999999999997642211 111111100


Q ss_pred             --cchhhhhhc------CcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 --LPERLAEIV------DPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 --~~~~~~~~~------d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                        ..+......      +...........          ........++..+.+++.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          242 GNLIPRHQELFNKNPVFAGVRLPEIKERE----------PLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             CSCCHHHHHHHHHCGGGTTCCCCCCSSCC----------CHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCCChhhhhHhhhccccccccCccccccc----------hhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              000000000      000000000000          0000012346779999999999999999999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.9e-41  Score=355.48  Aligned_cols=250  Identities=24%  Similarity=0.300  Sum_probs=200.9

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeecc---CccchHHHHHHHHHHHcC-CCCCceeEeeeeeeecc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ---HRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDF  232 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  232 (484)
                      ..++|++.+.||+|+||.||+|+..  .+++.||||+++..   .....+.+..|..++..+ +||+|++++++     +
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~-----~  411 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERK--GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSC-----F  411 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEES--SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEE-----C
T ss_pred             cccceEEEEEEccCCCEEEEEEEEC--CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----E
Confidence            3467999999999999999999954  46788999999753   233456788999999988 79999999988     4


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                      ...+..++||||+++|+|.++++...    .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+
T Consensus       412 ~~~~~~~lV~E~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~  484 (674)
T 3pfq_A          412 QTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIA  484 (674)
T ss_dssp             BCSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEEC
T ss_pred             EeCCEEEEEEeCcCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEe
Confidence            55668999999999999999998543    4899999999999999999999   8999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||+++......       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+...
T Consensus       485 DFGla~~~~~~~-------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~~  552 (674)
T 3pfq_A          485 DFGMCKENIWDG-------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQ  552 (674)
T ss_dssp             CCTTCEECCCTT-------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHH
T ss_pred             ecceeeccccCC-------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHHH
Confidence            999998542221       123346799999999999999999999999999999999999999976321     11111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH-----HHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM-----EEVAA  461 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~evl~  461 (484)
                              .+....+..                     +.....++.+|+..||+.||++||++     +||++
T Consensus       553 --------~i~~~~~~~---------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          553 --------SIMEHNVAY---------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --------HHHSSCCCC---------------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --------HHHhCCCCC---------------------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                    111111110                     11225678999999999999999998     66653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-41  Score=332.95  Aligned_cols=284  Identities=19%  Similarity=0.185  Sum_probs=193.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeec-cCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVD-FQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~  234 (484)
                      .++|++.+.||+|+||.||+|+.  ..+++.||||++.....  ...+.+.+|+.+++.++||||+++++++.... ...
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYD--AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhheeEeeeeEecCCEEEEEEEE--CCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            46899999999999999999984  44678899999975432  23457889999999999999999999865432 122


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||++ ++|.+++.      ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus       102 ~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Df  171 (371)
T 2xrw_A          102 FQDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF  171 (371)
T ss_dssp             CCEEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             ccceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEe
Confidence            347899999995 57888885      23889999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |+++......        ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+.......
T Consensus       172 g~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~  242 (371)
T 2xrw_A          172 GLARTAGTSF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQL  242 (371)
T ss_dssp             CC------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-C
T ss_pred             eccccccccc--------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence            9998653221        1223568999999999999999999999999999999999999997642110 111111100


Q ss_pred             cc--hhhhhhcCccccc----ccccccchhh---hhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          395 LP--ERLAEIVDPVLLV----EREEGETSEA---NAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       395 ~~--~~~~~~~d~~l~~----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..  ......+.+.+..    .+........   ..............+..++.+|+.+||+.||++|||++|+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            00  0000000000000    0000000000   0000000000122346789999999999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.4e-42  Score=329.46  Aligned_cols=269  Identities=26%  Similarity=0.347  Sum_probs=183.5

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ...++|.+.+.||+|+||.||+|+  +..+++.||||++.... ....+.+.+|+.++++++||||+++++++.     .
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   84 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAY--CAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----V   84 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEE--C----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----S
T ss_pred             cchhhhhhhheeccccceEEEEEE--ECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----e
Confidence            345789999999999999999998  44457889999986543 233467889999999999999999999864     3


Q ss_pred             CceeeEEeecccCCCHHHHHhhcC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNR----DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH  310 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k  310 (484)
                      .+..++||||+++++|.+++....    .....+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+|
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~k  161 (303)
T 2vwi_A           85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQ  161 (303)
T ss_dssp             SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEE
T ss_pred             cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEE
Confidence            447899999999999999987421    12345899999999999999999999   88999999999999999999999


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhH
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHN  389 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~  389 (484)
                      |+|||.+..........  .........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...
T Consensus       162 l~dfg~~~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~  238 (303)
T 2vwi_A          162 IADFGVSAFLATGGDIT--RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-LML  238 (303)
T ss_dssp             ECCCHHHHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHH
T ss_pred             EEeccchheeccCCCcc--chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-HHH
Confidence            99999987664322110  1111233568999999998765 5689999999999999999999999976422111 000


Q ss_pred             HHHhhcchhhh-hhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          390 FVKEALPERLA-EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       390 ~~~~~~~~~~~-~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .... .+.... ...++..                       ...++..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~-~~~~~~~~~~~~~~-----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          239 TLQN-DPPSLETGVQDKEM-----------------------LKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHTS-SCCCTTC-----CC-----------------------CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             Hhcc-CCCccccccccchh-----------------------hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0000 000000 0000000                       1122557889999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.2e-41  Score=344.36  Aligned_cols=251  Identities=21%  Similarity=0.272  Sum_probs=193.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||+||+|+.  ..++..||+|++....  ......+.+|+.+++.++||||+++++++.     ...
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~  109 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRD--KVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKR  109 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEE--TTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cCeEEeeEEecCCCEEEEEEEE--CCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence            4689999999999999999994  4467889999997543  233567899999999999999999999964     455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC---CceEEcc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVSD  313 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~D  313 (484)
                      ..++||||+++|+|.+++....    .+++..++.++.||+.||+|||   +++|+||||||+||+++.+   +.+||+|
T Consensus       110 ~~~lv~e~~~~g~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  182 (494)
T 3lij_A          110 NYYLVMECYKGGELFDEIIHRM----KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVD  182 (494)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEE
Confidence            8899999999999999887543    4899999999999999999999   8999999999999999764   4599999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||++.......        ......||+.|+|||++. ..++.++||||+||++|+|++|+.||......     .....
T Consensus       183 fG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~  248 (494)
T 3lij_A          183 FGLSAVFENQK--------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-----EILRK  248 (494)
T ss_dssp             CTTCEECBTTB--------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHH
T ss_pred             CCCCeECCCCc--------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHH
Confidence            99998764321        122356999999999876 46999999999999999999999999763211     11111


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..        ........                 .....++..+.+++.+||+.||++|||+.|+++.
T Consensus       249 i~--------~~~~~~~~-----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          249 VE--------KGKYTFDS-----------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             HH--------HTCCCCCS-----------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HH--------hCCCCCCc-----------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            00        00000000                 0011235678899999999999999999999864

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1e-41  Score=346.31  Aligned_cols=251  Identities=25%  Similarity=0.332  Sum_probs=199.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||||++....   ....+.+.+|+.++++++||||+++++++.     ..
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~   98 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKD--KITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DK   98 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEE--TTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CS
T ss_pred             CceEEeeEEecCCCEEEEEEEE--CCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eC
Confidence            5689999999999999999984  4467899999997543   234577999999999999999999999953     45


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee---cCCCceEEc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL---DGELTAHVS  312 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~  312 (484)
                      ...++||||+.+|+|.+++...    ..+++..++.++.|++.||+|||   +++|+||||||+||++   +.++.+||+
T Consensus        99 ~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  171 (484)
T 3nyv_A           99 GYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRII  171 (484)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             CEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEE
Confidence            5889999999999999998743    35899999999999999999999   8999999999999999   567899999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||++.......        ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......     ....
T Consensus       172 Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~  237 (484)
T 3nyv_A          172 DFGLSTHFEASK--------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-----DILK  237 (484)
T ss_dssp             CTTHHHHBCCCC--------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH
T ss_pred             eeeeeEEccccc--------ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-----HHHH
Confidence            999998653221        1223469999999999876 6899999999999999999999999763211     1111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..        .........                 .....++.++.+++.+||+.||++|||+.|+++.
T Consensus       238 ~i--------~~~~~~~~~-----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          238 KV--------EKGKYTFEL-----------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             HH--------HHCCCCCCS-----------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HH--------HcCCCCCCC-----------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            10        000000000                 0012235678999999999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4.8e-41  Score=328.55  Aligned_cols=255  Identities=23%  Similarity=0.334  Sum_probs=198.8

Q ss_pred             HHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--------chHHHHHHHHHHHcC-CCCCceeEee
Q 011508          155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--------ASKSFIAECQALRSI-RHRNLVKIIT  225 (484)
Q Consensus       155 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~~~~  225 (484)
                      ....++|.+.+.||+|+||.||+|+..  .+++.||||++......        ..+.+.+|+.+++++ +||||+++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~--~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHR--ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEEC--CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            344567999999999999999999954  35788999999755421        134678999999999 8999999999


Q ss_pred             eeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC
Q 011508          226 SCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG  305 (484)
Q Consensus       226 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~  305 (484)
                      ++.     .....++||||+++++|.+++...    ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.
T Consensus       168 ~~~-----~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~  235 (365)
T 2y7j_A          168 SYE-----SSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDD  235 (365)
T ss_dssp             EEE-----BSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred             EEe-----eCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECC
Confidence            853     345889999999999999999753    34899999999999999999999   889999999999999999


Q ss_pred             CCceEEcccCcccccccccccCCCCccccccccccccccCccccC------CCCCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM------GSEVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       306 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                      ++.+||+|||++..+....        ......||+.|+|||++.      ...++.++|||||||++|||++|+.||..
T Consensus       236 ~~~ikl~DfG~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          236 NMQIRLSDFGFSCHLEPGE--------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             TCCEEECCCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CCCEEEEecCcccccCCCc--------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence            9999999999998764321        122356899999999875      33588999999999999999999999965


Q ss_pred             CccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHH
Q 011508          380 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEV  459 (484)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev  459 (484)
                      ....  .....+..           .......            +     ....++..+.+++.+||+.||++|||+.|+
T Consensus       308 ~~~~--~~~~~i~~-----------~~~~~~~------------~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~el  357 (365)
T 2y7j_A          308 RRQI--LMLRMIME-----------GQYQFSS------------P-----EWDDRSSTVKDLISRLLQVDPEARLTAEQA  357 (365)
T ss_dssp             SSHH--HHHHHHHH-----------TCCCCCH------------H-----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCHH--HHHHHHHh-----------CCCCCCC------------c-----ccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            3110  01000000           0000000            0     011225568899999999999999999999


Q ss_pred             HH
Q 011508          460 AA  461 (484)
Q Consensus       460 l~  461 (484)
                      ++
T Consensus       358 l~  359 (365)
T 2y7j_A          358 LQ  359 (365)
T ss_dssp             HH
T ss_pred             hc
Confidence            86

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.3e-41  Score=335.19  Aligned_cols=284  Identities=19%  Similarity=0.234  Sum_probs=201.5

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC--------CCCceeEeeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR--------HRNLVKIITSCVS  229 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~~  229 (484)
                      .++|++.+.||+|+||+||+|+.  ..+++.||||+++.. ....+.+.+|+.+++.++        |+||+++++++..
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWD--IQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEe--cCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            36799999999999999999984  446789999999743 233467889999999985        7889999998754


Q ss_pred             eccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCeeecCCC-
Q 011508          230 VDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCET-PIVHCDLKPSNVLLDGEL-  307 (484)
Q Consensus       230 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~NIll~~~~-  307 (484)
                      .. ......++||||+ +++|.+++....  ...+++..++.++.||+.||+|||   ++ +|+||||||+|||++.++ 
T Consensus       113 ~~-~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~  185 (397)
T 1wak_A          113 SG-VNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             EE-TTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHH
T ss_pred             cC-CCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccch
Confidence            32 2455789999999 677777775432  245899999999999999999999   77 999999999999998775 


Q ss_pred             ------------------------------------------------ceEEcccCcccccccccccCCCCccccccccc
Q 011508          308 ------------------------------------------------TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG  339 (484)
Q Consensus       308 ------------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g  339 (484)
                                                                      .+||+|||.+......          .....|
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----------~~~~~g  255 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----------FTEDIQ  255 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----------SCSCCS
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----------CccCCC
Confidence                                                            7999999999865322          122468


Q ss_pred             cccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccH-----hHHHH--hhcchhhh-------hhcCc
Q 011508          340 TVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL-----HNFVK--EALPERLA-------EIVDP  405 (484)
Q Consensus       340 ~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~-----~~~~~--~~~~~~~~-------~~~d~  405 (484)
                      |..|+|||++.+..++.++|||||||++|||+||+.||..........     .....  ...+....       +....
T Consensus       256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  335 (397)
T 1wak_A          256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK  335 (397)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred             CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence            999999999999899999999999999999999999997644332111     00100  00011000       00000


Q ss_pred             ccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          406 VLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       406 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .-.......................+.++...+.+|+.+||+.||++|||++|+++
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            00000000000000000000001113455788999999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.4e-41  Score=343.88  Aligned_cols=253  Identities=22%  Similarity=0.291  Sum_probs=196.7

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-------------cchHHHHHHHHHHHcCCCCCceeE
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-------------GASKSFIAECQALRSIRHRNLVKI  223 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~  223 (484)
                      ..++|.+.+.||+|+||+||+|+..  .++..||+|++.....             ...+.+.+|+.++++++||||+++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEK--NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEET--TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             cccceEEEeEecccCCeEEEEEEEC--CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            3467999999999999999999944  4678899999875431             234678899999999999999999


Q ss_pred             eeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 011508          224 ITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL  303 (484)
Q Consensus       224 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll  303 (484)
                      ++++.     .....++||||+++|+|.+++....    .+++..++.++.||+.||+|||   +++|+||||||+||++
T Consensus       112 ~~~~~-----~~~~~~lv~e~~~gg~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~  179 (504)
T 3q5i_A          112 FDVFE-----DKKYFYLVTEFYEGGELFEQIINRH----KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILL  179 (504)
T ss_dssp             EEEEE-----CSSEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             EEEEE-----cCCEEEEEEecCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEE
Confidence            99953     4558899999999999999987543    4899999999999999999999   8999999999999999


Q ss_pred             cCCC---ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          304 DGEL---TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       304 ~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      +.++   .+||+|||++.......        ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...
T Consensus       180 ~~~~~~~~~kl~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~  250 (504)
T 3q5i_A          180 ENKNSLLNIKIVDFGLSSFFSKDY--------KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ  250 (504)
T ss_dssp             SSTTCCSSEEECCCTTCEECCTTS--------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ecCCCCccEEEEECCCCEEcCCCC--------ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            8775   69999999998764321        1223469999999999874 6899999999999999999999999763


Q ss_pred             ccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHH
Q 011508          381 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVA  460 (484)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  460 (484)
                      ...     ......        ..........                 ....++.++.+++..||+.||.+|||++|++
T Consensus       251 ~~~-----~~~~~i--------~~~~~~~~~~-----------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l  300 (504)
T 3q5i_A          251 NDQ-----DIIKKV--------EKGKYYFDFN-----------------DWKNISDEAKELIKLMLTYDYNKRCTAEEAL  300 (504)
T ss_dssp             SHH-----HHHHHH--------HHCCCCCCHH-----------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             CHH-----HHHHHH--------HcCCCCCCcc-----------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            211     111110        0000000000                 0112356789999999999999999999998


Q ss_pred             HH
Q 011508          461 AQ  462 (484)
Q Consensus       461 ~~  462 (484)
                      +.
T Consensus       301 ~h  302 (504)
T 3q5i_A          301 NS  302 (504)
T ss_dssp             TS
T ss_pred             cC
Confidence            53

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-41  Score=332.14  Aligned_cols=288  Identities=22%  Similarity=0.236  Sum_probs=202.1

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ..++|.+.+.||+|+||.||+|+..  .+++.||||++..... .....+.+|+.++++++||||+++++++....+...
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHK--PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEEC--CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            3578999999999999999999854  4578999999964432 234568899999999999999999998765555556


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+. ++|.+++..     ..+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFG  157 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecc
Confidence            78899999995 699999874     24899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCC---CccccccccccccccCccccC-CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          316 LAKFLPEAANNLSS---NQSSSVGVKGTVGYAAPEYGM-GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       316 ~a~~~~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      ++............   .........||..|+|||++. +..++.++|||||||++|||++|+.||....... .+....
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~  236 (353)
T 2b9h_A          158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIF  236 (353)
T ss_dssp             TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH
T ss_pred             cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHH
Confidence            99876543211110   011123356899999999765 4678999999999999999999999997642111 011110


Q ss_pred             Hhhcchh----hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          392 KEALPER----LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       392 ~~~~~~~----~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .......    ...+...........     ...............++.++.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          237 GIIGTPHSDNDLRCIESPRAREYIKS-----LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHCCCCSTTTTTTCCCHHHHHHHHT-----SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhCCCchhccccccccchhhHHhhc-----ccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000000    000000000000000     0000000000001234667899999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.6e-41  Score=323.07  Aligned_cols=252  Identities=25%  Similarity=0.337  Sum_probs=196.2

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ..++|++.+.||+|+||.||+|+..  .+++.||+|++....  ..+.+.+|+.++++++||||+++++++..     +.
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~   97 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHK--ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NT   97 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEET--TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred             chhhhhhheeeccCCCeEEEEEEEC--CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CC
Confidence            4567999999999999999999854  457889999997543  34678999999999999999999998643     44


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++...   ...+++..++.++.|++.||+|||   +.+++|+||||+||+++.++.+||+|||.
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  171 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGV  171 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEeecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeeccc
Confidence            789999999999999999743   235899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.......       .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......     .....   
T Consensus       172 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~---  236 (314)
T 3com_A          172 AGQLTDTM-------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFM---  236 (314)
T ss_dssp             CEECBTTB-------SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHH---
T ss_pred             chhhhhhc-------cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHH---
Confidence            97653321       1122346899999999999989999999999999999999999999753211     00000   


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                        +.....+.+.                     .+..++..+.+++..||+.||.+|||+.|+++
T Consensus       237 --~~~~~~~~~~---------------------~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          237 --IPTNPPPTFR---------------------KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             --HHHSCCCCCS---------------------SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             --HhcCCCcccC---------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence              0000000000                     01223567899999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.7e-41  Score=329.35  Aligned_cols=291  Identities=21%  Similarity=0.223  Sum_probs=194.3

Q ss_pred             HHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-
Q 011508          154 LFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDF-  232 (484)
Q Consensus       154 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-  232 (484)
                      .....++|++.+.||+|+||.||+|+..  .++..||||++.... .....+.++++.+..++||||+++++++..... 
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEK--STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEET--TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            3456689999999999999999999954  457889999886543 233567788889999999999999999866442 


Q ss_pred             -CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-CCceE
Q 011508          233 -QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG-ELTAH  310 (484)
Q Consensus       233 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~-~~~~k  310 (484)
                       ....+.++||||+++ +|.+.+.........+++..+..++.|++.||+|||.. +++|+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEE
Confidence             223347899999965 66655554333455689999999999999999999943 689999999999999997 89999


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhH
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHN  389 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~  389 (484)
                      |+|||++.......        ......||..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+..
T Consensus       173 l~Dfg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~  243 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE--------PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA-GQLHE  243 (360)
T ss_dssp             ECCCTTCBCCCTTS--------CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred             EeeCCCceecCCCC--------CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH-HHHHH
Confidence            99999998764322        12234689999999988664 4899999999999999999999999764221 11222


Q ss_pred             HHHhhc--chhhhhhcCccccc-ccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          390 FVKEAL--PERLAEIVDPVLLV-EREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       390 ~~~~~~--~~~~~~~~d~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ......  +......+++.... +..........   ... ......+..++.+++.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWS---NVF-SDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHH---HHT-TTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHcCCCCHHHHHhcccchhhccccccccCCcc---ccc-chhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            221111  11111111111100 00000000000   000 00011236789999999999999999999999863

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=331.68  Aligned_cols=257  Identities=24%  Similarity=0.321  Sum_probs=198.8

Q ss_pred             CCCCccCccccccceeEEEEEEcC-CCCeeEEEEEEeeccC----ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeecc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDH-DDHETLVAVKVLNLQH----RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDF  232 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  232 (484)
                      ++|++.+.||+|+||.||+|+... ..+++.||||+++...    ....+.+.+|+++++++ +||||+++++++..   
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~---  130 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---  130 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE---
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee---
Confidence            578999999999999999998632 3467899999986432    12335677899999999 79999999998543   


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                        +...++||||+++|+|.+++....    .+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+
T Consensus       131 --~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~  201 (355)
T 1vzo_A          131 --ETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLT  201 (355)
T ss_dssp             --TTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEES
T ss_pred             --CceEEEEeecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEe
Confidence              447899999999999999997543    4899999999999999999999   8899999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCC--CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG--SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      |||+++......      ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||....... .....
T Consensus       202 DfG~a~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~  274 (355)
T 1vzo_A          202 DFGLSKEFVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEI  274 (355)
T ss_dssp             CSSEEEECCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHH
T ss_pred             eCCCCeecccCC------CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHH
Confidence            999998653322      112233569999999999875  357899999999999999999999997532221 11111


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHHH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQL  463 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~L  463 (484)
                      .......      .+..                       +.++...+.+++.+||+.||++||     |++|+++..
T Consensus       275 ~~~~~~~------~~~~-----------------------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          275 SRRILKS------EPPY-----------------------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHHHHC------CCCC-----------------------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHHHhcc------CCCC-----------------------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            1111000      0000                       122255688999999999999999     999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.6e-41  Score=326.61  Aligned_cols=252  Identities=25%  Similarity=0.306  Sum_probs=193.1

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--------cchHHHHHHHHHHHcCCCCCceeEeeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--------GASKSFIAECQALRSIRHRNLVKIITSCVS  229 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  229 (484)
                      .++|.+.+.||+|+||.||+|+..  .+++.||||++.....        .....+.+|++++++++||||+++++++. 
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   85 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFER--KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-   85 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             hhceeEeeEEecCCCEEEEEEEEc--CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc-
Confidence            357899999999999999999854  4578999999864321        12245789999999999999999999853 


Q ss_pred             eccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc-
Q 011508          230 VDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT-  308 (484)
Q Consensus       230 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~-  308 (484)
                          .+ ..++||||+++++|.+++..    ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++. 
T Consensus        86 ----~~-~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~  153 (322)
T 2ycf_A           86 ----AE-DYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEED  153 (322)
T ss_dssp             ----SS-SEEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSS
T ss_pred             ----CC-ceEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCC
Confidence                22 37999999999999999863    245899999999999999999999   899999999999999987654 


Q ss_pred             --eEEcccCcccccccccccCCCCccccccccccccccCcccc---CCCCCCcccceehhhHHHHHHHhCCCCCCCCccC
Q 011508          309 --AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYG---MGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG  383 (484)
Q Consensus       309 --~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~  383 (484)
                        +||+|||++.......        ......||..|+|||++   ....++.++|||||||++|+|++|+.||......
T Consensus       154 ~~~kl~Dfg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  225 (322)
T 2ycf_A          154 CLIKITDFGHSKILGETS--------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  225 (322)
T ss_dssp             CCEEECCCTTCEECCCCH--------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred             CeEEEccCccceeccccc--------ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence              9999999998653221        11234589999999986   3567899999999999999999999999764322


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      . .+...+.........+.                            ...++..+.+++.+||+.||++|||+.|+++
T Consensus       226 ~-~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          226 V-SLKDQITSGKYNFIPEV----------------------------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             S-CHHHHHHHTCCCCCHHH----------------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             H-HHHHHHHhCccccCchh----------------------------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1 12111111000000000                            1122567899999999999999999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=8.4e-42  Score=335.10  Aligned_cols=267  Identities=12%  Similarity=0.022  Sum_probs=182.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHH---HHHHcCCCCCceeEeeeee----
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAEC---QALRSIRHRNLVKIITSCV----  228 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~---~~l~~l~h~niv~~~~~~~----  228 (484)
                      ..|.+.+.||+|+||.||+|+..  .+++.||+|++.....   ...+.+.+|+   .+|+. +||||++++..+.    
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDV--ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEET--TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCE
T ss_pred             eeeeeeeeccCCCCEEEEEEEEC--CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeeh
Confidence            45888999999999999999954  3578999999987543   2235567774   45555 7999888653321    


Q ss_pred             ---eecc------------CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcC
Q 011508          229 ---SVDF------------QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR------LSIAVDVASTLEYLHHYC  287 (484)
Q Consensus       229 ---~~~~------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~  287 (484)
                         ....            ......++||||++ |+|.+++.....   .+++..+      +.++.||+.||+|||   
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH---  211 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQ---  211 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHH---
Confidence               1100            00145799999998 899999985421   2344455      778899999999999   


Q ss_pred             CCCeeecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCC--CCCCcccceehhhH
Q 011508          288 ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG--SEVSTSGDVYSFGI  365 (484)
Q Consensus       288 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gv  365 (484)
                      +++|+||||||+|||++.++.+||+|||+++......          ....+|+.|+|||++.+  ..++.++|||||||
T Consensus       212 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~  281 (371)
T 3q60_A          212 SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----------PASSVPVTYAPREFLNASTATFTHALNAWQLGL  281 (371)
T ss_dssp             HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHH
T ss_pred             HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc----------cCccCCcCCcChhhccCCCCCcCccccHHHHHH
Confidence            8999999999999999999999999999998653211          12346799999999987  67999999999999


Q ss_pred             HHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhcc
Q 011508          366 LLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVIC  445 (484)
Q Consensus       366 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c  445 (484)
                      ++|||++|+.||..........  +..    .............                   .....++..+.+++.+|
T Consensus       282 il~elltg~~Pf~~~~~~~~~~--~~~----~~~~~~~~~~~~~-------------------~~~~~~~~~~~~li~~~  336 (371)
T 3q60_A          282 SIYRVWCLFLPFGLVTPGIKGS--WKR----PSLRVPGTDSLAF-------------------GSCTPLPDFVKTLIGRF  336 (371)
T ss_dssp             HHHHHHHSSCSTTBCCTTCTTC--CCB----CCTTSCCCCSCCC-------------------TTSSCCCHHHHHHHHHH
T ss_pred             HHHHHHhCCCCCCCcCcccccc--hhh----hhhhhccccccch-------------------hhccCCCHHHHHHHHHH
Confidence            9999999999997653221100  000    0000000000000                   00123366789999999


Q ss_pred             CCCCcCCCCCHHHHHH--HHHHHHHHH
Q 011508          446 SSELPRERMNMEEVAA--QLLSFRNKL  470 (484)
Q Consensus       446 l~~dP~~RPt~~evl~--~L~~i~~~~  470 (484)
                      |+.||++|||+.|+++  .++++....
T Consensus       337 L~~dP~~Rpt~~e~l~hp~f~~~~~~~  363 (371)
T 3q60_A          337 LNFDRRRRLLPLEAMETPEFLQLQNEI  363 (371)
T ss_dssp             TCSSTTTCCCHHHHTTSHHHHHHHHHH
T ss_pred             cCCChhhCCCHHHHhcCHHHHHHHHHH
Confidence            9999999999999985  355555444

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.5e-41  Score=319.89  Aligned_cols=255  Identities=23%  Similarity=0.342  Sum_probs=197.5

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC----ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH----RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      .++|.+.+.||+|+||.||+|.  +..++..||+|+++...    ....+.+.+|++++++++||||+++++++..   .
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~   78 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVL--DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---E   78 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEE--BTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C
T ss_pred             ccceeEeeEEecCCCeEEEEEE--ECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---C
Confidence            3689999999999999999998  44567899999997542    2334678999999999999999999998642   3


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||++++ |.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|
T Consensus        79 ~~~~~~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~d  152 (305)
T 2wtk_C           79 EKQKMYMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISA  152 (305)
T ss_dssp             ---CEEEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             CCCeEEEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeec
Confidence            345789999999766 777776543  346899999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCC--CCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE--VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      ||.+........     ........|+..|+|||++.+..  ++.++||||||+++|||++|+.||....     .....
T Consensus       153 fg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~  222 (305)
T 2wtk_C          153 LGVAEALHPFAA-----DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----IYKLF  222 (305)
T ss_dssp             CTTCEECCTTCS-----SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHH
T ss_pred             cccccccCcccc-----ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----HHHHH
Confidence            999987643211     11222346899999999987643  4789999999999999999999997531     11111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ....        ......                     +..+...+.+++.+||+.||++|||+.|+++.
T Consensus       223 ~~i~--------~~~~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          223 ENIG--------KGSYAI---------------------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHH--------HCCCCC---------------------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHHh--------cCCCCC---------------------CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1100        000000                     12235678899999999999999999999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.7e-41  Score=332.67  Aligned_cols=276  Identities=21%  Similarity=0.240  Sum_probs=194.0

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-CCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDF-QGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  237 (484)
                      .+|++.+.||+|+||.||+|+...  ++. +|+|++.....    ...+|+++++.++||||+++++++..... .+..+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~--~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~  112 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVE--SDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF  112 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETT--TEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECC--CCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence            568999999999999999998643  333 88887754322    22369999999999999999999866542 33445


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCCceEEcccCc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD-GELTAHVSDFGL  316 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfg~  316 (484)
                      .++||||++++ +.+.+.........+++..++.++.||+.||+|||   +++|+||||||+||+++ .++.+||+|||+
T Consensus       113 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~  188 (394)
T 4e7w_A          113 LNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGS  188 (394)
T ss_dssp             EEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence            78999999764 44444332223456999999999999999999999   89999999999999999 789999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++......        ......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... ..+........
T Consensus       189 a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g  259 (394)
T 4e7w_A          189 AKILIAGE--------PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLG  259 (394)
T ss_dssp             CEECCTTC--------CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred             cccccCCC--------CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhC
Confidence            98763322        12234689999999988764 5899999999999999999999999764221 11122221111


Q ss_pred             ch---hhhhhcCccccc-ccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 PE---RLAEIVDPVLLV-EREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~~---~~~~~~d~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..   .+... ++.... .......  .    + ........++.++.+|+.+||+.||++|||+.|+++.
T Consensus       260 ~p~~~~~~~~-~~~~~~~~~~~~~~--~----~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          260 TPSREQIKTM-NPNYMEHKFPQIRP--H----P-FSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             CCCHHHHHHH-CGGGSSSCCCCCCC--C----C-HHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHhh-ChhhhhhccccccC--C----c-HHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            00   01111 111000 0000000  0    0 0000012235679999999999999999999999863

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.9e-41  Score=338.31  Aligned_cols=199  Identities=25%  Similarity=0.372  Sum_probs=167.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC------CCCCceeEeeeeeeec
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI------RHRNLVKIITSCVSVD  231 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~  231 (484)
                      ..+|++.+.||+|+||.||+|+.  ..+++.||||+++... .....+.+|+.+++.+      +|+||+++++++..  
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~--~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYD--HKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEE--TTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--
T ss_pred             cCcEEEEEEcccCccEEEEEEEE--CCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--
Confidence            46799999999999999999984  4457899999997532 2345677888888877      57799999998643  


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc--e
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT--A  309 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~--~  309 (484)
                         ....++||||+. ++|.+++....  ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.  +
T Consensus       171 ---~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~v  241 (429)
T 3kvw_A          171 ---RNHICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGI  241 (429)
T ss_dssp             ---TTEEEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCE
T ss_pred             ---CCeEEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcce
Confidence               348899999994 79999997543  234899999999999999999999   889999999999999999887  9


Q ss_pred             EEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          310 HVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      ||+|||++......          .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       242 kL~DFG~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          242 KVIDFGSSCYEHQR----------VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             EECCCTTCEETTCC----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEeecccceecCCc----------ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            99999999754221          12346899999999999989999999999999999999999999764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.8e-42  Score=334.87  Aligned_cols=279  Identities=19%  Similarity=0.221  Sum_probs=184.9

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeec-cC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVD-FQ  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~  233 (484)
                      ..++|++.+.||+|+||.||+|..  ..+++.||||++.....  ...+.+.+|+++++.++||||+++++++.... ..
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFD--TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEE--TTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred             CCCceEEeeEEeecCCeEEEEEEE--CCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence            457899999999999999999984  44678999999865432  23467889999999999999999999875421 12


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++|+|++ +++|.+++..     ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus       105 ~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~D  175 (367)
T 2fst_X          105 EFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD  175 (367)
T ss_dssp             GCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEee
Confidence            235679999999 7899998863     35899999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||+++.....          .....||..|+|||++.+ ..++.++||||+||++|||++|+.||.+.... ..+.....
T Consensus       176 FG~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~  244 (367)
T 2fst_X          176 FGLARHTADE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILR  244 (367)
T ss_dssp             -------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred             cccccccccc----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence            9999865321          123468999999999876 67899999999999999999999999764211 11111111


Q ss_pred             hhcc--hh-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALP--ER-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~--~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ....  .. +..+....... ...    .........-......+...+.+|+.+||+.||++|||+.|+++.
T Consensus       245 ~~g~p~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          245 LVGTPGAELLKKISSESARN-YIQ----SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHCSCCHHHHTTCCCHHHHH-HHH----TSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCCHHHHHHhhhHHHHH-HHh----ccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            1000  00 11100000000 000    000000000000011225678999999999999999999999863

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.2e-41  Score=353.87  Aligned_cols=263  Identities=22%  Similarity=0.367  Sum_probs=205.0

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ..++|++.+.||+|+||.||+|++... ..+..||+|.++.... ...+.+.+|+.++++++||||+++++++.      
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------  461 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------  461 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe------
Confidence            345688889999999999999987543 2357899999875433 23367899999999999999999999852      


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ++..++||||+++|+|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+||
T Consensus       462 ~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DF  535 (656)
T 2j0j_A          462 ENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDF  535 (656)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             cCceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEec
Confidence            235789999999999999997432   35899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |+++.......      .......+++.|+|||++.+..++.++|||||||++|||++ |..||......     +....
T Consensus       536 G~a~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~~~~~  604 (656)
T 2j0j_A          536 GLSRYMEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----DVIGR  604 (656)
T ss_dssp             CCCCSCCC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHH
T ss_pred             CCCeecCCCcc------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----HHHHH
Confidence            99987643221      11122346789999999988899999999999999999997 99999753211     11110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      .     ..-....                       .+..++..+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus       605 i-----~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          605 I-----ENGERLP-----------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             H-----HHTCCCC-----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             H-----HcCCCCC-----------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            0     0000000                       02234667899999999999999999999999999987653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8.6e-41  Score=317.94  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=198.7

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---------cchHHHHHHHHHHHcCC-CCCceeEeee
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---------GASKSFIAECQALRSIR-HRNLVKIITS  226 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~  226 (484)
                      ..++|.+.+.||+|+||.||+|+.  ..+++.||+|+++....         ...+.+.+|+++++++. ||||++++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIH--KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT   92 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEE--cCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence            347899999999999999999995  44678999999975431         12356789999999995 9999999998


Q ss_pred             eeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC
Q 011508          227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE  306 (484)
Q Consensus       227 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~  306 (484)
                      +     ..+...++||||+++++|.+++...    ..+++..++.++.|++.||+|||   +++|+||||||+||+++.+
T Consensus        93 ~-----~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~  160 (298)
T 1phk_A           93 Y-----ETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDD  160 (298)
T ss_dssp             E-----ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTT
T ss_pred             e-----ccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCC
Confidence            5     3455889999999999999999754    35899999999999999999999   8999999999999999999


Q ss_pred             CceEEcccCcccccccccccCCCCccccccccccccccCccccC------CCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          307 LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM------GSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       307 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      +.+||+|||.+.......        ......++..|+|||++.      ...++.++||||||+++|+|++|+.||...
T Consensus       161 ~~~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  232 (298)
T 1phk_A          161 MNIKLTDFGFSCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR  232 (298)
T ss_dssp             CCEEECCCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CcEEEecccchhhcCCCc--------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence            999999999998654321        122346899999999874      456889999999999999999999999653


Q ss_pred             ccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHH
Q 011508          381 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVA  460 (484)
Q Consensus       381 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  460 (484)
                      ..     .......        .........                 .....++..+.+++.+||+.||++|||+.|++
T Consensus       233 ~~-----~~~~~~~--------~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  282 (298)
T 1phk_A          233 KQ-----MLMLRMI--------MSGNYQFGS-----------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL  282 (298)
T ss_dssp             SH-----HHHHHHH--------HHTCCCCCT-----------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred             cH-----HHHHHHH--------hcCCcccCc-----------------ccccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence            11     1111100        000000000                 00122356789999999999999999999997


Q ss_pred             H
Q 011508          461 A  461 (484)
Q Consensus       461 ~  461 (484)
                      +
T Consensus       283 ~  283 (298)
T 1phk_A          283 A  283 (298)
T ss_dssp             T
T ss_pred             h
Confidence            5

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.5e-40  Score=320.54  Aligned_cols=282  Identities=22%  Similarity=0.262  Sum_probs=203.6

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcC---CCCCceeEeeeeeee
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSI---RHRNLVKIITSCVSV  230 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~  230 (484)
                      ...++|++.+.||+|+||.||+|+.. ..+++.||+|+++....  .....+.+|+.+++.+   +||||+++++++...
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDL-KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEET-TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEec-CCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            45578999999999999999999853 23568899999875432  2234566777777766   899999999998654


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceE
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAH  310 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~k  310 (484)
                      ........++||||++ |+|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           87 RTDRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             ECSSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             ccCCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEE
Confidence            4445668899999996 69999997543  234899999999999999999999   89999999999999999999999


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      |+|||++.......        ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... .+...
T Consensus       161 l~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i  231 (326)
T 1blx_A          161 LADFGLARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKI  231 (326)
T ss_dssp             ECSCCSCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHH
T ss_pred             EecCcccccccCCC--------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHH
Confidence            99999998654321        1223468999999999999899999999999999999999999997642211 11111


Q ss_pred             HHhhcchhhhhhcCc-ccccc-cccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          391 VKEALPERLAEIVDP-VLLVE-REEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~-~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ...........+... ..... .....        ..........++..+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          232 LDVIGLPGEEDWPRDVALPRQAFHSKS--------AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHCCCCGGGSCTTCSSCGGGSCCCC--------CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHcCCCCcccCccccccchhhhcccC--------cchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111000000000000 00000 00000        00000001233567899999999999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.9e-41  Score=321.40  Aligned_cols=279  Identities=19%  Similarity=0.255  Sum_probs=195.5

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeec------
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVD------  231 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  231 (484)
                      .++|.+.+.||+|+||.||+|+..  .+++.||+|++........+.+.+|++++++++||||+++++++....      
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDN--DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEET--TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEEC--CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            467999999999999999999954  457899999998766555678899999999999999999999863211      


Q ss_pred             ---cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-CCC
Q 011508          232 ---FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD-GEL  307 (484)
Q Consensus       232 ---~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~-~~~  307 (484)
                         .......++||||++ |+|.+++..     ..+++..++.++.|++.||+|||   +++|+||||||+||+++ +++
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTT
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCC
Confidence               234467899999996 699999863     34889999999999999999999   89999999999999997 567


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCcc
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLT  386 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~  386 (484)
                      .+||+|||++.........    ........++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~  233 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSH----KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-Q  233 (320)
T ss_dssp             EEEECCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred             eEEEccCccccccCCCccc----ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-H
Confidence            9999999999876432111    111223457899999998755 678999999999999999999999997642211 1


Q ss_pred             HhHHHHhhcch----hhhhhcCc---ccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHH
Q 011508          387 LHNFVKEALPE----RLAEIVDP---VLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEV  459 (484)
Q Consensus       387 ~~~~~~~~~~~----~~~~~~d~---~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev  459 (484)
                      ...... ..+.    ...++.+.   .+.........       +  .......++.++.+++.+||+.||++|||++|+
T Consensus       234 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  303 (320)
T 2i6l_A          234 MQLILE-SIPVVHEEDRQELLSVIPVYIRNDMTEPHK-------P--LTQLLPGISREAVDFLEQILTFSPMDRLTAEEA  303 (320)
T ss_dssp             HHHHHH-HSCCCCHHHHHHHHTTSCHHHHHHTTSCCC-------C--HHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             HHHHHH-hcCCCchhhhhhhhhcCcccccccccCCCC-------C--hhHhcchhhHHHHHHHHHHcCCCccccCCHHHH
Confidence            111111 1100    00111000   00000000000       0  000012236678999999999999999999999


Q ss_pred             HHH
Q 011508          460 AAQ  462 (484)
Q Consensus       460 l~~  462 (484)
                      ++.
T Consensus       304 l~h  306 (320)
T 2i6l_A          304 LSH  306 (320)
T ss_dssp             HTS
T ss_pred             hCC
Confidence            863

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3e-41  Score=328.37  Aligned_cols=264  Identities=20%  Similarity=0.294  Sum_probs=199.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc-----------------hHHHHHHHHHHHcCCCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA-----------------SKSFIAECQALRSIRHRNL  220 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~ni  220 (484)
                      .++|.+.+.||+|+||.||+|..    +++.||+|++.......                 .+.+.+|+.++++++||||
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i  105 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK----DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC  105 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE----TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc----CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence            46899999999999999999985    57899999997542211                 1789999999999999999


Q ss_pred             eeEeeeeeeeccCCCceeeEEeecccCCCHHHH------HhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeee
Q 011508          221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEW------LHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCE-TPIVH  293 (484)
Q Consensus       221 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH  293 (484)
                      +++++++.     ..+..++||||+++++|.++      +..  .....+++..++.++.|++.||+|||   + ++|+|
T Consensus       106 ~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H  175 (348)
T 2pml_X          106 LTCEGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICH  175 (348)
T ss_dssp             CCCSEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEEC
T ss_pred             ceEEEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEee
Confidence            99999964     34588999999999999998      442  12456999999999999999999999   7 99999


Q ss_pred             cCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCC-CCCc-ccceehhhHHHHHHH
Q 011508          294 CDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVST-SGDVYSFGILLLEMF  371 (484)
Q Consensus       294 ~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dvws~Gvvl~ell  371 (484)
                      |||||+||+++.++.+||+|||.+......         ......|+..|+|||.+.+. .++. ++||||||+++|||+
T Consensus       176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~  246 (348)
T 2pml_X          176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK---------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF  246 (348)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECBTT---------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHH
T ss_pred             cCCChHhEEEcCCCcEEEeccccccccccc---------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHH
Confidence            999999999999999999999999865322         12234689999999998877 6666 999999999999999


Q ss_pred             hCCCCCCCCccCCccHhHHHHhh-c--chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCC
Q 011508          372 TGKGPTNEMFTGNLTLHNFVKEA-L--PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSE  448 (484)
Q Consensus       372 tg~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~  448 (484)
                      +|+.||....... .+...+... .  +........+..                ..........++.++.+++.+||+.
T Consensus       247 ~g~~pf~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~~L~~  309 (348)
T 2pml_X          247 YNVVPFSLKISLV-ELFNNIRTKNIEYPLDRNHFLYPLT----------------NKKSTCSNNFLSNEDIDFLKLFLRK  309 (348)
T ss_dssp             HSSCSSCCSSCSH-HHHHHHTSCCCCCCCSSSSSTTTTC----------------C--------CCCHHHHHHHHHHCCS
T ss_pred             hCCCCCCCCCcHH-HHHHHHhccCcCCccchhhhhcccc----------------ccccccchhhcCHHHHHHHHHHccC
Confidence            9999997643211 111111100 0  000000000000                0000000123356789999999999


Q ss_pred             CcCCCCCHHHHHH
Q 011508          449 LPRERMNMEEVAA  461 (484)
Q Consensus       449 dP~~RPt~~evl~  461 (484)
                      ||++|||+.|+++
T Consensus       310 dP~~Rps~~e~l~  322 (348)
T 2pml_X          310 NPAERITSEDALK  322 (348)
T ss_dssp             SGGGSCCHHHHHT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=327.13  Aligned_cols=266  Identities=23%  Similarity=0.303  Sum_probs=196.7

Q ss_pred             HHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       155 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      ....++|++.+.||+|+||.||+|...     ..+|+|+++....  ...+.+.+|+.++++++||||+++++++..   
T Consensus        29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---  100 (319)
T 2y4i_B           29 DIPFEQLEIGELIGKGRFGQVYHGRWH-----GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS---  100 (319)
T ss_dssp             SSCCSCEECCCBCCCSSSSEEEEEEES-----SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC---
T ss_pred             cCCHHHeEEeeEeccCCceEEEEEEEc-----CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec---
Confidence            345678999999999999999999864     2499999875432  233567889999999999999999999643   


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                        ....++||||+++++|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++ ++.+||+
T Consensus       101 --~~~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B          101 --PPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             --SSCEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEEC
T ss_pred             --CCceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEe
Confidence              44789999999999999999743   345889999999999999999999   88999999999999998 6799999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCC---------CCCCcccceehhhHHHHHHHhCCCCCCCCccC
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG---------SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTG  383 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~  383 (484)
                      |||++.........  ..........|+..|+|||++..         ..++.++||||||+++|||++|+.||......
T Consensus       172 Dfg~~~~~~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~  249 (319)
T 2y4i_B          172 DFGLFSISGVLQAG--RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE  249 (319)
T ss_dssp             CCSCCC------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH
T ss_pred             ecCCcccccccccc--ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99998765322111  11122233458999999998764         45788999999999999999999999753211


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                           ......     ..-..+...                      ...++.++.+++..||+.||++|||+.|+++.|
T Consensus       250 -----~~~~~~-----~~~~~~~~~----------------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l  297 (319)
T 2y4i_B          250 -----AIIWQM-----GTGMKPNLS----------------------QIGMGKEISDILLFCWAFEQEERPTFTKLMDML  297 (319)
T ss_dssp             -----HHHHHH-----HTTCCCCCC----------------------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred             -----HHHHHh-----ccCCCCCCC----------------------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence                 111110     000111100                      011244688999999999999999999999999


Q ss_pred             HHHHHHHh
Q 011508          464 LSFRNKLV  471 (484)
Q Consensus       464 ~~i~~~~~  471 (484)
                      +.+.....
T Consensus       298 ~~l~~~~~  305 (319)
T 2y4i_B          298 EKLPKRNR  305 (319)
T ss_dssp             TTC-----
T ss_pred             HHHHHhhc
Confidence            99887653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.8e-41  Score=328.93  Aligned_cols=279  Identities=18%  Similarity=0.202  Sum_probs=195.4

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--chHHHHHHHHHHHcCCCCCceeEeeeeeeeccC-
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ-  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-  233 (484)
                      ..++|.+.+.||+|+||.||+|+.  ..+++.||+|++......  ..+.+.+|+.+++.++||||+++++++...+.. 
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAID--KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred             ccccEEEEeEEecCCCeEEEEEEE--CCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence            346899999999999999999984  446789999999754322  246788999999999999999999987543211 


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||+. ++|.+++.      ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~D  187 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILD  187 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECS
T ss_pred             cceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEe
Confidence            1113489999996 68888774      23899999999999999999999   88999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||+++.....          .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.....
T Consensus       188 fg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~  256 (371)
T 4exu_A          188 FGLARHADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILK  256 (371)
T ss_dssp             TTCC------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHH
T ss_pred             cCcccccccC----------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHH
Confidence            9999865322          123468999999998877 678999999999999999999999997632111 1111111


Q ss_pred             hhc--chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EAL--PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ...  +......+..........    ................+...+.+++.+||+.||++|||+.|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          257 VTGVPGTEFVQKLNDKAAKSYIQ----SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHCCCCHHHHTTCSCHHHHHHHH----HSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhCCCcHHHHHHhhhhhhhhhhh----ccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            000  000111000000000000    000000000000012235678999999999999999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.3e-41  Score=323.18  Aligned_cols=263  Identities=24%  Similarity=0.367  Sum_probs=195.2

Q ss_pred             ccccHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCC--CCCcee
Q 011508          147 LRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIR--HRNLVK  222 (484)
Q Consensus       147 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~  222 (484)
                      ..++++.+....++|++.+.||+|+||.||+|...   +++.||+|++.....  ...+.+.+|++++.+++  |+||++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~   92 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE---KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR   92 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECT---TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC---CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence            34455555566678999999999999999999853   477899999975432  23467899999999997  599999


Q ss_pred             EeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 011508          223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVL  302 (484)
Q Consensus       223 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIl  302 (484)
                      +++++.     .+...++||| +.+++|.+++...    ..+++..++.++.|++.||+|||   +++|+||||||+||+
T Consensus        93 ~~~~~~-----~~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl  159 (313)
T 3cek_A           93 LYDYEI-----TDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFL  159 (313)
T ss_dssp             EEEEEE-----CSSEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEE
T ss_pred             EEEEee-----cCCEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEE
Confidence            999864     3447899999 5588999999753    35899999999999999999999   889999999999999


Q ss_pred             ecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCC-----------CCCCcccceehhhHHHHHHH
Q 011508          303 LDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-----------SEVSTSGDVYSFGILLLEMF  371 (484)
Q Consensus       303 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dvws~Gvvl~ell  371 (484)
                      +++ +.+||+|||++........     ........|++.|+|||++.+           ..++.++||||||+++|||+
T Consensus       160 ~~~-~~~kL~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~  233 (313)
T 3cek_A          160 IVD-GMLKLIDFGIANQMQPDTT-----SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT  233 (313)
T ss_dssp             EET-TEEEECCCSSSCC-------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHH
T ss_pred             EEC-CeEEEeeccccccccCccc-----cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHH
Confidence            975 7999999999987643221     111123468999999998765           46888999999999999999


Q ss_pred             hCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcC
Q 011508          372 TGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPR  451 (484)
Q Consensus       372 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~  451 (484)
                      +|+.||.........            ...++++......                   +..+...+.+++.+||+.||+
T Consensus       234 ~g~~pf~~~~~~~~~------------~~~~~~~~~~~~~-------------------~~~~~~~l~~li~~~l~~dp~  282 (313)
T 3cek_A          234 YGKTPFQQIINQISK------------LHAIIDPNHEIEF-------------------PDIPEKDLQDVLKCCLKRDPK  282 (313)
T ss_dssp             HSSCTTTTCCSHHHH------------HHHHHCTTSCCCC-------------------CCCSCHHHHHHHHHHTCSSTT
T ss_pred             hCCCchhhHHHHHHH------------HHHHHhcccccCC-------------------cccchHHHHHHHHHHccCCcc
Confidence            999999653221110            1111111111100                   111245688999999999999


Q ss_pred             CCCCHHHHHHH
Q 011508          452 ERMNMEEVAAQ  462 (484)
Q Consensus       452 ~RPt~~evl~~  462 (484)
                      +|||+.|+++.
T Consensus       283 ~Rps~~ell~h  293 (313)
T 3cek_A          283 QRISIPELLAH  293 (313)
T ss_dssp             TSCCHHHHHTS
T ss_pred             cCcCHHHHhcC
Confidence            99999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=9.7e-41  Score=327.97  Aligned_cols=283  Identities=19%  Similarity=0.247  Sum_probs=199.1

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-----------CCCceeEeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-----------HRNLVKIITS  226 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~  226 (484)
                      .++|.+.+.||+|+||.||+|+.  ..+++.||||++... ....+.+.+|+.++++++           |+||++++++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKD--MVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEe--cCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            36799999999999999999984  346789999998743 223467889999999886           8999999998


Q ss_pred             eeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCeeec-
Q 011508          227 CVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCET-PIVHCDLKPSNVLLD-  304 (484)
Q Consensus       227 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~NIll~-  304 (484)
                      +...+ .+....++||||+ +++|.+++....  ...+++..++.++.||+.||+|||   ++ +|+||||||+||+++ 
T Consensus        95 ~~~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           95 FNHKG-PNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEI  167 (373)
T ss_dssp             EEEEE-TTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEE
T ss_pred             hhccC-CCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEec
Confidence            76543 2344789999999 999999998543  234899999999999999999999   77 999999999999994 


Q ss_pred             -----CCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCC
Q 011508          305 -----GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE  379 (484)
Q Consensus       305 -----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~  379 (484)
                           ..+.+||+|||++......          .....||+.|+|||++.+..++.++|||||||++|||+||+.||..
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  237 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  237 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             cCCCcCcceEEEcccccccccCCC----------CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence                 3448999999999866322          1223689999999999999999999999999999999999999976


Q ss_pred             CccCCc-----cHhHHHHh--hcchhh-------hhhcCcc-cccccccccchhhhhhhccccccchhHHHHHHHhHhhc
Q 011508          380 MFTGNL-----TLHNFVKE--ALPERL-------AEIVDPV-LLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVI  444 (484)
Q Consensus       380 ~~~~~~-----~~~~~~~~--~~~~~~-------~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~  444 (484)
                      ......     .+......  ..+...       ....+.. .............. .........+..+..++.+|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~  316 (373)
T 1q8y_A          238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE-DVLTEKYKFSKDEAKEISDFLSP  316 (373)
T ss_dssp             -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH-HHHHHTTCCCHHHHHHHHHHHGG
T ss_pred             CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchh-hhhhhcccCCcchHHHHHHHHHH
Confidence            432111     11111110  001000       0000000 00000000000000 00000011234567889999999


Q ss_pred             cCCCCcCCCCCHHHHHH
Q 011508          445 CSSELPRERMNMEEVAA  461 (484)
Q Consensus       445 cl~~dP~~RPt~~evl~  461 (484)
                      ||+.||++|||++|+++
T Consensus       317 ~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          317 MLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             GGCSSTTTCBCHHHHHT
T ss_pred             HhccCccccCCHHHHhh
Confidence            99999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.7e-40  Score=312.79  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=197.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|+..  .+++.||+|++....  ....+.+.+|++++++++||||+++++++.     ..
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~--~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   93 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDR--ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DS   93 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEc--CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CC
Confidence            467999999999999999999853  457889999987543  234568899999999999999999999854     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC---CceEEc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVS  312 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~  312 (484)
                      ...++||||+++++|.+++....    .+++..++.++.|++.||+|||   +++|+||||||+||+++.+   +.+||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~  166 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKRK----RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKII  166 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CeEEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEe
Confidence            57899999999999999887543    4899999999999999999999   8899999999999999754   479999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||++.......        ......++..|+|||.+.+ .++.++||||||+++|+|++|+.||......     ....
T Consensus       167 Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~  232 (287)
T 2wei_A          167 DFGLSTCFQQNT--------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-----DILK  232 (287)
T ss_dssp             STTGGGTBCCCS--------SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHH
T ss_pred             ccCcceeecCCC--------ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-----HHHH
Confidence            999988653321        1122358899999998876 4899999999999999999999999753211     1111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ...        ........            +     ....++.++.+++.+||+.||++|||+.|+++.
T Consensus       233 ~~~--------~~~~~~~~------------~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          233 RVE--------TGKYAFDL------------P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             HHH--------HCCCCCCS------------G-----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHH--------cCCCCCCc------------h-----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            100        00000000            0     011235678999999999999999999999873

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.1e-40  Score=320.44  Aligned_cols=259  Identities=20%  Similarity=0.236  Sum_probs=174.1

Q ss_pred             hcCCCCccC-ccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          157 ATDGFSLEN-LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       157 ~~~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ..++|.+.+ .||+|+||.||+|+..  .+++.||+|++....    ....+....++.++||||+++++++.... .++
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~--~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~   98 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHR--RTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMH-HGK   98 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEEC--CCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCC
Confidence            346788855 6999999999999954  457899999986431    22223333456679999999999875532 334


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEEc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVS  312 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~  312 (484)
                      ...++||||+++|+|.+++....  ...+++.+++.++.|++.||+|||   +++|+||||||+||+++.   ++.+||+
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEe
Confidence            56899999999999999998543  246999999999999999999999   889999999999999976   4569999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||++......         ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||........... . .
T Consensus       174 Dfg~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~-~  242 (336)
T 3fhr_A          174 DFGFAKETTQN---------ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-M-K  242 (336)
T ss_dssp             CCTTCEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred             ccccceecccc---------ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-H-H
Confidence            99999765322         11234589999999999888999999999999999999999999965422211000 0 0


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                             ..+.......                 .......++.++.+++.+||+.||++|||+.|+++.
T Consensus       243 -------~~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          243 -------RRIRLGQYGF-----------------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ---------------CC-----------------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -------Hhhhcccccc-----------------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                   0000000000                 000012235678999999999999999999999874

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.8e-41  Score=322.60  Aligned_cols=258  Identities=22%  Similarity=0.268  Sum_probs=176.1

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHH-HHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQ-ALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|.+.+.||+|+||.||+|...  .+++.||||+++.... .....+..|+. +++.++||||+++++++..     +
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~   93 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHK--PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----E   93 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEET--TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----S
T ss_pred             HHHhhehheeccCCCEEEEEEEEc--CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----C
Confidence            367899999999999999999953  4578999999976533 22345566666 6777899999999999643     4


Q ss_pred             ceeeEEeecccCCCHHHHHhhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCeeecCCCceEEcc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNR-DAPRNLNLLQRLSIAVDVASTLEYLHHYCET-PIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      +..++||||++ ++|.+++.... .....+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~D  169 (327)
T 3aln_A           94 GDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCD  169 (327)
T ss_dssp             SEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECC
T ss_pred             CceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEcc
Confidence            47899999996 48888776321 12346899999999999999999999   77 999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCcccc----CCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYG----MGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHN  389 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~  389 (484)
                      ||++.......        ......||..|+|||++    .+..++.++||||||+++|||++|+.||.........   
T Consensus       170 fg~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---  238 (327)
T 3aln_A          170 FGISGQLVDSI--------AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---  238 (327)
T ss_dssp             CSSSCC--------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------
T ss_pred             CCCceeccccc--------ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---
Confidence            99998663321        11223589999999998    4567899999999999999999999999753211000   


Q ss_pred             HHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          390 FVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                               +..+.......                ........++..+.+++..||+.||++|||+.|+++.
T Consensus       239 ---------~~~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          239 ---------LTQVVKGDPPQ----------------LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             ----------CCCCCSCCCC----------------CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ---------HHHHhcCCCCC----------------CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence                     00111000000                0000011235678999999999999999999999863

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.1e-40  Score=319.00  Aligned_cols=280  Identities=20%  Similarity=0.261  Sum_probs=200.5

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCC------ceeEeeeeeeec
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN------LVKIITSCVSVD  231 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~  231 (484)
                      .++|++.+.||+|+||.||+|... ..+++.||+|+++.. ....+.+.+|+++++.++|++      ++++++++.   
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~---   87 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDH-KAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE---   87 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET-TTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE---
T ss_pred             cCceEEEEEEecCCCeEEEEEEec-CCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc---
Confidence            468999999999999999999852 335789999998643 233467889999999886654      899999854   


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC------
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG------  305 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~------  305 (484)
                        ..+..++||||+ +++|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+||+++.      
T Consensus        88 --~~~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~  159 (339)
T 1z57_A           88 --HHGHICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEA  159 (339)
T ss_dssp             --ETTEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEE
T ss_pred             --cCCcEEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccc
Confidence              345889999999 899999997543  235889999999999999999999   899999999999999987      


Q ss_pred             -------------CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh
Q 011508          306 -------------ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT  372 (484)
Q Consensus       306 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt  372 (484)
                                   ++.+||+|||++......          .....||..|+|||++.+..++.++|||||||++|||++
T Consensus       160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  229 (339)
T 1z57_A          160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH----------HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL  229 (339)
T ss_dssp             EC----CEEEEESCCCEEECCCSSCEETTSC----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred             cCCccccccccccCCCceEeeCcccccCccc----------cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence                         668999999999864321          123468999999999999899999999999999999999


Q ss_pred             CCCCCCCCccCCccHhHHHHh---hcchhh-hhhcCcccccccccccc--hhh------hhhhccccccchhHHHHHHHh
Q 011508          373 GKGPTNEMFTGNLTLHNFVKE---ALPERL-AEIVDPVLLVEREEGET--SEA------NAHKQRTRSFGGKECLVSVLG  440 (484)
Q Consensus       373 g~~p~~~~~~~~~~~~~~~~~---~~~~~~-~~~~d~~l~~~~~~~~~--~~~------~~~~~~~~~~~~~~~~~~l~~  440 (484)
                      |+.||.......  ....+..   ..+... .................  ...      ..............+...+.+
T Consensus       230 g~~pf~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  307 (339)
T 1z57_A          230 GFTVFPTHDSKE--HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFD  307 (339)
T ss_dssp             SSCSCCCSCHHH--HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred             CCCCCCCCChHH--HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHH
Confidence            999997542211  1111111   111111 10000000000000000  000      000000001113345788999


Q ss_pred             HhhccCCCCcCCCCCHHHHHHH
Q 011508          441 IGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       441 l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ++.+||+.||++|||+.|+++.
T Consensus       308 li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          308 LIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             HHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHHHhCcCcccccCHHHHhcC
Confidence            9999999999999999999853

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=3.8e-40  Score=314.04  Aligned_cols=264  Identities=22%  Similarity=0.306  Sum_probs=191.5

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeec------
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVD------  231 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  231 (484)
                      .++|++.+.||+|+||.||+|+.  ..+++.||+|++... ....+.+.+|+.++++++||||+++++++....      
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   81 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARN--ALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM   81 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEE--TTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred             cccchhhheeccCCcEEEEEEEE--cCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence            45789999999999999999984  345789999998643 233467889999999999999999999875421      


Q ss_pred             --cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCce
Q 011508          232 --FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTA  309 (484)
Q Consensus       232 --~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~  309 (484)
                        .......++||||+++++|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+
T Consensus        82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~  155 (303)
T 1zy4_A           82 TAVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNV  155 (303)
T ss_dssp             ----CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCE
T ss_pred             cccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCE
Confidence              12346789999999999999999743   245788999999999999999999   8899999999999999999999


Q ss_pred             EEcccCcccccccccccC-------CCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCc
Q 011508          310 HVSDFGLAKFLPEAANNL-------SSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMF  381 (484)
Q Consensus       310 kl~Dfg~a~~~~~~~~~~-------~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~  381 (484)
                      ||+|||++..........       ...........|+..|+|||++.+. .++.++|||||||++|||++   ||....
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            999999998764321100       0001122345689999999998764 68999999999999999998   543211


Q ss_pred             cCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          382 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .    .......     +... ...+...                   ....++..+.+++.+||+.||++|||+.|+++
T Consensus       233 ~----~~~~~~~-----~~~~-~~~~~~~-------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          233 E----RVNILKK-----LRSV-SIEFPPD-------------------FDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             H----HHHHHHH-----HHST-TCCCCTT-------------------CCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             h----HHHHHHh-----cccc-ccccCcc-------------------ccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            0    0011100     0000 0000000                   01222556889999999999999999999986


Q ss_pred             H
Q 011508          462 Q  462 (484)
Q Consensus       462 ~  462 (484)
                      .
T Consensus       284 h  284 (303)
T 1zy4_A          284 S  284 (303)
T ss_dssp             S
T ss_pred             C
Confidence            3

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.7e-40  Score=324.63  Aligned_cols=203  Identities=27%  Similarity=0.389  Sum_probs=167.7

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-CCC-----ceeEeeeeee
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRN-----LVKIITSCVS  229 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n-----iv~~~~~~~~  229 (484)
                      ...++|++.+.||+|+||+||+|+.  ..+++.||||+++.. ......+..|+.+++.++ |++     ++++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYD--RVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEE--TTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEE--cCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            4567899999999999999999984  445788999999743 223456778888888884 553     8888888543


Q ss_pred             eccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec--CCC
Q 011508          230 VDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD--GEL  307 (484)
Q Consensus       230 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~--~~~  307 (484)
                           ....++||||++ ++|.+++....  ...+++..+..++.|++.||+|||.. ..+|+||||||+|||++  .++
T Consensus       128 -----~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~  198 (382)
T 2vx3_A          128 -----RNHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS  198 (382)
T ss_dssp             -----TTEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred             -----CCceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence                 458899999995 69999998543  23589999999999999999999932 47899999999999995  477


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      .+||+|||++......          .....||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus       199 ~~kL~DFG~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQR----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CEEECCCTTCEETTCC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cEEEEeccCceecccc----------cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            8999999999866321          12346899999999999999999999999999999999999999764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=318.83  Aligned_cols=245  Identities=22%  Similarity=0.305  Sum_probs=189.4

Q ss_pred             HHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc------chHHHHHHHHHHHcC----CCCCceeEe
Q 011508          155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG------ASKSFIAECQALRSI----RHRNLVKII  224 (484)
Q Consensus       155 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~~~  224 (484)
                      ....++|++.+.||+|+||.||+|+  +..+++.||+|++......      ....+.+|+.++.++    +|+||++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGH--RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEE--CTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEE--EccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3456789999999999999999998  4456789999999754321      223456789999988    899999999


Q ss_pred             eeeeeeccCCCceeeEEeec-ccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee
Q 011508          225 TSCVSVDFQGNDFEALVYEL-MVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL  303 (484)
Q Consensus       225 ~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll  303 (484)
                      +++.     ..+..++|+|+ +.+++|.+++....    .+++..++.++.|++.||+|||   +++|+||||||+||++
T Consensus       105 ~~~~-----~~~~~~~v~e~~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  172 (312)
T 2iwi_A          105 DWFE-----TQEGFMLVLERPLPAQDLFDYITEKG----PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILI  172 (312)
T ss_dssp             EEC----------CEEEEECCSSEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEE
T ss_pred             EEEe-----cCCeEEEEEEecCCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEE
Confidence            9853     34578999999 78999999997543    4899999999999999999999   8899999999999999


Q ss_pred             c-CCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCc
Q 011508          304 D-GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMF  381 (484)
Q Consensus       304 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~  381 (484)
                      + .++.+||+|||++.......         .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus       173 ~~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  243 (312)
T 2iwi_A          173 DLRRGCAKLIDFGSGALLHDEP---------YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ  243 (312)
T ss_dssp             ETTTTEEEECCCSSCEECCSSC---------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred             eCCCCeEEEEEcchhhhcccCc---------ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH
Confidence            9 88999999999998764321         123458999999998876665 458999999999999999999996420


Q ss_pred             cCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          382 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       382 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                             ....            .....                     +..+...+.+++.+||+.||++|||++|+++
T Consensus       244 -------~~~~------------~~~~~---------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          244 -------EILE------------AELHF---------------------PAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -------HHHH------------TCCCC---------------------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -------HHhh------------hccCC---------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   0000            00000                     1122556889999999999999999999987


Q ss_pred             H
Q 011508          462 Q  462 (484)
Q Consensus       462 ~  462 (484)
                      .
T Consensus       284 ~  284 (312)
T 2iwi_A          284 D  284 (312)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.1e-40  Score=320.48  Aligned_cols=244  Identities=22%  Similarity=0.315  Sum_probs=195.0

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc------chHHHHHHHHHHHcCC--CCCceeEeeee
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG------ASKSFIAECQALRSIR--HRNLVKIITSC  227 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~  227 (484)
                      ...++|++.+.||+|+||.||+|+..  .+++.||||++......      ....+.+|+.++++++  |+||+++++++
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRV--SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEET--TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEEC--CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            34578999999999999999999843  45789999999754321      1245678999999996  59999999995


Q ss_pred             eeeccCCCceeeEEeecccC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec-C
Q 011508          228 VSVDFQGNDFEALVYELMVN-GSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD-G  305 (484)
Q Consensus       228 ~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~-~  305 (484)
                      .     ..+..++|+|++.+ ++|.+++...    ..+++..++.++.|++.||+|||   +.+|+||||||+||+++ +
T Consensus       118 ~-----~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  185 (320)
T 3a99_A          118 E-----RPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLN  185 (320)
T ss_dssp             E-----CSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETT
T ss_pred             e-----cCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCC
Confidence            4     44578999999976 8999999753    34899999999999999999999   89999999999999999 7


Q ss_pred             CCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCccCC
Q 011508          306 ELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGN  384 (484)
Q Consensus       306 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~  384 (484)
                      ++.+||+|||++.......         .....||..|+|||++.+..+ +.++||||||+++|||++|+.||....   
T Consensus       186 ~~~~kL~Dfg~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---  253 (320)
T 3a99_A          186 RGELKLIDFGSGALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---  253 (320)
T ss_dssp             TTEEEECCCTTCEECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---
T ss_pred             CCCEEEeeCcccccccccc---------ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---
Confidence            8899999999998764321         123458999999998876665 788999999999999999999996421   


Q ss_pred             ccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          385 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       385 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                          .....            ....                     ...++.++.+++.+||+.||++|||++|+++.
T Consensus       254 ----~~~~~------------~~~~---------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          254 ----EIIRG------------QVFF---------------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ----HHHHC------------CCCC---------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ----hhhcc------------cccc---------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                00000            0000                     11124578899999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.8e-40  Score=318.62  Aligned_cols=278  Identities=18%  Similarity=0.201  Sum_probs=194.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-CC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDF-QG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~  234 (484)
                      .++|.+.+.||+|+||.||+|+.  ..+++.||||++.....  ...+.+.+|+.+++.++||||+++++++..... ..
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  100 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAID--KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  100 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CceEEEeeeEecCCCeEEEEEEE--CCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccc
Confidence            46799999999999999999984  44678999999975432  224578899999999999999999998643221 11


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+. ++|.+++.      ..+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Df  170 (353)
T 3coi_A          101 FYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDF  170 (353)
T ss_dssp             CCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECST
T ss_pred             ceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeec
Confidence            123589999996 68887764      24899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |++......          .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+......
T Consensus       171 g~~~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~  239 (353)
T 3coi_A          171 GLARHADAE----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKV  239 (353)
T ss_dssp             TCTTC------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHH
T ss_pred             ccccCCCCC----------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence            999865321          123468999999998876 678999999999999999999999997632111 11111110


Q ss_pred             hc--chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 AL--PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~--~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..  +......+..........    .........-......++..+.+++.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          240 TGVPGTEFVQKLNDKAAKSYIQ----SLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HCBCCHHHHTTCSCHHHHHHHH----TSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hCCCCHHHHHHHhhHHHHHHHH----hCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00  000100000000000000    000000000000012336678999999999999999999999863

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.8e-40  Score=338.72  Aligned_cols=284  Identities=23%  Similarity=0.249  Sum_probs=201.9

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeec-cCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVD-FQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~  236 (484)
                      ++|++.+.||+|+||.||+|.  +..++..||||+++.... ...+.+.+|++++++++||||+++++++.... +..+.
T Consensus        14 grY~i~~~LG~G~fG~Vyla~--~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWI--HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCC--CTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCeEEEEEEeeCCCeEEEEEE--ECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            689999999999999999998  445678899999875432 33467899999999999999999999864321 22356


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc---eEEcc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT---AHVSD  313 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~D  313 (484)
                      ..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             eEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence            78999999999999999985432 235888999999999999999999   899999999999999997664   99999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||.+.......        ......||..|+|||++.+..++.++|||||||++|+|++|+.||.....    ...|...
T Consensus       168 FG~a~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~  235 (676)
T 3qa8_A          168 LGYAKELDQGE--------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGK  235 (676)
T ss_dssp             CCCCCBTTSCC--------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTT
T ss_pred             ccccccccccc--------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhh
Confidence            99998764321        12235689999999999999999999999999999999999999965311    1111111


Q ss_pred             hcchhhhh-hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHH-----HHHHHHHH
Q 011508          394 ALPERLAE-IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEV-----AAQLLSFR  467 (484)
Q Consensus       394 ~~~~~~~~-~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev-----l~~L~~i~  467 (484)
                      ........ ..............      . ...........+..+.+++..||+.||++|||+.|+     .+.++.+.
T Consensus       236 i~~~~~~~~~~~~~l~g~~~~~~------~-lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          236 VREKSNEHIVVYDDLTGAVKFSS------V-LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             CC------CCSCCCCSSSCCCCS------S-SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhcccchhhhhhhhhcccccccc------c-cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            11110000 01111100000000      0 000011123457889999999999999999999984     45555544

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-39  Score=316.80  Aligned_cols=280  Identities=20%  Similarity=0.261  Sum_probs=197.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCC------ceeEeeeeeeec
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN------LVKIITSCVSVD  231 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~  231 (484)
                      .++|++.+.||+|+||.||+|+.... .+..||+|+++.. ....+.+.+|+.++++++|++      ++.+++++.   
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~---   92 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHAR-GKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN---   92 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTT-TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE---
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCC-CceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee---
Confidence            46899999999999999999985432 2478999999743 233467888999999997665      788887743   


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeee--------
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLL--------  303 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll--------  303 (484)
                        .....++||||+ ++++.+++....  ...+++.+++.++.||+.||+|||   +++|+||||||+||++        
T Consensus        93 --~~~~~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~  164 (355)
T 2eu9_A           93 --FHGHMCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETL  164 (355)
T ss_dssp             --ETTEEEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEE
T ss_pred             --eCCeEEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccc
Confidence              345889999999 778888776432  235899999999999999999999   8999999999999999        


Q ss_pred             -----------cCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh
Q 011508          304 -----------DGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT  372 (484)
Q Consensus       304 -----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt  372 (484)
                                 +.++.+||+|||++......          .....||..|+|||++.+..++.++|||||||++|||++
T Consensus       165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  234 (355)
T 2eu9_A          165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH----------HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR  234 (355)
T ss_dssp             ECCC-CCCEEEESCCCEEECCCTTCEETTSC----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccCCCcEEEeecCcccccccc----------ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence                       66789999999999764321          123468999999999999999999999999999999999


Q ss_pred             CCCCCCCCccCCccHhHH--HHhhcchhhh-hhcCccccccccccc---chhhhh----h-hccccccchhHHHHHHHhH
Q 011508          373 GKGPTNEMFTGNLTLHNF--VKEALPERLA-EIVDPVLLVEREEGE---TSEANA----H-KQRTRSFGGKECLVSVLGI  441 (484)
Q Consensus       373 g~~p~~~~~~~~~~~~~~--~~~~~~~~~~-~~~d~~l~~~~~~~~---~~~~~~----~-~~~~~~~~~~~~~~~l~~l  441 (484)
                      |+.||....... .+...  .....+.... ...............   ......    . ...........+..++.++
T Consensus       235 g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  313 (355)
T 2eu9_A          235 GFTLFQTHENRE-HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL  313 (355)
T ss_dssp             SSCSCCCSSHHH-HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred             CCCCCCCCCHHH-HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHH
Confidence            999997642211 11111  1111111111 100000000000000   000000    0 0000001123346789999


Q ss_pred             hhccCCCCcCCCCCHHHHHH
Q 011508          442 GVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       442 ~~~cl~~dP~~RPt~~evl~  461 (484)
                      +.+||+.||++|||+.|+++
T Consensus       314 i~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          314 MRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHhcCChhhCcCHHHHhc
Confidence            99999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.2e-40  Score=327.94  Aligned_cols=256  Identities=23%  Similarity=0.313  Sum_probs=182.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      +.|.+.+.||+|+||+||.+...   +++.||||++...   ..+.+.+|+.++.++ +||||+++++++     ..+..
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~---~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~   83 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSF---QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRF   83 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEES---SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSE
T ss_pred             heeeccCeEeeCCCeEEEEEEEE---CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCe
Confidence            34555688999999999865432   5789999998753   235678999999886 899999999884     34558


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC--------
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRN---LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE--------  306 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~--------  306 (484)
                      .++||||+. |+|.+++.........   .++..++.++.||+.||+|||   +++|+||||||+||+++.+        
T Consensus        84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~  159 (434)
T 2rio_A           84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQ  159 (434)
T ss_dssp             EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCT
T ss_pred             EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccc
Confidence            899999995 6999999854322221   133456789999999999999   8999999999999999754        


Q ss_pred             -----CceEEcccCcccccccccccCCCCccccccccccccccCccccCC-------CCCCcccceehhhHHHHHHHh-C
Q 011508          307 -----LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-------SEVSTSGDVYSFGILLLEMFT-G  373 (484)
Q Consensus       307 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dvws~Gvvl~ellt-g  373 (484)
                           +.+||+|||+++.........   ........||+.|+|||++.+       ..++.++|||||||++|||+| |
T Consensus       160 ~~~~~~~~kL~DFG~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g  236 (434)
T 2rio_A          160 TGAENLRILISDFGLCKKLDSGQSSF---RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG  236 (434)
T ss_dssp             TCCCSCEEEECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             cCCCceEEEEcccccceecCCCCccc---eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCC
Confidence                 489999999998764432111   111223569999999999865       578999999999999999999 9


Q ss_pred             CCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCC
Q 011508          374 KGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRER  453 (484)
Q Consensus       374 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R  453 (484)
                      +.||.......   ......        ..+..                  .........++.++.+++.+||+.||++|
T Consensus       237 ~~Pf~~~~~~~---~~i~~~--------~~~~~------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R  287 (434)
T 2rio_A          237 KHPFGDKYSRE---SNIIRG--------IFSLD------------------EMKCLHDRSLIAEATDLISQMIDHDPLKR  287 (434)
T ss_dssp             CCTTCSTTTHH---HHHHHT--------CCCCC------------------CCTTCCCHHHHHHHHHHHHHHTCSSGGGS
T ss_pred             CCCCCCchhhH---HHHhcC--------CCCcc------------------cccccccccchHHHHHHHHHHhhCChhhC
Confidence            99996532111   111110        00000                  00001123456789999999999999999


Q ss_pred             CCHHHHHH
Q 011508          454 MNMEEVAA  461 (484)
Q Consensus       454 Pt~~evl~  461 (484)
                      ||+.||++
T Consensus       288 ps~~eil~  295 (434)
T 2rio_A          288 PTAMKVLR  295 (434)
T ss_dssp             CCHHHHHT
T ss_pred             CCHHHHHh
Confidence            99999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=311.83  Aligned_cols=253  Identities=23%  Similarity=0.281  Sum_probs=176.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccc-h-HHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA-S-KSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~-~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|+..  .+++.||||++....... . +.+.++..+++.++||||+++++++.     .+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~   96 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFR--KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TN   96 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEET--TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             hccccccceeeecCCeeEEEEEEe--cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cC
Confidence            467888999999999999999954  357889999997654322 2 23444556788889999999999864     34


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeecCCCCCCeeecCCCceEEccc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCET-PIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      +..++||||+ ++.+..+....   ...+++..++.++.|++.||+|||   ++ +|+||||||+||+++.++.+||+||
T Consensus        97 ~~~~lv~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~df  169 (318)
T 2dyl_A           97 TDVFIAMELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDF  169 (318)
T ss_dssp             SEEEEEECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             CcEEEEEecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEEC
Confidence            5889999999 55666655432   235899999999999999999999   64 9999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccC-----CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhH
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHN  389 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~  389 (484)
                      |++.......        ......++..|+|||++.     ...++.++||||||+++|||++|+.||.........+..
T Consensus       170 g~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  241 (318)
T 2dyl_A          170 GISGRLVDDK--------AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK  241 (318)
T ss_dssp             TTC----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred             CCchhccCCc--------cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH
Confidence            9997653321        112345899999999984     456889999999999999999999999753221111111


Q ss_pred             HHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          390 FVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       390 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ....         ..+.+..                     ...++..+.+++.+||+.||.+|||++|+++.
T Consensus       242 ~~~~---------~~~~~~~---------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          242 VLQE---------EPPLLPG---------------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             HHHS---------CCCCCCS---------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             Hhcc---------CCCCCCc---------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1100         0000000                     01125578899999999999999999999863

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-39  Score=322.36  Aligned_cols=252  Identities=24%  Similarity=0.282  Sum_probs=180.3

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  235 (484)
                      ...+|.+.+.||+|+||+||.....   +++.||||++.....   ..+.+|+++++.+ +||||+++++++.     +.
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~---~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~   90 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMF---DNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEK-----DR   90 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEES---SSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEE-----ET
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEe---CCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEe-----cC
Confidence            3456888899999999996543322   467899999865432   3356899999999 8999999998853     44


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-----CCceE
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG-----ELTAH  310 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~-----~~~~k  310 (484)
                      ...++||||+. |+|.+++.....   ...+..++.++.||+.||+|||   +++|+||||||+||+++.     ...+|
T Consensus        91 ~~~~lv~E~~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~k  163 (432)
T 3p23_A           91 QFQYIAIELCA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAM  163 (432)
T ss_dssp             TEEEEEEECCS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEE
T ss_pred             CEEEEEEECCC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEE
Confidence            57899999995 699999974432   2444456789999999999999   899999999999999943     33688


Q ss_pred             EcccCcccccccccccCCCCccccccccccccccCccccC---CCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCcc
Q 011508          311 VSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM---GSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLT  386 (484)
Q Consensus       311 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~  386 (484)
                      |+|||+++........    ........||+.|+|||++.   ...++.++|||||||++|||++ |..||......   
T Consensus       164 L~DFG~a~~~~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~---  236 (432)
T 3p23_A          164 ISDFGLCKKLAVGRHS----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR---  236 (432)
T ss_dssp             ECCTTEEECC----------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH---
T ss_pred             EecccceeeccCCCcc----eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH---
Confidence            9999999876433211    11223456999999999987   4567889999999999999999 99998542111   


Q ss_pred             HhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          387 LHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                         ...............                         ........+.+++.+||+.||++|||+.||++
T Consensus       237 ---~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          237 ---QANILLGACSLDCLH-------------------------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ---HHHHHTTCCCCTTSC-------------------------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHhccCCccccC-------------------------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence               000000000000000                         01122556789999999999999999999984

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.4e-39  Score=305.43  Aligned_cols=235  Identities=10%  Similarity=0.038  Sum_probs=181.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||||++......   ..+.+.+|+.++.+++||||+++++++..     +
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~  103 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALD--TALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----R  103 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEE--TTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred             CcEEEEEEEcccCCeEEEEEEe--cCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----C
Confidence            6799999999999999999995  445789999999765432   23678999999999999999999998643     4


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++++|.+++...      ....++..++.|++.||+|||   +++|+||||||+||+++.++.+||++++
T Consensus       104 ~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~  174 (286)
T 3uqc_A          104 AGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA  174 (286)
T ss_dssp             TEEEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred             CcEEEEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc
Confidence            5789999999999999999521      355678899999999999999   8999999999999999999999998544


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                                                 |++       .++.++|||||||++|||+||+.||........... .     
T Consensus       175 ---------------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-~-----  214 (286)
T 3uqc_A          175 ---------------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-A-----  214 (286)
T ss_dssp             ---------------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE-C-----
T ss_pred             ---------------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH-H-----
Confidence                                       222       368899999999999999999999976432210000 0     


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHh
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLV  471 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~  471 (484)
                          ...+......                 ......+++.++.+++.+||+.||++| |+.|+++.|+.+.....
T Consensus       215 ----~~~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          215 ----ERDTAGQPIE-----------------PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             ----CBCTTSCBCC-----------------HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             ----HHHhccCCCC-----------------hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence                0000000000                 000012235678999999999999999 99999999999875543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-39  Score=322.38  Aligned_cols=250  Identities=16%  Similarity=0.137  Sum_probs=182.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc---cchHHHHHHHHHHHcCCC-CCceeEe---------
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR---GASKSFIAECQALRSIRH-RNLVKII---------  224 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~~~---------  224 (484)
                      +..|...+.||+|+||.||+|+..  .+++.||||++.....   ...+.+.+|+.+++.++| +|.....         
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~--~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQ--ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             ceeEEEecccccCCCEEEEEEEec--CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            345777889999999999999944  4578999999874332   225779999999999987 3221111         


Q ss_pred             eeeee------------eccCCCceeeEEeecccCCCHHHHHhhc---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 011508          225 TSCVS------------VDFQGNDFEALVYELMVNGSLEEWLHLN---RDAPRNLNLLQRLSIAVDVASTLEYLHHYCET  289 (484)
Q Consensus       225 ~~~~~------------~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~  289 (484)
                      ..+..            .........+++|+++ +++|.+++...   ......+++..++.++.|++.||+|||   ++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~  230 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HY  230 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HT
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence            10000            0000012356777776 78999988522   223445888999999999999999999   89


Q ss_pred             CeeecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCcccc----------CCCCCCcccc
Q 011508          290 PIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYG----------MGSEVSTSGD  359 (484)
Q Consensus       290 ~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~D  359 (484)
                      +|+||||||+|||++.++.+||+|||+++.....          .....| +.|+|||++          ....++.++|
T Consensus       231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~D  299 (413)
T 3dzo_A          231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFD  299 (413)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHH
T ss_pred             CcccCCcccceEEEecCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhh
Confidence            9999999999999999999999999998865322          223457 999999998          6667899999


Q ss_pred             eehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHH
Q 011508          360 VYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVL  439 (484)
Q Consensus       360 vws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  439 (484)
                      ||||||++|||+||+.||........                 .+..+..                     ...++..+.
T Consensus       300 vwSlGvil~elltg~~Pf~~~~~~~~-----------------~~~~~~~---------------------~~~~~~~~~  341 (413)
T 3dzo_A          300 TWTLGLAIYWIWCADLPNTDDAALGG-----------------SEWIFRS---------------------CKNIPQPVR  341 (413)
T ss_dssp             HHHHHHHHHHHHHSSCCCCTTGGGSC-----------------SGGGGSS---------------------CCCCCHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCcchhhh-----------------HHHHHhh---------------------cccCCHHHH
Confidence            99999999999999999975321110                 0000000                     001245789


Q ss_pred             hHhhccCCCCcCCCCCHHHHHHH
Q 011508          440 GIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       440 ~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      +++.+||+.||++|||+.|+++.
T Consensus       342 ~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          342 ALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHccCChhhCcCHHHHHhC
Confidence            99999999999999999988653

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.7e-39  Score=338.82  Aligned_cols=250  Identities=23%  Similarity=0.281  Sum_probs=195.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .++|++.+.||+|+||.||+|+.... +++.||||++..... .....+.+|++++++++||||+++++++...+..+..
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGG-TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCC-CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            36899999999999999999986432 368899999865432 3345788999999999999999999998765533333


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++++|.+++..      .+++.+++.++.||+.||.|||   +++|+||||||+||+++.+ .+||+|||+
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEeccc
Confidence            46999999999999987752      5899999999999999999999   8999999999999999986 899999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ++.....           ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.........          
T Consensus       228 a~~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------  285 (681)
T 2pzi_A          228 VSRINSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------  285 (681)
T ss_dssp             CEETTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------
T ss_pred             chhcccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc----------
Confidence            9865321           2346899999999887654 88999999999999999999887642211100          


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-CHHHHHHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-NMEEVAAQLLSFRNKL  470 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~~~~  470 (484)
                      .           .                   .....+...+.+++.+||+.||++|| +++++...|..+....
T Consensus       286 ~-----------~-------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~  330 (681)
T 2pzi_A          286 E-----------D-------------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV  330 (681)
T ss_dssp             T-----------T-------------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred             c-----------c-------------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence            0           0                   00112245688999999999999999 5677777777765444

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.7e-38  Score=296.96  Aligned_cols=236  Identities=20%  Similarity=0.282  Sum_probs=178.9

Q ss_pred             CCCCcc-CccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHH-HcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLE-NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQAL-RSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~-~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|.+. +.||+|+||.||+|...  .+++.||+|+++.     ...+.+|+.++ +.++||||+++++++... ..+..
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~   88 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNK--RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRK   88 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEc--CCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCc
Confidence            456666 78999999999999843  4678999999863     25677889888 556999999999987542 23355


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEEcc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSD  313 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~D  313 (484)
                      ..++||||+++|+|.+++....  ...+++..++.++.|++.||+|||   +++|+||||||+||+++.   ++.+||+|
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             eEEEEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence            7899999999999999998543  245899999999999999999999   899999999999999998   78999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||++....                             +..++.++|||||||++|||++|+.||.........       
T Consensus       164 fg~a~~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------  207 (299)
T 3m2w_A          164 FGFAKETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------  207 (299)
T ss_dssp             CTTCEECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------
T ss_pred             cccccccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------
Confidence            99886431                             234788999999999999999999999653211100       


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                        ......+.......                 .......++.++.+++.+||+.||++|||+.|+++.
T Consensus       208 --~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          208 --PGMKTRIRMGQYEF-----------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             --CCSCCSSCTTCCSS-----------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --HHHHHHHhhccccC-----------------CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              00000000000000                 000012336678999999999999999999999874

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.5e-37  Score=297.40  Aligned_cols=248  Identities=15%  Similarity=0.146  Sum_probs=183.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--------cchHHHHHHHHHHHcCC---------CCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--------GASKSFIAECQALRSIR---------HRNL  220 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~ni  220 (484)
                      .++|++.+.||+|+||.||+|+.    +++.||||++.....        ...+.+.+|+.+++.++         ||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA----DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE----TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccchheeeecccCceEEEEEEe----CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            35688899999999999999985    358999999986532        22367889999998885         7888


Q ss_pred             eeEeeeeeeec-------------------------cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHH
Q 011508          221 VKIITSCVSVD-------------------------FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD  275 (484)
Q Consensus       221 v~~~~~~~~~~-------------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~  275 (484)
                      +++.+.+....                         +......++||||+++|++.+.+..     ..+++..++.++.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~q  169 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQ  169 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHH
Confidence            77777643211                         1135688999999999977666642     34899999999999


Q ss_pred             HHHHHHHHHhcCCCCeeecCCCCCCeeecCCC--------------------ceEEcccCcccccccccccCCCCccccc
Q 011508          276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGEL--------------------TAHVSDFGLAKFLPEAANNLSSNQSSSV  335 (484)
Q Consensus       276 i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~  335 (484)
                      |+.||+|||+  +++|+||||||+|||++.++                    .+||+|||+++.....            
T Consensus       170 i~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------  235 (336)
T 2vuw_A          170 LTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------  235 (336)
T ss_dssp             HHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------
T ss_pred             HHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------
Confidence            9999999993  36899999999999999887                    8999999999865321            


Q ss_pred             cccccccccCccccCCCCCCcccceehhhHH-HHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccc
Q 011508          336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGIL-LLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEG  414 (484)
Q Consensus       336 ~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  414 (484)
                      ...||+.|+|||++.+.. +.++||||+|++ .+++++|..||...        .|..... +.+.......  .     
T Consensus       236 ~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~-~~~~~~~~~~--~-----  298 (336)
T 2vuw_A          236 IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLT-DKMLKQMTFK--T-----  298 (336)
T ss_dssp             EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHH-HHHHHTCCCS--S-----
T ss_pred             cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHH-HhhhhhhccC--c-----
Confidence            236899999999998766 899999998777 77788899997431        1111110 0100000000  0     


Q ss_pred             cchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHH
Q 011508          415 ETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVA  460 (484)
Q Consensus       415 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl  460 (484)
                                .........++.++.+|+.+||+.|     |++|++
T Consensus       299 ----------~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          299 ----------KCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             ----------CCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             ----------ccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence                      0000013456788999999999976     898887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.7e-30  Score=266.80  Aligned_cols=186  Identities=16%  Similarity=0.040  Sum_probs=126.4

Q ss_pred             ccccccceeEEEEEEcCCCCeeEEEEEEeeccCc----------cchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCC
Q 011508          166 LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR----------GASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       166 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  234 (484)
                      ..+.|++|.+..++..  -.+..+++|++.....          ...++|.+|+++|+++ .|+||++++++     +++
T Consensus       241 ~~~~~~~~~h~~~rr~--~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~-----~ed  313 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRY--FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAH-----GEN  313 (569)
T ss_dssp             C-C--------CCEEE--EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEE-----EEC
T ss_pred             ccccCCcccccccccc--cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEE-----EEE
Confidence            3455666555544321  1356799999975421          1225699999999999 79999999999     566


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      +...||||||++|++|.+++...    .+++..   .|+.||+.||+|+|   +++||||||||+|||+++++.+||+||
T Consensus       314 ~~~~yLVMEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DF  383 (569)
T 4azs_A          314 AQSGWLVMEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDF  383 (569)
T ss_dssp             SSEEEEEEECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeec
Confidence            77999999999999999999743    345554   48899999999999   999999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCC
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP  376 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p  376 (484)
                      |+|+......       ......+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       384 GlAr~~~~~~-------~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          384 GSIVTTPQDC-------SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             TTEESCC----------CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             ccCeeCCCCC-------ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            9998764322       22234679999999999875 467789999999999888766544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.94  E-value=5.8e-28  Score=246.57  Aligned_cols=191  Identities=17%  Similarity=0.133  Sum_probs=141.7

Q ss_pred             CccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc--------chHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG--------ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       162 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      ...+.||+|+||.||+|.+.    +..+++|+.......        ..+.+.+|++++++++||||+++..++..    
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~----~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----  410 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL----DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD----  410 (540)
T ss_dssp             ---------CCEEEEEEECS----SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE----
T ss_pred             CCCCEEeeCCCEEEEEEEEC----CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe----
Confidence            34578999999999999643    466888876543211        12457899999999999999965555432    


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                       .+..++||||+++++|.+++..            +..++.|+++||+|||   +++|+||||||+|||++.  .+||+|
T Consensus       411 -~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~D  472 (540)
T 3en9_A          411 -LDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIID  472 (540)
T ss_dssp             -TTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECC
T ss_pred             -CCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEE
Confidence             2356999999999999999873            4579999999999999   899999999999999998  999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCC--CCCCcccceehhhHHHHHHHhCCCCCC
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG--SEVSTSGDVYSFGILLLEMFTGKGPTN  378 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dvws~Gvvl~elltg~~p~~  378 (484)
                      ||+++....................||+.|+|||++..  ..|+..+|+||..+-..+-+.++.+|.
T Consensus       473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            99999875432110000001234579999999999876  568889999999999988888777653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=2.4e-24  Score=201.85  Aligned_cols=143  Identities=20%  Similarity=0.206  Sum_probs=113.3

Q ss_pred             cHHhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc------------------cchHHHHHHHHH
Q 011508          150 SYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR------------------GASKSFIAECQA  211 (484)
Q Consensus       150 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~  211 (484)
                      ....+......|.+.+.||+|+||.||+|..   .+++.||+|+++....                  .....+.+|+.+
T Consensus        81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~---~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~  157 (282)
T 1zar_A           81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYS---EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA  157 (282)
T ss_dssp             HHHHHHHTTSCSEEEEEEEECSSEEEEEEEE---TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHH
T ss_pred             HHHHHHhCCeEEEecCEeccCCCceEEEEEe---CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHH
Confidence            3445556667788889999999999999996   3578999999864321                  123568899999


Q ss_pred             HHcCCCCCceeEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 011508          212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPI  291 (484)
Q Consensus       212 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i  291 (484)
                      +++++  | +++.+++. .     +..++||||+++++|.+ +.        .  .....++.|++.||+|||   +.+|
T Consensus       158 l~~l~--~-~~v~~~~~-~-----~~~~lvmE~~~g~~L~~-l~--------~--~~~~~i~~qi~~~l~~lH---~~gi  214 (282)
T 1zar_A          158 LQKLQ--G-LAVPKVYA-W-----EGNAVLMELIDAKELYR-VR--------V--ENPDEVLDMILEEVAKFY---HRGI  214 (282)
T ss_dssp             HHHTT--T-SSSCCEEE-E-----ETTEEEEECCCCEEGGG-CC--------C--SCHHHHHHHHHHHHHHHH---HTTE
T ss_pred             HHhcc--C-CCcCeEEe-c-----cceEEEEEecCCCcHHH-cc--------h--hhHHHHHHHHHHHHHHHH---HCCC
Confidence            99999  4 55555431 1     35699999999999988 42        1  124469999999999999   8999


Q ss_pred             eecCCCCCCeeecCCCceEEcccCcccc
Q 011508          292 VHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       292 vH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      +||||||+||+++ ++.+||+|||+++.
T Consensus       215 iHrDlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          215 VHGDLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             ECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             EeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence            9999999999999 99999999999873

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=2.2e-19  Score=166.04  Aligned_cols=146  Identities=21%  Similarity=0.155  Sum_probs=107.5

Q ss_pred             hHHHhcCCCCccCccccccceeEEEEEEcCCCCeeE--EEEEEeeccCccc------------------------hHHHH
Q 011508          153 NLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETL--VAVKVLNLQHRGA------------------------SKSFI  206 (484)
Q Consensus       153 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~--vavK~~~~~~~~~------------------------~~~~~  206 (484)
                      .+.....-|++.+.||+|+||.||+|....  +++.  ||||+++......                        ...+.
T Consensus        41 ~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~--~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  118 (258)
T 1zth_A           41 KLSAKGYITAMGGVISTGKEANVFYADGVF--DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTE  118 (258)
T ss_dssp             HHHHTTSEEEEEEEEEECSSEEEEEEEEEE--TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHH
T ss_pred             HHHhCCCchhhCCEEeecceEEEEEEEEcC--CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHH
Confidence            333333346788999999999999998622  4567  9999875432110                        12578


Q ss_pred             HHHHHHHcCCCCCc--eeEeeeeeeeccCCCceeeEEeecccC-C----CHHHHHhhcCCCCCCCCHHHHHHHHHHHHHH
Q 011508          207 AECQALRSIRHRNL--VKIITSCVSVDFQGNDFEALVYELMVN-G----SLEEWLHLNRDAPRNLNLLQRLSIAVDVAST  279 (484)
Q Consensus       207 ~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~  279 (484)
                      +|+.++.++.|+++  ..++..         ...++||||+.+ |    +|.++...       .++..+..++.|++.+
T Consensus       119 ~E~~~l~~l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~  182 (258)
T 1zth_A          119 KEFRNLERAKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVEN  182 (258)
T ss_dssp             HHHHHHHHHHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHH
Confidence            99999999988764  333322         245899999942 4    77776532       2234567899999999


Q ss_pred             HHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       280 l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      |.|||.  ..+|+||||||+|||++.  .++|+|||+|...
T Consensus       183 l~~lH~--~~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          183 VKRLYQ--EAELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHHHHH--TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHHHH--HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            999995  579999999999999998  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=1.1e-17  Score=160.66  Aligned_cols=144  Identities=16%  Similarity=0.182  Sum_probs=100.9

Q ss_pred             HhHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--------------cchHH--------HHHHH
Q 011508          152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--------------GASKS--------FIAEC  209 (484)
Q Consensus       152 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~e~  209 (484)
                      ..+.....-|++.+.||+|++|.||+|...   +++.||||+++....              .....        ..+|.
T Consensus        88 ~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~---~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~  164 (397)
T 4gyi_A           88 HTHAARKDVYSVGSRIGVGKESDIMIVADE---KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEF  164 (397)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEECT---TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHCCCEEEecCEeeeCCceEEEEEECC---CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHH
Confidence            344444455899999999999999999843   578899999763210              00111        23455


Q ss_pred             HHHHcCCCCCce--eEeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 011508          210 QALRSIRHRNLV--KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC  287 (484)
Q Consensus       210 ~~l~~l~h~niv--~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~  287 (484)
                      ..|.++.+.++.  ..++.         ...++||||++|++|.++..        .  .....++.|++.+|.+||   
T Consensus       165 ~nL~rL~~~gv~vp~p~~~---------~~~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH---  222 (397)
T 4gyi_A          165 AFMKALYEEGFPVPEPIAQ---------SRHTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLA---  222 (397)
T ss_dssp             HHHHHHHHTTCSCCCEEEE---------ETTEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHH---
T ss_pred             HHHHHHHhcCCCCCeeeec---------cCceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHH---
Confidence            666666444332  11111         13479999999888865432        1  123567899999999999   


Q ss_pred             CCCeeecCCCCCCeeecCCC----------ceEEcccCccccc
Q 011508          288 ETPIVHCDLKPSNVLLDGEL----------TAHVSDFGLAKFL  320 (484)
Q Consensus       288 ~~~ivH~dlk~~NIll~~~~----------~~kl~Dfg~a~~~  320 (484)
                      ..+||||||||.|||+++++          .+.|+||+.+...
T Consensus       223 ~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          223 KHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             HTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             HCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            88999999999999998776          3899999987643

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.43  E-value=1.1e-13  Score=147.82  Aligned_cols=83  Identities=35%  Similarity=0.606  Sum_probs=75.2

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|+|+|.||.++++|++|+.||||+|+|+|.||..++++++|+.||||+|+|+|.+|..+.+..+...++.||++|||
T Consensus       663 Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg  742 (768)
T 3rgz_A          663 LGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG  742 (768)
T ss_dssp             CCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEES
T ss_pred             CcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcC
Confidence            68899999999999999999999999999999999999999999999999999999999888888888899999999999


Q ss_pred             CCc
Q 011508           81 GIS   83 (484)
Q Consensus        81 ~~~   83 (484)
                      .+.
T Consensus       743 ~~l  745 (768)
T 3rgz_A          743 YPL  745 (768)
T ss_dssp             TTS
T ss_pred             CCC
Confidence            764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.32  E-value=3.7e-12  Score=117.80  Aligned_cols=144  Identities=15%  Similarity=0.090  Sum_probs=108.6

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  236 (484)
                      -++|++...++.|+.+.||++...    +..+++|+...........+.+|+++++.+. +..+.++++++.     ...
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~----~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~   83 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE----NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HDG   83 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS----SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ETT
T ss_pred             hccceeEeeccCCCCCeEEEEECC----CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cCC
Confidence            356888888999999999998732    4679999987532233356889999999884 666778887753     234


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC-----------------------------  287 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------------  287 (484)
                      ..++||||++|.+|.+.+.         +......++.+++++|+.||...                             
T Consensus        84 ~~~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T 3tm0_A           84 WSNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             EEEEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCS
T ss_pred             ceEEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccc
Confidence            7799999999999987632         11123467889999999999611                             


Q ss_pred             ---------------------------CCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          288 ---------------------------ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       288 ---------------------------~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                                                 ...++|+|++|.||+++++..+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                       14589999999999998766677999997754

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.25  E-value=4.4e-12  Score=135.57  Aligned_cols=83  Identities=34%  Similarity=0.540  Sum_probs=73.2

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|+|.+|.++++|++|+.|||++|+|+|.||.+++++++|+.||||+|+|+|.+|.. ..+++++.+++++| .+.
T Consensus       639 Ls~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N-~l~  717 (768)
T 3rgz_A          639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN-NLS  717 (768)
T ss_dssp             CCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSS-EEE
T ss_pred             CcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCC-ccc
Confidence            6789999999999999999999999999999999999999999999999999999988865 67888999999998 788


Q ss_pred             CCCcc
Q 011508           80 GGISE   84 (484)
Q Consensus        80 g~~~~   84 (484)
                      |.+|.
T Consensus       718 g~iP~  722 (768)
T 3rgz_A          718 GPIPE  722 (768)
T ss_dssp             EECCS
T ss_pred             ccCCC
Confidence            87664

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.21  E-value=1.2e-11  Score=117.57  Aligned_cols=83  Identities=28%  Similarity=0.490  Sum_probs=72.9

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|++++.+|. ++.+++|+.|+|++|+|+|.+|..+.++++|+.|+|++|+|+|.+|....++++..+++++|+.+||
T Consensus       228 L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~  306 (313)
T 1ogq_A          228 LAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             CCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred             CCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccC
Confidence            567788766665 7888999999999999999999999999999999999999999999888899999999999999999


Q ss_pred             CCcc
Q 011508           81 GISE   84 (484)
Q Consensus        81 ~~~~   84 (484)
                      .+.+
T Consensus       307 ~p~~  310 (313)
T 1ogq_A          307 SPLP  310 (313)
T ss_dssp             TTSS
T ss_pred             CCCC
Confidence            7543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.17  E-value=3.5e-11  Score=103.26  Aligned_cols=80  Identities=20%  Similarity=0.182  Sum_probs=62.4

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..|+.+++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.++. ...+.+++.+++++|+.-|
T Consensus        37 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  116 (170)
T 3g39_A           37 LYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDC  116 (170)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred             cCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence            578888877777888888888888888888854444567888888888888888887775 4667888888888886555


Q ss_pred             C
Q 011508           80 G   80 (484)
Q Consensus        80 g   80 (484)
                      .
T Consensus       117 ~  117 (170)
T 3g39_A          117 A  117 (170)
T ss_dssp             T
T ss_pred             C
Confidence            4

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.17  E-value=4.1e-11  Score=103.19  Aligned_cols=79  Identities=20%  Similarity=0.224  Sum_probs=53.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..|+++++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.++. ...+++++.+++++|+.-|
T Consensus        40 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c  119 (174)
T 2r9u_A           40 LNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDC  119 (174)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred             eCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCccc
Confidence            567777766667777777777777777777743333356777777777777777766664 3556777777777775444

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.15  E-value=6.5e-11  Score=109.17  Aligned_cols=138  Identities=14%  Similarity=0.081  Sum_probs=95.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCC--ceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN--LVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~  236 (484)
                      .++.+....+.|..+.||++...   ++..+++|+....   ....+.+|+.+++.+.+.+  +.+++++..     .++
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~---~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~   88 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQ---GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAG   88 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECT---TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSS
T ss_pred             CCCceEecccCCCCceEEEEecC---CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCC
Confidence            34454444446667999998643   3567999987543   2345778999999885545  445776532     234


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC-----------------------------  287 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----------------------------  287 (484)
                      ..++||||++|.+|.  ..   .    .+   ...++.++++.|+.||...                             
T Consensus        89 ~~~~v~e~i~G~~l~--~~---~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (264)
T 1nd4_A           89 RDWLLLGEVPGQDLL--SS---H----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD  156 (264)
T ss_dssp             CEEEEEECCSSEETT--TS---C----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred             CCEEEEEecCCcccC--cC---c----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccch
Confidence            679999999998884  21   0    11   2256778888888888531                             


Q ss_pred             --------------------------CCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          288 --------------------------ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       288 --------------------------~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                                                ...++|+|++|.||+++++..+.|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          157 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                      11299999999999998876677999998764

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.15  E-value=5.1e-11  Score=104.45  Aligned_cols=80  Identities=20%  Similarity=0.203  Sum_probs=59.0

Q ss_pred             CCCCcccccCch-hhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPS-SLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~-~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+|++..|. .++++++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.+|. ...+++++.+++++| .+
T Consensus        36 l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l  114 (192)
T 1w8a_A           36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN-QI  114 (192)
T ss_dssp             CCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSS-CC
T ss_pred             CCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCC-cC
Confidence            567788744443 377888888888888888877777788888888888888888877775 356777888888887 45


Q ss_pred             cCC
Q 011508           79 CGG   81 (484)
Q Consensus        79 ~g~   81 (484)
                      .+.
T Consensus       115 ~~~  117 (192)
T 1w8a_A          115 SCV  117 (192)
T ss_dssp             CEE
T ss_pred             Cee
Confidence            543

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.13  E-value=1.2e-12  Score=132.23  Aligned_cols=80  Identities=20%  Similarity=0.130  Sum_probs=58.9

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCcccc-CCCCCCeeeccccceecccccccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLE-NFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~-~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..++++++|+.|+|++|+|+|.+|..+. ++++|+.|+|++|.|++.++ ...++++..+++++| .+.
T Consensus       127 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~Ls~N-~l~  204 (487)
T 3oja_A          127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG-QVVFAKLKTLDLSSN-KLA  204 (487)
T ss_dssp             CCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC-CCCCTTCCEEECCSS-CCC
T ss_pred             CCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc-cccCCCCCEEECCCC-CCC
Confidence            567778877777788888888888888888877777775 67788888888888877644 335777777788777 555


Q ss_pred             CCC
Q 011508           80 GGI   82 (484)
Q Consensus        80 g~~   82 (484)
                      +.+
T Consensus       205 ~~~  207 (487)
T 3oja_A          205 FMG  207 (487)
T ss_dssp             EEC
T ss_pred             CCC
Confidence            533

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.06  E-value=2.1e-10  Score=100.52  Aligned_cols=78  Identities=28%  Similarity=0.401  Sum_probs=64.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|+ .+|..++++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|. ...+++++.+++++| .+.
T Consensus        38 L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N-~l~  115 (193)
T 2wfh_A           38 LDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGN-DIS  115 (193)
T ss_dssp             CCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSS-CCC
T ss_pred             CCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCC-CCC
Confidence            5788888 8888888999999999999999866667788889999999999999887774 366788888888888 444


Q ss_pred             C
Q 011508           80 G   80 (484)
Q Consensus        80 g   80 (484)
                      +
T Consensus       116 ~  116 (193)
T 2wfh_A          116 V  116 (193)
T ss_dssp             B
T ss_pred             e
Confidence            3

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.04  E-value=2.8e-10  Score=102.01  Aligned_cols=80  Identities=18%  Similarity=0.136  Sum_probs=59.6

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..|+.+++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.+|.. ..+.+++.+++++| .+.
T Consensus        64 L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~  142 (220)
T 2v70_A           64 FSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN-QIT  142 (220)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTS-CCC
T ss_pred             CCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCC-cCC
Confidence            5678888666667888888888888888888666666778888888888888888776643 56677888888887 455


Q ss_pred             CC
Q 011508           80 GG   81 (484)
Q Consensus        80 g~   81 (484)
                      +.
T Consensus       143 ~~  144 (220)
T 2v70_A          143 TV  144 (220)
T ss_dssp             CB
T ss_pred             EE
Confidence            43

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.01  E-value=3.2e-10  Score=109.26  Aligned_cols=73  Identities=16%  Similarity=0.138  Sum_probs=43.2

Q ss_pred             cccccCchhhhCCCCCCEEeCcC-CccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCccccC
Q 011508            5 FFQGNIPSSLSSLRGIENLDLSQ-NNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         5 ~l~g~~p~~~~~l~~l~~l~ls~-N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~g   80 (484)
                      +|+ .||. |+.+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++.+|.. ..+++|+.|++++| .|.+
T Consensus        20 ~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~   94 (347)
T 2ifg_A           20 ALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN-ALES   94 (347)
T ss_dssp             CCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS-CCSC
T ss_pred             CCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC-ccce
Confidence            565 4666 66666666666664 6666444455666666666666666666655543 45566666666666 4443

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.99  E-value=1.2e-09  Score=105.83  Aligned_cols=146  Identities=13%  Similarity=0.145  Sum_probs=103.6

Q ss_pred             ccCccccccceeEEEEEEcCCCCeeEEEEEEee--ccCc-cchHHHHHHHHHHHcCC--CCCceeEeeeeeeeccCCCce
Q 011508          163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHR-GASKSFIAECQALRSIR--HRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       163 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ..+.|+.|.++.||+....    +..+++|+..  .... .....+.+|..+++.+.  +..+.+++.++....  ..+.
T Consensus        42 ~~~~l~~G~sn~~y~v~~~----~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~  115 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP----GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGR  115 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS----SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSS
T ss_pred             eEEEcCCcccceEEEEEEC----CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCC
Confidence            3567899999999998743    2467788765  3221 12346788999999986  345777887754321  1135


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC------------------------------  287 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------  287 (484)
                      .++||||++|..+.+.      ....++..++..++.++++.|+.||...                              
T Consensus       116 ~~~vme~v~G~~l~~~------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQ------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             CEEEEECCCCBCCCCT------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEecCCeecCCC------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence            7899999998777431      1223678888899999999999999631                              


Q ss_pred             -------------------------CCCeeecCCCCCCeeecCCCc--eEEcccCccccc
Q 011508          288 -------------------------ETPIVHCDLKPSNVLLDGELT--AHVSDFGLAKFL  320 (484)
Q Consensus       288 -------------------------~~~ivH~dlk~~NIll~~~~~--~kl~Dfg~a~~~  320 (484)
                                               ...++|||+++.||+++.++.  +.|+||+.+...
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                     256999999999999987753  689999988754

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=98.97  E-value=9.8e-10  Score=96.26  Aligned_cols=70  Identities=21%  Similarity=0.299  Sum_probs=34.8

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCC
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGN   75 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n   75 (484)
                      ++|+|+ .+|..+.  ++|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..|. ...+.+|+.+++++|
T Consensus        18 ~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           18 SNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            344454 4554332  34555555555555 4555555555555555555555544443 234445555555555

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=98.97  E-value=6.8e-10  Score=97.22  Aligned_cols=79  Identities=22%  Similarity=0.304  Sum_probs=53.6

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++.+|..|+++++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.+|.. ..+++++.+++++|+.-|
T Consensus        61 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           61 LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            4667777666777777777777777777777666666677777777777777777766543 456667777777775433

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.93  E-value=1.6e-09  Score=93.56  Aligned_cols=80  Identities=20%  Similarity=0.188  Sum_probs=65.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..++.+++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.++.. ..+++++.+++++| .+.
T Consensus        35 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~  113 (177)
T 2o6r_A           35 LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTN-QLK  113 (177)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CCS
T ss_pred             eCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCC-cce
Confidence            5789998655566799999999999999999555555789999999999999999887764 67889999999999 565


Q ss_pred             CC
Q 011508           80 GG   81 (484)
Q Consensus        80 g~   81 (484)
                      +-
T Consensus       114 ~~  115 (177)
T 2o6r_A          114 SV  115 (177)
T ss_dssp             CC
T ss_pred             Ee
Confidence            43

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=98.92  E-value=1.4e-09  Score=97.50  Aligned_cols=79  Identities=25%  Similarity=0.251  Sum_probs=64.4

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCcc-ccCCCCCCeeeccccceecccccc-cccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKY-LENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+|++..|..|+.+++|+.|+|++|+|+ .+|.. +..+++|+.|+|++|+|++..|.. ..+++++.+++++| .+
T Consensus        63 Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l  140 (220)
T 2v9t_B           63 LSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDN-KL  140 (220)
T ss_dssp             CCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CC
T ss_pred             CCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCC-cC
Confidence            6789999777888999999999999999999 55554 678999999999999998887753 56788888889888 45


Q ss_pred             cCC
Q 011508           79 CGG   81 (484)
Q Consensus        79 ~g~   81 (484)
                      .+.
T Consensus       141 ~~~  143 (220)
T 2v9t_B          141 QTI  143 (220)
T ss_dssp             SCC
T ss_pred             CEE
Confidence            543

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=98.92  E-value=1.1e-09  Score=103.87  Aligned_cols=82  Identities=26%  Similarity=0.397  Sum_probs=70.0

Q ss_pred             CCCCcccc--cCchhhhCCCCCCEEeCcC-CccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCc
Q 011508            1 MNGNFFQG--NIPSSLSSLRGIENLDLSQ-NNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNV   76 (484)
Q Consensus         1 l~~n~l~g--~~p~~~~~l~~l~~l~ls~-N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~   76 (484)
                      |++|+++|  .+|..++++++|++|+|++ |+++|.+|..++++++|+.|+|++|+++|.+|. ...+++++.+++++| 
T Consensus        57 L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N-  135 (313)
T 1ogq_A           57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYN-  135 (313)
T ss_dssp             EECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSS-
T ss_pred             CCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCC-
Confidence            46788998  8999999999999999995 999999999999999999999999999988876 467888999999998 


Q ss_pred             cccCCCc
Q 011508           77 NLCGGIS   83 (484)
Q Consensus        77 ~l~g~~~   83 (484)
                      .+.+..+
T Consensus       136 ~l~~~~p  142 (313)
T 1ogq_A          136 ALSGTLP  142 (313)
T ss_dssp             EEESCCC
T ss_pred             ccCCcCC
Confidence            5665443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=98.91  E-value=1.7e-09  Score=96.87  Aligned_cols=81  Identities=15%  Similarity=0.117  Sum_probs=69.5

Q ss_pred             CCCCcccccCch-hhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPS-SLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~-~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+|++..|. .|+.+++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.+|. ...+++++.+++++| .+
T Consensus        39 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l  117 (220)
T 2v70_A           39 LNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSN-RI  117 (220)
T ss_dssp             CCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTS-CC
T ss_pred             cCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCC-cC
Confidence            689999976564 589999999999999999977777899999999999999999998886 467889999999999 56


Q ss_pred             cCCC
Q 011508           79 CGGI   82 (484)
Q Consensus        79 ~g~~   82 (484)
                      .+..
T Consensus       118 ~~~~  121 (220)
T 2v70_A          118 TCVG  121 (220)
T ss_dssp             CCBC
T ss_pred             CeEC
Confidence            5543

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=98.91  E-value=1.6e-09  Score=97.68  Aligned_cols=79  Identities=19%  Similarity=0.197  Sum_probs=58.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|+|++..|..++.+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|+..++....+.+++.+++++| .+.+
T Consensus        71 L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N-~l~~  149 (229)
T 3e6j_A           71 LGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQN-QLKS  149 (229)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSS-CCCC
T ss_pred             CCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCC-cCCc
Confidence            577888733334568888888888888888855455567888888888888888855555567778888888888 4544

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=98.90  E-value=1.8e-09  Score=92.83  Aligned_cols=77  Identities=16%  Similarity=0.207  Sum_probs=68.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      +++|+|+ .+|..+.  ++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.++.. ..+.+|+.+++++| .+.
T Consensus        19 ~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N-~l~   94 (174)
T 2r9u_A           19 CQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN-HLK   94 (174)
T ss_dssp             CCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CCC
T ss_pred             eCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC-ccc
Confidence            5789996 9999875  89999999999999888889999999999999999999987764 67899999999999 555


Q ss_pred             CC
Q 011508           80 GG   81 (484)
Q Consensus        80 g~   81 (484)
                      +-
T Consensus        95 ~l   96 (174)
T 2r9u_A           95 SI   96 (174)
T ss_dssp             CC
T ss_pred             ee
Confidence            43

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.90  E-value=1.5e-09  Score=113.25  Aligned_cols=80  Identities=23%  Similarity=0.253  Sum_probs=57.8

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-ccc-ccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVF-SNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~-~~~~~~~~~~n~~l   78 (484)
                      |++|+|++.+|..|++|++|+.|+|++|+|++..|..+.++++|+.|||++|+|++.+|.. ..+ ++++.+++++||..
T Consensus       501 Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~  580 (635)
T 4g8a_A          501 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA  580 (635)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred             CCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence            5677777777777777777777777777777666666777777777777777777777654 333 56777777777766


Q ss_pred             cC
Q 011508           79 CG   80 (484)
Q Consensus        79 ~g   80 (484)
                      |.
T Consensus       581 C~  582 (635)
T 4g8a_A          581 CT  582 (635)
T ss_dssp             CS
T ss_pred             cc
Confidence            54

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.89  E-value=1.7e-09  Score=110.80  Aligned_cols=98  Identities=23%  Similarity=0.223  Sum_probs=72.8

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|+|+ .+|. +++|++|+.|+|++|+|+ .+|..+++|++|+.|+|++|+|++ +|..+.+++|+.|++++| .+.+
T Consensus       448 Ls~n~l~-~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~l~~l~~L~~L~Ls~N-~l~~  522 (567)
T 1dce_A          448 LAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNN-RLQQ  522 (567)
T ss_dssp             CTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSS-CCCS
T ss_pred             ecCCCCC-CCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-CcccCCCCCCcEEECCCC-CCCC
Confidence            5788888 4786 889999999999999998 888889999999999999999987 456677888888999888 6666


Q ss_pred             CC-ccccccccccccccccccccce
Q 011508           81 GI-SELHLCTCSTKESKQSRSRSLK  104 (484)
Q Consensus        81 ~~-~~~~~~~c~~~~~~~~~~~~~~  104 (484)
                      .. +. ....++.......+.+.+.
T Consensus       523 ~~~p~-~l~~l~~L~~L~L~~N~l~  546 (567)
T 1dce_A          523 SAAIQ-PLVSCPRLVLLNLQGNSLC  546 (567)
T ss_dssp             SSTTG-GGGGCTTCCEEECTTSGGG
T ss_pred             CCCcH-HHhcCCCCCEEEecCCcCC
Confidence            53 22 2233444444444444433

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.88  E-value=1e-09  Score=103.54  Aligned_cols=195  Identities=16%  Similarity=0.134  Sum_probs=120.2

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-CCC--ceeEeeeeeeeccCCCceeeE
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRN--LVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~~~~~~~~~l  240 (484)
                      .+.++.|.+..||+..       ..+++|+....  .....+.+|.++++.+. +..  +.+++.....  ...-...++
T Consensus        25 i~~~~~G~~n~v~~v~-------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~   93 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFA   93 (304)
T ss_dssp             CCEEEECSSEEEEEST-------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCE
T ss_pred             eEecCCCCcceEEEEC-------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceE
Confidence            4568999999999863       34888875422  23467889999998883 333  3334433211  011124578


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC---------------------------------  287 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------  287 (484)
                      |||+++|.++.+...      ..++..++..++.++++.++.||...                                 
T Consensus        94 vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           94 GFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             EEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             EEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            999999988865332      13677778888888888888888511                                 


Q ss_pred             ----------------------CCCeeecCCCCCCeeecC--CCceEEcccCcccccccccccCCCCcc-------cccc
Q 011508          288 ----------------------ETPIVHCDLKPSNVLLDG--ELTAHVSDFGLAKFLPEAANNLSSNQS-------SSVG  336 (484)
Q Consensus       288 ----------------------~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~-------~~~~  336 (484)
                                            ...++|+|++|.||++++  +..+.|+||+.+...+...........       ....
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence                                  135799999999999998  556889999998765332110000000       0000


Q ss_pred             ccccccccC-ccccCCCCCCcccceehhhHHHHHHHhCCCCC
Q 011508          337 VKGTVGYAA-PEYGMGSEVSTSGDVYSFGILLLEMFTGKGPT  377 (484)
Q Consensus       337 ~~g~~~y~a-PE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~  377 (484)
                      ....++... |+...  ......+.|++|.++|.+.+|..+|
T Consensus       248 ~l~~Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            001111111 22111  0112258899999999999999775

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=98.87  E-value=2.7e-09  Score=91.39  Aligned_cols=78  Identities=18%  Similarity=0.235  Sum_probs=68.6

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      +++|+|+ .+|..+.  ++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.+|.. ..+++++.+++++| .+.
T Consensus        16 ~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N-~l~   91 (170)
T 3g39_A           16 CSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN-QLK   91 (170)
T ss_dssp             CTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CCC
T ss_pred             eCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC-ccC
Confidence            5789998 7998774  89999999999999877889999999999999999999888865 67899999999999 565


Q ss_pred             CCC
Q 011508           80 GGI   82 (484)
Q Consensus        80 g~~   82 (484)
                      +-+
T Consensus        92 ~~~   94 (170)
T 3g39_A           92 SIP   94 (170)
T ss_dssp             CCC
T ss_pred             EeC
Confidence            543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.86  E-value=2.5e-09  Score=109.54  Aligned_cols=79  Identities=28%  Similarity=0.402  Sum_probs=71.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccc--ccccccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEV--PIKGVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~--p~~~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+|+ .+|..+++|++|+.|+|++|+|++ +| .+++|++|+.|+|++|+|++.+  +....+++|+.+++++| .+
T Consensus       470 Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N-~l  545 (567)
T 1dce_A          470 LSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN-SL  545 (567)
T ss_dssp             CCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTS-GG
T ss_pred             cCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCC-cC
Confidence            6899999 999999999999999999999995 88 8999999999999999999984  45588999999999999 56


Q ss_pred             cCCCc
Q 011508           79 CGGIS   83 (484)
Q Consensus        79 ~g~~~   83 (484)
                      ++.++
T Consensus       546 ~~~~~  550 (567)
T 1dce_A          546 CQEEG  550 (567)
T ss_dssp             GGSSS
T ss_pred             CCCcc
Confidence            66543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.85  E-value=1.8e-09  Score=90.19  Aligned_cols=77  Identities=19%  Similarity=0.270  Sum_probs=67.8

Q ss_pred             CCCCccc-ccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCccc
Q 011508            1 MNGNFFQ-GNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~-g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+++ |.+|..++.+++|+.|+|++|++++.  ..++++++|+.|+|++|++++.+|.. ..+++++.+++++| .+
T Consensus        24 l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N-~i  100 (149)
T 2je0_A           24 LDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGN-KI  100 (149)
T ss_dssp             CTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTS-CC
T ss_pred             ccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCC-cC
Confidence            5789998 89999999999999999999999954  77999999999999999999977765 45899999999999 45


Q ss_pred             cC
Q 011508           79 CG   80 (484)
Q Consensus        79 ~g   80 (484)
                      .+
T Consensus       101 ~~  102 (149)
T 2je0_A          101 KD  102 (149)
T ss_dssp             CS
T ss_pred             CC
Confidence            54

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=98.85  E-value=3.9e-09  Score=94.51  Aligned_cols=81  Identities=19%  Similarity=0.175  Sum_probs=71.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..|..+++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.++.. ..+.+++.+++++| .+.
T Consensus        39 l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N-~l~  117 (220)
T 2v9t_B           39 LEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNAN-KIN  117 (220)
T ss_dssp             CCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CCC
T ss_pred             CCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCC-CCC
Confidence            6899999666668999999999999999999888999999999999999999999777654 67899999999999 555


Q ss_pred             CCC
Q 011508           80 GGI   82 (484)
Q Consensus        80 g~~   82 (484)
                      +..
T Consensus       118 ~~~  120 (220)
T 2v9t_B          118 CLR  120 (220)
T ss_dssp             CCC
T ss_pred             EeC
Confidence            443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.85  E-value=3.3e-09  Score=102.16  Aligned_cols=80  Identities=25%  Similarity=0.242  Sum_probs=70.3

Q ss_pred             CCC-CcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCcccc
Q 011508            1 MNG-NFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~-n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++ |+|++..|..|++|++|+.|+|++|+|+|..|..|.+|++|+.|+|++|+|++.++.......|+.+++.+|+.-|
T Consensus        38 l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~L~~l~l~~N~~~c  117 (347)
T 2ifg_A           38 IENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC  117 (347)
T ss_dssp             CCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred             ccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccceeCHHHcccCCceEEEeeCCCccC
Confidence            575 9999777789999999999999999999988889999999999999999999888765444449999999997666


Q ss_pred             C
Q 011508           80 G   80 (484)
Q Consensus        80 g   80 (484)
                      .
T Consensus       118 ~  118 (347)
T 2ifg_A          118 S  118 (347)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.84  E-value=5.4e-09  Score=90.12  Aligned_cols=77  Identities=18%  Similarity=0.228  Sum_probs=56.6

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      +++|+++ .+|..+.  ++|+.|+|++|++++..|..+.++++|+.|+|++|+|++.++.. ..+.+++.+++++| .+.
T Consensus        14 ~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N-~l~   89 (177)
T 2o6r_A           14 CNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN-KLQ   89 (177)
T ss_dssp             CCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CCC
T ss_pred             ecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC-Ccc
Confidence            3567777 6775543  68888888888888555555678888888888888888776654 56778888888888 555


Q ss_pred             CC
Q 011508           80 GG   81 (484)
Q Consensus        80 g~   81 (484)
                      +.
T Consensus        90 ~~   91 (177)
T 2o6r_A           90 SL   91 (177)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.82  E-value=2.9e-09  Score=111.12  Aligned_cols=81  Identities=15%  Similarity=0.210  Sum_probs=64.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCC----------------------------------------------------
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQN----------------------------------------------------   28 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N----------------------------------------------------   28 (484)
                      |++|+++|.+|+++++|++|+.|||++|                                                    
T Consensus        88 L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~  167 (636)
T 4eco_A           88 LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCIN  167 (636)
T ss_dssp             CTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHH
T ss_pred             ecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhh
Confidence            5788888888888899999999998887                                                    


Q ss_pred             --------------------------ccccccCccccCCCCCCeeeccccceecc-----------------cc-ccc--
Q 011508           29 --------------------------NLSGRIPKYLENFPFLQNLNLSFNHFEGE-----------------VP-IKG--   62 (484)
Q Consensus        29 --------------------------~l~g~~p~~~~~l~~L~~l~ls~N~l~g~-----------------~p-~~~--   62 (484)
                                                +|+| ||.+++++++|+.|+|++|+|+|.                 +| ..+  
T Consensus       168 ~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~  246 (636)
T 4eco_A          168 SDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWD  246 (636)
T ss_dssp             HCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGG
T ss_pred             cCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhc
Confidence                                      4556 888888888899999998888883                 44 446  


Q ss_pred             ccccCcccccCCCccccCCCc
Q 011508           63 VFSNSSAISLDGNVNLCGGIS   83 (484)
Q Consensus        63 ~~~~~~~~~~~~n~~l~g~~~   83 (484)
                      .+++++.+++++| .+.|..|
T Consensus       247 ~l~~L~~L~L~~n-~l~~~~p  266 (636)
T 4eco_A          247 NLKDLTDVEVYNC-PNLTKLP  266 (636)
T ss_dssp             GCTTCCEEEEECC-TTCSSCC
T ss_pred             ccCCCCEEEecCC-cCCccCh
Confidence            7888888888888 5566544

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=98.82  E-value=8.2e-09  Score=93.04  Aligned_cols=77  Identities=19%  Similarity=0.247  Sum_probs=59.2

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccC-ccccCCCCCCeeeccccceecccccc-cccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIP-KYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p-~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+|++..|..++.+++|+.|+|++|+|+ .+| ..+..+++|+.|+|++|+|++.++.. ..+.+++.+++++| .+
T Consensus        47 Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N-~l  124 (229)
T 3e6j_A           47 LHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCN-KL  124 (229)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CC
T ss_pred             cCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCC-cc
Confidence            5778888777788888888888888888887 444 44678888888888888888776654 56778888888888 44


Q ss_pred             c
Q 011508           79 C   79 (484)
Q Consensus        79 ~   79 (484)
                      .
T Consensus       125 ~  125 (229)
T 3e6j_A          125 T  125 (229)
T ss_dssp             C
T ss_pred             c
Confidence            4

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.82  E-value=2.7e-09  Score=114.11  Aligned_cols=82  Identities=13%  Similarity=0.178  Sum_probs=63.3

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeC-cCCccccc----------------------------------------------
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDL-SQNNLSGR----------------------------------------------   33 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~l-s~N~l~g~----------------------------------------------   33 (484)
                      |++|+|+|.+|++|++|++|+.||| ++|.++|.                                              
T Consensus       330 Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~  409 (876)
T 4ecn_A          330 LAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAIN  409 (876)
T ss_dssp             CTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHH
T ss_pred             CccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhh
Confidence            5788888888888888888888888 77766665                                              


Q ss_pred             ------------------------------cCccccCCCCCCeeeccccceec-----------------ccc-ccc--c
Q 011508           34 ------------------------------IPKYLENFPFLQNLNLSFNHFEG-----------------EVP-IKG--V   63 (484)
Q Consensus        34 ------------------------------~p~~~~~l~~L~~l~ls~N~l~g-----------------~~p-~~~--~   63 (484)
                                                    ||..+++|++|+.|+|++|+|+|                 .+| ..+  .
T Consensus       410 ~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~  489 (876)
T 4ecn_A          410 RNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSN  489 (876)
T ss_dssp             TCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGG
T ss_pred             hCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhcc
Confidence                                          78888888888888888888888                 244 335  6


Q ss_pred             cccCcccccCCCccccCCCc
Q 011508           64 FSNSSAISLDGNVNLCGGIS   83 (484)
Q Consensus        64 ~~~~~~~~~~~n~~l~g~~~   83 (484)
                      +++|+.+++++| .+.|..|
T Consensus       490 L~~L~~L~Ls~N-~l~~~iP  508 (876)
T 4ecn_A          490 LKDLTDVELYNC-PNMTQLP  508 (876)
T ss_dssp             CTTCCEEEEESC-TTCCSCC
T ss_pred             CCCCCEEECcCC-CCCccCh
Confidence            788888888888 5555544

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=98.81  E-value=5.8e-09  Score=95.47  Aligned_cols=80  Identities=19%  Similarity=0.196  Sum_probs=61.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..++.+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++.++. ...+++++.+++++| .+.
T Consensus        90 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~  168 (251)
T 3m19_A           90 LANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN-QLQ  168 (251)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CCS
T ss_pred             CCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCC-cCC
Confidence            578888866666778888888888888888854445567888888888888888877774 466788888888888 555


Q ss_pred             CC
Q 011508           80 GG   81 (484)
Q Consensus        80 g~   81 (484)
                      +.
T Consensus       169 ~~  170 (251)
T 3m19_A          169 SV  170 (251)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.81  E-value=2.2e-09  Score=89.71  Aligned_cols=78  Identities=23%  Similarity=0.225  Sum_probs=68.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccc--ccccccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEV--PIKGVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~--p~~~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+|++.  ..++++++|+.|+|++|++++.+|..+..+++|+.|+|++|++++..  +....+++++.+++++| .+
T Consensus        49 l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N-~l  125 (149)
T 2je0_A           49 TINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC-EV  125 (149)
T ss_dssp             CTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTC-GG
T ss_pred             CcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCC-cc
Confidence            578999955  78999999999999999999889988888999999999999999854  45578899999999999 55


Q ss_pred             cCC
Q 011508           79 CGG   81 (484)
Q Consensus        79 ~g~   81 (484)
                      .+.
T Consensus       126 ~~~  128 (149)
T 2je0_A          126 TNL  128 (149)
T ss_dssp             GGS
T ss_pred             cch
Confidence            544

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=98.81  E-value=4.6e-09  Score=100.21  Aligned_cols=73  Identities=18%  Similarity=0.265  Sum_probs=54.4

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      |++|+|+ .+|..++++++|+.|+|++|+++ .+|..++++++|+.|+|++|++.+.+|.. ..+++++.+++++|
T Consensus       190 L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n  263 (328)
T 4fcg_A          190 LEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC  263 (328)
T ss_dssp             EEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTC
T ss_pred             CcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCC
Confidence            3567777 77777777778888888888777 46767777777888888877777777653 56677777777777

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.81  E-value=7e-09  Score=91.95  Aligned_cols=79  Identities=20%  Similarity=0.234  Sum_probs=62.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..++.+++|++|+|++|+|++..|..+.++++|+.|+|++|+|++.++.. ..+++++.+++++| .+.
T Consensus        59 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~  137 (208)
T 2o6s_A           59 LGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQN-QLK  137 (208)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CCS
T ss_pred             CCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCC-ccc
Confidence            5788888554556788999999999999999554455788999999999999998877753 66788888889888 454


Q ss_pred             C
Q 011508           80 G   80 (484)
Q Consensus        80 g   80 (484)
                      +
T Consensus       138 ~  138 (208)
T 2o6s_A          138 S  138 (208)
T ss_dssp             C
T ss_pred             e
Confidence            4

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.81  E-value=3.3e-09  Score=90.59  Aligned_cols=77  Identities=25%  Similarity=0.335  Sum_probs=67.7

Q ss_pred             CCCCccc-ccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCccc
Q 011508            1 MNGNFFQ-GNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~-g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+++ |.+|..+..+++|+.|+|++|.+++ + ..+..+++|+.|+|++|++++.+|.. ..+++++.+++++| .+
T Consensus        31 l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l  107 (168)
T 2ell_A           31 LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-V-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN-KL  107 (168)
T ss_dssp             CCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCC-C-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSS-SC
T ss_pred             CCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCC-h-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCC-cc
Confidence            5789998 8999999999999999999999995 4 78999999999999999999977765 44899999999999 56


Q ss_pred             cC
Q 011508           79 CG   80 (484)
Q Consensus        79 ~g   80 (484)
                      .+
T Consensus       108 ~~  109 (168)
T 2ell_A          108 KD  109 (168)
T ss_dssp             CS
T ss_pred             Cc
Confidence            55

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.80  E-value=7.4e-09  Score=95.97  Aligned_cols=81  Identities=19%  Similarity=0.205  Sum_probs=62.3

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|++++..|..++++++|+.|+|++|++++..|..+..+++|+.|+|++|+|++.+|.. ..+++++.+++++| .+.
T Consensus       116 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~  194 (272)
T 3rfs_A          116 LVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN-QLK  194 (272)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CCS
T ss_pred             CCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC-cCC
Confidence            5778888666666788888888888888888655556788888888888888888777654 56778888888888 555


Q ss_pred             CCC
Q 011508           80 GGI   82 (484)
Q Consensus        80 g~~   82 (484)
                      +.+
T Consensus       195 ~~~  197 (272)
T 3rfs_A          195 SVP  197 (272)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.79  E-value=3.6e-09  Score=111.77  Aligned_cols=78  Identities=26%  Similarity=0.321  Sum_probs=55.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|+|+ .||.+|++|++|+.|||++|+|+ .||..|++|++|+.|+|++|.|+..++..+.+.+|+.|++++| .+.+
T Consensus       254 Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N-~l~~  330 (727)
T 4b8c_D          254 LNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGN-PLEK  330 (727)
T ss_dssp             CTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTS-CCCS
T ss_pred             eeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCC-ccCC
Confidence            5677777 77777777777777777777777 7777777777777777777777644444566677777777777 4544


Q ss_pred             C
Q 011508           81 G   81 (484)
Q Consensus        81 ~   81 (484)
                      .
T Consensus       331 ~  331 (727)
T 4b8c_D          331 Q  331 (727)
T ss_dssp             H
T ss_pred             C
Confidence            3

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.75  E-value=7.1e-09  Score=91.07  Aligned_cols=73  Identities=16%  Similarity=0.192  Sum_probs=50.1

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCc
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNV   76 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~   76 (484)
                      ++|+++  .++.++.+++|+.|+|++|++++..|..++.+++|+.|+|++|++++..|. ...+++++.+++++|.
T Consensus        74 ~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~  147 (197)
T 4ezg_A           74 NNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG  147 (197)
T ss_dssp             ESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred             cCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence            455443  334677777777777777777776777777777777777777777764443 3566777777777774

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=98.75  E-value=1.3e-08  Score=93.03  Aligned_cols=78  Identities=17%  Similarity=0.167  Sum_probs=54.4

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|++++..|..++++++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.++.. ..+++++.+++++| .+.
T Consensus        42 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~  120 (251)
T 3m19_A           42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGN-QLK  120 (251)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSS-CCC
T ss_pred             ccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCC-cCC
Confidence            4667777666667777777777777777777666666777777777777777777666543 55667777777777 444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.72  E-value=5.7e-09  Score=89.10  Aligned_cols=79  Identities=22%  Similarity=0.199  Sum_probs=64.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccc--ccccccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEV--PIKGVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~--p~~~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+|++.  ..++.+++|+.|+|++|++++.+|..+.++++|+.|+|++|++++..  +....+++++.+++++| .+
T Consensus        56 l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N-~l  132 (168)
T 2ell_A           56 LINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC-EV  132 (168)
T ss_dssp             EESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSS-GG
T ss_pred             CcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCC-cC
Confidence            467888854  77889999999999999999778888888999999999999998854  45567888999999998 45


Q ss_pred             cCCC
Q 011508           79 CGGI   82 (484)
Q Consensus        79 ~g~~   82 (484)
                      .+.+
T Consensus       133 ~~~~  136 (168)
T 2ell_A          133 TNLN  136 (168)
T ss_dssp             GTST
T ss_pred             cchH
Confidence            5443

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=98.72  E-value=2.3e-08  Score=92.67  Aligned_cols=73  Identities=22%  Similarity=0.261  Sum_probs=44.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      |++|++++ +| .++++++|++|+|++|++++..|..+.++++|+.|+|++|++++.+|.. ..+++++.+++++|
T Consensus        70 l~~n~l~~-~~-~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  143 (272)
T 3rfs_A           70 LGGNKLHD-IS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHN  143 (272)
T ss_dssp             CTTSCCCC-CG-GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCCCCCCC-ch-hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCC
Confidence            45566663 33 5666666666666666666544444566666666666666666555542 45566666666666

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.72  E-value=1.3e-08  Score=101.70  Aligned_cols=81  Identities=21%  Similarity=0.221  Sum_probs=62.3

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..|.++++|+.|+|++|++++..|..+.++++|+.|+|++|+|++.++.. ..+++++.+++++||..|
T Consensus       225 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  304 (452)
T 3zyi_A          225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC  304 (452)
T ss_dssp             CTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred             CcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence            5677888777778888888888888888888777777888888888888888888766653 556778888888887666


Q ss_pred             CC
Q 011508           80 GG   81 (484)
Q Consensus        80 g~   81 (484)
                      ..
T Consensus       305 dC  306 (452)
T 3zyi_A          305 DC  306 (452)
T ss_dssp             ST
T ss_pred             CC
Confidence            53

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.72  E-value=1.2e-08  Score=101.50  Aligned_cols=81  Identities=20%  Similarity=0.208  Sum_probs=58.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..|.++++|+.|+|++|++++..|..+.++++|+.|+|++|+|++.++.. ..+.+++.+++++||..|
T Consensus       214 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C  293 (440)
T 3zyj_A          214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC  293 (440)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred             CCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence            4677777666777777777777777777777666777777777777777777777666543 456777777788887666


Q ss_pred             CC
Q 011508           80 GG   81 (484)
Q Consensus        80 g~   81 (484)
                      +.
T Consensus       294 dC  295 (440)
T 3zyj_A          294 NC  295 (440)
T ss_dssp             SS
T ss_pred             CC
Confidence            43

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=98.71  E-value=2.4e-08  Score=88.49  Aligned_cols=80  Identities=19%  Similarity=0.182  Sum_probs=67.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..++++++|+.|+|++|+|++..+..+.++++|+.|+|++|+|++.++.. ..+++++.+++++| .+.
T Consensus        35 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~  113 (208)
T 2o6s_A           35 LETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTN-QLQ  113 (208)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CCC
T ss_pred             cCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCC-cCc
Confidence            6889999655567899999999999999999554555789999999999999999877764 67899999999999 555


Q ss_pred             CC
Q 011508           80 GG   81 (484)
Q Consensus        80 g~   81 (484)
                      +.
T Consensus       114 ~~  115 (208)
T 2o6s_A          114 SL  115 (208)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.71  E-value=1.9e-08  Score=94.12  Aligned_cols=78  Identities=23%  Similarity=0.208  Sum_probs=64.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..|+.+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|++.++.. ..+++++.+++++| .+.
T Consensus       107 l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N-~l~  185 (290)
T 1p9a_G          107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN-SLY  185 (290)
T ss_dssp             CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSS-CCC
T ss_pred             CCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCC-cCC
Confidence            6789999666678999999999999999999655566788999999999999999777654 56788888999888 444

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.70  E-value=1.8e-08  Score=100.76  Aligned_cols=79  Identities=27%  Similarity=0.249  Sum_probs=58.6

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|++++..|..|+++++|+.|+|++|++++..|..+.++++|+.|+|++|++++.+|. ...+++++.+++++| .+.
T Consensus       306 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~  384 (455)
T 3v47_A          306 LAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTN-QLK  384 (455)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS-CCS
T ss_pred             CCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCC-ccc
Confidence            567778777777788888888888888888766677777788888888888888777664 356777777777777 444


Q ss_pred             C
Q 011508           80 G   80 (484)
Q Consensus        80 g   80 (484)
                      +
T Consensus       385 ~  385 (455)
T 3v47_A          385 S  385 (455)
T ss_dssp             C
T ss_pred             c
Confidence            4

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.70  E-value=7.9e-09  Score=107.82  Aligned_cols=77  Identities=12%  Similarity=0.150  Sum_probs=69.0

Q ss_pred             CCcccccCchhhhCCCCCCEEeCcCCccccc-----------------cCcccc--CCCCCCeeeccccceecccccc-c
Q 011508            3 GNFFQGNIPSSLSSLRGIENLDLSQNNLSGR-----------------IPKYLE--NFPFLQNLNLSFNHFEGEVPIK-G   62 (484)
Q Consensus         3 ~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~-----------------~p~~~~--~l~~L~~l~ls~N~l~g~~p~~-~   62 (484)
                      +|+|+| ||.+++++++|++|+|++|+|+|.                 +|..++  ++++|+.|+|++|++.|.+|.. .
T Consensus       192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~  270 (636)
T 4eco_A          192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK  270 (636)
T ss_dssp             SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred             cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence            689998 999999999999999999999986                 999999  9999999999999999988864 7


Q ss_pred             ccccCcccccCCCccccC
Q 011508           63 VFSNSSAISLDGNVNLCG   80 (484)
Q Consensus        63 ~~~~~~~~~~~~n~~l~g   80 (484)
                      .+++++.+++++|..+.|
T Consensus       271 ~l~~L~~L~Ls~n~~l~~  288 (636)
T 4eco_A          271 ALPEMQLINVACNRGISG  288 (636)
T ss_dssp             TCSSCCEEECTTCTTSCH
T ss_pred             cCCCCCEEECcCCCCCcc
Confidence            788999999999953666

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.69  E-value=1.9e-08  Score=106.24  Aligned_cols=106  Identities=15%  Similarity=0.121  Sum_probs=81.3

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|+|. .||..+++|++|+.|+|++|+|+ .||..|++|++|+.|+|++|+|+..++..+.+.+|..|++++| .+. 
T Consensus       231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N-~l~-  306 (727)
T 4b8c_D          231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDN-MVT-  306 (727)
T ss_dssp             CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSS-CCC-
T ss_pred             CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCC-CCC-
Confidence            6889998 99999999999999999999999 9999999999999999999999955445688899999999999 554 


Q ss_pred             CCccccccccccccccccccccceEEehhhh
Q 011508           81 GISELHLCTCSTKESKQSRSRSLKLIIPIVT  111 (484)
Q Consensus        81 ~~~~~~~~~c~~~~~~~~~~~~~~~~i~~v~  111 (484)
                      ..+. ....+........+.+.+...++..+
T Consensus       307 ~lp~-~~~~l~~L~~L~L~~N~l~~~~p~~~  336 (727)
T 4b8c_D          307 TLPW-EFGNLCNLQFLGVEGNPLEKQFLKIL  336 (727)
T ss_dssp             CCCS-STTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred             ccCh-hhhcCCCccEEeCCCCccCCCChHHH
Confidence            2222 13344444444555555544444333

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.69  E-value=3.6e-08  Score=102.71  Aligned_cols=79  Identities=18%  Similarity=0.083  Sum_probs=62.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|.+|++|++|++|||++|+|++..|.+|.+|++|+.|+|++|+|++.+|.. ..+.+|+.+++++| .+.
T Consensus        59 Ls~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N-~l~  137 (635)
T 4g8a_A           59 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET-NLA  137 (635)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTS-CCC
T ss_pred             eeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCC-cCC
Confidence            6788888555567888888888888888888655667888888888888888888777653 66778888888887 444


Q ss_pred             C
Q 011508           80 G   80 (484)
Q Consensus        80 g   80 (484)
                      +
T Consensus       138 ~  138 (635)
T 4g8a_A          138 S  138 (635)
T ss_dssp             C
T ss_pred             C
Confidence            3

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.69  E-value=1.4e-08  Score=94.79  Aligned_cols=79  Identities=20%  Similarity=0.189  Sum_probs=57.8

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|++++..|..++.+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|.. ..+++++.+++++| .+.
T Consensus       136 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~  214 (285)
T 1ozn_A          136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN-NLS  214 (285)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS-CCS
T ss_pred             CCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCC-cCC
Confidence            5678887555556788888888888888888544445778888888888888888776643 56677888888887 454


Q ss_pred             C
Q 011508           80 G   80 (484)
Q Consensus        80 g   80 (484)
                      +
T Consensus       215 ~  215 (285)
T 1ozn_A          215 A  215 (285)
T ss_dssp             C
T ss_pred             c
Confidence            4

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=98.68  E-value=1.4e-08  Score=96.76  Aligned_cols=82  Identities=15%  Similarity=0.151  Sum_probs=73.2

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+++ .+|..++++++|+.|+|++|++.|.+|..++++++|+.|+|++|++.+.+|.. ..+++++.+++++| .+.
T Consensus       213 L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n-~~~  290 (328)
T 4fcg_A          213 IRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGC-VNL  290 (328)
T ss_dssp             EESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTC-TTC
T ss_pred             ccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCC-Cch
Confidence            4789999 68889999999999999999999999999999999999999999999999864 77899999999999 455


Q ss_pred             CCCcc
Q 011508           80 GGISE   84 (484)
Q Consensus        80 g~~~~   84 (484)
                      +..|.
T Consensus       291 ~~iP~  295 (328)
T 4fcg_A          291 SRLPS  295 (328)
T ss_dssp             CCCCG
T ss_pred             hhccH
Confidence            55543

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.67  E-value=2.9e-08  Score=91.88  Aligned_cols=79  Identities=20%  Similarity=0.235  Sum_probs=60.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|++++..|..++++++|+.|+|++|+|++..+..+..+++|+.|+|++|++++.++. ...+++++.+++++| .+.
T Consensus       116 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~  194 (270)
T 2o6q_A          116 LDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN-QLK  194 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS-CCS
T ss_pred             CCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC-cCC
Confidence            577888866666788888888888888888854444578888888888888888877664 356778888888888 444


Q ss_pred             C
Q 011508           80 G   80 (484)
Q Consensus        80 g   80 (484)
                      +
T Consensus       195 ~  195 (270)
T 2o6q_A          195 R  195 (270)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.67  E-value=1.9e-08  Score=104.47  Aligned_cols=75  Identities=24%  Similarity=0.224  Sum_probs=53.4

Q ss_pred             CCCCccccc-CchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCC
Q 011508            1 MNGNFFQGN-IPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~-~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      |++|++++. +|..++.+++|+.|+|++|++++..|..+.++++|+.|+|++|++++.+|.. ..+++++.+++++|
T Consensus       455 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N  531 (606)
T 3vq2_A          455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN  531 (606)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTS
T ss_pred             CCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCC
Confidence            466777763 6667777777777777777777766777777777777777777777765543 55667777777777

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.66  E-value=6.3e-09  Score=112.32  Aligned_cols=77  Identities=25%  Similarity=0.336  Sum_probs=62.2

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|+|++..|..++.+++|+.|+|++|+|++..|..+.  ++|+.|+|++|+|+|.+|..  +.++..+++++||..|.
T Consensus       487 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~  562 (844)
T 3j0a_A          487 LNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICE  562 (844)
T ss_dssp             CCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCS
T ss_pred             CCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccc
Confidence            577888877777788889999999999998854444444  78899999999998888853  67889999999998885


Q ss_pred             C
Q 011508           81 G   81 (484)
Q Consensus        81 ~   81 (484)
                      .
T Consensus       563 c  563 (844)
T 3j0a_A          563 C  563 (844)
T ss_dssp             S
T ss_pred             c
Confidence            4

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.64  E-value=3.4e-08  Score=93.14  Aligned_cols=81  Identities=28%  Similarity=0.359  Sum_probs=66.2

Q ss_pred             CCCCcccc-cCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCccc
Q 011508            1 MNGNFFQG-NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g-~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l   78 (484)
                      |++|++++ .+|..++.+++|+.|+|++|++++..|..+.++++|+.|+|++|++++..+. ...+++++.+++++| .+
T Consensus       157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l  235 (306)
T 2z66_A          157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN-HI  235 (306)
T ss_dssp             CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTS-CC
T ss_pred             CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCC-CC
Confidence            57888886 5788899999999999999999977788888899999999999999887663 356788888999988 55


Q ss_pred             cCCC
Q 011508           79 CGGI   82 (484)
Q Consensus        79 ~g~~   82 (484)
                      .+..
T Consensus       236 ~~~~  239 (306)
T 2z66_A          236 MTSK  239 (306)
T ss_dssp             CBCS
T ss_pred             cccC
Confidence            5543

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.64  E-value=1.5e-08  Score=108.45  Aligned_cols=77  Identities=12%  Similarity=0.078  Sum_probs=68.8

Q ss_pred             CCcccccCchhhhCCCCCCEEeCcCCcccc-----------------ccCcccc--CCCCCCeeeccccceecccccc-c
Q 011508            3 GNFFQGNIPSSLSSLRGIENLDLSQNNLSG-----------------RIPKYLE--NFPFLQNLNLSFNHFEGEVPIK-G   62 (484)
Q Consensus         3 ~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g-----------------~~p~~~~--~l~~L~~l~ls~N~l~g~~p~~-~   62 (484)
                      .|+|+| ||.+|++|++|+.|+|++|+|+|                 .||..++  +|++|+.|+|++|++.|.+|.. .
T Consensus       434 ~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~  512 (876)
T 4ecn_A          434 TNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLY  512 (876)
T ss_dssp             SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGG
T ss_pred             cCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHh
Confidence            589997 99999999999999999999998                 4999988  9999999999999999998864 7


Q ss_pred             ccccCcccccCCCccccC
Q 011508           63 VFSNSSAISLDGNVNLCG   80 (484)
Q Consensus        63 ~~~~~~~~~~~~n~~l~g   80 (484)
                      .+++|+.+++++|..+.|
T Consensus       513 ~L~~L~~L~Ls~N~~lsg  530 (876)
T 4ecn_A          513 DLPELQSLNIACNRGISA  530 (876)
T ss_dssp             GCSSCCEEECTTCTTSCH
T ss_pred             CCCCCCEEECcCCCCccc
Confidence            788999999999954666

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.64  E-value=9.5e-08  Score=88.60  Aligned_cols=79  Identities=18%  Similarity=0.071  Sum_probs=64.9

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|++++..|..++++++|+.|+|++|++++..|..+.++++|+.|+|++|++++..|. ...+.+++.+++++| .+.
T Consensus        35 ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~  113 (276)
T 2z62_A           35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET-NLA  113 (276)
T ss_dssp             CTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTS-CCC
T ss_pred             CCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCC-Ccc
Confidence            578899866666899999999999999999966666888999999999999999887765 366788888888888 444


Q ss_pred             C
Q 011508           80 G   80 (484)
Q Consensus        80 g   80 (484)
                      +
T Consensus       114 ~  114 (276)
T 2z62_A          114 S  114 (276)
T ss_dssp             C
T ss_pred             c
Confidence            3

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.63  E-value=1.9e-08  Score=86.65  Aligned_cols=73  Identities=16%  Similarity=0.180  Sum_probs=60.7

Q ss_pred             CCCCcccccCchhhhCCC-CCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLR-GIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~-~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+++ .+|. +..+. +|+.|+|++|+|++ + ..+..+++|+.|+|++|+|++.+|.. ..+++++.+++++| .+
T Consensus        26 l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~i  100 (176)
T 1a9n_A           26 LRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN-SL  100 (176)
T ss_dssp             CTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSC-CC
T ss_pred             eeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCC-cC
Confidence            5789998 6765 55554 99999999999995 4 67899999999999999999877665 67889999999999 44

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.63  E-value=4.1e-08  Score=94.99  Aligned_cols=78  Identities=21%  Similarity=0.166  Sum_probs=60.6

Q ss_pred             CCCCcccccCchhhh-CCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLS-SLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~-~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+|++..+..+. ++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. ...+.+|+.|++++| .+
T Consensus        46 Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~i  124 (361)
T 2xot_A           46 LSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNN-HI  124 (361)
T ss_dssp             CCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS-CC
T ss_pred             CCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCC-cc
Confidence            578888865566666 888888888888888866666788888888888888888877664 356778888888888 44


Q ss_pred             c
Q 011508           79 C   79 (484)
Q Consensus        79 ~   79 (484)
                      .
T Consensus       125 ~  125 (361)
T 2xot_A          125 V  125 (361)
T ss_dssp             C
T ss_pred             c
Confidence            3

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.62  E-value=4.7e-08  Score=91.39  Aligned_cols=72  Identities=24%  Similarity=0.335  Sum_probs=46.9

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n   75 (484)
                      |++|+|+ .+|.. +.+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|. ...+.+++.+++++|
T Consensus        62 L~~n~l~-~~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N  134 (290)
T 1p9a_G           62 LDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN  134 (290)
T ss_dssp             CTTSCCC-EEECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred             CCCCccC-cccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence            4566666 34443 66677777777777776 6666666677777777777777666554 255666667777666

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.62  E-value=7.5e-08  Score=99.94  Aligned_cols=75  Identities=19%  Similarity=0.093  Sum_probs=44.5

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n   75 (484)
                      |++|++++..|..|+++++|++|+|++|++++..|.+|.++++|+.|+|++|++++..|. ...+.+++.+++++|
T Consensus        39 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n  114 (606)
T 3vq2_A           39 LSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVET  114 (606)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTS
T ss_pred             CCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCC
Confidence            455666655555666666666666666666655555566666666666666666665443 245555555555555

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.59  E-value=4.8e-08  Score=92.12  Aligned_cols=79  Identities=18%  Similarity=0.275  Sum_probs=70.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCcccc-ccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSG-RIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g-~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l   78 (484)
                      |++|++++.+|..++.+++|+.|+|++|.+++ .+|..+..+++|+.|+|++|++++.+|.. ..+++++.+++++| .+
T Consensus       133 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N-~l  211 (306)
T 2z66_A          133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN-NF  211 (306)
T ss_dssp             CTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS-CC
T ss_pred             CCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCC-cc
Confidence            57899998899999999999999999999997 68999999999999999999999987754 67889999999999 45


Q ss_pred             cC
Q 011508           79 CG   80 (484)
Q Consensus        79 ~g   80 (484)
                      .+
T Consensus       212 ~~  213 (306)
T 2z66_A          212 FS  213 (306)
T ss_dssp             SB
T ss_pred             Cc
Confidence            44

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.58  E-value=6.1e-08  Score=99.31  Aligned_cols=79  Identities=19%  Similarity=0.115  Sum_probs=69.4

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|++++..|.+|+++++|++|+|++|++++..|..++++++|+.|+|++|++++.+|. ...+++++.+++++| .+.
T Consensus        33 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n-~l~  111 (549)
T 2z81_A           33 LSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGN-PYQ  111 (549)
T ss_dssp             CCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTC-CCS
T ss_pred             CcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCC-ccc
Confidence            678999988888999999999999999999987788899999999999999999988886 577889999999999 454


Q ss_pred             C
Q 011508           80 G   80 (484)
Q Consensus        80 g   80 (484)
                      +
T Consensus       112 ~  112 (549)
T 2z81_A          112 T  112 (549)
T ss_dssp             S
T ss_pred             c
Confidence            3

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.58  E-value=4.3e-08  Score=100.88  Aligned_cols=81  Identities=17%  Similarity=0.240  Sum_probs=61.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccc-cccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLS-GRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~-g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l   78 (484)
                      |++|++++.+|..++.+++|+.|+|++|+++ |.+|..+..+++|+.|+|++|++++.+|.. ..+++++.+++++| .+
T Consensus       428 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l  506 (570)
T 2z63_A          428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN-QL  506 (570)
T ss_dssp             CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS-CC
T ss_pred             CcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC-cC
Confidence            5678888777888888888888888888887 578888888888888888888888776643 56777888888887 55


Q ss_pred             cCCC
Q 011508           79 CGGI   82 (484)
Q Consensus        79 ~g~~   82 (484)
                      .+.+
T Consensus       507 ~~~~  510 (570)
T 2z63_A          507 KSVP  510 (570)
T ss_dssp             SCCC
T ss_pred             CCCC
Confidence            5543

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.58  E-value=3.4e-08  Score=102.50  Aligned_cols=74  Identities=23%  Similarity=0.296  Sum_probs=38.1

Q ss_pred             CCCCccccc---CchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCC
Q 011508            1 MNGNFFQGN---IPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~---~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      |++|++++.   .+..++.+++|+.|+|++|++++..|..+.++++|+.|+|++|++++.+|.. ..++++ .+++++|
T Consensus       456 L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N  533 (606)
T 3t6q_A          456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASN  533 (606)
T ss_dssp             CTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSS
T ss_pred             CCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCC
Confidence            345555542   1234555555555555555555555555555555555555555555554432 334444 4555555

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.58  E-value=6.2e-08  Score=98.59  Aligned_cols=77  Identities=19%  Similarity=0.144  Sum_probs=65.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|++++..|..|+++++|++|+|++|++++..|..++++++|+.|+|++|+|+. +|.. .+.+++.+++++| .+.+
T Consensus        28 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~-~l~~L~~L~L~~N-~l~~  104 (520)
T 2z7x_B           28 ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH-PTVNLKHLDLSFN-AFDA  104 (520)
T ss_dssp             CCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC-CCCCCSEEECCSS-CCSS
T ss_pred             CCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc-ccCCccEEeccCC-cccc
Confidence            67899997777889999999999999999998778899999999999999999985 4444 7889999999999 4544

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.57  E-value=4.9e-08  Score=85.64  Aligned_cols=79  Identities=15%  Similarity=0.249  Sum_probs=70.5

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|++++..|..++.+++|+.|+|++|++++..|..++++++|+.|+|++|++.+.+|....+++++.+++++| .+.+
T Consensus        95 l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n-~i~~  173 (197)
T 4ezg_A           95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFD-GVHD  173 (197)
T ss_dssp             EECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTB-CCCC
T ss_pred             eECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCC-CCcC
Confidence            468999988999999999999999999999998999999999999999999995556677788899999999999 4554

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.57  E-value=6.5e-08  Score=96.64  Aligned_cols=80  Identities=19%  Similarity=0.162  Sum_probs=71.5

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|++++.+|..++++++|+.|+|++|++++..|..+.++++|+.|+|++|++++.+|.. ..+++++.+++++| .+.
T Consensus       282 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~  360 (455)
T 3v47_A          282 LSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYN-HIR  360 (455)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSS-CCC
T ss_pred             ecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCC-ccc
Confidence            5789999999999999999999999999999888889999999999999999999887754 67889999999999 555


Q ss_pred             CC
Q 011508           80 GG   81 (484)
Q Consensus        80 g~   81 (484)
                      +.
T Consensus       361 ~~  362 (455)
T 3v47_A          361 AL  362 (455)
T ss_dssp             EE
T ss_pred             cc
Confidence            44

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.56  E-value=6.1e-08  Score=93.75  Aligned_cols=80  Identities=18%  Similarity=0.095  Sum_probs=69.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..|+++++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++..|. ...+.+|+.|++++| .+.
T Consensus        71 L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~  149 (361)
T 2xot_A           71 LSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQN-QIS  149 (361)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS-CCC
T ss_pred             CCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCC-cCC
Confidence            689999977677899999999999999999966666789999999999999999988765 367889999999999 555


Q ss_pred             CC
Q 011508           80 GG   81 (484)
Q Consensus        80 g~   81 (484)
                      +-
T Consensus       150 ~l  151 (361)
T 2xot_A          150 RF  151 (361)
T ss_dssp             SC
T ss_pred             ee
Confidence            43

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.55  E-value=1.1e-07  Score=88.70  Aligned_cols=79  Identities=20%  Similarity=0.246  Sum_probs=64.2

Q ss_pred             CCCCc-ccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCccc
Q 011508            1 MNGNF-FQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~-l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+ ++...|..++.+++|+.|+|++|++++..|..+.++++|+.|+|++|++++.++. ...+++++.+++++| .+
T Consensus        87 l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l  165 (285)
T 1ozn_A           87 LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN-RI  165 (285)
T ss_dssp             CCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CC
T ss_pred             CCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCC-cc
Confidence            56786 7655577889999999999999999977788888899999999999999877765 366788889999888 44


Q ss_pred             cC
Q 011508           79 CG   80 (484)
Q Consensus        79 ~g   80 (484)
                      .+
T Consensus       166 ~~  167 (285)
T 1ozn_A          166 SS  167 (285)
T ss_dssp             CE
T ss_pred             cc
Confidence            43

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.55  E-value=6.1e-08  Score=91.63  Aligned_cols=76  Identities=24%  Similarity=0.236  Sum_probs=60.1

Q ss_pred             CCCCcccccCch----hhhCCCCCCEEeCcCCccccccCccccCC---CCCCeeeccccceecccccccccccCcccccC
Q 011508            1 MNGNFFQGNIPS----SLSSLRGIENLDLSQNNLSGRIPKYLENF---PFLQNLNLSFNHFEGEVPIKGVFSNSSAISLD   73 (484)
Q Consensus         1 l~~n~l~g~~p~----~~~~l~~l~~l~ls~N~l~g~~p~~~~~l---~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~   73 (484)
                      |++|+|+ .+|.    .++++++|+.|||++|+|++.+|..+..+   ++|+.|+|++|+|+. +|... +++++.++++
T Consensus       204 Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~-~~~L~~L~Ls  280 (310)
T 4glp_A          204 LRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPKGL-PAKLRVLDLS  280 (310)
T ss_dssp             CCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCSCC-CSCCSCEECC
T ss_pred             CCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhhhh-cCCCCEEECC
Confidence            5788887 4454    25788999999999999998878888777   699999999999994 45432 4789999999


Q ss_pred             CCccccC
Q 011508           74 GNVNLCG   80 (484)
Q Consensus        74 ~n~~l~g   80 (484)
                      +| .+.+
T Consensus       281 ~N-~l~~  286 (310)
T 4glp_A          281 SN-RLNR  286 (310)
T ss_dssp             SC-CCCS
T ss_pred             CC-cCCC
Confidence            99 5665

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.54  E-value=1.1e-07  Score=97.63  Aligned_cols=77  Identities=17%  Similarity=0.110  Sum_probs=60.8

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|+|++..|..|+++++|+.|+|++|++++..|..+.++++|+.|+|++|+|+. +|.. .+.+++.+++++| .+.+
T Consensus        59 Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~-~l~~L~~L~Ls~N-~l~~  135 (562)
T 3a79_B           59 LSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC-PMASLRHLDLSFN-DFDV  135 (562)
T ss_dssp             CCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC-CCTTCSEEECCSS-CCSB
T ss_pred             CCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc-ccccCCEEECCCC-Cccc
Confidence            57888886666788888888888888888887778888888888888888888884 4444 6888888888888 4443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.54  E-value=8.8e-08  Score=96.48  Aligned_cols=77  Identities=25%  Similarity=0.134  Sum_probs=67.8

Q ss_pred             CCCCcccccCchhhh-CCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLS-SLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~-~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++.+|..++ ++++|+.|+|++|.|++. |. +..+++|+.|+|++|+|++.+|....++++..+++++| .+.
T Consensus       151 Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N-~l~  227 (487)
T 3oja_A          151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNN-KLV  227 (487)
T ss_dssp             CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTS-CCC
T ss_pred             CCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCC-cCc
Confidence            689999999999887 899999999999999965 43 44699999999999999999888888899999999999 566


Q ss_pred             C
Q 011508           80 G   80 (484)
Q Consensus        80 g   80 (484)
                      +
T Consensus       228 ~  228 (487)
T 3oja_A          228 L  228 (487)
T ss_dssp             E
T ss_pred             c
Confidence            5

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.54  E-value=1e-07  Score=90.90  Aligned_cols=75  Identities=25%  Similarity=0.238  Sum_probs=48.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      |++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|+|++|+|+..++....+++++.+++++|
T Consensus       199 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N  273 (330)
T 1xku_A          199 LDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN  273 (330)
T ss_dssp             CTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSS
T ss_pred             CCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCC
Confidence            456666665566667777777777777777655555666667777777777776644444455666666777666

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.54  E-value=1.4e-07  Score=89.94  Aligned_cols=79  Identities=19%  Similarity=0.127  Sum_probs=64.3

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|+|++|+|+..++....+++++.+++++| .+.+
T Consensus       200 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N-~l~~  278 (332)
T 2ft3_A          200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTN-NITK  278 (332)
T ss_dssp             CCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSS-CCCB
T ss_pred             CCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCC-CCCc
Confidence            578888877778889999999999999999976667888889999999999999855555577888888999888 4443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.53  E-value=4e-08  Score=84.49  Aligned_cols=75  Identities=17%  Similarity=0.184  Sum_probs=62.9

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCcc-ccCCCCCCeeeccccceecccc--cccccccCcccccCCCcc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKY-LENFPFLQNLNLSFNHFEGEVP--IKGVFSNSSAISLDGNVN   77 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~g~~p--~~~~~~~~~~~~~~~n~~   77 (484)
                      |++|+|++ + ..++.+++|+.|+|++|+|+ .+|.. +..+++|+.|+|++|+|+..++  ....+++++.+++++|+ 
T Consensus        49 Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~-  124 (176)
T 1a9n_A           49 FSDNEIRK-L-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP-  124 (176)
T ss_dssp             CCSSCCCE-E-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSG-
T ss_pred             CCCCCCCc-c-cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCC-
Confidence            68999995 4 67999999999999999999 45654 4899999999999999976444  45678899999999994 


Q ss_pred             cc
Q 011508           78 LC   79 (484)
Q Consensus        78 l~   79 (484)
                      ++
T Consensus       125 i~  126 (176)
T 1a9n_A          125 VT  126 (176)
T ss_dssp             GG
T ss_pred             CC
Confidence            44

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.53  E-value=7.5e-08  Score=96.86  Aligned_cols=73  Identities=19%  Similarity=0.189  Sum_probs=43.3

Q ss_pred             CCCcccccCc-hhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCC
Q 011508            2 NGNFFQGNIP-SSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         2 ~~n~l~g~~p-~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      ++|+|+ .+| ..++++++|+.|+|++|++++..+..+.++++|+.|+|++|++++..|.. ..+++|+.+++++|
T Consensus       232 ~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N  306 (477)
T 2id5_A          232 THCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN  306 (477)
T ss_dssp             ESSCCC-SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred             cCCccc-ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence            456666 344 45666666666666666666555555666666666666666666655432 44555666666666

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.53  E-value=9.7e-08  Score=98.87  Aligned_cols=75  Identities=17%  Similarity=0.146  Sum_probs=45.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      |++|+|++..|..|+.+++|+.|+|++|.|++..|..++++++|+.|+|++|.|++.++.. ..+++|+.+++++|
T Consensus        82 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N  157 (597)
T 3oja_B           82 LNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNN  157 (597)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCC
Confidence            4556666555556666666666666666666555555566666666666666666555543 45566666666666

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.53  E-value=8.5e-08  Score=95.75  Aligned_cols=76  Identities=18%  Similarity=0.089  Sum_probs=67.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNV   76 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~   76 (484)
                      |++|+|++..|..|+++++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.++. ...+++|+.+++++|.
T Consensus        82 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  158 (452)
T 3zyi_A           82 LMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNP  158 (452)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCC
T ss_pred             CcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCC
Confidence            678999988888999999999999999999987778899999999999999999987775 3668899999999983

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.52  E-value=1.5e-07  Score=87.00  Aligned_cols=80  Identities=19%  Similarity=0.234  Sum_probs=68.3

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|++++..|..++.+++|+.|+|++|++++..|..+.++++|+.|+|++|+|++.++.. ..+++++.+++++| .+.
T Consensus        92 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~  170 (270)
T 2o6q_A           92 VTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNN-QLK  170 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS-CCS
T ss_pred             CCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCC-cCc
Confidence            5789999655567899999999999999999777777899999999999999999877753 67899999999999 454


Q ss_pred             CC
Q 011508           80 GG   81 (484)
Q Consensus        80 g~   81 (484)
                      +.
T Consensus       171 ~~  172 (270)
T 2o6q_A          171 RV  172 (270)
T ss_dssp             CC
T ss_pred             Ee
Confidence            43

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.52  E-value=6e-08  Score=99.37  Aligned_cols=76  Identities=21%  Similarity=0.251  Sum_probs=66.6

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecc--cccccccccCcccccCCCc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGE--VPIKGVFSNSSAISLDGNV   76 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~--~p~~~~~~~~~~~~~~~n~   76 (484)
                      |++|++++..|..|+++++|++|||++|++++..|..++++++|+.|+|++|++++.  ++....+++++.+++++|.
T Consensus        57 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~  134 (549)
T 2z81_A           57 LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE  134 (549)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred             CCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCc
Confidence            688999988888999999999999999999977667799999999999999999863  3445788899999999984

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.52  E-value=1.6e-07  Score=89.46  Aligned_cols=81  Identities=21%  Similarity=0.158  Sum_probs=69.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccccc-------ccccCcccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKG-------VFSNSSAISLD   73 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~-------~~~~~~~~~~~   73 (484)
                      |++|++++..|..++.+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++..+...       ....+..+++.
T Consensus       223 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~  301 (330)
T 1xku_A          223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF  301 (330)
T ss_dssp             CCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECC
T ss_pred             CCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEee
Confidence            6899999877789999999999999999999 999999999999999999999998766431       23567788999


Q ss_pred             CCccccCCC
Q 011508           74 GNVNLCGGI   82 (484)
Q Consensus        74 ~n~~l~g~~   82 (484)
                      +|+..+...
T Consensus       302 ~N~~~~~~i  310 (330)
T 1xku_A          302 SNPVQYWEI  310 (330)
T ss_dssp             SSSSCGGGS
T ss_pred             cCccccccc
Confidence            997655433

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.52  E-value=2.2e-08  Score=94.84  Aligned_cols=79  Identities=19%  Similarity=0.244  Sum_probs=55.4

Q ss_pred             CCCCcc-cccCchhhh-------CCCCCCEEeCcCCccccccCccc--cCCCCCCeeeccccceeccccccccc-----c
Q 011508            1 MNGNFF-QGNIPSSLS-------SLRGIENLDLSQNNLSGRIPKYL--ENFPFLQNLNLSFNHFEGEVPIKGVF-----S   65 (484)
Q Consensus         1 l~~n~l-~g~~p~~~~-------~l~~l~~l~ls~N~l~g~~p~~~--~~l~~L~~l~ls~N~l~g~~p~~~~~-----~   65 (484)
                      |++|++ .+.+|..++       ++++|+.|+|++|+++|.+|..+  ..+++|+.|+|++|++++.++....+     +
T Consensus        70 L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~  149 (312)
T 1wwl_A           70 LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKP  149 (312)
T ss_dssp             CCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCT
T ss_pred             cccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcC
Confidence            456777 456777666       77788888888888887777765  77788888888888887773333334     6


Q ss_pred             cCcccccCCCccccC
Q 011508           66 NSSAISLDGNVNLCG   80 (484)
Q Consensus        66 ~~~~~~~~~n~~l~g   80 (484)
                      +++.+++++| .+.+
T Consensus       150 ~L~~L~L~~N-~l~~  163 (312)
T 1wwl_A          150 GLKVLSIAQA-HSLN  163 (312)
T ss_dssp             TCCEEEEESC-SCCC
T ss_pred             CCcEEEeeCC-CCcc
Confidence            7777777777 4443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.51  E-value=1e-07  Score=102.85  Aligned_cols=73  Identities=18%  Similarity=0.203  Sum_probs=38.1

Q ss_pred             CCcccccC-chhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc---ccccccCcccccCCC
Q 011508            3 GNFFQGNI-PSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI---KGVFSNSSAISLDGN   75 (484)
Q Consensus         3 ~n~l~g~~-p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~---~~~~~~~~~~~~~~n   75 (484)
                      +|++.+.| |..|++|++|++|+|++|++++..|..++++++|+.|+|++|++++.+|.   ...+++|+.+++++|
T Consensus        57 ~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N  133 (844)
T 3j0a_A           57 SQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN  133 (844)
T ss_dssp             TTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESC
T ss_pred             CCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCC
Confidence            34333344 34455555555555555555555555555555555555555555554332   234455555555555

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.51  E-value=1.3e-07  Score=87.57  Aligned_cols=70  Identities=33%  Similarity=0.272  Sum_probs=52.8

Q ss_pred             CCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCC
Q 011508            3 GNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGN   75 (484)
Q Consensus         3 ~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n   75 (484)
                      +++++ .+|..+.  ++|+.|+|++|++++..|..+.++++|+.|+|++|++++..+. ...+++++.+++++|
T Consensus        16 ~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n   86 (276)
T 2z62_A           16 ELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN   86 (276)
T ss_dssp             TSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred             CCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence            44555 6777554  5788888888888865555788888888888888888877663 366778888888888

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.51  E-value=1.6e-07  Score=94.53  Aligned_cols=79  Identities=20%  Similarity=0.188  Sum_probs=67.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++..|..|+++++|+.|+|++|++++..|..+.++++|+.|+|++|++++.++.. ..+++|+.+++++| .+.
T Consensus        39 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n-~i~  117 (477)
T 2id5_A           39 LGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISEN-KIV  117 (477)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTS-CCC
T ss_pred             CCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCC-ccc
Confidence            6789999777888999999999999999999877889999999999999999998777653 67888999999988 444


Q ss_pred             C
Q 011508           80 G   80 (484)
Q Consensus        80 g   80 (484)
                      +
T Consensus       118 ~  118 (477)
T 2id5_A          118 I  118 (477)
T ss_dssp             E
T ss_pred             c
Confidence            3

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.51  E-value=1.8e-07  Score=97.04  Aligned_cols=75  Identities=13%  Similarity=-0.000  Sum_probs=56.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      |++|+|++..|..|+++++|++|+|++|++++..|..|.++++|+.|+|++|++++..|.. ..+++++.+++++|
T Consensus        40 Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  115 (606)
T 3t6q_A           40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQT  115 (606)
T ss_dssp             CTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTS
T ss_pred             ccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecccc
Confidence            5678887666777888888888888888888777777888888888888888887776643 55667777777776

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.49  E-value=1.2e-07  Score=90.59  Aligned_cols=75  Identities=20%  Similarity=0.261  Sum_probs=61.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+++ .+|..+.  ++|+.|+|++|++++..|..+.++++|+.|+|++|++++.+|. ...+++++.+++++| .+.
T Consensus       179 l~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~  254 (332)
T 2ft3_A          179 ISEAKLT-GIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNN-KLS  254 (332)
T ss_dssp             CCSSBCS-SCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSS-CCC
T ss_pred             CcCCCCC-ccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCC-cCe
Confidence            5788888 5887665  7899999999999977778889999999999999999987774 467788899999988 444

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.47  E-value=1.3e-08  Score=89.44  Aligned_cols=77  Identities=25%  Similarity=0.314  Sum_probs=64.9

Q ss_pred             CCCCcccccCch------hhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCC
Q 011508            1 MNGNFFQGNIPS------SLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDG   74 (484)
Q Consensus         1 l~~n~l~g~~p~------~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~   74 (484)
                      |+.|+|+|.+|.      .++.+++|+.|+|++|++++ +| .+.++++|+.|+|++|+++..++....+++++.+++++
T Consensus        25 l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~  102 (198)
T 1ds9_A           25 AEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISY  102 (198)
T ss_dssp             CSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEE
T ss_pred             hheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcC
Confidence            467888888887      99999999999999999995 88 89999999999999999995444345568899999999


Q ss_pred             CccccC
Q 011508           75 NVNLCG   80 (484)
Q Consensus        75 n~~l~g   80 (484)
                      | .+.+
T Consensus       103 N-~l~~  107 (198)
T 1ds9_A          103 N-QIAS  107 (198)
T ss_dssp             E-ECCC
T ss_pred             C-cCCc
Confidence            8 4443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.47  E-value=1.1e-07  Score=91.51  Aligned_cols=75  Identities=20%  Similarity=0.201  Sum_probs=53.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n   75 (484)
                      |++|++++..+..++++++|+.|+|++|++++..|..+.++++|+.|+|++|++++.++. ...+++++.+++++|
T Consensus        59 l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  134 (353)
T 2z80_A           59 LSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGN  134 (353)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTC
T ss_pred             CCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCC
Confidence            466777744444677777777777777777766666677777777777777777765554 355677777777777

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.47  E-value=1.4e-07  Score=96.91  Aligned_cols=73  Identities=19%  Similarity=0.174  Sum_probs=45.9

Q ss_pred             CCCCcccccCchh-hhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSS-LSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~-~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      |++|++++.+|.. +..+++|+.|+|++|+++|.+|..+.  ++|+.|+|++|+|+..++....+++++.+++++|
T Consensus       410 l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N  483 (562)
T 3a79_B          410 VSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASN  483 (562)
T ss_dssp             CTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSS
T ss_pred             CCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCC
Confidence            4677777656654 66667777777777777666665543  4666666666666644444445566666666666

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.46  E-value=1.2e-07  Score=91.34  Aligned_cols=77  Identities=23%  Similarity=0.222  Sum_probs=66.6

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCcc-ccCCCCCCeeeccccceecccc--cccccccCcccccCCCcc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKY-LENFPFLQNLNLSFNHFEGEVP--IKGVFSNSSAISLDGNVN   77 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~g~~p--~~~~~~~~~~~~~~~n~~   77 (484)
                      |++|++++..|..++++++|++|+|++|+++ .+|.. +.++++|+.|+|++|++++.++  ....+++++.+++++|..
T Consensus        83 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~  161 (353)
T 2z80_A           83 LTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT  161 (353)
T ss_dssp             CTTSCCCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSS
T ss_pred             CCCCccCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcc
Confidence            6789999877889999999999999999999 56655 8999999999999999997665  346789999999999843


Q ss_pred             c
Q 011508           78 L   78 (484)
Q Consensus        78 l   78 (484)
                      +
T Consensus       162 ~  162 (353)
T 2z80_A          162 F  162 (353)
T ss_dssp             C
T ss_pred             c
Confidence            3

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.45  E-value=6.6e-08  Score=91.45  Aligned_cols=75  Identities=21%  Similarity=0.258  Sum_probs=65.8

Q ss_pred             CCCCcccccCchhh--hCCCCCCEEeCcCCccccccCccccCC-----CCCCeeeccccceeccccc-ccccccCccccc
Q 011508            1 MNGNFFQGNIPSSL--SSLRGIENLDLSQNNLSGRIPKYLENF-----PFLQNLNLSFNHFEGEVPI-KGVFSNSSAISL   72 (484)
Q Consensus         1 l~~n~l~g~~p~~~--~~l~~l~~l~ls~N~l~g~~p~~~~~l-----~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~   72 (484)
                      |++|+++|.+|..+  +.+++|+.|+|++|++++. |..++.+     ++|+.|+|++|++++.+|. ...+++++.+++
T Consensus       102 L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  180 (312)
T 1wwl_A          102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL  180 (312)
T ss_dssp             EEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEEC
T ss_pred             ccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEEC
Confidence            46899999999987  8999999999999999966 8888877     8999999999999988864 477889999999


Q ss_pred             CCCc
Q 011508           73 DGNV   76 (484)
Q Consensus        73 ~~n~   76 (484)
                      ++|.
T Consensus       181 s~N~  184 (312)
T 1wwl_A          181 SDNP  184 (312)
T ss_dssp             CSCT
T ss_pred             CCCC
Confidence            9993

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.45  E-value=4.5e-07  Score=93.24  Aligned_cols=75  Identities=16%  Similarity=0.036  Sum_probs=50.4

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n   75 (484)
                      |++|++++..|..|+++++|+.|||++|++++..|..+.++++|+.|+|++|++++.+|. ...+.+++.+++++|
T Consensus        35 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  110 (570)
T 2z63_A           35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET  110 (570)
T ss_dssp             CCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred             ccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccccc
Confidence            466777765566677777777777777777755556677777777777777777666553 245566666666666

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.44  E-value=1.2e-06  Score=80.92  Aligned_cols=136  Identities=16%  Similarity=0.088  Sum_probs=92.4

Q ss_pred             ccccccce-eEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCCceeeEEee
Q 011508          166 LIGAGSFG-SVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGNDFEALVYE  243 (484)
Q Consensus       166 ~lg~G~~g-~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e  243 (484)
                      .+..|..+ .||+..  ....+..+++|+-..   +....+.+|...|+.+. +--+.++++++..     ++..++|||
T Consensus        31 ~~~~G~S~~~v~rl~--~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme  100 (272)
T 4gkh_A           31 RDNVGQSGATIYRLY--GKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTT  100 (272)
T ss_dssp             EEECSSSSCEEEEEE--CCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEE
T ss_pred             EccCCCcCCeEEEEE--ecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEE
Confidence            34555555 689876  333456788887653   23456788999998883 2235566766532     346799999


Q ss_pred             cccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 011508          244 LMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC------------------------------------  287 (484)
Q Consensus       244 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------  287 (484)
                      +++|.++.+.....        ......+..+++..|+.||...                                    
T Consensus       101 ~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A          101 AIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             CCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             eeCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            99998887765421        1223345666777777777421                                    


Q ss_pred             -------------------CCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          288 -------------------ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       288 -------------------~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                                         ...++|+|+.+.||++++++.+-|+||+.+..
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                               11379999999999999887778999998764

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.43  E-value=2.4e-07  Score=95.85  Aligned_cols=79  Identities=24%  Similarity=0.225  Sum_probs=68.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCcc-ccCCCCCCeeeccccceeccccc-ccccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKY-LENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+|++..|..|+++++|++|+|++|.|+ .+|.. ++++++|+.|+|++|+|++.+|. ...+++++.+++++| .+
T Consensus       106 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l  183 (597)
T 3oja_B          106 MGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN-RL  183 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTS-CC
T ss_pred             CCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCC-CC
Confidence            6889999877888999999999999999999 56655 68999999999999999998885 477899999999999 55


Q ss_pred             cCC
Q 011508           79 CGG   81 (484)
Q Consensus        79 ~g~   81 (484)
                      .+.
T Consensus       184 ~~~  186 (597)
T 3oja_B          184 THV  186 (597)
T ss_dssp             SBC
T ss_pred             CCc
Confidence            543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.43  E-value=1.4e-07  Score=92.28  Aligned_cols=76  Identities=20%  Similarity=0.192  Sum_probs=56.6

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|++++.  +.++++++|+.|+|++|.+++..|..+.++++|+.|+|++|++++.++....+++++.+++++| .+.
T Consensus       233 l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n-~l~  308 (390)
T 3o6n_A          233 LQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHN-HLL  308 (390)
T ss_dssp             CCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSS-CCC
T ss_pred             CCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCC-cce
Confidence            467777742  4677888888888888888877777788888888888888888776555556777888888877 444

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.42  E-value=3.1e-07  Score=89.75  Aligned_cols=62  Identities=21%  Similarity=0.197  Sum_probs=28.6

Q ss_pred             hhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCC
Q 011508           14 LSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus        14 ~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      +.++++|+.|+|++|++++..|..+.++++|+.|+|++|++++.+|.. ..+++++.+++++|
T Consensus        65 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  127 (390)
T 3o6n_A           65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERN  127 (390)
T ss_dssp             HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             hcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCC
Confidence            344444444444444444333334444444444444444444444432 33444444444444

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.42  E-value=2.3e-07  Score=92.26  Aligned_cols=76  Identities=22%  Similarity=0.118  Sum_probs=64.6

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceeccccc-ccccccCcccccCCCc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGNV   76 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n~   76 (484)
                      |++|+|++..|..|+++++|+.|+|++|+|++..|..+.++++|+.|+|++|+|++.++. ...+++|+.+++++|.
T Consensus        71 L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~  147 (440)
T 3zyj_A           71 LHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNP  147 (440)
T ss_dssp             CCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCC
T ss_pred             ccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCc
Confidence            578899877778899999999999999999976668889999999999999999877764 4678889999999883

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.41  E-value=9e-08  Score=87.34  Aligned_cols=67  Identities=28%  Similarity=0.378  Sum_probs=55.6

Q ss_pred             hhCCCCCCEEeCcCCcccc--ccCccccCCCCCCeeeccccceecccccccccc--cCcccccCCCccccCCC
Q 011508           14 LSSLRGIENLDLSQNNLSG--RIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFS--NSSAISLDGNVNLCGGI   82 (484)
Q Consensus        14 ~~~l~~l~~l~ls~N~l~g--~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~--~~~~~~~~~n~~l~g~~   82 (484)
                      ..++++|+.|+||+|+|++  .+|..+..+++|+.|+|++|+|++. .....+.  +|+.|++++|| +|+..
T Consensus       166 ~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Np-l~~~~  236 (267)
T 3rw6_A          166 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNS-LCDTF  236 (267)
T ss_dssp             HHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTST-TGGGC
T ss_pred             HhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCc-Ccccc
Confidence            3679999999999999998  7778888999999999999999986 3333444  89999999995 67643

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.41  E-value=2.4e-07  Score=94.19  Aligned_cols=76  Identities=18%  Similarity=0.183  Sum_probs=55.9

Q ss_pred             CCCCcccccCchh-hhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSS-LSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~-~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|++++.+|.. +..+++|+.|+|++|+++|.+|..+.  ++|+.|+|++|+|+..++....+++++.+++++| .+.
T Consensus       381 Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N-~l~  457 (520)
T 2z7x_B          381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASN-QLK  457 (520)
T ss_dssp             CCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSS-CCC
T ss_pred             CCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCC-cCC
Confidence            5788888767765 77788888888888888877777654  6788888888888744444456777777888777 444

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.40  E-value=1.7e-07  Score=88.79  Aligned_cols=76  Identities=25%  Similarity=0.176  Sum_probs=62.9

Q ss_pred             CCCCcccccCchhhh-CCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLS-SLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~-~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|++++..|..+. .+++|+.|+|++|+++ .+|. ...+++|+.|+|++|++++.++....+++++.+++++| .+.
T Consensus       151 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N-~l~  227 (317)
T 3o53_A          151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNN-KLV  227 (317)
T ss_dssp             CTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC-EEEC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTS-CCC
T ss_pred             CCCCCCCcccHHHHhhccCcCCEEECCCCcCc-cccc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCC-ccc
Confidence            678999987777774 7899999999999999 4554 44589999999999999988887777889999999998 454

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.36  E-value=6.5e-07  Score=94.19  Aligned_cols=73  Identities=21%  Similarity=0.116  Sum_probs=33.8

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCc-cccCCCCCCeeeccccceeccccc-ccccccCcccccCCC
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPK-YLENFPFLQNLNLSFNHFEGEVPI-KGVFSNSSAISLDGN   75 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l~g~~p~-~~~~~~~~~~~~~~n   75 (484)
                      ++|++++..|..++++++|++|+|++|+++ .+|. .++++++|+.|+|++|++++.+|. ...+.+++.+++++|
T Consensus        57 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n  131 (680)
T 1ziw_A           57 GFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHN  131 (680)
T ss_dssp             CSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSS
T ss_pred             CCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCC
Confidence            344444444444444444444444444444 2332 344455555555555555444432 234444555555554

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.36  E-value=1.8e-06  Score=81.26  Aligned_cols=137  Identities=16%  Similarity=0.119  Sum_probs=91.4

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCC---CceeEeeeeeeeccCCCceeeE
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR---NLVKIITSCVSVDFQGNDFEAL  240 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~l  240 (484)
                      .+.++.|....||+.       +..+++|+-.  .......+.+|.++|+.+.+.   .+.+++.++.    ...+..++
T Consensus        24 v~~l~~G~~n~v~~v-------g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~   90 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-------NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFV   90 (306)
T ss_dssp             EEEEEECSSEEEEEE-------TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEE
T ss_pred             eeecCCCcceeEEEE-------CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEE
Confidence            356788888999987       1347788742  222346788999999999653   2445555432    22345689


Q ss_pred             EeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 011508          241 VYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC---------------------------------  287 (484)
Q Consensus       241 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------  287 (484)
                      |||+++|.++.+...      ..++..+...++.++++.|+.||...                                 
T Consensus        91 v~e~i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l  164 (306)
T 3tdw_A           91 GYRKVQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL  164 (306)
T ss_dssp             EEECCCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred             EEeccCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence            999999988866321      11344555555666666666655421                                 


Q ss_pred             ------------------------CCCeeecCCCCCCeeecC---CCc-eEEcccCcccc
Q 011508          288 ------------------------ETPIVHCDLKPSNVLLDG---ELT-AHVSDFGLAKF  319 (484)
Q Consensus       288 ------------------------~~~ivH~dlk~~NIll~~---~~~-~kl~Dfg~a~~  319 (484)
                                              ...++|+|+++.||++++   ++. ..|+||+.+..
T Consensus       165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                    335699999999999987   355 48999998764

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.35  E-value=3.1e-07  Score=96.67  Aligned_cols=66  Identities=26%  Similarity=0.271  Sum_probs=29.3

Q ss_pred             hhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-c-ccccCcccccCCCcccc
Q 011508           14 LSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-G-VFSNSSAISLDGNVNLC   79 (484)
Q Consensus        14 ~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~-~~~~~~~~~~~~n~~l~   79 (484)
                      |+++++|+.|||++|+|++..|..+.++++|+.|+|++|+|++.+|.. . .+++++.+++++||..|
T Consensus       556 ~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c  623 (680)
T 1ziw_A          556 FKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDC  623 (680)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCB
T ss_pred             cccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCccc
Confidence            444444444444444444222222344444444444444444444332 1 34445555555554444

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.35  E-value=3.3e-07  Score=86.79  Aligned_cols=73  Identities=21%  Similarity=0.152  Sum_probs=33.7

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCcccc-CCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLE-NFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~-~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      ++|++++..|..++.+++|+.|+|++|++++..|..+. .+++|+.|+|++|++++.. ....+++++.+++++|
T Consensus       128 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~l~~L~~L~Ls~N  201 (317)
T 3o53_A          128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSN  201 (317)
T ss_dssp             CSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE-CCCCCTTCCEEECCSS
T ss_pred             CCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccc-cccccccCCEEECCCC
Confidence            44444443344444555555555555555544444332 4455555555555554432 2223444555555554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.34  E-value=1.6e-07  Score=88.69  Aligned_cols=76  Identities=14%  Similarity=0.096  Sum_probs=62.2

Q ss_pred             CCCCcccccCchhh--hCCCCCCEEeCcCCccccccC----ccccCCCCCCeeeccccceecccccc-cccccCcccccC
Q 011508            1 MNGNFFQGNIPSSL--SSLRGIENLDLSQNNLSGRIP----KYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLD   73 (484)
Q Consensus         1 l~~n~l~g~~p~~~--~~l~~l~~l~ls~N~l~g~~p----~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~   73 (484)
                      |++|++++.+|..+  +.+++|+.|+|++|++++.+|    ..+..+++|+.|+|++|++++.+|.. ..+++++.++++
T Consensus        98 l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls  177 (310)
T 4glp_A           98 LEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLS  177 (310)
T ss_dssp             EESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECC
T ss_pred             eeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECC
Confidence            46788888888888  889999999999999987666    44567889999999999998877653 577888899999


Q ss_pred             CCc
Q 011508           74 GNV   76 (484)
Q Consensus        74 ~n~   76 (484)
                      +|.
T Consensus       178 ~N~  180 (310)
T 4glp_A          178 DNP  180 (310)
T ss_dssp             SCT
T ss_pred             CCC
Confidence            883

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.33  E-value=6.4e-07  Score=82.33  Aligned_cols=68  Identities=22%  Similarity=0.357  Sum_probs=36.3

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      ++|+|+ .+| .++.+++|+.|+|++|+|++ +|. +.++++|+.|+|++|++++..+.. . .+++.+++++|
T Consensus        49 ~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~l~~~~-~-~~L~~L~L~~N  116 (263)
T 1xeu_A           49 DNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKNLNGIP-S-ACLSRLFLDNN  116 (263)
T ss_dssp             TTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSCCTTCC-C-SSCCEEECCSS
T ss_pred             cCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCCcCccc-c-CcccEEEccCC
Confidence            455555 455 45555666666666666653 333 555566666666666655533221 1 55555555555

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.33  E-value=4.1e-07  Score=83.68  Aligned_cols=69  Identities=25%  Similarity=0.308  Sum_probs=45.9

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      |++|+|+ .+|....  ++|+.|+|++|++++ +| .+.++++|+.|+|++|++++. |....+++++.+++++|
T Consensus        92 L~~N~l~-~l~~~~~--~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N  160 (263)
T 1xeu_A           92 VNRNRLK-NLNGIPS--ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGN  160 (263)
T ss_dssp             CCSSCCS-CCTTCCC--SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTS
T ss_pred             CCCCccC-CcCcccc--CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCC
Confidence            4677776 4554333  777777777777774 44 467777777777777777764 34456677777777777

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.33  E-value=1.2e-08  Score=89.78  Aligned_cols=74  Identities=20%  Similarity=0.283  Sum_probs=65.2

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|++ +| .++.+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++++ +|....+++++.+++++| .+.
T Consensus        55 ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~l~~N-~i~  128 (198)
T 1ds9_A           55 LSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNN-KIT  128 (198)
T ss_dssp             CSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HHHHHHHHHSSEEEESEE-ECC
T ss_pred             CCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CCccccCCCCCEEECCCC-cCC
Confidence            57899985 88 8999999999999999999 899988888999999999999998 455677889999999998 444

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.32  E-value=2e-07  Score=84.38  Aligned_cols=79  Identities=10%  Similarity=0.039  Sum_probs=60.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCc-cccccCccccCCCCCCeeeccc-cceecccccc-cccccCcccccCCCcc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNN-LSGRIPKYLENFPFLQNLNLSF-NHFEGEVPIK-GVFSNSSAISLDGNVN   77 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~-l~g~~p~~~~~l~~L~~l~ls~-N~l~g~~p~~-~~~~~~~~~~~~~n~~   77 (484)
                      |++|+|++..|..++++++|+.|+|++|+ +++..|..+.++++|+.|+|++ |+|++..+.. ..+++++.+++++| .
T Consensus        38 l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n-~  116 (239)
T 2xwt_C           38 LIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNT-G  116 (239)
T ss_dssp             EESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEE-C
T ss_pred             EeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCC-C
Confidence            46788885555578888999999999986 7744444788888999999988 8888776643 56778888888888 4


Q ss_pred             ccC
Q 011508           78 LCG   80 (484)
Q Consensus        78 l~g   80 (484)
                      +.+
T Consensus       117 l~~  119 (239)
T 2xwt_C          117 LKM  119 (239)
T ss_dssp             CCS
T ss_pred             Ccc
Confidence            444

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.32  E-value=4.5e-07  Score=87.00  Aligned_cols=76  Identities=24%  Similarity=0.308  Sum_probs=58.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|++++ + +.+..+++|+.|+|++|++++ +| .+..+++|+.|+|++|++++..|.. ..+++++.+++++|+ +.
T Consensus       250 l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~-l~  324 (347)
T 4fmz_A          250 IGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH-IT  324 (347)
T ss_dssp             CCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSS-CC
T ss_pred             CCCCccCC-C-hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCc-cc
Confidence            56788874 4 458888888888888888884 54 5778888888888888888777653 567888888888884 54


Q ss_pred             CC
Q 011508           80 GG   81 (484)
Q Consensus        80 g~   81 (484)
                      +.
T Consensus       325 ~~  326 (347)
T 4fmz_A          325 DI  326 (347)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.31  E-value=2.4e-07  Score=83.85  Aligned_cols=79  Identities=15%  Similarity=0.219  Sum_probs=64.1

Q ss_pred             CCCCc-ccccCchhhhCCCCCCEEeCcC-CccccccCccccCCCCCCeeeccccceecccccccccccCc---ccccCCC
Q 011508            1 MNGNF-FQGNIPSSLSSLRGIENLDLSQ-NNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSS---AISLDGN   75 (484)
Q Consensus         1 l~~n~-l~g~~p~~~~~l~~l~~l~ls~-N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~---~~~~~~n   75 (484)
                      |++|+ +++..|..|+++++|+.|+|++ |+|++..|..+.++++|+.|+|++|++++ +|....+.+++   .+++++|
T Consensus        62 l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~~~~l~~L~~L~~L~l~~N  140 (239)
T 2xwt_C           62 VSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDN  140 (239)
T ss_dssp             EECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCCCTTCCBCCSEEEEEEESC
T ss_pred             CCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccccccccccccccEEECCCC
Confidence            46786 8744455899999999999999 99995555678999999999999999998 55566777777   9999998


Q ss_pred             ccccC
Q 011508           76 VNLCG   80 (484)
Q Consensus        76 ~~l~g   80 (484)
                      +.+.+
T Consensus       141 ~~l~~  145 (239)
T 2xwt_C          141 PYMTS  145 (239)
T ss_dssp             TTCCE
T ss_pred             cchhh
Confidence            55543

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.28  E-value=7.3e-07  Score=91.89  Aligned_cols=74  Identities=24%  Similarity=0.333  Sum_probs=60.4

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|+|++ +| .++.|++|+.|+|++|+|++ + ..+..|++|+.|+|++|+|++.+| ...+++|+.|++++| .+.+
T Consensus       116 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N-~i~~  189 (605)
T 1m9s_A          116 LEHNGISD-IN-GLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKN-HISD  189 (605)
T ss_dssp             CTTSCCCC-CG-GGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSS-CCCB
T ss_pred             ecCCCCCC-Cc-cccCCCccCEEECCCCccCC-c-hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCC-CCCC
Confidence            57888884 44 58889999999999999985 4 578889999999999999988877 667888888999888 5554

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.26  E-value=1.1e-06  Score=82.19  Aligned_cols=74  Identities=22%  Similarity=0.263  Sum_probs=53.9

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      +++|+++ .+|. ++.+++|+.|+|++|++++ +|. +.++++|+.|+|++|++++ +|....+++++.+++++| .+.+
T Consensus        53 l~~~~i~-~~~~-~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~~n-~i~~  126 (291)
T 1h6t_A           53 ANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHN-GISD  126 (291)
T ss_dssp             CTTSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTS-CCCC
T ss_pred             ccCCCcc-cChh-HhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-ChhhccCCCCCEEECCCC-cCCC
Confidence            4677776 5554 7888888888888888884 444 7788888888888888876 444566777888888887 4443

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.25  E-value=1.3e-06  Score=89.88  Aligned_cols=70  Identities=23%  Similarity=0.319  Sum_probs=36.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      |++|+|++ +|+ +++|++|+.|+|++|+|++ +| .+..|++|+.|+|++|+|++. |....+++|+.|++++|
T Consensus        72 Ls~N~l~~-~~~-l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N  141 (605)
T 1m9s_A           72 LNGNKLTD-IKP-LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNN  141 (605)
T ss_dssp             CTTSCCCC-CGG-GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC-GGGGGCTTCSEEECCSS
T ss_pred             eeCCCCCC-Chh-hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC-ccccCCCccCEEECCCC
Confidence            34555553 222 5555555555555555552 33 455555555555555555542 33344555555555555

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.25  E-value=1.2e-06  Score=82.45  Aligned_cols=74  Identities=19%  Similarity=0.319  Sum_probs=51.3

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|++++ +|. ++.+++|+.|+|++|++++ +|. +..+++|+.|+|++|++++..+ ...+++++.+++++| .+.+
T Consensus       114 l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n-~l~~  187 (308)
T 1h6u_A          114 LTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDN-KISD  187 (308)
T ss_dssp             CTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSS-CCCC
T ss_pred             CCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCC-ccCc
Confidence            56777773 554 7777888888888887774 443 7777777777777777776554 556677777777777 4443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.23  E-value=1.5e-06  Score=81.90  Aligned_cols=74  Identities=18%  Similarity=0.274  Sum_probs=57.8

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|+++ .+| .+..+++|+.|+|++|+++ .+|. +.++++|+.|+|++|++++. |....+.+++.+++++| .+.+
T Consensus        48 l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~-~~~~-~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~l~~n-~l~~  121 (308)
T 1h6u_A           48 AFGTGVT-TIE-GVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTST-QITD  121 (308)
T ss_dssp             CTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCCSCC-GGGTTCTTCCEEECTTS-CCCC
T ss_pred             eeCCCcc-Cch-hhhccCCCCEEEccCCcCC-CChh-HccCCCCCEEEccCCcCCCc-hhhcCCCCCCEEECCCC-CCCC
Confidence            4677787 566 5888888888888888888 4555 88888888888888888864 55667788888888888 4444

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.21  E-value=8.4e-07  Score=80.91  Aligned_cols=68  Identities=19%  Similarity=0.227  Sum_probs=55.0

Q ss_pred             CCCCcccc--cCchhhhCCCCCCEEeCcCCccccccCccccCCC--CCCeeeccccceecccccc--------cccccCc
Q 011508            1 MNGNFFQG--NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFP--FLQNLNLSFNHFEGEVPIK--------GVFSNSS   68 (484)
Q Consensus         1 l~~n~l~g--~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~--~L~~l~ls~N~l~g~~p~~--------~~~~~~~   68 (484)
                      |++|+|++  .+|..++.+++|+.|+|++|+|++.  ..+..++  +|+.|+|++|.+++..|..        ..+++|.
T Consensus       177 Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~  254 (267)
T 3rw6_A          177 LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLL  254 (267)
T ss_dssp             CTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCC
T ss_pred             CCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccC
Confidence            78999998  7778899999999999999999964  4455555  9999999999999977631        3455565


Q ss_pred             cc
Q 011508           69 AI   70 (484)
Q Consensus        69 ~~   70 (484)
                      .|
T Consensus       255 ~L  256 (267)
T 3rw6_A          255 RL  256 (267)
T ss_dssp             EE
T ss_pred             eE
Confidence            54

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.20  E-value=1.6e-06  Score=81.03  Aligned_cols=75  Identities=24%  Similarity=0.392  Sum_probs=58.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|++++ +|. ++.+++|+.|+|++|++++ + +.+..+++|+.|+|++|++++. +....+++++.+++++| .+.+
T Consensus        97 l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N-~l~~  170 (291)
T 1h6t_A           97 LDENKVKD-LSS-LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDN-QISD  170 (291)
T ss_dssp             CCSSCCCC-GGG-GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSS-CCCC
T ss_pred             CCCCcCCC-Chh-hccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCC-cccc
Confidence            57888874 554 8888999999999999884 4 4678888899999998888876 55677888888888888 5554


Q ss_pred             C
Q 011508           81 G   81 (484)
Q Consensus        81 ~   81 (484)
                      .
T Consensus       171 ~  171 (291)
T 1h6t_A          171 I  171 (291)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.14  E-value=1e-06  Score=89.90  Aligned_cols=67  Identities=21%  Similarity=0.250  Sum_probs=45.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccC-------cccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNS-------SAISLD   73 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~-------~~~~~~   73 (484)
                      |++|+|++ +|.   .+++|+.|+|++|+|++ +|. +.  ++|+.|+|++|+|+..++ ..  .++       ..++++
T Consensus       147 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~--~~L~~~~~~L~~L~Ls  215 (571)
T 3cvr_A          147 ADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VP--VRNHHSEETEIFFRCR  215 (571)
T ss_dssp             CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECC
T ss_pred             CCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HH--HhhhcccccceEEecC
Confidence            56777774 676   56788888888888885 777 55  788888888888874333 32  255       777777


Q ss_pred             CCcccc
Q 011508           74 GNVNLC   79 (484)
Q Consensus        74 ~n~~l~   79 (484)
                      +| .+.
T Consensus       216 ~N-~l~  220 (571)
T 3cvr_A          216 EN-RIT  220 (571)
T ss_dssp             SS-CCC
T ss_pred             CC-cce
Confidence            77 444

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.13  E-value=2.8e-06  Score=86.68  Aligned_cols=49  Identities=27%  Similarity=0.358  Sum_probs=24.2

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceec
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEG   56 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g   56 (484)
                      |++|+|++ ||..+.  ++|+.|+|++|+|+ .||   ..+++|+.|+|++|+|++
T Consensus        66 Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~  114 (571)
T 3cvr_A           66 LNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST  114 (571)
T ss_dssp             CCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC
T ss_pred             eCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC
Confidence            34555553 555442  44555555555555 454   234455555555555554

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.11  E-value=3e-06  Score=84.44  Aligned_cols=53  Identities=26%  Similarity=0.350  Sum_probs=27.7

Q ss_pred             CCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508           18 RGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus        18 ~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      ++|+.|+|++|++++ +| +++++++|+.|++++|++++ +|..  ..+++.+++++|
T Consensus       131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~--~~~L~~L~L~~n  183 (454)
T 1jl5_A          131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNN  183 (454)
T ss_dssp             TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSS
T ss_pred             CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCC--cccccEEECcCC
Confidence            355555555555553 55 35555555555555555554 2221  234555555555

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.09  E-value=3.2e-06  Score=84.56  Aligned_cols=76  Identities=22%  Similarity=0.242  Sum_probs=56.4

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|++++. |+ ++.+++|+.|+|++|++++..|  +..+++|+.|++++|++++. +....+++++.+++++| .+.+
T Consensus       294 L~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n-~l~~  367 (466)
T 1o6v_A          294 LNENQLEDI-SP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHN-QISD  367 (466)
T ss_dssp             CCSSCCSCC-GG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSS-CCCB
T ss_pred             cCCCcccCc-hh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCC-ccCc
Confidence            567888854 43 7888888888888888886555  67788888888888888875 45566778888888887 4554


Q ss_pred             CC
Q 011508           81 GI   82 (484)
Q Consensus        81 ~~   82 (484)
                      ..
T Consensus       368 ~~  369 (466)
T 1o6v_A          368 LT  369 (466)
T ss_dssp             CG
T ss_pred             cc
Confidence            43

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.08  E-value=1.9e-07  Score=93.07  Aligned_cols=75  Identities=8%  Similarity=0.035  Sum_probs=43.9

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCC-------------CeeeccccceecccccccccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFL-------------QNLNLSFNHFEGEVPIKGVFSNS   67 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L-------------~~l~ls~N~l~g~~p~~~~~~~~   67 (484)
                      +++|+| |.||.++++|++|++|+|++|.++|.+|.+++++.+|             +.|++++|.|++.++   ..+++
T Consensus        18 l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~---~~~~L   93 (454)
T 1jl5_A           18 RHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE---LPPHL   93 (454)
T ss_dssp             -----------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS---CCTTC
T ss_pred             cccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC---CcCCC
Confidence            468899 7999999999999999999999999999999887754             777777777776433   13456


Q ss_pred             cccccCCCccccC
Q 011508           68 SAISLDGNVNLCG   80 (484)
Q Consensus        68 ~~~~~~~n~~l~g   80 (484)
                      +.+++++| .+.+
T Consensus        94 ~~L~l~~n-~l~~  105 (454)
T 1jl5_A           94 ESLVASCN-SLTE  105 (454)
T ss_dssp             SEEECCSS-CCSS
T ss_pred             CEEEccCC-cCCc
Confidence            66666666 4444

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.07  E-value=4.3e-06  Score=83.32  Aligned_cols=72  Identities=17%  Similarity=0.221  Sum_probs=54.2

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|+|++ +| +++.+++|++|+|++|+|++ +|  ++.+++|+.|+|++|+|++. | .+.+++++.+++++| .+.+
T Consensus        49 Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~-~-~~~l~~L~~L~L~~N-~l~~  120 (457)
T 3bz5_A           49 CHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL-D-VTPLTKLTYLNCDTN-KLTK  120 (457)
T ss_dssp             CCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-C-CTTCTTCCEEECCSS-CCSC
T ss_pred             ccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-e-cCCCCcCCEEECCCC-cCCe
Confidence            56788884 56 68888888888888888885 55  77888888888888888875 3 556777888888877 4544

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.07  E-value=3.7e-06  Score=84.18  Aligned_cols=75  Identities=23%  Similarity=0.361  Sum_probs=64.3

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      |++|++++ +|. ++.+++|+.|+|++|++++. |. +..+++|+.|+|++|++++..| ...+++++.+++++| .+.+
T Consensus       272 l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n-~l~~  345 (466)
T 1o6v_A          272 LGANQISN-ISP-LAGLTALTNLELNENQLEDI-SP-ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNN-KVSD  345 (466)
T ss_dssp             CCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCC-GG-GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSS-CCCC
T ss_pred             CCCCccCc-ccc-ccCCCccCeEEcCCCcccCc-hh-hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCC-ccCC
Confidence            57899995 554 99999999999999999964 43 8899999999999999999887 568899999999999 5555


Q ss_pred             C
Q 011508           81 G   81 (484)
Q Consensus        81 ~   81 (484)
                      .
T Consensus       346 ~  346 (466)
T 1o6v_A          346 V  346 (466)
T ss_dssp             C
T ss_pred             c
Confidence            4

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.06  E-value=6.9e-07  Score=85.26  Aligned_cols=79  Identities=19%  Similarity=0.187  Sum_probs=64.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccc-cCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGR-IPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~-~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l   78 (484)
                      |++|.+++.+|. +.++++|+.|+|++|.+++. +|..+.++++|+.|+|++|++++..|.. ..+++++.+++++|..+
T Consensus        77 l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l  155 (336)
T 2ast_B           77 CPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF  155 (336)
T ss_dssp             CTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSC
T ss_pred             cCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCC
Confidence            577888866555 67899999999999999876 8888899999999999999988766643 56888999999998655


Q ss_pred             cC
Q 011508           79 CG   80 (484)
Q Consensus        79 ~g   80 (484)
                      .+
T Consensus       156 ~~  157 (336)
T 2ast_B          156 SE  157 (336)
T ss_dssp             CH
T ss_pred             CH
Confidence            54

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.06  E-value=8.3e-06  Score=78.46  Aligned_cols=85  Identities=5%  Similarity=-0.087  Sum_probs=51.9

Q ss_pred             Ccc-ccccceeEEEEEEc---CCC-CeeEEEEEEeeccC---ccchHHHHHHHHHHHcCC-C--CCceeEeeeeeeeccC
Q 011508          165 NLI-GAGSFGSVYKGIFD---HDD-HETLVAVKVLNLQH---RGASKSFIAECQALRSIR-H--RNLVKIITSCVSVDFQ  233 (484)
Q Consensus       165 ~~l-g~G~~g~Vy~~~~~---~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~  233 (484)
                      +.| +.|....+|+....   +.. ++..+++|+.....   ......+.+|..+++.+. +  -.+.+++.++....  
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~--  103 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD--  103 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST--
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC--
Confidence            567 88989999988643   100 14678888765322   101245778888888773 2  34666776643211  


Q ss_pred             CCceeeEEeecccCCCHH
Q 011508          234 GNDFEALVYELMVNGSLE  251 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~  251 (484)
                      .....++||||++|.++.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence            113457999999886654

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.05  E-value=1.6e-06  Score=83.79  Aligned_cols=79  Identities=27%  Similarity=0.221  Sum_probs=66.3

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccC----ccccCCC-CCCeeeccccceecccccc-ccc-----ccCcc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIP----KYLENFP-FLQNLNLSFNHFEGEVPIK-GVF-----SNSSA   69 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p----~~~~~l~-~L~~l~ls~N~l~g~~p~~-~~~-----~~~~~   69 (484)
                      |+.|+++|.+|..+...++|+.|||++|++++.-+    ..+.+++ +|+.|+|++|++++..+.. ..+     .+++.
T Consensus         5 ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~   84 (362)
T 3goz_A            5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTS   84 (362)
T ss_dssp             CCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCE
T ss_pred             cccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccE
Confidence            68899999999998988899999999999996555    6788898 9999999999999876643 232     78999


Q ss_pred             cccCCCccccC
Q 011508           70 ISLDGNVNLCG   80 (484)
Q Consensus        70 ~~~~~n~~l~g   80 (484)
                      +++++| .+.+
T Consensus        85 L~Ls~n-~l~~   94 (362)
T 3goz_A           85 LNLSGN-FLSY   94 (362)
T ss_dssp             EECCSS-CGGG
T ss_pred             EECcCC-cCCh
Confidence            999999 4544

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.04  E-value=1.1e-06  Score=85.79  Aligned_cols=79  Identities=20%  Similarity=0.192  Sum_probs=63.4

Q ss_pred             CCCCccc--c---cCchhhhCCCCCCEEeCcCCccc----cccCccccCCCCCCeeeccccceecc----cccc---ccc
Q 011508            1 MNGNFFQ--G---NIPSSLSSLRGIENLDLSQNNLS----GRIPKYLENFPFLQNLNLSFNHFEGE----VPIK---GVF   64 (484)
Q Consensus         1 l~~n~l~--g---~~p~~~~~l~~l~~l~ls~N~l~----g~~p~~~~~l~~L~~l~ls~N~l~g~----~p~~---~~~   64 (484)
                      |++|+|+  |   .+|..+..+++|+.|+|++|.++    +.+|..+..+++|+.|+|++|++++.    +|..   +.+
T Consensus       194 L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~  273 (386)
T 2ca6_A          194 MVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLEN  273 (386)
T ss_dssp             CCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSS
T ss_pred             CcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccC
Confidence            5788887  3   45558899999999999999996    68899999999999999999999876    3332   337


Q ss_pred             ccCcccccCCCccccC
Q 011508           65 SNSSAISLDGNVNLCG   80 (484)
Q Consensus        65 ~~~~~~~~~~n~~l~g   80 (484)
                      ++++.+++++| .+.+
T Consensus       274 ~~L~~L~L~~n-~i~~  288 (386)
T 2ca6_A          274 IGLQTLRLQYN-EIEL  288 (386)
T ss_dssp             CCCCEEECCSS-CCBH
T ss_pred             CCeEEEECcCC-cCCH
Confidence            88999999998 4544

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.02  E-value=1.5e-06  Score=82.87  Aligned_cols=75  Identities=17%  Similarity=0.206  Sum_probs=55.8

Q ss_pred             CCCCcccccCchhhhCC--CCCCEEeCcCCccccccCccccCCCCCCeeeccccceecc-ccc-ccccccCcccccCCCc
Q 011508            1 MNGNFFQGNIPSSLSSL--RGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGE-VPI-KGVFSNSSAISLDGNV   76 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l--~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~-~p~-~~~~~~~~~~~~~~n~   76 (484)
                      |++|++.   |..++.+  ++|+.|++++|.+++.+|. +..+++|+.|+|++|++++. +|. ...+++++.+++++| 
T Consensus        54 l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~-  128 (336)
T 2ast_B           54 LTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL-  128 (336)
T ss_dssp             CTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC-
T ss_pred             cccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCc-
Confidence            3556665   5667777  8889999999998876554 66788899999999888765 553 366788888888888 


Q ss_pred             cccC
Q 011508           77 NLCG   80 (484)
Q Consensus        77 ~l~g   80 (484)
                      .+.+
T Consensus       129 ~l~~  132 (336)
T 2ast_B          129 RLSD  132 (336)
T ss_dssp             BCCH
T ss_pred             ccCH
Confidence            4443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.01  E-value=5.1e-06  Score=82.79  Aligned_cols=67  Identities=22%  Similarity=0.173  Sum_probs=54.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccc----------cCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFS----------NSSAI   70 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~----------~~~~~   70 (484)
                      |++|+|++.   .++.+++|+.|+|++|+|+| +|  ++.+++|+.|+|++|+|++.++.  .++          +++.+
T Consensus       198 l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~--~l~~L~~L~l~~n~L~~L  269 (457)
T 3bz5_A          198 CDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVS--TLSKLTTLHCIQTDLLEI  269 (457)
T ss_dssp             CCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCT--TCTTCCEEECTTCCCSCC
T ss_pred             CcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHH--HCCCCCEEeccCCCCCEE
Confidence            578999954   38999999999999999996 88  88999999999999999987653  333          44566


Q ss_pred             ccCCC
Q 011508           71 SLDGN   75 (484)
Q Consensus        71 ~~~~n   75 (484)
                      ++++|
T Consensus       270 ~l~~n  274 (457)
T 3bz5_A          270 DLTHN  274 (457)
T ss_dssp             CCTTC
T ss_pred             ECCCC
Confidence            66666

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.00  E-value=8.1e-06  Score=78.14  Aligned_cols=70  Identities=23%  Similarity=0.362  Sum_probs=48.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      +++|+++ .+|. +..+++|+.|+|++|+++ .+|. +.++++|+.|+|++|+++. +|....+++++.+++++|
T Consensus        51 l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~~-~~~~~~l~~L~~L~l~~n  120 (347)
T 4fmz_A           51 VAGEKVA-SIQG-IEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKITD-ISALQNLTNLRELYLNED  120 (347)
T ss_dssp             CCSSCCC-CCTT-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-CGGGTTCTTCSEEECTTS
T ss_pred             EeCCccc-cchh-hhhcCCccEEEccCCccc-cchh-hhcCCcCCEEEccCCcccC-chHHcCCCcCCEEECcCC
Confidence            3566666 5554 777777777777777777 4554 7777777777777777775 355566677777777777

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=97.97  E-value=7.1e-06  Score=84.69  Aligned_cols=54  Identities=26%  Similarity=0.232  Sum_probs=36.9

Q ss_pred             CCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCcccc
Q 011508           18 RGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus        18 ~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   79 (484)
                      ++|+.|+|++|+|+ .+|   ..+++|+.|+|++|+|++.++   .+.+++.+++++| .+.
T Consensus       221 ~~L~~L~Ls~N~L~-~lp---~~l~~L~~L~Ls~N~L~~lp~---~~~~L~~L~Ls~N-~L~  274 (622)
T 3g06_A          221 SGLKELIVSGNRLT-SLP---VLPSELKELMVSGNRLTSLPM---LPSGLLSLSVYRN-QLT  274 (622)
T ss_dssp             TTCCEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSS-CCC
T ss_pred             CCCCEEEccCCccC-cCC---CCCCcCcEEECCCCCCCcCCc---ccccCcEEeCCCC-CCC
Confidence            66777777777777 466   345677777777777775333   4567777777777 444

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.94  E-value=4.3e-05  Score=74.63  Aligned_cols=76  Identities=16%  Similarity=0.112  Sum_probs=47.2

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-------cchHHHHHHHHHHHcCCC--CC-ceeEeeeeeeeccC
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-------GASKSFIAECQALRSIRH--RN-LVKIITSCVSVDFQ  233 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~n-iv~~~~~~~~~~~~  233 (484)
                      .+.||.|..+.||++....  .+..+++|.......       .....+..|.++++.+..  +. +.+++.+.      
T Consensus        35 ~~~lg~G~~n~vyrv~~~~--~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d------  106 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQE--HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD------  106 (397)
T ss_dssp             EEECCSSSSEEEEEEEC------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE------
T ss_pred             EEECCCCceEEEEEEEECC--CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc------
Confidence            4679999999999997432  356799997643211       123456788888887732  33 33444331      


Q ss_pred             CCceeeEEeecccCC
Q 011508          234 GNDFEALVYELMVNG  248 (484)
Q Consensus       234 ~~~~~~lv~e~~~~g  248 (484)
                       ....++|||++++.
T Consensus       107 -~~~~~lvmE~l~g~  120 (397)
T 2olc_A          107 -TEMAVTVMEDLSHL  120 (397)
T ss_dssp             -TTTTEEEECCCTTS
T ss_pred             -CCccEEEEEeCCCc
Confidence             22457999999764

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=97.94  E-value=2.2e-06  Score=83.49  Aligned_cols=79  Identities=22%  Similarity=0.299  Sum_probs=65.1

Q ss_pred             CCCCccc-ccCc---hhhhCCCCCCEEeCcCCccc--c---ccCccccCCCCCCeeecccccee----ccccc-cccccc
Q 011508            1 MNGNFFQ-GNIP---SSLSSLRGIENLDLSQNNLS--G---RIPKYLENFPFLQNLNLSFNHFE----GEVPI-KGVFSN   66 (484)
Q Consensus         1 l~~n~l~-g~~p---~~~~~l~~l~~l~ls~N~l~--g---~~p~~~~~l~~L~~l~ls~N~l~----g~~p~-~~~~~~   66 (484)
                      |++|+|+ +.+|   ..+..+++|+.|+|++|+++  |   .+|..+..+++|+.|+|++|.|+    +.+|. ...+++
T Consensus       166 L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~  245 (386)
T 2ca6_A          166 CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN  245 (386)
T ss_dssp             CCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTT
T ss_pred             CCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCC
Confidence            6889998 6777   57889999999999999998  4   45558899999999999999996    55554 366789


Q ss_pred             CcccccCCCccccC
Q 011508           67 SSAISLDGNVNLCG   80 (484)
Q Consensus        67 ~~~~~~~~n~~l~g   80 (484)
                      ++.+++++| .+.+
T Consensus       246 L~~L~L~~n-~i~~  258 (386)
T 2ca6_A          246 LRELGLNDC-LLSA  258 (386)
T ss_dssp             CCEEECTTC-CCCH
T ss_pred             cCEEECCCC-CCch
Confidence            999999999 4443

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=97.93  E-value=4.2e-06  Score=80.35  Aligned_cols=55  Identities=24%  Similarity=0.273  Sum_probs=34.8

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCc-cccCCCCCCeeeccccceeccccc
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPK-YLENFPFLQNLNLSFNHFEGEVPI   60 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l~g~~p~   60 (484)
                      ++|+|+ .||..+  .++|+.|+|++|+|+ .||. +|.++++|+.|+|++|++.+.+|.
T Consensus        17 ~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~   72 (350)
T 4ay9_X           17 QESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEA   72 (350)
T ss_dssp             ESTTCC-SCCTTC--CTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECT
T ss_pred             cCCCCC-ccCcCc--CCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccCh
Confidence            355666 666655  356677777777776 4553 466677777777777776655553

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.87  E-value=5.4e-06  Score=79.98  Aligned_cols=79  Identities=18%  Similarity=0.172  Sum_probs=64.5

Q ss_pred             CCCCcccccCc----hhhhCCC-CCCEEeCcCCccccccCccccCC-----CCCCeeeccccceecccccc-----ccc-
Q 011508            1 MNGNFFQGNIP----SSLSSLR-GIENLDLSQNNLSGRIPKYLENF-----PFLQNLNLSFNHFEGEVPIK-----GVF-   64 (484)
Q Consensus         1 l~~n~l~g~~p----~~~~~l~-~l~~l~ls~N~l~g~~p~~~~~l-----~~L~~l~ls~N~l~g~~p~~-----~~~-   64 (484)
                      |++|+|++..+    ..+.+++ +|+.|+|++|++++..+..+..+     ++|+.|+|++|++++..+..     ..+ 
T Consensus        29 Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~  108 (362)
T 3goz_A           29 LSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP  108 (362)
T ss_dssp             CTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHHTSC
T ss_pred             ccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHHhCC
Confidence            68899986666    6788898 99999999999998778777775     99999999999999877652     223 


Q ss_pred             ccCcccccCCCccccC
Q 011508           65 SNSSAISLDGNVNLCG   80 (484)
Q Consensus        65 ~~~~~~~~~~n~~l~g   80 (484)
                      ++++.+++++| .+.+
T Consensus       109 ~~L~~L~Ls~N-~l~~  123 (362)
T 3goz_A          109 FTITVLDLGWN-DFSS  123 (362)
T ss_dssp             TTCCEEECCSS-CGGG
T ss_pred             CCccEEECcCC-cCCc
Confidence            78999999999 4443

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.86  E-value=0.00013  Score=69.50  Aligned_cols=32  Identities=25%  Similarity=0.333  Sum_probs=28.6

Q ss_pred             CCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          288 ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       288 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      ...++|||+++.||+++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            67899999999999998888999999997753

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=97.74  E-value=2.5e-05  Score=80.62  Aligned_cols=65  Identities=23%  Similarity=0.283  Sum_probs=42.0

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      |++|+|+ .+|..+.  ++|+.|+|++|+|+ .||.   .+++|+.|+|++|+|++.++   .+++|+.+++++|
T Consensus        47 ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N  111 (622)
T 3g06_A           47 VGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV---LPPGLLELSIFSN  111 (622)
T ss_dssp             CCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC---CCTTCCEEEECSC
T ss_pred             ecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC---CCCCCCEEECcCC
Confidence            4667776 7776665  67777777777777 5665   45667777777777664333   4556666666666

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=97.63  E-value=2.9e-05  Score=74.45  Aligned_cols=72  Identities=19%  Similarity=0.165  Sum_probs=39.2

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCc-cccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPK-YLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      |++|+|+ .||..+...++|+.|++++|+..+.||. .+.++++|+.||||+|+|+..++.  .+.++..+...++
T Consensus       161 L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~--~~~~L~~L~~l~~  233 (350)
T 4ay9_X          161 LNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY--GLENLKKLRARST  233 (350)
T ss_dssp             CCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSS--SCTTCCEEECTTC
T ss_pred             ccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChh--hhccchHhhhccC
Confidence            4566665 5665555566666666654332225554 346666666666666666644432  2444444444444

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.51  E-value=0.00053  Score=64.18  Aligned_cols=140  Identities=16%  Similarity=0.104  Sum_probs=86.4

Q ss_pred             ccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC---CCCceeEeeeeeeeccCCCceee
Q 011508          163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR---HRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       163 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      -.+.|+.|....+|+...    ++..+++|+....   ....+..|.+.|+.|.   ...+.+++.++..     .+..+
T Consensus        40 ~~~~l~gG~~n~~y~v~~----~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~  107 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND----EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSF  107 (312)
T ss_dssp             EEEEECCSSSSEEEEEES----SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEE
T ss_pred             eeEEeCCccceeeeEEEE----CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceE
Confidence            346789999999999873    2456788887532   3466888998888883   3557777776432     34679


Q ss_pred             EEeecccCCCHH--------H---HHhhcCC-C-----------------CCCCCHHHHH---HHHH-------------
Q 011508          240 LVYELMVNGSLE--------E---WLHLNRD-A-----------------PRNLNLLQRL---SIAV-------------  274 (484)
Q Consensus       240 lv~e~~~~gsL~--------~---~l~~~~~-~-----------------~~~l~~~~~~---~i~~-------------  274 (484)
                      +||||+++..+.        .   .++.... .                 ...-+|....   ++..             
T Consensus       108 lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~  187 (312)
T 3jr1_A          108 LLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFG  187 (312)
T ss_dssp             EEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCS
T ss_pred             EEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChH
Confidence            999999887541        1   1222211 0                 0012454322   1111             


Q ss_pred             ---HHHHHH-HHHHh-cCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          275 ---DVASTL-EYLHH-YCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       275 ---~i~~~l-~~LH~-~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                         .+...+ ..|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus       188 ~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          188 NIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             CHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence               111111 23321 1146799999999999999887 8899984

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.48  E-value=1.9e-05  Score=78.68  Aligned_cols=75  Identities=19%  Similarity=0.123  Sum_probs=50.5

Q ss_pred             CCCCcccccCchhhhCC-----CCCCEEeCcCCccccc----cCccccCCCCCCeeeccccceecccccc-c-----ccc
Q 011508            1 MNGNFFQGNIPSSLSSL-----RGIENLDLSQNNLSGR----IPKYLENFPFLQNLNLSFNHFEGEVPIK-G-----VFS   65 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l-----~~l~~l~ls~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~-----~~~   65 (484)
                      |++|++++..+..+...     ++|+.|+|++|.+++.    +|..+..+++|+.|+|++|++++..+.. .     ..+
T Consensus       291 Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~  370 (461)
T 1z7x_W          291 LAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGS  370 (461)
T ss_dssp             CTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred             CCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCC
Confidence            46777765555555433     6788888888888764    5666777788888888888777654321 1     145


Q ss_pred             cCcccccCCC
Q 011508           66 NSSAISLDGN   75 (484)
Q Consensus        66 ~~~~~~~~~n   75 (484)
                      +++.+++++|
T Consensus       371 ~L~~L~L~~n  380 (461)
T 1z7x_W          371 VLRVLWLADC  380 (461)
T ss_dssp             CCCEEECTTS
T ss_pred             ceEEEECCCC
Confidence            7777888777

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.41  E-value=0.00048  Score=63.84  Aligned_cols=77  Identities=16%  Similarity=0.047  Sum_probs=53.9

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCC---CceeEeeeeeeeccCCCce
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR---NLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~~~  237 (484)
                      ..-...+|.|..+.||+.+..   +++.|.+|+-..........+..|...|+.|.-.   -+.+++++.         .
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~---DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~   84 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELA---DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------D   84 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET---TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------T
T ss_pred             eEEEEecCCCCCeEEEEEEEC---CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------C
Confidence            444577999999999999876   4678999987654443445678899999888422   244444431         2


Q ss_pred             eeEEeecccCCC
Q 011508          238 EALVYELMVNGS  249 (484)
Q Consensus       238 ~~lv~e~~~~gs  249 (484)
                      .++||||++++.
T Consensus        85 ~~lv~e~l~~~~   96 (288)
T 3f7w_A           85 RTLAMEWVDERP   96 (288)
T ss_dssp             TEEEEECCCCCC
T ss_pred             ceEEEEeecccC
Confidence            378999997764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.39  E-value=0.00073  Score=66.36  Aligned_cols=80  Identities=11%  Similarity=0.111  Sum_probs=49.2

Q ss_pred             CCCeeecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCC---CCCcccceehhh
Q 011508          288 ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS---EVSTSGDVYSFG  364 (484)
Q Consensus       288 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dvws~G  364 (484)
                      ...++|||+++.||++++++ ++++||+.+...+...+.     .... ..-...|.+|+.....   ......++....
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-----a~~l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-----GAYL-GNLILAFFAQDGHATQENDRKEYKQWILRTI  303 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-----HHHH-HHHHHHHHHGGGGCCSSCCSHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-----HHHH-HHHHHHHHhcccccccccchHHHHHHHHHHH
Confidence            78899999999999998876 999999988765332110     0000 0011345666544311   112234556778


Q ss_pred             HHHHHHHhCC
Q 011508          365 ILLLEMFTGK  374 (484)
Q Consensus       365 vvl~elltg~  374 (484)
                      ..+|+.++++
T Consensus       304 ~~~~~~y~~~  313 (420)
T 2pyw_A          304 EQTWNLFNKR  313 (420)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            8888877654

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=97.28  E-value=5.7e-05  Score=72.92  Aligned_cols=75  Identities=17%  Similarity=0.091  Sum_probs=52.5

Q ss_pred             CCCCcccccCchhhh-----CCCCCCEEeCcCCcccc----ccCccccCCCCCCeeeccccceeccc----c-ccccccc
Q 011508            1 MNGNFFQGNIPSSLS-----SLRGIENLDLSQNNLSG----RIPKYLENFPFLQNLNLSFNHFEGEV----P-IKGVFSN   66 (484)
Q Consensus         1 l~~n~l~g~~p~~~~-----~l~~l~~l~ls~N~l~g----~~p~~~~~l~~L~~l~ls~N~l~g~~----p-~~~~~~~   66 (484)
                      |++|+|+..-...++     ..++|+.|+|++|.|+.    .++..+..+++|+.|||++|+|+..-    + ......+
T Consensus       133 Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~  212 (372)
T 3un9_A          133 LQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQ  212 (372)
T ss_dssp             CCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSC
T ss_pred             cCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCC
Confidence            578888754444442     46788999999998874    35566677888999999998886422    1 1134457


Q ss_pred             CcccccCCC
Q 011508           67 SSAISLDGN   75 (484)
Q Consensus        67 ~~~~~~~~n   75 (484)
                      ++.+++++|
T Consensus       213 L~~L~Ls~N  221 (372)
T 3un9_A          213 LQELNVAYN  221 (372)
T ss_dssp             CCEEECCSS
T ss_pred             cCeEECCCC
Confidence            888888888

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.26  E-value=0.00075  Score=62.95  Aligned_cols=32  Identities=22%  Similarity=0.283  Sum_probs=26.2

Q ss_pred             CCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          288 ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       288 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ...++|+|+.+.||+ ..++.+.++||..+...
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            345899999999999 55667899999987643

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.23  E-value=0.00036  Score=56.08  Aligned_cols=58  Identities=17%  Similarity=0.182  Sum_probs=40.4

Q ss_pred             CEEeCcCCccc-cccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCccccC
Q 011508           21 ENLDLSQNNLS-GRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus        21 ~~l~ls~N~l~-g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~g   80 (484)
                      ..+|.++|.|+ ..+|..+.  ++|+.|+|++|+|+...+.. ..+.+++.+++.+||..|+
T Consensus        11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~Cd   70 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCD   70 (130)
T ss_dssp             TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCS
T ss_pred             CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeecc
Confidence            46788888876 46775532  36788888888887666543 4566777788888877664

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.19  E-value=0.0018  Score=56.14  Aligned_cols=100  Identities=17%  Similarity=0.156  Sum_probs=65.5

Q ss_pred             CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccccccccC
Q 011508          248 GSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL  327 (484)
Q Consensus       248 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  327 (484)
                      .||.+.|+...   .++++.++|.++.|.+.+|.-+-.  .+.-..+=+.|..|++..+|.+.+.+ ..+.         
T Consensus        33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------   97 (229)
T 2yle_A           33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------   97 (229)
T ss_dssp             EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred             ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc---------
Confidence            37999998654   469999999999999999887621  11111233456889999999888764 1111         


Q ss_pred             CCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhC
Q 011508          328 SSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG  373 (484)
Q Consensus       328 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg  373 (484)
                                .....+.|||... ...+.+.=|||+|+++|.-+-=
T Consensus        98 ----------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A           98 ----------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             -------------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred             ----------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence                      0123466888753 3456788999999999998873

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.08  E-value=0.0078  Score=56.46  Aligned_cols=149  Identities=13%  Similarity=0.089  Sum_probs=77.4

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCC--ceeEeeeeeeec-cCCCceeeEE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN--LVKIITSCVSVD-FQGNDFEALV  241 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~-~~~~~~~~lv  241 (484)
                      +.|+.|....+|+....+   + .+++|+....  .....+..|..++..+....  +.+++....... ...++..+++
T Consensus        28 ~~i~~G~~n~~~~v~~~~---g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l  101 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTK---D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL  101 (322)
T ss_dssp             EEECC---EEEEEEEESS---C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred             eccCCCcccceEEEEeCC---c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence            456778889999987542   2 5788887642  12245566777777663222  233332100000 0012356899


Q ss_pred             eecccCCCHH-----H---------HHhhcC-C--CCC--CC---CHHHHHH------------HHHHHHHHHHHHHhc-
Q 011508          242 YELMVNGSLE-----E---------WLHLNR-D--APR--NL---NLLQRLS------------IAVDVASTLEYLHHY-  286 (484)
Q Consensus       242 ~e~~~~gsL~-----~---------~l~~~~-~--~~~--~l---~~~~~~~------------i~~~i~~~l~~LH~~-  286 (484)
                      ++|++|..+.     .         .++... .  ...  ..   .|...+.            +...+...++.++.. 
T Consensus       102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~  181 (322)
T 2ppq_A          102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW  181 (322)
T ss_dssp             EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred             EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence            9999875431     0         112111 0  000  01   1222110            011234455555432 


Q ss_pred             ---CCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          287 ---CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       287 ---~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                         ....++|+|+.+.||+++++..+.|+||+.+..
T Consensus       182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               135799999999999999876668999997753

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.08  E-value=0.00015  Score=72.18  Aligned_cols=78  Identities=14%  Similarity=0.050  Sum_probs=53.3

Q ss_pred             CCCCcccccCchhhhC-----CCCCCEEeCcCCccccc----cCccccCCCCCCeeeccccceeccc-----ccc-cccc
Q 011508            1 MNGNFFQGNIPSSLSS-----LRGIENLDLSQNNLSGR----IPKYLENFPFLQNLNLSFNHFEGEV-----PIK-GVFS   65 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~-----l~~l~~l~ls~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~g~~-----p~~-~~~~   65 (484)
                      |++|+++...+..+..     +++|+.|+|++|++++.    +|..+..+++|+.|+|++|++++.-     +.. ..+.
T Consensus       177 L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~  256 (461)
T 1z7x_W          177 VSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSS  256 (461)
T ss_dssp             CCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTC
T ss_pred             CcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCC
Confidence            4677777555555543     66888888888888853    6777777888888888888876532     111 2356


Q ss_pred             cCcccccCCCcccc
Q 011508           66 NSSAISLDGNVNLC   79 (484)
Q Consensus        66 ~~~~~~~~~n~~l~   79 (484)
                      +++.+++++| .+.
T Consensus       257 ~L~~L~L~~n-~l~  269 (461)
T 1z7x_W          257 RLRTLWIWEC-GIT  269 (461)
T ss_dssp             CCCEEECTTS-CCC
T ss_pred             CceEEECcCC-CCC
Confidence            7888888887 443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.96  E-value=0.00067  Score=54.48  Aligned_cols=51  Identities=24%  Similarity=0.428  Sum_probs=40.8

Q ss_pred             CCCccc-ccCchhhhCCCCCCEEeCcCCccccccCc-cccCCCCCCeeecccccee
Q 011508            2 NGNFFQ-GNIPSSLSSLRGIENLDLSQNNLSGRIPK-YLENFPFLQNLNLSFNHFE   55 (484)
Q Consensus         2 ~~n~l~-g~~p~~~~~l~~l~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l~   55 (484)
                      ++++|+ ..+|..+  ..+|+.|+|++|+|+ .||. .|..+++|+.|+|++|.+.
T Consensus        16 s~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           16 GRRGLTWASLPTAF--PVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             CSSCCCTTTSCSCC--CTTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCCCccccCCCCC--CcCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            567775 4677643  247999999999999 6765 4688999999999999885

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=96.93  E-value=0.00022  Score=68.71  Aligned_cols=76  Identities=17%  Similarity=0.031  Sum_probs=54.8

Q ss_pred             CCCCcccccCchhh-hCCCCCCEEeCcCCccccccCccc-----cCCCCCCeeeccccceeccc----c-cccccccCcc
Q 011508            1 MNGNFFQGNIPSSL-SSLRGIENLDLSQNNLSGRIPKYL-----ENFPFLQNLNLSFNHFEGEV----P-IKGVFSNSSA   69 (484)
Q Consensus         1 l~~n~l~g~~p~~~-~~l~~l~~l~ls~N~l~g~~p~~~-----~~l~~L~~l~ls~N~l~g~~----p-~~~~~~~~~~   69 (484)
                      |++|+|+..-...+ ..+++|+.|||++|+|+..-...+     ...++|+.|+|++|.|+..-    + .....++++.
T Consensus       108 Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~  187 (372)
T 3un9_A          108 LASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTH  187 (372)
T ss_dssp             CTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCE
T ss_pred             ecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCE
Confidence            67888875444444 356789999999999985444444     35689999999999996522    1 1134678999


Q ss_pred             cccCCCc
Q 011508           70 ISLDGNV   76 (484)
Q Consensus        70 ~~~~~n~   76 (484)
                      +++++|.
T Consensus       188 L~Ls~N~  194 (372)
T 3un9_A          188 LSLLHTG  194 (372)
T ss_dssp             EECTTSS
T ss_pred             EeCCCCC
Confidence            9999993

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.90  E-value=0.01  Score=56.02  Aligned_cols=33  Identities=33%  Similarity=0.325  Sum_probs=28.4

Q ss_pred             CCCeeecCCCCCCeeecCC----CceEEcccCccccc
Q 011508          288 ETPIVHCDLKPSNVLLDGE----LTAHVSDFGLAKFL  320 (484)
Q Consensus       288 ~~~ivH~dlk~~NIll~~~----~~~kl~Dfg~a~~~  320 (484)
                      ...++|||+.+.||+++.+    ..+.|+||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            5679999999999999874    67899999988754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.84  E-value=0.003  Score=62.04  Aligned_cols=75  Identities=15%  Similarity=0.160  Sum_probs=47.9

Q ss_pred             cCccccccceeEEEEEEcCC-----CCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCc-eeEeeeeeeeccCCCce
Q 011508          164 ENLIGAGSFGSVYKGIFDHD-----DHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL-VKIITSCVSVDFQGNDF  237 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~  237 (484)
                      .+.|+.|....+|++...+.     ..+..+++|+....  .....+.+|..+++.+...++ .++++.+     .+   
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~---  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF-----SG---  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT---
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC---
Confidence            35688898999999986431     12457888887432  122556689998888843334 4555542     21   


Q ss_pred             eeEEeecccCCC
Q 011508          238 EALVYELMVNGS  249 (484)
Q Consensus       238 ~~lv~e~~~~gs  249 (484)
                       .+|+||++|.+
T Consensus       148 -g~v~e~l~G~~  158 (429)
T 1nw1_A          148 -GRLEEYIPSRP  158 (429)
T ss_dssp             -EEEECCCCEEE
T ss_pred             -CEEEEEeCCcc
Confidence             38999997633

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.81  E-value=0.0074  Score=59.61  Aligned_cols=75  Identities=15%  Similarity=0.054  Sum_probs=45.2

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCc-eeEeeeeeeeccCCCceeeEEe
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL-VKIITSCVSVDFQGNDFEALVY  242 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~  242 (484)
                      .+.|+.|-...+|+....+  .+..+++|+...... ..-...+|..++..|...++ .++++.+     . +   .+|+
T Consensus       113 i~~lsgG~tN~~y~v~~~~--~~~~~vLRi~g~~~~-~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~-~---G~v~  180 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMS--KQAKYLIRLYGPKTD-EIINREREKKISCILYNKNIAKKIYVFF-----T-N---GRIE  180 (458)
T ss_dssp             EEEECC--CEEEEEEEETT--TTEEEEEEEECC-CC-SCSCHHHHHHHHHHHTTSSSBCCEEEEE-----T-T---EEEE
T ss_pred             EEEcCCCeEeEEEEEEECC--CCceEEEEECCCChh-hhcCHHHHHHHHHHHHhcCCCCCEEEEe-----C-C---eEEE
Confidence            3568889999999998542  236688887643221 11122578888888865555 4555542     1 1   3599


Q ss_pred             ecccCCCH
Q 011508          243 ELMVNGSL  250 (484)
Q Consensus       243 e~~~~gsL  250 (484)
                      ||++|.+|
T Consensus       181 e~I~G~~l  188 (458)
T 2qg7_A          181 EFMDGYAL  188 (458)
T ss_dssp             ECCCSEEC
T ss_pred             EeeCCccC
Confidence            99987443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.71  E-value=0.0079  Score=56.61  Aligned_cols=147  Identities=12%  Similarity=0.086  Sum_probs=78.3

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCC--ceeEeeeeeeec-cCCCceeeEE
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN--LVKIITSCVSVD-FQGNDFEALV  241 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~-~~~~~~~~lv  241 (484)
                      ..++ |....||+....   +++.+++|+..... .....+..|..++..+....  +.+++.. .... ...++..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~---~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE---DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCT---TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcC---CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEE
Confidence            3466 888899987532   34568899886332 23456677888887773222  3333332 0000 0113456789


Q ss_pred             eecccCCCHH-----HH---------HhhcC---CC--CCCCCHHHH----HHH---------------HHHHHHHHHHH
Q 011508          242 YELMVNGSLE-----EW---------LHLNR---DA--PRNLNLLQR----LSI---------------AVDVASTLEYL  283 (484)
Q Consensus       242 ~e~~~~gsL~-----~~---------l~~~~---~~--~~~l~~~~~----~~i---------------~~~i~~~l~~L  283 (484)
                      |++++|.++.     .+         ++...   ..  ....++...    ..+               ...+...++.+
T Consensus       106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l  185 (328)
T 1zyl_A          106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV  185 (328)
T ss_dssp             EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred             EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence            9999774321     11         11110   00  011222211    000               11111222333


Q ss_pred             Hhc----CCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          284 HHY----CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       284 H~~----~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                      ...    ....++|||+++.||+++ + .+.|+||+.+..
T Consensus       186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            211    145689999999999999 4 899999987764

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.62  E-value=0.012  Score=56.45  Aligned_cols=145  Identities=11%  Similarity=0.138  Sum_probs=80.7

Q ss_pred             CccccccceeEEEEEEcC-----CCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCC-ceeEeeeeeeeccCCCcee
Q 011508          165 NLIGAGSFGSVYKGIFDH-----DDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN-LVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~  238 (484)
                      +.|..|-...+|+.....     ..++..+++|+.... ........+|.++++.+.-.+ ..++++.+     .+    
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----
Confidence            567778889999988542     112467888886332 223456678999988884222 24555542     22    


Q ss_pred             eEEeecccCCCHHH--------------H---HhhcC-CCCCCCC--HHHHHHHHHHHHH-------------------H
Q 011508          239 ALVYELMVNGSLEE--------------W---LHLNR-DAPRNLN--LLQRLSIAVDVAS-------------------T  279 (484)
Q Consensus       239 ~lv~e~~~~gsL~~--------------~---l~~~~-~~~~~l~--~~~~~~i~~~i~~-------------------~  279 (484)
                      .+||||++|.+|..              .   ++... ...+...  +.++.++..++..                   .
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            38999998754421              1   11111 1111122  3444445443322                   2


Q ss_pred             HHHHHh----c-CCCCeeecCCCCCCeeecCC----CceEEcccCcccc
Q 011508          280 LEYLHH----Y-CETPIVHCDLKPSNVLLDGE----LTAHVSDFGLAKF  319 (484)
Q Consensus       280 l~~LH~----~-~~~~ivH~dlk~~NIll~~~----~~~kl~Dfg~a~~  319 (484)
                      +..|..    . ....++|+|+.+.||+++++    +.+.++||..+..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            233321    1 13468999999999999876    6899999998764

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=96.58  E-value=0.00032  Score=72.13  Aligned_cols=67  Identities=12%  Similarity=0.101  Sum_probs=34.2

Q ss_pred             CchhhhCCCCCCEEeCcCC--ccccccCccccC-CCCCCeeeccccceec-ccccc-cccccCcccccCCCc
Q 011508           10 IPSSLSSLRGIENLDLSQN--NLSGRIPKYLEN-FPFLQNLNLSFNHFEG-EVPIK-GVFSNSSAISLDGNV   76 (484)
Q Consensus        10 ~p~~~~~l~~l~~l~ls~N--~l~g~~p~~~~~-l~~L~~l~ls~N~l~g-~~p~~-~~~~~~~~~~~~~n~   76 (484)
                      ++..+.++++|+.|+|+++  .+++..+..++. +++|+.|+|++|++++ .++.. ..+++++.+++++|+
T Consensus       428 ~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~  499 (592)
T 3ogk_B          428 VRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCC  499 (592)
T ss_dssp             HHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCC
T ss_pred             HHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCC
Confidence            4444555666666666532  355444444432 5566666666666554 12221 334556666666653

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=96.43  E-value=0.00079  Score=57.83  Aligned_cols=75  Identities=12%  Similarity=0.142  Sum_probs=53.9

Q ss_pred             CCCC-cccc----cCchhhhCCCCCCEEeCcCCcccc----ccCccccCCCCCCeeeccccceecc-----ccccccccc
Q 011508            1 MNGN-FFQG----NIPSSLSSLRGIENLDLSQNNLSG----RIPKYLENFPFLQNLNLSFNHFEGE-----VPIKGVFSN   66 (484)
Q Consensus         1 l~~n-~l~g----~~p~~~~~l~~l~~l~ls~N~l~g----~~p~~~~~l~~L~~l~ls~N~l~g~-----~p~~~~~~~   66 (484)
                      |++| +|..    .+...+...++|+.|+|++|+|+.    .+...+...++|+.|+|++|.|...     ........+
T Consensus        43 L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~  122 (185)
T 1io0_A           43 LNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTS  122 (185)
T ss_dssp             CTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSS
T ss_pred             ecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCC
Confidence            4566 6653    245567778999999999999974    2455566678999999999999753     112234567


Q ss_pred             Cccccc--CCC
Q 011508           67 SSAISL--DGN   75 (484)
Q Consensus        67 ~~~~~~--~~n   75 (484)
                      ++.+++  ++|
T Consensus       123 L~~L~L~~~~N  133 (185)
T 1io0_A          123 LIELRIDNQSQ  133 (185)
T ss_dssp             CCEEECCCCSS
T ss_pred             ceEEEecCCCC
Confidence            889999  667

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=96.42  E-value=0.00055  Score=70.42  Aligned_cols=41  Identities=20%  Similarity=0.338  Sum_probs=20.4

Q ss_pred             hCCCCCCEEeCcCCccccc----cCccccCCCCCCeeecccccee
Q 011508           15 SSLRGIENLDLSQNNLSGR----IPKYLENFPFLQNLNLSFNHFE   55 (484)
Q Consensus        15 ~~l~~l~~l~ls~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~   55 (484)
                      .++++|+.|+|++|.+++.    ++..+.++++|+.|+|++|.++
T Consensus       161 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~  205 (592)
T 3ogk_B          161 THCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFA  205 (592)
T ss_dssp             HHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCS
T ss_pred             hhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCC
Confidence            3455555555555555443    3333344555555555555554

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=96.39  E-value=0.00096  Score=57.30  Aligned_cols=66  Identities=11%  Similarity=0.191  Sum_probs=49.9

Q ss_pred             CchhhhCCCCCCEEeCcCC-cccc----ccCccccCCCCCCeeeccccceecccc-----cccccccCcccccCCC
Q 011508           10 IPSSLSSLRGIENLDLSQN-NLSG----RIPKYLENFPFLQNLNLSFNHFEGEVP-----IKGVFSNSSAISLDGN   75 (484)
Q Consensus        10 ~p~~~~~l~~l~~l~ls~N-~l~g----~~p~~~~~l~~L~~l~ls~N~l~g~~p-----~~~~~~~~~~~~~~~n   75 (484)
                      +...+...+.|+.|+|++| .+..    .+...+...++|+.|+|++|+|...--     ......+++.+++++|
T Consensus        28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N  103 (185)
T 1io0_A           28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESN  103 (185)
T ss_dssp             HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSS
T ss_pred             HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCC
Confidence            3445678999999999999 8874    355667778999999999999864211     1123467899999999

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=96.24  E-value=0.0006  Score=70.11  Aligned_cols=66  Identities=11%  Similarity=0.118  Sum_probs=48.0

Q ss_pred             CchhhhCCCCCCEEeCcCCccccccCccccC-CCCCCeeeccccceecccccc--cccccCcccccCCCc
Q 011508           10 IPSSLSSLRGIENLDLSQNNLSGRIPKYLEN-FPFLQNLNLSFNHFEGEVPIK--GVFSNSSAISLDGNV   76 (484)
Q Consensus        10 ~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~-l~~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~~~n~   76 (484)
                      ++.-+.++++|+.|+|++ ++++..+..++. +++|+.|+|++|.+++..+..  ..+++++.+++++|+
T Consensus       424 ~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~  492 (594)
T 2p1m_B          424 FGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCP  492 (594)
T ss_dssp             HHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCS
T ss_pred             HHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCC
Confidence            333467788899999977 777666666665 888888888888886543321  347788888888884

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.18  E-value=0.006  Score=58.56  Aligned_cols=75  Identities=9%  Similarity=0.165  Sum_probs=41.2

Q ss_pred             CccccccceeEEEEEEcCC------CCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCc-eeEeeeeeeeccCCCce
Q 011508          165 NLIGAGSFGSVYKGIFDHD------DHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL-VKIITSCVSVDFQGNDF  237 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~  237 (484)
                      ..|+.|....+|+....+.      ..+..+++|+...... .......|..+++.+...++ .++++..     .    
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~----  108 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF-----N----  108 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence            4678888899999875421      0125688887653221 11123578888877743333 3555431     1    


Q ss_pred             eeEEeecccCCC
Q 011508          238 EALVYELMVNGS  249 (484)
Q Consensus       238 ~~lv~e~~~~gs  249 (484)
                      -++||||++|.+
T Consensus       109 ~~~v~e~i~G~~  120 (369)
T 3c5i_A          109 GGRIEEWLYGDP  120 (369)
T ss_dssp             TEEEEECCCSEE
T ss_pred             CcEEEEEecCCc
Confidence            268999998753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.11  E-value=0.057  Score=50.98  Aligned_cols=33  Identities=21%  Similarity=0.351  Sum_probs=28.6

Q ss_pred             CCCeeecCCCCCCeeecCCCceEEcccCccccc
Q 011508          288 ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       288 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~  320 (484)
                      ...++|+|+.+.||++++++.+.|+||+.+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            356999999999999998888999999877654

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=95.68  E-value=0.0024  Score=65.57  Aligned_cols=53  Identities=15%  Similarity=0.180  Sum_probs=21.9

Q ss_pred             CcccccCchhhh-CCCCCCEEeCcCC-ccccc-cCccccCCCCCCeeeccccceec
Q 011508            4 NFFQGNIPSSLS-SLRGIENLDLSQN-NLSGR-IPKYLENFPFLQNLNLSFNHFEG   56 (484)
Q Consensus         4 n~l~g~~p~~~~-~l~~l~~l~ls~N-~l~g~-~p~~~~~l~~L~~l~ls~N~l~g   56 (484)
                      |.+++..+..++ ++++|+.|+|++| .++.. ++..+.++++|+.|+|++|.+++
T Consensus       115 ~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~  170 (594)
T 2p1m_B          115 MVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDD  170 (594)
T ss_dssp             CBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEEC
T ss_pred             cEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCC
Confidence            334433344343 3444444444444 23221 22223344444444444444443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=95.48  E-value=0.015  Score=54.81  Aligned_cols=57  Identities=18%  Similarity=0.293  Sum_probs=36.6

Q ss_pred             CCCCCEEeCcCCccccccCc-cccCCCCCCeeeccccceecccccc-cccccCc-ccccCCC
Q 011508           17 LRGIENLDLSQNNLSGRIPK-YLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSS-AISLDGN   75 (484)
Q Consensus        17 l~~l~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~-~~~~~~n   75 (484)
                      +++|+.|+|++|+++ .||. .|.+|.+|+.|+|++| ++...+.+ ..+.+|+ .+.+.++
T Consensus       225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~~  284 (329)
T 3sb4_A          225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPAS  284 (329)
T ss_dssp             CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECTT
T ss_pred             cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEccc
Confidence            677778888877777 5554 4677777777777776 54333322 4455566 6666554

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=95.05  E-value=0.0028  Score=60.61  Aligned_cols=61  Identities=11%  Similarity=0.164  Sum_probs=48.4

Q ss_pred             hCCCCCCEEeCcCCccccccCcccc---CCCCCCeeeccccceecc----cccc-cccccCcccccCCC
Q 011508           15 SSLRGIENLDLSQNNLSGRIPKYLE---NFPFLQNLNLSFNHFEGE----VPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus        15 ~~l~~l~~l~ls~N~l~g~~p~~~~---~l~~L~~l~ls~N~l~g~----~p~~-~~~~~~~~~~~~~n   75 (484)
                      +.+++|+.|+|++|.+++..+..+.   .+++|+.|+||.|.|.+.    ++.. ..+++|+.+++++|
T Consensus       249 ~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n  317 (362)
T 2ra8_A          249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN  317 (362)
T ss_dssp             TTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred             CCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence            3589999999999999876554443   588999999999999873    2322 45788999999888

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=94.70  E-value=0.006  Score=58.31  Aligned_cols=64  Identities=16%  Similarity=0.208  Sum_probs=44.1

Q ss_pred             CCCCCCEEeCcC--Cccccc-----cCccc--cCCCCCCeeeccccceeccccc----ccccccCcccccCCCccccC
Q 011508           16 SLRGIENLDLSQ--NNLSGR-----IPKYL--ENFPFLQNLNLSFNHFEGEVPI----KGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus        16 ~l~~l~~l~ls~--N~l~g~-----~p~~~--~~l~~L~~l~ls~N~l~g~~p~----~~~~~~~~~~~~~~n~~l~g   80 (484)
                      .+++|+.|+|+.  |...|.     +-..+  ..+++|+.|+|++|.+....+.    .+.+++|+.|+++.| .+.+
T Consensus       217 ~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n-~L~d  293 (362)
T 2ra8_A          217 DLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAG-VLTD  293 (362)
T ss_dssp             BCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSS-CCBH
T ss_pred             cCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCC-CCCh
Confidence            799999999964  332221     11223  3589999999999998754332    245788999999988 4443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.60  E-value=0.11  Score=50.42  Aligned_cols=144  Identities=14%  Similarity=0.161  Sum_probs=81.2

Q ss_pred             CccccccceeEEEEEEcCCCC-----eeEEEEEEeeccCccchHHHHHHHHHHHcCCCCC-ceeEeeeeeeeccCCCcee
Q 011508          165 NLIGAGSFGSVYKGIFDHDDH-----ETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN-LVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~  238 (484)
                      +.+..|-...+|+........     +..+++|+..... ...-...+|..+++.+...+ ..++++.+         .-
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~---------~~  145 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF---------PE  145 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE---------TT
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc---------CC
Confidence            467778889999988653211     4678888864322 11223457888887774323 34455431         12


Q ss_pred             eEEeecccCCCHHH-------H----------Hhhc-------CC--CCCCCCHHHHHHHHHHH----------------
Q 011508          239 ALVYELMVNGSLEE-------W----------LHLN-------RD--APRNLNLLQRLSIAVDV----------------  276 (484)
Q Consensus       239 ~lv~e~~~~gsL~~-------~----------l~~~-------~~--~~~~l~~~~~~~i~~~i----------------  276 (484)
                      +.|+||++|.+|..       .          ++..       ..  ...+.-+.++.++..++                
T Consensus       146 ~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~  225 (424)
T 3mes_A          146 GRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELY  225 (424)
T ss_dssp             EEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHH
T ss_pred             CEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccH
Confidence            78999998765311       0          1110       00  11111244444433322                


Q ss_pred             ---HHHHHHHHh---------------------cCCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          277 ---ASTLEYLHH---------------------YCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       277 ---~~~l~~LH~---------------------~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                         ...+.+|..                     .....++|+|+.+.||+ +.++.+.++||..+..
T Consensus       226 ~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          226 SKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence               222333321                     11346899999999999 7788999999998864

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.30  E-value=0.14  Score=49.64  Aligned_cols=29  Identities=24%  Similarity=0.447  Sum_probs=24.6

Q ss_pred             eeecCCCCCCeee------cCCCceEEcccCcccc
Q 011508          291 IVHCDLKPSNVLL------DGELTAHVSDFGLAKF  319 (484)
Q Consensus       291 ivH~dlk~~NIll------~~~~~~kl~Dfg~a~~  319 (484)
                      ++|+|+.+.||++      +++..++++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      3456799999998864

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=93.06  E-value=0.083  Score=49.56  Aligned_cols=71  Identities=17%  Similarity=0.154  Sum_probs=56.8

Q ss_pred             CCCCcccccCch-hhhCCCCCCEEeCcCCccccccC-ccccCCCCCC-eeeccccceecccccc-cccccCcccccCCC
Q 011508            1 MNGNFFQGNIPS-SLSSLRGIENLDLSQNNLSGRIP-KYLENFPFLQ-NLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~-~~~~l~~l~~l~ls~N~l~g~~p-~~~~~l~~L~-~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      |++|+++ .||. .|.+|++|+.|+|++| ++ .|+ .+|.+|++|+ .+++++ +++...+.+ ..+.+|+.+++.+|
T Consensus       233 L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n  307 (329)
T 3sb4_A          233 ISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGD  307 (329)
T ss_dssp             CTTBCCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSS
T ss_pred             CCCCCcc-eecHhhhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCC
Confidence            5678898 6664 6999999999999998 77 565 5689999999 999998 666444433 56778888888777

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=92.37  E-value=0.028  Score=47.27  Aligned_cols=73  Identities=11%  Similarity=0.134  Sum_probs=48.5

Q ss_pred             cCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccc-eecc-cccccc----cccCcccccCCCccccCC
Q 011508            9 NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNH-FEGE-VPIKGV----FSNSSAISLDGNVNLCGG   81 (484)
Q Consensus         9 ~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~-l~g~-~p~~~~----~~~~~~~~~~~n~~l~g~   81 (484)
                      .+|...-.--+|+.||||++.++..=-..+..|++|+.|+|+++. ++.. +.....    .++|+.|++++.+.++..
T Consensus        52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~  130 (176)
T 3e4g_A           52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDK  130 (176)
T ss_dssp             GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHH
T ss_pred             cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHH
Confidence            456543333579999999999885433557889999999999985 5421 111122    236888999887666543

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=88.92  E-value=0.51  Score=45.53  Aligned_cols=60  Identities=10%  Similarity=0.097  Sum_probs=35.3

Q ss_pred             hhhCCCCCCEEeCcCCccccccC-ccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508           13 SLSSLRGIENLDLSQNNLSGRIP-KYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus        13 ~~~~l~~l~~l~ls~N~l~g~~p-~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      .|.+ .+|+.++|.+ +++ .|+ .+|.+|++|+.++|++|+++......-...+++.+.+.+|
T Consensus       153 aF~~-~~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~~~~L~~l~lp~~  213 (401)
T 4fdw_A          153 AFFN-STVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKITKLPASTFVYAGIEEVLLPVT  213 (401)
T ss_dssp             TTTT-CCCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCSEECTTTTTTCCCSEEECCTT
T ss_pred             hcCC-CCceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcceEechhhEeecccCEEEeCCc
Confidence            3444 3577777764 555 343 5567777777777777777654444333345555555544

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=84.78  E-value=0.17  Score=31.14  Aligned_cols=28  Identities=18%  Similarity=0.262  Sum_probs=12.0

Q ss_pred             eEEehhhhhhHHHhhhhheeeeeecccCC
Q 011508          104 KLIIPIVTGILFLTGMSCLIITSWWSKTK  132 (484)
Q Consensus       104 ~~~i~~v~~~~~~~~~~~~~~~~~~~~~~  132 (484)
                      .++.+++.|+++++.++ +++++++++++
T Consensus        12 ~IA~gVVgGv~~~~ii~-~~~~~~~RRr~   39 (44)
T 2ks1_B           12 SIATGMVGALLLLLVVA-LGIGLFMRRRH   39 (44)
T ss_dssp             SSTHHHHHHHHHHHHHH-HHHHHHHHTTT
T ss_pred             eEEeehhHHHHHHHHHH-HHHHHHhhhhH
Confidence            34445555555543333 33334444433

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=84.42  E-value=1  Score=43.32  Aligned_cols=36  Identities=22%  Similarity=0.349  Sum_probs=22.1

Q ss_pred             CCCCEEeCcCCcccccc-CccccCCCCCCeeecccccee
Q 011508           18 RGIENLDLSQNNLSGRI-PKYLENFPFLQNLNLSFNHFE   55 (484)
Q Consensus        18 ~~l~~l~ls~N~l~g~~-p~~~~~l~~L~~l~ls~N~l~   55 (484)
                      .+|+.++| .|+++ .| +.+|.+|++|+.+++++|.+.
T Consensus       248 ~~L~~i~l-p~~i~-~I~~~aF~~c~~L~~l~l~~~~~~  284 (401)
T 4fdw_A          248 SGITTVKL-PNGVT-NIASRAFYYCPELAEVTTYGSTFN  284 (401)
T ss_dssp             CCCSEEEE-ETTCC-EECTTTTTTCTTCCEEEEESSCCC
T ss_pred             CCccEEEe-CCCcc-EEChhHhhCCCCCCEEEeCCcccc
Confidence            56777777 34455 34 345666777777777666654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=81.87  E-value=0.75  Score=38.48  Aligned_cols=63  Identities=11%  Similarity=0.119  Sum_probs=28.6

Q ss_pred             hhCCCCCCEEeCcCCc-cccccCccccCC----CCCCeeeccccc-eec-ccccccccccCcccccCCCc
Q 011508           14 LSSLRGIENLDLSQNN-LSGRIPKYLENF----PFLQNLNLSFNH-FEG-EVPIKGVFSNSSAISLDGNV   76 (484)
Q Consensus        14 ~~~l~~l~~l~ls~N~-l~g~~p~~~~~l----~~L~~l~ls~N~-l~g-~~p~~~~~~~~~~~~~~~n~   76 (484)
                      +..|++|+.|+|+++. ++..==..++.+    ++|+.|+|+++. ++. -+.....+++|+.|++++-+
T Consensus        81 L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~  150 (176)
T 3e4g_A           81 MEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP  150 (176)
T ss_dssp             GTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred             hcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence            4556666666666653 443211223332    246666666542 331 01111334555555555443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=80.88  E-value=0.28  Score=30.15  Aligned_cols=26  Identities=12%  Similarity=0.344  Sum_probs=10.7

Q ss_pred             EEehhhhhhHHHhhhhheeeeeecccC
Q 011508          105 LIIPIVTGILFLTGMSCLIITSWWSKT  131 (484)
Q Consensus       105 ~~i~~v~~~~~~~~~~~~~~~~~~~~~  131 (484)
                      ++.+++.|+++++.++ ++++++++++
T Consensus        12 IA~gVVgGv~~v~ii~-~~~~~~~RRR   37 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVG-LTFAVYVRRK   37 (44)
T ss_dssp             HHHHHHHHHHHHHHHH-HHHHHHHHTT
T ss_pred             EEEeehHHHHHHHHHH-HHHHHHhhhh
Confidence            3444444454443333 3333344443

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	484
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-54
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-54
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-54
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-53
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-52
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-52
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-52
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-51
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-50
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-49
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-49
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-48
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-48
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-48
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-47
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-47
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-47
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-47
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-47
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-46
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-46
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-46
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-45
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-45
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-45
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-44
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-43
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-42
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-40
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-38
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-38
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-38
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-37
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-37
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-35
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-33
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-33
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	8e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-09
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	8e-07
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.003
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.004
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.002
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.003
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 2e-59
 Identities = 76/317 (23%), Positives = 129/317 (40%), Gaps = 55/317 (17%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS--KSFIAECQALRSIRHR 218
            ++   IG+GSFG+VYKG +  D     VAVK+LN+        ++F  E   LR  RH 
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGD-----VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N++  +       +      A+V +     SL   LH+         +++ + IA   A 
Sbjct: 65  NILLFM------GYSTAPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQ 115

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            ++YLH      I+H DLK +N+ L  +LT  + DFGLA      + +    Q     + 
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ-----LS 167

Query: 339 GTVGYAAPEYGMGSE---VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL 395
           G++ + APE     +    S   DVY+FGI+L E+ TG+ P + +   +  +    +  L
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227

Query: 396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN 455
              L+++                               C  ++  +   C  +   ER  
Sbjct: 228 SPDLSKVRS----------------------------NCPKAMKRLMAECLKKKRDERPL 259

Query: 456 MEEVAAQLLSFRNKLVK 472
             ++ A +      L K
Sbjct: 260 FPQILASIELLARSLPK 276

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-54
 Identities = 70/331 (21%), Positives = 126/331 (38%), Gaps = 56/331 (16%)

Query: 152 QNLFKATDGFSLENL-IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ-HRGASKSFIAEC 209
           + LF   D   + ++ +G G+FGSV +G++     +  VA+KVL     +  ++  + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
           Q +  + +  +V++I  C +          LV E+   G L ++L   R     + +   
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKR---EEIPVSNV 111

Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSS 329
             +   V+  ++YL        VH DL   NVLL     A +SDFGL+K L        S
Sbjct: 112 AELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD----DS 164

Query: 330 NQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLH 388
             ++    K  + + APE     + S+  DV+S+G+ + E  + G+ P  +M      + 
Sbjct: 165 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVM 222

Query: 389 NFVKEALPERLAEIVDPVL--LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICS 446
            F+++           P L  L+                                   C 
Sbjct: 223 AFIEQGKRMECPPECPPELYALMSD---------------------------------CW 249

Query: 447 SELPRERMNMEEVAAQLLSFRNKLVKNVRGQ 477
                +R +   V  ++ +    L   V G 
Sbjct: 250 IYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (461), Expect = 3e-54
 Identities = 72/336 (21%), Positives = 143/336 (42%), Gaps = 62/336 (18%)

Query: 150 SYQNLFKATDGFS---------LENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLNLQH- 198
           ++++  +A   F+         +E +IGAG FG V  G        E  VA+K L   + 
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 199 RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR 258
               + F++E   +    H N++ +           +    ++ E M NGSL+ +L  N 
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLRQN- 121

Query: 259 DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK 318
                  ++Q + +   +A+ ++YL        VH DL   N+L++  L   VSDFGL++
Sbjct: 122 --DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 176

Query: 319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPT 377
           FL +  ++ +   +S++G K  + + APE     + +++ DV+S+GI++ E+ + G+ P 
Sbjct: 177 FLEDDTSDPTY--TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234

Query: 378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVS 437
            +M   ++                                  NA +Q  R     +C  +
Sbjct: 235 WDMTNQDV---------------------------------INAIEQDYRLPPPMDCPSA 261

Query: 438 VLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVKN 473
           +  + + C  +    R    ++   L    +K+++N
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQIVNTL----DKMIRN 293

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 3e-54
 Identities = 66/314 (21%), Positives = 118/314 (37%), Gaps = 33/314 (10%)

Query: 157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSI 215
             D F   + +GAG+ G V+K    H     ++A K+++L+ +       I E Q L   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVS--HKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               +V    +  S     +   ++  E M  GSL++ L         +       +++ 
Sbjct: 62  NSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIA 112

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           V   L YL       I+H D+KPSN+L++      + DFG++  L ++  N         
Sbjct: 113 VIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--------- 161

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP--------TNEMFTGNLTL 387
              GT  Y +PE   G+  S   D++S G+ L+EM  G+ P           MF   +  
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221

Query: 388 HNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVI--C 445
                   P      +    +  R      E   +            + S+     +  C
Sbjct: 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281

Query: 446 SSELPRERMNMEEV 459
             + P ER +++++
Sbjct: 282 LIKNPAERADLKQL 295

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 6e-53
 Identities = 56/253 (22%), Positives = 96/253 (37%), Gaps = 18/253 (7%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIR 216
           + + +   IG GS+G   K          ++  K L+         +  ++E   LR ++
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIR--RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N+V+     +    + N    +V E    G L   +       + L+    L +   +
Sbjct: 62  HPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 118

Query: 277 ASTLEYLH--HYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
              L+  H        ++H DLKP+NV LDG+    + DFGLA+        L+ + S +
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-------LNHDTSFA 171

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA 394
               GT  Y +PE       +   D++S G LL E+     P          L   ++E 
Sbjct: 172 KAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREG 229

Query: 395 LPERLAEIVDPVL 407
              R+       L
Sbjct: 230 KFRRIPYRYSDEL 242

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 68/309 (22%), Positives = 123/309 (39%), Gaps = 55/309 (17%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   L   +GAG FG V+ G   + +  T VAVK L  Q   +  +F+AE   ++ ++H+
Sbjct: 13  ETLKLVERLGAGQFGEVWMG---YYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQ 68

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++            +   ++ E M NGSL ++L         L + + L +A  +A 
Sbjct: 69  RLVRLY------AVVTQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAE 120

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            + ++        +H DL+ +N+L+   L+  ++DFGLA+ + +      +  ++  G K
Sbjct: 121 GMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED------NEYTAREGAK 171

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER 398
             + + APE       +   DV+SFGILL E+ T         T    + N  +     R
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231

Query: 399 LAEIVDPVL-LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME 457
                + +  L+                                   C  E P +R   +
Sbjct: 232 PDNCPEELYQLMRL---------------------------------CWKERPEDRPTFD 258

Query: 458 EVAAQLLSF 466
            + + L  F
Sbjct: 259 YLRSVLEDF 267

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-52
 Identities = 71/306 (23%), Positives = 117/306 (38%), Gaps = 55/306 (17%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           +   LE  +G G FG V+ G     +  T VA+K L        ++F+ E Q ++ +RH 
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGT---WNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHE 72

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV++            +   +V E M  GSL ++L         L   Q + +A  +AS
Sbjct: 73  KLVQLY------AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLP--QLVDMAAQIAS 124

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            + Y+        VH DL+ +N+L+   L   V+DFGLA+ + +      +  ++  G K
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED------NEYTARQGAK 175

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER 398
             + + APE  +    +   DV+SFGILL E+ T              L    +      
Sbjct: 176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235

Query: 399 LAEIVDPVL-LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME 457
             E  + +  L+ +                                 C  + P ER   E
Sbjct: 236 PPECPESLHDLMCQ---------------------------------CWRKEPEERPTFE 262

Query: 458 EVAAQL 463
            + A L
Sbjct: 263 YLQAFL 268

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-52
 Identities = 68/314 (21%), Positives = 113/314 (35%), Gaps = 41/314 (13%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVK 222
           L+  IG G FG V++G +        VAVK+ + +    S    AE      +RH N++ 
Sbjct: 7   LQESIGKGRFGEVWRGKWRG----EEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILG 61

Query: 223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEY 282
            I +    +        LV +   +GSL ++L+        + +   + +A+  AS L +
Sbjct: 62  FIAADNKDNGTWTQLW-LVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAH 115

Query: 283 LHHYC-----ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
           LH        +  I H DLK  N+L+    T  ++D GLA     A + +    +  V  
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-- 173

Query: 338 KGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV 391
            GT  Y APE    S      E     D+Y+ G++  E+              L  ++ V
Sbjct: 174 -GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232

Query: 392 KE--ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSEL 449
               ++ E    + +  L         S               E L  +  I   C    
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNIPNRWQSC--------------EALRVMAKIMRECWYAN 278

Query: 450 PRERMNMEEVAAQL 463
              R+    +   L
Sbjct: 279 GAARLTALRIKKTL 292

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 4e-51
 Identities = 68/254 (26%), Positives = 108/254 (42%), Gaps = 23/254 (9%)

Query: 159 DG--FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRS 214
           DG     +  IG GSF +VYKG+    +    VA   L  +   +   + F  E + L+ 
Sbjct: 7   DGRFLKFDIEIGRGSFKTVYKGL--DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKG 64

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           ++H N+V+   S  S   +G     LV ELM +G+L+ +L       + + +    S   
Sbjct: 65  LQHPNIVRFYDSWES-TVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCR 119

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVSDFGLAKFLPEAANNLSSNQSS 333
            +   L++LH     PI+H DLK  N+ + G   +  + D GLA              S 
Sbjct: 120 QILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---------RASF 169

Query: 334 SVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE 393
           +  V GT  + APE     +   S DVY+FG+ +LEM T + P +E              
Sbjct: 170 AKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 228

Query: 394 ALPERLAEIVDPVL 407
             P    ++  P +
Sbjct: 229 VKPASFDKVAIPEV 242

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 7e-50
 Identities = 63/313 (20%), Positives = 113/313 (36%), Gaps = 49/313 (15%)

Query: 163 LENLIGAGSFGSVYKGIF-DHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSIRHRNL 220
              +IG G FG VY G   D+D  +   AVK LN +   G    F+ E   ++   H N+
Sbjct: 31  FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           + ++  C     +      +V   M +G L  ++        N  +   +   + VA   
Sbjct: 91  LSLLGIC----LRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVA--- 140

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
           + +        VH DL   N +LD + T  V+DFGLA+ + +       +  +  G K  
Sbjct: 141 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD---KEFDSVHNKTGAKLP 197

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA 400
           V + A E     + +T  DV+SFG+LL E+ T   P              ++     +  
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 257

Query: 401 EIVDPVL-LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEV 459
              DP+  ++ +                                 C       R +  E+
Sbjct: 258 YCPDPLYEVMLK---------------------------------CWHPKAEMRPSFSEL 284

Query: 460 AAQLLSFRNKLVK 472
            +++ +  +  + 
Sbjct: 285 VSRISAIFSTFIG 297

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 1e-49
 Identities = 71/304 (23%), Positives = 118/304 (38%), Gaps = 53/304 (17%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
            +    +G G FG V  G       +  VA+K++          FI E + + ++ H  L
Sbjct: 6   LTFLKELGTGQFGVVKYG---KWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKL 61

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V++   C            ++ E M NG L  +L   R         Q L +  DV   +
Sbjct: 62  VQLYGVCTK-----QRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAM 113

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
           EYL        +H DL   N L++ +    VSDFGL++++ +         +SSVG K  
Sbjct: 114 EYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD------DEYTSSVGSKFP 164

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA 400
           V ++ PE  M S+ S+  D+++FG+L+ E+++      E FT                 A
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------------NSETA 211

Query: 401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVA 460
           E +   L + R    + +                   V  I   C  E   ER   + + 
Sbjct: 212 EHIAQGLRLYRPHLASEK-------------------VYTIMYSCWHEKADERPTFKILL 252

Query: 461 AQLL 464
           + +L
Sbjct: 253 SNIL 256

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 3e-49
 Identities = 59/306 (19%), Positives = 116/306 (37%), Gaps = 50/306 (16%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDH--ETLVAVKVLNLQHR-GASKSFIAECQALRSIRH 217
            + + +IGAG FG VYKG+        E  VA+K L   +       F+ E   +    H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            N++++                ++ E M NG+L       R+     ++LQ + +   +A
Sbjct: 69  HNIIRLEGVISK-----YKPMMIITEYMENGAL---DKFLREKDGEFSVLQLVGMLRGIA 120

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
           +    + +      VH DL   N+L++  L   VSDFGL++ L +          ++ G 
Sbjct: 121 A---GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD----PEATYTTSGG 173

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE 397
           K  + + APE     + +++ DV+SFGI++ E+ T         +               
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------NH 220

Query: 398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME 457
            + + ++    +                       +C  ++  + + C  +    R    
Sbjct: 221 EVMKAINDGFRLPTPM-------------------DCPSAIYQLMMQCWQQERARRPKFA 261

Query: 458 EVAAQL 463
           ++ + L
Sbjct: 262 DIVSIL 267

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 4e-49
 Identities = 72/309 (23%), Positives = 109/309 (35%), Gaps = 59/309 (19%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
             L   IG G FG V  G          VAVK +   +   +++F+AE   +  +RH NL
Sbjct: 9   LKLLQTIGKGEFGDVMLGD----YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNL 62

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V+++        +      +V E M  GSL ++L     +   L     L  ++DV   +
Sbjct: 63  VQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAM 116

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
           EYL        VH DL   NVL+  +  A VSDFGL K             S+    K  
Sbjct: 117 EYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----------STQDTGKLP 163

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA 400
           V + APE     + ST  DV+SFGILL E+++              +    K    +   
Sbjct: 164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPD 223

Query: 401 EIVDPVL-LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEV 459
                V  +++                                  C       R +  ++
Sbjct: 224 GCPPAVYEVMKN---------------------------------CWHLDAAMRPSFLQL 250

Query: 460 AAQLLSFRN 468
             QL   + 
Sbjct: 251 REQLEHIKT 259

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 2e-48
 Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 28/234 (11%)

Query: 151 YQNL---FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIA 207
           Y+++       D + +   +G G+FG VYK    + +   L A KV++ +     + ++ 
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQ--NKETSVLAAAKVIDTKSEEELEDYMV 58

Query: 208 ECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLL 267
           E   L S  H N+VK++ +         +   ++ E    G+++  +    +  R L   
Sbjct: 59  EIDILASCDHPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAVML---ELERPLTES 110

Query: 268 QRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNL 327
           Q   +       L YLH   +  I+H DLK  N+L   +    ++DFG++          
Sbjct: 111 QIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 167

Query: 328 SSNQSSSVGVKGTVGYAAPEYGMGSE-----VSTSGDVYSFGILLLEMFTGKGP 376
            S         GT  + APE  M             DV+S GI L+EM   + P
Sbjct: 168 DS-------FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  165 bits (418), Expect = 4e-48
 Identities = 63/311 (20%), Positives = 123/311 (39%), Gaps = 51/311 (16%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
              ++++ +G G +G VY+G+     +   VAVK L  +     + F+ E   ++ I+H 
Sbjct: 17  TDITMKHKLGGGQYGEVYEGV--WKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHP 73

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           NLV+++  C            ++ E M  G+L ++L       + ++ +  L +A  ++S
Sbjct: 74  NLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISS 126

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            +EYL        +H DL   N L+       V+DFGL++ +           ++  G K
Sbjct: 127 AMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG------DTYTAHAGAK 177

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER 398
             + + APE    ++ S   DV++FG+LL E+ T                         +
Sbjct: 178 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------PYPGIDLSQ 224

Query: 399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEE 458
           + E+++    +ER EG   +                      +   C    P +R +  E
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYE-------------------LMRACWQWNPSDRPSFAE 265

Query: 459 VAAQLLSFRNK 469
           +     +   +
Sbjct: 266 IHQAFETMFQE 276

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 7e-48
 Identities = 67/306 (21%), Positives = 113/306 (36%), Gaps = 53/306 (17%)

Query: 164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLV 221
           +  +G+G+FG+V KG +        VAVK+L  +          +AE   ++ + +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           ++I  C        +   LV E+   G L ++L  NR    ++     + +   V+  ++
Sbjct: 72  RMIGICE------AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMK 121

Query: 282 YLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTV 341
           YL     +  VH DL   NVLL  +  A +SDFGL+K L    N       +    K  V
Sbjct: 122 YLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY----YKAQTHGKWPV 174

Query: 342 GYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAE 401
            + APE     + S+  DV+SFG+L+ E F+          G+       K       A 
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 234

Query: 402 IVDPVL-LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVA 460
               +  L+                                   C +     R     V 
Sbjct: 235 CPREMYDLMNL---------------------------------CWTYDVENRPGFAAVE 261

Query: 461 AQLLSF 466
            +L ++
Sbjct: 262 LRLRNY 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 2e-47
 Identities = 54/263 (20%), Positives = 99/263 (37%), Gaps = 31/263 (11%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSI 215
           + F +   +G G FG+VY         + ++A+KVL    L+  G       E +    +
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAR--EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           RH N++++                L+ E    G++   L          +  +  +   +
Sbjct: 64  RHPNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITE 114

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           +A+ L Y H      ++H D+KP N+LL       ++DFG +   P          S   
Sbjct: 115 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS---------SRRT 162

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMFTGNLTLHNF 390
            + GT+ Y  PE   G       D++S G+L  E   GK P       E +     +   
Sbjct: 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 222

Query: 391 VKEALPERLAEIVDPVLLVEREE 413
             + + E   +++  +L     +
Sbjct: 223 FPDFVTEGARDLISRLLKHNPSQ 245

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-47
 Identities = 68/303 (22%), Positives = 115/303 (37%), Gaps = 53/303 (17%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
            +    IG+G FG V+ G   +  ++  VA+K +        + FI E + +  + H  L
Sbjct: 7   LTFVQEIGSGQFGLVHLG---YWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKL 62

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           V++   C+           LV+E M +G L ++    R           L + +DV    
Sbjct: 63  VQLYGVCLE-----QAPICLVFEFMEHGCLSDY---LRTQRGLFAAETLLGMCLDVC--- 111

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGT 340
           E + +  E  ++H DL   N L+       VSDFG+ +F+ +         +SS G K  
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD------DQYTSSTGTKFP 165

Query: 341 VGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLA 400
           V +A+PE    S  S+  DV+SFG+L+ E+F+      E  + +  + +           
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------F 219

Query: 401 EIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVA 460
            +  P                          +     V  I   C  E P +R     + 
Sbjct: 220 RLYKP--------------------------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253

Query: 461 AQL 463
            QL
Sbjct: 254 RQL 256

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 7e-47
 Identities = 55/240 (22%), Positives = 97/240 (40%), Gaps = 23/240 (9%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH 217
              ++    IG G+ G+VY  +         VA++ +NLQ +   +  I E   +R  ++
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN 76

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            N+V  + S +       D   +V E +  GSL + +             Q  ++  +  
Sbjct: 77  PNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAAVCRECL 126

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
             LE+LH      ++H D+K  N+LL  + +  ++DFG    +       +  QS    +
Sbjct: 127 QALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-------TPEQSKRSTM 176

Query: 338 KGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE 397
            GT  + APE           D++S GI+ +EM  G+ P          L+       PE
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPE 235

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  162 bits (410), Expect = 8e-47
 Identities = 65/329 (19%), Positives = 118/329 (35%), Gaps = 69/329 (20%)

Query: 159 DGFSLENLIGAGSFGSVYKGI---FDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRS 214
           +       IG G+FG V++         +  T+VAVK+L  +        F  E   +  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR---------------- 258
             + N+VK++  C            L++E M  G L E+L                    
Sbjct: 73  FDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127

Query: 259 ----DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF 314
                 P  L+  ++L IA  VA+ + YL        VH DL   N L+   +   ++DF
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADF 184

Query: 315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           GL++ +       +    +       + +  PE    +  +T  DV+++G++L E+F+  
Sbjct: 185 GLSRNIYS-----ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239

Query: 375 GPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKEC 434
                          +   A  E +  + D  +L   E                     C
Sbjct: 240 LQP------------YYGMAHEEVIYYVRDGNILACPEN--------------------C 267

Query: 435 LVSVLGIGVICSSELPRERMNMEEVAAQL 463
            + +  +  +C S+LP +R +   +   L
Sbjct: 268 PLELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 9e-47
 Identities = 66/337 (19%), Positives = 130/337 (38%), Gaps = 58/337 (17%)

Query: 145 SVLRVSYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLNLQHRG-A 201
           ++LR+      K T+ F    ++G+G+FG+VYKG++  +  +    VA+K L       A
Sbjct: 1   ALLRI-----LKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA 54

Query: 202 SKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAP 261
           +K  + E   + S+ + ++ +++  C++   Q      L+ +LM  G L +++  ++   
Sbjct: 55  NKEILDEAYVMASVDNPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHK--- 105

Query: 262 RNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP 321
            N+     L+  V +A  + YL       +VH DL   NVL+       ++DFGLAK L 
Sbjct: 106 DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162

Query: 322 EAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMF 381
                    +  + G K  + + A E  +    +   DV+S+G+ + E+ T      +  
Sbjct: 163 A-----EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217

Query: 382 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGI 441
                            ++ I++    + +    T +                      I
Sbjct: 218 P-------------ASEISSILEKGERLPQPPICTIDVYM-------------------I 245

Query: 442 GVICSSELPRERMNMEEVAAQLLSFRNKLVKNVRGQP 478
            V C       R    E+  +         + +  Q 
Sbjct: 246 MVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 3e-46
 Identities = 55/273 (20%), Positives = 96/273 (35%), Gaps = 37/273 (13%)

Query: 159 DGFSLENLIGAGSFGSVYKGIF---DHDDHETLVAVKVLNLQH-RGASKSFIAECQALRS 214
           +      ++G+G+FG V                VAVK+L  +      ++ ++E + +  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 215 I-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR--------------- 258
           +  H N+V ++ +C       +    L++E    G L  +L   R               
Sbjct: 97  LGSHENIVNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151

Query: 259 ----DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF 314
               +    L     L  A  VA  +E+L        VH DL   NVL+       + DF
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDF 208

Query: 315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
           GLA+ +        SN       +  V + APE       +   DV+S+GILL E+F+  
Sbjct: 209 GLARDIMS-----DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263

Query: 375 GPTNEMFTGNLTLHNFVKEALPERLAEIVDPVL 407
                    +   +  ++              +
Sbjct: 264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEI 296

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 3e-46
 Identities = 55/252 (21%), Positives = 101/252 (40%), Gaps = 21/252 (8%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRH 217
           + + L   +G G++G V   +  +   E  VAVK+++++      ++   E    + + H
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAV--NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62

Query: 218 RNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVA 277
            N+VK          +  + + L  E    G L + +  +      +           + 
Sbjct: 63  ENVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLM 113

Query: 278 STLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGV 337
           + + YLH      I H D+KP N+LLD      +SDFGLA          ++ +     +
Sbjct: 114 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY-----NNRERLLNKM 165

Query: 338 KGTVGYAAPEYGMGSEVST-SGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP 396
            GT+ Y APE     E      DV+S GI+L  M  G+ P ++         ++ ++   
Sbjct: 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 225

Query: 397 ERLAEIVDPVLL 408
               + +D   L
Sbjct: 226 LNPWKKIDSAPL 237

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 6e-46
 Identities = 55/256 (21%), Positives = 95/256 (37%), Gaps = 32/256 (12%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNL---QHRGASKSFIAECQALRS 214
              FS    IG GSFG+VY        +  +VA+K ++    Q     +  I E + L+ 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFAR--DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           +RH N ++     +           LV E  +  + +      +     L  ++  ++  
Sbjct: 72  LRHPNTIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTH 122

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
                L YLH +    ++H D+K  N+LL       + DFG A  +  A +         
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS--------- 170

Query: 335 VGVKGTVGYAAPEYGMGS---EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV 391
               GT  + APE  +     +     DV+S GI  +E+   K P   M   +  L++  
Sbjct: 171 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIA 227

Query: 392 KEALPERLAEIVDPVL 407
           +   P   +       
Sbjct: 228 QNESPALQSGHWSEYF 243

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 1e-45
 Identities = 60/269 (22%), Positives = 101/269 (37%), Gaps = 32/269 (11%)

Query: 159 DGFSLENLIGAGSFGSVYKGIF---DHDDHETLVAVKVLNL-QHRGASKSFIAECQALRS 214
           +  S    +GAG+FG V +         D    VAVK+L    H    ++ ++E + L  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 215 I-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN---------- 263
           +  H N+V ++ +C            ++ E    G L  +L   RD+             
Sbjct: 83  LGNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137

Query: 264 ----LNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
               L+L   LS +  VA  + +L        +H DL   N+LL       + DFGLA+ 
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 194

Query: 320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
           +   +N +          +  V + APE       +   DV+S+GI L E+F+       
Sbjct: 195 IKNDSNYVVKGN-----ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249

Query: 380 MFTGNLTLHNFVKEALPERLAEIVDPVLL 408
               +   +  +KE       E     + 
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMY 278

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-45
 Identities = 77/310 (24%), Positives = 112/310 (36%), Gaps = 51/310 (16%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETL-VAVKVLN---LQHRGASKSFIAECQALRS 214
               L   +G GSFG V +G +D    +T+ VAVK L    L    A   FI E  A+ S
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + HRNL+++    +           +V EL   GSL + L  ++    +  L      AV
Sbjct: 68  LDHRNLIRLYGVVL------TPPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAV 118

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
            VA  + YL        +H DL   N+LL       + DFGL + LP+  ++    +   
Sbjct: 119 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH-- 173

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA 394
              K    + APE       S + D + FG+ L EMFT          G+  LH   KE 
Sbjct: 174 --RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 231

Query: 395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM 454
                 E                                    +  + V C +  P +R 
Sbjct: 232 ERLPRPEDCPQ-------------------------------DIYNVMVQCWAHKPEDRP 260

Query: 455 NMEEVAAQLL 464
               +   LL
Sbjct: 261 TFVALRDFLL 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 2e-45
 Identities = 64/320 (20%), Positives = 114/320 (35%), Gaps = 64/320 (20%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQALRSI-R 216
           +    +++IG G+FG V K     D      A+K +     +   + F  E + L  +  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLN------------RDAPRNL 264
           H N++ ++ +C     +   +  L  E   +G+L ++L  +                  L
Sbjct: 70  HPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 265 NLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAA 324
           +  Q L  A DVA  ++YL    +   +H DL   N+L+     A ++DFGL++      
Sbjct: 125 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG----- 176

Query: 325 NNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGN 384
                        +  V + A E    S  +T+ DV+S+G+LL E+ +  G      T  
Sbjct: 177 ---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 233

Query: 385 LTLHNFVKEALPERLAEIVDPVL-LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGV 443
                  +    E+     D V  L+ +                                
Sbjct: 234 ELYEKLPQGYRLEKPLNCDDEVYDLMRQ-------------------------------- 261

Query: 444 ICSSELPRERMNMEEVAAQL 463
            C  E P ER +  ++   L
Sbjct: 262 -CWREKPYERPSFAQILVSL 280

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  158 bits (401), Expect = 5e-45
 Identities = 53/220 (24%), Positives = 90/220 (40%), Gaps = 23/220 (10%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           D + +   +G G+FG V++            A K +   H    ++   E Q +  +RH 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVT--ERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            LV +  +     F+ ++   ++YE M  G L E +    D    ++  + +     V  
Sbjct: 84  TLVNLHDA-----FEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCK 135

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSSSVG 336
            L ++H       VH DLKP N++   + +  +   DFGL   L          + S   
Sbjct: 136 GLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--------DPKQSVKV 184

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT  +AAPE   G  V    D++S G+L   + +G  P
Sbjct: 185 TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 1e-44
 Identities = 52/224 (23%), Positives = 90/224 (40%), Gaps = 22/224 (9%)

Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQAL 212
           K  + F    ++G GSF +V              A+K+L  +H            E   +
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLAR--ELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62

Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
             + H   VK+  +     FQ ++          NG L +++        + +       
Sbjct: 63  SRLDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFY 113

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
             ++ S LEYLH      I+H DLKP N+LL+ ++   ++DFG AK       +  S Q+
Sbjct: 114 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKV-----LSPESKQA 165

Query: 333 SSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            +    GT  Y +PE         S D+++ G ++ ++  G  P
Sbjct: 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  154 bits (390), Expect = 4e-44
 Identities = 61/268 (22%), Positives = 108/268 (40%), Gaps = 26/268 (9%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRS 214
           +D + L  ++G G    V+    D   H   VAVKVL     +       F  E Q   +
Sbjct: 6   SDRYELGEILGFGGMSEVHLAR-DLRLHR-DVAVKVLRADLARDPSFYLRFRREAQNAAA 63

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
           + H  +V +  +  +    G     +V E +   +L + +H        +   + + +  
Sbjct: 64  LNHPAIVAVYDTGEAETPAGPLP-YIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIA 118

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
           D     + L+   +  I+H D+KP+N+++       V DFG+A+ + ++ N+++   +  
Sbjct: 119 DA---CQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-- 173

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP---------TNEMFTGNL 385
             V GT  Y +PE   G  V    DVYS G +L E+ TG+ P           +    + 
Sbjct: 174 --VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 231

Query: 386 TLHNFVKEALPERLAEIVDPVLLVEREE 413
              +   E L   L  +V   L    E 
Sbjct: 232 IPPSARHEGLSADLDAVVLKALAKNPEN 259

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-43
 Identities = 59/308 (19%), Positives = 107/308 (34%), Gaps = 54/308 (17%)

Query: 159 DGFSLENLIGAGSFGSVYKGIF-DHDDHETLVAVKVL-NLQHRGASKSFIAECQALRSIR 216
           +   L   IG G FG V++GI+   ++    VA+K   N       + F+ E   +R   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H ++VK+I           +   ++ EL   G L       +    +L+L   +  A  +
Sbjct: 67  HPHIVKLIGVIT------ENPVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQL 117

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
           ++ L YL        VH D+   NVL+       + DFGL++++ +      S    +  
Sbjct: 118 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASK 168

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP 396
            K  + + APE       +++ DV+ FG+ + E+        +    N  +         
Sbjct: 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 228

Query: 397 ERLAEIVDPVL-LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN 455
                    +  L+ +                                 C +  P  R  
Sbjct: 229 PMPPNCPPTLYSLMTK---------------------------------CWAYDPSRRPR 255

Query: 456 MEEVAAQL 463
             E+ AQL
Sbjct: 256 FTELKAQL 263

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  153 bits (387), Expect = 7e-43
 Identities = 44/220 (20%), Positives = 88/220 (40%), Gaps = 23/220 (10%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           D + +   +G+G+FG V++ +        +   K +N  +     +   E   +  + H 
Sbjct: 29  DYYDILEELGSGAFGVVHRCV--EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHP 86

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
            L+ +  +     F+      L+ E +  G L + +         ++  + ++       
Sbjct: 87  KLINLHDA-----FEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACE 138

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSSSVG 336
            L+++H   E  IVH D+KP N++ + +  + V   DFGLA  L        +       
Sbjct: 139 GLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL--------NPDEIVKV 187

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              T  +AAPE      V    D+++ G+L   + +G  P
Sbjct: 188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 1e-42
 Identities = 62/314 (19%), Positives = 118/314 (37%), Gaps = 57/314 (18%)

Query: 161 FSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIR 216
            ++   +G GSFG VY+G+      D+ ET VA+K +N          F+ E   ++   
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRN------LNLLQRL 270
             ++V+++               ++ ELM  G L+ +L   R A  N       +L + +
Sbjct: 82  CHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSN 330
            +A ++A  + YL+       VH DL   N ++  + T  + DFG+ + + E     +  
Sbjct: 137 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-----TDY 188

Query: 331 QSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF 390
                     V + +PE       +T  DV+SFG++L E+ T      +  +    L   
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248

Query: 391 VKEALPERLAEIVDPVL-LVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSEL 449
           ++  L ++     D +  L+                                   C    
Sbjct: 249 MEGGLLDKPDNCPDMLFELMRM---------------------------------CWQYN 275

Query: 450 PRERMNMEEVAAQL 463
           P+ R +  E+ + +
Sbjct: 276 PKMRPSFLEIISSI 289

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-40
 Identities = 61/321 (19%), Positives = 105/321 (32%), Gaps = 58/321 (18%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHE---TLVAVKVLNLQH-RGASKSFIAECQALRS 214
           D   L   +G G+FG V +      D       VAVK+L         ++ ++E + L  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRD------------APR 262
           I H   V  +        +      ++ E    G+L  +L   R+               
Sbjct: 73  IGHHLNVVNLLGAC---TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 263 NLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE 322
            L L   +  +  VA  +E+L        +H DL   N+LL  +    + DFGLA+ + +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFT 382
             + +          +  + + APE       +   DV+SFG+LL E+F+          
Sbjct: 187 DPDYVRKGD-----ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241

Query: 383 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIG 442
            +      +KE    R  +   P                                +    
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTP-------------------------------EMYQTM 270

Query: 443 VICSSELPRERMNMEEVAAQL 463
           + C    P +R    E+   L
Sbjct: 271 LDCWHGEPSQRPTFSELVEHL 291

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 9e-40
 Identities = 54/226 (23%), Positives = 95/226 (42%), Gaps = 17/226 (7%)

Query: 153 NLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN-LQHRGASKSFIAECQA 211
            +F     ++  + IG G++G V       + ++  VA+K ++  +H+   +  + E + 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKI 59

Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           L   RH N++ I     +   +      LV  LM    L + L         L+      
Sbjct: 60  LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQH-----LSNDHICY 113

Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQ 331
               +   L+Y+H      ++H DLKPSN+LL+      + DFGLA+      ++     
Sbjct: 114 FLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170

Query: 332 SSSVGVKGTVGYAAPEYGMGSEVST-SGDVYSFGILLLEMFTGKGP 376
                   T  Y APE  + S+  T S D++S G +L EM + +  
Sbjct: 171 E----YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 3e-39
 Identities = 70/311 (22%), Positives = 117/311 (37%), Gaps = 31/311 (9%)

Query: 156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQ--HRGASKSFIAECQALR 213
           +A   +     IG G++G V+K   D  +    VA+K + +Q    G   S I E   LR
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKAR-DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLR 62

Query: 214 ---SIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRL 270
              +  H N+V++   C            LV+E +          +       +      
Sbjct: 63  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIK 119

Query: 271 SIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSN 330
            +   +   L++LH +    +VH DLKP N+L+       ++DFGLA+          S 
Sbjct: 120 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--------SF 168

Query: 331 QSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF 390
           Q +   V  T+ Y APE  + S  +T  D++S G +  EMF  K      F G+  +   
Sbjct: 169 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL----FRGSSDVDQL 224

Query: 391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVI--CSSE 448
            K      L  I  P       +        H +  +        +  LG  ++  C + 
Sbjct: 225 GK-----ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTF 279

Query: 449 LPRERMNMEEV 459
            P +R++    
Sbjct: 280 NPAKRISAYSA 290

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (355), Expect = 8e-39
 Identities = 47/220 (21%), Positives = 77/220 (35%), Gaps = 20/220 (9%)

Query: 158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSIR 216
            D +   +++G G+F  V          + LVA+K +  +   G   S   E   L  I+
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAE--DKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N+V +        ++      L+ +L+  G L + +                 +   V
Sbjct: 66  HPNIVALDDI-----YESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQV 116

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
              ++YLH                  LD +    +SDFGL+K             S    
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--------DPGSVLST 168

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
             GT GY APE       S + D +S G++   +  G  P
Sbjct: 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  140 bits (353), Expect = 1e-38
 Identities = 41/219 (18%), Positives = 79/219 (36%), Gaps = 20/219 (9%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           + +   IG GSFG +++G   +  +   VA+K      R  +     E +  + +     
Sbjct: 7   YKVGRRIGEGSFGVIFEGT--NLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62

Query: 221 VKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTL 280
           +  +        Q      LV +L+          L     R  ++      A  + + +
Sbjct: 63  IPNVYYF----GQEGLHNVLVIDLLGPS----LEDLLDLCGRKFSVKTVAMAAKQMLARV 114

Query: 281 EYLHHYCETPIVHCDLKPSNVLLDGELTAH-----VSDFGLAKFLPEAANNLSSNQSSSV 335
           + +H      +V+ D+KP N L+    + +     V DFG+ KF  +             
Sbjct: 115 QSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
            + GT  Y +    +G E S   D+ + G + +    G 
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  140 bits (353), Expect = 1e-38
 Identities = 52/219 (23%), Positives = 90/219 (41%), Gaps = 18/219 (8%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + + L   IG+GSFG +Y G          VA+K+  ++ +        E +  + ++  
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGT--DIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGG 62

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
             +  I  C        D+  +V EL+     + +   +R      +L   L +A  + S
Sbjct: 63  VGIPTIRWC----GAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMIS 114

Query: 279 TLEYLHHYCETPIVHCDLKPSNVL---LDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
            +EY+H       +H D+KP N L          ++ DFGLAK   +A  +       + 
Sbjct: 115 RIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK 374
            + GT  YA+    +G E S   D+ S G +L+    G 
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 210

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 1e-38
 Identities = 68/324 (20%), Positives = 119/324 (36%), Gaps = 64/324 (19%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHE-----TLVAVKVLNLQH-RGASKSFIAECQAL 212
           D   L   +G G+FG V        D +     T VAVK+L            I+E + +
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 213 RSI-RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNR------------D 259
           + I +H+N++ ++ +C       +    ++ E    G+L E+L   R            +
Sbjct: 73  KMIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 127

Query: 260 APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF 319
               L+    +S A  VA  +EYL        +H DL   NVL+  +    ++DFGLA+ 
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184

Query: 320 LPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNE 379
           +             +   +  V + APE       +   DV+SFG+LL E+FT  G    
Sbjct: 185 IHH-----IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239

Query: 380 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVL 439
                            E L +++     +++    T+E                     
Sbjct: 240 GVP-------------VEELFKLLKEGHRMDKPSNCTNELYM------------------ 268

Query: 440 GIGVICSSELPRERMNMEEVAAQL 463
            +   C   +P +R   +++   L
Sbjct: 269 -MMRDCWHAVPSQRPTFKQLVEDL 291

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-38
 Identities = 61/264 (23%), Positives = 107/264 (40%), Gaps = 30/264 (11%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQAL-RS 214
           + F L  ++G GSFG V+             A+K L    +      +  + E + L  +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAE--FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 59

Query: 215 IRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAV 274
             H  L  +  +  +      +    V E +  G L   +     +    +L +    A 
Sbjct: 60  WEHPFLTHMFCTFQT-----KENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAA 110

Query: 275 DVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSS 334
           ++   L++LH      IV+ DLK  N+LLD +    ++DFG+ K             + +
Sbjct: 111 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN-------MLGDAKT 160

Query: 335 VGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP-----TNEMFTGNLTLHN 389
               GT  Y APE  +G + + S D +SFG+LL EM  G+ P       E+F      + 
Sbjct: 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 220

Query: 390 FVKEALPERLAEIVDPVLLVEREE 413
           F    L +   +++  + + E E+
Sbjct: 221 FYPRWLEKEAKDLLVKLFVREPEK 244

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  139 bits (352), Expect = 2e-38
 Identities = 53/224 (23%), Positives = 88/224 (39%), Gaps = 32/224 (14%)

Query: 161 FSLEN-----LIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQAL 212
           +SL++      +G GSFG V+        +    A+KVL    +      +    E   L
Sbjct: 1   YSLQDFQILRTLGTGSFGRVHLIR--SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 58

Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
             + H  ++++  +             ++ + +  G L   L  ++  P  +        
Sbjct: 59  SIVTHPFIIRMWGTFQD-----AQQIFMIMDYIEGGELFSLLRKSQRFPNPV-------A 106

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
               A     L +     I++ DLKP N+LLD      ++DFG AK++P+          
Sbjct: 107 KFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT------ 160

Query: 333 SSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
               + GT  Y APE       + S D +SFGIL+ EM  G  P
Sbjct: 161 ----LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 4e-38
 Identities = 45/220 (20%), Positives = 89/220 (40%), Gaps = 24/220 (10%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHR 218
           + + +   +G G FG V++ +      +     K + ++          E   L   RHR
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCV--ETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHR 61

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N++ +  S     F+  +   +++E +    + E +     +   LN  + +S    V  
Sbjct: 62  NILHLHES-----FESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCE 113

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHV--SDFGLAKFLPEAANNLSSNQSSSVG 336
            L++LH      I H D++P N++     ++ +   +FG A+ L            +   
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--------KPGDNFRL 162

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           +     Y APE      VST+ D++S G L+  + +G  P
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  139 bits (351), Expect = 1e-37
 Identities = 60/270 (22%), Positives = 104/270 (38%), Gaps = 38/270 (14%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNL------QHRGASKSFIAECQAL 212
           + FS+  +IG G FG VY       D   + A+K L+       Q    + +       +
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCR--KADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
            +     +V +  +     F   D  + + +LM  G L   L  +               
Sbjct: 62  STGDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFY 112

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
           A ++   LE++H+     +V+ DLKP+N+LLD      +SD GLA    +          
Sbjct: 113 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK---------K 160

Query: 333 SSVGVKGTVGYAAPEYGM-GSEVSTSGDVYSFGILLLEMFTGKGP--------TNEMFTG 383
                 GT GY APE    G    +S D +S G +L ++  G  P         +E+   
Sbjct: 161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220

Query: 384 NLTLHNFVKEALPERLAEIVDPVLLVEREE 413
            LT+   + ++    L  +++ +L  +   
Sbjct: 221 TLTMAVELPDSFSPELRSLLEGLLQRDVNR 250

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  136 bits (343), Expect = 2e-37
 Identities = 54/234 (23%), Positives = 97/234 (41%), Gaps = 38/234 (16%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNL---------QHRGASKSFIAEC 209
           + +  + ++G G    V + I  H       AVK++++         + +   ++ + E 
Sbjct: 3   ENYEPKEILGRGVSSVVRRCI--HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 210 QALRSIR-HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQ 268
             LR +  H N++++        ++ N F  LV++LM  G L ++L         L+  +
Sbjct: 61  DILRKVSGHPNIIQLKD-----TYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKE 111

Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLS 328
              I   +   +  LH   +  IVH DLKP N+LLD ++   ++DFG +  L        
Sbjct: 112 TRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL-------- 160

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEV------STSGDVYSFGILLLEMFTGKGP 376
                   V GT  Y APE    S            D++S G+++  +  G  P
Sbjct: 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 2e-37
 Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 19/218 (8%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           ++   +IG GSFG VY+      D   LVA+K +    R        E Q +R + H N+
Sbjct: 22  YTDTKVIGNGSFGVVYQAK--LCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNI 75

Query: 221 VKIITSCVSV-DFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           V++     S  + +   +  LV + +         H +R A + L ++        +  +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR-AKQTLPVIYVKLYMYQLFRS 134

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
           L Y+H +    I H D+KP N+LLD +     + DFG AK        L   + +   + 
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-------LVRGEPNVSYIC 184

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                A       ++ ++S DV+S G +L E+  G+  
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 7e-37
 Identities = 61/307 (19%), Positives = 121/307 (39%), Gaps = 24/307 (7%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHR 218
           +     IG G+FG V+K    H      VA+K + +++   G   + + E + L+ ++H 
Sbjct: 12  YEKLAKIGQGTFGEVFKAR--HRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 219 NLVKIITSCVSVDFQGNDFEA---LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           N+V +I  C +     N  +    LV++   +       ++         L +   +   
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQM 125

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           +   L  L++     I+H D+K +NVL+  +    ++DFGLA+    A N+  +  ++ V
Sbjct: 126 L---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182

Query: 336 GVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA 394
               T+ Y  PE  +G  +     D++  G ++ EM+T          GN   H     +
Sbjct: 183 ---VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLALIS 235

Query: 395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVI--CSSELPRE 452
                        +   E  E  E    ++R      K  +     + +I       P +
Sbjct: 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 295

Query: 453 RMNMEEV 459
           R++ ++ 
Sbjct: 296 RIDSDDA 302

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 9e-36
 Identities = 63/308 (20%), Positives = 116/308 (37%), Gaps = 47/308 (15%)

Query: 165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-----GASKSFIAECQALRSIRHRN 219
           + +G G F +VYK      +   +VA+K + L HR     G +++ + E + L+ + H N
Sbjct: 4   DFLGEGQFATVYKAR--DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61

Query: 220 LVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAST 279
           ++ ++ +            +LV++ M      +   + +D    L      +  +     
Sbjct: 62  IIGLLDAF-----GHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQG 112

Query: 280 LEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKG 339
           LEYLH +    I+H DLKP+N+LLD      ++DFGLAK          S   +      
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS-------FGSPNRAYTHQVV 162

Query: 340 TVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER 398
           T  Y APE   G+ +     D+++ G +L E+                      ++  ++
Sbjct: 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF-------------LPGDSDLDQ 209

Query: 399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSEL-------PR 451
           L  I + +     E+     +       +SF G          G      +       P 
Sbjct: 210 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPC 269

Query: 452 ERMNMEEV 459
            R+   + 
Sbjct: 270 ARITATQA 277

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-35
 Identities = 45/218 (20%), Positives = 81/218 (37%), Gaps = 25/218 (11%)

Query: 163 LENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQAL-RSIRHRNLV 221
              ++G G  G V +    +   +   A+K+L             E +   R+ +  ++V
Sbjct: 16  TSQVLGLGINGKVLQIF--NKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIV 68

Query: 222 KIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLE 281
           +I+    ++ + G     +V E +  G L   +    D        +   I   +   ++
Sbjct: 69  RIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQ 125

Query: 282 YLHHYCETPIVHCDLKPSNVLLD---GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
           YLH      I H D+KP N+L           ++DFG AK             +S     
Sbjct: 126 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS--------HNSLTTPC 174

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            T  Y APE     +   S D++S G+++  +  G  P
Sbjct: 175 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 3e-35
 Identities = 61/305 (20%), Positives = 118/305 (38%), Gaps = 30/305 (9%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIR 216
           + F     IG G++G VYK    +     +VA+K + L     G   + I E   L+ + 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKAR--NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 59

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N+VK++    +      +   LV+E + +  L++++  +      L L++       +
Sbjct: 60  HPNIVKLLDVIHT-----ENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSY-----L 108

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
              L+ L       ++H DLKP N+L++ E    ++DFGLA+            ++ +  
Sbjct: 109 FQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG------VPVRTYTHE 162

Query: 337 VKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP 396
           V      A          ST+ D++S G +  EM T +      F G+  +    +    
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL----FPGDSEIDQLFR---I 215

Query: 397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVI--CSSELPRERM 454
            R     D V+          + +  K   + F      +   G  ++       P +R+
Sbjct: 216 FRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI 275

Query: 455 NMEEV 459
           + +  
Sbjct: 276 SAKAA 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 1e-34
 Identities = 45/228 (19%), Positives = 83/228 (36%), Gaps = 32/228 (14%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGAS------KSFIAECQAL 212
           D +     +G+G F  V K            A K +  +   +S      +    E   L
Sbjct: 10  DYYDTGEELGSGQFAVVKKCR--EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67

Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           + I+H N++ +        ++      L+ EL+  G L ++L        +L   +    
Sbjct: 68  KEIQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLA----EKESLTEEEATEF 118

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE----LTAHVSDFGLAKFLPEAANNLS 328
              +   L  +++     I H DLKP N++L           + DFGLA  +        
Sbjct: 119 LKQI---LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG----- 170

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              +    + GT  + APE      +    D++S G++   + +G  P
Sbjct: 171 ---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 1e-33
 Identities = 48/221 (21%), Positives = 84/221 (38%), Gaps = 24/221 (10%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN---LQHRGASKSFIAECQALRSI 215
           + F    L+G G+FG V              A+K+L    +  +      + E + L++ 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVR--EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
           RH  L  +  +  +     +D    V E    G L   L   R                 
Sbjct: 63  RHPFLTALKYAFQT-----HDRLCFVMEYANGGELFFHLSRERVFTEER-------ARFY 110

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
            A  +  L +     +V+ D+K  N++LD +    ++DFGL K          S+ ++  
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-------SDGATMK 163

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
              GT  Y APE    ++   + D +  G+++ EM  G+ P
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  124 bits (313), Expect = 3e-33
 Identities = 60/306 (19%), Positives = 115/306 (37%), Gaps = 34/306 (11%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIR 216
           + +     IG G++G VYK     +++    A+K + L+    G   + I E   L+ ++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKA---QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK 58

Query: 217 HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDV 276
           H N+VK+     +          LV+E +     +               L+ ++    +
Sbjct: 59  HSNIVKLYDVIHT-----KKRLVLVFEHLDQDLKKLLDVCEGG-------LESVTAKSFL 106

Query: 277 ASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVG 336
              L  + +  +  ++H DLKP N+L++ E    ++DFGLA+                  
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA-------FGIPVRKYTH 159

Query: 337 VKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL 395
              T+ Y AP+  MGS+  ST+ D++S G +  EM  G       F G       ++   
Sbjct: 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL----FPGVSEADQLMR--- 212

Query: 396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVI--CSSELPRER 453
             R+    +        E    + N        +      +   GI ++       P +R
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272

Query: 454 MNMEEV 459
           +  ++ 
Sbjct: 273 ITAKQA 278

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 5e-33
 Identities = 58/303 (19%), Positives = 108/303 (35%), Gaps = 30/303 (9%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHR 218
           +     IG G++G+V+K   + + HE +VA+K + L     G   S + E   L+ ++H+
Sbjct: 4   YEKLEKIGEGTYGTVFKAK-NRETHE-IVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 219 NLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVAS 278
           N+V++     S     +    LV+E       + +   N D           S    +  
Sbjct: 62  NIVRLHDVLHS-----DKKLTLVFEFCDQDLKKYFDSCNGDLDPE----IVKSFLFQL-- 110

Query: 279 TLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVK 338
            L+ L       ++H DLKP N+L++      +++FGLA+            +  S  V 
Sbjct: 111 -LKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI------PVRCYSAEVV 163

Query: 339 GTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER 398
                           STS D++S G +  E+     P       +  L    +      
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223

Query: 399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVI--CSSELPRERMNM 456
             +      L + +             T S       ++  G  ++       P +R++ 
Sbjct: 224 EEQWPSMTKLPDYKPYP------MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277

Query: 457 EEV 459
           EE 
Sbjct: 278 EEA 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 8e-33
 Identities = 50/248 (20%), Positives = 79/248 (31%), Gaps = 35/248 (14%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGA------SKSFIAECQALRS 214
           + +  L+G+G FGSVY GI         VA+K +                   E   L+ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGI--RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 215 IR--HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
           +      +++++           D   L+ E              R     L      S 
Sbjct: 64  VSSGFSGVIRLLDWFER-----PDSFVLILERPEPVQDLFDFITER---GALQEELARSF 115

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVSDFGLAKFLPEAANNLSSNQ 331
              V   + +        ++H D+K  N+L+D       + DFG    L +         
Sbjct: 116 FWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----- 167

Query: 332 SSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGP---TNEMFTGNLTL 387
                  GT  Y+ PE+         S  V+S GILL +M  G  P     E+  G +  
Sbjct: 168 ----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFF 223

Query: 388 HNFVKEAL 395
              V    
Sbjct: 224 RQRVSSEC 231

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  122 bits (306), Expect = 8e-32
 Identities = 62/317 (19%), Positives = 111/317 (35%), Gaps = 33/317 (10%)

Query: 150 SYQNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAEC 209
           S+   +   D + L   +G G +  V++ I  +  +   V VK+L    +   K    E 
Sbjct: 26  SHVVEWGNQDDYQLVRKLGRGKYSEVFEAI--NITNNEKVVVKILKPVKK---KKIKREI 80

Query: 210 QALRSIR-HRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQ 268
           + L ++R   N++ +           +   ALV+E + N   ++         + L    
Sbjct: 81  KILENLRGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYD 130

Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVSDFGLAKFLPEAANNL 327
                 ++   L+Y H      I+H D+KP NV++D E     + D+GLA+F        
Sbjct: 131 IRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY------- 180

Query: 328 SSNQSSSVGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLT 386
                       +  +  PE  +  +    S D++S G +L  M   K P          
Sbjct: 181 -HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239

Query: 387 LHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKEC--LVSVLGIGVI 444
           L    K    E L + +D   +              ++R   F   E   LVS   +  +
Sbjct: 240 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 299

Query: 445 --CSSELPRERMNMEEV 459
                   + R+   E 
Sbjct: 300 DKLLRYDHQSRLTAREA 316

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (303), Expect = 4e-31
 Identities = 55/221 (24%), Positives = 87/221 (39%), Gaps = 27/221 (12%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK---SFIAECQALRSI 215
           D F     +G GSFG V      H +     A+K+L+ Q     K     + E + L+++
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVK--HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV 98

Query: 216 RHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVD 275
               LVK+  S              V E +  G +   L          +       A  
Sbjct: 99  NFPFLVKLEFSFKDNSNLYM-----VMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQ 149

Query: 276 VASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSV 335
           +  T EYLH      +++ DLKP N+L+D +    V+DFG AK            +  + 
Sbjct: 150 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR----------VKGRTW 196

Query: 336 GVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
            + GT    APE  +    + + D ++ G+L+ EM  G  P
Sbjct: 197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 3e-30
 Identities = 54/313 (17%), Positives = 110/313 (35%), Gaps = 30/313 (9%)

Query: 152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAEC 209
           +  ++    +     +G+G++G+V   +         VA+K L    Q    +K    E 
Sbjct: 11  KTAWEVRAVYRDLQPVGSGAYGAVCSAV--DGRTGAKVAIKKLYRPFQSELFAKRAYREL 68

Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFE-ALVYELMVNGSLEEWLHLNRDAPRNLNLLQ 268
           + L+ +RH N++ ++      +   +  +  LV   M                  L   +
Sbjct: 69  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM------GTDLGKLMKHEKLGEDR 122

Query: 269 RLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLS 328
              +   +   L Y+H      I+H DLKP N+ ++ +    + DFGLA+          
Sbjct: 123 IQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-------- 171

Query: 329 SNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH 388
            +   +  V      A          + + D++S G ++ EM TGK       + +L   
Sbjct: 172 -DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF--KGSDHLDQL 228

Query: 389 NFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVI--CS 446
             + +      AE V     ++ +E +       +   + F       S L + ++    
Sbjct: 229 KEIMKVTGTPPAEFVQR---LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKML 285

Query: 447 SELPRERMNMEEV 459
                +R+   E 
Sbjct: 286 VLDAEQRVTAGEA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 4e-30
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 26/226 (11%)

Query: 159 DGFSLENLIGAGSFGSVYKGIFDHDDHET--LVAVKVLN----LQHRGASKSFIAECQAL 212
           + F L  ++G G++G V+        H+T  L A+KVL     +Q    ++    E Q L
Sbjct: 24  ENFELLKVLGTGAYGKVFLVR-KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 213 RSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
             IR    +  +       FQ      L+ + +  G L   L                 +
Sbjct: 83  EHIRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLS-------QRERFTEHEV 131

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQS 332
            + V   +  L H  +  I++ D+K  N+LLD      ++DFGL+K         +    
Sbjct: 132 QIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV------ADETE 185

Query: 333 SSVGVKGTVGYAAPEYGMGSE--VSTSGDVYSFGILLLEMFTGKGP 376
            +    GT+ Y AP+   G +     + D +S G+L+ E+ TG  P
Sbjct: 186 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 5e-30
 Identities = 43/227 (18%), Positives = 91/227 (40%), Gaps = 21/227 (9%)

Query: 152 QNLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAEC 209
           + +++  + +   + +G+G++GSV     D       VAVK L+   Q    +K    E 
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAF-DTKTGL-RVAVKKLSRPFQSIIHAKRTYREL 68

Query: 210 QALRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQR 269
           + L+ ++H N++ ++             +  +   ++   L   +   +     L     
Sbjct: 69  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-----LTDDHV 123

Query: 270 LSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSS 329
             +   +   L+Y+H      I+H DLKPSN+ ++ +    + DFGLA+           
Sbjct: 124 QFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT--------- 171

Query: 330 NQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
           +   +  V      A          + + D++S G ++ E+ TG+  
Sbjct: 172 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 8e-29
 Identities = 49/225 (21%), Positives = 89/225 (39%), Gaps = 23/225 (10%)

Query: 155 FKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLN--LQHRGASKSFIAECQAL 212
           F     +     IG+G+ G V          +  VA+K L+   Q++  +K    E   +
Sbjct: 13  FTVLKRYQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70

Query: 213 RSIRHRNLVKIITSCVSVD-FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
           + + H+N++ ++         +      LV ELM     +            L+  +   
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-------ELDHERMSY 123

Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQ 331
           +   +   +++LH      I+H DLKPSN+++  + T  + DFGLA+         +   
Sbjct: 124 LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--------AGTS 172

Query: 332 SSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                   T  Y APE  +G     + D++S G ++ EM   K  
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  110 bits (275), Expect = 3e-27
 Identities = 45/225 (20%), Positives = 88/225 (39%), Gaps = 20/225 (8%)

Query: 161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL 220
           + L   +G G F +V+        + T VA+K++    +  +++   E + L+ +   + 
Sbjct: 15  YILVRKLGWGHFSTVWLAK--DMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADN 71

Query: 221 VK--------IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSI 272
            K        I+      + +G +   +V    V G       + +   R + L+    I
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPLIYVKQI 130

Query: 273 AVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVSDFGLAKFLPEAANNLSSNQ 331
           +  +   L+Y+H  C   I+H D+KP NVL++      ++    +A        N     
Sbjct: 131 SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADL-----GNACWYD 183

Query: 332 SSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGP 376
                   T  Y +PE  +G+      D++S   L+ E+ TG   
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.0 bits (199), Expect = 2e-18
 Identities = 29/169 (17%), Positives = 51/169 (30%), Gaps = 29/169 (17%)

Query: 162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASK----------SFIAECQA 211
           ++  L+G G   +V+         E    VK   + H    K           F      
Sbjct: 3   AIGKLMGEGKESAVFNCY-SEKFGE--CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 212 LRSIRHRNLVKIITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLS 271
                 R L K+    V   +      A++ EL+           +      + +     
Sbjct: 60  SARNEFRALQKLQGLAVPKVYAWEGN-AVLMELI-----------DAKELYRVRVENPDE 107

Query: 272 IAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFL 320
           +   +   +   +H     IVH DL   NVL+  E    + DF  +  +
Sbjct: 108 VLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEV 152

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 70.2 bits (170), Expect = 7e-14
 Identities = 23/68 (33%), Positives = 32/68 (47%), Gaps = 4/68 (5%)

Query: 24  DLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCGGIS 83
           DL  N + G +P+ L    FL +LN+SFN+  GE+P  G        +   N  LCG   
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS-- 307

Query: 84  ELHLCTCS 91
              L  C+
Sbjct: 308 --PLPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 56.3 bits (134), Expect = 2e-09
 Identities = 16/60 (26%), Positives = 27/60 (45%), Gaps = 1/60 (1%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           +  N   G +P  L+ L+ + +L++S NNL G IP+   N         + N      P+
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPL 309

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.8 bits (115), Expect = 8e-07
 Identities = 14/75 (18%), Positives = 27/75 (36%), Gaps = 5/75 (6%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           +  N      P  +SSL  ++ L  + N +S      L N   +  L+   N      P+
Sbjct: 314 LYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL 369

Query: 61  KGVFSNSSAISLDGN 75
               +  + + L+  
Sbjct: 370 AN-LTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 10/52 (19%), Positives = 17/52 (32%), Gaps = 2/52 (3%)

Query: 11 PSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKG 62
            S + L  +  L   +  +       +E    L  +N S N      P+K 
Sbjct: 37 TVSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITPLKN 86

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.9 bits (84), Expect = 0.004
 Identities = 19/67 (28%), Positives = 31/67 (46%), Gaps = 4/67 (5%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           +NGN  +     +L+SL  + +LDL+ N +S   P  L     L  L L  N      P+
Sbjct: 226 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 281

Query: 61  KGVFSNS 67
            G+ + +
Sbjct: 282 AGLTALT 288

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 7e-05
 Identities = 12/55 (21%), Positives = 22/55 (40%), Gaps = 5/55 (9%)

Query: 10  IPSSLSSLRGIENLDLSQNNLSGRIPKYL-----ENFPFLQNLNLSFNHFEGEVP 59
           + ++L +   +  LDLS N L       L     +    L+ L L   ++  E+ 
Sbjct: 389 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 443

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 7e-05
 Identities = 12/52 (23%), Positives = 16/52 (30%), Gaps = 4/52 (7%)

Query: 10 IPSSLSSLRGIENLDLSQNNLSGR----IPKYLENFPFLQNLNLSFNHFEGE 57
              L  L+  + + L    L+      I   L   P L  LNL  N     
Sbjct: 19 WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDV 70

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.003
 Identities = 13/73 (17%), Positives = 23/73 (31%), Gaps = 4/73 (5%)

Query: 20 IENLDLSQNNLS-GRIPKYLENFPFLQNLNLSFNHFEGEVPI---KGVFSNSSAISLDGN 75
          I++LD+    LS  R  + L      Q + L                +  N +   L+  
Sbjct: 4  IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 76 VNLCGGISELHLC 88
           N  G +    + 
Sbjct: 64 SNELGDVGVHCVL 76

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.003
 Identities = 9/61 (14%), Positives = 18/61 (29%), Gaps = 4/61 (6%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGR----IPKYLENFPFLQNLNLSFNHFEG 56
           +     +            +  L L+  ++S      +   L     L+ L+LS N    
Sbjct: 352 LEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411

Query: 57  E 57
            
Sbjct: 412 A 412

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 22/140 (15%), Positives = 40/140 (28%), Gaps = 5/140 (3%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
           +  N           +L+ +  L L  N +S   P        L+ L LS N  +     
Sbjct: 38  LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK 97

Query: 61  KGVFSNSSAISLDGNVNLCGGISELHLCTCSTKESKQSRSRSLKLIIPIVTGILFLTGMS 120
                      L  + N    + +      +     +  +  LK           +  +S
Sbjct: 98  MPKTLQ----ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 153

Query: 121 CLIITSWWSKTKREPSTPPS 140
            + I +  + T      PPS
Sbjct: 154 YIRI-ADTNITTIPQGLPPS 172

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 37.7 bits (86), Expect = 0.002
 Identities = 18/84 (21%), Positives = 25/84 (29%), Gaps = 5/84 (5%)

Query: 10  IPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSN-SS 68
           +P  L        LDL  N ++       +N   L  L L  N      P  G F+    
Sbjct: 25  VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP--GAFAPLVK 80

Query: 69  AISLDGNVNLCGGISELHLCTCST 92
              L  + N    + E    T   
Sbjct: 81  LERLYLSKNQLKELPEKMPKTLQE 104

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 4e-04
 Identities = 13/50 (26%), Positives = 20/50 (40%), Gaps = 4/50 (8%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLS 50
            + N      P  L+SL  +  + L  N +S   P  L N   L  + L+
Sbjct: 180 ADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.5 bits (90), Expect = 6e-04
 Identities = 14/50 (28%), Positives = 19/50 (38%), Gaps = 5/50 (10%)

Query: 13  SLSSLRGIENLDLSQNNLSGRIPKYL-----ENFPFLQNLNLSFNHFEGE 57
           S     G++ L L  N +     + L     E  P L  L L+ N F  E
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 6/49 (12%), Positives = 17/49 (34%), Gaps = 4/49 (8%)

Query: 10 IPSSLSSLRGIENLDLSQNNLSGR----IPKYLENFPFLQNLNLSFNHF 54
          + + L     ++ + LS N +       + + + +   L+    S    
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 9e-04
 Identities = 13/56 (23%), Positives = 26/56 (46%), Gaps = 8/56 (14%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEG 56
           ++ N     +P+    L   E L  S N+L+  +P+  +N   L+ L++ +N    
Sbjct: 291 VSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQN---LKQLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 37.1 bits (84), Expect = 0.003
 Identities = 18/75 (24%), Positives = 28/75 (37%), Gaps = 7/75 (9%)

Query: 1   MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPI 60
              N     I S       +E L++S N L   +P      P L+ L  SFNH      +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLAE---V 319

Query: 61  KGVFSNSSAISLDGN 75
             +  N   + ++ N
Sbjct: 320 PELPQNLKQLHVEYN 334

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 12/45 (26%), Positives = 16/45 (35%), Gaps = 2/45 (4%)

Query: 10 IPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHF 54
          +P  L   +    L LS+N L       L  +  L  LNL     
Sbjct: 25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.9 bits (84), Expect = 0.002
 Identities = 7/52 (13%), Positives = 20/52 (38%), Gaps = 2/52 (3%)

Query: 11 PSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKG 62
            + + L  I+ +  + +++       ++  P +  L L+ N      P+  
Sbjct: 39 AVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLAN 88

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (83), Expect = 0.003
 Identities = 10/51 (19%), Positives = 18/51 (35%), Gaps = 1/51 (1%)

Query: 1   MNGNFFQGNIP-SSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLS 50
           ++ N     +P        G   LD+S+  +       LEN   L+  +  
Sbjct: 183 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	484
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.4
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.11
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.02
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.98
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.97
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.89
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	98.82
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.76
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.76
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.65
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.52
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.52
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.5
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.48
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.4
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.36
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.36
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.28
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.17
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	98.06
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.03
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.95
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.95
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	97.94
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	97.93
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.81
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.8
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	97.71
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.6
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.56
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.52
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.36
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.31
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.13
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.93
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.66
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.66
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.43
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	95.81
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	95.69
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	95.55
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	95.5
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	94.64
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	91.3
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	89.73

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-55  Score=408.67  Aligned_cols=264  Identities=28%  Similarity=0.425  Sum_probs=204.4

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ..++|++.+.||+|+||+||+|+++     ..||||+++...  ....+.|.+|+.++++++||||+++++++.      
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------   74 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH-----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------   74 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS-----SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------
T ss_pred             ccccEEEEEEEeeCCCcEEEEEEEC-----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------
Confidence            3568999999999999999999853     349999987543  334578999999999999999999999853      


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      +...++||||+++|+|.+++...   ...+++..++.++.||++||+|||   +++|+||||||+|||++.++.+||+||
T Consensus        75 ~~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DF  148 (276)
T d1uwha_          75 APQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDF  148 (276)
T ss_dssp             SSSCEEEEECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCC
T ss_pred             ccEEEEEEecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccc
Confidence            23578999999999999999743   235999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCC---CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG---SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      |+|+.......     ........||+.|+|||++.+   ..++.++|||||||++|||+||+.||.+..... .+...+
T Consensus       149 Gla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-~~~~~~  222 (276)
T d1uwha_         149 GLATVKSRWSG-----SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-QIIFMV  222 (276)
T ss_dssp             CCSCC-----------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHH
T ss_pred             cceeeccccCC-----cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-HHHHHH
Confidence            99987643221     112234569999999999864   358999999999999999999999997642211 111111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      ...       ...+.+..                    .+..|+.++.+++.+||+.||++|||++||++.|+.+++++
T Consensus       223 ~~~-------~~~p~~~~--------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         223 GRG-------YLSPDLSK--------------------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             HHT-------SCCCCGGG--------------------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             hcC-------CCCCcchh--------------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            110       01111100                    02334678999999999999999999999999999988654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=400.27  Aligned_cols=258  Identities=27%  Similarity=0.428  Sum_probs=198.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||+||+|++.   ++..||||+++... ...++|.+|++++++++||||++++|+|..     ++.
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~   74 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL---NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAP   74 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET---TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSS
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC---CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc-----CCc
Confidence            357889999999999999999975   35679999997543 345789999999999999999999999643     447


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++|+|.+++...   ...+++..++.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||++
T Consensus        75 ~~lv~E~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla  148 (263)
T d1sm2a_          75 ICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMT  148 (263)
T ss_dssp             CEEEEECCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--
T ss_pred             eEEEEEecCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchh
Confidence            89999999999999998743   345899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhC-CCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG-KGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.......      .......||+.|+|||++.+..++.++|||||||++|||+|+ ++||...     ...+.....  
T Consensus       149 ~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~~~~~~~~i--  215 (263)
T d1sm2a_         149 RFVLDDQY------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDI--  215 (263)
T ss_dssp             ----------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----CHHHHHHHH--
T ss_pred             eeccCCCc------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-----CHHHHHHHH--
Confidence            87643321      122234689999999999999999999999999999999995 5444331     111111110  


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                         ..-..                       ...+..|+.++.+++.+||+.||++||||+||++.|++++++
T Consensus       216 ---~~~~~-----------------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         216 ---STGFR-----------------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ---HHTCC-----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---HhcCC-----------------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence               00000                       000233466789999999999999999999999999998763

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=399.50  Aligned_cols=250  Identities=23%  Similarity=0.316  Sum_probs=204.9

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|++.+.||+|+||+||+|+  +..+++.||||+++.......+.+.+|++++++++||||+++++++.     .++..
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~--~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~   92 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDEL   92 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEE--BTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             cccEEEEEEecCcCcEEEEEE--ECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEE
Confidence            479999999999999999999  44567899999998766666678999999999999999999999964     34588


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++|+|.+++...     .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        93 ~ivmEy~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~  164 (293)
T d1yhwa1          93 WVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA  164 (293)
T ss_dssp             EEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhhe
Confidence            9999999999999988642     4899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchh
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPER  398 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  398 (484)
                      .+....       .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+..... .+.......    
T Consensus       165 ~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~----  232 (293)
T d1yhwa1         165 QITPEQ-------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNG----  232 (293)
T ss_dssp             ECCSTT-------CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHC----
T ss_pred             eecccc-------ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-HHHHHHhCC----
Confidence            764322       22234579999999999999999999999999999999999999996532110 011110000    


Q ss_pred             hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          399 LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       399 ~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                           .+.+.                     .+..++.++.+++.+||+.||++|||++|+++
T Consensus       233 -----~~~~~---------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         233 -----TPELQ---------------------NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -----SCCCS---------------------SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----CCCCC---------------------CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 00000                     02334567899999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-54  Score=399.94  Aligned_cols=253  Identities=23%  Similarity=0.314  Sum_probs=200.0

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|++.+.||+|+||+||+|+..  .+++.||||+++.... ...+.+.+|++++++++||||+++++++.     +++.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~   77 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNR--VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNI   77 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred             cceEEEEEEecCcCeEEEEEEEC--CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCce
Confidence            57999999999999999999954  4678999999976543 23457899999999999999999999954     3458


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++|+|.+++..    ...+++.++..++.||+.||+|||   +++|+||||||+|||+++++.+||+|||+|
T Consensus        78 ~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a  150 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLA  150 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhh
Confidence            8999999999999999863    345999999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +.......     .......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||............+..... 
T Consensus       151 ~~~~~~~~-----~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-  224 (271)
T d1nvra_         151 TVFRYNNR-----ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-  224 (271)
T ss_dssp             EECEETTE-----ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-
T ss_pred             eeeccCCc-----cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC-
Confidence            87643321     122234679999999999988776 67899999999999999999999764332222111111000 


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                                 ..                   .....++.++.+|+.+||+.||++|||++|+++
T Consensus       225 -----------~~-------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         225 -----------YL-------------------NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -----------TS-------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----------CC-------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                       00                   001223557789999999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.1e-54  Score=403.38  Aligned_cols=264  Identities=25%  Similarity=0.431  Sum_probs=197.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCC-CeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||+||+|++...+ ....||||.+..... ...+.|.+|+++|++++|||||+++++|.     .++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KST  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eCC
Confidence            45777899999999999999975432 234689998865433 33467999999999999999999999964     345


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++|||||++|+|.+++...   ...+++.+++.++.||++||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGl  174 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGL  174 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred             EEEEEEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCccc
Confidence            789999999999999988743   345899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++.+.......  .........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....  .+...+... 
T Consensus       175 a~~~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~-  249 (299)
T d1jpaa_         175 SRFLEDDTSDP--TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQD-  249 (299)
T ss_dssp             -----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTT-
T ss_pred             ceEccCCCCcc--eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC-
Confidence            98775432111  1112233458999999999999999999999999999999998 89999753211  111111100 


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRN  468 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~  468 (484)
                               ..+                     ..+.+++.++.+|+.+||+.||++|||+.||++.|+++.+
T Consensus       250 ---------~~~---------------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         250 ---------YRL---------------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             ---------CCC---------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---------CCC---------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                     000                     0023346789999999999999999999999999998765

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=397.64  Aligned_cols=270  Identities=24%  Similarity=0.381  Sum_probs=213.5

Q ss_pred             CCCCccCc-cccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENL-IGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~-lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|.+.+. ||+|+||+||+|+++...++..||||+++.... ...+.|.+|+++|++++|||||+++++|..      +
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------C
Confidence            45666674 999999999999987666677899999975443 334679999999999999999999998632      2


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+++|+|.+++...   ...+++.+++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGl  155 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGL  155 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             eEEEEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchh
Confidence            478999999999999998633   346999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++.+......    ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....  .+...+....
T Consensus       156 a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~~~  229 (285)
T d1u59a_         156 SKALGADDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQGK  229 (285)
T ss_dssp             CEECTTCSCE----ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHTTC
T ss_pred             hhcccccccc----cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC
Confidence            9877443211    112223468999999999998999999999999999999998 99999764221  1111111000


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHhhccC
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVKNVR  475 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~~  475 (484)
                              .+                       ..+..|+.++.+|+..||+.||++|||+.+|++.|+.+..++.....
T Consensus       230 --------~~-----------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~~  278 (285)
T d1u59a_         230 --------RM-----------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE  278 (285)
T ss_dssp             --------CC-----------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred             --------CC-----------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhccc
Confidence                    00                       01234567899999999999999999999999999988877766555


Q ss_pred             CC
Q 011508          476 GQ  477 (484)
Q Consensus       476 ~~  477 (484)
                      +.
T Consensus       279 ~~  280 (285)
T d1u59a_         279 GH  280 (285)
T ss_dssp             SC
T ss_pred             hh
Confidence            43

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=393.65  Aligned_cols=246  Identities=22%  Similarity=0.332  Sum_probs=201.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||+||+|+..  .+++.||+|++....   ....+.+.+|++++++++||||+++++++     .++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~   78 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREK--QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDA   78 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECS
T ss_pred             hHeEEEEEEecCCCcEEEEEEEC--CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EEC
Confidence            46899999999999999999954  467899999987432   33456789999999999999999999995     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|.+++....    .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~ivmEy~~~g~L~~~l~~~~----~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG  151 (263)
T d2j4za1          79 TRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG  151 (263)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CEEEEEEeecCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccc
Confidence            58899999999999999997543    4899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +|......         ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+....  
T Consensus       152 ~a~~~~~~---------~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~--  215 (263)
T d2j4za1         152 WSVHAPSS---------RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKR--  215 (263)
T ss_dssp             SCSCCCCC---------CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH--
T ss_pred             eeeecCCC---------cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----HHHHHH--
Confidence            99865322         12235699999999999999999999999999999999999999975311     111111  


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                            +.......                     +..++.++.+++.+||+.||++|||++|+++
T Consensus       216 ------i~~~~~~~---------------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         216 ------ISRVEFTF---------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ------HHTTCCCC---------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HHcCCCCC---------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                  11100000                     1223567889999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.7e-54  Score=403.29  Aligned_cols=261  Identities=24%  Similarity=0.408  Sum_probs=208.7

Q ss_pred             HhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          156 KATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       156 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ...++|++.+.||+|+||+||+|++..  +++.||||+++... ...+++.+|+++|++++|||||+++++|.     ++
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~   85 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKK--YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----RE   85 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGG--GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECC--CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe-----eC
Confidence            344678889999999999999999653  56889999987543 34578999999999999999999999964     44


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|.+++....  ...+++..++.++.||+.||+|||   +++|+||||||+|||+++++.+||+|||
T Consensus        86 ~~~~iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG  160 (287)
T d1opja_          86 PPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFG  160 (287)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             CeeEEEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEcccc
Confidence            57899999999999999997543  346899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +|+......      ........|++.|+|||++.+..++.++|||||||++|||++|..||.....    .....    
T Consensus       161 ~a~~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~~~~----  226 (287)
T d1opja_         161 LSRLMTGDT------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVY----  226 (287)
T ss_dssp             CTTTCCSSS------SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHH----
T ss_pred             ceeecCCCC------ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----HHHHH----
Confidence            998764322      1222334588999999999999999999999999999999997777643211    11111    


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                           +.+......                   ..+..++.++.+|+.+||+.||++|||++||++.|+.+.
T Consensus       227 -----~~i~~~~~~-------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         227 -----ELLEKDYRM-------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             -----HHHHTTCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -----HHHhcCCCC-------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                 111110000                   002234667899999999999999999999999998763

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-54  Score=400.10  Aligned_cols=257  Identities=26%  Similarity=0.443  Sum_probs=204.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||.||+|+++   +++.||||+++... ...+.|.+|++++++++|||||+++++|..      +.
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~   81 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN---GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP   81 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET---TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC---CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------CC
Confidence            457888999999999999999975   45789999997543 345789999999999999999999998632      24


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++|+|.+++....  ...+++.+++.|+.||++||+|||   +++|+||||||+|||+++++.+||+|||+|
T Consensus        82 ~~iv~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla  156 (272)
T d1qpca_          82 IYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLA  156 (272)
T ss_dssp             CEEEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             eEEEEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccce
Confidence            689999999999999876432  235899999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      +.......      .......||+.|+|||++.+..++.++|||||||++|||+||..|+......    .+....    
T Consensus       157 ~~~~~~~~------~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~----~~~~~~----  222 (272)
T d1qpca_         157 RLIEDNEY------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN----PEVIQN----  222 (272)
T ss_dssp             EECSSSCE------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHHHHH----
T ss_pred             EEccCCcc------ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH----HHHHHH----
Confidence            87743321      1223356899999999999889999999999999999999966655432111    111111    


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                       +..-..+                       ..+..++.++.+|+.+||+.||++||||+||++.|+++-
T Consensus       223 -i~~~~~~-----------------------~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         223 -LERGYRM-----------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             -HHTTCCC-----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -HHhcCCC-----------------------CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence             0000000                       002334667899999999999999999999999998864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-54  Score=398.37  Aligned_cols=259  Identities=22%  Similarity=0.283  Sum_probs=194.1

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||+||+|+..  .+++.||+|+++....  ...+.+.+|++++++++||||+++++++.+   ..+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~   77 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRK--SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTN   77 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC------
T ss_pred             chhCEEeEEEecCCCeEEEEEEEC--CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCC
Confidence            367999999999999999999944  4678999999976542  234568899999999999999999998743   234


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeecCCCCCCeeecCCCceEEcc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC--ETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      ...++|||||++|+|.+++.........+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            4679999999999999999765444567999999999999999999999431  23599999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||+++.+....       .......||+.|+|||++.+..++.++|||||||++|||+||+.||.....     .+....
T Consensus       158 FG~a~~~~~~~-------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~~  225 (269)
T d2java1         158 FGLARILNHDT-------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGK  225 (269)
T ss_dssp             HHHHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHH
T ss_pred             ccceeecccCC-------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHHH
Confidence            99998764322       122345799999999999999999999999999999999999999975321     111111


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .        .+.....                    .+..++.++.+++.+||+.||++|||++|+++
T Consensus       226 i--------~~~~~~~--------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         226 I--------REGKFRR--------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             H--------HHTCCCC--------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H--------HcCCCCC--------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            0        0000000                    01223567899999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=388.79  Aligned_cols=249  Identities=27%  Similarity=0.390  Sum_probs=195.4

Q ss_pred             CccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceee
Q 011508          162 SLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEA  239 (484)
Q Consensus       162 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  239 (484)
                      ++.+.||+|+||+||+|+..  .++..||+|++....  ....+.+.+|+++|++++|||||++++++.... .++...+
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~--~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~   88 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDT--ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV   88 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEET--TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred             EeeeEEecCcCcEEEEEEEC--CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEE
Confidence            56678999999999999954  467889999987543  233457899999999999999999999875432 4456789


Q ss_pred             EEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeecCCCCCCeeec-CCCceEEcccCc
Q 011508          240 LVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETP--IVHCDLKPSNVLLD-GELTAHVSDFGL  316 (484)
Q Consensus       240 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfg~  316 (484)
                      +||||+++|+|.+++....    .+++..+..++.||+.||+|||   +++  |+||||||+|||++ +++.+||+|||+
T Consensus        89 ivmE~~~~g~L~~~l~~~~----~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl  161 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  161 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEeCCCCCcHHHHHhccc----cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence            9999999999999997543    4899999999999999999999   777  99999999999996 578999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ++.....         ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....... .+...+.....
T Consensus       162 a~~~~~~---------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~~~i~~~~~  230 (270)
T d1t4ha_         162 ATLKRAS---------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSGVK  230 (270)
T ss_dssp             GGGCCTT---------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTTCC
T ss_pred             ceeccCC---------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HHHHHHHcCCC
Confidence            9764221         2234579999999999875 59999999999999999999999996532111 11111100000


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                             ...+                       +..+..++.+++.+||+.||++|||++|+++
T Consensus       231 -------~~~~-----------------------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 -------PASF-----------------------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -------CGGG-----------------------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------Cccc-----------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                   0000                       1112456889999999999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-53  Score=392.26  Aligned_cols=255  Identities=27%  Similarity=0.402  Sum_probs=202.1

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEEe
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALVY  242 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  242 (484)
                      ++||+|+||+||+|.++....++.||||+++....  ...+.+.+|+++|++++|||||+++++|..      +..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CCEEEEE
Confidence            46999999999999987777788999999975432  234679999999999999999999998632      2468999


Q ss_pred             ecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccccccc
Q 011508          243 ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLPE  322 (484)
Q Consensus       243 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~  322 (484)
                      ||+++|+|.++++..    ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.+..
T Consensus        87 E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~  159 (277)
T d1xbba_          87 EMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA  159 (277)
T ss_dssp             ECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             EcCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccc
Confidence            999999999999743    35899999999999999999999   89999999999999999999999999999987643


Q ss_pred             ccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcchhhhh
Q 011508          323 AANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPERLAE  401 (484)
Q Consensus       323 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  401 (484)
                      ....    ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....  .+...+....      
T Consensus       160 ~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~~------  227 (277)
T d1xbba_         160 DENY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKGE------  227 (277)
T ss_dssp             TCSE----EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC------
T ss_pred             cccc----cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--HHHHHHHcCC------
Confidence            3211    112233568999999999999999999999999999999998 89999763211  1111111000      


Q ss_pred             hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          402 IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       402 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                          .+                     ..+..|+.++.+|+.+||+.||++|||++||++.|+.+-.+
T Consensus       228 ----~~---------------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         228 ----RM---------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             ----CC---------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ----CC---------------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence                00                     00234467889999999999999999999999999886543

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-53  Score=394.90  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=203.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      +.|++.+.||+|+||+||+|+..  .++..||||+++.......+.+.+|+++|++++|||||++++++..     ++..
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~--~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~   84 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNK--ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNL   84 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEEC--CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeE
Confidence            46899999999999999999944  4678999999987766667889999999999999999999999643     4588


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++|||||++|+|.+++....   ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus        85 ~lvmEy~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~  158 (288)
T d2jfla1          85 WILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSA  158 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhh
Confidence            99999999999999986432   35999999999999999999999   8999999999999999999999999999997


Q ss_pred             ccccccccCCCCccccccccccccccCccccC-----CCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM-----GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ......       .......||+.|+|||++.     ...|+.++|||||||++|||+||+.||.+..... .+......
T Consensus       159 ~~~~~~-------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-~~~~i~~~  230 (288)
T d2jfla1         159 KNTRTI-------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-VLLKIAKS  230 (288)
T ss_dssp             ECHHHH-------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-HHHHHHHS
T ss_pred             ccCCCc-------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-HHHHHHcC
Confidence            653321       1122356999999999874     4568999999999999999999999997642211 11111110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .         .+.+.                     .+..++.++.+|+.+||+.||++|||++|+++
T Consensus       231 ~---------~~~~~---------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         231 E---------PPTLA---------------------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             C---------CCCCS---------------------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C---------CCCCC---------------------ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0         00000                     02234667899999999999999999999976

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=393.02  Aligned_cols=265  Identities=25%  Similarity=0.412  Sum_probs=200.4

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCC--CeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDD--HETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .+.|++.++||+|+||.||+|+++...  ....||||+++..... ...+|.+|++++++++|||||+++|+|.     .
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~   80 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----K   80 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----S
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----c
Confidence            356788899999999999999976443  2357999999754432 3357899999999999999999999964     3


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+.++++.+++....   ..+++.+++.++.|++.||+|||   +++|+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DF  154 (283)
T d1mqba_          81 YKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDF  154 (283)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred             CCceEEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEccc
Confidence            447899999999999999886432   45999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |+++.+......    ........||+.|+|||++.+..++.++|||||||++|||++|..|+......    .+.... 
T Consensus       155 Gla~~~~~~~~~----~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~----~~~~~~-  225 (283)
T d1mqba_         155 GLSRVLEDDPEA----TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HEVMKA-  225 (283)
T ss_dssp             CC---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHHHHH-
T ss_pred             chhhcccCCCcc----ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH----HHHHHH-
Confidence            999876443211    11223346899999999999999999999999999999999976665432111    111111 


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                             +.+. ...                   ..+.+++.++.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus       226 -------i~~~-~~~-------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         226 -------INDG-FRL-------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             -------HHTT-CCC-------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -------Hhcc-CCC-------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                   0000 000                   00233467789999999999999999999999999988653

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=383.59  Aligned_cols=254  Identities=26%  Similarity=0.439  Sum_probs=207.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||+||+|+++   ++..||||+++.... ..++|.+|+.++++++||||++++|+|.     .++.
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~   73 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR---GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRP   73 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET---TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSS
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC---CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCc
Confidence            368999999999999999999975   567899999986543 4578999999999999999999999964     3457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++|+|.+++...   ...+++..++.++.|+++||+|||   +++|+||||||+||++++++.+||+|||++
T Consensus        74 ~~iv~Ey~~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a  147 (258)
T d1k2pa_          74 IFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLS  147 (258)
T ss_dssp             EEEEEECCTTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSC
T ss_pred             eEEEEEccCCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhh
Confidence            89999999999999997643   235889999999999999999999   899999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcc
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      +......      ........||+.|+|||++.+..++.++|||||||++|||+| |+.||......+  +...+..   
T Consensus       148 ~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~---  216 (258)
T d1k2pa_         148 RYVLDDE------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQ---  216 (258)
T ss_dssp             CBCSSSS------CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHT---
T ss_pred             eeccCCC------ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHh---
Confidence            8764432      112233568999999999999999999999999999999998 899997642211  1111110   


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLS  465 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~  465 (484)
                           -..  +                     ..+..++.++.+++.+||+.||++|||++||++.|.+
T Consensus       217 -----~~~--~---------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         217 -----GLR--L---------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -----TCC--C---------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -----CCC--C---------------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                 000  0                     0022335678999999999999999999999999865

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-52  Score=396.39  Aligned_cols=262  Identities=23%  Similarity=0.343  Sum_probs=204.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccC-ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeecc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQH-RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDF  232 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  232 (484)
                      .++|++.+.||+|+||+||+|++...   .....||+|.+.... ......+.+|+.++.++ +|||||++++++.    
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~----  111 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT----  111 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe----
Confidence            35788999999999999999997533   224579999886443 33446789999999998 8999999999954    


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRD-------------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVH  293 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH  293 (484)
                       ..+..++|||||++|+|.++++....                   ....+++..++.++.||+.||+|||   +++|+|
T Consensus       112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiH  187 (325)
T d1rjba_         112 -LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVH  187 (325)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             -eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence             44578999999999999999975432                   1235899999999999999999999   899999


Q ss_pred             cCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-
Q 011508          294 CDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-  372 (484)
Q Consensus       294 ~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-  372 (484)
                      |||||+||+++.++.+||+|||+|+.......     ........||+.|+|||++.+..++.++|||||||++|||+| 
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~  262 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL  262 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTT-----SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCc-----eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhC
Confidence            99999999999999999999999987643321     112234568999999999999999999999999999999998 


Q ss_pred             CCCCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCC
Q 011508          373 GKGPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRE  452 (484)
Q Consensus       373 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~  452 (484)
                      |+.||.+..... .+.+.+....            ..                   ..+..++.++.+|+.+||+.||++
T Consensus       263 g~~Pf~~~~~~~-~~~~~~~~~~------------~~-------------------~~p~~~~~~l~~li~~cl~~dP~~  310 (325)
T d1rjba_         263 GVNPYPGIPVDA-NFYKLIQNGF------------KM-------------------DQPFYATEEIYIIMQSCWAFDSRK  310 (325)
T ss_dssp             SCCSSTTCCCSH-HHHHHHHTTC------------CC-------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             CCCCCCCCCHHH-HHHHHHhcCC------------CC-------------------CCCCcCCHHHHHHHHHHcCCChhH
Confidence            899997643221 1222211110            00                   002334667999999999999999


Q ss_pred             CCCHHHHHHHHH
Q 011508          453 RMNMEEVAAQLL  464 (484)
Q Consensus       453 RPt~~evl~~L~  464 (484)
                      |||++||++.|.
T Consensus       311 RPt~~ei~~~L~  322 (325)
T d1rjba_         311 RPSFPNLTSFLG  322 (325)
T ss_dssp             SCCHHHHHHHHH
T ss_pred             CcCHHHHHHHHh
Confidence            999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=397.18  Aligned_cols=201  Identities=27%  Similarity=0.387  Sum_probs=174.5

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ..++|++.+.||+|+||+||+|+.  ..+++.||+|+++.... .....+.+|+.+|++++|||||+++++|.     ++
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~--~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~   76 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSH--KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SD   76 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEE--TTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CS
T ss_pred             CccCCEEEEEEecCCCeEEEEEEE--CCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence            356899999999999999999994  44678999999976533 33467899999999999999999999964     45


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeeecCCCCCCeeecCCCceEEccc
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCE-TPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ...++||||+++|+|.+++....    .+++..+..++.|++.||.|||   + ++|+||||||+|||++.++.+||+||
T Consensus        77 ~~~~iVmEy~~gg~L~~~l~~~~----~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DF  149 (322)
T d1s9ja_          77 GEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDF  149 (322)
T ss_dssp             SEEEEEEECCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCC
T ss_pred             CEEEEEEEcCCCCcHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeC
Confidence            58999999999999999997543    4899999999999999999999   5 48999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCC
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEM  380 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~  380 (484)
                      |+|+......         ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus       150 Gla~~~~~~~---------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         150 GVSGQLIDSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             CCCHHHHHHT---------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             CCccccCCCc---------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            9998763321         12357999999999999999999999999999999999999999764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=390.66  Aligned_cols=251  Identities=22%  Similarity=0.321  Sum_probs=200.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||+||+|+.  ..+++.||||+++...   ....+.+.+|++++++++||||+++++++     .++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~   80 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARE--LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDD   80 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEE--CCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EEC
Confidence            5699999999999999999994  3457889999997432   33456789999999999999999999985     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|.+++....    .+++..++.++.|++.||+|||   +++|+||||||+||++++++.+||+|||
T Consensus        81 ~~~~ivmEy~~gg~L~~~~~~~~----~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG  153 (288)
T d1uu3a_          81 EKLYFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFG  153 (288)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEccCCCCHHHhhhccC----CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccc
Confidence            68899999999999999987543    5899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +|+.+.....     ........||+.|+|||++.+..++.++||||+||++|||+||+.||.....     ......  
T Consensus       154 ~a~~~~~~~~-----~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~--  221 (288)
T d1uu3a_         154 TAKVLSPESK-----QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQK--  221 (288)
T ss_dssp             TCEECC---------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH--
T ss_pred             cceecccCCc-----ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHHHHH--
Confidence            9987643321     1122345799999999999999999999999999999999999999975311     111111  


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                            +.......                     +..++.++.+|+.+||+.||++|||++|+++.
T Consensus       222 ------i~~~~~~~---------------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         222 ------IIKLEYDF---------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             ------HHTTCCCC---------------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             ------HHcCCCCC---------------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence                  11100000                     11225578899999999999999999997654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-51  Score=389.71  Aligned_cols=252  Identities=23%  Similarity=0.305  Sum_probs=187.1

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .+.|++.+.||+|+||+||+|+.  ..+++.||||++..... .....+.+|+.+|++++||||+++++++     .+++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~   80 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAED--KRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGG   80 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEE--TTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccceEEEEEEeeccCeEEEEEEE--CCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence            35699999999999999999984  44678899999975542 2335678999999999999999999985     4556


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCceEEcc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD---GELTAHVSD  313 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~D  313 (484)
                      ..++|||||++|+|.+++..    ...+++.++..++.||+.||+|||   +++|+||||||+||+++   +++.+||+|
T Consensus        81 ~~~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~D  153 (307)
T d1a06a_          81 HLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISD  153 (307)
T ss_dssp             EEEEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEec
Confidence            89999999999999999974    345999999999999999999999   89999999999999994   578999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||+++......        ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....     .... 
T Consensus       154 FG~a~~~~~~~--------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~-  219 (307)
T d1a06a_         154 FGLSKMEDPGS--------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-----KLFE-  219 (307)
T ss_dssp             C--------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHH-
T ss_pred             cceeEEccCCC--------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH-----HHHH-
Confidence            99998653321        223356999999999999999999999999999999999999999753211     1111 


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                             .+.........                 .....++.++.+++.+||+.||++|||++|+++
T Consensus       220 -------~i~~~~~~~~~-----------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         220 -------QILKAEYEFDS-----------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             -------HHHTTCCCCCT-----------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -------HHhccCCCCCC-----------------ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                   01110000000                 001223567899999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-51  Score=388.91  Aligned_cols=275  Identities=24%  Similarity=0.404  Sum_probs=212.1

Q ss_pred             cCccccccceeEEEEEEcCCC-CeeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCceeeEE
Q 011508          164 ENLIGAGSFGSVYKGIFDHDD-HETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFEALV  241 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  241 (484)
                      .++||+|+||+||+|++.+.. ....||||+++... ....++|.+|+++|++++||||++++|+|..    .+...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence            468999999999999976543 34579999997533 3345789999999999999999999999743    33478999


Q ss_pred             eecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcccccc
Q 011508          242 YELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAKFLP  321 (484)
Q Consensus       242 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~  321 (484)
                      ||||++|+|.+++...   ...+++..++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus       108 ~E~~~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~  181 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  181 (311)
T ss_dssp             EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred             EEEeecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence            9999999999998743   345788999999999999999999   8999999999999999999999999999998775


Q ss_pred             cccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcchhhhh
Q 011508          322 EAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPERLAE  401 (484)
Q Consensus       322 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  401 (484)
                      .....   .........||..|+|||.+....++.++||||||+++|||+||..||....... .+...+....      
T Consensus       182 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~~i~~g~------  251 (311)
T d1r0pa_         182 DKEFD---SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGR------  251 (311)
T ss_dssp             TTTCC---CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTC------
T ss_pred             ccccc---cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHHHHHcCC------
Confidence            43211   1122234568999999999999999999999999999999999888876532221 1111111000      


Q ss_pred             hcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHHhhcc-CCCcce
Q 011508          402 IVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKLVKNV-RGQPAT  480 (484)
Q Consensus       402 ~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~~~~~-~~~~~~  480 (484)
                          ..                     ..+..|+.++.+|+.+||+.||++||||.||++.|+.+.+++.... -.-.++
T Consensus       252 ----~~---------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~~~~~~~~  306 (311)
T d1r0pa_         252 ----RL---------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNAT  306 (311)
T ss_dssp             ----CC---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCCCCTT
T ss_pred             ----CC---------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhhchhccCc
Confidence                00                     0023346678999999999999999999999999999988765543 334567


Q ss_pred             eec
Q 011508          481 YVT  483 (484)
Q Consensus       481 ~~~  483 (484)
                      |++
T Consensus       307 ~~~  309 (311)
T d1r0pa_         307 YVN  309 (311)
T ss_dssp             TTT
T ss_pred             ccC
Confidence            754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8e-52  Score=391.03  Aligned_cols=267  Identities=25%  Similarity=0.392  Sum_probs=209.6

Q ss_pred             HHhcCCCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeee
Q 011508          155 FKATDGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSV  230 (484)
Q Consensus       155 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  230 (484)
                      +...++|++.+.||+|+||+||+|++..   ..+++.||||+++..... ..+++.+|++++++++||||++++++|.. 
T Consensus         9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-   87 (301)
T d1lufa_           9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-   87 (301)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc-
Confidence            3345689999999999999999999753   345788999999755433 34679999999999999999999999643 


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRD--------------------APRNLNLLQRLSIAVDVASTLEYLHHYCETP  290 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~  290 (484)
                          ....++||||+++|+|.++++....                    ....+++..++.|+.|++.||+|||   +++
T Consensus        88 ----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~  160 (301)
T d1lufa_          88 ----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERK  160 (301)
T ss_dssp             ----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             ----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCC
Confidence                4478999999999999999974321                    1235899999999999999999999   899


Q ss_pred             eeecCCCCCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHH
Q 011508          291 IVHCDLKPSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEM  370 (484)
Q Consensus       291 ivH~dlk~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~el  370 (484)
                      |+||||||+|||++.++.+||+|||+++.......     ........+++.|+|||++.+..++.++|||||||++|||
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~el  235 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI  235 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCcc-----ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHH
Confidence            99999999999999999999999999986644321     1122335688999999999999999999999999999999


Q ss_pred             HhCC-CCCCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCC
Q 011508          371 FTGK-GPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSEL  449 (484)
Q Consensus       371 ltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d  449 (484)
                      ++|. +||......     +....        +.+.....                    .+..++.++.+|+.+||+.|
T Consensus       236 l~~~~~p~~~~~~~-----e~~~~--------v~~~~~~~--------------------~p~~~~~~~~~li~~cl~~~  282 (301)
T d1lufa_         236 FSYGLQPYYGMAHE-----EVIYY--------VRDGNILA--------------------CPENCPLELYNLMRLCWSKL  282 (301)
T ss_dssp             HTTTCCTTTTSCHH-----HHHHH--------HHTTCCCC--------------------CCTTCCHHHHHHHHHHTCSS
T ss_pred             HccCCCCCCCCCHH-----HHHHH--------HHcCCCCC--------------------CCccchHHHHHHHHHHcCCC
Confidence            9985 566543111     11111        11111000                    02334667899999999999


Q ss_pred             cCCCCCHHHHHHHHHHHH
Q 011508          450 PRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       450 P~~RPt~~evl~~L~~i~  467 (484)
                      |++||||.||+++|++|.
T Consensus       283 P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         283 PADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             GGGSCCHHHHHHHHHHTT
T ss_pred             hhHCcCHHHHHHHHHHhc
Confidence            999999999999999874

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.6e-51  Score=393.70  Aligned_cols=252  Identities=22%  Similarity=0.283  Sum_probs=203.1

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||||++........+.+.+|+.+|++++|||||++++++.     +++..
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~   98 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTE--RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEM   98 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE--TTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEE--CCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence            5799999999999999999994  4467899999998666555678899999999999999999999854     45589


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC--CCceEEcccCc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG--ELTAHVSDFGL  316 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfg~  316 (484)
                      ++|||||++|+|.+++...   ...+++..+..++.||+.||+|||   +++|+||||||+|||++.  ++.+||+|||+
T Consensus        99 ~ivmE~~~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~  172 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGL  172 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecch
Confidence            9999999999999998632   345999999999999999999999   899999999999999954  57899999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ++.+...        .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+...     .+.....  
T Consensus       173 a~~~~~~--------~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i--  237 (350)
T d1koaa2         173 TAHLDPK--------QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETLRNV--  237 (350)
T ss_dssp             CEECCTT--------SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH--
T ss_pred             heecccc--------cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHH--
Confidence            9876432        122345799999999999999999999999999999999999999975311     1111111  


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                            ........                 ......++.++.+|+.+||+.||++|||++|+++
T Consensus       238 ------~~~~~~~~-----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         238 ------KSCDWNMD-----------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             ------HHTCCCSC-----------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ------HhCCCCCC-----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  00000000                 0001223567899999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=386.31  Aligned_cols=268  Identities=23%  Similarity=0.310  Sum_probs=200.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCC---CCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeeecc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHD---DHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSVDF  232 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  232 (484)
                      .++|++.+.||+|+||.||+|++...   .+++.||||+++.... ...+.+.+|...+.++ +|+||+.+++++    .
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~----~   87 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC----T   87 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----C
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee----c
Confidence            46799999999999999999997533   3467899999975433 3345688888888877 688999999886    3


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCC
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRD------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSN  300 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N  300 (484)
                      ..+...++|||||++|+|.++++....            ....+++.+++.++.||++||+|||   +++|+||||||+|
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~N  164 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN  164 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccc
Confidence            445578999999999999999975432            1235899999999999999999999   8999999999999


Q ss_pred             eeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCC-CCCCC
Q 011508          301 VLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK-GPTNE  379 (484)
Q Consensus       301 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~-~p~~~  379 (484)
                      ||+++++.+||+|||+|+.......     ........||+.|+|||++.+..++.++|||||||++|||+||. .||..
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTT-----SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             eeECCCCcEEEccCcchhhcccccc-----ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999987643321     12223457999999999999999999999999999999999964 56754


Q ss_pred             CccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHH
Q 011508          380 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEV  459 (484)
Q Consensus       380 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev  459 (484)
                      .... ..+...+....        .+.                       .+..++.++.+++.+||+.||++|||++||
T Consensus       240 ~~~~-~~~~~~~~~~~--------~~~-----------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~ei  287 (299)
T d1ywna1         240 VKID-EEFCRRLKEGT--------RMR-----------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSEL  287 (299)
T ss_dssp             CCCS-HHHHHHHHHTC--------CCC-----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             CCHH-HHHHHHHhcCC--------CCC-----------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence            3221 11111111100        000                       022335678999999999999999999999


Q ss_pred             HHHHHHHHHH
Q 011508          460 AAQLLSFRNK  469 (484)
Q Consensus       460 l~~L~~i~~~  469 (484)
                      +++|+.+.+.
T Consensus       288 l~~L~~ilq~  297 (299)
T d1ywna1         288 VEHLGNLLQA  297 (299)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHhC
Confidence            9999988653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-51  Score=386.00  Aligned_cols=245  Identities=24%  Similarity=0.300  Sum_probs=196.0

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .|+..+.||+|+||+||+|+.  ..+++.||||+++.....   ..+.+.+|+++|++++|||||++++++..     ++
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~   88 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARD--VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EH   88 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEE--TTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TT
T ss_pred             hcEeeEEEecCCCeEEEEEEE--CCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CC
Confidence            488999999999999999984  446789999999765432   23568899999999999999999999643     45


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++|||||++|+|..++...    ..+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        89 ~~~iv~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~  161 (309)
T d1u5ra_          89 TAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGS  161 (309)
T ss_dssp             EEEEEEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             EEEEEEEecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeeccc
Confidence            889999999999998776532    35899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC---CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG---SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |......           ....||+.|+|||++.+   ..|+.++|||||||++|||++|+.||.+....     +....
T Consensus       162 a~~~~~~-----------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-----~~~~~  225 (309)
T d1u5ra_         162 ASIMAPA-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYH  225 (309)
T ss_dssp             CBSSSSB-----------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHH
T ss_pred             ccccCCC-----------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-----HHHHH
Confidence            9865321           23469999999998754   46899999999999999999999999653211     11110


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....     ..+.+                      ....++.++.+++.+||+.||++|||++|+++
T Consensus       226 i~~~-----~~~~~----------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         226 IAQN-----ESPAL----------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHS-----CCCCC----------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHhC-----CCCCC----------------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            0000     00000                      01123567899999999999999999999975

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=379.21  Aligned_cols=253  Identities=30%  Similarity=0.395  Sum_probs=197.9

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|++.+.||+|+||.||+|+++    ++.||||+++..  ...+.+.+|++++++++||||++++|+|.    ..++..
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~----~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~----~~~~~~   76 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR----GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGL   76 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET----TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEEC----CC--CC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC----CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEE----ecCCcE
Confidence            45788899999999999999974    567999999654  34578999999999999999999999874    333467


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+++|+|.+++....  ...+++..++.|+.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             EEEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccce
Confidence            99999999999999997432  224899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ......          ....++..|+|||++.+..++.++|||||||++|||+| |+.||......  .+...+...   
T Consensus       152 ~~~~~~----------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--~~~~~i~~~---  216 (262)
T d1byga_         152 EASSTQ----------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKG---  216 (262)
T ss_dssp             --------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--GHHHHHTTT---
T ss_pred             ecCCCC----------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcC---
Confidence            653221          22357889999999998999999999999999999998 68777653221  122221110   


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                           ..+.                       .+..++.++.+|+.+||+.||++|||+.||+++|+.++..
T Consensus       217 -----~~~~-----------------------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         217 -----YKMD-----------------------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             -----CCCC-----------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCCC-----------------------CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence                 0000                       0223356789999999999999999999999999998753

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-52  Score=387.16  Aligned_cols=257  Identities=28%  Similarity=0.442  Sum_probs=199.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||.||+|++++   ...||||+++... ...+.|.+|+.++++++|||||+++++|.      ++.
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~---~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~------~~~   85 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNG---TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEP   85 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT---TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSS
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECC---CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe------cCC
Confidence            3568999999999999999999753   3569999997543 34578999999999999999999999863      124


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCcc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLA  317 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a  317 (484)
                      .++||||+++|+|..++....  ...+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        86 ~~lv~Ey~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla  160 (285)
T d1fmka3          86 IYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA  160 (285)
T ss_dssp             CEEEECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             eEEEEEecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchh
Confidence            689999999999999987543  235899999999999999999999   889999999999999999999999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      +......      ........||+.|+|||++....++.++|||||||++|||+||..|+....... .+...+...   
T Consensus       161 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~i~~~---  230 (285)
T d1fmka3         161 RLIEDNE------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERG---  230 (285)
T ss_dssp             C--------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHHHHTT---
T ss_pred             hhccCCC------ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHHHHhc---
Confidence            8764332      112233568999999999999999999999999999999999766654422111 111111100   


Q ss_pred             hhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHH
Q 011508          398 RLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFR  467 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~  467 (484)
                           ...                       ..+..|+.++.+++.+||+.||++|||+++|+++|+.+.
T Consensus       231 -----~~~-----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         231 -----YRM-----------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             -----CCC-----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             -----CCC-----------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence                 000                       002334667899999999999999999999999888754

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=382.82  Aligned_cols=282  Identities=23%  Similarity=0.274  Sum_probs=204.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHH--HHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFI--AECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      .+|.+.+.||+|+||.||+|++.    ++.||||+++...   ...+.  .|+..+.+++||||++++++|...+ ....
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~----g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~   74 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR----GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWT   74 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET----TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC----CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-Ccce
Confidence            45778889999999999999864    6789999986442   23333  4555556789999999999987654 3334


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeecCCCCCCeeecCCCceEE
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHY-----CETPIVHCDLKPSNVLLDGELTAHV  311 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl  311 (484)
                      ..++|||||++|+|.++++..     .++|.+++.++.|++.||+|||+.     ++++|+||||||+||||+.++.+||
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             EEEEEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence            689999999999999999853     489999999999999999999942     2379999999999999999999999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCC------CCCcccceehhhHHHHHHHhCCCCCCCCccCCc
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS------EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNL  385 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~  385 (484)
                      +|||+++.........   ........||+.|+|||++.+.      .++.++|||||||++|||+||..||........
T Consensus       150 ~DFGl~~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~  226 (303)
T d1vjya_         150 ADLGLAVRHDSATDTI---DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             CCCTTCEEEETTTTEE---CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             EecCccccccCCCcce---eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence            9999998764432111   1122346799999999997764      367799999999999999999988764332221


Q ss_pred             cHhHHHHhh-cchh-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          386 TLHNFVKEA-LPER-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       386 ~~~~~~~~~-~~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                      ......... .... ...+.+..+.....              ......++...+.+|+.+||+.||++|||+.||++.|
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~--------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L  292 (303)
T d1vjya_         227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIP--------------NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL  292 (303)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCC--------------GGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHH
T ss_pred             chhhcccccchHHHHHHHHhccccCCCCC--------------cccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence            111110000 0000 11111111111100              1111334567899999999999999999999999999


Q ss_pred             HHHHHHH
Q 011508          464 LSFRNKL  470 (484)
Q Consensus       464 ~~i~~~~  470 (484)
                      +++.++-
T Consensus       293 ~~i~~~~  299 (303)
T d1vjya_         293 SQLSQQE  299 (303)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHhc
Confidence            9998653

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.6e-51  Score=390.73  Aligned_cols=252  Identities=18%  Similarity=0.233  Sum_probs=203.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||||+++.......+.+.+|+++|++++||||+++++++     .+++..
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~  101 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVE--KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEM  101 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEE--TTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEE
T ss_pred             cceEEEEEEecCCCeEEEEEEE--CCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence            5799999999999999999994  446789999999876555556788999999999999999999985     455689


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec--CCCceEEcccCc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD--GELTAHVSDFGL  316 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfg~  316 (484)
                      ++|||||++|+|.+++..   ....+++.+++.|+.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+
T Consensus       102 ~ivmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGl  175 (352)
T d1koba_         102 VLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGL  175 (352)
T ss_dssp             EEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTT
T ss_pred             EEEEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeeccc
Confidence            999999999999988753   2345999999999999999999999   89999999999999997  578999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      |..+...        .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....     ........
T Consensus       176 a~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~i~~  242 (352)
T d1koba_         176 ATKLNPD--------EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-----ETLQNVKR  242 (352)
T ss_dssp             CEECCTT--------SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHH
T ss_pred             ceecCCC--------CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh
Confidence            9876432        1223356899999999999999999999999999999999999999753211     11110000


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .      +.....                   .....++.++.+|+.+||+.||++|||++|+++
T Consensus       243 ~------~~~~~~-------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         243 C------DWEFDE-------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             C------CCCCCS-------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             C------CCCCCc-------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0      000000                   001223567899999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-50  Score=378.35  Aligned_cols=266  Identities=23%  Similarity=0.352  Sum_probs=203.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .++|++.+.||+|+||+||+|+.  ..+++.||||+++.....   ..+.+.+|+++++.++||||+++++++...+ ..
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~   82 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARD--LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PA   82 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SS
T ss_pred             cceeEEeEEEeeCCCeEEEEEEE--CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CC
Confidence            46799999999999999999994  446789999999754332   2357899999999999999999999876543 33


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ....++||||+++++|.+++....    .+++.+++.++.||+.||+|||   +++|+||||||+||+++.++..+|+||
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~----~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCC
T ss_pred             CceEEEEEECCCCCEehhhhcccC----CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehh
Confidence            446799999999999999987543    5899999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |.+........    .........||+.|+|||++.+..++.++||||+||++|||+||+.||......     +.....
T Consensus       156 ~~~~~~~~~~~----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~~~~~  226 (277)
T d1o6ya_         156 GIARAIADSGN----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-----SVAYQH  226 (277)
T ss_dssp             TTCEECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHH
T ss_pred             hhhhhhccccc----cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH-----HHHHHH
Confidence            99876543321    112233457999999999999999999999999999999999999999753211     111111


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-CHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-NMEEVAAQLLSFR  467 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~evl~~L~~i~  467 (484)
                      ....   ...+.                      .....++.++.+++.+||+.||++|| |++++++.|.+++
T Consensus       227 ~~~~---~~~~~----------------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         227 VRED---PIPPS----------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHCC---CCCGG----------------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HhcC---CCCCc----------------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            0000   00000                      00122356789999999999999999 8999999998875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=378.95  Aligned_cols=252  Identities=20%  Similarity=0.251  Sum_probs=201.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc------cchHHHHHHHHHHHcCCCCCceeEeeeeeeec
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR------GASKSFIAECQALRSIRHRNLVKIITSCVSVD  231 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  231 (484)
                      .++|++.+.||+|+||+||+|+.  ..+++.||||+++....      ...+.+.+|+.+|++++|||||++++++    
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~--~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~----   82 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCRE--KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY----   82 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEE--TTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred             ccCEEEeEEEecCCCeEEEEEEE--CCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE----
Confidence            36799999999999999999994  44678999999975432      2346799999999999999999999995    


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC----
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL----  307 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~----  307 (484)
                       .++...++|||||++|+|.+++....    .+++..++.++.|++.||+|||   +++|+||||||+||+++.++    
T Consensus        83 -~~~~~~~iv~E~~~gg~L~~~i~~~~----~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~  154 (293)
T d1jksa_          83 -ENKTDVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKP  154 (293)
T ss_dssp             -ECSSEEEEEEECCCSCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSC
T ss_pred             -EECCEEEEEEEcCCCccccchhcccc----ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCccc
Confidence             44568999999999999999997543    5999999999999999999999   89999999999999998776    


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      .+||+|||++.......        ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....    
T Consensus       155 ~vkl~DfG~a~~~~~~~--------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----  222 (293)
T d1jksa_         155 RIKIIDFGLAHKIDFGN--------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----  222 (293)
T ss_dssp             CEEECCCTTCEECTTSC--------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----
T ss_pred             ceEecchhhhhhcCCCc--------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH----
Confidence            59999999998764322        223356899999999999999999999999999999999999999753211    


Q ss_pred             hHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          388 HNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                       +....        +........                 ...+..++.++.+++.+||+.||++|||++|+++
T Consensus       223 -~~~~~--------i~~~~~~~~-----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         223 -ETLAN--------VSAVNYEFE-----------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -HHHHH--------HHTTCCCCC-----------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -HHHHH--------HHhcCCCCC-----------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             11110        100000000                 0001223567889999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-51  Score=380.42  Aligned_cols=262  Identities=23%  Similarity=0.372  Sum_probs=199.2

Q ss_pred             cCCCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccCcc-chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQHRG-ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      .++|++.+.||+|+||.||+|++... ..+..||||.++..... ..+.+.+|++++++++||||+++++++.      +
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------c
Confidence            35789999999999999999987543 23467999988654333 3467999999999999999999999862      2


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|.+++...   ...+++..++.++.||++||+|||   +++|+||||||+||+++.++.+||+|||
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG  153 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG  153 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred             CeEEEEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccch
Confidence            3679999999999999987643   245899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      +++.......      .......||+.|+|||++.+..++.++|||||||++|||+| |.+||......  .+...+...
T Consensus       154 ~a~~~~~~~~------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~~  225 (273)
T d1mp8a_         154 LSRYMEDSTY------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENG  225 (273)
T ss_dssp             -----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTT
T ss_pred             hheeccCCcc------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--HHHHHHHcC
Confidence            9987643221      12223468999999999999999999999999999999998 89998764221  111111100


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      .        .  .                     ..+..++.++.+|+.+||+.||++|||+.||++.|+.+.++.
T Consensus       226 ~--------~--~---------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         226 E--------R--L---------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             C--------C--C---------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             C--------C--C---------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            0        0  0                     002334678999999999999999999999999999987653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-51  Score=385.76  Aligned_cols=263  Identities=24%  Similarity=0.366  Sum_probs=206.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC-ccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-RGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||.||+|++..++....||||+++... ....+.+.+|+++|+++ +||||++++++|..     ++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RG   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----TT
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-----CC
Confidence            5788899999999999999998766555678899886443 33456799999999999 79999999999754     34


Q ss_pred             eeeEEeecccCCCHHHHHhhcC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec
Q 011508          237 FEALVYELMVNGSLEEWLHLNR------------DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD  304 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~  304 (484)
                      ..++||||+++|+|.++++...            .....+++.+++.++.||+.||.|||   +++|+||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEc
Confidence            8899999999999999997431            23456999999999999999999999   89999999999999999


Q ss_pred             CCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCC-CCCCCccC
Q 011508          305 GELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKG-PTNEMFTG  383 (484)
Q Consensus       305 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~-p~~~~~~~  383 (484)
                      .++.+||+|||+++......        ......||..|+|||.+.+..++.++|||||||++|||++|.. ||....  
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--  231 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--  231 (309)
T ss_dssp             GGGCEEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred             CCCceEEccccccccccccc--------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--
Confidence            99999999999998653322        1123458999999999999999999999999999999999764 565421  


Q ss_pred             CccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHH
Q 011508          384 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQL  463 (484)
Q Consensus       384 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L  463 (484)
                         ..+........     ..+.                       .+..++.++.+|+.+||+.||++||||+||++.|
T Consensus       232 ---~~~~~~~i~~~-----~~~~-----------------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L  280 (309)
T d1fvra_         232 ---CAELYEKLPQG-----YRLE-----------------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL  280 (309)
T ss_dssp             ---HHHHHHHGGGT-----CCCC-----------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             ---HHHHHHHHHhc-----CCCC-----------------------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence               11111111000     0000                       0223466799999999999999999999999999


Q ss_pred             HHHHHHH
Q 011508          464 LSFRNKL  470 (484)
Q Consensus       464 ~~i~~~~  470 (484)
                      +++.+..
T Consensus       281 ~~i~~~~  287 (309)
T d1fvra_         281 NRMLEER  287 (309)
T ss_dssp             HHHHHSS
T ss_pred             HHHHhcC
Confidence            9987654

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=385.54  Aligned_cols=262  Identities=24%  Similarity=0.398  Sum_probs=204.0

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCC--eeEEEEEEeeccC-ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDH--ETLVAVKVLNLQH-RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||+||+|++..++.  ...||+|.++... ....+.+.+|++++++++|||||+++++|..      
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            469999999999999999998654322  3468999886433 3445789999999999999999999999743      


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++++||+.+|+|.+++...   ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFG  156 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFG  156 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCS
T ss_pred             CCeeEEEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccc
Confidence            2457889999999999988753   345899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHhh
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      +++.......     ........||+.|+|||++.++.++.++|||||||++|||+| |+.||......  .+...+...
T Consensus       157 la~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~~~  229 (317)
T d1xkka_         157 LAKLLGAEEK-----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKG  229 (317)
T ss_dssp             HHHHTTTTCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHHHT
T ss_pred             cceecccccc-----cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcC
Confidence            9987643321     112223468999999999999999999999999999999999 78888754221  111111110


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNKL  470 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~~  470 (484)
                      .          .+                     ..+..|+.++.+|+.+||+.||++|||+.||++.|+.+....
T Consensus       230 ~----------~~---------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~  274 (317)
T d1xkka_         230 E----------RL---------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  274 (317)
T ss_dssp             C----------CC---------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred             C----------CC---------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence            0          00                     002334677899999999999999999999999999886544

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-50  Score=383.05  Aligned_cols=248  Identities=23%  Similarity=0.294  Sum_probs=202.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||||+++...   ....+.+.+|+.+|++++||||+++++++     .++
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~--~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~   77 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVRE--KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTH   77 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEE--TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECS
T ss_pred             HhcEEEEEEecCcCeEEEEEEE--CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccc
Confidence            4689999999999999999994  4467899999997542   33457789999999999999999999984     455


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++|||||++|+|.+++....    .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        78 ~~~~iv~ey~~gg~L~~~~~~~~----~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG  150 (337)
T d1o6la_          78 DRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG  150 (337)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             cccccceeccCCCchhhhhhccc----CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecc
Confidence            68999999999999999998543    4889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +|+......       ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.....     ........
T Consensus       151 ~a~~~~~~~-------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~~~~i~  218 (337)
T d1o6la_         151 LCKEGISDG-------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELIL  218 (337)
T ss_dssp             TCBCSCCTT-------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHH
T ss_pred             cccccccCC-------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----HHHHHHHh
Confidence            998653321       222346799999999999999999999999999999999999999976321     11111100


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-----HHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-----MEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~  461 (484)
                      ..        .+..                     +..++.++.+|+.+||+.||++||+     ++|+++
T Consensus       219 ~~--------~~~~---------------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         219 ME--------EIRF---------------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HC--------CCCC---------------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             cC--------CCCC---------------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            00        0000                     1223556889999999999999995     788876

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=374.77  Aligned_cols=260  Identities=28%  Similarity=0.384  Sum_probs=196.7

Q ss_pred             CCCCccCccccccceeEEEEEEcCC-CCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHD-DHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ++|++.+.||+|+||.||+|++... +....||||+++...   ....+.|.+|+.+|++++||||++++|+|..     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            5689999999999999999987533 345679999987542   2334679999999999999999999998632     


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                       ...++||||+++|++.+++....   ..+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+||
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~Df  155 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDF  155 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred             -cchheeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccc
Confidence             24689999999999999887543   35999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |+++........    ........|+..|+|||++.+..++.++|||||||++|||+| |+.||.+....     +....
T Consensus       156 Gl~~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-----~~~~~  226 (273)
T d1u46a_         156 GLMRALPQNDDH----YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QILHK  226 (273)
T ss_dssp             TTCEECCC-CCE----EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHH
T ss_pred             hhhhhcccCCCc----ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH-----HHHHH
Confidence            999977443211    112233457889999999999999999999999999999998 89999753211     11111


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                      .        .......                   ..+..++..+.+|+..||+.||++|||+.||.+.|++.
T Consensus       227 i--------~~~~~~~-------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         227 I--------DKEGERL-------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             H--------HTSCCCC-------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H--------HhCCCCC-------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            1        1000000                   00223466789999999999999999999999988764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.3e-50  Score=377.97  Aligned_cols=246  Identities=26%  Similarity=0.327  Sum_probs=200.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||+||+|+.  ..+++.||||+++...   ....+.+.+|+.++++++||||+++++++     .++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~   76 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRS--RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDA   76 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECS
T ss_pred             hHeEEEEEEecCcCcEEEEEEE--CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeC
Confidence            4689999999999999999994  4467899999997432   33457789999999999999999999995     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      +..++||||+++|+|..++....    .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus        77 ~~~~ivmE~~~gg~l~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG  149 (316)
T d1fota_          77 QQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFG  149 (316)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHTS----SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CeeeeEeeecCCccccccccccc----cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCc
Confidence            68999999999999999987443    4788899999999999999999   9999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +|+.....          .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+...     .+....  
T Consensus       150 ~a~~~~~~----------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~--  212 (316)
T d1fota_         150 FAKYVPDV----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTYEK--  212 (316)
T ss_dssp             SCEECSSC----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHH--
T ss_pred             cceEeccc----------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HHHHHH--
Confidence            99876432          1235799999999999999999999999999999999999999975321     111111  


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAAQ  462 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~~  462 (484)
                            +.......                     +..++.++.+++.+||+.||.+||     |++|+++.
T Consensus       213 ------i~~~~~~~---------------------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         213 ------ILNAELRF---------------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ------HHHCCCCC---------------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------HHcCCCCC---------------------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                  11000000                     112255688999999999999996     89999763

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=376.54  Aligned_cols=268  Identities=24%  Similarity=0.369  Sum_probs=210.8

Q ss_pred             hcCCCCccCccccccceeEEEEEEc---CCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcC-CCCCceeEeeeeeeec
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFD---HDDHETLVAVKVLNLQHR-GASKSFIAECQALRSI-RHRNLVKIITSCVSVD  231 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  231 (484)
                      ..++|++.+.||+|+||.||+|++.   +..+++.||||+++.... .....+.+|+.+++++ +|||||+++++|.   
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~---   97 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT---   97 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe---
Confidence            3467889999999999999999874   235678999999976543 3345788999999999 7999999999964   


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRD--------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLK  297 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk  297 (484)
                        .+...++|||||++|+|.++++....              ....+++..+..++.||+.||+|||   +++++|||||
T Consensus        98 --~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLK  172 (311)
T d1t46a_          98 --IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLA  172 (311)
T ss_dssp             --SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCS
T ss_pred             --eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccc
Confidence              34478999999999999999975432              2235899999999999999999999   8999999999


Q ss_pred             CCCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhC-CCC
Q 011508          298 PSNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTG-KGP  376 (484)
Q Consensus       298 ~~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg-~~p  376 (484)
                      |+||+++.++.+|++|||.++.......     ........||+.|+|||++.+..++.++|||||||++|||+|+ .+|
T Consensus       173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~  247 (311)
T d1t46a_         173 ARNILLTHGRITKICDFGLARDIKNDSN-----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP  247 (311)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCTTSCTT-----SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccccccccCcccccccchheeccCCCc-----ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCC
Confidence            9999999999999999999987654321     1222345789999999999999999999999999999999995 554


Q ss_pred             CCCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCH
Q 011508          377 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNM  456 (484)
Q Consensus       377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~  456 (484)
                      |... .....+.+.+....+.                               ..+..++..+.+|+.+||+.||++|||+
T Consensus       248 ~~~~-~~~~~~~~~i~~~~~~-------------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~  295 (311)
T d1t46a_         248 YPGM-PVDSKFYKMIKEGFRM-------------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTF  295 (311)
T ss_dssp             STTC-CSSHHHHHHHHHTCCC-------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCC-CHHHHHHHHHhcCCCC-------------------------------CCcccccHHHHHHHHHHcCCChhHCcCH
Confidence            5432 2222222222211100                               0012235678999999999999999999


Q ss_pred             HHHHHHHHHHHHH
Q 011508          457 EEVAAQLLSFRNK  469 (484)
Q Consensus       457 ~evl~~L~~i~~~  469 (484)
                      .||+++|+++...
T Consensus       296 ~~il~~L~~~i~~  308 (311)
T d1t46a_         296 KQIVQLIEKQISE  308 (311)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhcc
Confidence            9999999887543

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-49  Score=372.66  Aligned_cols=265  Identities=26%  Similarity=0.386  Sum_probs=205.1

Q ss_pred             cCCCCccCccccccceeEEEEEEcCC-----CCeeEEEEEEeeccCcc-chHHHHHHHHHHHcC-CCCCceeEeeeeeee
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHD-----DHETLVAVKVLNLQHRG-ASKSFIAECQALRSI-RHRNLVKIITSCVSV  230 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  230 (484)
                      .++|++.+.||+|+||.||+|+....     ..+..||||+++..... ....+.+|...+.++ +||||++++++|.  
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~--   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc--
Confidence            35788999999999999999986433     23468999999765542 346788899999888 8999999999964  


Q ss_pred             ccCCCceeeEEeecccCCCHHHHHhhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 011508          231 DFQGNDFEALVYELMVNGSLEEWLHLNRD------------APRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKP  298 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~  298 (484)
                         .++..++||||+++|+|.+++.....            ....+++.+++.++.||+.||+|||   +++|+||||||
T Consensus        90 ---~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp  163 (299)
T d1fgka_          90 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAA  163 (299)
T ss_dssp             ---SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             ---cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecc
Confidence               34578999999999999999975432            1345899999999999999999999   89999999999


Q ss_pred             CCeeecCCCceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHh-CCCCC
Q 011508          299 SNVLLDGELTAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFT-GKGPT  377 (484)
Q Consensus       299 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~ellt-g~~p~  377 (484)
                      +|||++.++.+||+|||+++.......     ........+++.|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~  238 (299)
T d1fgka_         164 RNVLVTEDNVMKIADFGLARDIHHIDY-----YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  238 (299)
T ss_dssp             GGEEECTTCCEEECSTTCCCCGGGCCT-----TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cceeecCCCCeEeccchhhcccccccc-----ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence            999999999999999999987754321     122234568999999999999999999999999999999998 78888


Q ss_pred             CCCccCCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH
Q 011508          378 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME  457 (484)
Q Consensus       378 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~  457 (484)
                      ......  .+...+...        ..+.                       .+..++..+.+|+.+||+.||++|||+.
T Consensus       239 ~~~~~~--~~~~~i~~~--------~~~~-----------------------~p~~~~~~l~~li~~cl~~dP~~Rps~~  285 (299)
T d1fgka_         239 PGVPVE--ELFKLLKEG--------HRMD-----------------------KPSNCTNELYMMMRDCWHAVPSQRPTFK  285 (299)
T ss_dssp             TTCCHH--HHHHHHHTT--------CCCC-----------------------CCSSCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCHH--HHHHHHHcC--------CCCC-----------------------CCccchHHHHHHHHHHccCCHhHCcCHH
Confidence            653211  111111100        0000                       0122356789999999999999999999


Q ss_pred             HHHHHHHHHHH
Q 011508          458 EVAAQLLSFRN  468 (484)
Q Consensus       458 evl~~L~~i~~  468 (484)
                      ||++.|+++.+
T Consensus       286 eil~~L~~i~a  296 (299)
T d1fgka_         286 QLVEDLDRIVA  296 (299)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHhh
Confidence            99999998854

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.7e-49  Score=366.02  Aligned_cols=251  Identities=24%  Similarity=0.341  Sum_probs=199.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc---------chHHHHHHHHHHHcCC-CCCceeEeeeee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG---------ASKSFIAECQALRSIR-HRNLVKIITSCV  228 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~~~~~~~  228 (484)
                      ++|++.+.||+|+||+||+|+.  ..+++.||||+++.....         ..+.+.+|+.++++++ ||||+++++++ 
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~--~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-   79 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIH--KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY-   79 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred             ccCEEceEEecCcCeEEEEEEE--CCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec-
Confidence            6899999999999999999984  446789999999765321         1245889999999996 99999999995 


Q ss_pred             eeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCc
Q 011508          229 SVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELT  308 (484)
Q Consensus       229 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~  308 (484)
                          .+++..++|||||++|+|.++++...    .+++.++..++.||+.||+|||   +++|+||||||+||+++.++.
T Consensus        80 ----~~~~~~~ivmE~~~~g~L~~~l~~~~----~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~  148 (277)
T d1phka_          80 ----ETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMN  148 (277)
T ss_dssp             ----ECSSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCC
T ss_pred             ----ccCcceEEEEEcCCCchHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCC
Confidence                45668999999999999999997543    5899999999999999999999   899999999999999999999


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccC------CCCCCcccceehhhHHHHHHHhCCCCCCCCcc
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGM------GSEVSTSGDVYSFGILLLEMFTGKGPTNEMFT  382 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~  382 (484)
                      +||+|||+++......        ......||..|+|||.+.      ...++.++||||+||++|||+||+.||.+...
T Consensus       149 ~kl~DFG~a~~~~~~~--------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~  220 (277)
T d1phka_         149 IKLTDFGFSCQLDPGE--------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ  220 (277)
T ss_dssp             EEECCCTTCEECCTTC--------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eEEccchheeEccCCC--------ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence            9999999998764321        123356999999999864      34578899999999999999999999976321


Q ss_pred             CCccHhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          383 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       383 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..  .   ...        +.......                 .......++.++.+++.+||+.||++|||++||++
T Consensus       221 ~~--~---~~~--------i~~~~~~~-----------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         221 ML--M---LRM--------IMSGNYQF-----------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HH--H---HHH--------HHHTCCCC-----------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HH--H---HHH--------HHhCCCCC-----------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            10  1   000        00000000                 00002233667899999999999999999999865

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-49  Score=376.65  Aligned_cols=256  Identities=20%  Similarity=0.230  Sum_probs=197.5

Q ss_pred             CCCCccC-ccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcC-CCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLEN-LIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSI-RHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~-~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|.+.. .||+|+||+||+|+.  ..+++.||||+++.     ...+.+|+.++.++ +||||+++++++... ...+.
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~--~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~   82 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFN--KRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRK   82 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEE--TTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEE--CCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCC
Confidence            5788765 699999999999994  44678999999863     35678899987655 899999999986543 23456


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC---CCceEEcc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG---ELTAHVSD  313 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~D  313 (484)
                      ..++|||||+||+|.+++....  ...+++.++..++.||+.||+|||   +++|+||||||+|||++.   ++.+||+|
T Consensus        83 ~~~ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          83 CLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEEEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccc
Confidence            7899999999999999997432  346999999999999999999999   899999999999999975   45799999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      ||+++......        ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+......  ......
T Consensus       158 FG~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~~  227 (335)
T d2ozaa1         158 FGFAKETTSHN--------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKT  227 (335)
T ss_dssp             CTTCEECCCCC--------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------
T ss_pred             cceeeeccCCC--------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHHH
Confidence            99998764322        22335699999999999999999999999999999999999999975322110  000000


Q ss_pred             hcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 ALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                             .+.......                 .......++.++.+|+.+||+.||++|||+.|+++
T Consensus       228 -------~i~~~~~~~-----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         228 -------RIRMGQYEF-----------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -------CCCSCSSSC-----------------CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -------HHhcCCCCC-----------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                   000000000                 00012334677899999999999999999999976

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-49  Score=378.85  Aligned_cols=245  Identities=23%  Similarity=0.261  Sum_probs=200.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  235 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||||+++...   ....+.+.+|+++|+.++||||+++++++     ...
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~--~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~  113 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKH--KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN  113 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             cCeEEEEEeecCcCcEEEEEEE--CCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----ccc
Confidence            5799999999999999999994  4467899999987432   23446789999999999999999999985     445


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+.+|+|.+++....    .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       114 ~~~~~v~e~~~~g~l~~~l~~~~----~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         114 SNLYMVMEYVAGGEMFSHLRRIG----RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             cccccccccccccchhhhHhhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeece
Confidence            58899999999999999997543    4899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +|+.....          .....||+.|+|||++.+..++.++|||||||++|||+||+.||.+..     ........ 
T Consensus       187 ~a~~~~~~----------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~~~~~~~i-  250 (350)
T d1rdqe_         187 FAKRVKGR----------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----PIQIYEKI-  250 (350)
T ss_dssp             TCEECSSC----------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHH-
T ss_pred             eeeecccc----------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-----HHHHHHHH-
Confidence            99876322          123569999999999999999999999999999999999999997531     11111111 


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCC-----CHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERM-----NMEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~evl~  461 (484)
                             .......                     +..++.++.+++.+||+.||.+|+     |++|+++
T Consensus       251 -------~~~~~~~---------------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         251 -------VSGKVRF---------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -------HHCCCCC---------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -------hcCCCCC---------------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                   0000000                     122356789999999999999994     8999886

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.1e-49  Score=378.61  Aligned_cols=249  Identities=23%  Similarity=0.283  Sum_probs=194.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHH---HHHHHHHcCCCCCceeEeeeeeeecc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFI---AECQALRSIRHRNLVKIITSCVSVDF  232 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~  232 (484)
                      ++|++.+.||+|+||.||+|+.  ..+++.||||++....   ......+.   +|+.+++.++||||+++++++     
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~--~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----   76 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRK--ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----   76 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEE--TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----
T ss_pred             HhCeeeeEEecCCCeEEEEEEE--CCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----
Confidence            5799999999999999999994  4467899999986432   11222333   447778888999999999985     


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                      ..++..++||||+++|+|.+++....    .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+
T Consensus        77 ~~~~~~~ivmE~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~  149 (364)
T d1omwa3          77 HTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRIS  149 (364)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHC----SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEEC
T ss_pred             EECCEEEEEEEecCCCcHHHHHHhcc----cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEe
Confidence            44558899999999999999997543    4789999999999999999999   8999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      |||+|+.+....         .....||+.|+|||++.. ..++.++|||||||++|||+||+.||.......  .....
T Consensus       150 DFGla~~~~~~~---------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~~  218 (364)
T d1omwa3         150 DLGLACDFSKKK---------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEID  218 (364)
T ss_dssp             CCTTCEECSSSC---------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC--HHHHH
T ss_pred             eeceeeecCCCc---------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence            999998664321         223469999999999864 568999999999999999999999997643221  11111


Q ss_pred             HhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-----HHHHHH
Q 011508          392 KEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-----MEEVAA  461 (484)
Q Consensus       392 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~  461 (484)
                      ...        ......                     .+..++.++.+|+.+||+.||++|||     ++|+++
T Consensus       219 ~~~--------~~~~~~---------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         219 RMT--------LTMAVE---------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHS--------SSCCCC---------------------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             Hhc--------ccCCCC---------------------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            110        000000                     01223567899999999999999999     678765

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-49  Score=372.67  Aligned_cols=251  Identities=20%  Similarity=0.292  Sum_probs=200.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      ++|++.+.||+|+||+||+|+.  ..+++.||||+++.... ....+.+|+++|+.++||||+++++++     .+++..
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~--~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~   76 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVE--TSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESF-----ESMEEL   76 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEE--TTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEE
T ss_pred             cceEEEEEEecCCCeEEEEEEE--CCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEE
Confidence            6799999999999999999994  44678999999976532 335688999999999999999999985     445589


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC--CceEEcccCc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE--LTAHVSDFGL  316 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfg~  316 (484)
                      ++|||||++|+|.+++...   ...+++.++..++.||+.||+|||   +++|+||||||+|||++.+  ..+||+|||+
T Consensus        77 ~lvmE~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~  150 (321)
T d1tkia_          77 VMIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ  150 (321)
T ss_dssp             EEEECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred             EEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccch
Confidence            9999999999999999743   235899999999999999999999   8999999999999999854  4899999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALP  396 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  396 (484)
                      ++.....        .......+|+.|+|||...+..++.++||||+||++|+|++|+.||......     +....   
T Consensus       151 ~~~~~~~--------~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-----~~~~~---  214 (321)
T d1tkia_         151 ARQLKPG--------DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIEN---  214 (321)
T ss_dssp             CEECCTT--------CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHH---
T ss_pred             hhccccC--------CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----HHHHH---
Confidence            9865322        1223356899999999999999999999999999999999999999763211     11111   


Q ss_pred             hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          397 ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       397 ~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                           +.........                 .....++.++.+|+.+||+.||++|||++|+++
T Consensus       215 -----i~~~~~~~~~-----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         215 -----IMNAEYTFDE-----------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -----HHHTCCCCCH-----------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----HHhCCCCCCh-----------------hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 1110000000                 001123556889999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-49  Score=376.15  Aligned_cols=266  Identities=23%  Similarity=0.367  Sum_probs=208.3

Q ss_pred             cCCCCccCccccccceeEEEEEEcC---CCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccC
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDH---DDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQ  233 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  233 (484)
                      .++|++.+.||+|+||+||+|++..   ...++.||||+++.... .....+.+|++++++++||||++++++|.     
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----   93 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   93 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe-----
Confidence            4678899999999999999998642   23457899999975433 23356899999999999999999999963     


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNR------DAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL  307 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~  307 (484)
                      .+...++||||+++|+|.+++....      .....+++..+..++.|+++||+|||   +++|+||||||+|||+++++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCc
Confidence            3447899999999999999986432      22235789999999999999999999   89999999999999999999


Q ss_pred             ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCC-CCCCCCccCCcc
Q 011508          308 TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGK-GPTNEMFTGNLT  386 (484)
Q Consensus       308 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~-~p~~~~~~~~~~  386 (484)
                      ++||+|||+++.......     ........+|+.|+|||.+.+..++.++|||||||++|||+||. .||...     .
T Consensus       171 ~~Kl~DFGla~~~~~~~~-----~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-----~  240 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDY-----YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-----S  240 (308)
T ss_dssp             CEEECCTTCCCGGGGGGC-----EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----C
T ss_pred             eEEEeecccceeccCCcc-----eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-----C
Confidence            999999999987644321     12223346899999999999999999999999999999999985 666542     1


Q ss_pred             HhHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHH
Q 011508          387 LHNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSF  466 (484)
Q Consensus       387 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i  466 (484)
                      ..+...        .+.+.....                    .+..|+..+.+++.+||+.||++|||++||+++|++.
T Consensus       241 ~~~~~~--------~i~~~~~~~--------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         241 NEQVLR--------FVMEGGLLD--------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHHHHH--------HHHTTCCCC--------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHHH--------HHHhCCCCC--------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            111111        111111100                    0233466799999999999999999999999998776


Q ss_pred             HHH
Q 011508          467 RNK  469 (484)
Q Consensus       467 ~~~  469 (484)
                      .+.
T Consensus       293 ~~~  295 (308)
T d1p4oa_         293 MEP  295 (308)
T ss_dssp             SCT
T ss_pred             cCC
Confidence            443

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=374.83  Aligned_cols=248  Identities=25%  Similarity=0.365  Sum_probs=198.4

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC---ccchHHHHHHHHHHH-cCCCCCceeEeeeeeeeccCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH---RGASKSFIAECQALR-SIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~  234 (484)
                      ++|++.+.||+|+||+||+|+.  ..+++.||||+++...   ....+.+..|..++. .++||||+++++++     .+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~--~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~   74 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEF--KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT   74 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE--TTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred             CCeEEeeEEecCCCcEEEEEEE--CCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----cc
Confidence            5799999999999999999994  4467899999997532   233456777777765 68999999999995     44


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      ++..++||||+++|+|.+++....    .+++.++..++.||+.||+|||   +++|+||||||+|||+++++.+||+||
T Consensus        75 ~~~~yivmEy~~~g~L~~~i~~~~----~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DF  147 (320)
T d1xjda_          75 KENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADF  147 (320)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS----SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             CCceeEEEeecCCCcHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceecccc
Confidence            558999999999999999998543    4889999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEA  394 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  394 (484)
                      |+++......       .......||+.|+|||++.+..++.++||||+||++|||+||+.||.+....     +.....
T Consensus       148 G~a~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~-----~~~~~i  215 (320)
T d1xjda_         148 GMCKENMLGD-------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-----ELFHSI  215 (320)
T ss_dssp             TTCBCCCCTT-------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHH
T ss_pred             chhhhccccc-------ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH-----HHHHHH
Confidence            9998653321       2223356999999999999999999999999999999999999999753211     111110


Q ss_pred             cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHH-HHHH
Q 011508          395 LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNME-EVAA  461 (484)
Q Consensus       395 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-evl~  461 (484)
                      ...      .+.+                       +..++.++.+|+.+||+.||++|||+. |+++
T Consensus       216 ~~~------~~~~-----------------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         216 RMD------NPFY-----------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             HHC------CCCC-----------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             HcC------CCCC-----------------------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            000      0000                       122356789999999999999999995 6753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-48  Score=364.64  Aligned_cols=281  Identities=21%  Similarity=0.233  Sum_probs=201.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcC---CCCCceeEeeeeeeecc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSI---RHRNLVKIITSCVSVDF  232 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~  232 (484)
                      .++|++.+.||+|+||+||+|+.... +++.||||+++....  .....+.+|+.+++.+   +||||+++++++.....
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKN-GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTT-TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECC-CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            46899999999999999999985322 357899999875432  2234566777777665   89999999999877666


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                      ......+++|||+.++++......   ....+++..+..++.|++.||+|||   +++|+||||||+|||+++++.+||+
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             ccCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeec
Confidence            667788999999987766544432   2345899999999999999999999   8999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      |||+++.....        .......||+.|+|||++.+..++.++||||+||++|||+||+.||...... ..+.....
T Consensus       159 dfg~~~~~~~~--------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~  229 (305)
T d1blxa_         159 DFGLARIYSFQ--------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILD  229 (305)
T ss_dssp             SCCSCCCCCGG--------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHH
T ss_pred             chhhhhhhccc--------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHH
Confidence            99998865332        2223457999999999999999999999999999999999999999764221 11111111


Q ss_pred             hhcchhhhhhcCc-ccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          393 EALPERLAEIVDP-VLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       393 ~~~~~~~~~~~d~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .........+-.. ......... . .     ..............+.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~-~-~-----~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         230 VIGLPGEEDWPRDVALPRQAFHS-K-S-----AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHCCCCGGGSCTTCSSCGGGSCC-C-C-----CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhCCCchhcccccccchhhhhcc-c-c-----ccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1111000000000 000000000 0 0     00000001223556889999999999999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-48  Score=366.30  Aligned_cols=270  Identities=21%  Similarity=0.235  Sum_probs=191.0

Q ss_pred             cCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc-----chHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCcee
Q 011508          164 ENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG-----ASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       164 ~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  238 (484)
                      .++||+|+||+||+|+  +..+++.||||+++.....     ..+.+.+|+.++++++|||||++++++     ..++..
T Consensus         3 l~~lG~G~fg~Vy~~~--~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~   75 (299)
T d1ua2a_           3 LDFLGEGQFATVYKAR--DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNI   75 (299)
T ss_dssp             EEEEEEETTEEEEEEE--CSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCC
T ss_pred             ceEeccCcCeEEEEEE--ECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCce
Confidence            5789999999999999  5556889999998754322     135688999999999999999999995     455688


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ++||||+.++++..+..    ....+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        76 ~ivmE~~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~  148 (299)
T d1ua2a_          76 SLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK  148 (299)
T ss_dssp             EEEEECCSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eehhhhhcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCcccc
Confidence            99999998877766554    2345888999999999999999999   8999999999999999999999999999998


Q ss_pred             ccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhcch
Q 011508          319 FLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEALPE  397 (484)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  397 (484)
                      ......       .......||+.|+|||++.. ..++.++||||+||++|||+||+.||......+ .+..........
T Consensus       149 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~  220 (299)
T d1ua2a_         149 SFGSPN-------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTP  220 (299)
T ss_dssp             TTTSCC-------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCC
T ss_pred             ccCCCc-------ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCC
Confidence            654322       12233569999999998765 467999999999999999999999997532211 111111111000


Q ss_pred             hhhhhcCccccccccc-ccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          398 RLAEIVDPVLLVEREE-GETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       398 ~~~~~~d~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ......+..-...... ......... .     .......++.+|+.+||+.||++|||++|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         221 TEEQWPDMCSLPDYVTFKSFPGIPLH-H-----IFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CTTTSSSTTSSTTCCCCCCCCCCCHH-H-----HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhccchhhhhccCCCCChH-H-----hcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            0000000000000000 000000000 0     00122457899999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-48  Score=363.76  Aligned_cols=275  Identities=23%  Similarity=0.292  Sum_probs=196.6

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||+||+|+.  ..+++.||||+++....  ...+++.+|++++++++||||+++++++.     .+.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~   74 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARN--KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TEN   74 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEE--TTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred             CCCEeccEEecCcCeEEEEEEE--CCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----ccc
Confidence            5799999999999999999994  44678999999965432  23578999999999999999999999954     455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++||||+.+ ++.+++...  ....+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.
T Consensus        75 ~~~iv~e~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          75 KLYLVFEFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             EEEEEEECCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             ceeEEEeecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCc
Confidence            89999999955 555555432  2345999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCC-CCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      |+......       .......||+.|+|||.+.... ++.++||||+||++|+|++|+.||....... .+........
T Consensus       149 a~~~~~~~-------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~  220 (298)
T d1gz8a_         149 ARAFGVPV-------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLG  220 (298)
T ss_dssp             HHHHCCCS-------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred             ceeccCCc-------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcC
Confidence            98653322       2233456999999999876655 5889999999999999999999997542211 1111111110


Q ss_pred             -chh-hhhhcC--cccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 -PER-LAEIVD--PVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 -~~~-~~~~~d--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                       +.. ......  +...........  ... ..     .......++.+++.+||+.||++|||++|+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~-----~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         221 TPDEVVWPGVTSMPDYKPSFPKWAR--QDF-SK-----VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCCTTTSTTGGGSTTCCTTSCCCCC--CCH-HH-----HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCchhhccccccccccccccccccc--cch-hh-----hccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             000 000000  000000000000  000 00     011224678899999999999999999999863

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=362.98  Aligned_cols=240  Identities=22%  Similarity=0.318  Sum_probs=191.8

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc------chHHHHHHHHHHHcCC--CCCceeEeeeeeee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG------ASKSFIAECQALRSIR--HRNLVKIITSCVSV  230 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~  230 (484)
                      ++|++.+.||+|+||+||+|+.  ..+++.||||+++.....      ....+.+|+.++++++  ||||+++++++   
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~---   78 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIR--VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF---   78 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEE--TTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE---
T ss_pred             CeEEEeEEEeeCCCeEEEEEEE--CCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE---
Confidence            5799999999999999999994  446789999998754211      1234678999999996  89999999985   


Q ss_pred             ccCCCceeeEEeecccC-CCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCC-Cc
Q 011508          231 DFQGNDFEALVYELMVN-GSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGE-LT  308 (484)
Q Consensus       231 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~-~~  308 (484)
                        ..++..++||||+.+ +++.+++...    ..+++.++..++.||+.||+|||   +++|+||||||+|||++.+ +.
T Consensus        79 --~~~~~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~  149 (273)
T d1xwsa_          79 --ERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGE  149 (273)
T ss_dssp             --ECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTE
T ss_pred             --eeCCeEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCe
Confidence              445588999999975 6888888643    35899999999999999999999   8999999999999999854 79


Q ss_pred             eEEcccCcccccccccccCCCCccccccccccccccCccccCCCCC-CcccceehhhHHHHHHHhCCCCCCCCccCCccH
Q 011508          309 AHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEV-STSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL  387 (484)
Q Consensus       309 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~  387 (484)
                      +||+|||+|+.....         ......||+.|+|||++.+..+ +.++||||+||++|||+||+.||....      
T Consensus       150 vkl~DFG~a~~~~~~---------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------  214 (273)
T d1xwsa_         150 LKLIDFGSGALLKDT---------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------  214 (273)
T ss_dssp             EEECCCTTCEECCSS---------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred             EEECccccceecccc---------cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------
Confidence            999999999865322         1223569999999999877665 677999999999999999999996521      


Q ss_pred             hHHHHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          388 HNFVKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       388 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                       .....            ....                     +..++.++.+++.+||+.||++|||++|+++
T Consensus       215 -~i~~~------------~~~~---------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         215 -EIIRG------------QVFF---------------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -HHHHC------------CCCC---------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHhhc------------ccCC---------------------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence             01000            0000                     1112557889999999999999999999976

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.4e-47  Score=356.76  Aligned_cols=269  Identities=22%  Similarity=0.318  Sum_probs=203.9

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCce
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  237 (484)
                      .++|++.+.||+|+||.||+|+..  .+++.||||++.....  .+++..|+++++.++|+|++..+..+.    ..++.
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~~   77 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDI--AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG----AEGDY   77 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEET--TTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEE----EETTE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEEC--CCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEE----ecCCE
Confidence            357999999999999999999853  4578999999875432  245788999999999888777776653    34457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeec---CCCceEEccc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLD---GELTAHVSDF  314 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Df  314 (484)
                      .++||||+ ++++.+.+...   ...+++..+..++.|++.||+|||   +++|+||||||+||+++   .+..+||+||
T Consensus        78 ~~ivme~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DF  150 (299)
T d1ckia_          78 NVMVMELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDF  150 (299)
T ss_dssp             EEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred             EEEEEEEc-CCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeecc
Confidence            89999999 66777766532   345899999999999999999999   89999999999999875   4557999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHh--HHHH
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLH--NFVK  392 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~--~~~~  392 (484)
                      |+|+.+..................||+.|+|||.+.+..++.++|||||||++|||+||+.||...........  ....
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~  230 (299)
T d1ckia_         151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE  230 (299)
T ss_dssp             SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred             CcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence            99998755432222222333456799999999999999999999999999999999999999976533221111  1111


Q ss_pred             hhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          393 EALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       393 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                      ..........                            ...++.++.+++..||+.+|++||++.++.+.|+.+..+
T Consensus       231 ~~~~~~~~~~----------------------------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         231 KKMSTPIEVL----------------------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHHSCHHHH----------------------------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccCCCChhHh----------------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            0000000000                            123366789999999999999999999999988887543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.7e-47  Score=356.15  Aligned_cols=276  Identities=21%  Similarity=0.253  Sum_probs=196.3

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||+||+|+.+   +++.||||+++....  ...+.+.+|+.+|++++||||+++++++     .+++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~   73 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN---YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKK   73 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET---TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSS
T ss_pred             CCceeccEEecCCCcEEEEEEeC---CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCC
Confidence            57999999999999999999864   568899999975432  2357899999999999999999999985     4455


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++++|++.++.+..+..    ....+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||.
T Consensus        74 ~~~i~~e~~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~  146 (286)
T d1ob3a_          74 RLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGL  146 (286)
T ss_dssp             CEEEEEECCSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred             ceeEEEEeehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEeccccc
Confidence            8899999997776666654    2345999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.......       .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+..... .+........
T Consensus       147 a~~~~~~~-------~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~  218 (286)
T d1ob3a_         147 ARAFGIPV-------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILG  218 (286)
T ss_dssp             HHHHCC----------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred             ceecccCc-------cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhC
Confidence            98753321       12233468999999998765 457899999999999999999999997642211 1111111111


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ........+..-.......    ...................+.+++.+||+.||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         219 TPNSKNWPNVTELPKYDPN----FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCTTTSTTGGGSTTCCTT----CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCChhhccchhhhhhcccc----cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1000000000000000000    0000000000011223567889999999999999999999974

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-47  Score=363.26  Aligned_cols=280  Identities=20%  Similarity=0.230  Sum_probs=198.7

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc-cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR-GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      +++|++.+.||+|+||+||+|+  +..+++.||||+++.... ...+.+.+|+++|++++||||+++++++....+....
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~--~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAY--DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEE--ETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEE--ECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            4679999999999999999998  445678999999975432 3346788999999999999999999998665544444


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++++ |+.+|+|.+++...     .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        85 ~~~l~~-~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~  155 (345)
T d1pmea_          85 DVYLVT-HLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGL  155 (345)
T ss_dssp             CEEEEE-ECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEE-eecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCc
Confidence            555555 55699999999743     4899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +.........    ........||+.|+|||++.. ..++.++||||+||++|||++|+.||......... ........
T Consensus       156 a~~~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~-~~~~~~~~  230 (345)
T d1pmea_         156 ARVADPDHDH----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL-NHILGILG  230 (345)
T ss_dssp             CEECCGGGCB----CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHC
T ss_pred             eeeccCCCcc----ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH-HHHhhhcc
Confidence            9876443211    122234679999999998754 56789999999999999999999999764221110 00000000


Q ss_pred             -chh--hhhhcCcccc----cccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 -PER--LAEIVDPVLL----VEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 -~~~--~~~~~d~~l~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                       +..  ..........    ...........    .     .......++.+|+.+||+.||++|||++|+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~-----~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWN----R-----LFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHH----H-----HCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCChhhhhhhhhhhhhcccccCCccCCCCHH----H-----hCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             000  0000000000    00000000000    0     011124568899999999999999999999864

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=359.02  Aligned_cols=286  Identities=19%  Similarity=0.237  Sum_probs=196.0

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccC--ccchHHHHHHHHHHHcCCCCCceeEeeeeeeec---c
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH--RGASKSFIAECQALRSIRHRNLVKIITSCVSVD---F  232 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~  232 (484)
                      .++|++.+.||+|+||+||+|+.  ..+++.||||++....  ....+++.+|+++|++++|||++++++++....   .
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARH--RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEE--CCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            37899999999999999999994  3467899999986543  334567899999999999999999999875532   1


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                      ..+...++||||+.++.+..+..    ....+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             ccCceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEee
Confidence            22456899999998776655443    2345889999999999999999999   8999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFV  391 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~  391 (484)
                      |||++.........   .........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+....  .....+
T Consensus       160 dfg~~~~~~~~~~~---~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~--~~~~~i  234 (318)
T d3blha1         160 DFGLARAFSLAKNS---QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ--HQLALI  234 (318)
T ss_dssp             CCTTCEECCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH
T ss_pred             ecceeeeccccccc---ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH--HHHHHH
Confidence            99999876543211   11222335799999999988764 6899999999999999999999999753211  111111


Q ss_pred             Hhhc---chh-hhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          392 KEAL---PER-LAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       392 ~~~~---~~~-~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ....   +.. .....................    .....+........+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         235 SQLCGSITPEVWPNVDNYELYEKLELVKGQKR----KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHCCCCTTTSTTCCCC-------CCSSCCB----CHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhcCCCChhhccccchhhhhhhhcccccccc----cchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            1111   111 111111100000000000000    00000001112456788999999999999999999985

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-46  Score=359.08  Aligned_cols=282  Identities=23%  Similarity=0.257  Sum_probs=197.3

Q ss_pred             CCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-CCCcee
Q 011508          160 GFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNLVKIITSCVSVDF-QGNDFE  238 (484)
Q Consensus       160 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~  238 (484)
                      +|+..++||+|+||+||+|+..  .+++.||||++.....    ...+|+++|++++||||+++++++..... .+..+.
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~--~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLC--DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEET--TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEEC--CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            4777899999999999999944  4678999999975432    23479999999999999999999765432 344567


Q ss_pred             eEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcccCcc
Q 011508          239 ALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVSDFGLA  317 (484)
Q Consensus       239 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~a  317 (484)
                      ++|||||+++ +.+.+.........+++.++..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||++
T Consensus        95 ~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          95 NLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccch
Confidence            8999999765 44444332223456999999999999999999999   99999999999999999775 8999999999


Q ss_pred             cccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc-
Q 011508          318 KFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL-  395 (484)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-  395 (484)
                      .......        ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+........ 
T Consensus       171 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~  241 (350)
T d1q5ka_         171 KQLVRGE--------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGT  241 (350)
T ss_dssp             EECCTTS--------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCC
T ss_pred             hhccCCc--------ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCC
Confidence            8663321        2223569999999998765 57899999999999999999999999754221 11111111110 


Q ss_pred             --chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH--HHHHH
Q 011508          396 --PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ--LLSFR  467 (484)
Q Consensus       396 --~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~--L~~i~  467 (484)
                        .+.+.................       ..........+..++.+|+.+||+.||++|||+.|+++.  +++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         242 PTREQIREMNPNYTEFKFPQIKA-------HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             CCHHHHHHHCC---CCCCCCCCC-------CCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             ChHHhhhhhccchhhcccccccc-------CchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence              011111111000000000000       000000112235678999999999999999999999863  44443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-45  Score=347.22  Aligned_cols=269  Identities=19%  Similarity=0.239  Sum_probs=207.8

Q ss_pred             cCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCC-CCceeEeeeeeeeccCCCc
Q 011508          158 TDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRH-RNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       158 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~  236 (484)
                      .++|++.+.||+|+||+||+|+..  .+++.||||+++...  ..+.+.+|++.++.+.| +|++.+++++     ..+.
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~   74 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNL--LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGL   74 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEET--TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETT
T ss_pred             CCceEEEEEEecCCCeEEEEEEEC--CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCC
Confidence            368999999999999999999944  467899999986543  23457789999999965 8999998874     3445


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecC-----CCceEE
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDG-----ELTAHV  311 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~-----~~~~kl  311 (484)
                      ..++||||+ +++|.+++....   ..+++.++..++.|++.||+|||   +++|+||||||+||+++.     ++.+||
T Consensus        75 ~~~~vme~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl  147 (293)
T d1csna_          75 HNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYV  147 (293)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred             ccEEEEEec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEE
Confidence            789999999 789999987433   35899999999999999999999   999999999999999964     568999


Q ss_pred             cccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccH-hHH
Q 011508          312 SDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTL-HNF  390 (484)
Q Consensus       312 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~-~~~  390 (484)
                      +|||+|+....................||+.|+|||++.+..++.++|||||||++|||+||+.||.......... ...
T Consensus       148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~  227 (293)
T d1csna_         148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER  227 (293)
T ss_dssp             CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred             cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence            9999999875543222222233345679999999999999999999999999999999999999997643322111 000


Q ss_pred             HHhhc-chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHHHHHHHHH
Q 011508          391 VKEAL-PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQLLSFRNK  469 (484)
Q Consensus       391 ~~~~~-~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~L~~i~~~  469 (484)
                      +.... .....++                            ...++.++.+++..|++.+|++||+++.+.+.|+++.++
T Consensus       228 i~~~~~~~~~~~l----------------------------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         228 IGEKKQSTPLREL----------------------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             HHHHHHHSCHHHH----------------------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHhccCCCChHHh----------------------------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence            10000 0000000                            122356789999999999999999999999988887665


Q ss_pred             H
Q 011508          470 L  470 (484)
Q Consensus       470 ~  470 (484)
                      .
T Consensus       280 ~  280 (293)
T d1csna_         280 L  280 (293)
T ss_dssp             T
T ss_pred             c
Confidence            4

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-46  Score=358.75  Aligned_cols=280  Identities=20%  Similarity=0.215  Sum_probs=195.2

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-C
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDF-Q  233 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~  233 (484)
                      ..++|++.+.||+|+||+||+|+.  ..+++.||||+++....  ...+.+.+|+++|++++|||||+++++|...+. .
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVD--GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEE--TTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEE--CCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence            357899999999999999999994  44678999999975432  234578899999999999999999999754431 2


Q ss_pred             CCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcc
Q 011508          234 GNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSD  313 (484)
Q Consensus       234 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D  313 (484)
                      .....++||||+ +.+|..+++.     ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+|++|
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~D  164 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILD  164 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             ccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccc
Confidence            334679999999 6788887763     24999999999999999999999   89999999999999999999999999


Q ss_pred             cCcccccccccccCCCCccccccccccccccCccccCC-CCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHH
Q 011508          314 FGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMG-SEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVK  392 (484)
Q Consensus       314 fg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  392 (484)
                      ||+++.....          .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+.....
T Consensus       165 fg~a~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~~~~  233 (346)
T d1cm8a_         165 FGLARQADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMK  233 (346)
T ss_dssp             CTTCEECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHH
T ss_pred             ccceeccCCc----------cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH-HHHHHHHh
Confidence            9999865322          123568999999998765 45789999999999999999999999764211 11111111


Q ss_pred             hh--cchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          393 EA--LPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       393 ~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      ..  .+...................    ..............+...+.+|+.+||+.||++|||++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         234 VTGTPPAEFVQRLQSDEAKNYMKGL----PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHCCCCHHHHHTCSCHHHHHHHHHS----CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccCCCcHHHHhhhcchhhhhhhccC----CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            11  111111100000000000000    0000000000011224567899999999999999999999874

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=346.78  Aligned_cols=278  Identities=19%  Similarity=0.216  Sum_probs=200.2

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCCCc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQGND  236 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  236 (484)
                      ++|++.+.||+|+||+||+|+.  ..+++.||||+++....  ....++.+|+.+++.++||||+++++++.     +..
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~   74 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKN--RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDK   74 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEE--TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             CCCEeeeEEecCcCeEEEEEEE--CCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----ccc
Confidence            5799999999999999999994  44678999999975543  33578899999999999999999999854     445


Q ss_pred             eeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccCc
Q 011508          237 FEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFGL  316 (484)
Q Consensus       237 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~  316 (484)
                      ..++|+|++.+++|..++..    ...+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.
T Consensus        75 ~~~iv~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          75 KLTLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EEEEEEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ceeEEeeecccccccccccc----ccccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecch
Confidence            88999999999998888763    345889999999999999999999   89999999999999999999999999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCCC-CCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSE-VSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      ++......       .......++..|+|||.+.... ++.++||||+||++|||++|+.||.........+........
T Consensus       148 a~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  220 (292)
T d1unla_         148 ARAFGIPV-------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  220 (292)
T ss_dssp             CEECCSCC-------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHC
T ss_pred             hhcccCCC-------ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcC
Confidence            98764332       1222345788899999887654 689999999999999999999997543221111111111111


Q ss_pred             chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 ~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      +. ........... .+.........  ..............+.+|+.+||+.||++|||++||++
T Consensus       221 ~~-~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         221 TP-TEEQWPSMTKL-PDYKPYPMYPA--TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CC-CTTTCTTGGGS-TTCCCCCCCCT--TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CC-Chhhhhhhhhc-ccccccccccc--cchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10 00000000000 00000000000  00000011223557889999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3e-45  Score=350.72  Aligned_cols=277  Identities=21%  Similarity=0.219  Sum_probs=197.5

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-CCCceeEeeeeeeeccCCCce
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRNLVKIITSCVSVDFQGNDF  237 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  237 (484)
                      ++|++.++||+|+||+||+|+  +..+++.||||+++..   ..+++.+|+++|++++ ||||+++++++..   .....
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~--~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~  106 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAI--NITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKD---PVSRT  106 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEE--ETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCS
T ss_pred             cCeEEEEEEecCcCeEEEEEE--ECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCc
Confidence            579999999999999999999  4446789999998743   3467899999999995 9999999998642   34457


Q ss_pred             eeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC-ceEEcccCc
Q 011508          238 EALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVSDFGL  316 (484)
Q Consensus       238 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~  316 (484)
                      .++||||+.+++|..+.       +.+++..+..++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+
T Consensus       107 ~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~  176 (328)
T d3bqca1         107 PALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGL  176 (328)
T ss_dssp             EEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred             eeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeeccccc
Confidence            89999999999987653       24899999999999999999999   89999999999999998655 699999999


Q ss_pred             ccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          317 AKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       317 a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      |+......        ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..................
T Consensus       177 a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g  248 (328)
T d3bqca1         177 AEFYHPGQ--------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG  248 (328)
T ss_dssp             CEECCTTC--------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred             ceeccCCC--------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHC
Confidence            98764322        12335689999999987764 5799999999999999999999999754322111111111000


Q ss_pred             chhhh---hhcCcccccccccccc-hhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          396 PERLA---EIVDPVLLVEREEGET-SEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       396 ~~~~~---~~~d~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      .+...   ...+............ .................+..++.+|+.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000   0000000000000000 000000000111112334567899999999999999999999975

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-45  Score=347.79  Aligned_cols=255  Identities=24%  Similarity=0.291  Sum_probs=198.5

Q ss_pred             CCCCccCccccccceeEEEEEEcC-CCCeeEEEEEEeeccC----ccchHHHHHHHHHHHcCCC-CCceeEeeeeeeecc
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDH-DDHETLVAVKVLNLQH----RGASKSFIAECQALRSIRH-RNLVKIITSCVSVDF  232 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  232 (484)
                      ++|++.+.||+|+||+||+|+... ..+++.||||+++...    ....+.+.+|++++++++| |||+++++++     
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~-----   98 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----   98 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence            569999999999999999998633 3467899999986432    2234678899999999976 8999999884     


Q ss_pred             CCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEc
Q 011508          233 QGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVS  312 (484)
Q Consensus       233 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~  312 (484)
                      .+....++||||+.+|+|.+++....    .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~  171 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLT  171 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEES
T ss_pred             ccCCceeeeeecccccHHHHHHHhcc----cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEe
Confidence            44558999999999999999998554    3678899999999999999999   8999999999999999999999999


Q ss_pred             ccCcccccccccccCCCCccccccccccccccCccccCCC--CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHH
Q 011508          313 DFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS--EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNF  390 (484)
Q Consensus       313 Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~  390 (484)
                      |||+++.+....      ........|++.|+|||.+.+.  .++.++||||+||+||||+||+.||........ ....
T Consensus       172 DFG~a~~~~~~~------~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i  244 (322)
T d1vzoa_         172 DFGLSKEFVADE------TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEI  244 (322)
T ss_dssp             CSSEEEECCGGG------GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHH
T ss_pred             eccchhhhcccc------cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence            999998764332      1122345689999999988654  468899999999999999999999976533321 1111


Q ss_pred             HHhhcchhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCC-----HHHHHH
Q 011508          391 VKEALPERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMN-----MEEVAA  461 (484)
Q Consensus       391 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~evl~  461 (484)
                      .......        ...                     .+..++.++.+++.+||++||++|||     ++|+++
T Consensus       245 ~~~~~~~--------~~~---------------------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         245 SRRILKS--------EPP---------------------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHHC--------CCC---------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HHhcccC--------CCC---------------------CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            1111100        000                     01233667899999999999999994     788875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=348.12  Aligned_cols=282  Identities=19%  Similarity=0.159  Sum_probs=193.0

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeecc-CCC
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDF-QGN  235 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~  235 (484)
                      ++|++.++||+|+||+||+|+  +..+++.||||++.....  .....+.+|+.++++++||||+++++++...+. +..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~--d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAY--DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEE--ETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             CCeEEEEEeecCcCeEEEEEE--ECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            679999999999999999999  444689999999975543  233568899999999999999999998754432 345


Q ss_pred             ceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEcccC
Q 011508          236 DFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDFG  315 (484)
Q Consensus       236 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg  315 (484)
                      ...++||||+.++ +.+.+.      ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+|++|||
T Consensus        95 ~~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          95 QDVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             CEEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             ceeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechh
Confidence            6889999999654 545443      24889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHhhc
Q 011508          316 LAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKEAL  395 (484)
Q Consensus       316 ~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  395 (484)
                      +++.....        .......+|+.|+|||++.+..++.++||||+||++|||++|+.||...... ...........
T Consensus       165 ~~~~~~~~--------~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~-~~~~~i~~~~~  235 (355)
T d2b1pa1         165 LARTAGTS--------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLG  235 (355)
T ss_dssp             C-----------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHC
T ss_pred             hhhccccc--------cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH-HHHHHHHHhcc
Confidence            98765332        1223456899999999999999999999999999999999999999753211 11111111000


Q ss_pred             c----------hhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHHH
Q 011508          396 P----------ERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAAQ  462 (484)
Q Consensus       396 ~----------~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~~  462 (484)
                      .          .......+......... ......................++.+|+.+||+.||++|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         236 TPCPEFMKKLQPTVRNYVENRPKYAGLT-FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTSCCCCCCC-HHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCHHHHHHhhhhHHHHhhcCccccccc-cccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0          00011111000000000 000000000011111133446788999999999999999999999853

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-45  Score=352.10  Aligned_cols=280  Identities=18%  Similarity=0.212  Sum_probs=196.1

Q ss_pred             hcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCc--cchHHHHHHHHHHHcCCCCCceeEeeeeeeeccCC
Q 011508          157 ATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHR--GASKSFIAECQALRSIRHRNLVKIITSCVSVDFQG  234 (484)
Q Consensus       157 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  234 (484)
                      .+++|++.+.||+|+||+||+|+  +..+++.||||+++....  ...+.+.+|+++|++++|||++++++++.......
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~--~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~   93 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAF--DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE   93 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEE--ETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTT
T ss_pred             CCCCeEEEEEEecCCCeEEEEEE--ECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccc
Confidence            36789999999999999999998  445688999999975433  23457889999999999999999999875443323


Q ss_pred             CceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCCceEEccc
Q 011508          235 NDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGELTAHVSDF  314 (484)
Q Consensus       235 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df  314 (484)
                      +...+++++|+.+|+|.+++..     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+|++||
T Consensus        94 ~~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~df  165 (348)
T d2gfsa1          94 EFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDF  165 (348)
T ss_dssp             TCCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred             cCceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCcccccccccccccccc
Confidence            3445667777889999999863     35999999999999999999999   899999999999999999999999999


Q ss_pred             CcccccccccccCCCCccccccccccccccCccccCCC-CCCcccceehhhHHHHHHHhCCCCCCCCccCCccHhHHHHh
Q 011508          315 GLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGS-EVSTSGDVYSFGILLLEMFTGKGPTNEMFTGNLTLHNFVKE  393 (484)
Q Consensus       315 g~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dvws~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  393 (484)
                      |.+......          .....|+..|+|||...+. .++.++||||+||++|+|++|+.||.+..... ........
T Consensus       166 g~a~~~~~~----------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~  234 (348)
T d2gfsa1         166 GLARHTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRL  234 (348)
T ss_dssp             ----CCTGG----------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred             chhcccCcc----------cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence            998765322          2235689999999986664 56899999999999999999999997532111 01111111


Q ss_pred             hc--chhhhhhcCcccccccccccchhhhhhhccccccchhHHHHHHHhHhhccCCCCcCCCCCHHHHHH
Q 011508          394 AL--PERLAEIVDPVLLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICSSELPRERMNMEEVAA  461 (484)
Q Consensus       394 ~~--~~~~~~~~d~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~evl~  461 (484)
                      ..  +.................... ..   ...........+..++.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         235 VGTPGAELLKKISSESARNYIQSLT-QM---PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HCCCCHHHHTTCCCHHHHHHHTTSC-CC---CCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCChHHhhhccchhhhhhhhhcc-cC---CCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            00  000000000000000000000 00   000000001123566889999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.9e-39  Score=313.63  Aligned_cols=283  Identities=19%  Similarity=0.212  Sum_probs=188.9

Q ss_pred             CCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-----------CCCceeEeeee
Q 011508          159 DGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-----------HRNLVKIITSC  227 (484)
Q Consensus       159 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~  227 (484)
                      ++|++.+.||+|+||+||+|+  +..+++.||||+++... ...+.+.+|+++++.++           |+||+++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~--~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAK--DMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEE--ETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEE--ECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            459999999999999999999  44467899999997543 23467788999988875           57899998886


Q ss_pred             eeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCeeecCCC
Q 011508          228 VSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVLLDGEL  307 (484)
Q Consensus       228 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIll~~~~  307 (484)
                      ...   .....+++++++..+......... .....+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++
T Consensus        90 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~  163 (362)
T d1q8ya_          90 NHK---GPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVD  163 (362)
T ss_dssp             EEE---ETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEE
T ss_pred             eec---cccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccC
Confidence            532   234556666666554333322222 234568899999999999999999994  48999999999999997665


Q ss_pred             ------ceEEcccCcccccccccccCCCCccccccccccccccCccccCCCCCCcccceehhhHHHHHHHhCCCCCCCCc
Q 011508          308 ------TAHVSDFGLAKFLPEAANNLSSNQSSSVGVKGTVGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKGPTNEMF  381 (484)
Q Consensus       308 ------~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws~Gvvl~elltg~~p~~~~~  381 (484)
                            .++++|||.+......          .....||+.|+|||++....++.++||||+||++++|++|+.||....
T Consensus       164 ~~~~~~~~kl~dfg~s~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         164 SPENLIQIKIADLGNACWYDEH----------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC----------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             cccccceeeEeecccccccccc----------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence                  4999999998765321          123469999999999999999999999999999999999999997532


Q ss_pred             cCC-c----cHhHHHHh--hcchhh-------hhhcCcc-cccccccccchhhhhhhccccccchhHHHHHHHhHhhccC
Q 011508          382 TGN-L----TLHNFVKE--ALPERL-------AEIVDPV-LLVEREEGETSEANAHKQRTRSFGGKECLVSVLGIGVICS  446 (484)
Q Consensus       382 ~~~-~----~~~~~~~~--~~~~~~-------~~~~d~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl  446 (484)
                      ... .    .+...+..  ..+...       ....+.. .............. ...............++.+|+.+||
T Consensus       234 ~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~dll~~mL  312 (362)
T d1q8ya_         234 GHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE-DVLTEKYKFSKDEAKEISDFLSPML  312 (362)
T ss_dssp             -----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH-HHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred             cccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchh-hhcccccccCcccCHHHHHHHHHHC
Confidence            211 0    01111110  001110       0000000 00000000000000 0000011123455788999999999


Q ss_pred             CCCcCCCCCHHHHHH
Q 011508          447 SELPRERMNMEEVAA  461 (484)
Q Consensus       447 ~~dP~~RPt~~evl~  461 (484)
                      +.||.+|||++|+++
T Consensus       313 ~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         313 QLDPRKRADAGGLVN  327 (362)
T ss_dssp             CSSTTTCBCHHHHHT
T ss_pred             CCChhHCcCHHHHhc
Confidence            999999999999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=2e-24  Score=188.51  Aligned_cols=133  Identities=21%  Similarity=0.202  Sum_probs=103.2

Q ss_pred             CCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCcc------------------chHHHHHHHHHHHcCCCCCcee
Q 011508          161 FSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRG------------------ASKSFIAECQALRSIRHRNLVK  222 (484)
Q Consensus       161 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~  222 (484)
                      +.+.++||+|+||+||+|+..   +++.||||+++.....                  .......|...+.++.|.+++.
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~---~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~   78 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE---KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK   78 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET---TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCC
T ss_pred             chhCCEeeeCcceEEEEEECC---CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcce
Confidence            356789999999999999854   4678999987532110                  0123456888999999999988


Q ss_pred             EeeeeeeeccCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCCee
Q 011508          223 IITSCVSVDFQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYCETPIVHCDLKPSNVL  302 (484)
Q Consensus       223 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~NIl  302 (484)
                      .+++.         ..+++|||+++..+.+           ++......++.|++.+++|||   +++|+||||||+|||
T Consensus        79 ~~~~~---------~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NIL  135 (191)
T d1zara2          79 VYAWE---------GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVL  135 (191)
T ss_dssp             EEEEE---------TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEE
T ss_pred             EEEec---------CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhhee
Confidence            87652         2379999998765432           333445678999999999999   899999999999999


Q ss_pred             ecCCCceEEcccCccccc
Q 011508          303 LDGELTAHVSDFGLAKFL  320 (484)
Q Consensus       303 l~~~~~~kl~Dfg~a~~~  320 (484)
                      +++++ ++|+|||.|...
T Consensus       136 v~~~~-~~liDFG~a~~~  152 (191)
T d1zara2         136 VSEEG-IWIIDFPQSVEV  152 (191)
T ss_dssp             EETTE-EEECCCTTCEET
T ss_pred             eeCCC-EEEEECCCcccC
Confidence            99764 899999998765

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.40  E-value=1.1e-13  Score=129.49  Aligned_cols=82  Identities=28%  Similarity=0.498  Sum_probs=76.1

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      +++|+++|.+| +++.+++|+.|||++|+|+|.+|.++++|++|+.|+|++|+|+|.+|..+.+.+++.+++++|+.+||
T Consensus       228 ~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g  306 (313)
T d1ogqa_         228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             CCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred             ccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccC
Confidence            46888987665 69999999999999999999999999999999999999999999999888899999999999999999


Q ss_pred             CCc
Q 011508           81 GIS   83 (484)
Q Consensus        81 ~~~   83 (484)
                      .+.
T Consensus       307 ~pl  309 (313)
T d1ogqa_         307 SPL  309 (313)
T ss_dssp             TTS
T ss_pred             CCC
Confidence            764

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.11  E-value=7.3e-11  Score=93.27  Aligned_cols=74  Identities=24%  Similarity=0.224  Sum_probs=65.2

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   79 (484)
                      |++|+|+ .+|. ++++++|++|||++|+|+ .+|..++.+++|+.|++++|+|++. |....+++++.+++++| .+.
T Consensus         5 Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N-~i~   78 (124)
T d1dcea3           5 LAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNN-RLQ   78 (124)
T ss_dssp             CTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSS-CCC
T ss_pred             cCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCC-ccC
Confidence            6899998 7775 899999999999999999 7998899999999999999999864 56778899999999999 444

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.02  E-value=1.1e-10  Score=108.43  Aligned_cols=77  Identities=25%  Similarity=0.351  Sum_probs=69.2

Q ss_pred             CCCCcccc--cCchhhhCCCCCCEEeCcC-CccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCc
Q 011508            1 MNGNFFQG--NIPSSLSSLRGIENLDLSQ-NNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNV   76 (484)
Q Consensus         1 l~~n~l~g--~~p~~~~~l~~l~~l~ls~-N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~   76 (484)
                      |++|+++|  .||+++++|++|++|||++ |+|+|.||.+|++|++|++|+|++|+|.+.+|.. ..+.++..+++++|.
T Consensus        57 L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~  136 (313)
T d1ogqa_          57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNA  136 (313)
T ss_dssp             EECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSE
T ss_pred             CCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccccccc
Confidence            46788988  5899999999999999997 9999999999999999999999999999988864 667788999999984


Q ss_pred             c
Q 011508           77 N   77 (484)
Q Consensus        77 ~   77 (484)
                      .
T Consensus       137 ~  137 (313)
T d1ogqa_         137 L  137 (313)
T ss_dssp             E
T ss_pred             c
Confidence            3

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.98  E-value=3.7e-10  Score=89.11  Aligned_cols=76  Identities=29%  Similarity=0.425  Sum_probs=65.9

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccc--cccccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVP--IKGVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p--~~~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+|+ .+|+.++.+++|+.|+|++|+|+ .+| .+.++++|+.|++++|+++....  ....+++++.+++++|+ +
T Consensus        27 ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~-i  102 (124)
T d1dcea3          27 LSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS-L  102 (124)
T ss_dssp             CCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSG-G
T ss_pred             CCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCEEECCCCc-C
Confidence            6899998 89999999999999999999999 676 48999999999999999986543  34677899999999994 4


Q ss_pred             cC
Q 011508           79 CG   80 (484)
Q Consensus        79 ~g   80 (484)
                      |.
T Consensus       103 ~~  104 (124)
T d1dcea3         103 CQ  104 (124)
T ss_dssp             GG
T ss_pred             Cc
Confidence            43

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.97  E-value=3.9e-10  Score=96.66  Aligned_cols=79  Identities=20%  Similarity=0.227  Sum_probs=61.7

Q ss_pred             CCCCcccccCc-hhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCccc
Q 011508            1 MNGNFFQGNIP-SSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNL   78 (484)
Q Consensus         1 l~~n~l~g~~p-~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l   78 (484)
                      |++|+|++.++ ..|+++++|+.|+|++|++++..+..+..+++|+.|+|++|+|++.+|.. ..+++|+.+++++| .+
T Consensus        36 Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N-~l  114 (192)
T d1w8aa_          36 LNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDN-QI  114 (192)
T ss_dssp             CCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSS-CC
T ss_pred             eCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCc-cc
Confidence            67888876554 45788888888888888888777778888888888888888888777754 56778888888888 45


Q ss_pred             cC
Q 011508           79 CG   80 (484)
Q Consensus        79 ~g   80 (484)
                      .+
T Consensus       115 ~~  116 (192)
T d1w8aa_         115 SC  116 (192)
T ss_dssp             CE
T ss_pred             cc
Confidence            44

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.89  E-value=1.2e-09  Score=89.90  Aligned_cols=79  Identities=25%  Similarity=0.235  Sum_probs=59.0

Q ss_pred             CCC-cccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            2 NGN-FFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         2 ~~n-~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      ++| .|+..-+..|.++++|+.|+|++|+|+..-|.+|..+++|+.|+|++|+|+..++......++..+++++|+.-|.
T Consensus        39 ~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~  118 (156)
T d2ifga3          39 ENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCS  118 (156)
T ss_dssp             CSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred             CCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhccccccccccCCCcccCC
Confidence            444 4773334568888889999999999885556778888889999999999887666654455688888888876553

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=98.82  E-value=2.5e-09  Score=91.50  Aligned_cols=75  Identities=21%  Similarity=0.283  Sum_probs=35.8

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCc
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNV   76 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~   76 (484)
                      ++|++++..|..+..+++|+.|+|++|+|++..|.+|.++++|+.|+|++|+|++.+|.. ..+.+++.+++++|+
T Consensus        62 ~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~  137 (192)
T d1w8aa_          62 KRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNP  137 (192)
T ss_dssp             CSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCC
T ss_pred             cccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccc
Confidence            445555444444555555555555555555333334444555555555555555444432 334444455555553

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.76  E-value=5.1e-09  Score=94.53  Aligned_cols=80  Identities=25%  Similarity=0.177  Sum_probs=67.9

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      +++|.+++..|..+..+++|+.|++++|+|++..|..+..+++|+.|+|++|+|+..++....+.+++.+++++||..|+
T Consensus       131 l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             ccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCC
Confidence            46788985555667889999999999999997666778999999999999999995555567788999999999988775

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.76  E-value=5.7e-09  Score=86.31  Aligned_cols=73  Identities=15%  Similarity=0.155  Sum_probs=62.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNV   76 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~   76 (484)
                      |++|+|+ .||..+..+++|+.||||+|+|+ .++ .+..+++|+.|+|++|+++...+.. ..+++++.+++++|.
T Consensus        25 L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~   98 (162)
T d1a9na_          25 LRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS   98 (162)
T ss_dssp             CTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCC
T ss_pred             CCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccc
Confidence            6889998 78887788999999999999999 775 4889999999999999999877654 468899999999993

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.65  E-value=9.9e-09  Score=93.53  Aligned_cols=75  Identities=19%  Similarity=0.162  Sum_probs=46.8

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      +++|+|++..|..|..+++|+.|+|++|+|++..|.++.++++|+.+++++|++++..|.. ..+++++.+++++|
T Consensus       136 l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N  211 (284)
T d1ozna_         136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN  211 (284)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             hccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccc
Confidence            3566666433455666666777777777666555555666666666666666666665543 44556666666666

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.52  E-value=2.6e-07  Score=82.72  Aligned_cols=149  Identities=15%  Similarity=0.093  Sum_probs=96.2

Q ss_pred             hHHHhcCCCCccCccccccceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCC-CCCceeEeeeeeeec
Q 011508          153 NLFKATDGFSLENLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIR-HRNLVKIITSCVSVD  231 (484)
Q Consensus       153 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  231 (484)
                      ++...-+.|+..+..+.++.+.||+...    ++..+++|+...........+.+|...+..+. +--+.+++.++    
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~----~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~----   79 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG----ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE----   79 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC----SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE----
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe----CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE----
Confidence            3444456677666655555678998863    24457788876554444556778888887773 32245555553    


Q ss_pred             cCCCceeeEEeecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------
Q 011508          232 FQGNDFEALVYELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHHYC------------------------  287 (484)
Q Consensus       232 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------  287 (484)
                       .+++..++||++++|.++.+.....      .   ....++.++++.++.||+..                        
T Consensus        80 -~~~~~~~lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (263)
T d1j7la_          80 -RHDGWSNLLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND  149 (263)
T ss_dssp             -EETTEEEEEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred             -ecCCceEEEEEeccccccccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHH
Confidence             2335678999999998876543210      1   12234555666666666321                        


Q ss_pred             --------------------------------CCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          288 --------------------------------ETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       288 --------------------------------~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                                                      ...++|+|+.|.||+++++....|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                            12378999999999999877777999998764

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.52  E-value=4.1e-08  Score=88.35  Aligned_cols=70  Identities=21%  Similarity=0.280  Sum_probs=53.9

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      ++|+|+ .||..+.  ++|+.|||++|+|++..|.+|.++++|+.|+|++|+|+. +|..+.+++++.+++++|
T Consensus        18 ~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~~~~~l~~L~~L~Ls~N   87 (266)
T d1p9ag_          18 DKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHN   87 (266)
T ss_dssp             TTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECCSCCTTCCEEECCSS
T ss_pred             cCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cccccccccccccccccc
Confidence            567788 7887664  578888888888885444668888888888888888874 444567788888888888

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.50  E-value=3.5e-08  Score=81.39  Aligned_cols=73  Identities=18%  Similarity=0.186  Sum_probs=61.4

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCcc-ccCCCCCCeeeccccceeccc--ccccccccCcccccCCCc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKY-LENFPFLQNLNLSFNHFEGEV--PIKGVFSNSSAISLDGNV   76 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~g~~--p~~~~~~~~~~~~~~~n~   76 (484)
                      |++|+|+ .++ .+..+++|+.|+|++|+++ .+|.. +..+++|+.|+|++|+++...  .....+++++.+++++|+
T Consensus        48 Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~  123 (162)
T d1a9na_          48 FSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP  123 (162)
T ss_dssp             CCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSG
T ss_pred             CCCCCCC-ccC-CcccCcchhhhhccccccc-CCCccccccccccccceeccccccccccccccccccccchhhcCCCc
Confidence            6899999 776 4899999999999999999 56654 567999999999999998643  234667899999999994

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.48  E-value=8.9e-08  Score=87.96  Aligned_cols=74  Identities=26%  Similarity=0.228  Sum_probs=34.2

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      ++|.+++.+|..+..++.++.|++++|.+++..|..+.++++|+.|+|++|+|+..++....+++++.+++++|
T Consensus       179 ~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N  252 (305)
T d1xkua_         179 DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN  252 (305)
T ss_dssp             TTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSS
T ss_pred             CCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCCEEECCCC
Confidence            34444444444444444444455544444443344444444444455544444433333333444444444444

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.40  E-value=1.1e-07  Score=90.29  Aligned_cols=59  Identities=27%  Similarity=0.304  Sum_probs=29.6

Q ss_pred             hhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508           14 LSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus        14 ~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      +..+++++.|+|++|++++ ++ .+..+++|+.|+|++|+|++ +|....+++|+.+++++|
T Consensus       303 ~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~-l~~l~~l~~L~~L~l~~N  361 (384)
T d2omza2         303 ISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHN  361 (384)
T ss_dssp             GGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECCSS
T ss_pred             cchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCCC-ChhHcCCCCCCEEECCCC
Confidence            4555555555555555553 22 14455555555555555543 233344555555555555

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.36  E-value=2.6e-07  Score=75.47  Aligned_cols=75  Identities=16%  Similarity=0.125  Sum_probs=63.9

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCc-cccccC-ccccCCCCCCeeeccccceecccccc-cccccCcccccCCCccc
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNN-LSGRIP-KYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNL   78 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~-l~g~~p-~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l   78 (484)
                      ++|++. .+|..+..+++|+.|+|++|+ |+ .|| ..|.++++|+.|+|++|+|+...|.. ..+++++.+++++| .+
T Consensus        16 ~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N-~l   92 (156)
T d2ifga3          16 TRDGAL-DSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN-AL   92 (156)
T ss_dssp             CSSCCC-TTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS-CC
T ss_pred             cCCCCc-cCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccceeccCC-CC
Confidence            567777 789999999999999998765 88 565 56999999999999999999887764 67889999999999 44


Q ss_pred             c
Q 011508           79 C   79 (484)
Q Consensus        79 ~   79 (484)
                      .
T Consensus        93 ~   93 (156)
T d2ifga3          93 E   93 (156)
T ss_dssp             S
T ss_pred             c
Confidence            4

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.36  E-value=2.6e-07  Score=83.82  Aligned_cols=74  Identities=18%  Similarity=0.106  Sum_probs=38.4

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-cccccCcccccCCC
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      ++|.+.+..+..++.+.+|+.+++++|+|++..|..+..+++|+.|+|++|+|++.+|.. ..++++..+++++|
T Consensus       113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N  187 (284)
T d1ozna_         113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN  187 (284)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhc
Confidence            445554333444555555555555555555333344555555555555555555544432 33455555555555

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.28  E-value=4.2e-07  Score=83.24  Aligned_cols=78  Identities=21%  Similarity=0.184  Sum_probs=50.6

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccc-------cccccCcccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIK-------GVFSNSSAISLD   73 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~-------~~~~~~~~~~~~   73 (484)
                      +++|++++..|..+.++++|+.|+|++|+|+ .||.++.++++|+.|+|++|+|+......       ....+++.++++
T Consensus       202 ~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~  280 (305)
T d1xkua_         202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF  280 (305)
T ss_dssp             CCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECC
T ss_pred             cccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECC
Confidence            3567777666666777777777777777777 67777777777777777777776432211       233456667777


Q ss_pred             CCcccc
Q 011508           74 GNVNLC   79 (484)
Q Consensus        74 ~n~~l~   79 (484)
                      +|+.-+
T Consensus       281 ~N~~~~  286 (305)
T d1xkua_         281 SNPVQY  286 (305)
T ss_dssp             SSSSCG
T ss_pred             CCcCcc
Confidence            775433

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.17  E-value=6.3e-07  Score=78.24  Aligned_cols=73  Identities=19%  Similarity=0.241  Sum_probs=54.3

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCccccC
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLCG   80 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~g   80 (484)
                      +++++...  ..+.++++|+.|++++|.+++ ++ .+.++++|+.|+|++|++++. |....+++++.+++++| .+.+
T Consensus       137 ~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N-~lt~  209 (227)
T d1h6ua2         137 DLNQITNI--SPLAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNN-QISD  209 (227)
T ss_dssp             CSSCCCCC--GGGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTS-CCCB
T ss_pred             hhhhhchh--hhhcccccccccccccccccc-ch-hhcccccceecccCCCccCCC-hhhcCCCCCCEEECcCC-cCCC
Confidence            45555532  337788889999999998884 33 378889999999999998864 44567888999999888 4554

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.06  E-value=2.4e-06  Score=73.46  Aligned_cols=69  Identities=23%  Similarity=0.257  Sum_probs=40.3

Q ss_pred             CCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            2 NGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         2 ~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      ++|+++ .++. +..+++|+.|+|++|+|++ +| .+++|++|+.|++++|++++ +|....+++++.+++++|
T Consensus        54 ~~~~i~-~l~~-l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~  122 (210)
T d1h6ta2          54 NNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHN  122 (210)
T ss_dssp             TTSCCC-CCTT-GGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTS
T ss_pred             cCCCCC-Cchh-HhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccccc-cccccccccccccccccc
Confidence            455555 3332 5666666666666666663 44 24566666666666666664 333445566666666665

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.03  E-value=6.9e-08  Score=82.52  Aligned_cols=68  Identities=24%  Similarity=0.328  Sum_probs=55.6

Q ss_pred             cCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCcccc
Q 011508            9 NIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         9 ~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   79 (484)
                      .+|.+++.|++|+.|+|++|+|+ .++ .+..|++|+.|+|++|+++...+....+.+++.+++++| .+.
T Consensus        39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N-~i~  106 (198)
T d1m9la_          39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYN-QIA  106 (198)
T ss_dssp             CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEE-ECC
T ss_pred             hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccccccccccccccccccccccc-ccc
Confidence            45578999999999999999999 786 588999999999999999854433344567899999998 454

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.95  E-value=3.8e-06  Score=72.14  Aligned_cols=73  Identities=23%  Similarity=0.316  Sum_probs=54.8

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCcccc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   79 (484)
                      +++|.+. .++ .+.++++|+.+++++|.+++  +..+..+++|+.+++++|++++..| ...+++++.+++++| .+.
T Consensus       119 l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~-l~~l~~L~~L~Ls~N-~i~  191 (210)
T d1h6ta2         119 LEHNGIS-DIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKN-HIS  191 (210)
T ss_dssp             CTTSCCC-CCG-GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSS-CCC
T ss_pred             ccccccc-ccc-cccccccccccccccccccc--ccccccccccccccccccccccccc-ccCCCCCCEEECCCC-CCC
Confidence            3566665 444 58888889999999998884  3357788889999999998886544 567888888888888 443

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.95  E-value=5.4e-06  Score=70.47  Aligned_cols=57  Identities=19%  Similarity=0.263  Sum_probs=29.4

Q ss_pred             CCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508           16 SLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus        16 ~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      .+.+|+.|++++|.++ .++ .+..+++|+.|+|++|+|++..| ...+++++.+++++|
T Consensus        38 ~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n   94 (199)
T d2omxa2          38 DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNN   94 (199)
T ss_dssp             HHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred             HhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc-ccCCccccccccccc
Confidence            3455555555555555 343 24555555555555555554433 344555555555555

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=97.94  E-value=4.7e-07  Score=77.14  Aligned_cols=71  Identities=21%  Similarity=0.268  Sum_probs=54.8

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      |++|+|+ .+| .+..|++|+.|+|++|+|+ .+|.....+++|+.|++++|+++.. +....+++++.+++++|
T Consensus        55 Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~L~~N  125 (198)
T d1m9la_          55 LSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNN  125 (198)
T ss_dssp             CSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSSEEEESEE
T ss_pred             CcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc-ccccccccccccccccc
Confidence            5778887 676 4888888888888888888 7776666667888888888888753 44566778888888887

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.93  E-value=4.9e-06  Score=78.37  Aligned_cols=70  Identities=20%  Similarity=0.316  Sum_probs=52.7

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      +++|+|+ .++ .+..|++|++|||++|+|+ .+|+ +++|++|+.|+|++|++++..| ...+++++.+++.+|
T Consensus        51 l~~~~I~-~l~-gl~~L~nL~~L~Ls~N~l~-~l~~-l~~L~~L~~L~L~~n~i~~i~~-l~~l~~L~~L~~~~~  120 (384)
T d2omza2          51 ADRLGIK-SID-GVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADITP-LANLTNLTGLTLFNN  120 (384)
T ss_dssp             CCSSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred             CCCCCCC-Ccc-ccccCCCCCEEeCcCCcCC-CCcc-ccCCcccccccccccccccccc-ccccccccccccccc
Confidence            4567776 453 5778888888888888888 4553 8888888888888888886544 556778888887776

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.81  E-value=1.3e-05  Score=67.91  Aligned_cols=71  Identities=18%  Similarity=0.258  Sum_probs=57.2

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCc
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNV   76 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~   76 (484)
                      +++|+++ .++ .+..+++|++|+|++|++++ +|+ ++++++|+.|++++|.+.... ....+..++.+++++|.
T Consensus        47 l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~~~  117 (199)
T d2omxa2          47 ADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQ  117 (199)
T ss_dssp             CTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCG-GGTTCTTCSEEECCSSC
T ss_pred             CCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCccccccccccccccccc-ccccccccccccccccc
Confidence            4678887 665 48899999999999999995 544 889999999999999987544 45677888888888874

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.80  E-value=3.1e-05  Score=68.23  Aligned_cols=131  Identities=13%  Similarity=0.060  Sum_probs=77.6

Q ss_pred             cccccc-ceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCC--ceeEeeeeeeeccCCCceeeEEe
Q 011508          166 LIGAGS-FGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRN--LVKIITSCVSVDFQGNDFEALVY  242 (484)
Q Consensus       166 ~lg~G~-~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~  242 (484)
                      .+..|. .+.||+....   ++..+++|......   ...+..|...++.+....  +.+++.++     .+++..++||
T Consensus        17 ~~~~G~s~~~v~r~~~~---~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~   85 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ---GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLL   85 (255)
T ss_dssp             ECSCTTSSCEEEEEECT---TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEE
T ss_pred             EcCCcccCCeEEEEEeC---CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEE
Confidence            344454 3678998743   35567888765432   234667787777763322  45556553     2334678999


Q ss_pred             ecccCCCHHHHHhhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 011508          243 ELMVNGSLEEWLHLNRDAPRNLNLLQRLSIAVDVASTLEYLHH-------------------------------------  285 (484)
Q Consensus       243 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-------------------------------------  285 (484)
                      ++++|.++.+..         ...   ..++.++.+.|+-||.                                     
T Consensus        86 ~~i~G~~~~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (255)
T d1nd4a_          86 GEVPGQDLLSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  153 (255)
T ss_dssp             ECCSSEETTTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             Eeeecccccccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence            999876543210         110   1112223333333331                                     


Q ss_pred             --------------c----CCCCeeecCCCCCCeeecCCCceEEcccCcccc
Q 011508          286 --------------Y----CETPIVHCDLKPSNVLLDGELTAHVSDFGLAKF  319 (484)
Q Consensus       286 --------------~----~~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~~  319 (484)
                                    .    ....++|+|+.|.||+++++..+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                          0    012379999999999999877778999997753

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.79  E-value=1.2e-06  Score=72.01  Aligned_cols=67  Identities=27%  Similarity=0.295  Sum_probs=51.5

Q ss_pred             cCchhhhCCCCCCEEeCcCCcccccc---CccccCCCCCCeeeccccceecccccc-cccccCcccccCCCc
Q 011508            9 NIPSSLSSLRGIENLDLSQNNLSGRI---PKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNV   76 (484)
Q Consensus         9 ~~p~~~~~l~~l~~l~ls~N~l~g~~---p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~   76 (484)
                      .++.....+++|+.||||+|+|+ .+   +..+..+++|+.|+||+|.++...+.. ....++..+++++||
T Consensus        56 ~l~~~~~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Np  126 (162)
T d1koha1          56 TLRIIEENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS  126 (162)
T ss_dssp             HHHHHHHHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTST
T ss_pred             hhHHHHHhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCC
Confidence            34444567999999999999999 44   345678999999999999998654421 334568889999995

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.71  E-value=2.4e-05  Score=67.73  Aligned_cols=68  Identities=22%  Similarity=0.336  Sum_probs=48.8

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLD   73 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~   73 (484)
                      +++|+++ .++. ++++++|+.|||++|+++ .+|. +.++++|+.|+|++|++++..| ...+++|+.++++
T Consensus       158 l~~n~~~-~~~~-l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~ls  225 (227)
T d1h6ua2         158 IGNAQVS-DLTP-LANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLT  225 (227)
T ss_dssp             CCSSCCC-CCGG-GTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEE
T ss_pred             ccccccc-cchh-hcccccceecccCCCccC-CChh-hcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEee
Confidence            3567666 3333 788888888888888888 4553 7788888888888888886544 4567777777664

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.60  E-value=4.2e-05  Score=70.62  Aligned_cols=64  Identities=19%  Similarity=0.189  Sum_probs=47.8

Q ss_pred             CCCCcccccCchhhhCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCC
Q 011508            1 MNGNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n   75 (484)
                      |++|+|+ .+|..   +++|+.|+|++|+|+ .+|..+   .+|+.|++++|+++.. +..  ...++.+++++|
T Consensus        45 Ls~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~~l--p~~L~~L~L~~n  108 (353)
T d1jl5a_          45 LNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-SDL--PPLLEYLGVSNN  108 (353)
T ss_dssp             CTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-CSC--CTTCCEEECCSS
T ss_pred             eCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-hhh--cccccccccccc
Confidence            6789998 78864   578999999999999 898764   4678888888877633 321  235777788777

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.56  E-value=0.00017  Score=67.73  Aligned_cols=76  Identities=17%  Similarity=0.139  Sum_probs=45.9

Q ss_pred             CccccccceeEEEEEEcCCCCeeEEEEEEeeccC-------ccchHHHHHHHHHHHcC-CC--CCceeEeeeeeeeccCC
Q 011508          165 NLIGAGSFGSVYKGIFDHDDHETLVAVKVLNLQH-------RGASKSFIAECQALRSI-RH--RNLVKIITSCVSVDFQG  234 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l-~h--~niv~~~~~~~~~~~~~  234 (484)
                      +.||.|....||++..  ..+++.++||.-....       .....+...|.+.|+.+ .+  ..+.+++.+.       
T Consensus        32 ~eig~G~~N~vfrV~~--~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------  102 (392)
T d2pula1          32 QEIGDGNLNYVFHIYD--QEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------  102 (392)
T ss_dssp             EECCSSSSEEEEEEEC------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------
T ss_pred             EEeCCCceEeEEEEEe--CCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------
Confidence            4689999999999973  3345678888653211       11234456688888766 22  3355555442       


Q ss_pred             CceeeEEeecccCCC
Q 011508          235 NDFEALVYELMVNGS  249 (484)
Q Consensus       235 ~~~~~lv~e~~~~gs  249 (484)
                      .+..++|||++++..
T Consensus       103 ~~~~~lvmE~L~~~~  117 (392)
T d2pula1         103 TEMAVTVMEDLSHLK  117 (392)
T ss_dssp             TTTTEEEECCCTTSE
T ss_pred             CCCCEEEEeccCCcc
Confidence            224579999997653

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.52  E-value=1.8e-05  Score=64.61  Aligned_cols=58  Identities=19%  Similarity=0.101  Sum_probs=46.5

Q ss_pred             CCCCccccc--CchhhhCCCCCCEEeCcCCccccccCc-cccCCCCCCeeeccccceecccc
Q 011508            1 MNGNFFQGN--IPSSLSSLRGIENLDLSQNNLSGRIPK-YLENFPFLQNLNLSFNHFEGEVP   59 (484)
Q Consensus         1 l~~n~l~g~--~p~~~~~l~~l~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l~g~~p   59 (484)
                      |++|+|+..  ++..+..+++|+.||||+|.++ .++. ......+|+.|+|++|.++....
T Consensus        72 Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~  132 (162)
T d1koha1          72 LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFR  132 (162)
T ss_dssp             CCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSS
T ss_pred             CCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCcc
Confidence            689999842  3456889999999999999999 6664 33345679999999999987654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.36  E-value=5.2e-05  Score=66.18  Aligned_cols=69  Identities=20%  Similarity=0.263  Sum_probs=52.9

Q ss_pred             CCcccccCchhhhCCCCCCEEeCcCCccccccCc-cccCCCCCCeeeccccceecccccc--cccccCcccccCCC
Q 011508            3 GNFFQGNIPSSLSSLRGIENLDLSQNNLSGRIPK-YLENFPFLQNLNLSFNHFEGEVPIK--GVFSNSSAISLDGN   75 (484)
Q Consensus         3 ~n~l~g~~p~~~~~l~~l~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~N~l~g~~p~~--~~~~~~~~~~~~~n   75 (484)
                      +++++ .+|.++-  ++++.|||++|+|+ .+|. .|.++++|+.|+|++|.+...+|..  ..+.++..+.+..+
T Consensus        17 ~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~   88 (242)
T d1xwdc1          17 ESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   88 (242)
T ss_dssp             SCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred             CCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence            45677 8887663  68999999999999 6665 6889999999999999998766542  44566676666543

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.31  E-value=5.7e-05  Score=65.93  Aligned_cols=74  Identities=18%  Similarity=0.246  Sum_probs=61.4

Q ss_pred             CCCCcccccCch-hhhCCCCCCEEeCcCCccccccCc-cccCCCCCCeeeccc-cceecccccc-cccccCcccccCCC
Q 011508            1 MNGNFFQGNIPS-SLSSLRGIENLDLSQNNLSGRIPK-YLENFPFLQNLNLSF-NHFEGEVPIK-GVFSNSSAISLDGN   75 (484)
Q Consensus         1 l~~n~l~g~~p~-~~~~l~~l~~l~ls~N~l~g~~p~-~~~~l~~L~~l~ls~-N~l~g~~p~~-~~~~~~~~~~~~~n   75 (484)
                      |++|+|+ .+|. .|.++++|++|+|++|.+...+|. .+.++++++.++++. |++....+.. ..+++++.+++.+|
T Consensus        36 Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~  113 (242)
T d1xwdc1          36 FVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT  113 (242)
T ss_dssp             EESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESC
T ss_pred             CcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchh
Confidence            4689998 6665 689999999999999999877764 578899999999874 7787777654 66789999999988

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.13  E-value=0.00018  Score=66.10  Aligned_cols=57  Identities=32%  Similarity=0.427  Sum_probs=47.2

Q ss_pred             hCCCCCCEEeCcCCccccccCccccCCCCCCeeeccccceecccccccccccCcccccCCCcccc
Q 011508           15 SSLRGIENLDLSQNNLSGRIPKYLENFPFLQNLNLSFNHFEGEVPIKGVFSNSSAISLDGNVNLC   79 (484)
Q Consensus        15 ~~l~~l~~l~ls~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~l~   79 (484)
                      ..+++|+.|+|++|+|+ .+|..   +++|+.|+|++|+|+. +|.  .+.+++.+++++|+ +.
T Consensus       281 ~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~~-l~~--~~~~L~~L~L~~N~-L~  337 (353)
T d1jl5a_         281 DLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLAE-VPE--LPQNLKQLHVEYNP-LR  337 (353)
T ss_dssp             CCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCC--CCTTCCEEECCSSC-CS
T ss_pred             ccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCCc-ccc--ccCCCCEEECcCCc-CC
Confidence            44689999999999999 89964   6789999999999984 554  35689999999995 54

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.93  E-value=0.0014  Score=59.66  Aligned_cols=73  Identities=11%  Similarity=0.036  Sum_probs=43.6

Q ss_pred             ceeEEEEEEcCCCCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCc--eeEeeeeeeeccCCCceeeEEeecccCC
Q 011508          172 FGSVYKGIFDHDDHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL--VKIITSCVSVDFQGNDFEALVYELMVNG  248 (484)
Q Consensus       172 ~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~g  248 (484)
                      --.||++...   ++..+++|+.+... ...+++..|...+..|....+  +..+.......+..+...+.++++++|.
T Consensus        35 EN~vy~v~~~---dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          35 ENRVYQFQDE---DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             SSEEEEECCT---TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             cceeEEEEcC---CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            3589998754   56779999986543 244678888888888742222  1111111111122345678899998653

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.66  E-value=0.00021  Score=63.98  Aligned_cols=66  Identities=21%  Similarity=0.182  Sum_probs=45.7

Q ss_pred             hhCCCCCCEEeCcCCccccc-cCccccCCCCCCeeeccccceecccccc-cccccCcccccCCCcccc
Q 011508           14 LSSLRGIENLDLSQNNLSGR-IPKYLENFPFLQNLNLSFNHFEGEVPIK-GVFSNSSAISLDGNVNLC   79 (484)
Q Consensus        14 ~~~l~~l~~l~ls~N~l~g~-~p~~~~~l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~l~   79 (484)
                      .....+|++|||++|.+++. ++..+.++++|+.|+|+++.++...+.. ..+++++.++++++..+.
T Consensus        42 ~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~it  109 (284)
T d2astb2          42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS  109 (284)
T ss_dssp             CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCC
T ss_pred             hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccccccc
Confidence            44566788888888887644 4445677888888888888876544432 556778888887765544

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.66  E-value=0.0024  Score=59.75  Aligned_cols=74  Identities=14%  Similarity=0.138  Sum_probs=47.8

Q ss_pred             CccccccceeEEEEEEcCC-----CCeeEEEEEEeeccCccchHHHHHHHHHHHcCCCCCc-eeEeeeeeeeccCCCcee
Q 011508          165 NLIGAGSFGSVYKGIFDHD-----DHETLVAVKVLNLQHRGASKSFIAECQALRSIRHRNL-VKIITSCVSVDFQGNDFE  238 (484)
Q Consensus       165 ~~lg~G~~g~Vy~~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~  238 (484)
                      +.|+.|-.-.+|++.....     .....|.+++...  ........+|..+++.+.-.++ .++++++     .    -
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~----~  116 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIF-----S----G  116 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----T----T
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----C----C
Confidence            5788899999999986543     1234566776642  2223456688888888843344 4666653     1    2


Q ss_pred             eEEeecccCCC
Q 011508          239 ALVYELMVNGS  249 (484)
Q Consensus       239 ~lv~e~~~~gs  249 (484)
                      ++|+||++|.+
T Consensus       117 g~I~efi~g~~  127 (395)
T d1nw1a_         117 GRLEEYIPSRP  127 (395)
T ss_dssp             EEEECCCCEEE
T ss_pred             ceEEEEecccc
Confidence            68999997643

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.43  E-value=0.0077  Score=54.11  Aligned_cols=31  Identities=29%  Similarity=0.413  Sum_probs=27.9

Q ss_pred             CCCeeecCCCCCCeeecCCCceEEcccCccc
Q 011508          288 ETPIVHCDLKPSNVLLDGELTAHVSDFGLAK  318 (484)
Q Consensus       288 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~a~  318 (484)
                      ..++||+|+.++||+++++...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            5689999999999999998877899999775

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.81  E-value=0.0013  Score=62.41  Aligned_cols=41  Identities=29%  Similarity=0.336  Sum_probs=21.1

Q ss_pred             hhCCCCCCEEeCcCCccc----cccCccccCCCCCCeeeccccce
Q 011508           14 LSSLRGIENLDLSQNNLS----GRIPKYLENFPFLQNLNLSFNHF   54 (484)
Q Consensus        14 ~~~l~~l~~l~ls~N~l~----g~~p~~~~~l~~L~~l~ls~N~l   54 (484)
                      +..+++|+.|+|++|.++    ..|+..+..+++|+.|||++|+|
T Consensus        23 ~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i   67 (460)
T d1z7xw1          23 LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL   67 (460)
T ss_dssp             HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCC
T ss_pred             HHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcC
Confidence            344555555555555554    13334445555555555555555

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=95.69  E-value=0.0016  Score=59.61  Aligned_cols=74  Identities=18%  Similarity=0.185  Sum_probs=51.2

Q ss_pred             CCCccc----ccCchhhhCCCCCCEEeCcCCccccc-----cCccccCCCCCCeeeccccceecc----c-ccccccccC
Q 011508            2 NGNFFQ----GNIPSSLSSLRGIENLDLSQNNLSGR-----IPKYLENFPFLQNLNLSFNHFEGE----V-PIKGVFSNS   67 (484)
Q Consensus         2 ~~n~l~----g~~p~~~~~l~~l~~l~ls~N~l~g~-----~p~~~~~l~~L~~l~ls~N~l~g~----~-p~~~~~~~~   67 (484)
                      ++|+++    ..+...+..++.|+.|+|++|+++..     +...+..+++|+.|+|++|.|+..    + ......+++
T Consensus       166 ~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L  245 (344)
T d2ca6a1         166 GRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL  245 (344)
T ss_dssp             CSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTC
T ss_pred             ccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccc
Confidence            455554    13445567788899999999988632     344567788999999999987542    1 122456778


Q ss_pred             cccccCCC
Q 011508           68 SAISLDGN   75 (484)
Q Consensus        68 ~~~~~~~n   75 (484)
                      +.+++++|
T Consensus       246 ~~L~Ls~n  253 (344)
T d2ca6a1         246 RELGLNDC  253 (344)
T ss_dssp             CEEECTTC
T ss_pred             hhhhhhcC
Confidence            88888888

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.55  E-value=0.0043  Score=54.95  Aligned_cols=36  Identities=28%  Similarity=0.310  Sum_probs=16.7

Q ss_pred             CCCCCCEEeCcCC-ccccccCccccCCCCCCeeeccc
Q 011508           16 SLRGIENLDLSQN-NLSGRIPKYLENFPFLQNLNLSF   51 (484)
Q Consensus        16 ~l~~l~~l~ls~N-~l~g~~p~~~~~l~~L~~l~ls~   51 (484)
                      ++++|+.|+|++| .+++..+..+.++++|+.|+|++
T Consensus       173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~  209 (284)
T d2astb2         173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR  209 (284)
T ss_dssp             HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred             ccccccccccccccCCCchhhhhhcccCcCCEEECCC
Confidence            3444444554442 34444444444444455554444

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.50  E-value=0.0018  Score=61.37  Aligned_cols=39  Identities=23%  Similarity=0.129  Sum_probs=17.7

Q ss_pred             CCCCCEEeCcCCcccc----ccCcccc-CCCCCCeeecccccee
Q 011508           17 LRGIENLDLSQNNLSG----RIPKYLE-NFPFLQNLNLSFNHFE   55 (484)
Q Consensus        17 l~~l~~l~ls~N~l~g----~~p~~~~-~l~~L~~l~ls~N~l~   55 (484)
                      +.+|+.|||++|+++.    .++..+. ..+.|+.|+|++|+|+
T Consensus       339 ~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~  382 (460)
T d1z7xw1         339 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS  382 (460)
T ss_dssp             CSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             ccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCC
Confidence            3445555555555542    1222222 2344555555555554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=94.64  E-value=0.0051  Score=56.07  Aligned_cols=63  Identities=13%  Similarity=0.171  Sum_probs=45.2

Q ss_pred             hhCCCCCCEEeCcCCcccc----ccCccccCCCCCCeeeccccceecc-----c-ccccccccCcccccCCCc
Q 011508           14 LSSLRGIENLDLSQNNLSG----RIPKYLENFPFLQNLNLSFNHFEGE-----V-PIKGVFSNSSAISLDGNV   76 (484)
Q Consensus        14 ~~~l~~l~~l~ls~N~l~g----~~p~~~~~l~~L~~l~ls~N~l~g~-----~-p~~~~~~~~~~~~~~~n~   76 (484)
                      ....+.|+.|++++|+++.    .+...+..+++|+.|+|++|+++..     + .....++++..+++++|.
T Consensus       154 ~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~  226 (344)
T d2ca6a1         154 AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT  226 (344)
T ss_dssp             HHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSC
T ss_pred             cccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccc
Confidence            3567789999999998862    3444566778999999999988642     1 122456778888998884

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=91.30  E-value=0.032  Score=44.63  Aligned_cols=60  Identities=7%  Similarity=0.111  Sum_probs=30.1

Q ss_pred             CCCCCCEEeCcCC-ccccc----cCccccCCCCCCeeeccccceeccccc-c----cccccCcccccCCC
Q 011508           16 SLRGIENLDLSQN-NLSGR----IPKYLENFPFLQNLNLSFNHFEGEVPI-K----GVFSNSSAISLDGN   75 (484)
Q Consensus        16 ~l~~l~~l~ls~N-~l~g~----~p~~~~~l~~L~~l~ls~N~l~g~~p~-~----~~~~~~~~~~~~~n   75 (484)
                      +.++|+.|+|+++ .++..    +-..+...++|+.|+|++|.+...-.. .    ...+.++.+++++|
T Consensus        13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n   82 (167)
T d1pgva_          13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESN   82 (167)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSS
T ss_pred             CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehh
Confidence            3466666666653 34321    223344556666666666666421111 0    12345666666666

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=89.73  E-value=0.084  Score=42.02  Aligned_cols=63  Identities=21%  Similarity=0.259  Sum_probs=46.5

Q ss_pred             hhhCCCCCCEEeCcCCccccc----cCccccCCCCCCeeeccccceecccc-----cccccccCcccccCCC
Q 011508           13 SLSSLRGIENLDLSQNNLSGR----IPKYLENFPFLQNLNLSFNHFEGEVP-----IKGVFSNSSAISLDGN   75 (484)
Q Consensus        13 ~~~~l~~l~~l~ls~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~g~~p-----~~~~~~~~~~~~~~~n   75 (484)
                      .+...+.|+.|+|++|.+...    +...+...++|+.|+|++|.++..--     ......+++.+++++|
T Consensus        39 ~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n  110 (167)
T d1pgva_          39 AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ  110 (167)
T ss_dssp             HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred             HHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCC
Confidence            467789999999999999742    22345567899999999999875221     1133456888999888